PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Conway, LC; Cardarelli, RA; Moore, YE; Jones, K; McWilliams, LJ; Baker, DJ; Burnham, MP; Burli, RW; Wang, Q; Brandon, NJ; Moss, SJ; Deeb, TZ				Conway, Leslie C.; Cardarelli, Ross A.; Moore, Yvonne E.; Jones, Karen; McWilliams, Lisa J.; Baker, David J.; Burnham, Matthew P.; Burli, Roland W.; Wang, Qi; Brandon, Nicholas J.; Moss, Stephen J.; Deeb, Tarek Z.			N-Ethylmaleimide increases KCC2 cotransporter activity by modulating transporter phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chloride transport; epilepsy; GABA receptor; membrane protein; phosphorylation; KCC2; N-ethylmaleimide	K-CL COTRANSPORTER; CATION-CHLORIDE COTRANSPORTERS; NEUROPATHIC PAIN; NA+-K+-2CL(-) COTRANSPORT; PROTEIN PHOSPHATASE; NITRATE TRANSPORTER; HUMAN-ERYTHROCYTES; KCL COTRANSPORT; ACTIVATION; CELL	K+/Cl- cotransporter 2 (KCC2) is selectively expressed in the adult nervous system and allows neurons to maintain low intracellular Cl- levels. Thus, KCC2 activity is an essential prerequisite for fast hyperpolarizing synaptic inhibition mediated by type A -aminobutyric acid (GABA(A)) receptors, which are Cl--permeable, ligand-gated ion channels. Consistent with this, deficits in the activity of KCC2 lead to epilepsy and are also implicated in neurodevelopmental disorders, neuropathic pain, and schizophrenia. Accordingly, there is significant interest in developing activators of KCC2 as therapeutic agents. To provide insights into the cellular processes that determine KCC2 activity, we have investigated the mechanism by which N-ethylmaleimide (NEM) enhances transporter activity using a combination of biochemical and electrophysiological approaches. Our results revealed that, within 15 min, NEM increased cell surface levels of KCC2 and modulated the phosphorylation of key regulatory residues within the large cytoplasmic domain of KCC2 in neurons. More specifically, NEM increased the phosphorylation of serine 940 (Ser-940), whereas it decreased phosphorylation of threonine 1007 (Thr-1007). NEM also reduced with no lysine (WNK) kinase phosphorylation of Ste20-related proline/alanine-rich kinase (SPAK), a kinase that directly phosphorylates KCC2 at residue Thr-1007. Mutational analysis revealed that Thr-1007 dephosphorylation mediated the effects of NEM on KCC2 activity. Collectively, our results suggest that compounds that either increase the surface stability of KCC2 or reduce Thr-1007 phosphorylation may be of use as enhancers of KCC2 activity.	[Conway, Leslie C.; Cardarelli, Ross A.; Wang, Qi; Brandon, Nicholas J.; Moss, Stephen J.; Deeb, Tarek Z.] AstraZeneca Tufts Lab Basic & Translat Neurosci, Boston, MA 02111 USA; [Moore, Yvonne E.; Moss, Stephen J.; Deeb, Tarek Z.] Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA; [Moore, Yvonne E.; Moss, Stephen J.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Jones, Karen; Burnham, Matthew P.] AstraZeneca, IMED Biotech Unit, Discovery Sci, Alderley Pk, Macclesfield SK10 4TG, Cheshire, England; [McWilliams, Lisa J.; Baker, David J.] AstraZeneca, IMED Biotech Unit, Discovery Sci, Cambridge CB4 0WG, England; [Burli, Roland W.] AstraZeneca, IMED Biotech Unit, Neurosci, Cambridge CB21 6GH, England; [Wang, Qi; Brandon, Nicholas J.] AstraZeneca, Neurosci, IMED Biotech Unit, Boston, MA 02451 USA	Tufts University; University of London; University College London; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca	Moss, SJ (corresponding author), Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA.	Stephen.Moss@Tufts.edu		Burnham, Matthew/0000-0001-9136-937X; Brandon, Nicholas/0000-0002-3917-0096	AstraZeneca; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS080064] Funding Source: NIH RePORTER	AstraZeneca(AstraZeneca); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by funding from AstraZeneca. K. J., L. J. M., D. J. B., M. P. B., R. W. B., Q. W., and N. J. B. are full-time employees and shareholders of AstraZeneca. S. J. M. serves as a consultant for SAGE Therapeutics and AstraZeneca, relationships that are regulated by Tufts University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adragna NC, 2004, J MEMBRANE BIOL, V201, P109, DOI 10.1007/s00232-004-0695-6; Bize I, 2000, J MEMBRANE BIOL, V177, P159, DOI 10.1007/s002320001109; Brown FC, 2015, BLOOD, V126, P2863, DOI 10.1182/blood-2014-10-609362; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; de los Heros P, 2014, BIOCHEM J, V458, P559, DOI 10.1042/BJ20131478; Delpire E, 2009, P NATL ACAD SCI USA, V106, P5383, DOI 10.1073/pnas.0812756106; Doyon N, 2013, EXPERT REV NEUROTHER, V13, P469, DOI [10.1586/ern.13.40, 10.1586/ERN.13.40]; DUNHAM PB, 1980, P NATL ACAD SCI-BIOL, V77, P1711, DOI 10.1073/pnas.77.3.1711; Gagnon KB, 2010, AM J PHYSIOL-CELL PH, V299, pC614, DOI 10.1152/ajpcell.00074.2010; Gillen CM, 1999, AM J PHYSIOL-CELL PH, V276, pC328, DOI 10.1152/ajpcell.1999.276.2.C328; GLICK BS, 1987, NATURE, V326, P309, DOI 10.1038/326309a0; JENNINGS ML, 1991, J GEN PHYSIOL, V97, P799, DOI 10.1085/jgp.97.4.799; Jung JJ, 2012, BIOSCIENCE REP, V32, P383, DOI 10.1042/BSR20120006; Kahle KT, 2008, NAT CLIN PRACT NEURO, V4, P490, DOI 10.1038/ncpneuro0883; Kahle KT, 2014, EMBO REP, V15, P766, DOI 10.15252/embr.201438840; Kahle KT, 2013, TRENDS NEUROSCI, V36, P726, DOI 10.1016/j.tins.2013.08.006; KAILA K, 1994, PROG NEUROBIOL, V42, P489, DOI 10.1016/0301-0082(94)90049-3; KAJI DM, 1991, AM J PHYSIOL, V260, pC176, DOI 10.1152/ajpcell.1991.260.1.C176; LAUF PK, 1980, BIOCHEM BIOPH RES CO, V92, P1422, DOI 10.1016/0006-291X(80)90445-3; LAUF PK, 1985, J MEMBRANE BIOL, V88, P1, DOI 10.1007/BF01871208; Lavertu G, 2014, BRAIN, V137, P724, DOI 10.1093/brain/awt334; Lee HHC, 2007, J BIOL CHEM, V282, P29777, DOI 10.1074/jbc.M705053200; Lee HHC, 2011, NAT NEUROSCI, V14, P736, DOI 10.1038/nn.2806; Lee HHC, 2010, MOL CELL NEUROSCI, V45, P173, DOI 10.1016/j.mcn.2010.06.008; Loscher W, 2013, NEUROPHARMACOLOGY, V69, P62, DOI 10.1016/j.neuropharm.2012.05.045; LYTLE C, 1992, J BIOL CHEM, V267, P25438; Medina I, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00027; Mercado A, 2000, J BIOL CHEM, V275, P30326, DOI 10.1074/jbc.M003112200; Miles R., 2012, JASPERS BASIC MECH E; Moore YE, 2017, TRENDS NEUROSCI, V40, P555, DOI 10.1016/j.tins.2017.06.008; Muzyamba MC, 1999, J PHYSIOL-LONDON, V517, P421, DOI 10.1111/j.1469-7793.1999.0421t.x; Parker JL, 2014, NATURE, V507, P68, DOI 10.1038/nature13116; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; Payne JA, 1997, AM J PHYSIOL-CELL PH, V273, pC1516, DOI 10.1152/ajpcell.1997.273.5.C1516; Price TJ, 2009, BRAIN RES REV, V60, P149, DOI 10.1016/j.brainresrev.2008.12.015; Richardson C, 2008, J CELL SCI, V121, P3293, DOI 10.1242/jcs.029223; Rinehart J, 2009, CELL, V138, P525, DOI 10.1016/j.cell.2009.05.031; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Saitsu H, 2016, SCI REP-UK, V6, DOI 10.1038/srep30072; Shen MR, 2001, P NATL ACAD SCI USA, V98, P14714, DOI 10.1073/pnas.251388798; Silayeva L, 2015, P NATL ACAD SCI USA, V112, P3523, DOI 10.1073/pnas.1415126112; Sivakumaran S, 2015, J NEUROSCI, V35, P8291, DOI 10.1523/JNEUROSCI.5205-14.2015; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; STEIN WD, 1986, AM J PHYSIOL, V250, pC523, DOI 10.1152/ajpcell.1986.250.4.C523; Stodberg T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9038; Sun J, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00386; Thastrup JO, 2012, BIOCHEM J, V441, P325, DOI 10.1042/BJ20111879; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P512, DOI 10.1152/jn.1989.61.3.512; Titz S, 2015, NEUROPHARMACOLOGY, V95, P321, DOI 10.1016/j.neuropharm.2015.03.026; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Weber M, 2014, J BIOL CHEM, V289, P18668, DOI 10.1074/jbc.M114.567834; Zhang Z, 2013, MOL PHARMACOL, V84, P511, DOI 10.1124/mol.113.086496; Zhou HY, 2012, J BIOL CHEM, V287, P33853, DOI 10.1074/jbc.M112.395830	53	21	21	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21253	21263		10.1074/jbc.M117.817841	http://dx.doi.org/10.1074/jbc.M117.817841			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29092909	Green Published, hybrid			2022-12-26	WOS:000419013000004
J	Gonsberg, A; Jung, S; Ulbrich, S; Origi, A; Ziska, A; Baier, M; Koch, HG; Zimmermann, R; Winklhofer, KF; Tatzelt, J				Gonsberg, Anika; Jung, Sebastian; Ulbrich, Sarah; Origi, Andrea; Ziska, Anke; Baier, Michael; Koch, Hans-Georg; Zimmermann, Richard; Winklhofer, Konstanze F.; Tatzelt, Joerg			The Sec61/SecY complex is inherently deficient in translocating intrinsically disordered proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum (ER); intrinsically disordered protein; prion; protein secretion; protein translocation; SecY; Sec61; ER import	SIGNAL RECOGNITION PARTICLE; ENDOPLASMIC-RETICULUM MEMBRANE; PRION PROTEIN; QUALITY-CONTROL; NASCENT POLYPEPTIDE; SECRETORY PROTEINS; ESCHERICHIA-COLI; PROTEASOMAL DEGRADATION; MISLOCALIZED PROTEINS; RIBOSOME	About one-quarter to nearly one-third of the proteins synthesized in the cytosol of eukaryotic cells are integrated into the plasma membrane or are secreted. Translocation of secretory proteins into the lumen of the endoplasmic reticulum or the periplasm of bacteria is mediated by a highly conserved heterotrimeric membrane protein complex denoted Sec61 in eukaryotes and SecYEG in bacteria. To evaluate a possible modulation of the translocation efficiency by secondary structures of the nascent peptide chain, we performed a comparative analysis in bacteria, yeast, and mammalian cells. Strikingly, neither the bacterial SecY nor the eukaryotic Sec61 translocon was able to efficiently transport proteins entirely composed of intrinsically disordered domains (IDDs) or -strands. However, translocation could be restored by -helical domains in a position- and organism-dependent manner. In bacteria, we found that the -helical domains have to precede the IDD or -strands, whereas in mammalian cells, C-terminally located -helical domains are sufficient to promote translocation. Our study reveals an evolutionarily conserved deficiency of the Sec61/SecY complex to translocate IDDs and -strands in the absence of -helical domains. Moreover, our results may suggest that adaptive pathways co-evolved with the expansion of IDDs in the proteome of eukaryotic cells to increase the transport capacity of the Sec61 translocon.	[Gonsberg, Anika; Jung, Sebastian; Ulbrich, Sarah; Tatzelt, Joerg] Ruhr Univ Bochum, Inst Biochem & Pathobiochem, Dept Biochem Neurodegenerat Dis, D-44801 Bochum, Germany; [Winklhofer, Konstanze F.] Ruhr Univ Bochum, Inst Biochem & Pathobiochem, Dept Mol Cell Biol, D-44801 Bochum, Germany; [Origi, Andrea; Koch, Hans-Georg] Albert Ludwigs Univ Freiburg, Fac Med, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Ziska, Anke; Zimmermann, Richard] Saarland Univ, Dept Med Biochem & Mol Biol, D-66421 Homburg, Germany; [Baier, Michael] Robert Koch Inst, Ctr Biol Threats & Special Pathogens, Res Grp Proteinopathies Neurodegenerat Dis, D-13353 Berlin, Germany	Ruhr University Bochum; Ruhr University Bochum; University of Freiburg; Universitatsklinikum des Saarlandes; Robert Koch Institute	Tatzelt, J (corresponding author), Ruhr Univ Bochum, Univ Str 150, D-44801 Bochum, Germany.	Joerg.Tatzelt@rub.de		Tatzelt, Jorg/0000-0001-5017-5528; Winklhofer, Konstanze/0000-0002-7256-8231; Jung, Sebastian/0000-0002-0365-5710	International Max Planck Research School in Chemical and Molecular Biology; Deutsche Forschungsgemeinschaft [TA 167/6, GRK 1326, ZI 234/13-1, Ko2184/8-1, RTG 2202]	International Max Planck Research School in Chemical and Molecular Biology; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a short-term fellowship of the International Max Planck Research School in Chemical and Molecular Biology (to A. G.) and Deutsche Forschungsgemeinschaft Grants TA 167/6 (to J. T.), GRK 1326 (to A. Z.), ZI 234/13-1 (to R. Z.), and Ko2184/8-1 and RTG 2202 (to H. G. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Bhushan S, 2010, NAT STRUCT MOL BIOL, V17, P313, DOI 10.1038/nsmb.1756; Conti BJ, 2015, MOL CELL, V58, P269, DOI 10.1016/j.molcel.2015.02.018; Conti BJ, 2014, NAT STRUCT MOL BIOL, V21, P228, DOI 10.1038/nsmb.2779; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; Daniel CJ, 2008, J BIOL CHEM, V283, P20864, DOI 10.1074/jbc.M803517200; Daude N, 2010, J NEUROCHEM, V113, P92, DOI 10.1111/j.1471-4159.2010.06575.x; Dirndorfer D, 2013, J BIOL CHEM, V288, P13961, DOI 10.1074/jbc.M112.430264; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Drisaldi B, 2003, J BIOL CHEM, V278, P21732, DOI 10.1074/jbc.M213247200; Eberl H, 2002, BIOPHYS CHEM, V96, P293, DOI 10.1016/S0301-4622(02)00015-7; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fujita H, 2011, J CELL SCI, V124, P4184, DOI 10.1242/jcs.086850; Fuxreiter M, 2008, NAT CHEM BIOL, V4, P728, DOI 10.1038/nchembio.127; Fuxreiter M, 2012, ADV EXP MED BIOL, V725, P1, DOI 10.1007/978-1-4614-0659-4_1; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GILMORE R, 1982, J CELL BIOL, V95, P463, DOI 10.1083/jcb.95.2.463; GILMORE R, 1982, J CELL BIOL, V95, P470, DOI 10.1083/jcb.95.2.470; Hegde RS, 2008, J CELL BIOL, V182, P225, DOI 10.1083/jcb.200804157; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; Heller U, 2003, J BIOL CHEM, V278, P36139, DOI 10.1074/jbc.M304002200; Heske J, 2004, J BIOL CHEM, V279, P5435, DOI 10.1074/jbc.M309570200; Hessa T, 2011, NATURE, V475, P394, DOI 10.1038/nature10181; HOFFSCHUTE HK, 1994, J BIOL CHEM, V269, P12833; Holtkamp W, 2015, SCIENCE, V350, P1104, DOI 10.1126/science.aad0344; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Koch HG, 2000, J CELL BIOL, V150, P689, DOI 10.1083/jcb.150.3.689; Koch HG, 1999, MOL BIOL CELL, V10, P2163, DOI 10.1091/mbc.10.7.2163; Li AM, 2004, J BIOL CHEM, V279, P29469, DOI 10.1074/jbc.M402517200; Li L, 2016, NATURE, V531, P395, DOI 10.1038/nature17163; Liang FC, 2012, J BIOL CHEM, V287, P12703, DOI 10.1074/jbc.M111.240903; Lin PJ, 2011, J CELL BIOL, V195, P55, DOI 10.1083/jcb.201103118; Longhi S, 2012, ADV EXP MED BIOL, V725, P126, DOI 10.1007/978-1-4614-0659-4_8; Lu JL, 2005, BIOCHEMISTRY-US, V44, P8230, DOI 10.1021/bi050372q; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Mandon EC, 2009, CURR OPIN CELL BIOL, V21, P501, DOI 10.1016/j.ceb.2009.04.010; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; MEYER DI, 1980, J CELL BIOL, V87, P503, DOI 10.1083/jcb.87.2.503; Miesbauer M, 2009, J BIOL CHEM, V284, P24384, DOI 10.1074/jbc.M109.023135; Mingarro I, 2000, BMC Cell Biol, V1, P3, DOI 10.1186/1471-2121-1-3; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Nouwen N, 2009, J MOL BIOL, V386, P1000, DOI 10.1016/j.jmb.2009.01.031; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Patterson MA, 2015, J BIOL CHEM, V290, P28944, DOI 10.1074/jbc.M115.672261; Pfeiffer NV, 2013, EMBO J, V32, P1036, DOI 10.1038/emboj.2013.46; Quan Shu, 2013, Methods Mol Biol, V966, P359, DOI 10.1007/978-1-62703-245-2_22; Rambold AS, 2006, MOL BIOL CELL, V17, P3356, DOI 10.1091/mbc.E06-01-0083; Rane NS, 2004, EMBO J, V23, P4550, DOI 10.1038/sj.emboj.7600462; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Riek R, 1997, FEBS LETT, V413, P282, DOI 10.1016/S0014-5793(97)00920-4; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Rodrigo-Brenni MC, 2014, MOL CELL, V55, P227, DOI 10.1016/j.molcel.2014.05.025; Rodrigo-Brenni MC, 2012, DEV CELL, V23, P896, DOI 10.1016/j.devcel.2012.10.012; Rutkowski DT, 2003, J BIOL CHEM, V278, P30365, DOI 10.1074/jbc.M302117200; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Schierle CF, 2003, J BACTERIOL, V185, P5706, DOI 10.1128/JB.185.19.5706-5713.2003; Shaffer KL, 2005, DEV CELL, V9, P545, DOI 10.1016/j.devcel.2005.09.001; Steiner D, 2006, NAT BIOTECHNOL, V24, P823, DOI 10.1038/nbt1218; Tompa P, 2009, BIOESSAYS, V31, P328, DOI 10.1002/bies.200800151; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Voorhees RM, 2016, SCIENCE, V351, P88, DOI 10.1126/science.aad4992; WALTER P, 1980, P NATL ACAD SCI-BIOL, V77, P7112, DOI 10.1073/pnas.77.12.7112; WALTER P, 1984, CELL, V38, P5, DOI 10.1016/0092-8674(84)90520-8; WALTER P, 1982, NATURE, V299, P691, DOI 10.1038/299691a0; Wang XH, 2009, BBA-MOL BASIS DIS, V1792, P555, DOI 10.1016/j.bbadis.2009.02.014; Watts JC, 2007, EMBO J, V26, P4038, DOI 10.1038/sj.emboj.7601830; Whitley P, 1996, J BIOL CHEM, V271, P6241, DOI 10.1074/jbc.271.11.6241; Winklhofer KF, 2003, J BIOL CHEM, V278, P14961, DOI 10.1074/jbc.M209942200; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; Woolhead CA, 2006, MOL CELL, V22, P587, DOI 10.1016/j.molcel.2006.05.021; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Xue B, 2012, J BIOMOL STRUCT DYN, V30, P137, DOI 10.1080/07391102.2012.675145; Yogev O, 2011, FEBS J, V278, P4230, DOI 10.1111/j.1742-4658.2011.08359.x; Zanusso G, 1999, J BIOL CHEM, V274, P23396, DOI 10.1074/jbc.274.33.23396; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015	82	12	12	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21383	21396		10.1074/jbc.M117.788067	http://dx.doi.org/10.1074/jbc.M117.788067			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29084847	Green Published, hybrid			2022-12-26	WOS:000419013000015
J	Kanemitsu, T; Tsurudome, Y; Kusunose, N; Oda, M; Matsunaga, N; Koyanagi, S; Ohdo, S				Kanemitsu, Takumi; Tsurudome, Yuya; Kusunose, Naoki; Oda, Masayuki; Matsunaga, Naoya; Koyanagi, Satoru; Ohdo, Shigehiro			Periodic variation in bile acids controls circadian changes in uric acid via regulation of xanthine oxidase by the orphan nuclear receptor PPAR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bile acid; circadian rhythm; nucleoside; nucleotide metabolism; peroxisome proliferator-activated receptor (PPAR); uric acid; xanthine oxidase	PROLIFERATOR-ACTIVATED-RECEPTOR; POLYUNSATURATED FATTY-ACIDS; ALPHA ACTIVITY; INTESTINAL EXPRESSION; OXIDATIVE STRESS; CLOCK; LIVER; METABOLISM; PROTEIN; GENE	Xanthine oxidase (XOD), also known as xanthine dehydrogenase, is a rate-limiting enzyme in purine nucleotide degradation, which produces uric acid. Uric acid concentrations in the blood and liver exhibit circadian oscillations in both humans and rodents; however, the underlying mechanisms remain unclear. Here, we demonstrate that XOD expression and enzymatic activity exhibit circadian oscillations in the mouse liver. We found that the orphan nuclear receptor peroxisome proliferator-activated receptor- (PPAR) transcriptionally activated the mouse XOD gene and that bile acids suppressed XOD transactivation. The synthesis of bile acids is known to be under the control of the circadian clock, and we observed that the time-dependent accumulation of bile acids in hepatic cells interfered with the recruitment of the co-transcriptional activator p300 to PPAR, thereby repressing XOD expression. This time-dependent suppression of PPAR-mediated transactivation by bile acids caused an oscillation in the hepatic expression of XOD, which, in turn, led to circadian alterations in uric acid production. Finally, we also demonstrated that the anti-hyperuricemic effect of the XOD inhibitor febuxostat was enhanced by administering it at the time of day before hepatic XOD activity increased. These results suggest an underlying mechanism for the circadian alterations in uric acid production and also underscore the importance of selecting an appropriate time of day for administering XOD inhibitors.	[Kanemitsu, Takumi; Tsurudome, Yuya; Kusunose, Naoki; Oda, Masayuki; Matsunaga, Naoya; Koyanagi, Satoru; Ohdo, Shigehiro] Kyushu Univ, Dept Pharmaceut, Fukuoka 8128582, Japan; [Matsunaga, Naoya; Koyanagi, Satoru] Kyushu Univ, Dept Glocal Healthcare Sci, Fukuoka 8128582, Japan	Kyushu University; Kyushu University	Ohdo, S (corresponding author), Kyushu Univ, Fac Pharmaceut Sci, Dept Pharmaceut, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	ohdo@phar.kyushu-u.ac.jp	Koyanagi, Satoru/AAE-6843-2020	Koyanagi, Satoru/0000-0003-4849-2377; Tsurudome, Yuya/0000-0002-6454-9778; matsunaga2, naoya2/0000-0001-6226-8473	Japan Society for the Promotion of Science (JSPS) [16H02636, 17H06262]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by KAKENHI Grant-in-aid for Scientific Research 16H02636 and 17H06262 from the Japan Society for the Promotion of Science (JSPS) (to S. O.). The authors declare that they have no conflicts of interest with the contents of this article.	Abhishek A, 2017, CLIN MED, V17, P54, DOI 10.7861/clinmedicine.17-1-54; Barsotti C, 2002, J BIOL CHEM, V277, P9865, DOI 10.1074/jbc.M111418200; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Cansev M, 2006, BRAIN RES REV, V52, P389, DOI 10.1016/j.brainresrev.2006.05.001; Cao DL, 2005, J BIOL CHEM, V280, P21169, DOI 10.1074/jbc.M412343200; Choi HK, 2005, ARTHRITIS RHEUM-US, V52, P283, DOI 10.1002/art.20761; Committee on Biochemical Constituents and Their Analytical Regents, 1993, JPN J CLIN CHEM, V22, P300; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Fustin JM, 2012, CELL REP, V1, P341, DOI 10.1016/j.celrep.2012.03.001; Gachon F, 2011, P NATL ACAD SCI USA, V108, P4794, DOI 10.1073/pnas.1002862108; GASSER T, 1981, SCIENCE, V213, P777, DOI 10.1126/science.7256279; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gliozzi M, 2016, INT J CARDIOL, V213, P23, DOI 10.1016/j.ijcard.2015.08.087; Hamdan AM, 2012, J BIOL CHEM, V287, P17224, DOI 10.1074/jbc.M111.333377; Han S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8231; Harris CM, 1997, J BIOL CHEM, V272, P28335, DOI 10.1074/jbc.272.45.28335; Jump DB, 2002, J BIOL CHEM, V277, P8755, DOI 10.1074/jbc.R100062200; Kliewer SA, 1999, SCIENCE, V284, P757, DOI 10.1126/science.284.5415.757; KRENITSKY TA, 1972, ARCH BIOCHEM BIOPHYS, V150, P585, DOI 10.1016/0003-9861(72)90078-1; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; LAVERY DJ, 1993, GENE DEV, V7, P1871, DOI 10.1101/gad.7.10.1871; Lemberger T, 1996, J BIOL CHEM, V271, P1764, DOI 10.1074/jbc.271.3.1764; Lipkowitz MS, 2012, CURR RHEUMATOL REP, V14, DOI 10.1007/s11926-012-0240-z; Lu YF, 2013, CHRONOBIOL INT, V30, P1135, DOI 10.3109/07420528.2013.805762; Mazzali M, 2002, AM J PHYSIOL-RENAL, V282, pF991, DOI 10.1152/ajprenal.00283.2001; McKenna NJ, 2002, ENDOCRINOLOGY, V143, P2461, DOI 10.1210/endo.143.7.8892; MINEMATSU S, 1995, EXP ANIM TOKYO, V44, P223, DOI 10.1538/expanim.44.223; Mochizuki K, 2002, GENE, V291, P271, DOI 10.1016/S0378-1119(02)00625-X; Moriwaki Y, 1996, HISTOCHEM CELL BIOL, V105, P71, DOI 10.1007/BF01450880; Oishi K, 2005, BIOCHEM J, V386, P575, DOI 10.1042/BJ20041150; Okamura A, 2014, J BIOL CHEM, V289, P25296, DOI 10.1074/jbc.M114.577023; ONEILL RD, 1990, BRAIN RES, V507, P267, DOI 10.1016/0006-8993(90)90281-F; OSADA Y, 1993, EUR J PHARMACOL, V241, P183, DOI 10.1016/0014-2999(93)90201-R; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Pandey A., 2012, NATL J PHYSL PHARM P, V2, P23; Ripperger JA, 2000, GENE DEV, V14, P679; ROSEMEYER H, 1983, EUR J BIOCHEM, V134, P513, DOI 10.1111/j.1432-1033.1983.tb07596.x; Sanchez-Lozada LG, 2008, AM J PHYSIOL-RENAL, V295, pF1134, DOI 10.1152/ajprenal.00104.2008; SHINOSAKI T, 1992, JPN J PHARMACOL, V58, P443, DOI 10.1254/jjp.58.443; Singh R, 2005, BIOMED PHARMACOTHER, V59, pS229, DOI 10.1016/S0753-3322(05)80037-X; Tapia E, 2013, AM J PHYSIOL-RENAL, V304, pF727, DOI 10.1152/ajprenal.00485.2012; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Vallim TQD, 2013, CELL METAB, V17, P657, DOI 10.1016/j.cmet.2013.03.013; Wada E, 2015, MOL PHARMACOL, V87, P314, DOI 10.1124/mol.114.094979; WU XW, 1992, J MOL EVOL, V34, P78, DOI 10.1007/BF00163854; Xu XX, 2016, PHARM BIOL, V54, P3151, DOI 10.1080/13880209.2016.1195847; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Zhang YKJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016683	48	24	26	4	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21397	21406		10.1074/jbc.M117.791285	http://dx.doi.org/10.1074/jbc.M117.791285			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29101234	hybrid, Green Published			2022-12-26	WOS:000419013000016
J	Dannhauser, PN; Camus, SM; Sakamoto, K; Sadacca, LA; Torres, JA; Camus, MD; Briant, K; Vassilopoulos, S; Rothnie, A; Smith, CJ; Brodsky, FM				Dannhauser, Philip N.; Camus, Stephane M.; Sakamoto, Kazuho; Sadacca, L. Amanda; Torres, Jorge A.; Camus, Marine D.; Briant, Kit; Vassilopoulos, Stephane; Rothnie, Alice; Smith, Corinne J.; Brodsky, Frances M.			CHC22 and CHC17 clathrins have distinct biochemical properties and display differential regulation and function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN ISOFORM; COATED VESICLES; INSULIN-RESISTANCE; LIGHT-CHAINS; PROTEIN; AUXILIN; GLUT4; DISSOCIATION; ENDOCYTOSIS; MECHANISMS	Clathrins are cytoplasmic proteins that play essential roles in endocytosis and other membrane traffic pathways. Upon recruitment to intracellular membranes, the canonical clathrin triskelion assembles into a polyhedral protein coat that facilitates vesicle formation and captures cargo molecules for transport. The triskelion is formed by trimerization of three clathrin heavy-chain subunits. Most vertebrates have two isoforms of clathrin heavy chains, CHC17 and CHC22, generating two clathrins with distinct cellular functions. CHC17 forms vesicles at the plasma membrane for receptor-mediated endocytosis and at the trans-Golgi network for organelle biogenesis. CHC22 plays a key role in intracellular targeting of the insulin-regulated glucose transporter 4 (GLUT4), accumulates at the site of GLUT4 sequestration during insulin resistance, and has also been implicated in neuronal development. Here, we demonstrate that CHC22 and CHC17 share morphological features, in that CHC22 forms a triskelion and latticed vesicle coats. However, cellular CHC22-coated vesicles were distinct from those formed by CHC17. The CHC22 coat was more stable to pH change and was not removed by the enzyme complex that disassembles the CHC17 coat. Moreover, the two clathrins were differentially recruited to membranes by adaptors, and CHC22 did not support vesicle formation or transferrin endocytosis at the plasma membrane in the presence or absence of CHC17. Our findings provide biochemical evidence for separate regulation and distinct functional niches for CHC17 and CHC22 in human cells. Furthermore, the greater stability of the CHC22 coat relative to the CHC17 coat may be relevant to its excessive accumulation with GLUT4 during insulin resistance.	[Dannhauser, Philip N.; Camus, Stephane M.; Sadacca, L. Amanda; Camus, Marine D.; Briant, Kit; Brodsky, Frances M.] UCL, Div Biosci, London WC1E 6BT, England; [Dannhauser, Philip N.] Hannover Med Sch, Ctr Anat, Inst Cell Biol Electron Microscopy, D-30625 Hannover, Germany; [Sakamoto, Kazuho; Torres, Jorge A.; Camus, Marine D.; Vassilopoulos, Stephane; Brodsky, Frances M.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Sakamoto, Kazuho; Torres, Jorge A.; Camus, Marine D.; Vassilopoulos, Stephane; Brodsky, Frances M.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Sakamoto, Kazuho; Torres, Jorge A.; Camus, Marine D.; Vassilopoulos, Stephane; Brodsky, Frances M.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Sakamoto, Kazuho] Fukushima Med Univ, Sch Med, Dept Pharmacol, Fukushima, Fukushima 9601295, Japan; [Vassilopoulos, Stephane] Inst Myol, F-75013 Paris, France; [Rothnie, Alice] Aston Univ, Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Smith, Corinne J.] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; Univ Shizuoka, Sch Pharmaceut Sci, Dept Bioinformat Pharmacol, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan	University of London; University College London; Hannover Medical School; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Fukushima Medical University; UDICE-French Research Universities; Sorbonne Universite; Aston University; University of Warwick; University of Shizuoka	Brodsky, FM (corresponding author), UCL, Div Biosci, Gower St, London WC1E 6BT, England.	f.brodsky@ucl.ac.uk	Dannhauser, Philip/A-5675-2018; vassilopoulos, stéphane/F-6041-2014; vassilopoulos, stephane/AAF-3865-2021; Smith, Corinne/A-3170-2009; Rothnie, Alice/F-1358-2011	Dannhauser, Philip/0000-0002-6749-7678; vassilopoulos, stephane/0000-0003-0172-330X; Smith, Corinne/0000-0003-3364-7946; Rothnie, Alice/0000-0002-4259-7015; Briant, Kit/0000-0002-1368-6262; Camus, Stephane/0000-0002-4326-1724; Brodsky, Frances/0000-0002-1334-9258	National Institutes of Health [R56-DK083589, P30-DK063720, R01-DK095663]; Wellcome Trust [107858/Z/15/Z]; American Heart Association; Japan Society for the Promotion of Science KAKENHI [25460338]; Royal Society; Medical Research Council [G0601125]; University College London Excellence Fellowship; BBSRC [BB/N008391/1, BB/K003461/1, BB/L018888/1] Funding Source: UKRI; MRC [G0601125] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/N008391/1, BB/L018888/1, BB/K003461/1] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095663, R56DK083589, P30DK063720] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome Trust); American Heart Association(American Heart Association); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University College London Excellence Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R56-DK083589, P30-DK063720 (a Pilot and Feasibility Study from the UCSF DERC), and R01-DK095663, Wellcome Trust Investigator Award 107858/Z/15/Z (to F.M.B.), a grant from the American Heart Association (to S.M.C.), Japan Society for the Promotion of Science KAKENHI Grant 25460338 (to K.S.), an International Exchange Award by the Royal Society (to C.J.S. and F.M.B.), Medical Research Council Grant G0601125 (to C.J.S. and A.R.), and a University College London Excellence Fellowship (to P.N.D.) The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ACTON SL, 1993, MOL BIOL CELL, V4, P647, DOI 10.1091/mbc.4.6.647; Borner GHH, 2006, J CELL BIOL, V175, P571, DOI 10.1083/jcb.200607164; Brodsky FM, 2012, ANNU REV CELL DEV BI, V28, P309, DOI 10.1146/annurev-cellbio-101011-155716; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; CROWTHER RA, 1981, J CELL BIOL, V91, P790, DOI 10.1083/jcb.91.3.790; Dannhauser PN, 2015, TRAFFIC, V16, P519, DOI 10.1111/tra.12263; Dannhauser PN, 2012, NAT CELL BIOL, V14, P634, DOI 10.1038/ncb2478; Esk C, 2010, J CELL BIOL, V188, P131, DOI 10.1083/jcb.200908057; HEUSER J, 1989, J ELECTRON MICR TECH, V13, P244, DOI 10.1002/jemt.1060130310; Hirst J, 2004, MOL BIOL CELL, V15, P5593, DOI 10.1091/mbc.E04-06-0468; Hirst J, 2007, TRAFFIC, V8, P594, DOI 10.1111/j.1600-0854.2007.00556.x; Hood FE, 2009, J CELL SCI, V122, P2185, DOI 10.1242/jcs.046177; Hoshino S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077787; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; KEEN JH, 1979, CELL, V16, P303, DOI 10.1016/0092-8674(79)90007-2; Kelly BT, 2011, CURR OPIN CELL BIOL, V23, P404, DOI 10.1016/j.ceb.2011.03.004; KIRCHHAUSEN T, 1981, CELL, V23, P755, DOI 10.1016/0092-8674(81)90439-6; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Liu SH, 2001, EMBO J, V20, P272, DOI 10.1093/emboj/20.1.272; Meyerholz A, 2005, TRAFFIC, V6, P1225, DOI 10.1111/j.1600-0854.2005.00355.x; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Nahorski MS, 2015, BRAIN, V138, P2147, DOI 10.1093/brain/awv149; NATHKE IS, 1992, CELL, V68, P899, DOI 10.1016/0092-8674(92)90033-9; Rapoport I, 2008, MOL BIOL CELL, V19, P405, DOI 10.1091/mbc.E07-09-0870; Rothnie A, 2011, P NATL ACAD SCI USA, V108, P6927, DOI 10.1073/pnas.1018845108; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; UNANUE ER, 1981, CELL, V26, P439, DOI 10.1016/0092-8674(81)90213-0; UNGEWICKELL E, 1995, NATURE, V378, P632, DOI 10.1038/378632a0; UNGEWICKELL E, 1981, NATURE, V289, P420, DOI 10.1038/289420a0; UNGEWICKELL E, 1989, ANAL BIOCHEM, V179, P352, DOI 10.1016/0003-2697(89)90143-7; Vassilopoulos S, 2009, SCIENCE, V324, P1192, DOI 10.1126/science.1171529; Wakeham DE, 2005, P NATL ACAD SCI USA, V102, P7209, DOI 10.1073/pnas.0502058102; Watson RT, 2004, EMBO J, V23, P2059, DOI 10.1038/sj.emboj.7600159; Wilbur JD, 2010, DEV CELL, V18, P841, DOI 10.1016/j.devcel.2010.04.007; WOODWARD MP, 1978, P NATL ACAD SCI USA, V75, P4394, DOI 10.1073/pnas.75.9.4394; Young A, 2013, TRAFFIC, V14, P987, DOI 10.1111/tra.12085	37	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					20834	20844		10.1074/jbc.M117.816256	http://dx.doi.org/10.1074/jbc.M117.816256			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29097553	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000418453400003
J	Wakai, R; Ishitsuka, M; Kishimoto, T; Ochiai, T; Nacher, JC				Wakai, Ryouji; Ishitsuka, Masayuki; Kishimoto, Toshihiko; Ochiai, Tomoshiro; Nacher, Jose C.			Identification of genes and critical control proteins associated with inflammatory breast cancer using network controllability	PLOS ONE			English	Article							EXPRESSION PROFILES; POOR-PROGNOSIS; CELL; CARCINOMA; ABSENCE; FOXJ1; NODES; CDC6; SET	One of the most aggressive forms of breast cancer is inflammatory breast cancer (IBC), whose lack of tumour mass also makes a prompt diagnosis difficult. Moreover, genomic differences between common breast cancers and IBC have not been completely assessed, thus substantially limiting the identification of biomarkers unique to IBC. Here, we developed a novel statistical analysis of gene expression profiles corresponding to microdissected IBC, non-IBC (nIBC) and normal samples that enabled us to identify a set of genes significantly associated with a specific disease state. Second, by using advanced methods based on controllability network theory, we identified a set of critical control proteins that uniquely and structurally control the entire proteome. By mapping high change variance genes in protein interaction networks, we found that a large statistically significant fraction of genes whose variance changed significantly between normal and IBC and nIBC disease states were among the set of critical control proteins. Moreover, this analysis identified the overlapping genes with the highest statistical significance; these genes may assist in developing future biomarkers and determining drug targets to disrupt the molecular pathways driving carcinogenesis in IBC.	[Wakai, Ryouji; Ishitsuka, Masayuki; Nacher, Jose C.] Toho Univ, Dept Informat Sci, Fac Sci, Miyama 2-2-1, Funabashi, Chiba 2748510, Japan; [Kishimoto, Toshihiko] Toho Univ, Dept Mol Biol, Fac Sci, Miyama 2-2-1, Funabashi, Chiba 2748510, Japan; [Kishimoto, Toshihiko] Toho Univ, Proteome Anal Ctr, Fac Sci, Miyama 2-2-1, Funabashi, Chiba 2748510, Japan; [Ochiai, Tomoshiro] Otsuma Womens Univ, Fac Social Informat Studies, 2-7-1 Karakida, Tama, Tokyo 2068540, Japan	Toho University; Toho University; Toho University	Nacher, JC (corresponding author), Toho Univ, Dept Informat Sci, Fac Sci, Miyama 2-2-1, Funabashi, Chiba 2748510, Japan.	nacher@is.sci.toho-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [25330351]; Japan Society for the Promotion of Science [15K011200]; MEXT, Japan [25330351]; JSPS [15K01200]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	J.C.N. was partially supported by Ministry of Education, Culture, Sports, Science and Technology, Japan (Grant-in-Aid No. 25330351) and T.O. was partially supported by Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (Grant Number 15K011200, https://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.; We thank Dr. Dai Ogura and Dr. Shin-Ichiro Niwa from Link Genomics Co Ltd for their contribution to experimental transcriptome analyses. J.C.N. was partially supported by MEXT, Japan (Grant-in-Aid No. 25330351), and T.O. was partially supported by JSPS Grants-in-Aid for Scientific Research (Grant Number 15K01200).	Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bertucci F, 2014, ANN ONCOL, V25, P358, DOI 10.1093/annonc/mdt496; Braekeveldt N, 2015, INT J CANCER, V136, pE252, DOI 10.1002/ijc.29217; Chen HW, 2013, MOL CARCINOGEN, V52, P647, DOI 10.1002/mc.21904; Csermely P, 2013, PHARMACOL THERAPEUT, V138, P333, DOI 10.1016/j.pharmthera.2013.01.016; Das J, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-92; Dasgupta S, 2013, J MOL MED, V91, P381, DOI 10.1007/s00109-012-0955-3; De Smet R, 2010, NAT REV MICROBIOL, V8, P717, DOI 10.1038/nrmicro2419; Deng Y, 2016, PATHOL RES PRACT, V212, P239, DOI 10.1016/j.prp.2015.09.014; DHOUAILLY D, 1989, EXP CELL RES, V181, P141, DOI 10.1016/0014-4827(89)90189-4; Huang SJ, 2016, J CELL SCI, V129, P1429, DOI 10.1242/jcs.178723; HUNG MC, 1986, P NATL ACAD SCI USA, V83, P261, DOI 10.1073/pnas.83.2.261; Ishitsuka M, 2016, SCI REP-UK, V6, DOI 10.1038/srep23541; Jolly MK, 2017, NPJ BREAST CANCER, V3, DOI 10.1038/s41523-017-0023-9; Kagami H, 2015, SCI REP-UK, V5, DOI 10.1038/srep14577; Khosravi P, 2015, ALGORITHM MOL BIOL, V10, DOI 10.1186/s13015-015-0054-4; KRISHNAN R, 1990, CANCER RES, V50, P2164; Liu CX, 2014, INT J CLIN EXP PATHO, V7, P5242; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Majumdar S, 2013, NEOPLASIA, V15, P749, DOI 10.1593/neo.121956; Menche J, 2015, SCIENCE, V347, DOI 10.1126/science.1257601; Mollaoglu N, 2008, DIS MARKERS, V24, P27, DOI 10.1155/2008/359840; Molnar F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01736; Nacher JC, 2016, METHODS, V102, P57, DOI 10.1016/j.ymeth.2015.12.017; Nacher JC, 2014, J COMPLEX NETW, V2, P394, DOI 10.1093/comnet/cnu029; Nacher JC, 2013, SCI REP-UK, V3, DOI 10.1038/srep01647; Nacher JC, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/7/073005; Nagayoshi K, 2015, ONCOL REP, V33, P539, DOI 10.3892/or.2014.3660; Ntayi C, 2004, J INVEST DERMATOL, V122, P256, DOI 10.1046/j.0022-202X.2004.22228.x; Ochiai T, 2016, BIOSYSTEMS, V145, P9, DOI 10.1016/j.biosystems.2016.05.003; Ribeiro ED, 2014, CELL, V159, P1447, DOI 10.1016/j.cell.2014.10.056; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Sun PG, 2015, INFORM SCIENCES, V325, P20, DOI 10.1016/j.ins.2015.07.024; Tan M, 2000, MADAME CURIE BIOSCIE; Vinayagam A, 2016, P NATL ACAD SCI USA, V113, P4976, DOI 10.1073/pnas.1603992113; Wang J, 2015, ANN SURG ONCOL, V22, P685, DOI 10.1245/s10434-014-3742-2; Wischnewski F, 2006, MOL CANCER RES, V4, P339, DOI 10.1158/1541-7786.MCR-05-0229; Woodward WA, 2013, BREAST CANCER RES TR, V138, P761, DOI 10.1007/s10549-013-2501-6; Wuchty S, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201700056; Wuchty S, 2014, P NATL ACAD SCI USA, V111, P7156, DOI 10.1073/pnas.1311231111; Yamada R, 2013, TISSUE ANTIGENS, V81, P428, DOI 10.1111/tan.12113; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhang XF, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0591-3	43	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0186353	10.1371/journal.pone.0186353	http://dx.doi.org/10.1371/journal.pone.0186353			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29108005	Green Submitted, Green Published, gold			2022-12-26	WOS:000414424600004
J	Bao, YZ; Yao, ZQ; Cao, XL; Peng, JF; Xu, Y; Chen, MX; Zhao, SF				Bao, Ya Zhou; Yao, Zhao Qun; Cao, Xiao Lei; Peng, Jin Feng; Xu, Ying; Chen, Mei Xiu; Zhao, Si Feng			Transcriptome analysis of Phelipanche aegyptiaca seed germination mechanisms stimulated by fluridone, TIS108, and GR24	PLOS ONE			English	Article							ROOT-PARASITIC PLANT; ABSCISIC-ACID; OROBANCHE-MINOR; LEPIDIUM-SATIVUM; GIBBERELLIN; STRIGA; STRIGOLACTONE; ARABIDOPSIS; PATHWAY; RAMOSA	P. aegyptiaca is one of the most destructive root parasitic plants worldwide, causing serious damage to many crop species. Under natural conditions P. aegyptiaca seeds must be conditioned and then stimulated by host root exudates before germinating. However, preliminary experiments indicated that TIS108 (a triazole-type inhibitor of strigolactone) and fluridone (FL, an inhibitor of carotenoid-biosynthesis) both stimulated the germination of P. aegyptiaca seeds without a water preconditioning step (i.e. unconditioned seeds). The objective of this study was to use deep RNA sequencing to learn more about the mechanisms by which TIS108 and FL stimulate the germination of unconditioned P. aegyptiaca seeds. Deep RNA sequencing was performed to compare the mechanisms of germination in the following treatments: (i) unconditioned P. aegyptiaca seeds with no other treatment, (ii) unconditioned seeds treated with 100 mg/L TIS108, (iii) unconditioned seeds treated with 100 mg/L FL + 100 mg/L GA(3), (iv) conditioned seeds treated with sterile water, and (v) conditioned seeds treated with 0.03 mg/L GR24. The de novo assembled transcriptome was used to analyze transcriptional dynamics during seed germination. The key gene categories involved in germination were also identified. The results showed that only 119 differentially expressed genes were identified in the conditioned treatment vs TIS108 treatment. This indicated that the vast majority of conditions for germination were met during the conditioning stage. Abscisic acid (ABA) and gibberellic acid (GA) played important roles during P. aegyptiaca germination. The common pathway of TIS108, FL+GA(3), and GR24 in stimulating P. aegyptiaca germination was the simultaneous reduction in ABA concentrations and increase GA concentrations. These results could potentially aid the identification of more compounds that are capable of stimulating P. aegyptiaca germination. Some potential target sites of TIS108 were also identified in our transcriptome data. The results of this experiment suggest that TIS108 and FL+GA(3) could be used to control P. aegyptiaca through suicidal germination.	[Bao, Ya Zhou; Yao, Zhao Qun; Cao, Xiao Lei; Peng, Jin Feng; Xu, Ying; Chen, Mei Xiu; Zhao, Si Feng] Shihezi Univ, Key Lab Univ Xinjiang Uygur Autonomous Reg Oasis, Shihezi, Peoples R China	Shihezi University	Zhao, SF (corresponding author), Shihezi Univ, Key Lab Univ Xinjiang Uygur Autonomous Reg Oasis, Shihezi, Peoples R China.	zhsf_agr@shzu.edu.cn	sifeng, Zhao/AAW-4283-2020		National Natural Science Foundation of China [31460467]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 31460467).	Auger B, 2012, MOL PLANT MICROBE IN, V25, P993, DOI 10.1094/MPMI-01-12-0006-R; Bar-Nun N, 2002, ISR J PLANT SCI, V50, P277, DOI 10.1560/E2KB-FM11-X4U2-YC9J; BARTELS PG, 1978, WEED SCI, V26, P198, DOI 10.1017/S0043174500049675; Batge SL, 1999, PHYSIOL PLANTARUM, V105, P485, DOI 10.1034/j.1399-3054.1999.105313.x; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Bouwmeester HJ, 2003, CURR OPIN PLANT BIOL, V6, P358, DOI 10.1016/S1369-5266(03)00065-7; Chae SH, 2004, PHYSIOL PLANTARUM, V120, P328, DOI 10.1111/j.0031-9317.2004.0243.x; CHANG M, 1986, J AM CHEM SOC, V108, P7858, DOI 10.1021/ja00284a074; FONG F, 1979, PLANTA, V146, P119, DOI 10.1007/BF00388221; Goldwasser Y., 2004, WEED BIOL MANAG, P439; Gonzalez-Verdejo C, 2008, ANAL BIOCHEM, V379, P38; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Graeber K, 2010, PLANT MOL BIOL, V73, P67, DOI 10.1007/s11103-009-9583-x; Hershenhorn J, 2009, WEED RES, V49, P34, DOI 10.1111/j.1365-3180.2009.00739.x; Ito S, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24193; Ito S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021723; Joel D. M., 2007, Horticultural Reviews, V33, P267, DOI 10.1002/9780470168011.ch4; Joel D. M., 1991, Progress in Orobanche research. Proceedings of the international workshop on Orobanche research, Obermarchtal, Germany, 19-22 August 1989., P147; Joel DM, 2012, ANN BOT-LONDON, V109, P181, DOI 10.1093/aob/mcr261; Joel DM, 2000, CROP PROT, V19, P753, DOI 10.1016/S0261-2194(00)00100-9; Kucera B, 2005, SEED SCI RES, V15, P281, DOI 10.1079/SSR2005218; Lechat MM, 2015, J EXP BOT, V66, P3129, DOI 10.1093/jxb/erv119; Lechat MM, 2012, J EXP BOT, V63, P5311, DOI 10.1093/jxb/ers189; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Linkies A, 2009, PLANT CELL, V21, P3803, DOI 10.1105/tpc.109.070201; Liu SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048156; Malik H, 2010, TETRAHEDRON, V66, P7198, DOI 10.1016/j.tet.2010.06.072; Matilla AJ, 2008, PLANT SCI, V175, P87, DOI 10.1016/j.plantsci.2008.01.014; Matusova R, 2005, PLANT PHYSIOL, V139, P920, DOI 10.1104/pp.105.061382; Mauro RP, 2015, SCI HORTIC-AMSTERDAM, V193, P62, DOI 10.1016/j.scienta.2015.06.038; Morris K, 2011, PLANT PHYSIOL, V155, P1851, DOI 10.1104/pp.110.169706; Nakasugi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059534; Parker C, 2009, PEST MANAG SCI, V65, P453, DOI 10.1002/ps.1713; Perez-de-Luque A, 2010, FIELD CROP RES, V115, P319, DOI 10.1016/j.fcr.2009.02.013; Pritchard SL, 2002, PLANT J, V31, P639, DOI 10.1046/j.1365-313X.2002.01376.x; Quatrano RS, 1997, PLANT CELL, V9, P470, DOI 10.1105/tpc.9.4.470; Ranjan A, 2014, PLANT PHYSIOL, V166, P1186, DOI 10.1104/pp.113.234864; Razem FA, 2006, CURR OPIN PLANT BIOL, V9, P454, DOI 10.1016/j.pbi.2006.07.007; Sheoran IS, 2005, PROTEOMICS, V5, P3752, DOI 10.1002/pmic.200401209; Song WJ, 2005, WEED RES, V45, P467, DOI 10.1111/j.1365-3180.2005.00477.x; Sugimoto Y, 2008, PHYTOCHEMISTRY, V69, P212, DOI 10.1016/j.phytochem.2007.06.011; Sun TP, 2004, ANNU REV PLANT BIOL, V55, P197, DOI 10.1146/annurev.arplant.55.031903.141753; TAKEUCHI Y, 1995, PLANT GROWTH REGUL, V16, P153, DOI 10.1007/BF00029536; Uematsu K, 2007, J PLANT GROWTH REGUL, V26, P245, DOI 10.1007/s00344-007-9012-9; Weiss D, 2007, PLANT PHYSIOL, V144, P1240, DOI 10.1104/pp.107.100370; Weitbrecht K, 2011, J EXP BOT, V62, P3289, DOI 10.1093/jxb/err030; Westwood JH, 2012, WEED SCI, V60, P295, DOI 10.1614/WS-D-11-00113.1; White CN, 2000, PLANT PHYSIOL, V122, P1081, DOI 10.1104/pp.122.4.1081; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xie XN, 2010, ANNU REV PHYTOPATHOL, V48, P93, DOI 10.1146/annurev-phyto-073009-114453; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Yang PF, 2007, PROTEOMICS, V7, P3358, DOI 10.1002/pmic.200700207; Yao ZQ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071139; Zehar N, 2002, WEED RES, V42, P464, DOI 10.1046/j.1365-3180.2002.00306.x	55	17	17	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							e0187539	10.1371/journal.pone.0187539	http://dx.doi.org/10.1371/journal.pone.0187539			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6TA	29099877	Green Published, Green Submitted, gold			2022-12-26	WOS:000414377900026
J	Thanuthanakhun, N; Nuntakarn, L; Sampattavanich, S; Anurathapan, U; Phuphanitcharoenkun, S; Pornpaiboonstid, S; Borwornpinyo, S; Hongeng, S				Thanuthanakhun, Naruchit; Nuntakarn, Lalana; Sampattavanich, Somponnat; Anurathapan, Usanarat; Phuphanitcharoenkun, Suphanun; Pornpaiboonstid, Savichaya; Borwornpinyo, Suparerk; Hongeng, Suradej			Investigation of FoxO3 dynamics during erythroblast development in beta-thalassemia major	PLOS ONE			English	Article							PROTEIN-QUALITY-CONTROL; ALPHA-GLOBIN; STEM-CELL; ERYTHROPOIESIS; AUTOPHAGY; MATURATION; ANEMIA; AKT	The FoxO3 transcription factor is a key regulator of oxidative stress and erythroid maturation during erythropoiesis. In this study, we explored the involvement of FoxO3 in severe beta-thalassemia. Using primary CD34(+) hematopoietic progenitor cells from patients with beta-thalassemia major, we successfully developed an in vitro model of ineffective erythropoiesis. Based on this model, FoxO3 activity was quantified in single cells using high throughput imaging flow cytometry. This study revealed a significant reduction of FoxO3 activity during the late stage of erythroblast differentiation in beta-thalassemia, in contrast to erythropoiesis in normal cells that maintain persistent activation of FoxO3. In agreement with the decreased FoxO3 activity in beta-thalassemia, the expression of FoxO3 target genes was also found to decrease, concurrent with elevated phosphorylation of AKT, most clearly at the late stage of erythroid differentiation. Our findings provide further evidence for the involvement of FoxO3 during terminal erythropoiesis and confirm the modulation of the PI3K/AKT pathway as a potential therapeutic strategy for beta-thalassemia.	[Thanuthanakhun, Naruchit; Phuphanitcharoenkun, Suphanun; Borwornpinyo, Suparerk] Mahidol Univ, Dept Biotechnol, Fac Sci, Bangkok, Thailand; [Nuntakarn, Lalana] Mahidol Univ, Ramathibodi Hosp, Dept Obstet & Gynecol, Fac Med, Bangkok, Thailand; [Sampattavanich, Somponnat] Mahidol Univ, Siriraj Hosp, Dept Pharmacol, Siriraj Lab Syst Pharmacol,Fac Med, Bangkok, Thailand; [Anurathapan, Usanarat; Hongeng, Suradej] Mahidol Univ, Ramathibodi Hosp, Dept Pediat, Fac Med, Bangkok, Thailand; [Pornpaiboonstid, Savichaya] Merck Ltd, Bangkok, Thailand; [Borwornpinyo, Suparerk; Hongeng, Suradej] Mahidol Univ, Excellent Ctr Drug Discovery, Fac Sci, Bangkok, Thailand	Mahidol University; Mahidol University; Mahidol University; Mahidol University; Mahidol University	Borwornpinyo, S (corresponding author), Mahidol Univ, Dept Biotechnol, Fac Sci, Bangkok, Thailand.; Hongeng, S (corresponding author), Mahidol Univ, Ramathibodi Hosp, Dept Pediat, Fac Med, Bangkok, Thailand.; Borwornpinyo, S; Hongeng, S (corresponding author), Mahidol Univ, Excellent Ctr Drug Discovery, Fac Sci, Bangkok, Thailand.	bsuparerk@gmail.com; suradej.hon@mahidol.ac.th	Sampattavanich, Somponnat/C-5284-2011	Sampattavanich, Somponnat/0000-0001-7783-6103; Borwornpinyo, Suparerk/0000-0001-6211-3615; Anurathapan, Usanarat/0000-0002-2791-7471; Hongeng, Suradej/0000-0002-7376-9393	Thailand Center of Excellence for Life Sciences (TCELS) [TC 21/59]; Research Chair Grant; National Science and Technology Development Agency (NSTDA), Thailand [P-11-00435]; Merck Ltd (Thailand)	Thailand Center of Excellence for Life Sciences (TCELS); Research Chair Grant; National Science and Technology Development Agency (NSTDA), Thailand; Merck Ltd (Thailand)	This work was supported by Thailand Center of Excellence for Life Sciences (TCELS) (TC 21/59) and the Research Chair Grant, the National Science and Technology Development Agency (NSTDA), Thailand (P-11-00435). Merck Ltd (Thailand) provided support in the form of salaries for Savichaya Pornpaiboonstid. All funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao A, 2010, GENET MED, V12, P61, DOI [10.1097/GIM.0b013e3181cd68ed, 10.1038/gim.2016.173]; De Franceschi L, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/985210; Dobson M, 2011, BBA-MOL CELL RES, V1813, P1453, DOI 10.1016/j.bbamcr.2011.05.001; Franco SS, 2014, HAEMATOLOGICA, V99, P267, DOI 10.3324/haematol.2013.090076; Griffiths RE, 2012, BLOOD, V119, P6296, DOI 10.1182/blood-2011-09-376475; Hagenbuchner J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00147; Hattangadi SM, 2011, BLOOD, V118, P6258, DOI 10.1182/blood-2011-07-356006; Khandros E, 2012, BLOOD, V119, P5265, DOI 10.1182/blood-2011-12-397729; Khandros E, 2010, HEMATOL ONCOL CLIN N, V24, P1071, DOI 10.1016/j.hoc.2010.08.013; Koury MJ, 2015, NAT REV NEPHROL, V11, P394, DOI 10.1038/nrneph.2015.82; Leecharoenkiat A, 2011, BLOOD CELL MOL DIS, V47, P143, DOI 10.1016/j.bcmd.2011.06.005; Liang R, 2016, BRIT J HAEMATOL, V174, P661, DOI 10.1111/bjh.14194; Liang R, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005526; Makis A, 2016, AM J HEMATOL, V91, P1135, DOI 10.1002/ajh.24530; Marinkovic D, 2007, J CLIN INVEST, V117, P2133, DOI 10.1172/JCI31807; Merryweather-Clarke AT, 2011, BLOOD, V117, pE96, DOI 10.1182/blood-2010-07-290825; Mettananda S, 2015, BLOOD, V125, P3694, DOI 10.1182/blood-2015-03-633594; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Mortensen M, 2010, CELL CYCLE, V9, P1901, DOI 10.4161/cc.9.10.11603; Psaila B, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0939-7; Ribeil J-A, 2013, SCI WORLD J, V2013; Rivella S, 2009, CURR OPIN HEMATOL, V16, P187, DOI 10.1097/MOH.0b013e32832990a4; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; Wang Huan, 2015, Zhong Yao Cai, V38, P460; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Yang YD, 2013, GENOMICS, V102, P431, DOI 10.1016/j.ygeno.2013.09.005; Zhang JY, 2015, INT J MOL SCI, V16, P4083, DOI 10.3390/ijms16024083; Zhang X, 2014, AM J HEMATOL, V89, P954, DOI 10.1002/ajh.23786	28	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							e0187610	10.1371/journal.pone.0187610	http://dx.doi.org/10.1371/journal.pone.0187610			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6TA	29099866	gold, Green Published, Green Submitted			2022-12-26	WOS:000414377900032
J	Hameed, SS; Hassan, R; Muhammad, FF				Hameed, Shilan S.; Hassan, Rohayanti; Muhammad, Fahmi F.			Selection and classification of gene expression in autism disorder: Use of a combination of statistical filters and a GBPSO-SVM algorithm	PLOS ONE			English	Article							PARTICLE SWARM OPTIMIZATION; DATA MINING METHODS; CANCER CLASSIFICATION; SPECTRUM DISORDERS; ACTIVATOR PROTEIN; MICROARRAY; SYSTEM	In this work, gene expression in autism spectrum disorder (ASD) is analyzed with the goal of selecting the most attributed genes and performing classification. The objective was achieved by utilizing a combination of various statistical filters and a wrapper-based geometric binary particle swarm optimization-support vector machine (GBPSO-SVM) algorithm. The utilization of different filters was accentuated by incorporating a mean and median ratio criterion to remove very similar genes. The results showed that the most discriminative genes that were identified in the first and last selection steps included the presence of a repetitive gene (CAPS2), which was assigned as the gene most highly related to ASD risk. The merged gene subset that was selected by the GBPSO-SVM algorithm was able to enhance the classification accuracy.	[Hameed, Shilan S.] Univ Teknol Malaysia, Fac Comp, Dept Comp Sci, Johor Baharu, Malaysia; [Hameed, Shilan S.] Salahaddin Univ, Coll Engn, Dept Software & Informat Engn, Erbil, Kurdistan Regio, Iraq; [Hassan, Rohayanti] Univ Teknol Malaysia, Fac Comp, Dept Software Engn, Johor Baharu, Malaysia; [Muhammad, Fahmi F.] Koya Univ, Fac Sci & Hlth, Dept Phys, Koya, Kurdistan Regio, Iraq	Universiti Teknologi Malaysia; Salahaddin University; Universiti Teknologi Malaysia; Koya University	Muhammad, FF (corresponding author), Koya Univ, Fac Sci & Hlth, Dept Phys, Koya, Kurdistan Regio, Iraq.	fahmi.fariq@koyauniversity.org	Muhammadsharif, Fahmi F./B-3802-2010; Hassan, Rohayanti/M-1203-2015; Hameed, Shilan S./AAQ-9823-2020	Muhammadsharif, Fahmi F./0000-0002-4563-9671; Hassan, Rohayanti/0000-0003-1062-1719; Hameed, Shilan S./0000-0002-8596-644X	UTM Research University Grant Scheme [11H84]; Koya University	UTM Research University Grant Scheme; Koya University	This work was financially supported in part by the UTM Research University Grant Scheme (Vot number 11H84) and in part by Koya University.r The authors are grateful to the Department of Computer Science and Software Engineering of the Universiti Teknologi Malaysia for their administrative support. The authors would also like to express their deepest gratitude for the financial support received under the UTM Research University Grant Scheme (Vot number 11H84).	Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Alba E, 2007, 2007 CEC 2007 IEEE C; Alter MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016715; Annavarapu CSR, 2016, EXCLI J, V15, P460, DOI 10.17179/excli2016-481; [Anonymous], 2011, AUTISTIC CHILDREN TH; Ardjani F, 2010, 2010 2ND INTERNATIONAL WORKSHOP ON DATABASE TECHNOLOGY AND APPLICATIONS PROCEEDINGS (DBTA); Bolon-Canedo V, 2014, INFORM SCIENCES, V282, P111, DOI 10.1016/j.ins.2014.05.042; Bridge PD, 1999, J CLIN EPIDEMIOL, V52, P229, DOI 10.1016/S0895-4356(98)00168-1; Cateni S, 2013, MULTIVARIATE ANAL MA; Cervante L, 2012, IEEE C EVOL COMPUTAT; Chen LF, 2012, NEURAL COMPUT APPL, V21, P2087, DOI 10.1007/s00521-011-0632-4; Chen YM, 2010, PATTERN RECOGN LETT, V31, P226, DOI 10.1016/j.patrec.2009.10.013; Christobel M, 2015, SCI WORLD J, V2015; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Das S., 2001, FILTERS WRAPPERS BOO; de Menezes Renee X, 2004, Appl Bioinformatics, V3, P229; De Rubeis S, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0553-1; El-Fishawy P, 2010, PSYCHIAT CLIN N AM, V33, P83, DOI 10.1016/j.psc.2009.12.002; Fisher RA, 1925, MATH P CAMBRIDGE PHI; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Garcia-Nieto J, 2009, INFORM PROCESS LETT, V109, P887, DOI 10.1016/j.ipl.2009.03.029; Gnana DAA, 2016, METHODS, V136; Gonzalez F., 2013, ARXIV13021733; Govindarajan R, 2012, J PHARM BIOALLIED SC, V4, pS310, DOI 10.4103/0975-7406.100283; Gregg JP, 2008, GENOMICS, V91, P22, DOI 10.1016/j.ygeno.2007.09.003; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Han J, 2012, MOR KAUF D, P1; Hassanien AE, 2013, COMPUT BIOL CHEM, V47, P37, DOI 10.1016/j.compbiolchem.2013.04.007; Haury AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028210; He F, 2012, P INT C 4 EL SYST IN; Hira Zena M., 2015, Advances in Bioinformatics, V2015, P198363, DOI 10.1155/2015/198363; Hu VW, 2009, AUTISM RES, V2, P78, DOI 10.1002/aur.73; Huang JW, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0277-0; Huerta E.B., 2006, WORKSH APPL EV COMP; Huertas C, 2014, INF FUD FUSION 2014; Jirapech-Umpai T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-148; John L. Z., 2010, JR STAT SOC A, V173, P693, DOI DOI 10.1111/J.1467-985X.2010.00646_6.X; Kennedy J, 1997, 1997 COMP CYB SIM 19; Khoshgoftaar T, 2012, MACH LEARN APPL ICML; Krey JF, 2007, CURR OPIN NEUROBIOL, V17, P112, DOI 10.1016/j.conb.2007.01.010; Lai C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-235; Latkowski T, 2015, INT WORK C ART NEUR; Latkowski T, 2015, COMPUT BIOL MED, V56, P82, DOI 10.1016/j.compbiomed.2014.11.004; Latkowski T, 2015, EXPERT SYST APPL, V42, P864, DOI 10.1016/j.eswa.2014.08.043; Lazar C, 2012, IEEE ACM T COMPUT BI, V9, P1106, DOI 10.1109/TCBB.2012.33; Leung MKK, 2016, P IEEE, V104, P176, DOI 10.1109/JPROC.2015.2494198; Li ST, 2008, SOFT COMPUT, V12, P1039, DOI 10.1007/s00500-007-0272-x; Libbrecht MW, 2015, NAT REV GENET, V16, P321, DOI 10.1038/nrg3920; Lin IF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129451; Liu BQ, 2014, PR ELECTROMAGN RES S, P2014; Liu B, 2017, ONCOTARGET, V8, P13338, DOI 10.18632/oncotarget.14524; Liu B, 2016, MOL GENET GENOMICS, V291, P473, DOI 10.1007/s00438-015-1078-7; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121501; Liu B, 2014, BIOINFORMATICS, V30, P472, DOI 10.1093/bioinformatics/btt709; Moraglio A, 2008, J ARTIFICIAL EVOLUTI, V2008; Muszynski M, 2014, INT J AP MAT COM-POL, V24, P657, DOI 10.2478/amcs-2014-0048; Purcell AE, 2001, NEUROLOGY, V57, P1618, DOI 10.1212/WNL.57.9.1618; Rejani Y. I. A., 2009, ARXIV09122314; Sadakata T, 2017, NEUROSCI LETT, V639, P88, DOI 10.1016/j.neulet.2016.12.068; Sadakata T, 2012, FEBS J, V279, P384, DOI 10.1111/j.1742-4658.2011.08431.x; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Saha S, 2016, INT J BIOINFORMATICS, V12, P263; Singh RK, 2015, PROCEDIA COMPUT SCI, V50, P52, DOI 10.1016/j.procs.2015.04.060; Sprent P., 2016, APPL NONPARAMETRIC S; Talbi E-G, 2008, COMP SYST APPL 2008; Taniai H, 2008, AM J MED GENET B, V147B, P844, DOI 10.1002/ajmg.b.30740; Teng XY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173907; Thurm Audrey, 2012, Dialogues Clin Neurosci, V14, P219; Tran B., 2014, AS PAC C SIM EV LEAR; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Wild C, 2011, WILCOXON RANK SUM TE; Wilinski A, 2012, B POL ACAD SCI-TECH, V60, P461, DOI 10.2478/v10175-012-0058-x; Wing L, 1996, BRIT MED J, V312, P327; Xue B, 2013, IEEE T CYBERNETICS, V43, P1656, DOI 10.1109/TSMCB.2012.2227469; Yoo H, 2015, EXP NEUROBIOL, V24, P257, DOI 10.5607/en.2015.24.4.257; Zhang H, 2016, ICCAD-IEEE ACM INT, DOI 10.1145/2906980.2967032; Zhu L, 2017, IEEE ACM T COMPUTATI	78	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187371	10.1371/journal.pone.0187371	http://dx.doi.org/10.1371/journal.pone.0187371			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095904	gold, Green Published, Green Submitted			2022-12-26	WOS:000414340200078
J	Wen, JP; Hao, J; Liang, YB; Li, SZ; Cao, K; Lu, XL; Lu, XX; Wang, NL				Wen, Jiangping; Hao, Jie; Liang, Yuanbo; Li, Sizhen; Cao, Kai; Lu, Xilin; Lu, Xinxin; Wang, Ningli			A non-invasive risk score for predicting incident diabetes among rural Chinese people: A village-based cohort study	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE INTERVENTIONS; FOLLOW-UP; TYPE-2; POPULATION; PREVALENCE; ADULTS; VALIDATION; PREVENTION; REDUCTION	Objective To develop a new non-invasive risk score for predicting incident diabetes in a rural Chinese population. Methods Data from the Handan Eye Study conducted from 2006-2013 were utilized as part of this analysis. The present study utilized data generated from 4132 participants who were >= 30 years of age. A non-invasive risk model was derived using two-thirds of the sample cohort (selected randomly) using stepwise logistic regression. The model was subsequently validated using data from individuals from the final third of the sample cohort. In addition, a simple point system for incident diabetes was generated according to the procedures described in the Framingham Study. Incident diabetes was defined as follows: (1) fasting plasma glucose (FPG) >= 7.0 mmol/L; or (2) hemoglobin A1c (HbA1c) >= 6.5%; or (3) self-reported diagnosis of diabetes or use of anti-diabetic medications during the follow-up period. Results The simple non-invasive riskscore included age (8 points), Body mass index (BMI) (3 points), waist circumference (WC) (7 points), and family history of diabetes (9 points). The score ranged from 0 to 27 and the area under the receiver operating curve (AUC) of the score was 0.686 in the validation sample. At the optimal cutoff value (which was 9), the sensitivity and specificity were 74.32% and 58.82%, respectively. Conclusions Using information based upon age, BMI, WC, and family history of diabetes, we developed a simple new non-invasive risk score for predicting diabetes onset in a rural Chinese population using information from individuals aged 30 years of age and older. The new risk score proved to be more optimal in the prediction of incident diabetes than most of the existing risk scores developed in Western and Asian countries. This score system will aid in the identification of individuals who are at risk of developing incident diabetes in rural China.	[Wen, Jiangping; Lu, Xinxin] Capital Med Univ, Beijing Tongren Hosp, Dept Lab Med, Beijing, Peoples R China; [Hao, Jie; Wang, Ningli] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China; [Liang, Yuanbo] Wenzhou Med Univ, Affiliated Eye Hosp, Clin & Epidemiol Res Ctr, Wenzhou, Peoples R China; [Li, Sizhen] Nanjing Aier Eye Hosp, Nanjing, Jiangsu, Peoples R China; [Cao, Kai] Beijing Inst Ophthalmol, Beijing, Peoples R China; [Lu, Xilin] Handan 3rd Hosp, Dept Lab Med, Handan, Peoples R China	Capital Medical University; Capital Medical University; Wenzhou Medical University	Lu, XX (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Lab Med, Beijing, Peoples R China.; Wang, NL (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China.	luxinxin2009@126.com; wningli@vip.163.com			National Basic Research Program of China (973 Program); Ministry of Science and Technology of China [2007CB512201]; Foundation of Beijing Tongren Hospital	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Foundation of Beijing Tongren Hospital	This study was financially supported by the National Basic Research Program of China (973 Program), the Ministry of Science and Technology of China (Grant 2007CB512201). Additional support was provided by the Foundation of Beijing Tongren Hospital (Grant 2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5900; Aekplakorn W, 2006, DIABETES CARE, V29, P1872, DOI 10.2337/dc05-2141; Balkau B, 2008, DIABETES CARE, V31, P2056, DOI 10.2337/dc08-0368; Chen L, 2010, MED J AUSTRALIA, V192, P197, DOI 10.5694/j.1326-5377.2010.tb03478.x; Gao WG, 2010, DIABETIC MED, V27, P274, DOI 10.1111/j.1464-5491.2010.02943.x; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Gillies CL, 2007, BMJ-BRIT MED J, V334, P299, DOI 10.1136/bmj.39063.689375.55; Glumer C, 2006, DIABETES CARE, V29, P410, DOI 10.2337/diacare.29.02.06.dc05-0945; Griffin SJ, 2000, DIABETES-METAB RES, V16, P164, DOI 10.1002/1520-7560(200005/06)16:3<164::AID-DMRR103>3.0.CO;2-R; Heianza Y, 2012, DIABETOLOGIA, V55, P3213, DOI 10.1007/s00125-012-2712-0; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V338, pb880, DOI DOI 10.1136/bmj.b880; Kengne AP, 2014, LANCET DIABETES ENDO, V2, P19, DOI 10.1016/S2213-8587(13)70103-7; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lee YH, 2012, DIABETES CARE, V35, P1723, DOI 10.2337/dc11-2347; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Liang YB, 2009, OPHTHAL EPIDEMIOL, V16, P115, DOI 10.1080/09286580902738159; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; Schulze MB, 2007, DIABETES CARE, V30, P510, DOI 10.2337/dc06-2089; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Zhou MG, 2015, DIABETES CARE, V38, P72, DOI 10.2337/dc14-1100; Zhou XH, 2013, DIABETES CARE, V36, P3944, DOI 10.2337/dc13-0593	25	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186172	10.1371/journal.pone.0186172	http://dx.doi.org/10.1371/journal.pone.0186172			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095851	Green Published, gold, Green Submitted			2022-12-26	WOS:000414340200014
J	Espelt, A; Bosque-Prous, M; Folch, C; Sarasa-Renedo, A; Majo, X; Casabona, J; Brugal, MT				Espelt, Albert; Bosque-Prous, Marina; Folch, Cinta; Sarasa-Renedo, Ana; Majo, Xavier; Casabona, Jordi; Teresa Brugal, M.		REDAN Grp	Is systematic training in opioid overdose prevention effective?	PLOS ONE			English	Article							TAKE-HOME NALOXONE; NONFATAL HEROIN OVERDOSE; INJECTION-DRUG USERS; OPIATE USERS; RISK-FACTORS; KNOWLEDGE; PROGRAMS; DEATH; METAANALYSIS; REGRESSION	The objectives were to analyze the knowledge about overdose prevention, the use of naloxone, and the number of fatal overdoses after the implementation of Systematic Training in Overdose Prevention (STOOP) program. We conducted a quasi-experimental study, and held face-to-face interviews before (n = 725) and after (n = 722) implementation of systematic training in two different samples of people who injected opioids attending harm reduction centers. We asked participants to list the main causes of overdose and the main actions that should be taken when witnessing an overdose. We created two dependent variables, the number of (a) correct and (b) incorrect answers. The main independent variable was Study Group: Intervention Group (IG), Comparison Group (CG), Pre-Intervention Group With Sporadic Training in Overdose Prevention (PREIGS), or Pre-Intervention Group Without Training in Overdose Prevention (PREIGW). The relationship between the dependent and independent variables was assessed using a multivariate Poisson regression analysis. Finally, we conducted an interrupted time series analysis of monthly fatal overdoses before and after the implementation of systematic program during the period 2006 +/- 2015. Knowledge of overdose prevention increased after implementing systematic training program. Compared to the PREIGW, the IG gave more correct answers (IRR = 1.40; 95% CI: 1.33-1.47), and fewer incorrect answers (IRR = 0.33; 95% CI: 0.25-0.44). Forty percent of people who injected opioids who received a naloxone kit had used the kit in response to an overdose they witnessed. These courses increase knowledge of overdose prevention in people who use opioids, give them the necessary skills to use naloxone, and slightly diminish the number of fatal opioid overdoses in the city of Barcelona.	[Espelt, Albert; Bosque-Prous, Marina; Sarasa-Renedo, Ana; Teresa Brugal, M.] Agencia Salut Publ Barcelona, Barcelona, Spain; [Espelt, Albert] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Calle Melchor Fernandez Almagro, Madrid, Spain; [Espelt, Albert] UVicUCC, Fac Ciencies Salut Manresa, Ave Univ, Manresa, Spain; [Espelt, Albert] Univ Autonoma Barcelona, Dept Psicobiol Metodol Ciencies Salut, Campus UAB, Bellaterra, Spain; [Folch, Cinta] Generalitat Catalunya, Ctr Estudis Epidemiol Infecc Transmissio Sexual &, ASPC, Carretera Canyet S-N, Badalona, Spain; [Sarasa-Renedo, Ana] Inst Salud Carlos III, PEAC, Calle Sinesio Delgado, Madrid, Spain; [Majo, Xavier; Casabona, Jordi] Generalitat Catalunya, Dept Salut, Subdireccio Gen Drogodependencies, Carrer Roc Boronat, Barcelona, Spain	Public Health Agency of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); Autonomous University of Barcelona; Instituto de Salud Carlos III	Espelt, A (corresponding author), Agencia Salut Publ Barcelona, Barcelona, Spain.; Espelt, A (corresponding author), Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Calle Melchor Fernandez Almagro, Madrid, Spain.; Espelt, A (corresponding author), UVicUCC, Fac Ciencies Salut Manresa, Ave Univ, Manresa, Spain.; Espelt, A (corresponding author), Univ Autonoma Barcelona, Dept Psicobiol Metodol Ciencies Salut, Campus UAB, Bellaterra, Spain.	aespelt@umanresa.cat	Brugal, M. Teresa/K-5190-2012; Bosque-Prous, Marina/AAE-1562-2020; Espelt, Albert/G-2281-2014	Brugal, M. Teresa/0000-0003-0580-676X; Bosque-Prous, Marina/0000-0002-8830-8880; Folch, Cinta/0000-0001-8400-2668; Espelt, Albert/0000-0002-8625-4356; Colom Farran, Joan/0000-0001-6861-7865	Spanish Network on Addictive Disorders [RD06/0001/1018, RD12/0028/0018]	Spanish Network on Addictive Disorders	This work was supported by the Spanish Network on Addictive Disorders [grant numbers RD06/0001/1018, and RD12/0028/0018] (http:// www.eng.isciii.es/ISCIII/es/cortenidos/fd-investigacion/fd-ejecucion/fd-centros-participados/centros-participados-redes-retics.shmtl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arribas-Ibar E, 2014, HARM REDUCT J, V11, DOI 10.1186/1477-7517-11-33; Bhaskaran K, 2013, INT J EPIDEMIOL, V42, P1187, DOI 10.1093/ije/dyt092; Binswanger IA, 2016, ADDICTION, V111, P499, DOI 10.1111/add.13200; Bird SM, 2016, ADDICTION, V111, P883, DOI 10.1111/add.13265; Brugal MT, 2002, ADDICTION, V97, P319, DOI 10.1046/j.1360-0443.2002.00058.x; CEESCAT. SIVES, 2012, SIVES 2012 INT SURV; Clark AK, 2014, J ADDICT MED, V8, P153, DOI 10.1097/ADM.0000000000000034; Darke S, 1996, ADDICTION, V91, P413, DOI 10.1046/j.1360-0443.1996.91341310.x; Darke S, 2003, ADDICTION, V98, P1169, DOI 10.1046/j.1360-0443.2003.00474.x; de la Fuente de Hoz Luis, 2005, Rev Esp Salud Publica, V79, P475, DOI 10.1590/S1135-57272005000400005; EMCDDA, 2013, PREV OV DEATHS EUR; EMCDDA, 2016, 2016 ANN REP STAT DR; Espelt A, NALOXON UBERLEBENSHI; Espelt A, 2015, EUR ADDICT RES, V21, P300, DOI 10.1159/000377626; Frisher M., 2012, PREVENTING OPIOID OV; Galea S, 2006, ADDICT BEHAV, V31, P907, DOI 10.1016/j.addbeh.2005.07.020; Gaston RL, 2009, HARM REDUCT J, V6, DOI 10.1186/1477-7517-6-26; Gossop M, 1996, BRIT MED J, V313, P402; Green TC, 2008, ADDICTION, V103, P979, DOI 10.1111/j.1360-0443.2008.02182.x; Hilbe J.M., 2014, MODELING COUNT DATA; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; Lopez Ma Jose, 2011, Gac Sanit, V25 Suppl 1, P9, DOI 10.1016/S0213-9111(11)70003-6; Majo A X, 2009, ADRECAT GEN CATALUNY; Maldjian L, 2016, SUBST ABUS, V37, P459, DOI 10.1080/08897077.2015.1135850; McAuley A, 2015, INT J DRUG POLICY, V26, P1183, DOI 10.1016/j.drugpo.2015.09.011; McDonald R, 2016, ADDICTION, V111, P1177, DOI 10.1111/add.13326; Merrall ELC, 2010, ADDICTION, V105, P1545, DOI 10.1111/j.1360-0443.2010.02990.x; Neale J, 2003, ADDICTION, V98, P1171, DOI 10.1046/j.1360-0443.2003.00476.x; Neira-Leon M, 2006, J URBAN HEALTH, V83, P477, DOI 10.1007/s11524-006-9054-5; Neira-Leon M, 2011, INT J DRUG POLICY, V22, P16, DOI 10.1016/j.drugpo.2010.06.003; Rossi C., 1999, INT J DRUG POLICY, V10, P131; Sarasa-Renedo A, 2014, GAC SANIT, V28, P146, DOI 10.1016/j.gaceta.2013.10.012; Seal KH, 2005, J URBAN HEALTH, V82, P303, DOI 10.1093/jurban/jti053; Sherman SG, 2009, INT J DRUG POLICY, V20, P137, DOI 10.1016/j.drugpo.2008.02.004; Strang J, 2008, ADDICTION, V103, P1648, DOI 10.1111/j.1360-0443.2008.02314.x; Strang J, 2015, ADDICTION, V110, P27, DOI 10.1111/add.12904; Tobin KE, 2009, INT J DRUG POLICY, V20, P131, DOI 10.1016/j.drugpo.2008.03.002; Wagner KD, 2010, INT J DRUG POLICY, V21, P186, DOI 10.1016/j.drugpo.2009.01.003; Walley AY, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f174; Warner-Smith M, 2001, ADDICTION, V96, P1113, DOI 10.1046/j.1360-0443.2001.96811135.x; WHO, 1994, MULT STUD INJ RISK H; Williams AV, 2013, DRUG ALCOHOL DEPEN, V132, P383, DOI 10.1016/j.drugalcdep.2013.02.007	42	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186833	10.1371/journal.pone.0186833	http://dx.doi.org/10.1371/journal.pone.0186833			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL2ZD	29088247	Green Published, gold, Green Submitted			2022-12-26	WOS:000414088900024
J	Hasegawa, D; Ochiai-Shino, H; Onodera, S; Nakamura, T; Saito, A; Onda, T; Watanabe, K; Nishimura, K; Ohtaka, M; Nakanishi, M; Kosaki, K; Yamaguchi, A; Shibahara, T; Azuma, T				Hasegawa, Daigo; Ochiai-Shino, Hiromi; Onodera, Shoko; Nakamura, Takashi; Saito, Akiko; Onda, Takeshi; Watanabe, Katsuhito; Nishimura, Ken; Ohtaka, Manami; Nakanishi, Mahito; Kosaki, Kenjiro; Yamaguchi, Akira; Shibahara, Takahiko; Azuma, Toshifumi			Gorlin syndrome-derived induced pluripotent stem cells are hypersensitive to hedgehog-mediated osteogenic induction	PLOS ONE			English	Article							CARCINOMA SYNDROME; SIGNALING PATHWAY; HUMAN FIBROBLASTS; SONIC HEDGEHOG; NEVUS SYNDROME; MUTATIONS; DISEASE; FAMILY; BETA; RHABDOMYOSARCOMA	Gorlin syndrome is an autosomal dominant inherited syndrome that predisposes a patient to the formation of basal cell carcinomas, odontogenic keratocysts, and skeletal anomalies. Causative mutations in several genes associated with the sonic hedgehog (SHH) signaling pathway, including PTCH1, have been identified in Gorlin syndrome patients. However, no definitive genotype-phenotype correlations are evident in these patients, and their clinical presentation varies greatly, often leading to delayed diagnosis and treatment. We generated iPSCs from four unrelated Gorlin syndrome patients with loss-of-function mutations in PTCH1 using the Sendai virus vector (SeVdp(KOSM) 302). The patient-derived iPSCs exhibited basic iPSC features, including stem cell marker expression, totipotency, and the ability to form teratomas. GLI1 expression levels were greater in fibroblasts and patient-derived iPSCs than in the corresponding control cells. Patient-derived iPSCs expressed lower basal levels than control iPSCs of the genes encoding the Hh ligands Indian Hedgehog (IHH) and SHH, the Hh acetyltransferase HHAT, Wnt proteins, BMP4, and BMP6. Most of these genes were upregulated in patient-derived iPSCs grown in osteoblast differentiation medium (OBM) and downregulated in control iPSCs cultured in OBM. The expression of GLI1 and GLI2 substantially decreased in both control and patient-derived iPSCs cultured in OBM, whereas GLI3, SHH, and IHH were upregulated in patient-derived iPSCs and downregulated in control iPSCs grown in OBM. Activation of Smoothened by SAG in cells grown in OBM significantly enhanced alkaline phosphatase activity in patient-derived iPSCs compared with control iPSC lines. In summary, patient-derived iPSCs expressed lower basal levels than the control iPSCs of the genes encoding Hh, Wnt, and bone morphogenetic proteins, but their expression of these genes strongly increased under osteogenic conditions. These findings indicate that patient-derived iPSCs are hypersensitive to osteogenic induction. We propose that Hh signaling is constituently active in iPSCs from Gorlin syndrome patients, enhancing their response to osteogenic induction and contributing to disease-associated abnormalities.	[Hasegawa, Daigo; Watanabe, Katsuhito; Shibahara, Takahiko] Tokyo Dent Coll, Dept Oral & Maxillofacial Surg, Tokyo, Japan; [Ochiai-Shino, Hiromi; Onodera, Shoko; Nakamura, Takashi; Saito, Akiko; Azuma, Toshifumi] Tokyo Dent Coll, Dept Biochem, Tokyo, Japan; [Nishimura, Ken] Univ Tsukuba, Fac Med, Lab Gene Regulat, Ibaraki, Japan; [Ohtaka, Manami; Nakanishi, Mahito] Natl Inst Adv Ind Sci & Technol, Biotechnol Res Inst Drug Discovery, Tsukuba, Ibaraki, Japan; [Kosaki, Kenjiro] Keio Univ, Sch Med, Ctr Med Genet, Tokyo, Japan; [Yamaguchi, Akira; Azuma, Toshifumi] Tokyo Dent Coll, Oral Hlth Sci Ctr, Tokyo, Japan	Tokyo Dental College; Tokyo Dental College; University of Tsukuba; National Institute of Advanced Industrial Science & Technology (AIST); Keio University; Tokyo Dental College	Azuma, T (corresponding author), Tokyo Dent Coll, Dept Biochem, Tokyo, Japan.; Azuma, T (corresponding author), Tokyo Dent Coll, Oral Hlth Sci Ctr, Tokyo, Japan.	tazuma@tdc.ac.jp	Onda, Takeshi/V-7114-2019; Nakanishi, Mahito/I-9888-2018; Nishimura, KEN/HGC-6147-2022; Yamaguchi, Akira/AAX-9286-2020	Nakanishi, Mahito/0000-0002-7068-7587; Onda, Takeshi/0000-0003-4722-1954; Onodera, Shoko/0000-0003-0673-3400; Nakamura, Takashi/0000-0002-6124-061X	Japan Society for the Promotion of Science (JSPS), KAKENHI [25462900]; JSPS KAKENHI [25462900, 25861761, 26861686, 26861560, 15K20379, 16K20427, 16K20428]	Japan Society for the Promotion of Science (JSPS), KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) (http://www.jsps.go.jp/english/e-grants/index.html), KAKENHI (C) (Grant number 25462900(T.A)) and by JSPS KAKENHI for young scientists (B) (Grant numbers 25861761(H.S), 26861686(S.O), 26861560(A.S), 15K20379(H.S), 16K20427(S.O), and 16K20428(A.S)), http://www.jsps.go.jp/english/e-grants/index.html.; This work was supported by JSPS KAKENHI (C) (Grant number 25462900) and by JSPS KAKENHI for young scientists (B) (Grant numbers 25861761, 26861686, 26861560, 15K20379, 16K20427, and 16K20428). The authors would like to thank Ajinomoto Co Ltd for the technical advices. The authors would like to thank Enago (www.enago.jp) for the English language review.	Alman BA, 2015, NAT REV RHEUMATOL, V11, P552, DOI 10.1038/nrrheum.2015.84; Athar M, 2014, CANCER RES, V74, P4967, DOI 10.1158/0008-5472.CAN-14-1666; Bale AE, 1997, AM J HUM GENET, V60, P10; Bellin M, 2012, NAT REV MOL CELL BIO, V13, P713, DOI 10.1038/nrm3448; Brellier F, 2008, BRIT J DERMATOL, V159, P445, DOI 10.1111/j.1365-2133.2008.08650.x; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; Fan Z, 2008, J MED GENET, V45, P303, DOI 10.1136/jmg.2007.055343; Fujii K, 2014, PEDIATR INT, V56, P667, DOI 10.1111/ped.12461; GORLIN RJ, 1960, NEW ENGL J MED, V262, P908, DOI 10.1056/NEJM196005052621803; Hahn H, 1996, J BIOL CHEM, V271, P12125, DOI 10.1074/jbc.271.21.12125; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kato H, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.140201; Katoh M, 2013, CANCER LETT, V328, P198, DOI 10.1016/j.canlet.2012.09.017; Katoh M, 2009, INT J MOL MED, V23, P763, DOI 10.3892/ijmm_00000190; Katoh Y, 2008, INT J MOL MED, V22, P271, DOI 10.3892/ijmm_00000019; Kimonis VE, 1997, AM J MED GENET, V69, P299, DOI 10.1002/(SICI)1096-8628(19970331)69:3<299::AID-AJMG16>3.0.CO;2-M; Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009; Konitsiotis AD, 2015, J BIOL CHEM, V290, P3293, DOI 10.1074/jbc.M114.614578; Kurosaka H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120821; Li TJ, 2011, J DENT RES, V90, P133, DOI 10.1177/0022034510379016; Lindstrom E, 2006, HUM MUTAT, V27, P215, DOI 10.1002/humu.20296; Matevossian A, 2015, J BIOL CHEM, V290, P2235, DOI 10.1074/jbc.M114.625764; Matsumoto Y, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-190; Mizuochi H, 2015, BIOCHEM BIOPH RES CO, V457, P318, DOI 10.1016/j.bbrc.2014.12.108; Naujok O, 2014, STEM CELL REV REP, V10, P480, DOI 10.1007/s12015-014-9509-0; Nishimura K, 2011, J BIOL CHEM, V286, P4760, DOI 10.1074/jbc.M110.183780; Ochiai-Shino H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099534; Ohba S, 2008, DEV CELL, V14, P689, DOI 10.1016/j.devcel.2008.03.007; Ono M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042855; Onodera S, UNPUB; Pandolfi S, 2015, EXPERT REV MOL MED, V17, DOI 10.1017/erm.2015.3; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Pastorino L, 2009, AM J MED GENET A, V149A, P1539, DOI 10.1002/ajmg.a.32944; Petrova E, 2015, ONCOGENE, V34, P263, DOI 10.1038/onc.2013.575; Pressey JG, 2011, PEDIATR BLOOD CANCER, V57, P930, DOI 10.1002/pbc.23174; Qualtrough D, 2004, INT J CANCER, V110, P831, DOI 10.1002/ijc.20227; Qualtrough D, 2015, CANCERS, V7, P1885, DOI 10.3390/cancers7030867; Rajurkar M, 2014, ONCOGENE, V33, P5370, DOI 10.1038/onc.2013.480; Shimizu T., 2016, Reproductive Medicine and Biology, V15, P35, DOI 10.1007/s12522-015-0213-9; So PL, 2008, MOL CANCER THER, V7, P1275, DOI 10.1158/1535-7163.MCT-07-2043; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wicking C, 1997, AM J HUM GENET, V60, P21; Wicking Carol, 1997, Current Opinion in Pediatrics, V9, P630, DOI 10.1097/00008480-199712000-00013; Xie JW, 2013, ONCOTARGETS THER, V6, P1425, DOI 10.2147/OTT.S34678; Yang J, 2015, INT J ORAL SCI, V7, P73, DOI 10.1038/ijos.2015.14; Zheng X, 2013, ONCOL REP, V30, P2020, DOI 10.3892/or.2013.2690	48	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186879	10.1371/journal.pone.0186879	http://dx.doi.org/10.1371/journal.pone.0186879			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088246	Green Published, Green Submitted, gold			2022-12-26	WOS:000414088900028
J	Liu, ZH; Foo, DCC; Law, WL; Chan, FSY; Fan, JKM; Peng, JS				Liu, Zhong Hui; Foo, Dominic Chi Chung; Law, Wai Lun; Chan, Fion Siu Yin; Fan, Joe King Man; Peng, Jun Sheng			Melanosis coli: Harmless pigmentation? A case-control retrospective study of 657 cases	PLOS ONE			English	Article							BOWEL MOVEMENT FREQUENCY; LAXATIVE USE; COLORECTAL-CANCER; APOPTOSIS; RISK; TOXICITY; ADENOMA; CELLS; WOMEN	Backgrounds and aims The association of melanosis coli with the development of colorectal polyps remains uncertain. Methods From a total of 18263 patients who had received colonoscopy in our hospital, 219 with melanosis coli cases and 438 controls matched by age and sex (at 1:2 ratio) were included in this study. The association of incidence, number, location, and pathology of colorectal neoplasm with grades and distribution of melanosis coli were analyzed. Results Melanosis coli was associated with significantly more colorectal polyps than control, a higher incidence of numerous colorectal polyps (number >= 20) (7.3% vs 0.5%; p < 0.001), and higher number of small colorectal polyps (diameter <= 5 mm; p < 0.01). Patients with melanosis coli had higher incidences of low-grade adenomas (31.1% vs 23.3%, p < 0.05) and non-adenoma polyps (20.1% vs 12.8%, p < 0.05) than the controls. On multivariate analysis, melanosis coli was independently associated with increased detecting rates of low grade adenoma (OR = 1.54; 95%: 1.06-2.23; p < .05), non-adenoma polyp (OR = 1.72; 95%: 1.11-2.70; p < .05) and numerous polyps (OR = 16.2, 95%: 3.66-71.6; p < .05). There was no significant difference in the incidence of high-grade adenomas or adenocarcinomas in the two population groups, but the numbers of these lesions were insufficient to permit firm conclusions. No significant differences in incidence, number, and pathology of colorectal polyps between individuals with melanosis coli of three different grades of severity were found. Melanosis located predominantly in the right colon had an interestingly lower incidence of colonic polyps in right colon than did melanosis located predominantly in the left colon or total colon (8.9% vs. 26.3%, 24.0%, p < 0.05). Patients with melanosis coli had significantly more nonspecific distal ileal ulcers than did controls (8.0% vs 0%, p < 0.001). Conclusion Melanosis coli is associated with a higher incidence and number of colonic non-adenoma polyps and low-grade adenomas, and higher incidence of distal ileal ulcers. Melanosis coli may not be a harmless pigmentation, but a sign of chronic injury of colonic and intestinal mucosa.	[Liu, Zhong Hui; Peng, Jun Sheng] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Surg, Guangzhou, Guangdong, Peoples R China; [Foo, Dominic Chi Chung; Law, Wai Lun; Chan, Fion Siu Yin; Fan, Joe King Man] Univ Hong Kong, Shenzhen Hosp, Dept Surg, Shenzhen, Guangdong, Peoples R China; [Foo, Dominic Chi Chung; Law, Wai Lun; Chan, Fion Siu Yin; Fan, Joe King Man] Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China	Sun Yat Sen University; University of Hong Kong; University of Hong Kong	Peng, JS (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Dept Surg, Guangzhou, Guangdong, Peoples R China.; Fan, JKM (corresponding author), Univ Hong Kong, Shenzhen Hosp, Dept Surg, Shenzhen, Guangdong, Peoples R China.; Fan, JKM (corresponding author), Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China.	drjoefan@hku.hk; pengsir1010@126.com	Foo, Chi Chung/S-1508-2018; Liu, Zhong-Hui/AAF-5991-2020	Foo, Chi Chung/0000-0001-8849-6597; Liu, Zhong Hui/0000-0002-8604-4818				Blackett JW, 2016, J CLIN GASTROENTEROL; Bockus HL, 1933, J AMER MED ASSOC, V101, P1; Byers RJ, 1997, HISTOPATHOLOGY, V30, P160, DOI 10.1046/j.1365-2559.1997.d01-574.x; Citronberg J, 2014, AM J GASTROENTEROL, V109, P1640, DOI 10.1038/ajg.2014.233; Cruveilheir J, 1835, ANATOMIE PATHOLOGIQU, P1829; Dukas L, 2000, AM J EPIDEMIOL, V151, P958, DOI 10.1093/oxfordjournals.aje.a010139; GHADIALLY FN, 1966, J PATHOL BACTERIOL, V92, P313, DOI 10.1002/path.1700920207; Hung CY, 2012, GASTROENTEROLOGY, V142, pE10, DOI 10.1053/j.gastro.2011.07.032; Kang HW, 2010, AM J GASTROENTEROL, V105, P178, DOI 10.1038/ajg.2009.541; KOSKELA E, 1989, DIS COLON RECTUM, V32, P235, DOI 10.1007/BF02554536; LEE FD, 1993, J CLIN PATHOL, V46, P118, DOI 10.1136/jcp.46.2.118; Ma JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065032; MARSHALL JB, 1995, AM J GASTROENTEROL, V90, P372; MONKS TJ, 1992, TOXICOL APPL PHARM, V112, P2, DOI 10.1016/0041-008X(92)90273-U; Nusko G, 1997, Z GASTROENTEROL, V35, P313; Nusko G, 2000, GUT, V46, P651, DOI 10.1136/gut.46.5.651; Roberts-Thompson IC, 1999, J GASTROEN HEPATOL, V14, P1047; SENDELBACH LE, 1989, TOXICOLOGY, V57, P227, DOI 10.1016/0300-483X(89)90113-3; SHARP JR, 1980, GASTROENTEROLOGY, V78, P366; STEER HW, 1975, J PATHOL, V115, P199, DOI 10.1002/path.1711150403; van Gorkom BAP, 2001, J PATHOL, V194, P493, DOI 10.1002/path.914; Virchow R., 1847, ARCH PATH ANAT, V1, P379; WALKER NI, 1988, AM J PATHOL, V131, P465; WALKER NI, 1993, PATHOLOGY, V25, P120, DOI 10.3109/00313029309084783; Wang ZC, 2013, J DIGEST DIS, V14, P417, DOI 10.1111/1751-2980.12060; Yoshimoto AN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045332; Zhang L., 2015, CHIN J GASTROENTEROL, V24, P257; Zhang XH, 2013, CANCER CAUSE CONTROL, V24, P1015, DOI 10.1007/s10552-013-0176-2; Zhu JK, 2016, ONCOL RES, V24, P137, DOI 10.3727/096504016X14611963142218	29	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186668	10.1371/journal.pone.0186668	http://dx.doi.org/10.1371/journal.pone.0186668			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088250	gold, Green Published, Green Submitted			2022-12-26	WOS:000414088900020
J	Murray, T; Zeil, J				Murray, Trevor; Zeil, Jochen			Quantifying navigational information: The catchment volumes of panoramic snapshots in outdoor scenes	PLOS ONE			English	Article							INSECT NAVIGATION; DESERT ANTS; LANDMARK NAVIGATION; EXPERIMENTAL ARENAS; LEARNING-WALKS; VIEW; CONTRAST; MEMORY; ROUTES	Panoramic views of natural environments provide visually navigating animals with two kinds of information: they define locations because image differences increase smoothly with distance from a reference location and they provide compass information, because image differences increase smoothly with rotation away from a reference orientation. The range over which a given reference image can provide navigational guidance (its 'catchment area') has to date been quantified from the perspective of walking animals by determining how image differences develop across the ground plane of natural habitats. However, to understand the information available to flying animals there is a need to characterize the 'catchment volumes' within which panoramic snapshots can provide navigational guidance. We used recently developed camera-based methods for constructing 3D models of natural environments and rendered panoramic views at defined locations within these models with the aim of mapping navigational information in three dimensions. We find that in relatively open woodland habitats, catchment volumes are surprisingly large extending for metres depending on the sensitivity of the viewer to image differences. The size and the shape of catchment volumes depend on the distance of visual features in the environment. Catchment volumes are smaller for reference images close to the ground and become larger for reference images at some distance from the ground and in more open environments. Interestingly, catchment volumes become smaller when only above horizon views are used and also when views include a 1 km distant panorama. We discuss the current limitations of mapping navigational information in natural environments and the relevance of our findings for our understanding of visual navigation in animals and autonomous robots.	[Murray, Trevor; Zeil, Jochen] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia	Australian National University	Murray, T (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia.	trevor.murray@anu.edu.au			Australian Research Council [DP150101172, DP150102699]	Australian Research Council(Australian Research Council)	The work was supported by Australian Research Council Discovery Project Grants DP150101172 and DP150102699 to Jochen Zeil.	Baddeley B, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002336; Baddeley B, 2011, ADAPT BEHAV, V19, P3, DOI 10.1177/1059712310395410; BECKER L, 1958, Z VERGL PHYSIOL, V41, P1; Cheung A, 2008, J EXP PSYCHOL ANIM B, V34, P15, DOI 10.1037/0097-7403.34.1.15; Collett M, 2013, CURR BIOL, V23, pR789, DOI 10.1016/j.cub.2013.07.020; d'Angelo P., 2010, HUGIN PANORAMA PHOTO; Degen J, 2016, CURR BIOL, V26, P2800, DOI 10.1016/j.cub.2016.08.013; Dewar ADM, 2015, BIOSYSTEMS; Dewar ADM, 2014, ADAPT BEHAV, V22, P163, DOI 10.1177/1059712313516132; Fleischmann PN, 2017, J EXP BIOL, V220, P2426, DOI 10.1242/jeb.158147; Fleischmann PN, 2016, J EXP BIOL, V219, P3137, DOI 10.1242/jeb.140459; Gaffin DD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122077; Graham P, 2010, CURR BIOL, V20, pR639, DOI 10.1016/j.cub.2010.06.018; Graham P, 2009, CURR BIOL, V19, pR935, DOI 10.1016/j.cub.2009.08.015; Graham P, 2009, J COMP PHYSIOL A, V195, P681, DOI 10.1007/s00359-009-0443-6; Kollmeier T, 2007, J OPT SOC AM A, V24, P1, DOI 10.1364/JOSAA.24.000001; Mangan M, 2012, BEHAV ECOL, V23, P944, DOI 10.1093/beheco/ars051; Mangan M, 2009, BIOL CYBERN, V101, P307, DOI 10.1007/s00422-009-0338-1; Menzel R, 2015, J COMP PHYSIOL A, V201, P547, DOI 10.1007/s00359-015-0987-6; Moller R, 2002, J THEOR BIOL, V214, P619, DOI 10.1006/jtbi.2001.2484; Muller M, 2010, CURR BIOL, V20, P1368, DOI 10.1016/j.cub.2010.06.035; Narendra A, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0683; Philippides A, 2016, C BIOM BIOH SYST, P263; Philippides A, 2011, J EXP BIOL, V214, P445, DOI 10.1242/jeb.046755; Stone T., 2014, ROBOT SCI SYST, V10, P47; Sturzl W, 2008, J EXP PSYCHOL ANIM B, V34, P1, DOI 10.1037/0097-7403.34.1.1; Sturzl W, 2007, BIOL CYBERN, V96, P519, DOI 10.1007/s00422-007-0147-3; Sturzl W, 2016, CURR BIOL, V26, P470, DOI 10.1016/j.cub.2015.12.052; Sturzl W, 2015, J COMP PHYSIOL A, V201, P563, DOI 10.1007/s00359-015-1002-y; Towne WF, 2017, J EXP BIOL; Webb B, 2016, CURR OPIN INSECT SCI, V15, P27, DOI 10.1016/j.cois.2016.02.011; Wystrach A, 2016, J COMP PHYSIOL A, V202, P87, DOI 10.1007/s00359-015-1052-1; Wystrach A, 2012, J EXP BIOL, V215, P44, DOI 10.1242/jeb.059584; Zahedi M, FRACTAL DIMENS UNPUB; Zeil J, 2003, J OPT SOC AM A, V20, P450, DOI 10.1364/JOSAA.20.000450; Zeil J, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0034; Zeil J, 2012, CURR OPIN NEUROBIOL, V22, P285, DOI 10.1016/j.conb.2011.12.008	37	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187226	10.1371/journal.pone.0187226	http://dx.doi.org/10.1371/journal.pone.0187226			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088300	gold, Green Submitted, Green Published			2022-12-26	WOS:000414088900051
J	Chkhartishvili, N; Chokoshvili, O; Bolokadze, N; Tsintsadze, M; Sharvadze, L; Gabunia, P; Dvali, N; Abutidze, A; Tsertsvadze, T				Chkhartishvili, Nikoloz; Chokoshvili, Otar; Bolokadze, Natalia; Tsintsadze, Maya; Sharvadze, Lali; Gabunia, Pati; Dvali, Natia; Abutidze, Akaki; Tsertsvadze, Tengiz			Late presentation of HIV infection in the country of Georgia: 2012-2015	PLOS ONE			English	Article							EASTERN-EUROPEAN COUNTRY; INJECTING DRUG-USE; ANTIRETROVIRAL THERAPY; COHORT; DEATH; CARE; MORTALITY; INDIVIDUALS; DIAGNOSIS; PEOPLE	Late presentation for HIV care has important individual and population implications. The objective of this study was to explore the problem of late presentation in the country of Georgia. Data on adult persons newly diagnosed with HIV in Georgia between 2012 and 2015 were extracted from the national AIDS Health Information System. Late presenter was defined as a person diagnosed with HIV with a CD4 cell count <350 cells/mm(3) or an AIDS defining illness regardless of the CD4 cell count in the six months after HIV diagnosis. Late presenter with advanced disease was defined as a person diagnosed with HIV with a CD4 cell count <200 cells/mm(3) or an AIDS defining illness, regardless of CD4 cell count in the six months after HIV diagnosis. Among 2267 adults diagnosed with HIV in Georgia in 2012-2015, 1987 (87.6%) had CD4 cell count measured within 6 months of HIV diagnosis and were included in the analysis. Among them 1260 (63.4%) patients were classified as late presenters and 870 (43.8%) as late presenters with advanced disease. The proportion of late presenters declined from 71.1% in 2012 to 55.5% in 2015 (p<0.0001), while presentation late with advanced disease decreased from 56.6% in 2012 to 34.5% in 2015 (p<0.0001). Late presentation was most common among people who inject drugs (77.7%). Overall 186 patients died over the studied period. Mortality was higher both among late presenters (6.74 per 100 person-years vs. 1.08 per 100 person-years, p<0.0001) and late presenters with advanced disease (8.93 per 100 person-years vs. 1.34 per 100 person-years, p<0.0001). High prevalence of late presentation in Georgia reflects insufficiency in HIV testing services. Better testing strategies are needed to improve earlier diagnosis and disease outcomes.	[Chkhartishvili, Nikoloz; Chokoshvili, Otar; Bolokadze, Natalia; Tsintsadze, Maya; Sharvadze, Lali; Gabunia, Pati; Dvali, Natia; Abutidze, Akaki; Tsertsvadze, Tengiz] AIDS & Clin Immunol Res Ctr, Infect Dis, Tbilisi, Georgia; [Sharvadze, Lali; Tsertsvadze, Tengiz] Ivane Javakhishvili Tbilisi State Univ, Tbilisi, Georgia	Ivane Javakhishvili Tbilisi State University	Chkhartishvili, N (corresponding author), AIDS & Clin Immunol Res Ctr, Infect Dis, Tbilisi, Georgia.	nc@aidscenter.ge	Tsertsvadze, Tengiz/GXG-5822-2022; Gabunia, Pati/AAJ-9790-2021; Chokoshvili, Otar/F-7394-2018; Chokoshvili, Otar/AAG-3477-2021	Tsertsvadze, Tengiz/0000-0002-4986-7874; Chokoshvili, Otar/0000-0003-3023-1902; Chokoshvili, Otar/0000-0003-3023-1902; Chkhartishvili, Nikoloz/0000-0002-1309-825X	Infectious Diseases, AIDS and Clinical Immunology Research Center	Infectious Diseases, AIDS and Clinical Immunology Research Center	The work was supported with internal resources of the Infectious Diseases, AIDS and Clinical Immunology Research Center. No external funding was available for this work.; Authors would like to thank all persons involved in the implementation of national HIV programs. This study would not be possible without support provided by Infectious Diseases, AIDS and Clinical Immunology Research Center.	[Anonymous], HIV RISK PREVENTION; [Anonymous], 1993, MMWR RECOMM REP, V41, P1; Antinori A, 2011, HIV MED, V12, P61, DOI 10.1111/j.1468-1293.2010.00857.x; Chene G, 2016, INT J EPIDEMIOL; Chkhartishvili N, 2015, HIV MED, V16, P62, DOI 10.1111/hiv.12172; Chkhartishvili N, 2012, LATE HIV DIAGNOSIS G; Chkhartishvili N, 2016, TCM GMJ, V1, P11; Chkhartishvili N, 2014, AIDS RES HUM RETROV, V30, P560, DOI [10.1089/aid.2013.0219, 10.1089/AID.2013.0219]; Degenhardt L, 2014, INT J DRUG POLICY, V25, P53, DOI 10.1016/j.drugpo.2013.08.004; Dickson NP, 2012, HIV MED, V13, P182, DOI 10.1111/j.1468-1293.2011.00959.x; European Centre for Disease Prevention and Control, 2016, HIV AIDS SURV EUR 20; Garriga C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145701; Hachfeld A, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20317; Kowalska JD, 2016, HIV MED; Kowalska JD, 2011, EPIDEMIOLOGY, V22, P516, DOI 10.1097/EDE.0b013e31821b5332; Lodi S, 2011, CLIN INFECT DIS, V53, P817, DOI 10.1093/cid/cir494; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; May M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6016; Mocroft, 2015, EUROSURVEILLANCE, V20, P47, DOI [DOI 10.2807/1560-7917.ES.2015.20.47.30070, DOI HTTPS://DOI.ORG/10.2807/1560-7917.ES.2015.20.47.30070]; Mocroft A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001510; Moreno S, 2010, ANTIVIR THER, V15, P9, DOI 10.3851/IMP1523; Murray M, 2012, HIV MED, V13, P89, DOI 10.1111/j.1468-1293.2011.00940.x; O'Connell S, 2016, INT J STD AIDS; Otiashvili D, 2016, SUBST ABUSE TREAT PR, V11, DOI 10.1186/s13011-016-0049-2; Raffetti E, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3477-z; Skarbinski J, 2015, JAMA INTERN MED, V175, P588, DOI 10.1001/jamainternmed.2014.8180; Sobrino-Vegas P, 2016, J INFECTION, V72, P587, DOI 10.1016/j.jinf.2016.01.017; Tsereteli N, 2015, HIV RISK PREVENTION; Tsereteli N, 2014, HIV RISK PREVENTION; Tsertsvadze T, 2009, GUIDELLINES ROUTINE; Tsertsvadze T, 2014, INT J STD AIDS, V25, P913, DOI 10.1177/0956462414525939; UNAIDS, 2016, PREV GAP REP; Weber R, 2015, HIV MED, V16, P137, DOI 10.1111/hiv.12184; Zoufaly A, 2012, HIV MED, V13, P172, DOI 10.1111/j.1468-1293.2011.00958.x	34	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0186835	10.1371/journal.pone.0186835	http://dx.doi.org/10.1371/journal.pone.0186835			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084276	gold, Green Submitted, Green Published			2022-12-26	WOS:000413910200015
J	Kim, HS; Kim, YY; Oh, JK; Bae, KH				Kim, Hye-Sung; Kim, Young-Youn; Oh, Jeong-Kyu; Bae, Kwang-Hak			Is yogurt intake associated with periodontitis due to calcium?	PLOS ONE			English	Article							DAIRY-PRODUCTS; LACTOBACILLUS-REUTERI; RISK-FACTORS; DISEASE; ADULTS; OLDER	The purpose of this study is to determine whether the lower intakes of yogurt, milk, and calcium are associated with periodontitis in a nationally representative sample of Korean adults. This study comprised 6,150 adults 19 or more years old who took both periodontal examination and nutrition survey. The frequency of yogurt and milk intake was examined with a food frequency questionnaire. The amount of calcium intake was calculated with dietary intakes data gained from complete one-day 24-hour recall interviews. Periodontitis was assessed using the Community Periodontal Index (CPI). Multivariate logistic regression analyses were performed for the whole sample and subgroups with the strata of age, gender, or smoking, in a complex sampling design. Less intake of yogurt was significantly associated with periodontitis (odds ratio [OR] 0.82, 95% confidential interval [CI] 0.70 +/- 0.97), but neither less intake of milk (OR 1.04, 95% CI 0.89 +/- 1.20) nor lower intake of calcium (OR 1.04, 95% CI 0.89 +/- 1.21) was significantly associated with periodontitis. In the subgroup analysis, no difference in the association of yogurt intake with periodontitis was found according to the strata of age, gender, and smoking. In conclusion, periodonitis was significantly associated with the less intake of yogurt among the Korean adults, but the calcium contained in yogurt is not likely to cause it.	[Kim, Hye-Sung; Kim, Young-Youn; Oh, Jeong-Kyu; Bae, Kwang-Hak] Apple tree Dent Hosp, Oral Hlth Sci Res Ctr, Goyang Si, Gyounggi Do, South Korea		Bae, KH (corresponding author), Apple tree Dent Hosp, Oral Hlth Sci Res Ctr, Goyang Si, Gyounggi Do, South Korea.	baekh@snu.ac.kr						Adegboye ARA, 2012, NUTRIENTS, V4, P1219, DOI 10.3390/nu4091219; Al-Zahrani MS, 2006, J PERIODONTOL, V77, P289, DOI 10.1902/jop.2006.050082; Al-Zahrani Mohammad S, 2005, J Int Acad Periodontol, V7, P21; Albandar JM, 1999, J PERIODONTOL, V70, P13, DOI 10.1902/jop.1999.70.1.13; Albandar JM, 2002, PERIODONTOL 2000, V29, P177, DOI 10.1034/j.1600-0757.2002.290109.x; Genco RJ, 1996, J PERIODONTOL, V67, P1041, DOI 10.1902/jop.1996.67.10s.1041; Hur Inyoung, 2011, Osong Public Health Res Perspect, V2, P192, DOI 10.1016/j.phrp.2011.11.044; Kingman A, 2002, PERIODONTOL 2000, V29, P11, DOI 10.1034/j.1600-0757.2002.290102.x; Korea Center for Disease Control and Prevention, 2010, GUID RAW MAT FORT KO; Korea Center for Disease Control and Prevention, 2010, GUID RAW MAT FORTH K; Korea Centers for Disease Control and Prevention, 2010, SMAPL DES FORTH KOR; Korea Centers for Disease Control and Prevention, 2010, FORTH KOR NAT HLTH N; Korea Centers for Disease Control & Prevention, 2010, STAND OR HLTH SURV K; Korea Health Industry Development Institute (KHIDI), 2019, KOR NAT HLTH NUTR EX; Lee HS, 2009, 2009 14TH OPTOELECTRONICS AND COMMUNICATIONS CONFERENCE (OECC 2009), P9, DOI 10.1109/NUSOD.2009.5297207; Nishida M, 2000, J PERIODONTOL, V71, P1215, DOI 10.1902/jop.2000.71.8.1215; Nishida M, 2000, J PERIODONTOL, V71, P1057, DOI 10.1902/jop.2000.71.7.1057; Petersen PE, 2012, PERIODONTOL 2000, V60, P15, DOI 10.1111/j.1600-0757.2011.00425.x; Shimazaki Y, 2008, J PERIODONTOL, V79, P131, DOI [10.1902/jop.2008.070202, 10.1902/jop.2008.070202 ]; Sookkhee S, 2001, J APPL MICROBIOL, V90, P172, DOI 10.1046/j.1365-2672.2001.01229.x; Tekce M, 2015, J CLIN PERIODONTOL, V42, P363, DOI 10.1111/jcpe.12387; Teughels W, 2013, J CLIN PERIODONTOL, V40, P1025, DOI 10.1111/jcpe.12155; The Korean Nutrition Society, 2010, DIET REF INT KOR 201; Twetman S, 2009, ACTA ODONTOL SCAND, V67, P19, DOI 10.1080/00016350802516170; Van Loan M, 2009, J AM COLL NUTR, V28, p120S, DOI 10.1080/07315724.2009.10719805; WILLIAMS RC, 1990, NEW ENGL J MED, V322, P373, DOI 10.1056/NEJM199002083220606; World Health Organization, 2013, ORAL HLTH SURVEYS BA, V5th edn, p., P19	27	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187258	10.1371/journal.pone.0187258	http://dx.doi.org/10.1371/journal.pone.0187258			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084251	gold, Green Published, Green Submitted			2022-12-26	WOS:000413910200042
J	Scibisz, G; Dec, R; Dzwolak, W				Scibisz, Grzegorz; Dec, Robert; Dzwolak, Wojciech			Mellitate: A multivalent anion with extreme charge density causes rapid aggregation and misfolding of wild type lysozyme at neutral pH	PLOS ONE			English	Article							THIOFLAVIN-T; AMYLOID FIBRILS; ACID; PROTEINS; INSULIN; MARS; STABILIZATION; STABILITY; SALT	Due to its symmetric structure and abundance of carboxyl groups, mellitic acid (MA-benzenehexacarboxylic acid) has an uncommon capacity to form highly ordered molecular networks. Dissolved in water, MA dissociates to yield various mellitate anions with pronounced tendencies to form complexes with cations including protonated amines. Deprotonation of MA at physiological pH produces anions with high charge densities (MA(5-) and MA(6-)) whose influence on co-dissolved proteins has not been thoroughly studied. As electrostatic attraction between highly symmetric MA(6-) anions and positively charged low-symmetry globular proteins could lead to interesting self-assembly patterns we have chosen hen egg white lysozyme (HEWL), a basic stably folded globular protein as a cationic partner for mellitate anions to form such hypothetical nanostructures. Indeed, mixing of neutral HEWL and MA solutions does result in precipitation of electrostatic complexes with the stoichiometry dependent on pH. We have studied the self-assembly of HEWL-MA structures using vibrational spectroscopy (infrared absorption and Raman scattering), circular dichroism (CD), atomic force microscopy (AFM). Possible HEWL-MA(6-) molecular docking scenarios were analyzed using computational tools. Our results indicate that even at equimolar ratios (in respect to HEWL), MA(5-) and MA(6-) anions are capable of inducing misfolding and aggregation of the protein upon mild heating which results in non-native intermolecular beta-sheet appearing in the amide I' region of the corresponding infrared spectra. The association process leads to aggregates with compacted morphologies entrapping mellitate anions. The capacity of extremely diluted mellitate anions (i.e. at sub-millimolar concentration range) to trigger aggregation of proteins is discussed in the context of mechanisms of misfolding.	[Scibisz, Grzegorz; Dec, Robert; Dzwolak, Wojciech] Univ Warsaw, Fac Chem, Biol & Chem Res Ctr, Warsaw, Poland	University of Warsaw	Dzwolak, W (corresponding author), Univ Warsaw, Fac Chem, Biol & Chem Res Ctr, Warsaw, Poland.	wdzwolak@chem.umeci.pl		Dzwolak, Wojciech/0000-0002-1407-1497	National Science Centre of Poland [DEC-2011/03/B/ST4/03063]; University of Warsaw [501/64-BST-176309]; EU from European Regional Development Fund under Operational Programme Innovative Economy; EU programme	National Science Centre of Poland(National Science Centre, Poland); University of Warsaw; EU from European Regional Development Fund under Operational Programme Innovative Economy; EU programme	This work was supported by the National Science Centre of Poland, grant no. DEC-2011/03/B/ST4/03063, and in part by University of Warsaw project 501/64-BST-176309. The study was carried out at the Biological and Chemical Research Centre, University of Warsaw, established within the project co-financed by EU from the European Regional Development Fund under the Operational Programme Innovative Economy, 2007-2013, and with the use of CePT infrastructure financed by the same EU programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolvahabi A, 2015, BIOPHYS J, V108, P1199, DOI 10.1016/j.bpj.2015.01.014; Amdursky N, 2012, ACCOUNTS CHEM RES, V45, P1548, DOI 10.1021/ar300053p; Apelblat A, 2006, J PHYS CHEM B, V110, P8893, DOI 10.1021/jp057371s; Azia A, 2009, J MOL BIOL, V393, P527, DOI 10.1016/j.jmb.2009.08.010; Babenko V, 2015, LANGMUIR, V31, P2180, DOI 10.1021/la5048694; Benner SA, 2000, P NATL ACAD SCI USA, V97, P2425, DOI 10.1073/pnas.040539497; BLAKE CCF, 1965, NATURE, V206, P757, DOI 10.1038/206757a0; Blanco Y, 2013, ICARUS, V224, P326, DOI 10.1016/j.icarus.2012.06.006; BUCCI E, 1978, J BIOL CHEM, V253, P821; Bye JW, 2014, J PHYS CHEM B, V118, P4282, DOI 10.1021/jp412140v; Chang ESH, 2009, J MOL BIOL, V385, P1257, DOI 10.1016/j.jmb.2008.11.009; Colton IJ, 1997, J AM CHEM SOC, V119, P12701, DOI 10.1021/ja9723491; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Halskau O, 2008, P NATL ACAD SCI USA, V105, P8625, DOI 10.1073/pnas.0709881105; Humphrey SM, 2010, INORG CHEM, V49, P3441, DOI 10.1021/ic902527e; Inabe T, 2005, J MATER CHEM, V15, P1317, DOI 10.1039/b413848a; Jehlicka J, 2006, SPECTROCHIM ACTA A, V65, P229, DOI 10.1016/j.saa.2005.10.036; Johnson BB, 2004, LANGMUIR, V20, P823, DOI 10.1021/la035471o; Karle IL, 2005, J CHEM CRYSTALLOGR, V35, P835, DOI 10.1007/sl0870-005-4554-9; Karle IL, 2009, J CHEM CRYSTALLOGR, V39, P201, DOI 10.1007/s10870-008-9458-z; Kiyotsukuri T, 1995, POLYMER, V36, P5045, DOI 10.1016/0032-3861(96)81634-X; Kvaratskhelia E, 2008, J SOLUTION CHEM, V37, P1063, DOI 10.1007/s10953-008-9292-0; Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Linding R, 2004, J MOL BIOL, V342, P345, DOI 10.1016/j.jmb.2004.06.088; MALLETTE MF, 1967, J BACTERIOL, V94, P283, DOI 10.1128/JB.94.2.283-290.1967; McMenimen KA, 2001, J AM CHEM SOC, V123, P6453, DOI 10.1021/ja016043c; Minemawari H, 2009, CRYST GROWTH DES, V9, P4830, DOI 10.1021/cg900655v; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; MOZHAEV VV, 1988, EUR J BIOCHEM, V173, P147, DOI 10.1111/j.1432-1033.1988.tb13978.x; NAGATA M, 1995, POLYMER, V36, P2657, DOI 10.1016/0032-3861(95)91214-R; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Park LY, 2003, J AM CHEM SOC, V125, P10586, DOI 10.1021/ja036540o; Piejko M, 2015, J BIOL CHEM, V290, P5947, DOI 10.1074/jbc.M114.608844; Plater MJ, 2015, J CHEM RES, P279, DOI 10.3184/174751915X14303279945021; Rousseau F, 2006, CURR OPIN STRUC BIOL, V16, P118, DOI 10.1016/j.sbi.2006.01.011; Stalport F, 2009, ASTROBIOLOGY, V9, P543, DOI 10.1089/ast.2008.0300; Strickler SS, 2006, BIOCHEMISTRY-US, V45, P2761, DOI 10.1021/bi0600143; Stsiapura VI, 2008, J PHYS CHEM B, V112, P15893, DOI 10.1021/jp805822c; Wu LP, 1995, INORG CHIM ACTA, V239, P165, DOI 10.1016/0020-1693(95)04713-1; Zhou T, 2010, J CHROMATOGR A, V1217, P82, DOI 10.1016/j.chroma.2009.11.016; Zurdo J, 2001, J AM CHEM SOC, V123, P8141, DOI 10.1021/ja016229b	43	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187328	10.1371/journal.pone.0187328	http://dx.doi.org/10.1371/journal.pone.0187328			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084264	Green Published, Green Submitted, gold			2022-12-26	WOS:000413910200051
J	Qi, M; Jiao, M; Li, X; Hu, J; Wang, L; Zou, Y; Zhao, M; Zhang, R; Liu, H; Mi, J; Zhang, L; Liu, L; Gong, Y; Han, B				Qi, M.; Jiao, M.; Li, X.; Hu, J.; Wang, L.; Zou, Y.; Zhao, M.; Zhang, R.; Liu, H.; Mi, J.; Zhang, L.; Liu, L.; Gong, Y.; Han, B.			CUL4B promotes gastric cancer invasion and metastasis-involvement of upregulation of HER2	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; PROSTATE-CANCER; TUMORIGENESIS; PROGRESSION; CARCINOMA; MICRORNAS; PATHWAY	Cullin 4B (CUL4B) is a scaffold protein overexpressed in several solid malignancies. It is known to silence tumor suppressor through post-transcriptional manner. However, its clinical significance and underlying molecular mechanisms in gastric cancer (GC) remain largely unknown. In this study, we found that CUL4B was significantly overexpressed in GC tissues and its overexpression was correlated with lymph node metastasis and poor prognosis. Through gain-and loss-of-function experiments, we showed that CUL4B promotes GC cell invasion and epithelial-mesenchymal transition (EMT) in vitro, as well as tumor growth and metastasis in vivo. Mechanistically, we identified HER2 as a downstream target gene of CUL4B in GC. CUL4B unregulated HER2 expression via transcriptionally repressing miR-125a. Intriguingly, HER2 inhibitors significantly reversed CUL4B-induced EMT in vitro and partially blocked GC metastasis in tumor xenografts with CUL4B overexpression. Finally, we suggested the involvement of the PI3K/AKT pathway in CUL4B-induced HER2 upregulation in GC. In all, we proposed a model for a CUL4B-miR-125a-HER2 oncoprotein axis, which provided novel insight into how HER2 was activated and contributed to GC progression and metastasis.	[Qi, M.; Jiao, M.; Li, X.; Hu, J.; Zou, Y.; Zhao, M.; Zhang, R.; Liu, H.; Mi, J.; Zhang, L.; Gong, Y.; Han, B.] Shandong Univ, QiLu Med Coll, Sch Basic Med Sci, Key Lab Expt Teratol,Minist Educ, Jinan 250012, Shandong, Peoples R China; [Qi, M.; Jiao, M.; Li, X.; Hu, J.; Zhao, M.; Zhang, R.; Liu, H.; Zhang, L.; Han, B.] Shandong Univ, QiLu Med Coll, Sch Basic Med Sci, Dept Pathol, Jinan 250012, Shandong, Peoples R China; [Qi, M.; Liu, L.; Han, B.] Shandong Univ, Dept Pathol, Qilu Hosp, Jinan, Shandong, Peoples R China; [Li, X.] Binzhou Peoples Hosp, Dept Pathol, Binzhou, Peoples R China; [Wang, L.] Shandong Acad Med Sci, Res Ctr Med Biotechnol, Key Lab Rare & Uncommon Dis Shandong Prov, Jinan, Shandong, Peoples R China; [Zou, Y.; Mi, J.; Gong, Y.] Shandong Univ, QiLu Med Coll, Sch Basic Med Sci, Key Lab Expt Teratol,Minist Educ, Jinan 250012, Shandong, Peoples R China; [Zou, Y.; Mi, J.; Gong, Y.] Shandong Univ, QiLu Med Coll, Sch Basic Med Sci, Dept Mol Med & Genet, Jinan 250012, Shandong, Peoples R China; [Zhao, M.] Binzhou Med Coll, Affiliated Hosp, Dept Pathol, Binzhou, Peoples R China; [Zhang, R.] Xintai Tradit Chinese Med Hosp, Dept Pathol, Tai An, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong University; Shandong University; Binzhou Medical University	Han, B (corresponding author), Shandong Univ, QiLu Med Coll, Sch Basic Med Sci, Key Lab Expt Teratol,Minist Educ, Jinan 250012, Shandong, Peoples R China.; Han, B (corresponding author), Shandong Univ, QiLu Med Coll, Sch Basic Med Sci, Dept Pathol, Jinan 250012, Shandong, Peoples R China.	boh@sdu.edu.cn			National Natural Science Foundation of China [81672554, 81472417, 31371369, 31671427]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Baichun Jiang for technical assistance. This work was supported by National Natural Science Foundation of China (Grants No. 81672554 and 81472417 to BH, 31371369 and 31671427 to YZ).	Bang YJ, 2010, LANCET, V376, P1302; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen RS, 2009, ONCOGENE, V28, P599, DOI 10.1038/onc.2008.414; Gravalos C, 2008, ANN ONCOL, V19, P1523, DOI 10.1093/annonc/mdn169; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Hu HL, 2012, CANCER CELL, V22, P781, DOI 10.1016/j.ccr.2012.10.024; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Ji QH, 2014, J CELL SCI, V127, P4679, DOI 10.1242/jcs.154245; Jiang T, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0534-7; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; Lee J, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00021; Lin CH, 2016, ONCOTARGET, V7, P39680, DOI 10.18632/oncotarget.9444; Liu HT, 2016, TUMOR BIOL, V37, P15383, DOI 10.1007/s13277-016-5436-9; Liu HT, 2015, ONCOTARGET, V6, P37467, DOI 10.18632/oncotarget.6059; Mi J, 2017, MOL ONCOL, V11, P305, DOI 10.1002/1878-0261.12038; Mirzaei H, 2016, CURR MED CHEM, V23, P4135, DOI 10.2174/0929867323666160818093854; Nishida N, 2011, CLIN CANCER RES, V17, P2725, DOI 10.1158/1078-0432.CCR-10-2132; Pencheva N, 2013, NAT CELL BIOL, V15, P546, DOI 10.1038/ncb2769; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Qi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084959; Shan YQ, 2015, CANCER GENE THER, V22, P101, DOI 10.1038/cgt.2014.61; Stern HM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3001539; Sukawa Y, 2014, DIGESTION, V89, P12, DOI 10.1159/000356201; Van Cutsem E, 2016, LANCET, V388, P2654, DOI 10.1016/S0140-6736(16)30354-3; Van Cutsem E, 2015, GASTRIC CANCER, V18, P476, DOI 10.1007/s10120-014-0402-y; Wang CN, 2014, PROSTATE, V74, P689, DOI 10.1002/pros.22787; Wang L, 2015, ONCOTARGET, V6, P35978, DOI 10.18632/oncotarget.5427; Wang L, 2014, PROSTATE, V74, P647, DOI 10.1002/pros.22783; Yang Y, 2015, ONCOGENE, V34, P104, DOI 10.1038/onc.2013.522; Yuan JP, 2015, J PATHOL, V235, P784, DOI 10.1002/path.4492; Zhang C.J., 2016, BIOENERG OPEN ACCESS, V5, P1; Zou YX, 2009, J BIOL CHEM, V284, P33320, DOI 10.1074/jbc.M109.050427	33	31	34	3	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 22	2018	37	8					1075	1085		10.1038/onc.2017.380	http://dx.doi.org/10.1038/onc.2017.380			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FX2QD	29106389				2022-12-26	WOS:000425905700010
J	McMichael, TM; Zhang, LZ; Chemudupati, M; Hach, JC; Kenney, AD; Hang, HC; Yount, JS				McMichael, Temet M.; Zhang, Lizhi; Chemudupati, Mahesh; Hach, Jocelyn C.; Kenney, Adam D.; Hang, Howard C.; Yount, Jacob S.			The palmitoyltransferase ZDHHC20 enhances interferon-induced transmembrane protein 3 (IFITM3) palmitoylation and antiviral activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						influenza virus; innate immunity; interferon; post-translational modification (PTM); protein palmitoylation; DHHC; IFITM; IFITM3; ZDHHC; palmitoyltransferase	WEST NILE VIRUS; S-PALMITOYLATION; FATTY-ACYLATION; SEVERE INFLUENZA; INFECTION; LOCALIZATION; RESISTANCE; STABILITY; RESTRICTS; CELLS	Interferon-induced transmembrane protein 3 (IFITM3) is a cellular endosome- and lysosome-localized protein that restricts numerous virus infections. IFITM3 is activated by palmitoylation, a lipid posttranslational modification. Palmitoylation of proteins is primarily mediated by zinc finger DHHC domain-containing palmitoyltransferases (ZDHHCs), but which members of this enzyme family can modify IFITM3 is not known. Here, we screened a library of human cell lines individually lacking ZDHHCs 1-24 and found that IFITM3 palmitoylation and its inhibition of influenza virus infection remained strong in the absence of any single ZDHHC, suggesting functional redundancy of these enzymes in the IFITM3-mediated antiviral response. In an overexpression screen with 23 mammalian ZDHHCs, we unexpectedly observed that more than half of the ZDHHCs were capable of increasing IFITM3 palmitoylation with ZDHHCs 3, 7, 15, and 20 having the greatest effect. Among these four enzymes, ZDHHC20 uniquely increased IFITM3 antiviral activity when both proteins were overexpressed. ZDHHC20 colocalized extensively with IFITM3 at lysosomes unlike ZDHHCs 3, 7, and 15, which showed a defined perinuclear localization pattern, suggesting that the location at which IFITM3 is palmitoylated may influence its activity. Unlike knock-out of individual ZDHHCs, siRNA-mediated knockdown of both ZDHHC3 and ZDHHC7 in ZDHHC20 knock-out cells decreased endogenous IFITM3 palmitoylation. Overall, our results demonstrate that multiple ZDHHCs can palmitoylate IFITM3 to ensure a robust antiviral response and that ZDHHC20 may serve as a particularly useful tool for understanding and enhancing IFITM3 activity.	[McMichael, Temet M.; Zhang, Lizhi; Chemudupati, Mahesh; Hach, Jocelyn C.; Kenney, Adam D.; Yount, Jacob S.] Ohio State Univ, Dept Microbial Infect & Immun, 460 W 12th Ave,Biomed Res Tower 790, Columbus, OH 43210 USA; [Hang, Howard C.] Rockefeller Univ, Lab Chem Biol & Microbial Pathogenesis, New York, NY 10065 USA	University System of Ohio; Ohio State University; Rockefeller University	Yount, JS (corresponding author), Ohio State Univ, Dept Microbial Infect & Immun, 460 W 12th Ave,Biomed Res Tower 790, Columbus, OH 43210 USA.	yount.37@osu.edu		Yount, Jacob/0000-0002-6128-4575; Chemudupati, Mahesh/0000-0002-6430-2484	National Institutes of Health [AI130110, GM087544]; Gilliam Fellowship for Advanced Study from the Howard Hughes Medical Institute; Ohio State University Systems and Integrative Biology Training Program - National Institutes of Health [GM068412]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI130110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM068412, R01GM087544] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gilliam Fellowship for Advanced Study from the Howard Hughes Medical Institute; Ohio State University Systems and Integrative Biology Training Program - National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant AI130110 (to J. S. Y.) and GM087544 (to H. C. H.), a Gilliam Fellowship for Advanced Study from the Howard Hughes Medical Institute (to T. M. M.), and The Ohio State University Systems and Integrative Biology Training Program funded by National Institutes of Health Grant GM068412 (to A. D. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Allen EK, 2017, NAT MED, V23, P975, DOI 10.1038/nm.4370; Almen MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031961; Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909; Blaskovic S, 2013, FEBS J, V280, P2766, DOI 10.1111/febs.12263; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Charron G, 2011, MOL BIOSYST, V7, P67, DOI 10.1039/c0mb00183j; Charron G, 2009, J AM CHEM SOC, V131, P4967, DOI 10.1021/ja810122f; Chesarino NM, 2017, EMBO REP, V18, P1740, DOI 10.15252/embr.201744100; Chesarino NM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005095; Chesarino NM, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0091-3; Chesarino NM, 2014, FUTURE MICROBIOL, V9, P1151, DOI [10.2217/FMB.14.65, 10.2217/fmb.14.65]; Chesarino NM, 2014, J BIOL CHEM, V289, P11986, DOI 10.1074/jbc.M114.557694; Compton AA, 2016, EMBO REP, V17, P1657, DOI 10.15252/embr.201642771; Dallavilla T, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004774; Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2006, METHODS, V40, P177, DOI 10.1016/j.ymeth.2006.05.015; Gorman MJ, 2016, J VIROL, V90, P8212, DOI 10.1128/JVI.00581-16; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Hach JC, 2013, J VIROL, V87, P9923, DOI 10.1128/JVI.00621-13; Huang K, 2009, FASEB J, V23, P2605, DOI 10.1096/fj.08-127399; Jia R, 2012, J VIROL, V86, P13697, DOI 10.1128/JVI.01828-12; Kaur I, 2016, J NEUROSCI, V36, P7562, DOI 10.1523/JNEUROSCI.4859-14.2016; Korycka J, 2012, EUR J CELL BIOL, V91, P107, DOI 10.1016/j.ejcb.2011.09.013; Lakkaraju AKK, 2012, EMBO J, V31, P1823, DOI 10.1038/emboj.2012.15; Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124; Lin TY, 2013, CELL REP, V5, P895, DOI 10.1016/j.celrep.2013.10.033; Linder ME, 2013, BIOCHEM SOC T, V41, P29, DOI 10.1042/BST20120328; Lynes EM, 2013, J CELL SCI, V126, P3893, DOI 10.1242/jcs.125856; Melvin WJ, 2015, VIRUSES-BASEL, V7, P3035, DOI 10.3390/v7062759; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Moltedo B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002345; Narayana SK, 2015, J BIOL CHEM, V290, P25946, DOI 10.1074/jbc.M115.657346; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Pedram A, 2012, MOL BIOL CELL, V23, P188, DOI 10.1091/mbc.E11-07-0638; Percher A, 2016, P NATL ACAD SCI USA, V113, P4302, DOI 10.1073/pnas.1602244113; Poddar S, 2016, J VIROL, V90, P8780, DOI 10.1128/JVI.00655-16; Runkle KB, 2016, MOL CELL, V62, P385, DOI 10.1016/j.molcel.2016.04.003; Shan Z, 2013, J BIOL CHEM, V288, P35093, DOI 10.1074/jbc.M113.511949; Sharma C, 2008, MOL BIOL CELL, V19, P3415, DOI 10.1091/mbc.E07-11-1164; Swarthout JT, 2005, J BIOL CHEM, V280, P31141, DOI 10.1074/jbc.M504113200; Tsukamoto T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075831; Tsutsumi R, 2009, MOL CELL BIOL, V29, P435, DOI 10.1128/MCB.01144-08; Vavouri T, 2008, TRENDS GENET, V24, P485, DOI 10.1016/j.tig.2008.08.005; Wang ZF, 2014, P NATL ACAD SCI USA, V111, P769, DOI 10.1073/pnas.1321748111; Xuan Y, 2015, EPIDEMIOL INFECT, V143, P2975, DOI 10.1017/S0950268815000278; Yount JS, 2006, J IMMUNOL, V177, P4503, DOI 10.4049/jimmunol.177.7.4503; Yount JS, 2013, CURR OPIN CHEM BIOL, V17, P27, DOI 10.1016/j.cbpa.2012.11.008; Yount Jacob S, 2011, Curr Protoc Chem Biol, V3, P65; Yount JS, 2012, J BIOL CHEM, V287, P19631, DOI 10.1074/jbc.M112.362095; Yount JS, 2012, BIOORGAN MED CHEM, V20, P650, DOI 10.1016/j.bmc.2011.03.062; Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/NCHEMBIO.405, 10.1038/nchembio.405]; Zhang YH, 2015, AIDS, V29, P889, DOI 10.1097/QAD.0000000000000632	57	46	47	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21517	21526		10.1074/jbc.M117.800482	http://dx.doi.org/10.1074/jbc.M117.800482			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29079573	hybrid, Green Published			2022-12-26	WOS:000419013000026
J	Barthel, D; Kriston, L; Fordjour, D; Mohammed, Y; Kra-Yao, ED; Kotchi, CEB; Armel, EJK; Eberhardt, KA; Feldt, T; Hinz, R; Mathurin, K; Schoppen, S; Bindt, C; Ehrhardt, S				Barthel, Dana; Kriston, Levente; Fordjour, Daniel; Mohammed, Yasmin; Kra-Yao, Esther Doris; Kotchi, Carine Esther Bony; Armel, Ekissi Jean Koffi; Eberhardt, Kirsten Alexandra; Feldt, Torsten; Hinz, Rebecca; Mathurin, Koffi; Schoppen, Stefanie; Bindt, Carola; Ehrhardt, Stephan		Int CDS Study Grp	Trajectories of maternal ante- and postpartum depressive symptoms and their association with child-and mother-related characteristics in a West African birth cohort study	PLOS ONE			English	Article							GENERALIZED ANXIETY DISORDER; MIDDLE-INCOME COUNTRIES; RISK-FACTORS; PREGNANT-WOMEN; COTE-DIVOIRE; PSYCHOMETRIC PROPERTIES; ANTENATAL DEPRESSION; POSTNATAL DEPRESSION; MENTAL-HEALTH; PREVALENCE	Background The vast majority of research on mental health has been undertaken in high income countries. This study aimed at investigating the long-term course of maternal depressive symptoms and its association with various mother-and child-related characteristics in two West African lower middle income countries with focus on the relationship with long-term anxiety symptoms. Methods In the Child Development Study, a prospective birth cohort study in Cote d'lvoire and Ghana, the 9-item Patient Health Questionnaire (PHQ-9) was answered by N= 776 women 3 months antepartum, and 3, 12, and 24 months postpartum between April 2010 and March 2014. Growth mixture modeling was used to identify distinct trajectories of depressive symptoms. Several psychosocial, obstetric, and sociodemographic characteristics were assessed and multinomial regression analysis was performed to investigate the influence of these variables on the different depression trajectories. Results We found three distinct classes of depressive symptoms that were characterized by an asymptomatic trajectory (91.5%), by recurrent risk (4.3%) and by postnatal risk (4.3%). The longitudinal course of depressive symptoms was strongly associated with anxiety symptoms chi(2) = 258.54, df = 6, p < 0.001; phi = .577). Among other factors, higher levels of anxiety, new pregnancy 2 years after birth, economic stress, and family stress were associated with the risk classes. Conclusions A substantial proportion of West African women in our sample developed unfavorable patterns of depressive symptoms during the vulnerable phase of pregnancy and early motherhood. Psychosocial factors, especially antepartum anxiety symptoms, played a decisive role in this process. Perceived economic hardship further exaggerated the mental health burden.	[Barthel, Dana; Eberhardt, Kirsten Alexandra; Feldt, Torsten; Hinz, Rebecca; Schoppen, Stefanie; Ehrhardt, Stephan] Bernhard Nocht Inst Trop Med, Clin Res Unit, Hamburg, Germany; [Barthel, Dana; Bindt, Carola] Univ Med Ctr Hamburg Eppendorf, Dept Child & Adolescent Psychiat Psychotherapy &, Hamburg, Germany; [Kriston, Levente] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany; [Fordjour, Daniel; Mohammed, Yasmin] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Dept Behav Sci, Kumasi, Ghana; [Kra-Yao, Esther Doris] Univ Alassane Ouattara, Ctr Rech Dev, Lab Sante Nutr & Hyg, Bouake, Cote Ivoire; [Kotchi, Carine Esther Bony; Armel, Ekissi Jean Koffi] Univ Felix Houphouet Boigny Cocody, Dept Psychol, Abidjan, Cote Ivoire; [Feldt, Torsten] Heinrich Heine Univ, Clin Gastroenterol Hepatol & Infect Dis, Dusseldorf, Germany; [Hinz, Rebecca] Univ Med Ctr Hamburg Eppendorf, Inst Med Microbiol Virol & Hyg, Hamburg, Germany; [Mathurin, Koffi] Jean Lorougnon Guede Univ, Lab Interact Hote Microorganisme, Daloa, Cote Ivoire; [Schoppen, Stefanie] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Bernhard Nocht Institut fur Tropenmedizin; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Kwame Nkrumah University Science & Technology; Heinrich Heine University Dusseldorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Barthel, D (corresponding author), Bernhard Nocht Inst Trop Med, Clin Res Unit, Hamburg, Germany.; Barthel, D (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Child & Adolescent Psychiat Psychotherapy &, Hamburg, Germany.	d.barthel@uke.de	Mohammed, Yasmin/AAY-1391-2021; Kriston, Levente/D-1713-2013; Feldt, Torsten/ABF-5894-2021; Eberhardt, Kirsten/AAP-8440-2021	Mohammed, Yasmin/0000-0002-3561-3945; Kriston, Levente/0000-0003-0748-264X; Eberhardt, Kirsten/0000-0002-1002-0326; Barthel, Dana/0000-0001-8779-2554	German Research Foundation (Stephan Ehrhardt, DFG) [EH 384/1-1]	German Research Foundation (Stephan Ehrhardt, DFG)(German Research Foundation (DFG))	Funding for this research was provided by the German Research Foundation (Stephan Ehrhardt, DFG; grant EH 384/1-1). The funders had no role in study design. data collection and analysis, decision to publish, or preparation of the manuscript. URL of the funder: http://www.dfg.de/.	Abuidhail J, 2014, J PSYCHIATR MENT HLT, V21, P573, DOI 10.1111/jpm.12125; Ali NS, 2012, SCI WORLD J, DOI 10.1100/2012/653098; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Andersson L, 2006, ACTA OBSTET GYN SCAN, V85, P937, DOI 10.1080/00016340600697652; Arthur E, 2012, HEALTH ECON REV, V2, DOI 10.1186/2191-1991-2-14; Barry TJ, 2015, PSYCHONEUROENDOCRINO, V52, P251, DOI 10.1016/j.psyneuen.2014.12.003; Barthel D, 2016, J AFFECT DISORDERS, V197, P125, DOI 10.1016/j.jad.2016.03.014; Barthel D, 2015, J AFFECT DISORDERS, V187, P232, DOI 10.1016/j.jad.2015.06.042; Barthel D, 2014, J AFFECT DISORDERS, V169, P203, DOI 10.1016/j.jad.2014.08.004; Bindt C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048396; Black MM, 2016, LANCET; Brittain K, 2015, PAEDIATR PERINAT EP, V29, P505, DOI 10.1111/ppe.12216; Cooper PJ, 1999, BRIT J PSYCHIAT, V175, P554, DOI 10.1192/bjp.175.6.554; Davalos DB, 2012, ARCH WOMEN MENT HLTH, V15, P1, DOI 10.1007/s00737-011-0251-1; Dibaba Y, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-135; Field T, 2003, DEPRESS ANXIETY, V17, P140, DOI 10.1002/da.10071; Fisher J, 2013, J AFFECT DISORDERS, V146, P213, DOI 10.1016/j.jad.2012.09.007; Ghana Statistical Service, 2014, GHANA DEMOGRAPHIC HL; Golbasi Z, 2010, MATERN CHILD HLTH J, V14, P485, DOI 10.1007/s10995-009-0459-0; Goodman SH, 2011, CLIN CHILD FAM PSYCH, V14, P1, DOI 10.1007/s10567-010-0080-1; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Guo N, 2013, AM J EPIDEMIOL, V178, P1394, DOI 10.1093/aje/kwt142; Hartley M, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-9; Heaton TB, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0372-2; Herba CM, 2016, LANCET PSYCHIAT, V3, P983, DOI 10.1016/S2215-0366(16)30148-1; Heron J, 2004, J AFFECT DISORDERS, V80, P65, DOI 10.1016/j.jad.2003.08.004; Husain N, 2011, ARCH WOMEN MENT HLTH, V14, P395, DOI 10.1007/s00737-011-0233-3; IBM Crop, 2011, IBM SPSS STAT WIND V; Institut National de la Statistique (INS) et ICF International, 2012, COT DLVOIR DEM SANT; Jung T, 2008, SOC PERSONAL PSYCHOL, V2, P302, DOI 10.1111/j.1751-9004.2007.00054.x; Kone-Pefoyo A, 2006, REV EPIDEMIOL SANTE, V54, P485, DOI 10.1016/S0398-7620(06)76748-7; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lee AM, 2007, OBSTET GYNECOL, V110, P1102, DOI 10.1097/01.AOG.0000287065.59491.70; Martini J, 2015, J AFFECT DISORDERS, V175, P385, DOI 10.1016/j.jad.2015.01.012; Mora PA, 2009, AM J EPIDEMIOL, V169, P24, DOI 10.1093/aje/kwn283; Nasreen HE, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-22; Patel V, 2007, BRIT J PSYCHIAT, V190, P77, DOI 10.1192/bjp.bp.106.025692; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Ramchandani PG, 2009, J AFFECT DISORDERS, V113, P279, DOI 10.1016/j.jad.2008.05.007; Rubin D. B., 2004, MULTIPLE IMPUTATION; Sawyer A, 2010, J AFFECT DISORDERS, V123, P17, DOI 10.1016/j.jad.2009.06.027; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Sutter-Dallay AL, 2012, J AFFECT DISORDERS, V139, P23, DOI 10.1016/j.jad.2011.08.018; Tsai AC, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001943; Ustun B., 2010, MEASURING HLTH DISAB; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; Weobong B, 2014, J AFFECT DISORDERS, V165, P1, DOI 10.1016/j.jad.2014.04.009; World Health Organization, 2016, MENT HLTH INCL SUST; World Health Organization, 2008, GLOB BURD DIS 2004 U	49	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187267	10.1371/journal.pone.0187267	http://dx.doi.org/10.1371/journal.pone.0187267			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL7JU	29107975	Green Submitted, Green Published, gold			2022-12-26	WOS:000414424600022
J	Meng, HW; Kath, S; Li, DP; Nguyen, QC				Meng, Hsien-Wen; Kath, Suraj; Li, Dapeng; Nguyen, Quynh C.			National substance use patterns on Twitter	PLOS ONE			English	Article							ADOLESCENT ALCOHOL-USE; DRUG-USE; NEIGHBORHOOD DISADVANTAGE; ETHNIC-IDENTITY; RISK BEHAVIORS; ADULTS ALCOHOL; BINGE DRINKING; SOCIAL MEDIA; PREDICTORS; SMOKING	Purpose We examined openly shared substance-related tweets to estimate prevalent sentiment around substance use and identify popular substance use activities. Additionally, we investigated associations between substance-related tweets and business characteristics and demographics at the zip code level. Methods A total of 79,848,992 tweets were collected from 48 states in the continental United States from April 2015-March 2016 through the Twitter API, of which 688,757 were identified as being related to substance use. We implemented a machine learning algorithm (maximum entropy text classifier) to estimate sentiment score for each tweet. Zip code level summaries of substance use tweets were created and merged with the 2013 Zip Code Business Patterns and 2010 US Census Data. Results Quality control analyses with a random subset of tweets yielded excellent agreement rates between computer generated and manually generated labels: 97%, 88%, 86%, 75% for underage engagement in substance use, alcohol, drug, and smoking tweets, respectively. Overall, 34.1% of all substance-related tweets were classified as happy. Alcohol was the most frequently tweeted substance, followed by marijuana. Regression results suggested more convenience stores in a zip code were associated with higher percentages of tweets about alcohol. Larger zip code population size and higher percentages of African Americans and Hispanics were associated with fewer tweets about substance use and underage engagement. Zip code economic disadvantage was associated with fewer alcohol tweets but more drug tweets. Conclusions The patterns in substance use mentions on Twitter differ by zip code economic and demographic characteristics. Online discussions have great potential to glorify and normalize risky behaviors. Health promotion and underage substance prevention efforts may include interactive social media campaigns to counter the social modeling of risky behaviors.	[Meng, Hsien-Wen] Univ Utah, Coll Hlth, Dept Hlth Kinesiol & Recreat, Salt Lake City, UT 84112 USA; [Kath, Suraj] Univ Utah, Sch Comp, Salt Lake City, UT USA; [Li, Dapeng] South Dakota State Univ, Dept Geog, Brookings, SD USA; [Nguyen, Quynh C.] Univ Maryland, Sch Publ Hlth, Dept Epidemiol & Biostat, College Pk, MD 20742 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; South Dakota State University; University System of Maryland; University of Maryland College Park	Meng, HW (corresponding author), Univ Utah, Coll Hlth, Dept Hlth Kinesiol & Recreat, Salt Lake City, UT 84112 USA.	sherry.meng@utah.edu			National Institutes of Healths Big Data to Knowledge Initiative (BD2K) [5K01ES025433, 3K01ES025433-03S1]; UMD Libraries' Open Access Publishing Fund; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K01ES025433] Funding Source: NIH RePORTER	National Institutes of Healths Big Data to Knowledge Initiative (BD2K)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UMD Libraries' Open Access Publishing Fund; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the National Institutes of Healths Big Data to Knowledge Initiative (BD2K) grants 5K01ES025433; 3K01ES025433-03S1 (Dr. Nguyen, PI). Partial funding for open access provided by the UMD Libraries' Open Access Publishing Fund.; This study was supported by the National Institutes of Health's Big Data to Knowledge Initiative (BD2K) grants 5K01ES025433; 3K01ES025433-03S1 (Dr. Nguyen, PD. Partial funding for open access provided by the UMD Libraries' Open Access Publishing Fund. The authors want to thank Matthew McCullough for the creation of figures for this study.	Ahern J, 2009, DRUG ALCOHOL DEPEN, V100, P138, DOI 10.1016/j.drugalcdep.2008.09.012; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; [Anonymous], 2000, NO PLAC HID SUBST AB; [Anonymous], 2016, COMM AB DRUG CHARTS; Boardman JD, 2001, J HEALTH SOC BEHAV, V42, P151, DOI 10.2307/3090175; Brenner AB, 2011, J STUD ALCOHOL DRUGS, V72, P651, DOI 10.15288/jsad.2011.72.651; Brook JS, 1998, PSYCHOL REP, V83, P1427, DOI 10.2466/PR0.83.7.1427-1446; Cavazos-Rehg PA, 2015, J STUD ALCOHOL DRUGS, V76, P635, DOI 10.15288/jsad.2015.76.635; Cavazos-Rehg PA, 2015, J ADOLESCENT HEALTH, V56, P139, DOI 10.1016/j.jadohealth.2014.10.270; Cerda M, 2010, EPIDEMIOLOGY, V21, P482, DOI 10.1097/EDE.0b013e3181e13539; Chan B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135072; Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118; Cody EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136092; Cook SH, 2013, J YOUTH ADOLESCENCE, V42, P1674, DOI 10.1007/s10964-012-9869-1; CURRY SJ, 1993, AM J PREV MED, V9, P78, DOI 10.1016/S0749-3797(18)30744-X; Curtis LH, 2007, MED CARE, V45, pS103, DOI 10.1097/MLR.0b013e31806518ac; De Choudhury M., 2013, P INT AAAI C WEB SOC, P2; Fan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110184; Fox JC, 1999, INT J PSYCHIAT MED, V29, P181, DOI 10.2190/Y4KA-8XYC-KQWH-DUXN; Greggo J, 2005, AM J HEALTH EDUC, V36, P148, DOI 10.1080/19325037.2005.10608176; Hanson CL, 2013, J MED INTERNET RES, V15, P256, DOI 10.2196/jmir.2741; Havens JR, 2011, ARCH PEDIAT ADOL MED, V165, P250, DOI 10.1001/archpediatrics.2010.217; Hearst MO, 2007, PREV MED, V44, P471, DOI 10.1016/j.ypmed.2007.02.018; Karriker-Jaffe KJ, 2016, PREV SCI, V17, P513, DOI 10.1007/s11121-016-0641-8; Karriker-Jaffe KJ, 2012, J STUD ALCOHOL DRUGS, V73, P865, DOI 10.15288/jsad.2012.73.865; Krauss MJ, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.150140; Lee JL, 2014, J MED INTERNET RES, V16, P251, DOI 10.2196/jmir.3765; Lenhart A., 2015, TEENS SOCIAL MEDIA T; Love AS, 2006, PSYCHOL REP, V98, P735, DOI 10.2466/PR0.98.3.735-744; Madden M., 2013, TEENS TECHNOLOGY 201; McDermott MJ, 2013, SUBST ABUS, V34, P371, DOI 10.1080/08897077.2013.776000; Miller JW, 2007, PEDIATRICS, V119, P76, DOI 10.1542/peds.2006-1517; Moreno MA, 2014, ALCOHOL RES-CURR REV, V36, P91; Myslin M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2534; Nagar R, 2014, J MED INTERNET RES, V16, P260, DOI 10.2196/jmir.3416; Naimi TS, 2003, JAMA-J AM MED ASSOC, V289, P70, DOI 10.1001/jama.289.1.70; Nguyen Quynh C, 2016, JMIR Public Health Surveill, V2, pe158; PARKER KD, 1995, J SOC PSYCHOL, V135, P581, DOI 10.1080/00224545.1995.9712231; Paul MJ, 2014, PLOS ONE, V9, DOI [10.1371/currents.outbreaks.90b9ed0f59bae4ccaa683a39865d9117, 10.1371/journal.pone.0103408]; Pew Research Center, 2015, SOCIAL MEDIA USAGE 2; Rhew IC, 2017, J URBAN HEALTH, V94, P542, DOI 10.1007/s11524-017-0161-2; Shah DV, 2015, ANN AM ACAD POLIT SS, V659, P78, DOI DOI 10.1177/0002716215569197; Shah DV, 2015, ANN AM ACAD POLIT SS, V659, P48; SIMPSON GA, 1994, PEDIATRICS, V93, P303; Stoddard SA, 2012, J STUD ALCOHOL DRUGS, V73, P968, DOI 10.15288/jsad.2012.73.968; Theall KP, 2011, ALCOHOL CLIN EXP RES, V35, P996, DOI 10.1111/j.1530-0277.2010.01430.x; Tucker JS, 2015, DRUG ALCOHOL DEPEN, V156, P254, DOI 10.1016/j.drugalcdep.2015.09.018; United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality, 2015, NAT SURV DRUG US HLT; Valente TW, 2013, J ADOLESCENT HEALTH, V52, P358, DOI 10.1016/j.jadohealth.2012.06.014; Verkooijen KT, 2007, PSYCHOL ADDICT BEHAV, V21, P55, DOI 10.1037/0893-164X.21.1.55; Wang KH, 2013, DRUG ALCOHOL DEPEN, V127, P156, DOI 10.1016/j.drugalcdep.2012.06.027; Wang SH, 2013, ADDICTION, V108, P2081, DOI 10.1111/add.12278; Wilson C, 2012, ACM T WEB, V6, DOI 10.1145/2382616.2382620; Wu LT, 2015, J PSYCHIATR RES, V64, P79, DOI 10.1016/j.jpsychires.2015.02.022; Young SD, 2014, PREV MED, V63, P112, DOI 10.1016/j.ypmed.2014.01.024	55	14	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187691	10.1371/journal.pone.0187691	http://dx.doi.org/10.1371/journal.pone.0187691			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL7JU	29107961	Green Published, gold			2022-12-26	WOS:000414424600059
J	Proctor, CJ; Smith, GR				Proctor, Carole J.; Smith, Graham R.			Computer simulation models as a tool to investigate the role of microRNAs in osteoarthritis	PLOS ONE			English	Article							HYPERTROPHIC CHONDROCYTE DIFFERENTIATION; CARTILAGE-SPECIFIC MICRORNA-140; MESSENGER-RNA EXPRESSION; GROWTH-FACTOR-I; TRANSCRIPTION FACTORS; ONCOSTATIN-M; INSULIN; SYSTEMS; TARGETS; BIOLOGY	The aim of this study was to show how computational models can be used to increase our understanding of the role of microRNAs in osteoarthritis (OA) using miR-140 as an example. Bioinformatics analysis and experimental results from the literature were used to create and calibrate models of gene regulatory networks in OA involving miR-140 along with key regulators such as NF-kB, SMAD3, and RUNX2. The individual models were created with the modelling standard, Systems Biology Markup Language, and integrated to examine the overall effect of miR-140 on cartilage homeostasis. Down-regulation of miR-140 may have either detrimental or protective effects for cartilage, indicating that the role of miR-140 is complex. Studies of individual networks in isolation may therefore lead to different conclusions. This indicated the need to combine the five chosen individual networks involving miR-140 into an integrated model. This model suggests that the overall effect of miR-140 is to change the response to an IL-1 stimulus from a prolonged increase in matrix degrading enzymes to a pulse-like response so that cartilage degradation is temporary. Our current model can easily be modified and extended as more experimental data become available about the role of miR-140 in OA. In addition, networks of other microRNAs that are important in OA could be incorporated. A fully integrated model could not only aid our understanding of the mechanisms of microRNAs in ageing cartilage but could also provide a useful tool to investigate the effect of potential interventions to prevent cartilage loss.	[Proctor, Carole J.; Smith, Graham R.] Newcastle Univ, Inst Ageing, Newcastle Upon Tyne, Tyne & Wear, England; [Proctor, Carole J.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Smith, Graham R.] Newcastle Univ, Bioinformat Support Unit, Fac Med Sci, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Proctor, CJ (corresponding author), Newcastle Univ, Inst Ageing, Newcastle Upon Tyne, Tyne & Wear, England.; Proctor, CJ (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England.	carole.proctor@ncl.ac.uk		Proctor, Carole/0000-0002-1366-1399	Medical Research Council; Arthritis Research UK as part of MRC-Arthritis Research UK Centre for Integrated research into Musculoskeletal Ageing (CIMA) [MR/K006312/1]; MRC [MR/P020941/1, MR/K006312/1] Funding Source: UKRI; Medical Research Council [MR/K006312/1, MR/P020941/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK as part of MRC-Arthritis Research UK Centre for Integrated research into Musculoskeletal Ageing (CIMA)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	CJP was supported by the Medical Research Council (https://www.mrc.ac.uk/) and Arthritis Research UK (http://www.arthritisresearchuk.org/)as part of the MRC-Arthritis Research UK Centre for Integrated research into Musculoskeletal Ageing (CIMA) (grant number MR/K006312/1). The funders had no role in study design, computational methods and analysis, decision to publish, or preparation of the manuscript.	Alon U., 2006, INTRO SYSTEMS BIOL D; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Barter MJ, 2015, STEM CELLS, V33, P3266, DOI 10.1002/stem.2093; Bellon E, 2009, J CELL BIOL, V187, P685, DOI 10.1083/jcb.200904034; BOHME K, 1992, J CELL BIOL, V116, P1035, DOI 10.1083/jcb.116.4.1035; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Chelliah V, 2014, NUCL ACIDS RES; Cheng AX, 2010, J BONE MINER RES, V25, P2404, DOI 10.1002/jbmr.174; Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258; Crowe N, 2016, OSTEOARTHR CARTILAGE, V24, P534, DOI 10.1016/j.joca.2015.10.002; Davies SR, 2002, J HISTOCHEM CYTOCHEM, V50, P1059, DOI 10.1177/002215540205000808; Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715; Funahashi A, 2008, P IEEE, V96, P1254, DOI 10.1109/JPROC.2008.925458; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Gillespie CS, 2006, BIOINFORMATICS, V22, P628, DOI 10.1093/bioinformatics/btk042; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Hui W, 2001, ANN RHEUM DIS, V60, P254, DOI 10.1136/ard.60.3.254; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; JONES JI, 1993, J CELL BIOL, V121, P679, DOI 10.1083/jcb.121.3.679; Kang HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053663; Koscielny G, 2017, NUCLEIC ACIDS RES, V45, pD985, DOI 10.1093/nar/gkw1055; Koshy PJT, 2002, ARTHRITIS RHEUM, V46, P961, DOI 10.1002/art.10212; Le LTT, 2013, ARTHRITIS RHEUM-US, V65, P1963, DOI 10.1002/art.37990; Le Novere N, 2009, NAT BIOTECHNOL, V27, P735, DOI 10.1038/nbt.1558; Liang ZJ, 2012, INFLAMM RES, V61, P503, DOI 10.1007/s00011-012-0438-6; Magenta A, 2011, CELL DEATH DIFFER, V18, P1628, DOI 10.1038/cdd.2011.42; Martinez NJ, 2009, BIOESSAYS, V31, P435, DOI 10.1002/bies.200800212; MCQUILLAN DJ, 1986, BIOCHEM J, V240, P423, DOI 10.1042/bj2400423; Miyaki S, 2010, GENE DEV, V24, P1173, DOI 10.1101/gad.1915510; Miyaki S, 2009, ARTHRITIS RHEUM-US, V60, P2723, DOI 10.1002/art.24745; Nakamura Y, 2012, APPL BIOCHEM BIOTECH, V166, P64, DOI 10.1007/s12010-011-9404-y; Nikolov S, 2011, THEOR BIOSCI, V130, P55, DOI 10.1007/s12064-010-0109-5; Osella M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001101; Pais H, 2010, RNA, V16, P489, DOI 10.1261/rna.1701210; Papaioannou G, 2015, J BONE MINER RES, V30, P1044, DOI 10.1002/jbmr.2438; PETZOLD L, 1983, SIAM J SCI STAT COMP, V4, P136, DOI 10.1137/0904010; Proctor CJ, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-75; Swingler TE, 2015, J MOL MED BERL; Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101; Tan L, 2015, MOL NEUROBIOL, V51, P1249, DOI 10.1007/s12035-014-8803-9; Tardif G, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-148; Tuddenham L, 2006, FEBS LETT, V580, P4214, DOI 10.1016/j.febslet.2006.06.080; Vera J, 2013, ADV EXP MED BIOL, V774, P55, DOI 10.1007/978-94-007-5590-1_4; Wang GN, 2009, J BIOL CHEM, V284, P9663, DOI 10.1074/jbc.M809281200; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilkinson D.J, 2011, STOCHASTIC MODELLING; Wu J, 2017, J CELLULAR MOL MED; Yang J, 2011, FEBS LETT, V585, P2992, DOI 10.1016/j.febslet.2011.08.013; Zhang R, 2013, INFLAMM RES, V62, P871, DOI 10.1007/s00011-013-0654-8; Zhao C, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004612	52	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187568	10.1371/journal.pone.0187568	http://dx.doi.org/10.1371/journal.pone.0187568			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095952	Green Published, gold, Green Submitted			2022-12-26	WOS:000414340200119
J	Somers, CM; Graham, CF; Martino, JA; Frasier, TR; Lance, SL; Gardiner, LE; Poulin, RG				Somers, Christopher M.; Graham, Carly F.; Martino, Jessica A.; Frasier, Timothy R.; Lance, Stacey L.; Gardiner, Laura E.; Poulin, Ray G.			Conservation genetics of the eastern yellow-bellied racer (Coluber constrictor flaviventris) and bullsnake (Pituophis catenifer sayi): River valleys are critical features for snakes at northern range limits	PLOS ONE			English	Article							POPULATION-STRUCTURE; MASSASAUGA RATTLESNAKE; SISTRURUS-CATENATUS; CORONELLA-AUSTRIACA; LANDSCAPE GENETICS; HABITAT SELECTION; BIASED DISPERSAL; F-STATISTICS; MICROSATELLITE; SOFTWARE	On the North American Great Plains, several snake species reach their northern range limit where they rely on sparsely distributed hibernacula located in major river valleys. Independent colonization histories for the river valleys and barriers to gene flow caused by the lack of suitable habitat between them may have produced genetically differentiated snake populations. To test this hypothesis, we used 10 microsatellite loci to examine the population structure of two species of conservation concern in Canada: the eastern yellow-bellied racer (Coluber constrictor flaviventris) and bullsnake (Pituophis catenifer sayi) in 3 major river valleys in southern Saskatchewan. Fixation indices (F-ST) showed that populations in river valleys were significantly differentiated for both species (racers, F-ST = 0.096, P = 0.001; bullsnakes F-ST = 0.045-0.157, P = 0.001). Bayesian assignment (STRUCTURE) and ordination (DAPC) strongly supported genetically differentiated groups in the geographically distinct river valleys. Finer-scale subdivision of populations within river valleys was not apparent based on our data, but is a topic that should be investigated further. Our findings highlight the importance of major river valleys for snakes at the northern extent of their ranges, and raise the possibility that populations in each river valley may warrant separate management strategies.	[Somers, Christopher M.; Graham, Carly F.; Martino, Jessica A.; Gardiner, Laura E.] Univ Regina, Dept Biol, Regina, SK, Canada; [Frasier, Timothy R.] St Marys Univ, Dept Biol, Halifax, NS, Canada; [Lance, Stacey L.] Univ Georgia, Savannah River Ecol Lab, Aiken, SC USA; [Poulin, Ray G.] Royal Saskatchewan Museum, Regina, SK, Canada	University of Regina; Saint Marys University - Canada; United States Department of Energy (DOE); Savannah River Ecology Laboratory; University System of Georgia; University of Georgia	Somers, CM (corresponding author), Univ Regina, Dept Biol, Regina, SK, Canada.	chris.somers@uregina.ca	Somers, Christopher/AAE-6390-2019		Science and Innovation Fund of the province of Saskatchewan; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs Program; University of Regina; Royal Saskatchewan Museum; Saskatchewan Parks; Canadian Museum of Nature; Canadian Wildlife Federation; Agriculture and Agri-food Canada; Environment Canada's Inter-Departmental Recovery Fund; U. S. Department of Energy [DE-FC09-07SR22506]; Parks Canada Agency; Grasslands National Park	Science and Innovation Fund of the province of Saskatchewan; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs Program(Canada Research Chairs); University of Regina; Royal Saskatchewan Museum; Saskatchewan Parks; Canadian Museum of Nature; Canadian Wildlife Federation; Agriculture and Agri-food Canada(Agriculture & Agri Food Canada); Environment Canada's Inter-Departmental Recovery Fund; U. S. Department of Energy(United States Department of Energy (DOE)); Parks Canada Agency; Grasslands National Park	We thank the Science and Innovation Fund of the province of Saskatchewan, the Natural Sciences and Engineering Research Council of Canada, the Canada Research Chairs Program, the University of Regina, the Royal Saskatchewan Museum, Friends of the Royal Saskatchewan Museum, Saskatchewan Parks, the Parks Canada Agency and Grasslands National Park, the Canadian Museum of Nature, the Canadian Wildlife Federation, and Agriculture and Agri-food Canada and Environment Canada's Inter-Departmental Recovery Fund for financial support. This research was partially supported by U. S. Department of Energy under Award Number DE-FC09-07SR22506 to the University of Georgia Research Foundation.	Almany GR, 2009, MOL ECOL RESOUR, V9, P1460, DOI 10.1111/j.1755-0998.2009.02759.x; Bernard AM, 2009, CAN J FISH AQUAT SCI, V66, P1617, DOI 10.1139/F09-106; Bronikowski AM, 2000, EVOLUTION, V54, P1760; Clark RW, 2008, MOL ECOL, V17, P719; COSEWIC, 2017, SUMM WILDL SPEC ASS; COSEWIC, 2017, GUID REC REC DES UN; COSEWIC [Committee on the Status of Endangered Wildlife in Canada], 2015, COSEWIC ASS STAT REP; Daltry JC, 1996, NATURE, V379, P537, DOI 10.1038/379537a0; Dileo MF, 2013, MOL ECOL, V22, P4483, DOI 10.1111/mec.12411; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ernst C.H., 2003, SNAKES US CANADA; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Galarza JA, 2015, BIOL J LINN SOC, V114, P426, DOI 10.1111/bij.12424; Gardiner LE, 2013, J WILDLIFE MANAGE, V77, P975, DOI 10.1002/jwmg.555; Gardiner Laura E., 2011, Blue Jay, V69, P120; Gardiner Laura E., 2011, Blue Jay, V69, P70; Gibbs HL, 2001, J HERED, V92, P173, DOI 10.1093/jhered/92.2.173; Gibbs HL, 1997, MOL ECOL, V6, P1123, DOI 10.1046/j.1365-294X.1997.00284.x; Gosselin T., 2016, STACKR GBS RAD DATA; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Harvey DS, 2006, J HERPETOL, V40, P66, DOI 10.1670/89-05A.1; Hofmann S, 2014, J BIOGEOGR, V41, P2162, DOI 10.1111/jbi.12358; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jaeger CP, 2016, ECOL EVOL, V6, P3991, DOI 10.1002/ece3.2159; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Kapfer JM, 2008, COPEIA, P815, DOI 10.1643/CE-07-104; Keogh JS, 2007, BIOL LETTERS, V3, P33, DOI 10.1098/rsbl.2006.0570; Klug PE, 2011, LANDSCAPE ECOL, V26, P281, DOI 10.1007/s10980-010-9554-2; Kwiatkowski MA, 2010, CONSERV GENET RESOUR, V2, P163, DOI 10.1007/s12686-010-9208-3; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Marshall JCJ, 2009, CONSERV GENET, V10, P465, DOI 10.1007/s10592-008-9624-z; Martino JA, 2012, J WILDLIFE MANAGE, V76, P759, DOI 10.1002/jwmg.313; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Meister B, 2010, BIOL J LINN SOC, V101, P51, DOI 10.1111/j.1095-8312.2010.01474.x; Parks Canada Agency, 2010, SPECIES RISK ACT REC; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pernetta AP, 2011, HEREDITY, V107, P231, DOI 10.1038/hdy.2011.7; Prior KA, 1997, CONSERV BIOL, V11, P1147, DOI 10.1046/j.1523-1739.1997.96098.x; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2014, R LANG ENV STAT COMP; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Samson FB, 2004, WILDLIFE SOC B, V32, P6, DOI 10.2193/0091-7648(2004)32[6:GPEPPA]2.0.CO;2; Shaffer HB, 2015, ANNU REV ANIM BIOSCI, V3, P113, DOI 10.1146/annurev-animal-022114-110920; Simonov E, 2012, AMPHIBIA-REPTILIA, V33, P273, DOI 10.1163/156853812X642045; Sunny A, 2015, GENETICA, V143, P705, DOI 10.1007/s10709-015-9868-8; Ursenbacher S, 2009, CONSERV GENET, V10, P303, DOI 10.1007/s10592-008-9580-7; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Williams KE, 2012, CAN J ZOOL, V90, P304, DOI [10.1139/Z11-136, 10.1139/z11-136]; Wood DA, 2015, CONSERV GENET, V16, P1025, DOI 10.1007/s10592-015-0720-6; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Xuereb ATJ, 2015, CONSERV GENET, V16, P1265, DOI 10.1007/s10592-015-0737-x	54	2	5	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187322	10.1371/journal.pone.0187322	http://dx.doi.org/10.1371/journal.pone.0187322			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095863	Green Published, gold, Green Submitted			2022-12-26	WOS:000414340200073
J	Sugiyama, A; Sone, D; Sato, N; Kimura, Y; Ota, M; Maikusa, N; Maekawa, T; Enokizono, M; Mori-Yoshimura, M; Ohya, Y; Kuwabara, S; Matsuda, H				Sugiyama, Atsuhiko; Sone, Daichi; Sato, Noriko; Kimura, Yukio; Ota, Miho; Maikusa, Norihide; Maekawa, Tomoko; Enokizono, Mikako; Mori-Yoshimura, Madoka; Ohya, Yasushi; Kuwabara, Satoshi; Matsuda, Hiroshi			Brain gray matter structural network in myotonic dystrophy type 1	PLOS ONE			English	Article							FACIAL EMOTION RECOGNITION; COGNITIVE IMPAIRMENT; ORBITOFRONTAL CORTEX; ODOR RECOGNITION; EXPANSION SIZE; CTG REPEAT; WHITE; DISEASE; LATERALIZATION; PERSONALITY	This study aimed to investigate abnormalities in structural covariance network constructed from gray matter volume in myotonic dystrophy type 1 (DM1) patients by using graph theoretical analysis for further clarification of the underlying mechanisms of central nervous system involvement. Twenty-eight DM1 patients (4 childhood onset, 10 juvenile onset, 14 adult onset), excluding three cases from 31 consecutive patients who underwent magnetic resonance imaging in a certain period, and 28 age-and sex-matched healthy control subjects were included in this study. The normalized gray matter images of both groups were subjected to voxel based morphometry (VBM) and Graph Analysis Toolbox for graph theoretical analysis. VBM revealed extensive gray matter atrophy in DM1 patients, including cortical and subcortical structures. On graph theoretical analysis, there were no significant differences between DM1 and control groups in terms of the global measures of connectivity. Betweenness centrality was increased in several regions including the left fusiform gyrus, whereas it was decreased in the right striatum. The absence of significant differences between the groups in global network measurements on graph theoretical analysis is consistent with the fact that the general cognitive function is preserved in DM1 patients. In DM1 patients, increased connectivity in the left fusiform gyrus and decreased connectivity in the right striatum might be associated with impairment in face perception and theory of mind, and schizotypal-paranoid personality traits, respectively.	[Sugiyama, Atsuhiko; Sato, Noriko; Kimura, Yukio; Maekawa, Tomoko; Enokizono, Mikako] Natl Ctr Neurol & Psychiat, Dept Radiol, Tokyo, Japan; [Sugiyama, Atsuhiko; Kuwabara, Satoshi] Chiba Univ, Grad Sch Med, Dept Neurol, Chiba, Japan; [Sone, Daichi; Maikusa, Norihide; Matsuda, Hiroshi] Natl Ctr Neurol & Psychiat, Integrat Brain Imaging Ctr, Tokyo, Japan; [Ota, Miho] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Disorder Res, Tokyo, Japan; [Mori-Yoshimura, Madoka; Ohya, Yasushi] Natl Ctr Neurol & Psychiat, Dept Neurol, Tokyo, Japan	National Center for Neurology & Psychiatry - Japan; Chiba University; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan	Sato, N (corresponding author), Natl Ctr Neurol & Psychiat, Dept Radiol, Tokyo, Japan.	snoriko@ncnp.go.jp	Sone, Daichi/J-7634-2019	Sone, Daichi/0000-0001-9617-706X; Kuwabara, Satoshi/0000-0002-4716-8578				Alexander-Bloch A, 2013, NAT REV NEUROSCI, V14, P322, DOI 10.1038/nrn3465; Antonini G, 2004, J NEUROL NEUROSUR PS, V75, P1611, DOI 10.1136/jnnp.2003.032417; Baldanzi S, 2016, NEUROIMAGE-CLIN, V12, P190, DOI 10.1016/j.nicl.2016.06.011; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Caso F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104697; Dai ZJ, 2014, NEUROSCI BULL, V30, P217, DOI 10.1007/s12264-013-1421-0; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Filippi M, 2013, LANCET NEUROL, V12, P1189, DOI 10.1016/S1474-4422(13)70144-3; Frassle S, 2016, NEUROIMAGE, V124, P977, DOI 10.1016/j.neuroimage.2015.09.055; Gourdon G, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00101; Hosseini SMH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040709; Kleberg JL, 2014, ACTA NEUROL SCAND, V130, P312, DOI 10.1111/ane.12228; Kobayakawa M, 2012, NEUROSCI RES, V72, P341, DOI 10.1016/j.neures.2012.01.005; Kobayakawa M, 2010, J NEUROL SCI, V290, P48, DOI 10.1016/j.jns.2009.11.011; Masaoka Y, 2007, NEUROSCI LETT, V412, P45, DOI 10.1016/j.neulet.2006.10.055; Masaoka Y, 2011, NEUROSCI LETT, V503, P163, DOI 10.1016/j.neulet.2011.08.006; Meng M, 2012, P ROY SOC B-BIOL SCI, V279, P2052, DOI 10.1098/rspb.2011.1784; Meola G, 2007, MUSCLE NERVE, V36, P294, DOI 10.1002/mus.20800; Minnerop M, 2011, BRAIN, V134, P3527, DOI 10.1093/brain/awr299; Modoni A, 2008, J NEUROL, V255, P1737, DOI 10.1007/s00415-008-0017-5; Okkersen K, 2017, NEUROLOGY, V89, P960, DOI 10.1212/WNL.0000000000004300; Ota M, 2006, NEUROSCI LETT, V407, P234, DOI 10.1016/j.neulet.2006.08.077; Rolls ET, 2001, CHEM SENSES, V26, P595, DOI 10.1093/chemse/26.5.595; Romeo V, 2010, NEUROL SCI, V31, P757, DOI 10.1007/s10072-010-0406-2; Romeo V, 2010, J NEUROL, V257, P1246, DOI 10.1007/s00415-010-5498-3; Rossion B, 2000, J COGNITIVE NEUROSCI, V12, P793, DOI 10.1162/089892900562606; Sansone V, 2007, NEUROL SCI, V28, P9, DOI 10.1007/s10072-007-0742-z; Schneider-Gold C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130352; Serra L, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/2696085; Serra L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156901; Serra L, 2015, FUNCT NEUROL, V30, P21; Serra L, 2014, JAMA NEUROL, V71, P603, DOI 10.1001/jamaneurol.2014.130; Sistiaga A, 2010, PSYCHOL MED, V40, P487, DOI 10.1017/S0033291709990602; Sone D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158728; Sporns O., 2011, NETWORKS BRAIN; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Udd B, 2012, LANCET NEUROL, V11, P891, DOI 10.1016/S1474-4422(12)70204-1; Weber YG, 2010, NEUROLOGY, V74, P1108, DOI 10.1212/WNL.0b013e3181d8c35f; Winblad S, 2006, J NEUROL NEUROSUR PS, V77, P219, DOI 10.1136/jnnp.2005.070763; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Yoo WK, 2017, YONSEI MED J, V58, P807, DOI 10.3349/ymj.2017.58.4.807; Zanigni S, 2016, NEUROIMAGE-CLIN, V11, P678, DOI 10.1016/j.nicl.2016.04.012	43	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187343	10.1371/journal.pone.0187343	http://dx.doi.org/10.1371/journal.pone.0187343			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095898	Green Published, Green Submitted, gold			2022-12-26	WOS:000414340200076
J	Tang, J; Cheng, H; Fang, CM				Tang, Jie; Cheng, Hao; Fang, Changming			The temperature sensitivity of soil organic carbon decomposition is not related to labile and recalcitrant carbon	PLOS ONE			English	Article							MATTER DECOMPOSITION; RESPIRATION; MINERALIZATION; INCUBATION; DEPENDENCE; CLIMATE; Q(10); UNCERTAINTIES; ECOSYSTEMS; VEGETATION	The response of resistant soil organic matter to temperature change is crucial for predicting climate change impacts on C cycling in terrestrial ecosystems. However, the response of the decomposition of different soil organic carbon (SOC) fractions to temperature is still under debate. To investigate whether the labile and resistant SOC components have different temperature sensitivities, soil samples were collected from three forest and two grass land sites, along with a gradient of latitude from 18 degrees 40'to 43 degrees 17'N and elevation from 600 to 3510 m across China, and were incubated under changing temperature (from 12 to 32 degrees C) for at least 260 days. Soil respiration rates were positively related to the content of soil organic carbon and soil microbial carbon. The temperature sensitivity of soil respiration, presented as Q(10) value, varies from 1.93 +/- 0.15 to 2.60 +/- 0.21. During the incubation, there were no significant differences between the Q(10) values of soil samples from different layers of the same site, nor a clear pattern of Q(10) values along with the gradient of latitude. The result of this study does not support current opinion that resistant soil carbon decomposition is more sensitive to temperature change than labile soil carbon.	[Tang, Jie; Cheng, Hao; Fang, Changming] Fudan Univ, Inst Biodivers Sci, Key Lab Biodivers & Ecol Engn, Minist Educ, Shanghai, Peoples R China	Fudan University	Fang, CM (corresponding author), Fudan Univ, Inst Biodivers Sci, Key Lab Biodivers & Ecol Engn, Minist Educ, Shanghai, Peoples R China.	cmfang@fudan.edu.cn			National Natural Science Foundation of China [40671106, 31070461]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant No. 40671106 and 31070461) (CF has received the funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This study was supported by the National Natural Science Foundation of China (40671106, 31070461).	Agren GI, 2000, AMBIO, V29, P55, DOI 10.1639/0044-7447(2000)029[0055:TDOOSO]2.0.CO;2; Agren GI, 2007, SOIL BIOL BIOCHEM, V39, P1794, DOI 10.1016/j.soilbio.2007.02.007; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Bosatta E, 1999, SOIL BIOL BIOCHEM, V31, P1889, DOI 10.1016/S0038-0717(99)00105-4; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Chen XP, 2010, SOIL BIOL BIOCHEM, V42, P2282, DOI 10.1016/j.soilbio.2010.08.030; Conant RT, 2008, GLOBAL CHANGE BIOL, V14, P868, DOI 10.1111/j.1365-2486.2008.01541.x; Conen F, 2006, BIOGEOSCI DISCUSS, V3, P1355, DOI DOI 10.5194/bgd-3-1355-2006; Conen F, 2008, SOIL BIOL BIOCHEM, V40, P2703, DOI 10.1016/j.soilbio.2008.07.004; Dalias P, 2001, GLOBAL CHANGE BIOL, V7, P181, DOI 10.1046/j.1365-2486.2001.00386.x; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2000, NATURE, V408, P789, DOI 10.1038/35048672; Fang C, 2006, BIOGEOSCIENCES, V3, P65, DOI 10.5194/bg-3-65-2006; Fang CM, 2005, NATURE, V433, P57, DOI 10.1038/nature03138; Fissore C, 2008, GLOBAL CHANGE BIOL, V14, P193, DOI 10.1111/j.1365-2486.2007.01478.x; Gershenson A, 2009, GLOBAL CHANGE BIOL, V15, P176, DOI 10.1111/j.1365-2486.2008.01827.x; Holland EA, 2000, GLOBAL BIOGEOCHEM CY, V14, P1137, DOI 10.1029/2000GB001264; Janssens IA, 2003, GLOBAL CHANGE BIOL, V9, P911, DOI 10.1046/j.1365-2486.2003.00636.x; Karhu K, 2010, SOIL BIOL BIOCHEM, V42, P72, DOI 10.1016/j.soilbio.2009.10.002; Kirschbaum MUF, 2006, SOIL BIOL BIOCHEM, V38, P2510, DOI 10.1016/j.soilbio.2006.01.030; Knorr W, 2005, NATURE, V433, P298, DOI 10.1038/nature03226; LAVELLE P, 1993, BIOTROPICA, V25, P130, DOI 10.2307/2389178; Lenton TM, 2003, GLOBAL CHANGE BIOL, V9, P1333, DOI 10.1046/j.1365-2486.2003.00674.x; Lipson DA, 2007, FEMS MICROBIOL ECOL, V59, P418, DOI 10.1111/j.1574-6941.2006.00240.x; Liski J, 1999, AMBIO, V28, P171; Monson RK, 2006, NATURE, V439, P711, DOI 10.1038/nature04555; Niklinska M, 1999, BIOGEOCHEMISTRY, V44, P239, DOI 10.1023/A:1006049204600; Plante AF, 2010, SOIL BIOL BIOCHEM, V42, P1991, DOI 10.1016/j.soilbio.2010.07.022; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Reichstein M, 2000, SOIL BIOL BIOCHEM, V32, P947, DOI 10.1016/S0038-0717(00)00002-X; Rey A, 2008, EUR J SOIL SCI, V59, P1049, DOI 10.1111/j.1365-2389.2008.01065.x; Townsend AR, 1997, BIOGEOCHEMISTRY, V38, P1, DOI 10.1023/A:1017942918708; Vanhala P, 2007, SOIL BIOL BIOCHEM, V39, P2967, DOI 10.1016/j.soilbio.2007.05.022; Winkler JP, 1996, SOIL BIOL BIOCHEM, V28, P1067, DOI 10.1016/0038-0717(96)00076-4; Zogg GP, 1997, SOIL SCI SOC AM J, V61, P475, DOI 10.2136/sssaj1997.03615995006100020015x	35	13	13	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186675	10.1371/journal.pone.0186675	http://dx.doi.org/10.1371/journal.pone.0186675			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095839	Green Published, Green Submitted, gold			2022-12-26	WOS:000414340200020
J	Yao, XH; Yan, JW; Ginda, M; Borner, K; Saykin, AJ; Shen, L				Yao, Xiaohui; Yan, Jingwen; Ginda, Michael; Borner, Katy; Saykin, Andrew J.; Shen, Li		Alzheimer's Dis Neuroimaging	Mapping longitudinal scientific progress, collaboration and impact of the Alzheimer's disease neuroimaging initiative	PLOS ONE			English	Article							BIOMARKER CORE; PHENOTYPES; AIMS	Background Alzheimer's disease neuroimaging initiative (ADNI) is a landmark imaging and omics study in AD. ADNI research literature has increased substantially over the past decade, which poses challenges for effectively communicating information about the results and impact of ADNI-related studies. In this work, we employed advanced information visualization techniques to perform a comprehensive and systematic mapping of the ADNI scientific growth and impact over a period of 12 years. Methods Citation information of ADNI-related publications from 01/01/2003 to 05/12/2015 were downloaded from the Scopus database. Five fields, including authors, years, affiliations, sources (journals), and keywords, were extracted and preprocessed. Statistical analyses were performed on basic publication data as well as journal and citations information. Science mapping workflows were conducted using the Science of Science (Sci2) Tool to generate geospatial, topical, and collaboration visualizations at the micro (individual) to macro (global) levels such as geospatial layouts of institutional collaboration networks, keyword co-occurrence networks, and author collaboration networks evolving overtime. Results During the studied period, 996 ADNI manuscripts were published across 233 journals and conference proceedings. The number of publications grew linearly from 2008 to 2015, so did the number of involved institutions. ADNI publications received much more citations than typical papers from the same set of journals. Collaborations were visualized at multiple levels, including authors, institutions, and research areas. The evolution of key ADNI research topics was also plotted over the studied period. Conclusions Both statistical and visualization results demonstrate the increasing attention of ADNI research, strong citation impact of ADNI publications, the expanding collaboration networks among researchers, institutions and ADNI core areas, and the dynamic evolution of ADNI research topics. The visualizations presented here can help improve daily decision making based on a deep understanding of existing patterns and trends using proven and replicable data analysis and visualization methods. They have great potential to provide new insights and actionable knowledge for helping translational research in AD.	[Yao, Xiaohui; Yan, Jingwen; Saykin, Andrew J.; Shen, Li] Indiana Univ, Ctr Neuroimaging, Indianapolis, IN 46204 USA; [Ginda, Michael; Borner, Katy] Indiana Univ, Cyberinfrastruct Network Sci Ctr, Bloomington, IN USA; [Yao, Xiaohui; Yan, Jingwen; Ginda, Michael; Borner, Katy; Saykin, Andrew J.; Shen, Li] Indiana Univ, Network Sci Inst, Bloomington, IN 47405 USA; [Yao, Xiaohui; Yan, Jingwen; Shen, Li] Indiana Univ, Sch Informat & Comp, Indianapolis, IN 46204 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis	Shen, L (corresponding author), Indiana Univ, Ctr Neuroimaging, Indianapolis, IN 46204 USA.; Shen, L (corresponding author), Indiana Univ, Network Sci Inst, Bloomington, IN 47405 USA.; Shen, L (corresponding author), Indiana Univ, Sch Informat & Comp, Indianapolis, IN 46204 USA.	shenli@iu.edu	Shen, Li/AAB-6870-2021	Shen, Li/0000-0002-5443-0503; Ginda, Michael/0000-0002-7500-8096	Project Development Team within Indiana Clinical and Translational Sciences Institute (ICTSI) grant [UL1TR001108]; Alzheimer's disease neuroimaging initiative (ADNI) (National Institutes of Health) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging (NIA) [U01 AG024904, P01 AG039347, RC2 AG036535, R01 AG019771, P30 AG10133, R01 AG042437, R01 AG046171]; National Cancer Institute (NCI) [U01 CA198934]; National Center for Advancing Translational Sciences (NCATS) [UL1 TR001108]; National Library of Medicine (NLM) [R01 LM011360]; National Institute of Biomedical Imaging and Bioengineering (NIBIB) [R01 EB022574]; Department of Defense (DOD) [W81XWH-12-2-0012, W81XWH-14-2-0151, W81XWH-13-1-0259]; National Collegiate Athletic Association (NCAA) [14132004]; Clinical and Translational Sciences Institute (CTSI) SPARC Program; Indiana University Precision Health Initiative; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB022574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG046171, P30AG010133] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM011360] Funding Source: NIH RePORTER	Project Development Team within Indiana Clinical and Translational Sciences Institute (ICTSI) grant; Alzheimer's disease neuroimaging initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DOD ADNI (Department of Defense); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Library of Medicine (NLM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Department of Defense (DOD)(United States Department of Defense); National Collegiate Athletic Association (NCAA); Clinical and Translational Sciences Institute (CTSI) SPARC Program; Indiana University Precision Health Initiative; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by a Project Development Team within the Indiana Clinical and Translational Sciences Institute (ICTSI) grant UL1TR001108 to LS, AJS and KB. ADNI data collection and sharing for this project was funded by the Alzheimer's disease neuroimaging initiative (ADNI) (National Institutes of Health Grant U01 AG024904 to AJS) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). This work was also partially supported by National Institute on Aging (NIA) grant P01 AG039347, U01 AG024904 to AJS, RC2 AG036535 to AJS, R01 AG019771, P30 AG10133 to AJS, R01 AG042437, and R01 AG046171 to AJS; National Cancer Institute (NCI) grant U01 CA198934; National Center for Advancing Translational Sciences (NCATS) grant UL1 TR001108 to LS; National Library of Medicine (NLM) grant R01 LM011360 to LS; National Institute of Biomedical Imaging and Bioengineering (NIBIB) grant R01 EB022574 to LS; U.S. Department of Defense (DOD) grant W81XWH-14-2-0151 to LS, W81XWH-13-1-0259 to AJS, and W81XWH-12-2-0012 to AJS; National Collegiate Athletic Association (NCAA) grant 14132004 to LS; Clinical and Translational Sciences Institute (CTSI) SPARC Program; and Indiana University Precision Health Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adar E., 2006, Conference on Human Factors in Computing Systems. CHI2006, P791; Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; [Anonymous], ATLAS KNOWLEDGE ANYO; Bastian M., 2009, 3 INT AAAI C WEBL SO; Borner K, 2015, PLOS ONE, V10; Borner K., 2014, VISUAL INSIGHTS PRAC; Borner K, 2007, ENVIRON PLANN B, V34, P808, DOI 10.1068/b3302t; Boyack KW, 2005, SCIENTOMETRICS, V64, P351, DOI 10.1007/s11192-005-0255-6; Bu┬rner K., 2010, ATLAS SCI VISUALIZIN; Elsevier, 2015, IMP PUBL IPP; Elsevier, 2015, SOURC NORM IMP PAP S; Elsevier, 2015, SCIMAGO J RANK SJR; Elsevier, 2015, SCOPUS; Elsevier, 2015, J METRIC VALUES 1999; Exhibit Team, 2005, PLAC SPAC MAPP SCI; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Hughes ME, 2014, JAMA NEUROL, V71, P412, DOI 10.1001/jamaneurol.2013.6225; Huynh D, 2013, OPEN REFINE VERSION; Jack CR, 2015, ALZHEIMERS DEMENT, V11, P740, DOI 10.1016/j.jalz.2015.05.002; Kang JH, 2015, ALZHEIMERS DEMENT, V11, P772, DOI 10.1016/j.jalz.2015.05.003; Liggins C, 2014, ALZHEIMERS DEMENT, V10, P405, DOI 10.1016/j.jalz.2013.12.013; Light RP, 2014, SCIENTOMETRICS, V101, P1535, DOI 10.1007/s11192-014-1238-2; Martin S, 2008, SAND REPORTS, P1; Morris T, 2013, CLUSTERING DEPTHHB M; Morris T, 2015, GEOCODING; Mueller SG, 2005, NEUROIMAG CLIN N AM, V15, P869, DOI 10.1016/j.nic.2005.09.008; Prince M., WORLD ALZHEIMER REPO; R Core Team, 2015, LANG ENV STAT COMP V; Saykin AJ, 2015, ALZHEIMERS DEMENT, V11, P792, DOI 10.1016/j.jalz.2015.05.009; Saykin AJ, 2010, ALZHEIMERS DEMENT, V6, P265, DOI 10.1016/j.jalz.2010.03.013; Sci2 Team, 2009, SCI CSI SCI2 TOOL; Shaw LM, 2011, ACTA NEUROPATHOL, V121, P597, DOI 10.1007/s00401-011-0808-0; Shen L, 2014, BRAIN IMAGING BEHAV, V8, P183, DOI 10.1007/s11682-013-9262-z; Skupin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058779; Toga AW, 2015, ALZHEIMERS DEMENT, V11, P832, DOI 10.1016/j.jalz.2015.04.004; Trojanowski JQ, 2010, ALZHEIMERS DEMENT, V6, P230, DOI 10.1016/j.jalz.2010.03.008; Weiner MW, 2017, ALZHEIMERS DEMENT, V13, P561, DOI 10.1016/j.jalz.2016.10.006; Weiner Michael W, 2015, Alzheimers Dement, V11, pe1, DOI 10.1016/j.jalz.2014.11.001; Yao X, 2016, AAIC 17 ALZH ASS INT	39	10	10	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186095	10.1371/journal.pone.0186095	http://dx.doi.org/10.1371/journal.pone.0186095			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL6FI	29095836	Green Published, Green Submitted			2022-12-26	WOS:000414340200013
J	Huang, YT; Chang, YL; Chen, CC; Lai, PY; Chan, CK				Huang, Yu-Ting; Chang, Yu-Lin; Chen, Chun-Chung; Lai, Pik-Yin; Chan, C. K.			Positive feedback and synchronized bursts in neuronal cultures	PLOS ONE			English	Article							TERM SYNAPTIC PLASTICITY; REVERBERATORY ACTIVITY; ACTION-POTENTIALS; NETWORKS; MECHANISMS; DYNAMICS; PATTERNS; DENSITY; CALCIUM; CELLS	Synchronized bursts (SBs) with complex structures are common in neuronal cultures. Although the phenomenon of SBs has been discovered for a long time, its origin is still unclear. Here, we investigate the properties of these SBs in cultures grown on a multi -electrode array. We find that structures of these SBs are related to the different developmental stages of the cultures and these structures can be modified by changing the magnesium concentration in the culture medium; indicating that synaptic mechanism is involved in the generation of SBs. A model based on short term synaptic plasticity (STSP), recurrent connections and astrocytic recycling of neurotransmitters has been developed successfully to understand the observed structures of SBs in experiments. A phase diagram obtained from this model shows that networks exhibiting SBs are in a complex oscillatory state due to large enough positive feedback provided by synaptic facilitation and recurrent connections. In this model, while STSP controls the fast oscillations (similar to 100 ms) within a SB, the astrocytic recycling determines the slow time scale (similar to 10 s) of inter-burst intervals. Our study suggests that glia-neuron interactions can be important in the understanding of the complex dynamics of neuronal networks.	[Huang, Yu-Ting; Lai, Pik-Yin; Chan, C. K.] Natl Cent Univ, Dept Phys, Chungli 320, Taiwan; [Huang, Yu-Ting; Lai, Pik-Yin; Chan, C. K.] Natl Cent Univ, Ctr Complex Syst, Chungli 320, Taiwan; [Huang, Yu-Ting; Chang, Yu-Lin; Chen, Chun-Chung; Chan, C. K.] Acad Sinica, Inst Phys, Taipei 115, Taiwan	National Central University; National Central University; Academia Sinica - Taiwan	Lai, PY; Chan, CK (corresponding author), Natl Cent Univ, Dept Phys, Chungli 320, Taiwan.; Lai, PY; Chan, CK (corresponding author), Natl Cent Univ, Ctr Complex Syst, Chungli 320, Taiwan.; Chan, CK (corresponding author), Acad Sinica, Inst Phys, Taipei 115, Taiwan.	pylai@ncu.phy.edu.tw; ckchan@gate.sinica.edu.tw	Chan, Chi-Keung/AAP-7916-2021; Chen, Chun-Chung/A-5905-2008	Chan, Chi-Keung/0000-0002-1496-1086; Chen, Chun-Chung/0000-0002-7664-8300	MOST of ROC [NSC 100-2923-M-001-008-MY3, 102-2112-M-001-009-MY3]	MOST of ROC	This work has been supported by the MOST of ROC under the grant nos. NSC 100-2923-M-001-008-MY3, 102-2112-M-001-009-MY3 and NCTS of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CM, 2000, GLIA, V32, P1; Axmacher N, 2006, BRAIN RES REV, V52, P170, DOI 10.1016/j.brainresrev.2006.01.007; Baruchi I, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.050901; Biffi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083899; Bisio M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107400; Blitz DM, 2004, NAT REV NEUROSCI, V5, P630, DOI 10.1038/nrn1475; Chiappalone M, 2005, NEUROCOMPUTING, V65, P653, DOI 10.1016/j.neucom.2004.10.094; Cohen E, 2008, BRAIN RES, V1235, P21, DOI 10.1016/j.brainres.2008.06.022; Cortes JM, 2013, P NATL ACAD SCI USA, V110, P16610, DOI 10.1073/pnas.1316071110; Czarnecki A, 2012, EUR J NEUROSCI, V35, P375, DOI 10.1111/j.1460-9568.2011.07966.x; De Pitta M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002293; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; Gritsun TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043352; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Haydon PG, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020438; Hennig MH, 2015, NEURAL INFORM PROCES, P5; Hulata E, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198105; Ito D, 2010, NEUROSCIENCE, V171, P50, DOI 10.1016/j.neuroscience.2010.08.038; Ivenshitz M, 2010, J NEUROPHYSIOL, V104, P1052, DOI 10.1152/jn.00914.2009; Jia LC, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.088101; Johnson SE, 2015, J NEUROPHYSIOL, V113, P2461, DOI 10.1152/jn.00286.2014; Jolivet R, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004036; Krahe R, 2004, NAT REV NEUROSCI, V5, P13, DOI 10.1038/nrn1296; Lau PM, 2005, P NATL ACAD SCI USA, V102, P10333, DOI 10.1073/pnas.0500717102; MAEDA E, 1995, J NEUROSCI, V15, P6834; Maheswaranathan N, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00015; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; Masquelier T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075824; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Mi YY, 2017, NEURON, V93, P323, DOI 10.1016/j.neuron.2016.12.004; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; Niedringhaus M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057144; Penn Y, 2016, P NATL ACAD SCI USA, V113, P3341, DOI 10.1073/pnas.1515105113; Poli D, 2015, FRONT NEURAL CIRCUIT, P9; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Sara Y, 2002, J NEUROSCI, V22, P1608, DOI 10.1523/JNEUROSCI.22-05-01608.2002; Segev R, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.118102; Sibille J, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00189; Stephens CL, 2012, EXP NEUROL, V234, P20, DOI 10.1016/j.expneurol.2011.12.009; van Pelt J, 2004, IEEE T BIO-MED ENG, V51, P2051, DOI 10.1109/TBME.2004.827936; Vardi R, 2016, SCI REP-UK, V6, DOI 10.1038/srep36228; Volman V, 2007, PHYS BIOL, V4, P91, DOI 10.1088/1478-3975/4/2/003; Voss LJ, 2010, J NEUROSCI METH, V192, P214, DOI 10.1016/j.jneumeth.2010.07.025; Wagenaar DA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-11; Wagenaar DA, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.051907; Wilson NR, 2007, J NEUROSCI, V27, P13581, DOI 10.1523/JNEUROSCI.3863-07.2007; Zhan X, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.011907	47	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187276	10.1371/journal.pone.0187276	http://dx.doi.org/10.1371/journal.pone.0187276			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091966	Green Published, Green Submitted, gold			2022-12-26	WOS:000414229700050
J	Minato, T; Maeda, T; Fujisawa, Y; Tsuji, H; Nomoto, K; Ohno, K; Hirayama, M				Minato, Tomomi; Maeda, Tetsuya; Fujisawa, Yoshiro; Tsuji, Hirokazu; Nomoto, Koji; Ohno, Kinji; Hirayama, Masaaki			Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; INTESTINAL MICROFLORA; COGNITIVE IMPAIRMENT; FECAL MICROBIOTA; LACTOBACILLUS; PCR; BIFIDOBACTERIA; METAANALYSIS; CHILDREN; BACTERIA	Background We previously reported gut dysbiosis in patients with Parkinson's disease (PD). Objective The aim of this study is to examine whether gut dysbiosis correlates with the progression of PD. Methods We examined changes in gut microbiota and demographic features in 2 years in 36 PD patients. Results A change of total UPDRS scores in 2 years was predicted by the counts of Bifidobacterium and Atopobium cluster at year 0 with a correlation coefficient of 0.52. Correlation analysis additionally revealed that low counts of Bifidobacterium and Bacteroides fragilis at year 0 were associated with worsening of UPDRS I scores in 2 years. In addition, low counts of Bifidobacterium at year 0 were associated with worsening of hallucinations/delusions in 2 years. Similarly, low counts of B. fragilis at year 0 were associated with worsening of motivation/initiative in 2 years. The patients were evenly divided into the deteriorated and stable groups based on the degree of worsening of total UPDRS scores. The deteriorated group had lower counts of Bifidobacterium, B. fragilis, and Clostridium leptium than the stable group at year 0 but not at year 2, suggesting that the deteriorated group may demonstrate accelerated lowering of these bacteria at year 0. Conclusions The total counts of intestinal bacterial decrease in the course of PD progression. Temporal profiles of lowering of bacterial counts are likely to be different from bacteria to bacteria, and also between the deteriorating and stable groups, which may be able to be exploited to differentiate patients with rapidly and slowly progressive PD pathology.	[Minato, Tomomi; Fujisawa, Yoshiro; Hirayama, Masaaki] Nagoya Univ, Dept Pathophysiol Lab Sci, Grad Sch Med, Nagoya, Aichi, Japan; [Maeda, Tetsuya] Iwate Med Univ, Sch Med, Div Neurol & Gerontol, Dept Internal Med, Morioka, Iwate, Japan; [Tsuji, Hirokazu; Nomoto, Koji] Yakult Cent Inst, Tokyo, Japan; [Ohno, Kinji] Nagoya Univ, Grad Sch Med, Div Neurogenet, Ctr Neurol Dis & Canc, Nagoya, Aichi, Japan	Nagoya University; Iwate Medical University; Yakult Honsha Company, Limited; Nagoya University	Hirayama, M (corresponding author), Nagoya Univ, Dept Pathophysiol Lab Sci, Grad Sch Med, Nagoya, Aichi, Japan.; Ohno, K (corresponding author), Nagoya Univ, Grad Sch Med, Div Neurogenet, Ctr Neurol Dis & Canc, Nagoya, Aichi, Japan.	ohnok@med.nagoya-u.ac.jp; hirasan@met.nagoya-u.ac.jp	Hirayama, Masaaki/ABH-2669-2020; Ohno, Kinji/ABD-5787-2020; Hirayama, Masaaki/I-9341-2018; Ohno, Kinji/H-4020-2012	Ohno, Kinji/0000-0002-1529-2750; Hirayama, Masaaki/0000-0003-0092-7837; Ohno, Kinji/0000-0002-1529-2750; Hirokazu, Tsuji/0000-0003-2856-6447; Maeda, Tetsuya/0000-0002-6207-8343	Japan Society for the Promotion of Science [24500458, 15H04840]; Japan Agency for Medical Research and Development [17gm1010002h0002]; Smoking Research Foundation; Grants-in-Aid for Scientific Research [15H04840] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Smoking Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors acknowledge funding by the Japan Society for the Promotion of Science (JP) (24500458, 15H04840) (http://www.jsps.go.ip/), the Japan Agency for Medical Research and Development (JP) (17gm1010002h0002) (http://www.amed.go.jp/); and Smoking Research Foundation (JP) (http://www.srf.or.jp/). The Yakult Central Institute provided support in the form of salaries for HT and KN, but did not play any further role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. HT and KN blindly quantified intestinal microbiota, and were not involved in the data analysis. HT and KN provided essential experimental information, but did not affect the results and interpretation of our study.	Abbott RD, 2001, NEUROLOGY, V57, P456, DOI 10.1212/WNL.57.3.456; Akbari E, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00256; Bedarf JR, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0428-y; Bjorksten B, 1999, CLIN EXP ALLERGY, V29, P342, DOI 10.1046/j.1365-2222.1999.00560.x; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Braak H, 2002, J NEUROL, V249, DOI [1007/s00415-002-1301-4, 10.1007/s00415-002-1301-4, DOI 10.1007/S00415-002-1301-4]; BRAEKHUS A, 1992, J AM GERIATR SOC, V40, P1139, DOI 10.1111/j.1532-5415.1992.tb01804.x; Ding PH, 2014, J PERIODONTAL RES, V49, P1, DOI 10.1111/jre.12081; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Forsyth CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028032; Fujiwara Y, 2010, GERIATR GERONTOL INT, V10, P225, DOI 10.1111/j.1447-0594.2010.00585.x; Goetze O, 2005, NEUROSCI LETT, V375, P170, DOI 10.1016/j.neulet.2004.11.007; Hasegawa S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142164; Hawkes CH, 2010, PARKINSONISM RELAT D, V16, P79, DOI 10.1016/j.parkreldis.2009.08.007; Hill-Burns EM, 2017, MOV DISORD; HIRAYAMA M, 1995, J AUTONOM NERV SYST, V53, P230, DOI 10.1016/0165-1838(95)00002-F; Hirayama M, 2011, PARKINSONISM RELAT D, V17, P46, DOI 10.1016/j.parkreldis.2010.11.004; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Hopfner F, 2017, BRAIN RES, V1667, P41, DOI 10.1016/j.brainres.2017.04.019; Jeong JJ, 2016, BENEF MICROBES, V7, P707, DOI 10.3920/BM2016.0016; Katzenschlager R, 2004, CURR OPIN NEUROL, V17, P417, DOI 10.1097/01.wco.0000137531.76491.c2; Kelly LP, 2014, MOVEMENT DISORD, V29, P999, DOI 10.1002/mds.25736; Keshavarzian A, 2015, MOVEMENT DISORD, V30, P1351, DOI 10.1002/mds.26307; Li W., 2017, SCI CHINA LIFE SCI; Malinen E, 2005, AM J GASTROENTEROL, V100, P373, DOI 10.1111/j.1572-0241.2005.40312.x; Matsuda K, 2007, APPL ENVIRON MICROB, V73, P32, DOI 10.1128/AEM.01224-06; Matsuda K, 2009, APPL ENVIRON MICROB, V75, P1961, DOI 10.1128/AEM.01843-08; MITSUOKA T, 1992, NUTR REV, V50, P438, DOI 10.1111/j.1753-4887.1992.tb02499.x; Mountzouris KC, 2002, BRIT J NUTR, V87, P405, DOI 10.1079/BJN2002563; Nakayama J, 2015, SCI REP-UK, V5, DOI 10.1038/srep08397; Noh SY, 2015, MOL IMMUNOL, V64, P183, DOI 10.1016/j.molimm.2014.11.014; Noyce AJ, 2012, ANN NEUROL, V72, P893, DOI 10.1002/ana.23687; O'Mahony L, 2005, GASTROENTEROLOGY, V128, P541, DOI 10.1053/j.gastro.2004.11.050; Odamaki T, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0708-5; Ohigashi S, 2013, DIGEST DIS SCI, V58, P1717, DOI 10.1007/s10620-012-2526-4; Petrov VA, 2017, B EXP BIOL MED+, V162, P734, DOI 10.1007/s10517-017-3700-7; Pompei A, 2007, APPL ENVIRON MICROB, V73, P179, DOI 10.1128/AEM.01763-06; Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945; Ramaker C, 2002, MOVEMENT DISORD, V17, P867, DOI 10.1002/mds.10248; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Saito S, 2006, CHEM SENSES, V31, P379, DOI 10.1093/chemse/bjj042; Sakaguchi S, 2010, J CLIN MICROBIOL, V48, P1624, DOI 10.1128/JCM.01724-09; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Sato J, 2014, DIABETES CARE, V37, P2343, DOI 10.2337/dc13-2817; Scheperjans F, 2015, MOVEMENT DISORD, V30, P350, DOI 10.1002/mds.26069; Shannon KM, 2012, MOVEMENT DISORD, V27, P709, DOI 10.1002/mds.23838; Sinha R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0841-8; Ueno N, 2011, INFLAMM BOWEL DIS, V17, P2235, DOI 10.1002/ibd.21597; Unger MM, 2016, PARKINSONISM RELAT D; Ventura M, 2014, J SCI FOOD AGR, V94, P163, DOI 10.1002/jsfa.6356	51	137	143	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187307	10.1371/journal.pone.0187307	http://dx.doi.org/10.1371/journal.pone.0187307			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091972	Green Submitted, Green Published, gold			2022-12-26	WOS:000414229700054
J	Qin, LZ; Li, T; Liu, YH				Qin, Lianzhi; Li, Ting; Liu, Yuhua			High SLC4A11 expression is an independent predictor for poor overall survival in grade 3/4 serous ovarian cancer	PLOS ONE			English	Article							INTRACELLULAR PH; BREAST-CANCER; MUTATIONS; FAMILY	In this study, we aimed to examine the expression of SLC4A1 1 in ovarian cancer and in normal ovarian tissues, its prognostic value and the possible mechanism of its dysregulation. Bioinformatic analysis was performed by using data from the GEO datasets, the Cancer Genome Atlas-Ovarian Cancer (TCGA-OV) and the Human Protein Atlas (HPA). Results showed that SLC4A11 was upregulated in ovarian cancer compared with normal ovarian epithelial tissues. In patients with primary serous ovarian cancer in TCGA-OV, the cases with lymphatic invasion (N = 133) had significantly higher SLC4A11 expression than those without lymphatic invasion (N = 77) (p = 0.0069). High SLC4A11 expression was consistently associated with worse overall survival (OS). Univariate and multivariate analysis confirmed that high SLC4A1 1 expression was an independent prognostic factor for poor OS in grade 3/4 (G3/G4) tumors (HR = 1.416, 95`)/X1: 1.098-1.824, p = 0.007). 320 out of 578 (55.4%) ovarian cancer cases had SLC4A11 amplification. High methylation group had a significantly lower level of SLC4A1 1 expression. Based on these findings, we infer that high SLC4A1 1 expression is an independent predictor for poor OS in grade 3/4 serous ovarian cancer. Both DNA amplification and hypomethylation contribute to its upregulation in ovarian cancer.	[Qin, Lianzhi] Linyi Cent Hosp, Delivery Room, Linyi, Shandong, Peoples R China; [Li, Ting] Zoucheng Peoples Hosp, Dept Gynecol, Zoucheng, Shandong, Peoples R China; [Liu, Yuhua] Anqiu Peoples Hosp, Dept Obstet, Anqiu, Shandong, Peoples R China		Liu, YH (corresponding author), Anqiu Peoples Hosp, Dept Obstet, Anqiu, Shandong, Peoples R China.	yuhualiu1@foxmail.com						Andersen AP, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0098; Asadollahi R, 2010, GYNECOL ONCOL, V118, P81, DOI 10.1016/j.ygyno.2010.03.015; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Boedtkjer E, 2013, INT J CANCER, V132, P1288, DOI 10.1002/ijc.27782; Bowen NJ, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-71; Estrella V, 2013, CANCER RES, V73, P1524, DOI 10.1158/0008-5472.CAN-12-2796; Gatenby RA, 2006, CANCER RES, V66, P5216, DOI 10.1158/0008-5472.CAN-05-4193; Gorbatenko A, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00130; Kao LY, 2015, AM J PHYSIOL-CELL PH, V308, pC176, DOI 10.1152/ajpcell.00271.2014; Koshiyama M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/934261; Kurman RJ, 2016, AM J PATHOL, V186, P733, DOI 10.1016/j.ajpath.2015.11.011; Kwon MJ, 2011, INT J MOL SCI, V12, P983, DOI 10.3390/ijms12020983; Lambros MBK, 2005, J PATHOL, V205, P29, DOI 10.1002/path.1681; Lee S, 2016, ONCOGENE, V35, P2112, DOI 10.1038/onc.2015.273; McCluggage WG, 2011, PATHOLOGY, V43, P420, DOI 10.1097/PAT.0b013e328348a6e7; McIntyre A, 2016, CANCER RES, V76, P3744, DOI 10.1158/0008-5472.CAN-15-1862; Ogando DG, 2013, AM J PHYSIOL-CELL PH, V305, pC716, DOI 10.1152/ajpcell.00056.2013; Parks SK, 2015, J CELL PHYSIOL, V230, P1954, DOI 10.1002/jcp.24930; Parks SK, 2013, NAT REV CANCER, V13, P611, DOI 10.1038/nrc3579; Patel SP, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/475392; Pedersen SF, 2013, CANCER RES, V73, P1658, DOI 10.1158/0008-5472.CAN-12-4188; Romero MF, 2013, MOL ASPECTS MED, V34, P159, DOI 10.1016/j.mam.2012.10.008; Sanhueza C, 2016, CURR MOL MED, V16, P23, DOI 10.2174/1566524016666151222143437; Sanhueza C, 2017, BBA-MOL BASIS DIS, V1863, P81, DOI 10.1016/j.bbadis.2016.10.013; Shei W, 2013, MOL VIS, V19, P1096; Shimada T, 2017, JPN J CLIN ONCOL, V47, P494, DOI 10.1093/jjco/hyx026; Thornell IM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00166; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Vilas GL, 2013, HUM MOL GENET, V22, P4579, DOI 10.1093/hmg/ddt307; Vithana EN, 2008, HUM MOL GENET, V17, P656, DOI 10.1093/hmg/ddm337; Vithana EN, 2006, NAT GENET, V38, P755, DOI 10.1038/ng1824; Watanabe T, 2001, GYNECOL ONCOL, V81, P172, DOI 10.1006/gyno.2001.6132	33	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187385	10.1371/journal.pone.0187385	http://dx.doi.org/10.1371/journal.pone.0187385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091960	Green Submitted, gold, Green Published			2022-12-26	WOS:000414229700062
J	Hong, ZL; Lin, F; Xiao, B				Hong, Zhiling; Lin, Fan; Xiao, Bin			A novel Gravity-FREAK feature extraction and Gravity-KLT tracking registration algorithm based on iPhone MEMS mobile sensor in mobile environment	PLOS ONE			English	Article								Based on the traditional Fast Retina Keypoint (FREAK) feature description algorithm, this paper proposed a Gravity-FREAK feature description algorithm based on Micro-electromechanical Systems (MEMS) sensor to overcome the limited computing performance and memory resources of mobile devices and further improve the reality interaction experience of clients through digital information added to the real world by augmented reality technology. The algorithm takes the gravity projection vector corresponding to the feature point as its feature orientation, which saved the time of calculating the neighborhood gray gradient of each feature point, reduced the cost of calculation and improved the accuracy of feature extraction. In the case of registration method of matching and tracking natural features, the adaptive and generic corner detection based on the Gravity-FREAK matching purification algorithm was used to eliminate abnormal matches, and Gravity Kaneda-Lucas Tracking (KLT) algorithm based on MEMS sensor can be used for the tracking registration of the targets and robustness improvement of tracking registration algorithm under mobile environment.	[Hong, Zhiling; Lin, Fan; Xiao, Bin] Xiamen Univ, Software Sch, Xiamen, Fujian, Peoples R China	Xiamen University	Hong, ZL (corresponding author), Xiamen Univ, Software Sch, Xiamen, Fujian, Peoples R China.	hongzl@xmu.edu.cn			National Natural Science Foundation of China [31200769]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The Project was supported by the National Natural Science Foundation of China (Grant No. 31200769).; The Project was supported by the National Natural Science Foundation of China (Grant No. 31200769). And the authors would like to thank the anonymous reviewers who helped to improve the quality of the paper.	Alahi A, 2012, PROC CVPR IEEE, P510, DOI 10.1109/CVPR.2012.6247715; [Anonymous], 1992, P 25 HAWAII INT C SY, DOI [10.1109/HICSS.1992.183317, DOI 10.1109/HICSS.1992.183317]; Azuma R, 2001, IEEE COMPUT GRAPH, V21, P34, DOI 10.1109/38.963459; Baker S, 2004, INT J COMPUT VISION, V56, P221, DOI 10.1023/B:VISI.0000011205.11775.fd; Bazin J C, 2008, 19 INT C PATT REC IC, P1; Bimber O, 2002, INTERNATIONAL SYMPOSIUM ON MIXED AND AUGMENTED REALITY, PROCEEDINGS, P186, DOI 10.1109/ISMAR.2002.1115088; Capel D P., 2005, EFFECTIVE BAIL OUT T; Chekhlov D., 2007, P IEEE INT C COMP VI, P1, DOI DOI 10.1109/CVPR.2007.383026; Chen Fu-Xing, 2005, Journal of Software, V16, P1431, DOI 10.1360/jos161431; Chum O, 2003, LOCALLY OPTIMIZED RA, P236; Chum O., 2004, P ACCV, V2, P812; Davison AJ, 2007, IEEE T PATTERN ANAL, V29, P1052, DOI 10.1109/TPAMI.2007.1049; Debevec Paul., 2008, ACM SIGGRAPH 2008 CL, P1; Dong SY, 2013, ADV ENG SOFTW, V55, P45, DOI 10.1016/j.advengsoft.2012.09.001; Feiner S, 1997, FIRST INTERNATIONAL SYMPOSIUM ON WEARABLE COMPUTERS - DIGEST OF PAPERS, P74, DOI 10.1109/ISWC.1997.629922; Huynh D.-N. T., 2009, P 2009 ACM SIGGRAPH, P135, DOI DOI 10.1145/1581073.1581095; Jin HL, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL I, PROCEEDINGS, P684, DOI 10.1109/ICCV.2001.937588; Kato H., 2002, ARTOOLKIT LIB VISION, P79; Klein G, 2008, LECT NOTES COMPUT SC, V5303, P802, DOI 10.1007/978-3-540-88688-4_59; Klein G, 2009, INT SYM MIX AUGMENT, P83, DOI 10.1109/ISMAR.2009.5336495; Kurz D., 2011, 2011 IEEE International Symposium on Mixed and Augmented Reality, P111, DOI 10.1109/ISMAR.2011.6092376; Kurz D, 2011, PROC CVPR IEEE, P161, DOI 10.1109/CVPR.2011.5995339; Lee JD, 2012, EXPERT SYST APPL, V39, P5286, DOI 10.1016/j.eswa.2011.11.009; Lieberknecht S, 2009, INT SYM MIX AUGMENT, P145, DOI 10.1109/ISMAR.2009.5336487; Lucas B.D., 1981, IJCAI 81 P 7 INT JOI, P674, DOI DOI 10.1109/HPDC.2004.1323531; Mair Elmar, 2010, Computer Vision - ECCV 2010. Proceedings 11th European Conference on Computer Vision, P183, DOI 10.1007/978-3-642-15552-9_14; Nowicki M, 2013, ADV INTELL SYST, V226, P835, DOI 10.1007/978-3-319-00969-8_82; Ohta Yutchi, 2014, MIXED REALITY MERGIN; Pupilli M, 2005, REAL TIME CAMERA TRA; Rosten E, 2006, LECT NOTES COMPUT SC, V3951, P430, DOI 10.1007/11744023_34; Samir C, 2014, IEEE T MED IMAGING, V33, P1035, DOI 10.1109/TMI.2014.2300935; Schnabel R, 2007, COMPUT GRAPH FORUM, V26, P214, DOI 10.1111/j.1467-8659.2007.01016.x; Verykokou S., 2016, LNCS, V10058, P50, DOI [DOI 10.1007/978-3-319-48496-9_5, 10.1007/978-3-319-48496, DOI 10.1007/978-3-319-48496]; Verykokou S, 2014, LECT NOTES COMPUT SC, V8740, P279, DOI 10.1007/978-3-319-13695-0_27; Wagner D, 2003, IEEE INTERNATIONAL AUGMENTED REALITY TOOLKIT WORKSHOP, P14, DOI 10.1109/ART.2003.1320418; Wagner D, 2009, INT SYM MIX AUGMENT, P57, DOI 10.1109/ISMAR.2009.5336497; Wagner D, 2010, IEEE T VIS COMPUT GR, V16, P355, DOI 10.1109/TVCG.2009.99; Wu YZ, 2015, IEEE SENS J, V15, P750, DOI 10.1109/JSEN.2014.2354331; Yang MD, 2013, AUTOMAT CONSTR, V33, P48, DOI 10.1016/j.autcon.2012.09.017; You S, 1999, P IEEE VIRT REAL ANN, P260, DOI 10.1109/VR.1999.756960	40	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186176	10.1371/journal.pone.0186176	http://dx.doi.org/10.1371/journal.pone.0186176			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088228	Green Published, gold, Green Submitted			2022-12-26	WOS:000414088900007
J	Sun, ZP; de Roos, AM				Sun, Zepeng; de Roos, Andre M.			Seasonal reproduction leads to population collapse and an Allee effect in a stage-structured consumer-resource biomass model when mortality rate increases	PLOS ONE			English	Article							FISH POPULATIONS; MATURATION; SIZE; HISTORY; PREDATION; STATES; RISK	Many populations collapse suddenly when reaching low densities even if they have abundant food conditions, a phenomenon known as an Allee effect. Such collapses can have disastrous consequences, for example, for loss of biodiversity. In this paper, we formulate a stage-structured consumer-resource biomass model in which adults only reproduce at the beginning of each growing season, and investigate the effect of an increasing stage-independent background mortality rate of the consumer. As the main difference with previously studied continuous-time models, seasonal reproduction can result in an Allee effect and consumer population collapses at high consumer mortality rate. However, unlike the mechanisms reported in the literature, in our model the Allee effect results from the time difference between the maturation of juveniles and the reproduction of adults. The timing of maturation plays a crucial role because it not only determines the body size of the individuals at maturation but also influences the duration of the period during which adults can invest in reproductive energy, which together determine the reproductive output at the end of the season. We suggest that there exists an optimal timing of maturation and that consumer persistence is promoted if individuals mature later in the season at a larger body size, rather than maturing early, despite high food availability supporting rapid growth.	[Sun, Zepeng; de Roos, Andre M.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands	University of Amsterdam	Sun, ZP (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands.	zepengsun@gmail.com	Sun, Zepeng/P-3663-2016; De Roos, Andre M./A-1590-2008	Sun, Zepeng/0000-0002-9846-4174; De Roos, Andre M./0000-0002-6944-2048	China Scholarship Council; European Research Council under the European Union's Seventh Framework Programme/ERC [322814]	China Scholarship Council(China Scholarship Council); European Research Council under the European Union's Seventh Framework Programme/ERC(European Research Council (ERC))	ZS is grateful for the support of China Scholarship Council (http://www.csc.edu.cn/). AMdR is supported by funding from the European Research Council (https://erc.europa.eu/) under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement No. 322814. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; ZS is grateful for the support of China Scholarship Council. AMdR is supported by funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement No. 322814. We thank Floor Soudijn for helpful discussions and an anonymous reviewer for helpful comments on an earlier version of this article.	Alos J, 2014, MAR ECOL PROG SER, V503, P219, DOI 10.3354/meps10745; Berec L, 2001, AM NAT, V157, P217, DOI 10.1086/318626; Blackburn TM, 2015, MOL ECOL, V24, P1942, DOI 10.1111/mec.13075; Cassey P, 2014, OECOLOGIA, V175, P417, DOI 10.1007/s00442-014-2902-1; Clutton-Brock TH, 1999, J ANIM ECOL, V68, P672, DOI 10.1046/j.1365-2656.1999.00317.x; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Courchamp F, 2001, ANIM CONSERV, V4, P169, DOI 10.1017/S1367943001001196; De Roos AM, 2002, P NATL ACAD SCI USA, V99, P12907, DOI 10.1073/pnas.192174199; De Roos AM, 2008, THEOR POPUL BIOL, V73, P47, DOI 10.1016/j.tpb.2007.09.004; De Roos AM, 2008, ECOL LETT, V11, P1, DOI 10.1111/j.1461-0248.2007.01121.x; de Roos AM, 2007, AM NAT, V170, pE59, DOI 10.1086/520119; De Roos AM, 2013, J MATH BIOL, V66, P889, DOI 10.1007/s00285-012-0583-0; Dennis B., 1989, Natural Resource Modeling, V3, P481; DeRoos AM, FINDCURVE C BASED PA; Gascoigne JC, 2004, J APPL ECOL, V41, P801, DOI 10.1111/j.0021-8901.2004.00944.x; Gjedrem T, 2000, AQUAC RES, V31, P25, DOI 10.1046/j.1365-2109.2000.00389.x; Good C, 2016, J WORLD AQUACULT SOC, V47, P605, DOI 10.1111/jwas.12342; Grunbaum D, 2003, ECOLOGY, V84, P3265, DOI 10.1890/01-4098; Guill C, 2009, THEOR POPUL BIOL, V76, P168, DOI 10.1016/j.tpb.2009.06.002; Higgins L, 2000, OECOLOGIA, V122, P51, DOI 10.1007/PL00008835; Hutchings JA, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0693; Hutchings JA, 2014, ICES J MAR SCI, V71, P2152, DOI 10.1093/icesjms/fst179; Jennings S, 1998, P ROY SOC B-BIOL SCI, V265, P333, DOI 10.1098/rspb.1998.0300; Jorgensen C, 2007, SCIENCE, V318, P1247, DOI 10.1126/science.1148089; Kramer AM, 2010, J ANIM ECOL, V79, P633, DOI 10.1111/j.1365-2656.2009.01657.x; Kuparinen A, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140075; Lever JJ, 2014, ECOL LETT, V17, P350, DOI 10.1111/ele.12236; Liebhold A, 2003, ECOL LETT, V6, P133, DOI 10.1046/j.1461-0248.2003.00405.x; McCallum H, 1996, TRENDS ECOL EVOL, V11, P491, DOI 10.1016/S0169-5347(96)30050-5; McClure CA, 2007, AQUACULTURE, V272, P370, DOI 10.1016/j.aquaculture.2007.08.039; Mooring MS, 2004, J WILDLIFE MANAGE, V68, P519, DOI 10.2193/0022-541X(2004)068[0519:VPRATA]2.0.CO;2; Morita K, 2002, J FISH BIOL, V61, P1230, DOI [10.1006/jfbi.2002.2138, 10.1111/j.1095-8649.2002.tb02467.x]; Olsen EM, 2004, NATURE, V428, P932, DOI 10.1038/nature02430; Persson L., 2013, MONOGRAPHS POPULATIO, V51; Persson L, 2013, ECOLOGY, V94, P1487, DOI 10.1890/12-1883.1; Roff Derek A., 1992; Schneider JM, 1997, BIOL J LINN SOC, V60, P517; Shimada Y, 2014, PLOS ONE, V6; Soudijn FH, 2017, THEOR ECOL-NETH, V10, P73, DOI 10.1007/s12080-016-0309-9; Stearns S.C., 1992, pi; Sun ZP, 2015, THEOR POPUL BIOL, V103, P60, DOI 10.1016/j.tpb.2015.04.004; Swain DP, 2015, MAR ECOL PROG SER, V519, P165, DOI 10.3354/meps11012	42	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187338	10.1371/journal.pone.0187338	http://dx.doi.org/10.1371/journal.pone.0187338			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088273	Green Submitted, Green Published, gold			2022-12-26	WOS:000414088900068
J	Yano, T; Ohira, M; Nakano, R; Tanaka, Y; Ohdan, H				Yano, Takuya; Ohira, Masahiro; Nakano, Ryosuke; Tanaka, Yuka; Ohdan, Hideki			Hepatectomy leads to loss of TRAIL-expressing liver NK cells via downregulation of the CXCL9-CXCR3 axis in mice	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; APOPTOSIS-INDUCING LIGAND; T-CELLS; IFN-GAMMA; HEPATOCELLULAR-CARCINOMA; MEDIATED CYTOTOXICITY; CYTOKINE PRODUCTION; TUMOR-METASTASIS; KUPFFER CELLS; ACTIVATION	Liver-resident natural killer (NK) cells express TNF-related apoptosis-inducing ligand (TRAIL), a critical molecule for NK cell-mediated tumor cell killing. We previously reported that TRAIL expression in liver NK cells decreases markedly after hepatectomy; however, the mechanism underlying this drastic alteration remains unknown. In this study, we assessed the role of chemokine signaling in liver-resident NK cells during the perioperative period of hepatectomy. The expression levels of various chemokine receptors on liver-resident NK cells and their associations with TRAIL expression were analyzed by flow cytometry. The expression of various intrahepatic chemokines/cytokines was analyzed after 70% hepatectomy in mice by quantitative RT-PCR and flow cytometry. We further investigated whether polyinosinic-polycytidylic acid (poly I:C)-induced NK cell activation could ameliorate TRAIL expression in the liver after 70% hepatectomy in CXCR3(-/-) and wild-type mice. TRAIL(+)NK cells strongly and exclusively expressed CXCR3, and the expression of its ligand CXCL9 was significantly decreased in the liver after hepatectomy. The kinetics of hepatic CXCL9 expression resembled the changes in hepatic TRAIL(+)NK cells after hepatectomy. Among liver-resident mononuclear cells, CXCL9 was predominantly secreted by macrophages in response to interferon-gamma stimulation. Although the administration of poly I: C, an inducer of interferon-gamma, increased hepatic CXCL9 levels in both CXCR3(-/-) and wildtype mice even after hepatectomy, only wild-type mice exhibited the recovery of TRAIL expression on NK cells. Partial hepatectomy remarkably reduced the proportion of TRAIL-expressing NK cells in the liver via the downregulation of the CXCL9-CXCR3 axis in mice. These findings extend our knowledge of the factors contributing to hepatocellular carcinoma recurrence after hepatectomy.	[Yano, Takuya; Ohira, Masahiro; Nakano, Ryosuke; Tanaka, Yuka; Ohdan, Hideki] Hiroshima Univ, Dept Gastroenterol & Transplant Surg, Appl Life Sci, Inst Biomed & Hlth Sci, Hiroshima, Japan	Hiroshima University	Ohira, M (corresponding author), Hiroshima Univ, Dept Gastroenterol & Transplant Surg, Appl Life Sci, Inst Biomed & Hlth Sci, Hiroshima, Japan.	mohira@hiroshima-u.ac.jp	Ohdan, Hideki/G-4719-2019; Ohira, Masahiro/G-7350-2019; Tanaka, Yuka/G-9580-2019	Ohdan, Hideki/0000-0002-9066-1288; Ohira, Masahiro/0000-0002-5433-5303	Ichino Kanehara Foundation for the Promotion of Medical Sciences and Medical Care; Hiroshima University Education and Research Support Foundation; Takeda Science Foundation; Ministry of Education, Science, Sports, and Culture of Japan [KAKENHI JP15K19893]	Ichino Kanehara Foundation for the Promotion of Medical Sciences and Medical Care; Hiroshima University Education and Research Support Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Ichino Kanehara Foundation for the Promotion of Medical Sciences and Medical Care, the Hiroshima University Education and Research Support Foundation, Takeda Science Foundation, and a Grant-in-Aid for Scientific Research (KAKENHI JP15K19893 to M.O.) from the Ministry of Education, Science, Sports, and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi JC, 2014, HEPATOLOGY, V60, P1389, DOI 10.1002/hep.27245; BOUWENS L, 1987, EUR J IMMUNOL, V17, P37, DOI 10.1002/eji.1830170107; Brady J, 2010, J IMMUNOL, V185, P6679, DOI 10.4049/jimmunol.0903354; Carrega P, 2014, J IMMUNOL, V192, P3805, DOI 10.4049/jimmunol.1301889; Curbishley SM, 2005, AM J PATHOL, V167, P887, DOI 10.1016/S0002-9440(10)62060-3; Daussy C, 2014, J EXP MED, V211, P563, DOI 10.1084/jem.20131560; FARBER JM, 1990, P NATL ACAD SCI USA, V87, P5238, DOI 10.1073/pnas.87.14.5238; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Ishiyama K, 2006, HEPATOLOGY, V43, P362, DOI 10.1002/hep.21035; Kayagaki N, 1999, J IMMUNOL, V163, P1906; Knolle PA, 1999, GASTROENTEROLOGY, V116, P1428, DOI 10.1016/S0016-5085(99)70508-1; Lambeir AM, 2001, J BIOL CHEM, V276, P29839, DOI 10.1074/jbc.M103106200; Lanier LL, 2003, CURR OPIN IMMUNOL, V15, P308, DOI 10.1016/S0952-7915(03)00039-6; Liu Q, 2012, AM J PATHOL, V181, P452, DOI 10.1016/j.ajpath.2012.04.010; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Matsumoto M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7280; Minagawa M, 2000, HEPATOLOGY, V31, P907, DOI 10.1053/he.2000.5850; Miyake T, 2009, J IMMUNOL, V183, P2522, DOI 10.4049/jimmunol.0901500; MORIMOTO H, 1992, CANCER DETECT PREV, V16, P137; Ochi M, 2004, HEPATOLOGY, V39, P1321, DOI 10.1002/hep.20204; Ohdan H, 2003, TRANSPLANTATION, V76, P791, DOI 10.1097/01.TP.0000074603.36553.BD; Ohira M, 2006, TRANSPLANTATION, V82, P1712, DOI 10.1097/01.tp.0000250935.41034.2d; Pak-Wittel MA, 2013, P NATL ACAD SCI USA, V110, pE50, DOI 10.1073/pnas.1220456110; PARK SK, 1971, LANCET, V1, P53; Paul WE, 1999, FUNDAMENTAL IMMUNOLO, P575; Robertson MJ, 2002, J LEUKOCYTE BIOL, V71, P173; ROBINSON RA, 1976, JNCI-J NATL CANCER I, V57, P599, DOI 10.1093/jnci/57.3.599; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Seki S, 2000, IMMUNOL REV, V174, P35, DOI 10.1034/j.1600-0528.2002.017404.x; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Smyth MJ, 2000, J EXP MED, V192, P755, DOI 10.1084/jem.192.5.755; Smyth MJ, 2001, J EXP MED, V193, P661, DOI 10.1084/jem.193.6.661; Suzuki A, 2006, J HEPATOL, V45, P410, DOI 10.1016/j.jhep.2006.04.008; Takahashi M, 1996, J IMMUNOL, V156, P2436; Takeda K, 2005, BLOOD, V105, P2082, DOI 10.1182/blood-2004-08-3262; Takeda K, 2001, NAT MED, V7, P94, DOI 10.1038/83416; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Vujanovic NL, 1996, J IMMUNOL, V157, P1117; Wald O, 2006, J IMMUNOL, V176, P4716, DOI 10.4049/jimmunol.176.8.4716; Watanabe T, 2008, HEPATOL RES, V38, P441, DOI 10.1111/j.1872-034X.2007.00313.x; Wendel M, 2008, CANCER RES, V68, P8437, DOI 10.1158/0008-5472.CAN-08-1440; Zamai L, 1998, J EXP MED, V188, P2375, DOI 10.1084/jem.188.12.2375	43	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186997	10.1371/journal.pone.0186997	http://dx.doi.org/10.1371/journal.pone.0186997			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088306	Green Published, Green Submitted, gold			2022-12-26	WOS:000414088900035
J	Alemayehu, T; Mekasha, A; Abebe, T				Alemayehu, Tinsae; Mekasha, Amha; Abebe, Tamrat			Nasal carriage rate and antibiotic susceptibility pattern of Neisseria meningitidis in healthy Ethiopian children and adolescents: A cross-sectional study	PLOS ONE			English	Article							COLONIZATION	Background Community nasal meningococcal carriage rates are high across Africa. Meningococcal infections are major causes of morbidity and mortality in the continent; especially among children and adolescents. This study aimed to determine the prevalence of nasal carriage and antibiotic susceptibilities of meningococcal isolates from healthy Ethiopian children and adolescents. Method A cross-sectional study was conducted in one of the sub-cities of Addis Ababa, Ethiopia. Nasal swabs were collected and processed for identification, serogrouping and testing susceptibilities for three antibiotics using standard microbiological techniques. Data on epidemiologic risk factors were collected using a structured questionnaire and the magnitude of their association with carriage was assessed using bivariate and multivariate analysis. Result A total of 240 samples were collected (115 from males and 125 from females). The mean age of study participants was 11.1 years. The prevalence of nasal carriage for Neisseria meningitidis was 20.4% (49/240). Carriage was significantly higher among children living under crowded conditions (OR 1.268; 95% CI: 1.186-1.355; p = 0.006). The predominant serogroups were W135-20/49 isolates (40.8%) and C-12/49 isolates (24.5%) and 83.7% of meningococci were sensitive for Ciprofloxacin. In contrast, isolates showed high resistance to Ceftriaxone (69.4%) while only 4.2% were sensitive for Penicillin. Multi-drug resistance was documented for 14.3% of the isolates. Conclusions Meningococcal carriage rate was found to be high with higher rates associated with children and adolescents living in crowded living conditions. Predominant isolates were of serogroup W135 and C and the isolates showed marked susceptibility to Ciprofloxacin and resistance to Ceftriaxone and Penicillin.	[Alemayehu, Tinsae; Mekasha, Amha] Addis Ababa Univ, Dept Pediat & Child Hlth, Coll Hlth Sci, Addis Ababa, Ethiopia; [Abebe, Tamrat] Addis Ababa Univ, Dept Microbiol Immunol & Parasitol, Coll Hlth Sci, Addis Ababa, Ethiopia	Addis Ababa University; Addis Ababa University	Alemayehu, T (corresponding author), Addis Ababa Univ, Dept Pediat & Child Hlth, Coll Hlth Sci, Addis Ababa, Ethiopia.	tigisttinsae@gmail.com		Alemayehu, Tinsae/0000-0003-0699-8433	Office of the Director for Research at the Office of the Vice President for Research and Technology Transfer of the Addis Ababa University;  [6223]	Office of the Director for Research at the Office of the Vice President for Research and Technology Transfer of the Addis Ababa University; 	We would like to acknowledge the Office of the Director for Research at the Office of the Vice President for Research and Technology Transfer of the Addis Ababa University for funding the study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Grant number: 6223; We would like to thank the families of the children enrolled in the study, the data collectors and the administration and teachers of the Major General Hayelom Araya Primary and Junior Secondary school. We would also like to acknowledge the Office of the Director for Research at the Office of the Vice President for Research and Technology Transfer of the Addis Ababa University for funding the study.	Assefa A., 2013, THE J, V1, P2, DOI [10.4172/jidt.1000109, DOI 10.4172/JIDT.1000109]; Bakir M, 2001, EUR J EPIDEMIOL, V17, P1015, DOI 10.1023/A:1020021109462; Basta NE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078336; Bogaert D, 2005, CLIN INFECT DIS, V40, P899, DOI 10.1086/428351; British society for antimicrobial chemotherapy, 2015, METH ANT SUSC TEST; Centers for Disease Control and Prevention, 2021, INFL ANT MED SUMM CL; Chang Qiuzhi, 2012, Clin Epidemiol, V4, P237, DOI 10.2147/CLEP.S28410; Clinical & Laboratory Standard Institute, 2016, PERFORMANCE STANDARD; de los Monteros LEED, 2009, SALUD PUBLICA MEXICO, V51, P114, DOI 10.1590/S0036-36342009000200006; Fahimzad A., 2008, Iranian Journal of Clinical Infectious Diseases, V3, P25; Forgor AA, 2005, TROP MED INT HEALTH, V10, P1229, DOI 10.1111/j.1365-3156.2005.01520.x; Gazi H, 2004, ANN ACAD MED SINGAP, V33, P758; Pavlopoulou ID, 2004, CLIN MICROBIOL INFEC, V10, P137, DOI 10.1111/j.1469-0691.2004.00750.x; The MenAfriCar Consortium, 2015, J INFECT DIS, V212, P1298; Trotter CL, 2007, LANCET INFECT DIS, V7, P797, DOI 10.1016/S1473-3099(07)70288-8; US Department of housing & urban development, 2007, MEAS OV HOUS; World Health Organization, 2003, MANUAL LAB IDENTIFIC	17	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187207	10.1371/journal.pone.0187207	http://dx.doi.org/10.1371/journal.pone.0187207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073269	Green Published, Green Submitted, gold			2022-12-26	WOS:000413845400133
J	Zhao, SJ; Jiang, YQ; Xu, NW; Li, Q; Zhang, Q; Wang, SY; Li, J; Wang, YH; Zhang, YL; Jiang, SH; Wang, YJ; Huang, YJ; Zhang, XX; Tian, GA; Zhang, CC; Lv, YY; Dai, M; Liu, F; Zhang, R; Zhou, D; Zhang, ZG				Zhao, S-J; Jiang, Y-Q; Xu, N-W; Li, Q.; Zhang, Q.; Wang, S-Y; Li, J.; Wang, Y-H; Zhang, Y-L; Jiang, S-H; Wang, Y-J; Huang, Y-J; Zhang, X-X; Tian, G-A; Zhang, C-C; Lv, Y-Y; Dai, M.; Liu, F.; Zhang, R.; Zhou, D.; Zhang, Z-G			SPARCL1 suppresses osteosarcoma metastasis and recruits macrophages by activation of canonical WNT/beta-catenin signaling through stabilization of the WNT-receptor complex	ONCOGENE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; NEGATIVE REGULATOR; SELF-RENEWAL; STEM-CELLS; GROWTH; SURVIVAL; CANCER; MECHANISMS; SARCOMAS; PATHWAY	Metastasis significantly reduces the survival rate of osteosarcoma (OS) patients. Therefore, identification of novel targets remains extremely important to prevent metastasis and treat OS. In this report, we show that SPARCL1 is downregulated in OS by epigenetic methylation of promoter DNA. In vitro and in vivo experiments revealed that SPARCL1 inhibits OS metastasis. We further demonstrated that SPARCL1-activated WNT/beta-catenin signaling by physical interaction with various frizzled receptors and lipoprotein receptor-related protein 5/6, leading to WNT-receptor complex stabilization. Activation of WNT/beta-catenin signaling contributes to the SPARCL1-mediated inhibitory effects on OS metastasis. Furthermore, we uncovered a paracrine effect of SPARCL1 on macrophage recruitment through activated WNT/beta-catenin signaling-mediated secretion of chemokine ligand5 from OS cells. These findings suggest that the targeting of SPARCL1 as a new anti-metastatic strategy for OS patients.	[Zhao, S-J; Jiang, Y-Q; Xu, N-W; Zhang, Q.; Wang, S-Y; Wang, Y-J; Huang, Y-J; Zhou, D.] Nanjing Med Univ, Changzhou Peoples Hosp 2, Affiliated Hosp, Dept Orthoped, Changzhou 213003, Jiangsu, Peoples R China; [Li, Q.; Li, J.; Wang, Y-H; Zhang, Y-L; Jiang, S-H; Zhang, X-X; Tian, G-A; Zhang, Z-G] Shanghai Jiao Tong Univ, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Sch Med,Ren Ji Hosp, Shanghai, Peoples R China; [Zhang, C-C; Lv, Y-Y; Zhang, R.] Southern Med Univ, Fengxian Hosp, Dept Obstet & Gynecol, Shanghai, Peoples R China; [Dai, M.; Liu, F.] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Obstet & Gynecol, Shanghai, Peoples R China	Nanjing Medical University; Shanghai Jiao Tong University; Southern Medical University - China; Shanghai Jiao Tong University	Zhou, D; Zhang, ZG (corresponding author), Nanjing Med Univ, Changzhou Peoples Hosp 2, Affiliated Hosp, Dept Orthoped, Changzhou 213003, Jiangsu, Peoples R China.	zhoudong1012@hotmail.com; zzhang@shsci.org	Jiang, Shuheng/M-6584-2019	Jiang, Shuheng/0000-0001-8516-6234; Zhao, Shujie/0000-0002-2820-2232	Major Program of Changzhou Health Bureau [CJ20160047]; Nineteenth Batch of Science Technology Program of Changzhou [2014YLC011]; H-level Medical Talents Training Project [2016CZBJ023]	Major Program of Changzhou Health Bureau; Nineteenth Batch of Science Technology Program of Changzhou; H-level Medical Talents Training Project	We are grateful to Dr Xiao-Li Zhou, Dr Xiao-Mei Yang, Dr Qin Yang, Dr Lei Zhu, Dr Li-Peng Hu and and Dr Xiao-Yan Cao for assistance with our experiments. This study was supported by grants from the Major Program of Changzhou Health Bureau (Grant number CJ20160047), the Nineteenth Batch of Science Technology Program of Changzhou (Grant number 2014YLC011) and the H-level Medical Talents Training Project (Grant number 2016CZBJ023).	Adamopoulos C, 2016, EXP BIOL MED, V241, P1296, DOI 10.1177/1535370216648806; Basu-Roy U, 2012, ONCOGENE, V31, P2270, DOI 10.1038/onc.2011.405; Basu-Roy U, 2013, CANCER LETT, V338, P158, DOI 10.1016/j.canlet.2012.05.028; Berraondo P, 2016, IMMUNOL REV, V274, P290, DOI 10.1111/imr.12464; Bhardwaj D, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00052; Bradshaw AD, 2012, INT J BIOCHEM CELL B, V44, P480, DOI 10.1016/j.biocel.2011.12.021; Buddingh EP, 2011, CLIN CANCER RES, V17, P2110, DOI 10.1158/1078-0432.CCR-10-2047; Cai YP, 2010, J PATHOL, V220, P24, DOI 10.1002/path.2628; Canalis E, 2013, NAT REV ENDOCRINOL, V9, P575, DOI 10.1038/nrendo.2013.154; Chanmee T, 2014, CANCERS, V6, P1670, DOI 10.3390/cancers6031670; Chen EY, 2014, P NATL ACAD SCI USA, V111, P5349, DOI 10.1073/pnas.1317731111; Chiodoni C, 2010, CANCER METAST REV, V29, P295, DOI 10.1007/s10555-010-9221-8; Claeskens A, 2000, BRIT J CANCER, V82, P1123, DOI 10.1054/bjoc.1999.1051; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Dancsok AR, 2017, ONCOTARGET, V8, P7068, DOI 10.18632/oncotarget.12548; De Palma M, 2013, CANCER CELL, V23, P277, DOI 10.1016/j.ccr.2013.02.013; Du XL, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-450; Fu Y, 2014, ONCOTARGET, V5, P6701, DOI 10.18632/oncotarget.2239; Gibault L, 2011, J PATHOL, V223, P64, DOI 10.1002/path.2787; Goldstein SD, 2016, ONCOTARGET, V7, P21114, DOI 10.18632/oncotarget.8522; Halleskog C, 2011, GLIA, V59, P119, DOI 10.1002/glia.21081; Hao NB, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/948098; Hingorani P, 2016, CANCER GENET-NY, V209, P182, DOI 10.1016/j.cancergen.2016.03.004; Hu HG, 2012, CLIN CANCER RES, V18, P5438, DOI 10.1158/1078-0432.CCR-12-0124; Hurley PJ, 2015, CANCER RES, V75, P4322, DOI 10.1158/0008-5472.CAN-15-0024; Kansara M, 2014, NAT REV CANCER, V14, P722, DOI 10.1038/nrc3838; Kim J, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6058147; Kovac M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9940; Matushansky I, 2007, J CLIN INVEST, V117, P3248, DOI 10.1172/JCI31377; Meyers PA, 2008, J CLIN ONCOL, V26, P633, DOI 10.1200/JCO.2008.14.0095; Mintz MB, 2005, CANCER RES, V65, P1748, DOI 10.1158/0008-5472.CAN-04-2463; Mirabello L, 2009, CANCER-AM CANCER SOC, V115, P1531, DOI 10.1002/cncr.24121; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Naschberger E, 2016, J CLIN INVEST, V126, P4187, DOI 10.1172/JCI78260; Nie J, 2009, J BIOL CHEM, V284, P1279, DOI 10.1074/jbc.M808285200; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Perry JA, 2014, P NATL ACAD SCI USA, V111, pE5564, DOI 10.1073/pnas.1419260111; Ren DN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7906; Ribeiro N, 2014, J CELL BIOCHEM, V115, P17, DOI 10.1002/jcb.24649; Sullivan MM, 2008, WOUND REPAIR REGEN, V16, P310, DOI 10.1111/j.1524-475X.2008.00370.x; Sullivan MM, 2004, INT J BIOCHEM CELL B, V36, P991, DOI 10.1016/j.biocel.2004.01.017; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tang N, 2008, CLIN ORTHOP RELAT R, V466, P2114, DOI 10.1007/s11999-008-0335-z; Wan Y, 2014, HUM PATHOL, V45, P1459, DOI 10.1016/j.humpath.2014.02.022; Zanganeh S, 2016, NAT NANOTECHNOL, V11, P986, DOI [10.1038/nnano.2016.168, 10.1038/NNANO.2016.168]; Zhan T, 2017, ONCOGENE, V36, P1461, DOI 10.1038/onc.2016.304; Zhang ZG, 2006, CELL MOL LIFE SCI, V63, P82, DOI 10.1007/s00018-005-5416-5; Zhao S, 2015, ONCOGENE, V34, P5069, DOI 10.1038/onc.2014.429	49	46	47	0	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 22	2018	37	8					1049	1061		10.1038/onc.2017.403	http://dx.doi.org/10.1038/onc.2017.403			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FX2QD	29084211	Green Published, hybrid			2022-12-26	WOS:000425905700008
J	Hanke-Gogokhia, C; Wu, ZJ; Sharif, A; Yazigi, H; Frederick, JM; Baehr, W				Hanke-Gogokhia, Christin; Wu, Zhijian; Sharif, Ali; Yazigi, Hussein; Frederick, Jeanne M.; Baehr, Wolfgang			The guanine nucleotide exchange factor Arf-like protein 13b is essential for assembly of the mouse photoreceptor transition zone and outer segment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Joubert syndrome; photoreceptor; cilia; retinal degeneration; guanine nucleotide exchange factor (GEF); small GTPase; ARL13b; ARL3-GTP; ciliogenesis; transition zone; photoreceptor outer segment	INTRAFLAGELLAR TRANSPORT; JOUBERT-SYNDROME; RETINITIS-PIGMENTOSA; MEMBRANE-PROTEIN; SMALL GTPASES; PRIMARY CILIA; GENE-THERAPY; GTP-BINDING; ARL13B; CELLS	Arf-like protein 13b (ARL13b) is a small GTPase that functions as a guanosine nucleotide exchange factor (GEF) for ARL3-GDP. ARL13b is located exclusively in photoreceptor outer segments (OS) presumably anchored to discs by palmitoylation, whereas ARL3 is an inner segment cytoplasmic protein. Hypomorphic mutations affecting the ARL13b G-domain inactivate GEF activity and lead to Joubert syndrome (JS) in humans. However, the molecular mechanisms in ARL13b mutation-induced Joubert syndrome, particularly the function of primary cilia, are still incompletely understood. Because Arl13b germline knockouts in mouse are lethal, we generated retina-specific deletions of ARL13b in which ARL3-GTP formation is impaired. In mouse (ret)Arl13b(-/-) central retina at postnatal day 6 (P6) and older, outer segments were absent, thereby preventing trafficking of outer segment proteins to their destination. Ultrastructure of postnatal day 10 (P10) central (ret)Arl13b(-/-) photoreceptors revealed docking of basal bodies to cell membranes, but mature transition zones and disc structures were absent. Deletion of ARL13b in adult mice via tamoxifen-induced Cre/loxP recombination indicated that axonemes gradually shorten and outer segments progressively degenerate. IFT88, essential for anterograde intraflagellar transport (IFT), was significantly reduced at (tam)Arl13b(-/-) basal bodies, suggesting impairment of intraflagellar transport. AAV2/8 vector-mediated ARL13b expression in the (ret)Arl13b(-/-) retina rescued ciliogenesis.	[Hanke-Gogokhia, Christin; Sharif, Ali; Yazigi, Hussein; Frederick, Jeanne M.; Baehr, Wolfgang] Univ Utah, Hlth Sci Ctr, John A Moran Eye Ctr, Dept Ophthalmol, Salt Lake City, UT 84132 USA; [Wu, Zhijian] NEI, NIH, Bethesda, MD 20892 USA; [Baehr, Wolfgang] Univ Utah, Hlth Sci Ctr, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA; [Baehr, Wolfgang] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Baehr, W (corresponding author), Univ Utah, Hlth Sci Ctr, John A Moran Eye Ctr, Dept Ophthalmol, Salt Lake City, UT 84132 USA.; Baehr, W (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA.; Baehr, W (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	wbaehr@hsc.utah.edu	wu, zhi/GXH-3041-2022		National Institutes of Health [EY08123, EY019298]; NEI, National Institutes of Health [EY014800-039003]; Research to Prevent Blindness (RPB) (New York); NATIONAL EYE INSTITUTE [T32EY024234, P30EY014800, R01EY008123, ZIAEY000443, R01EY019298] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness (RPB) (New York)(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by National Institutes of Health Grants EY08123 and EY019298 (to W. B.), NEI, National Institutes of Health, Core Grant EY014800-039003, and Research to Prevent Blindness (RPB) (New York) unrestricted grants to the University of Utah Department of Ophthalmology. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Avasthi P, 2009, J NEUROSCI, V29, P14287, DOI 10.1523/JNEUROSCI.3976-09.2009; Baehr W, 2014, INVEST OPHTH VIS SCI, V55, P8653, DOI 10.1167/iovs.14-16066; Barabas P, 2011, INVEST OPHTH VIS SCI, V52, P6766, DOI 10.1167/iovs.10-7147; Blacque OE, 2008, FRONT BIOSCI-LANDMRK, V13, P2633, DOI 10.2741/2871; Branham K, 2012, INVEST OPHTH VIS SCI, V53, P8232, DOI 10.1167/iovs.12-11025; Cantagrel V, 2008, AM J HUM GENET, V83, P170, DOI 10.1016/j.ajhg.2008.06.023; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Cevik S, 2010, J CELL BIOL, V188, P953, DOI 10.1083/jcb.200908133; Chuang Jen-Zen, 2015, Cilia, V4, P4, DOI 10.1186/s13630-015-0013-1; Cideciyan AV, 2011, HUM MOL GENET, V20, P1411, DOI 10.1093/hmg/ddr022; Duldulao NA, 2009, DEVELOPMENT, V136, P4033, DOI 10.1242/dev.036350; Fan YL, 2004, NAT GENET, V36, P989, DOI 10.1038/ng1414; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Gilliam JC, 2012, CELL, V151, P1029, DOI 10.1016/j.cell.2012.10.038; Gotthardt K, 2015, ELIFE, V4, DOI 10.7554/eLife.11859; Grimm D, 2003, BLOOD, V102, P2412, DOI 10.1182/blood-2003-02-0495; Hanke-Gogokhia C, 2016, J BIOL CHEM, V291, P7142, DOI 10.1074/jbc.M115.710954; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Higginbotham H, 2004, TRANSGENIC RES, V13, P155, DOI 10.1023/B:TRAG.0000026071.41735.8e; Higginbotham H, 2013, NAT NEUROSCI, V16, P1000, DOI 10.1038/nn.3451; Ismail SA, 2012, EMBO J, V31, P4085, DOI 10.1038/emboj.2012.257; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/nchembio.686, 10.1038/NCHEMBIO.686]; Jayasundera T, 2010, ARCH OPHTHALMOL-CHIC, V128, P915, DOI 10.1001/archophthalmol.2010.122; Jiang L, 2015, FASEB J, V29, P4866, DOI 10.1096/fj.15-275677; Jiang L, 2015, J BIOL CHEM, V290, P12765, DOI 10.1074/jbc.M115.638437; Joiner AM, 2015, J NEUROSCI, V35, P13761, DOI 10.1523/JNEUROSCI.1708-15.2015; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Kim YK, 2013, ACTA HISTOCHEM, V115, P789, DOI 10.1016/j.acthis.2013.03.005; Larkins CE, 2011, MOL BIOL CELL, V22, P4694, DOI 10.1091/mbc.E10-12-0994; Li S, 2005, GENESIS, V41, P73, DOI 10.1002/gene.20097; Li YY, 2016, J AM SOC NEPHROL, V27, P3628, DOI 10.1681/ASN.2015091004; Li YJ, 2010, J CELL BIOL, V189, P1039, DOI 10.1083/jcb.200912001; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; Liu Q, 2010, ADV EXP MED BIOL, V664, P223, DOI 10.1007/978-1-4419-1399-9_26; Mariani LE, 2016, MOL BIOL CELL, V27, P3780, DOI 10.1091/mbc.E16-03-0189; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Miertzschke M, 2014, BIOCHEM J, V457, P301, DOI 10.1042/BJ20131097; Nozaki S, 2017, J CELL SCI, V130, P563, DOI 10.1242/jcs.197004; Otto EA, 2005, NAT GENET, V37, P282, DOI 10.1038/ng1520; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Pearring JN, 2013, PROG RETIN EYE RES, V36, P24, DOI 10.1016/j.preteyeres.2013.03.002; Ronquillo CC, 2016, FASEB J, V30, P3400, DOI 10.1096/fj.201600511R; Roy K, 2017, J BIOL CHEM, V292, P17703, DOI 10.1074/jbc.M117.792937; Scholey JM, 2008, J CELL BIOL, V180, P23, DOI 10.1083/jcb.200709133; Schrick JJ, 2006, AM J PATHOL, V168, P1288, DOI 10.2353/ajpath.2006.050941; Sedmak T, 2011, BIOL CELL, V103, P449, DOI 10.1042/BC20110034; Sedmak T, 2010, J CELL BIOL, V189, P171, DOI 10.1083/jcb.200911095; Seixas C, 2016, MOL BIOL CELL, V27, P308, DOI 10.1091/mbc.E15-02-0061; Song P, 2016, INVEST OPHTH VIS SCI, V57, P4517, DOI 10.1167/iovs.16-19898; Strom SP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150944; Su CY, 2012, DEVELOPMENT, V139, P4062, DOI 10.1242/dev.082321; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Sung CH, 2010, J CELL BIOL, V190, P953, DOI 10.1083/jcb.201006020; Taschner M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a028092; Thomas S, 2015, EUR J HUM GENET, V23, P621, DOI 10.1038/ejhg.2014.156; Veltel S, 2008, NAT STRUCT MOL BIOL, V15, P373, DOI 10.1038/nsmb.1396; Wright ZC, 2016, HUM MOL GENET, V25, P2031, DOI 10.1093/hmg/ddw077; Zhang HB, 2008, J NEUROSCI, V28, P4008, DOI 10.1523/JNEUROSCI.0317-08.2008; Zhang HB, 2015, FASEB J, V29, P932, DOI 10.1096/fj.14-257915; Zhang Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep24534; Zhang Q, 2013, EXP CELL RES, V319, P2316, DOI 10.1016/j.yexcr.2013.03.024	61	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21442	21456		10.1074/jbc.RA117.000141	http://dx.doi.org/10.1074/jbc.RA117.000141			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29089384	hybrid, Green Published			2022-12-26	WOS:000419013000020
J	Plitzko, B; Kaweesa, EN; Loesgen, S				Plitzko, Birte; Kaweesa, Elizabeth N.; Loesgen, Sandra			The natural product mensacarcin induces mitochondrial toxicity and apoptosis in melanoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMET ASSAY; DNA-DAMAGE; DEATH; GENE; CYTOTOXICITY; DOXORUBICIN; INHIBITION; ORGANELLES; MUTATIONS; DISTINCT	Mensacarcin is a highly oxygenated polyketide that was first isolated from soil-dwelling Streptomyces bacteria. It exhibits potent cytostatic properties (mean of 50% growth inhibition = 0.2 mu M) in almost all cell lines of the National Cancer Institute (NCI)-60 cell line screen and relatively selective cytotoxicity against melanoma cells. Moreover, its low COMPARE correlations with known standard antitumor agents indicate a unique mechanism of action. Effective therapies for managing melanoma are limited, so we sought to investigate mensacarcin's unique cytostatic and cytotoxic effects and its mode of action. By assessing morphological and biochemical features, we demonstrated that mensacarcin activates caspase-3/7-dependent apoptotic pathways and induces cell death in melanoma cells. Upon mensacarcin exposure, SK-Mel-28 and SK-Mel-5 melanoma cells, which have the BRAFV600E mutation associated with drug resistance, showed characteristic chromatin condensation as well as distinct poly(ADP-ribose) polymerase-1 cleavage. Flow cytometry identified a large population of apoptotic melanoma cells, and single-cell electrophoresis indicated that mensacarcin causes genetic instability, a hallmark of early apoptosis. To visualize mensacarcin's subcellular localization, we synthesized a fluorescent mensacarcin probe that retained activity. The natural product probe was localized to mitochondria within 20 min of treatment. Live-cell bioenergetic flux analysis confirmed that mensacarcin disturbs energy production and mitochondrial function rapidly. The subcellular localization of the fluorescently labeled mensacarcin together with its unusual metabolic effects in melanoma cells provide evidence that mensacarcin targets mitochondria. Mensacarcin's unique mode of action suggests that it may be a useful probe for examining energy metabolism, particularly in BRAF-mutant melanoma, and represent a promising lead for the development of new anticancer drugs.	[Plitzko, Birte; Kaweesa, Elizabeth N.; Loesgen, Sandra] Oregon State Univ, Dept Chem, Gilbert Hall 153, Corvallis, OR 97331 USA	Oregon State University	Loesgen, S (corresponding author), Oregon State Univ, Dept Chem, Gilbert Hall 153, Corvallis, OR 97331 USA.	sandra.loesgen@oregonstate.edu			Oregon State University	Oregon State University	This work was primarily supported by Oregon State University startup funds. The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], 2017, CANC FACTS FIG 2017, P24; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Beck D, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003057; BOYD MR, 1995, DRUG DEVELOP RES, V34, P91, DOI 10.1002/ddr.430340203; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Cliby WA, 2002, J BIOL CHEM, V277, P1599, DOI 10.1074/jbc.M106287200; Curtius T., 1894, J PRAKT CHEM, V50, P275, DOI [10.1002/prac.18940500125, DOI 10.1002/PRAC.18940500125]; D'Souza GGM, 2011, BBA-BIOENERGETICS, V1807, P689, DOI 10.1016/j.bbabio.2010.08.008; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dykens JA, 2007, DRUG DISCOV TODAY, V12, P777, DOI 10.1016/j.drudis.2007.07.013; Giordano S, 2012, BIOENERGETIC RESPONS, V7, P1, DOI DOI 10.1371/J0URNAL.P0NE; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Hall A, 2013, ONCOTARGET, V4, P584, DOI 10.18632/oncotarget.965; Huang SN, 2003, J PHARMACOL EXP THER, V306, P681, DOI 10.1124/jpet.103.051581; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; KORZENIEWSKI C, 1983, J IMMUNOL METHODS, V64, P313, DOI 10.1016/0022-1759(83)90438-6; Los M, 2002, MOL BIOL CELL, V13, P978, DOI 10.1091/mbc.01-05-0272; Lupertz R, 2010, TOXICOLOGY, V271, P115, DOI 10.1016/j.tox.2010.03.012; Ma HT, 2011, METHODS MOL BIOL, V761, P151, DOI 10.1007/978-1-61779-182-6_10; Maier S, 2015, CHEMBIOCHEM, V16, P1175, DOI 10.1002/cbic.201500048; Maier S, 2014, CHEMBIOCHEM, V15, P749, DOI 10.1002/cbic.201300704; Moreau S, 2012, ANN SURG ONCOL, V19, P4314, DOI 10.1245/s10434-012-2457-5; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NAGATSU J, 1963, J ANTIBIOT, V16, P203; Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Parmenter TJ, 2014, CANCER DISCOV, V4, P423, DOI 10.1158/2159-8290.CD-13-0440; PAULL KD, 1992, CANCER RES, V52, P3892; PAULL KD, 1989, J NATL CANCER I, V81, P1088, DOI 10.1093/jnci/81.14.1088; Piehler J, 1997, ANAL BIOCHEM, V249, P94, DOI 10.1006/abio.1997.2160; Poulikakos PI, 2011, CANCER CELL, V19, P11, DOI 10.1016/j.ccr.2011.01.008; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Rundell MS, 2003, ENVIRON MOL MUTAGEN, V42, P61, DOI 10.1002/em.10175; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schockel L, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0138-0; Serrill JD, 2015, BIOCHEM PHARMACOL, V93, P251, DOI 10.1016/j.bcp.2014.11.015; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Smith P. A. S., 2004, ORG REACTIONS, V3, P337; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Tietze LF, 2005, EUR J ORG CHEM, V2005, P2459, DOI 10.1002/ejoc.200400826; Tietze LF, 2004, CHEM-EUR J, V10, P5233, DOI 10.1002/chem.200400342; Tietze LF, 2005, EUR J ORG CHEM, V2005, P1752, DOI 10.1002/ejoc.200400786; Tietze LF, 2007, EUR J ORG CHEM, V2007, P4563, DOI 10.1002/ejoc.200700418; Tone S, 2007, EXP CELL RES, V313, P3635, DOI 10.1016/j.yexcr.2007.06.018; Tse WC, 2004, CHEM BIOL, V11, P1607, DOI 10.1016/j.chembiol.2003.08.012; Van Noorden CJF, 2001, ACTA HISTOCHEM, V103, P241, DOI 10.1078/0065-1281-00601; VonSteyern FV, 1996, J HISTOCHEM CYTOCHEM, V44, P267, DOI 10.1177/44.3.8648087; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yan XH, 2012, CHEMBIOCHEM, V13, P224, DOI 10.1002/cbic.201100574; Zhao JY, 2013, INT J MOL SCI, V14, P16851, DOI 10.3390/ijms140816851; Zheng J, 2012, ONCOL LETT, V4, P1151, DOI 10.3892/ol.2012.928	54	20	20	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					21102	21116		10.1074/jbc.M116.774836	http://dx.doi.org/10.1074/jbc.M116.774836			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29074620	hybrid, Green Published			2022-12-26	WOS:000418453400025
J	Vyklicka, L; Boukalova, S; Macikova, L; Chvojka, S; Vlachova, V				Vyklicka, Lenka; Boukalova, Stepana; Macikova, Lucie; Chvojka, Stepan; Vlachova, Viktorie			The human transient receptor potential vanilloid 3 channel is sensitized via the ERK pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLMSTED SYNDROME; CATION CHANNEL; TRPV3 CHANNEL; PROTEIN; SKIN; MUTATIONS; HEAT	The transient receptor potential vanilloid 3 (TRPV3) channel is a Ca2+-permeable thermosensitive ion channel widely expressed in keratinocytes, where together with epidermal growth factor receptor (EGFR) forms a signaling complex regulating epidermal homeostasis. Proper signaling through this complex is achieved and maintained via several pathways in whichTRPV3activation is absolutely required. Results of recent studies have suggested that low-level constitutive activity of TRPV3 induces EGFR-dependent signaling that, in turn, amplifies TRPV3 via activation of the mitogen-activated protein kinase ERK in a positive feedback loop. Here, we explored the molecular mechanism that increases TRPV3 activity through EGFR activation. We used mutagenesis and whole-cell patch clamp experiments on TRPV3 channels endogenously expressed in an immortalized human keratinocyte cell line (HaCaT) and in transiently transfected HEK293T cells and found that the sensitizing effect of EGFR on TRPV3 is mediated by ERK. We observed that ERK-mediated phosphorylation of TRPV3 alters its responsiveness to repeated chemical stimuli. Among several putative ERK phosphorylation sites, we identified threonine 264 in the N-terminal ankyrin repeat domain as the most critical site for the ERK-dependent modulation of TRPV3 channel activity. Of note, Thr264 is in close vicinity to a structurally and functionally important TRPV3 region comprising an atypical finger 3 and oxygen-dependent hydroxylation site. In summary, our findings indicate that Thr264 in TRPV3 is a key ERK phosphorylation site mediating EGFR-induced sensitization of the channel to stimulate signaling pathways involved in regulating skin homeostasis.	[Vyklicka, Lenka; Boukalova, Stepana; Macikova, Lucie; Chvojka, Stepan; Vlachova, Viktorie] Czech Acad Sci, Inst Physiol, Dept Cellular Neurophysiol, Prague 14220 4, Czech Republic	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Vyklicka, L (corresponding author), Czech Acad Sci, Inst Physiol, Dept Cellular Neurophysiol, Prague 14220 4, Czech Republic.; Vlachova, V (corresponding author), Inst Physiol CAS, Dept Cellular Neurophysiol, Videnska 1083, Prague 14220 4, Czech Republic.	lenka.vyklicka@fgu.cas.cz; viktorie.vlachova@fgu.cas.cz	Boukalova, Stepana/H-2610-2014; Boukalova, Stepana/AAM-3541-2020; Marsakova, Lenka/F-8637-2014; Vlachova, Viktorie/Q-2040-2019; Vlachova, Viktorie/A-4380-2012; Macikova, Lucie/O-1048-2017	Boukalova, Stepana/0000-0002-6478-4604; Boukalova, Stepana/0000-0002-6478-4604; Vlachova, Viktorie/0000-0002-8621-0935; Vlachova, Viktorie/0000-0002-8621-0935; Macikova, Lucie/0000-0003-2249-442X	Czech Science Foundation [15-15839S]; Grant Agency of Charles University [GA UK 74417]	Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of Charles University	This work was supported by Czech Science Foundation Grant 15-15839S and the Grant Agency of Charles University Grant GA UK 74417. The authors declare that they have no conflicts of interest with the contents of this article.	Bang S, 2010, J BIOL CHEM, V285, P19362, DOI 10.1074/jbc.M109.087742; Benedikt J, 2007, J NEUROCHEM, V100, P211, DOI 10.1111/j.1471-4159.2006.04192.x; Billen B, 2015, J BIOL CHEM, V290, P12964, DOI 10.1074/jbc.M114.628925; Busca R, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00053; Cheng XP, 2010, CELL, V141, P331, DOI 10.1016/j.cell.2010.03.013; Dittert I, 2006, J NEUROSCI METH, V151, P178, DOI 10.1016/j.jneumeth.2005.07.005; Doerner JF, 2011, J GEN PHYSIOL, V137, P271, DOI 10.1085/jgp.200910388; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hu HZ, 2006, J CELL PHYSIOL, V208, P201, DOI 10.1002/jcp.20648; Hu HJ, 2007, J NEUROSCI, V27, P13181, DOI 10.1523/JNEUROSCI.0269-07.2007; Karttunen S, 2015, J CELL SCI, V128, P225, DOI 10.1242/jcs.158451; Lai-Cheong JE, 2012, BRIT J DERMATOL, V167, P440, DOI 10.1111/j.1365-2133.2012.11115.x; Lin ZM, 2012, AM J HUM GENET, V90, P558, DOI 10.1016/j.ajhg.2012.02.006; Liu BY, 2017, P NATL ACAD SCI USA, V114, P1589, DOI 10.1073/pnas.1615304114; Liu BY, 2011, J GEN PHYSIOL, V138, P509, DOI 10.1085/jgp.201110689; Luo JL, 2014, CURR TOP MEMBR, V74, P325, DOI [10.1016/B978-0-12-800181-3.00012-9, 10.1016/B978-0-12-80018-3.00012-9]; Martin SW, 2006, CELL CALCIUM, V39, P275, DOI 10.1016/j.ceca.2005.11.002; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Nilius B, 2014, J PHYSIOL-LONDON, V592, P295, DOI 10.1113/jphysiol.2013.255968; Nilius B, 2013, EXP DERMATOL, V22, P447, DOI 10.1111/exd.12163; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Phelps CB, 2010, J BIOL CHEM, V285, P731, DOI 10.1074/jbc.M109.052548; Shen B, 2011, J BIOL CHEM, V286, P19439, DOI 10.1074/jbc.M110.210294; Shi DJ, 2013, PROTEIN CELL, V4, P942, DOI 10.1007/s13238-013-3091-0; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Stamboulian S, 2010, J NEUROSCI, V30, P1637, DOI 10.1523/JNEUROSCI.4872-09.2010; Xiao R, 2008, J BIOL CHEM, V283, P6162, DOI 10.1074/jbc.M706535200; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yang P, 2014, HANDB EXP PHARMACOL, V222, P273, DOI 10.1007/978-3-642-54215-2_11	30	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					21083	21091		10.1074/jbc.M117.801167	http://dx.doi.org/10.1074/jbc.M117.801167			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29084846	hybrid, Green Published			2022-12-26	WOS:000418453400023
J	Klaassen, I; de Vries, EW; Vogels, IMC; van Kampen, AHC; Bosscha, MI; Steel, DHW; Van Noorden, CJF; Lesnik-Oberstein, SY; Schlingemann, RO				Klaassen, Ingeborg; de Vries, Ewout W.; Vogels, Ilse M. C.; van Kampen, Antoine H. C.; Bosscha, Machteld I.; Steel, David H. W.; Van Noorden, Cornelis J. F.; Lesnik-Oberstein, Sarit Y.; Schlingemann, Reinier O.			Identification of proteins associated with clinical and pathological features of proliferative diabetic retinopathy in vitreous and fibrovascular membranes	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; GANGLION-CELL NEURITES; BLOOD-RETINAL BARRIER; ANGIOGENESIS IN-VITRO; EPIRETINAL MEMBRANES; MACULAR EDEMA; OCULAR NEOVASCULARIZATION; BINDING PROTEIN-3; FACTOR EXPRESSION; IGF-I	Purpose To identify the protein profiles in vitreous associated with retinal fibrosis, angiogenesis, and neurite formation in epiretinal fibrovascular membranes (FVMs) in patients with proliferative diabetic retinopathy (PDR). Methods Vitreous samples of 5 non-diabetic control patients with vitreous debris and 7 patients with PDR membranes were screened for 507 preselected proteins using the semi-quantitative RayBio (R) L-series 507 antibody array. From this array, 60 proteins were selected for a custom quantitative antibody array (Raybiotech, Human Quantibody (R) array), analyzing 7 control patients, 8 PDR patients with FVMs, and 5 PDR patients without FVMs. Additionally, mRNA levels of proteins of interest were measured in 10 PDR membranes and 11 idiopathic membranes and in retinal tissues and cells to identify possible sources of protein production. Results Of the 507 proteins screened, 21 were found to be significantly elevated in PDR patients, including neurogenic and angiogenic factors such as neuregulin 1 (NRG1), nerve growth factor receptor (NGFR), placental growth factor (PlGF) and platelet derived growth factor (PDGF). Angiopoietin-2 (Ang2) concentrations were strongly correlated to the degree of fibrosis and the presence of FVMs in patients with PDR. Protein correlation analysis showed PDGF to be extensively co-regulated with other proteins, including thrombospondin-1 and Ang2. mRNA levels of glial-derived and brain/derived neurotrophic factor (GDNF and BDNF) were elevated in PDR membranes. These results were validated in a second study of 52 vitreous samples of 32 PDR patients and 20 control patients. Conclusions This exploratory study reveals protein networks that potentially contribute to neurite outgrowth, angiogenesis and fibrosis in the formation of fibrovascular membranes in PDR. We identified a possible role of Ang2 in fibrosis and the formation of FVMs, and of the neurotrophic factors NRG1, PDGF and GDNF in neurite growth that occurs in all FVMs in PDR.	[Klaassen, Ingeborg; de Vries, Ewout W.; Vogels, Ilse M. C.; Van Noorden, Cornelis J. F.; Schlingemann, Reinier O.] Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, Ocular Angiogenesis Grp, Amsterdam, Netherlands; [Klaassen, Ingeborg; de Vries, Ewout W.; Vogels, Ilse M. C.; Van Noorden, Cornelis J. F.; Schlingemann, Reinier O.] Univ Amsterdam, Acad Med Ctr, Dept Med Biol, Amsterdam, Netherlands; [van Kampen, Antoine H. C.] Univ Amsterdam, Acad Med Ctr, Bioinformat Lab, Clin Epidemiol Biostat & Bioinformat, Amsterdam, Netherlands; [Bosscha, Machteld I.] Vrije Univ Amsterdam Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands; [Steel, David H. W.] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne, Tyne & Wear, England; [Steel, David H. W.] Sunderland Eye Infirm, Sunderland, Durham, England; [Lesnik-Oberstein, Sarit Y.] Harley St Eye Clin, London, England	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Newcastle University - UK	Klaassen, I (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, Ocular Angiogenesis Grp, Amsterdam, Netherlands.; Klaassen, I (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biol, Amsterdam, Netherlands.	i.klaassen@amc.uva.nl	Bosscha, Machteld/T-2808-2019; Klaassen, Ingeborg/F-7333-2015; Steel, David/I-8053-2015	Steel, David/0000-0001-8734-3089; de Vries, Ewout/0000-0002-6407-4303; Klaassen, Ingeborg/0000-0003-1695-9403	Landelijke Stichting voor Blinden en Slechtzienden (LSBS); Stichting Blinden-Penning; Stichting Ooglijders; Nederlandse Vereniging ter Verbetering van het Lot der Blinden; MaculaFonds through UitZicht; Stichting Nederlands Oogheelkundig Onderzoek	Landelijke Stichting voor Blinden en Slechtzienden (LSBS); Stichting Blinden-Penning; Stichting Ooglijders; Nederlandse Vereniging ter Verbetering van het Lot der Blinden; MaculaFonds through UitZicht; Stichting Nederlands Oogheelkundig Onderzoek	The study was supported by Landelijke Stichting voor Blinden en Slechtzienden (LSBS), Stichting Blinden-Penning and MaculaFonds that contributed through UitZicht (Grant UitZicht 2011-15), Stichting Ooglijders, Nederlandse Vereniging ter Verbetering van het Lot der Blinden and Stichting Nederlands Oogheelkundig Onderzoek (Grant 2011-03). This study was published with the help of Edward en Marianne Blaauw Fonds voor Oogheelkunde (Edward and Marianne Blaauw Fund for Ophthalmology). The funder provided support in the form of salaries for authors [IK, IMCV], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abu El-Asrar AM, 2007, BRIT J OPHTHALMOL, V91, P822, DOI 10.1136/bjo.2006.109876; Abu El-Asrar AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065472; Abu El-Asrar AM, 2013, ACTA DIABETOL, V50, P545, DOI 10.1007/s00592-011-0330-9; Bach LA, 2015, J MOL ENDOCRINOL, V54, pR1, DOI 10.1530/JME-14-0215; Barber AJ, 2011, INVEST OPHTH VIS SCI, V52, P1156, DOI 10.1167/iovs.10-6293; BATTEGAY EJ, 1994, J CELL BIOL, V125, P917, DOI 10.1083/jcb.125.4.917; BerminghamMcDonogh O, 1996, DEVELOPMENT, V122, P1427; Biancotto A, 2012, CYTOKINE, V60, P438, DOI 10.1016/j.cyto.2012.05.019; Boulton M, 1997, BRIT J OPHTHALMOL, V81, P228, DOI 10.1136/bjo.81.3.228; Bringmann A, 2009, GRAEF ARCH CLIN EXP, V247, P865, DOI 10.1007/s00417-009-1082-x; Burgos R, 2000, DIABETES CARE, V23, P80, DOI 10.2337/diacare.23.1.80; Chen JX, 2012, AM J PHYSIOL-HEART C, V302, pH1003, DOI 10.1152/ajpheart.00866.2011; Cui JZ, 2007, EYE, V21, P200, DOI 10.1038/sj.eye.6702169; de Carvalho JER, 2013, INVEST OPHTH VIS SCI, V54, P6489, DOI 10.1167/iovs.13-12374; Dorrell MI, 2002, INVEST OPHTH VIS SCI, V43, P3500; Elman MJ, 2015, OPHTHALMOLOGY, V122, P375, DOI 10.1016/j.ophtha.2014.08.047; Fickweiler W, 2016, INVEST OPHTH VIS SCI, V57, P6234, DOI 10.1167/iovs.16-20157; Frank RN, 2004, NEW ENGL J MED, V350, P48, DOI 10.1056/NEJMra021678; Franklin SL, 2003, J CLIN ENDOCR METAB, V88, P900, DOI 10.1210/jc.2002-020472; Funa K, 2014, J NEUROIMMUNE PHARM, V9, P168, DOI 10.1007/s11481-013-9479-z; Granata R, 2007, J THROMB HAEMOST, V5, P835, DOI 10.1111/j.1538-7836.2007.02431.x; Guangqi E, 2012, J BIOL CHEM, V287, P3029, DOI 10.1074/jbc.M111.293985; Gulkilik Gokhan, 2010, International Ophthalmology, V30, P697, DOI 10.1007/s10792-010-9403-y; HARRISON AA, 1994, DIABETOLOGIA, V37, P1142, DOI 10.1007/BF00418378; Hellemans J, 2014, METHODS MOL BIOL, V1160, P19, DOI 10.1007/978-1-4939-0733-5_3; Hinton DR, 2002, EYE, V16, P422, DOI 10.1038/sj.eye.6700190; HOPKINS KD, 1993, HORM METAB RES, V25, P331, DOI 10.1055/s-2007-1002114; Huang H, 2015, DIABETES, V64, P200, DOI 10.2337/db14-0016; Jarajapu YPR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039398; Kita T, 2015, DIABETES, V64, P3588, DOI 10.2337/db15-0317; Klaassen I, 2015, EXP EYE RES, V133, P37, DOI 10.1016/j.exer.2014.10.016; Klaassen I, 2009, EXP EYE RES, V89, P4, DOI 10.1016/j.exer.2009.01.006; Kuiper EJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002675; Lee T, 2003, J VASC SURG, V38, P147, DOI 10.1016/S0741-5214(02)75468-2; Lei HT, 2010, EXP EYE RES, V90, P376, DOI 10.1016/j.exer.2009.11.003; Lewis GP, 2007, BRIT J OPHTHALMOL, V91, P1234, DOI 10.1136/bjo.2006.104612; Li JK, 2015, INT J OPHTHALMOL-CHI, V8, P1202, DOI 10.3980/j.issn.2222-3959.2015.06.22; Liu Z, 2011, PEPTIDES, V32, P1244, DOI 10.1016/j.peptides.2011.04.005; Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Loukovaara S, 2014, GRAEF ARCH CLIN EXP, V252, P881, DOI 10.1007/s00417-013-2508-z; Martinez-Zapata MJ, 2014, COCHRANE DB SYST REV, V11, DOI DOI 10.1002/14651858.CD008721.PUB2; Masli S, 2014, CURR EYE RES, V39, P759, DOI 10.3109/02713683.2013.877936; Moon SW, 2009, BIOCHEM BIOPH RES CO, V388, P167, DOI 10.1016/j.bbrc.2009.07.144; Mori K, 2002, INVEST OPHTH VIS SCI, V43, P2001; Nambu H, 2004, GENE THER, V11, P865, DOI 10.1038/sj.gt.3302230; Neely KA, 1998, AM J PATHOL, V153, P665, DOI 10.1016/S0002-9440(10)65607-6; Nishikiori N, 2005, DIABETES CARE, V28, P2588, DOI 10.2337/diacare.28.10.2588; Oberstein SYL, 2008, BRIT J OPHTHALMOL, V92, P981, DOI 10.1136/bjo.2007.132332; Oberstein SYL, 2011, MOL VIS, V17, P1794; Oberstein SYL, 2011, BRIT J OPHTHALMOL, V95, P266, DOI 10.1136/bjo.2010.180679; Ogden TL, 2010, ANN OCCUP HYG, V54, P255, DOI 10.1093/annhyg/mep099; Osaadon P, 2014, EYE, V28, P510, DOI 10.1038/eye.2014.13; Park N, 2012, MOL CELLS, V34, P549, DOI 10.1007/s10059-012-0235-7; Patel JI, 2005, BRIT J OPHTHALMOL, V89, P480, DOI 10.1136/bjo.2004.049940; Pauta M, 2015, LIVER INT, V35, P1383, DOI 10.1111/liv.12505; Pfeiffer A, 1997, DIABETES, V46, pS26, DOI 10.2337/diab.46.2.S26; Pfister F, 2010, ACTA DIABETOL, V47, P59, DOI 10.1007/s00592-009-0099-2; Qian XH, 1997, EXP CELL RES, V235, P403, DOI 10.1006/excr.1997.3681; Sapieha P, 2008, NAT MED, V14, P1067, DOI 10.1038/nm.1873; Schlingemann RO, 2004, GRAEF ARCH CLIN EXP, V242, P91, DOI 10.1007/s00417-003-0828-0; SCHULTZCHERRY S, 1995, J BIOL CHEM, V270, P7304, DOI 10.1074/jbc.270.13.7304; Sheibani N, 2000, BIOCHEM BIOPH RES CO, V267, P257, DOI 10.1006/bbrc.1999.1903; Siemerink MJ, 2013, J HISTOCHEM CYTOCHEM, V61, P101, DOI 10.1369/0022155412467635; Simo R, 2012, BRIT J OPHTHALMOL, V96, P1285, DOI 10.1136/bjophthalmol-2012-302005; Simo-Servat O, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/872978; Smith JM, 2015, COCHRANE DB SYST REV, V8; SMITS A, 1991, P NATL ACAD SCI USA, V88, P8159, DOI 10.1073/pnas.88.18.8159; Snead DRJ, 2008, EYE, V22, P1310, DOI 10.1038/eye.2008.36; Suzuki Y, 2011, JPN J OPHTHALMOL, V55, P256, DOI 10.1007/s10384-011-0004-8; Taguchi M, 2016, J NEUROCHEM, V136, P741, DOI 10.1111/jnc.13427; Umeda N, 2003, OPHTHALMIC RES, V35, P217, DOI 10.1159/000071173; Van Geest RJ, 2012, BRIT J OPHTHALMOL, V96, P587, DOI 10.1136/bjophthalmol-2011-301005; Warren RS, 1996, J BIOL CHEM, V271, P29483, DOI 10.1074/jbc.271.46.29483; Watanabe D, 2005, AM J OPHTHALMOL, V139, P476, DOI 10.1016/j.ajo.2004.10.004; Wisniewska-Kruk J, 2012, EXP EYE RES, V96, P181, DOI 10.1016/j.exer.2011.12.003; Xiao JH, 2009, J NEUROSCI, V29, P4016, DOI 10.1523/JNEUROSCI.3811-08.2009; Zhao B, 2004, MICROVASC RES, V68, P239, DOI 10.1016/j.mvr.2004.07.004; Zhou AY, 2014, WORLD J PEDIATR, V10, P262, DOI 10.1007/s12519-014-0502-0	79	39	41	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187304	10.1371/journal.pone.0187304	http://dx.doi.org/10.1371/journal.pone.0187304			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095861	Green Published, gold, Green Submitted			2022-12-26	WOS:000414340200068
J	Ong, M; Bulmer, M; Groening, J; Srinivasan, MV				Ong, Marielle; Bulmer, Michael; Groening, Julia; Srinivasan, Mandyam V.			Obstacle traversal and route choice in flying honeybees: Evidence for individual handedness	PLOS ONE			English	Article							LATERALIZATION; EVOLUTION; ASYMMETRY; FLIGHT; PERFORMANCE; COMPETITION; NAVIGATION; RESPONSES; BEHAVIOR; BIASES	Flying insects constantly face the challenge of choosing efficient, safe and collision-free routes while navigating through dense foliage. We examined the route-choice behavior of foraging honeybees when they encountered a barrier which could be traversed by flying through one of two apertures, positioned side by side. When the bees' choice behavior was averaged over the entire tested population, the two apertures were chosen with equal frequency when they were equally wide. When the apertures were of different width, the bees, on average, showed a preference for the wider aperture, which increased sharply with the difference between the aperture widths. Thus, bees are able to discriminate the widths of oncoming gaps and choose the passage which is presumably safer and quicker to transit. Examination of the behavior of individual bees revealed that, when the two apertures were equally wide, ca. 55% of the bees displayed no side bias in their choices. However, the remaining 45% showed varying degrees of bias, with one half of them preferring the left-hand aperture, and the other half the right-hand aperture. The existence of distinct individual biases was confirmed by measuring the times required by biased bees to transit various aperture configurations: The transit time was longer if a bee's intrinsic bias forced it to engage with the narrower aperture. Our results show that, at the population level, bees do not exhibit 'handedness' in choosing routes; however, individual bees display an idiosyncratic bias that can range from a strong left bias, through zero bias, to a strong right bias. In honeybees, previous studies of olfactory and visual learning have demonstrated clear biases at the population level. To our knowledge, our study is the first to uncover the existence of individually distinct biases in honeybees. We also show how a distribution of biases among individual honeybees can be advantageous in facilitating rapid transit of a group of bees through a cluttered environment, without any centralized decision-making or control.	[Ong, Marielle; Groening, Julia; Srinivasan, Mandyam V.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Ong, Marielle; Bulmer, Michael] Univ Queensland, Sch Math & Phys, Brisbane, Qld, Australia; [Srinivasan, Mandyam V.] Univ Queensland, Sch Informat Technol & Elect Engn, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland	Srinivasan, MV (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.; Srinivasan, MV (corresponding author), Univ Queensland, Sch Informat Technol & Elect Engn, Brisbane, Qld, Australia.	m.srinivasan@uq.edu.au		Muthukumarasamy, Srinivasan/0000-0002-2948-6206; Groening, Julia/0000-0003-2857-6290	Australian Research Council (ARC) [DP140100914]	Australian Research Council (ARC)(Australian Research Council)	This study was funded by the Australian Research Council (ARC DP140100914), http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anfora G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018903; Anfora G, 2010, BEHAV BRAIN RES, V206, P236, DOI 10.1016/j.bbr.2009.09.023; Baird E, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.2988; Bell ATA, 2014, CURR BIOL, V24, pR382, DOI 10.1016/j.cub.2014.03.064; Bell ATA, 2016, THESIS; Bhagavatula PS, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003473; Bibost AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080907; Bisazza A, 2000, LATERALITY, V5, P269, DOI 10.1080/135765000406111; Bisazza A, 2000, NEUROPSYCHOLOGIA, V38, P907, DOI 10.1016/S0028-3932(00)00018-X; Brown C, 2011, BEHAV ECOL, V22, P1201, DOI 10.1093/beheco/arr114; Buchanan SM, 2015, P NATL ACAD SCI USA, V112, P6700, DOI 10.1073/pnas.1500804112; Corballis MC, 2003, BEHAV BRAIN SCI, V26, P199, DOI 10.1017/S0140525X03000062; Crall JD, 2015, J EXP BIOL, V218, P2728, DOI 10.1242/jeb.121293; Dukas R, 2011, ANIM BEHAV, V81, P635, DOI 10.1016/j.anbehav.2010.12.011; Frasnelli E, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00939; Frasnelli E, 2012, NEUROSCI BIOBEHAV R, V36, P1273, DOI 10.1016/j.neubiorev.2012.02.006; Frasnelli E, 2010, BEHAV BRAIN RES, V209, P36, DOI 10.1016/j.bbr.2010.01.014; Ghirlanda S, 2004, P ROY SOC B-BIOL SCI, V271, P853, DOI 10.1098/rspb.2003.2669; Ghirlanda S, 2009, PHILOS T R SOC B, V364, P861, DOI 10.1098/rstb.2008.0227; Girling RD, 2007, BEHAVIOUR, V144, P143, DOI 10.1163/156853907779947337; Honicke C, 2015, SCI NAT-HEIDELBERG, V102, DOI 10.1007/s00114-015-1267-6; Hook MA, 2008, J COMP PSYCHOL, V122, P41, DOI 10.1037/0735-7036.122.1.41; Kells AR, 2001, J INSECT BEHAV, V14, P47, DOI 10.1023/A:1007897512570; Letzkus P, 2008, BIOL LETTERS, V4, P16, DOI 10.1098/rsbl.2007.0466; Letzkus P, 2006, CURR BIOL, V16, P1471, DOI 10.1016/j.cub.2006.05.060; Lihoreau M, 2016, SCI REP-UK, V6, DOI 10.1038/srep30401; Lippolis G, 2002, LATERALITY, V7, P163, DOI 10.1080/13576500143000221; LOCK A, 1980, PROC R SOC SER B-BIO, V206, P481, DOI 10.1098/rspb.1980.0009; McGrew WC, 2001, BEHAVIOUR, V138, P329, DOI 10.1163/15685390152032497; Mountcastle AM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0531; Portelli G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019486; Robins A, 2006, ANIM BEHAV, V72, P843, DOI 10.1016/j.anbehav.2006.01.022; Robins A, 2006, NEUROBIOL LEARN MEM, V86, P214, DOI 10.1016/j.nlm.2006.03.002; Rogers L.J., 2013, DIVIDED BRAINS; Rogers LJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02045; Rogers LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002340; Rogers LJ, 2002, COMP VERTEBRATE LATE; Ros IG, 2017, INTERFACE FOCUS, V7, DOI 10.1098/rsfs.2016.0093; Rutledge R, 2004, ANIM BEHAV, V67, P327, DOI 10.1016/j.anbehav.2003.07.002; Schiffner I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082670; SCHMIDHEMPEL P, 1985, BEHAV ECOL SOCIOBIOL, V17, P61, DOI 10.1007/BF00299430; Schnell AK, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00620; Serres JR, 2008, NATURWISSENSCHAFTEN, V95, P1181, DOI 10.1007/s00114-008-0440-6; Srinivasan MV, 2011, PHYSIOL REV, V91, P413, DOI 10.1152/physrev.00005.2010; Srinivasan MV, 1996, J EXP BIOL, V199, P237; TAKEDA S, 1993, BIOL BULL-US, V184, P203, DOI 10.2307/1542227; Tobo S, 2012, ECOL RES, V27, P53, DOI 10.1007/s11284-011-0867-7; WATERS NS, 1991, PHYSIOL BEHAV, V50, P853, DOI 10.1016/0031-9384(91)90030-R; Weir AAS, 2004, P ROY SOC B-BIOL SCI, V271, pS344, DOI 10.1098/rsbl.2004.0183	49	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0184343	10.1371/journal.pone.0184343	http://dx.doi.org/10.1371/journal.pone.0184343			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095830	Green Published, gold, Green Submitted			2022-12-26	WOS:000414340200001
J	Honge, BL; Petersen, MS; Olesen, R; Moller, BK; Erikstrup, C				Honge, Bo Langhoff; Petersen, Mikkel Steen; Olesen, Rikke; Moller, Bjarne Kuno; Erikstrup, Christian			Optimizing recovery of frozen human peripheral blood mononuclear cells for flow cytometry	PLOS ONE			English	Article							CLINICAL-TRIALS; CRYOPRESERVATION; RESPONSES; PBMCS; SUBSETS; VACCINE; OPTIMIZATION; INDIVIDUALS; IMMUNOLOGY; PHENOTYPE	Introduction Live peripheral blood mononuclear cells (PBMCs) can be frozen and thawed for later analyses by adding and removing a cryoprotectant, such as dimethyl sulfoxide (DMSO). Laboratories across the world use various procedures, but published evidence of optimal thawing procedures is scarce. Materials and methods PBMCs were separated from blood collected from healthy Danish blood donors, and stored at-80 degrees C after adding of DMSO. The essential steps in the thawing procedure were modified and performance was evaluated by flow cytometry with respect to the percentage and total yield of viable PMBCs. Results The best-performing washing medium was Roswell Park Memorial Institute (RPMI) 1640 at 37 degrees C with 20% fetal bovine serum. When using 10 mL washing medium in a 15-mL Falcon tube, samples should be centrifuged for at least 10 minutes at 500 g. We failed to detect any differences between the tested methods of mixing PBMCs with washing medium. Likewise, neither the thawing duration nor centrifugation temperature (20 C and 37 degrees C) had any effect. PBMCs could be incubated (rested) for up to eight hours in a 37 degrees C 5% CO2 incubator without affecting cell counts, but incubating PBMCs for 16 hours significantly decreased viability and recovery. In general, high viability was not necessarily associated with high recovery. Conclusion Changing the thawing procedure significantly impacted PBMC viability and live cell recovery. Evaluating both viability and live PBMC recovery are necessary to evaluate method performance. Investigation of differential loss of PBMC subtypes and phenotypic changes during thawing and incubation requires further evaluation.	[Honge, Bo Langhoff; Petersen, Mikkel Steen; Moller, Bjarne Kuno; Erikstrup, Christian] Aarhus Univ Hosp, Dept Clin Immunol, Aarhus, Denmark; [Honge, Bo Langhoff] Indepth Network, Bandim Hlth Project, Bissau, Guinea Bissau; [Olesen, Rikke] Aarhus Univ Hosp, Dept Infect Dis, Aarhus, Denmark	Aarhus University; Aarhus University	Honge, BL (corresponding author), Aarhus Univ Hosp, Dept Clin Immunol, Aarhus, Denmark.; Honge, BL (corresponding author), Indepth Network, Bandim Hlth Project, Bissau, Guinea Bissau.	bohonge@gmail.com	; Honge, Bo Langhoff/H-7017-2014	Olesen, Rikke/0000-0002-5157-080X; Honge, Bo Langhoff/0000-0001-9636-4519; Erikstrup, Christian/0000-0001-6551-6647				Boaz MJ, 2009, CLIN VACCINE IMMUNOL, V16, P147, DOI 10.1128/CVI.00326-08; Brooks-Worrell B, 2011, DIABETES-METAB RES, V27, P737, DOI 10.1002/dmrr.1245; Buhl T, 2012, CANCER IMMUNOL IMMUN, V61, P2021, DOI 10.1007/s00262-012-1262-0; Costantini A, 2003, J IMMUNOL METHODS, V278, P145, DOI 10.1016/S0022-1759(03)00202-3; Disis ML, 2006, J IMMUNOL METHODS, V308, P13, DOI 10.1016/j.jim.2005.09.011; Elkord E, 2009, J IMMUNOL METHODS, V347, P87, DOI 10.1016/j.jim.2009.06.001; Ferreira VD, 2015, CRYOBIOLOGY, V71, P507, DOI 10.1016/j.cryobiol.2015.10.149; Germann A, 2013, CRYOBIOLOGY, V67, P193, DOI 10.1016/j.cryobiol.2013.06.012; Hensley-McBain T, 2014, J IMMUNOL METHODS, V411, P23, DOI 10.1016/j.jim.2014.06.002; Keane KN, 2015, CLIN SCI, V128, P723, DOI 10.1042/CS20140725; Kierstead LS, 2007, AIDS RES HUM RETROV, V23, P86, DOI 10.1089/aid.2006.0129; Kloverpris H, 2010, J IMMUNOL METHODS, V356, P70, DOI 10.1016/j.jim.2010.01.014; Kutscher S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076215; Liseth K, 2005, CYTOTHERAPY, V7, P328, DOI 10.1080/14653240500238251; Lockmann A, 2013, EXP DERMATOL, V22, P358, DOI 10.1111/exd.12123; Mallone R, 2011, CLIN EXP IMMUNOL, V163, P33, DOI 10.1111/j.1365-2249.2010.04272.x; Mata MM, 2014, J IMMUNOL METHODS, V406, P1, DOI 10.1016/j.jim.2014.01.017; Meijerink M, 2011, J IMMUNOL METHODS, V373, P136, DOI 10.1016/j.jim.2011.08.010; Nazarpour R, 2012, INT J MOL CELL MED, V1, P88; Nettenstrom L, 2013, J IMMUNOL METHODS, V387, P81, DOI 10.1016/j.jim.2012.09.014; Pedersen OB, 2012, VOX SANG, V102, P271, DOI 10.1111/j.1423-0410.2011.01553.x; Ramachandran Hari, 2012, Cells, V1, P313, DOI 10.3390/cells1030313; Rasmussen SM, 2015, CYTOM PART B-CLIN CY, V88, P40, DOI 10.1002/cyto.b.21192; Riedhammer C, 2014, MULT SCLER, P53; Sarzotti-Kelsoe M, 2014, J IMMUNOL METHODS, V409, P21, DOI 10.1016/j.jim.2014.05.013; Sattui S, 2012, CYTOM PART B-CLIN CY, V82B, P54, DOI 10.1002/cyto.b.20621; Seale AC, 2008, J CLIN LAB ANAL, V22, P153, DOI 10.1002/jcla.20234; Shete A, 2013, J IMMUNOASS IMMUNOCH, V34, P333, DOI 10.1080/15321819.2012.741087; Sputtek A, 2011, CYTOTHERAPY, V13, P481, DOI 10.3109/14653249.2010.529891; Stevens VL, 2007, CANCER EPIDEM BIOMAR, V16, P2160, DOI 10.1158/1055-9965.EPI-07-0604; Truck J, 2014, HUM VACC IMMUNOTHER, V10, P2490, DOI 10.4161/hv.29318; Yang J, 2016, BMC IMMUNOL, V17, DOI 10.1186/s12865-016-0144-1; Zhang W, 2016, J IMMUNOL METHODS, V431, P31, DOI 10.1016/j.jim.2016.02.004	33	27	27	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187440	10.1371/journal.pone.0187440	http://dx.doi.org/10.1371/journal.pone.0187440			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091947	gold, Green Published, Green Submitted			2022-12-26	WOS:000414229700066
J	Anderson, GA; Ilcisin, L; Kayima, P; Abesiga, L; Benitez, NP; Ngonzi, J; Ronald, M; Shrime, MG				Anderson, Geoffrey A.; Ilcisin, Lenka; Kayima, Peter; Abesiga, Lenard; Benitez, Noralis Portal; Ngonzi, Joseph; Ronald, Mayanja; Shrime, Mark G.			Out-of-pocket payment for surgery in Uganda: The rate of impoverishing and catastrophic expenditure at a government hospital	PLOS ONE			English	Article							HEALTH-CARE; GLOBAL HEALTH; COUNTRIES; DELIVERY; POLICY; COST; PAY	Background and objectives It is Ugandan governmental policy that all surgical care delivered at government hospitals in Uganda is to be provided to patients free of charge. In practice, however, frequent stock-outs and broken equipment require patients to pay for large portions of their care out of their own pocket. The purpose of this study was to determine the financial impact on patients who undergo surgery at a government hospital in Uganda. Methods Every surgical patient discharged from a surgical ward at a large regional referral hospital in rural southwestern Uganda over a 3-week period in April 2016 was asked to participate. Patients who agreed were surveyed to determine their baseline level of poverty and to assess the financial impact of the hospitalization. Rates of impoverishment and catastrophic expenditure were then calculated. An "impoverishing expense" is defined as one that pushes a household below published poverty thresholds. A "catastrophic expense" was incurred if the patient spent more than 10% of their average annual expenditures. Results We interviewed 295 out of a possible 320 patients during the study period. 46% (CI 40-52%) of our patients met the World Bank's definition of extreme poverty ($1.90/person/day). After receiving surgical care an additional 10 patients faced extreme poverty, and 5 patients were newly impoverished by the World Bank's definition ($3.10/person/day). 31% of patients faced a catastrophic expenditure of more than 10% of their estimated total yearly expenses. 53% of the households in our study had to borrow money to pay for care, 21% had to sell possessions, and 17% lost a job as a result of the patient's hospitalization. Only 5% of our patients received some form of charity. Conclusions and relevance Despite the government's policy to provide "free care," undergoing an operation at a government hospital in Uganda can result in a severe economic burden to patients and their families. Alternative financing schemes to provide financial protection are critically needed.	[Anderson, Geoffrey A.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Anderson, Geoffrey A.; Ilcisin, Lenka; Shrime, Mark G.] Harvard Med Sch, Dept Global Hlth & Social Med, Program Global Surg & Social Change, Boston, MA 02115 USA; [Kayima, Peter; Benitez, Noralis Portal] Mbarara Univ Sci & Technol, Dept Surg, Mbarara, Uganda; [Abesiga, Lenard; Ngonzi, Joseph; Ronald, Mayanja] Mbarara Univ Sci & Technol, Dept Obstet & Gynecol, Mbarara, Uganda	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Mbarara University of Science & Technology; Mbarara University of Science & Technology	Shrime, MG (corresponding author), Harvard Med Sch, Dept Global Hlth & Social Med, Program Global Surg & Social Change, Boston, MA 02115 USA.	Shrime@mail.harvard.edu	Ngonzi, Joseph/AAC-6536-2020	Portal Benitez, Noralis/0000-0002-2801-213X	Doris Duke Charitable Foundation through the Harvard Medical School Doris Duke International Clinical Research Fellow Program; Boston Children's Hospital	Doris Duke Charitable Foundation through the Harvard Medical School Doris Duke International Clinical Research Fellow Program; Boston Children's Hospital	: LI received salary and travel support from the Doris Duke Charitable Foundation through the Harvard Medical School Doris Duke International Clinical Research Fellow Program (http://dorisduke.hms.harvard.edu/home). GAA received salary and travel support from the Massachusetts General Hospital Department of Surgery (http://www.massgeneral.org/surgery/?display=health-care-professionals). MGS receives salary support from the General Electric Foundation Safe Surgery 2020 program (http://safesurgery2020.org) and the Steven C Kletjian Foundation. Salaries of the research assistants and basic study materials were funded through a grant from Boston Children's Hospital (http://www.childrenshospital.org/global-health/about). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WORLD BANK OP DAT; Boukhalfa C, 2016, TROP MED INT HEALTH, V21, P245, DOI 10.1111/tmi.12638; Bruno E, 2017, WORLD J SURG, V41, P1218, DOI 10.1007/s00268-016-3847-9; Chao TE, 2014, LANCET GLOB HEALTH, V2, pE334, DOI 10.1016/S2214-109X(14)70213-X; Cruz M., 2015, ENDING EXTREME POVER; Group TWB, 2016, POV OV; Nguyen H, 2015, LANCET, V385, P50, DOI 10.1016/S0140-6736(15)60845-5; Kassebaum NJ, 2016, LANCET, V388, P1603, DOI [10.1016/S0140-6736(16)31460-X, 10.1016/S0140-6736(16)31470-2]; Nguyen KT, 2012, SOC SCI MED, V74, P724, DOI 10.1016/j.socscimed.2011.10.027; Kruk ME, 2009, HEALTH AFFAIR, V28, P1056, DOI 10.1377/hlthaff.28.4.1056; Lofgren J, 2015, SURGERY, V157, P983, DOI 10.1016/j.surg.2015.01.026; Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X; Museveni HEYK, 2011, STATE NATION ADDRESS, P1; Prinja S, 2015, LANCET, V385, P57, DOI 10.1016/S0140-6736(15)60852-2; Prinja S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137315; Pronyk PM, 2016, LANCET GLOB HEALTH, V4, pE276, DOI 10.1016/S2214-109X(16)00046-2; Raj M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131348; Rose J, 2015, LANCET GLOB HEALTH, V3, pS13, DOI 10.1016/S2214-109X(15)70087-2; Shrime MG, 2015, LANCET GLOB HEALTH, V3, pS38, DOI 10.1016/S2214-109X(15)70085-9; Tsai A., 2015, LIVELIHOOD INTERVENT; Tuller DM, 2010, AIDS BEHAV, V14, P778, DOI 10.1007/s10461-009-9533-2; Ugandan Bureau of S, 2014, NAT POP HOUS CENS 20; Urua U, 2017, INT J INJ CONTROL SA, P1; van Doorslaer E, 2006, LANCET, V368, P1357, DOI 10.1016/S0140-6736(06)69560-3; Ware NC, 2009, PLOS MED, V6, P39, DOI 10.1371/journal.pmed.1000011; Weiser TG, 2016, B WORLD HEALTH ORGAN, V94, P201, DOI 10.2471/BLT.15.159293; Windisch R, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-25	27	48	48	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187293	10.1371/journal.pone.0187293	http://dx.doi.org/10.1371/journal.pone.0187293			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL2ZD	29088302	Green Submitted, Green Published, gold			2022-12-26	WOS:000414088900061
J	Bernardo, I; Wong, J; Wlodek, ME; Vlahos, R; Soeding, P				Bernardo, Ivan; Wong, James; Wlodek, Mary E.; Vlahos, Ross; Soeding, Paul			Evaluation of right heart function in a rat model using modified echocardiographic views	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ARTERIAL-HYPERTENSION; DYSFUNCTION; STRAIN; COPD; MICE	Echocardiography plays a major role in assessing cardiac function in animal models. We investigated use of a modified parasternal mid right-ventricular (MRV) and right ventricle (RV) outflow (RVOT) view, in assessing RV size and function, and the suitability of advanced 2D-strain analysis. 15 WKY rats were examined using transthoracic echocardiography. The left heart was assessed using standard short and long axis views. For the right ventricle a MRV and RVOT view were used to measure RV chamber and free wall area. 2D-strain analysis was applied to both ventricles using off-line analysis. RV chamber volume was determined by injection of 2% agarose gel, and RV free wall dissected and weighed. Echocardiography measurement was correlated with necropsy findings. The RV mid-ventricular dimension (R1) was 0.42 +/- 0.07cm and the right ventricular outflow tract dimension (R2) was 0.34 +/- 0.06cm, chamber end-diastolic area measurements were 0.38 +/- 0.09cm(2) and 0.29 +/- 0.08cm(2) for MRV and RVOT views respectively. RVOT and MRV chamber area correlated with gel mass. Doppler RV stroke volume was 0.32 +/- 0.08ml, cardiac output (CO) 110 +/- 27 ml.min(-1) and RV free wall contractility assessed using 2D-strain analysis was demonstrated. We have shown that modified MRV and RVOT views can provide detailed assessment of the RV in rodents, with 2D-strain analysis of the RV free wall potentially feasible.	[Bernardo, Ivan; Vlahos, Ross] RMIT Univ, Sch Hlth & Biomed Sci, Bundoora, Vic, Australia; [Wong, James] Royal Melbourne Hosp, Dept Cardiol, Parkville, Vic, Australia; [Wlodek, Mary E.] Univ Melbourne, Dept Physiol, Parkville, Vic, Australia; [Soeding, Paul] Univ Melbourne, Dept Pharmacol, Cardiovasc Therapeut Unit, Parkville, Vic, Australia; [Soeding, Paul] Royal Melbourne Hosp, Dept Anaesthesia & Pain Management, Grattan St, Parkville, Vic, Australia	Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Hospital; University of Melbourne; University of Melbourne; Royal Melbourne Hospital	Vlahos, R (corresponding author), RMIT Univ, Sch Hlth & Biomed Sci, Bundoora, Vic, Australia.; Soeding, P (corresponding author), Univ Melbourne, Dept Pharmacol, Cardiovasc Therapeut Unit, Parkville, Vic, Australia.; Soeding, P (corresponding author), Royal Melbourne Hosp, Dept Anaesthesia & Pain Management, Grattan St, Parkville, Vic, Australia.	ross.vlahos@rmit.edu.au; paulsoeding@bigpond.com	Vlahos, Ross/AAM-3837-2020; wlodek, Mary/A-8939-2019	Vlahos, Ross/0000-0001-8443-7071; wlodek, Mary/0000-0002-8490-9099	NHMRC Australia [APP1084627, 1084627]	NHMRC Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by NHMRC Australia APP1084627.; We thank Ms Chandra Lennie (GE Healthcare) and Mr Andrew Jefferies for technical support, Mr Adrian Cajili for designing the diagrams in Fig 1, and NHMRC Australia (grant 1084627) for funding.	Anderson RH, 2009, CLIN ANAT, V22, P64, DOI 10.1002/ca.20645; Barnes PJ, 2009, EUR RESPIR J, V33, P1165, DOI 10.1183/09031936.00128008; Berger JS, 2004, AM J CARDIOL, V94, P649, DOI 10.1016/j.amjcard.2004.05.034; Bernardo I, 2015, PHARMACOL THERAPEUT, V155, P60, DOI 10.1016/j.pharmthera.2015.08.005; Bhan A, 2014, AM J PHYSIOL-HEART C, V306, pH1371, DOI 10.1152/ajpheart.00553.2013; Bhatt SP, 2013, TRANSL RES, V162, P237, DOI 10.1016/j.trsl.2013.05.001; Brown Lindsay, 2002, Heart Lung Circ, V11, P167, DOI 10.1046/j.1444-2892.2002.00148.x; Chaouat A, 2008, EUR RESPIR J, V32, P1371, DOI 10.1183/09031936.00015608; Gorcsan J, 2011, J AM COLL CARDIOL, V58, P1401, DOI 10.1016/j.jacc.2011.06.038; Hilde JM, 2013, J AM COLL CARDIOL, V62, P1103, DOI 10.1016/j.jacc.2013.04.091; Hurdman J, 2013, EUR RESPIR J, V41, P1292, DOI 10.1183/09031936.00079512; Jones JE, 2002, AM J PHYSIOL-HEART C, V283, pH364, DOI 10.1152/ajpheart.00979.2001; Kalam K, 2014, HEART, V100, P1673, DOI 10.1136/heartjnl-2014-305538; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Leather HA, 2006, AM J PHYSIOL-HEART C, V290, pH2369, DOI 10.1152/ajpheart.01211.2004; Li YB, 2007, ULTRASOUND MED BIOL, V33, P894, DOI 10.1016/j.ultrasmedbio.2006.12.008; Lindqvist P, 2003, Eur J Echocardiogr, V4, P29, DOI 10.1053/euje.2002.0177; MacNee W, 2010, SEMIN RESP CRIT CARE, V31, P295, DOI 10.1055/s-0030-1254070; PARISI A F, 1979, Clinical Cardiology, V2, P257; Perk G, 2007, J AM SOC ECHOCARDIOG, V20, P234, DOI 10.1016/j.echo.2006.08.023; Scherrer-Crosbie M, 1998, CIRCULATION, V98, P1015, DOI 10.1161/01.CIR.98.10.1015; Shehata ML, 2013, RADIOLOGY, V266, P114, DOI 10.1148/radiol.12111599; Slama M, 2003, AM J PHYSIOL-HEART C, V284, pH691, DOI 10.1152/ajpheart.00653.2002; Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, pL1013, DOI 10.1152/ajplung.00217.2009; Tee N, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/148501; TRAMARIN R, 1991, EUR HEART J, V12, P103, DOI 10.1093/oxfordjournals.eurheartj.a059855; Vlahos R, 2015, EUR J PHARMACOL, V759, P265, DOI 10.1016/j.ejphar.2015.03.029; Vlahos R, 2014, CLIN SCI, V126, P253, DOI 10.1042/CS20130182; Wright Joanne L, 2010, Expert Rev Respir Med, V4, P723, DOI 10.1586/ers.10.68	29	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187345	10.1371/journal.pone.0187345	http://dx.doi.org/10.1371/journal.pone.0187345			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088272	Green Published, gold, Green Submitted			2022-12-26	WOS:000414088900069
J	van Vugt, JLA; Buettner, S; Levolger, S; van den Braak, RRJC; Suker, M; Gaspersz, MP; de Bruin, RWF; Verhoef, C; van Eijck, CHC; Bossche, N; Koerkamp, BG; IJzermans, JNM				van Vugt, Jeroen L. A.; Buettner, Stefan; Levolger, Stef; van den Braak, Robert R. J. Coebergh; Suker, Mustafa; Gaspersz, Marcia P.; de Bruin, Ron W. F.; Verhoef, Cornelis; van Eijck, Casper H. C.; Bossche, Niek; Koerkamp, Bas Groot; IJzermans, Jan N. M.			Low skeletal muscle mass is associated with increased hospital expenditure in patients undergoing cancer surgery of the alimentary tract	PLOS ONE			English	Article							COLORECTAL-CANCER; SARCOPENIA; COMPLICATIONS; METAANALYSIS; CACHEXIA; CLASSIFICATION; CHEMOTHERAPY; MORTALITY; RESECTION; TOXICITY	Background Low skeletal muscle mass is associated with poor postoperative outcomes in cancer patients. Furthermore, it is associated with increased healthcare costs in the United States. We investigated its effect on hospital expenditure in a Western-European healthcare system, with universal access. Methods Skeletal muscle mass (assessed on CT) and costs were obtained for patients who underwent curative-intent abdominal cancer surgery. Low skeletal muscle mass was defined based on pre-established cut-offs. The relationship between low skeletal muscle mass and hospital costs was assessed using linear regression analysis and Mann-Whitney U-tests. Results 452 patients were included (median age 65, 61.5% males). Patients underwent surgery for colorectal cancer (38.9%), colorectal liver metastases (27.4%), primary liver tumours (23.2%), and pancreatic/periampullary cancer (10.4%). In total, 45.6% had sarcopenia. Median costs were (sic)2,183 higher in patients with low compared with patients with high skeletal muscle mass ((sic)17,144 versus (sic) 14,961; P<0.001). Hospital costs incrementally increased with lower sex-specific skeletal muscle mass quartiles (P = 0.029). After adjustment for confounders, low skeletal muscle mass was associated with a cost increase of (sic)4,061 (P = 0.015). Conclusion Low skeletal muscle mass was independently associated with increased hospital costs of about (sic)4,000 per patient. Strategies to reduce skeletal muscle wasting could reduce hospital costs in an era of incremental healthcare costs and an increasingly ageing population.	[van Vugt, Jeroen L. A.; Buettner, Stefan; Levolger, Stef; van den Braak, Robert R. J. Coebergh; Suker, Mustafa; Gaspersz, Marcia P.; de Bruin, Ron W. F.; van Eijck, Casper H. C.; Koerkamp, Bas Groot; IJzermans, Jan N. M.] Erasmus MC Univ, Med Ctr, Dept Surg, Rotterdam, Netherlands; [Verhoef, Cornelis] Erasmus MC Univ, Med Ctr, Dept Control & Compliance, Rotterdam, Netherlands; [Bossche, Niek] Erasmus MC Canc Inst, Dept Surg Oncol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute	van Vugt, JLA (corresponding author), Erasmus MC Univ, Med Ctr, Dept Surg, Rotterdam, Netherlands.	j.l.a.vanvugt@erasmusmc.nl	van Eijck, casper/K-5983-2019; Suker, Mustafa/AAH-8789-2020; Van Eijck, Casper/ABD-1655-2020; Coebergh, Robert/AAG-2520-2019; Verhoef, Cornelis/ABD-3648-2020; Groot koerkamp, Bas/ABD-1621-2020	Suker, Mustafa/0000-0002-7935-4666; Verhoef, Cornelis/0000-0001-9980-8613; Groot koerkamp, Bas/0000-0003-1917-6973; Coebergh van den Braak, Robert/0000-0001-9310-6629; Buettner, Stefan/0000-0002-0942-127X				[Anonymous], 2016, HEALTHC NETH; Antoun S, 2010, ANN ONCOL, V21, P1594, DOI 10.1093/annonc/mdp605; Buettner S, 2017, SURVIVAL RE IN PRESS; Buttner S, 2017, ACTA CHIR BELG, V117, P181, DOI 10.1080/00015458.2017.1279872; Coebergh JW, 2001, EUR J CANCER, V37, pS217; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Dingemans AMC, 2014, EXPERT OPIN INV DRUG, V23, P1655, DOI 10.1517/13543784.2014.942729; DRIPPS RD, 1961, JAMA-J AM MED ASSOC, V178, P261, DOI 10.1001/jama.1961.03040420001001; Dunn MA, 2016, AM J GASTROENTEROL; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Gani F, 2016, SURGERY, V160, P1162, DOI 10.1016/j.surg.2016.05.002; Gornick ME, 1996, NEW ENGL J MED, V335, P791, DOI 10.1056/NEJM199609123351106; Huillard O, 2013, BRIT J CANCER, V108, P1034, DOI 10.1038/bjc.2013.58; Kirk PS, 2015, J SURG RES, V199, P51, DOI 10.1016/j.jss.2015.04.074; Kroneman Madelon, 2016, Health Syst Transit, V18, P1; Lalmahomed ZS, 2017, CELL TISSUE BANK, V18, P425, DOI 10.1007/s10561-017-9613-x; Levolger S, 2017, CLIN NUTR; Levolger S, 2015, J SURG ONCOL, V112, P208, DOI 10.1002/jso.23976; Lieffers JR, 2012, BRIT J CANCER, V107, P931, DOI 10.1038/bjc.2012.350; Mak PHK, 2002, ANAESTH INTENS CARE, V30, P633, DOI 10.1177/0310057X0203000516; Makary MA, 2010, J AM COLL SURGEONS, V210, P901, DOI 10.1016/j.jamcollsurg.2010.01.028; Martin L, 2013, J CLIN ONCOL, V31, P1539, DOI 10.1200/JCO.2012.45.2722; Morak MJM, 2008, ANN SURG, V248, P1031, DOI 10.1097/SLA.0b013e318190c53e; Obama B, 2016, JAMA-J AM MED ASSOC, V316, P525, DOI 10.1001/jama.2016.9797; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Rolland Y, 2011, CURR OPIN CLIN NUTR, V14, P15, DOI 10.1097/MCO.0b013e328340c2c2; Shachar SS, 2016, EUR J CANCER, V57, P58, DOI 10.1016/j.ejca.2015.12.030; Sheetz KH, 2013, J AM COLL SURGEONS, V217, P813, DOI 10.1016/j.jamcollsurg.2013.04.042; Snijders HS, 2012, EJSO-EUR J SURG ONC, V38, P1013, DOI 10.1016/j.ejso.2012.07.111; Straatman J, 2015, DIGEST SURG, V32, P150, DOI 10.1159/000371861; Tan BHL, 2015, EJSO-EUR J SURG ONC, V41, P333, DOI 10.1016/j.ejso.2014.11.040; van Vledder MG, 2012, BRIT J SURG, V99, P550, DOI 10.1002/bjs.7823; van Vugt JLA, 2016, AM J TRANSPLANT, V16, P2277, DOI 10.1111/ajt.13732; van Vugt JLA, 2017, J CACHEXIA SARCOPENI, V8, P285, DOI 10.1002/jcsm.12158; Vonlanthen R, 2011, ANN SURG, V254, P907, DOI 10.1097/SLA.0b013e31821d4a43; Wang SL, 2016, ANN SURG ONCOL, V23, P556, DOI 10.1245/s10434-015-4887-3; Yoshizumi T, 1999, RADIOLOGY, V211, P283, DOI 10.1148/radiology.211.1.r99ap15283; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011	39	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186547	10.1371/journal.pone.0186547	http://dx.doi.org/10.1371/journal.pone.0186547			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088245	Green Submitted, Green Published, gold			2022-12-26	WOS:000414088900015
J	Ishikawa, R; Iwata, M; Taniko, K; Monden, G; Miyazaki, N; Orn, C; Tsujimura, Y; Yoshida, S; Ma, JF; Ishii, T				Ishikawa, Ryo; Iwata, Masahide; Taniko, Kenta; Monden, Gotaro; Miyazaki, Naoya; Orn, Chhourn; Tsujimura, Yuki; Yoshida, Shusaku; Ma, Jian Feng; Ishii, Takashige			Detection of quantitative trait loci controlling grain zinc concentration using Australian wild rice, Oryza meridionalis, a potential genetic resource for biofortification of rice	PLOS ONE			English	Article							DEVELOPING-TISSUES; TRANSPORTER; NODE; TOLERANCE; DIVERSITY; ELEMENTS; OSZIP4; IRON; SSLP; SOIL	Zinc (Zn) is one of the essential mineral elements for both plants and humans. Zn deficiency in human is one of the major causes of hidden hunger, a serious health problem observed in many developing countries. Therefore, increasing Zn concentration in edible part is an important issue for improving human Zn nutrition. Here, we found that an Australian wild rice O. meridionalis showed higher grain Zn concentrations compared with cultivated and other wild rice species. The quantitative trait loci (QTL) analysis was then performed to identify the genomic regions controlling grain Zn levels using backcross recombinant inbred lines derived from O. sativa 'Nipponbare' and O. meridionalis W1627. Four QTLs responsible for high grain Zn were detected on chromosomes 2, 9, and 10. The QTL on the chromosome 9 (named qGZn9), which showed the largest effect on grain Zn concentration was confirmed with the introgression line, which had a W1627 chromosomal segment covering the qGZn9 region in the genetic background of O. sativa 'Nipponbare'. Fine mapping of this QTL resulted in identification of two tightly linked loci, qGZn9a and qGZn9b. The candidate regions of qGZn9a and qGZn9b were estimated to be 190 and 950 kb, respectively. Furthermore, we also found that plants having a wild chromosomal segment covering qGZn9a, but not qGZn9b, is associated with fertility reduction. qGZn9b, therefore, provides a valuable allele for breeding rice with high Zn in the grains.	[Ishikawa, Ryo; Iwata, Masahide; Taniko, Kenta; Monden, Gotaro; Miyazaki, Naoya; Orn, Chhourn; Tsujimura, Yuki; Yoshida, Shusaku; Ishii, Takashige] Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo, Japan; [Ma, Jian Feng] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama, Japan; [Orn, Chhourn] Cambodian Agr Res & Dev Inst, Phnom Penh, Cambodia	Kobe University; Okayama University	Ishikawa, R (corresponding author), Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo, Japan.	r-ishika@port.kobe-u.ac.jp	Ma, Jianfeng/GZB-0110-2022; Ishii, Takashige/AAG-1486-2021	Ishikawa, Ryo/0000-0003-1848-2493	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan as part of the Joint Research Program at the Institute of Plant Science and Resources, Okayama University, Japan [2513, 2614, 2714, 2811, 2910]; Joint Research Program from the Institute of Plant Science and Resources, Okayama University; National BioResource Project (MEXT, Japan)	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan as part of the Joint Research Program at the Institute of Plant Science and Resources, Okayama University, Japan; Joint Research Program from the Institute of Plant Science and Resources, Okayama University; National BioResource Project (MEXT, Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan as part of the Joint Research Program implemented at the Institute of Plant Science and Resources, Okayama University, Japan (nos. 2513, 2614, 2714, 2811, and 2910 to R.I.). English URLs of the fund are not available. The Joint Research Program from the Institute of Plant Science and Resources, Okayama University, supported consumables and travel fee for the collaborative research between R.I and J.F.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ms. Sanae Rikiishi and Ms. Akemi Morita (Institute of Plant Science and Resources, Okayama University) for their measurement of rice grain Zn concentrations. We also thank Cristina Castillo for her critical reading of the manuscript. The wild rice accessions used in this study were provided by the National Institute of Genetics (Japan) supported by the National BioResource Project (MEXT, Japan).	Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Atwell BJ, 2014, PLANT SCI, V215, P48, DOI 10.1016/j.plantsci.2013.10.007; Bautista NS, 2001, GENES GENET SYST, V76, P71, DOI 10.1266/ggs.76.71; Borrill P, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00053; Chen XW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04992-z; Cheng ZQ, 2005, J INTEGR PLANT BIOL, V47, P1260, DOI 10.1111/j.1744-7909.2005.00130.x; Doi K, 2008, CURR OPIN PLANT BIOL, V11, P144, DOI 10.1016/j.pbi.2008.01.008; Ishimaru Y, 2007, J EXP BOT, V58, P2909, DOI 10.1093/jxb/erm147; Khush GS, 2005, PLANT MOL BIOL, V59, P1, DOI 10.1007/s11103-005-2159-5; MABERLY GF, 1994, ANNU REV PUBL HEALTH, V15, P277; Menguer PK, 2017, GENET MOL BIOL, V40, P238, DOI [10.1590/1678-4685-gmb-2016-0093, 10.1590/1678-4685-GMB-2016-0093]; Messias RD, 2015, CRIT REV FOOD SCI, V55, P123, DOI 10.1080/10408398.2011.649314; Monna L, 2002, THEOR APPL GENET, V104, P772, DOI 10.1007/s00122-001-0813-0; Moreno-Moyano LT, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01463; NG NQ, 1981, BOT J LINN SOC, V82, P327, DOI 10.1111/j.1095-8339.1981.tb00964.x; Panaud O, 1996, MOL GEN GENET, V252, P597, DOI 10.1007/s004380050267; Ricachenevsky FK, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00974; Roohani N, 2013, J RES MED SCI, V18, P144; Sakai H, 2013, PLANT CELL PHYSIOL, V54, pE6, DOI 10.1093/pcp/pcs183; Sasaki A, 2015, PLANT J, V84, P374, DOI 10.1111/tpj.13005; Sasaki A, 2012, PLANT CELL, V24, P2155, DOI 10.1105/tpc.112.096925; Scafaro AP, 2016, NEW PHYTOL, V211, P899, DOI 10.1111/nph.13963; Scafaro AP, 2012, PHYSIOL PLANTARUM, V146, P99, DOI 10.1111/j.1399-3054.2012.01597.x; Scafaro AP, 2010, J EXP BOT, V61, P191, DOI 10.1093/jxb/erp294; Swamy BPM, 2016, RICE, V9, DOI 10.1186/s12284-016-0122-5; Vaughan DA, 2003, CURR OPIN PLANT BIOL, V6, P139, DOI 10.1016/S1369-5266(03)00009-8; Velu G, 2014, J CEREAL SCI, V59, P365, DOI 10.1016/j.jcs.2013.09.001; Wang S, 2012, WINDOWS QTL CARTOGRA; Wissuwa M, 2008, PLANT SOIL, V306, P37, DOI 10.1007/s11104-007-9368-4; Xue YF, 2016, ANN BOT-LONDON, V117, P363, DOI 10.1093/aob/mcv182; Yamaji N, 2017, CURR OPIN PLANT BIOL, V39, P18, DOI 10.1016/j.pbi.2017.05.002; Yamaji N, 2014, TRENDS PLANT SCI, V19, P556, DOI 10.1016/j.tplants.2014.05.007; Yamaji N, 2013, PLANT PHYSIOL, V162, P927, DOI 10.1104/pp.113.216564; Zhang QJ, 2014, P NATL ACAD SCI USA, V111, pE4954, DOI 10.1073/pnas.1418307111	39	16	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187224	10.1371/journal.pone.0187224	http://dx.doi.org/10.1371/journal.pone.0187224			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077764	Green Published, gold, Green Submitted			2022-12-26	WOS:000413861200054
J	Nobeyama, Y; Watanabe, Y; Nakagawa, H				Nobeyama, Yoshimasa; Watanabe, Yoshinori; Nakagawa, Hidemi			Silencing of G0/G1 switch gene 2 in cutaneous squamous cell carcinoma	PLOS ONE			English	Article							DNA METHYLATION; LUNG-CANCER; PROTEIN; IDENTIFICATION; EXPRESSION; G0S2; HEAD	Background Methylation of a CpG island (CGI; a dense cluster of CpGs) located in the 5' region of a gene suppresses that gene's transcription. The expression of G0/G1 switch gene 2 (G0S2) is potentially associated with tumorigenesis. The aim of this study is to elucidate the methylation status of the CGI located in the 5' region of G0S2 (hereinafter called 5' G0S2 CGI) in cutaneous squamous cell carcinoma (SCC). Methods Quantitative real-time methylation-specific PCR (RT-MSP) and bisulfite sequencing were performed to evaluate the methylation statuses of cutaneous SCC and normal epithelial cell samples. Quantitative real-time reverse transcription-PCR was performed to evaluate RNA expression levels. Immunohistochemical analysis was performed to detect protein expression. Results G0S2 was suppressed in the five SCC cell lines with 5' G0S2 CGI methylation levels of nearly 100.0% and was expressed in the two normal cultured keratinocytes with methylation levels of almost 0.0%. G0S2 was re-expressed in SCC cell lines treated with a demethylating agent. The in vivo methylation levels of 5' G0S2 CGI as determined by RT-MSP varied widely (0.0% to 77.7%) in 17 cutaneous SCC samples and narrowly (0.1% to 7.3%) in 6 normal epidermis samples. Nine cutaneous SCC samples exhibited higher methylation levels than the highest methylation level (7.3%) of the 6 normal epidermis samples. Bisulfite sequencing showed dense methylated CpG sites within 5' G0S2 CGI in these highly methylated cutaneous SCC samples. The methylation levels of the cutaneous SCC samples did not correlate with any clinical parameters investigated or with histopathological grading. Conclusions G0S2 is silenced by aberrant DNA methylation in a subset of cutaneous SCCs.	[Nobeyama, Yoshimasa; Watanabe, Yoshinori; Nakagawa, Hidemi] Jikei Univ, Sch Med, Dept Dermatol, Tokyo, Japan	Jikei University	Nobeyama, Y (corresponding author), Jikei Univ, Sch Med, Dept Dermatol, Tokyo, Japan.	nobederm@jikei.ac.jp		Nobeyama, Yoshimasa/0000-0002-0125-8930				Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Brown VL, 2004, J INVEST DERMATOL, V122, P1284, DOI 10.1111/j.0022-202X.2004.22501.x; Chang XF, 2010, CANCER RES, V70, P2870, DOI 10.1158/0008-5472.CAN-09-3427; Darr OA, 2015, HEAD NECK-J SCI SPEC, V37, P994, DOI 10.1002/hed.23701; Davidson MR, 2013, J THORAC DIS, V5, pS463, DOI 10.3978/j.issn.2072-1439.2013.08.43; Ehrlich M, 2013, EPIGENOMICS-UK, V5, P553, DOI 10.2217/epi.13.43; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Green AC, 2017, BRIT J DERMATOL, V177, P373, DOI 10.1111/bjd.15324; Harwood CA, 2016, ACTA DERM-VENEREOL, V96, P3, DOI 10.2340/00015555-2181; Heist RS, 2012, J THORAC ONCOL, V7, P924, DOI 10.1097/JTO.0b013e31824cc334; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kusakabe M, 2010, INT J CANCER, V126, P1895, DOI 10.1002/ijc.24947; Liang JQ, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1650-x; Meier K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164742; Rothenberg SM, 2012, J CLIN INVEST, V122, P1951, DOI 10.1172/JCI59889; RUSSELL L, 1991, DNA CELL BIOL, V10, P581, DOI 10.1089/dna.1991.10.581; SIDEROVSKI DP, 1990, DNA CELL BIOL, V9, P579, DOI 10.1089/dna.1990.9.579; Takeuchi T, 2002, LAB INVEST, V82, P1023, DOI 10.1097/01.LAB.0000025391.35798.F1; Tokumaru Y, 2004, CANCER RES, V64, P5982, DOI 10.1158/0008-5472.CAN-04-0993; Ushijima T, 2005, CANCER RES, V65, P11; Venza I, 2010, BRIT J DERMATOL, V162, P1093, DOI 10.1111/j.1365-2133.2009.09560.x; Weedon D, 2006, WHO CLASSIFICATION T; Welch C, 2009, CANCER RES, V69, P6782, DOI 10.1158/0008-5472.CAN-09-0128; Yim CY, 2016, CANCER RES, V76, P1204, DOI 10.1158/0008-5472.CAN-15-2265	24	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187047	10.1371/journal.pone.0187047	http://dx.doi.org/10.1371/journal.pone.0187047			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073263	gold, Green Published, Green Submitted			2022-12-26	WOS:000413845400101
J	Stromvall, K; Lundholm, M; Thysell, E; Bergh, A; Bergstrom, SH				Stromvall, Kerstin; Lundholm, Marie; Thysell, Elin; Bergh, Anders; Bergstrom, Sofia Halin			Highly aggressive rat prostate tumors rapidly precondition regional lymph nodes for subsequent metastatic growth	PLOS ONE			English	Article							CANCER PROGRESSION; IMMUNE MODULATION; FACTOR RECEPTOR; MICROENVIRONMENT; IMMUNOTHERAPY; NICHE; NEUTROPHILS; CELLS; IMMUNOBIOLOGY; EXPRESSION	The aim of this study was to examine in what ways MatLyLu (MLL) rat prostate tumors with high metastatic capacity influence regional lymph nodes prior to metastatic establishment compared to AT1 rat prostate tumors with low metastatic potential. MLL or AT1 tumor cells were injected into the ventral prostate of immunocompetent rats. Tumor and lymph node morphology, and lymph node mRNA expression of macrophage associated markers, T-cell associated markers, and cytokines were examined over time until the first microscopic signs of metastases (at day 14 for MLL-and at day 28 for AT1-tumors). Already at day 3 after tumor cell injection, when the tumors were extremely small and occupied less than 1% of the prostate volume, MLL-and AT1-tumors provoked different immune responses in both the prostate and the regional lymph nodes. MLL-tumors induced expression of immunosuppressive cytokines, suppressed T-cell accumulation, and directed T-cells towards an immunosuppressive phenotype. AT1-tumors caused a response more similar to that in vehicle-injected animals, with accumulation of T-cells in tumors and regional lymph nodes. Prostate tumors with high metastatic potential were able to precondition regional lymph nodes to subsequent metastatic growth in ways different from tumors with less metastatic potential. This may indicate the existence of a time-window when pre-metastatic changes in regional lymph nodes can aid in the prognostication of locally aggressive and potentially metastatic prostate cancer.	[Stromvall, Kerstin; Lundholm, Marie; Thysell, Elin; Bergh, Anders; Bergstrom, Sofia Halin] Umea Univ, Pathol, Dept Med Biosci, Umea, Sweden	Umea University	Bergstrom, SH (corresponding author), Umea Univ, Pathol, Dept Med Biosci, Umea, Sweden.	sofia.halin@umu.se			Swedish Research Council [Co257301]; Swedish Cancer Foundation [130293]; Lion's Cancer Research Foundation, Umea University; King Gustaf V and Queen Victoria's Foundation of Freemasons	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Lion's Cancer Research Foundation, Umea University; King Gustaf V and Queen Victoria's Foundation of Freemasons	This work was supported by grants from the:Swedish Research Council, http://www.vr.se/, (AB), grant number Co257301; The Swedish Cancer Foundation, https://www.cancerfonden.se/, (AB), grant number 130293; The Lion's Cancer Research Foundation, Umea University, http://www.cancerforskningsfonden.se/, (KS, SHB); King Gustaf V and Queen Victoria's Foundation of Freemasons, https://www.frimurarorden.se/organisation/barmhartighetsverksamhet/frimurarstiftelsen/, (AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achkova D, 2016, BIOCHEM SOC T, V44, P333, DOI 10.1042/BST20150245; Adamo HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141601; Adamo HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130076; Anderson KG, 2017, CANCER CELL, V31, P311, DOI 10.1016/j.ccell.2017.02.008; Benezech C, 2014, BLOOD, V123, P3200, DOI 10.1182/blood-2013-03-489286; Bergstrom SH, 2016, SCI REP-UK, V6, DOI 10.1038/srep31805; Chin AR, 2016, CLIN CANCER RES, V22, P3725, DOI 10.1158/1078-0432.CCR-16-0028; Cochran AJ, 2006, NAT REV IMMUNOL, V6, P659, DOI 10.1038/nri1919; Cochran AJ, 2015, CANCER J, V21, P39, DOI 10.1097/PPO.0000000000000094; Deng JH, 2012, CANCER CELL, V21, P642, DOI 10.1016/j.ccr.2012.03.039; Deryugina EI, 2014, NEOPLASIA, V16, P771, DOI 10.1016/j.neo.2014.08.013; Di Meo S, 2014, CLIN CANCER RES, V20, P585, DOI 10.1158/1078-0432.CCR-13-2240; Drake CG, 2010, NAT REV IMMUNOL, V10, P580, DOI 10.1038/nri2817; Filipazzi P, 2012, SEMIN CANCER BIOL, V22, P342, DOI 10.1016/j.semcancer.2012.02.005; Fujita K, 2009, CANCER SCI, V100, P1047, DOI 10.1111/j.1349-7006.2009.01146.x; Gannon PO, 2006, PROSTATE, V66, P1710, DOI 10.1002/pros.20466; Garlanda C, 2013, SEMIN IMMUNOL, V25, P408, DOI 10.1016/j.smim.2013.10.019; Grotz TE, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1026504; Hagglof Christina, 2012, Cancers (Basel), V4, P531, DOI 10.3390/cancers4020531; Halin Sofia, 2011, Expert Opin Med Diagn, V5, P37, DOI 10.1517/17530059.2011.540009; Halin S, 2009, NEOPLASIA, V11, P177, DOI 10.1593/neo.81338; Hammarsten P, 2010, CLIN CANCER RES, V16, P1245, DOI 10.1158/1078-0432.CCR-09-0103; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Herzog BH, 2013, NATURE, V502, P105, DOI 10.1038/nature12501; Ioachim Medeiras, 2009, TUM REACT LYMPH LYMP; ISAACS JT, 1986, PROSTATE, V9, P261, DOI 10.1002/pros.2990090306; Jain RK, 2014, ANNU REV BIOMED ENG, V16, P321, DOI 10.1146/annurev-bioeng-071813-105259; Ji RC, 2006, CANCER METAST REV, V25, P677, DOI 10.1007/s10555-006-9026-y; Kim R, 2006, LANCET ONCOL, V7, P1006, DOI 10.1016/S1470-2045(06)70975-5; Kitamura T, 2015, NAT REV IMMUNOL, V15, P73, DOI 10.1038/nri3789; Kryvenko ON, 2017, CURR OPIN UROL, V27, P191, DOI 10.1097/MOU.0000000000000388; Liu Y, 2016, CANCER CELL, V30, P668, DOI 10.1016/j.ccell.2016.09.011; Lundholm M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108925; Mansfield AS, 2011, MODERN PATHOL, V24, P487, DOI 10.1038/modpathol.2010.227; McAllister SS, 2014, NAT CELL BIOL, V16, P717, DOI 10.1038/ncb3015; Motallebnezhad M, 2016, TUMOR BIOL, V37, P1387, DOI 10.1007/s13277-015-4477-9; Munn DH, 2006, CURR OPIN IMMUNOL, V18, P220, DOI 10.1016/j.coi.2006.01.002; NEAVES WB, 1979, TRANSPLANTATION, V27, P127, DOI 10.1097/00007890-197902000-00011; O'Neill ASG, 2013, IMMUNOLOGY, V138, P198, DOI 10.1111/imm.12042; Ohnishi K, 2013, CANCER SCI, V104, P1236, DOI 10.1111/cas.12212; Pal SK, 2015, MOL CANCER THER, V14, P2896, DOI 10.1158/1535-7163.MCT-15-0367; Peinado H, 2017, NAT REV CANCER, V17, P302, DOI 10.1038/nrc.2017.6; Pencik J, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14215; Pizzola C, 2016, CURR MOL PHARMACOL, V9, P217, DOI 10.2174/1874467208666150716120551; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Sceneay J, 2013, CANCER METAST REV, V32, P449, DOI 10.1007/s10555-013-9420-1; Shen MX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098259; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Singel KL, 2016, IMMUNOL REV, V273, P329, DOI 10.1111/imr.12459; Sleeman JP, 2015, J MOL MED, V93, P1173, DOI 10.1007/s00109-015-1351-6; Steele CW, 2016, CANCER CELL, V29, P832, DOI 10.1016/j.ccell.2016.04.014; Stromvall K, 2017, PROSTATE; Stromvall K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176679; Turnis ME, 2015, EUR J IMMUNOL, V45, P1892, DOI 10.1002/eji.201344413; Zhang X, 2016, INT J ONCOL, V49, P857, DOI 10.3892/ijo.2016.3616	55	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187086	10.1371/journal.pone.0187086	http://dx.doi.org/10.1371/journal.pone.0187086			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073272	Green Published, gold, Green Submitted			2022-12-26	WOS:000413845400110
J	Edwards, RL; Luis, PB; Varuzza, PV; Joseph, AI; Presley, SH; Chaturvedi, R; Schneider, C				Edwards, Rebecca L.; Luis, Paula B.; Varuzza, Paolo V.; Joseph, Akil I.; Presley, Sai Han; Chaturvedi, Rupesh; Schneider, Claus			The anti-inflammatory activity of curcumin is mediated by its oxidative metabolites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						autoxidation; cysteine; electrophile; glutathione; protein adduction; polyphenol; flavonoid; quinone; NF-B; redox regulation	NF-KAPPA-B; DEGRADATION-PRODUCTS; ENDOTHELIAL-CELLS; CLINICAL-TRIALS; KINASE-ACTIVITY; CANCER; INFLAMMATION; MECHANISMS; DERIVATIVES; ACTIVATION	The spice turmeric, with its active polyphenol curcumin, has been used as anti-inflammatory remedy in traditional Asian medicine for centuries. Many cellular targets of curcumin have been identified, but how such a wide range of targets can be affected by a single compound is unclear. Here, we identified curcumin as a pro-drug that requires oxidative activation into reactive metabolites to exert anti-inflammatory activities. Synthetic curcumin analogs that undergo oxidative transformation potently inhibited the pro-inflammatory transcription factor nuclear factor B (NF-B), whereas stable, non-oxidizable analogs were less active, with a correlation coefficient (R-2) of IC(50)versus log of autoxidation rate of 0.75. Inhibition of glutathione biosynthesis, which protects cells from reactive metabolites, increased the potency of curcumin and decreased the amount of curcumin-glutathione adducts in cells. Oxidative metabolites of curcumin adducted to and inhibited the inhibitor of NF-B kinase subunit (IKK), an activating kinase upstream of NF-B. An unstable, alkynyl-tagged curcumin analog yielded abundant adducts with cellular protein that were decreased by pretreatment with curcumin or an unstable analog but not by a stable analog. Bioactivation of curcumin occurred readily in vitro, which may explain the wide range of cellular targets, but if bioactivation is insufficient in vivo, it may also help explain the inconclusive results in human studies with curcumin so far. We conclude that the paradigm of metabolic bioactivation uncovered here should be considered for the evaluation and design of clinical trials of curcumin and other polyphenols of medicinal interest.	[Edwards, Rebecca L.; Luis, Paula B.; Varuzza, Paolo V.; Joseph, Akil I.; Presley, Sai Han; Schneider, Claus] Vanderbilt Univ, Dept Pharmacol, Sch Med, Nashville, TN 37232 USA; [Edwards, Rebecca L.; Luis, Paula B.; Varuzza, Paolo V.; Joseph, Akil I.; Presley, Sai Han; Schneider, Claus] Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA; [Chaturvedi, Rupesh] Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India	Vanderbilt University; Vanderbilt University; Jawaharlal Nehru University, New Delhi	Schneider, C (corresponding author), 23rd Ave S & Pierce, Nashville, TN 37232 USA.	claus.schneider@vanderbilt.edu			National Institutes of Health from the National Center for Complementary and Integrative Health (NCCIH) [R01AT006896]; Office of Dietary Supplements (ODS); Vanderbilt Institute in Chemical Biology; National Cancer Institute SPORE in GI Cancer Grant [5P50CA095103]; NATIONAL CANCER INSTITUTE [P50CA095103] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT006896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER	National Institutes of Health from the National Center for Complementary and Integrative Health (NCCIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Dietary Supplements (ODS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Institute in Chemical Biology; National Cancer Institute SPORE in GI Cancer Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grant R01AT006896 from the National Center for Complementary and Integrative Health (NCCIH) and the Office of Dietary Supplements (ODS) and in part by pilot awards from the Vanderbilt Institute in Chemical Biology and National Cancer Institute SPORE in GI Cancer Grant 5P50CA095103 (to C. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; Amin HP, 2015, MOL NUTR FOOD RES, V59, P1095, DOI 10.1002/mnfr.201400803; Angelo LS, 2013, BIOORGAN MED CHEM, V21, P932, DOI 10.1016/j.bmc.2012.12.008; Awasthi S, 2000, CHEM-BIOL INTERACT, V128, P19, DOI 10.1016/S0009-2797(00)00185-X; Byun MS, 2006, EXP MOL MED, V38, P546, DOI 10.1038/emm.2006.64; COMMANDEUR JNM, 1995, PHARMACOL REV, V47, P271; Cottart CH, 2014, MOL NUTR FOOD RES, V58, P7, DOI 10.1002/mnfr.201200589; Daily JW, 2016, J MED FOOD, V19, P717, DOI 10.1089/jmf.2016.3705; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Dietz BM, 2011, CHEM-BIOL INTERACT, V192, P72, DOI 10.1016/j.cbi.2010.10.007; Dinkova-Kostova AT, 1998, J MED CHEM, V41, P5287, DOI 10.1021/jm980424s; DREW R, 1984, BIOCHEM PHARMACOL, V33, P2989, DOI 10.1016/0006-2952(84)90598-7; Edwards M, 2015, J AGR FOOD CHEM, V63, P2423, DOI 10.1021/jf5041993; Epstein J, 2010, BRIT J NUTR, V103, P1545, DOI 10.1017/S0007114509993667; Esatbeyoglu T, 2012, ANGEW CHEM INT EDIT, V51, P5308, DOI 10.1002/anie.201107724; Gafner S, 2004, PHYTOCHEMISTRY, V65, P2849, DOI 10.1016/j.phytochem.2004.08.008; Gimenez-Bastida JA, 2012, MOL NUTR FOOD RES, V56, P784, DOI 10.1002/mnfr.201100677; Gonzalez-Sarrias A, 2016, MOL NUTR FOOD RES, V60, P701, DOI 10.1002/mnfr.201500780; Gordon ON, 2015, CHEM RES TOXICOL, V28, P989, DOI 10.1021/acs.chemrestox.5b00009; Gordon ON, 2015, J BIOL CHEM, V290, P4817, DOI 10.1074/jbc.M114.618785; Gordon ON, 2013, J LABELLED COMPD RAD, V56, P696, DOI 10.1002/jlcr.3102; Gordon ON, 2012, TRENDS MOL MED, V18, P361, DOI 10.1016/j.molmed.2012.04.011; Griesser M, 2011, J BIOL CHEM, V286, P1114, DOI 10.1074/jbc.M110.178806; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gupta SC, 2013, MOL NUTR FOOD RES, V57, P1510, DOI 10.1002/mnfr.201100741; Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4; Heger M, 2014, PHARMACOL REV, V66, P222, DOI 10.1124/pr.110.004044; Jacobs AT, 2010, ACCOUNTS CHEM RES, V43, P673, DOI 10.1021/ar900286y; Ji C, 2001, J BIOL CHEM, V276, P18223, DOI 10.1074/jbc.M101266200; Jiao Y, 2006, FREE RADICAL BIO MED, V40, P1152, DOI 10.1016/j.freeradbiomed.2005.11.003; Jobin C, 1999, J IMMUNOL, V163, P3474; Ketron AC, 2013, BIOCHEMISTRY-US, V52, P221, DOI 10.1021/bi3014455; Kunwar A, 2008, BBA-GEN SUBJECTS, V1780, P673, DOI 10.1016/j.bbagen.2007.11.016; Ligeret H, 2004, FREE RADICAL BIO MED, V36, P919, DOI 10.1016/j.freeradbiomed.2003.12.018; Lo Conte M, 2013, J BIOL CHEM, V288, P26480, DOI 10.1074/jbc.R113.467738; Luis PB, 2017, BIOCHEM PHARMACOL, V132, P143, DOI 10.1016/j.bcp.2017.03.002; Luo Z, 2014, BIOCONJUGATE CHEM, V25, P32, DOI 10.1021/bc4002008; Mahran RI, 2017, AAPS J, V19, P54, DOI 10.1208/s12248-016-0003-2; Masuda T, 1999, J AGR FOOD CHEM, V47, P71, DOI 10.1021/jf9805348; Metzler M, 2013, BIOFACTORS, V39, P14, DOI 10.1002/biof.1042; Nunez-Sanchez MA, 2015, MOL NUTR FOOD RES, V59, P1274, DOI 10.1002/mnfr.201400866; Nurfina AN, 1997, EUR J MED CHEM, V32, P321, DOI 10.1016/S0223-5234(97)89084-8; PABON HJJ, 1964, RECL TRAV CHIM PAY B, V83, P379; Pan MH, 1999, DRUG METAB DISPOS, V27, P486; Philip S, 2003, J BIOL CHEM, V278, P14487, DOI 10.1074/jbc.M207309200; Poole LB, 2015, FREE RADICAL BIO MED, V80, P148, DOI 10.1016/j.freeradbiomed.2014.11.013; Portes E, 2007, TETRAHEDRON, V63, P9092, DOI 10.1016/j.tet.2007.06.085; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Rietjens IMCM, 2011, CHEM-BIOL INTERACT, V192, P87, DOI 10.1016/j.cbi.2010.09.016; Russo M, 2012, BIOCHEM PHARMACOL, V83, P6, DOI 10.1016/j.bcp.2011.08.010; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Sanidad KZ, 2016, J AGR FOOD CHEM, V64, P9189, DOI 10.1021/acs.jafc.6b04343; Schneider C, 2015, J AGR FOOD CHEM, V63, P7606, DOI 10.1021/acs.jafc.5b00244; SCHNEIDER S, 1992, J LABELLED COMPD RAD, V31, P489, DOI 10.1002/jlcr.2580310609; Shen L, 2012, TRENDS MOL MED, V18, P138, DOI 10.1016/j.molmed.2012.01.004; Singh BN, 2011, BIOCHEM PHARMACOL, V82, P1807, DOI 10.1016/j.bcp.2011.07.093; SINGH S, 1995, J BIOL CHEM, V270, P24995, DOI 10.1074/jbc.270.42.24995; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Vauzour D, 2010, NUTRIENTS, V2, P1106, DOI 10.3390/nu2111106; Villacorta L, 2013, CARDIOVASC RES, V98, P116, DOI 10.1093/cvr/cvt002; Wang JG, 2016, SCI REP-UK, V6, DOI 10.1038/srep22146; Wang YJ, 1997, J PHARMACEUT BIOMED, V15, P1867, DOI 10.1016/S0731-7085(96)02024-9; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]; Wright MH, 2016, NAT PROD REP, V33, P681, DOI 10.1039/c6np00001k; Zhu JL, 2017, FOOD FUNCT, V8, P907, DOI 10.1039/c6fo01770c	65	108	114	3	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21243	21252		10.1074/jbc.RA117.000123	http://dx.doi.org/10.1074/jbc.RA117.000123			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29097552	Green Published, hybrid			2022-12-26	WOS:000419013000003
J	Smeazzetto, S; Armanious, GP; Moncelli, MR; Bak, JJ; Lemieux, MJ; Young, HS; Tadini-Buoninsegni, F				Smeazzetto, Serena; Armanious, Gareth P.; Moncelli, Maria Rosa; Bak, Jessi J.; Lemieux, M. Joanne; Young, Howard S.; Tadini-Buoninsegni, Francesco			Conformational memory in the association of the transmembrane protein phospholamban with the sarcoplasmic reticulum calcium pump SERCA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; calcium ATPase; cardiac muscle; membrane transport; sarcoplasmic reticulum (SR); calcium translocation; phospholamban; sarcolipin; solid supported membrane	CHARGE TRANSLOCATION; CRYSTAL-STRUCTURES; LIPID-BILAYERS; ATPASE SERCA; SARCOLIPIN; CA2+-ATPASE; PHOSPHORYLATION; INHIBITION; MEMBRANES; DYNAMICS	The sarcoplasmic reticulum Ca2+-ATPase SERCA promotes muscle relaxation by pumping calcium ions from the cytoplasm into the sarcoplasmic reticulum. SERCA activity is regulated by a variety of small transmembrane peptides, most notably by phospholamban in cardiac muscle and sarcolipin in skeletal muscle. However, how phospholamban and sarcolipin regulate SERCA is not fully understood. In the present study, we evaluated the effects of phospholamban and sarcolipin on calcium translocation and ATP hydrolysis by SERCA under conditions that mimic environments in sarcoplasmic reticulum membranes. For pre-steady-state current measurements, proteoliposomes containing SERCA and phospholamban or sarcolipin were adsorbed to a solid-supported membrane and activated by substrate concentration jumps. We observed that phospholamban altered ATP-dependent calcium translocation by SERCA within the first transport cycle, whereas sarcolipin did not. Using pre-steady-state charge (calcium) translocation and steady-state ATPase activity under substrate conditions (various calcium and/or ATP concentrations) promoting particular conformational states of SERCA, we found that the effect of phospholamban on SERCA depends on substrate preincubation conditions. Our results also indicated that phospholamban can establish an inhibitory interaction with multiple SERCA conformational states with distinct effects on SERCA's kinetic properties. Moreover, we noted multiple modes of interaction between SERCA and phospholamban and observed that once a particular mode of association is engaged it persists throughout the SERCA transport cycle and multiple turnover events. These observations are consistent with conformational memory in the interaction between SERCA and phospholamban, thus providing insights into the physiological role of phospholamban and its regulatory effect on SERCA transport activity.	[Smeazzetto, Serena; Moncelli, Maria Rosa; Tadini-Buoninsegni, Francesco] Univ Florence, Dept Chem Ugo Schiff, Via Lastruccia 3-13, I-50019 Sesto Fiorentino, Italy; [Armanious, Gareth P.; Bak, Jessi J.; Lemieux, M. Joanne; Young, Howard S.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada	University of Florence; University of Alberta	Tadini-Buoninsegni, F (corresponding author), Univ Florence, Dept Chem Ugo Schiff, Via Lastruccia 3-13, I-50019 Sesto Fiorentino, Italy.; Young, HS (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.	hyoung@ualberta.ca; francesco.tadini@unifi.it	Tadini-Buoninsegni, Francesco/CAJ-5745-2022	TADINI-BUONINSEGNI, Francesco/0000-0001-5594-2554; Young, Howard/0000-0002-5990-8422	Ente Cassa di Risparmio di Firenze; Programma Operativo Regione Toscana (POR) - Competitivita Regionale e Occupazione (CRO) - Fondo Sociale Europeo (FSE); Heart and Stroke Foundation of Canada; Natural Sciences and Engineering Research Council of Canada-Collaborative Research and Training Experience program; International Research Training Group in Membrane Biology	Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); Programma Operativo Regione Toscana (POR) - Competitivita Regionale e Occupazione (CRO) - Fondo Sociale Europeo (FSE); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Natural Sciences and Engineering Research Council of Canada-Collaborative Research and Training Experience program; International Research Training Group in Membrane Biology	This work was supported by Ente Cassa di Risparmio di Firenze and Programma Operativo Regione Toscana (POR) - Competitivita Regionale e Occupazione (CRO) - Fondo Sociale Europeo (FSE) 2007-2013 (to S. S., M. R. M., and F. T.-B.), the Heart and Stroke Foundation of Canada (to H. S. Y.), and the Natural Sciences and Engineering Research Council of Canada-Collaborative Research and Training Experience program and the International Research Training Group in Membrane Biology (to G. P. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Akin BL, 2013, J BIOL CHEM, V288, P30181, DOI 10.1074/jbc.M113.501585; Andronesi OC, 2005, J AM CHEM SOC, V127, P12965, DOI 10.1021/ja0530164; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Bidwell P, 2011, J BIOL CHEM, V286, P35044, DOI 10.1074/jbc.M111.266759; BILEZIKJIAN LM, 1981, CIRC RES, V49, P1356, DOI 10.1161/01.RES.49.6.1356; Blackwell DJ, 2016, BIOPHYS J, V111, P1192, DOI 10.1016/j.bpj.2016.08.005; Buoninsegni FT, 2004, BIOPHYS J, V86, P3671, DOI 10.1529/biophysj.103.036608; CANTILINA T, 1993, J BIOL CHEM, V268, P17018; Catalucci D, 2009, J BIOL CHEM, V284, P28180, DOI 10.1074/jbc.M109.036566; Ceholski DK, 2012, J BIOL CHEM, V287, P16521, DOI 10.1074/jbc.M112.360859; Chu GX, 1998, J BIOL CHEM, V273, P33674, DOI 10.1074/jbc.273.50.33674; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; Douglas JL, 2005, PROTEIN EXPRES PURIF, V40, P118, DOI 10.1016/j.pep.2004.11.015; ELETR S, 1972, BIOCHIM BIOPHYS ACTA, V282, P174, DOI 10.1016/0005-2736(72)90321-5; Ferrandi M, 2013, BRIT J PHARMACOL, V169, P1849, DOI 10.1111/bph.12278; Glaves JP, 2011, J MOL BIOL, V405, P707, DOI 10.1016/j.jmb.2010.11.014; Gorski PA, 2013, J BIOL CHEM, V288, P8456, DOI 10.1074/jbc.M112.446161; Gorski PA, 2015, J BIOL CHEM, V290, P6777, DOI 10.1074/jbc.M114.585604; Gustavsson M, 2013, P NATL ACAD SCI USA, V110, P17338, DOI 10.1073/pnas.1303006110; Gustavsson M, 2011, BIOCHEMISTRY-US, V50, P10367, DOI 10.1021/bi200759y; Inesi G, 2008, J BIOL CHEM, V283, P1189, DOI 10.1074/jbc.M707189200; Ji Y, 1999, AM J PHYSIOL-HEART C, V276, pH89, DOI 10.1152/ajpheart.1999.276.1.H89; Jones LR, 2002, J BIOL CHEM, V277, P28319, DOI 10.1074/jbc.M204085200; KOVACS RJ, 1988, J BIOL CHEM, V263, P18364; Li J, 2012, J MOL BIOL, V418, P379, DOI 10.1016/j.jmb.2012.02.011; Loukianov E, 1998, CIRC RES, V83, P889; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Odermatt A, 1998, J BIOL CHEM, V273, P12360, DOI 10.1074/jbc.273.20.12360; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Pintschovius J, 1999, BIOPHYS J, V76, P814, DOI 10.1016/S0006-3495(99)77245-0; Reddy LG, 1996, J BIOL CHEM, V271, P14964, DOI 10.1074/jbc.271.25.14964; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; Sahoo SK, 2013, J BIOL CHEM, V288, P6881, DOI 10.1074/jbc.M112.436915; Schorner M, 2015, J PHYS CHEM B, V119, P13964, DOI 10.1021/acs.jpcb.5b07494; Seidel K, 2008, BIOCHEMISTRY-US, V47, P4369, DOI 10.1021/bi7024194; Smeazzetto S, 2016, PHYS CHEM CHEM PHYS, V18, P1629, DOI 10.1039/c5cp05893g; Smeazzetto S, 2011, PHYS CHEM CHEM PHYS, V13, P12935, DOI 10.1039/c1cp20460b; STOKES DL, 1990, BIOPHYS J, V57, P1, DOI 10.1016/S0006-3495(90)82501-7; Tada M, 1976, Recent Adv Stud Cardiac Struct Metab, V9, P225; Tadini-Buoninsegni F, 2008, MOL PHARMACOL, V73, P1134, DOI 10.1124/mol.107.043745; Tadini-Buoninsegni F, 2006, J BIOL CHEM, V281, P37720, DOI 10.1074/jbc.M606040200; Tadini-Buoninsegni F, 2015, SCI REP-UK, V5, DOI 10.1038/srep14282; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2013, CURR OPIN STRUC BIOL, V23, P507, DOI 10.1016/j.sbi.2013.06.005; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; Toyoshima C, 2011, P NATL ACAD SCI USA, V108, P1833, DOI 10.1073/pnas.1017659108; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Trieber CA, 2005, BIOCHEMISTRY-US, V44, P3289, DOI 10.1021/bi047878d; Trieber CA, 2009, BIOCHEMISTRY-US, V48, P9287, DOI 10.1021/bi900852m; WARREN GB, 1974, P NATL ACAD SCI USA, V71, P622, DOI 10.1073/pnas.71.3.622; Winther AML, 2013, NATURE, V495, P265, DOI 10.1038/nature11900; Young HS, 2001, BIOPHYS J, V81, P884, DOI 10.1016/S0006-3495(01)75748-7	54	13	14	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21330	21339		10.1074/jbc.M117.794453	http://dx.doi.org/10.1074/jbc.M117.794453			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29081402	Green Published, hybrid			2022-12-26	WOS:000419013000010
J	Lee, JH; Wendorff, TJ; Berger, JM				Lee, Joyce H.; Wendorff, Timothy J.; Berger, James M.			Resveratrol: A novel type of topoisomerase II inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL FRAGMENT; DNA TOPOISOMERASE; DIETARY-SUPPLEMENTS; CATALYTIC INHIBITOR; ATPASE DOMAIN; STEADY-STATE; MECHANISM; GYRASE; BINDING; DOXORUBICIN	Resveratrol, a polyphenol found in various plant sources, has gained attention as a possible agent responsible for the purported health benefits of certain foods, such as red wine. Despite annual multi-million dollar market sales as a nutriceutical, there is little consensus about the physiological roles of resveratrol. One suggested molecular target of resveratrol is eukaryotic topoisomerase II (topo II), an enzyme essential for chromosome segregation and DNA supercoiling homeostasis. Interestingly, resveratrol is chemically similar to ICRF-187, a clinically approved chemotherapeutic that stabilizes an ATP-dependent dimerization interface in topo II to block enzyme activity. Based on this similarity, we hypothesized that resveratrol may antagonize topo II by a similar mechanism. Using a variety of biochemical assays, we find that resveratrol indeed acts through the ICRF-187 binding locus, but that it inhibits topo II by preventing ATPase domain dimerization rather than stabilizing it. This work presents the first comprehensive analysis of the biochemical effects of both ICRF-187 and resveratrol on the human isoforms of topo II, and reveals a new mode for the allosteric regulation of topo II through modulation of ATPase status. Natural polyphenols related to resveratrol that have been shown to impact topo II function may operate in a similar manner.	[Lee, Joyce H.; Berger, James M.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, 725 N Wolfe St,WBSB 713, Baltimore, MD 21205 USA; [Wendorff, Timothy J.] Univ Calif Berkeley, Biophys Grad Program, Berkeley, CA 94720 USA	Johns Hopkins University; University of California System; University of California Berkeley	Berger, JM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, 725 N Wolfe St,WBSB 713, Baltimore, MD 21205 USA.	jmberger@jhmi.edu		Wendorff, Timothy/0000-0002-3729-4706	National Institutes of Health [T32-GM007445, R01-CA077373]; NATIONAL CANCER INSTITUTE [R01CA077373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants T32-GM007445 (to J. H. L.) and R01-CA077373 (to J. M. B). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALI JA, 1995, BIOCHEMISTRY-US, V34, P9801, DOI 10.1021/bi00030a018; ALVARADO F, 1967, BIOCHIM BIOPHYS ACTA, V135, P483, DOI 10.1016/0005-2736(67)90038-7; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; BODLEY A, 1989, CANCER RES, V49, P5969; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; BROWN PO, 1979, SCIENCE, V206, P1081, DOI 10.1126/science.227059; CARON PR, 1994, MOL CELL BIOL, V14, P3197, DOI 10.1128/MCB.14.5.3197; Christenson J, 2016, METAB SYNDR RELAT D, V14, P323, DOI 10.1089/met.2016.0035; Classen S, 2003, P NATL ACAD SCI USA, V100, P10629, DOI 10.1073/pnas.1832879100; CREIGHTON AM, 1969, NATURE, V222, P384, DOI 10.1038/222384a0; Csiszar A, 2011, ANN NY ACAD SCI, V1215, P117, DOI 10.1111/j.1749-6632.2010.05848.x; Cuya SM, 2017, CANCER CHEMOTH PHARM, V80, P1, DOI 10.1007/s00280-017-3334-5; Cuzzola VF, 2011, CNS NEUROL DISORD-DR, V10, P849, DOI 10.2174/187152711798072310; Demoulin B, 2015, TOXICOL IN VITRO, V29, P1156, DOI 10.1016/j.tiv.2015.04.015; Frojdo S, 2007, BIOCHEM J, V406, P511, DOI 10.1042/BJ20070236; Gahche Jamie, 2011, NCHS Data Brief, P1; Gu J, 2016, INT IMMUNOPHARMACOL, V32, P1, DOI 10.1016/j.intimp.2016.01.002; Halsted CH, 2003, AM J CLIN NUTR, V77, p1001S, DOI 10.1093/ajcn/77.4.1001S; Harkins TT, 1998, BIOCHEMISTRY-US, V37, P7292, DOI 10.1021/bi9729099; Hasinoff BB, 1997, BIOCHEM PHARMACOL, V53, P1843, DOI 10.1016/S0006-2952(97)00013-0; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hu T, 2002, J BIOL CHEM, V277, P5944, DOI 10.1074/jbc.M111394200; Huang CS, 1999, CARCINOGENESIS, V20, P237, DOI 10.1093/carcin/20.2.237; Huang KC, 2001, J BIOL CHEM, V276, P44488, DOI 10.1074/jbc.M104383200; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jensen LH, 2000, J BIOL CHEM, V275, P2137, DOI 10.1074/jbc.275.3.2137; Jo JY, 2006, J AGR FOOD CHEM, V54, P2083, DOI 10.1021/jf052700z; Jo JY, 2005, J AGR FOOD CHEM, V53, P2489, DOI 10.1021/jf048524w; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Lamour V, 2002, J BIOL CHEM, V277, P18947, DOI 10.1074/jbc.M111740200; Larsen AK, 2003, PHARMACOL THERAPEUT, V99, P167, DOI 10.1016/S0163-7258(03)00058-5; Leone S, 2012, INT J CANCER, V131, pE173, DOI 10.1002/ijc.27358; Leone S, 2010, CANCER LETT, V295, P167, DOI 10.1016/j.canlet.2010.02.022; Lewis RJ, 1996, EMBO J, V15, P1412, DOI 10.1002/j.1460-2075.1996.tb00483.x; LINDSLEY JE, 1993, J BIOL CHEM, V268, P8096; Manna SK, 2000, J IMMUNOL, V164, P6509, DOI 10.4049/jimmunol.164.12.6509; Mennen LI, 2005, AM J CLIN NUTR, V81, p326S, DOI 10.1093/ajcn/81.1.326S; MIZUUCHI K, 1980, P NATL ACAD SCI-BIOL, V77, P1847, DOI 10.1073/pnas.77.4.1847; MORRICAL SW, 1986, BIOCHEMISTRY-US, V25, P1482, DOI 10.1021/bi00355a003; Morris SK, 2000, J BIOL CHEM, V275, P2613, DOI 10.1074/jbc.275.4.2613; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Novelle MG, 2015, AGEING RES REV, V21, P1, DOI 10.1016/j.arr.2015.01.002; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Renodon-Corniere A, 2003, BIOCHEMISTRY-US, V42, P9749, DOI 10.1021/bi034557d; ROCA J, 1992, CELL, V71, P833, DOI 10.1016/0092-8674(92)90558-T; ROCA J, 1994, P NATL ACAD SCI USA, V91, P1781, DOI 10.1073/pnas.91.5.1781; SANDER M, 1983, J BIOL CHEM, V258, P8421; Schmidt BH, 2012, NAT STRUCT MOL BIOL, V19, P1147, DOI 10.1038/nsmb.2388; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sehested M, 1998, CANCER RES, V58, P1460; SIEMANN EH, 1992, AM J ENOL VITICULT, V43, P49; Smoliga JM, 2011, MOL NUTR FOOD RES, V55, P1129, DOI 10.1002/mnfr.201100143; SPEYER JL, 1988, NEW ENGL J MED, V319, P745, DOI 10.1056/NEJM198809223191203; SPEYER JL, 1992, J CLIN ONCOL, V10, P117, DOI 10.1200/JCO.1992.10.1.117; Starr RR, 2015, AM J PUBLIC HEALTH, V105, P478, DOI 10.2105/AJPH.2014.302348; Sun AY, 2010, MOL NEUROBIOL, V41, P375, DOI 10.1007/s12035-010-8111-y; Swain SM, 2004, J CANCER RES CLIN, V130, P1, DOI 10.1007/s00432-003-0498-7; TAMURA JK, 1990, J BIOL CHEM, V265, P21342; Tapiero H, 2002, BIOMED PHARMACOTHER, V56, P200, DOI 10.1016/S0753-3322(02)00178-6; Tome-Carneiro J, 2013, CURR PHARM DESIGN, V19, P6064, DOI 10.2174/13816128113199990407; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; WASSERMAN RA, 1994, J BIOL CHEM, V269, P20943; Wei H, 2005, J BIOL CHEM, V280, P37041, DOI 10.1074/jbc.M506520200; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0; Wu CC, 2011, SCIENCE, V333, P459, DOI 10.1126/science.1204117	72	31	33	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					21011	21022		10.1074/jbc.M117.810580	http://dx.doi.org/10.1074/jbc.M117.810580			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29074616	hybrid, Green Published			2022-12-26	WOS:000418453400017
J	Armstrong-Hough, M; Turimumahoro, P; Meyer, AJ; Ochom, E; Babirye, D; Ayakaka, I; Mark, D; Ggita, J; Cattamanchi, A; Dowdy, D; Mugabe, F; Fair, E; Haberer, JE; Katamba, A; Davis, JL				Armstrong-Hough, Mari; Turimumahoro, Patricia; Meyer, Amanda J.; Ochom, Emmanuel; Babirye, Diana; Ayakaka, Irene; Mark, David; Ggita, Joseph; Cattamanchi, Adithya; Dowdy, David; Mugabe, Frank; Fair, Elizabeth; Haberer, Jessica E.; Katamba, Achilles; Davis, J. Lucian			Drop-out from the tuberculosis contact investigation cascade in a routine public health setting in urban Uganda: A prospective, multi-center study	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; DIAGNOSIS; BARRIERS	Setting Seven public tuberculosis (TB) units in Kampala, Uganda, where Uganda's national TB program recently introduced household contact investigation, as recommended by 2012 guidelines from WHO. Objective To apply a cascade analysis to implementation of household contact investigation in a programmatic setting. Design Prospective, multi-center observational study. Methods We constructed a cascade for household contact investigation to describe the proportions of: 1) index patient households recruited; 2) index patient households visited; 3) contacts screened for TB; and 4) contacts completing evaluation for, and diagnosed with, active TB. Results 338 (33%) of 1022 consecutive index TB patients were eligible for contact investigation. Lay health workers scheduled home visits for 207 (61%) index patients and completed 104 (50%). Among 287 eligible contacts, they screened 256 (89%) for symptoms or risk factors for TB. 131 (51%) had an indication for further TB evaluation. These included 59 (45%) with symptoms alone, 58 (44%) children < 5, and 14 (11%) with HIV. Among 131 contacts found to be symptomatic or at risk, 26 (20%) contacts completed evaluation, including five (19%) diagnosed with and treated for active TB, for an overall yield of 1.7%. The cumulative conditional probability of completing the entire cascade was 5%. Conclusion Major opportunities exist for improving the effectiveness and yield of TB contact investigation by increasing the proportion of index households completing screening visits by lay health workers and the proportion of at-risk contacts completing TB evaluation.	[Armstrong-Hough, Mari; Turimumahoro, Patricia; Meyer, Amanda J.; Ochom, Emmanuel; Babirye, Diana; Ayakaka, Irene; Mark, David; Ggita, Joseph; Cattamanchi, Adithya; Dowdy, David; Katamba, Achilles; Davis, J. Lucian] Makerere Univ, Uganda TB Implementat Res Consortium, Kampala, Uganda; [Armstrong-Hough, Mari; Meyer, Amanda J.; Davis, J. Lucian] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA; [Cattamanchi, Adithya; Fair, Elizabeth] Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Dowdy, David] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Mugabe, Frank] Uganda Minist Hlth, Natl TB & Leprosy Programme, Kampala, Uganda; [Haberer, Jessica E.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Katamba, Achilles] Makerere Univ, Clin Epidemiol Unit, Kampala, Uganda; [Davis, J. Lucian] Yale Sch Med, Pulm Crit Care & Sleep Med Sect, New Haven, CT 06510 USA	Makerere University; Yale University; University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Massachusetts General Hospital; Makerere University; Yale University	Davis, JL (corresponding author), Makerere Univ, Uganda TB Implementat Res Consortium, Kampala, Uganda.; Davis, JL (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.; Davis, JL (corresponding author), Yale Sch Med, Pulm Crit Care & Sleep Med Sect, New Haven, CT 06510 USA.	lucian.davis@yale.edu	Haberer, Jessica/AAH-7976-2019; Davis, J. Lucian/AAC-8376-2019	Haberer, Jessica/0000-0001-5845-3190; Davis, J. Lucian/0000-0002-8629-9992; Gupta, Amanda J/0000-0003-2318-1783; EMMANUEL, OCHOM/0000-0003-0999-3275; Ggita, Joseph/0000-0001-9282-563X	U.S. National Institute of Allergy and Infectious Diseases [NIHR01AI104824]; University of California San Francisco; FOGARTY INTERNATIONAL CENTER [D43TW009607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104824] Funding Source: NIH RePORTER	U.S. National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of California San Francisco(University of California System); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by the U.S. National Institute of Allergy and Infectious Diseases grant NIHR01AI104824 (JLD), and by an Innovative Grants Program Award from the Nina Ireland Program in Lung Health (https://pulmonary.ucsf.edu/ireland/) at the University of California San Francisco (JLD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayakaka I, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0561-4; Becerra MC, 2005, PUBLIC HEALTH REP, V120, P271, DOI 10.1177/003335490512000309; Blok L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119822; Botha E, 2008, INT J TUBERC LUNG D, V12, P820; Chiang SS, 2015, INT J TUBERC LUNG D, V19, P1144, DOI 10.5588/ijtld.15.0178; Fair E, 2015, INT J TUBERC LUNG D, V19, P269, DOI 10.5588/ijtld.14.0512; Fox GJ, 2011, COCHRANE DB SYST REV, V14; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Fox GJ, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0816-0; Gashu Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160514; Gueler A, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0562-z; Hwang TJ, 2011, INT J TUBERC LUNG D, V15, P1620, DOI 10.5588/ijtld.11.0222; Jerene D, 2015, INT J TUBERC LUNG D, V19, P898, DOI 10.5588/ijtld.14.0978; Morishita F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162796; Morishita F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150405; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; Nair D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162090; Roberts S, 2015, J TELEMED TELECARE, V21, P14, DOI 10.1177/1357633X14545433; Siedner MJ, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0397-1; Siedner MJ, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-56; Subbaraman R, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002149; TB CARE I, 2015, AD IMPL GUID REC INV; UNAIDS, 2014, 90 90 90 AMB TREATM; World Health Organization, 2012, REC INV CONT PERS IN	24	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187145	10.1371/journal.pone.0187145	http://dx.doi.org/10.1371/journal.pone.0187145			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29108007	gold, Green Published, Green Submitted			2022-12-26	WOS:000414424600016
J	Song, B; Wei, ZL; Xu, XF; Wang, X; He, XJ; Wu, H; Zhou, P; Cao, YX				Song, Bing; Wei, Zhao-Lian; Xu, Xiao-Feng; Wang, Xue; He, Xiao-Jin; Wu, Huan; Zhou, Ping; Cao, Yun-Xia			Prevalence and risk factors of monochorionic diamniotic twinning after assisted reproduction: A six-year experience base on a large cohort of pregnancies	PLOS ONE			English	Article							STAGE EMBRYO-TRANSFER; BLASTOCYST TRANSFER; IVF; TECHNOLOGIES; TWINS	Objective To characterize the incidence and risk factors for monochorionic diamniotic(MC-DA) twinning after assisted reproductive technologies (ART). Design Retrospective population-based study. Setting The study was conducted in China; Department of Reproductive Medicine Center at The First Affiliated Hospital of Anhui Medical University. Population A cohort of 8860 clinical pregnancies after embryo transfer (ET) carried out in our center between 2011 and 2016 were retrospectively analyzed for the incidence of MC-DA twinning. Methods Logistic regression was used to model the effect on the incidence of MC-DA twinning after ART. Different clinical data (maternal age) and laboratory procedures (type of ET (fresh versus frozen), insemination (IVF or ICSI)), embryo stage at time of ET (cleavage or blastocyst)) on the incidence of MC-DA twinning were evaluated. Main outcome measures Monochorionic-diamniotic pregnancies were identified when more than one fetal poles was visualized in one gestational sac via trans-vaginal ultrasound at early first-trimester (7 to 8 weeks). Results The overall MC-DA twinning rate was 2.55% (226/8860). Eighty one MC-DA twinnings occurred in the fresh cycles and 145 in the frozen cycles (2.67% vs. 2.49%). MC-DA twinning incidence showed no significant difference whether ICSI was performed or not (2.79% vs. 2.44%). The MZT that resulted from single embryo transfer (SET) cycles (1.99%) was slightly lower than multiple embryo transfer cycles (2.61 %), but with non-significance. However, women < 35 years displayed a significant higher rate (2.81%) than women > 35 years old (1.16%). Blastocyst transfer was associated with a significantly increase in MC-DA twinning incidence than cleavage-stage embryos transfer (2.79% VS 2.02%, P= 0.008). In the results of logistic regression analysis, blastocyst transfer is a major risk factor of MZT in the fresh cycles (P= 0.044), while maternal age plays a more important role in the frozen cycles (P = 0.004). Conclusions There is an elevated prevalence of MC-DA twinning after ART. Both maternal age and blastocyst transfer are risk factors of monozygotic pregnancy independently. Blastocyst transfer is a major risk factor of MC-DA twinning in the fresh cycles, while maternal age plays a more important role in the frozen cycles.	[Song, Bing; Wei, Zhao-Lian; Xu, Xiao-Feng; Wang, Xue; He, Xiao-Jin; Wu, Huan; Zhou, Ping; Cao, Yun-Xia] Anhui Med Univ, Reprod Med Ctr, Dept Obstet & Gynecol, Affiliated Hosp 1, Hefei, Anhui, Peoples R China; [Song, Bing; Wei, Zhao-Lian; Xu, Xiao-Feng; Wang, Xue; He, Xiao-Jin; Wu, Huan; Zhou, Ping; Cao, Yun-Xia] AHMU, Prov Key Lab Reprod Hlth & Genet, Hefei, Anhui, Peoples R China; [Song, Bing; Wei, Zhao-Lian; Xu, Xiao-Feng; Wang, Xue; He, Xiao-Jin; Wu, Huan; Zhou, Ping; Cao, Yun-Xia] Anhui Prov Engn Technol Res Ctr Biopreservat & Ar, Hefei, Anhui, Peoples R China	Anhui Medical University	Cao, YX (corresponding author), Anhui Med Univ, Reprod Med Ctr, Dept Obstet & Gynecol, Affiliated Hosp 1, Hefei, Anhui, Peoples R China.; Cao, YX (corresponding author), AHMU, Prov Key Lab Reprod Hlth & Genet, Hefei, Anhui, Peoples R China.; Cao, YX (corresponding author), Anhui Prov Engn Technol Res Ctr Biopreservat & Ar, Hefei, Anhui, Peoples R China.	caoyunxia6@126.com			National Key Research and Development Plan of China [2016YFC1000204]	National Key Research and Development Plan of China	This study was supported by the National Key Research and Development Plan of China (2016YFC1000204).	Abusheika N, 2000, HUM REPROD UPDATE, V6, P396, DOI 10.1093/humupd/6.4.396; Alikani M, 2003, HUM REPROD, V18, P1937, DOI 10.1093/humrep/deg369; Allegra A, 2005, J ASSIST REPROD GEN, V22, P437, DOI 10.1007/s10815-005-7483-9; Aston KI, 2008, REPRODUCTION, V136, P377, DOI 10.1530/REP-08-0206; Behr B, 2003, FERTIL STERIL, V80, P1502, DOI 10.1016/j.fertnstert.2003.07.001; Behr B, 2000, J ASSIST REPROD GEN, V17, P349, DOI 10.1023/A:1009461213139; Benirschke K, 2009, PLACENTA, V30, P923, DOI 10.1016/j.placenta.2009.08.009; Blickstein I, 1999, NEW ENGL J MED, V340, P738, DOI 10.1056/NEJM199903043400916; Chang HJ, 2009, FERTIL STERIL, V91, P2381, DOI 10.1016/j.fertnstert.2008.03.066; Chauhan SP, 2010, AM J OBSTET GYNECOL, V203, P305, DOI 10.1016/j.ajog.2010.04.031; DEROM C, 1987, LANCET, V1, P1236; Derom R, 2001, Twin Res, V4, P134, DOI 10.1375/twin.4.3.134; Dube J, 2002, AM J OBSTET GYNECOL, V186, P579, DOI 10.1067/mob.2002.121721; Franasiak JM, 2015, FERTIL STERIL, V103, P95, DOI 10.1016/j.fertnstert.2014.10.013; Hall JG, 2003, LANCET, V362, P735, DOI 10.1016/S0140-6736(03)14237-7; Kawachiya S, 2011, FERTIL STERIL, V95, P2140, DOI 10.1016/j.fertnstert.2010.12.018; Knopman J, 2010, FERTIL STERIL, V94, P502, DOI 10.1016/j.fertnstert.2009.03.064; Mateizel I, 2016, HUMAN REPROD; Milki AA, 2003, FERTIL STERIL, V79, P503, DOI 10.1016/S0015-0282(02)04754-4; Papanikolaou EG, 2010, FERTIL STERIL, V93, P592, DOI 10.1016/j.fertnstert.2008.12.088; Sills ES, 2000, HUM REPROD, V15, P890, DOI 10.1093/humrep/15.4.890; Skiadas CC, 2008, HUM REPROD, V23, P1366, DOI 10.1093/humrep/den045; Sobek A, 2016, BIOMED PAP, V160, P358, DOI 10.5507/bp.2016.016; Sobek A, 2015, FERTIL STERIL, V103, P756, DOI 10.1016/j.fertnstert.2014.12.098; Sparks Amy E, 2012, Methods Mol Biol, V912, P387, DOI 10.1007/978-1-61779-971-6_22; Steinman G, 2003, J REPROD MED, V48, P583; Tarlatzis BC, 2002, FERTIL STERIL, V77, P196, DOI 10.1016/S0015-0282(01)02958-2; Tingting L, 2015, ACTA U MED ANHUI, V50, P749; Verpoest W, 2009, HUM REPROD, V24, P2945, DOI 10.1093/humrep/dep280; Wright V, 2004, HUM REPROD, V19, P1831, DOI 10.1093/humrep/deh338	30	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0186813	10.1371/journal.pone.0186813	http://dx.doi.org/10.1371/journal.pone.0186813			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29107981	Green Submitted, Green Published, gold			2022-12-26	WOS:000414424600007
J	Uemura, Y; Hagiwara, K; Kobayashi, K				Uemura, Yasunori; Hagiwara, Kenji; Kobayashi, Katsuya			The intratracheal administration of locked nucleic acid containing antisense oligonucleotides induced gene silencing and an immune-stimulatory effect in the murine lung	PLOS ONE			English	Article							MESSENGER-RNA; RECEPTOR; MICE; HEPATOTOXICITY; MACROPHAGES; INHALATION; EXPRESSION; TOXICITY; DELIVERY; DESIGN	Locked nucleic acid containing antisense oligonucleotides (LNA-ASOs) have the potential to modulate the disease-related gene expression by the RNaseH-dependent degradation of mRNAs. Pulmonary drug delivery has been widely used for the treatment of lung disease. Thus, the inhalation of LNA-ASOs is expected to be an efficient therapy that can be applied to several types of lung disease. Because the lung has a distinct immune system against pathogens, the immune-stimulatory effect of LNA-ASOs should be considered for the development of novel inhaled LNA-ASOs therapies. However, there have been no reports on the relationship between knock-down (KD) and the immune-stimulatory effects of inhaled LNAASOs in the lung. In this report, LNA-ASOs targeting Scarbl (Scarbl-ASOs) or negative control LNA-ASOs targeting ApoB (ApoB-ASOs) were intratracheally administered to mice to investigate the KD of the gene expression and the immune-stimulatory effects in the lung. We confirmed that the intratracheal administration of Scarbl-ASOs exerted a KD effect in the lung without a drug delivery system. On the other hand, both Scarbl-ASOs and ApoB-ASOs induced neutrophilic infiltration in the alveoli and increased the expression levels of G-CSF and CXCL1 in the lung. The dose required for KD was the same as the dose that induced the neutrophilic immune response. In addition, in our in vitro experiments, Scarbl ASOs did not increase the G-CSF or CXCL1 expression in primary lung cells, even though Scarbl-ASOs exerted a strong KD effect. Hence, we hypothesize that inhaled LNA-ASOs have the potential to exert a KD effect in the lung, but that they may be associated with a risk of immune stimulation. Further studies about the mechanism underlying the immune-stimulatory effect of LNA-ASOs is necessary for the development of novel inhaled LNA-ASO therapies.	[Uemura, Yasunori; Kobayashi, Katsuya] Kyowa Hakko Kirin Co Ltd, R&D Div, Immunol & Allergy R&D Unit, Nagaizumi Cho, Shizuoka, Japan; [Hagiwara, Kenji] Kyowa Hakko Kirin Co Ltd, R&D Div, Res Funct Unit, Innovat Technol Labs, Machida, Tokyo, Japan	Kyowa Kirin Ltd; Kyowa Kirin Ltd	Uemura, Y (corresponding author), Kyowa Hakko Kirin Co Ltd, R&D Div, Immunol & Allergy R&D Unit, Nagaizumi Cho, Shizuoka, Japan.	yasunori.uemura@kyowa-kirin.co.jp			Kyowa Hakko Kirin Co., Ltd.	Kyowa Hakko Kirin Co., Ltd.(Kyowa Kirin Ltd)	The commercial company, Kyowa Hakko Kirin Co., Ltd., provided support in the form of salaries for authors YU, KH and KK, but did not have any additiorial role in the study design, data collection arid analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in he 'author contributions' section,	Allakhverdi Z, 2002, AM J RESP CRIT CARE, V165, P1015, DOI 10.1164/ajrccm.165.7.2109095; Alton EW, 2012, NUCLEIC ACID THER, V22, P246, DOI 10.1089/nat.2012.0345; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Bivas-Benita M, 2005, EUR J PHARM BIOPHARM, V61, P214, DOI 10.1016/j.ejpb.2005.04.009; Braber S, 2011, EUR J PHARMACOL, V668, P443, DOI 10.1016/j.ejphar.2011.03.025; Burel SA, 2016, NUCLEIC ACIDS RES, V44, P2093, DOI 10.1093/nar/gkv1210; Chua F, 2007, AM J PATHOL, V170, P65, DOI 10.2353/ajpath.2007.060352; Crosby JR, 2007, J PHARMACOL EXP THER, V321, P938, DOI 10.1124/jpet.106.119214; De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217; Delgado E, 2015, J HEPATOL, V62, P380, DOI 10.1016/j.jhep.2014.10.021; Duan W, 2005, AM J RESP CRIT CARE, V171, P571, DOI 10.1164/rccm.200408-1006OC; Duechs MJ, 2011, PULM PHARMACOL THER, V24, P203, DOI 10.1016/j.pupt.2010.12.009; Eisele N. A., 2011, J PATHOL, V2011, P16; Eyles JL, 2008, BLOOD, V112, P5193, DOI 10.1182/blood-2008-02-139535; Feng H, ARTERIOSCLER THROMB, V31, P2543; Frazier KS, 2015, TOXICOL PATHOL, V43, P78, DOI 10.1177/0192623314551840; Greenberg J, 2016, PATIENT PREFER ADHER, V10, P2163, DOI 10.2147/PPA.S102234; Guimond A, 2008, PULM PHARMACOL THER, V21, P845, DOI 10.1016/j.pupt.2008.08.001; Guo L, 2009, J BIOL CHEM, V284, P19826, DOI 10.1074/jbc.M109.020933; Gupta N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010682; Hizawa N, 2015, INT J CHRONIC OBSTR, V10, P1093, DOI 10.2147/COPD.S72858; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Ikematsu H, 2016, J INFECT CHEMOTHER, V22, P605, DOI 10.1016/j.jiac.2016.06.003; Karras JG, 2007, AM J RESP CELL MOL, V36, P276, DOI 10.1165/rcmb.2005-0456OC; Kasuya T, 2016, SCI REP-UK, V6, DOI 10.1038/srep30377; Kauppinen Sakari, 2005, Drug Discov Today Technol, V2, P287, DOI 10.1016/j.ddtec.2005.08.012; Kopf M, 2015, NAT IMMUNOL, V16, P36, DOI 10.1038/ni.3052; Kurreck J, 2002, NUCLEIC ACIDS RES, V30, P1911, DOI 10.1093/nar/30.9.1911; Lafferty EI, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-57; Morihara H, 2016, J CARDIOVASC PHARM T; Murray S, 2012, NUCLEIC ACIDS RES, V40, P6135, DOI 10.1093/nar/gks273; Nishina K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8969; Opitz B, 2010, AM J RESP CRIT CARE, V181, P1294, DOI 10.1164/rccm.200909-1427SO; Ripple MJ, 2010, J IMMUNOL, V185, P4804, DOI 10.4049/jimmunol.1000484; Shen WJ, 2014, METABOLISM, V63, P875, DOI 10.1016/j.metabol.2014.03.011; Singh P, 2012, LEUKEMIA, V26, P2375, DOI 10.1038/leu.2012.117; Soifer HS, 2012, METHODS MOL BIOL, V815, P333, DOI 10.1007/978-1-61779-424-7_25; Stein CA, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp841; Stenton GR, 2002, J IMMUNOL, V169, P1028, DOI 10.4049/jimmunol.169.2.1028; Stenton GR, 2000, J IMMUNOL, V164, P3790, DOI 10.4049/jimmunol.164.7.3790; Straarup EM, 2010, NUCLEIC ACIDS RES, V38, P7100, DOI 10.1093/nar/gkq457; Swayze EE, 2007, NUCLEIC ACIDS RES, V35, P687, DOI 10.1093/nar/gkl1071; Tanaka M, 2001, RESPIR RES, V2, P5, DOI 10.1186/rr32; van Haren SD, 2016, J IMMUNOL, V197, P4413, DOI 10.4049/jimmunol.1600282; van Rijt LS, 2004, J IMMUNOL METHODS, V288, P111, DOI 10.1016/j.jim.2004.03.004; Veedu RN, 2010, CHEM BIODIVERS, V7, P536, DOI 10.1002/cbdv.200900343; Wolthers OD, 2016, EXPERT OPIN PHARMACO, V17, P1023, DOI 10.1517/14656566.2016.1165207; Zhang Y, 2011, GENE THER, V18, P326, DOI 10.1038/gt.2010.133; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	49	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187286	10.1371/journal.pone.0187286	http://dx.doi.org/10.1371/journal.pone.0187286			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29107995	Green Submitted, Green Published, gold			2022-12-26	WOS:000414424600023
J	Murugesan, G; Abdulkadhar, S; Natarajan, J				Murugesan, Gurusamy; Abdulkadhar, Sabenabanu; Natarajan, Jeyakumar			Distributed smoothed tree kernel for protein-protein interaction extraction from the biomedical literature	PLOS ONE			English	Article							PREDICTION	Automatic extraction of protein-protein interaction (PPI) pairs from biomedical literature is a widely examined task in biological information extraction. Currently, many kernel based approaches such as linear kernel, tree kernel, graph kernel and combination of multiple kernels has achieved promising results in PPI task. However, most of these kernel methods fail to capture the semantic relation information between two entities. In this paper, we present a special type of tree kernel for PPI extraction which exploits both syntactic (structural) and semantic vectors information known as Distributed Smoothed Tree kernel (DSTK). DSTK comprises of distributed trees with syntactic information along with distributional semantic vectors representing semantic information of the sentences or phrases. To generate robust machine learning model composition of feature based kernel and DSTK were combined using ensemble support vector machine (SVM). Five different corpora (AIMed, BioInfer, HPRD50, IEPA, and LLL) were used for evaluating the performance of our system. Experimental results show that our system achieves better f-score with five different corpora compared to other state-of-the-art systems.	[Murugesan, Gurusamy; Abdulkadhar, Sabenabanu; Natarajan, Jeyakumar] Bharathiar Univ, Dept Bioinformat, Data Min & Text Min Lab, Coimbatore, Tamil Nadu, India	Bharathiar University	Natarajan, J (corresponding author), Bharathiar Univ, Dept Bioinformat, Data Min & Text Min Lab, Coimbatore, Tamil Nadu, India.	n.jeyakumar@yahoo.co.in	Natarajan, Jeyakumar/C-9319-2013; Abdulkadhar, Sabenabanu/GLQ-7051-2022	Natarajan, Jeyakumar/0000-0003-3981-619X; Murugesan, Gurusamy/0000-0003-1812-5218; Abdulkadhar, sabenabanu/0000-0002-7347-0930				Airola A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S11-S2; Baldridge Jason, 2005, OPENNLP PROJECT; Bui QC, 2011, BIOINFORMATICS, V27, P259, DOI 10.1093/bioinformatics/btq620; Bunescu R, 2005, ARTIF INTELL MED, V33, P139, DOI 10.1016/j.artmed.2004.07.016; Bunescu R., 2006, P WORKSH LINK NAT LA, P49; Chang YC, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw101; Chen XW, 2005, BIOINFORMATICS, V21, P4394, DOI 10.1093/bioinformatics/bti721; Chiang JH, 2014, J BIOINF COMPUT BIOL, V12, DOI 10.1142/S0219720014420086; Choi S.-P., 2010, P 23 INT C COMP LING, P206; Claesen M, 2014, J MACH LEARN RES, V15, P141; Collins M, PARSING SINGLE NEURO; Croce D., 2011, P 20 ACM INT C INFOR, P2013; Ding J., 2002, PAC S BIOCOMPUT, P326; Dinu G, P 51 ANN M ASS COMP, P31; Ferrone L, COLING 2014, P721; Fundel K, 2007, BIOINFORMATICS, V23, P365, DOI 10.1093/bioinformatics/btl616; Giuliano C., 2006, P 11 C EUR CHAPT ASS, P401; Haussler D, 1999, TECHNICAL REPORT; Huang ML, 2004, BIOINFORMATICS, V20, P3604, DOI 10.1093/bioinformatics/bth451; Kim S, 2008, BIOINFORMATICS, V24, P118, DOI 10.1093/bioinformatics/btm544; Klein D., 2003, ANN M ASS COMP LING, DOI DOI 10.3115/1075096.1075150; Li LS, 2015, METHODS, V83, P44, DOI 10.1016/j.ymeth.2015.03.026; Li LS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091898; Liu B, COLING 2010, P757; Liu B, 2017, MOL THER-NUCL ACIDS, V7, P267, DOI 10.1016/j.omtn.2017.04.008; Liu B, 2016, BIOINFORMATICS, V32, P2411, DOI 10.1093/bioinformatics/btw186; Liu B, 2017, BIOINFORMATICS, V33, P35, DOI [10.1093/bioinformatics/btv604, 10.1093/bioinformatics/btw539]; Miwa M, 2009, INT J MED INFORM, V78, pE39, DOI 10.1016/j.ijmedinf.2009.04.010; Miyao Y, 2009, BIOINFORMATICS, V25, P394, DOI 10.1093/bioinformatics/btn631; Moschitti A, 2006, ASS COMPUTATIONAL LI, V113, P24; Nedellec C., 2005, P 4 LEARN LANG LOG W, P31; Niu Y, 2015, ARTIF INTELL MED, V64, P185, DOI 10.1016/j.artmed.2015.05.003; Peng Y, 2017, ARXIV170601556; Pyysalo S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-50; Raja K, 2013, DATABASE-OXFORD, DOI 10.1093/database/bas052; S<dipthong ae>tre R, 2007, LBM SHORT PAPERS, P319; Saetre R, 2010, IEEE ACM T COMPUT BI, V7, P442, DOI 10.1109/TCBB.2010.46; Sun L, 2014, PROCEEDINGS OF THE 52ND ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 2, P61; Phan TTT, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1100-z; Tkachenko M, CONVOLUTION KERNEL A; Van Landeghem  S., 2008, P 3 INT S SEM MIN BI, P77; Viswanathan SVN, 2003, ADV NEURAL INFORM PR, P585; Xiao J, 2005, P S SEM MIN BIOM, P51; Yang ZH, 2011, ARTIF INTELL MED, V51, P163, DOI 10.1016/j.artmed.2010.12.002; Zahiri J, 2013, CURR GENOMICS, V14, P397, DOI 10.2174/1389202911314060004; Zanzotto FM, 2012, ARXIV12064607; Zhao ZH, 2016, INT J DATA MIN BIOIN, V15, P145, DOI 10.1504/IJDMB.2016.076534; Zhou DY, 2006, LECT NOTES COMPUT SC, V3992, P718, DOI 10.1007/11758525_97; Zhou DY, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/298473	50	15	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							e0187379	10.1371/journal.pone.0187379	http://dx.doi.org/10.1371/journal.pone.0187379			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6TA	29099838	Green Published, gold, Green Submitted			2022-12-26	WOS:000414377900017
J	Lu, MC; Tung, CH; Yang, CC; Wang, CL; Huang, KY; Koo, M; Lai, NS				Lu, Ming-Chi; Tung, Chien-Hsueh; Yang, Chang-Chen; Wang, Chun-Lung; Huang, Kuang-Yung; Koo, Malcolm; Lai, Ning-Sheng			Incident osteoarthritis and osteoarthritis-related joint replacement surgery in patients with ankylosing spondylitis: A secondary cohort analysis of a nationwide, population-based health claims database	PLOS ONE			English	Article							AXIAL SPONDYLOARTHRITIS; ARTHRITIS; CRITERIA	Background Ankylosing spondylitis (AS) might be associated with an increased risk of secondary osteoarthritis. However, there is a lack of studies assessing its impact on osteoarthritis-related surgery. The aim of this secondary cohort study was to investigate the risk of symptomatic osteoarthritis and osteoarthritis-related surgery, including total hip replacement surgery (THRS) and total knee replacement surgery (THRS) in patients with AS. Methods Using the Taiwan's National Health Insurance Research Database, we identified 3,462 patients with AS between 2000 and 2012. A comparison cohort was assembled consisting of five patients without AS, based on frequency matching for sex, 10-year age interval, and index year, for each patient with AS. Both groups were followed until diagnosis of the study outcomes or the end of the follow-up period. Results Male patients with AS exhibited a significantly higher incidence of osteoarthritis (adjusted incidence rate ratio [IRR] 1.43; P< 0.001), THRS (adjusted IRR 12.59; P< 0.001), and TKRS (adjusted IRR 1.89; P=0.036). Moreover, analyses stratified by age group (20-39 years versus 40-80 years) indicated a high IRR (adjusted IRR 27.66; P<.001) for THRS among younger patients with AS. Conclusions Male patients with AS had a significant higher risk of developing osteoarthritis, and receiving THRS and TKRS. Young patients with AS also showed a significant higher risk of receiving THRS.	[Lu, Ming-Chi; Tung, Chien-Hsueh; Huang, Kuang-Yung; Lai, Ning-Sheng] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Div Allergy Immunol & Rheumatol, Chiayi, Taiwan; [Lu, Ming-Chi; Huang, Kuang-Yung; Lai, Ning-Sheng] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Yang, Chang-Chen] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Div Orthoped, Chiayi, Taiwan; [Wang, Chun-Lung] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Div Pediat, Chiayi, Taiwan; [Koo, Malcolm] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Med Res, Chiayi, Taiwan; [Koo, Malcolm] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; University of Toronto	Lai, NS (corresponding author), Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Div Allergy Immunol & Rheumatol, Chiayi, Taiwan.; Lai, NS (corresponding author), Tzu Chi Univ, Sch Med, Hualien, Taiwan.; Koo, M (corresponding author), Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Med Res, Chiayi, Taiwan.; Koo, M (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	m.koo@utoronto.ca; tzuchilai@gmail.com	Koo, Malcolm/AAE-5822-2020	Koo, Malcolm/0000-0002-9242-9167	Buddhist Tzu Chi Medical Foundation [TCMMP105-01-01, TCMMP105-01-02]	Buddhist Tzu Chi Medical Foundation	This work was supported by Buddhist Tzu Chi Medical Foundation, grant numbers TCMMP105-01-01 and TCMMP105-01-02. The URL of the funding institution is http://www.tzuchimedicalfoundation.org/. NSL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This study is based in part on data from the National Health Insurance Research Database provided by the National Health Insurance Administration, Ministry of Health and Welfare and managed by the National Health Research Institutes, Taiwan. The interpretation and conclusions contained herein do not represent those of the National Health Insurance Administration, Ministry of Health and Welfare or the National Health Research Institutes, Taiwan. This work was supported by grants from the Buddhist Tzu Chi Medical Foundation (TCMMP105-01-01 andTCMMP105-01-02).	Berenbaum F, 2013, OSTEOARTHR CARTILAGE, V21, P16, DOI 10.1016/j.joca.2012.11.012; CHOU CT, 1994, J RHEUMATOL, V21, P302; Dakwar E, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/1/E2; Das SK, 2008, BEST PRACT RES CL RH, V22, P657, DOI 10.1016/j.berh.2008.07.002; Gorman JD, 2002, NEW ENGL J MED, V346, P1349, DOI 10.1056/NEJMoa012664; Gracey E, 2016, ARTHRITIS RHEUMATOL, V68, P679, DOI 10.1002/art.39464; Haut ER, 2011, JAMA-J AM MED ASSOC, V305, P2462, DOI 10.1001/jama.2011.822; Ibn Yacoub Y, 2012, CLIN RHEUMATOL, V31, P293, DOI 10.1007/s10067-011-1819-x; Kristensen LE, 2010, ARTHRIT CARE RES, V62, P1362, DOI 10.1002/acr.20258; Lee W, 2007, ANN RHEUM DIS, V66, P633, DOI 10.1136/ard.2006.060293; Loeser RF, 2013, CURR OPIN RHEUMATOL, V25, P108, DOI 10.1097/BOR.0b013e32835a9428; National Health Insurance Administration Ministry of Health and Welfare Taiwan, NAT HLTH INS TAIW 20; Rudwaleit M, 2009, ANN RHEUM DIS, V68, P770, DOI 10.1136/ard.2009.108217; Saglam Y, 2016, ACTA ORTHOP TRAUMATO, V50, P443, DOI 10.1016/j.aott.2016.06.010; Schafer VS, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-358; Sochart DH, 1997, J BONE JOINT SURG AM, V79A, P1181, DOI 10.2106/00004623-199708000-00010; Sokolove J, 2013, THER ADV MUSCULOSKEL, V5, P77, DOI 10.1177/1759720X12467868; Taurog JD, 2016, NEW ENGL J MED, V374, P2563, DOI 10.1056/NEJMra1406182; Thijssen E, 2015, RHEUMATOLOGY, V54, P588, DOI 10.1093/rheumatology/keu464; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Webers C, 2016, RHEUMATOLOGY, V55, P419, DOI 10.1093/rheumatology/kev340; Yucesoy B, 2015, WORK, V50, P261, DOI 10.3233/WOR-131739	22	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187594	10.1371/journal.pone.0187594	http://dx.doi.org/10.1371/journal.pone.0187594			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095939	Green Submitted, Green Published, gold			2022-12-26	WOS:000414340200122
J	Nocchi, N; Soares, AR; Souto, ML; Fernandez, JJ; Martin, MN; Pereira, RC				Nocchi, N.; Soares, A. R.; Souto, M. L.; Fernandez, J. J.; Martin, M. N.; Pereira, R. C.			Detection of a chemical cue from the host seaweed Laurencia dendroidea by the associated mollusc Aplysia brasiliana	PLOS ONE			English	Article							HALOGENATED METABOLITES; ANTIBACTERIAL ACTIVITY; CHAMIGRANE METABOLITES; RED ALGAE; SEA HARES; MARINE; SESQUITERPENES; DACTYLOMELA; BEHAVIOR; SIGNALS	Chemical cues from sessile hosts can attract mobile and associated organisms and they are also impotant to maintain associations and overall biodiversity, but the identity and molecular structures of these chemicals have been little explored in the marine environment. Secondary metabolites are recognized as possible chemical mediators in the association between species of Laurencia and Aplysia, but the identity of the compounds has not been established. Here, for the first time, we experimentally verify that the sesquiterpene (+)-ela-tol, a compound produced by the red seaweed Laurencia dendroidea, is a chemical cue attracting the associated sea hare Aplysia brasiliana. In addition to revealing the nature of the chemical mediation between these two species, we provide evidence of a chemical cue that allows young individuals of A. brasiliana to live in association with L. dendroidea. This study highlights the importance of chemical cues in Laurencia-Aplysia association.	[Nocchi, N.; Pereira, R. C.] Univ Fed Fluminense, Programa Posgrad Dinamica Oceano & Terra, Campus Praia Vermelha, Niteroi, RJ, Brazil; [Nocchi, N.; Soares, A. R.] Univ Fed Rio de Janeiro, GPNOA, Nucl Ecol & Desenvolvimento Socioambiental Macae, Macae, Brazil; [Souto, M. L.; Fernandez, J. J.; Martin, M. N.] Univ La Laguna, Dept Quim Organ, Ctr Invest Biomed Canarias CIBICAN, Inst Univ Bioorgan Antonio Gonzalez IUBO, Tenerife, Spain	Universidade Federal Fluminense; Universidade Federal do Rio de Janeiro; Universidad de la Laguna	Pereira, RC (corresponding author), Univ Fed Fluminense, Programa Posgrad Dinamica Oceano & Terra, Campus Praia Vermelha, Niteroi, RJ, Brazil.; Soares, AR (corresponding author), Univ Fed Rio de Janeiro, GPNOA, Nucl Ecol & Desenvolvimento Socioambiental Macae, Macae, Brazil.	angelica.r.soares@gmail.com; rcrespo@id.uff.br	Fernandez, Jose/L-3343-2014; Fernández, José Javier/AAA-3439-2019; Pereira, Renato Crespo/AAA-7832-2020; Soares, Angelica/AAW-6611-2021; Souto, Maria L/L-5911-2014	Fernandez, Jose/0000-0002-0805-8317; Fernández, José Javier/0000-0002-0805-8317; Soares, Angelica/0000-0001-9126-3778; Souto, Maria L/0000-0001-9123-0749; Pereira, Renato/0000-0001-7576-226X; Nocchi, Nathalia/0000-0001-6811-1581	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; Project of the Spain National Plan [CTQ2014-55888-C03-01]; CNPq; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Project of the Spain National Plan; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Financial Support was provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro and the Project of the Spain National Plan (CTQ2014-55888-C03-01). RCP thanks CNPq for Research Productivity fellowships. M thanks Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for a doctoral fellowship and CNPq for a sandwich doctoral fellowship.r We are grateful to the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), the Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro and the Project of the Spain National Plan (CTQ2014-55888-C03-01) for financial support. RCP thanks CNPq for Research Productivity fellowships. NN thanks Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for a doctoral fellowship and CNPq for a sandwich doctoral fellowship. We are also grateful to the peer reviewers for the substantial contributions in improving our manuscript.	ALINO PM, 1992, J EXP MAR BIOL ECOL, V164, P209, DOI 10.1016/0022-0981(92)90175-A; [Anonymous], 2016, MAR DRUGS, V14, P1; AUDESIRK TE, 1975, BEHAV BIOL, V15, P45, DOI 10.1016/S0091-6773(75)92066-0; Bansemir A, 2004, CHEM BIODIVERS, V1, P463, DOI 10.1002/cbdv.200490039; BRENNAN MR, 1987, PHYTOCHEMISTRY, V26, P1053, DOI 10.1016/S0031-9422(00)82349-3; Carefoot TH, 2003, J EXP MAR BIOL ECOL, V288, P223, DOI 10.1016/S0022-0981(03)00019-4; COLL JC, 1989, AUST J CHEM, V42, P1591, DOI 10.1071/CH9891591; Da Gama BAP, 2002, BIOFOULING, V18, P13, DOI 10.1080/08927010290017680; Machado FLD, 2011, PLANTA MED, V77, P733, DOI 10.1055/s-0030-1250526; DASILVAMACHADO FL, 2014, J AGARDH MOL, V19, P3181, DOI DOI 10.3390/MOLECULES19033181; Derby CD, 2007, BIOL BULL-US, V213, P274, DOI 10.2307/25066645; Dias T, 2005, J NAT PROD, V68, P1677, DOI 10.1021/np050240y; Diaz-Marrero AR, 2012, J NAT PROD, V75, P115, DOI 10.1021/np200845f; Gavagnin M, 2000, J CHEM ECOL, V26, P1563, DOI 10.1023/A:1005526526884; Gillette R, 2000, P NATL ACAD SCI USA, V97, P3585, DOI 10.1073/pnas.97.7.3585; Ginsburg DW, 2001, MAR ECOL PROG SER, V215, P261, DOI 10.3354/meps215261; Harizani M, 2016, PROG CHEM ORG NAT PR, V102, P91, DOI 10.1007/978-3-319-33172-0_2; Hay Mark E., 1992, P93; Hay ME, 2009, ANNU REV MAR SCI, V1, P193, DOI 10.1146/annurev.marine.010908.163708; Jimenez-Romero C, 2014, BIOORG MED CHEM LETT, V24, P344, DOI 10.1016/j.bmcl.2013.11.008; Kamio M, 2017, NAT PROD REP, V34, P514, DOI 10.1039/c6np00121a; Kamio M, 2010, ANIM BEHAV, V80, P89, DOI 10.1016/j.anbehav.2010.04.003; Kamiya H, 2006, PROG MOLEC, V43, P215, DOI 10.1007/978-3-540-30880-5_10; KENNEDY DJ, 1988, PHYTOCHEMISTRY, V27, P1761, DOI 10.1016/0031-9422(88)80439-4; Machado FLD, 2014, REV BRAS FARMACOGN, V24, P635, DOI 10.1016/j.bjp.2014.10.009; Machado FLD, 2010, REV BRAS FARMACOGN, V20, P441, DOI 10.1590/S0102-695X2010000300024; Machado FLS, 2016, CHEM BIODIVERS, V13, P845, DOI 10.1002/cbdv.201500246; Mollo E, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00092; Nielsen NPV, 1998, J CHROMATOGR A, V805, P17, DOI 10.1016/S0021-9673(98)00021-1; Nunez-Acuna G, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060700; Palaniveloo K, 2014, J APPL PHYCOL, V26, P1199, DOI 10.1007/s10811-013-0127-z; Paradas WC, 2016, PLANT CELL PHYSIOL, V57, P1008, DOI 10.1093/pcp/pcw039; Pennings SC, 2001, CORAL REEFS, V20, P320, DOI 10.1007/s003380100178; PENNINGS SC, 1990, J EXP MAR BIOL ECOL, V142, P43, DOI 10.1016/0022-0981(90)90136-Z; Pereira R. C., 2008, P25, DOI 10.1007/978-3-540-74181-7_2; Pereira RC, 2013, BRAZ J BIOL, V63, P665; Rasher DB, 2015, P NATL ACAD SCI USA, V112, P12110, DOI 10.1073/pnas.1508133112; ROGERS CN, 1995, J EXP MAR BIOL ECOL, V192, P47, DOI 10.1016/0022-0981(95)00057-X; Rogers CN, 2002, MAR ECOL PROG SER, V236, P241, DOI 10.3354/meps236241; Saleh N, 2007, ARTHROPOD-PLANT INTE, V1, P119, DOI 10.1007/s11829-007-9011-6; Salgado LT, 2008, J STRUCT BIOL, V162, P345, DOI 10.1016/j.jsb.2008.01.015; Steiger S, 2010, P R SOC LOND B; Sudatti DB, 2006, J CHEM ECOL, V32, P835, DOI 10.1007/s10886-006-9033-z; Sudatti DB, 2016, BIOCHEM SYST ECOL, V64, P131, DOI 10.1016/j.bse.2015.12.001; Switzer-Dunlap M, 1978, P S SETTL MET MAR IN, P197; Tebben J, 2015, SCI REP-UK, V5, DOI 10.1038/srep10803; Vairappan C.S., 2009, MALAYS J SCI, V28, P269; Vairappan CS, 2003, BIOMOL ENG, V20, P255, DOI 10.1016/S1389-0344(03)00067-4; Vairappan CS, 2001, PHYTOCHEMISTRY, V58, P517, DOI 10.1016/S0031-9422(01)00260-6; Wang BG, 2013, CHEM REV, V113, P3632, DOI 10.1021/cr9002215; Weissburg J., 2015, CHEM ECOLOGY AQUATIC; Wessels M, 2000, J NAT PROD, V63, P920, DOI 10.1021/np9905721; Zimmer RK, 1999, ECOLOGY, V80, P1432, DOI 10.1890/0012-9658(1999)080[1432:REOECS]2.0.CO;2	53	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187126	10.1371/journal.pone.0187126	http://dx.doi.org/10.1371/journal.pone.0187126			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095906	Green Submitted, gold, Green Published			2022-12-26	WOS:000414340200047
J	Joshi, S; Wang, W; Khan, SR				Joshi, Sunil; Wang, Wei; Khan, Saeed R.			Transcriptional study of hyperoxaluria and calcium oxalate nephrolithiasis in male rats: Inflammatory changes are mainly associated with crystal deposition	PLOS ONE			English	Article							KIDNEY-STONE FORMATION; MATRIX GLA-PROTEIN; RENAL EPITHELIAL-CELLS; TAMM-HORSFALL PROTEIN; MESSENGER-RNA; OXIDATIVE STRESS; TEMPORAL-CHANGES; URINARY BIKUNIN; GENE-EXPRESSION; INHIBITOR	Hyperoxaluria associated with renal deposition of calcium oxalate (CaOx) crystals causes renal injury and inflammation leading to number of diseases including chronic kidney disease (CKD). It is however, not been possible to separate the renal consequences of hyperoxaluria from that of CaOx crystal deposition. We decided to utilize ethylene glycol (EG) model where hyperoxaluria and CaOx crystal deposition can be separated in time. To test our hypothesis, male rats were made hyperoxaluric by administering EG, rats were euthanized and kidneys were extracted on day 14, when occasional crystal is seen in the kidneys and day 28, when all animals have developed renal CaOx crystal deposits. Total RNA was extracted for microarray analysis and genome wide analysis of differentially expressed genes was performed to investigate differences between hyperoxaluria and crystal induced alterations in the kidneys. Immunohistochemical and Hematoxylin and Eosin (H&E) staining was also done for macromolecules with significant role in stone formation. All EG fed rats became hyperoxaluric by day 7, showed a few crystal deposits on day 14, and had heavy crystal deposition by day 28. There were significant changes in the expression of genes encoding for NADPH Oxidases; macromolecular crystallization modulators; genes involved in inflammasome activation; and osteogenic marker genes. Results demonstrate major differences between hyperoxaluria and CaOx crystal induced changes in the kidneys. Injury and inflammation are mainly associated with crystal deposition indicating significant role played by crystal retention.	[Joshi, Sunil; Wang, Wei; Khan, Saeed R.] Univ Florida, Dept Pathol Immunol & Lab Med, Coll Med, Gainesville, FL 32611 USA; [Khan, Saeed R.] Univ Florida, Dept Urol, Coll Med, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Khan, SR (corresponding author), Univ Florida, Dept Pathol Immunol & Lab Med, Coll Med, Gainesville, FL 32611 USA.; Khan, SR (corresponding author), Univ Florida, Dept Urol, Coll Med, Gainesville, FL 32611 USA.	Khan@pathology.ufl.edu		Khan, Saeed/0000-0001-6975-5952	National Institutes of Health [R01-DK078602, DK092311]; University of Florida Center for the Study of Lithiasis; University of Florida Open Access Publishing Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078602, R01DK092311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Florida Center for the Study of Lithiasis; University of Florida Open Access Publishing Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health grant #RO1-DK078602, DK092311 and University of Florida Center for the Study of Lithiasis. Publication of this article was funded in part by the University of Florida Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Jin Yao and Dr. Yijun Sun from the University of Florida's Interdisciplinary Center for Biotechnology Research (ICBR) for running the microarrays and data analyses, Dr. Ammon B. Peck for his advice and suggestions during studies, and Dr. Vineet Sangar from Institute of Systems Biology (ISB), Seattle, WA for providing expert assistance in data analysis and Bioinformatics. Supported by National Institutes of Health grant #RO1-DK078602, DK092311 and University of Florida Center for the Study of Lithiasis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asplin JR, 2002, ENDOCRIN METAB CLIN, V31, P927, DOI 10.1016/S0889-8529(02)00030-0; Asselman M, 2003, J AM SOC NEPHROL, V14, P3155, DOI 10.1097/01.ASN.0000099380.18995.F7; Atmani F, 1999, J AM SOC NEPHROL, V10, pS385; Atmani F, 1996, EUR J BIOCHEM, V236, P984, DOI 10.1111/j.1432-1033.1996.00984.x; Canales BK, 2012, NUTRITION, V28, P76, DOI 10.1016/j.nut.2011.03.003; Correa-Rotter R, 1998, J AM SOC NEPHROL, V9, P33; Denecke B, 2003, BIOCHEM J, V376, P135, DOI 10.1042/BJ20030676; Gao B, 2010, UROL INT, V85, P237, DOI 10.1159/000314947; Glaros T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034633; Gokhale JA, 2001, J UROLOGY, V166, P1492, DOI 10.1016/S0022-5347(05)65818-1; Grewal JS, 2005, BIOCHEM J, V387, P609, DOI 10.1042/BJ20041465; Han WK, 2002, KIDNEY INT, V62, P237, DOI 10.1046/j.1523-1755.2002.00433.x; HARDING MA, 1991, DEV BIOL, V146, P483, DOI 10.1016/0012-1606(91)90249-3; Hellmann M, 2012, TRENDS CARDIOVAS MED, V22, P197, DOI 10.1016/j.tcm.2012.07.020; Holmes RP, 2005, J UROLOGY, V174, P943, DOI 10.1097/01.ju.0000169476.85935.e2; Holmes RP, 2000, KIDNEY INT, V57, P1662, DOI 10.1046/j.1523-1755.2000.00010.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang HS, 2002, J UROLOGY, V167, P2584, DOI 10.1016/S0022-5347(05)65042-2; Hunter GK, 2013, CALCIF TISSUE INT; Hunter GK, 2009, CELLS TISSUES ORGANS, V189, P44, DOI 10.1159/000151430; Iida S, 1999, J UROLOGY, V162, P1480, DOI 10.1016/S0022-5347(05)68344-9; Iida S, 1999, J AM SOC NEPHROL, V10, P986; Joshi S, 2015, BBA-MOL BASIS DIS, V1852, P2000, DOI 10.1016/j.bbadis.2015.06.020; Joshi S, 2015, J UROLOGY, V193, P1684, DOI 10.1016/j.juro.2014.11.093; Joshi S, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/462361; Joshi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047738; Jungers P, 2004, AM J KIDNEY DIS, V44, P799, DOI 10.1053/j.ajkd.2004.08.014; Khan A, 2014, WORLD J UROL, V32, P123, DOI 10.1007/s00345-013-1050-2; Khan SR, 2006, KIDNEY INT, V70, P914, DOI 10.1038/sj.ki.5001699; Khan Saeed R, 2004, Clin Exp Nephrol, V8, P75; Khan SR, 2014, AM J PHYSIOL-RENAL, V306, pF1285, DOI 10.1152/ajprenal.00057.2014; Khan SR, 2013, J UROLOGY, V189, P803, DOI 10.1016/j.juro.2012.05.078; Khan SR, 2012, UROL RES, V40, P95, DOI 10.1007/s00240-011-0448-9; Khan SR, 2011, NEPHROL DIAL TRANSPL, V26, P1778, DOI 10.1093/ndt/gfq692; Khan Saeed R, 2011, Arch Ital Urol Androl, V83, P1; Khan SR, 2010, J UROLOGY, V184, P1189, DOI 10.1016/j.juro.2010.04.065; Khan SR, 1997, WORLD J UROL, V15, P236, DOI 10.1007/BF01367661; Khan SR, 2004, FRONT BIOSCI-LANDMRK, V9, P1450, DOI 10.2741/1347; Khan SR, 1999, J AM SOC NEPHROL, V10, pS457; Khan SR, 2000, MOL UROL, V4, P305; Khand FD, 2002, FREE RADICAL BIO MED, V32, P1339, DOI 10.1016/S0891-5849(02)00846-8; Kleinman JG, 2004, NEPHRON PHYSIOL, V98, P43, DOI DOI 10.1159/000080263; Kohri K, 2012, UROL RES, V40, P623, DOI 10.1007/s00240-012-0514-y; Koul S, 2002, KIDNEY INT, V61, P525, DOI 10.1046/j.1523-1755.2002.00163.x; Koul S, 2014, AM J PHYSIOL-RENAL, V306, pF1039, DOI 10.1152/ajprenal.00462.2013; Koul S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043886; Mandel NS, 2004, J UROLOGY, V171, P1301, DOI 10.1097/01.ju.0000110101.41653.bb; Marengo SR, 2002, J UROLOGY, V167, P2192, DOI 10.1016/S0022-5347(05)65127-0; Miyazawa K, 2009, UROL RES, V37, P27, DOI 10.1007/s00240-008-0164-2; Mo L, 2007, AM J PHYSIOL-RENAL, V293, pF1935, DOI 10.1152/ajprenal.00383.2007; Monico CG, 2002, KIDNEY INT, V62, P392, DOI 10.1046/j.1523-1755.2002.00468.x; Moriyama MT, 2001, J UROLOGY, V165, P1687, DOI 10.1016/S0022-5347(05)66394-X; Mulay SR, 2013, J CLIN INVEST, V123, P236, DOI 10.1172/JCI63679; Okada A, 2010, J BONE MINER RES, V25, P2425, DOI 10.1002/jbmr.158; Okada A, 2009, J BONE MINER RES, V24, P908, DOI [10.1359/JBMR.081245, 10.1359/jbmr.081245]; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rule AD, 2010, J AM SOC NEPHROL, V21, P1641, DOI 10.1681/ASN.2010030253; Rule AD, 2009, CLIN J AM SOC NEPHRO, V4, P804, DOI 10.2215/CJN.05811108; RYALL RL, 2004, NEPHRON PHYSIOL, V98, P37, DOI DOI 10.1159/000080262; Scales CD, 2012, EUR UROL, V62, P160, DOI 10.1016/j.eururo.2012.03.052; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Schepers MSJ, 2005, KIDNEY INT, V68, P1543, DOI 10.1111/j.1523-1755.2005.00566.x; Schurgers LJ, 2008, THROMB HAEMOSTASIS, V100, P593, DOI 10.1160/TH08-02-0087; Stamatelou KK, 2003, KIDNEY INT, V63, P1817, DOI 10.1046/j.1523-1755.2003.00917.x; Stapleton AMF, 1998, BRIT J UROL, V81, P666; Stejskal D, 2008, BJU INT, V101, P1151, DOI 10.1111/j.1464-410X.2007.07432.x; Thamilselvan S, 1997, J UROLOGY, V157, P1059, DOI 10.1016/S0022-5347(01)65141-3; Thamilselvan S, 1999, J AM SOC NEPHROL, V10, pS452; Tsujihata M, 2000, J UROLOGY, V164, P1718, DOI 10.1016/S0022-5347(05)67095-4; Umekawa T, 2004, J AM SOC NEPHROL, V15, P635, DOI 10.1097/01.ASN.0000113321.49771.2D; Umekawa T, 2002, KIDNEY INT, V61, P105, DOI 10.1046/j.1523-1755.2002.00106.x; Wesson JA, 2003, J AM SOC NEPHROL, V14, P139, DOI 10.1097/01.ASN.0000040593.93815.9D; Yasui T, 1999, UROL RES, V27, P255, DOI 10.1007/s002400050119; Zuo J, 2011, NEPHROL DIAL TRANSPL, V26, P1785, DOI 10.1093/ndt/gfr035	74	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0185009	10.1371/journal.pone.0185009	http://dx.doi.org/10.1371/journal.pone.0185009			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091707	Green Submitted, Green Published, gold			2022-12-26	WOS:000414229700003
J	Oyeyemi, OT; Odaibo, AB				Oyeyemi, Oyetunde T.; Odaibo, Alexander B.			Maternal urogenital schistosomiasis; monitoring disease morbidity by simple reagent strips	PLOS ONE			English	Article							URINARY SCHISTOSOMIASIS; PREGNANT-WOMEN; HAEMATOBIUM INFECTION; RURAL COMMUNITIES; OGUN STATE; HEMATURIA; QUESTIONNAIRES; DIAGNOSIS; CHILDREN; PROTEINURIA	Background Urine analysis is one of the recommended antenatal guidelines for early diagnosis of pregnancy -associated complications. While in practice, urine analysis by dipstick had been used to provide useful information on other urinary tract infections, its applications for early detection of urogenital schistosomiasis in pregnant women is often times not given due attention in most endemic areas. Our study therefore assessed the performance of some common urinalysis parameters in the diagnosis of maternal urogenital schistosomiasis in endemic rural communities of Nigeria. Methodology/Principal findings The cross-sectional epidemiologic survey of urogenital schistosomiasis was conducted among pregnant women in Yewa North Local Government, Ogun State, Nigeria. The women were microscopically examined for infection with Schistosoma haematobium, visually observed for macrohematuria, and screened for microhematuria and proteinuria using standard urine chemical reagent strips. Of 261 volunteered participants, 19.9% tested positive for S. haematobium infection. The proportion of microhematuria (23.8%) was significantly higher than that of macrohematuria (3.8%) and proteinuria (16.8%) (P<0.05). Microhematuria with sensitivity (82.7%) and specificity (89.0%) was the best diagnostic indicator of urogenital schistosomiasis. Macrohematuria with the least sensitivity (11.8%) was however the most specific (98.1%) for diagnosing urogenital schistosomiasis in pregnant women. Maximum microhematuria sensitivity (100.0%) was observed in women between 15-19 years but sensitivity was consistently low in older age groups. Maximum sensitivity, specificity and predictive values (100.0%) were recorded for microhematuria in first trimester women. Diagnostic efficiency of proteinuria and macrohematuria was also better in the first trimester women except the 25.0% specificity recorded for proteinuria. The overall diagnostic performance of microhematuria and proteinuria was better in secundigravidae. Conclusions/Significance Microhematuria can be used for early detection of urogenital schistosomiasis in endemic areas especially in younger women. However because microhematuria is a condition that occurs during pregnancy and in several other diseases, it is necessary to compliment the diagnosis with other diagnostic tools such as microscopy and serology. Treatment with praziquantel is recommended for the women in their late trimesters after follow up test in order to avert associated adverse pregnancy outcomes.	[Oyeyemi, Oyetunde T.] Univ Med Sci, Dept Biol Sci, Ondo, Ondo State, Nigeria; [Odaibo, Alexander B.] Univ Ibadan, Dept Zool, Ibadan, Oyo State, Nigeria	University of Ibadan	Oyeyemi, OT (corresponding author), Univ Med Sci, Dept Biol Sci, Ondo, Ondo State, Nigeria.	zootund@yahoo.com	Oyeyemi, Oyetunde T./G-7824-2012	Oyeyemi, Oyetunde T./0000-0002-3089-2578				Adegnika AA, 2010, TROP MED INT HEALTH, V15, P1204, DOI 10.1111/j.1365-3156.2010.02598.x; Akinwale Olaoluwa, 2015, Folia Malacologica, V23, P137, DOI 10.12657/folmal.023.009; [Anonymous], 2013, SCHIST PROGR REP 200; Anosike JC, 2001, J HELMINTHOL, V75, P223; Ayele B, 2008, PARASITE, V15, P69, DOI 10.1051/parasite/2008151069; Basra A, 2013, CLIN INFECT DIS, V56, pE68, DOI 10.1093/cid/cis976; Daniel WW, 1999, BIOSTATISTICS FDN AN, V7th; DANIELLI L, 1987, OBSTET GYNECOL, V69, P446; Eyo JE, 2012, TROP BIOMED, V29, P575; Friedman JF, 2007, TRENDS PARASITOL, V23, P159, DOI 10.1016/j.pt.2007.02.006; Gundersen SG, 1996, ACTA TROP, V62, P281, DOI 10.1016/S0001-706X(96)00029-0; Guyatt H, 1999, TROP MED INT HEALTH, V4, P751, DOI 10.1046/j.1365-3156.1999.00483.x; Jou WW, 1998, SOUTHERN MED J, V91, P266, DOI 10.1097/00007611-199803000-00010; Kapito-Tembo AP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000361; Khalid A, 2012, INT J GYNECOL OBSTET, V116, P10, DOI 10.1016/j.ijgo.2011.08.018; King CH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002431; Kjetland EF, 2012, TRENDS PARASITOL, V28, P58, DOI 10.1016/j.pt.2011.10.008; Koukounari A, 2009, AM J TROP MED HYG, V80, P435, DOI 10.4269/ajtmh.2009.80.435; Krauth SJ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1165-y; Lengeler C, 2002, B WORLD HEALTH ORGAN, V80, P235; Mafe MA, 1997, ACTA TROP, V68, P277, DOI 10.1016/S0001-706X(97)00102-2; Mafe MA, 2000, TROP MED INT HEALTH, V5, P53, DOI 10.1046/j.1365-3156.2000.00508.x; Meurs L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001829; Morenikeji O, 2014, AFR HEALTH SCI, V14, P390, DOI 10.4314/ahs.v14i2.15; MOTT KE, 1983, LANCET, V1, P1005; Ochodo EA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009579.pub2; Poggensee G, 2000, B WORLD HEALTH ORGAN, V78, P542; Rudra P, 2011, BJMP, V4, P433; Salawu OT, 2014, HELMINTHOLOGIA, V51, P337, DOI 10.2478/s11687-014-0250-7; Salawu Oyetunde T, 2016, J Parasit Dis, V40, P93, DOI 10.1007/s12639-014-0454-2; Salawu OT, 2014, J PEDIATR UROL, V10, P88, DOI 10.1016/j.jpurol.2013.06.010; Salawu OT, 2013, AFR J ECOL, V51, P441, DOI 10.1111/aje.12054; Salawu OT, 2013, INT J GYNECOL OBSTET, V122, P1, DOI 10.1016/j.ijgo.2013.01.024; Stothard JR, 2009, T ROY SOC TROP MED H, V103, P325, DOI 10.1016/j.trstmh.2008.12.012; Stothard JR, 2006, ACTA TROP, V97, P219, DOI 10.1016/j.actatropica.2005.11.004; TAYLOR P, 1990, ACTA TROP, V47, P91, DOI 10.1016/0001-706X(90)90071-7; Thigpen MC, 2011, AM J TROP MED HYG, V84, P379, DOI 10.4269/ajtmh.2011.10-0186; Ugbomoiko US, 2010, ANN TROP MED PARASIT, V104, P409, DOI 10.1179/136485910X12743554760469; Utzinger J, 2009, PARASITOLOGY, V136, P1859, DOI 10.1017/S0031182009991600; Venyo A., 2010, WEBMEDCENTRAL UROL, V1; WILKINS HA, 1979, T ROY SOC TROP MED H, V73, P74, DOI 10.1016/0035-9203(79)90134-2; World Health Organization, REP WHO INF CONS US	42	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187433	10.1371/journal.pone.0187433	http://dx.doi.org/10.1371/journal.pone.0187433			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091946	Green Published, gold, Green Submitted			2022-12-26	WOS:000414229700065
J	Zheng, HN; Wang, MY; Zhao, CC; Wu, SL; Yu, PF; Lu, Y; Wang, TD; Ai, YX				Zheng, Hainan; Wang, Mengyun; Zhao, Chengcheng; Wu, Shanli; Yu, Peifeng; Lu, Yan; Wang, Tiedong; Ai, Yongxing			Characterization of the deubiquitination activity and substrate specificity of the chicken ubiquitin-specific protease 1/USP associated factor 1 complex	PLOS ONE			English	Article							FANCONI-ANEMIA PATHWAY; STRENGTH-DEPENDENT CONFORMATIONS; IONIC-STRENGTH; HOMOLOGOUS RECOMBINATION; HALOFERAX-VOLCANII; ENZYME; UAF1; USP1; PROTEINS; AUTOCLEAVAGE	Deubiquitinases (DUBs) are essential regulators of intracellular processes involving ubiquitin (Ub) modification. The human DUB ubiquitin-specific protease 1 (hUSP1) interacts with human USP-associated factor 1 (hUAF1), and helps to regulate processes such as DNA damage repair. Previously, we identified a chicken USP1 homologue (chUSP1) during an investigation into the properties of Marek's disease virus (MDV). However, chUSP1's deubiquitination activity, interaction with chUAF1, and substrate specificity remained unknown. In the present study, we expressed and purified both chUAF1 and chUSP1 with or without putative catalytic core mutations using the Bac-to-Bac system, before investigating their deubiquitination activity and kinetics using various substrates. chUSP1 was shown to interact with chUAF1 both in cellular assays in which the two proteins were co-expressed, and in in vitro assays using purified proteins. Heterodimerization with chUAF1 increased the deubiquitination activity of chUSP1 up to 54-fold compared with chUSP1 alone. The chUSP1 mutants C91S, H603A, and D758A reduced the deubiquitination activity of the chUSP1/chUAF1 complex by 10-, 7-, and 33-fold, respectively, while the C91A and H594A chUSP1 mutants eliminated deubiquitination activity of the chUSP1/chUAF1 complex completely. This suggests that C91 and H594, but not D758, are essential for chUSP1 deubiquitination activity, and that a nucleophilic group at position 91 is needed for the deubiquitination reaction. The chUSP1/chUAF1 complex was found to have distinct substrate preferences; efficient hydrolysis of Ub dimers with K11-, K48-, and K63-linkages was seen, with weaker hydrolysis observed with K6-, K27-, and K33-linkages and no hydrolysis seen with a K29 linkage. Furthermore, other Ub-like substrates were disfavored by the complex. No activity was seen with SUMO1-GST, SUMO2- and SUMO3-dimers, ISG15-Rho, FAT10-Rho, or Ufm1-Rho, and only weak activity was observed with NEDD8-Rho. Overall, the data presented here characterize the activity and substrate preferences of chUSP1, and thus may facilitate future studies on its in vivo role.	[Zheng, Hainan; Wang, Mengyun; Yu, Peifeng; Lu, Yan; Wang, Tiedong; Ai, Yongxing] Jilin Univ, Coll Anim Sci, Changchun, Jilin, Peoples R China; [Zhao, Chengcheng] Jilin Univ, Inst Translat Med, Changchun, Jilin, Peoples R China; [Wu, Shanli] Jilin Univ, Coll Basic Med Sci, Changchun, Jilin, Peoples R China	Jilin University; Jilin University; Jilin University	Wang, TD; Ai, YX (corresponding author), Jilin Univ, Coll Anim Sci, Changchun, Jilin, Peoples R China.	wangtd@jlu.edu.cn; aiyx@jlu.edu.cn			National Natural Science Foundation of China [31272528]; Program for New Century Excellent Talents in University of China [NCET-12-0232]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University of China(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Natural Science Foundation of China (No. 31272528, http://www.nsfc.gov.cn/) and the Program for New Century Excellent Talents in University of China (No. NCET-12-0232, http://www.moe.gov.cn./) YXA is the funding recipient. The funders had no role in study design, collection and analysis, decision to publish, or preparation of the manuscript.	Allende-Vega N, 2010, ONCOGENE, V29, P432, DOI 10.1038/onc.2009.330; Berthouze M, 2009, EMBO J, V28, P1684, DOI 10.1038/emboj.2009.128; Buller AR, 2013, P NATL ACAD SCI USA, V110, pE653, DOI 10.1073/pnas.1221050110; Caldwell RB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r6; Castaneda CA, 2016, STRUCTURE, V24, P423, DOI 10.1016/j.str.2016.01.007; Chen JJ, 2011, CHEM BIOL, V18, P1390, DOI 10.1016/j.chembiol.2011.08.014; Chen R, 2010, CELL RES, V20, P802, DOI 10.1038/cr.2010.41; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Cohn MA, 2009, J BIOL CHEM, V284, P5343, DOI 10.1074/jbc.M808430200; Dharadhar S, 2016, J STRUCT BIOL, V196, P437, DOI 10.1016/j.jsb.2016.09.011; Faesen AC, 2011, CHEM BIOL, V18, P1550, DOI 10.1016/j.chembiol.2011.10.017; Ferreira T., 2010, IMAGEJ USER GUIDE IJ; Fraile JM, 2012, ONCOGENE, V31, P2373, DOI 10.1038/onc.2011.443; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Kee Y, 2010, J BIOL CHEM, V285, P11252, DOI 10.1074/jbc.M109.095141; Kim M, 2016, FEBS LETT, V590, P340, DOI 10.1002/1873-3468.12060; Lehoux M, 2014, J VIROL, V88, P8545, DOI 10.1128/JVI.00379-14; Li H, 2016, MOL CELL, V63, P249, DOI 10.1016/j.molcel.2016.05.031; Liao SH, 2013, SCI REP-UK, V3, DOI 10.1038/srep02136; Lindner HA, 2007, VIROLOGY, V362, P245, DOI 10.1016/j.virol.2006.12.035; Miranda M, 2007, MOL INTERV, V7, P157, DOI 10.1124/mi.7.3.7; Murai J, 2011, MOL CELL BIOL, V31, P2462, DOI 10.1128/MCB.05058-11; Nakagawa T, 2008, GENE DEV, V22, P37, DOI 10.1101/gad.1609708; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Nishina K, 2004, J BIOL CHEM, V279, P40788, DOI 10.1074/jbc.M406548200; Olazabal-Herrero A, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0311-7; Ovaa H, 2004, P NATL ACAD SCI USA, V101, P2253, DOI 10.1073/pnas.0308411100; Panier S, 2013, NAT REV MOL CELL BIO, V14, P661, DOI 10.1038/nrm3659; Park E, 2013, MOL CELL BIOL, V33, P4360, DOI 10.1128/MCB.00870-13; Park J, 2003, J VIROL, V77, P9041, DOI 10.1128/JVI.77.16.9041-9051.2003; Park J, 2002, IMMUNITY, V17, P221, DOI 10.1016/S1074-7613(02)00368-0; Scortegagna M, 2011, J BIOL CHEM, V286, P27333, DOI 10.1074/jbc.M111.218214; Sompallae R, 2008, J VIROL, V82, P10477, DOI 10.1128/JVI.01113-08; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Villamil MA, 2013, CELL BIOCHEM BIOPHYS, V67, P111, DOI 10.1007/s12013-013-9637-1; Villamil MA, 2012, BIOCHEMISTRY-US, V51, P9112, DOI 10.1021/bi300845s; Villamil MA, 2012, BIOCHEMISTRY-US, V51, P2829, DOI 10.1021/bi3000512; Wickliffe KE, 2011, TRENDS CELL BIOL, V21, P656, DOI 10.1016/j.tcb.2011.08.008; Williams SA, 2011, CELL, V146, P917, DOI 10.1016/j.cell.2011.07.040; Xu DQ, 2012, VIRUS RES, V169, P264, DOI 10.1016/j.virusres.2012.07.002; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yang KL, 2011, GENE DEV, V25, P1847, DOI 10.1101/gad.17020911; Ye KQ, 2013, PROTEIN SCI, V22, P1174, DOI 10.1002/pro.2302; Ye Y, 2012, NATURE, V492, P266, DOI 10.1038/nature11722; Yeh HM, 2013, J IMMUNOL, V191, P3328, DOI 10.4049/jimmunol.1300225; Yin JP, 2015, STRUCTURE, V23, P2043, DOI 10.1016/j.str.2015.08.010; Yue W, 2014, CELL RES, V24, P482, DOI 10.1038/cr.2014.20	49	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11								10.1371/journal.pone.0186535	http://dx.doi.org/10.1371/journal.pone.0186535			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091922	Green Published, gold, Green Submitted			2022-12-26	WOS:000414229700022
J	Pazhoohan, S; Raoufy, MR; Javan, M; Hajizadeh, S				Pazhoohan, Saeed; Raoufy, Mohammad Reza; Javan, Mohammad; Hajizadeh, Sohrab			Effect of Rho-kinase inhibition on complexity of breathing pattern in a guinea pig model of asthma	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; AIRWAY HYPERRESPONSIVE RATS; BRONCHIAL SMOOTH-MUSCLE; TIME-SERIES ANALYSIS; CHRONIC INFLAMMATION; FLUCTUATION ANALYSIS; ALLERGIC-ASTHMA; ANTIGEN; FLOW; BRONCHOCONSTRICTION	Asthma represents an episodic and fluctuating behavior characterized with decreased complexity of respiratory dynamics. Several evidence indicate that asthma severity or control is associated with alteration in variability of lung function. The pathophysiological basis of alteration in complexity of breathing pattern in asthma has remained poorly understood. Regarding the point that Rho-kinase is involved in pathophysiology of asthma, in present study we investigated the effect of Rho-kinase inhibition on complexity of respiratory dynamics in a guinea pig model of asthma. Male Dunkin Hartley guinea pigs were exposed to 12 series of inhalations with ovalbumin or saline. Animals were treated by the Rho-kinase inhibitor Y-27632 (1mM aerosols) prior to each allergen challenge. We recorded respiration of conscious animals using whole-body plethysmography. Exposure to ovalbumin induced lung inflammation, airway hyperresponsiveness and remodeling including goblet cell hyperplasia, increase in the thickness of airways smooth muscles and subepithelial collagen deposition. Complexity analysis of respiratory dynamics revealed a dramatic decrease in irregularity of respiratory rhythm representing less complexity in asthmatic guinea pigs. Inhibition of Rho-kinase reduced the airway remodeling and hyperreponsiveness, but had no significant effect on lung inflammation and complexity of respiratory dynamics in asthmatic animals. It seems that airway hyperresponsiveness and remodeling do not significantly affect the complexity of respiratory dynamics. Our results suggest that inflammation might be the probable cause of shift in the respiratory dynamics away from the normal fluctuation in asthma.	[Pazhoohan, Saeed; Raoufy, Mohammad Reza; Javan, Mohammad; Hajizadeh, Sohrab] Tarbiat Modares Univ, Dept Physiol, Fac Med Sci, Tehran, Iran	Tarbiat Modares University	Raoufy, MR; Hajizadeh, S (corresponding author), Tarbiat Modares Univ, Dept Physiol, Fac Med Sci, Tehran, Iran.	raoufy@modares.ac.ir; hajizads@modares.ac.ir	Javan, Mohammad/C-6758-2008; pazhoohan, saeed/Q-2257-2018	Javan, Mohammad/0000-0003-2045-6171; 	Tarbiat Modares University; Iran National Science Foundation (INSF)	Tarbiat Modares University; Iran National Science Foundation (INSF)(Iran National Science Foundation (INSF))	This work was supported by grants from the Tarbiat Modares University to S. Pazhoohan and Iran National Science Foundation (INSF) to S. Hajizadeh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki H, 2008, BIOCHEM BIOPH RES CO, V367, P509, DOI 10.1016/j.bbrc.2008.01.012; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Benchetrit G, 2000, RESP PHYSIOL, V122, P123, DOI 10.1016/S0034-5687(00)00154-7; BOUSQUET J, 1992, ALLERGY, V47, P3, DOI 10.1111/j.1398-9995.1992.tb02242.x; Chen CY, 2001, J ALLERGY CLIN IMMUN, V108, P557; Chiba Y, 1999, BRIT J PHARMACOL, V127, P597, DOI 10.1038/sj.bjp.0702585; Chiba Y, 2001, BRIT J PHARMACOL, V133, P886, DOI 10.1038/sj.bjp.0704137; COSIO M, 1978, NEW ENGL J MED, V298, P1277, DOI 10.1056/NEJM197806082982303; Duan W, 2005, AM J RESP CRIT CARE, V171, P571, DOI 10.1164/rccm.200408-1006OC; Frey U, 2005, NATURE, V438, P667, DOI 10.1038/nature04176; Frey U, 2008, LANCET, V372, P1088, DOI 10.1016/S0140-6736(08)61450-6; Frey U, 2011, J APPL PHYSIOL, V110, P1723, DOI 10.1152/japplphysiol.01297.2010; Gulotta C, 2012, AM J RESP CRIT CARE, V185, P1330, DOI 10.1164/ajrccm.185.12.1330; Htwe SS, 2017, AM J RESP CELL MOL B; HUTSON PA, 1988, AM REV RESPIR DIS, V137, P548, DOI 10.1164/ajrccm/137.3.548; Jain M, 2011, CURR SCI INDIA, V101, P1435; Kaminsky DA, 2017, AM J RESP CRIT CARE, V195, P993, DOI 10.1164/rccm.201601-0076OC; Kasahara DI, 2015, CLIN EXP ALLERGY, V45, P457, DOI 10.1111/cea.12438; Lan B, 2015, AM J PHYSIOL-LUNG C, V308, pL1, DOI 10.1152/ajplung.00222.2014; Lancas T, 2006, J APPL PHYSIOL, V100, P1610, DOI 10.1152/japplphysiol.00828.2005; Lee M, 2009, INT IMMUNOPHARMACOL, V9, P418, DOI 10.1016/j.intimp.2009.01.005; Mangin L, 2008, RESP PHYSIOL NEUROBI, V161, P189, DOI 10.1016/j.resp.2008.02.006; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Pigati PA, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0073-4; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; Possa SS, 2012, AM J PHYSIOL-LUNG C, V303, pL939, DOI 10.1152/ajplung.00034.2012; Que CL, 2001, J APPL PHYSIOL, V91, P1131, DOI 10.1152/jappl.2001.91.3.1131; Raoufy MR, 2017, AM J RESP CRIT CARE, V196, P247, DOI 10.1164/rccm.201701-0026LE; Raoufy MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147976; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; RighettI RF, 2014, RESP PHYSIOL NEUROBI, V192, P134, DOI 10.1016/j.resp.2013.12.012; Samara Z, 2009, RESP PHYSIOL NEUROBI, V165, P82, DOI 10.1016/j.resp.2008.10.015; SAMMON M, 1994, J APPL PHYSIOL, V77, P2481, DOI 10.1152/jappl.1994.77.5.2481; Sarlus H, 2012, J CELL MOL MED, V16, P2401, DOI 10.1111/j.1582-4934.2012.01556.x; Schaafsma D, 2008, AM J PHYSIOL-LUNG C, V295, pL214, DOI 10.1152/ajplung.00498.2007; Schaafsma D, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-121; Shaykhiev R, 2009, J IMMUNOL, V183, P2867, DOI 10.4049/jimmunol.0900473; Shirazi AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072854; Smith JC, 2000, RESP PHYSIOL, V122, P131, DOI 10.1016/S0034-5687(00)00155-9; Taki F, 2007, CLIN EXP ALLERGY, V37, P599, DOI 10.1111/j.1365-2222.2007.02693.x; Thamrin C, 2016, AM J RESP CRIT CARE, V194, P1053, DOI 10.1164/rccm.201511-2288PP; Thamrin C, 2011, THORAX, V66, P1036, DOI 10.1136/thx.2010.156489; Thamrin C, 2009, J APPL PHYSIOL, V106, P753, DOI 10.1152/japplphysiol.91588.2008; Tiberio IFLC, 1997, AM J RESP CRIT CARE, V155, P1739, DOI 10.1164/ajrccm.155.5.9154886; van den Aardweg JG, 2002, AM J RESP CRIT CARE, V165, P1041, DOI 10.1164/ajrccm.165.8.2104100; Veiga J, 2011, J APPL PHYSIOL, V111, P412, DOI 10.1152/japplphysiol.00267.2011; Walline CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062222; Wills-Karp M, 1999, ANNU REV IMMUNOL, V17, P255, DOI 10.1146/annurev.immunol.17.1.255; Wills-Karp M, 2001, J ALLERGY CLIN IMMUN, V107, P9, DOI 10.1067/mai.2001.112265; YING S, 1991, Clinical and Experimental Allergy, V21, P745, DOI 10.1111/j.1365-2222.1991.tb03205.x; Yoshida M, 2005, J ALLERGY CLIN IMMUN, V115, P1004, DOI 10.1016/j.jaci.2005.02.003; Zhang H, 2014, GENET MOL RES, V13, P8320, DOI [10.4238/2014.October.20.8, 10.4238/2014.January.22.2]; Zhou H, 2011, CLIN EXP PHARMACOL P, V38, P387, DOI 10.1111/j.1440-1681.2011.05523.x; Zhu M, 2011, EUR RESPIR J, V38, P841, DOI 10.1183/09031936.00125010	55	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187249	10.1371/journal.pone.0187249	http://dx.doi.org/10.1371/journal.pone.0187249			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088265	Green Published, Green Submitted, gold			2022-12-26	WOS:000414088900054
J	Tian, L; Yang, YQ; Sui, WJ; Hu, Y; Li, HL; Wang, F; Qian, KY; Ji, J; Tao, M				Tian, Li; Yang, Yiqun; Sui, Wenjie; Hu, Yan; Li, Huiling; Wang, Fen; Qian, Keyan; Ji, Juan; Tao, Min			Implementation of evidence into practice for cancer-related fatigue management of hospitalized adult patients using the PARIHS framework	PLOS ONE			English	Article							COLORECTAL-CANCER; CLINICAL-TRIAL; HEALTH-CARE; METAANALYSIS; BREAST; EXERCISE; INTERVENTIONS; SURVIVORS; CRITERIA; PROSTATE	This study aimed to explore an evidence-based nursing practice model of CRF management in hospitalized adult patients using the PARIHS evidence-implementation framework as the theoretical structure to provide guidance for similar nursing practices. The implementation of guideline evidence into clinical practice was conducted on the oncology and radiotherapy wards of a university-affiliated hospital. The process of integrating the guideline into the symptom management system of cancer patients was described. The impact of the evidence implementation was evaluated from three aspects: organizational innovations and outcome measures associated with nurses and with patients pre- and post-evidence implementation. During the implementation of evidence into practice on the wards, a nursing process, health education, a quality control sheet and CRF training courses were established. Through this implementation, compliance with evidence related to CRF increased significantly on the two wards, with that of ward B being higher than that of ward A. Regarding nursing outcomes, nursing knowledge, attitude and behavior scores with respect to CRF nursing care increased substantially after its application on the two wards, and the ward B nurses' scoring was higher than that of the ward A nurses. Qualitative analysis concerning the nurses suggested that leadership, patient concern about CRF management, and the need for professional development were the main motivators of the application, whereas the shortage and mobility of nursing human resources and insufficient communication between doctors and nurses were the main barriers. Additionally, most nurses felt more professional and confident about their work. Regarding patient outcomes, patient knowledge, attitude and behavior scores regarding CRF self-management increased significantly. Patients' post-implementation CRF was alleviated compared with the pre-implementation treatment cycle. The PARIHS framework may provide instructive guidance for the incorporation of evidence into practice, and the process-oriented framework might provide greater operational utility of the application.	[Tian, Li; Yang, Yiqun; Sui, Wenjie; Wang, Fen; Qian, Keyan; Ji, Juan; Tao, Min] Soochow Univ, Affiliated Hosp 1, Suzhou, Peoples R China; [Hu, Yan] Fudan Univ, Sch Nursing, Shanghai, Peoples R China; [Li, Huiling] Soochow Univ, Sch Nursing, Suzhou, Peoples R China	Soochow University - China; Fudan University; Soochow University - China	Li, HL (corresponding author), Soochow Univ, Sch Nursing, Suzhou, Peoples R China.	sdfyytl@163.com		Li, Huiling/0000-0001-9025-436X	Suzhou Science and Technology Development Project [SYS 201526]	Suzhou Science and Technology Development Project	This work was supported by Suzhou Science and Technology Development Project (SYS 201526) to Li Tian. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken LM, 2011, AUST CRIT CARE, V24, P244, DOI 10.1016/j.aucc.2011.01.004; Berger AM, 2010, J NATL COMPR CANC NE, V8, P904, DOI 10.6004/jnccn.2010.0067; Bucknall Tracey, 2006, J Healthc Qual, V28, P12; Campbell J, 1998, DEV SCALE ASSESS CAN; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Cramer H, 2014, EUR J CANCER CARE, V23, P3, DOI 10.1111/ecc.12093; Davis DA, 1997, CAN MED ASSOC J, V157, P408; de Nijs EJM, 2008, CANCER NURS, V31, P191, DOI 10.1097/01.NCC.0000305721.98518.7c; Eisinger F, 1999, LANCET, V353, P919, DOI 10.1016/S0140-6736(98)07516-3; Epstein Dana R, 2007, Oncol Nurs Forum, V34, pE51, DOI 10.1188/07.ONF.E51-E59; Fernandez-Lao C, 2012, EUR J CANCER CARE, V21, P233, DOI 10.1111/j.1365-2354.2011.01306.x; Fineout-Overholt E, 2005, J PROF NURS, V21, P335, DOI 10.1016/j.profnurs.2005.10.005; Gong S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084391; Grant M, 1998, Oncol Nurs Forum, V25, P1404; Greenhalgh T, 2004, SPREAD GOOD IDEAS SY; Horneber M, 2012, DTSCH ARZTEBL INT, V109, P161, DOI 10.3238/arztebl.2012.0161; Huang Y, 2012, CHIN J MOD NURS, V18, P1412; Jean-Pierre P, 2010, CANCER-AM CANCER SOC, V116, P3513, DOI 10.1002/cncr.25083; Jiang M.Y., 2013, CHIN NURS RES, V27, P420, DOI [DOI 10.3969/J.ISSN.1009-6493.2013.05.018, 10.3969/j.issn.1009]; Kitson A, 1998, QUAL HEALTH CARE, V7, P149, DOI 10.1136/qshc.7.3.149; Kitson A., 2013, IMPLEMENT SCI, V8, P54, DOI DOI 10.1186/1748-5908-8-54; Larkin D, 2014, INT J NURS PRACT, V20, P549, DOI 10.1111/ijn.12211; Lee S, 2014, SUPPORT CARE CANCER, V22, P1429, DOI 10.1007/s00520-014-2161-z; Melnyk Bernadette Mazurek, 2002, Reflect Nurs Leadersh, V28, P22; Minton O, 2008, JNCI-J NATL CANCER I, V100, P1155, DOI 10.1093/jnci/djn250; Mishra SI, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008465.pub2; Nicholls M.C., 2014, QUALITATIVE RES PRAC, P177, DOI DOI 10.1186/1745-6215-14-166; OCEBM Levels of evidence working group, 2012, OXFORD 2011 LEVELS E; Oldervoll LM, 2004, EUR J CANCER, V40, P951, DOI 10.1016/j.ejca.2003.12.005; Pearson A, 2005, INT J EVID-BASED HEA, V3, P207, DOI 10.1111/j.1479-6988.2005.00026.x; Garcia VR, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004310.pub3; Rycroft-Malone J, 2004, J NURS CARE QUAL, V19, P297, DOI 10.1097/00001786-200410000-00002; Seyidova-Khoshknabi D, 2011, AM J HOSP PALLIAT ME, V28, P119, DOI 10.1177/1049909110381590; Shun S, 2004, POCKET GUIDE MANAGIN, P91; SIGN, 2019, SIGN 50 GUID DEV HDB; Stone P, 2001, J PAIN SYMPTOM MANAG, V22, P1007, DOI 10.1016/S0885-3924(01)00361-X; Su CX, 2014, COMPLEMENT THER MED, V22, P567, DOI 10.1016/j.ctim.2014.04.007; The Joanna Briggs institute levels of evidence and grades of Recommendation Working Party, 2014, SUPP DOC J BRIGGS I; Thompson DS, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-15; Tian L, 2016, ONCOLOGIST, V21, P1349, DOI 10.1634/theoncologist.2015-0537; Tomlinson D, 2014, AM J PHYS MED REHAB, V93, P675, DOI 10.1097/PHM.0000000000000083; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Vallance JKH, 2007, J CLIN ONCOL, V25, P2352, DOI 10.1200/JCO.2006.07.9988; Van Belle S, 2005, SUPPORT CARE CANCER, V13, P246, DOI 10.1007/s00520-004-0734-y; Waltz C. F., 2016, MEASUREMENT NURSING, DOI DOI 10.1891/9780826170620; Wils J, 2001, ANN ONCOL, V12, P13, DOI 10.1023/A:1008357725209; Zeng YC, 2014, INTEGR CANCER THER, V13, P193, DOI 10.1177/1534735413510024	47	6	7	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187257	10.1371/journal.pone.0187257	http://dx.doi.org/10.1371/journal.pone.0187257			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL2ZD	29088266	Green Published, gold, Green Submitted			2022-12-26	WOS:000414088900056
J	Suen, LKP; Cheng, HL; Yeung, SKW; Au-Yeung, CH; Lee, JCY; Ho, KKY; Lau, NMY; Ng, CKF; Chan, IWS				Suen, Lorna Kwai Ping; Cheng, Hui Lin; Yeung, Simon Kai Wang; Au-Yeung, Cypher Ho; Lee, Jillianne Chi Yen; Ho, Kathy Kit Ying; Lau, Natalie Ming Yan; Ng, Cristina Ka Fu; Chan, Iris Wai Sze			Qualitative insights into the experiences of living with moderate-to-severe lower urinary tract symptoms among community-dwelling ageing males	PLOS ONE			English	Article							BENIGN PROSTATIC HYPERPLASIA; MALE SEXUAL DYSFUNCTION; SEEKING BEHAVIOR; CHRONIC ILLNESS; MEDICAL-CARE; MEN; HEALTH; LUTS; INDIVIDUALS; ASSOCIATION	Background Lower urinary tract symptoms (LUTS) comprise a highly prevalent chronic condition among the aging male population. Existing literature on the experiences of men with LUTS is scarce given that only a few studies explored medical care-seeking behaviors and coping strategies. The current understanding of the experiences of elderly males with LUTS is considerably limited. Therefore, the present study aimed to identify the experiences of living with moderate-to-severe LUTS among community-dwelling Chinese ageing males and their coping strategies to facilitate the management of LUTS by healthcare providers. Methods and findings A qualitative exploratory design using thematic analysis was used. Semi-structured interviews with 24 Chinese ageing males with moderate-to-severe LUTS were conducted. According to the participants, LUTS adversely affect the physical aspects of their daily lives. Most of them were unwilling to seek social support and were even embarrassed to share this topic with their peers. A range of psychological responses could be observed from the participants that range from regarding the condition as a natural life course to loss of one's self-esteem. Most of the interviewees lacked knowledge and held misconceptions toward LUTS, which prevented them from pursuing medical advice. Most of the participants also sought alternative treatments and developed self-help methods to cope with their symptoms. Conclusion LUTS affects the physical and social aspects of sufferers. The findings of this qualitative study can raise awareness about the life experiences, perceptions, misconceptions, and help-seeking behaviors of Chinese elderly with LUTS. Proper health education and advice can be provided for this population.	[Suen, Lorna Kwai Ping; Cheng, Hui Lin; Yeung, Simon Kai Wang; Au-Yeung, Cypher Ho] Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Hong Kong, Peoples R China; [Lee, Jillianne Chi Yen] Tseung Kwan O Hosp, Ambulatory Surg Ctr, Hong Kong, Hong Kong, Peoples R China; [Ho, Kathy Kit Ying] Gleneagles Hong Kong Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Lau, Natalie Ming Yan] Hong Kong Sanat Hosp, Nursing Dept, Hong Kong, Hong Kong, Peoples R China; [Ng, Cristina Ka Fu] Princess Margaret Hosp, Operat Theatre, Hong Kong, Hong Kong, Peoples R China; [Chan, Iris Wai Sze] Princess Margaret Hosp, Dept Med & Geriatr, Hong Kong, Hong Kong, Peoples R China	Hong Kong Polytechnic University	Suen, LKP (corresponding author), Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Hong Kong, Peoples R China.	lorna.suen@polu.edu.hk	Suen, Lorna KP/F-5077-2014	Suen, Lorna KP/0000-0002-0126-6674; Cheng, Huilin/0000-0002-6117-3832	School of Nursing, The Hong Kong Polytechnic University [1-ZVD4]	School of Nursing, The Hong Kong Polytechnic University(Hong Kong Polytechnic University)	This project was supported by the Block Grant (1-ZVD4), School of Nursing, The Hong Kong Polytechnic University.	Abrams P, 2010, NEUROUROL URODYNAM, V29, P213, DOI 10.1002/nau.20870; Andersson SO, 2004, BJU INT, V94, P327, DOI 10.1111/j.1464-410X.2004.04930.x; BARRY MJ, 1992, J UROLOGY, V148, P1549, DOI 10.1016/S0022-5347(17)36966-5; Botelho EM, 2011, QUAL HEALTH RES, V21, P1229, DOI 10.1177/1049732311405682; Boyle P, 2003, BJU INT, V92, P409, DOI 10.1046/j.1464-410X.2003.04369.x; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Coyne KS, 2010, INT J CLIN PRACT, V64, P1260, DOI 10.1111/j.1742-1241.2010.02450.x; CunninghamBurley S, 1996, BRIT J GEN PRACT, V46, P349; de Jong Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101320; Elstad EA, 2011, J CLIN NURS, V20, P156, DOI 10.1111/j.1365-2702.2010.03493.x; Fowke JH, 2013, BJU INT, V111, P122, DOI 10.1111/j.1464-410X.2012.11287.x; Frankel SJ, 1998, J CLIN EPIDEMIOL, V51, P677, DOI 10.1016/S0895-4356(98)00044-4; Gannon K, 2004, J HEALTH PSYCHOL, V9, P411, DOI 10.1177/1359105304042350; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hansen BL, 2004, EUR UROL, V46, P229, DOI 10.1016/j.eururo.2004.04.005; Ho CCK, 2011, ASIAN J ANDROL, V13, P537, DOI 10.1038/aja.2010.135; Holmes-Rovner M, 2006, J GEN INTERN MED, V21, P56, DOI 10.1111/j.1525-1497.2005.0280.x; Huang TT, 2009, GERIATR NURS, V30, P28, DOI 10.1016/j.gerinurse.2008.03.006; Hunter DJW, TREATMENT SEEKING BE; Irwin DE, 2011, BJU INT, V108, P1132, DOI 10.1111/j.1464-410X.2010.09993.x; Jacobs-Lawson JM, 2011, CURR PSYCHOL, V30, P173, DOI 10.1007/s12144-011-9108-z; Jeong WS, 2015, INT NEUROUROL J, V19, P286, DOI 10.5213/inj.2015.19.4.286; Kiviniemi K, 1999, J CLIN NURS, V8, P542, DOI 10.1046/j.1365-2702.1999.00305.x; Lammers HA, 2015, J EVAL CLIN PRACT, V21, P931, DOI 10.1111/jep.12407; Lee Eun Hyun, 2005, Taehan Kanho Hakhoe Chi, V35, P1508; Li M, ASIAN MULTINATIONAL; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Noguchi N, 2016, AGING MALE, V19, P168, DOI 10.3109/13685538.2016.1169399; Patton M. Q, QUALITATIVE RES EVAL, V4th; Pinnock C, 1998, AUST NZ J PUBL HEAL, V22, P368, DOI 10.1111/j.1467-842X.1998.tb01393.x; Ramesh A, 2009, ASIAN J PHARM CLIN R, V2, P97; Rosen R, 2003, EUR UROL, V44, P637, DOI 10.1016/j.eururo.2003.08.015; Russo A, 2016, EXPERT OPIN DRUG SAF, V15, P1661, DOI 10.1080/14740338.2016.1190830; Schulman CC, 2005, EUR UROL SUPPL, V4, P1, DOI 10.1016/j.eursup.2004.10.007; Stebbins R.A, 2001, EXPLORATORY RES SOCI, DOI DOI 10.4135/9781412984249; Taylor J, 2006, BJU INT, V98, P605, DOI 10.1111/j.1464-410X.2006.06377.x; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Wareing M, 2005, J CLIN NURS, V14, P239, DOI 10.1111/j.1365-2702.2004.01003.x; Wein AJ, 2009, BJU INT, V103, P33, DOI 10.1111/j.1464-410X.2009.08447.x; Welch LC, 2011, NURS RES, V60, P165, DOI 10.1097/NNR.0b013e3182159cac; Willams Paora N, 2003, Pac Health Dialog, V10, P71; Wolters R, 2002, BJU INT, V90, P655, DOI 10.1046/j.1464-410X.2002.02996.x; Wong SYS, 2006, J AFFECT DISORDERS, V96, P83, DOI 10.1016/j.jad.2006.05.013; Xianquan S, 2005, J MED FOOD, V8, P413, DOI 10.1089/jmf.2005.8.413; Yan E., 2013, ASIAN J GERONTOL GER, V8, P78; Zhang EQ, 1997, CHINESE MED DIET; Zhang EQ, 1996, HLTH PRESERVATION RE; Zhang H, 2014, INT J NURS PRACT, V20, P530, DOI 10.1111/ijn.12198	48	13	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187085	10.1371/journal.pone.0187085	http://dx.doi.org/10.1371/journal.pone.0187085			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL0OH	29084282	Green Published, Green Submitted, gold			2022-12-26	WOS:000413910200030
J	Kivelitz, L; Kriston, L; Christalle, E; Schulz, H; Watzke, B; Harter, M; Gotzmann, L; Bailee, H; Zahn, S; Melchior, H				Kivelitz, Laura; Kriston, Levente; Christalle, Eva; Schulz, Holger; Watzke, Birgit; Haerter, Martin; Goetzmann, Lutz; Bailee, Harald; Zahn, Sabine; Melchior, Hanne			Effectiveness of telephone-based aftercare case management for adult patients with unipolar depression compared to usual care: A randomized controlled trial	PLOS ONE			English	Article							MENTAL-DISORDERS; HEALTH-CARE; GERMANY; ANXIETY; SERVICES; IMPROVE; BURDEN; COST	Background Patients with depression often have limited access to outpatient psychotherapy following inpatient treatment. The objective of the study was to evaluate the long-term effectiveness of a telephone-based aftercare case management (ACM) intervention for patients with depression. Methods We performed a prospective randomized controlled trial in four psychotherapeutic inpatient care units with N = 199 patients with major depression or dysthymia (F32.x, F33.x, F34.1, according to the ICD-10). The ACM consisted of six phone contacts at two-week intervals performed by trained and certified psychotherapists. The control group received usual care (UC). The primary outcome was depressive symptom severity (BDI-II) at 9-month follow-up, and secondary outcomes were health-related quality of life (SF-8, EQ-5D), self-efficacy (SWE), and the proportion of patients initiating outpatient psychotherapy. Mixed model analyses were conducted to compare improvements between treatment groups. Results Regarding the primary outcome of symptom severity, the groups did not significantly differ after 3 months (p = .132; ES = -0.23) or at the 9-month follow-up (p = .284; ES = -0.20). No significant differences in health-related quality of life or self-efficacy were found between groups. Patients receiving ACM were more likely to be in outpatient psychotherapy after 3 months (OR: 3.00[1.12-8.07]; p = .029) and 9 months (OR: 4.78 [1.55-14.74]; p = .006) than those receiving UC. Conclusions Although telephone-based ACM did not significantly improve symptom severity, it seems to be a valuable approach for overcoming treatment barriers to the clinical pathways of patients with depression regarding their access to outpatient psychotherapy.	[Kivelitz, Laura; Kriston, Levente; Schulz, Holger; Haerter, Martin; Melchior, Hanne] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany; [Watzke, Birgit] Univ Zurich, Inst Psychol, Clin Psychol & Psychotherapy Res, Zurich, Switzerland; [Goetzmann, Lutz] Segeberg Hosp, Dept Psychosomat Med & Psychotherapy, Bad Segeberg, Bad Segeberg, Germany; [Bailee, Harald] Luisenklin Zentrum Verhaltensmed, Bad Durrheim, Germany; [Zahn, Sabine] MediClin Seepark Klin, Fachklin Psychosomat Med & Psychotherapie, Bad Bodenteich, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Zurich	Kivelitz, L (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany.	l.kivelitz@uke.de	Kriston, Levente/D-1713-2013	Kriston, Levente/0000-0003-0748-264X; Harter, Martin/0000-0001-7443-9890	Germany's Federal Ministry of Education and Research; German Federal Pension Fund as part of the research priority 'Chronic Diseases and Patient Orientation';  [0421-FSCP-Z202]	Germany's Federal Ministry of Education and Research; German Federal Pension Fund as part of the research priority 'Chronic Diseases and Patient Orientation'; 	The study was funded by Germany's Federal Ministry of Education and Research and the German Federal Pension Fund as part of the research priority 'Chronic Diseases and Patient Orientation' (http://www.forschung-patientenoriertierung.de/index.php/home.html). The project was competitively adopted based on a detailed research proposal (grant number: 0421-FSCP-Z202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barekatain M, 2014, J RES MED SCI, V19, P240; Baron S, 2011, PSYCHIAT PRAX, V38, P342, DOI 10.1055/s-0030-1266091; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Burcusa SL, 2007, CLIN PSYCHOL REV, V27, P959, DOI 10.1016/j.cpr.2007.02.005; Christensen H, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-25; Collins KA, 2004, CLIN PSYCHOL REV, V24, P583, DOI 10.1016/j.cpr.2004.06.001; Deck R, 2014, REHABILITATION, V53, P305, DOI 10.1055/s-0034-1384594; DGPPNB KBV AWMF AkdA BPtK BApK DAGSHG DEGAM DGPM DGPs DGRW, S3 GUIDL NAT DIS MAN, DOI [10.6101/AZQ/0002622015, DOI 10.6101/AZQ/0002622015]; Dilling H, 1991, INT CLASS DIS; Ellert U, 2005, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V48, P1330, DOI 10.1007/s00103-005-1168-5; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gensichen J, 2006, PSYCHOL MED, V36, P7, DOI 10.1017/S0033291705005568; Gensichen J, 2009, ANN INTERN MED, V151, P369, DOI 10.7326/0003-4819-151-6-200909150-00001; Gilbody S, 2003, JAMA-J AM MED ASSOC, V289, P3145, DOI 10.1001/jama.289.23.3145; Grabe HJ, 2009, SOC PSYCH PSYCH EPID, V44, P835, DOI 10.1007/s00127-009-0005-9; Gunther OH, 2007, PSYCHIAT PRAX, V34, P292, DOI 10.1055/s-2006-940066; Harfst T, 2002, Rehabilitation (Stuttg), V41, P407; Jacobi F, 2014, NERVENARZT, V85, P77, DOI 10.1007/s00115-013-3961-y; Jerusalem M., 1999, SKALEN ERFASSUNG LEH; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kim SE, 2011, AM J MANAG CARE, V17, pE375; Kivelitz L, 2015, PSYCHIAT PRAX, V42, P424, DOI 10.1055/s-0034-1370306; Kivelitz L, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0469-y; Klesse C, 2007, NERVENARZT, V78, P585, DOI 10.1007/s00115-007-2368-z; Kordy H, 2016, PSYCHOTHER PSYCHOSOM, V85, P91, DOI 10.1159/000441951; Lambert M.J., 2013, BERGIN GARFIELDS HDB, V6th ed., P169; Lange M., 2011, PHYS MED REHAB KUROR, V21, P1; Lehmann S, 2010, GESUNDHEITSWESEN, V72, pE33, DOI 10.1055/s-0029-1242769; Mack S, 2014, INT J METHODS PSYCHI; Margraf J., 1994, MINI DIPS DIAGNOSTIS; Reiser A., 2013, THESIS; Rosen CS, 2013, PSYCHIAT SERV, V64, P13, DOI 10.1176/appi.ps.201200142; Schneider S., 2011, DIPS DIAGNOSTISCHES, DOI 10.1007/978-3-642-15529-1; Schulz H, 2011, KLIN PSYCHOL PSYCHOT, P361; Simon GE, 2009, ARCH GEN PSYCHIAT, V66, P1081, DOI 10.1001/archgenpsychiatry.2009.123; van den Berg N, 2015, PSYCHOTHER PSYCHOSOM, V84, P82, DOI 10.1159/000369468; Wang PS, 2007, JAMA-J AM MED ASSOC, V298, P1401, DOI 10.1001/jama.298.12.1401; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P629, DOI 10.1001/archpsyc.62.6.629; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018	41	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186967	10.1371/journal.pone.0186967	http://dx.doi.org/10.1371/journal.pone.0186967			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK9WD	29077724	gold, Green Published, Green Accepted			2022-12-26	WOS:000413861200032
J	Azage, M; Kumie, A; Worku, A; Bagtzoglou, AC; Anagnostou, E				Azage, Muluken; Kumie, Abera; Worku, Alemayehu; Bagtzoglou, Amvrossios C.; Anagnostou, Emmanouil			Effect of climatic variability on childhood diarrhea and its high risk periods in northwestern parts of Ethiopia	PLOS ONE			English	Article							PRECIPITATION PRODUCTS; WEATHER VARIABILITY; RELATIVE-HUMIDITY; RAINFALL; TEMPERATURE; DISEASE; VALIDATION; ROTAVIRUS; SURVIVAL; CHOLERA	Background Increasing climate variability as a result of climate change will be one of the public health challenges to control infectious diseases in the future, particularly in sub-Saharan Africa including Ethiopia. Objective To investigate the effect of climate variability on childhood diarrhea (CDD) and identify high risk periods of diarrheal diseases. Methods The study was conducted in all districts located in three Zones (Awi, West and East Gojjam) of Amhara Region in northwestern parts of Ethiopia. Monthly CDD cases for 24 months (from July 2013 to June 2015) reported to each district health office from the routine surveillance system were used for the study. Temperature, rainfall and humidity data for each district were extracted from satellite precipitation estimates and global atmospheric reanalysis. The space-time permutation scan statistic was used to identify high risk periods of CDD. A negative binomial regression was used to investigate the relationship between cases of CDD and climate variables. Statistical analyses were conducted using SaTScan program and StataSE v. 12. Results The monthly average incidence rate of CDD was 11.4 per 1000 (95% CI 10.8-12.0) with significant variation between males [12.5 per 1000 (95% CI 11.9 to 13.2)] and females [10.2 per 1000 (95% CI 9.6 to 10.8)]. The space-time permutation scan statistic identified the most likely high risk period of CDD between March and June 2014 located in Huletej Enese district of East Gojjam Zone. Monthly average temperature and monthly average rainfall were positively associated with the rate of CDD, whereas the relative humidity was negatively associated with the rate of CDD. Conclusions This study found that the most likely high risk period is in the beginning of the dry season. Climatic factors have an association with the occurrence of CDD. Therefore, CDD prevention and control strategy should consider local weather variations to improve programs on CDD.	[Azage, Muluken] Bahir Dar Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Bahir Dar, Ethiopia; [Azage, Muluken] Addis Ababa Univ, Ethiopian Inst Water Resources, Addis Ababa, Ethiopia; [Kumie, Abera; Worku, Alemayehu] Addis Ababa Univ, Coll Hlth Sci, Sch Publ Hlth, Addis Ababa, Ethiopia; [Bagtzoglou, Amvrossios C.; Anagnostou, Emmanouil] Univ Connecticut, Sch Engn, Dept Civil & Environm Engn, Storrs, CT USA	Bahir Dar University; Addis Ababa University; Addis Ababa University; University of Connecticut	Azage, M (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Bahir Dar, Ethiopia.; Azage, M (corresponding author), Addis Ababa Univ, Ethiopian Inst Water Resources, Addis Ababa, Ethiopia.	mulukenag@yahoo.com	Bagtzoglou, Amvrossios/AAG-6598-2019; Azage, Muluken/AAF-6515-2020; Kumie, Abera/AAC-8537-2022	Azage, Muluken/0000-0003-3222-0158; Bagtzoglou, Amvrossios/0000-0002-4707-4336	Ethiopian Institute of Water Resources Addis Ababa University; Bahir Dar University; University of Connecticut; USAID	Ethiopian Institute of Water Resources Addis Ababa University; Bahir Dar University; University of Connecticut; USAID(United States Agency for International Development (USAID))	The authors would like to acknowledge Ethiopian Institute of Water Resources Addis Ababa University, Bahir Dar University, the University of Connecticut and USAID for funding this research project and their technical support. The authors would like to thank Amhara National Regional State Health Bureau, Zonal Health Offices of Awi and East and West Gojjam and the District Health Office for their cooperation in providing monthly childhood diarrhea.	Alexander KA, 2013, INT J ENV RES PUB HE, V10, P1202, DOI 10.3390/ijerph10041202; Amhara National Regional State Health Bureau, 2010, ANN REP BAH DAR ETH; Amhara National Regional State Health Bureau, 2012, ANN REP BAH DAR ETH; Amhara National Regional State Health Bureau, 2013, ANN REP BAH DAR ETH; Amhara National Regional State Health Bureau, 2011, ANN REP BAH DAR ETH; Amhara National Regional State Health Bureau, 2009, ANN REP BAH DAR ETH; [Anonymous], 1989, APPL LINEAR REGRESSI; Azage M, 2015, CHILDHOOD DIARRHEA E, V10, P12, DOI DOI 10.1371/J0URNAL.P0NE.0144690; Azage M, 2016, J HEALTH POPUL NUTR, V35, DOI 10.1186/s41043-016-0052-2; Bandyopadhyay S, 2012, APPL GEOGR, V33, P63, DOI 10.1016/j.apgeog.2011.07.017; Bentham G, 2001, INT J BIOMETEOROL, V45, P22, DOI 10.1007/s004840000083; Bureau of Finance and Economic Development of Amhara Region, 2014, POP SIZ AMH REG; Campbell-Lendrum D, 2003, CLIMATE CHANGE HLTH; Cardinal M, 1999, STAT MED, V18, P2025, DOI 10.1002/(SICI)1097-0258(19990815)18:15<2025::AID-SIM163>3.3.CO;2-4; Carlton EJ, 2016, INT J EPIDEMIOL, V45, P117, DOI 10.1093/ije/dyv296; Cheung WH, 2008, INT J CLIMATOL, V28, P1723, DOI 10.1002/joc.1623; Chou WC, 2010, SCI TOTAL ENVIRON, V409, P43, DOI 10.1016/j.scitotenv.2010.09.001; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Deribew A, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0112-2; Derin Y, 2016, J HYDROMETEOROL, V17, P1817, DOI 10.1175/JHM-D-15-0197.1; Dinku T, 2007, INT J REMOTE SENS, V28, P1503, DOI 10.1080/01431160600954688; Estrada F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172201; Ethiopian Demographic Health Survey, 2011, ETH DEM HLTH SURV 20; Farag TH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002280; Fewtrell L, 2011, J FLOOD RISK MANAG, V4, P77, DOI 10.1111/j.1753-318X.2011.01092.x; Hair F., 1995, MULTIVARIATE DATA AN, V4th; Hashizume M, 2008, EPIDEMIOLOGY, V19, P103, DOI 10.1097/EDE.0b013e31815c09ea; Hashizume M, 2007, INT J EPIDEMIOL, V36, P1030, DOI 10.1093/ije/dym148; Hirpa FA, 2010, J APPL METEOROL CLIM, V49, P1044, DOI 10.1175/2009JAMC2298.1; Hoque BA, 2006, INT J HYG ENVIR HEAL, V209, P451, DOI 10.1016/j.ijheh.2006.04.008; ICPAC and IGAD, 2007, CLIM CHANG HUM DEV A; IJAZ MK, 1985, CAN J MICROBIOL, V31, P681, DOI 10.1139/m85-129; IPCC, 2007, CONTRIBUTION WORKING; Islam MS, 2009, T ROY SOC TROP MED H, V103, P1165, DOI 10.1016/j.trstmh.2009.04.016; Joyce RJ, 2004, J HYDROMETEOROL, V5, P487, DOI 10.1175/1525-7541(2004)005<0487:CAMTPG>2.0.CO;2; Kelly-Hope LA, 2008, ENVIRON HEALTH PERSP, V116, P7, DOI 10.1289/ehp.9658; Kolstad EW, 2011, ENVIRON HEALTH PERSP, V119, P299, DOI 10.1289/ehp.1002060; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M., 2015, SATSCAN USER GUIDE V; Kulldorff M., 2013, SATSCAN TM SER GUIDE; Levy K, 2009, INT J EPIDEMIOL, V38, P1487, DOI 10.1093/ije/dyn260; Limin W, 2009, 4979 PO RES; Fernandez MAL, 2009, T ROY SOC TROP MED H, V103, P137, DOI 10.1016/j.trstmh.2008.07.017; MARQUARDT DW, 1970, TECHNOMETRICS, V12, P591, DOI 10.2307/1267205; McMichael A. J., 2004, COMP QUANTIFICATION; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; Medina DC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001181; Mellander PE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068461; MOE K, 1982, ARCH VIROL, V72, P179, DOI 10.1007/BF01348963; Moors E, 2013, SCI TOTAL ENVIRON, V22; Motbainor A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133542; Myers MF, 2000, ADV PARASIT, V47, P309, DOI 10.1016/S0065-308X(00)47013-2; Nobre FF, 2001, STAT MED, V20, P3051, DOI 10.1002/sim.963; Onozuka D, 2011, EPIDEMIOL INFECT, V139, P1369, DOI 10.1017/S0950268810002451; Onozuka D, 2010, EPIDEMIOL INFECT, V138, P236, DOI 10.1017/S0950268809990574; Pachauri RK, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, pVII; Pan Y, 2008, EPIDEMIOL INFECT, V136, P421, DOI 10.1017/S095026880700831X; Phung D, 2015, EPIDEMIOL INFECT, V143, P3488, DOI 10.1017/S0950268815000709; Rodell M, 2004, B AM METEOROL SOC, V85, P381, DOI 10.1175/BAMS-85-3-381; Rogerson P.A., 2001, STAT METHODS GEOGRAP; Semenza JC, 2009, LANCET INFECT DIS, V9, P365, DOI 10.1016/S1473-3099(09)70104-5; Tekleaba S, 2013, PHYS CHEM EARTH PT A; Thiemig V, 2012, J HYDROMETEOROL, V13, P1760, DOI 10.1175/JHM-D-12-032.1; Weaver CG, 2015, NEPHROL DIAL TRANSPL, V30, P1244, DOI 10.1093/ndt/gfv071; WHO, 2008, PROT HLTH CLIM CHANG; Xiao GX, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-998; Xie P, 2011, BIAS CORRECTED CMORP; Zeleke T, 2013, THEOR APPL CLIMATOL, V111, P665, DOI 10.1007/s00704-012-0700-4	68	33	34	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186933	10.1371/journal.pone.0186933	http://dx.doi.org/10.1371/journal.pone.0186933			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073259	gold, Green Submitted, Green Published			2022-12-26	WOS:000413845400077
J	Raknes, G; Smabrekke, L				Raknes, Guttorm; Smabrekke, Lars			Low dose naltrexone in multiple sclerosis: Effects on medication use. A quasi-experimental study	PLOS ONE			English	Article							QUALITY-OF-LIFE	Low dose naltrexone (LDN) has become a popular off-label therapy for multiple sclerosis (MS). A few small, randomized studies indicate that LDN may have beneficial effects in MS and other autoimmune diseases. If proven efficacious, it would be a cheap and safe alternative to the expensive treatments currently recommended for MS. We investigated whether a sudden increase in LDN use in Norway in 2013 was followed by changes in dispensing of other medications used to treat MS. We performed a quasi-experimental before-and-after study based on population data from the Norwegian Prescription Database (NorPD). We included all patients that collected at least one LDN prescription in 2013, and had collected at least two medications with a reimbursement code for MS, or collected a medication with MS as the only indication in 2009 or 2010. Outcomes were differences in cumulative dispensed doses and incidence of users of disease modifying MS therapies, and medications used to treat MS symptoms two years before and two years after dispensing the initial LDN prescription. The eligible 341 patients collected 20 921 prescriptions in the observation period. Apart from changes in line with general trends in MS therapy in Norway, there was no difference in neither dispensed cumulative doses or number of prevalent users of MS specific medication. Initiation of LDN was not followed by reductions of other medications used to treat symptoms associated with MS.	[Raknes, Guttorm] Univ Hosp North Norway, Reg Med Informat & Pharmacovigilance Ctr RELIS, Tromso, Norway; [Raknes, Guttorm] Raknes Res, Ulset, Norway; [Smabrekke, Lars] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Pharm, Tromso, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso	Raknes, G (corresponding author), Univ Hosp North Norway, Reg Med Informat & Pharmacovigilance Ctr RELIS, Tromso, Norway.; Raknes, G (corresponding author), Raknes Res, Ulset, Norway.	guttorm.raknes@gmail.com	Raknes, Guttorm/I-2145-2019	Raknes, Guttorm/0000-0002-3376-6761	RELIS North Norway; Arctic University of Norway	RELIS North Norway; Arctic University of Norway	The study was funded by RELIS North Norway and The Arctic University of Norway. The funding organizations had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. We would like to thank Frode Skjold for preparing data files, Pia Simonsen for help with interrupted time series, and Elin Lehnbom for proof reading the manuscript.	Agrawal YP, 2005, MED HYPOTHESES, V64, P721, DOI 10.1016/j.mehy.2004.09.024; Altman DG, 1991, PRACTICAL STAT MED R, V1, P234; Brown N, 2009, MED HYPOTHESES, V72, P333, DOI 10.1016/j.mehy.2008.06.048; Cree BAC, 2010, ANN NEUROL, V68, P145, DOI 10.1002/ana.22006; CureTogether, 2017, MULT SCLER INF TREAT; Furu K., 2008, Norsk Epidemiologi, V18, P129; Garbutt JC, 2010, CURR PHARM DESIGN, V16, P2091; Larochelle C, 2014, MULT SCLER J, V20, P1783, DOI 10.1177/1352458514523692; Minozzi S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001333.pub4; O'Connor AB, 2008, PAIN, V137, P96, DOI 10.1016/j.pain.2007.08.024; Raknes G, 2017, PHARMACOEPIDEM DR S, V26, P685, DOI 10.1002/pds.4201; Raknes G, 2017, PHARMACOEPIDEM DR S, V26, P136, DOI 10.1002/pds.4110; Raknes Guttorm, 2011, Tidsskr Nor Laegeforen, V131, P844, DOI 10.4045/tidsskr.10.1126; Rosner S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001867.pub3; Sharafaddinzadeh N, 2010, MULT SCLER J, V16, P964, DOI 10.1177/1352458510366857; Skard K., 2013, UNKNOWN MED LDN GIVE; Torkildsen O, 2014, NEUROL-NEUROIMMUNOL, V1, DOI 10.1212/NXI.0000000000000025	18	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							e0187423	10.1371/journal.pone.0187423	http://dx.doi.org/10.1371/journal.pone.0187423			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6TA	29099849	Green Published, gold, Green Submitted			2022-12-26	WOS:000414377900019
J	Babo, YD; Alemie, GA; Fentaye, FW				Babo, Yohannes Demissie; Alemie, Getahun Asres; Fentaye, Fasil Walelign			Predictors of first-line antiretroviral therapy failure amongst HIV-infected adult clients at Woldia Hospital, Northeast Ethiopia	PLOS ONE			English	Article							HIV-1-INFECTED ADULTS; VIROLOGICAL RESPONSES; RECOVERY; SUCCESS	Background Due to the limited availability of viral load testing for treatment outcome monitoring in resource limited settings, identifying predictive factors of antiretroviral treatment failure will help in selecting clients who will benefit most from the targeted use of viral load monitoring. Little is known about the predictors of treatment failure in the study area. This study was conducted to determine factors that predict first-line antiretroviral therapy failure among HIV-infected adult clients at Woldia Hospital, Northeast Ethiopia. For this study, antiretroviral therapy treatment failure was defined as the fulfillment of clinical and/or immunological criteria set by WHO. Methods Case-control study was carried out from November to December 2014. Cases were adult clients who were on failing first line regimen and on active follow up while controls were those adult clients on a non-failing first-line regimen for 36 months and above and on active follow up. Data was entered in to Epi Info version 7 and was exported to SPSS version 20 for analysis. Binary logistic regression model was used to identify predictors of ART failure. Results A total of 59 cases and 245 controls were included in the analysis. Sixty three percent of the participants were females and the median age at ART enrollment was 33 years (IQR; 28, 40). The median baseline CD4 count was not significantly different among cases and controls (105 (IQR = 60-174)vs.131 (IQR = 72.5-189.0); p = 0.301). The median peak CD4 count in the failure group (230 (IQR = 123-387)) was significantly low compared to the non-failure group (463 (IQR = 348.5-577)) [p< 0.001]. High peak CD4count (AOR = 0.993; 95% Cl 0.990, 0.996) and longer duration on ART (AOR = 0.923; 95% Cl 0.893, 0.954) were protective of treatment failure. In addition stavudine based regimen (AOR = 3.47; 95% Cl 1.343,10.555), low baseline BMI (AOR = 2.75; 95% Cl 1.012, 7.457), unemployment (AOR = 4.93; 95% Cl 1.493,16.305) and formal educational level (AOR = 5.15; 95% Cl 1.534,17.276) were independently significant predictors of treatment failure. Conclusions In this setting low peak CD4count, shorter duration on first line ART, d4T based regimen, low baseline BMI, unemployment and formal educational level were significantly associated with increased treatment failure. Retaining patients on their initial first line regimen with appropriate follow up and improving their socioeconomic status through various livelihood initiatives should be strengthened.	[Babo, Yohannes Demissie] Management Sci Hlth, Bahirdar, Ethiopia; [Alemie, Getahun Asres] Univ Gondar, Publ Hlth Inst, Coll Med & Hlth Sci, Gondar, Ethiopia; [Fentaye, Fasil Walelign] Wollo Univ, Dept Publ Hlth, Coll Med & Hlth Sci, Dessie, Ethiopia	University of Gondar	Fentaye, FW (corresponding author), Wollo Univ, Dept Publ Hlth, Coll Med & Hlth Sci, Dessie, Ethiopia.	fasil.walelign@wu.edu.et		Fentaye, Fasil Walelign/0000-0001-6567-1129	United States Agency for International Development (USAID) [AID-611-A-11-00006]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This study was made possible by the generous support of the United States Agency for International Development (USAID) under Cooperative Agreement No. AID-611-A-11-00006. The contents are the responsibility of the authors and don't necessarily reflect the views of USAID or the United States Government.	Abdissa A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-181; Agarwal A, 2013, J AIDS CLIN RES, V4, P210, DOI [10.4172/2155-6113.1000210, DOI 10.4172/2155-6113.1000210]; Ahoua L, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-81; Amhara HIV/AIDS Prevention and Control Coordination Office, FACTAND FIG; [Anonymous], 2012, WORLD J AIDS, DOI DOI 10.4236/WJA.2012.24036; Anude CJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-113; Assefa A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-468; Assefa Y, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-81; Bennett DE, 2008, ANTIVIR THER, V13, P1; Cozzi-Lepri A, 2012, HIV MED, V13, P62, DOI 10.1111/j.1468-1293.2011.00943.x; CSA ICF, 2012, ETH DEM HLTH SURV 20; Datay MI, 2010, JAIDS-J ACQ IMM DEF, V54, P489, DOI 10.1097/QAI.0b013e3181d91788; Dragsted UB, 2004, J INFECT DIS, V190, P148, DOI 10.1086/420786; EHNRI, 2013, HIV DRUG RES HIVDR E; Federal HAPCO, 2014, COUNTR PROGR REP HIV; Ferreyra C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049834; FMOH, 2008, GUID MAN OPP INF ANT; Gilks C, 2006, AIDS, V20, P1391; Greig JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071407; Harries AD, 2010, LANCET INFECT DIS, V10, P60, DOI 10.1016/S1473-3099(09)70321-4; Hassan AS, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-9; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Kassa D, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-18; Khienprasit N, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-42; Kifle M., 2013, FMOH VIR LOAD COST P; Lawn SD, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-59; Meriki HD, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-5; Misgena DK, 2011, ETHIOP J HEALTH DEV, V25, P61; Mulu A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-28; Murri R, 2014, J GEN INTERN MED, V19, P104; Palladino C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082718; Palmisano L, 2011, ANN I SUPER SANITA, V47, P44, DOI 10.4415/ANN_11_01_10; Peltzer K, 2013, J HEALTH POPUL NUTR, V31, P150; Penot P, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18646; Prabhakar B, 2011, Indian J Sex Transm Dis AIDS, V32, P94, DOI 10.4103/0253-7184.85412; Rajasekaran S, 2007, AIDS, V21, pS47, DOI 10.1097/01.aids.0000279706.24428.78; Rawizza HE, 2011, CLIN INFECT DIS, V53, P1283, DOI 10.1093/cid/cir729; Stafford K, 4 IAS C HIV PATH TRE; Teshome W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115125; UNAIDS, 2016, UNAIDS PREV GAP REP; WHO, 2013, GLOB UPD HIV TREATM; Woldia Hospital, 2014, MONTHL FAC ART REP; World Health Organisation, 2007, WHO CAS DEF HIV SURV; World Health Organization (WHO), 2012, HIV DRUG RES REP; Yayehirad Alemu Melsew, 2013, Journal of AIDS and Clinical Research, V4, P211	45	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187694	10.1371/journal.pone.0187694	http://dx.doi.org/10.1371/journal.pone.0187694			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095936	Green Submitted, Green Published, gold			2022-12-26	WOS:000414340200128
J	Sabljic, I; Mestrovic, N; Vukelic, B; Macheroux, P; Gruber, K; Luic, M; Abramic, M				Sabljic, Igor; Mestrovic, Nevenka; Vukelic, Bojana; Macheroux, Peter; Gruber, Karl; Luic, Marija; Abramic, Marija			Crystal structure of dipeptidyl peptidase III from the human gut symbiont Bacteroides thetaiotaomicron	PLOS ONE			English	Article							PROTEIN-STRUCTURE; DOMAIN MOTIONS; REFINEMENT; MECHANISM; ALIGNMENT; REVEALS; INSIGHT; MODE	Bacteroides thetaiotaomicron is a dominant member of the human intestinal microbiome. The genome of this anaerobe encodes more than 100 proteolytic enzymes, the majority of which have not been characterized. In the present study, we have produced and purified recombinant dipeptidyl peptidase 111 (DPP III) from B. thetaiotaomicron for the purposes of biochemical and structural investigations. DPP III is a cytosolic zinc-metallopeptidase of the M49 family, involved in protein metabolism. The biochemical results for B. thetaiotaomicron DPP III from our research showed both some similarities to, as well as certain differences from, previously characterised yeast and human DPP III. The 3D-structure of B. thetaiotaomicron DPP III was determined by X-ray crystallography and revealed a two-domain protein. The ligand-free structure (refined to 2.4 A) was in the open conformation, while in the presence of the hydroxamate inhibitor Tyr-Phe-NHOH, the closed form (refined to 3.3 A) was observed. Compared to the closed form, the two domains of the open form are rotated away from each other by about 28 degrees. A comparison of the crystal structure of B. thetaiotaomicron DPP III with that of the human and yeast enzymes revealed a similar overall fold. However, a significant difference with functional implications was discovered in the upper domain, farther away from the catalytic centre. In addition, our data indicate that large protein flexibility might be conserved in the M49 family.	[Sabljic, Igor; Luic, Marija] Rudjer Boskovic Inst, Div Phys Chem, Zagreb, Croatia; [Mestrovic, Nevenka] Rudjer Boskovic Inst, Div Mol Biol, Zagreb, Croatia; [Vukelic, Bojana; Abramic, Marija] Rudjer Boskovic Inst, Div Organ Chem & Biochem, Zagreb, Croatia; [Macheroux, Peter] Graz Univ Technol, Inst Biochem, Graz, Austria; [Gruber, Karl] Karl Franzens Univ Graz, Inst Mol Biosci, Graz, Austria	Rudjer Boskovic Institute; Rudjer Boskovic Institute; Rudjer Boskovic Institute; Graz University of Technology; University of Graz	Sabljic, I (corresponding author), Rudjer Boskovic Inst, Div Phys Chem, Zagreb, Croatia.; Abramic, M (corresponding author), Rudjer Boskovic Inst, Div Organ Chem & Biochem, Zagreb, Croatia.	isabljic@irb.hr; abramic@irb.hr	Macheroux, Peter/AAB-5157-2019; Gruber, Karl/GPP-6706-2022	Macheroux, Peter/0000-0002-0242-454X; Gruber, Karl/0000-0002-3485-9740; Sabljic, Igor/0000-0001-9044-2678	Croatian Ministry of Science, Education and Sport [098-1191344-2938]; European Community's Seventh Framework Programme (FP7) under BioStruct-X [283570]; European Community's Seventh Framework Programme under New Molecular Solutions in Research and Development for Innovative Drugs [lnnoMol-FP7-REGPOT-2012-2013-1, 316289]; Austrian Science Funds (FWF) [W901]; DK "Molecular Enzymology", Austrian Exchange Service (OeAD) within the Scientific & Technological Cooperation (WTZ) [HR 09/2012, HR 06/2016]	Croatian Ministry of Science, Education and Sport(Ministry of Science, Education and Sports, Republic of Croatia); European Community's Seventh Framework Programme (FP7) under BioStruct-X; European Community's Seventh Framework Programme under New Molecular Solutions in Research and Development for Innovative Drugs; Austrian Science Funds (FWF)(Austrian Science Fund (FWF)); DK "Molecular Enzymology", Austrian Exchange Service (OeAD) within the Scientific & Technological Cooperation (WTZ)	This work has been supported by: Croatian Ministry of Science, Education and Sport (project 098-1191344-2938 to MA; https://mzo.hr/en), the European Community's Seventh Framework Programme (FP7/2007-2013) under BioStruct-X (grant agreement no. 283570 to ML; https:/www.biostruct-x.eu), the European Community's Seventh Framework Programme under New Molecular Solutions in Research and Development for Innovative Drugs (lnnoMol-FP7-REGPOT-2012-2013-1, grant agreement number 316289; www.innomol.eu), Austrian Science Funds (FWF) http://www.fwf.ac.at/en/, project: W901 (to KG), DK "Molecular Enzymology", Austrian Exchange Service (OeAD) through grants HR 09/2012 (to PM) and HR 06/2016 (to KG) within the Scientific & Technological Cooperation (WTZ) between Austria and Croatia (https://www.bmbf.de/en/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMIC M, 1988, BIOL CHEM H-S, V369, P29, DOI 10.1515/bchm3.1988.369.1.29; Abramic M, 2004, PERIOD BIOL, V106, P161; Abramic M, 2015, BIOL CHEM, V396, P359, DOI 10.1515/hsz-2014-0247; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baral PK, 2008, J BIOL CHEM, V283, P22316, DOI 10.1074/jbc.M803522200; Bezerra GA, 2012, P NATL ACAD SCI USA, V109, P6525, DOI 10.1073/pnas.1118005109; BUDISA N, 1995, EUR J BIOCHEM, V230, P788; Chen J.M., 2004, HDB PROTEOLYTIC ENZY, P809, DOI 10.1016/B978-0-12-079611-3.50247-0; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Corel Corporation., 2003, CORELDRAW 12; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Cvitesic A, 2016, J ENZYM INHIB MED CH, V31, P40, DOI 10.1080/14756366.2016.1186021; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fukasawa K, 1998, BIOCHEM J, V329, P275, DOI 10.1042/bj3290275; Fukasawa K, 1999, BIOCHEMISTRY-US, V38, P8299, DOI 10.1021/bi9904959; Gacesa R, 2015, FREE RADICAL BIO MED, V88, P373, DOI 10.1016/j.freeradbiomed.2015.06.015; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hast BE, 2013, CANCER RES, V73, P2199, DOI 10.1158/0008-5472.CAN-12-4400; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Hayward S, 1997, PROTEINS, V27, P425, DOI 10.1002/(SICI)1097-0134(199703)27:3<425::AID-PROT10>3.0.CO;2-N; Jajcannin-Jozic N, 2013, BIOL CHEM, V394, P767, DOI 10.1515/hsz-2012-0347; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karacic Z, 2012, BIOL CHEM, V393, P1523, DOI 10.1515/hsz-2012-0181; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kumar P, 2016, SCI REP-UK, V6, DOI 10.1038/srep23787; Liu YX, 2007, P NATL ACAD SCI USA, V104, P5205, DOI 10.1073/pnas.0700898104; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Toole GA, 2016, J BACTERIOL, V198, P2763, DOI 10.1128/JB.00615-16; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Rambaut A, 2012, FIGTREE TREE FIGURE; Rawlings ND, 2016, NUCLEIC ACIDS RES, V44, pD343, DOI 10.1093/nar/gkv1118; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Spoljaric J, 2009, BIOORG CHEM, V37, P70, DOI 10.1016/j.bioorg.2009.03.002; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vukelic B, 2012, BIOL CHEM, V393, P37, DOI 10.1515/BC-2011-193; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029	42	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187295	10.1371/journal.pone.0187295	http://dx.doi.org/10.1371/journal.pone.0187295			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095893	Green Published, Green Submitted, gold			2022-12-26	WOS:000414340200066
J	Mayfield, AB; Chen, CS; Dempsey, AC				Mayfield, Anderson B.; Chen, Chii-Shiarng; Dempsey, Alexandra C.			Biomarker profiling in reef corals of Tonga's Ha'apai and Vava'u archipelagos	PLOS ONE			English	Article							GENE-EXPRESSION; BUILDING CORAL; POCILLOPORA-DAMICORNIS; ELEVATED-TEMPERATURE; PROTEIN; PHYSIOLOGY; ANTHOZOAN; STRESS; SYSTEM; HEALTH	Given the significant threats towards Earth's coral reefs, there is an urgent need to document the current physiological condition of the resident organisms, particularly the reef building scleractinians themselves. Unfortunately, most of the planet's reefs are understudied, and some have yet to be seen. For instance, the Kingdom of Tonga possesses an extensive reef system, with thousands of hectares of unobserved reefs; little is known about their ecology, nor is there any information on the health of the resident corals. Given such knowledge deficiencies, 59 reefs across three Tongan archipelagos were surveyed herein, and pocilloporid corals were sampled from approximately half of these surveyed sites; 10 molecular-scale response variable were assessed in 88 of the sampled colonies, and 12 colonies were found to be outliers based on employment of a multivariate statistics-based aberrancy detection system. These outliers differed from the statistically normally behaving colonies in having not only higher RNA/DNA ratios but also elevated expression levels of three genes: 1) Symbiodinium zinc-induced facilitator-like 1-like, 2) host coral copper-zinc superoxide dismutase, and 3) host green fluorescent protein-like chromoprotein. Outliers were also characterized by significantly higher variation amongst the molecular response variables assessed, and the response variables that contributed most significantly to colonies being delineated as outliers differed between the two predominant reef coral species sampled, Pocillopora damicornis and P. acuta. These closely related species also displayed dissimilar temporal fluctuation patterns in their molecular physiologies, an observation that may have been driven by differences in their feeding strategies. Future works should attempt to determine whether corals displaying statistically aberrant molecular physiology, such as the 12 Tongan outliers identified herein, are indeed characterized by a diminished capacity for acclimating to the rapid changes in their abiotic milieu occurring as a result of global climate change.	[Mayfield, Anderson B.; Chen, Chii-Shiarng] Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan; [Mayfield, Anderson B.; Dempsey, Alexandra C.] Khaled bin Sultan Living Oceans Fdn, Annapolis, MD USA; [Mayfield, Anderson B.; Chen, Chii-Shiarng] Taiwan Coral Res Ctr, Pingtung, Taiwan; [Chen, Chii-Shiarng] Natl Dong Hwa Univ, Grad Inst Marine Biotechnol, Pingtung, Taiwan; [Chen, Chii-Shiarng] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung, Taiwan	National Museum of Marine Biology & Aquarium; National Dong Hwa University; National Sun Yat Sen University	Mayfield, AB (corresponding author), Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan.; Mayfield, AB (corresponding author), Khaled bin Sultan Living Oceans Fdn, Annapolis, MD USA.; Mayfield, AB (corresponding author), Taiwan Coral Res Ctr, Pingtung, Taiwan.	andersonblairmayfield@gmail.com		Mayfield, Anderson/0000-0003-0138-7844	Khaled bin Sultan Living Oceans Foundation as part of their Global Reef Expedition	Khaled bin Sultan Living Oceans Foundation as part of their Global Reef Expedition	This work was funded exclusively by the Khaled bin Sultan Living Oceans Foundation as part of their Global Reef Expedition. This included a postdoctoral research fellowship to ABM. The funder had no influence on the interpretation of the data, though one author (ACD) is an employee of the funding institution (a non-profit NGO).	Barshis DJ, 2013, P NATL ACAD SCI USA, V110, P1387, DOI 10.1073/pnas.1210224110; Chen HK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132519; Chen WNU, 2016, PEERJ, V4, DOI 10.7717/peerj.2358; Clarke KR, 1994, CHANGE MARINE COMMUN; Correa AMS, 2009, MAR BIOL, V156, P2403, DOI 10.1007/s00227-009-1263-5; Downs CA, 2005, MAR POLLUT BULL, V51, P558, DOI 10.1016/j.marpolbul.2005.04.017; Downs CA, 2000, MAR BIOTECHNOL, V2, P533, DOI 10.1007/s101260000038; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Feder M.E., 1996, Society for Experimental Biology Seminar Series, V59, P79; Furla P, 2005, INTEGR COMP BIOL, V45, P595, DOI 10.1093/icb/45.4.595; GATES RD, 1990, CORAL REEFS, V8, P193, DOI 10.1007/BF00265010; Grottoli AG, 2004, MAR BIOL, V145, P621, DOI 10.1007/s00227-004-1337-3; Haydon MJ, 2007, PLANT PHYSIOL, V143, P1705, DOI 10.1104/pp.106.092015; Ho JWK, 2008, BIOINFORMATICS, V24, pI390, DOI 10.1093/bioinformatics/btn142; Hochachka P. W., 2002, BIOCH ADAPTATION; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Huang YCA, 2011, MAR ECOL PROG SER, V423, P83, DOI 10.3354/meps08944; Lesser MP, 1996, LIMNOL OCEANOGR, V41, P271, DOI 10.4319/lo.1996.41.2.0271; Liu PJ, 2012, MAR POLLUT BULL, V64, P1129, DOI 10.1016/j.marpolbul.2012.03.031; Mayfield AB, 2013, CORAL REEFS, V32, P909, DOI 10.1007/s00338-013-1067-4; Mayfield AB, 2014, INT J MARINE SCI, V4, P1, DOI DOI 10.5376/IJMS.2014.04.0050; Mayfield AB, 2016, CORAL REEFS ECOSYSTE, P13; Mayfield AB, PLATAX IN PRESS; Mayfield AB, 2007, COMP BIOCHEM PHYS A, V147, P1, DOI 10.1016/j.cbpa.2006.12.042; Mayfield AB, 2016, J MAR SCI ENG, V4, DOI 10.3390/jmse4030063; Mayfield Anderson B., 2016, Platax, V13, P1; Mayfield AB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177267; Mayfield Anderson B., 2015, Platax, V12, P1; Mayfield AB, 2016, MOL ECOL, V25, P5944, DOI 10.1111/mec.13896; Mayfield Anderson B., 2014, Platax, V11, P1; Mayfield Anderson B., 2013, Platax, V10, P1; Mayfield AB, 2014, MOL ECOL, V23, P5816, DOI 10.1111/mec.12982; Mayfield AB, 2014, MAR BIOTECHNOL, V16, P371, DOI 10.1007/s10126-014-9558-z; Mayfield Anderson B., 2012, Platax, V9, P1; Mayfield AB, 2013, MAR ENVIRON RES, V86, P1, DOI 10.1016/j.marenvres.2013.01.004; Mayfield AB, 2012, J EXP BIOL, V215, P4183, DOI 10.1242/jeb.071688; Mayfield AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026529; Mayfield AB, 2010, J EXP MAR BIOL ECOL, V395, P215, DOI 10.1016/j.jembe.2010.09.007; Mayfield AB, 2009, MOL ECOL RESOUR, V9, P462, DOI 10.1111/j.1755-0998.2008.02349.x; Peng SE, 2011, PROTEOMICS, V11, P3540, DOI 10.1002/pmic.201000552; Putnam HM, 2013, MAR BIOL, V160, P2157, DOI 10.1007/s00227-012-2129-9; Rinkevich B, 2005, ENVIRON SCI TECHNOL, V39, P4333, DOI 10.1021/es0482583; Saul S, 2015, REMOTE SENS-BASEL, V7, P15894, DOI 10.3390/rs71215810; Schmidt-Roach S, 2014, ZOOL J LINN SOC-LOND, V170, P1, DOI 10.1111/zoj12092; Smith EG, 2013, CORAL REEFS, V32, P463, DOI 10.1007/s00338-012-0994-9; Sokal RR, 1995, BIOMETRY; Traylor-Knowles N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-585; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700	48	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0185857	10.1371/journal.pone.0185857	http://dx.doi.org/10.1371/journal.pone.0185857			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091723	Green Published, gold, Green Submitted			2022-12-26	WOS:000414229700011
J	Das, A; Ranganathan, V; Umar, D; Thukral, S; George, A; Rath, S; Bal, V				Das, Arundhoti; Ranganathan, Vidya; Umar, Danish; Thukral, Shipra; George, Anna; Rath, Satyajit; Bal, Vineeta			Effector/memory CD4 T cells making either Th1 or Th2 cytokines commonly co-express T-bet and GATA-3	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; IN-VITRO; GENE-EXPRESSION; PHENOTYPE DEVELOPMENT; HELPER-CELLS; EX-VIVO; DIFFERENTIATION; POLARIZATION; RESPONSES; NAIVE	Naive CD4 T (NCD4T) cells post-activation undergo programming for inducible production of cytokines leading to generation of memory cells with various functions. Based on cytokine based polarization of NCD4T cells in vitro, programming for either 'Th1' (interferon-gamma [IFNg]) or 'Th2' (interleukin [IL]-4/5/13) cytokines is thought to occur via mutually exclusive expression and functioning of T-bet or GATA-3 transcription factors (TFs). However, we show that a high proportion of mouse and human memory-phenotype CD4 T (MCD4T) cells generated in vivo which expressed either Th1 or Th2 cytokines commonly co-expressed T-bet and GATA-3. While T-bet levels did not differ between IFNg-expressing and IL-4/5/13-expressing MCD4T cells, GATA-3 levels were higher in the latter. These observations were also confirmed in MCD4T cells from FVB/NJ or aged C57BL/6 or IFNg-deficient mice. While MCD4T cells from these strains showed greater Th2 commitment than those from young C57BL/6 mice, pattern of co-expression of TF was similar. Effector T cells generated in vivo following immunization also showed TF co-expression in Th1 or Th2 cytokine producing cells. We speculated that the difference in TF expression pattern of MCD4T cells generated in vivo and those generated in cytokine polarized cultures in vitro could be due to relative absence of polarizing conditions during activation in vivo. We tested this by NCD4T cell activation in non-polarizing conditions in vitro. Anti-CD3 and anti-CD28-mediated priming of polyclonal NCD4T cells in vitro without polarizing milieu generated cells that expressed either IFNg or IL-4/5/13 but not both, yet both IFNg-and IL-4/5/13-expressing cells showed upregulation of both TFs. We also tested monoclonal T cell populations activated in non-polarizing conditions. TCR-transgenic NCD4T cells primed in vitro by cognate peptide in non-polarizing conditions which expressed either IFNg or IL-4/5/13 also showed a high proportion of cells co-expressing TFs, and their cytokine commitment varied depending on genetic background or priming conditions, without altering pattern of TF co-expression. Thus, the model of mutually antagonistic differentiation programs driven by mutually exclusively expressed T-bet or GATA-3 does not completely explain natural CD4 T cell priming outcomes.	[Das, Arundhoti; Ranganathan, Vidya; Umar, Danish; Thukral, Shipra; George, Anna; Rath, Satyajit; Bal, Vineeta] Natl Inst Immunol, New Delhi, India; [Thukral, Shipra] BD Diagnost, Bd, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Bal, V (corresponding author), Natl Inst Immunol, New Delhi, India.	vineeta@nii.res.in		Bal, Vineeta/0000-0002-8995-2045	Department of Biotechnology, Government of India [BT/PR5138/BRB/10/1064/2012, BT/PR14592/BRB/10/858/2010, BT/PR7012/BRB/1159/2012]; Science and Engineering Research Board, Department of Science and Technology, Government of India [SR/SO/BB-0035/2013, SB/SO/HS/210/2013, SR/SO/HS-0005/2011, EMR/2015/001074]; Council for Scientific and Industrial Research, Government of India; Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Science and Engineering Research Board, Department of Science and Technology, Government of India; Council for Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported in part by grants from the Department of Biotechnology, Government of India (to A.G. # BT/PR5138/BRB/ 10/1064/2012, to S.R. # BT/PR14592/BRB/10/858/ 2010, to V.B. # BT/PR7012/BRB/1159/2012); the Science and Engineering Research Board, Department of Science and Technology, Government of India (to A.G. # SR/SO/BB-0035/2013, S.R. # SB/SO/HS/210/2013, to V.B. #SR/SO/HS-0005/2011, EMR/2015/001074); and a fellowship from the Council for Scientific and Industrial Research, Government of India to A.D. and D.U. The National Institute of Immunology is supported by the Department of Biotechnology, Government of India. There were no sponsors for this work. Funding agencies had no role in either conceptualization or implementation of the work.	Antebi YE, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001616; Becattini S, 2015, SCIENCE, V347, P400, DOI 10.1126/science.1260668; Ben-Sasson SZ, 2000, EUR J IMMUNOL, V30, P1308, DOI 10.1002/(SICI)1521-4141(200005)30:5<1308::AID-IMMU1308>3.0.CO;2-I; Bian Y, 2005, INT IMMUNOL, V17, P73, DOI 10.1093/intimm/dxh188; Brewer JP, 1999, AM J RESP CRIT CARE, V160, P1150, DOI 10.1164/ajrccm.160.4.9806034; Califano D, 2014, J CLIN INVEST, V124, P174, DOI 10.1172/JCI70103; Chaudhry A, 2009, J IMMUNOL, V183, P2415, DOI 10.4049/jimmunol.0804014; Cimmino L, 2008, J IMMUNOL, V181, P2338, DOI 10.4049/jimmunol.181.4.2338; Corthay A, 2006, SCAND J IMMUNOL, V64, P93, DOI 10.1111/j.1365-3083.2006.01782.x; Cosmi L, 2010, J ALLERGY CLIN IMMUN, V125, P222, DOI 10.1016/j.jaci.2009.10.012; Deng YP, 2004, J IMMUNOL, V172, P3437, DOI 10.4049/jimmunol.172.6.3437; Dong C, 2000, Sci STKE, V2000, ppe1, DOI 10.1126/stke.2000.49.pe1; Garlanda C, 2009, TRENDS IMMUNOL, V30, P439, DOI 10.1016/j.it.2009.06.001; Hata M, 2009, IMMUNOL LETT, V126, P29, DOI 10.1016/j.imlet.2009.07.008; Hegazy AN, 2010, IMMUNITY, V32, P116, DOI 10.1016/j.immuni.2009.12.004; Hirata M, 2001, PARASITE IMMUNOL, V23, P271, DOI 10.1046/j.1365-3024.2001.00382.x; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; HSIEH CS, 1995, J EXP MED, V181, P713, DOI 10.1084/jem.181.2.713; Iezzi G, 1999, EUR J IMMUNOL, V29, P4092, DOI 10.1002/(SICI)1521-4141(199912)29:12<4092::AID-IMMU4092>3.3.CO;2-1; Jenner RG, 2009, P NATL ACAD SCI USA, V106, P17876, DOI 10.1073/pnas.0909357106; Kanhere A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2260; KELSO A, 1988, P NATL ACAD SCI USA, V85, P9189, DOI 10.1073/pnas.85.23.9189; Lai W, 2011, J IMMUNOL, V187, P133, DOI 10.4049/jimmunol.1002742; Lexberg MH, 2010, EUR J IMMUNOL, V40, P3017, DOI 10.1002/eji.201040539; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Liew FY, 2002, NAT REV IMMUNOL, V2, P55, DOI 10.1038/nri705; Lin JX, 2012, IMMUNITY, V36, P586, DOI 10.1016/j.immuni.2012.02.017; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohning M, 1999, J IMMUNOL, V162, P3882; McAlees JW, 2015, EUR J IMMUNOL, V45, P1019, DOI 10.1002/eji.201444778; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Mudter J, 2003, INFLAMM BOWEL DIS, V9, P332, DOI 10.1097/00054725-200309000-00008; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; O'Garra A, 2016, J IMMUNOL, V196, P4423, DOI 10.4049/jimmunol.1600646; Oestreich KJ, 2012, NAT REV IMMUNOL, V12, P799, DOI 10.1038/nri3321; Okamoto M, 2009, NAT IMMUNOL, V10, P872, DOI 10.1038/ni.1747; OPENSHAW P, 1995, J EXP MED, V182, P1357, DOI 10.1084/jem.182.5.1357; Owaki T, 2006, J IMMUNOL, V177, P7579, DOI 10.4049/jimmunol.177.11.7579; Park HR, 2011, CELL IMMUNOL, V267, P1, DOI 10.1016/j.cellimm.2010.10.004; Pearson-White S, 2003, MOL CELL BIOL, V23, P5446, DOI 10.1128/MCB.23.15.5446-5459.2003; Peck A, 2010, IMMUNOLOGY, V129, P147, DOI 10.1111/j.1365-2567.2009.03189.x; Peine M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001633; Preusse C, 2012, AM J PATHOL; Rane S, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0106-0; Rengarajan J, 2000, IMMUNOL TODAY, V21, P479, DOI 10.1016/S0167-5699(00)01712-6; Rhodes SG, 2002, TRENDS IMMUNOL, V23, P246, DOI 10.1016/S1471-4906(02)02200-7; Rogers PR, 2000, J IMMUNOL, V164, P2955, DOI 10.4049/jimmunol.164.6.2955; ROMAGNANI S, 1991, INT J CLIN LAB RES, V21, P152; Saini AS, 2014, NAT IMMUNOL; Smits HH, 2002, J IMMUNOL, V168, P1710, DOI 10.4049/jimmunol.168.4.1710; Tumes DJ, 2013, IMMUNITY, V39, P819, DOI 10.1016/j.immuni.2013.09.012; Upadhyay M, 2014, J CELL PHYSL; Wang ZE, 1994, J EXP MED, V179; Wesa A, 2007, J IMMUNOTHER, V30, P75, DOI 10.1097/01.cji.0000211316.15278.6e; Whitehead GS, 2003, AM J PHYSIOL-LUNG C, V285, pL32, DOI 10.1152/ajplung.00390.2002; Yagi J, 2006, INT IMMUNOL, V18, P1681, DOI 10.1093/intimm/dxl102; Yagi R, 2011, INT IMMUNOL, V23, P415, DOI 10.1093/intimm/dxr029; YANG DM, 1991, IMMUNOLOGY, V72, P3; Zhu JF, 2012, IMMUNITY, V37, P660, DOI 10.1016/j.immuni.2012.09.007; Zhu JF, 2010, IMMUNOL REV, V238, P247, DOI 10.1111/j.1600-065X.2010.00951.x; Zhu JF, 2010, IMMUNITY, V32, P11, DOI 10.1016/j.immuni.2010.01.001; Zygmunt B, 2011, ADV IMMUNOL, V109, P159, DOI 10.1016/B978-0-12-387664-5.00005-4	63	10	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0185932	10.1371/journal.pone.0185932	http://dx.doi.org/10.1371/journal.pone.0185932			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088218	Green Published, Green Submitted, gold			2022-12-26	WOS:000414088900006
J	Lee, JS; Seo, H; Im, K; Park, SN; Kim, SM; Lee, EK; Kim, JA; Lee, JH; Kwon, S; Kim, M; Koh, I; Hwang, S; Park, HW; Kang, HR; Park, KS; Kim, JH; Lee, DS				Lee, Jee-Soo; Seo, Heewon; Im, Kyongok; Park, Si Nae; Kim, Sung-Min; Lee, Eun Kyoung; Kim, Jung-Ah; Lee, Joon-hee; Kwon, Sunghoon; Kim, Miyoung; Koh, Insong; Hwang, Seungwoo; Park, Heung-Woo; Kang, Hye-Ryun; Park, Kyoung Soo; Kim, Ju Han; Lee, Dong Soon			Idiopathic hypereosinophilia is clonal disorder? Clonality identified by targeted sequencing	PLOS ONE			English	Article							EOSINOPHILIA; MUTATIONS; LEUKEMIA; ABNORMALITIES; NEOPLASMS; DIAGNOSIS; FRAMEWORK; PDGFRB; SIFT	Idiopathic hypereosinophilia (IHE)/idiopathic hypereosinophilic syndrome (IHES) has been defined by a persistent elevation of the blood eosinophil count exceeding 1.5x10(3)/mu L, without evidence of reactive or clonal causes. While T-cell clonality assessment has been recommended for unexplained hypereosinophilia, this approach is not often applied to routine practice in the clinic. We hypothesized that the clonality would exist in a subset of IHE/IHES patients. We aimed to investigate the candidate mutations and T-cell clonality in IHE/IHES and to explore the role of mutations in eosinophil proliferation. We performed targeted capture sequencing for 88 genes using next-generation sequencing, T-cell receptor (TCR) gene rearrangement assays, and pathway network analysis in relation to eosinophil proliferation. By targeted sequencing, 140 variants in 59 genes were identified. Sixteen out of 30 patients (53.3%) harbored at least one candidate mutation. The most frequently affected genes were NOTCH1 (26.7%), SCRIB and STAG2 (16.7%), and SH2B3 (13.3%). Network analysis revealed that our 21 candidate genes (BIRC3, BRD4, CSF3R, DNMT3A, EGR2, EZH2, FAT4, FLT3, GATA2, IKZF, JAK2, MAPK1, MPL, NF1, NOTCH1, PTEN, RB1, RUNX1, TET2, TP53 and WT1) are functionally linked to the eosinophilopoietic pathway. Among the 21 candidate genes, five genes (MAPK1, RUNX1, GATA2, NOTCH1 and TP53) with the highest number of linkages were considered major genes. A TCR assay revealed that four patients (13.3%) had a clonal TCR rearrangement. NOTCH1 was the most frequently mutated gene and was shown to be a common node for eosinophilopoiesis in our network analysis, while the possibility of hidden T cell malignancy was indwelling in the presence of NOTCH1 mutation, though not revealed by aberrant T cell study. Collectively, these results provide new evidence that mutations affecting eosinophilopoiesis underlie a subset of IHE/IHES, and the candidate genes are inferred to act their potential roles in the eosino-philopoietic pathway.	[Lee, Jee-Soo; Kim, Jung-Ah; Lee, Joon-hee; Lee, Dong Soon] Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Seo, Heewon; Kim, Ju Han] Seoul Natl Univ, Coll Med, Div Biomed Informat, SNUBI, Seoul, South Korea; [Seo, Heewon; Kim, Ju Han] Seoul Natl Univ, Coll Med, Div Biomed Informat, Syst Biomed Informat Natl Core Res Ctr, Seoul, South Korea; [Im, Kyongok; Park, Si Nae; Kim, Sung-Min; Lee, Eun Kyoung; Lee, Dong Soon] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Kwon, Sunghoon] Seoul Natl Univ, Dept Elect Engn, Seoul, South Korea; [Lee, Jee-Soo; Kim, Miyoung] Hallym Univ, Sacred Heart Hosp, Dept Lab Med, Anyang, South Korea; [Koh, Insong] Hanyang Univ, Coll Med, Dept Physiol, Seoul, South Korea; [Hwang, Seungwoo] KRIBB, Korean Bioinformat Ctr KOBIC, Daejeon, South Korea; [Park, Heung-Woo; Kang, Hye-Ryun; Park, Kyoung Soo] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Hallym University; Hanyang University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Seoul National University (SNU)	Lee, DS (corresponding author), Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul, South Korea.; Lee, DS (corresponding author), Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea.	soonlee@snu.ac.kr	Park, Heung-Woo/AAW-7690-2020; Park, Kyong Soo/C-2265-2008	Park, Heung-Woo/0000-0002-6970-3228; Lee, Joon Hee/0000-0002-9649-1371; Seo, Heewon/0000-0001-6218-8609; Park, Kyong Soo/0000-0003-3597-342X	National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2014R1A2A1A10052286]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2014R1A2A1A10052286). http://www,nrf.re.kr/index. DSL received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bain BJ, 2010, HAEMATOL-HEMATOL J, V95, P696, DOI 10.3324/haematol.2009.021675; Beer PA, 2010, HAEMATOL-HEMATOL J, V95, P2153, DOI 10.3324/haematol.2010.029306; Bruggemann M, 2007, LEUKEMIA, V21, P215, DOI 10.1038/sj.leu.2404481; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Faderl S, 2011, LEUKEMIAS: PRINCIPLES AND PRACTICE OF THERAPY, pIX; Gotlib J, 2015, AM J HEMATOL, V90, P1078, DOI 10.1002/ajh.24196; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; Groenen Patricia J T A, 2008, J Hematop, V1, P97, DOI 10.1007/s12308-008-0013-9; Helbig G, 2009, HAEMATOL-HEMATOL J, V94, P1236, DOI 10.3324/haematol.2008.005447; Hodges E, 2003, J CLIN PATHOL, V56, P1, DOI 10.1136/jcp.56.1.1; Kim N, 2016, J EXPT STROKE TRANSL, V9, P1, DOI DOI 10.4172/1939-067X.1000145; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Klion AD, 2015, BLOOD, V126, P1069, DOI 10.1182/blood-2014-11-551614; Koren-Michowitz M, 2013, BRIT J HAEMATOL, V161, P811, DOI 10.1111/bjh.12327; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Langerak AW, 2012, LEUKEMIA, V26, P2159, DOI 10.1038/leu.2012.246; Lasho TL, 2011, LEUKEMIA, V25, P1056, DOI 10.1038/leu.2011.45; Leeke B, 2014, EXP HEMATOL ONCOL, V3, DOI 10.1186/2162-3619-3-13; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Losada A, 2014, NAT REV CANCER, V14, P389, DOI 10.1038/nrc3743; Lykkegaard C, 2015, ONCOTARGET, V6, P40588, DOI 10.18632/oncotarget.5845; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Oh ST, 2010, BLOOD, V116, P988, DOI 10.1182/blood-2010-02-270108; Pardanani A, 2016, LEUKEMIA, V30, P1924, DOI 10.1038/leu.2016.73; Patterer V, 2013, ANN HEMATOL, V92, P759, DOI 10.1007/s00277-013-1695-3; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roufosse F, 2000, BRIT J HAEMATOL, V109, P540, DOI 10.1046/j.1365-2141.2000.02097.x; Sakai R, 2006, INT J HEMATOL, V84, P417, DOI 10.1532/IJH97.06054; Sandberg Y, 2005, J MOL DIAGN, V7, P495, DOI 10.1016/S1525-1578(10)60580-6; SCHMIDT U, 1988, BRIT J HAEMATOL, V68, P175, DOI 10.1111/j.1365-2141.1988.tb06186.x; SHAFFER LG, 2013, ISCN 2013 INT SYSTEM, P140; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Simon HU, 1999, NEW ENGL J MED, V341, P1112, DOI 10.1056/NEJM199910073411503; Sulong S, 2009, BLOOD, V113, P100, DOI 10.1182/blood-2008-07-166801; Tefferi A, 2010, MAYO CLIN PROC, V85, P158, DOI 10.4065/mcp.2009.0503; Tenedini E, 2014, LEUKEMIA, V28, P1052, DOI 10.1038/leu.2013.302; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Vaklavas C, 2007, LEUKEMIA RES, V31, P691, DOI 10.1016/j.leukres.2006.10.005; Wang SY, 2016, INT J DISTRIB SENS N, DOI 10.1155/2016/3159805; WHO, 2008, WHO CLASSIFICATION T; Wilkinson K, 2003, BLOOD, V102, P4187, DOI 10.1182/blood-2003-04-1150; Xu Chen, 2011, Chin J Cancer, V30, P264; Yamamoto K, 2014, LEUKEMIA LYMPHOMA, V55, P2402, DOI 10.3109/10428194.2014.885516	45	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0185602	10.1371/journal.pone.0185602	http://dx.doi.org/10.1371/journal.pone.0185602			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088303	Green Published, gold, Green Submitted			2022-12-26	WOS:000414088900003
J	Shimoni, Z; Glick, J; Hermush, V; Froom, P				Shimoni, Zvi; Glick, Joseph; Hermush, Vered; Froom, Paul			Sensitivity of the dipstick in detecting bacteremic urinary tract infections in elderly hospitalized patients	PLOS ONE			English	Article							NURSING-HOME RESIDENTS; DIAGNOSTIC-ACCURACY; OLDER WOMEN; URINALYSIS; COHORT	Background The sensitivity of the dipstick in elderly patients with a suspected urinary tract infection (UTI) is unclear because of the inclusion of patients with urine contamination or asymptomatic bacteriuria in previous studies. Methods We selected consecutive patients aged 65 years or older hospitalized in internal medicine departments with bacteremic UTI (same organism in blood and urine cultures) minimizing misclassifications. The false positive rate was determined in consecutive patients with negative culture results. A positive dipstick was a test result with a trace leukocyte esterase and/or nitrite positivity. Bacteriuria was the growth of at least 10(5) colony-forming units per milliliter of urine. Results Of 20,555 consecutive patients, 228 had a bacteremic UTI, and 4069 a negative culture result. The sensitivity of the dipstick was 96.9% (95% CI-93.7-98.6) with a false positive rate of 42.4% (95% CI, 41.0-43.8) in those with a negative culture result. Conclusions In elderly hospitalized patients with a bacteremic UTI, the dipstick urinalysis is highly sensitive, much higher than reported previously in studies of UTIs in the elderly. It is unclear whether the observed high sensitivity of the dipstick was due to the exclusion of patients with asymptomatic bacteriuria or to spectrum bias. Studies of the clinical utility/disutility of using a negative dipstick to rule out a urinary tract infection are warranted.	[Shimoni, Zvi] Laniado Hosp, Sanz Med Ctr, Dept Internal Med B, Netanya, Israel; [Shimoni, Zvi] Ruth & Bruce Rappaport Sch Med, Haifa, Israel; [Glick, Joseph] Laniado Hosp, Sanz Med Ctr, Cent Lab, Netanya, Israel; [Hermush, Vered] Laniado Hosp, Sanz Med Ctr, Dept Geriatr, Netanya, Israel; [Froom, Paul] Laniado Hosp, Sanz Med Ctr, Dept Clin Util, Netanya, Israel; [Froom, Paul] Tel Aviv Univ, Sch Publ Hlth, Ramat Aviv, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Tel Aviv University	Froom, P (corresponding author), Laniado Hosp, Sanz Med Ctr, Dept Clin Util, Netanya, Israel.; Froom, P (corresponding author), Tel Aviv Univ, Sch Publ Hlth, Ramat Aviv, Israel.	froomp@gmail.com		Froom, Paul/0000-0001-5126-8590				Chen MC, 2016, ACS NANO, V10, P93, DOI 10.1021/acsnano.5b05043; Clinical and Laboratory Standards Institute, 2011, PHYS NONPH PROV PERF; Detweiler K, 2015, UROL CLIN N AM, V42, P561, DOI 10.1016/j.ucl.2015.07.002; Deville Walter L J M, 2004, BMC Urol, V4, P4, DOI 10.1186/1471-2490-4-4; Froom P, 2000, CLIN CHEM, V46, P1384; Froom P, 2012, AM J CLIN PATHOL, V137, P486, DOI 10.1309/AJCPLJFSS62YBAWN; Jones CW, 2014, J EMERG MED, V46, P71, DOI 10.1016/j.jemermed.2013.08.042; Juthani-Mehta M, 2007, J AM GERIATR SOC, V55, P1072, DOI 10.1111/j.1532-5415.2007.01217.x; Juthani-Mehta M, 2009, J AM GERIATR SOC, V57, P963, DOI 10.1111/j.1532-5415.2009.02227.x; Kayalp D, 2013, CLIN BIOCHEM, V46, P1285, DOI 10.1016/j.clinbiochem.2013.06.015; Kaye D, 1989, Trans Am Clin Climatol Assoc, V100, P155; Mayo S, 2008, J CLIN LAB ANAL, V22, P262, DOI 10.1002/jcla.20257; Mody L, 2014, JAMA-J AM MED ASSOC, V311, P844, DOI 10.1001/jama.2014.303; MONANE M, 1995, J AM GERIATR SOC, V43, P618, DOI 10.1111/j.1532-5415.1995.tb07194.x; Ouslander JG, 1996, J AM GERIATR SOC, V44, P420, DOI 10.1111/j.1532-5415.1996.tb06414.x; Schroeder AR, 2015, PEDIATRICS, V135, P965, DOI 10.1542/peds.2015-0012; Shimoni Z, 2008, EUR J INTERN MED, V19, P494, DOI 10.1016/j.ejim.2007.04.028; Shimoni Z, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013696; Woodford HJ, 2009, J AM GERIATR SOC, V57, P107, DOI 10.1111/j.1532-5415.2008.02073.x	19	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187381	10.1371/journal.pone.0187381	http://dx.doi.org/10.1371/journal.pone.0187381			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL2ZD	29088289	Green Published, Green Submitted, gold			2022-12-26	WOS:000414088900079
J	Esteve, C; Samson, M; Guilhem, A; Nicolas, B; Leguy-Seguin, V; Berthier, S; Bonnotte, B; Audia, S				Esteve, Clementine; Samson, Maxime; Guilhem, Alexandre; Nicolas, Barbara; Leguy-Seguin, Vanessa; Berthier, Sabine; Bonnotte, Bernard; Audia, Sylvain			Efficacy and safety of dapsone as second line therapy for adult immune thrombocytopenia: A retrospective study of 42 patients	PLOS ONE			English	Article							2ND-LINE TREATMENT; DOUBLE-BLIND; PURPURA; CHILDREN; SPLENECTOMY; ELTROMBOPAG; MANAGEMENT; REMISSION; RITUXIMAB; DISCONTINUATION	Dapsone is recommended as a second line therapy in immune thrombocytopenia (ITP), but is underused because of its potential side effects. The medical charts of 42 ITP patients treated with dapsone (100 mg/day) were retrospectively reviewed in order to assess its efficacy and safety in daily clinical practice. The overall response rate was 54.8% (n = 22, with a complete response in 38.1%) with a median time to response of 29 days (24-41 days). Patients with complete response had shorter disease duration whereas no difference was observed between responders and non-responders regarding age, sex or previous treatments received. Importantly, after dapsone withdrawal, a sustained response was observed in 5 patients, representing 12% of the whole cohort. Twenty percent of patients (n = 8) relapsed on therapy after 8.1 (6.5-13.6) months. Side effects occurred in 31% (n = 13) of patients, and required dapsone withdrawal in 22% (n = 9) or dosage reduction in 10% (n = 4) of the cases. Side effects resolved in all but one case. Overall, these data support dapsone as an interesting second line therapy in ITP, with a good safety and efficacy profile at a low cost.	[Esteve, Clementine; Samson, Maxime; Guilhem, Alexandre; Nicolas, Barbara; Leguy-Seguin, Vanessa; Berthier, Sabine; Bonnotte, Bernard; Audia, Sylvain] Univ Bourgogne Franche Comte, CHU Dijon Bourgogne, Serv Med Interne & Immunol Clin, Ctr Reference Constitutif Cytopenies Autoimmunes, Dijon, France	CHU Dijon Bourgogne	Audia, S (corresponding author), Univ Bourgogne Franche Comte, CHU Dijon Bourgogne, Serv Med Interne & Immunol Clin, Ctr Reference Constitutif Cytopenies Autoimmunes, Dijon, France.	sylvain.audia@u-bourgogne.fr	Bonnotte, Bernard/ABA-2525-2021; Samson, Maxime/ABE-1461-2021; Audia, Sylvain/H-3366-2019	Bonnotte, Bernard/0000-0002-1098-4598; Samson, Maxime/0000-0002-6547-232X; Audia, Sylvain/0000-0003-1772-1392				Arnold DM, 2007, ANN INTERN MED, V146, P25, DOI 10.7326/0003-4819-146-1-200701020-00006; Audia S, 2016, REV MED INTERNE, V37, P43, DOI 10.1016/j.revmed.2015.08.007; Audia S, 2010, REV MED INTERNE, V31, P337, DOI 10.1016/j.revmed.2009.11.008; Bussel JB, 2009, LANCET, V373, P641, DOI 10.1016/S0140-6736(09)60402-5; Vancine-Califani SMC, 2008, PLATELETS, V19, P489, DOI 10.1080/09537100802315110; Cines DB, 2002, NEW ENGL J MED, V346, P995, DOI 10.1056/NEJMra010501; Damodar S, 2005, EUR J HAEMATOL, V75, P328, DOI 10.1111/j.1600-0609.2005.00545.x; DURAND JM, 1991, BRIT J HAEMATOL, V78, P460, DOI 10.1111/j.1365-2141.1991.tb04467.x; Dutta T K, 2001, J Assoc Physicians India, V49, P421; Godeau B, 1997, BRIT J HAEMATOL, V97, P336, DOI 10.1046/j.1365-2141.1997.412687.x; GODEAU B, 1993, AM J HEMATOL, V44, P70, DOI 10.1002/ajh.2830440117; Godeau B, 2008, BLOOD, V112, P999, DOI 10.1182/blood-2008-01-131029; HERNANDEZ F, 1995, BRIT J HAEMATOL, V90, P473, DOI 10.1111/j.1365-2141.1995.tb05179.x; Gonzalez-Lopez TJ, 2015, AM J HEMATOL, V90, pE40, DOI 10.1002/ajh.23900; Gonzalez-Lopez TJ, 2015, PLATELETS, V26, P83, DOI 10.3109/09537104.2013.870987; Khellaf M, 2005, HAEMATOLOGICA, V90, P829; Khellaf M, 2014, BLOOD, V124, P3228, DOI 10.1182/blood-2014-06-582346; Khellaf M, 2014, AM J HEMATOL, V89, P194, DOI 10.1002/ajh.23609; Kojouri K, 2004, BLOOD, V104, P2623, DOI 10.1182/blood-2004-03-1168; Kuter DJ, 2008, LANCET, V371, P395, DOI 10.1016/S0140-6736(08)60203-2; Le Louet H, 1999, AM J HEMATOL, V62, P251, DOI 10.1002/(SICI)1096-8652(199912)62:4<251::AID-AJH10>3.3.CO;2-D; Loustau V, 2015, REV MED INTERNE, V36, P167, DOI 10.1016/j.revmed.2014.07.009; Mahevas M, 2016, BLOOD, V128, P1625, DOI 10.1182/blood-2016-03-704734; Mahevas M, 2014, BRIT J HAEMATOL, V165, P865, DOI 10.1111/bjh.12888; Maloisel F, 2004, AM J MED, V116, P590, DOI 10.1016/j.amjmed.2003.12.024; Meeker ND, 2003, J PEDIAT HEMATOL ONC, V25, P173, DOI 10.1097/00043426-200302000-00019; MOSS C, 1988, BRIT MED J, V297, P266, DOI 10.1136/bmj.297.6643.266; Neunert C, 2011, BLOOD, V117, P4190, DOI 10.1182/blood-2010-08-302984; Newland A, 2016, BRIT J HAEMATOL, V172, P262, DOI 10.1111/bjh.13827; Patel AP, 2015, PLATELETS, V26, P164, DOI 10.3109/09537104.2014.886677; Patel VL, 2012, BLOOD, V119, P5989, DOI 10.1182/blood-2011-11-393975; Provan D, 2003, BRIT J HAEMATOL, V120, P574; Provan D, 2010, BLOOD, V115, P168, DOI 10.1182/blood-2009-06-225565; Rodeghiero F, 2009, BLOOD, V113, P2386, DOI 10.1182/blood-2008-07-162503; Rodrigo C, 2013, J THROMB HAEMOST, V11, P1946, DOI 10.1111/jth.12371; Sauvetre G, 2015, AM J HEMATOL, V90, pE201, DOI 10.1002/ajh.24068; Vianelli N, 2013, HAEMATOLOGICA, V98, P875, DOI 10.3324/haematol.2012.075648; Zaja F, 2012, AM J HEMATOL, V87, P321, DOI 10.1002/ajh.22266	38	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187296	10.1371/journal.pone.0187296	http://dx.doi.org/10.1371/journal.pone.0187296			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084292	Green Submitted, Green Published, gold			2022-12-26	WOS:000413910200046
J	Gram, M; Erlenwein, J; Petzke, F; Falla, D; Przemeck, M; Emons, MI; Reuster, M; Olesen, SS; Drewes, AM				Gram, Mikkel; Erlenwein, Joachim; Petzke, Frank; Falla, Deborah; Przemeck, Michael; Emons, Miriam I.; Reuster, Michael; Olesen, Soren S.; Drewes, Asbjorn M.			The cortical responses to evoked clinical pain in patients with hip osteoarthritis	PLOS ONE			English	Article							TONIC PAIN; EEG; PERCEPTION; POWER; OSCILLATIONS	Background Experimental models have been used extensively to evaluate pain using e.g., visual analogue scales or electroencephalography (EEG). Stimulation using tonic pain has been shown to better mimic the unpleasantness of chronic pain, but has mainly been evoked by non-clinical stimuli. This study aims to, evaluate the EEG during clinical pain in patients scheduled for total hip replacement with control and resting conditions. Methods The hip scheduled for replacement was moved by the examiner to evoke pain for 30 seconds while recording EEG. The control condition entailed movement of the opposite hip in a similar fashion and holding it for 30 seconds. In addition, EEG was recorded during the resting condition with open eyes. The relative spectral content was calculated from the EEG as well as functional connectivity using phase-lag index for frequency bands delta (1 -4Hz), theta (4-8Hz), alpha (8 -12Hz) and beta (12 -32Hz). A mixed model was used for statistical comparison between the three recording conditions. Results Spectral content differed between conditions in all bands. Functional connectivity differed in delta and theta frequency bands. Post-hoc analysis revealed differences between the painful and control condition in delta, theta and beta for spectral content. Pain during the hip rotation was correlated to the theta (r = -0.24 P = 0.03) and beta (r = 0.25 P = 0.02) content in the EEG. Conclusion EEG differences during hip movements in the affected and unaffected hip appeared in the spectral beta and theta content. This was correlated to the reported pain perceived, pointing towards pain specific brain activity related to clinical pain.	[Gram, Mikkel; Olesen, Soren S.; Drewes, Asbjorn M.] Aalborg Univ Hosp, Mech Sense, Dept Gastroenterol & Hepatol, Aalborg, Denmark; [Gram, Mikkel] Coaze IVS, Aalborg, Denmark; [Erlenwein, Joachim; Petzke, Frank; Falla, Deborah; Emons, Miriam I.; Reuster, Michael] Univ Gottingen, Univ Hosp, Dept Anesthesiol, Pain Clin, Gottingen, Germany; [Przemeck, Michael] Annastift, Dept Anesthesiol & Intens Care, Hannover, Germany; [Drewes, Asbjorn M.] Aalborg Univ Hosp, Clin Inst, Aalborg, Denmark	Aalborg University; Aalborg University Hospital; University of Gottingen; Aalborg University; Aalborg University Hospital	Drewes, AM (corresponding author), Aalborg Univ Hosp, Mech Sense, Dept Gastroenterol & Hepatol, Aalborg, Denmark.; Drewes, AM (corresponding author), Aalborg Univ Hosp, Clin Inst, Aalborg, Denmark.	amd@mech-sensa.com	Drewes, Asbjørn/AAR-7479-2021; Falla, Deborah/ABA-7734-2021	Drewes, Asbjørn/0000-0001-7465-964X; Falla, Deborah/0000-0003-1689-6190; Erlenwein, Joachim/0000-0003-4782-3402	Innovation Fund Denmark - Individuals, Disease and Society [10-092786]	Innovation Fund Denmark - Individuals, Disease and Society	This study was funded from Innovation Fund Denmark - Individuals, Disease and Society, grant number 10-092786 http:// innovationsfonden.dk/en.	Akin M, 2002, J Med Syst, V26, P241, DOI 10.1023/A:1015075101937; BACKONJA M, 1991, ELECTROEN CLIN NEURO, V79, P192, DOI 10.1016/0013-4694(91)90137-S; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; BRESLAU J, 1989, ELECTROEN CLIN NEURO, V72, P281, DOI 10.1016/0013-4694(89)90063-1; Castellanos NP, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00090; Chang PF, 2002, BRAIN RES BULL, V57, P667, DOI 10.1016/S0361-9230(01)00763-8; Downian R, 2008, CLIN NEUROPHYSIOL, V119, P1201, DOI 10.1016/j.clinph.2008.01.019; Drewes AM, 2003, SCAND J GASTROENTERO, V38, P1115, DOI 10.1080/00365520310004399; DUSTMAN RE, 1985, NEUROBIOL AGING, V6, P193, DOI 10.1016/0197-4580(85)90049-1; Gram M, 2015, CLIN NEUROPHYSIOL, V126, P763, DOI 10.1016/j.clinph.2014.07.027; Gross J, 2007, PLOS BIOL, V5, P1168, DOI 10.1371/journal.pbio.0050133; Hardmeier M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108648; Iannetti GD, 2008, J NEUROPHYSIOL, V100, P815, DOI 10.1152/jn.00097.2008; Khodayari-Rostamabad A, 2015, ANESTHESIOLOGY, V122, P140, DOI 10.1097/ALN.0000000000000510; Kramer JLK, 2012, J NEUROSCI, V32, P12981, DOI 10.1523/JNEUROSCI.3175-12.2012; Legrain V, 2011, PROG NEUROBIOL, V93, P111, DOI 10.1016/j.pneurobio.2010.10.005; Lehembre R, 2012, FUNCT NEUROL, V27, P41; Malver LP, 2014, BRIT J CLIN PHARMACO, V77, P72, DOI 10.1111/bcp.12137; Mouraux A, 2009, J NEUROPHYSIOL, V101, P3258, DOI 10.1152/jn.91181.2008; Nir RR, 2012, CLIN NEUROPHYSIOL, V123, P605, DOI 10.1016/j.clinph.2011.08.006; Nolte G, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.234101; Olesen AE, 2012, PHARMACOL REV, V64, P722, DOI 10.1124/pr.111.005447; Olesen SS, 2011, EUR J GASTROEN HEPAT, V23, P418, DOI 10.1097/MEG.0b013e3283457b09; Olesen SS, 2011, SCAND J GASTROENTERO, V46, P988, DOI 10.3109/00365521.2011.579160; RAINVILLE P, 1992, SOMATOSENS MOT RES, V9, P265, DOI 10.3109/08990229209144776; Shao SY, 2012, CLIN NEUROPHYSIOL, V123, P2042, DOI 10.1016/j.clinph.2012.02.084; STEEDMAN SM, 1992, CLIN J PAIN, V8, P204, DOI 10.1097/00002508-199209000-00004; Stormo K, 1998, CURR REV PAIN, V2, P171, DOI DOI 10.1007/S11916-998-0015-4; Zhang ZG, 2012, J NEUROSCI, V32, P7429, DOI 10.1523/JNEUROSCI.5877-11.2012	29	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0186400	10.1371/journal.pone.0186400	http://dx.doi.org/10.1371/journal.pone.0186400			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084278	Green Published, gold			2022-12-26	WOS:000413910200006
J	Hensel, Z				Hensel, Zach			A plasmid-based Escherichia coli gene expression system with cell-to-cell variation below the extrinsic noise limit	PLOS ONE			English	Article							PROPAGATION; CONSTRUCTION; SIMULATION; MOLECULES; NETWORKS; BINDING; DESIGN; IMAGE	Experiments in synthetic biology and microbiology can benefit from protein expression systems with low cell(to(cell variability (noise) and expression levels precisely tunable across a useful dynamic range. Despite advances in understanding the molecular biology of microbial gene regulation, many experiments employ protein(expression systems exhibiting high noise and nearly all(or(none responses to induction. I present an expression system that incorporates elements known to reduce gene expression noise: negative autoregulation and bicistronic transcription. I show by stochastic simulation that while negative autoregulation can produce a more gradual response to induction, bicistronic expression of a repressor and gene of interest can be necessary to reduce noise below the extrinsic limit. I synthesized a plasmid(based system incorporating these principles and studied its properties in Escherichia coli cells, using flow cytometry and fluorescence microscopy to characterize induction dose(response, induction/repression kinetics and gene expression noise. By varying ribosome binding site strengths, expression levels from 55-10,740 molecules/cell were achieved with noise below the extrinsic limit. Individual strains are inducible across a dynamic range greater than 20(fold. Experimental comparison of different regulatory networks confirmed that bicistronic autoregulation reduces noise, and revealed unexpectedly high noise for a conventional expression system with a constitutively expressed transcriptional repressor. I suggest a hybrid, low(noise expression system to increase the dynamic range.	[Hensel, Zach] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Oeiras, Portugal; [Hensel, Zach] Okinawa Inst Sci & Technol, Deans Res Unit, Okinawa, Japan	Universidade Nova de Lisboa; Okinawa Institute of Science & Technology Graduate University	Hensel, Z (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Oeiras, Portugal.; Hensel, Z (corresponding author), Okinawa Inst Sci & Technol, Deans Res Unit, Okinawa, Japan.	zach.hensel@itqb.unl.pt	Hensel, Zach/G-2941-2015	Hensel, Zach/0000-0002-4348-6229	Microbiologia Molecular, Estrutural e Celular [LISBOA-01-0145-FEDER-007660]; national funds through FCT - Fundacao para a Ciencia e a Tecnologia; Research Unit at the Okinawa Institute of Science and Technology (OIST); FEDER funds through COMPETE - Programa Operacional Competitividade e Internacionalizacao (POCI)	Microbiologia Molecular, Estrutural e Celular; national funds through FCT - Fundacao para a Ciencia e a Tecnologia; Research Unit at the Okinawa Institute of Science and Technology (OIST); FEDER funds through COMPETE - Programa Operacional Competitividade e Internacionalizacao (POCI)	This work was financially supported by: Project LISBOA-01-0145-FEDER-007660 (Microbiologia Molecular, Estrutural e Celular) funded by FEDER funds through COMPETE2020 - Programa Operacional Competitividade e Internacionalizacao (POCI), by national funds through FCT - Fundacao para a Ciencia e a Tecnologia, and by the Dean's Research Unit at the Okinawa Institute of Science and Technology (OIST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was financially supported by: Project LISBOA-01-0145-FEDER-007660 (Microbiologia Molecular, Estrutural e Celular) funded by FEDER funds through COMPETE2020-Programa Operacional Competitividade e Internacionalizacao (POCI), by national funds through FCT-Fundacao para a Ciencia e a Tecnologia, and by the Dean's Research Unit at the Okinawa Institute of Science and Technology (GIST). Experiments were done at GIST; data analysis, simulations, additional experiments and paper writing were done at the Instituto de Tecnologia Quimica e Biologica Antonio Xavier. I thank Dr. Eder Zavala (University of Exeter) for his insightful comments on the manuscript.	Austin DW, 2006, NATURE, V439, P608, DOI 10.1038/nature04194; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Binder D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160711; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Davis JH, 2011, NUCLEIC ACIDS RES, V39, P1131, DOI 10.1093/nar/gkq810; Dublanche Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100081; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gillespie DT, 1996, PHYS REV E, V54, P2084, DOI 10.1103/PhysRevE.54.2084; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Hartvig L, 1996, EMBO J, V15, P4767, DOI 10.1002/j.1460-2075.1996.tb00854.x; Hensel Z, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001591; Hensel Z, 2012, NAT STRUCT MOL BIOL, V19, P797, DOI 10.1038/nsmb.2336; Hooshangi S, 2006, CHAOS, V16, DOI 10.1063/1.2208927; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Kang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029800; Karig DK, 2012, NUCLEIC ACIDS RES, V40, P3763, DOI 10.1093/nar/gkr1191; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Lederer T, 1996, BIOCHEMISTRY-US, V35, P7439, DOI 10.1021/bi952683e; Lovdok L, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000171; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Nevozhay D, 2009, P NATL ACAD SCI USA, V106, P5123, DOI 10.1073/pnas.0809901106; Ovesny M, 2014, BIOINFORMATICS, V30, P2389, DOI 10.1093/bioinformatics/btu202; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; POSTLE K, 1984, NUCLEIC ACIDS RES, V12, P4849, DOI 10.1093/nar/12.12.4849; Ray JCJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002672; Rosano GL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00172; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shahrezaei V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.31; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Sneppen K, 2010, MBIO, V1, DOI 10.1128/mBio.00177-10; Swain PS, 2004, J MOL BIOL, V344, P965, DOI 10.1016/j.jmb.2004.09.073; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308	36	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187259	10.1371/journal.pone.0187259	http://dx.doi.org/10.1371/journal.pone.0187259			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084263	Green Published, gold, Green Submitted			2022-12-26	WOS:000413910200043
J	Kumar, S; Tanti, B; Patil, BL; Mukherjee, SK; Sahoo, L				Kumar, Sanjeev; Tanti, Bhaben; Patil, Basavaprabhu L.; Mukherjee, Sunil Kumar; Sahoo, Lingaraj			RNAi-derived transgenic resistance to Mungbean yellow mosaic India virus in cowpea	PLOS ONE			English	Article							LEAF CURL DISEASE; ENGINEERING RESISTANCE; HAIRPIN RNA; MEDIATED RESISTANCE; GENOMIC COMPONENTS; ADENOSINE KINASE; GEMINIVIRUS AL2; DNA VIRUS; GENE; PLANTS	Cowpea is an important grain legume crop of Africa, Latin America, and Southeast Asia. Leaf curl and golden mosaic diseases caused by Mungbean yellow mosaic India virus (MYMIV) have emerged as most devastating viral diseases of cowpea in Southeast Asia. In this study, we employed RNA interference (RNAi) strategy to control cowpea-infecting MYMIV. For this, we generated transgenic cowpea plants harbouring three different intron hairpin RNAi constructs, containing the AC2, AC4 and fusion of AC2 and AC4 (AC2+AC4) of seven cowpea-infecting begomoviruses. The T-0 and T-1 transgenic cowpea lines of all the three constructs accumulated transgene-specific siRNAs. Transgenic plants were further assayed up to T-1 generations, for resistance to MYMIV using agro-infectious clones. Nearly 100% resistance against MYMIV infection was observed in transgenic lines, expressing AC2-hp and AC2+AC4-hp RNA, when compared with untransformed controls and plants transformed with empty vectors, which developed severe viral disease symptoms within 3 weeks. The AC4-hp RNA expressing lines displayed appearance of milder symptoms after 5 weeks of MYMIV-inoculation. Northern blots revealed a positive correlation between the level of transgene-specific siRNAs accumulation and virus resistance. The MYMIV-resistant transgenic lines accumulated nearly zero or very low titres of viral DNA. The transgenic cowpea plants had normal phenotype with no yield penalty in greenhouse conditions. This is the first demonstration of RNAi-derived resistance to MYMIV in cowpea.	[Kumar, Sanjeev; Sahoo, Lingaraj] Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Gauhati, India; [Kumar, Sanjeev; Tanti, Bhaben] Gauhati Univ, Dept Bot, Gauhati, Assam, India; [Patil, Basavaprabhu L.] ICAR Natl Res Ctr Plant Biotechnol, LBS Ctr, IARI, Pusa Campus, New Delhi, India; [Mukherjee, Sunil Kumar] Indian Agr Res Inst, Div Plant Pathol, New Delhi, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati; Gauhati University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; ICAR - National Institute For Plant Biotechnology (NIPB); Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute	Sahoo, L (corresponding author), Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Gauhati, India.	ls@iitg.ernet.in		Sahoo, Lingaraj/0000-0001-8103-2714; Patil, Basavaprabhu/0000-0002-6023-5894	Department of Biotechnology, Government of India [BT/173/NE/TDP/2011, BT/PR13560/COE/34/44/2015]; DBT	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); DBT(Department of Biotechnology (DBT) India)	The work was funded by a research grant to LS and SKM from the Department of Biotechnology, Government of India (BT/173/NE/TDP/2011 and BT/PR13560/COE/34/44/2015). S.K. is grateful to DBT for Research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to CSIRO, Australia for the pHANNIBAL, pKANNIBAL and pART27 vectors. We express our sincere thanks to Prof. Sampa Das, Bose Institute for providing Agrobacterium tumefaciens strain, EHA105 and Center for Application of Molecular Biology to International Agriculture (CAMBIA), Australia for pCAMBIA3300. S.K. is grateful to DBT for Research fellowship.	Alegbejo MD, 2001, J SUSTAIN AGR, V18, P55, DOI 10.1300/J064v18n01_05; Aragao FJL, 1998, MOL BREEDING, V4, P491, DOI 10.1023/A:1009613607559; Bakshi S, 2012, J PLANT GROWTH REGUL; Bakshi S, 2012, PLANT CELL TISS ORG, V110, P77, DOI 10.1007/s11240-012-0132-y; Bakshi S, 2012, PLANT CELL REP, V31, P1093, DOI 10.1007/s00299-012-1230-3; Bakshi S, 2011, PLANT CELL REP, V30, P2281, DOI 10.1007/s00299-011-1133-8; Behura R, 2015, METHODS MOL BIOL, V1223, P255, DOI 10.1007/978-1-4939-1695-5_20; Bendahmane M, 1997, PLANT MOL BIOL, V33, P351, DOI 10.1023/A:1005715805000; Bonfim K, 2007, MOL PLANT MICROBE IN, V20, P717, DOI 10.1094/MPMI-20-6-0717; Chakraborty S, 2008, J GEN VIROL, V89, P818, DOI 10.1099/vir.0.82873-0; Chellappan P, 2004, PLANT MOL BIOL, V56, P601, DOI 10.1007/s11103-004-0147-9; Chuang CF, 2000, P NATL ACAD SCI USA, V97, P4985, DOI 10.1073/pnas.060034297; Cruz ARR, 2014, PLANT PATHOL, V63, P831, DOI 10.1111/ppa.12178; DAY AG, 1991, P NATL ACAD SCI USA, V88, P6721, DOI 10.1073/pnas.88.15.6721; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; FARGETTE D, 1994, PHYTOPATHOLOGY, V84, P91, DOI 10.1094/Phyto-84-91; Gelvin SB, 2003, MICROBIOL MOL BIOL R, V67, P16, DOI 10.1128/MMBR.67.1.16-37.2003; Hanley-Bowdoin L, 1999, CRIT REV PLANT SCI, V18, P71, DOI 10.1016/S0735-2689(99)00383-4; Haq QMI, 2010, INDIAN J VIROL, V21, P82, DOI 10.1007/s13337-010-0003-2; Hema M, 2014, ADV VIRUS RES, V90, P431, DOI 10.1016/B978-0-12-801246-8.00009-3; Jeske H, 2009, CURR TOP MICROBIOL, V331, P185; John P, 2008, ARCH VIROL, V153, P1359, DOI 10.1007/s00705-008-0116-8; Kang BC, 2005, ANNU REV PHYTOPATHOL, V43, P581, DOI 10.1146/annurev.phyto.43.011205.141140; KAREEM KT, 2007, VIROL J, V4, DOI DOI 10.1186/1743-; Kumar S, 2016, WORLD RES J BIOTECHN, V3, P53; Kumar S, 2017, BIOCATAL AGRIC BIOTE, V11, P183, DOI 10.1016/j.bcab.2017.07.004; Langyintuo AS, 2003, FIELD CROP RES, V82, P215, DOI 10.1016/S0378-4290(03)00039-x; Lin CY, 2012, TRANSGENIC RES, V21, P231, DOI 10.1007/s11248-011-9523-9; Malathi VG, 2005, CAN J PLANT PATHOL, V27, P439; Matzke MA, 2001, CURR OPIN GENET DEV, V11, P221, DOI 10.1016/S0959-437X(00)00183-0; Mendez-Lozano J, 2003, PHYTOPATHOLOGY, V93, P270, DOI 10.1094/PHYTO.2003.93.3.270; Mishra S, 2015, PLANT CELL TISS ORG, V120, P19, DOI 10.1007/s11240-014-0572-7; Mishra S, 2014, MOL BREEDING, V34, P1345, DOI 10.1007/s11032-014-0120-5; Mlotshwa S, 2008, TRENDS PLANT SCI, V13, P375, DOI 10.1016/j.tplants.2008.04.009; NENE YL, 1973, PLANT DIS REP, V57, P463; Owor BE, 2011, J GEN VIROL, V92, P2458, DOI 10.1099/vir.0.032862-0; Patil BL, 2016, VIRUS RES, V213, P109, DOI 10.1016/j.virusres.2015.11.011; Patil BL, 2015, VIRUS GENES, V50, P474, DOI 10.1007/s11262-015-1184-y; Patil BL, 2015, MOL PLANT PATHOL, V16, P484, DOI 10.1111/mpp.12205; Patil BL, 2011, MOL PLANT PATHOL, V12, P31, DOI 10.1111/j.1364-3703.2010.00650.x; Pooggin M, 2003, NAT BIOTECHNOL, V21, P131, DOI 10.1038/nbt0203-131b; Praveen S, 2010, TRANSGENIC RES, V19, P45, DOI 10.1007/s11248-009-9291-y; Rahman J, 2012, APPL BIOCHEM BIOTECH, V167, P758, DOI 10.1007/s12010-012-9702-z; Rajeswaran R, 2007, MOL PLANT MICROBE IN, V20, P1545, DOI 10.1094/MPMI-20-12-1545; Ramesh SV, 2007, OLIGONUCLEOTIDES, V17, P251, DOI 10.1089/oli.2006.0063; Renteria-Canett I, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-104; Ribeiro SG, 2007, J VIROL, V81, P1563, DOI 10.1128/JVI.01238-06; Rodriguez-Negrete EA, 2009, J VIROL, V83, P1332, DOI 10.1128/JVI.01474-08; Rouhibakhsh A, 2005, PLANT PATHOL, V54, P259, DOI 10.1111/j.1365-3059.2005.01139.x; Roy A., 2001, Tropical Agricultural Research, V13, P341; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; SAUNDERS K, 1995, J GEN VIROL, V76, P2287, DOI 10.1099/0022-1317-76-9-2287; Shanmugapriya Gnanasekaran, 2015, VirusDisease, V26, P55, DOI 10.1007/s13337-015-0251-2; Shivaprasad PV, 2005, J VIROL, V79, P8149, DOI 10.1128/JVI.79.13.8149-8163.2005; Singh BB, 2005, GEN RESOUR CHROM ENG, V1, P117; Singh BB, 2002, RECENT PROGR COWPEA, P22; Smith NA, 2000, NATURE, V407, P319, DOI 10.1038/35030305; Solleti SK, 2008, J BIOTECHNOL, V135, P97, DOI 10.1016/j.jbiotec.2008.02.008; Solleti SK, 2008, PLANT CELL REP; Sunitha S, 2013, VIRUS GENES, V46, P496, DOI 10.1007/s11262-013-0889-z; Surendranath B, 2005, ARCH VIROL, V150, P1833, DOI 10.1007/s00705-005-0542-9; Szittya G, 2013, CURR TOP MICROBIOL, V371, P153, DOI 10.1007/978-3-642-37765-5_6; THOTTAPPILLY G, 1992, TROP PEST MANAGE, V38, P337; Timko M.P., 2007, PULSES SUGAR TUBER C, V3, P49, DOI DOI 10.1007/978-3-540-34516-9_3; Trinks D, 2005, J VIROL, V79, P2517, DOI 10.1128/JVI.79.4.2517-2527.2005; Tzfira T, 2006, CURR OPIN BIOTECH, V17, P147, DOI 10.1016/j.copbio.2006.01.009; Vance V, 2001, SCIENCE, V292, P2277, DOI 10.1126/science.1061334; Vanderschuren H, 2007, PLANT BIOTECHNOL J, V5, P207, DOI 10.1111/j.1467-7652.2006.00217.x; Vanderschuren H, 2009, PLANT MOL BIOL, V70, P265, DOI 10.1007/s11103-009-9472-3; Vanitharani R, 2004, J VIROL, V78, P9487, DOI 10.1128/JVI.78.17.9487-9498.2004; Varma A, 2003, ANN APPL BIOL, V142, P145, DOI 10.1111/j.1744-7348.2003.tb00240.x; VARMA A, 1992, MUNGBEAN YELLOW MOSAIC DISEASE: PROCEEDINGS OF AN INTERNATIONAL WORKSHOP, BANGKOK, THAILAND, 2-3 JULY 1991, P8; Wang H, 2005, J VIROL, V79, P7410, DOI 10.1128/JVI.79.12.7410-7418.2005; Wang H, 2003, PLANT CELL, V15, P3020, DOI 10.1105/tpc.015180; Wang MB, 2000, MOL PLANT PATHOL, V1, P347, DOI 10.1046/j.1364-3703.2000.00038.x; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; Zhang P, 2005, PLANT BIOTECHNOL J, V3, P385, DOI 10.1111/j.1467-7652.2005.00132.x; [No title captured]	79	25	27	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186786	10.1371/journal.pone.0186786	http://dx.doi.org/10.1371/journal.pone.0186786			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077738	Green Published, Green Submitted, gold			2022-12-26	WOS:000413861200022
J	Lee, HW; Kim, KJ; Jung, KS; Chon, YE; Huh, JH; Park, KH; Chung, JB; Kim, CO; Han, KH; Park, JY				Lee, Hye Won; Kim, Kwang Joon; Jung, Kyu Sik; Chon, Young Eun; Huh, Ji Hye; Park, Kyeong Hye; Chung, Jae Bock; Kim, Chang Oh; Han, Kwang-Hyub; Park, Jun Yong			The relationship between visceral obesity and hepatic steatosis measured by controlled attenuation parameter	PLOS ONE			English	Article							FATTY LIVER-DISEASE; RISK-FACTORS; METABOLIC SYNDROME; MASS; PREVALENCE; DIAGNOSIS; PREDICTORS; ULTRASOUND; ADIPOSITY; FIBROSIS	Background Nonalcoholic fatty liver disease (NAFLD) is closely related with obesity. However, obese subjects, generally represented by high BMI, do not always develop NAFLD. A number of possible causes of NAFLD have been studied, but the exact mechanism has not yet been elucidated. Methods A total of 304 consecutive subjects who underwent general health examinations including abdominal ultrasonography, transient elastography and abdominal fat computed tomography were prospectively enrolled. Significant steatosis was diagnosed by ultrasonography and controlled attenuation parameter (CAP) assessed by transient elastography. Results Visceral fat area (VFA) was significantly related to hepatic steatosis assessed by CAP, whereas body mass index (BMI) was related to CAP only in univariate analysis. In multiple logistic regression analysis, VFA (odds ratio [OR], 1.010; 95% confidence interval [CI], 1.001-1.019; P = 0.028) and triglycerides (TG) (OR, 1.006; 95% CI, 1.001-1.011; P = 0.022) were independent risk factors for significant hepatic steatosis. The risk of significant hepatic steatosis was higher in patients with higher VFA: the OR was 4.838 (P< 0.001; 95% CI, 2.912-8.039) for 100< VFA <= 200 cm(2) and 7.474 (P< 0.001; 95% CI, 2.462-22.693) for VFA > 200 cm(2), compared to patients with a VFA <= 100 cm(2). Conclusions Our data demonstrated that VFA and TG is significantly related to hepatic steatosis assessed by CAP not BMI. This finding suggests that surveillance for subjects with NAFLD should incorporate an indicator of visceral obesity, and not simply rely on BMI.	[Lee, Hye Won; Jung, Kyu Sik; Chung, Jae Bock; Han, Kwang-Hyub; Park, Jun Yong] Yonsei Univ, Coll Med, Inst Gastroenterol, Dept Internal Med, Seoul, South Korea; [Lee, Hye Won; Jung, Kyu Sik; Chung, Jae Bock; Han, Kwang-Hyub; Park, Jun Yong] Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea; [Kim, Kwang Joon; Kim, Chang Oh] Yonsei Univ, Coll Med, Dept Internal Med, Div Geriatr, Seoul, South Korea; [Chon, Young Eun] CHA Univ, CHA Bundang Med Ctr, Dept Internal Med, Seongman, South Korea; [Huh, Ji Hye] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Div Endocrinol & Metab, Wonju, South Korea; [Park, Kyeong Hye] Ilsan Hosp, Dept Internal Med, Div Endocrinol & Metab, Natl Hlth Insurance Serv, Goyang, Gyeonggi, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Pochon Cha University; Yonsei University; National Health Insurance Service; NHIS Ilsan Hospital	Park, JY (corresponding author), Yonsei Univ, Coll Med, Inst Gastroenterol, Dept Internal Med, Seoul, South Korea.; Park, JY (corresponding author), Severance Hosp, Yonsei Liver Ctr, Seoul, South Korea.	DRPJY@yuhs.ac	Park, Jun Yong/H-7127-2019	Kim, Chang Oh/0000-0002-0773-5443; Park, Jun Yong/0000-0001-6324-2224; Han, Kwang-Hyub/0000-0003-3960-6539; Lee, Hye Won/0000-0002-3552-3560				Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Chon YE, 2013, LIVER INT, V30, P12282; de Ledinghen V, 2012, LIVER INT, V32, P911, DOI 10.1111/j.1478-3231.2012.02820.x; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Dowman JK, 2011, ALIMENT PHARM THER, V33, P525, DOI 10.1111/j.1365-2036.2010.04556.x; FOSTER KJ, 1980, BRIT J RADIOL, V53, P440, DOI 10.1259/0007-1285-53-629-440; Hamaguchi M, 2007, AM J GASTROENTEROL, V102, P2708, DOI 10.1111/j.1572-0241.2007.01526.x; Hsieh SD, 2000, INT J OBESITY, V24, P358, DOI 10.1038/sj.ijo.0801157; Jung SH, 2016, YONSEI MED J, V57, P674, DOI 10.3349/ymj.2016.57.3.674; Karlas T, 2017, J HEPATOL, V66, P1022, DOI 10.1016/j.jhep.2016.12.022; Kim D, 2017, CLIN GASTROENTEROL H, V15, P474, DOI 10.1016/j.cgh.2016.08.028; Kim HJ, 2004, ARCH INTERN MED, V164, P2169, DOI 10.1001/archinte.164.19.2169; Lee HW, 2017, DIGEST DIS SCI, V62, P2150, DOI 10.1007/s10620-017-4592-0; Lee HW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157358; Lee KK, 2012, YONSEI MED J, V53, P99, DOI 10.3349/ymj.2012.53.1.99; Lin YC, 2010, PEDIATR NEONATOL, V51, P149, DOI 10.1016/S1875-9572(10)60028-9; Liu CJ, 2012, J GASTROEN HEPATOL, V27, P1555, DOI 10.1111/j.1440-1746.2012.07222.x; Loomis AK, 2016, J CLIN ENDOCR METAB, V101, P945, DOI 10.1210/jc.2015-3444; Myers RP, 2012, LIVER INT, V32, P902, DOI 10.1111/j.1478-3231.2012.02781.x; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Oh H, 2016, CLIN MOL HEPATOL, V22, P327, DOI 10.3350/cmh.2016.0049; Ong JP, 2008, J HEPATOL, V49, P608, DOI 10.1016/j.jhep.2008.06.018; Pang Q, 2015, WORLD J GASTROENTERO, V21, P1650, DOI 10.3748/wjg.v21.i5.1650; Park BJ, 2008, J GASTROEN HEPATOL, V23, P900, DOI 10.1111/j.1440-1746.2007.05212.x; Pickhardt PJ, 2012, AM J ROENTGENOL, V198, P1100, DOI 10.2214/AJR.11.7361; POULIOT MC, 1994, AM J CARDIOL, V73, P460, DOI 10.1016/0002-9149(94)90676-9; Ratziu V, 2002, HEPATOLOGY, V35, P1485, DOI 10.1053/jhep.2002.33324; Sasso M, 2012, J VIRAL HEPATITIS, V19, P244, DOI 10.1111/j.1365-2893.2011.01534.x; Sasso M, 2010, ULTRASOUND MED BIOL, V36, P1825, DOI 10.1016/j.ultrasmedbio.2010.07.005; SAVERYMUTTU SH, 1986, BRIT MED J, V292, P13, DOI 10.1136/bmj.292.6512.13; Sobhonslidsuk A, 2007, WORLD J GASTROENTERO, V13, P3614, DOI 10.3748/wjg.v13.i26.3614; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Vongsuvanh R, 2012, J HEPATOL, V57, P392, DOI 10.1016/j.jhep.2012.03.013; Xu CF, 2013, AM J GASTROENTEROL, V108, P1299, DOI 10.1038/ajg.2013.104	35	14	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187066	10.1371/journal.pone.0187066	http://dx.doi.org/10.1371/journal.pone.0187066			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077769	Green Published, gold, Green Submitted			2022-12-26	WOS:000413861200040
J	Romero-Ugalde, HM; Le Rolle, V; Bonnet, JL; Henry, C; Belo, A; Mabo, P; Carrault, G; Hernandez, AI				Romero-Ugalde, Hector M.; Le Rolle, Virginie; Bonnet, Jean-Luc; Henry, Christine; Belo, Alain; Mabo, Philippe; Carrault, Guy; Hernandez, Alfredo I.			A novel controller based on state-transition models for closed-loop vagus nerve stimulation: Application to heart rate regulation	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; VENTRICULAR RATE; FAILURE; DESIGN	Vagus nerve stimulation (VNS) is an established adjunctive therapy for pharmacologically refractory epilepsy and depression and is currently in active clinical research for other applications. In current clinical studies, VNS is delivered in an open-loop approach, where VNS parameters are defined during a manual titration phase. However, the physiological response to a given VNS configuration shows significant inter and intra-patient variability and may significantly evolve through time. VNS closed-loop approaches, allowing for the optimization of the therapy in an adaptive manner, may be necessary to improve efficacy while reducing side effects. This paper proposes a generic, closed-loop control VNS system that is able to optimize a number of VNS parameters in an adaptive fashion, in order to keep a control variable within a specified range. Although the proposed control method is completely generic, an example application using the cardiac beat to beat interval (RR) as control variable will be developed in this paper. The proposed controller is based on a state transition model (STM) that can be configured using a partially or a fully-connected architecture, different model orders and different state-transition algorithms. The controller is applied to the adaptive regulation of heart rate and evaluated on 6 sheep, for 13 different targets, using partially-connected STM with 10 states. Also, partially and fully-connected STM defined by 30 states were applied to 7 other sheep for the same 10 targets. Results illustrate the interest of the proposed fully-connected STM and the feasibility of integrating this control system into an implantable neuromodulator.	[Romero-Ugalde, Hector M.; Le Rolle, Virginie; Mabo, Philippe; Carrault, Guy; Hernandez, Alfredo I.] INSERM, U1099, F-35000 Rennes, France; [Romero-Ugalde, Hector M.; Le Rolle, Virginie; Mabo, Philippe; Carrault, Guy; Hernandez, Alfredo I.] Univ Rennes 1, LTSI, F-35000 Rennes, France; [Bonnet, Jean-Luc; Henry, Christine] Sorin CRM SAS, Clamart, France; [Belo, Alain] INSERM, UMR970, Paris Cardiovasc Res Ctr, Paris, France; [Belo, Alain] Hop Europeen Georges Pompidou, AP HP, Dept Cardiol, Paris, France; [Belo, Alain] Paris Descartes Univ, PRES Paris Sorbonne, Paris, France; [Mabo, Philippe] CHU Rennes, Dept Cardiol, F-35000 Rennes, France; [Mabo, Philippe] INSERM, CIC IT 1414, F-35000 Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm)	Le Rolle, V (corresponding author), INSERM, U1099, F-35000 Rennes, France.; Le Rolle, V (corresponding author), Univ Rennes 1, LTSI, F-35000 Rennes, France.	virginie.lerolle@univ-rennes1.fr	carrault, guy/ABC-4463-2020; Hernández, Alfredo I/K-4933-2015; Le Rolle, Virginie/AAQ-7010-2020	carrault, guy/0000-0003-1482-2067; Hernández, Alfredo I/0000-0003-0765-2311; Le Rolle, Virginie/0000-0003-1068-5587; Romero Ugalde, Hector Manuel/0000-0002-7614-6474	BPIFRANCE within French "Investments for the future" program - INTENSE project; BPIFRANCE within French "Investments for the future" program INTENSE project	BPIFRANCE within French "Investments for the future" program - INTENSE project; BPIFRANCE within French "Investments for the future" program INTENSE project	This work was supported by BPIFRANCE within the framework of the French "Investments for the future" program (http://investissementsdavenir.bpifrance.fr) - INTENSE project. SORIN CRM SAS did not support financially the project. JLB and CH are employed by SORIN CRM SAS. No other authors received a salary or gratification from SORIN CRM SAS for their contribution to this work. The specific roles of the authors are articulated in the "author contributions" section.; This work was partially supported by BPIFRANCE within the framework of the French "Investments for the future" program INTENSE project.	Akhtar H, 2016, NEUROSCI BULL, V32, P115, DOI 10.1007/s12264-015-0009-2; Andreu D, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/2/026001; BILGUTAY AM, 1968, J THORAC CARDIOV SUR, V56, P71, DOI 10.1016/S0022-5223(19)42875-4; Buschman HP, 2006, NEUROMODULATION, V9, P214, DOI 10.1111/j.1525-1403.2006.00062.x; De Ferrari GM, 2009, IEEE ENG MED BIO, P2037, DOI 10.1109/IEMBS.2009.5334414; Hauptman PJ, 2012, AM HEART J, V163, P954, DOI 10.1016/j.ahj.2012.03.021; Healy S, 2013, CHILD NERV SYST, V29, P2095, DOI 10.1007/s00381-013-2143-3; Kobayashi M, 2013, ANN THORAC SURG, V96, P339, DOI 10.1016/j.athoracsur.2012.12.060; Ojeda D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163734; Pednault E. P. D., 1994, Journal of Logic and Computation, V4, P467, DOI 10.1093/logcom/4.5.467; Premchand RK, 2015, J CARD FAIL; Reiter R., 2001, KNOWLEDGE ACTION LOG; Romer H, 2016, BIOL CYBERN, V110, P247, DOI 10.1007/s00422-015-0672-4; Rousselet L, 2014, IEEE ENG MED BIO, P526, DOI 10.1109/EMBC.2014.6943644; Rychticki F, 2006, SEIZURE-EUR J EPILEP, V15, P483, DOI 10.1016/j.seizure.2006.06.001; Schwartz PJ, 2009, HEART RHYTHM, V6, pS76, DOI 10.1016/j.hrthm.2009.08.012; Tosato M, 2006, MED BIOL ENG COMPUT, V44, P161, DOI 10.1007/s11517-006-0037-1; Ugalde HMR, 2015, I IEEE EMBS C NEUR E, P462, DOI 10.1109/NER.2015.7146659; Ugalde HR, 2014, IEEE ENG MED BIO, P6262, DOI 10.1109/EMBC.2014.6945060; Waninger MS, 2000, PACE, V23, P1239, DOI 10.1111/j.1540-8159.2000.tb00937.x; Zannad F, 2015, EUR HEART J, V36, P425, DOI 10.1093/eurheartj/ehu345; Zhang YH, 2002, AM J PHYSIOL-HEART C, V282, pH1102, DOI 10.1152/ajpheart.00738.2001; Zhou YX, 2010, J BIOMED RES, V24, P107, DOI 10.1016/S1674-8301(10)60018-8	23	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186068	10.1371/journal.pone.0186068	http://dx.doi.org/10.1371/journal.pone.0186068			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077707	Green Published, gold, Green Submitted			2022-12-26	WOS:000413861200009
J	Zhang, XX; Chen, K; Wu, YD; Wiest, O				Zhang, Xiaoxiao; Chen, Kai; Wu, Yun-Dong; Wiest, Olaf			Protein dynamics and structural waters in bromodomains	PLOS ONE			English	Article							FORCE-FIELD; LYSINE ACETYLATION; HISTONE RECOGNITION; MOLECULAR-DYNAMICS; ATAD2 BROMODOMAIN; INHIBITORS; SIMULATIONS; METABOLISM; LANDSCAPE; PROGRESS	Bromodomains are epigenetic readers of acetylated lysines that are integral parts of histone tails. The 61 bromodomains in humans are structurally highly conserved but specifically bind to widely varying recognition motifs, suggesting that dynamic rather than static factors are responsible for recognition selectivity. To test this hypothesis, the dynamics of the binding sites and structural water molecules of four bromodomains (ATAD2, BAZ2B, BRD2(1) and CREBBP) representing four different subtypes is studied with 1 mu s MD simulations using the RSFF2 force field. The different dynamics of the ZA-loops and BC-loops between the four bromodomains leads to distinct patterns for the opening and closing of the binding pocket. This in turn determines the structural and energetic properties of the structural waters in the binding pocket, suggesting that these waters are not only important for the recognition itself, as has been proposed previously, but also contribute to the selectivity of different bromodomains.	[Zhang, Xiaoxiao; Chen, Kai; Wu, Yun-Dong; Wiest, Olaf] Peking Univ, Lab Computat Chem & Drug Design, Lab Chem Genom, Shenzhen Grad Sch, Shenzhen, Peoples R China; [Chen, Kai] South China Univ Technol, Sch Chem & Chem Engn, Key Lab Funct Mol Engn Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Wu, Yun-Dong] Peking Univ, Coll Chem & Mol Engn, Beijing, Peoples R China; [Wiest, Olaf] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	Peking University; University Town of Shenzhen; South China University of Technology; Peking University; University of Notre Dame	Wiest, O (corresponding author), Peking Univ, Lab Computat Chem & Drug Design, Lab Chem Genom, Shenzhen Grad Sch, Shenzhen, Peoples R China.; Wiest, O (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.	owiest@nd.edu	Wu, Yun-Dong/G-8463-2013; Chen, Kai/U-9373-2017; Chen, Kai/AAF-4663-2019	Chen, Kai/0000-0003-1012-0383; Chen, Kai/0000-0003-1012-0383; Wiest, Olaf/0000-0001-9316-7720	National Science Foundation of China [NSFC 21133002]; Shenzhen Peacock Program [JCYJ20140509093817689]; Nanshan District [KC2014ZDZJ0026A]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Peacock Program; Nanshan District	This work was supported by National Science Foundation of China (NSFC 21133002), Shenzhen Peacock Program (JCYJ20140509093817689), and Nanshan District (KC2014ZDZJ0026A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the National Science Foundation of China (NSFC 21133002) the Shenzhen Peacock Program (JCYJ20140509093817689) and the Nanshan District (KC2014ZDZJ0026A) for financial support.	Arking DE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002158; Bamborough P, 2015, J MED CHEM, V58, P6151, DOI 10.1021/acs.jmedchem.5b00773; Baud MGJ, 2014, SCIENCE, V346, P638, DOI 10.1126/science.1249830; Belkina AC, 2012, NAT REV CANCER, V12, P465, DOI 10.1038/nrc3256; Chaikuad A, 2014, MEDCHEMCOMM, V5, P1843, DOI 10.1039/c4md00237g; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Chung CW, 2012, J MED CHEM, V55, P576, DOI 10.1021/jm201320w; Crawford TD, 2016, J MED CHEM, V59, P5391, DOI 10.1021/acs.jmedchem.6b00264; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Dror RO, 2012, ANNU REV BIOPHYS, V41, P429, DOI 10.1146/annurev-biophys-042910-155245; Drouin L, 2015, J MED CHEM, V58, P2553, DOI 10.1021/jm501963e; Ferguson FM, 2014, BIOCHEMISTRY-US, V53, P6706, DOI 10.1021/bi500909d; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Flynn EM, 2015, STRUCTURE, V23, P1801, DOI 10.1016/j.str.2015.08.004; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hewings DS, 2012, J MED CHEM, V55, P9393, DOI 10.1021/jm300915b; Hnilicova J, 2013, MOL BIOL CELL, V24, P3557, DOI 10.1091/mbc.E13-06-0303; Huang DZ, 2014, CHEMMEDCHEM, V9, P573, DOI 10.1002/cmdc.201300156; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jiang F, 2014, J AM CHEM SOC, V136, P9536, DOI 10.1021/ja502735c; Jiang F, 2013, PHYS CHEM CHEM PHYS, V15, P3413, DOI 10.1039/c2cp43633g; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaypee S, 2016, PHARMACOL THERAPEUT, V162, P98, DOI 10.1016/j.pharmthera.2016.01.011; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li SX, 2015, J PHYS CHEM LETT, V6, P2127, DOI 10.1021/acs.jpclett.5b00654; Michel J, 2009, J PHYS CHEM B, V113, P13337, DOI 10.1021/jp9047456; Morozumi Y, 2016, J MOL CELL BIOL, V8, P349, DOI 10.1093/jmcb/mjv060; Picaud S, 2015, CANCER RES, V75, P5106, DOI 10.1158/0008-5472.CAN-15-0236; Poncet-Montange G, 2015, BIOCHEM J, V466, P337, DOI 10.1042/BJ20140933; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Revenko AS, 2010, MOL CELL BIOL, V30, P5260, DOI 10.1128/MCB.00484-10; Romero FA, 2016, J MED CHEM, V59, P1271, DOI 10.1021/acs.jmedchem.5b01514; Schrodinger, 2010, PYMOL MOL GRAPHICS S; Steiner S, 2013, FEBS LETT, V587, P2158, DOI 10.1016/j.febslet.2013.05.032; Verdin E, 2015, NAT REV MOL CELL BIO, V16, P258, DOI 10.1038/nrm3931; Vidler LR, 2012, J MED CHEM, V55, P7346, DOI 10.1021/jm300346w; Waring MJ, 2016, NAT CHEM BIOL, V12, P1097, DOI [10.1038/NCHEMBIO.2210, 10.1038/nchembio.2210]; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Zhang GT, 2012, J MED CHEM, V55, P7342, DOI 10.1021/jm3011977; Zhou CY, 2015, J CHEM THEORY COMPUT, V11, P5473, DOI 10.1021/acs.jctc.5b00581; Zhou CY, 2015, J PHYS CHEM B, V119, P1035, DOI 10.1021/jp5064676	45	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186570	10.1371/journal.pone.0186570	http://dx.doi.org/10.1371/journal.pone.0186570			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077715	Green Published, Green Submitted, gold			2022-12-26	WOS:000413861200012
J	Lee, YH; Kim, KN; Heo, DW; Kang, TS; Lee, SB; Kim, CS				Lee, Yeon Hee; Kim, Kyoung Nam; Heo, Dong Won; Kang, Tae Seen; Lee, Sung Bok; Kim, Chang-sik			Difference in patterns of retinal ganglion cell damage between primary open-angle glaucoma and non-arteritic anterior ischaemic optic neuropathy	PLOS ONE			English	Article							NERVE-FIBER LAYER; COHERENCE TOMOGRAPHY; DIAGNOSTIC-ACCURACY; DISC MORPHOLOGY; CIRRUS HD; THICKNESS; TOPOGRAPHY; OPHTHALMOSCOPY; PREVALENCE; COMPLEX	Purpose To compare the patterns of retinal ganglion cell damage between primary open-angle glaucoma (POAG) and non-arteritic anterior ischaemic optic neuropathy (NAION). Methods In total, 35 eyes with unilateral NAION, and 70 age-and average peripapillary retinal nerve fibre layer (RNFL) thickness-matched eyes with POAG, were enrolled as disease groups; 35 unaffected fellow eyes of the NAION, and 70 age-and refractive error-matched normal subjects for the POAG, were enrolled as their control groups, respectively. The peripapillary RNFL thickness and macular ganglion cell plus inner plexiform layer (GCIPL) thickness were compared between the disease groups and their controls, and between the two disease groups. Results Mean RNFL thicknesses at the 1 and 2 o'clock (superonasal) positions were thinner in NAION than in POAG (both p < 0.05). Mean RNFL thickness at 7 o'clock (inferotemporal) was thinner in POAG than in NAION (p = 0.001). Although there was no significant difference between NAION and POAG in average GCIPL thickness, all of the sectoral GCIPL thicknesses were thinner in NAION (all p < 0.05), except in the inferior and inferotemporal sectors. The ranges of the clock-hour RNFL with damage greater than the average RNFL thickness reduction, versus fellow eyes and control eyes, were 7 hours in NAION and 4 hours in POAG. Conclusions The more damaged clock-hour RNFL regions differed between NAION (1 and 2 o'clock) and POAG (7 o'clock). Most sectoral GCIPL thicknesses were thinner in NAION than in POAG.	[Lee, Yeon Hee; Kim, Kyoung Nam; Heo, Dong Won; Kang, Tae Seen; Lee, Sung Bok; Kim, Chang-sik] Chungnam Natl Univ, Sch Med, Dept Ophthalmol, Chungnam Natl Univ Hosp, Daejeon, South Korea	Chungnam National University; Chungnam National University Hospital	Kim, KN (corresponding author), Chungnam Natl Univ, Sch Med, Dept Ophthalmol, Chungnam Natl Univ Hosp, Daejeon, South Korea.	kknace@cnuhco.kr		Kim, Kyoung Nam/0000-0003-3898-3236; LEE, SUNG-BOK/0000-0002-9665-6463; Lee, Yeon-Hee/0000-0003-0993-7548; Kim, Chang-sik/0000-0001-9595-244X				Aggarwal D, 2012, INVEST OPHTH VIS SCI, V53, P4539, DOI 10.1167/iovs.11-9300; Larrea BA, 2014, GRAEF ARCH CLIN EXP, V252, P1839, DOI 10.1007/s00417-014-2697-0; Arnold AC, 2003, J NEURO-OPHTHALMOL, V23, P157, DOI 10.1097/00041327-200306000-00012; Arnold AC, 2002, SEMINARS OPHTHALMOLO; Bowd C, 2006, INVEST OPHTH VIS SCI, V47, P2889, DOI 10.1167/iovs.05-1489; Contreras I, 2007, OPHTHALMOLOGY, V114, P2338, DOI 10.1016/j.ophtha.2007.05.042; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; Danesh-Meyer HV, 2010, INVEST OPHTH VIS SCI, V51, P2003, DOI 10.1167/iovs.09-3492; Danesh-Meyer HV, 2001, OPHTHALMOLOGY, V108, P593, DOI 10.1016/S0161-6420(00)00602-3; ELLENBERGER C, 1973, ARCH NEUROL-CHICAGO, V28, P182, DOI 10.1001/archneur.1973.00490210062008; Fard MA, 2016, INVEST OPHTH VIS SCI, V57, P1011, DOI 10.1167/iovs.15-18618; Fiscella RG, 2003, AM J OPHTHALMOL, V136, P18, DOI 10.1016/S0002-9394(03)00102-8; Gerling J, 1998, GRAEF ARCH CLIN EXP, V236, P188, DOI 10.1007/s004170050062; Gonul S, 2013, BRIT J OPHTHALMOLOGY; Hayreh SS, 2005, ARCH OPHTHALMOL-CHIC, V123, P1554, DOI 10.1001/archopht.123.11.1554; HAYREH SS, 1974, BRIT J OPHTHALMOL, V58, P964, DOI 10.1136/bjo.58.12.964; Hood DC, 2008, OPHTHALMOLOGY, V115, P904, DOI 10.1016/j.ophtha.2007.06.001; Hood DC, 2013, PROG RETIN EYE RES, V32, P1, DOI 10.1016/j.preteyeres.2012.08.003; Horowitz J, 2010, GRAEF ARCH CLIN EXP, V248, P845, DOI 10.1007/s00417-010-1323-z; HOYT WF, 1962, ARCH OPHTHALMOL-CHIC, V68, P94, DOI 10.1001/archopht.1962.00960030098018; Hwang YH, 2015, CLIN EXP OPHTHALMOL, V43, P720, DOI 10.1111/ceo.12545; Hwang YH, 2012, INVEST OPHTH VIS SCI, V53, P2226, DOI 10.1167/iovs.11-8689; Janz NK, 2001, OPHTHALMOLOGY, V108, P887, DOI 10.1016/S0161-6420(00)00624-2; Jeoung JW, 2013, INVEST OPHTH VIS SCI, V54, P4422, DOI 10.1167/iovs.12-11273; JOHNSON LN, 1994, J NEURO-OPHTHALMOL, V14, P38; JONAS JB, 1993, INVEST OPHTH VIS SCI, V34, P2260; JONAS JB, 1993, OPHTHALMOLOGY, V100, P63; Kim YK, 2016, INVEST OPHTH VIS SCI, V57, P5856, DOI 10.1167/iovs.16-20116; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Leung CKS, 2009, OPHTHALMOLOGY, V116, P1257, DOI 10.1016/j.ophtha.2009.04.013; Mwanza JC, 2012, OPHTHALMOLOGY, V119, P1151, DOI 10.1016/j.ophtha.2011.12.014; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P8323, DOI 10.1167/iovs.11-7962; OLVER JM, 1990, EYE, V4, P7, DOI 10.1038/eye.1990.3; ONDA E, 1995, AM J OPHTHALMOL, V120, P92, DOI 10.1016/S0002-9394(14)73763-8; Park SB, 2009, ARCH OPHTHALMOL-CHIC, V127, P1603, DOI 10.1001/archophthalmol.2009.296; Quigley H, 1976, T SECTION OPHTHALMOL, V83, P755; QUIGLEY HA, 1988, OPHTHALMOLOGY, V95, P357; Saito H, 2006, OPHTHALMOLOGY, V113, P1340, DOI 10.1016/j.ophtha.2006.01.072; Seo SJ, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/1690256; Suh MH, 2013, GRAEF ARCH CLIN EXP, V251, P2617, DOI 10.1007/s00417-013-2468-3; Suh MH, 2011, AM J OPHTHALMOL, V151, P277, DOI 10.1016/j.ajo.2010.08.033; Tan O, 2009, OPHTHALMOLOGY, V116, P2305, DOI 10.1016/j.ophtha.2009.05.025; Tesser RA, 2003, OPHTHALMOLOGY, V110, P2031, DOI 10.1016/S0161-6420(03)00804-2; TROBE JD, 1980, ARCH OPHTHALMOL-CHIC, V98, P1040, DOI 10.1001/archopht.1980.01020031030003	44	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187093	10.1371/journal.pone.0187093	http://dx.doi.org/10.1371/journal.pone.0187093			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073261	Green Submitted, Green Published, gold			2022-12-26	WOS:000413845400112
J	Fujita-Yamaguchi, Y; Bagramyan, K; Yamaguchi, Y; Ikeda, A; Dohmae, N; Hong, TB; Kalkum, M				Fujita-Yamaguchi, Yoko; Bagramyan, Karine; Yamaguchi, Yoshiki; Ikeda, Akemi; Dohmae, Naoshi; Hong, Teresa B.; Kalkum, Markus			Mass spectrometric revival of an l-rhamnose- and d-galactose-specific lectin from a lost strain of Streptomyces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate-binding protein; lectin; mass spectrometry (MS); microarray; nuclear magnetic resonance (NMR); protein sequence; recombinant protein expression; glycan; rhamnose binding; Streptomyces	BINDING LECTINS; EXPRESSION; REVEALS; EGGS	Blood type B-specific Streptomyces sp. 27S5 hemagglutinin (SHA) was discovered and characterized in the 1970s. Although strain 27S5 has been lost, the purified SHA protein survived intact under frozen conditions and retained its activity. Using modern techniques, here we further characterized SHA. Fourier-transform ion cyclotron resonance MS analysis determined the average molecular mass of SHA as 13,314.67 Da. MS of digested SHA peptides, Streptomyces genomic database matching, and N-terminal sequencing solved the 131-residue amino acid sequence of SHA. We found that SHA is homologous to N-terminally truncated hypothetical proteins encoded by the genomes of Streptomyces lavendulae, Streptomyces sp. Mg1, and others. The gene of the closest homologue in S. lavendulae, a putative polysaccharide deacetylase (PDSL), encodes 68 additional N-terminal amino acids, and its C terminus perfectly matched the SHA sequence, except for a single Ala-to-Glu amino acid difference. We expressed recombinant SHA(PDSL-A108E) (rSHA) as an enzymatically cleavable fusion protein in Escherichia coli, and glycan microarray analyses indicated that refolded rSHA exhibits the blood type B- and l-rhamnose-specific characteristics of authentic SHA, confirming that rSHA is essentially identical with SHA produced by Streptomyces sp. 27S5. We noted that SHA comprises three similar domains, representing 70% of the protein, and that these SHA domains partially overlap with annotated clostridial hydrophobic with conserved W domains. Furthermore, examination of GFP-tagged SHA revealed binding to microbial surfaces. rSHA may be useful both for studying the role of SHA/clostridial hydrophobic with conserved W domains in carbohydrate binding and for developing novel diagnostics and therapeutics for l-rhamnose-containing microorganisms.	[Fujita-Yamaguchi, Yoko] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol & Cellular Biol, Duarte, CA 91010 USA; [Fujita-Yamaguchi, Yoko] City Hope Natl Med Ctr, Beckman Res Inst, Dept Diabet Complicat & Metab, 1500 East Duarte Rd, Duarte, CA 91010 USA; [Bagramyan, Karine; Hong, Teresa B.; Kalkum, Markus] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Immunol, 1500 East Duarte Rd, Duarte, CA 91010 USA; [Yamaguchi, Yoshiki; Ikeda, Akemi] RIKEN Global Res Cluster, Struct Glycobiol Team, Syst Glycobiol Res Grp, Wako, Saitama 3510198, Japan; [Dohmae, Naoshi] RIKEN, RIKEN Ctr Sustainable Resource Sci, Biomol Characterizat Unit, Wako, Saitama 3510198, Japan	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; RIKEN; RIKEN	Fujita-Yamaguchi, Y (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Diabet Complicat & Metab, 1500 East Duarte Rd, Duarte, CA 91010 USA.; Kalkum, M (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Immunol, 1500 East Duarte Rd, Duarte, CA 91010 USA.	yyamaguchi@coh.org; mkalkum@coh.org	Dohmae, Naoshi/C-2040-2011; Yamaguchi, Yoshiki/N-5246-2015	Dohmae, Naoshi/0000-0002-5242-9410; Yamaguchi, Yoshiki/0000-0003-0100-5439; Kalkum, Markus/0000-0002-9506-671X	NCI, National Institutes of Health [P30 CA33572]; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. Paul Straight of Texas A&M University for the kind gift of Streptomyces sp. Mg1. We also thank Dr. Alexander Pozhitkov for helping with microarray reader setup and Dr. Sarah T. Wilkinson for editing the manuscript. Y. F.-Y. thanks the late Drs. Kunio Oishi, Koichi Suzuki, and Kazutomo Imahori for the excellent mentoring and valuable comments she received while conducting the initial phase of this research at the University of Tokyo Graduate School. City of Hope facilities, including the Integrative Genomics Core used in this study, were supported, in part, by the NCI, National Institutes of Health under Grant P30 CA33572.	Carpentier G., 2010, IMAGEJ NEWS, V10; Cheng HN, 2012, POLYM REV, V52, P81, DOI 10.1080/15583724.2012.668154; Fujimoto Z, 2013, J BIOL CHEM, V288, P12376, DOI 10.1074/jbc.M113.460097; FUJITA Y, 1975, BIOCHEMISTRY-US, V14, P4465, DOI 10.1021/bi00691a019; FUJITA Y, 1972, J GEN APPL MICROBIOL, V18, P73, DOI 10.2323/jgam.18.73; FUJITA Y, 1973, BIOCHEM BIOPH RES CO, V53, P495, DOI 10.1016/0006-291X(73)90689-X; Fujita Y., 1976, THESIS; FUJITAYAMAGUCHI Y, 1982, BIOCHIM BIOPHYS ACTA, V701, P86, DOI 10.1016/0167-4838(82)90315-6; Guerrero F, 2015, PROTEIN EXPRES PURIF, V116, P42, DOI 10.1016/j.pep.2015.08.019; Harrison J, 2014, MICROB BIOTECHNOL, V7, P373, DOI 10.1111/1751-7915.12143; Hoefler BC, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00535-13; Hosono M, 1999, BBA-GEN SUBJECTS, V1472, P668, DOI 10.1016/S0304-4165(99)00185-3; Negre-Salvayre A, 2009, ANTIOXID REDOX SIGN, V11, P3071, DOI [10.1089/ars.2009.2484, 10.1089/ARS.2009.2484]; Ng SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115296; Nolling J, 2001, J BACTERIOL, V183, P4823, DOI 10.1128/JB.183.16.4823-4838.2001; Ogawa Tomohisa, 2011, J Amino Acids, V2011, P838914, DOI 10.4061/2011/838914; OSMAN ME, 1993, J AGR FOOD CHEM, V41, P71, DOI 10.1021/jf00025a016; OZEKI Y, 1995, EXP CELL RES, V216, P318, DOI 10.1006/excr.1995.1040; SHARON N, 1987, FEBS LETT, V217, P145, DOI 10.1016/0014-5793(87)80654-3; Sullivan L, 2007, ENZYME MICROB TECH, V42, P29, DOI 10.1016/j.enzmictec.2007.07.022; Tateno H, 2002, BIOSCI BIOTECH BIOCH, V66, P604, DOI 10.1271/bbb.66.604; Tateno H, 2002, BIOSCI BIOTECH BIOCH, V66, P1356, DOI 10.1271/bbb.66.1356; Tateno H, 1998, J BIOL CHEM, V273, P19190, DOI 10.1074/jbc.273.30.19190; Tateno H, 2010, BIOSCI BIOTECH BIOCH, V74, P1141, DOI 10.1271/bbb.100086; Terada T, 2007, BBA-GEN SUBJECTS, V1770, P617, DOI 10.1016/j.bbagen.2006.11.003; Watanabe Y, 2009, DEV COMP IMMUNOL, V33, P187, DOI 10.1016/j.dci.2008.08.008; Yasuda E, 2011, APPL ENVIRON MICROB, V77, P4539, DOI 10.1128/AEM.00240-11; Zhang QB, 2009, J PROTEOME RES, V8, P754, DOI 10.1021/pr800858h	28	3	3	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					368	378		10.1074/jbc.M117.812719	http://dx.doi.org/10.1074/jbc.M117.812719			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29101228	Green Published, hybrid			2022-12-26	WOS:000419453200031
J	Bond, JG; Ramirez-Osorio, A; Marina, CF; Fernandez-Salas, I; Liedo, P; Dor, A; Williams, T				Bond, J. G.; Ramirez-Osorio, A.; Marina, C. F.; Fernandez-Salas, I.; Liedo, P.; Dor, A.; Williams, T.			Efficiency of two larval diets for mass-rearing of the mosquito Aedes aegypti	PLOS ONE			English	Article							ALBOPICTUS DIPTERA-CULICIDAE; DISPERSAL; OUTBREAKS; DISEASE; MALES	Aedes aegypti is a major vector of arboviruses that may be controlled on an area-wide basis using the sterile insect technique (SIT). Larval diet is a major factor in mass-rearing for SIT programs. We compared dietary effects on immature development and adult fitness-related characteristics for an International Atomic Energy Agency (IAEA) diet, developed for rearing Ae. albopictus, and a standardized laboratory rodent diet (LRD), under a 14:10 h (light:dark) photoperiod ("light" treatment) or continuous darkness during larval rearing. Larval development was generally fastest in the IAEA diet, likely reflecting the high protein and lipid content of this diet. The proportion of larvae that survived to pupation or to adult emergence did not differ significantly between diets or light treatments. Insects from the LRD-dark treatment produced the highest proportion of male pupae (93% at 24 h after the beginning of pupation) whereas adult sex ratio from the IAEA diet tended to be more male-biased than that of the LRD diet. Adult longevity did not differ significantly with larval diet or light conditions, irrespective of sex. In other aspects the LRD diet generally performed best. Adult males from the LRD diet were significantly larger than those from the IAEA diet, irrespective of light treatment. Females from the LRD diet had-25% higher fecundity and-8% higher egg fertility compared to those from the IAEA diet. Adult flight ability did not differ between larval diets, and males had a similar number of copulations with wild females, irrespective of larval diet. The LRD diet had lower protein and fat content but a higher carbohydrate and energetic content than the IAEA diet. We conclude that the LRD diet is a low-cost standardized diet that is likely to be suitable for mass-rearing of Ae. aegypti for area-wide SIT-based vector control.	[Bond, J. G.; Ramirez-Osorio, A.; Marina, C. F.; Fernandez-Salas, I.] INSP, CRISP, Tapachula, Chiapas, Mexico; [Liedo, P.; Dor, A.] Colegio Frontera Sur ECOSUR, Tapachula, Chiapas, Mexico; [Williams, T.] Inst Ecol AC INECOL, Xalapa, Veracruz, Mexico	El Colegio de la Frontera Sur (ECOSUR); Instituto de Ecologia - Mexico	Williams, T (corresponding author), Inst Ecol AC INECOL, Xalapa, Veracruz, Mexico.	trevor.inecol@gmail.com	Williams, Trevor/ABG-3961-2020; Liedo, Pablo/E-9313-2010; Dor, Ariane/A-7975-2013; Dor, Ariane/AAQ-7554-2020; Williams, Trevor/F-1447-2011	Liedo, Pablo/0000-0002-0004-1721; Dor, Ariane/0000-0002-3483-9547; Williams, Trevor/0000-0003-3414-3440; Marina Fernandez, Carlos Felix/0000-0002-4804-8949	Fondo Institucional del Consejo Nacional de Ciencia y Tecnologia (FOINS-CONACYT) [247673]	Fondo Institucional del Consejo Nacional de Ciencia y Tecnologia (FOINS-CONACYT)	The study received financial support from the Fondo Institucional del Consejo Nacional de Ciencia y Tecnologia (FOINS-CONACYT) project 247673. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Arrivillaga J, 2004, J VECTOR ECOL, V29, P11; Balestrino F, 2010, J MED ENTOMOL, V47, P581, DOI 10.1603/ME09272; Balestrino F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091914; Bargielowski I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020699; Bellini R., 2007, P505, DOI 10.1007/978-1-4020-6059-5_47; Benedict MQ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S4; BRIEGEL H, 1990, J INSECT PHYSIOL, V36, P165, DOI 10.1016/0022-1910(90)90118-Y; Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281; *CDCP, 2016, SURV CONTR AED AEG A; CHAMBERS GM, 1990, J AM MOSQUITO CONTR, V6, P394; CLEMENTS AN, 1955, J EXP BIOL, V32, P547; Damiens D, 2012, J MED ENTOMOL, V49, P1001, DOI 10.1603/ME11289; Dyck V.A., 2006, STERILE INSECT TECHN; Fernandez-Salas I, 2015, ANTIVIR RES, V124, P30, DOI 10.1016/j.antiviral.2015.10.015; Gerberg EJ, 1970, B AM MOSQ CONTROL AS, V5, P1; Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302; Joslyn M.A., 1970, METHODS FOOD ANAL PH; Joy TK, 2010, EXP GERONTOL, V45, P685, DOI 10.1016/j.exger.2010.04.009; Karunamoorthi K, 2013, HEALTH SCOPE, V2, DOI 10.17795/jhealthscope-9840; KLOWDEN MJ, 1986, J INSECT PHYSIOL, V32, P479, DOI 10.1016/0022-1910(86)90009-0; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Lee SS, 2013, J THEOR BIOL, V331, P78, DOI 10.1016/j.jtbi.2013.04.014; Lees RS, 2015, CURR OPIN INSECT SCI, V10, P156, DOI 10.1016/j.cois.2015.05.011; Maciel-De-Freitas R, 2007, MED VET ENTOMOL, V21, P284, DOI 10.1111/j.1365-2915.2007.00694.x; Marina CF, 1999, OECOLOGIA, V119, P383, DOI 10.1007/s004420050799; Mellanby K., 1958, Entomologia Experimentalis et Applicata, V1, P153, DOI 10.1007/BF00291058; NASCI RS, 1991, J MED ENTOMOL, V28, P522, DOI 10.1093/jmedent/28.4.522; OMARDEEN T. A., 1957, BULL ENT RES, V48, P349, DOI 10.1017/S0007485300047180; Parker AG, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P209, DOI 10.1007/1-4020-4051-2_8; Ptitsyn AA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-153; Puggioli A, 2013, J MED ENTOMOL, V50, P819, DOI 10.1603/ME13011; Rund SSC, 2016, INSECTS, V7, DOI 10.3390/insects7020014; Soekiman S., 1984, ICMR ANN, V4, P143; Souza JA, 2007, COMP BIOCHEM PHYS A, V147, P993, DOI 10.1016/j.cbpa.2007.03.008; TAYLOR B, 1969, J EXP BIOL, V51, P59; THOMAS IM, 1950, AUST J SCI RES SER B, V3, P113, DOI 10.1071/BI9500113; VANHANDEL E, 1988, J AM MOSQUITO CONTR, V4, P374; VANHANDEL E, 1965, J PHYSIOL-LONDON, V181, P478, DOI 10.1113/jphysiol.1965.sp007776; Yee DA, 2012, J MED ENTOMOL, V49, P825, DOI 10.1603/ME11132	41	35	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187420	10.1371/journal.pone.0187420	http://dx.doi.org/10.1371/journal.pone.0187420			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095933	Green Submitted, gold, Green Published			2022-12-26	WOS:000414340200086
J	Yoo, YJ; Yang, HK; Kim, N; Hwang, JM				Yoo, Yung Ju; Yang, Hee Kyung; Kim, Namju; Hwang, Jeong-Min			Pediatric orbital wall fractures: Prognostic factors of diplopia and ocular motility limitation	PLOS ONE			English	Article							BLOW-OUT FRACTURES; FLOOR FRACTURES; TRAPDOOR FRACTURE; MUSCLE INVOLVEMENT; CHILDREN; OUTCOMES; REPAIR; SURGERY; ADOLESCENTS; MANAGEMENT	Objectives To investigate the factors affecting recovery of diplopia and limited ocular motility in pediatric patients who underwent surgery for orbital wall fracture. Design Retrospective observational case series. Methods In this retrospective observational case series, 150 pediatric patients (1-18 years old) who were diagnosed with orbital medial wall or floor fracture and underwent corrective surgery between 2004 and 2016 at Seoul National University Bundang Hospital were included. The medical records of patients with orbital medial wall or floor fracture were reviewed, including sex, age, diplopia, ocular motility, preoperative computed tomographic finding, and surgical outcomes. Factors affecting recovery of diplopia and ocular motility limitation were analyzed. Results Of the 150 patients (134 boys; mean age, 14.4 years) who underwent corrective surgery for orbital wall fracture, preoperative binocular diplopia was found in 76 (50.7%) patients and limited ocular motility in 81 (54.0%). Presence of muscle incarceration or severe supraduction limitation delayed the recovery of diplopia. In case of ocular motility limitation, presence of muscle incarceration and retrobulbar hemorrhage were related with the delayed resolution. Multivariate analysis revealed supraduction limitation (Hazard ratio [HR] = 1.74, 95% confidence interval [CI] = 1.19-2.55), larger horizontal orbital floor defects (HR = 1.22, 95% CI = 1.07-1.38), and shorter time interval to first visit (HR = 0.73) as negative prognostic factors for the recovery of diplopia. In addition, muscle incarceration (HR = 3.53, 95% CI = 1.54-8.07) and retrobulbar hemorrhage (HR = 3.77, 95% CI = 1.45-9.82) were found as negative prognostic factors for the recovery of motility limitation. Conclusions Presence of muscle incarceration and retrobulbar hemorrhage, horizontal length of floor fracture, supraduction limitation, and time interval from trauma to first visit were correlated with the surgical outcomes in pediatric orbital wall fracture patients. These results strengthen that the soft tissue damage associated with bony fracture affects the orbital functional unit. When managing children with orbital wall fracture, meticulous physical examination and thorough preoperative computed tomography based evaluation will help physicians to identify damage of orbital functional unit.	[Yoo, Yung Ju] Kangwon Natl Univ, Kangwon Natl Univ Hosp, Grad Sch Med, Dept Ophthalmol, Chunchon, South Korea; [Yang, Hee Kyung; Kim, Namju; Hwang, Jeong-Min] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Seongnam, South Korea	Kangwon National University; Kangwon National University Hospital; Seoul National University (SNU)	Kim, N; Hwang, JM (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Seongnam, South Korea.	resourceful@hanmail.net; hjm@snu.ac.kr						ANDERSON PJ, 1995, J CRANIO MAXILL SURG, V23, P151, DOI 10.1016/S1010-5182(05)80003-4; Bansagi ZC, 2000, OPHTHALMOLOGY, V107, P829, DOI 10.1016/S0161-6420(00)00015-4; Burnstine MA, 2002, OPHTHALMOLOGY, V109, P1207, DOI 10.1016/S0161-6420(02)01057-6; Carroll SC, 2010, BRIT J OPHTHALMOL, V94, P736, DOI 10.1136/bjo.2008.155143; CONVERSE J M, 1960, Trans Am Acad Ophthalmol Otolaryngol, V64, P676; Cope MR, 1999, BRIT J ORAL MAX SURG, V37, P46, DOI 10.1054/bjom.1998.0382; Dal Canto AJ, 2008, OPHTHAL PLAST RECONS, V24, P437, DOI 10.1097/IOP.0b013e31818aac9b; DEMAN K, 1991, INT J ORAL MAX SURG, V20, P330, DOI 10.1016/S0901-5027(05)80260-7; Egbert JE, 2000, OPHTHALMOLOGY, V107, P1875, DOI 10.1016/S0161-6420(00)00334-1; Gerbino G, 2010, J ORAL MAXIL SURG, V68, P1310, DOI 10.1016/j.joms.2009.12.037; Grant JH, 2002, PLAST RECONSTR SURG, V109, P482, DOI 10.1097/00006534-200202000-00011; Harris GJ, 2006, EYE, V20, P1207, DOI 10.1038/sj.eye.6702384; Hatt SR, 2007, OPHTHALMOLOGY, V114, P2316, DOI 10.1016/j.ophtha.2007.01.033; Hink EM, 2014, OPHTHAL PLAST RECONS, V30, P124, DOI 10.1097/IOP.0000000000000026; Hink Eric M, 2013, Int Ophthalmol Clin, V53, P103, DOI 10.1097/IIO.0b013e31828b7913; Iliff N, 1999, PLAST RECONSTR SURG, V103, P787, DOI 10.1097/00006534-199903000-00004; Jordan DR, 1998, OPHTHALMIC PLAST REC, V14, P379, DOI 10.1097/00002341-199811000-00001; Kwon JH, 2005, ARCH OTOLARYNGOL, V131, P723, DOI 10.1001/archotol.131.8.723; Lee WT, 2009, J CRANIOFAC SURG, V20, P75, DOI 10.1097/SCS.0b013e318190df0d; Neinstein RM, 2012, J PLAST RECONSTR AES, V65, P869, DOI 10.1016/j.bjps.2012.02.004; Park MS, 2012, ARCH PLAST SURG-APS, V39, P204, DOI 10.5999/aps.2012.39.3.204; Shin KH, 2011, J CRANIOFAC SURG, V22, P1426, DOI 10.1097/SCS.0b013e31821cc2cd; Stotland MA, 2011, J CRANIOFAC SURG, V22, P1230, DOI 10.1097/SCS.0b013e31821c0f52; Su Y, 2015, J NANOMATER, V2015, DOI 10.1155/2015/276753; Wachler BSB, 1998, OPHTHALMIC PLAST REC, V14, P17; Wang Ning-Chia, 2010, Chang Gung Med J, V33, P313; Wei LA, 2011, J AAPOS, V15, P173, DOI 10.1016/j.jaapos.2011.02.005; Yang JW, 2015, J CRANIO MAXILL SURG, V43, P444, DOI 10.1016/j.jcms.2015.01.010; Yano H, 2010, J CRANIOFAC SURG, V21, P1072, DOI 10.1097/SCS.0b013e3181e20647; Yoon KC, 2003, J KOREAN MED SCI, V18, P881, DOI 10.3346/jkms.2003.18.6.881; Yu DY, 2016, ANN PLAS SURG, V76, pS91, DOI 10.1097/SAP.0000000000000726	31	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0184945	10.1371/journal.pone.0184945	http://dx.doi.org/10.1371/journal.pone.0184945			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095826	gold, Green Published, Green Submitted			2022-12-26	WOS:000414340200004
J	Kawatsu, L; Uchimura, K; Ohkado, A				Kawatsu, Lisa; Uchimura, Kazuhiro; Ohkado, Akihiro			Trend and treatment status of latent tuberculosis infection patients in Japan Analysis of Japan TB Surveillance data	PLOS ONE			English	Article							CONTACT INVESTIGATIONS; TREATMENT COMPLETION	Objective and method Management of latent tuberculosis infection (LTBI) is one of the core elements of End TB Strategy. Japan is one of the few countries in which notification of LTBI is mandatory, yet so far, the data has not been analyzed in detail. We thus conducted a cross-sectional study to examine the trend of LTBI, its treatment outcome and factors predicting treatment non-completion in Japan for the period of 2007 and 2014, using the data from the electronic Japan Tuberculosis Surveillance system. Treatment completion was defined as those whose reason for terminating the treatment was recorded as "treatment completed" and whose treatment duration was 180 days or more. Results During the study period, a total of 50,268 LTBI patients were notified, of which 49,525, who had started treatment, were analyzed for characteristics. 57.5% were females, and 38.5% were aged 25-44 years. As for the job category, healthcare professionals, that is medical doctors, nurses and other healthcare workers, consisted the largest group (30.4%). Overall, the number of LTBI notification has been on an increase, with a large increase observed among those aged 65 years and above. Of the 49,525 patients, the information regarding reason for termination of treatment was available for 46,128 (93.1%). Of them, 33,156 (71.9%) had completed treatment as according to the study definition. The risk factors for not completing LTBI treatment included being aged 65 years and above (adjusted odds ratio [aOR] 1.27, 95% confidence interval [95%Cl] 1.10-1.47), foreign-born (aOR 1.14, 95%Cl 1.02-1.28), healthcare professional (aOR 1.44, 95%Cl 1.24-1.69), full-time and part-time worker (aOR 1.40, 95%Cl, 1.20-1.63) and detected via contact investigation (aOR 1.26, 95%Cl 1.12-1.41). Conclusions Our study results revealed that the treatment completion rate was 71.9%, falling short of the national target of 85%, and also that the treatment duration was recorded as less than 180 days for approximately 20% of those who were reported as having completed treatment. Further studies may be built on ours to explore the reasons for not completing the treatment across different population groups, and identify those who benefit the most, and who has the greatest impact on ending TB, by receiving LTBI treatment.	[Kawatsu, Lisa; Uchimura, Kazuhiro; Ohkado, Akihiro] Japan AntiTB Assoc RIT JATA, Res Inst TB, Dept Epidemiol & Clin Res, Tokyo, Japan		Kawatsu, L (corresponding author), Japan AntiTB Assoc RIT JATA, Res Inst TB, Dept Epidemiol & Clin Res, Tokyo, Japan.	kawatsu@jata.or.jp	Ohkado, Akihiro/HGF-2977-2022		Japan Society for the Promotion of Science [16K09155]; LK	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); LK	This work was supported by grant 16K09155, Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science (http:// tutivwtsps.gotp/kgrantsinaid/index.html). Funding was received by LK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, MISSED OPPORTUNITIES, V49, P685; Bock NM, 1999, AM J RESP CRIT CARE, V159, P295, DOI 10.1164/ajrccm.159.1.9807020; Brassard P, 2004, INT J TUBERC LUNG D, V8, P988; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Erkens CGM, 2016, EUR RESPIR J, V47, P1492, DOI 10.1183/13993003.01397-2015; Horsburgh CR, 2010, CHEST, V137, P401, DOI 10.1378/chest.09-0394; Ishikawa N, 2010, GUIDELINE TUBERCULOS; Izumi K, 2017, INT J TUBERC LUNG D, V21, P188, DOI 10.5588/ijtld.16.0508; Kasai K, 2015, KEKKAKU, V90, P507; Lardizabal A, 2006, CHEST, V130, P1712, DOI 10.1378/chest.130.6.1712; Lavigne M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-66; Lobato MN, 2005, CHEST, V127, P1296, DOI 10.1378/chest.127.4.1296; Lobue P, 1993, CHEST, V113, P1184; LoBue PA, 2003, AM J RESP CRIT CARE, V168, P443, DOI 10.1164/rccm.200303-390OC; Marks SM, 2000, AM J RESP CRIT CARE, V162, P2033, DOI 10.1164/ajrccm.162.6.2004022; Menzies D, 2004, AM J RESP CRIT CARE, V170, P445, DOI 10.1164/rccm.200404-478OC; Nyamathi AM, 2006, INT J TUBERC LUNG D, V10, P775; Ohkado Akihiro, 2015, Kekkaku, V90, P657; Page KR, 2006, ARCH INTERN MED, V166, P1863, DOI 10.1001/archinte.166.17.1863; Parsyan AE, 2007, J INFECTION, V54, P262, DOI 10.1016/j.jinf.2006.04.010; RamphalNaley L, 1996, AM J INFECT CONTROL, V24, P243, DOI 10.1016/S0196-6553(96)90056-5; Shieh FK, 2006, AM J RESP CRIT CARE, V174, P717, DOI 10.1164/rccm.200510-1667OC; The Prevention Committee and the Treatment Committee of the Japanese Society for Tuberculosis, 2013, TREATMENT GUIDELINE, V88, P497; White MC, 2005, HEALTH EDUC RES, V20, P163, DOI 10.1093/her/cyg109; World Health Organisation, 2015, GUID MAN LAT TUB INF; World Health Organization, 2015, IMPL END TB STRAT ES	26	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11								10.1371/journal.pone.018588	http://dx.doi.org/10.1371/journal.pone.018588			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091917				2022-12-26	WOS:000414229700025
J	Auckle, R; Su, BJ; Li, HL; Xu, SL; Xie, MJ; Song, YC; Quddus, MA; Xu, YW; Liu, B; Che, WL				Auckle, Ranshaka; Su, Binjie; Li, Hailing; Xu, Siling; Xie, Mujin; Song, Yangchun; Quddus, Mohammed Abdul; Xu, Yawei; Liu, Ban; Che, Wenliang			Familial hypercholesterolemia in Chinese patients with premature ST-segment-elevation myocardial infarction: Prevalence, lipid management and 1-year follow-up	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; LOWERING TREATMENT; GUIDANCE; BURDEN; IMPACT	Background Familial hypercholesterolemia (FH), characterized by elevated plasma low-density lipoprotein-cholesterol (LDL-C) levels and premature coronary artery disease (CAD), remains mostly underdiagnosed and undertreated. We investigated the prevalence of clinical FH among Chinese patients with premature ST-segment-elevation myocardial infarction (STEMI) and one-year follow-up on their lipid management and cardiovascular events. Methods Four hundred and ninety-eight premature STEMI patients (363men) were enrolled. FH patients were identified using the Dutch Lipid Clinic Network Criteria. Lipid management and cardiovascular events in all patients were assessed. Results Nineteen patients (3.8%) were diagnosed as definite/probable FH, 211 (42.4%) as possible FH and 268 (53.8%) as unlikely FH. All patients were divided into two main groups: unlikely FH (0-2 points) and possible FH (>= 3 points). Possible FH patients were younger (50.1 years vs. 53.5 years) with higher NT-proBNP level (3014.15 pg/mL vs. 2326.25 pg/mL), occurrence of multi-vessel CAD (37.4% vs. 18.3%), lower LVEF (47% vs. 49%) and more severe Killip classification (Class 3, 20.0% vs. 9.7%). Follow-up data were available for 203 patients from the possible FH group and 243 patients from the unlikely FH group. High intensity statin intake status (%) of possible FH vs. unlikely FH was as follows: 1) on admission: 4.8% vs. 0.4%; 2) at discharge: 10.4% vs. 1.6% and 3) at one year follow-up: 5.4% vs. 0.8%. A significantly low percentage of possible FH patients (18.7% vs. 51.4%) achieved target LDL-C levels. There were no significant differences in MACE defined as a composite of cardiogenic shock or Class IV heart failure, recurrent MI, cardiovascular-related rehospitalization, TLR and CV death between the two groups. However, the proportion of cardiogenic shock or Class IV heart failure was significantly higher in possible FH patients group (5.9% vs. 1.2%). Conclusion Clinical diagnosis of possible FH is common in Chinese patients with premature STEMI. A low proportion of FH patients were prescribed high intensity statins. Despite aggressive cholesterol-lowering drugs, a significantly lower proportion of FH patients achieved LDL-C targets compared to unlikely FH patients. Possible FH patients were younger with a significantly higher occurrence of multi-vessel CAD and impaired cardiac function.	[Auckle, Ranshaka; Su, Binjie; Li, Hailing; Xu, Siling; Xie, Mujin; Song, Yangchun; Quddus, Mohammed Abdul; Xu, Yawei; Liu, Ban; Che, Wenliang] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Cardiol, Shanghai, Peoples R China; [Che, Wenliang] Shanghai Tenth Peoples Hosp, Chongming branch, Dept Cardiol, Shanghai, Peoples R China	Tongji University	Liu, B; Che, WL (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Cardiol, Shanghai, Peoples R China.; Che, WL (corresponding author), Shanghai Tenth Peoples Hosp, Chongming branch, Dept Cardiol, Shanghai, Peoples R China.	niefei527@163.com; chewenliang@tongji.edu.cn			National Natural Science Foundation of China [81570436]; Foundation of Shanghai Municipal Commission of Health and Family Planning [201640053]; Shanghai Medical Guiding Project [124119a6900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Shanghai Municipal Commission of Health and Family Planning; Shanghai Medical Guiding Project	This study was supported by National Natural Science Foundation of China (81570436), WLC; Foundation of Shanghai Municipal Commission of Health and Family Planning (201640053), WLC; Shanghai Medical Guiding Project (124119a6900), WLC.	Austin MA, 2004, AM J EPIDEMIOL, V160, P421, DOI 10.1093/aje/kwh237; Benn M, 2012, J CLIN ENDOCR METAB, V97, P3956, DOI 10.1210/jc.2012-1563; Bibbins-Domingo K, 2007, JAMA-J AM MED ASSOC, V297, P169, DOI 10.1001/jama.297.2.169; De Backer G, 2015, ATHEROSCLEROSIS, V241, P169, DOI 10.1016/j.atherosclerosis.2015.04.809; de Ferranti SD, 2016, CIRCULATION, V133, P1067, DOI 10.1161/CIRCULATIONAHA.115.018791; Elis A, 2011, AM J CARDIOL, V108, P223, DOI 10.1016/j.amjcard.2011.03.027; Goldberg AC, 2011, J CLIN LIPIDOL, V5, P133, DOI 10.1016/j.jacl.2011.03.001; Goldstein JL, 2001, METABOLIC MOL BASES, P2863; Gumbs PD, 2007, PHARMACOECONOMICS, V25, P187, DOI 10.2165/00019053-200725030-00002; Henderson R, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0256-1; Huijgen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009220; Kawada-Watanabe E, 2017, J CARDIOL, V69, P536, DOI 10.1016/j.jjcc.2016.05.002; Knowles JW, 2014, AM HEART J, V168, P807, DOI 10.1016/j.ahj.2014.09.001; Li S, 2016, J CLIN LIPIDOL, V10, P1344, DOI 10.1016/j.jacl.2016.08.013; Mortensen MB, 2016, J CLIN LIPIDOL, V10, P1145, DOI 10.1016/j.jacl.2016.06.002; Nanchen D, 2015, EUR HEART J, V36, P2438, DOI 10.1093/eurheartj/ehv289; Neefjes LA, 2011, ATHEROSCLEROSIS, V219, P721, DOI 10.1016/j.atherosclerosis.2011.09.052; Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273; Pang J, 2015, J CLIN LIPIDOL, V9, P703, DOI 10.1016/j.jacl.2015.07.005; Pijlman AH, 2010, ATHEROSCLEROSIS, V209, P189, DOI 10.1016/j.atherosclerosis.2009.09.014; Rallidis LS, 2016, ATHEROSCLEROSIS, V249, P17, DOI 10.1016/j.atherosclerosis.2016.03.023; Rerup SA, 2016, AM HEART J, V181, P35, DOI 10.1016/j.ahj.2016.08.001; Shi ZM, 2014, INT J CARDIOL, V174, P834, DOI 10.1016/j.ijcard.2014.04.165; Sjouke B, 2015, EUR HEART J, V36, P560, DOI 10.1093/eurheartj/ehu058; Zhao SP, 2014, ATHEROSCLEROSIS, V233, P707, DOI 10.1016/j.atherosclerosis.2013.12.003	25	13	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186815	10.1371/journal.pone.0186815	http://dx.doi.org/10.1371/journal.pone.0186815			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088271	gold, Green Published, Green Submitted			2022-12-26	WOS:000414088900021
J	Law, S; Panwar, P; Li, J; Aguda, AH; Jamroz, A; Guido, RVC; Bromme, D				Law, Simon; Panwar, Preety; Li, Jody; Aguda, Adeleke H.; Jamroz, Andrew; Guido, Rafael V. C.; Bromme, Dieter			A composite docking approach for the identification and characterization of ectosteric inhibitors of cathepsin K	PLOS ONE			English	Article							CYSTEINE PROTEASES; MOLECULAR DOCKING; SCORING FUNCTIONS; DRUG DESIGN; PROTEIN; OSTEOPOROSIS; DEGRADATION; OSTEOCLASTS; EXPRESSION; DISCOVERY	Cathepsin K (CatK) is a cysteine protease that plays an important role in mammalian intra and extracellular protein turnover and is known for its unique and potent collagenase activity. Through studies on the mechanism of its collagenase activity, selective ectosteric sites were identified that are remote from the active site. Inhibitors targeting these ectosteric sites are collagenase selective and do not interfere with other proteolytic activities of the enzyme. Potential ectosteric inhibitors were identified using a computational approach to screen the druggable subset of and the entire 281,987 compounds comprising Chemical Repository library of the National Cancer Institute-Developmental Therapeutics Program (NCI-DTP). Compounds were scored based on their affinity for the ectosteric site. Here we compared the scores of three individual molecular docking methods with that of a composite score of all three methods together. The composite docking method was up to five-fold more effective at identifying potent collagenase inhibitors (IC50 < 20 mu M) than the individual methods. Of 160 top compounds tested in enzymatic assays, 28 compounds revealed blocking of the collagenase activity of CatK at 100 mu M. Two compounds exhibited IC50 values below 5 mu M corresponding to a molar protease: inhibitor concentration of < 1:12. Both compounds were subsequently tested in osteoclast bone resorption assays where the most potent inhibitor, 10-[2-[bis(2-hydroxyethyl) amino] ethyl]-7,8-diethylbenzo[g] pteridine-2,4-dione, (NSC-374902), displayed an inhibition of bone resorption with an IC50-value of approximately 300 nM and no cell toxicity effects.	[Law, Simon; Aguda, Adeleke H.; Bromme, Dieter] Univ British Columbia, Fac Med, Dept Biochem & Mol Biol, Vancouver, BC, Canada; [Law, Simon; Panwar, Preety; Li, Jody; Jamroz, Andrew; Bromme, Dieter] Univ British Columbia, Ctr Blood Res, Vancouver, BC, Canada; [Panwar, Preety; Li, Jody; Jamroz, Andrew; Bromme, Dieter] Univ British Columbia, Fac Dent, Dept Oral Biol & Med Sci, Vancouver, BC, Canada; [Guido, Rafael V. C.] Univ Sao Paulo, Inst Fis Sao Carlos, Ctr Inovacao Biodiversidade & Farmacos, Sao Carlos, SP, Brazil	University of British Columbia; University of British Columbia; University of British Columbia; Universidade de Sao Paulo	Bromme, D (corresponding author), Univ British Columbia, Fac Med, Dept Biochem & Mol Biol, Vancouver, BC, Canada.; Bromme, D (corresponding author), Univ British Columbia, Ctr Blood Res, Vancouver, BC, Canada.; Bromme, D (corresponding author), Univ British Columbia, Fac Dent, Dept Oral Biol & Med Sci, Vancouver, BC, Canada.	dbromme@dentistry.ubc.ca	Guido, Rafael Victorio Carvalho/A-7450-2009	Guido, Rafael Victorio Carvalho/0000-0002-7187-0818; Jamroz, Andrew/0000-0002-6199-1667; Aguda, Adeleke/0000-0001-5187-3264	Canadian Institutes of Health Research [MOP-89974, MOP-125866]; Natural Sciences & Engineering Research Council of Canada [RGPIN-326803-13]; Canada Research Chair	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences & Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	The present work was supported by the Canadian Institutes of Health Research [grant numbers MOP-89974, MOP-125866] (CIHR: http://www.cihr-irsc.gc.ca/e/193.html), the Natural Sciences & Engineering Research Council of Canada [grant number RGPIN-326803-13] (NSERC: http://www.nserc-crsng.gc.ca/index_eng.asp), and a Canada Research Chair award (to D.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguda AH, 2014, P NATL ACAD SCI USA, V111, P17474, DOI 10.1073/pnas.1414126111; Alonso H, 2006, MED RES REV, V26, P531, DOI 10.1002/med.20067; [Anonymous], 2004, NCI YEAST ANT DRUG S; Bromme D, 2016, EXPERT OPIN DRUG DIS, V11, P457, DOI 10.1517/17460441.2016.1160884; Bromme D, 1996, J BIOL CHEM, V271, P2126, DOI 10.1074/jbc.271.4.2126; Bromme D, 2002, CURR PHARM DESIGN, V8, P1639, DOI 10.2174/1381612023394179; Bromme D, 2009, EXPERT OPIN INV DRUG, V18, P585, DOI [10.1517/13543780902832661 , 10.1517/13543780902832661]; Carta G, 2007, J CHEM INF MODEL, V47, P1564, DOI 10.1021/ci600471m; Corsino P, 2009, J BIOL CHEM, V284, P29945, DOI 10.1074/jbc.M109.055251; Drake MT, 2017, ENDOCR REV, V38, P325, DOI 10.1210/er.2015-1114; Du X, 2013, J BIOL CHEM, V288, P34871, DOI 10.1074/jbc.M113.510008; Dunstan MS, 2011, J MED CHEM, V54, P6597, DOI 10.1021/jm200416e; Feng BY, 2006, NAT PROTOC, V1, P550, DOI 10.1038/nprot.2006.77; Feng BY, 2007, J MED CHEM, V50, P2385, DOI 10.1021/jm061317y; Ferrara P, 2004, J MED CHEM, V47, P3032, DOI 10.1021/jm030489h; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Garnero P, 1998, J BIOL CHEM, V273, P32347, DOI 10.1074/jbc.273.48.32347; Ghose AK, 1999, J COMB CHEM, V1, P55, DOI 10.1021/cc9800071; Grinter SZ, 2014, MOLECULES, V19, P10150, DOI 10.3390/molecules190710150; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Houston DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121424; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kafienah W, 1998, BIOCHEM J, V331, P727, DOI 10.1042/bj3310727; Lecaille F, 2002, CHEM REV, V102, P4459, DOI 10.1021/cr0101656; Linnevers CJ, 1997, PROTEIN SCI, V6, P919; Lipinski Christopher A, 2004, Drug Discov Today Technol, V1, P337, DOI 10.1016/j.ddtec.2004.11.007; Lutgens SPM, 2007, FASEB J, V21, P3029, DOI 10.1096/fj.06-7924com; Mullard A, 2016, NAT REV DRUG DISCOV, V15, P669, DOI 10.1038/nrd.2016.207; Ntie-Kang F, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-353; PAN YP, 2002, ABSTR PAP AM CHEM 1, V224, P29531; Panwar P, 2017, MATRIX BIOL; Panwar P, 2017, J BONE MINER RES; Panwar P, 2016, BRIT J PHARMACOL, V173, P396, DOI 10.1111/bph.13383; Rastelli G, 2002, BIOORGAN MED CHEM, V10, P1437, DOI 10.1016/S0968-0896(01)00410-2; Runger TM, 2012, J AM ACAD DERMATOL, V66, pE89, DOI 10.1016/j.jaad.2010.11.033; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharma V, 2015, BIOCHEM J, V465, P163, DOI 10.1042/BJ20140809; Soe K, 2010, J BONE MINER RES, V25, P2184, DOI 10.1002/jbmr.113; Spitzer R, 2012, J COMPUT AID MOL DES, V26, P687, DOI 10.1007/s10822-011-9533-y; Sullivan K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147230; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Valasani KR, 2014, J CHEM INF MODEL, V54, P902, DOI 10.1021/ci5000196; Yamashita DS, 2000, CURR PHARM DESIGN, V6, P1, DOI 10.2174/1381612003401569; Yamashita DS, 1997, J AM CHEM SOC, V119, P11351, DOI 10.1021/ja972204u; Yasuda Y, 2004, J BIOL CHEM, V279, P36761, DOI 10.1074/jbc.M403986200	46	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186869	10.1371/journal.pone.0186869	http://dx.doi.org/10.1371/journal.pone.0186869			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088253	gold, Green Published, Green Submitted			2022-12-26	WOS:000414088900027
J	Stack, RJ; Southworth, S; Fisher, BA; Barone, F; Buckley, CD; Rauz, S; Bowman, SJ				Stack, Rebecca J.; Southworth, Sue; Fisher, Benjamin A.; Barone, Francesca; Buckley, Christopher D.; Rauz, Saaeha; Bowman, Simon J.			A qualitative exploration of physical, mental and ocular fatigue in patients with primary Sjogren's Syndrome	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; DEPRESSION; SLEEP; ASSOCIATIONS; MANAGEMENT; KNOWLEDGE; ESSPRI; WOMEN	Introduction Primary Sjogren's Syndrome (pSS) affects exocrine glands such as those producing the tear film, leading to dry and painful eyes, but is also associated with fatigue. The experience of fatigue in pSS, and its relationship with sicca symptoms, is poorly understood. Methods Twenty people diagnosed with pSS were recruited to participate in a semi-structured qualitative interview about their symptoms experience. Interviews were audio-recorded, transcribed verbatim and analysed using thematic analysis. Results People with pSS described physical tiredness, mental fatigue and ocular fatigue. Mental fatigue was characterised by difficulties in attention, particularly, the ability to follow conversations and short-term memory problems. Participants linked their experience of fatigue to feeling of depression, frustration, irritation and anxiety, and therefore, fatigue was suggested to have had a large impact on their psychological well-being. People with pSS also described a range of ocular symptoms including pain, dryness, and itching, which were compounded by fatigue. For some, eye fatigue was pervasive, and daily activities involving the eyes such as reading, using the computer and driving were impaired. In some cases, the level of ocular discomfort was so severe it prevented sleep, which in turn impacted on general fatigue levels. Conclusions People with pSS experience fatigue in a range of ways; physical, mental and ocular fatigue were described. Fatigue was suggested to exacerbate other ocular symptoms, posed serious physical limitations and caused psychological distress. Further research into the nature of fatigue and ocular symptoms in pSS is required.	[Stack, Rebecca J.; Southworth, Sue; Fisher, Benjamin A.; Barone, Francesca; Buckley, Christopher D.; Rauz, Saaeha; Bowman, Simon J.] Univ Birmingham, Ctr Translat Inflammat Res, Birmingham, W Midlands, England; [Southworth, Sue; Rauz, Saaeha] Birmingham & Midland Eye Ctr, Acad Unit Ophthalmol, Birmingham, W Midlands, England; [Bowman, Simon J.] Univ Hosp Birmingham NHS Fdn Trust, Dept Rheumatol, Birmingham, W Midlands, England; [Stack, Rebecca J.] Nottingham Trent Univ, Div Psychol, Nottingham, England	University of Birmingham; University of Birmingham; Nottingham Trent University	Stack, RJ (corresponding author), Univ Birmingham, Ctr Translat Inflammat Res, Birmingham, W Midlands, England.; Stack, RJ (corresponding author), Nottingham Trent Univ, Div Psychol, Nottingham, England.	rebecca.stack@ntu.ac.uk	Stack, Rebecca J/Y-5034-2018; Rauz, Saaeha/ABF-2202-2021; Buckley, Christopher/AAN-6378-2021	Stack, Rebecca J/0000-0002-0516-0228; Buckley, Christopher/0000-0001-6924-6402; Rauz, Saaeha/0000-0003-4627-3496	Queen Elizabeth Hospitals Birmingham Charitable Trust; National Institute for Health Research (NIHR)/Wellcome Trust Birmingham Clinical Research Facility; MRC [MR/M009157/1] Funding Source: UKRI; Medical Research Council [MR/M009157/1] Funding Source: researchfish; Versus Arthritis [21236] Funding Source: researchfish	Queen Elizabeth Hospitals Birmingham Charitable Trust; National Institute for Health Research (NIHR)/Wellcome Trust Birmingham Clinical Research Facility; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis)	This research was supported with funding from the Queen Elizabeth Hospitals Birmingham Charitable Trust (http://www.uhb.nhs.uk/charity.htm). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r OASIS recruitment is supported by the National Institute for Health Research (NIHR)/Wellcome Trust Birmingham Clinical Research Facility. The views expressed are those of the authors(s) and not necessarily those of the NHS, the NIHR or the Department of Health."	Barendregt PJ, 1998, ANN RHEUM DIS, V57, P291, DOI 10.1136/ard.57.5.291; Bjerrum KB, 2000, ACTA OPHTHALMOL SCAN, V78, P1; Goodchild CE, 2010, MUSCULOSKELET CARE, V8, P107, DOI 10.1002/msc.174; Goodchild CE, 2008, MUSCULOSKELET CARE, V6, P31, DOI 10.1002/msc.124; Guest G, 2012, APPL THEMATIC ANAL, DOI 10.4135/9781483384436; Hewlett S, 2005, ARTHRIT RHEUM-ARTHR, V53, P697, DOI 10.1002/art.21450; Irwin MR, 2012, SLEEP, V35, P537, DOI 10.5665/sleep.1742; Karaiskos D, 2010, RHEUMATOLOGY, V49, P1762, DOI 10.1093/rheumatology/keq158; Lee E, 2013, SLEEP, V36, P1685, DOI 10.5665/sleep.3128; Lwin CTT, 2003, SCAND J RHEUMATOL, V32, P33, DOI 10.1080/03009740310000373; Mengshoel AM, 2014, ARTHRIT CARE RES, V66, P1227, DOI 10.1002/acr.22263; Ng WF, 2010, RHEUMATOLOGY, V49, P844, DOI 10.1093/rheumatology/keq009; Repping-Wuts H, 2008, CLIN RHEUMATOL, V27, P1549, DOI 10.1007/s10067-008-0967-0; Repping-Wuts H, 2009, J ADV NURS, V65, P901, DOI 10.1111/j.1365-2648.2008.04904.x; Segal B, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-46; Segal B, 2008, ARTHRIT RHEUM-ARTHR, V59, P1780, DOI 10.1002/art.24311; Seror R, 2016, ANN RHEUM DIS, V75, P382, DOI 10.1136/annrheumdis-2014-206008; Seror R, 2015, ANN RHEUM DIS, V74, P859, DOI 10.1136/annrheumdis-2013-204615; Seror R, 2011, ANN RHEUM DIS, V70, P968, DOI 10.1136/ard.2010.143743; Sorensen I M, 2000, Tidsskr Nor Laegeforen, V120, P794; Stevenson H A, 2004, Gerodontology, V21, P141, DOI 10.1111/j.1741-2358.2004.00027.x; Valtysdottir ST, 2000, J RHEUMATOL, V27, P165; van Leeuwen N, 2015, RHEUMATOLOGY, V54, P776, DOI 10.1093/rheumatology/keu387; Wouters EJM, 2012, ANN RHEUM DIS, V71, P668, DOI 10.1136/ard.2011.154245	24	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187272	10.1371/journal.pone.0187272	http://dx.doi.org/10.1371/journal.pone.0187272			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL2ZD	29088284	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000414088900057
J	Huang, HR; Xu, ZZ; Shao, XH; Wismeijer, D; Sun, P; Wang, JX; Wu, G				Huang, Hairong; Xu, Zanzan; Shao, Xianhong; Wismeijer, Daniel; Sun, Ping; Wang, Jingxiao; Wu, Gang			Multivariate linear regression analysis to identify general factors for quantitative predictions of implant stability quotient values	PLOS ONE			English	Article							RESONANCE-FREQUENCY-ANALYSIS; LOADED IMPLANTS; DESIGN	Objectives This study identified potential general influencing factors for a mathematical prediction of implant stability quotient (ISQ) values in clinical practice. Methods We collected the ISQ values of 557 implants from 2 different brands (SICace and Osstem) placed by 2 surgeons in 336 patients. Surgeon 1 placed 329 SICace implants, and surgeon 2 placed 113 SICace implants and 115 Osstem implants. ISQ measurements were taken at T1 (immediately after implant placement) and T2 (before dental restoration). A multivariate linear regression model was used to analyze the influence of the following 11 candidate factors for stability prediction: sex, age, maxillary/mandibular location, bone type, immediate/delayed implantation, bone grafting, insertion torque, I-stage or II-stage healing pattern, implant diameter, implant length and T1-T2 time interval. Results The need for bone grafting as a predictor significantly influenced ISQ values in all three groups at T1 (weight coefficients ranging from -4 to -5). In contrast, implant diameter consistently influenced the ISQ values in all three groups at T2 (weight coefficients ranging from 3.4 to 4.2). Other factors, such as sex, age, I/II-stage implantation and bone type, did not significantly influence ISQ values at T2, and implant length did not significantly influence ISQ values at T1 or T2. Conclusions These findings provide a rational basis for mathematical models to quantitatively predict the ISQ values of implants in clinical practice.	[Huang, Hairong; Wismeijer, Daniel; Wu, Gang] Univ Amsterdam, Dept Oral Implantol & Prosthet Dent, Acad Ctr Dent Amsterdam ACTA, Amsterdam, Nord Holland, Netherlands; [Huang, Hairong; Wismeijer, Daniel; Wu, Gang] Vrije Univ Amsterdam, Amsterdam, Nord Holland, Netherlands; [Xu, Zanzan] Goethe Univ Frankfurt, Dept Prosthodont Dent, Frankfurt, Hessen, Germany; [Shao, Xianhong] Best & Easy Dent Clin, Hangzhou, Zhejiang, Peoples R China; [Sun, Ping] Zhejiang Univ, Affiliated Stomatol Hosp, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Wang, Jingxiao] Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China	Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Goethe University Frankfurt; Zhejiang University; Wenzhou Medical University	Sun, P (corresponding author), Zhejiang Univ, Affiliated Stomatol Hosp, Sch Med, Hangzhou, Zhejiang, Peoples R China.; Wang, JX (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China.	doctorsp@163.com; wangjingxiao@zju.edu.cn	wu, gang/C-5072-2012	wu, gang/0000-0001-8941-2500	China Scholarship Council; National Natural Science Foundation of China [81400475, 81470724]; Zhejiang Provincial Natural Science Foundation of China [LY14H140002, LY17H140010]	China Scholarship Council(China Scholarship Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported by: China Scholarship Council, www.csc.edu.cn; National Natural Science Foundation of China (Grant No. 81400475 and No. 81470724), http://www.nsfc.gov.cn/; and Zhejiang Provincial Natural Science Foundation of China (Grant No. LY14H140002 and No. LY17H140010), www.zjnsf.gov.cn.	Atsumi M, 2007, INT J ORAL MAX IMPL, V22, P743; Barikani Hamidreza, 2013, J Dent (Tehran), V10, P449; Bataineh Anwar B, 2017, J Clin Exp Dent, V9, pe1, DOI 10.4317/jced.53302; Bischof M, 2004, CLIN ORAL IMPLAN RES, V15, P529, DOI 10.1111/j.1600-0501.2004.01042.x; Brizuela-Velasco A, 2015, IMPLANT DENT, V24, P607, DOI 10.1097/ID.0000000000000318; Brochu JF, 2005, INT J PROSTHODONT, V18, P506; Degidi M, 2013, IMPLANT DENT, V22, P530, DOI 10.1097/ID.0b013e31829f1ef2; Dias DR, 2016, CLIN ORAL IMPLAN RES, V27, P1212, DOI 10.1111/clr.12728; Dottore AM, 2014, CLIN IMPLANT DENT R, V16, P330, DOI 10.1111/cid.12010; Gehrke SA, 2016, CLIN ORAL IMPLANTS R; Gehrke SA, 2015, J ORAL IMPLANTOL, V41, pE281, DOI 10.1563/aaid-joi-D-13-00294; Gehrke SA, 2014, J CRANIOFAC SURG, V25, P2117, DOI 10.1097/SCS.0000000000001067; Guo CY, 2012, INT J BIOMATER, V2012, DOI 10.1155/2012/381535; Hagi TT, 2010, CLIN ORAL IMPLAN RES, V21, P1214, DOI 10.1111/j.1600-0501.2010.01916.x; Han J, 2010, CLIN ORAL IMPLAN RES, V21, P605, DOI 10.1111/j.1600-0501.2009.01909.x; Huang HR, 2016, THER CLIN RISK MANAG, V12, P1525, DOI 10.2147/TCRM.S113764; Huang HL, 2013, OR SURG OR MED OR PA, V116, pE356, DOI 10.1016/j.oooo.2012.01.037; Liaje A, 2012, INT J ORAL MAX IMPL, V27, P162; Lozano-Carrascal N, 2016, MED ORAL PATOL ORAL, V21, pE214, DOI 10.4317/medoral.21024; Morris Harold F, 2004, J Oral Implantol, V30, P162, DOI 10.1563/1548-1336(2004)30<162:APVFII>2.0.CO;2; Ostman PO, 2006, INT J PROSTHODONT, V19, P77; Park IP, 2011, J ADV PROSTHODONT, V3, P76, DOI 10.4047/jap.2011.3.2.76; Quesada-Garcia MP, 2009, MED ORAL PATOL ORAL, V14, pE538; Raghavendra S, 2005, INT J ORAL MAX IMPL, V20, P425; Rastelli C, 2014, Oral Implantol (Rome), V7, P33; Romanos GE, 2016, CLIN ORAL IMPLANTS R; T A, 1985, TISSUE INTEGRATED PR, P199, DOI DOI 10.1111/J.1708-8208.2002.TB00174.X; Tsolaki IN, 2016, J ORAL IMPLANTOL; Valiyaparambil JV, 2012, INT J ORAL MAX IMPL, V27, P1271; Wada M, 2015, INT J IMPLANT DENT, V1, DOI 10.1186/s40729-014-0003-x; Zix J, 2005, INT J ORAL MAX IMPL, V20, P747	31	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187010	10.1371/journal.pone.0187010	http://dx.doi.org/10.1371/journal.pone.0187010			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084260	Green Submitted, Green Published, gold			2022-12-26	WOS:000413910200024
J	Alvarenga, JM; Vieira, CR; Godinho, LB; Campelo, PH; Pitts, JP; Colli, GR				Alvarenga, Julio Miguel; Vieira, Cecilia Rodrigues; Godinho, Leandro Braga; Campelo, Pedro Henrique; Pitts, James Purser; Colli, Guarino Rinaldi			Spatial-temporal dynamics of neotropical velvet ant (Hymenoptera: Mutillidae) communities along a forest-savanna gradient	PLOS ONE			English	Article							BETA-DIVERSITY; WASPS HYMENOPTERA; NATIONAL-PARK; MATO-GROSSO; HISTORICAL BIOGEOGRAPHY; HABITAT HETEROGENEITY; SPECIES-DIVERSITY; BRAZILIAN CERRADO; BEES HYMENOPTERA; WOODY VEGETATION	Understanding how and why biological communities are organized over space and time is a major challenge and can aid biodiversity conservation in times of global changes. Herein, spatial-temporal variation in the structure of velvet ant communities was examined along a forest-savanna gradient in the Brazilian Cerrado to assess the roles of environmental filters and interspecific interactions upon community assembly. Velvet ants were sampled using 25 arrays of Y-shaped pitfall traps with drift fences for one year along an environmental gradient from cerrado sensu stricto (open canopy, warmer, drier) to cerradao (closed canopy, cooler, moister). Dataloggers installed on each trap recorded microclimate parameters throughout the study period. The effects of spatial distances, microclimate parameters and shared ancestry on species abundances and turnover were assessed with canonical correspondence analysis, generalized dissimilarity modelling and variance components analysis. Velvet ant diversity and abundance were higher in the cerrado sensu stricto and early in the wet season. There was pronounced compositional turnover along the environmental gradient, and temporal variation in richness and abundance was stronger than spatial variation. The dry season blooming of woody plant species fosters host abundance and, subsequently, velvet ant captures. Species were taxonomically clustered along the gradient with Sphaeropthalmina (especially Traumatomutilla spp.) and Pseudomethocina more associated, respectively, with cerrado sensu stricto and cerradao. This suggests a predominant role of environmental filters on community assemble, with physiological tolerances and host preferences being shared among members of the same lineages. Induced environmental changes in Cerrado can impact communities of wasps and their hosts with unpredictable consequences upon ecosystem functioning and services.	[Alvarenga, Julio Miguel; Godinho, Leandro Braga] Univ Estado Mato Grosso, Programa Posgrad Ecol & Conservacao, Dept Biol, Nova Xavantina, Mato Grosso, Brazil; [Vieira, Cecilia Rodrigues; Pitts, James Purser] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Campelo, Pedro Henrique] Univ Fed Tocantins, Programa Posgrad Biodiversidade Ecol & Conservaca, Porto Nacl, Tocantins, Brazil; [Colli, Guarino Rinaldi] Univ Brasilia, Dept Zool, Brasilia, DF, Brazil	Universidade do Estado de Mato Grosso; Utah System of Higher Education; Utah State University; Universidade Federal do Tocantins (UFT); Universidade de Brasilia	Vieira, CR (corresponding author), Utah State Univ, Dept Biol, Logan, UT 84322 USA.	ceciliavieira@iclouci.com	Vieira, Cecília R/T-2677-2017; Campelo, Pedro Henrique/GPP-7234-2022; Vieira, Cecilia R/O-4454-2014; Colli, Guarino Rinaldi/A-5368-2008	Vieira, Cecília R/0000-0002-4273-3697; Vieira, Cecilia R/0000-0002-4273-3697; Colli, Guarino Rinaldi/0000-0002-2628-5652; Braga Godinho, Leandro/0000-0001-7653-5720; Alvarenga da Silva, Julio Miguel/0000-0003-2276-3810	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES [1221/13-2, 88881.068430-2014-01]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [457587/2012-1]; Fundacao de Apoio a Pesquisa do Distrito Federal - FAPDF [193.000.456/2011]; United States Agency for International Development, Partnerships for Enhanced Engagement in Research - PEER [PEER NAS/USAID PGA-2000005316]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio a Pesquisa do Distrito Federal - FAPDF(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); United States Agency for International Development, Partnerships for Enhanced Engagement in Research - PEER(United States Agency for International Development (USAID))	This study was supported by the following agencies: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES (http://www.capes.gov.br), Award Number: None; Recipient: Julio Miguel Alvarenga, MSc, Award Number: 1221/13-2; Recipient: Cecilia Rodrigues Vieira, MSc, Award Number: 88881.068430-2014-01; Recipient: Guarino Rinaldi Colli, PhD; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (http://www.cnpq.br), Award Number: 457587/2012-1; Recipient: Guarino Rinaldi Colli, PhD; Fundacao de Apoio a Pesquisa do Distrito Federal - FAPDF (http://www.fap.df.gov.br), Award Number: 193.000.456/2011; Recipient: Guarino Rinaldi Colli, PhD; United States Agency for International Development, Partnerships for Enhanced Engagement in Research - PEER (http://sites.nationalacademies.org/PGA/PEER/index.htm), Award Number: PEER NAS/USAID PGA-2000005316; Recipient: Guarino Rinaldi Colli, PhD. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad JCS, 2008, GESTAO EDUCACAO AMBI, P23; Albrecht M, 2001, OECOLOGIA, V126, P134, DOI 10.1007/s004420000494; Anderegg WRL, 2013, NAT CLIM CHANGE, V3, P30, DOI 10.1038/nclimate1635; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; [Anonymous], THESIS; Aranda R, 2016, ENVIRON ENTOMOL, V45, P1146, DOI 10.1093/ee/nvw098; Auko TH, 2013, BIOTA NEOTROP, V13, P292, DOI 10.1590/S1676-06032013000100028; Batalha MA, 2004, AUST J BOT, V52, P149, DOI 10.1071/BT03098; BELL G, 1989, AM NAT, V133, P553, DOI 10.1086/284935; Bino G, 2013, EVOL ECOL, V27, P1159, DOI 10.1007/s10682-013-9631-5; Bolker BM, 2008, ECOLOGICAL MODELS DA; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brannstrom C, 2008, LAND USE POLICY, V25, P579, DOI 10.1016/j.landusepol.2007.11.008; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Brothers D. J., 1993, Hymenoptera of the world: an identification guide to families., P161; Brothers DJ, 2000, INSECT SOC, V47, P201, DOI 10.1007/PL00001704; Brothers DJ, 1999, ZOOL SCR, V28, P233, DOI 10.1046/j.1463-6409.1999.00003.x; Buckley LB, 2008, P NATL ACAD SCI USA, V105, P17836, DOI 10.1073/pnas.0803524105; BULHÃO CLARISSA F., 2002, Braz. J. Bot., V25, P361, DOI 10.1590/S0100-84042002000300012; Burbrink FT, 2015, ECOGRAPHY, V38, P1036, DOI 10.1111/ecog.01148; Buschini MLT, 2008, ACTA ZOOL-STOCKHOLM, V89, P351, DOI 10.1111/j.1463-6395.2008.00325.x; Cardillo M, 2016, GLOBAL ECOL BIOGEOGR, V25, P951, DOI 10.1111/geb.12455; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Crawley M. J., 2013, R BOOK; DEYRUP M, 1986, FLA ENTOMOL, V69, P327, DOI 10.2307/3494937; dos Santos EF, 2014, NEOTROP ENTOMOL, V43, P97, DOI 10.1007/s13744-013-0183-8; EITEN G., 1993, CERRADO CARACTERIZAC, P17; Ellis N, 2012, ECOLOGY, V93, P156, DOI 10.1890/11-0252.1; Emerson BC, 2008, TRENDS ECOL EVOL, V23, P619, DOI 10.1016/j.tree.2008.07.005; Fahr J, 2011, ECOGRAPHY, V34, P177, DOI 10.1111/j.1600-0587.2010.05510.x; Ferrier S, 2002, BIODIVERS CONSERV, V11, P2309, DOI 10.1023/A:1021374009951; Ferrier S, 2002, SYST BIOL, V51, P331, DOI 10.1080/10635150252899806; Ferrier S, 2007, DIVERS DISTRIB, V13, P252, DOI 10.1111/j.1472-4642.2007.00341.x; Fitzpatrick MC, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1201; Gao YL, 2017, ANNU REV ENTOMOL, V62, P165, DOI 10.1146/annurev-ento-031616-035425; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Guerin GR, 2013, ECOGRAPHY, V36, P1086, DOI 10.1111/j.1600-0587.2013.00215.x; Hance T, 2007, ANNU REV ENTOMOL, V52, P107, DOI 10.1146/annurev.ento.52.110405.091333; Harms TM, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1288; Harvey P.H., 1991, COMP METHOD EVOLUTIO; HEINRICH B, 1984, J COMP PHYSIOL, V154, P175, DOI 10.1007/BF00684142; HilleRisLambers J, 2012, ANNU REV ECOL EVOL S, V43, P227, DOI 10.1146/annurev-ecolsys-110411-160411; Honaker J, 2011, J STAT SOFTW, V45, P1; Hortal J, 2015, ANNU REV ECOL EVOL S, V46, P523, DOI 10.1146/annurev-ecolsys-112414-054400; INMET, 2017, PAR DIAR EST MET NOV; Jepson W, 2010, ANN ASSOC AM GEOGR, V100, P87, DOI 10.1080/00045600903378960; Kovac H, 2009, J INSECT PHYSIOL, V55, P959, DOI 10.1016/j.jinsphys.2009.06.012; Kraft NJB, 2011, SCIENCE, V333, P1755, DOI 10.1126/science.1208584; Laporta GZ, 2014, BMC ECOL, V14, DOI 10.1186/s12898-014-0030-8; Lassau SA, 2005, AUSTRAL ECOL, V30, P179, DOI 10.1111/j.1442-9993.2005.01435.x; Lassau SA, 2007, AUSTRAL ECOL, V32, P656, DOI 10.1111/j.1442-9993.2007.01751.x; Laurance WF, 2014, TRENDS ECOL EVOL, V29, P107, DOI 10.1016/j.tree.2013.12.001; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Legendre P., 2012, NUMERICAL ECOLOGY; Leite GLD, 2006, FOREST ECOL MANAG, V236, P286, DOI 10.1016/j.foreco.2006.09.013; Lelej A.S., 2005, P1; Lelej Arkady S., 2008, Zootaxa, V1889, P1; Loader C., 2013, LOCFIT LOCAL REGRESS; Lortie CJ, 2007, J ECOL, V95, P468, DOI 10.1111/j.1365-2745.2007.01231.x; Loyola RD, 2006, NEOTROP ENTOMOL, V35, P41, DOI 10.1590/S1519-566X2006000100006; Luz DR, 2016, REV BRAS ENTOMOL, V60, P302, DOI 10.1016/j.rbe.2016.06.001; Manion G., 2016, GDM FUNCTIONS GEN DI; MANLEY DG, 1983, J GEORGIA ENTOMOL SO, V18, P235; Manley DG, 2007, ZOOTAXA, P1; Maracahipes L, 2011, BIOTA NEOTROP, V11, P133, DOI 10.1590/S1676-06032011000100013; Marimon B. S., 2002, Edinburgh Journal of Botany, V59, P303; Marimon Junior BH, 2005, ACTA BOT BRAS, V19, P913, DOI DOI 10.1590/S0102-33062005000400026; Marris E, 2005, NATURE, V437, P944, DOI 10.1038/437944a; Martin LM, 2015, ECOLOGY, V96, P1042, DOI 10.1890/14-0772.1; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; Morato Elder F., 2008, Acta Amaz., V38, P789, DOI 10.1590/S0044-59672008000400025; Nenadic O, 2007, J STAT SOFTW, V20; Nimer E., 1989, CLIMATOLOGIA BRASIL, Vsecond; Nonveiller G., 1990, PARS 18 CATALOGUE MU; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Oliveira PE, 2000, FLORA, V195, P311; Oliveira-Filho A., 2002, CERRADOS BRAZIL, P91, DOI [10.1590/1519-6984.02016, DOI 10.7312/OLIV12042-007]; Parr CL, 2014, TRENDS ECOL EVOL, V29, P205, DOI 10.1016/j.tree.2014.02.004; Penone C, 2014, METHODS ECOL EVOL, V5, P961, DOI 10.1111/2041-210X.12232; da Silva NAP, 2011, REV BRAS ENTOMOL, V55, P79, DOI 10.1590/S0085-56262011000100013; Pilgrim EM, 2008, PAN-PAC ENTOMOL, V84, P57, DOI 10.3956/2007-13.1; Pilgrim EM, 2006, J KANSAS ENTOMOL SOC, V79, P222, DOI 10.2317/0511.09.1; Pinheiro F, 2002, AUSTRAL ECOL, V27, P132, DOI 10.1046/j.1442-9993.2002.01165.x; Polidori C, 2010, J ETHOL, V28, P353, DOI 10.1007/s10164-009-0196-2; Polidori C, 2009, ENTOMOL SCI, V12, P116, DOI 10.1111/j.1479-8298.2009.00311.x; Qian H, 2008, DIVERS DISTRIB, V14, P556, DOI 10.1111/j.1472-4642.2008.00466.x; Quinn G.P., 2002, EXPT DESIGN DATA ANA; Quintero D, 1996, SOUTHWEST ENTOMOL, V21, P205; R Core Team, 2021, R LANGUAGE ENV STAT; RATTER JA, 1973, PHILOS T R SOC B, V266, P449, DOI DOI 10.1098/RSTB.1973.0053; Ribeiro JF, 2008, CERRADO ECOLOGIA FLO, P153, DOI DOI 10.1023/A:1015819219386; Ricklefs RE, 2007, AM NAT, V170, pS56, DOI 10.1086/519402; Ricklefs RE, 2011, PHILOS T R SOC B, V366, P2438, DOI 10.1098/rstb.2011.0066; Rossetti MR, 2013, J INSECT CONSERV, V17, P1137, DOI 10.1007/s10841-013-9594-4; Rosauer DF, 2014, ECOGRAPHY, V37, P21, DOI 10.1111/j.1600-0587.2013.00466.x; Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908; Sanders NJ, 2007, J BIOGEOGR, V34, P1632, DOI 10.1111/j.1365-2699.2007.01714.x; Santos GMDM, 2007, NEOTROP ENTOMOL, V36, P180, DOI 10.1590/S1519-566X2007000200002; Schuetzenmeister A, 2016, VCA VARIANCE COMPONE; Silverio DV, 2010, BIOTA NEOTROP, V10, P205, DOI 10.1590/S1676-06032010000300024; SMITH RJ, 1994, AM J PHYS ANTHROPOL, V93, P95, DOI 10.1002/ajpa.1330930107; Smith TB, 1997, SCIENCE, V276, P1855, DOI 10.1126/science.276.5320.1855; Smith TB, 2001, TRENDS ECOL EVOL, V16, P431, DOI 10.1016/S0169-5347(01)02201-7; Socolar JB, 2016, TRENDS ECOL EVOL, V31, P67, DOI 10.1016/j.tree.2015.11.005; Souza AKP, 2005, REV BRAS ZOOL, V22, P320, DOI DOI 10.1590/S0101-81752005000200004; Stephens PR, 2009, MOL ECOL, V18, P4664, DOI 10.1111/j.1365-294X.2009.04378.x; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Tylianakis JM, 2006, J BIOGEOGR, V33, P1295, DOI 10.1111/j.1365-2699.2006.01493.x; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Van Buuren S, 2006, J STAT COMPUT SIM, V76, P1049, DOI 10.1080/10629360600810434; Vieira CR, 2017, ENVIRON ENTOMOL, V46, P353, DOI 10.1093/ee/nvx046; Vieira CR, 2015, J INSECT CONSERV, V19, P849, DOI 10.1007/s10841-015-9803-4; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; WHITTAKER RH, 1967, BIOL REV, V42, P207, DOI 10.1111/j.1469-185X.1967.tb01419.x; WHITTAKER RH, 1953, ECOL MONOGR, V23, P41, DOI 10.2307/1943519; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Willis KJ, 2002, SCIENCE, V295, P1245, DOI 10.1126/science.1067335; Wilson JS, 2012, J BIOGEOGR, V39, P336, DOI 10.1111/j.1365-2699.2011.02580.x; Wilson JS, 2010, WEST N AM NATURALIST, V70, P224, DOI 10.3398/064.070.0209; Zanette LRS, 2004, TROP ZOOL, V17, P145, DOI 10.1080/03946975.2004.10531204; Zhao ZH, 2015, BASIC APPL ECOL, V16, P510, DOI 10.1016/j.baae.2015.06.002	127	2	2	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187142	10.1371/journal.pone.0187142	http://dx.doi.org/10.1371/journal.pone.0187142			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077763	Green Submitted, gold, Green Published			2022-12-26	WOS:000413861200049
J	De Jong, CN; Saes, L; Klerk, CPW; Van der Klift, M; Cornelissen, JJ; Broers, AEC				De Jong, Cornelis N.; Saes, Lotte; Klerk, Clara P. W.; Van der Klift, Marjolein; Cornelissen, Jan J.; Broers, Annoek E. C.			Etanercept for steroid-refractory acute graft-versus-host disease: A single center experience	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; ACUTE GVHD; MARROW-TRANSPLANTATION; THERAPY; ALPHA; BLOOD	Background Acute graft-versus-host disease (aGVHD) is an important complication of allogeneic stem cell transplantation (alloSCT). High dose glucocorticosteroids, are currently recommended as first-line treatment for grade II-IV aGVHD resulting in overall complete responses (CR) in 40%-50% of patients. No standard second-line regimen has been established. Different options have been reported, including anti-TNF alpha antibodies. Methods We retrospectively reviewed the outcome of 15 patients with steroid-refractory (SR) aGVHD treated with etanercept at our institution. Patients were transplanted for a hematological malignancy and received either a myeloablative or a non-myeloablative conditioning regimen. Prophylaxis of GVHD consisted of cyclosporin A and mycophenolic acid. Results Acute GVHD was diagnosed at a median of 61 days post-transplantation. All patients had grade III aGVHD of the gut. Second-line treatment with etanercept was started at a median of 13 days after initiation of first-line therapy. Overall response rate was 53%, with CR in 3 patients and PR in 5 patients. Median overall survival after initiation of treatment with etanercept was 66 days (range 5-267) for the entire group. Median overall survival was 99 days (range 47-267 days) for responders and 17 days (range 5-66 days) for non-responders (p<0.01). Nevertheless, all patients died. Causes of death were progressive GVHD in 7 patients (47%), infection in 6 patients (40%), cardiac death in 1 patient (6.7%) and relapse in 1 patient (6,7%). Conclusion Second-line treatment with etanercept does induce responses in SR-aGVHD of the gut but appears to be associated with poor long-term survival even in responding patients.	[De Jong, Cornelis N.; Saes, Lotte; Cornelissen, Jan J.; Broers, Annoek E. C.] Erasmus MC, Dept Hematol, Rotterdam, Netherlands; [Klerk, Clara P. W.] Onze Lieve Vrouw Hosp, Dept Hematol & Oncol, Amsterdam, Netherlands; [Van der Klift, Marjolein] Amphia Hosp, Dept Hematol, Breda, Netherlands	Erasmus University Rotterdam; Erasmus MC; Onze Lieve Vrouwe Gasthuis Hospital; Amphia Hospital	De Jong, CN (corresponding author), Erasmus MC, Dept Hematol, Rotterdam, Netherlands.	c.n.dejong@erasmusmc.nl		De Jong, Cornelis/0000-0003-2054-0752				Bacigalupo A, 2009, BIOL BLOOD MARROW TR, V15, P1628, DOI 10.1016/j.bbmt.2009.07.004; Busca A, 2007, AM J HEMATOL, V82, P45, DOI 10.1002/ajh.20752; Deeg HJ, 2007, BLOOD, V109, P4119, DOI 10.1182/blood-2006-12-041889; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Girmenia C, 2014, BIOL BLOOD MARROW TR, V20, P872, DOI 10.1016/j.bbmt.2014.03.004; Jacobson CA, 2012, BIOL BLOOD MARROW TR, V18, P565, DOI 10.1016/j.bbmt.2011.08.018; Kennedy GA, 2006, BONE MARROW TRANSPL, V37, P1143, DOI 10.1038/sj.bmt.1705380; Korngold R, 2003, BIOL BLOOD MARROW TR, V9, P292, DOI 10.1016/S1083-8791(03)00087-9; Levine JE, 2008, BLOOD, V111, P2470, DOI 10.1182/blood-2007-09-112987; MacMillan ML, 2002, BIOL BLOOD MARROW TR, V8, P387, DOI 10.1053/bbmt.2002.v8.pm12171485; Martin PJ, 2012, BIOL BLOOD MARROW TR, V18, P1150, DOI 10.1016/j.bbmt.2012.04.005; Murdaca G, 2015, EXPERT OPIN DRUG SAF, V14, P571, DOI 10.1517/14740338.2015.1009036; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; van Groningen LFJ, 2016, BIOL BLOOD MARROW TR, V22, P179, DOI 10.1016/j.bbmt.2015.08.039; WEISDORF D, 1990, BLOOD, V75, P1024, DOI 10.1182/blood.V75.4.1024.1024; Wolff D, 2005, BONE MARROW TRANSPL, V35, P1003, DOI 10.1038/sj.bmt.1704929; Xhaard A, 2012, BIOL BLOOD MARROW TR, V18, P406, DOI 10.1016/j.bbmt.2011.06.012	17	15	15	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187184	10.1371/journal.pone.0187184	http://dx.doi.org/10.1371/journal.pone.0187184			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073260	Green Published, gold, Green Submitted			2022-12-26	WOS:000413845400130
J	Huang, C; Mezencev, R; McDonald, JF; Vannberg, F				Huang, Cai; Mezencev, Roman; McDonald, John F.; Vannberg, Fredrik			Open source machine-learning algorithms for the prediction of optimal cancer drug therapies	PLOS ONE			English	Article							CLASSIFICATION; APOPTOSIS	Precision medicine is a rapidly growing area of modern medical science and open source machine-learning codes promise to be a critical component for the successful development of standardized and automated analysis of patient data. One important goal of precision cancer medicine is the accurate prediction of optimal drug therapies from the genomic profiles of individual patient tumors. We introduce here an open source software platform that employs a highly versatile support vector machine (SVM) algorithm combined with a standard recursive feature elimination (RFE) approach to predict personalized drug responses from gene expression profiles. Drug specific models were built using gene expression and drug response data from the National Cancer Institute panel of 60 human cancer cell lines (NCI-60). The models are highly accurate in predicting the drug responsiveness of a variety of cancer cell lines including those comprising the recent NCI-DREAM Challenge. We demonstrate that predictive accuracy is optimized when the learning dataset utilizes all probeset expression values from a diversity of cancer cell types without pre-filtering for genes generally considered to be "drivers" of cancer onset/progression. Application of our models to publically available ovarian cancer (OC) patient gene expression datasets generated predictions consistent with observed responses previously reported in the literature. By making our algorithm "open source", we hope to facilitate its testing in a variety of cancer types and contexts leading to community-driven improvements and refinements in subsequent applications.	[Huang, Cai; Mezencev, Roman; McDonald, John F.; Vannberg, Fredrik] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA; [Huang, Cai; Mezencev, Roman; McDonald, John F.; Vannberg, Fredrik] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Vannberg, F (corresponding author), Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA.; Vannberg, F (corresponding author), Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.	vannberg@gatech.edu	Mezencev, Roman/A-8573-2009; Mezencev, Roman/O-8489-2019	Mezencev, Roman/0000-0003-4361-7628	Rising Tide Foundation	Rising Tide Foundation	Funding was provided by the Rising Tide Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaratunga D, 2001, J AM STAT ASSOC, V96, P1161, DOI 10.1198/016214501753381814; Azuaje F., 2016, BRIEF BIOINFORM; Bedo J, 2006, LECT NOTES COMPUT SC, V4304, P170; Bode AM, 2017, NPJ PRECIS ONCOL, V1, DOI 10.1038/s41698-017-0010-5; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Costello JC, 2014, NAT BIOTECHNOL, V32, P1202, DOI 10.1038/nbt.2877; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Gaul DA, 2015, SCI REP-UK, V5, DOI 10.1038/srep16351; Geeleher P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107468; Guan W, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-259; Gysels E, 2005, SIGNAL PROCESS, V85, P2178, DOI 10.1016/j.sigpro.2005.07.008; Haibe-Kains B, 2013, NATURE, V504, P389, DOI 10.1038/nature12831; Hansen SW, 1999, ANN ONCOL, V10, P51, DOI 10.1023/A:1008359418422; Haverty PM, 2016, NATURE, V533, P333, DOI 10.1038/nature17987; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Hsu C. W., 2003, PRACTICAL GUIDE SUPP; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Liu B, 2014, BIOINFORMATICS, V30, P472, DOI 10.1093/bioinformatics/btt709; Liu TG, 2015, J THEOR BIOL, V366, P8, DOI 10.1016/j.jtbi.2014.11.010; Mezencev R, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2274-5; Ozols RF, 2006, ANN ONCOL, V17, pV181, DOI 10.1093/annonc/mdj978; Piccolo SR, 2013, P NATL ACAD SCI USA, V110, P17778, DOI 10.1073/pnas.1305823110; Radovic M, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-016-1423-9; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Saez-Rodriguez J, 2016, NAT REV GENET, V17, P470, DOI 10.1038/nrg.2016.69; Salesse S, 2002, ONCOGENE, V21, P8547, DOI 10.1038/sj.onc.1206082; Wen YJ, 2011, PHARMACOGENET GENOM, V21, P476, DOI 10.1097/FPC.0b013e3283481967	30	45	46	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186906	10.1371/journal.pone.0186906	http://dx.doi.org/10.1371/journal.pone.0186906			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073279	Green Submitted, gold, Green Published			2022-12-26	WOS:000413845400074
J	Zhang, YY; Wang, HB; Wang, YN; Wang, HC; Zhang, S; Hong, JY; Guo, HF; Chen, D; Yang, Y; Zan, LS				Zhang, Ying-Ying; Wang, Hong-Bao; Wang, Ya-Ning; Wang, Hong-Cheng; Zhang, Song; Hong, Jie-Yun; Guo, Hong-Fang; Chen, Dai; Yang, Yang; Zan, Lin-Sen			Transcriptome analysis of mRNA and microRNAs in intramuscular fat tissues of castrated and intact male Chinese Qinchuan cattle	PLOS ONE			English	Article							FALSE DISCOVERY RATE; SKELETAL-MUSCLE; ADIPOSE-TISSUE; PREADIPOCYTE PROLIFERATION; TESTOSTERONE DEFICIENCY; HEPATIC STEATOSIS; LONGISSIMUS-DORSI; GENE-EXPRESSION; PATHWAY; ADIPOGENESIS	Intramuscular fat (IMF) is known to enhance beef palatability and can be markedly increased by castration. However, there is little understanding of the molecular mechanism underlying the IMF deposition after castration of beef cattle. We hypothesize that genetic regulators function differently in IMF from bulls and steers. Therefore, after detecting serum testosterone and lipid parameter, as well as the contents of IMF at 6, 12, 18 and 24 months, we have investigated differentially expressed (DE) microRNAs (miRNAs) and mRNAs in IMF of bulls and steers at 24 months of age in Qinchuan cattle using next-generation sequencing, and then explored the possible biopathways regulating IMF deposition. Serum testosterone levels were significantly decreased in steers, whereas IMF content, serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) and triglycerides (TGs) were markedly increased in steers. Comparing the results of steers and bulls, 580 upregulated genes and 1,120 downregulated genes in IMF tissues were identified as DE genes correlated with IMF deposition. The upregulated genes were mainly associated with lipid metabolism, lipogenesis and fatty acid transportation signalling pathways, and the downregulated genes were correlated with immune response and intracellular signal transduction. Concurrently, the DE miRNAs D important players in adipose tissue accumulation induced by castration D were also examined in IMF tissues; 52 DE miRNAs were identified. The expression profiles of selected genes and miRNAs were also confirmed by quantitative realtime PCR (qRT-PCR) assays. Using integrated analysis, we constructed the microRNA-target regulatory network which was supported by target validation using the dual luciferase reporter system. Moreover, Ingenuity Pathway Analysis (IPA) software was used to construct a molecular interaction network that could be involved in regulating IMF after castration. The detected molecular network is closely associated with lipid metabolism and adipocyte differentiation, which is supported by functional identification results of bta-let-7i on bovine preadipocytes. These results provided valuable insights into the molecular mechanisms of the IMF phenotype differences between steers and bulls.	[Zhang, Ying-Ying; Wang, Hong-Bao; Wang, Ya-Ning; Wang, Hong-Cheng; Zhang, Song; Hong, Jie-Yun; Guo, Hong-Fang; Zan, Lin-Sen] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Zhang, Ying-Ying; Wang, Hong-Bao; Zan, Lin-Sen] Northwest A&F Univ, Natl Beef Cattle Improvement Ctr, Yangling, Shaanxi, Peoples R China; [Zhang, Ying-Ying] Shanghai Acad Agr Sci, Anim Husb & Vet Res Inst, Shanghai, Peoples R China; [Chen, Dai; Yang, Yang] NovelBio Biopharm Technol Co Ltd, Shanghai, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Shanghai Academy of Agricultural Sciences	Zan, LS (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.; Zan, LS (corresponding author), Northwest A&F Univ, Natl Beef Cattle Improvement Ctr, Yangling, Shaanxi, Peoples R China.	zanlinsen@163.com		Zhang, Ying Ying/0000-0003-4200-2760; Zan, Lin-sen/0000-0001-6644-0250	National Natural Science Foundation of China [31272411, 31501937]; China Postdoctoral Science Foundation [2014M562467]; NovelBio Bio-Pharm Technology Co., Ltd.	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); NovelBio Bio-Pharm Technology Co., Ltd.	This work was supported by the National Natural Science Foundation of China (Grant No. 31272411, https://isisn.nsfc.gov.cn/egrantweb/ index; Grant No. 31501937, https://isisn.nstc.gov. cn/egranhnebanaex), the China Postdoctoral Science Foundation (Grant No. 2014M562467, http://www.chinapostdoctor.org.cn/WebSite/ progra/lnfo_Show.aspx?InfoID=09858058-91c5-417a-9ab0-c4f1f102f8cd). DC and YY received support in the form of salary from the commercial company, NovelBio Bio-Pharm Technology Co., Ltd. The specific roles of these authors are articulated in the 'author contributions' section.; This work was supported by the National Natural Science Foundation of China (Grant No. 31272411; Grant No. 31501937), the China Postdoctoral Science Foundation (Grant No. 2014M562467). Careful preparation of the final manuscript was carried out by BioMedES Ltd., UK.	Abdel-Aziz HO, 2007, J CANCER RES CLIN, V133, P107, DOI 10.1007/s00432-006-0149-x; Albrecht E, 2011, J ANIM SCI, V89, P4339, DOI 10.2527/jas.2011-4039; Albrecht E, 2010, P 9 WORLD C GEN APPL; An JY, 2013, NUCLEIC ACIDS RES, V41, P727, DOI 10.1093/nar/gks1187; Anderson LA, 2001, J CLIN ENDOCR METAB, V86, P5045, DOI 10.1210/jc.86.10.5045; Aoki-Kinoshita Kiyoko F., 2007, V396, P71; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-47; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernlohr D. A., 2002, BIOCH LIPIDS LIPOPRO, P263; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; BJORNTORP P, 1991, DIABETES CARE, V14, P1132, DOI 10.2337/diacare.14.12.1132; Bong JJ, 2012, MEAT SCI, V91, P284, DOI 10.1016/j.meatsci.2012.02.004; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cai ZW, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1283-0; Cai ZW, 2014, J APPL GENET, V55, P259, DOI 10.1007/s13353-014-0194-0; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chartoumpekis DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034872; Clark AL, 2015, J BIOL CHEM, V290, P23162, DOI 10.1074/jbc.M115.672659; Davalos A, 2011, P NATL ACAD SCI USA, V108, P9232, DOI 10.1073/pnas.1102281108; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Du M, 2010, J ANIM SCI, V88, pE51, DOI 10.2527/jas.2009-2311; Duarte MS, 2013, J ANIM SCI, V91, P2938, DOI 10.2527/jas.2012-5892; Floryk D, 2011, MOL CELL ENDOCRINOL, V345, P58, DOI 10.1016/j.mce.2011.07.011; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Garcia E, 1999, J ENDOCRINOL, V161, P89, DOI 10.1677/joe.0.1610089; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hocquette JF, 2010, ANIMAL, V4, P303, DOI 10.1017/S1751731109991091; Jeong J, 2013, J ANIM SCI, V91, P4692, DOI 10.2527/jas.2012-6089; Jeong J, 2012, J ANIM SCI, V90, P2044, DOI 10.2527/jas.2011-4753; Ortega FJ, 2013, CLIN CHEM, V59, P781, DOI 10.1373/clinchem.2012.195776; Keeton JIT, 2003, J AOAC INT, V86, P1193; Kinoshita M, 2010, MOL ENDOCRINOL, V24, P1978, DOI 10.1210/me.2010-0054; Kopp C, 2014, INT J MOL SCI, V15, P21401, DOI 10.3390/ijms151121401; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Lea-Currie YR, 1999, COMP BIOCHEM PHYS C, V123, P17, DOI 10.1016/S0742-8413(99)00003-1; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li GL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-811; Li HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071568; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022570; Mach N, 2009, MEAT SCI, V81, P329, DOI 10.1016/j.meatsci.2008.08.007; Mayburd AL, 2006, CLIN CANCER RES, V12, P1820, DOI 10.1158/1078-0432.CCR-05-2149; Ogata H, 1998, BIOSYSTEMS, V47, P119, DOI 10.1016/S0303-2647(98)00017-3; Ongusaha PP, 2004, CANCER RES, V64, P5283, DOI 10.1158/0008-5472.CAN-04-0925; OPPENHEIMER JH, 1991, J CLIN INVEST, V87, P125, DOI 10.1172/JCI114961; Peng XJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-26; Peng YD, 2013, INT J BIOCHEM CELL B, V45, P1585, DOI 10.1016/j.biocel.2013.04.029; Pethick DW, 2004, AUST J EXP AGR, V44, P705, DOI 10.1071/EA02165; Pospisil P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105/7/354; Reusch JEB, 2000, MOL CELL BIOL, V20, P1008, DOI 10.1128/MCB.20.3.1008-1020.2000; Schlitt T, 2003, GENOME RES, V13, P2568, DOI 10.1101/gr.1111403; SCHWARTZ Y, 1991, P NATL ACAD SCI USA, V88, P6790, DOI 10.1073/pnas.88.15.6790; Senmaru T, 2013, METABOLISM, V62, P851, DOI 10.1016/j.metabol.2012.12.007; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Su YQ, 2007, DEV BIOL, V302, P104, DOI 10.1016/j.ydbio.2006.09.008; Sun L, 2011, NAT CELL BIOL, V13, P958, DOI 10.1038/ncb2286; Takanabe R, 2008, BIOCHEM BIOPH RES CO, V376, P728, DOI 10.1016/j.bbrc.2008.09.050; Timokhina I, 1998, EMBO J, V17, P6250, DOI 10.1093/emboj/17.21.6250; Tominaga S, 2005, BIOCHEM BIOPH RES CO, V326, P499, DOI 10.1016/j.bbrc.2004.11.056; Villanueva CJ, 2009, HEPATOLOGY, V50, P434, DOI 10.1002/hep.22980; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Wang M, 2009, AM J PHYSIOL-ENDOC M, V297, pE1378, DOI 10.1152/ajpendo.00252.2009; Whitsel EA, 2001, AM J MED, V111, P261, DOI 10.1016/S0002-9343(01)00833-6; XU XF, 1990, ENDOCRINOLOGY, V126, P1229, DOI 10.1210/endo-126-2-1229; Yang FC, 2000, IMMUNITY, V12, P557, DOI 10.1016/S1074-7613(00)80207-1; Zhang ZQ, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-29; Zhao CP, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-12; Zhao SM, 2009, LIPIDS, V44, P1029, DOI 10.1007/s11745-009-3356-9; Zheng L, 2010, J GASTROEN HEPATOL, V25, P156, DOI 10.1111/j.1440-1746.2009.05949.x; Zhou YP, 2014, 2014 IEEE VISUAL COMMUNICATIONS AND IMAGE PROCESSING CONFERENCE, P9, DOI 10.1109/VCIP.2014.7051491	74	19	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0185961	10.1371/journal.pone.0185961	http://dx.doi.org/10.1371/journal.pone.0185961			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073274	gold, Green Published			2022-12-26	WOS:000413845400010
J	Zhou, Y; Wang, L; Ban, X; Zeng, T; Zhu, Y; Li, M; Guan, XY; Li, Y				Zhou, Y.; Wang, L.; Ban, X.; Zeng, T.; Zhu, Y.; Li, M.; Guan, X-Y; Li, Y.			DHRS2 inhibits cell growth and motility in esophageal squamous cell carcinoma	ONCOGENE			English	Article							CANCER CELL; DOWN-REGULATION; BREAST-CANCER; GENE; EXPRESSION; FAMILY; HEP27; ACTIVATION; PROTEINS; INVASION	Esophageal squamous cell carcinoma (ESCC) is highly prevailing in Asia and it is ranked in the most aggressive squamous cell carcinomas. High-frequency loss of heterozygosity occurred in chromosome 14q11.2 in many tumors including ESCC, suggesting that one or more tumor-suppressor genes might exist within this region. In this study, we identified the tumor-suppressing role of DHRS2 (short-chain dehydrogenase/reductase family, member 2) at 14q11.2 in ESCCs. Downregulation of DHRS2 occurred in 30.8% of primary ESCC tumor tissues vs paired non-tumorous tissues. DHRS2 downregulation was associated significantly with ESCC invasion, lymph nodes metastasis and clinical staging (P<0.001). Survival analysis revealed that DHRS2 downregulation was significantly associated with worse outcome of patients with ESCC. In vitro and in vivo studies indicated that both DHRS2 variants could suppress cell proliferation and cell motility. Moreover, we demonstrated that DHRS2 could reduce reactive oxygen species and decrease nicotinamide adenine dinucleotide phosphate (oxidized/reduced), increase p53 stability and decrease Rb phosphorylation; it also decreased p38 mitogen-activated protein kinase phosphorylation and matrix metalloproteinase 2. In summary, these findings demonstrated that DHRS2 had an important part in ESCC development and progression.	[Zhou, Y.; Wang, L.; Ban, X.; Zeng, T.; Zhu, Y.; Li, M.; Guan, X-Y; Li, Y.] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China; [Zhou, Y.] Guangdong Esophageal Canc Inst, Guangzhou, Guangdong, Peoples R China; [Guan, X-Y] Univ Hong Kong, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; University of Hong Kong	Guan, XY; Li, Y (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China.	xyguan@hku.hk; liy6@mail.sysu.edu.cn	/A-3639-2009	/0000-0003-1874-9805	National Natural Science Foundation of China [81472255, 81472250]; Guangdong Esophageal Cancer Institute [M201511]; Guangdong Science and Technology Foundation [2016A020214008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Esophageal Cancer Institute; Guangdong Science and Technology Foundation	This research was supported by the National Natural Science Foundation of China (81472255 and 81472250); Guangdong Esophageal Cancer Institute Funding (M201511); Guangdong Science and Technology Foundation (2016A020214008).	Alberghina L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.513; Benhar M, 2002, EMBO REP, V3, P420, DOI 10.1093/embo-reports/kvf094; Binker MG, 2009, BIOCHEM BIOPH RES CO, V379, P445, DOI 10.1016/j.bbrc.2008.12.080; Bjorkqvist AM, 1999, BRIT J CANCER, V81, P1111, DOI 10.1038/sj.bjc.6690816; Bray JE, 2009, CHEM-BIOL INTERACT, V178, P99, DOI 10.1016/j.cbi.2008.10.058; Chiu WT, 2010, NEUROBIOL DIS, V37, P118, DOI 10.1016/j.nbd.2009.09.015; Crean D, 2012, MOL CELL BIOCHEM, V366, P231, DOI 10.1007/s11010-012-1300-4; Deblec-Rychter M, 2001, GENE CHROMOSOME CANC, V32, P26; Deisenroth C, 2010, MOL CELL BIOL, V30, P3981, DOI 10.1128/MCB.01284-09; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; El-Rifai W, 2000, GENE CHROMOSOME CANC, V27, P387, DOI 10.1002/(SICI)1098-2264(200004)27:4<387::AID-GCC8>3.0.CO;2-C; Fang L, 2016, CANCER BIOL THER, V17, P664, DOI 10.1080/15384047.2016.1190485; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; GABRIELLI F, 1995, EUR J BIOCHEM, V232, P473, DOI 10.1111/j.1432-1033.1995.tb20833.x; Gabrielli F, 2012, GENE, V511, P461, DOI 10.1016/j.gene.2012.09.013; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Guan XY, 2001, CANCER RES, V61, P3806; Hu L, 2016, TUMOR BIOL, V37, P837, DOI 10.1007/s13277-015-3880-6; Hurd TR, 2012, TRENDS CELL BIOL, V22, P107, DOI 10.1016/j.tcb.2011.11.002; Li J, 2014, INT J BIOL SCI, V10, P142, DOI 10.7150/ijbs.7727; Li Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060027; Li Y, 2011, CANCER RES, V71, P6106, DOI 10.1158/0008-5472.CAN-10-4291; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Monge M, 2009, CARCINOGENESIS, V30, P1288, DOI 10.1093/carcin/bgp119; Nishikawa M, 2008, CANCER LETT, V266, P53, DOI 10.1016/j.canlet.2008.02.031; Oppermann U, 2007, ANNU REV PHARMACOL, V47, P293, DOI 10.1146/annurev.pharmtox.47.120505.105316; Pelicano H, 2009, CANCER RES, V69, P2375, DOI 10.1158/0008-5472.CAN-08-3359; Pellegrini S, 2002, BBA-GENE STRUCT EXPR, V1574, P215, DOI 10.1016/S0167-4781(01)00323-2; Rushton JJ, 2003, ONCOGENE, V22, P308, DOI 10.1038/sj.onc.1206131; Shafqat N, 2006, CELL MOL LIFE SCI, V63, P1205, DOI 10.1007/s00018-006-6013-y; Shao JY, 2001, ANTICANCER RES, V21, P3021; Shi ZZ, 2014, CLIN TRANSL ONCOL, V16, P606, DOI 10.1007/s12094-013-1124-z; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Tochhawng L, 2013, MITOCHONDRION, V13, P246, DOI 10.1016/j.mito.2012.08.002; Wang J, 2017, INT J CANCER, V140, P2484, DOI 10.1002/ijc.30680; Wang P, 2015, CHIN J CANCER, V34, DOI 10.1186/s40880-015-0012-z; Wong ML, 2006, INT J ONCOL, V28, P767; Wu XQ, 2007, MOL CELL ENDOCRINOL, V265, P71, DOI 10.1016/j.mce.2006.12.006	38	27	29	0	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 22	2018	37	8					1086	1094		10.1038/onc.2017.383	http://dx.doi.org/10.1038/onc.2017.383			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FX2QD	29106393	Green Published, hybrid			2022-12-26	WOS:000425905700011
J	Kurtenbach, S; Ding, W; Goss, GM; Hare, JM; Goldstein, BJ; Shehadeh, LA				Kurtenbach, Sarah; Ding, Wen; Goss, Garrett M.; Hare, Joshua M.; Goldstein, Bradley J.; Shehadeh, Lina A.			Differential expression of microRNAs among cell populations in the regenerating adult mouse olfactory epithelium	PLOS ONE			English	Article							HORIZONTAL BASAL-CELLS; SENSORY NEURONS; PROGENITOR CELLS; MARKER PROTEIN; NEUROGENESIS; STEM; SYSTEM; TARGET; RNAS; RECONSTITUTION	Despite a robust capacity for adult neurogenesis in the olfactory epithelium (OE), olfactory sensory losses are common. Identification of mechanisms regulating adult OE neurogenesis is, therefore, of interest. MicroRNAs (miRNAs) are broadly important in regulating vertebrate neurodevelopment, and are required in embryonic olfactory differentiation. We report here that a panel of miRNAs is differentially expressed by either progenitor or progeny cells in the regenerating mouse OE. Progenitor cells were purified from lesioned OE based on c-Kit expression, and miRNA expression was assayed in c-Kit (+) and c-Kit (-) cell populations. 28 miRNAs were significantly downregulated by at least 4 fold in the c-Kit (+) fraction, which marks the globose basal progenitor cell population. In addition, 10 miRNAs were upregulated in these basal cells. MiR-486, the most strongly downregulated miRNA identified, was further characterized to verify results. MiR-486 expression was confirmed in the c-Kit (-) OE layers using in situ hybridization. As a functional assay, over-expression of miR-486 in purified c-Kit (+) basal cell cultures resulted in a reduction in neurogenesis, consistent with a possible negative feedback regulatory model. Our data provide new insights regarding miRNA expression and function during adult OE neurogenesis, and identify candidate miRNAs warranting further study.	[Kurtenbach, Sarah; Ding, Wen; Goss, Garrett M.; Hare, Joshua M.; Goldstein, Bradley J.; Shehadeh, Lina A.] Univ Miami, Leonard M Miller Sch Med, Interdisciplinary Stem Cell Inst, Miami, FL 33136 USA; [Kurtenbach, Sarah; Goss, Garrett M.; Goldstein, Bradley J.] Univ Miami, Leonard M Miller Sch Med, Dept Otolaryngol, Miami, FL 33136 USA; [Ding, Wen] Univ Miami, Leonard M Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL USA; [Hare, Joshua M.; Shehadeh, Lina A.] Univ Miami, Leonard M Miller Sch Med, Dept Med, Div Cardiol, Miami, FL 33136 USA; [Shehadeh, Lina A.] Univ Miami, Leonard M Miller Sch Med, Vasc Biol Inst, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami; University of Miami; University of Miami	Goldstein, BJ; Shehadeh, LA (corresponding author), Univ Miami, Leonard M Miller Sch Med, Interdisciplinary Stem Cell Inst, Miami, FL 33136 USA.; Goldstein, BJ (corresponding author), Univ Miami, Leonard M Miller Sch Med, Dept Otolaryngol, Miami, FL 33136 USA.; Shehadeh, LA (corresponding author), Univ Miami, Leonard M Miller Sch Med, Dept Med, Div Cardiol, Miami, FL 33136 USA.; Shehadeh, LA (corresponding author), Univ Miami, Leonard M Miller Sch Med, Vasc Biol Inst, Miami, FL 33136 USA.	b.goldstein4@med.miami.edu; lshehadeh@med.miami.edu		Goldstein, Bradley/0000-0002-9612-1696; Goss, Garrett/0000-0002-0155-4334	National Institutes of Health [K08 DC013556]; Triological Society/American College of Surgeons; NIH [5R01 HL094849, 1R01 HL107110, 5UM1 HL113460, 1R01 HL084275, R01 HL111874]; Starr Family Foundation; Soffer Family Foundation; National Institute of Health [R56HL132209]; Miami Heart Research Institute; Sublett AHA [15PRE22450019]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K08DC013556] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Triological Society/American College of Surgeons; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Family Foundation; Soffer Family Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Miami Heart Research Institute; Sublett AHA(American Heart Association); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	B.J.G. is supported by grants from the National Institutes of Health (K08 DC013556) and a Clinician-Scientist Development Award from the Triological Society/American College of Surgeons. J.M.H. is supported by NIH grants 5R01 HL094849, 1R01 HL107110, 5UM1 HL113460, 1R01 HL084275, R01 HL111874 and The Starr and Soffer Family Foundations. L.A.S. is supported by grants from the National Institute of Health (R56HL132209) and the Miami Heart Research Institute. W.D. is a recipient of a Sublett AHA predoctoral fellowship (15PRE22450019).	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bergman U, 2002, ARCH TOXICOL, V76, P104, DOI 10.1007/s00204-002-0321-2; CALOF AL, 1989, NEURON, V3, P115, DOI 10.1016/0896-6273(89)90120-7; Cao XW, 2006, ANNU REV NEUROSCI, V29, P77, DOI 10.1146/annurev.neuro.29.051605.112839; CARR VM, 1993, EXP NEUROL, V124, P308, DOI 10.1006/exnr.1993.1201; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Cheng LE, 2007, NEURON, V54, P547, DOI 10.1016/j.neuron.2007.04.029; Choi PS, 2008, NEURON, V57, P41, DOI 10.1016/j.neuron.2007.11.018; Christensen MD, 2001, CHEM SENSES, V26, P359, DOI 10.1093/chemse/26.4.359; Fletcher RB, 2017, CELL STEM CELL, V20, P817, DOI 10.1016/j.stem.2017.04.003; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gokoffski KK, 2011, DEVELOPMENT, V138, P4131, DOI 10.1242/dev.065870; Goldstein BJ, 2003, JARO-J ASSOC RES OTO, V4, P74, DOI 10.1007/s10162-002-2039-5; Goldstein BJ, 2016, DEVELOPMENT, V143, P4394, DOI 10.1242/dev.142653; Goldstein BJ, 2015, J COMP NEUROL, V523, P15, DOI 10.1002/cne.23653; Goss GM, 2016, DEV NEUROBIOL, V76, P241, DOI 10.1002/dneu.22310; GRAZIADEI GAM, 1979, J NEUROCYTOL, V8, P197; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Guo Z, 2010, J COMP NEUROL, V518, P4395, DOI 10.1002/cne.22463; Haider BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089565; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; Heron PM, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-49; HOLBROOK EH, 1995, J COMP NEUROL, V363, P129, DOI 10.1002/cne.903630111; Holbrook Eric H, 2006, Curr Opin Otolaryngol Head Neck Surg, V14, P23, DOI 10.1097/01.moo.0000193174.77321.39; Huard JMT, 1998, J COMP NEUROL, V400, P469; Jee MK, 2012, BRAIN, V135, P1237, DOI 10.1093/brain/aws047; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; KELLER A, 1975, J NEUROCHEM, V24, P1101, DOI 10.1111/j.1471-4159.1975.tb03883.x; Krolewski RC, 2013, J COMP NEUROL, V521, P833, DOI 10.1002/cne.23204; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Leung CT, 2007, NAT NEUROSCI, V10, P720, DOI 10.1038/nn1882; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; Lindsay SL, 2016, STEM CELL REP, V6, P729, DOI 10.1016/j.stemcr.2016.03.009; Loo AT, 1996, INT J DEV NEUROSCI, V14, P881, DOI 10.1016/S0736-5748(96)00046-9; McCall MN, 2017, GENOME RES, V27, P1769, DOI 10.1101/gr.222067.117; McCall Matthew N. K M-S, HUMAN CELLULAR MICRO; Nickell MD, 2012, J COMP NEUROL, V520, P2608, DOI 10.1002/cne.23052; Packard A, 2011, J COMP NEUROL, V519, P3580, DOI 10.1002/cne.22726; Rupaimoole R, 2017, NAT REV DRUG DISCOV, V16, P203, DOI 10.1038/nrd.2016.246; Schnittke N, 2015, P NATL ACAD SCI USA, V112, pE5068, DOI 10.1073/pnas.1512272112; Schwob JE, 2017, J COMP NEUROL, V525, P1034, DOI 10.1002/cne.24105; SCHWOB JE, 1995, J COMP NEUROL, V359, P15, DOI 10.1002/cne.903590103; SCHWOB JE, 1992, J NEUROSCI, V12, P3896; Shetty RS, 2005, MOL CELL NEUROSCI, V30, P583, DOI 10.1016/j.mcn.2005.06.003; Smith CG, 1938, CAN MED ASSOC J, V39, P138; VERHAAGEN J, 1990, J NEUROSCI RES, V26, P31, DOI 10.1002/jnr.490260105; Weiler E, 1997, J NEUROSCI, V17, P3610	48	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187576	10.1371/journal.pone.0187576	http://dx.doi.org/10.1371/journal.pone.0187576			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29107942	gold, Green Published, Green Submitted			2022-12-26	WOS:000414424600045
J	Bierle, CJ; Fernandez-Alarcon, C; Hernandez-Alvarado, N; Zabeli, JC; Janus, BC; Putri, DS; Schleiss, MR				Bierle, Craig J.; Fernandez-Alarcon, Claudia; Hernandez-Alvarado, Nelmary; Zabeli, Jason C.; Janus, Bradley C.; Putri, Dira S.; Schleiss, Mark R.			Assessing Zika virus replication and the development of Zika-specific antibodies after a mid-gestation viral challenge in guinea pigs	PLOS ONE			English	Article							BIRTH-DEFECTS; INFECTION; MODEL; CYTOMEGALOVIRUS; PLASMA; PLACENTATION; PREGNANCY; MOSQUITOS; CORRELATE; DYNAMICS	Primary Zika virus (ZIKV) infections that occur during pregnancy can cause spontaneous abortion and profoundly disrupt fetal development. While the full range of developmental abnormalities associated with congenital Zika syndrome is not yet known, severe cases of the syndrome can present with microcephaly, extensive neurologic and ocular damage, and pronounced joint malformations. Animal models that accurately recapitulate congenital Zika syndrome are urgently needed for vaccine development and for the study of ZIKV pathogenesis. As guinea pigs have successfully been used to model transplacental infections by cytomegalovirus, syphilis, and Listeria monocytogenes, we sought to test whether ZIKV could productively infect guinea pigs and whether viral transmission with attendant fetal pathology would occur after a mid-gestation viral challenge. We found that guinea pig cells supported ZIKV replication in vitro. Experimental infection of non-pregnant animals did not result in overt disease but low-level, detectable viremia was observed. When pregnant guinea pigs were challenged with ZIKV at between 18 and 21 days gestational age, ZIKV was not detected in maternal or pup blood, plasma, or tissues and no significant differences in maternal weight gain or pup size were observed following challenge. Nonetheless, a robust antibody response against ZIKV was detected in both the pups and dams. These results suggest that, while guinea pigs can model aspects of the immune response to ZIKV infection during pregnancy, naturally circulating ZIKV strains are not pathogenic during the pregnancy of immunocompetent guinea pigs and do not interfere with normal pup development.	[Bierle, Craig J.; Fernandez-Alarcon, Claudia; Hernandez-Alvarado, Nelmary; Zabeli, Jason C.; Janus, Bradley C.; Putri, Dira S.; Schleiss, Mark R.] Univ Minnesota, Dept Pediat, Div Pediat Infect Dis & Immunol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Bierle, CJ; Schleiss, MR (corresponding author), Univ Minnesota, Dept Pediat, Div Pediat Infect Dis & Immunol, Minneapolis, MN 55455 USA.	cjbierle@umn.edu; schleiss@umn.edu	Schleiss, Mark/ABI-8450-2020	Schleiss, Mark/0000-0002-2108-9433; Putri, Dira/0000-0002-9715-3171; Bierle, Craig/0000-0002-7890-7409	National Institutes of Health [R01HD044864, R01HD079918, R56AI114013, R03HD082273, T90DE022732, R21HD087496]; University of Minnesota (Academic Health Center Faculty Research Development Grant Program) [16.55]; University of Minnesota (Masonic Neurogenomic and Neuroimaging Research Grant); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD082273, R01HD079918, R21HD087496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI114013] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota (Academic Health Center Faculty Research Development Grant Program); University of Minnesota (Masonic Neurogenomic and Neuroimaging Research Grant); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Grants from the National Institutes of Health (R01HD044864, R01HD079918, R56AI114013, and R03HD082273 to MRS; T90DE022732 and R21HD087496 to CJB) and the University of Minnesota (Academic Health Center Faculty Research Development Grant Program 2016 [FRD #16.55] to MRS; Masonic Neurogenomic and Neuroimaging Research Grant to CJB) supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS FH, 1949, P SOC EXP BIOL MED, V70, P258, DOI 10.3181/00379727-70-16892; Adams Waldorf K.M., 2016, NAT MED; Bakardjiev AI, 2004, INFECT IMMUN, V72, P489, DOI 10.1128/IAI.72.1.489-497.2004; Baronti C, 2014, GENOME ANNOUNC, V2; Best K, 2017, P NATL ACAD SCI USA, V114, P8847, DOI 10.1073/pnas.1704011114; Bierle CJ, 2012, VIROLOGY, V433, P157, DOI 10.1016/j.virol.2012.08.005; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021; Carter AM, 2007, PLACENTA, V28, pS41, DOI 10.1016/j.placenta.2006.11.002; CHALLIS JRG, 1971, J ENDOCRINOL, V51, P333, DOI 10.1677/joe.0.0510333; Cox J, 2012, J VIROL, V86, P7637, DOI 10.1128/JVI.00534-12; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; Silva FMD, 2016, PESQUI VET BRASIL, V36, P753, DOI 10.1590/S0100-736X2016000800013; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6; DOYLE RE, 1976, LAB ANIM SCI, V26, P573; Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204; Duyen HTL, 2011, J INFECT DIS, V203, P1292, DOI 10.1093/infdis/jir014; Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556; Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009; Hashira S, 2000, PEDIATR INT, V42, P337, DOI 10.1046/j.1442-200x.2000.01245.x; Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006; INOUYE S, 1984, MICROBIOL IMMUNOL, V28, P569, DOI 10.1111/j.1348-0421.1984.tb00709.x; Kaufmann P, 1977, Adv Anat Embryol Cell Biol, V53, P5; KUMAR ML, 1978, J INFECT DIS, V138, P650, DOI 10.1093/infdis/138.5.650; Kumar M, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0750-4; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16; Lazear HM, 2016, CELL HOST MICROBE; LEISSRING J, 1961, AM J ANAT, V109, P149, DOI 10.1002/aja.1001090205; Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813; Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625; Medina Freddy, 2012, Curr Protoc Microbiol, VChapter 15, DOI 10.1002/9780471729259.mc15d02s27; Mess A, 2007, PLACENTA, V28, P1234, DOI 10.1016/j.placenta.2007.08.003; Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008; Mlakar J., 2016, N ENGL J MED; Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378; Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720; Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206; SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30; Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517; Schleiss MR, 2004, J INFECT DIS, V189, P1374, DOI 10.1086/382751; Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132; Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258; Watanabe S, 2012, J VIROL, V86, P5508, DOI 10.1128/JVI.07081-11; WICHER K, 1992, INFECT IMMUN, V60, P271, DOI 10.1128/IAI.60.1.271-277.1992; Xu YQ, 2015, PLACENTA, V36, P1370, DOI 10.1016/j.placenta.2015.10.018; Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004	48	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							e0187720	10.1371/journal.pone.0187720	http://dx.doi.org/10.1371/journal.pone.0187720			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6TA	29099873	Green Submitted, Green Published, gold			2022-12-26	WOS:000414377900041
J	Reina, R; Sarabia, JM; Caballero, C; Yanci, J				Reina, Raul; Manuel Sarabia, Jose; Caballero, Caria; Yanci, Javier			How does the ball influence the performance of change of direction and sprint tests in para-footballers with brain impairments? Implications for evidence-based classification in CP-Football	PLOS ONE			English	Article							CHANGE-OF-DIRECTION; ACTIVITY PROFILE; SOCCER PLAYERS; VERTICAL JUMP; AGILITY; ELITE; STRENGTH; ABILITY; SPEED; RELIABILITY	The aims of this study were: i) to analyze the reliability and validity of three tests that require sprinting (10 m, 25 m, 40 m), accelerations/decelerations (Stop and Go Test) and change of direction (Illinois Agility Test), with and without ball, in para-footballers with neurological impairments, and ii) to compare the performance in the tests when ball dribbling is required and to explore the practical implications for evidence-based classification in cerebral palsy (CP)-Football. Eighty-two international para-footballers (25.2 +/- 6.8 years; 68.7 +/- 8.3 kg; 175.3 +/- 7.4 cm; 22.5 +/- 2.7 kg.m(-2)), classified according to the International Federation of Cerebral Palsy Football (IFCPF) Classification Rules (classes FT5-FT8), participated in the study. A group of 31 players without CP was also included in the study as a control group. The para-footballers showed good reliability scores in all tests, with and without ball (ICC = 0.53-0.95, SEM = 2.5-9.8%). Nevertheless, the inclusion of the ball influenced testing reproducibility. The low or moderate relationships shown among sprint, acceleration/deceleration and change of direction tests with and without ball also evidenced that they measure different capabilities. Significant differences and large effect sizes (0.53 < eta p2 < 0.97; p < 0.05) were found when para-footballers performed the tests with and without dribbling the ball. Players with moderate neurological impairments (i.e. FT5, FT6, and FT7) had higher coefficients of variation in the trial requiring ball dribbling. For all the tests, we also obtained between-group (FT5-FT8) statistical and large practical differences (eta p2 = 0.35-0.62, large; p < 0.01). The proposed sprint, acceleration/deceleration and change of direction tests with and without ball may be applicable for classification purposes, that is, evaluation of activity limitation from neurological impairments, or decision-making between current CP-Football classes.	[Reina, Raul; Manuel Sarabia, Jose; Caballero, Caria] Miguel Hernandez Univ, Sports Res Ctr, Elche, Spain; [Yanci, Javier] Univ Basque Country, UPV EHU, Fac Educ & Sport, Vitoria, Spain	Universidad Miguel Hernandez de Elche; University of Basque Country	Reina, R (corresponding author), Miguel Hernandez Univ, Sports Res Ctr, Elche, Spain.	rreina@goumh..es	Sarabia, Jose M/F-4014-2016; IRIGOYEN, JAVIER YANCI/L-4346-2019; Reina, Raul/F-6888-2016; Caballero, Carla/Q-2654-2019	Sarabia, Jose M/0000-0002-1917-6634; IRIGOYEN, JAVIER YANCI/0000-0002-8965-5024; Caballero, Carla/0000-0001-7624-232X	International Federation of Cerebral Palsy Football	International Federation of Cerebral Palsy Football	The the International Federation of Cerebral Palsy Football supported the logistic of the data collection (i.e. travel expenses, researcher's accommodation and facilities's reservation).	Altmann VC, 2016, SCAND J MED SCI SPOR; Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; BANGSBO J, 1991, CAN J SPORT SCI, V16, P110; Bangsbo J, 2006, J SPORT SCI, V24, P665, DOI 10.1080/02640410500482529; Bar-Or O, MED SCI SPORTS EXERC, V28, P421; Beckman EM, 2016, EUR J SPORT SCI, V16, P669, DOI 10.1080/17461391.2015.1132775; Beckman EM, 2009, BRIT J SPORT MED, V43, P1067, DOI 10.1136/bjsm.2009.061804; Bloomfield J, 2007, J SPORT SCI MED, V6, P63; Boyd C, 2016, INT J SPORTS SCI COA, P1; BROOKE MH, 1969, NEUROLOGY, V19, P591, DOI 10.1212/WNL.19.6.591; Brughelli M, 2008, SPORTS MED, V38, P1045, DOI 10.2165/00007256-200838120-00007; Cammidge SA, 2017, THESIS; Chaouachi A, 2012, J STRENGTH COND RES, V26, P2667, DOI 10.1519/JSC.0b013e318242f97a; Cohen J.E., 1988, STAT POWER ANAL BEHA; Connick MJ, 2015, MED SCI SPORT EXER, V47, P2216, DOI 10.1249/MSS.0000000000000643; Cox RH, 2002, SPORT PSYCHOL CONCEP; Davies MJ, 2013, INT J SPORT PHYSIOL, V8, P139, DOI 10.1123/ijspp.8.2.139; Dawson B, 2004, J SCI MED SPORT, V7, P278, DOI 10.1016/S1440-2440(04)80023-9; Di Salvo V, 2007, INT J SPORTS MED, V28, P222, DOI 10.1055/s-2006-924294; Faude O, 2012, J SPORT SCI, V30, P625, DOI 10.1080/02640414.2012.665940; Garcia-Pinillos F, 2015, J SPORT SCI, V33, P1293, DOI 10.1080/02640414.2015.1022577; Haugen TA, 2014, INT J SPORT PHYSIOL, V9, P432, DOI [10.1123/IJSPP.2013-0121, 10.1123/ijspp.2013-0121]; HEDGES LV, 1985, STAT METHODS METAANA, DOI [10.1016/C2009-0-03396-0, DOI 10.1016/C2009-0-03396-0]; Hoff J, 2004, SPORTS MED, V34, P165, DOI 10.2165/00007256-200434030-00003; IFCPF, 2017, IFCPF WEBS SECT IFCP; IFCPF International Federation of Cerebral palsy Football, 2017, IFCPF CLASS RUL; Impellizzeri FM, 2008, INT J SPORTS MED, V29, P899, DOI 10.1055/s-2008-1038491; IPC International Paralympic Committee, 2011, INT PAR COMM WEBS SE; IPC International Paralympic Committee. IPC Athlete Classification Code, 2016, INT PAR COMM WEBS SE; Jung JW, 2013, J PHYS THER SCI, V25, P1259, DOI 10.1589/jpts.25.1259; Koklu Y, 2015, SCI SPORT, V30, pE1, DOI 10.1016/j.scispo.2013.04.006; Little T, 2005, J STRENGTH COND RES, V19, P76; Lockie RG, 2003, J STRENGTH COND RES, V17, P760; Lockie RG, 2013, J SPORT SCI MED, V12, P88; Malina RM, 2000, J SPORT SCI, V18, P685, DOI 10.1080/02640410050120069; MAYHEW JL, 1995, J SPORT MED PHYS FIT, V35, P108; Nimphius S, 2016, J STRENGTH COND RES, V30, P3024, DOI 10.1519/JSC.0000000000001421; Niogi S, 2010, FRONT NEUROANAT, V4, DOI [10.3389/neuro.05.002.2010, 10.3389/fneur.2010.00149]; PARKER DF, 1992, AM J DIS CHILD, V146, P1069, DOI 10.1001/archpedi.1992.02160210071024; Pierce CA, 2004, EDUC PSYCHOL MEAS, V64, P916, DOI 10.1177/0013164404264848; Portney LG, 2000, FDN CLIN RES APPL PR, V2; Randers MB, 2014, SCAND J MED SCI SPOR, V24, P17, DOI 10.1111/sms.12255; Reina R, 2014, EUR J HUM MOV, V32, P161; Reina R, 2016, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00409; Rhea MR, 2004, J STRENGTH COND RES, V18, P918, DOI 10.1519/00124278-200411000-00040; Rouissi M, 2016, J SPORT SCI, V34, P542, DOI 10.1080/02640414.2015.1129432; Salaj S, 2011, J STRENGTH COND RES, V25, P1249, DOI 10.1519/JSC.0b013e3181da77df; Sheppard JM, 2006, J SPORT SCI, V24, P919, DOI 10.1080/02640410500457109; Sheppard JM, 2006, J SCI MED SPORT, V9, P342, DOI 10.1016/j.jsams.2006.05.019; Spencer M, 2006, J SCI MED SPORT, V9, P181, DOI 10.1016/j.jsams.2005.05.001; Stolen T, 2005, SPORTS MED, V35, P501; Taboga P, 2014, J APPL BIOMECH, V30, P381, DOI 10.1123/jab.2013-0113; Tweedy SM, 2011, BRIT J SPORT MED, V45, P259, DOI 10.1136/bjsm.2009.065060; Vanlandewijck YC, 2011, MED SCI SPORT EXER, V43, P2344, DOI 10.1249/MSS.0b013e318223af14; Vanlandewijck YC, 2011, J SPORT SCI, V29, P1089, DOI 10.1080/02640414.2011.576694; Verschuren Olaf, 2007, Pediatr Phys Ther, V19, P108, DOI 10.1097/pep.0b013e318036bfce; Vescovi JD, 2008, J SPORT SCI, V26, P97, DOI 10.1080/02640410701348644; Williams G, 2013, BRAIN INJURY, V27, P434, DOI 10.3109/02699052.2012.750754; Yanci J., 2014, J STRENGTH COND RES, V28, P45; Young WB, 2001, J STRENGTH COND RES, V15, P315, DOI 10.1519/00124278-200108000-00009	60	22	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							e0187237	10.1371/journal.pone.0187237	http://dx.doi.org/10.1371/journal.pone.0187237			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6TA	29099836	Green Submitted, Green Published, gold			2022-12-26	WOS:000414377900015
J	Abd Rahman, M; Zaki, RA; Sarimin, R; Ariff, MI; Suli, Z; Mahmud, M; Bee, KH; Anthonysamy, C; Rahim, AA; Gill, BS; Deva, SR; Sani, AFA; Romli, EZ; Ghazali, IMM; Yusof, MAM; Lutfi, NA; Shuib, SE; Darus, NM; Bakri, R; Yahya, A				Abd Rahman, Marzilawati; Zaki, Rafdzah Ahmad; Sarimin, Roza; Ariff, Mohd Izhar; Suli, Zailiza; Mahmud, Maimunah; Bee, Ker Hong; Anthonysamy, Cecilia; Rahim, Azahirafairud Abdul; Gill, Balvinder Singh; Deva, Shanti Rudra; Sani, Ana Fizalinda Abdullah; Romli, Erni Zurina; Ghazali, Izzuna Mudla Mohamed; Yusof, Mohd. Aminuddin Mohd.; Lutfi, Nafisah Ahmad; Shuib, Shahril Effendi; Darus, Noormah Mohd; Bakri, Rugayah; Yahya, Abqariyah			Adherence to Clinical Practice Guidelines (CPG) management of dengue infection in adults (revised 2nd edition)	PLOS ONE			English	Article							MALAYSIA	The Malaysian Dengue Clinical Practice Guidelines (CPG) have been developed to provide evidence-based guidance in the management of dengue infections. The use of these guidelines is essential to ensure its recommendations are being practiced. However, the adherence to the guidelines for management of dengue (revised 2nd edition) by healthcare providers still remains unknown. Therefore, the aim of this study was to evaluate the proportion among healthcare providers that adhere to this Dengue CPG. A retrospective cohort study of dengue cases registered from 1 January 2014 to 1 June 2015 was conducted in public hospitals and health clinics in Selangor, Putrajaya and Kuala Lumpur. Adherence to the CPG recommendations were recorded by reviewing patients' case notes. Overall proportion of adherence in clinical components of the recommendation were (7.1 to 100.0% versus 7.7 to 73.8%) in history taking, (6.7 to 100.0% versus 12.3 to 60.0%) in physical examinations, (18.4 to 100.0% versus 23.1 to 83.2%) in assessment of warning signs, (0.6 to 100.0% versus 12.3 to 87.7%) in assessment of haemodynamic status, (60.0 to 100.0% versus 27.7 to 40.0%) in diagnosis, (46.6 to 80.0% versus 52.3%) in case notifications, (73.2 to 100.0% versus 89.2 to 96.9%) in performing specific laboratory investigations and (7.9 to 100.0% versus 21.5%) in monitoring, for outpatient versus inpatient, respectively. Adherence trends were demonstrated to be higher in hospital settings compared to outpatient settings. Adherence to this Dengue CPG varies widely with overall good clinical outcomes observed.	[Abd Rahman, Marzilawati] Hosp Kuala Lumpur, Dept Med, Kuala Lumpur, Malaysia; [Zaki, Rafdzah Ahmad; Ariff, Mohd Izhar; Yahya, Abqariyah] Univ Malaya, Julius Ctr Univ Malaya, Dept Social & Prevent Med, Fac Med, Kuala Lumpur, Malaysia; [Sarimin, Roza; Sani, Ana Fizalinda Abdullah; Romli, Erni Zurina; Ghazali, Izzuna Mudla Mohamed; Yusof, Mohd. Aminuddin Mohd.; Lutfi, Nafisah Ahmad; Shuib, Shahril Effendi; Darus, Noormah Mohd; Bakri, Rugayah] Minist Hlth, Hlth Technol Assessment Sect, Putrajaya, Malaysia; [Suli, Zailiza; Gill, Balvinder Singh] Minist Hlth, Dis Control Div, Putrajaya, Malaysia; [Mahmud, Maimunah] Minist Hlth, Hlth Clin, Jinjang, Malaysia; [Bee, Ker Hong; Deva, Shanti Rudra] Hosp Raja Permaisuri Bainun, Dept Med, Ipoh, Malaysia; [Anthonysamy, Cecilia] Hosp Serdang, Dept Emergency Med, Selangor, Malaysia; [Rahim, Azahirafairud Abdul] Hosp Kuala Lumpur, Dept Anaesthesiol, Kuala Lumpur, Malaysia	Universiti Malaya; Kementerian Kesihatan Malaysia; Kementerian Kesihatan Malaysia; Kementerian Kesihatan Malaysia; University of Kuala Lumpur	Yahya, A (corresponding author), Univ Malaya, Julius Ctr Univ Malaya, Dept Social & Prevent Med, Fac Med, Kuala Lumpur, Malaysia.	abqariyah.yahya@um.edu.my	ZAKI, RAFDZAH AHMAD/B-9520-2010; Suli, Zailiza/AAG-4045-2019; Yahya, Abqariyah/B-5638-2017	ZAKI, RAFDZAH AHMAD/0000-0003-2884-5198; Yahya, Abqariyah/0000-0001-9158-415X	University Malaya grants 'Geran Bantuan Kecil Penyelidikan (BKP) Universiti Malaya' [BK029-2014]; University Malaya Research Grant [RP034C15HTM]	University Malaya grants 'Geran Bantuan Kecil Penyelidikan (BKP) Universiti Malaya'; University Malaya Research Grant	This study has been funded by University Malaya grants 'Geran Bantuan Kecil Penyelidikan (BKP) Universiti Malaya' - BK029-2014 and University Malaya Research Grant-RP034C15HTM.	Afzal M, NATURE, V11, P56; Ayyub Muhammad, 2006, J Ayub Med Coll Abbottabad, V18, P9; Azami NAM, 2011, BIOMED CENTRAL, V4, P1; Chew MH, 2012, PAK J MED SCI, V28, P643; Ghosh G, 2013, INT J BIOASSAYS, V02, P1462; Grimshaw J M, 1994, Qual Health Care, V3, P45, DOI 10.1136/qshc.3.1.45; Khalil Muhammad Abdul Mabood, 2014, BMC Res Notes, V7, P473, DOI 10.1186/1756-0500-7-473; Ministry of Health Malaysia, 2010, CLIN PRACT GUID MAN; Mohd-Zaki AH, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003159; Mudin RN, 2015, INT MED J MALAYS, V14, P5; Pun R., 2012, KATHMANDU U MED J, V10, P3; Rowe EK, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002777; Saqib Muhammad Arif Nadeem, 2014, BMC Res Notes, V7, P205, DOI 10.1186/1756-0500-7-205; World Health Organization, 2009, EP PAND AL DENG GUID	14	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0184559	10.1371/journal.pone.0184559	http://dx.doi.org/10.1371/journal.pone.0184559			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095822	gold, Green Submitted, Green Published			2022-12-26	WOS:000414340200002
J	Liu, XY; Lister, DL; Zhao, ZJ; Petrie, CA; Zeng, XS; Jones, PJ; Staff, RA; Pokharia, AK; Bates, J; Singh, RN; Weber, SA; Matuzeviciute, GM; Dong, GH; Li, HM; Lu, HL; Jiang, HE; Wang, JX; Ma, J; Tian, D; Jin, GY; Zhou, LP; Wu, XH; Jones, MK				Liu, Xinyi; Lister, Diane L.; Zhao, Zhijun; Petrie, Cameron A.; Zeng, Xiongsheng; Jones, Penelope J.; Staff, Richard A.; Pokharia, Anil K.; Bates, Jennifer; Singh, Ravindra N.; Weber, Steven A.; Matuzeviciute, Giedre Motuzaite; Dong, Guanghui; Li, Haiming; Lu, Hongliang; Jiang, Hongen; Wang, Jianxin; Ma, Jian; Tian, Duo; Jin, Guiyun; Zhou, Liping; Wu, Xiaohong; Jones, Martin K.			Journey to the east: Diverse routes and variable flowering times for wheat and barley en route to prehistoric China	PLOS ONE			English	Article							FOOD GLOBALIZATION; SOUTH-ASIA; AGRICULTURE; SPREAD; CROPS; ADAPTATION; PATHWAYS; ORIGINS	Today, farmers in many regions of eastern Asia sow their barley grains in the spring and harvest them in the autumn of the same year (spring barley). However, when it was first domesticated in southwest Asia, barley was grown between the autumn and subsequent spring (winter barley), to complete their life cycles before the summer drought. The question of when the eastern barley shifted from the original winter habit to flexible growing schedules is of significance in terms of understanding its spread. This article investigates when barley cultivation dispersed from southwest Asia to regions of eastern Asia and how the eastern spring barley evolved in this context. We report 70 new radiocarbon measurements obtained directly from barley grains recovered from archaeological sites in eastern Eurasia. Our results indicate that the eastern dispersals of wheat and barley were distinct in both space and time. We infer that barley had been cultivated in a range of markedly contrasting environments by the second millennium BC. In this context, we consider the distribution of known haplotypes of a flowering-time gene in barley, Ppd-H1, and infer that the distributions of those haplotypes may reflect the early dispersal of barley. These patterns of dispersal resonate with the second and first millennia BC textual records documenting sowing and harvesting times for barley in central/eastern China.	[Liu, Xinyi] Washington Univ, Dept Anthropol, St Louis, MO 63130 USA; [Lister, Diane L.; Petrie, Cameron A.; Jones, Penelope J.; Bates, Jennifer; Jones, Martin K.] Univ Cambridge, McDonald Inst Archaeol Res, Cambridge, England; [Zhao, Zhijun] Chinese Acad Social Sci, Inst Archaeol, Beijing, Peoples R China; [Zeng, Xiongsheng] Chinese Acad Sci, Inst Hist Nat Sci, Beijing, Peoples R China; [Staff, Richard A.] Univ Oxford, Res Lab Archaeol & Hist Art, Oxford, England; [Staff, Richard A.] Univ Glasgow, SUERC, E Kilbride, Scotland; [Pokharia, Anil K.] Birbal Sahni Inst Paleobot, Lucknow, Uttar Pradesh, India; [Singh, Ravindra N.] Banaras Hindu Univ, Dept AIHC & Archaeol, Varanasi, Uttar Pradesh, India; [Weber, Steven A.] Washington State Univ, Dept Anthropol, Vancouver, WA USA; [Matuzeviciute, Giedre Motuzaite] Vilnius Univ, Dept Archaeol, Vilnius, Lithuania; [Dong, Guanghui; Li, Haiming] Lanzhou Univ, Key Lab Western Chinas Environm Syst, Lanzhou, Gansu, Peoples R China; [Lu, Hongliang] Sichuan Univ, Dept Archaeol, Chengdu, Sichuan, Peoples R China; [Jiang, Hongen] Univ Chinese Acad Sci, Dept Hist Sci & Archaeometry, Beijing, Peoples R China; [Wang, Jianxin; Ma, Jian; Tian, Duo] Northwest Univ Xian, Sch Cultural Heritage, Xian, Shaanxi, Peoples R China; [Jin, Guiyun] Shandong Univ, Sch Hist & Culture, Jinan, Shandong, Peoples R China; [Zhou, Liping] Peking Univ, Lab Earth Surface Proc, Beijing, Peoples R China; [Wu, Xiaohong] Peking Univ, Sch Archaeol & Museol, Beijing, Peoples R China	Washington University (WUSTL); University of Cambridge; Chinese Academy of Social Sciences; Chinese Academy of Sciences; Institute for the History of Natural Science, CAS; University of Oxford; Scottish Universities Research & Reactor Center; University of Glasgow; Department of Science & Technology (India); Birbal Sahni Institute of Palaeobotany (BSIP); Banaras Hindu University (BHU); Washington State University; Vilnius University; Lanzhou University; Sichuan University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Northwest University Xi'an; Shandong University; Peking University; Peking University	Liu, XY (corresponding author), Washington Univ, Dept Anthropol, St Louis, MO 63130 USA.	liuxinyi@wustl.edu	liu, xinyi/GWZ-8739-2022; Wu, Xiaohong/AAH-4348-2020; JIN, GUIYUN/P-4936-2019; Dong, Guanghui/C-5985-2013; Petrie, Cameron/ABB-8528-2021; Singh, Ravindra Nath/AAO-2784-2020; Motuzaite Matuzeviciute, Giedre/AAK-2928-2021; Lu, Hongliang/AAO-1322-2021	Wu, Xiaohong/0000-0002-3819-0829; JIN, GUIYUN/0000-0002-4253-6271; Petrie, Cameron/0000-0002-2926-7230; Singh, Ravindra Nath/0000-0002-1102-4839; Motuzaite Matuzeviciute, Giedre/0000-0001-9069-1551; Staff, Richard/0000-0002-8634-014X; Bates, Jennifer/0000-0002-7100-4741; Jones, Penelope/0000-0002-4880-6711; Dong, Guanghui/0000-0001-8005-759X; Pokharia, Anil/0000-0003-1453-0646	European Research Council [249642]; National Natural Science Foundation of China [41620104007, 41672171]; National Social Science Foundation of China [11AZD116, 14ZDB052]; University of Chinese Academy of Sciences [Y65201YY00]; Department of Science and Technology, New Delhi, India [EMR/2015/000881]; International Center for Energy, Environment and Sustainability (InCEES)	European Research Council(European Research Council (ERC)European Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Social Science Foundation of China; University of Chinese Academy of Sciences(Chinese Academy of Sciences); Department of Science and Technology, New Delhi, India(Department of Science & Technology (India)); International Center for Energy, Environment and Sustainability (InCEES)	Financial support was provided by the European Research Council (249642-MKJ), National Natural Science Foundation of China (41620104007-GD and 41672171-HJ), National Social Science Foundation of China (11AZD116-GJ and 14ZDB052-JM), University of Chinese Academy of Sciences (Y65201YY00-HJ), the Department of Science and Technology, New Delhi, India (EMR/2015/000881-AP), and International Center for Energy, Environment and Sustainability (InCEES-XL).r The authors are grateful to Jingang Yang, Xuexiang Chen, Fuqiang Wang, Jixiang Song, Yua-nyuan Gao, Wangdue Shargan, Hui Wang, Meng Ren, Shalini Sharma, George Willcox, Catherine Kneale, Pan Gao and Kexin Liu for assistance in accessing samples and conducting lab work. Financial support was provided by the European Research Council (249642), National Natural Science Foundation of China (41620104007 and 41672171), National Social Science Foundation of China (11AZD116 and 14ZDB052), University of Chinese Academy of Sciences (Y65201YY00), the Department of Science and Technology, New Delhi, India (EMR/2015/000881), and International Center for Energy, Environment and Sustainability (InCEES).	Barton L, 2014, WORLD ARCHAEOL, V46, P775, DOI 10.1080/00438243.2014.953703; Bogaard, 2004, NEOLITHIC FARMING CE, DOI DOI 10.4324/9780203358009; Brock F, 2010, RADIOCARBON, V52, P103, DOI 10.1017/S0033822200045069; Chen FH, 2015, SCIENCE, V347, P248, DOI 10.1126/science.1259172; Cockram J, 2007, J EXP BOT, V58, P1231, DOI 10.1093/jxb/erm042; d'Alpoim Guedes J, 2014, ARCHAEOL ANTHROP SCI, V6, P255, DOI 10.1007/s12520-013-0153-4; Dodson JR, 2013, QUATERNARY SCI REV, V72, P108, DOI 10.1016/j.quascirev.2013.04.021; Flad R., 2010, HOLOCENE, V17, P555; Frachetti MD, 2012, CURR ANTHROPOL, V53, P2, DOI 10.1086/663692; Frachetti MD, 2010, ANTIQUITY, V84, P993, DOI 10.1017/S0003598X0006703X; Fuller D. Q., 2014, GEN ANTHR, V21, P1, DOI [10.1111/gena.01001, DOI 10.1111/GENA.01001]; Fuller DQ, 2006, J WORLD PREHIST, V20, P1, DOI 10.1007/s10963-006-9006-8; Fuller DQ, 2007, ANTIQUITY, V81, P316, DOI 10.1017/S0003598X0009520X; Fuller DQ, 2017, HUMAN DISPERSAL AND SPECIES MOVEMENT: FROM PREHISTORY TO THE PRESENT, P304; Goyal P, 2013, RADIOCARBON, V55, P141; Guedes JAD, 2015, P NATL ACAD SCI USA, V112, P5625, DOI 10.1073/pnas.1423708112; Harris D., 2010, ORIGINS AGR W CENTRA; Harvey E.L, 2006, EARLY AGR COMMUNITIE; Jin G., 2008, JIAOZHOU SHANDONG PR, V22; Jones G, 2012, J ARCHAEOL SCI, V39, P3230, DOI 10.1016/j.jas.2012.05.014; Jones H, 2008, MOL BIOL EVOL, V25, P2211, DOI 10.1093/molbev/msn167; Jones H, 2016, QUATERN INT, V426, P26, DOI 10.1016/j.quaint.2016.02.029; Jones M, 2011, WORLD ARCHAEOL, V43, P665, DOI 10.1080/00438243.2011.624764; Lister D. L., 2012, VEG HIST ARCHAEOBOT, V22, P439; Lister DL, 2009, J ARCHAEOL SCI, V36, P1092, DOI 10.1016/j.jas.2008.12.012; Liu L, 2012, ARCHAEOLOGY CHINA LA; Liu XY, 2016, QUATERN INT, V426, P107, DOI 10.1016/j.quaint.2016.02.059; Liu XY, 2014, WORLD ARCHAEOL, V46, P661, DOI 10.1080/00438243.2014.953706; Liu XY, 2014, ANTIQUITY, V88, P956, DOI 10.1017/S0003598X00050912; Meadow R. H., 1996, ORIGINS SPREAD AGR P, P390; Miller N., 2003, CENTRAL ASIAN VILLAG, P127; Motuzaite Matuzeviciute G., 2015, QUATERN INT, V137, P35; Newton AC, 2011, FOOD SECUR, V3, P141, DOI 10.1007/s12571-011-0126-3; Petrie CA., 2015, CAMBRIDGE WORLD HIST, V2, P289; Petrie CA, 2010, SHERI KHAN TARAKAI E; Qiu X., 1989, GU WENZI LUNJI; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Spengler R.N., 2014, P R SOC, V281, P1, DOI DOI 10.1098/RSPB.2013.3382; Spengler RN, 2015, J WORLD PREHIST, V28, P215, DOI 10.1007/s10963-015-9087-3; Spengler RN, 2013, ENVIRON ARCHAEOL, V18, P211, DOI 10.1179/1749631413Y.0000000008; Stevens CJ, 2016, HOLOCENE, V26, P1541, DOI 10.1177/0959683616650268; Tengberg M., 1999, VEG HIST ARCHAEOBOT, V8, P3; Tewari R., 2006, PRAGDHARA, V16, P35; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Weber S, 1999, ANTIQUITY, V73, P813, DOI 10.1017/S0003598X00065558; Weber SA., 2003, INDUS ETHNOBIOLOGY N, P175; Weiss E, 2011, CURR ANTHROPOL, V52, pS237, DOI 10.1086/658367; Willcox G., 1991, NEW LIGHT EARLY FARM, P139; ZENG X., 2005, ZHONGGUO YINSHI WENH, V1, P99; Zhao ZJ, 2009, CHIN ARCHAEOL, V9, P1; Zhao ZJ, 2011, CURR ANTHROPOL, V52, pS295, DOI 10.1086/659308; Zhuang YJ, 2017, WORLD ARCHAEOL, V48, P563, DOI 10.1080/00438243.2016.1251850; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001	54	61	66	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187405	10.1371/journal.pone.0187405	http://dx.doi.org/10.1371/journal.pone.0187405			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	FL6FI	29095896	Green Published, Green Accepted, gold			2022-12-26	WOS:000414340200080
J	Fronza, MG; Brod, LMP; Casaril, AM; Sacramento, M; Alves, D; Savegnago, L				Fronza, Mariana G.; Pinto Brod, Lucimar M.; Casaril, Angela Maria; Sacramento, Manoela; Alves, Diego; Savegnago, Lucielli			Computational and biological evidences on the serotonergic involvement of SeTACN antidepressant-like effect in mice	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; FORCED SWIMMING TEST; DIPHENYL DISELENIDE; OXIDATIVE STRESS; 5-HT1A RECEPTOR; MOUSE; SYSTEMS; MODEL; ANTIOXIDANT; TRANSPORTER	A series of phenylselany1-1H-1,2,3-triazole-4-carbonitriles with different substituents were screened for their binding affinity with serotonin transporter (SERT) and dopamine transporter (DAT) by docking molecular. 5-(4methoxphenyI)-1-(2-(phenylselanyl)pheny1)-1H1,2,3-triazole-4-carbonitrile (SeTACN) exhibited the best conformation with SERT even higher than fluoxetine and serotonin, suggesting a competitive inhibition. SeTACN demonstrated additional affinity to other serotonergic receptors involved in antidepressant effects: 5HT1a, 5HT2a and 51-1-13. In another set of experiments, SeTACN led to significant reductions in the immobility time of mice submitted to forced swimming test (FST) in the dose range of 0.1- 20mg/kg, suggesting an antidepressant-like effect. The possible mechanism of action was investigated using serotonergic and dopaminergic antagonists. The antidepressant -like effect of SeTACN (0.1 mg/kg i.g.) was prevented by the pretreatment with WAY100635 (a selective 5HT1a antagonist), ketanserin (a 5HT2a/c antagonist) and ondansetron (a selective 5ht3 antagonist), PCPA (an inhibitor of serotonin synthesis) but not with SCH23390 (dopaminergic D1 antagonist) and sulpiride (D2 antagonist). Sub-effective dose of fluoxetine was able to potentiate the effects of a sub-effective dose of SeTACN in FST. None of the treatments affected locomotor activity in open field test (OFT). These results together, suggest that the SeTACN antidepressant-like effect is mediate, at least in parts, by serotonergic system.	[Fronza, Mariana G.; Pinto Brod, Lucimar M.; Casaril, Angela Maria; Savegnago, Lucielli] Univ Fed Pelotas, Programa Posgrad Biotecnol, GPN, CDTec,UFPeI, Pelotas, RS, Brazil; [Sacramento, Manoela; Alves, Diego] Univ Fed Pelotas, PPGQ, Lab Sintese Organ Limpa LASOL, CCQFA, Pelotas, RS, Brazil	Universidade Federal de Pelotas; Universidade Federal de Pelotas	Savegnago, L (corresponding author), Univ Fed Pelotas, Programa Posgrad Biotecnol, GPN, CDTec,UFPeI, Pelotas, RS, Brazil.	luciellisavegnago@yahoo.com.br	Alves, Diego/G-5273-2012; Savegnago, Lucielli/L-7287-2013; Brod, Lucimar Pinto/AAG-3494-2020; Sacramento, Manoela/AAD-9232-2022; Casaril, Angela Maria/L-5565-2016	Alves, Diego/0000-0002-1074-0294; Savegnago, Lucielli/0000-0003-0494-5610; Casaril, Angela Maria/0000-0003-4994-1891	Coordenagao de Aperfeigoamento Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul [FAPERGS PRONEN 16/25510000240-1]	Coordenagao de Aperfeigoamento Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS))	The project was supported by Coordenagao de Aperfeigoamento Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS PRONEN 16/25510000240-1).	Anderson G, 2014, CURR PHARM DESIGN, V20, P3812, DOI 10.2174/13816128113196660738; Artigas F, 1996, TRENDS NEUROSCI, V19, P378, DOI 10.1016/S0166-2236(96)10037-0; Artigas F, 2013, PHARMACOL THERAPEUT, V137, P119, DOI 10.1016/j.pharmthera.2012.09.006; Gerzson MFB, 2012, PHARMACOL BIOCHEM BE, V102, P21, DOI 10.1016/j.pbb.2012.03.016; Behr GA, 2012, OXID MED CELL LONGEV, V609, P4; BENTON D, 1991, BIOL PSYCHIAT, V29, P1092, DOI 10.1016/0006-3223(91)90251-G; Benton D, 2002, NUTR NEUROSCI, V5, P363, DOI 10.1080/1028415021000055925; BLIER P, 1987, SYNAPSE, V1, P470, DOI 10.1002/syn.890010511; Blier P, 2003, BIOL PSYCHIAT, V53, P193, DOI 10.1016/S0006-3223(02)01643-8; Bruning CA, 2011, EUR J PHARMACOL, V658, P145, DOI 10.1016/j.ejphar.2011.02.039; Carr GV, 2011, PSYCHOPHARMACOLOGY, V213, P265, DOI [10.1007/s00213-010-1832-9, 10.1007/s00213-010-2097-z]; Celada P, 2004, J PSYCHIATR NEUROSCI, V29, P252; Chang CC, 2015, PSYCHIAT RES, V230, P575, DOI 10.1016/j.psychres.2015.10.006; Colla ARS, 2014, PHARMACOL BIOCHEM BE, V124, P108, DOI 10.1016/j.pbb.2014.05.015; Dale E, 2015, BIOCHEM PHARMACOL, V95, P81, DOI 10.1016/j.bcp.2015.03.011; de Ruyck Jerome, 2016, Adv Appl Bioinform Chem, V9, P1, DOI 10.2147/AABC.S105289; Deng XQ, 2014, EUR J MED CHEM, V73, P217, DOI 10.1016/j.ejmech.2013.12.014; Donato F, 2013, LIFE SCI, V93, P393, DOI 10.1016/j.lfs.2013.07.024; Duman Ronald S, 2009, Dialogues Clin Neurosci, V11, P239; Gabrielsen M, 2013, CHEM BIOL DRUG DES, V81, P695, DOI 10.1111/cbdd.12116; Gandhimathi A, 2016, J BIOMOL STRUCT DYN, V34, P952, DOI 10.1080/07391102.2015.1062802; Gay BM, 2010, NEUROPHARMACOLOGY, V59, P172, DOI 10.1016/j.neuropharm.2010.05.003; Goldberg JF, 2013, J AFFECT DISORDERS, V144, P176, DOI 10.1016/j.jad.2012.04.037; Gupta D, 2016, NEUROSCI BIOBEHAV R, V64, P311, DOI 10.1016/j.neubiorev.2016.03.001; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Jacobsen JPR, 2012, PHILOS T R SOC B, V367, P2444, DOI 10.1098/rstb.2012.0109; Khan I, 2016, BIOORG CHEM, V68, P41, DOI 10.1016/j.bioorg.2016.07.007; Lummis SCR, 2012, J BIOL CHEM, V287, P40239, DOI 10.1074/jbc.R112.406496; Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P676, DOI 10.1016/j.pnpbp.2010.05.004; Malykhin NV, 2010, J PSYCHIATR NEUROSCI, V35, P337, DOI 10.1503/jpn.100002; Marek GJ, 2003, NEUROPSYCHOPHARMACOL, V28, P402, DOI 10.1038/sj.npp.1300057; Martinez DM, 2014, PHARMACOL BIOCHEM BE, V127, P111, DOI 10.1016/j.pbb.2014.10.010; Massart R, 2012, PHILOS T R SOC B, V367, P2485, DOI 10.1098/rstb.2012.0212; McIntyre RS, 2013, DEPRESS ANXIETY, V30, P515, DOI 10.1002/da.22063; Menard C, 2016, NEUROSCIENCE, V321, P138, DOI 10.1016/j.neuroscience.2015.05.053; Michel TM, 2012, CURR PHARM DESIGN, V18, P5890; Miguel-Hidalgo JJ, 2002, CNS DRUGS, V16, P361, DOI 10.2165/00023210-200216060-00001; Millan MJ, 2004, EUR J PHARMACOL, V500, P371, DOI 10.1016/j.ejphar.2004.07.038; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morrissette DA, 2014, CNS SPECTRUMS, V19, P57, DOI 10.1017/S1092852914000613; Moylan S, 2014, NEUROSCI BIOBEHAV R, V45, P46, DOI 10.1016/j.neubiorev.2014.05.007; Muller LG, 2012, PROG NEURO-PSYCHOPH, V36, P101, DOI 10.1016/j.pnpbp.2011.08.015; Neis VB, 2015, PHARMACOL BIOCHEM BE, V130, P9, DOI 10.1016/j.pbb.2014.12.009; Nutt DJ, 2007, J CLIN PSYCHIAT, V68, P42; Penmatsa A, 2015, NAT STRUCT MOL BIOL, V22, P506, DOI 10.1038/nsmb.3029; Pesarico AP, 2014, PROG NEURO-PSYCHOPH, V54, P179, DOI 10.1016/j.pnpbp.2014.06.001; Petit-Demouliere B, 2005, PSYCHOPHARMACOLOGY, V177, P245, DOI 10.1007/s00213-004-2048-7; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pilar-Cuellar F, 2014, CURR PHARM DESIGN, V20, P3776, DOI 10.2174/13816128113196660736; Brod LMP, 2016, PROG NEURO-PSYCHOPH, V65, DOI 10.1016/j.pnpbp.2015.10.008; Pissurlenkar Raghuvir R. S., 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P228; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Praveen C, 2012, J CHEM SCI, V124, P451, DOI 10.1007/s12039-011-0150-z; Pytka K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142499; Qin B, 2014, CLIN THER, V36, P1087, DOI 10.1016/j.clinthera.2014.06.001; Quesseveur G, 2013, EXP BRAIN RES, V226, P285, DOI 10.1007/s00221-013-3434-3; Ramezanpour M, 2015, BIOPHYS J, V1, P108; Rantamaki T, 2016, PROG NEURO-PSYCHOPH, V64, P285, DOI 10.1016/j.pnpbp.2015.06.001; Rayman M, 2002, LANCET, V379, P1256; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Salim S, 2014, CURR NEUROPHARMACOL, V12, P140, DOI 10.2174/1570159X11666131120230309; Savegnago L, 2008, PHARMACOL BIOCHEM BE, V88, P418, DOI 10.1016/j.pbb.2007.09.015; Savegnago L, 2016, RSC ADV, V6, P8021, DOI 10.1039/c5ra22445d; Schechter Lee E, 2005, NeuroRx, V2, P590, DOI 10.1602/neurorx.2.4.590; Scorza MC, 2012, BRIT J PHARMACOL, V167, P1021, DOI 10.1111/j.1476-5381.2011.01770.x; Sorensen L, 2012, J BIOL CHEM, V287, P43694, DOI 10.1074/jbc.M112.342212; Sylte I, 2001, EUR J PHARMACOL, V416, P33, DOI 10.1016/S0014-2999(01)00860-3; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; URSINI F, 1987, CHEM PHYS LIPIDS, V44, P255, DOI 10.1016/0009-3084(87)90053-3; Victoria FN, 2014, EUR J PHARMACOL, V742, P131, DOI 10.1016/j.ejphar.2014.09.005; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Wang H, 2013, NATURE, V503, P141, DOI 10.1038/nature12648; World Health Organization, 2012, DEPRESSION GLOBAL PU; Yankelevitch-Yahav R, 2015, J VISUALIZED EXPT JO; Zheng W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120080; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602	77	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187445	10.1371/journal.pone.0187445	http://dx.doi.org/10.1371/journal.pone.0187445			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091968	gold, Green Submitted, Green Published			2022-12-26	WOS:000414229700067
J	Xu, J; Sun, YX; Wu, TY; Wang, B; Liu, Y; Zhang, JF; Lee, WY; Kang, QL; Chai, YM; Li, G				Xu, Jia; Sun, Yuxin; Wu, Tianyi; Wang, Bin; Liu, Yang; Zhang, Jinfang; Lee, Wayne Yukwai; Kang, Qinglin; Chai, Yimin; Li, Gang			Porcine brain extract promotes osteogenic differentiation of bone marrow derived mesenchymal stem cells and bone consolidation in a rat distraction osteogenesis model	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; MANDIBULAR DISTRACTION; MASS; CARTILAGE; TISSUE; BETA; MICE	Distraction osteogenesis (DO) is the gold standard to treat large bone defects, but long consolidation period is a major limitation. Innovative efforts to promote osteogenesis are needed. Porcine brain extract (PBE) was reported to enhance the proliferation and differentiation of multiple primary cells. In this study, we aimed to develop a method for collecting PBE and investigate its effects on osteogenic differentiation of rat bone marrow derived mesenchymal stem cells (rBMSCs) and bone consolidation in a rat DO model. The PBE was collected from neonatal brain tissues of porcine fetus and was used to treat rBMSCs. Following PBE treatment (700 ng/ml), osteogenic differentiation was assessed. Further, we locally injected PBE (7 fag/ml, 100p1) or PBS (100p1) into the gap in a Sprague-Dawley (SD) male rat DO model every three days till termination. X-rays, micro-computed tomography, mechanical testing, histology and immunohischemistry examinations were used to exam the quality of the regenerates. The alkaline phosphatase, calcium deposits, and steogenic markers in the PBE treated rBMSCs were significantly increased. In the rat model, new bone properties of bone volume/total tissue volume and mechanical strength were higher in the PBE treated group. Histological analysis also confirmed more mineralized bone after PBE treatment. The current study reports a standard protocol for PBE collection and demonstrated its positive effects on osteogenic differentiation and bone consolidation in DO. Since the PBE is readily available and very cost effective, PBE may be a potential new biosource to promote bone formation in patients undergo DO treatment.	[Xu, Jia; Wu, Tianyi; Kang, Qinglin; Chai, Yimin] Shanghai Jiao Tong Univ, Dept Orthopaed Surg, Peoples Hosp 6, Shanghai, Peoples R China; [Sun, Yuxin; Wang, Bin; Liu, Yang; Zhang, Jinfang; Lee, Wayne Yukwai; Li, Gang] Chinese Univ Hong Kong, Stem Cells & Regenerat Lab, Dept Orthopaed &Traumatol, Li Ka Shing Inst Hlth Sci,Fac Med,Prince Wales Ho, Shatin, Hong Kong, Peoples R China; [Zhang, Jinfang; Li, Gang] Chinese Univ Hong Kong, Shenzhen Res Inst, CUHK ACC Space Med Ctr, Shenzhen, Peoples R China	Shanghai Jiao Tong University; Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen	Chai, YM (corresponding author), Shanghai Jiao Tong Univ, Dept Orthopaed Surg, Peoples Hosp 6, Shanghai, Peoples R China.; Li, G (corresponding author), Chinese Univ Hong Kong, Stem Cells & Regenerat Lab, Dept Orthopaed &Traumatol, Li Ka Shing Inst Hlth Sci,Fac Med,Prince Wales Ho, Shatin, Hong Kong, Peoples R China.; Li, G (corresponding author), Chinese Univ Hong Kong, Shenzhen Res Inst, CUHK ACC Space Med Ctr, Shenzhen, Peoples R China.	ymchai@sjtu.edu.cn; gangli@cuhk.edu.hk	WANG, BIN/O-2346-2019; Li, Gang/J-7830-2018; Lee, Wayne YW/H-8298-2013	WANG, BIN/0000-0002-1348-1494; Li, Gang/0000-0002-3981-2239; Lee, Wayne YW/0000-0002-0486-360X; Kang, Qinglin/0000-0001-9825-0451	National Natural Science Foundation of China [81572122, 81371946, 81430049, 81772322]; Hong Kong Government Research Grant Council, General Research Fund [14119115, 14160917, 9054014 N_CityU102/15, T12-402/17-N]; Hong Kong Innovation Technology Commission Funding [ITS/UIM-305]; China Shenzhen City Science and Technology Bureau [JCYJ20150630165236960]; SMART program, Lui Che Woo Institute of Innovative Medicine; Chinese University of Hong Kong	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hong Kong Government Research Grant Council, General Research Fund; Hong Kong Innovation Technology Commission Funding; China Shenzhen City Science and Technology Bureau; SMART program, Lui Che Woo Institute of Innovative Medicine; Chinese University of Hong Kong(Chinese University of Hong Kong)	The work was partially supported by grants from National Natural Science Foundation of China (81572122, 81371946, 81430049 and 81772322); Hong Kong Government Research Grant Council, General Research Fund (14119115, 14160917, 9054014 N_CityU102/15 and T12-402/17-N); Hong Kong Innovation Technology Commission Funding (ITS/UIM-305) and grants from China Shenzhen City Science and Technology Bureau (JCYJ20150630165236960). This study was also supported in part by SMART program, Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong and the research was made possible by resources donated by Lui Che Woo Foundation Limited. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbaspour A, 2008, BONE, V42, P98, DOI 10.1016/j.bone.2007.08.031; Asawa Y, 2004, J ELECTRON MICROSC, V53, P423, DOI 10.1093/jmicro/dfh057; Baek WY, 2009, J BONE MINER RES, V24, P1055, DOI [10.1359/JBMR.081248, 10.1359/jbmr.081248]; Bais MV, 2009, BONE, V45, P254, DOI 10.1016/j.bone.2009.04.239; Baldock PA, 2006, J BONE MINER RES, V21, P1600, DOI 10.1359/JBMR.060705; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; Camerino C, 2012, ENDOCRINOLOGY, V153, P5394, DOI 10.1210/en.2012-1378; Carvalho RS, 2004, BONE, V34, P849, DOI 10.1016/j.bone.2003.12.027; Chan CW, 2006, J ORTHOP RES, V24, P2072, DOI 10.1002/jor.20258; Chen Y, 2015, OSTEOARTHR CARTILAGE, V23, P1728, DOI 10.1016/j.joca.2015.05.018; Cruz R, 1998, REV NEUROLOGIA, V26, P551, DOI 10.33588/rn.26152.98025; Duque G, 2011, J BONE MINER RES, V26, P1472, DOI 10.1002/jbmr.350; Duque G, 2009, STEM CELLS, V27, P550, DOI 10.1634/stemcells.2008-0886; El-Alfy B, 2010, INT ORTHOP, V34, P115, DOI 10.1007/s00264-008-0574-3; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Farhadieh RD, 1999, J CRANIOFAC SURG, V10, P80, DOI 10.1097/00001665-199901000-00016; Gonzalez C, 1998, CELL MOL BIOL, V44, P1117; GOSPODAROWICZ D, 1984, P NATL ACAD SCI-BIOL, V81, P6963, DOI 10.1073/pnas.81.22.6963; Hao YJ, 2007, BONE, V41, P631, DOI 10.1016/j.bone.2007.06.006; HARRISON G, 1995, J BONE MINER RES, V10, P568, DOI 10.1002/jbmr.5650100409; He YX, 2011, BONE, V48, P1388, DOI 10.1016/j.bone.2011.03.720; HutterPaier B, 1996, J NEURAL TRANSM-SUPP, P267; Jinatta J., 2009, AM J APPL SCI, V6, P1662, DOI DOI 10.3844/AJASSP.2009.1662.1668; Kode A, 2012, J CLIN INVEST, V122, P3490, DOI 10.1172/JCI64906; Komori T, 2003, J BONE MINER METAB, V21, P193, DOI 10.1007/s00774-002-0408-0; Koroleva VI, 1999, BRAIN RES, V816, P618, DOI 10.1016/S0006-8993(98)01246-3; Lee KH, 2013, J ANIM SCI, V91, P2405, DOI 10.2527/jas.2012-5208; Li G, 1997, J ORTHOP RES, V15, P765, DOI 10.1002/jor.1100150520; Liu Z, 1999, HISTOL HISTOPATHOL, V14, P587, DOI 10.14670/HH-14.587; Ma DY, 2013, J ORTHOP RES, V31, P1082, DOI 10.1002/jor.22336; Masi L, 2012, CLIN CASES MINER BON, V9, P13; McCarthy JG, 2002, PLAST RECONSTR SURG, V110, P1704, DOI 10.1097/00006534-200212000-00013; Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641; Niedzwiedzki T, 2015, J MOL ENDOCRINOL, V55, pR23, DOI 10.1530/JME-15-0067; Ornitz DM, 2001, GENOME BIOL, V2; PALEY D, 1990, CLIN ORTHOP RELAT R, P81; Perrien DS, 2002, J PHARMACOL EXP THER, V303, P904, DOI 10.1124/jpet.102.039636; Srcek VG, 2009, IN VITRO CELL DEV-AN, V45, P28, DOI 10.1007/s11626-008-9148-3; Staines KA, 2013, J ENDOCRINOL, V219, pR1, DOI 10.1530/JOE-13-0276; Sun YX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00466-4; Sun YX, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/412327; Wan C, 2008, P NATL ACAD SCI USA, V105, P686, DOI 10.1073/pnas.0708474105; Xu LL, 2012, INT J BIOCHEM CELL B, V44, P612, DOI 10.1016/j.biocel.2011.12.018; Yeung HY, 2001, CLIN ORTHOP RELAT R, P219	44	6	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187362	10.1371/journal.pone.0187362	http://dx.doi.org/10.1371/journal.pone.0187362			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091962	Green Submitted, gold, Green Published			2022-12-26	WOS:000414229700060
J	Amorim, JL; Figueiredo, JD; Amaral, ACF; Barros, EGD; Palmero, C; MPalantinos, MA; Ramos, AD; Ferreira, JLP; Silva, JRD; Benjamim, CF; Basso, SL; Nasciutti, LE; Fernandes, PD				Amorim, Jorge Luis; Figueiredo, Janaina de Barros; Fernandes Amaral, Ana Claudia; de Oliveira Barros, Eliane Gouvea; Palmero, Celia; MPalantinos, Maria Athana; Ramos, Aline de Souza; Pinto Ferreira, Jose Luiz; de Andrade Silva, Jefferson Rocha; Benjamim, Claudia Farias; Basso, Silvia Luciane; Nasciutti, Luiz Eurico; Fernandes, Patricia Dias			Wound healing properties of Copaifera paupera in diabetic mice	PLOS ONE			English	Article							MULTIJUGA HAYNE; COPAIBA OILS; EXTRACELLULAR-MATRIX; RETICULATA DUCKE; GROWTH-FACTORS; VENOUS ULCERS; OLEORESIN; RATS; FRACTIONS; CYTOKINES	Copaifera oleoresin is one of the most used natural products in popular medicine all over the world. Among other effects (i.e., anti-inflammatory, antinociceptive, microbicidal) one of the most well-known is its wound healing capacity. However, the mechanism by which the oleoresin presents its effect is still not clear. In this study, our aim was to evaluate the wound healing capacity of oleoresin obtained from Copaifera paupera, its mechanism of action and identify its major components. For these purposes, diabetic Swiss Webster mice were topically treated with oleoresin (100, 150 or 200 mg/kg) for 14 consecutive days after an excision was performed in the back of the mice. Cytokines, wound retraction and histological evaluation were conducted at 3, 7 and 10 days (for cytokines); 0, 3, 7, 10 and 14 days (for wound retraction); and 7 and 14 days (for histological evaluation). Our data indicate that oleoresin significantly reduced production of MCP-1 and TNF-alpha at days 7 and 10 post-excision and increased IL-10 production at both days. All treatments demonstrated an effect similar or higher to that in collagenase-treated mice. Histological evaluations demonstrated that higher dose treatment resulted in better resolution and closure of the wound and higher levels of collagen deposition and indexes of re-epithelialization even when compared with the collagenase-treated group. The treatment with oleoresin from Copaifera paupera demonstrated that it is even better than an ointment routinely used for improvement of wound healing, suggesting this oleoresin as an option for use in diabetic patients.	[Amorim, Jorge Luis; Fernandes, Patricia Dias] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Farmacol Dor & Inflamacao, Rio De Janeiro, Brazil; [Figueiredo, Janaina de Barros; Benjamim, Claudia Farias] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil; [Fernandes Amaral, Ana Claudia; MPalantinos, Maria Athana; Ramos, Aline de Souza; Pinto Ferreira, Jose Luiz; de Andrade Silva, Jefferson Rocha] Fiocruz MS, Farmanguinhos, Rio De Janeiro, Brazil; [de Oliveira Barros, Eliane Gouvea; Palmero, Celia; Nasciutti, Luiz Eurico] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Interacoes Celulares, Rio De Janeiro, Brazil; [Basso, Silvia Luciane] Univ Fed Amazonas, Dept Quim, Lab Cromatog, Manaus, Amazonas, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Universidade Federal de Amazonas	Fernandes, PD (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Farmacol Dor & Inflamacao, Rio De Janeiro, Brazil.	patricia.dias@icb.ufrj.br	Fernandes, Patricia Dias/W-1565-2019; Amaral, Ana/Y-7832-2018; SILVA, JEFFERSON RA/A-6845-2008; Benjamim, Claudia/T-5090-2019; Ramos, Aline de Souza/M-1575-2018	Fernandes, Patricia Dias/0000-0001-6870-6745; Benjamim, Claudia/0000-0001-6247-9596; Ramos, Aline de Souza/0000-0002-3478-1904; Fernandes AMARAL, ANA CLAUDIA/0000-0002-2532-471X; SILVA, JEFFERSON/0000-0003-2569-1306; Barros, Janaina/0000-0002-3642-3035; Gouvea de Oliveira Barros, Eliane/0000-0002-0020-6653; Ferreira, Jose Luiz Pinto/0000-0003-1027-9861	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [303033/2013-4, 405332/20165]; Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/203.018/2015]; Conselho de Administracao de Pessoal de Ensino Superior (CAPES); FAPEAM (REDEBIO); FAPEAM (PAPAC)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho de Administracao de Pessoal de Ensino Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPEAM (REDEBIO); FAPEAM (PAPAC)	We would like to thank Mr. Alan Minho for technical assistance, Institute Vital Brazil (Niteroi City, Brazil) for mouse donation and Prof. Fabio Boylan (Trinity University, Dublin) for English revision. This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, grant support and fellowship #303033/2013-4 and 405332/20165 to PDF), Fundacao Carlos Chagas Filho de Apoio a Pesquisa do Estado do Rio de Janeiro (FAPERJ, grant support #E-26/203.018/2015 to PDF), Conselho de Administracao de Pessoal de Ensino Superior (CAPES, fellowship to JLA) and FAPEAM (REDEBIO and PAPAC projects, fellowship to SLB).	[Anonymous], [No title captured]; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Comelli E, 2010, ACTA CIR BRAS, V25, P362, DOI 10.1590/S0102-86502010000400012; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Gomes ND, 2008, J ETHNOPHARMACOL, V119, P179, DOI 10.1016/j.jep.2008.06.033; Gomes ND, 2010, J ETHNOPHARMACOL, V128, P177, DOI 10.1016/j.jep.2010.01.005; Gomes NM, 2007, J ETHNOPHARMACOL, V109, P486, DOI 10.1016/j.jep.2006.08.018; Greaves NS, 2013, J DERMATOL SCI, V72, P206, DOI 10.1016/j.jdermsci.2013.07.008; Herrero-Jauregui C, 2011, CHEM BIODIVERS, V8, P674, DOI 10.1002/cbdv.201000258; HERRICK SE, 1992, AM J PATHOL, V141, P1085; Lee K, 2015, ORIENTAL PHARM EXP M, V15, P1, DOI 10.1007/s13596-014-0159-1; Loots MAM, 1998, J INVEST DERMATOL, V111, P850, DOI 10.1046/j.1523-1747.1998.00381.x; Martins-da-Silva Regina C. V., 2008, Rodriguésia, V59, P455, DOI 10.1590/2175-7860200859304; Nogueira E. de O., 2012, Brazilian Journal of Veterinary Research and Animal Science, V49, P293, DOI 10.11606/issn.1678-4456.v49i4p293-300; Paiva LAF, 2002, PHYTOTHER RES, V16, P737, DOI 10.1002/ptr.1049; Peranteau WH, 2008, J INVEST DERMATOL, V128, P1852, DOI 10.1038/sj.jid.5701232; Ram M, 2015, EUR J PHARMACOL, V764, P9, DOI 10.1016/j.ejphar.2015.06.029; Souza Barbosa PC, 2013, CHEM BIODIVERS, V10, P1350, DOI 10.1002/cbdv.201200356; Tincusi BM, 2002, PLANTA MED, V68, P808, DOI 10.1055/s-2002-34399; Veiga VF, 2007, J ETHNOPHARMACOL, V112, P248, DOI 10.1016/j.jep.2007.03.005; Veiga-Junior VF, 2011, PHYTOTHER RES, V15, P476; Vieira RC, 2008, PESQUISA VET BRASIL, V28, P358, DOI 10.1590/S0100-736X2008000800002; Westphal Fernando Luiz, 2007, Rev. Col. Bras. Cir., V34, P170; Wong V, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/969618; Zoghbi MDB, 2009, J ESSENT OIL RES, V21, P403	25	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187380	10.1371/journal.pone.0187380	http://dx.doi.org/10.1371/journal.pone.0187380			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088304	Green Published, gold, Green Submitted			2022-12-26	WOS:000414088900078
J	Cherney, D; Perkins, BA; Lytvyn, Y; Heerspink, H; Rodriguez-Ortie, ME; Mischak, H				Cherney, David; Perkins, Bruce A.; Lytvyn, Yuliya; Heerspink, Hiddo; Rodriguez-Ortie, Maria E.; Mischak, Harald			The effect of sodium/glucose cotransporter 2 (SGLT2) inhibition on the urinary proteome	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CORONARY-ARTERY-DISEASE; MASS-SPECTROMETRY; DIABETES-MELLITUS; DIAGNOSIS; PEPTIDES; PROGRESSION; BIOMARKERS	Treatment with empagliflozin, an inhibitor of the sodium/glucose cotransporter 2 (SGLT2), is associated with slower progression of diabetic kidney disease. In this analysis, we explored the hypothesis that empagliflozin may have an impact on urinary peptides associated with chronic kidney disease (CKD). In this post-hoc, exploratory analysis, we investigated urine samples obtained from 40 patients with uncomplicated type 1 diabetes (T1D) before and after treatment with empagliflozin for 8 weeks to for significant post-therapy changes in urinary peptides. We further assessed the association of these changes with CKD in an independent cohort, and with a previously established urinary proteomic panel, termed CKD273. 107 individual peptides significantly changed after treatment. The majority of the empagliflozin-induced changes were in the direction of "CKD absent" when compare to patients with CKD and controls. A classifier consisting of these 107 peptides scored significantly different in controls, in comparison to CKD patients. However, empagliflozin did not impact the CKD273 classifier. Our data indicate that empagliflozin induces multiple significant changes in the urinary proteomic markers such as mucin and clusterin. The relationship between empagliflozin-induced proteomic changes and clinical outcomes merits further investigation.	[Cherney, David; Lytvyn, Yuliya] Univ Toronto, Univ Hlth Network, Div Nephrol, Toronto, ON, Canada; [Perkins, Bruce A.] Univ Toronto, Univ Hlth Network, Div Endocrinol, Toronto, ON, Canada; [Heerspink, Hiddo] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharmacol, Groningen, Netherlands; [Rodriguez-Ortie, Maria E.] Univ Autonoma Madrid, REDinREN, Inst Invest Sanitaria, Fdn Jimenez Diaz,Fdn Renal Inigo Alvarez de Toled, Madrid, Spain; [Mischak, Harald] Mosa Diagnost GmbH, Hannover, Germany; [Mischak, Harald] Univ Glasgow, Inst Cardiovasc & Med Sci, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Groningen; Autonomous University of Madrid; Fundacion Jimenez Diaz; Modular Open Systems Approach (MOSA) Solutions; University of Glasgow	Mischak, H (corresponding author), Mosa Diagnost GmbH, Hannover, Germany.; Mischak, H (corresponding author), Univ Glasgow, Inst Cardiovasc & Med Sci, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland.	mischak@mosaiques-diagnostics.com	Heerspink, Hiddo J Lambers/K-3358-2014; Perkins, Bruce A/L-3726-2017	Heerspink, Hiddo J Lambers/0000-0002-3126-3730; Mischak, Harald/0000-0003-0323-0306	Janssen; Boehringer Ingelheim-Eli Lilly; AstraZeneca; Merck; Sanofi; Boehringer Ingelheim	Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Boehringer Ingelheim-Eli Lilly; AstraZeneca(AstraZeneca); Merck(Merck & Company); Sanofi; Boehringer Ingelheim(Boehringer Ingelheim)	DC has received consulting fees or speaking honorarium or both from Janssen, Boehringer Ingelheim-Eli Lilly, AstraZeneca, Merck, Sanofi, and his institution has received operating funding from Janssen, Boehringer Ingelheim-Eli Lilly, AstraZeneca, Merck. HM is the co-founder and co-owner of Mosaiques Diagnostics. BAP has received fees for continuing medical education events from Janssen and Boehringer Ingelheim, has served as an advisor for Boehringer Ingelheim, and his research institute has received research grants on his behalf from Boehringer Ingelheim. The funder provided support in the form of salaries for author HM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andersen S, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-29; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cherney DZI, 2014, CIRCULATION, V129, P587, DOI 10.1161/CIRCULATIONAHA.113.005081; Dakna M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-594; Girolami Mark, 2006, Drug Discov Today Technol, V3, P13, DOI 10.1016/j.ddtec.2006.03.010; Good DM, 2010, MOL CELL PROTEOMICS, V9, P2424, DOI 10.1074/mcp.M110.001917; Haubitz M, 2009, MOL CELL PROTEOMICS, V8, P2296, DOI 10.1074/mcp.M800529-MCP200; Heerspink HJL, 2016, CIRCULATION, V134, P752, DOI 10.1161/CIRCULATIONAHA.116.021887; Jantos-Siwy J, 2009, J PROTEOME RES, V8, P268, DOI 10.1021/pr800401m; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Kaiser T, 2003, J CHROMATOGR A, V1013, P157, DOI 10.1016/S0021-9673(03)00712-X; Klein J, 2014, ELECTROPHORESIS, V35, P1060, DOI 10.1002/elps.201300327; Lankisch TO, 2011, HEPATOLOGY, V53, P875, DOI 10.1002/hep.24103; Mischak H, 2015, NAT REV NEPHROL, V11, P221, DOI 10.1038/nrneph.2014.247; Mischak H, 2013, CLIN BIOCHEM, V46, P432, DOI 10.1016/j.clinbiochem.2012.09.025; Mischak H, 2009, J MED BIOCHEM, V28, P223, DOI 10.2478/v10011-009-0020-0; Nkuipou-Kenfack E, 2015, ONCOTARGET, V6, P34106, DOI 10.18632/oncotarget.5896; Pontillo C, 2017, KIDNEY INT IN PRESS; Pontillo C, 2016, NEPHROL DIAL TRANSPL; Pontillo C, 2017, CLIN KIDNEY J, V10, P192, DOI 10.1093/ckj/sfx002; Schanstra JP, 2015, J AM SOC NEPHROL, V26, P1999, DOI 10.1681/ASN.2014050423; Silva S, 2015, AM J CLIN NUTR, V101, P44, DOI 10.3945/ajcn.114.094219; Stalmach A, 2013, ELECTROPHORESIS, V34, P1452, DOI 10.1002/elps.201200708; Wanner C, 2016, NEW ENGL J MED, V375, P323, DOI [10.1056/NEJMoa1515920, 10.1056/NEJMc1611290]; Zhang ZH, 2017, STRUCT BOND, V173, P1, DOI 10.1007/430_2016_12; Zimmerli LU, 2008, MOL CELL PROTEOMICS, V7, P290, DOI 10.1074/mcp.M700394-MCP200	26	18	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0186910	10.1371/journal.pone.0186910	http://dx.doi.org/10.1371/journal.pone.0186910			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084249	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000413910200018
J	Naaman, H; Rall, G; Matullo, C; Veksler-Lublinsky, I; Shemer-Avni, Y; Gopas, J				Naaman, Hila; Rall, Glenn; Matullo, Christine; Veksler-Lublinsky, Isana; Shemer-Avni, Yonat; Gopas, Jacob			MiRNA-124 is a link between measles virus persistent infection and cell division of human neuroblastoma cells	PLOS ONE			English	Article							SUBACUTE SCLEROSING-PANENCEPHALITIS; HEPATOCELLULAR-CARCINOMA; NEURONAL DIFFERENTIATION; MESSENGER-RNA; BRAIN-TISSUES; CYCLE ARREST; MICRORNA; EXPRESSION; APOPTOSIS; REPLICATION	Measles virus (MV) infects a variety of lymphoid and non-lymphoid peripheral organs. However, in rare cases, the virus can persistently infect cells within the central nervous system. Although some of the factors that allow MV to persist are known, the contribution of host cell-encoded microRNAs (miRNA) have not been described. MiRNAs are a class of noncoding RNAs transcribed from genomes of all multicellular organisms and some viruses, which regulate gene expression in a sequence-specific manner. We have studied the contribution of host cell-encoded miRNAs to the establishment of MV persistent infection in human neuroblastoma cells. Persistent MV infection was accompanied by differences in the expression profile and levels of several host cell-encoded microRNAs as compared to uninfected cells. MV persistence infection of a human neuroblastoma cell line (UKF-NB-MV), exhibit high miRNA-124 expression, and reduced expression of cyclin dependent kinase 6 (CDK6), a known target of miRNA-124, resulting in slower cell division but not cell death. By contrast, acute MV infection of UKF-NB cells did not result in increased miRNA-124 levels or CDK6 reduction. Ectopic overexpression of miRNA-124 affected cell viability only in UKF-NB-MV cells, causing cell death; implying that miRNA-124 over expression can sensitize cells to death only in the presence of MV persistent infection. To determine if miRNA-124 directly contributes to the establishment of MV persistence, UKF-NB cells overexpressing miRNA-124 were acutely infected, resulting in establishment of persistently infected colonies. We propose that miRNA-124 triggers a CDK6-dependent decrease in cell proliferation, which facilitates the establishment of MV persistence in neuroblastoma cells. To our knowledge, this is the first report to describe the role of a specific miRNA in MV persistence.	[Naaman, Hila; Shemer-Avni, Yonat; Gopas, Jacob] Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol & Immunol & Genet, Beer Sheva, Israel; [Rall, Glenn; Matullo, Christine] Fox Chase Canc Ctr, Blood Cell Dev & Funct, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Veksler-Lublinsky, Isana] Ben Gurion Univ Negev, Software & Informat Syst Engn, Beer Sheva, Israel; [Shemer-Avni, Yonat] Soroka Univ Med Ctr, Clin Virol, Beer Sheva, Israel; [Gopas, Jacob] Soroka Univ Med Ctr, Dept Oncol, Beer Sheva, Israel	Ben Gurion University; Fox Chase Cancer Center; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center	Gopas, J (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol & Immunol & Genet, Beer Sheva, Israel.; Gopas, J (corresponding author), Soroka Univ Med Ctr, Dept Oncol, Beer Sheva, Israel.	jacob@bgu.ac.il	Veksler-Lublinsky, Isana/AAF-2496-2019; AVNI, YONAT SHEMER/F-1772-2012	Veksler-Lublinsky, Isana/0000-0002-4251-6158; Matullo, Christine/0000-0003-1598-7007; Gopas, Jacob/0000-0001-9289-8898	NIH [R03 AI094164-01A1]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded by NIH R03 AI094164-01A1 to Glenn Rall and Jacob Gopas, https://grants.nih.gov/grants/funding/r03.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Richard H. Holzer Foundation to Jacob Gopas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The American Associates of the Ben Gurion University (AABGU) the Philadelphia Chapter to Hila Naaman, https://aabgu.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACZKO K, 1986, J VIROL, V59, P472, DOI 10.1128/JVI.59.2.472-478.1986; Barber GN, 2001, CELL DEATH DIFFER, V8, P113, DOI 10.1038/sj.cdd.4400823; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhaskar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018765; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; CATTANEO R, 1993, J VIROL, V67, P1493, DOI 10.1128/JVI.67.3.1493-1502.1993; CATTANEO R, 1988, CELL, V55, P255, DOI 10.1016/0092-8674(88)90048-7; Chiang K, 2013, VIROLOGY, V438, P1, DOI 10.1016/j.virol.2012.12.016; Chowdhury JB, 2012, J VIROL, V86, P10221, DOI 10.1128/JVI.00882-12; Cinatl J, 1998, CANCER RES, V58, P367; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Doi T, 2016, SCI REP-UK, V6, DOI 10.1038/srep37163; Engelking O, 1999, J GEN VIROL, V80, P1599, DOI 10.1099/0022-1317-80-7-1599; ESOLEN LM, 1995, J VIROL, V69, P3955, DOI 10.1128/JVI.69.6.3955-3958.1995; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; Avila-Bonilla RG, 2017, VIRUS RES, V232, P139, DOI 10.1016/j.virusres.2017.03.005; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Griffin DE, 2012, FEMS MICROBIOL REV, V36, P649, DOI 10.1111/j.1574-6976.2012.00330.x; Hay S, 2002, J GEN VIROL, V83, P1547, DOI 10.1099/0022-1317-83-7-1547; Israelow B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6408; Jopling CL, 2012, RNA BIOL, V9, DOI 10.4161/rna.18827; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; KATAYAMA Y, 1995, J GEN VIROL, V76, P3201, DOI 10.1099/0022-1317-76-12-3201; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lawrence DMP, 2000, J VIROL, V74, P1908, DOI 10.1128/JVI.74.4.1908-1918.2000; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li KKW, 2009, HUM PATHOL, V40, P1234, DOI 10.1016/j.humpath.2009.02.003; Lin WHW, 2012, P NATL ACAD SCI USA, V109, P14989, DOI 10.1073/pnas.1211138109; Linnstaedt SD, 2010, J VIROL, V84, P11670, DOI 10.1128/JVI.01248-10; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; McQuaid S, 1998, J VIROL, V72, P5245, DOI 10.1128/JVI.72.6.5245-5250.1998; McQuaid S, 1997, NEUROPATH APPL NEURO, V23, P218, DOI 10.1111/j.1365-2990.1997.tb01205.x; Moss WJ, 2012, LANCET, V379, P153, DOI 10.1016/S0140-6736(10)62352-5; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Naniche D, 1999, J VIROL, V73, P1894, DOI 10.1128/JVI.73.3.1894-1901.1999; Nguyen MD, 2002, CELL DEATH DIFFER, V9, P1294, DOI 10.1038/sj.cdd.4401108; Patterson JB, 2001, VIROLOGY, V291, P215, DOI 10.1006/viro.2001.1182; Pierson J, 2008, J NEURO-ONCOL, V90, P1, DOI 10.1007/s11060-008-9624-3; Ponomarev Eugene D, 2011, BMC Res Notes, V4, P517, DOI 10.1186/1756-0500-4-517; Rader J, 2013, CLIN CANCER RES, V19, P6173, DOI 10.1158/1078-0432.CCR-13-1675; Rall GF, 2003, ANNU REV MICROBIOL, V57, P343, DOI 10.1146/annurev.micro.57.030502.090843; Rima BK, 2005, VIRUS RES, V111, P132, DOI 10.1016/j.virusres.2005.04.005; Roberts APE, 2011, NUCLEIC ACIDS RES, V39, P7716, DOI 10.1093/nar/gkr426; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; Schneider-Schaulies J, 1999, J NEUROVIROL, V5, P613, DOI 10.3109/13550289909021290; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Silber J, 2013, NEURO-ONCOLOGY, V15, P83, DOI 10.1093/neuonc/nos281; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Sun Y, 2013, CNS NEUROSCI THER, V19, P813, DOI 10.1111/cns.12142; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Trobaugh DW, 2017, TRENDS MOL MED, V23, P80, DOI 10.1016/j.molmed.2016.11.003; Villanueva RA, 2010, ANTIVIR RES, V88, P119, DOI 10.1016/j.antiviral.2010.07.004; Watanabe M, 1995, J NEUROVIROL, V1, P412, DOI 10.3109/13550289509111034; Wong KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019027; Yeung ML, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-81; Yi CH, 2013, CAN J MICROBIOL, V59, P814, DOI 10.1139/cjm-2013-0544; Yis U, 2015, J CHILD NEUROL, V30, P69, DOI 10.1177/0883073814531329; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Zheng F, 2012, GUT, V61, P278, DOI 10.1136/gut.2011.239145; Zou DF, 2014, NEURAL REGEN RES, V9, P1241, DOI 10.4103/1673-5374.135333	64	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187077	10.1371/journal.pone.0187077	http://dx.doi.org/10.1371/journal.pone.0187077			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073265	Green Published, Green Submitted, gold			2022-12-26	WOS:000413845400109
J	Gill, K; Macdonald-Obermann, JL; Pike, LJ				Gill, Kamaldeep; Macdonald-Obermann, Jennifer L.; Pike, Linda J.			Epidermal growth factor receptors containing a single tyrosine in their C-terminal tail bind different effector molecules and are signaling-competent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epidermal growth factor (EGF); epidermal growth factor receptor (EGFR); growth factor receptor-bound protein 2 (GRB2); receptor tyrosine kinase; signal transduction; Gab1; Shc	SITE-SPECIFIC PHOSPHORYLATION; AUTOPHOSPHORYLATION SITES; EGF RECEPTOR; SH2 DOMAINS; GRB2; KINASES; IDENTIFICATION; ACTIVATION; CELLS; REQUIREMENT	The EGF receptor is a classic receptor tyrosine kinase. It contains nine tyrosines in its C-terminal tail, many of which are phosphorylated and bind proteins containing SH2 or phosphotyrosine-binding (PTB) domains. To determine how many and which tyrosines are required to enable EGF receptor-mediated signaling, we generated a series of EGF receptors that contained only one tyrosine in their C-terminal tail. Assays of the signaling capabilities of these single-Tyr EGF receptors indicated that they can activate a range of downstream signaling pathways, including MAP kinase and Akt. The ability of the single-Tyr receptors to signal correlated with their ability to bind Gab1 (Grb2-associated binding protein 1). However, Tyr-992 appeared to be almost uniquely required to observe activation of phospholipase C. These results demonstrate that multiply phosphorylated receptors are not required to support most EGF-stimulated signaling but identify Tyr-992 and its binding partners as a unique node within the network. We also studied the binding of the isolated SH2 domain of Grb2 (growth factor receptor-bound protein 2) and the isolated PTB domain of Shc (SHC adaptor protein) to the EGF receptor. Although these adapter proteins bound readily to wild-type EGF receptor, they bound poorly to the single-Tyr EGF receptors, even those that bound full-length Grb2 and Shc well. This suggests that in addition to pTyr-directed associations, secondary interactions between the tail and regions of the adapter proteins outside of the SH2/PTB domains are important for stabilizing the binding of Grb2 and Shc to the single-Tyr EGF receptors.	[Gill, Kamaldeep; Macdonald-Obermann, Jennifer L.; Pike, Linda J.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Pike, LJ (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.	pike@wustl.edu			National Institutes of Health [R01 GM099695, R01 GM108785]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099695, R01GM108785] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM099695 and R01 GM108785 (to L. J. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BATZER AG, 1994, MOL CELL BIOL, V14, P5192, DOI 10.1128/MCB.14.8.5192; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Chen ZM, 2012, J VIROL, V86, P1421, DOI 10.1128/JVI.05993-11; Curran TG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6924; Dengjel J, 2007, NAT BIOTECHNOL, V25, P566, DOI 10.1038/nbt1301; DORAN DM, 1980, J IMMUNOL METHODS, V39, P155, DOI 10.1016/0022-1759(80)90304-X; DOWNWARD J, 1984, NATURE, V311, P483, DOI 10.1038/311483a0; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Guo L, 2003, J AM SOC MASS SPECTR, V14, P1022, DOI 10.1016/S1044-0305(03)00206-X; HSUAN JJ, 1989, BIOCHEM J, V262, P659, DOI 10.1042/bj2620659; Huang J, 2007, CANCER RES, V67, P5906, DOI 10.1158/0008-5472.CAN-07-0691; Huang YJ, 2016, ELIFE, V5, DOI 10.7554/eLife.14107; Kim KL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11107; Kim Y, 2012, BIOCHEMISTRY-US, V51, P5212, DOI 10.1021/bi300476v; Koland JG, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003435; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Macdonald-Obermann JL, 2014, J BIOL CHEM, V289, P26178, DOI 10.1074/jbc.M114.586826; Mahankali M, 2011, CELL SIGNAL, V23, P1291, DOI 10.1016/j.cellsig.2011.03.010; MARGOLIS BL, 1989, J BIOL CHEM, V264, P10667; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; PIKE LJ, 1982, P NATL ACAD SCI-BIOL, V79, P1443, DOI 10.1073/pnas.79.5.1443; PIKE LJ, 1987, METHOD ENZYMOL, V146, P353; POWIS G, 1994, CANCER RES, V54, P2419; Reddy RJ, 2016, P NATL ACAD SCI USA, V113, P3114, DOI 10.1073/pnas.1521288113; Rodrigues GA, 2000, MOL CELL BIOL, V20, P1448, DOI 10.1128/MCB.20.4.1448-1459.2000; Ronan T, 2016, J BIOL CHEM, V291, P5528, DOI 10.1074/jbc.M115.710087; ROTIN D, 1992, EMBO J, V11, P559, DOI 10.1002/j.1460-2075.1992.tb05087.x; Sakaguchi K, 1998, MOL ENDOCRINOL, V12, P536, DOI 10.1210/me.12.4.536; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; Simister PC, 2012, MOL BIOSYST, V8, P33, DOI 10.1039/c1mb05272a; SONGYANG Z, 1995, J BIOL CHEM, V270, P14863, DOI 10.1074/jbc.270.25.14863; SORKIN A, 1992, J BIOL CHEM, V267, P8672; Sturla LM, 2005, J BIOL CHEM, V280, P14597, DOI 10.1074/jbc.M413287200; Tong JF, 2009, MOL CELL PROTEOMICS, V8, P2131, DOI 10.1074/mcp.M900148-MCP200; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; Ward CW, 1996, J BIOL CHEM, V271, P5603, DOI 10.1074/jbc.271.10.5603; Westover EJ, 2003, J BIOL CHEM, V278, P51125, DOI 10.1074/jbc.M304332200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wohrle FU, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-22; Yang KS, 2009, J BIOL CHEM, V284, P7474, DOI 10.1074/jbc.M808041200; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	49	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20744	20755		10.1074/jbc.M117.802553	http://dx.doi.org/10.1074/jbc.M117.802553			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29074618	hybrid, Green Published			2022-12-26	WOS:000418267000034
J	Krout, D; Schaar, A; Sun, YY; Sukumaran, P; Roemmich, JN; Singh, BB; Claycombe-Larson, KJ				Krout, Danielle; Schaar, Anne; Sun, Yuyang; Sukumaran, Pramod; Roemmich, James N.; Singh, Brij B.; Claycombe-Larson, Kate J.			The TRPC1 Ca2+-permeable channel inhibits exercise-induced protection against high-fat diet-induced obesity and type II diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium; diabetes; exercise; obesity; transient receptor potential channels (TRP channels); SOCE; TRPC1	PRENATAL LOW-PROTEIN; RECEPTOR POTENTIAL CHANNELS; ADIPOSE-TISSUE; SKELETAL-MUSCLE; MITOCHONDRIAL RESPIRATION; METABOLIC SYNDROME; CA2+; CELLS; EXPRESSION; ACIDS	The transient receptor potential canonical channel-1 (TRPC1) is a Ca2+-permeable channel found in key metabolic organs and tissues, including the hypothalamus, adipose tissue, and skeletal muscle. Loss of TRPC1 may alter the regulation of cellular energy metabolism resulting in insulin resistance thereby leading to diabetes. Exercise reduces insulin resistance, but it is not known whether TRPC1 is involved in exercise-induced insulin sensitivity. The role of TRPC1 in adiposity and obesity-associated metabolic diseases has not yet been determined. Our results show that TRPC1 functions as a major Ca2+ entry channel in adipocytes. We have also shown that fat mass and fasting glucose concentrations were lower in TRPC1 KO mice that were fed a high-fat (HF) (45% fat) diet and exercised as compared with WT mice fed a HF diet and exercised. Adipocyte numbers were decreased in both subcutaneous and visceral adipose tissue of TRPC1 KO mice fed a HF diet and exercised. Finally, autophagy markers were decreased and apoptosis markers increased in TRPC1 KO mice fed a HF diet and exercised. Overall, these findings suggest that TRPC1 plays an important role in the regulation of adiposity via autophagy and apoptosis and that TRPC1 inhibits the positive effect of exercise on type II diabetes risk under a HF diet-induced obesity environment.	[Krout, Danielle; Roemmich, James N.; Claycombe-Larson, Kate J.] USDA ARS, Grand Forks Human Nutr Res Ctr, Grand Forks, ND 58203 USA; [Schaar, Anne; Sun, Yuyang; Sukumaran, Pramod; Singh, Brij B.] Univ North Dakota, Sch Med & Hlth Sci, Dept Biomed Sci, Grand Forks, ND 58203 USA	United States Department of Agriculture (USDA); University of North Dakota Grand Forks	Singh, BB (corresponding author), 1301 North Columbia Rd,Ste W221,POB 9037, Grand Forks, ND 58201 USA.; Claycombe-Larson, KJ (corresponding author), 2420 2nd Ave North, Grand Forks, ND 58203 USA.	brij.singh@med.und.edu; kate.larson@ars.usda.gov		Singh, Brij/0000-0003-0535-5997; SCHAAR, ANNE/0000-0002-5315-333X; Roemmich, James/0000-0002-6270-9678	National Institutes of Health [R01DE017102, R01DE022765, R21DE024300, P20GM113123]; U.S. Department of Agriculture, Agricultural Research Service Project [3062-51000-052-00D]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE024300, R01DE022765, R01DE017102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM113123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Agriculture, Agricultural Research Service Project; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01DE017102, R01DE022765, R21DE024300, and P20GM113123 (to B. B. S.) and by the U.S. Department of Agriculture, Agricultural Research Service Project 3062-51000-052-00D (to K. J. C.-L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or reflect the position or policy of the United States government.	ARMSTRONG CM, 1972, BIOCHIM BIOPHYS ACTA, V267, P605, DOI 10.1016/0005-2728(72)90194-6; Bluhre M, 2009, EXP CLIN ENDOCR DIAB, V117, P241, DOI 10.1055/s-0029-1192044; Bollimuntha S, 2006, BRAIN RES, V1099, P141, DOI 10.1016/j.brainres.2006.04.104; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Chan CS, 2009, TRENDS NEUROSCI, V32, P249, DOI 10.1016/j.tins.2009.01.006; Claycombe KJ, 2016, J NUTR BIOCHEM, V31, P113, DOI 10.1016/j.jnutbio.2016.01.008; Claycombe KJ, 2015, J NUTR BIOCHEM, V26, P729, DOI 10.1016/j.jnutbio.2015.01.008; Claycombe KJ, 2015, J NUTR BIOCHEM, V26, P184, DOI 10.1016/j.jnutbio.2014.10.003; Claycombe KJ, 2013, J NUTR, V143, P1533, DOI 10.3945/jn.113.178038; CRAIG BW, 1981, J APPL PHYSIOL, V51, P1500, DOI 10.1152/jappl.1981.51.6.1500; Davis FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036923; Filadi R, 2017, CELL CALCIUM, V62, P1, DOI 10.1016/j.ceca.2017.01.003; Gollisch KSC, 2009, AM J PHYSIOL-ENDOC M, V297, pE495, DOI 10.1152/ajpendo.90424.2008; Graham S, 2012, EXP BIOL MED, V237, P111, DOI 10.1258/ebm.2011.011208; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; Holzer RG, 2011, CELL, V147, P173, DOI 10.1016/j.cell.2011.08.034; Hu GQ, 2009, MOL ENDOCRINOL, V23, P689, DOI 10.1210/me.2008-0350; Kalupahana NS, 2010, J NUTR, V140, P1915, DOI 10.3945/jn.110.125732; Kuda O, 2016, DIABETES, V65, P2580, DOI 10.2337/db16-0385; Liu XB, 2000, J BIOL CHEM, V275, P3403, DOI 10.1074/jbc.275.5.3403; Liu XB, 2007, P NATL ACAD SCI USA, V104, P17542, DOI 10.1073/pnas.0701254104; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Ouguerram K, 2006, BRIT J NUTR, V96, P100, DOI 10.1079/BJN20061806; Pan Z, 2001, J BIOL CHEM, V276, P32257, DOI 10.1074/jbc.M100178200; Pani B, 2006, MOL BIOL CELL, V17, P4446, DOI 10.1091/mbc.E06-03-0251; Pani B, 2009, CELL CALCIUM, V45, P625, DOI 10.1016/j.ceca.2009.02.009; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Pla AF, 2005, J NEUROSCI, V25, P2687, DOI 10.1523/JNEUROSCI.0951-04.2005; Qiu J, 2010, J NEUROSCI, V30, P1560, DOI 10.1523/JNEUROSCI.4816-09.2010; Rao JN, 2006, AM J PHYSIOL-GASTR L, V290, pG782, DOI 10.1152/ajpgi.00441.2005; Sabourin J, 2015, J BIOL CHEM, V290, P30530, DOI 10.1074/jbc.M115.682583; Saltevo J, 2011, EUR J ENDOCRINOL, V165, P429, DOI 10.1530/EJE-11-0066; Scalzo RL, 2014, FASEB J, V28, P2705, DOI 10.1096/fj.13-246595; Selvaraj S, 2009, CELL CALCIUM, V46, P209, DOI 10.1016/j.ceca.2009.07.008; SORVA A, 1990, GERONTOLOGY, V36, P212, DOI 10.1159/000213202; Stanford KI, 2015, DIABETES, V64, P2002, DOI 10.2337/db14-0704; Sukumar P, 2012, CIRC RES, V111, P191, DOI [10.1161/CIRCRESAHA.112.270751, 10.1161/circresaha.112.270751]; Sukumaran P, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.7; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Witczak CA, 2006, J APPL PHYSIOL, V101, P752, DOI 10.1152/japplphysiol.00235.2006; Ye L, 2012, CELL, V151, P96, DOI 10.1016/j.cell.2012.08.034; Yuan JP, 2009, CHANNELS, V3, P221, DOI 10.4161/chan.3.4.9198; Zanou N, 2010, AM J PHYSIOL-CELL PH, V298, pC149, DOI 10.1152/ajpcell.00241.2009	44	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20799	20807		10.1074/jbc.M117.809954	http://dx.doi.org/10.1074/jbc.M117.809954			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29074621	Green Published, hybrid			2022-12-26	WOS:000418267000038
J	Gillissen, A; Henriquez, DDCA; van den Akker, T; Cararn-Deelder, C; Winds, M; Zwart, JJ; van Roosmalen, J; Eikenboom, J; Eloernenkamp, KWM; van der Bom, JG				Gillissen, Ada; Henriquez, Dacia D. C. A.; van den Akker, Thomas; Cararn-Deelder, Camila; Winds, Merlijn; Zwart, Joost J.; van Roosmalen, Jos; Eikenboom, Jeroen; Eloernenkamp, Kitty W. M.; van der Bom, Johanna G.		TeMpOH-1 Study Grp	The effect of tranexamic acid on blood loss and maternal outcome in the treatment of persistent postpartum hemorrhage: A nationwide retrospective cohort study	PLOS ONE			English	Article							TRAUMA PATIENTS; PREGNANCY; CRASH-2	Background Recent results show a protective effect of tranexamic acid on death due to bleeding in patients with postpartum hemorrhage in low-and middle-resource countries. We quantify the association between early administration of tranexamic acid compared to late or no administration and severe acute maternal morbidity and blood loss among women suffering from persistent severe postpartum hemorrhage in a high-income country. Methods and findings We performed a nationwide retrospective cohort study in 61 hospitals in the Netherlands. The study population consisted of 1260 women with persistent postpartum hemorrhage who had received at least four units of red cells, or fresh frozen plasma or platelets in addition to red cells. A review of medical records was performed and cross-referenced with blood bank data. The composite endpoint comprised maternal morbidity (hysterectomy, ligation of the uterine arteries, emergency B-Lynch suture, arterial embolization or admission into an intensive care unit) and mortality. Results 247 women received early tranexamic acid treatment. After adjustment for confounding, odds ratio for the composite endpoint for early tranexamic acid (n = 247) versus no/late tranexamic acid (n = 984) was 0.92 (95% confidence interval (Cl) 0.66 to 1.27). Propensity matched analysis confirmed the absence of a difference between women with and without tranexamic acid. Blood loss after administration of first line therapy did not differ significantly between the two groups (adjusted difference -177 mL, Cl -509.4 to +155.0). Conclusions Our findings suggest that in a high-resource country the effect of tranexamic acid on both blood loss and the combined endpoint of maternal mortality and morbidity may be disappointing.	[Gillissen, Ada; Henriquez, Dacia D. C. A.; Cararn-Deelder, Camila; van der Bom, Johanna G.] Sanquin Res, Ctr Clin Transfus Res, Leiden, Netherlands; [Gillissen, Ada; Henriquez, Dacia D. C. A.; van der Bom, Johanna G.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Gillissen, Ada; Henriquez, Dacia D. C. A.; van den Akker, Thomas; van Roosmalen, Jos] Leiden Univ, Med Ctr, Dept Obstet, Leiden, Netherlands; [van den Akker, Thomas] Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford, England; [Winds, Merlijn] Leiden Univ, Med Ctr, Leiden, Netherlands; [Zwart, Joost J.] Deventer Hosp, Dept Obstet & Gynecol, Deventer, Netherlands; [van Roosmalen, Jos] Vrije Univ Amsterdam, Athena Inst, Amsterdam, Netherlands; [Eikenboom, Jeroen] Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, Leiden, Netherlands; [Eloernenkamp, Kitty W. M.] Birth Ctr Wilhelminas Children Hosp, Univ Med Ctr Utrecht, Dept Obstet, Utrecht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Oxford; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Deventer Hospital; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center	van der Bom, JG (corresponding author), Sanquin Res, Ctr Clin Transfus Res, Leiden, Netherlands.; van der Bom, JG (corresponding author), Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands.	j.g.vanderbom@lumc.nl	Eikenboom, Jeroen/F-9156-2018; van der Bom, Johanna G./G-1965-2018	Eikenboom, Jeroen/0000-0002-3268-5759; Henriquez, Dacia/0000-0003-3164-8611; van der Bom, Johanna G./0000-0001-9095-2475; Caram-Deelder, Camila/0000-0003-3161-5684; Wind, Merlijn/0000-0002-8002-9369				Abdul-Kadir R, 2014, TRANSFUSION, V54, P1756, DOI 10.1111/trf.12550; Alam A, 2015, TRANSFUS MED REV, V29, P231, DOI 10.1016/j.tmrv.2015.07.002; Bonnet MP, 2012, SEMIN THROMB HEMOST, V38, P259, DOI 10.1055/s-0032-1302441; Bouet PE, 2015, BRIT J ANAESTH, V114, P339, DOI 10.1093/bja/aeu468; Ducloy-Bouthors AS, 2011, CRIT CARE, V15, DOI 10.1186/cc10143; Grobman WA, 2014, OBSTET GYNECOL, V123, P804, DOI 10.1097/AOG.0000000000000173; Hellgren M, 2003, SEMIN THROMB HEMOST, V29, P125, DOI 10.1055/s-2003-38897; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Ker K, 2015, COCHRANE DB SYST REV, V5, DOI DOI 10.1002/14651858.CD004896.PUB4; Ker K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3054; Knight M, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-55; McCormack PL, 2012, DRUGS, V72, P585, DOI 10.2165/11209070-000000000-00000; Novikova N, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007872.pub3; Peitsidis P, 2011, EXPERT OPIN PHARMACO, V12, P503, DOI 10.1517/14656566.2011.545818; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Shakur H, LANCET; Shakur H, 2017, LANCET, V389, P2105, DOI 10.1016/S0140-6736(17)30638-4; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Solomon C, 2012, BRIT J ANAESTH, V109, P851, DOI 10.1093/bja/aes361; WHO, 2012, EV QUAL CAR SEV PREG; Zwart JJ, 2008, BJOG-INT J OBSTET GY, V115, P842, DOI 10.1111/j.1471-0528.2008.01713.x	21	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187555	10.1371/journal.pone.0187555	http://dx.doi.org/10.1371/journal.pone.0187555			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29107951	Green Submitted, gold, Green Published			2022-12-26	WOS:000414424600041
J	Gutierrez, JKT; Zanatta, GC; Ortega, ALM; Balastegui, MIC; Sanita, PV; Pavarina, AC; Barbugli, PA; Mima, EGD				Trigo Gutierrez, Jeffersson Krishan; Zanatta, Gabriela Cristina; Mira Ortega, Ana Laura; Cuba Balastegui, Maria Isabella; Sanita, Paula Volpato; Pavarina, Ana Claudia; Barbugli, Paula Aboud; de Oliveira Mima, Ewerton Garcia			Encapsulation of curcumin in polymeric nanoparticles for antimicrobial Photodynamic Therapy	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; STREPTOCOCCUS-MUTANS; CANDIDA-ALBICANS; BIOFILM FORMATION; LOADED PLGA; ALAMAR BLUE; FORMULATION; INACTIVATION; PHARMACOKINETICS; PHOTOSENSITIZER	Curcumin (CUR) has been used as photosensitizer in antimicrobial Photodynamic Therapy (aPDT). However its poor water solubility, instability, and scarce bioavalibility hinder its in vivo application. The aim of this study was to synthesize curcumin in polymeric nanoparticles (NP) and to evaluate their antimicrobial photodynamic effect and cytoxicity. CUR in anionic and cationic NP was synthesized using polylactic acid and dextran sulfate by the nanoprecipitation method. For cationic NP, cetyltrimethylammonium bromide was added. CUR-NP were characterized by physicochemical properties, photodegradation, encapsulation efficiency and release of curcumin from nanoparticles. CUR-NP was compared with free CUR in 10% dimethyl sulfoxide (DMSO) as a photosensitizer for aPDT against planktonic and biofilms (mono-, dual-and triple-species) cultures of Streptococcus mutans, Candida albicans and Methicillin-Resistant Staphylococcus aureus. The cytotoxicity effect of formulations was evaluated on keratinocytes. Data were analysed by parametric (ANOVA) and non-parametric (Kruskal-Wallis) tests (alpha = 0.05). CUR-NP showed alteration in the physicochemical properties along time, photodegradation similar to free curcumin, encapsulation efficiency up to 67%, and 96% of release after 48h. After aPDT planktonic cultures showed reductions from 0.78 loglo to complete eradication, while biofilms showed no antimicrobial effect or reductions up to 4.44 loglo. Anionic CUR-NP showed reduced photoinactivation of biofilms. Cationic CUR-NP showed microbicidal effect even in absence of light. Anionic formulations showed no cytotoxic effect compared with free CUR and cationic CURNP and NP. The synthesized formulations improved the water solubility of CUR, showed higher antimicrobial photodynamic effect for planktonic cultures than for biofilms, and the encapsulation of CUR in anionic NP reduced the cytotoxicity of 10% DMSO used for free CUR.	[Trigo Gutierrez, Jeffersson Krishan; Zanatta, Gabriela Cristina; Mira Ortega, Ana Laura; Cuba Balastegui, Maria Isabella; Sanita, Paula Volpato; Pavarina, Ana Claudia; Barbugli, Paula Aboud; de Oliveira Mima, Ewerton Garcia] Sao Paulo State Univ, UNESP, Sch Dent, Dept Dent Mat & Prosthodont, Araraquara, SP, Brazil	Universidade Estadual Paulista	Mima, EGD (corresponding author), Sao Paulo State Univ, UNESP, Sch Dent, Dept Dent Mat & Prosthodont, Araraquara, SP, Brazil.	ewertonmima@foar.unesp.br	Barbugli, Paula/AAK-8605-2021; Pavarina, Ana Claudia/J-8640-2013; Mima, Ewerton/F-9496-2014; Trigo-Gutierrez, Jeffersson K./G-2648-2019; Mima, Ewerton/X-5176-2019; Sanitá, Paula/A-7777-2015; Barbugli, Paula/D-7148-2013; Trigo-Gutierrez, Jeffersson Krishan/F-9246-2017	Mima, Ewerton/0000-0002-9575-7625; Mima, Ewerton/0000-0002-9575-7625; Trigo-Gutierrez, Jeffersson Krishan/0000-0002-1004-2429; Barbugli, Paula/0000-0002-0078-1172; Ortega Granados, Ana Laura/0000-0002-5727-3371	Sao Paulo Research Foundation (FAPESP) [2013/23165-5, 2014/18345-7, 2014/20119-5]; National Counsel of Technological and Scientific Development [446401/2014-5]; Coordination for the Improvement of Higher Education Personnel (CAPES); Program of Scientific Initiation [30641, 34828, 34848, 30288]; PROINTER PROPe/PROPG [1732]; Sao Paulo Research Foundation (FAPESP, RIDC, CEPOF) [2013/07276-1]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Counsel of Technological and Scientific Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Program of Scientific Initiation; PROINTER PROPe/PROPG; Sao Paulo Research Foundation (FAPESP, RIDC, CEPOF)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by Sao Paulo Research Foundation (FAPESP): grant numbers 2013/23165-5 (EGOM), 2014/18345-7 (ALMO), 2014/20119-5 (EGOM), www.fapesp.br; Sao Paulo Research Foundation (FAPESP, RIDC, CEPOF): grant number 2013/07276-1 (ACP), http://cepid.fapesp.br/en/centro/17/; National Counsel of Technological and Scientific Development: grant number 446401/2014-5 (EGOM), www.cnpq.br; Coordination for the Improvement of Higher Education Personnel (CAPES) (JKTG), www.capes.gov.br; Program of Scientific Initiation: 30641, 34828 (MICB), 30288, and 34848 (GCZ), http://prope.unesp.br/pibic/; PROINTER PROPe/PROPG 03/2017, grant 1732 (EGOM), www.unesp.br/prope.	Al-Fattani MA, 2006, J MED MICROBIOL, V55, P999, DOI 10.1099/jmm.0.46569-0; Andrade MC, 2013, ARCH ORAL BIOL, V58, P200, DOI 10.1016/j.archoralbio.2012.10.011; Araujo NC, 2012, PHOTOMED LASER SURG, V30, P393, DOI 10.1089/pho.2011.3195; Arunraj TR, 2014, J BIOMED NANOTECHNOL, V10, P238, DOI 10.1166/jbn.2014.1786; Baltazar LM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120179; BENTRIVEDI A, 1990, AGR BIOL CHEM TOKYO, V54, P2961; Bhawana, 2011, J AGR FOOD CHEM, V59, P2056, DOI 10.1021/jf104402t; Cassone A, 2012, AIDS, V26, P1457, DOI 10.1097/QAD.0b013e3283536ba8; Castilho RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010503; Chereddy KK, 2013, J CONTROL RELEASE, V171, P208, DOI 10.1016/j.jconrel.2013.07.015; Cieplik F, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00405; Quishida CCC, 2016, LASER MED SCI, V31, P997, DOI 10.1007/s10103-016-1942-7; Couvreur P, 2002, CRIT REV THER DRUG, V19, P99, DOI 10.1615/CritRevTherDrugCarrierSyst.v19.i2.10; DAHL TA, 1989, ARCH MICROBIOL, V151, P183, DOI 10.1007/BF00414437; Dias KD, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1031-5; Ribeiro APD, 2015, LASER MED SCI, V30, P549, DOI 10.1007/s10103-013-1354-x; Ribeiro APD, 2013, LASER MED SCI, V28, P391, DOI 10.1007/s10103-012-1064-9; Dovigo LN, 2011, LASER SURG MED, V43, P927, DOI 10.1002/lsm.21110; Dovigo LN, 2011, PHOTOCHEM PHOTOBIOL, V87, P895, DOI 10.1111/j.1751-1097.2011.00937.x; Falsetta ML, 2014, INFECT IMMUN, V82, P1968, DOI 10.1128/IAI.00087-14; Farah S, 2016, ADV DRUG DELIVER REV, V107, P367, DOI 10.1016/j.addr.2016.06.012; Gaumet M, 2008, EUR J PHARM BIOPHARM, V69, P1, DOI 10.1016/j.ejpb.2007.08.001; Ghosh D, 2012, CHEM-BIOL INTERACT, V195, P206, DOI 10.1016/j.cbi.2011.12.004; Gunes H, 2016, TOXICOL IND HEALTH, V32, P246, DOI 10.1177/0748233713498458; Hamblin MR, 2016, CURR OPIN MICROBIOL, V33, P67, DOI 10.1016/j.mib.2016.06.008; Hamid R, 2004, TOXICOL IN VITRO, V18, P703, DOI 10.1016/j.tiv.2004.03.012; Hazzah HA, 2015, J PHARM SCI-US, V104, P3913, DOI 10.1002/jps.24590; Hegge AB, 2012, EUR J PHARM SCI, V47, P65, DOI 10.1016/j.ejps.2012.05.002; Hu P, 2013, ARCH ORAL BIOL, V58, P1343, DOI 10.1016/j.archoralbio.2013.05.004; Junqueira JC, 2012, LASER MED SCI, V27, P1205, DOI 10.1007/s10103-012-1050-2; Khalil NM, 2013, COLLOID SURFACE B, V101, P353, DOI 10.1016/j.colsurfb.2012.06.024; Kiesslich T, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/840417; Krausz AE, 2015, NANOMED-NANOTECHNOL, V11, P195, DOI 10.1016/j.nano.2014.09.004; Kumari A, 2010, COLLOID SURFACE B, V75, P1, DOI 10.1016/j.colsurfb.2009.09.001; Lemos JA, 2013, MICROBIOL-SGM, V159, P436, DOI 10.1099/mic.0.066134-0; Loo CY, 2016, J AGR FOOD CHEM, V64, P2513, DOI 10.1021/acs.jafc.5b04559; Maghsoudi A, 2017, MAT SCI ENG C-MATER, V75, P1259, DOI 10.1016/j.msec.2017.03.032; Martins CVB, 2009, J ANTIMICROB CHEMOTH, V63, P337, DOI 10.1093/jac/dkn488; Moghadamtousi SZ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/186864; Mohamed F, 2008, J PHARM SCI-US, V97, P71, DOI 10.1002/jps.21082; Mohanty C, 2010, BIOMATERIALS, V31, P6597, DOI 10.1016/j.biomaterials.2010.04.062; Mukerjee A, 2009, ANTICANCER RES, V29, P3867; Mun SH, 2014, MOLECULES, V19, P18283, DOI 10.3390/molecules191118283; Nakonieczna J, 2017, LASER MED SCI, V32, P1667, DOI 10.1007/s10103-016-2107-4; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Oud Lavi, 2016, J Clin Med Res, V8, P40, DOI 10.14740/jocmr2387w; Paschoal MA, 2013, PHOTODIAGN PHOTODYN, V10, P313, DOI 10.1016/j.pdpdt.2013.02.002; Pereira CA, 2011, LASER MED SCI, V26, P341, DOI 10.1007/s10103-010-0852-3; Ramalingam N, 2015, J BIOMED MATER RES A, V103, P16, DOI 10.1002/jbm.a.35138; Russotto V, 2015, INFECT DRUG RESIST, V8, P287, DOI 10.2147/IDR.S48810; SALTON MRJ, 1951, J GEN MICROBIOL, V5, P391, DOI 10.1099/00221287-5-2-391; Sardi JCO, 2013, J MED MICROBIOL, V62, P10, DOI 10.1099/jmm.0.045054-0; Sartori T, 2008, J CHROMATOGR SCI, V46, P505, DOI 10.1093/chromsci/46.6.505; Shah AA, 2014, APPL MICROBIOL BIOT, V98, P3437, DOI 10.1007/s00253-014-5558-1; Shaikh J, 2009, EUR J PHARM SCI, V37, P223, DOI 10.1016/j.ejps.2009.02.019; Song J, 2012, EUR J CLIN MICROBIOL, V31, P1347, DOI 10.1007/s10096-011-1448-y; Soukos NS, 2011, PERIODONTOL 2000, V55, P143, DOI 10.1111/j.1600-0757.2010.00346.x; Taraszkiewicz A, 2013, APPL ENVIRON MICROB, V79, P3692, DOI 10.1128/AEM.00748-13; Tortik N, 2016, PHOTOCH PHOTOBIO SCI, V15, P187, DOI 10.1039/c5pp00393h; Tortik N, 2014, PHOTOCH PHOTOBIO SCI, V13, P1402, DOI 10.1039/c4pp00123k; Tsai YM, 2011, INT J PHARMACEUT, V416, P331, DOI 10.1016/j.ijpharm.2011.06.030; Tyagi P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121313; Udompornmongkol P, 2015, J BIOMATER APPL, V30, P537, DOI 10.1177/0885328215594479; Vauthier C, 2009, PHARM RES-DORDR, V26, P1025, DOI 10.1007/s11095-008-9800-3; Vrignaud S, 2011, BIOMATERIALS, V32, P8593, DOI 10.1016/j.biomaterials.2011.07.057; Winter S, 2013, PHOTOCH PHOTOBIO SCI, V12, P1795, DOI 10.1039/c3pp50095k; Yallapu MM, 2010, J COLLOID INTERF SCI, V351, P19, DOI 10.1016/j.jcis.2010.05.022; Ye Y, 2014, INT J NANOMED, V9, P5157, DOI 10.2147/IJN.S71365; Zago CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123206; Zou WW, 2009, NANOSCALE RES LETT, V4, P982, DOI 10.1007/s11671-009-9345-3	70	61	63	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0i 87418	10.1371/journal.pone.0187418	http://dx.doi.org/10.1371/journal.pone.0187418			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29107978	Green Submitted, Green Published, gold			2022-12-26	WOS:000414424600028
J	Rose, J; Homa, L; Meropol, SB; Debanne, SM; Bielefeld, R; Hoyen, C; Singer, ME				Rose, Johnie; Homa, Laura; Meropol, Sharon B.; Debanne, Sara M.; Bielefeld, Roger; Hoyen, Claudia; Singer, Mendel E.			Health impact and cost-effectiveness of a domestically-produced rotavirus vaccine in India: A model based analysis	PLOS ONE			English	Article							CLINICAL SEVERITY; CHILDREN; DISEASE; INFECTION; EFFICACY; DIARRHEA; PROTECTION; GASTROENTERITIS; TRANSMISSION; MORTALITY	Background Currently, Indian officials are incorporating a domestically manufactured rotavirus vaccine (based on the 116E rotavirus strain) into the country's universal immunization program; this vaccine will cost significantly less than western rotavirus vaccines. Here, we examine the public health impact, cost, and cost-effectiveness of universal vaccination in India using the 116E vaccine. This work will allow comparison of universal 116E vaccination with other approaches to child mortality reduction, shed light on the future burden of rotavirus disease in India, and help stakeholders understand future resource needs. Methods Using information from published literature, we developed a dynamic simulation model of rotavirus transmission, natural history, and related utilization among Indian infants followed until age five. Infection risk depended on the degree of viral shedding in the population. Infection risk and severity were influenced by age, number of previous infections, and vaccination history. Probabilities of inpatient and outpatient health services utilization depended on symptom severity. With the model, we compared a strategy of nationwide 116E vaccination to one of no vaccination. Costs were considered from the perspective of all payers (including families) and from the societal perspective. Results We estimated that an established 116E vaccination program would reduce symptomatic rotavirus infection by 13.0%, while reducing population-wide rotavirus mortality by 34.6% (over 34,000 lives annually). Rotavirus outpatient visits would decline by 21.3%, and hospitalization would decline by 28.1%. The cost per disability-adjusted life year (DALY) averted was estimated at 3,429 Rupees (approximately $56). Predicted mortality reduction in children born during the first five years of vaccination implementation was nearly identical to that in children born in later years (34.4% versus 34.6%). Conclusions 116E vaccination of Indian infants would likely substantially reduce rotavirus-related morbidity, mortality, and utilization at a cost considered highly cost-effective by standard criteria. Nearly the entire mortality reduction benefit of vaccination was attributable to direct protection of those vaccinated, as opposed to indirect "herd immunity" effects.	[Rose, Johnie] Case Western Reserve Univ, Sch Med, Ctr Community Hlth Integrat, Cleveland, OH USA; [Rose, Johnie; Homa, Laura] Case Western Reserve Univ, Sch Med, Dept Family Med & Community Hlth, Cleveland, OH USA; [Meropol, Sharon B.; Hoyen, Claudia] Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA; [Meropol, Sharon B.; Hoyen, Claudia] Case Western Reserve Univ, Sch Med, Cleveland, OH USA; [Meropol, Sharon B.] Rainbow Babies & Childrens Hosp, Ctr Child Hlth & Policy, 2101 Adelbert Rd, Cleveland, OH 44106 USA; [Debanne, Sara M.; Singer, Mendel E.] Case Western Reserve Univ, Sch Med, Dept Populat & Quantitat Hlth Sci, Cleveland, OH USA; [Bielefeld, Roger] Case Western Reserve Univ, Res Comp, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Case Western Reserve University; Case Western Reserve University	Singer, ME (corresponding author), Case Western Reserve Univ, Sch Med, Dept Populat & Quantitat Hlth Sci, Cleveland, OH USA.	mendel@casa.edu	Singer, Mendel/S-8775-2019; /AHA-3700-2022; /AAB-7864-2021	/0000-0001-7458-9303; /0000-0001-7458-9303; Singer, Mendel/0000-0002-3331-3340	United States Agency for Healthcare Research and Quality Institutional Training Grant [T32-H5000059-19]	United States Agency for Healthcare Research and Quality Institutional Training Grant	JR received support while completing this work from a United States Agency for Healthcare Research and Quality Institutional Training Grant (T32-H5000059-19). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, WKLY EPIDEMIOL REC; [Anonymous], 2015, IND OUT ROT PRIV SEC; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Atherly D, 2009, J INFECT DIS, V200, pS28, DOI 10.1086/605033; Atherly DE, 2012, VACCINE, V30, pA7, DOI 10.1016/j.vaccine.2011.12.096; Bahl R, 2005, J INFECT DIS, V192, pS114, DOI 10.1086/431497; Banerjee I, 2006, J CLIN MICROBIOL, V44, P2468, DOI 10.1128/JCM.01882-05; BHAN MK, 1993, J INFECT DIS, V168, P282, DOI 10.1093/infdis/168.2.282; Bhandari N, 2014, LANCET, V383, P2136, DOI 10.1016/S0140-6736(13)62630-6; Bureau GoIPI, 2014, 3 NEW VACC INCL IND; de Blasio BF, 2010, VACCINE, V28, P7923, DOI 10.1016/j.vaccine.2010.09.070; Dennehy PH, 2012, CURR OPIN PEDIATR, V24, P76, DOI 10.1097/MOP.0b013e32834ee594; Dennehy PH, 2011, HUM VACCINES, V7, P563, DOI 10.4161/hv.7.5.15406; Dennehy PH, 2000, PEDIATR INFECT DIS J, V19, pS103, DOI 10.1097/00006454-200010001-00003; Dhawan A., 2015, 2015 HLTH CARE OUTLO; Edejer TT-T World Health Organization, 2003, MAKING CHOICES HLTH, Vxiii; Esposito DH, 2011, CLIN INFECT DIS, V52, P171, DOI 10.1093/cid/ciq094; Fischer TK, 2005, J INFECT DIS, V192, P1720, DOI 10.1086/497339; Gladstone BP, 2011, NEW ENGL J MED, V365, P337, DOI 10.1056/NEJMoa1006261; Glass RI, 2005, J INFECT DIS, V192, pS160, DOI 10.1086/431504; Glass RI, 2014, NEW ENGL J MED, V370, P568, DOI 10.1056/NEJMe1315836; John J, 2014, VACCINE, V32, pA5, DOI 10.1016/j.vaccine.2014.03.004; Kang G, 2004, J MED VIROL, V73, P118, DOI 10.1002/jmv.20053; Li RC, 2014, HUM VACC IMMUNOTHER, V10, P11, DOI 10.4161/hv.26319; Madsen LB, 2012, B WORLD HEALTH ORGAN, V90, P554, DOI 10.2471/BLT.11.094656; Megiddo I, 2014, VACCINE, V32, pA151, DOI 10.1016/j.vaccine.2014.04.080; Mendelsohn AS, 2008, TROP MED INT HEALTH, V13, P934, DOI 10.1111/j.1365-3156.2008.02094.x; Morris SK, 2012, B WORLD HEALTH ORGAN, V90, P720, DOI 10.2471/BLT.12.101873; Mukhopadhya I, 2013, J MED VIROL, V85, P1661, DOI 10.1002/jmv.23641; Panda S, 2014, VACCINE, V32, pA162, DOI 10.1016/j.vaccine.2014.03.037; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; PICKERING LK, 1988, J PEDIATR-US, V112, P361, DOI 10.1016/S0022-3476(88)80313-5; Pitzer VE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042320; Pitzer VE, 2009, SCIENCE, V325, P290, DOI 10.1126/science.1172330; Podewils LJ, 2005, J INFECT DIS, V192, pS133, DOI 10.1086/431513; Puliyel JM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7832; Rheingans R, 2014, VACCINE, V32, pA140, DOI 10.1016/j.vaccine.2014.05.073; Rheingans RD, 2007, REV PANAM SALUD PUBL, V21, P205, DOI 10.1590/S1020-49892007000300003; Richardson S, 1998, LANCET, V351, P1844, DOI 10.1016/S0140-6736(97)11257-0; Rose J, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3653; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; RUUSKA T, 1990, SCAND J INFECT DIS, V22, P259, DOI 10.3109/00365549009027046; Sen Gupta S, 2013, VACCINE, V31, pB43, DOI 10.1016/j.vaccine.2012.11.079; Soares-Weiser K, 2012, COCHRANE DB SYST REV, V2; United Nations Children's Fund (UNICEF), 2012, PNEUM DIARRH TACKL D; Velazquez FR, 1996, NEW ENGL J MED, V335, P1022, DOI 10.1056/NEJM199610033351404; Velazquez FR, 2000, J INFECT DIS, V182, P1602, DOI 10.1086/317619; White LJ, 2008, J R SOC INTERFACE, V5, P1481, DOI 10.1098/rsif.2008.0115; World Health Organization, 2014, WHO VACCINE PREVENTA; World Health Organization, 2014, WHO LIF LAB EST 2012; World Health Organization (WHO), 2002, MON INT; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6	52	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							e0187446	10.1371/journal.pone.0187446	http://dx.doi.org/10.1371/journal.pone.0187446			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6TA	29099848	gold, Green Published, Green Submitted			2022-12-26	WOS:000414377900021
J	Weinstein, B; Graham, CH; Parra, JL				Weinstein, Ben G.; Graham, Catherine H.; Luis Parra, Juan			The role of environment, dispersal and competition in explaining reduced cooccurrence among related species	PLOS ONE			English	Article							BIOTIC INTERACTIONS; DISTRIBUTION MODELS; PHYLOGENETIC RELATEDNESS; COMMUNITY STRUCTURE; HUMMINGBIRD FLIGHT; BETA DIVERSITY; DISTRIBUTIONS; ECOLOGY; NICHE; CLIMATE	The composition of ecological assemblages depends on a variety of factors including environmental filtering, biotic interactions and dispersal limitation. By evaluating the phylogenetic pattern of assemblages, we gain insight into the relative contribution of these mechanisms to generating observed assemblages. We address some limitations in the field of community phylogenetics by using simulations, biologically relevant null models, and cost distance analysis to evaluate simultaneous mechanisms leading to observed patterns of cooccurrence. Building from past studies of phylogenetic community structure, we applied our approach to hummingbird assemblages in the Northern Andes. We compared the relationship between relatedness and co-occurrence among predicted assemblages, based on estimates of suitable habitat and dispersal limitation, and observed assemblages. Hummingbird co-occurrence peaked at intermediate relatedness and decreased when a closely-related species was present. This result was most similar to simulations that included simultaneous effects of phylogenetic conservatism and repulsion. In addition, we found older sister taxa were only weakly more separated by geographic barriers, suggesting that time since dispersal is unlikely to be the sole factor influencing co-occurrence of closely related species. Our analysis highlights the role of multiple mechanisms acting simultaneously, and provides a hypothesis for the potential importance of competition at regional scales.	[Weinstein, Ben G.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Graham, Catherine H.] Swiss Fed Res Inst WSL, Zurich, Switzerland; [Luis Parra, Juan] Univ Antioquia, Inst Biol, Medellin, Colombia	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Universidad de Antioquia	Weinstein, B (corresponding author), SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA.	weinsteb@oregonstate.edu	Graham, Catherine/A-9560-2011	Graham, Catherine/0000-0001-9267-7948; Weinstein, Ben/0000-0002-2176-7935	National Science Foundation Division of Environmental Biology [1136705]; NSF Dimensions of Biodiversity [DEB 1136705]; NASA [NNX11A028G]; NSF Graduate Research Fellowship	National Science Foundation Division of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NSF Dimensions of Biodiversity(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NASA(National Aeronautics & Space Administration (NASA)); NSF Graduate Research Fellowship(National Science Foundation (NSF))	This work was supported by National Science Foundation Division of Environmental Biology (https://nsf.gov) 1136705 to CG. Research was supported by NSF Dimensions of Biodiversity (DEB 1136705) and NASA (NNX11A028G) grants to CHG and the NSF Graduate Research Fellowship to BGW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This manuscript was improved by feedback and T. Ives and D. Futuyma. W. Pearse and M. Helmus made PEZ code available, and H. Lynch advised in developing the Bayesian approach. We thank M. Lentino and the Phelps collection for provided localities for Venezuela and M. Lim, A. Shankar and B. Tinoco assisted in checking hummingbird localities. Research was supported by NSF Dimensions of Biodiversity (DEB 1136705) and NASA (NNX11A028G) grants to CHG and the NSF Graduate Research Fellowship to BGW. All code can be found on the github repo https://github.com/bw4sz/Pred_Obs, and the output can be viewed at http://bw4sz.github.io/Pred_Obs/. The authors declare no conflict of interests.	Maglianesi MA, 2014, ECOLOGY, V95, P3325, DOI 10.1890/13-2261.1; Algar AC, 2013, GLOBAL ECOL BIOGEOGR, V22, P391, DOI 10.1111/geb.12003; Altshuler DL, 2002, J EXP BIOL, V205, P2325; Altshuler DL, 2004, P NATL ACAD SCI USA, V101, P17731, DOI 10.1073/pnas.0405260101; American Ornithologists Union, 1998, CHECK LIST N AM BIRD, V7th; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Barnagaud JY, 2014, ECOL LETT, V17, P811, DOI 10.1111/ele.12285; Benham PM, 2015, J BIOGEOGR, V42, P763, DOI 10.1111/jbi.12452; Bleiweiss R, 1998, BIOL J LINN SOC, V65, P77, DOI 10.1111/j.1095-8312.1998.tb00352.x; Borregaard MK, 2017, BIOL REV, V92, P830, DOI 10.1111/brv.12256; Cadena CD, 2007, ECOGRAPHY, V30, P491, DOI 10.1111/j.2007.0906-7590.05045.x; Carstensen DW, 2013, ECOGRAPHY, V36, P1310, DOI 10.1111/j.1600-0587.2013.00329.x; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Dalsgaard B, 2013, ECOGRAPHY, V36, P1331, DOI 10.1111/j.1600-0587.2013.00201.x; Dalsgaard B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025891; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Emerson BC, 2008, TRENDS ECOL EVOL, V23, P619, DOI 10.1016/j.tree.2008.07.005; FEINSINGER P, 1978, AM ZOOL, V18, P779; FEINSINGER P, 1976, ECOL MONOGR, V46, P257, DOI 10.2307/1942255; Feldman RE, 2014, J BIOGEOGR, V41, P489, DOI 10.1111/jbi.12226; GAUSE G. F., 1934, SCIENCE, V79, P16, DOI 10.1126/science.79.2036.16-a; Georges D, 2012, R CRAN PROJ, V1, P1; Godoy O, 2014, ECOL LETT, V17, P836, DOI 10.1111/ele.12289; Gonzalez AMM, 2015, GLOBAL ECOL BIOGEOGR, V24, P1212, DOI 10.1111/geb.12355; Graham CH, 2008, ECOL LETT, V11, P1265, DOI 10.1111/j.1461-0248.2008.01256.x; Graham CH, 2012, ECOLOGY, V93, pS99, DOI 10.1890/11-0493.1; Graham CH, 2010, J BIOGEOGR, V37, P1863, DOI 10.1111/j.1365-2699.2010.02356.x; Graham CH, 2009, P NATL ACAD SCI USA, V106, P19673, DOI 10.1073/pnas.0901649106; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Gutierrez EE, 2014, ECOGRAPHY, V37, P741, DOI 10.1111/ecog.00620; Helmus MR, 2007, ECOL LETT, V10, P917, DOI 10.1111/j.1461-0248.2007.01083.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ., 2012, INTRO RASTER PACKAG, P1; Ives AR, 2011, ECOL MONOGR, V81, P511, DOI 10.1890/10-1264.1; Jankowski JE, 2012, EXPLORING ROLE PHYSL, P1, DOI [10.1111/j.1600-0587.2012.07785.x, DOI 10.1111/J.1600-0587.2012.07785.X]; Jankowski JE, 2010, ECOLOGY, V91, P1877, DOI 10.1890/09-2063.1; KEDDY PA, 1992, J VEG SCI, V3, P157, DOI 10.2307/3235676; Kraft NJB, 2015, FUNCT ECOL, V29, P592, DOI 10.1111/1365-2435.12345; Laube I, 2012, GLOBAL ECOL BIOGEOGR, V22; Laube I, 2013, GLOBAL ECOL BIOGEOGR, V22, P223, DOI 10.1111/j.1466-8238.2012.00796.x; Lessard JP, 2016, AM NAT, V187, P75, DOI 10.1086/684128; LEVIN SA, 1970, AM NAT, V104, P413, DOI 10.1086/282676; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Londono GA, 2015, FUNCT ECOL, V29, P338, DOI 10.1111/1365-2435.12348; Losos JB, 2003, TRENDS ECOL EVOL, V18, P220, DOI 10.1016/S0169-5347(03)00037-5; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; MACARTHUR RH, 1958, ECOLOGY, V39, P599, DOI 10.2307/1931600; Mateo RG, 2010, J VEG SCI, V21, P908, DOI 10.1111/j.1654-1103.2010.01198.x; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; McGuire JA, 2007, SYST BIOL, V56, P837, DOI 10.1080/10635150701656360; McGuire JA, 2014, CURR BIOL, V24, P910, DOI 10.1016/j.cub.2014.03.016; Nogues-Bravo D, 2009, GLOBAL ECOL BIOGEOGR, V18, P521, DOI 10.1111/j.1466-8238.2009.00476.x; Gomez JP, 2010, J ANIM ECOL, V79, P1181, DOI 10.1111/j.1365-2656.2010.01725.x; Parra JL, 2012, ECOGRAPHY COP, V27, P350; Parra JL, 2011, CONTRASTING PATTERNS, P2350, DOI [10.1111/j.1365-2699.2011.02558.x, DOI 10.1111/J.1365-2699.2011.02558.X]; Parra JL, 2010, AM NAT, V176, P573, DOI 10.1086/656619; Pearse WD, 2015, BIOINFORMATICS, V31, P2888, DOI 10.1093/bioinformatics/btv277; Pearson RG, 2004, ECOGRAPHY, V27, P285, DOI 10.1111/j.0906-7590.2004.03740.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pigot AL, 2013, ECOL LETT, V16, P330, DOI 10.1111/ele.12043; Pigota L, 2014, P R SOC B, V282; Projecto-Garcia J, 2013, P NATL ACAD SCI USA, V110, P20669, DOI 10.1073/pnas.1315456110; Stiles FG, 2008, ORNITOL NEOTROP, V19, P511; Stiles FG, 2004, ORNITOL NEOTROP, V15, P191; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; TERBORGH J, 1975, ECOLOGY, V56, P562, DOI 10.2307/1935491; Tinoco BA, 2009, BIRD CONSERV INT, V19, P63, DOI 10.1017/S0959270908007703; Van Etten J, 2011, R PACKAGE GDISTANCE; Velasquez-Tibata J, 2013, REG ENVIRON CHANGE, V13, P235, DOI 10.1007/s10113-012-0329-y; Vizentin-Bugoni J, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2397; Warren DL, 2014, TRENDS ECOL EVOL, V29, P572, DOI 10.1016/j.tree.2014.08.003; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Weinstein BG, 2014, AM NAT, V184, P211, DOI 10.1086/676991; Wiens JJ, 2011, PHILOS T R SOC B, V366, P2336, DOI 10.1098/rstb.2011.0059; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x; Yackulic CB, 2013, METHODS ECOL EVOL, V4, P236, DOI 10.1111/2041-210x.12004	77	9	9	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							e0185493	10.1371/journal.pone.0185493	http://dx.doi.org/10.1371/journal.pone.0185493			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6TA	29099852	Green Published, gold			2022-12-26	WOS:000414377900004
J	Hinzpeter, R; Wagner, MW; Wurnig, MC; Seifert, B; Manka, R; Alkadhi, H				Hinzpeter, Ricarda; Wagner, Matthias W.; Wurnig, Moritz C.; Seifert, Burkhardt; Manka, Robert; Alkadhi, Hatem			Texture analysis of acute myocardial infarction with CT: First experience study	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; FEATURES; CANCER	Objective To investigate the feasibility and accuracy of texture analysis to distinguish through objective and quantitative image information between healthy and infarcted myocardium with computed tomography (CT). Materials and methods Twenty patients (5 females; mean age 56 +/- 10years) with proven acute myocardial infarction (Ml) and 20 patients (8 females; mean age 42 +/- 15years) with no cardiac abnormalities (hereafter termed controls) underwent contrast-enhanced cardiac CT. Short axis CT images of the left ventricle (LV) were reconstructed at the slice thicknesses 1 mm, 2mm, and 5mm. Two independent, blinded readers segmented the LV in controls and patients. Texture analysis was performed yielding first-level features based on the histogram (variance, skewness, kurtosis, entropy), second-level features based on the gray-level co-occurrence matrix (GLCM) (contrast, correlation, energy and homogeneity), and third-level features based on the gray-level run-length matrix (GLRLM). Results Inter-and intrareader agreement was good to excellent for all histogram (intraclass correlation coefficient (ICC):0.70-0.93) and for all GLCM features (ICC:0.66-0.99), and was variable for the GLRLM features (ICC:-0.12-0.99). Univariate analysis showed significant differences between patients and controls for 2/4 histogram features, 3/4 GLCM and for 6/11 GLRLM features and all assessed slice thicknesses (all,p<0.05). In a multivariate logistic regression model, the single best variable from each level, determined by ROC analysis, was included stepwise. The best model included kurtosis (OR 0.08, 95%CI:0.01-0.65,P = 0.018) and short run high gray-level emphasis (SRHGE, OR 0.97, 95%CI:0.94-0.99,P = 0.007), with an area-under-the-curve (AUC) of 0.90 (95%CI:0.80-0.99). The best results for kurtosis and SRHGE (AUC = 0.78) were obtained at a 5mm slice thickness. A cut-off value of 14.4 for kurtosis+0.013*SRHGE predicted acute Ml with a sensitivity of 95% (specificity 55%). Conclusion Our study illustrates the feasibility of texture analysis for distinguishing healthy from acutely infarcted myocardium with cardiac CT using objective, quantitative features, with most reproducible and accurate results at a short axis slice thickness of 5mm.	[Hinzpeter, Ricarda; Wagner, Matthias W.; Wurnig, Moritz C.; Manka, Robert; Alkadhi, Hatem] Univ Zurich, Univ Zurich Hosp, Inst Diagnost & Intervent Radiol, Zurich, Switzerland; [Seifert, Burkhardt] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland; [Manka, Robert] Univ Zurich, Univ Heart Ctr Zurich, Dept Cardiol, Zurich, Switzerland; [Manka, Robert] Univ Zurich, Inst Biomed Engn, Zurich, Switzerland; [Manka, Robert] Swiss Fed Inst Technol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Alkadhi, H (corresponding author), Univ Zurich, Univ Zurich Hosp, Inst Diagnost & Intervent Radiol, Zurich, Switzerland.	hatem.alkadhi@usz.ch		Seifert, Burkhardt/0000-0002-5829-2478; Wurnig, Moritz/0000-0001-7865-4010				ADAMS DF, 1976, AM J ROENTGENOL, V126, P786, DOI 10.2214/ajr.126.4.786; Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Antunes S, 2016, 2016 IEEE 38 ANN INT; Bayanati H, 2015, EUR RADIOL, V25, P480, DOI 10.1007/s00330-014-3420-6; Becker AS, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3669; CHU A, 1990, PATTERN RECOGN LETT, V11, P415, DOI 10.1016/0167-8655(90)90112-F; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Collewet G, 2004, MAGN RESON IMAGING, V22, P81, DOI 10.1016/j.mri.2003.09.001; DASARATHY BV, 1991, PATTERN RECOGN LETT, V12, P497, DOI 10.1016/0167-8655(91)80014-2; Sanchez-Gracian CD, 2016, EUR RADIOL, V26, P3199, DOI 10.1007/s00330-015-4128-y; Dennie C, 2016, QUANT IMAG MED SURG, V6, P6, DOI 10.3978/j.issn.2223-4292.2016.02.01; Galloway M., 1975, COMPUTER GRAPHICS IM, V4, P172, DOI DOI 10.1016/S0146-664X(75)80008-6; Goetti R, 2011, EUR RADIOL, V21, P2091, DOI 10.1007/s00330-011-2149-8; GRAY WR, 1978, CIRCULATION, V58, P497, DOI 10.1161/01.CIR.58.3.497; Guggenbuhl P, 2008, EUR J RADIOL, V67, P514, DOI 10.1016/j.ejrad.2007.08.003; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hodgdon T, 2015, RADIOLOGY, V276, P787, DOI 10.1148/radiol.2015142215; Jin KN, 2016, EUR J RADIOL, V85, P1914, DOI 10.1016/j.ejrad.2016.06.023; Kim H, 2016, INVEST RADIOL, V51, P569, DOI 10.1097/RLI.0000000000000267; Lee H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160188; MacKay JW, 2016, J MAGN RESON IMAGING, V43, P1159, DOI 10.1002/jmri.25088; Mayerhoefer ME, 2009, INVEST RADIOL, V44, P405, DOI 10.1097/RLI.0b013e3181a50a66; Meinel FG, 2014, RADIOLOGY, V270, P708, DOI 10.1148/radiol.13131183; Mendoza DD, 2010, J CARDIOVASC COMPUT, V4, P83, DOI 10.1016/j.jcct.2010.01.019; Mougiakakou SG, 2007, ARTIF INTELL MED, V41, P25, DOI 10.1016/j.artmed.2007.05.002; Ng F, 2013, RADIOLOGY, V266, P177, DOI 10.1148/radiol.12120254; Savio SJ, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-60; TAMURA H, 1978, IEEE T SYST MAN CYB, V8, P460, DOI 10.1109/TSMC.1978.4309999; TERPOGOSSIAN MM, 1976, AM J ROENTGENOL, V127, P79, DOI 10.2214/ajr.127.1.79; Thornhill RE., 2014, J CARDIOVASC MAGN R, V16, DOI [10.1186/1532-429X-16-S1-P351, DOI 10.1186/1532-429X-16-S1-P351]; Vallieres M, 2015, PHYS MED BIOL, V60, P5471, DOI 10.1088/0031-9155/60/14/5471; von Ballmoos MW, 2011, ANN INTERN MED, V154, P413, DOI 10.7326/0003-4819-154-6-201103150-00007; Wei X., 2007, GRAY LEVEL RUN LENGT; Wibmer A, 2015, EUR RADIOL, V25, P2840, DOI 10.1007/s00330-015-3701-8; Xu D-H, 2004, HEART, V27, P25; Yang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134194	36	27	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186876	10.1371/journal.pone.0186876	http://dx.doi.org/10.1371/journal.pone.0186876			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095833	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000414340200027
J	Maski, K; Steinhart, E; Holbrook, H; Katz, ES; Kapur, K; Stickgold, R				Maski, Kiran; Steinhart, Erin; Holbrook, Hannah; Katz, Eliot S.; Kapur, Kush; Stickgold, Robert			Impaired memory consolidation in children with obstructive sleep disordered breathing	PLOS ONE			English	Article							DECLARATIVE MEMORY; PRESCHOOL-CHILDREN; TUCSON CHILDRENS; APNEA; PERFORMANCE; SPINDLE; RELIABILITY; CHILDHOOD; MORBIDITY; VALIDITY	Memory consolidation is stabilized and even enhanced by sleep (and particularly by 12-15 Hz sleep spindles in NREM stage 2 sleep) in healthy children but it is unclear what happens to these processes when sleep is disturbed by obstructive sleep disordered breathing. This cross-sectional study investigates differences in declarative memory consolidation among children with primary snoring (PS) and obstructive sleep apnea (OSA) compared to controls. We further investigate whether memory consolidation group differences are associated with NREM stage 2 (N2) sigma (12-15 Hz) or NREM slow oscillation (0.5-1 Hz) spectral power bands. In this study, we trained and tested participants on a spatial declarative memory task with cued recall. Retest occurred after a period of daytime wake (Wake) or a night of sleep (Sleep) with in-lab polysomnography. 36 participants ages 5-9 years completed the protocol: 14 with OSA as defined by respiratory disturbance index (RDI) >1/hour, 12 with primary snoring (PS) and 10 controls. OSA participants had poorer overall memory consolidation than controls across Wake and Sleep conditions [OSA: mean =-18.7% (5.8), controls: mean = 1.9% (7.2), t =-2.20, P = 0.04]. In contrast, PS participants and controls had comparable memory consolidation across conditions (t = 0.41; P = 0.38). We did not detect a main effect for condition (Sleep, Wake) or group x condition interaction on memory consolidation. OSA participants had lower N2 sigma power than PS (P = 0.03) and controls (P = 0.004) and N2 sigma power inversely correlated with percentage of time snoring on the study night (r =-0.33, P<0.05). Across all participants, N2 sigma power modestly correlated with memory consolidation in both Sleep (r = 0.37, P = 0.03) and Wake conditions (r = 0.44, P = 0.009). Further observed variable path analysis showed that N2 sigma power mediated the relationship between group and mean memory consolidation across Sleep and Wake states [B-indirect = 6.76(3.5), z = 2.03, P = 0.04]. NREM slow oscillation power did not correlate with memory consolidation. All results retained significance after controlling for age and BMI. In sum, participants with mild OSA had impaired memory consolidation and results were mediated by N2 sigma power. These results suggest that N2 sigma power could serve as biomarker of risk for cognitive dysfunction in children with sleep disordered breathing.	[Maski, Kiran; Steinhart, Erin; Kapur, Kush] Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Holbrook, Hannah] Univ Vermont, Dept Psychol, Burlington, VT 05405 USA; [Katz, Eliot S.] Boston Childrens Hosp, Div Resp Dis, Boston, MA USA; [Stickgold, Robert] Beth Israel Deaconess Med Ctr, Dept Psychiat, Boston, MA 02215 USA; [Stickgold, Robert] Harvard Med Sch, Dept Psychiat, Boston, MA USA	Harvard University; Boston Children's Hospital; University of Vermont; Harvard University; Boston Children's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Maski, K (corresponding author), Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA.	Kiran.maski@childrens.harvard.edu	Kapur, Kush/AAQ-3437-2020	Kapur, Kush/0000-0001-9022-913X	American Sleep Medicine Foundation Physician Scientist Training Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048832] Funding Source: NIH RePORTER	American Sleep Medicine Foundation Physician Scientist Training Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by the American Sleep Medicine Foundation Physician Scientist Training Award to Kiran Maski.	Achenbach TM, 2001, J CONSULT CLIN PSYCH, V69, P699, DOI 10.1037/0022-006X.69.4.699; [Anonymous], 2014, INT CLASSIFICATION S; Beebe DW, 2006, SLEEP, V29, P1115, DOI 10.1093/sleep/29.9.1115; Beebe DW, 2010, SLEEP, V33, P1447, DOI 10.1093/sleep/33.11.1447; Beebe DW, 2003, SLEEP, V26, P298, DOI 10.1093/sleep/26.3.298; Biggs SN, 2011, SLEEP MED, V12, P887, DOI 10.1016/j.sleep.2011.07.003; Blunden S, 2000, J CLIN EXP NEUROPSYC, V22, P554, DOI 10.1076/1380-3395(200010)22:5;1-9;FT554; Bourke R, 2011, SLEEP MED, V12, P489, DOI 10.1016/j.sleep.2010.11.010; Bourke RS, 2011, SLEEP MED, V12, P222, DOI 10.1016/j.sleep.2010.08.011; Brockmann PE, 2012, SLEEP BREATH, V16, P23, DOI 10.1007/s11325-011-0480-6; Calhoun SL, 2009, J CLIN SLEEP MED, V5, P228; Chervin RD, 2000, SLEEP MED, V1, P21, DOI 10.1016/S1389-9457(99)00009-X; Conners CK, 1998, J ABNORM CHILD PSYCH, V26, P257, DOI 10.1023/A:1022602400621; Diekelmann S, 2009, SLEEP MED REV, V13, P309, DOI 10.1016/j.smrv.2008.08.002; Djonlagic I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034106; Gais S, 2002, J NEUROSCI, V22, P6830; Goodwin JL, 2003, SLEEP, V26, P587, DOI 10.1093/sleep/26.5.587; Halbower AC, 2006, PLOS MED, V3, P1391, DOI 10.1371/journal.pmed.0030301; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hoedlmoser K, 2014, SLEEP, V37, P1501, DOI 10.5665/sleep.4000; Holz J, 2012, J SLEEP RES, V21, P612, DOI 10.1111/j.1365-2869.2012.01017.x; Iber C., 2007, AASM MANUAL SCORING; Jackman AR, 2012, SLEEP MED, V13, P621, DOI 10.1016/j.sleep.2012.01.013; Kheirandish-Gozal L, 2010, EUR RESPIR J, V36, P164, DOI 10.1183/09031936.00114209; Kurdziel L, 2013, P NATL ACAD SCI USA, V110, P17267, DOI 10.1073/pnas.1306418110; Liang J, 2014, INT J OBESITY, V38, P494, DOI 10.1038/ijo.2013.142; Marcus CL, 2012, PEDIATRICS, V130, P576, DOI 10.1542/peds.2012-1671; Marshall L, 2003, NEUROSCIENCE, V121, P1047, DOI 10.1016/S0306-4522(03)00458-5; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Maski K, 2015, SLEEP DEPENDENT MEMO; Moreira GA, 2005, PEDIATR PULM, V40, P300, DOI 10.1002/ppul.20219; Philby MF, 2017, SCI REP-UK, V7, DOI 10.1038/srep44566; Prehn-Kristensen A, 2011, SLEEP MED, V12, P672, DOI 10.1016/j.sleep.2010.10.010; Rosen CL, 2004, PEDIATRICS, V114, P1640, DOI 10.1542/peds.2004-0103; Schabus M, 2004, SLEEP, V27, P1479, DOI 10.1093/sleep/27.7.1479; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Venker CC, 2007, SLEEP BREATH, V11, P217, DOI 10.1007/s11325-007-0103-4; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Wilhelm I, 2012, NEUROSCI BIOBEHAV R, V36, P1718, DOI 10.1016/j.neubiorev.2012.03.002; Wilhelm I, 2008, LEARN MEMORY, V15, P373, DOI 10.1101/lm.803708	41	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186915	10.1371/journal.pone.0186915	http://dx.doi.org/10.1371/journal.pone.0186915			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095855	Green Published, gold, Green Submitted			2022-12-26	WOS:000414340200030
J	Zabielski, P; Achnio-Zabielska, AUBO; Wojcik, B; Chabowski, A; Gorski, J				Zabielski, Piotr; Achnio-Zabielska, Agnieszka Urszula B. O.; Wojcik, Beata; Chabowski, Adrian; Gorski, Jan			Effect of plasma free fatty acid supply on the rate of ceramide synthesis in different muscle types in the rat	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; SPHINGOLIPID METABOLISM; INSULIN SENSITIVITY; VENTILATORY MUSCLES; EXERCISE; HEART; DIAPHRAGM; ENDURANCE; HUMANS; RESISTANCE	Ceramide is a key compound in sphingolipid metabolism. Dynamics of ceramide synthesis is important in the several biological processes, such as induction of apoptosis or insulin resistance. So far, its de novo synthesis rate was evaluated indirectly, based on the content of the compound, its intermediates and the activity of respective enzymes. The aim of the present study was to directly measure ceramide synthesis rate (FSR) in different muscle types under varied plasma FFA supply in rat with the use of [U-C-13] palmitate tracer and LC/MS/MS. The experiments were carried out on male Wistar rats, divided into three groups: 1-control, 2-with elevated plasma free fatty acid (FFA) concentration by means of intralipid and heparin, 3-with reduced plasma FFA concentration by means of nicotinic acid. The stable plasma FFA concentration and plasma [U-C-13] palmitate enrichment was maintained for two hours by simultaneous infusion of the tracer and the respective compounds. At the end of the experiment, samples of blood from the abdominal aorta, the heart, diaphragm, soleus and white section of the gastrocnemius were taken. Muscle sphinganine, sphingosine and ceramide content and enrichment and plasma palmitate enrichment was measured with the use of LC/MS/MS. Plasma FFA concentration and composition was measured by means of gas-liquid chromatography. Under basal conditions ceramide FSR in the heart and the diaphragm was higher than in the soleus and the white gastrocnemius. Elevation in the plasma FFA concentration increased the FSR and ceramide content in each muscle, which correlated with increased HOMA-IR. The highest FSR was noted in the heart. Reduction in the plasma FFA concentration decreased ceramide FSR in each muscle type, which was accompanied by marked reduction in HOMA-IR. It is concluded that ceramide FSR depends on both the muscle type and the plasma FFA supply and is correlated with whole body insulin sensitivity under varying plasma FFA supply.	[Zabielski, Piotr; Achnio-Zabielska, Agnieszka Urszula B. O.; Wojcik, Beata; Chabowski, Adrian; Gorski, Jan] Med Univ Bialystok, Dept Physiol, Bialystok, Poland; [Zabielski, Piotr] Med Univ Bialystok, Dept Med Biol, Bialystok, Poland; [Achnio-Zabielska, Agnieszka Urszula B. O.] Med Univ Bialystok, Dept Hyg Epidemiol & Metab Disorders, Bialystok, Poland; [Gorski, Jan] Lomza State Univ Appl Sci, Med Inst, Lomza, Poland	Medical University of Bialystok; Medical University of Bialystok; Medical University of Bialystok	Zabielski, P (corresponding author), Med Univ Bialystok, Dept Physiol, Bialystok, Poland.; Zabielski, P (corresponding author), Med Univ Bialystok, Dept Med Biol, Bialystok, Poland.	piotr.zabielski@umb.edu.pl	Wójcik, Beata/T-8994-2018; Górski, Jan/T-4828-2018; Blachnio-Zabielsk, Agnieszka U/A-4879-2018; Chabowski, Adrian/T-2225-2018	Wójcik, Beata/0000-0002-9373-9810; Górski, Jan/0000-0001-9886-5069; Blachnio-Zabielsk, Agnieszka U/0000-0002-8055-0576; Chabowski, Adrian/0000-0002-7407-8156	Medical University of Bialystok [N/ST/ZB/16/008/1118, N/ST/ZB/17/002/1118]	Medical University of Bialystok	This work was supported by the Medical University of Bialystok, grant numbers: N/ST/ZB/16/008/1118 and N/ST/ZB/17/002/1118.	Adams JM, 2004, DIABETES, V53, P25, DOI 10.2337/diabetes.53.1.25; ARIANO MA, 1973, J HISTOCHEM CYTOCHEM, V21, P51, DOI 10.1177/21.1.51; Badin PM, 2013, TRENDS ENDOCRIN MET, V24, P607, DOI 10.1016/j.tem.2013.08.001; Bajaj M, 2002, AM J PHYSIOL-ENDOC M, V283, pE346, DOI 10.1152/ajpendo.00329.2001; Baranowski M, 2008, ACTA PHYSIOL, V192, P519, DOI 10.1111/j.1748-1716.2007.01755.x; Baranowski M, 2007, J PHYSIOL PHARMACOL, V58, P57; Baranowski M, 2011, ADV EXP MED BIOL, V721, P41, DOI 10.1007/978-1-4614-0650-1_3; Blachnio-Zabielska A, 2010, HORM METAB RES, V42, P1, DOI 10.1055/s-0029-1238322; Blachnio-Zabielska A, 2010, J CELL PHYSIOL, V225, P786, DOI 10.1002/jcp.22283; Blachnio-Zabielska AU, 2016, CELL PHYSIOL BIOCHEM, V40, P1207, DOI 10.1159/000453174; Blachnio-Zabielska AU, 2013, J LIPID RES, V54, P1705, DOI 10.1194/jlr.D035006; Bonen A, 2007, PHYSIOLOGY, V22, P15, DOI 10.1152/physiologyonline.2007.22.1.15; Cacho J, 2008, AM J PHYSIOL-ENDOC M, V295, pE1269, DOI 10.1152/ajpendo.90207.2008; Carpinteiro A, 2008, CANCER LETT, V264, P1, DOI 10.1016/j.canlet.2008.02.020; Chaurasia B, 2015, TRENDS ENDOCRIN MET, V26, P538, DOI 10.1016/j.tem.2015.07.006; Chung JO, 2017, DIABETES, V66, P2082, DOI 10.2337/db17-0082; Davitt PM, 2013, J APPL PHYSIOL, V114, P1743, DOI 10.1152/japplphysiol.00095.2013; Dobrzyn A, 2002, AM J PHYSIOL-ENDOC M, V282, pE277, DOI 10.1152/ajpendo.00151.2001; Donati C, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00338; Empinado HM, 2014, EUR J HEART FAIL, V16, P519, DOI 10.1002/ejhf.73; Frangioudakis G, 2013, DIABETOLOGIA, V56, P2697, DOI 10.1007/s00125-013-3035-5; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; GOSSELIN LE, 1992, J APPL PHYSIOL, V72, P1506, DOI 10.1152/jappl.1992.72.4.1506; GREEN HJ, 1989, J APPL PHYSIOL, V66, P1914, DOI 10.1152/jappl.1989.66.4.1914; Guo ZK, 1997, J LIPID RES, V38, P1888; Hagman DK, 2008, DIABETES, V57, P424, DOI 10.2337/db07-1285; Holmes AG, 2004, J APPL PHYSIOL, V97, P689, DOI 10.1152/japplphysiol.00195.2004; Hu W, 2009, J LIPID RES, V50, P1852, DOI 10.1194/jlr.M800635-JLR200; Kabir MM, 2010, PHYSIOL BEHAV, V101, P22, DOI 10.1016/j.physbeh.2010.04.004; KEENS TG, 1978, J APPL PHYSIOL, V44, P905, DOI 10.1152/jappl.1978.44.6.905; Kelley RC, 2016, HEART FAIL REV; Knapp M, 2011, J PHYSIOL PHARMACOL, V62, P601; Korthuis RJ., 2011, INTEGRATED SYSTEMS P; LEE HB, 1985, J NUCL MED, V26, P72; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Lipina C, 2011, DIABETOLOGIA, V54, P1596, DOI 10.1007/s00125-011-2127-3; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Miklosz A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085547; MOORE RL, 1982, PFLUG ARCH EUR J PHY, V392, P268, DOI 10.1007/BF00584308; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Nawrocki A, 2004, HORM METAB RES, V36, P601, DOI 10.1055/s-2004-825922; Nikolova-Karakashian MN, 2011, ANTIOXID REDOX SIGN, V15, P2501, DOI 10.1089/ars.2011.3940; Nikolova-Karakashian MN, 2010, ADV EXP MED BIOL, V688, P86; Oh YT, 2014, ENDOCRINOLOGY, V155, P923, DOI 10.1210/en.2013-1700; Park TS, 2012, HEART FAIL CLIN, V8, P633, DOI 10.1016/j.hfc.2012.06.003; Persson XMT, 2010, J LIPID RES, V51, P2761, DOI 10.1194/jlr.M008011; Pilegaard H, 2006, DIABETES, V55, P3020, DOI 10.2337/db06-0152; Riboni L, 1997, PROG LIPID RES, V36, P153, DOI 10.1016/S0163-7827(97)00008-8; Russo S B, 2013, Handb Exp Pharmacol, P373, DOI 10.1007/978-3-7091-1511-4_19; Rutherford C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.455; Schmitz-Peiffer C, 1999, J BIOL CHEM, V274, P24202, DOI 10.1074/jbc.274.34.24202; Serikawa T, 2009, EXP ANIM TOKYO, V58, P333, DOI 10.1538/expanim.58.333; Serlie MJ, 2007, J CLIN ENDOCR METAB, V92, P1524, DOI 10.1210/jc.2006-2347; Straczkowski M, 2004, DIABETES, V53, P1215, DOI 10.2337/diabetes.53.5.1215; SULLIVAN TE, 1978, J APPL PHYSIOL, V44, P358, DOI 10.1152/jappl.1978.44.3.358; TAMAKI N, 1987, EUR J APPL PHYSIOL, V56, P127, DOI 10.1007/BF00640634; Wojcik B, 2015, J PHYSIOL PHARMACOL, V66, P385; Zabielski P, 2017, J ENDOCRINOL, V233, P329, DOI 10.1530/JOE-16-0381; Zhang XJ, 2012, J LIPID RES, V53, P119, DOI 10.1194/jlr.M019901	59	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187136	10.1371/journal.pone.0187136	http://dx.doi.org/10.1371/journal.pone.0187136			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095868	Green Submitted, Green Published, gold			2022-12-26	WOS:000414340200048
J	Fawzy, MS; Toraih, EA; Ibrahiem, A; Abdeldayem, H; Mohamed, AO; Abdel-Daim, MM				Fawzy, Manal S.; Toraih, Eman A.; Ibrahiem, Afaf; Abdeldayem, Hala; Mohamed, Amany O.; Abdel-Daim, Mohamed M.			Evaluation of miRNA-196a2 and apoptosis-related target genes: ANX41, DFFA and PDCD4 expression in gastrointestinal cancer patients: A pilot study	PLOS ONE			English	Article							CASPASE-ACTIVATED DNASE; ANNEXIN A1; DOWN-REGULATION; CIRCULATING MICRORNAS; COLORECTAL-CANCER; DECREASED EXPRESSION; BREAST-CANCER; UP-REGULATION; ESOPHAGEAL; CARCINOMA	Previous reports have suggested the significant association of miRNAs aberrant expression with tumor initiation, progression and metastasis in cancer, including gastrointestinal (GI) cancers. The current preliminary study aimed to evaluate the relative expression levels of miR-196a2 and three of its selected apoptosis-related targets; ANXA1, DFFA and PDCD4 in a sample of GI cancer patients. Quantitative real-time PCR for miR-196a2 and its selected mRNA targets, as well as immunohistochemical assay for annexin Al protein expression were detected in 58 tissues with different GI cancer samples. In addition, correlation with the clinicopathological features and in silico network analysis of the selected molecular markers were analyzed. Stratified analyses by cancer site revealed elevated levels of miR-196a2 and low expression of the selected target genes. Annexin protein expression was positively correlated with its gene expression profile. In colorectal cancer, miR-196a over-expression was negatively correlated with annexin Al protein expression (r =-0.738, p < 0.001), and both were indicators of unfavorable prognosis in terms of poor differentiation, larger tumor size, and advanced clinical stage. Taken together, aberrant expression of miR-196a2 and the selected apoptosis-related biomarkers might be involved in GI cancer development and progression and could have potential diagnostic and prognostic roles in these types of cancer; particularly colorectal cancer, provided the results experimentally validated and confirmed in larger multi-center studies.	[Fawzy, Manal S.] Suez Canal Univ, Dept Med Biochem, Fac Med, Ismailia, Egypt; [Fawzy, Manal S.] Northern Border Univ, Dept Biochem, Fac Med, Ar Ar, Saudi Arabia; [Toraih, Eman A.] Suez Canal Univ, Dept Histol & Cell Biol, Genet Unit, Fac Med, Ismailia, Egypt; [Ibrahiem, Afaf] Mansoura Univ, Dept Pathol, Fac Med, Mansoura, Egypt; [Abdeldayem, Hala] Suez Canal Univ, Dept Pathol, Fac Med, Ismailia, Egypt; [Mohamed, Amany O.] Assiut Univ, Dept Med Biochem, Fac Med, Assiut, Egypt; [Abdel-Daim, Mohamed M.] Suez Canal Univ, Dept Pharmacol, Fac Vet Med, Ismailia, Egypt; [Abdel-Daim, Mohamed M.] Yokohama City Univ, Dept Ophthalmol & Microtechnol, Yokohama, Kanagawa, Japan	Egyptian Knowledge Bank (EKB); Suez Canal University; Northern Borders University; Egyptian Knowledge Bank (EKB); Suez Canal University; Egyptian Knowledge Bank (EKB); Mansoura University; Egyptian Knowledge Bank (EKB); Suez Canal University; Egyptian Knowledge Bank (EKB); Assiut University; Egyptian Knowledge Bank (EKB); Suez Canal University; Yokohama City University	Fawzy, MS (corresponding author), Suez Canal Univ, Dept Med Biochem, Fac Med, Ismailia, Egypt.; Fawzy, MS (corresponding author), Northern Border Univ, Dept Biochem, Fac Med, Ar Ar, Saudi Arabia.; Toraih, EA (corresponding author), Suez Canal Univ, Dept Histol & Cell Biol, Genet Unit, Fac Med, Ismailia, Egypt.	manal2_khashana@ymail.com; emantoraih@gmail.com	Ibrahiem, Afaf Taha/AEJ-2582-2022; Toraih, Eman/I-3024-2019; Fawzy, Manal S./L-1516-2016; Abdel-Daim, Mohamed M./B-2545-2013	Toraih, Eman/0000-0001-9267-3787; Fawzy, Manal S./0000-0003-1252-8403; Abdel-Daim, Mohamed M./0000-0002-4341-2713; abdeldayem, hala/0000-0001-9215-1575; Mohamed, Amany/0000-0003-3131-3846				Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Allgayer H, 2010, CRIT REV ONCOL HEMAT, V73, P185, DOI 10.1016/j.critrevonc.2009.09.001; Aravalli RN, 2015, TRANSL RES, V166, P219, DOI 10.1016/j.trsl.2015.04.007; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Belvedere R, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-961; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bitomsky N, 2008, ONCOGENE, V27, P4820, DOI 10.1038/onc.2008.115; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Brustmann H, 2006, PATHOL RES PRACT, V202, P713, DOI 10.1016/j.prp.2006.06.003; Charrier L, 2002, CANCER RES, V62, P2169; Chen B, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20155020; Chen Y, 2003, J PATHOL, V200, P640, DOI 10.1002/path.1378; Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258; Da J, 2001, Zhonghua Bing Li Xue Za Zhi, V30, P256; Ding XL, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002729; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Errami Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057871; Fawzy MS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152834; Fischer N, 2012, BIOCHEM BIOPH RES CO, V417, P29, DOI 10.1016/j.bbrc.2011.11.035; Gao YS, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-520; Garman KS, 2013, DIGEST DIS SCI, V58, P3178, DOI 10.1007/s10620-013-2806-7; Gaur AB, 2011, NEURO-ONCOLOGY, V13, P580, DOI 10.1093/neuonc/nor033; Ge J, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0128-2; Gottwein E, 2011, CELL HOST MICROBE, V10, P515, DOI 10.1016/j.chom.2011.09.012; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hamilton SR, 2000, WHO CLASSIFICATION T; Hao YX, 2015, BIOMED PHARMACOTHER, V72, P1, DOI 10.1016/j.biopha.2014.10.032; Hoffman AE, 2009, CANCER RES, V69, P5970, DOI 10.1158/0008-5472.CAN-09-0236; Hou T, 2014, BRIT J CANCER, V110, P1260, DOI 10.1038/bjc.2013.829; Hsu SD, 2008, NUCLEIC ACIDS RES, V36, pD165, DOI 10.1093/nar/gkm1012; Hu N, 2004, CLIN CANCER RES, V10, P6013, DOI 10.1158/1078-0432.CCR-04-0317; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Huang F, 2014, PLOS ONE, V92; Inokuchi J, 2009, CARCINOGENESIS, V30, P1082, DOI 10.1093/carcin/bgp078; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Jansen AP, 2004, MOL CANCER THER, V3, P103; Jiang Y, 2010, BIOMED PHARMACOTHER, V64, P424, DOI 10.1016/j.biopha.2010.01.015; Jorge YC, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/152860; Kishore S, 2011, NAT METHODS, V8, P559, DOI [10.1038/NMETH.1608, 10.1038/nmeth.1608]; Konishi S, 2002, CANCER-AM CANCER SOC, V95, P2473, DOI 10.1002/cncr.10987; Lankat-Buttgereit B, 2004, MOL CELL ENDOCRINOL, V214, P149, DOI 10.1016/j.mce.2003.10.058; Lankat-Buttgereit B, 2009, BIOL CELL, V101, P309, DOI 10.1042/BC20080191; Lee S, 2006, ONCOL REP, V16, P747; Leupold JH, 2007, ONCOGENE, V26, P4550, DOI 10.1038/sj.onc.1210234; Li Hai-Long, 2015, Asian Pac J Cancer Prev, V16, P1781; Liu HQ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-51; Liu Qing-Hua, 2015, Asian Pac J Cancer Prev, V16, P2719; Liu XH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-348; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luthra R, 2008, ONCOGENE, V27, P6667, DOI 10.1038/onc.2008.256; Ma G, 2013, TUMOR BIOL, V34, P3879, DOI 10.1007/s13277-013-0975-9; Maru DM, 2009, AM J PATHOL, V174, P1940, DOI 10.2353/ajpath.2009.080718; Moqadam FA, 2013, LEUKEMIA, V27, P16, DOI 10.1038/leu.2012.179; Omata K, 2008, APOPTOSIS, V13, P929, DOI 10.1007/s10495-008-0223-8; Park JJ, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.32; Paweletz CP, 2000, CANCER RES, V60, P6293; Pedrero JMG, 2004, AM J PATHOL, V164, P73, DOI 10.1016/S0002-9440(10)63098-2; Petrella A, 2006, CANCER BIOL THER, V5, P643, DOI 10.4161/cbt.5.6.2700; Pin AL, 2012, J BIOL CHEM, V287, P30541, DOI 10.1074/jbc.M112.393561; Ramdas L, 2009, HEAD NECK-J SCI SPEC, V31, P642, DOI 10.1002/hed.21017; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Rokkas T, 2015, EUR J GASTROEN HEPAT, V27, P819, DOI 10.1097/MEG.0000000000000363; Schimanski CC, 2009, WORLD J GASTROENTERO, V15, P2089, DOI 10.3748/wjg.15.2089; Spain SL, 2012, HUM MOL GENET, V21, P934, DOI 10.1093/hmg/ddr523; Suh YE, 2015, INT J CANCER, V137, P1021, DOI 10.1002/ijc.29397; Sun M, 2012, MOL CANCER THER, V11, P842, DOI 10.1158/1535-7163.MCT-11-1015; Symonds ME, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00283; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tazawa H, 2015, TRANSL GASTROIN CANC, V4, P219, DOI 10.3978/j.issn.2224-4778.2015.04.01; Toraih EA, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/3269379; Toraih EA, 2016, MOL DIAGN THER, V20, P559, DOI 10.1007/s40291-016-0223-2; Toraih EA, 2015, MOL DIAGN THER, V19, P179, DOI 10.1007/s40291-015-0143-6; Tsai KW, 2012, GENE CHROMOSOME CANC, V51, P394, DOI 10.1002/gcc.21924; Vishwanatha JK, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-8; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pD153, DOI 10.1093/nar/gku1215; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wang F, 2013, MOL BIOL REP, V40, P109, DOI 10.1007/s11033-012-2039-4; Wang J, 2015, INT J MOL SCI, V16, P19886, DOI 10.3390/ijms160819886; Wang KL, 2006, CLIN CANCER RES, V12, P4598, DOI 10.1158/1078-0432.CCR-06-0483; Wang LD, 2008, J INT MED RES, V36, P665, DOI 10.1177/147323000803600407; Wei N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030311; Whisnant AW, 2013, MBIO, V4, DOI 10.1128/mBio.00193-13; Widlak P, 2000, J BIOL CHEM, V275, P8226, DOI 10.1074/jbc.275.11.8226; Winnepenninckx B, 2001, GENE SCREEN, V1, P131; Wu CM, 2006, ONCOL REP, V15, P57; Wu HH, 2014, EXPERT REV MOL MED, V16, DOI 10.1017/erm.2013.16; Xin W, 2003, AM J PATHOL, V162, P255, DOI 10.1016/S0002-9440(10)63816-3; Yang HS, 2006, MOL CELL BIOL, V26, P1297, DOI 10.1128/MCB.26.4.1297-1306.2006; Yu GZ, 2008, CLIN EXP METASTAS, V25, P695, DOI 10.1007/s10585-008-9178-y; Yu H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105306; Zeng JH, 2017, ONCOTARGET, V8, P35681, DOI 10.18632/oncotarget.16051; Zhang JJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-211; Zhang J, 2013, BIOCHEM BIOPH RES CO, V440, P582, DOI 10.1016/j.bbrc.2013.09.142; Zhang Q, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-103; Zhang SH, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-71; Zhao HH, 2016, DNA CELL BIOL, V35, P81, DOI 10.1089/dna.2014.2785; Zhu FJ, 2010, ANAT REC, V293, P1310, DOI 10.1002/ar.21176; Zhu XY, 2014, DIGEST DIS SCI, V59, P911, DOI 10.1007/s10620-013-2970-9	99	30	29	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187310	10.1371/journal.pone.0187310	http://dx.doi.org/10.1371/journal.pone.0187310			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091952	gold, Green Published, Green Submitted			2022-12-26	WOS:000414229700055
J	Brylka, LJ; Koppert, S; Babler, A; Kratz, B; Denecke, B; Yorgan, TA; Etich, J; Costa, IG; Brachvogel, B; Boor, P; Schinke, T; Jahnen-Dechent, W				Brylka, Laura J.; Koeppert, Sina; Babler, Anne; Kratz, Beate; Denecke, Bernd; Yorgan, Timur A.; Etich, Julia; Costa, Ivan G.; Brachvogel, Bent; Boor, Peter; Schinke, Thorsten; Jahnen-Dechent, Willi			Post-weaning epiphysiolysis causes distal femur dysplasia and foreshortened hindlimbs in fetuin-A-deficient mice	PLOS ONE			English	Article							CAPITAL FEMORAL EPIPHYSIS; CALCIPROTEIN PARTICLES; GLYCOPROTEIN/FETUIN-A; APATITE FORMATION; GENE-EXPRESSION; HS-GLYCOPROTEIN; CELL SUBSETS; GROWTH-PLATE; BONE; CALCIFICATION	Fetuin-A / alpha(2)-Heremans-Schmid-glycoprotein (gene name Ahsg) is a systemic inhibitor of ectopic calcification. Due to its high affinity for calcium phosphate, fetuin-A is highly abundant in mineralized bone matrix. Foreshortened femora in fetuin-A-deficient Ahsg(-/-) mice indicated a role for fetuin-A in bone formation. We studied early postnatal bone development in fetuin-A-deficient mice and discovered that femora from Ahsg(-/-) mice exhibited severely displaced distal epiphyses and deformed growth plates, similar to the human disease slipped capital femoral epiphysis (SCFE). The growth plate slippage occurred in 70% of Ahsg(-/-) mice of both sexes around three weeks postnatal. At this time point, mice weaned and rapidly gained weight and mobility. Epiphysis slippage never occurred in wildtype and heterozygous Ahsg(+/-) mice. Homozygous fetuin-A-deficient Ahsg(-/-) mice and, to a lesser degree, heterozygous Ahsg(+/-) mice showed lesions separating the proliferative zone from the hypertrophic zone of the growth plate. The hypertrophic growth plate cartilage in long bones from Ahsg(-/-) mice was significantly elongated and V-shaped until three weeks of age and thus prior to the slippage. Genome-wide transcriptome analysis of laser-dissected distal femoral growth plates from 13-day-old Ahsg(-/-) mice revealed a JAK-STAT-mediated inflammatory response including a 550-fold induction of the chemokine Cxcl9. At this stage, vascularization of the elongated growth plates was impaired, which was visualized by immunofluorescence staining. Thus, fetuin-A-deficient mice may serve as a rodent model of growth plate pathologies including SCFE and inflammatory cartilage degradation.	[Brylka, Laura J.; Koeppert, Sina; Babler, Anne; Jahnen-Dechent, Willi] RWTH Aachen Univ Hosp, Biointerface Lab, Helmholtz Inst Biomed Engn, Aachen, Germany; [Kratz, Beate; Denecke, Bernd] RWTH Aachen Univ Hosp, IZKF Genom Facil, Interdisciplinary Ctr Clin Res, Aachen, Germany; [Yorgan, Timur A.; Schinke, Thorsten] Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, Hamburg, Germany; [Etich, Julia; Brachvogel, Bent] Univ Cologne, Dept Pediat & Adolescent Med, Expt Neonatol, Fac Med, Cologne, Germany; [Etich, Julia; Brachvogel, Bent] Univ Cologne, Ctr Biochem, Med Fac, Cologne, Germany; [Costa, Ivan G.] RWTH Aachen Univ Hosp, IZKF Res Grp Computat Biol & Bioinformat, Interdisciplinary Ctr Clin Res, Aachen, Germany; [Boor, Peter] RWTH Aachen Univ Hosp, Dept Pathol, Aachen, Germany; [Boor, Peter] RWTH Aachen Univ Hosp, Div Nephrol & Immunol, Aachen, Germany	Helmholtz Association; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Cologne; University of Cologne; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital	Jahnen-Dechent, W (corresponding author), RWTH Aachen Univ Hosp, Biointerface Lab, Helmholtz Inst Biomed Engn, Aachen, Germany.	willi.jahnen@rwth-aachen.de	Costa, Ivan G./D-5335-2014; Brylka, Laura J/D-7908-2014; Boor, Peter/C-7707-2011; Babler, Anne/AAA-7250-2021	Costa, Ivan G./0000-0003-2890-8697; Brylka, Laura J/0000-0003-4734-9966; Boor, Peter/0000-0001-9921-4284; Etich, Julia/0000-0003-3238-6692; Brachvogel, Bent/0000-0002-3923-0554	Deutsche Forschungsgemeinschaft [JA 562/10, IRTG 1508]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by Deutsche Forschungsgemeinschaft JA 562/10 and IRTG 1508 to Professor Willi Jahnen-Dechent.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Denecke B, 2003, BIOCHEM J, V376, P135, DOI 10.1042/BJ20030676; DICKSON IR, 1975, NATURE, V256, P430, DOI 10.1038/256430a0; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gremse F, 2015, JOVE-J VIS EXP, DOI 10.3791/52770; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Heiss A, 2003, J BIOL CHEM, V278, P13333, DOI 10.1074/jbc.M210868200; Heiss A, 2008, J BIOL CHEM, V283, P14815, DOI 10.1074/jbc.M709938200; Herrmann M, 2012, CIRC RES, V111, P575, DOI 10.1161/CIRCRESAHA.111.261479; Huang B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13885; Jahnen-Dechent W, 2016, BONE, P93; Jahnen-Dechent W, 2011, CIRC RES, V108, P1494, DOI 10.1161/CIRCRESAHA.110.234260; JahnenDechent W, 1997, J BIOL CHEM, V272, P31496, DOI 10.1074/jbc.272.50.31496; Johnson JS, 2016, J PEDIATR ENDOCR MET, V29, P971, DOI 10.1515/jpem-2016-0023; Karin N, 2016, J LEUKOCYTE BIOL, V99, P857, DOI 10.1189/jlb.2MR0915-441R; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kutmon M, 2016, NUCLEIC ACIDS RES, V44, pD488, DOI 10.1093/nar/gkv1024; LEBRETON JP, 1979, J CLIN INVEST, V64, P1118, DOI 10.1172/JCI109551; Maes C, 2002, MECH DEVELOP, V111, P61, DOI 10.1016/S0925-4773(01)00601-3; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875; Packialakshmi B, 2015, AVIAN DIS, V59, P349, DOI 10.1637/11082-040715-Review.1; Peck K, 2014, ORTHOP CLIN N AM, V45, P77, DOI 10.1016/j.ocl.2013.09.002; Peterson HA, 2007, EPIPHYSEAL GROWTH PL; Reynolds JL, 2004, J AM SOC NEPHROL, V15, P2857, DOI 10.1097/01.ASN.0000141960.01035.28; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Scharschmidt T, 2009, J BONE JOINT SURG AM, V91A, P366, DOI 10.2106/JBJS.G.00039; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789; Seto J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047338; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Szweras M, 2002, J BIOL CHEM, V277, P19991, DOI 10.1074/jbc.M112234200; TERMINE JD, 1988, CIBA FDN S, V136, P178; TRIFFITT JT, 1976, NATURE, V262, P226, DOI 10.1038/262226a0; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Westenfeld R, 2007, NEPHROL DIAL TRANSPL, V22, P1537, DOI 10.1093/ndt/gfm094; Westenfeld R, 2009, J AM SOC NEPHROL, V20, P1264, DOI 10.1681/ASN.2008060572; Yuasa K, 2016, GENES CELLS, V21, P25, DOI 10.1111/gtc.12316	40	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187030	10.1371/journal.pone.0187030	http://dx.doi.org/10.1371/journal.pone.0187030			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088242	Green Published, Green Submitted, gold			2022-12-26	WOS:000414088900036
J	Kiat, Y				Kiat, Yosef			Divergent primary moult-A rare moult sequence among Western Palaearctic passerines	PLOS ONE			English	Article							POST-JUVENILE; FEATHER MOLT; BIRDS; GAPS	Wing morphology strongly affects flight performance which may consequently decline during feather moult due to the creation of feather gaps in the wing. Hence, the size and shape of moult-related wing gap may directly affect flight capacity. Here I examined the rare divergent primary moult sequence compared to the more common descendant moult sequence. In the divergent moult, the focus of primary moult is shifted from P-1 (primary feather numbered descendantly) to another primary between P-2 and P-5, and then primaries are moulted in two concurrent waves, one descendant and the other ascendant. The result of this rare moult sequence is the splitting of the wing gap to two smaller gaps. Using a large moult database including 6,763 individuals of 32 Western Palaearctic passerine species, I found evidence of divergent moult only among 27 individuals of 12 species. I examined the speed of wing-feather moult for each individual that moulted divergently compared to a control group of individuals at the same moult stage which moulted following the common descending sequence. The results indicate that the sequence of primary moult and moult speed are correlated. Individuals which moulted divergently moulted their primaries with higher moult speed than descendant moulters. The applicability of this study is weakened by the dearth of moult data, thus making it difficult to draw conclusions for a large range of species. Ornithologists and bird ringers are therefore encouraged to collect more basic moult data during their field study.	[Kiat, Yosef] Hebrew Univ Jerusalem, Dept Ecol Evolut & Behav, Alexander Silberman Inst Life Sci, Edmond J Safra Campus, Jerusalem, Israel	Hebrew University of Jerusalem	Kiat, Y (corresponding author), Hebrew Univ Jerusalem, Dept Ecol Evolut & Behav, Alexander Silberman Inst Life Sci, Edmond J Safra Campus, Jerusalem, Israel.	yosefkiat@gmail.com		Kiat, Yosef/0000-0002-3485-3517				BAHRMANN U., 1971, BEITR VOGELKDE, V17, P413; Baker K, 1993, IDENTIFICATION GUIDE; BENSCH S, 1993, CONDOR, V95, P305, DOI 10.2307/1369353; Bridge ES, 2011, CONDOR, V113, P1, DOI 10.1525/cond.2011.100228; FRANCIS I S, 1991, Ringing and Migration, V12, P28; Ginn H. B., 1983, MOULT BIRDS BTO GUID; GREEN GH, 1975, BIRD STUDY, V22, P9, DOI 10.1080/00063657509476435; Haukioja E., 1971, ORNIS FENNICA, V48, P1; Hedenstrom A, 2003, J AVIAN BIOL, V34, P324, DOI 10.1111/j.0908-8857.2003.03324.x; Hedenstrom A, 1999, J EXP BIOL, V202, P67; Jenni L., 1994, BIOL MOULT BIRDS; Kelemen Marton, 2000, Ornis Hungarica, V10, P99; Kiat Y, 2016, EVOL ECOL, V30, P783, DOI 10.1007/s10682-016-9838-3; Kiat Y, 2016, J AVIAN BIOL, V47, P47, DOI 10.1111/jav.00717; Lind J, 2001, FUNCT ECOL, V15, P29; LINDSTROM A, 1993, PHYSIOL ZOOL, V66, P490, DOI 10.1086/physzool.66.4.30163805; MARCHETTI K, 1989, BIOL REV, V64, P51, DOI 10.1111/j.1469-185X.1989.tb00638.x; Neto JM, 2006, IBIS, V148, P39, DOI 10.1111/j.1474-919X.2006.00477.x; Newton Ian, 2009, Ringing & Migration, V24, P220; Rohwer S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000132; Rohwer VG, 2013, AUK, V130, P699, DOI 10.1525/auk.2013.13042; Slagsvold T, 1996, ECOLOGY, V77, P461, DOI 10.2307/2265622; STRESEMANN E, 1971, Journal fuer Ornithologie, V112, P373; Stresemann E., 1966, DIE MAUSER DER VOGEL; STRESEMANN VESTA, 1963, JOUR ORNITHOL, V104, P101, DOI 10.1007/BF01677685; Swaddle JP, 1997, CAN J ZOOL, V75, P1135, DOI 10.1139/z97-136; THOMAS D K, 1977, Ringing and Migration, V1, P125; Thompson CW, 1998, AUK, V115, P653, DOI 10.2307/4089414; Williamson K., 1972, British Birds, V65, P50	29	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187282	10.1371/journal.pone.0187282	http://dx.doi.org/10.1371/journal.pone.0187282			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088288	Green Published, Green Submitted, gold			2022-12-26	WOS:000414088900058
J	Meyers, C; Milici, J; Robison, R				Meyers, Craig; Milici, Janice; Robison, Richard			UVC radiation as an effective disinfectant method to inactivate human papillomaviruses	PLOS ONE			English	Article							MAJOR CAPSID PROTEIN; IN-VITRO; TRANSMISSION; REPLICATION; RISK; SUSCEPTIBILITY; CONTAMINATION; TYPE-16	Endocavitary ultrasound probes are part of a commonly used procedure in the clinical arena. The cavities examined, vaginal canal and cervix, anal canal, and oral cavity are all areas commonly infected with the human papillomavirus (HPV), thus making them susceptible to contamination by HPV. It has been demonstrated that these probes can remain contaminated with high-risk HPV even when approved disinfection protocols have been performed. we have previously shown that HPV is resistant to some high-level disinfectant (HLD). In our present study we analyzed efficacy of using high-level ultra-violet C (UVC) radiation against HPV16 and HPV18 using a hard-surface carrier test. Stocks of infectious authentic HPV16 and HPV18 virions were dried onto carriers with a 5% (v/v) protein soil or 4ppm hard water. Efficacy testing were performed with the automated device, Antigermix S1 device (UVC radiation at 253.7nm) and 0.55% OPA in quadruplicate with matched input, neutralization, and cytotoxicity controls. Hypochlorite was included as a positive control for viral deactivation. Infectivity was determined by the abundance (qRT-PCR) of the spliced E1<^>E4 transcript in infected recipient cells. The automated Antigermix S1 device showed excellent efficacy against HPV16 and HPV18 whereas OPA showed minimal efficacy. While HPV is highly resistant to OPA, high-level UVC radiation offers an effective disinfection practice for ultrasound probes. Our results suggest that healthcare facilities using endocavitary ultrasound probes need to strongly consider disinfection methods that are effective against HPV.	[Meyers, Craig; Milici, Janice] Penn State Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA; [Robison, Richard] Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Brigham Young University	Meyers, C (corresponding author), Penn State Coll Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA.	cmeyers@pennstatehealth.psu.edu		Robison, Richard/0000-0002-4324-5169	Germitec France	Germitec France	This work was supported by Germitec France. Germitec is a privately owned company. They provided the funding, the Antigermix 51 device, and in discussion with the corresponding author the basic conceptualization for the study.	BEDELL MA, 1991, J VIROL, V65, P2254, DOI 10.1128/JVI.65.5.2254-2260.1991; Biryukov J, 2015, METHODS MOL BIOL, V1249, P317, DOI 10.1007/978-1-4939-2013-6_24; Casalegno JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048137; Centers for Disease Control, 2008, GUIDELINE DISINFECTI; Conway MJ, 2009, J DENT RES, V88, P307, DOI 10.1177/0022034509333446; Conway MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022427; Conway MJ, 2009, VIROLOGY, V393, P295, DOI 10.1016/j.virol.2009.08.010; Conway MJ, 2009, J VIROL, V83, P10515, DOI 10.1128/JVI.00731-09; FDA, 2000, GUID IND FDA REV CON; Feldman M Y, 1973, Prog Nucleic Acid Res Mol Biol, V13, P1, DOI 10.1016/S0079-6603(08)60099-9; Fisher CW, 2012, AM J INFECT CONTROL, V40, P880, DOI 10.1016/j.ajic.2011.11.004; Freitas AC, 2013, CLIN INFECT DIS, V56, P1451, DOI 10.1093/cid/cit066; Hahn HS, 2013, EUR J OBSTET GYN R B, V169, P202, DOI 10.1016/j.ejogrb.2013.02.024; HIGNETT M, 1995, J ASSIST REPROD GEN, V12, P606, DOI 10.1007/BF02212583; Hong Y, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-109; HUMMEL M, 1992, J VIROL, V66, P6070, DOI 10.1128/JVI.66.10.6070-6080.1992; International ASTM E1053-11, 2011, E105311 INT ASTM; Ishii Y, 2003, VIROLOGY, V308, P128, DOI 10.1016/S0042-6822(02)00099-5; Kac G, 2010, INFECT CONT HOSP EP, V31, P165, DOI 10.1086/649794; Liu ZY, 2016, SEX HEALTH, V13, P10, DOI 10.1071/SH15089; M'Zali F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093368; Ma STC, 2013, EMERG MED J, V30, P472, DOI 10.1136/emermed-2012-201407; McLaughlin-Drubin ME, 2003, VIROLOGY, V312, P1, DOI 10.1016/S0042-6822(03)00312-X; MEYERS C, 1992, SCIENCE, V257, P971, DOI 10.1126/science.1323879; Meyers J, 2014, J ANTIMICROB CHEMOTH, V69, P1546, DOI 10.1093/jac/dku006; Milki AA, 1998, FERTIL STERIL, V69, P409, DOI 10.1016/S0015-0282(97)00571-2; Modis Y, 2002, EMBO J, V21, P4754, DOI 10.1093/emboj/cdf494; Ozbun MA, 1997, J VIROL, V71, P5161, DOI 10.1128/JVI.71.7.5161-5172.1997; Park H, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-80; Rooks VJ, 1996, OBSTET GYNECOL, V87, P27, DOI 10.1016/0029-7844(95)00336-3; Rutala W.A., 2019, GUIDELINE DISINFECTI; Rutala WA, 2010, INFECT CONT HOSP EP, V31, P1025, DOI 10.1086/656244; Ryndock E, 2016, J MED VIROL, V88, P1076, DOI 10.1002/jmv.24421; Ryndock EJ, 2015, METHODS MOL BIOL, V1249, P39, DOI 10.1007/978-1-4939-2013-6_3; Ryndock EJ, 2014, EXPERT REV ANTI-INFE, V12, P1165, DOI 10.1586/14787210.2014.959497; Ryndock EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099488; Sabeena S, 2017, J OBSTET GYNAECOL RE, V43, P429, DOI 10.1111/jog.13248; Sapp M, 1998, J VIROL, V72, P6186, DOI 10.1128/JVI.72.7.6186-6189.1998; Smith Elaine M, 2010, Infect Dis Obstet Gynecol, V2010, P326369, DOI 10.1155/2010/326369; Sonnex C, 1999, INT J STD AIDS, V10, P726, DOI 10.1258/0956462991913402; Storment JM, 1997, SOUTHERN MED J, V90, P206, DOI 10.1097/00007611-199702000-00007; Tenti P, 1999, OBSTET GYNECOL, V93, P475, DOI 10.1016/S0029-7844(98)00459-1; Winer RL, 2010, CANCER EPIDEM BIOMAR, V19, P1682, DOI 10.1158/1055-9965.EPI-10-0226	43	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187377	10.1371/journal.pone.0187377	http://dx.doi.org/10.1371/journal.pone.0187377			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088277	Green Published, gold, Green Submitted			2022-12-26	WOS:000414088900077
J	Sittner, A; Bar-David, E; Glinert, I; Ben-Shmuel, A; Weiss, S; Schlomovitz, J; Kobiler, D; Levy, H				Sittner, Assa; Bar-David, Elad; Glinert, Itai; Ben-Shmuel, Amir; Weiss, Shay; Schlomovitz, Josef; Kobiler, David; Levy, Haim			Pathology of wild-type and toxin-independent Bacillus anthracis meningitis in rabbits	PLOS ONE			English	Article							FIBRIN CLOT STRUCTURE; INHALATIONAL ANTHRAX; ANIMAL-MODELS; PATHOGENESIS; PROTECTION; INFECTION; LETHAL; SPORES	Hemorrhagic meningitis is considered a complication of anthrax and was reported in about 50% of deadly cases in humans and non-human primates (NHP). Recently we demonstrated in Guinea pigs and rabbits that 100% of the B. anthracis-infected animals presented histopathology of meningitis at the time of death, some without any sign of hemorrhage. A similar pathology was observed in animals that succumbed following infection with the toxin deficient mutant, thus indicating that anthrax meningitis is a toxin-independent phenomenon. In this manuscript we describe a histopathological study of the B. anthracis infection of the central nervous system (CNS). Though we could find sporadic growth of the bacteria around blood vessels in the cortex, we report that the main infiltration route is the choroid plexus. We found massive destruction of entire sections of the choroid plexus coupled with massive aggregation of bacilli in the ventricles, in close proximity to the parenchyma. The choroid plexus also contained significant amounts of intravascular bacterial aggregates, often enclosed in what appear to be fibrin-like clots. The high concentration of these aggregates in areas of significant tissue destruction combined with the fact that capsular B. anthracis bacteria have a low tendency to adhere to endothelial cells, might suggest that these clots are used as an adherence mechanism by the bacteria. The major histopathological finding is meningitis. We find massive bacterial growth in the meninges without evidence of encephalitis, even when the bacteria emerge from a parenchymal blood vessel. Erythrocytes were present within the meningeal space but no clear vasculitis could be detected. Histology of the brain stem indicates meningitis, edema and hemorrhages that might explain death from suffocation due to direct damage to the respiratory center. All of these processes are toxin-independent, since they were observed following infection with either the wild type strain or the toxin-deficient mutant. Herein, we propose that the first step of anthrax-meningitis is bacterial adhesion to the blood vessels by manipulating coagulation, mainly in the choroid plexus. The trapped bacteria then destroy sections of the choroid plexus, resulting in penetration into the CSF, leading to meningitis and hemorrhage. Death could be the result of increased intracranial pressure and/or damage to the brain stem.	[Sittner, Assa; Bar-David, Elad; Glinert, Itai; Ben-Shmuel, Amir; Weiss, Shay; Schlomovitz, Josef; Kobiler, David; Levy, Haim] Israel Inst Biol Res, Dept Infect Dis, Ness Ziona, Israel		Levy, H (corresponding author), Israel Inst Biol Res, Dept Infect Dis, Ness Ziona, Israel.	haiml@iibr.gov.il		Sittner, Assa/0000-0002-1633-8191				Amaral A, 2004, INTENS CARE MED, V30, P1032, DOI 10.1007/s00134-004-2291-8; Biemond BJ, 1995, THROMB HEAMOST, V73, P8; Dando SJ, 2014, CLIN MICROBIOL REV, V27, P691, DOI 10.1128/CMR.00118-13; Delvaeye M, 2009, BLOOD, V114, P2367, DOI 10.1182/blood-2009-05-199208; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Ebrahimi CM, 2011, INFECT IMMUN, V79, P2510, DOI 10.1128/IAI.00006-11; Ebrahimi CM, 2009, J BACTERIOL, V191, P7165, DOI 10.1128/JB.00903-09; Fouet A, 2009, MOL ASPECTS MED, V30, P374, DOI 10.1016/j.mam.2009.07.001; Glinert I, 2016, ANTIMICROB AGENTS CH, V60, P4878, DOI 10.1128/AAC.00546-16; Grinberg LM, 2001, MODERN PATHOL, V14, P482, DOI 10.1038/modpathol.3880337; Hendricks Katherine A, 2014, Emerg Infect Dis, V20, DOI 10.3201/eid2002.130687; Kobiler D, 2002, INFECT IMMUN, V70, P544, DOI 10.1128/IAI.70.2.544-550.2002; Levy H, 2014, PLOS ONE, V9, P1; Levy H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084947; Levy H, 2012, INFECT IMMUN, V80, P2623, DOI 10.1128/IAI.00244-12; Liu SH, 2014, TRENDS MICROBIOL, V22, P317, DOI 10.1016/j.tim.2014.02.012; Loof TG, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00128; McAdow M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002307; Meselson M, 1994, SCIENCE, V266, P7; OBRIEN J, 1985, INFECT IMMUN, V47, P306, DOI 10.1128/IAI.47.1.306-310.1985; Pillai KS, 2015, HEALTH SECUR, V6, P10; Plotkin AS, 1960, AM J MED, V29, P10; Savransky V, 2013, INFECT IMMUN, V81, P1152, DOI 10.1128/IAI.01289-12; Swartz MN, 2001, NEW ENGL J MED, V345, P6; Twenhafel NA, 2010, VET PATHOL, V47, P819, DOI 10.1177/0300985810378112; van Sorge NM, 2012, FUTURE MICROBIOL, V7, P383, DOI [10.2217/fmb.12.1, 10.2217/FMB.12.1]; Vasconcelos D, 2003, LAB INVEST, V83, P1201, DOI 10.1097/01.LAB.0000080599.43791.01; Weigandt KM, 2012, BIOPHYS J, V103, P2399, DOI 10.1016/j.bpj.2012.10.036; Weiss S, 2006, INFECT IMMUN, V74, P394, DOI 10.1128/IAI.74.1.394-398.2006; Weiss S, 2015, ANTIMICROB AGENTS CH, V59, P7497, DOI 10.1128/AAC.01376-15; Weiss S, 2011, ANTIMICROB AGENTS CH, V55, P1533, DOI 10.1128/AAC.01689-10; Wolberg AS, 2007, BLOOD REV, V21, P131, DOI 10.1016/j.blre.2006.11.001; Zaucha GM, 1998, ARCH PATHOL LAB MED, V122, P982	33	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186613	10.1371/journal.pone.0186613	http://dx.doi.org/10.1371/journal.pone.0186613			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088287	Green Submitted, Green Published, gold			2022-12-26	WOS:000414088900017
J	Smouse, PE; Banks, SC; Peakall, R				Smouse, Peter E.; Banks, Sam C.; Peakall, Rod			Converting quadratic entropy to diversity: Both animals and alleles are diverse, but some are more diverse than others	PLOS ONE			English	Article							PHYLOGENETIC DIVERSITY; DISSIMILARITY COEFFICIENTS; ECOLOGICAL COMMUNITIES; INBREEDING AVOIDANCE; POPULATION-GENETICS; SPECIES-DIFFERENCES; FINITE POPULATION; ANTECHINUS-AGILIS; MEDIAN NETWORKS; DISPERSAL	The use of diversity metrics has a long history in population ecology, while population genetic work has been dominated by variance-derived metrics instead, a technical gap that has slowed cross-communication between the fields. Interestingly, Rao's Quadratic Entropy (RQE), comparing elements for 'degrees of divergence', was originally developed for population ecology, but has recently been deployed for evolutionary studies. We here translate RQE into a continuous diversity analogue, and then construct a multiply nested diversity partition for alleles, individuals, populations, and species, each component of which exhibits the behavior of proper diversity metrics, and then translate these components into [0,1] D scaled form. We also deploy non-parametric statistical tests of the among-stratum components and novel tests of the homogeneity of within-stratum diversity components at any hierarchical level. We then illustrate this new analysis with eight nSSR loci and a pair of close Australian marsupial (Antechinus) congeners, using both 'different is different' and 'degree of difference' distance metrics. The total diversity in the collection is larger than that within either species, but most of the within-species diversity is resident within single populations. The combined A. agilis collection exhibits more diversity than does the combined A. stuartii collection, possibly attributable to localized differences in either local ecological disturbance regimes or differential levels of population isolation. Beyond exhibiting different allelic compositions, the two congeners are becoming more divergent for the arrays of allele sizes they possess.	[Smouse, Peter E.] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ USA; [Banks, Sam C.] Australian Natl Univ, Fenner Sch Environm & Soc, Acton, ACT, Australia; [Peakall, Rod] Australian Natl Univ, Res Sch Biol, Acton, ACT, Australia	Rutgers State University New Brunswick; Australian National University; Australian National University	Banks, SC (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, Acton, ACT, Australia.	Sam.Banks@anu.edu.au	Peakall, Rod/C-9623-2009; /K-4907-2012	Peakall, Rod/0000-0001-9407-8404; /0000-0003-2415-0057	USDA National Institute of Food and Agriculture [1005333]; New Jersey Agricultural Experiment Station [NJ17160]; Australian Research Council [FT130100043]; USDA	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); New Jersey Agricultural Experiment Station; Australian Research Council(Australian Research Council); USDA(United States Department of Agriculture (USDA))	PES was supported by the USDA National Institute of Food and Agriculture Hatch Project 1005333, and the New Jersey Agricultural Experiment Station, Hatch project NJ17160; SCB was supported by Australian Research Council Future Fellowship FT130100043. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; (Fig 1), Bill Sherwin, Oscar Gaggiotti, and a trio of anonymous reviewers for helpful critique on earlier drafts of the manuscript. PES was supported by the USDA and the New Jersey Agricultural Experiment Station, Hatch project NJ17160; SCB was supported by Australian Research Council Future Fellowship FT130100043.	Allen B, 2009, AM NAT, V174, P236, DOI 10.1086/600101; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson MJ, 2005, PERMANOVA FORTRAN CO; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Bandelt HJ, 2000, MOL PHYLOGENET EVOL, V16, P8, DOI 10.1006/mpev.2000.0792; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Banks S.C., 2017, ECOGRAPHY; Banks SC, 2014, J ANIM ECOL, V83, P515, DOI 10.1111/1365-2656.12128; Banks SC, 2011, OIKOS, V120, P26, DOI 10.1111/j.1600-0706.2010.18765.x; Banks SC, 2005, BIOL CONSERV, V122, P581, DOI 10.1016/j.biocon.2004.09.013; Bartlett MS, 1937, PROC R SOC LON SER-A, V160, P0268, DOI 10.1098/rspa.1937.0109; Botta-Dukat Z, 2005, J VEG SCI, V16, P533, DOI 10.1111/j.1654-1103.2005.tb02393.x; Bruvo R, 2004, MOL ECOL, V13, P2101, DOI 10.1111/j.1365-294X.2004.02209.x; Chao A, 2008, BIOMETRICS, V64, P1178, DOI 10.1111/j.1541-0420.2008.01010.x; Chao A, 2016, METHODS ECOL EVOL, V7, P919, DOI 10.1111/2041-210X.12551; Chao A, 2010, PHILOS T R SOC B, V365, P3599, DOI 10.1098/rstb.2010.0272; Chiu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100014; COCKBURN A, 1985, ANIM BEHAV, V33, P908, DOI 10.1016/S0003-3472(85)80025-7; Coop G, 2010, GENETICS, V185, P1411, DOI 10.1534/genetics.110.114819; Coulson TN, 1998, P ROY SOC B-BIOL SCI, V265, P489, DOI 10.1098/rspb.1998.0321; Davies ID, 2016, ECOL EVOL, V6, P1181, DOI 10.1002/ece3.1948; De Bello F, 2010, J VEG SCI, V21, P1992; Dickman CR, 1998, AUST J ZOOL, V46, P1, DOI 10.1071/ZO97036; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Eastman JM, 2011, BIOINFORMATICS, V27, P2437, DOI 10.1093/bioinformatics/btr403; Enard D, 2016, ELIFE, V5, DOI 10.7554/eLife.12469; EXCOFFIER L, 1994, GENETICS, V136, P343; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; FELSENSTEIN J, 1988, ANNU REV ECOL SYST, V19, P445, DOI 10.1146/annurev.es.19.110188.002305; Foll M, 2014, AM J HUM GENET, V95, P394, DOI 10.1016/j.ajhg.2014.09.002; Fu YX, 1998, GENETICS, V150, P487; Gaggiotti OE, 1999, MOL ECOL, V8, P1513, DOI 10.1046/j.1365-294x.1999.00730.x; GOLDSTEIN DB, 1995, GENETICS, V139, P463; Gonzales E, 2008, AM J BOT, V95, P1254, DOI 10.3732/ajb.2007159; GOWER JC, 1986, J CLASSIF, V3, P5, DOI 10.1007/BF01896809; Grivet D, 2005, MOL ECOL, V14, P3585, DOI 10.1111/j.1365-294X.2005.02680.x; Grivet D, 2009, MOL ECOL, V18, P3967, DOI 10.1111/j.1365-294X.2009.04326.x; Hardy OJ, 2008, J ECOL, V96, P849, DOI 10.1111/j.1365-2745.2008.01423.x; Hardy OJ, 2007, J ECOL, V95, P493, DOI 10.1111/j.1365-2745.2007.01222.x; Izsak J, 1995, J ENV ECOL STAT, V2, P213; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Jost L, 2009, MOL ECOL, V18, P2088, DOI 10.1111/j.1365-294X.2009.04186.x; KIMURA M, 1964, GENETICS, V49, P725; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Leinster T, 2012, ECOLOGY, V93, P477, DOI 10.1890/10-2402.1; Lindenmayer DB, 2016, ECOL APPL, V26, P557, DOI 10.1890/15-0575; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Nicotra AB, 2016, MOL ECOL, V25, P2000, DOI 10.1111/mec.13584; Nievergelt CM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030051; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; Otter KA, 2001, J AVIAN BIOL, V32, P338, DOI 10.1111/j.0908-8857.2001.320408.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; PEAKALL R, 1995, MOL ECOL, V4, P135, DOI 10.1111/j.1365-294X.1995.tb00203.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Rao, 1982, SANKHY INDIAN J ST A, V44, P1, DOI DOI 10.1007/S13171-010-0002-9; Rao CR, 2010, SANKHYA SER A, V72, P70, DOI 10.1007/s13171-010-0016-3; Rao C. R., 1986, ENCY STAT SCI, V7, P614; Rao C.R., 1982, UTILITAS MATHEMATICA, V21, P273; Rao C.R., 1982, STAT DECISION THEORY, P235; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; RICHARDSON RH, 1977, GENETICS, V85, P141; Ricotta C, 2005, BASIC APPL ECOL, V6, P479, DOI 10.1016/j.baae.2005.02.008; Ricotta C, 2005, ECOL MODEL, V183, P365, DOI 10.1016/j.ecolmodel.2004.08.020; Ricotta C, 2008, J VEG SCI, V19, P229, DOI 10.3170/2008-8-18363; Ricotta C, 2006, THEOR POPUL BIOL, V70, P237, DOI 10.1016/j.tpb.2006.06.003; Ricotta C, 2009, THEOR POPUL BIOL, V76, P299, DOI 10.1016/j.tpb.2009.10.001; Scofield DG, 2012, AM NAT, V180, P719, DOI 10.1086/668202; Scofield DG, 2010, J ECOL, V98, P561, DOI 10.1111/j.1365-2745.2010.01649.x; Sherwin WB, 2006, MOL ECOL, V15, P2857, DOI 10.1111/j.1365-294X.2006.02992.x; Sherwin WB, 2010, ENTROPY-SWITZ, V12, P1765, DOI 10.3390/e12071765; Shimatani K, 2001, OIKOS, V93, P135, DOI 10.1034/j.1600-0706.2001.930115.x; SLATKIN M, 1995, GENETICS, V139, P457; Smith BT, 2014, SYST BIOL, V63, P83, DOI 10.1093/sysbio/syt061; Smouse PE, 2005, HEREDITY, V94, P640, DOI 10.1038/sj.hdy.6800674; Smouse PE, 2015, MOL ECOL RESOUR, V15, P1375, DOI 10.1111/1755-0998.12422; Sokal RR, 1963, PRINCIPLES NUMERICAL; Sork VL, 2015, EVOL ECOL, V29, P927, DOI 10.1007/s10682-015-9769-4; Trumbo DR, 2016, MOL ECOL, V25, P4161, DOI 10.1111/mec.13754; Villeger S, 2008, J ECOL, V96, P845, DOI 10.1111/j.1365-2745.2007.01351.x; Warwick RM, 1995, MAR ECOL PROG SER, V129, P301, DOI 10.3354/meps129301; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Westerman M, 2016, ZOOL J LINN SOC-LOND, V176, P686, DOI 10.1111/zoj.12323	88	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0185499	10.1371/journal.pone.0185499	http://dx.doi.org/10.1371/journal.pone.0185499			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088229	gold, Green Published, Green Submitted			2022-12-26	WOS:000414088900002
J	Chuang, BI; Kuo, LC; Yang, TH; Su, FC; Jou, IM; Lin, WJ; Sun, YN				Chuang, Bo-I; Kuo, Li-Chieh; Yang, Tai-Hua; Su, Fong-Chin; Jou, I-Ming; Lin, Wei-Jr; Sun, Yung-Nien			ocr A medical imaging analysis system for trigger finger using an adaptive texture-based active shape model (ATASM) in ultrasound images	PLOS ONE			English	Article							SONOGRAPHIC APPEARANCE; SEGMENTATION; CLASSIFICATION; PULLEY	Trigger finger has become a prevalent disease that greatly affects occupational activity and daily life. Ultrasound imaging is commonly used for the clinical diagnosis of trigger finger severity. Due to image property variations, traditional methods cannot effectively segment the finger joint's tendon structure. In this study, an adaptive texture-based active shape model method is used for segmenting the tendon and synovial sheath. Adapted weights are applied in the segmentation process to adjust the contribution of energy terms depending on image characteristics at different positions. The pathology is then determined according to the wavelet and co-occurrence texture features of the segmented tendon area. In the experiments, the segmentation results have fewer errors, with respect to the ground truth, than contours drawn by regular users. The mean values of the absolute segmentation difference of the tendon and synovial sheath are 3.14 and 4.54 pixels, respectively. The average accuracy of pathological determination is 87.14%. The segmentation results are all acceptable in data of both clear and fuzzy boundary cases in 74 images. And the symptom classifications of 42 cases are also a good reference for diagnosis according to the expert clinicians' opinions.	[Chuang, Bo-I; Sun, Yung-Nien] Natl Cheng Kung Univ, Dept Comp Sci & Informat Engn, Tainan, Taiwan; [Kuo, Li-Chieh] Natl Cheng Kung Univ, Dept Occupat Therapy, Tainan, Taiwan; [Yang, Tai-Hua; Su, Fong-Chin; Lin, Wei-Jr] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan, Taiwan; [Jou, I-Ming] E Da Hosp, Dept Orthoped, Kaohsiung, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; E-Da Hospital	Sun, YN (corresponding author), Natl Cheng Kung Univ, Dept Comp Sci & Informat Engn, Tainan, Taiwan.	ynsun@mail.ncku.edu.tw	Kuo, Li-Chieh/ABC-3826-2021; SU, FONG-CHIN/C-8094-2011	Kuo, Li-Chieh/0000-0001-7728-0096; SU, FONG-CHIN/0000-0002-3870-4842; Kuo, Li-Chieh/0000-0002-5644-655X; Yang, Tai-Hua/0000-0001-5068-2570	Ministry of Science and Technology, Taiwan, R.O.C. [NSC 101-2221-E-006-059-MY3]	Ministry of Science and Technology, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	This work was supported by NSC 101-2221-E-006-059-MY3 from the Ministry of Science and Technology (formally National Science Council), Taiwan, R.O.C. https://www.most.gov.twl. Authors who received the funding: YNS.; The authors would like to express their appreciation for the grant under contract NSC 101-2221-E-006-059-MY3 from the Ministry of Science and Technology, Taiwan, R.O.C.. This work also utilized shared facilities supported by the Medical Device Innovation Center, National Cheng Kung University, Tainan, Taiwan, R.O.C..	Al Rahhal MM, 2016, INFORM SCIENCES, V345, P340, DOI 10.1016/j.ins.2016.01.082; Anavi Y, 2015, IEEE ENG MED BIO, P2940, DOI 10.1109/EMBC.2015.7319008; Casio FA, 2008, MED IMAGE ANAL, V12, P469, DOI 10.1016/j.media.2008.02.001; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen HC, 2012, ULTRASOUND MED BIOL, V38, P811, DOI 10.1016/j.ultrasmedbio.2012.01.025; Christodoulou CI, 2003, IEEE T MED IMAGING, V22, P902, DOI 10.1109/TMI.2003.815066; Fan RE, 2005, J MACH LEARN RES, V6, P1889; Gabor D., 1946, J I ELECT ENG LOND, V93, P429, DOI DOI 10.1049/JI-3-2.1946.0074; Goldberg DE, 1989, GENETIC ALGORITHMS S, DOI DOI 10.1111/J.1365-2486.2009.02080.X; Gong XH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141046; Guerini H, 2008, J ULTRAS MED, V27, P1407, DOI 10.7863/jum.2008.27.10.1407; Hamarneh G, 2000, COMPUT CARDIOL, V27, P115, DOI 10.1109/CIC.2000.898469; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; He P, 2001, ENG MED BIOL SOC 200, V3, P2712; Huang YL, 2006, NEURAL COMPUT APPL, V15, P164, DOI 10.1007/s00521-005-0019-5; Iakovidis DK, 2010, ARTIF INTELL MED, V50, P33, DOI 10.1016/j.artmed.2010.04.004; Kendall D. G., 1989, STAT SCI, V4, P87, DOI DOI 10.1214/SS/1177012582; Kim ND, 1998, PROCEEDINGS OF THE IEEE-SP INTERNATIONAL SYMPOSIUM ON TIME-FREQUENCY AND TIME-SCALE ANALYSIS, P241, DOI 10.1109/TFSA.1998.721406; Kussul N, 2017, IEEE GEOSCI REMOTE S, V14, P778, DOI 10.1109/LGRS.2017.2681128; Laws KI, 1980, TEXTURED IMAGE SEGME; Liao XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103334; MALLAT SG, 1989, IEEE T PATTERN ANAL, V11, P674, DOI 10.1109/34.192463; Medina R, 2005, P ANN INT IEEE EMBS, P3363, DOI 10.1109/IEMBS.2005.1617198; Miyamoto H, 2011, J HAND SURG-AM, V36A, P1486, DOI 10.1016/j.jhsa.2011.05.038; Niu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072988; Padmanabhan K, 1998, MED BIOL ENG COMPUT, V36, P270, DOI 10.1007/BF02522470; Puri M, 2005, MED BIOL ENG COMPUT, V43, P756, DOI 10.1007/BF02430954; Qi Huang, 2004, Canadian Conference on Electrical and Computer Engineering 2004 (IEEE Cat. No.04CH37513), P1269, DOI 10.1109/CCECE.2004.1349629; Ryzewicz M, 2006, J HAND SURG-AM, V31A, P135, DOI 10.1016/j.jhsa.2005.10.013; Santhiyakumari N, 2011, MED BIOL ENG COMPUT, V49, P1299, DOI 10.1007/s11517-011-0800-9; Sato J, 2012, J HAND SURG-AM, V37A, P2012, DOI 10.1016/j.jhsa.2012.06.027; Shen DG, 2003, IEEE T MED IMAGING, V22, P539, DOI 10.1109/TMI.2003.809057; Tsai PY, 2012, ULTRASOUND OBST GYN, V39, P642, DOI 10.1002/uog.10104; Tsiaparas NN, 2011, IEEE T INF TECHNOL B, V15, P130, DOI 10.1109/TITB.2010.2091511; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Zhy Chang-ming, 2008, 2008 International Conference on Computer Science and Software Engineering (CSSE 2008), P795, DOI 10.1109/CSSE.2008.294	36	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187042	10.1371/journal.pone.0187042	http://dx.doi.org/10.1371/journal.pone.0187042			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077737	gold, Green Published, Green Submitted			2022-12-26	WOS:000413861200039
J	Furukawa, K; Tanemura, M; Miyoshi, E; Eguchi, H; Nagano, H; Matsunami, K; Nagaoka, S; Yamada, D; Asaoka, T; Noda, T; Wada, H; Kawamoto, K; Goto, K; Taniyama, K; Mori, M; Doki, Y				Furukawa, Kenta; Tanemura, Masahiro; Miyoshi, Eiji; Eguchi, Hidetoshi; Nagano, Hiroaki; Matsunami, Katsuyoshi; Nagaoka, Satoshi; Yamada, Daisaku; Asaoka, Tadafumi; Noda, Takehiro; Wada, Hiroshi; Kawamoto, Koichi; Goto, Kunihito; Taniyama, Kiyomi; Mori, Masaki; Doki, Yuichiro			A practical approach to pancreatic cancer immunotherapy using resected tumor lysate vaccines processed to express alpha-gal epitopes	PLOS ONE			English	Article							ANTI-GAL; DENDRITIC CELLS; PREOPERATIVE CHEMORADIATION; INCREASED IMMUNOGENICITY; COMBINATION THERAPY; IMMUNE-RESPONSES; IN-VITRO; T-CELLS; ADENOCARCINOMA; GEMCITABINE	Objectives Single-agent immunotherapy is ineffective against poorly immunogenic cancers, including pancreatic ductal adenocarcinoma (PDAC). The aims of this study were to demonstrate the feasibility of production of novel autologous tumor lysate vaccines from resected PDAC tumors, and verify vaccine safety and efficacy. Methods Fresh surgically resected tumors obtained from human patients were processed to enzymatically synthesize alpha-gal epitopes on the carbohydrate chains of membrane glycoproteins. Processed membranes were analyzed for the expression of alpha-gal epitopes and the binding of anti-Gal, and vaccine efficacy was assessed in vitro and in vivo. Results Effective synthesis of alpha-gal epitopes was demonstrated after processing of PDAC tumor lysates from 10 different patients, and tumor lysates readily bound an anti-Gal monoclonal antibody. alpha-gal(+) PDAC tumor lysate vaccines elicited strong antibody production against multiple tumor-associated antigens and activated multiple tumor-specific T cells. The lysate vaccines stimulated a robust immune response in animal models, resulting in tumor suppression and a significant improvement in survival without any adverse events. Conclusions Our data suggest that alpha- gal(+) PDAC tumor lysate vaccination may be a practical and effective new immunotherapeutic approach for treating pancreatic cancer.	[Furukawa, Kenta; Tanemura, Masahiro] Osaka Police Hosp, Dept Gastroenterol Surg, Osaka, Japan; [Miyoshi, Eiji] Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Invest, Osaka, Japan; [Eguchi, Hidetoshi; Nagaoka, Satoshi; Yamada, Daisaku; Asaoka, Tadafumi; Noda, Takehiro; Wada, Hiroshi; Kawamoto, Koichi; Goto, Kunihito; Mori, Masaki; Doki, Yuichiro] Osaka Univ, Grad Sch Med, Dept Surg, Osaka, Japan; [Nagano, Hiroaki] Yamaguchi Univ, Grad Sch Med, Dept Gastroenterol Breast & Endocrine Surg, Yamaguchi, Japan; [Matsunami, Katsuyoshi] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Phamacognosy, Hiroshima, Japan; [Taniyama, Kiyomi] Natl Hosp Org, Kure Med Ctr, Inst Clin Res, Kure, Japan; [Taniyama, Kiyomi] Chugoku Canc Ctr, Kure, Japan	Osaka Police Hospital; Osaka University; Osaka University; Yamaguchi University; Hiroshima University	Tanemura, M (corresponding author), Osaka Police Hosp, Dept Gastroenterol Surg, Osaka, Japan.	tanemuram@oph.gr.jp	Matsunami, Katsuyoshi/AHC-4234-2022	Matsunami, Katsuyoshi/0000-0002-8034-0253; Noda, Takehiro/0000-0002-6768-5783	Ministry of Education, Sports and Culture of Japan [16K10618]	Ministry of Education, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Ministry of Education, Sports and Culture of Japan to M. T. (No. 16K10618).	Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Brossart Peter, 1997, Blood, V90, P1594; Chang K, 1996, P NATL ACAD SCI USA, V93, P136, DOI 10.1073/pnas.93.1.136; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Chen ZC, 2001, GLYCOBIOLOGY, V11, P577, DOI 10.1093/glycob/11.7.577; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Deguchi T, 2010, CANCER RES, V70, P5259, DOI 10.1158/0008-5472.CAN-09-4313; Dodson LF, 2011, IMMUNOTHERAPY-UK, V3, P517, DOI [10.2217/IMT.11.10, 10.2217/imt.11.10]; Eguchi H, 2014, CANCER CHEMOTH PHARM, V73, P309, DOI 10.1007/s00280-013-2357-9; Eguchi H, 2013, HEPATO-GASTROENTEROL, V60, P904, DOI 10.5754/hge12974; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; EVANS DB, 1992, ARCH SURG-CHICAGO, V127, P1335; Evans DB, 2008, J CLIN ONCOL, V26, P3496, DOI 10.1200/JCO.2007.15.8634; Fields RC, 1998, P NATL ACAD SCI USA, V95, P9482, DOI 10.1073/pnas.95.16.9482; Galili U, 2003, GYNECOL ONCOL, V90, P100, DOI 10.1016/S0090-8258(03)00148-3; Galili U, 1997, IMMUNOL TODAY, V18, P281, DOI 10.1016/S0167-5699(97)80024-2; Galili U, 2013, IMMUNOLOGY, V140, P1, DOI 10.1111/imm.12110; Gendler SJ, 2001, J MAMMARY GLAND BIOL, V6, P339, DOI 10.1023/A:1011379725811; Gillen S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000267; Guillerey C, 2015, J CLIN INVEST, V125, P2077, DOI 10.1172/JCI77181; Hartwig W, 2013, LANCET ONCOL, V14, pE476, DOI 10.1016/S1470-2045(13)70172-4; Hassan R, 2005, AM J CLIN PATHOL, V124, P838, DOI 10.1309/F1B64CL7H8VJKEAF; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; HOFFMAN JP, 1995, AM J SURG, V169, P71, DOI 10.1016/S0002-9610(99)80112-3; Kakizaki A, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1047584; Kobayashi T, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.990793; Koido S, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/267539; LaTemple DC, 1998, XENOTRANSPLANTATION, V5, P191, DOI 10.1111/j.1399-3089.1998.tb00027.x; LaTemple DC, 1999, CANCER RES, V59, P3417; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Melero I, 2014, NAT REV CLIN ONCOL, V11, P509, DOI 10.1038/nrclinonc.2014.111; Motta JM, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/4753607; Ohigashi H, 2009, ANN SURG, V250, P88, DOI 10.1097/SLA.0b013e3181ad65cc; Ostrand-Rosenberg S, 2010, CANCER IMMUNOL IMMUN, V59, P1593, DOI 10.1007/s00262-010-0855-8; Pandolfi F, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/894704; Qu CF, 2004, BRIT J CANCER, V91, P2086, DOI 10.1038/sj.bjc.6602232; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Saito H, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1621; Schnurr M, 2002, CANCER RES, V62, P2347; Shen ZH, 1997, J IMMUNOL, V158, P2723; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Soares KC, 2012, CANCER J, V18, P642, DOI 10.1097/PPO.0b013e3182756903; Spitz FR, 1997, J CLIN ONCOL, V15, P928, DOI 10.1200/JCO.1997.15.3.928; Tanemura M, 2000, J CLIN INVEST, V105, P301, DOI 10.1172/JCI7358; Tanemura M, 2013, CANCER SCI, V104, P282, DOI 10.1111/cas.12084; Tanida T, 2015, INT J ONCOL, V46, P78, DOI 10.3892/ijo.2014.2717; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369	48	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0184901	10.1371/journal.pone.0184901	http://dx.doi.org/10.1371/journal.pone.0184901			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077749	Green Published, Green Submitted, gold			2022-12-26	WOS:000413861200002
J	Alonso, J; Martinez, M				Alonso, Joaquin; Martinez, Manuel			Insights into the molecular evolution of peptidase inhibitors in arthropods	PLOS ONE			English	Article							PROTEASE INHIBITORS; FUNCTIONAL-CHARACTERIZATION; GENOME SEQUENCE; DEATH EVOLUTION; GENE; EXPRESSION; SILKWORM; FAMILY; DIVERGENCE; PROHIBITIN	Peptidase inhibitors are key proteins involved in the control of peptidases. In arthropods, peptidase inhibitors modulate the activity of peptidases involved in endogenous physiological processes and peptidases of the organisms with which they interact. Exploring available arthropod genomic sequences is a powerful way to obtain the repertoire of peptidase inhibitors in every arthropod species and to understand the evolutionary mechanisms involved in the diversification of this kind of proteins. A genomic comparative analysis of peptidase inhibitors in species belonging to different arthropod taxonomic groups was performed. The results point out: i) species or clade-specific presence is shown for several families of peptidase inhibitors; ii) multidomain peptidase inhibitors are commonly found in many peptidase inhibitor families; iii) several families have a wide range of members in different arthropod species; iv) several peptidase inhibitor families show species-specific (or clade-specific) gene family expansions; v) functional divergence may be assumed for particular clades; vi) passive expansions may be used by natural selection to fix adaptations. In conclusion, conservation and divergence of duplicated genes and the potential recruitment as peptidase inhibitors of proteins from other families are the main mechanisms used by arthropods to fix diversity. This diversity would be associated to the control of target peptidases and, as consequence, to adapt to specific environments.	[Alonso, Joaquin; Martinez, Manuel] Univ Politecn Madrid, Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Ctr Biotecnol & Genom Plantas, Campus Montegancedo UPM, Pozuelo De Alarcon, Madrid, Spain; [Martinez, Manuel] UPM, Escuela Tecn Super Ingn Agronom Alimentaria & Bio, Dept Biotecnol Biol Vegetal, Madrid, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Universidad Politecnica de Madrid; Universidad Politecnica de Madrid	Martinez, M (corresponding author), Univ Politecn Madrid, Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Ctr Biotecnol & Genom Plantas, Campus Montegancedo UPM, Pozuelo De Alarcon, Madrid, Spain.; Martinez, M (corresponding author), UPM, Escuela Tecn Super Ingn Agronom Alimentaria & Bio, Dept Biotecnol Biol Vegetal, Madrid, Spain.	m.martinez@upm.es	Martinez, Manuel/I-8743-2014	Martinez, Manuel/0000-0002-7826-5872	Ministerio de Economia y Competitividad [BIO2014-53508-R, 618105-FACCE-Era Net Plus]	Ministerio de Economia y Competitividad(Spanish Government)	This work was supported by projects BIO2014-53508-R and 618105-FACCE-Era Net Plus from Ministerio de Economia y Competitividad. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Corral-Rodriguez MA, 2009, INSECT BIOCHEM MOLEC, V39, P579, DOI 10.1016/j.ibmb.2009.07.003; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Arolas JL, 2005, J MOL BIOL, V350, P489, DOI 10.1016/j.jmb.2005.05.015; Breugelmans B, 2009, PEPTIDES, V30, P622, DOI 10.1016/j.peptides.2008.07.026; Buarque DS, 2011, BIOCHEM BIOPH RES CO, V413, P241, DOI 10.1016/j.bbrc.2011.08.078; Cao ZJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3602; Chipman AD, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002005; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Dai SX, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-4; Decaestecker E, 2011, DEV COMP IMMUNOL, V35, P1066, DOI 10.1016/j.dci.2011.04.004; Demuth JP, 2009, BIOESSAYS, V31, P29, DOI 10.1002/bies.080085; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eirin-Lopez JM, 2012, GENOME DYNAM, V7, P170, DOI 10.1159/000337119; Santamara ME, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-812; Feyereisen R, 2011, BBA-PROTEINS PROTEOM, V1814, P19, DOI 10.1016/j.bbapap.2010.06.012; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Francischetti IMB, 2007, INSECT BIOCHEM MOLEC, V37, P903, DOI 10.1016/j.ibmb.2007.04.007; Francischetti IMB, 2009, FRONT BIOSCI-LANDMRK, V14, P2051, DOI 10.2741/3363; Garrett M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-489; Goto SG, 2002, GENE, V292, P121, DOI 10.1016/S0378-1119(02)00652-2; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080; Gu X, 2013, MOL BIOL EVOL, V30, P1713, DOI 10.1093/molbev/mst069; Gubb D, 2010, BIOCHIMIE, V92, P1749, DOI 10.1016/j.biochi.2010.09.004; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hernandez-Vargas MJ, 2016, TOXINS, V8, DOI 10.3390/toxins8020044; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Horita S, 2010, J BIOL CHEM, V285, P30150, DOI 10.1074/jbc.M110.124735; Hwang JR, 2000, J BIOL CHEM, V275, P17886, DOI 10.1074/jbc.M000032200; Joshi RS, 2013, BBA-GEN SUBJECTS, V1830, P5087, DOI 10.1016/j.bbagen.2013.07.019; Kantyka T, 2010, BIOCHIMIE, V92, P1644, DOI 10.1016/j.biochi.2010.06.004; Kenny NJ, 2015, GENOME BIOL EVOL, V7, P1280, DOI 10.1093/gbe/evv070; Knorr E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004751; Koh CY, 2009, THROMB HAEMOSTASIS, V102, P437, DOI 10.1160/TH09-04-0221; Kotsyfakis M, 2007, J BIOL CHEM, V282, P29256, DOI 10.1074/jbc.M703143200; Kuadkitkan A, 2010, VIROLOGY, V406, P149, DOI 10.1016/j.virol.2010.07.015; Kubiak MR, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9040080; Li JL, 2016, INSECT BIOCHEM MOLEC, V73, P27, DOI 10.1016/j.ibmb.2016.04.003; Li YS, 2015, INSECT BIOCHEM MOLEC, V57, P11, DOI 10.1016/j.ibmb.2014.11.006; Lu AR, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00252; Lv ZB, 2012, GENE, V502, P118, DOI 10.1016/j.gene.2012.03.035; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Martinez M, 2011, TRENDS PLANT SCI, V16, P558, DOI 10.1016/j.tplants.2011.06.003; Mulenga A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-217; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Ohno S., 1970, P1; Orme M, 2009, APOPTOSIS, V14, P950, DOI 10.1007/s10495-009-0358-2; Poelchau M, 2015, NUCLEIC ACIDS RES, V43, pD714, DOI 10.1093/nar/gku983; Ranasinghe S, 2013, DEV COMP IMMUNOL, V39, P219, DOI 10.1016/j.dci.2012.10.005; Rawlings ND, 2016, NUCLEIC ACIDS RES, V44, pD343, DOI 10.1093/nar/gkv1118; Reichhart JM, 2011, METHOD ENZYMOL, V499, P205, DOI 10.1016/B978-0-12-386471-0.00011-0; Reumer A, 2009, DEV COMP IMMUNOL, V33, P1186, DOI 10.1016/j.dci.2009.06.010; Rodriguez-Valle M, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0605-4; Roy S, 2012, APPL BIOCHEM BIOTECH, V168, P1076, DOI 10.1007/s12010-012-9842-1; SAITO H, 1989, BIOCHEMISTRY-US, V28, P1749, DOI 10.1021/bi00430a049; Santamaria ME, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-307; Schwarz A, 2012, TICKS TICK-BORNE DIS, V3, P117, DOI 10.1016/j.ttbdis.2012.03.004; Smith VJ, 2011, BIOCHEM SOC T, V39, P1403, DOI 10.1042/BST0391403; Suwanchaichinda C, 2009, GENE, V442, P47, DOI 10.1016/j.gene.2009.04.013; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tirloni L, 2016, INSECT BIOCHEM MOLEC, V71, P12, DOI 10.1016/j.ibmb.2016.01.004; Urbanova V, 2015, DEV COMP IMMUNOL, V48, P55, DOI 10.1016/j.dci.2014.09.004; van Hoef V, 2013, PEPTIDES, V41, P59, DOI 10.1016/j.peptides.2012.10.015; Wang Y, 2015, BIOMED RES INT, V2015, P6, DOI DOI 10.1128/MBI0.01280-15; Waterhouse RM, 2015, CURR OPIN INSECT SCI, V7, P15, DOI 10.1016/j.cois.2015.01.004; Wu CL, 2012, INSECT BIOCHEM MOLEC, V42, P71, DOI 10.1016/j.ibmb.2011.10.006; Yin CL, 2016, NUCLEIC ACIDS RES, V44, pD801, DOI 10.1093/nar/gkv1204; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; ZHAO P, 2012, PLOS ONE, V7; ZHEN Z, 2009, GENOMICS, V93, P367, DOI DOI 10.1016/J.YGENO.2008.12.010	72	1	1	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187643	10.1371/journal.pone.0187643	http://dx.doi.org/10.1371/journal.pone.0187643			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29108008	Green Published, gold, Green Submitted			2022-12-26	WOS:000414424600052
J	Honorat, JA; Nakatsuji, Y; Shimizu, M; Kinoshita, M; Sumi-Akamaru, H; Sasaki, T; Takata, K; Koda, T; Namba, A; Yamashita, K; Sanda, E; Sakaguchi, M; Kumanogoh, A; Shirakura, T; Tamura, M; Sakoda, S; Mochizuki, H; Okuno, T				Honorat, Josephe A.; Nakatsuji, Yuji; Shimizu, Mikito; Kinoshita, Makoto; Sumi-Akamaru, Hisae; Sasaki, Tsutomu; Takata, Kazushiro; Koda, Toru; Namba, Akiko; Yamashita, Kazuya; Sanda, Eri; Sakaguchi, Manabu; Kumanogoh, Atsushi; Shirakura, Takashi; Tamura, Mizuho; Sakoda, Saburo; Mochizuki, Hideki; Okuno, Tatsusada			Febuxostat ameliorates secondary progressive experimental autoimmune encephalomyelitis by restoring mitochondrial energy production in a GOT2-dependent manner	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS PATIENTS; WHITE-MATTER DAMAGE; AXONAL LOSS; ASPARTATE-AMINOTRANSFERASE; OXIDATIVE DAMAGE; DYSFUNCTION; BRAIN; DEGENERATION; PATHOGENESIS; PATHOLOGY	Oxidative stress and mitochondrial dysfunction are important determinants of neurodegeneration in secondary progressive multiple sclerosis (SPMS). We previously showed that febuxostat, a xanthine oxidase inhibitor, ameliorated both relapsing-remitting and secondary progressive experimental autoimmune encephalomyelitis (EAE) by preventing neurodegeneration in mice. In this study, we investigated how febuxostat protects neuron in secondary progressive EAE. A DNA microarray analysis revealed that febuxostat treatment increased the CNS expression of several mitochondria-related genes in EAE mice, most notably including GOT2, which encodes glutamate oxaloacetate transaminase 2 (GOT2). GOT2 is a mitochondrial enzyme that oxidizes glutamate to produce alpha-ketoglutarate for the Krebs cycle, eventually leading to the production of adenosine triphosphate (ATP). Whereas GOT2 expression was decreased in the spinal cord during the chronic progressive phase of EAE, febuxostat-treated EAE mice showed increased GOT2 expression. Moreover, febuxostat treatment of Neuro2a cells in vitro ameliorated ATP exhaustion induced by rotenone application. The ability of febuxostat to preserve ATP production in the presence of rotenone was significantly reduced by GOT2 siRNA. GOT2-mediated ATP synthesis may be a pivotal mechanism underlying the protective effect of febuxostat against neurodegeneration in EAE. Accordingly, febuxostat may also have clinical utility as a disease-modifying drug in SPMS.	[Honorat, Josephe A.; Nakatsuji, Yuji; Shimizu, Mikito; Sumi-Akamaru, Hisae; Sasaki, Tsutomu; Koda, Toru; Namba, Akiko; Yamashita, Kazuya; Sanda, Eri; Sakaguchi, Manabu; Mochizuki, Hideki; Okuno, Tatsusada] Osaka Univ, Grad Sch Med, Dept Neurol, Suita, Osaka, Japan; [Kinoshita, Makoto; Takata, Kazushiro] Osaka Gen Med Ctr, Dept Neurol, Osaka, Osaka, Japan; [Kumanogoh, Atsushi] Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, Suita, Osaka, Japan; [Shirakura, Takashi; Tamura, Mizuho] Teijin Pharma Ltd, Pharmaceut Dev Res Labs, Hino, Tokyo, Japan; [Sakoda, Saburo] Natl Hosp Org, Toneyama Natl Hosp, Dept Neurol, Toyonaka, Osaka, Japan	Osaka University; Osaka University; Teijin Pharma Limited	Nakatsuji, Y; Okuno, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Neurol, Suita, Osaka, Japan.	nakatsuj@med.u-toyama.ac.jp; okuno@neurol.med.osaka-u.ac.jp		sasaki, tsutomu/0000-0001-8726-978X	Japan Agency for Medical Research and Development (AMED); JSPS KAKENHI [JP26461293, JP15K09339]; Ministry of Health, Labor and Welfare of Japan; Teijin Pharma Ltd.	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Teijin Pharma Ltd.	This study is supported in part by the Practical Research Project for Rare/Intractable Diseases of the Japan Agency for Medical Research and Development (AMED), JSPS KAKENHI (grant numbers JP26461293 and JP15K09339), and a Health and Labor Sciences Research Grant for Rare and Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan. Teijin Pharma Ltd. provided support in the form of salaries for authors T.S. and M.T., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aboul-Enein F, 2003, J NEUROPATH EXP NEUR, V62, P25, DOI 10.1093/jnen/62.1.25; Aboul-Enein F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011625; Andrews HE, 2005, MED HYPOTHESES, V64, P669, DOI 10.1016/j.mehy.2004.09.001; Arun P, 2013, J NEUROTRAUM, V30, P1645, DOI 10.1089/neu.2012.2834; Bjartmar C, 2000, ANN NEUROL, V48, P893, DOI 10.1002/1531-8249(200012)48:6<893::AID-ANA10>3.3.CO;2-2; Bjartmar C, 2003, J NEUROL SCI, V206, P165, DOI 10.1016/S0022-510X(02)00069-2; Bros H, 2014, EXP NEUROL, V261, P127, DOI 10.1016/j.expneurol.2014.06.018; Campbell GR, 2011, ANN NEUROL, V69, P481, DOI 10.1002/ana.22109; Choi BY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0325-5; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Dutta R, 2007, NEUROLOGY, V68, pS22, DOI 10.1212/01.wnl.0000275229.13012.32; Farez MF, 2009, NAT IMMUNOL, V10, P958, DOI 10.1038/ni.1775; Feinstein A, 2015, LANCET NEUROL, V14, P194, DOI 10.1016/S1474-4422(14)70231-5; Haider L, 2011, BRAIN, V134, P1914, DOI 10.1093/brain/awr128; Honorat JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071329; Jasperse B, 2007, J NEUROL, V254, P631, DOI 10.1007/s00415-006-0415-5; Lassmann H, 2012, NAT REV NEUROL, V8, P647, DOI 10.1038/nrneurol.2012.168; Lee J, 2011, J CARDIOVASC TRANSL, V4, P504, DOI 10.1007/s12265-011-9276-0; Magliozzi R, 2010, ANN NEUROL, V68, P477, DOI 10.1002/ana.22230; Mahad DJ, 2009, BRAIN, V132, P1161, DOI 10.1093/brain/awp046; McKenna MC, 2000, NEUROCHEM INT, V37, P229, DOI 10.1016/S0197-0186(00)00042-5; Mervaala EMA, 2001, HYPERTENSION, V37, P414, DOI 10.1161/01.HYP.37.2.414; Minchenko O H, 2016, Ukr Biochem J, V88, P54, DOI 10.15407/ubj88.03.054; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Moran J, 1999, INT J DEV NEUROSCI, V17, P57, DOI 10.1016/S0736-5748(98)00063-X; Moriya M, 2008, NEUROSCI LETT, V440, P323, DOI 10.1016/j.neulet.2008.05.110; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Sijens PE, 2006, EUR RADIOL, V16, P489, DOI 10.1007/s00330-005-2839-1; Trapp BD, 2009, LANCET NEUROL, V8, P280, DOI 10.1016/S1474-4422(09)70043-2; van den Berg R, 2017, ACTA NEUROPATHOL, V134, P1, DOI 10.1007/s00401-017-1697-7; Vincenzetti S, 2016, BIOCHIMIE, V121, P79, DOI 10.1016/j.biochi.2015.11.026; Wang SL, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0578-x; Yudkoff M, 2005, NEUROCHEM INT, V47, P119, DOI 10.1016/j.neuint.2005.04.014	33	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187215	10.1371/journal.pone.0187215	http://dx.doi.org/10.1371/journal.pone.0187215			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29107957	Green Submitted, Green Published, gold			2022-12-26	WOS:000414424600018
J	Hutabarat, M; Wibowo, N; Huppertz, B				Hutabarat, Martina; Wibowo, Noroyono; Huppertz, Berthold			The trophoblast survival capacity in preeclampsia	PLOS ONE			English	Article							STRESS-RESPONSE; AUTOPHAGY; APOPTOSIS; PLACENTAS	Background Preeclampsia has become the world's major maternal health problem putting a huge burden on mothers, newborns and also on the health systems. The pathogenesis of preeclampsia seems to include events in very early pregnancy affecting differentiation of placental villous trophoblast. The arising changes of the cell death spectrum from apoptosis via increased autophagy and aponecrosis to necrosis in turn induce systemic inflammation of the mother. Methods Placental tissue samples and maternal serum samples from 40 pregnant women were collected from normal pregnancy, IUGR, early-onset and late-onset preeclampsia. Immunohistochemistry for LC3B and Beclin-1 was quantified using systematic random sampling techniques. Serum levels of LDH and other markers were assessed in serum. Results Expression of the autophagy markers LC3B and Beclin-1 was significantly different between groups as was the LC3B/Beclin-1 ratio. Early-onset preeclampsia and IUGR had the highest autophagy protein expression levels, while normal pregnancy and late-onset preeclampsia had the highest LC3B/Beclin-1 ratio. Early-onset preeclampsia had the highest negative correlation with free LDH as cell defect marker. Conclusions Autophagy plays a critical role in the cell death spectrum and cellular survival capacity of villous trophoblast. Alterations in autophagic protein expression are involved in pathological pregnancies such as preeclampsia.	[Hutabarat, Martina] Univ Indonesia, Postgrad Dept, Doctorate Program Med Sci, Jakarta, Dki Jakarta, Indonesia; [Wibowo, Noroyono] Univ Indonesia, Dept Obstetr & Gynecol, Div Maternal Fetal Med, Fac Med, Jakarta, Dki Jakarta, Indonesia; [Huppertz, Berthold] Med Univ Graz, Inst Cell Biol Histol & Embryol, Graz, Austria; [Huppertz, Berthold] Neue Stiftingtalstr, Graz, Austria	University of Indonesia; University of Indonesia; Medical University of Graz	Hutabarat, M (corresponding author), Univ Indonesia, Postgrad Dept, Doctorate Program Med Sci, Jakarta, Dki Jakarta, Indonesia.	martina.hutabarat28@yahoo.com	Huppertz, Berthold/I-2331-2019	Huppertz, Berthold/0000-0003-4814-2158; Wibowo, Noroyono/0000-0003-3995-6870				Adhami F, 2007, AUTOPHAGY, V3, P42, DOI 10.4161/auto.3412; Bailey LJ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.483; Bildirici I, 2012, PLACENTA, V33, P591, DOI 10.1016/j.placenta.2012.04.011; Burton GJ, 2009, PLACENTA, V30, P473, DOI 10.1016/j.placenta.2009.02.009; Cali U, 2013, CLIN EXP OBSTET GYN, V40, P45; Cantu J, 2014, OBSTET GYNECOL, V124, P933, DOI 10.1097/AOG.0000000000000509; Chifenti Barbara, 2013, Clin Exp Reprod Med, V40, P33, DOI 10.5653/cerm.2013.40.1.33; Demirovic D, 2013, EXP GERONTOL, V48, P94, DOI 10.1016/j.exger.2012.02.005; Gong Jin-Sung, 2014, Clin Exp Reprod Med, V41, P97, DOI 10.5653/cerm.2014.41.3.97; Hung TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040957; Huppertz B, 2010, PLACENTA, V31, pS75, DOI 10.1016/j.placenta.2009.12.001; Huppertz B., 1999, TROPHOBLAST RES, V13, P215, DOI 10.1016/S0143-4004(99)80018-6; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Huppertz B, 2015, J REPROD IMMUNOL, V108, P26, DOI 10.1016/j.jri.2014.11.003; Huppertz B, 2014, J REPROD IMMUNOL, V101, P74, DOI 10.1016/j.jri.2013.04.003; Huppertz B, 2011, THROMB RES, V127, pS96, DOI 10.1016/S0049-3848(11)70026-3; Jaiswar SP, 2011, J OBSTET GYN INDIA, V61, P645, DOI 10.1007/s13224-011-0093-9; Ji L, 2013, MOL ASPECTS MED, V34, P981, DOI 10.1016/j.mam.2012.12.008; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kourtis N, 2011, EMBO J, V30, P2520, DOI 10.1038/emboj.2011.162; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Longtine MS, 2012, PLACENTA, V33, P352, DOI 10.1016/j.placenta.2012.01.017; Nakashima A, 2013, AUTOPHAGY, V9, P303, DOI 10.4161/auto.22927; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; Oh SY, 2008, REPROD SCI, V15, P912, DOI 10.1177/1933719108319159; Pantham P, 2011, PLACENTA, V32, P724, DOI 10.1016/j.placenta.2011.06.019; Roberts JM, 2012, PREGNANCY HYPERTENS, V2, P72, DOI 10.1016/j.preghy.2012.01.001; Signorelli P, 2011, PLACENTA, V32, P482, DOI 10.1016/j.placenta.2011.03.005; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Tranquilli AL, 2012, PREGNANCY HYPERTENS, V2, P350, DOI [10.1016/j.preghy.2012.05.006, 10.1016/j.preghy.2012.04.146]	30	24	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0186909	10.1371/journal.pone.0186909	http://dx.doi.org/10.1371/journal.pone.0186909			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29107968	gold, Green Published, Green Submitted			2022-12-26	WOS:000414424600009
J	Kim, JY; Kim, HY; Jeon, JY; Kim, DM; Zhou, YY; Lee, JS; Lee, H; Choi, HK				Kim, Jin-Young; Kim, Hye-Youn; Jeon, Jun-Yeong; Kim, Dong-Min; Zhou, Yaoyao; Lee, Jae Soung; Lee, Heayyean; Choi, Hyung-Kyoon			Effects of coronatine elicitation on growth and metabolic profiles of Lemna paucicostata culture	PLOS ONE			English	Article							ANTIOXIDATIVE DEFENSE SYSTEM; WATER TREATMENT SYSTEMS; ACID PHENETHYL ESTER; METHYL JASMONATE; FERULIC ACID; SINAPIC ACID; CELL-CULTURES; IN-VITRO; BIOSYNTHESIS; STRESS	In this study, the effects of coronatine treatment on the growth, comprehensive metabolic profiles, and productivity of bioactive compounds, including phenolics and phytosterols, in whole plant cultures of Lemna paucicostata were investigated using gas chromatography-mass spectrometry (GC-MS) coupled with multivariate statistical analysis. To determine the optimal timing of coronatine elicitation, coronatine was added on days 0, 23, and 28 after inoculation. The total growth of L. paucicostata was not significantly different between the coronatine treated groups and the control. The coronatine treatment in L. paucicostata induced increases in the content of hydroxycinnamic acids, such as caffeic acid, isoferulic acid, rho-coumaric acid, sinapic acid, and phytosterols, such as campesterol and beta-sitosterol. The productivity of these useful metabolites was highest when coronatine was added on day 0 and harvested on day 32. These results suggest that coronatine treatment on day 0 activates the phenolic and phytosterol biosynthetic pathways in L. paucicostata to a greater extent than in the control. To the best of our knowledge, this is the first report to investigate the effects of coronatine on the alteration of metabolism in L. paucicostata based on GC-MS profiling. The results of this research provide a foundation for designing strategies for enhanced production of useful metabolites for pharmaceutical and nutraceutical industries by cultivation of L. paucicostata.	[Kim, Jin-Young; Kim, Hye-Youn; Jeon, Jun-Yeong; Kim, Dong-Min; Zhou, Yaoyao; Lee, Jae Soung; Lee, Heayyean; Choi, Hyung-Kyoon] Chung Ang Univ, Coll Pharm, Seoul, South Korea	Chung Ang University	Choi, HK (corresponding author), Chung Ang Univ, Coll Pharm, Seoul, South Korea.	hykychoi@cau.ac.kr		Zhou, Yaoyao/0000-0001-5104-0457; Choi, Hyung-Kyoon/0000-0002-4523-0534	Basic Core Technology Development Program for the Oceans and the Polar Regions of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning [NRF-2016M1A5A1027464]; Chung-Ang University	Basic Core Technology Development Program for the Oceans and the Polar Regions of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning; Chung-Ang University	This work was supported by the Basic Core Technology Development Program for the Oceans and the Polar Regions of the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning (No. NRF-2016M1A5A1027464) and by the Chung-Ang University Graduate Research Scholarship in 2017.	Almagro L, 2015, PLANT PHYSIOL BIOCH, V97, P361, DOI 10.1016/j.plaphy.2015.10.025; BACH TJ, 1986, LIPIDS, V21, P82, DOI 10.1007/BF02534307; Bender CL, 1999, MICROBIOL MOL BIOL R, V63, P266, DOI 10.1128/MMBR.63.2.266-292.1999; Chen JH, 1996, CANCER LETT, V108, P211, DOI 10.1016/S0304-3835(96)04425-4; DICOSMO F, 1985, TRENDS BIOTECHNOL, V3, P318, DOI 10.1016/0167-7799(85)90036-8; FARMER EE, 1990, P NATL ACAD SCI USA, V87, P7713, DOI 10.1073/pnas.87.19.7713; Farmer EE, 2003, CURR OPIN PLANT BIOL, V6, P372, DOI 10.1016/S1369-5266(03)00045-1; Fumagalli E, 2009, J AGRON CROP SCI, V195, P77, DOI 10.1111/j.1439-037X.2008.00344.x; Gallego A, 2015, J BIOTECHNOL, V195, P93, DOI 10.1016/j.jbiotec.2014.12.023; Gantet P, 2002, TRENDS PHARMACOL SCI, V23, P563, DOI 10.1016/S0165-6147(02)02098-9; Gatidou G, 2017, SCI TOTAL ENVIRON, V596, P12, DOI 10.1016/j.scitotenv.2017.04.051; GRAF E, 1992, FREE RADICAL BIO MED, V13, P435, DOI 10.1016/0891-5849(92)90184-I; Gupta A.K., 2013, IUCN RED LIST THREAT; Hao L, 2013, PLANT SCI, V210, P1, DOI 10.1016/j.plantsci.2013.05.006; Harvey AL, 2008, DRUG DISCOV TODAY, V13, P894, DOI 10.1016/j.drudis.2008.07.004; Hidalgo D, 2016, ENG LIFE SCI, V16, P1; Iatrou EI, 2017, J HAZARD MATER, V330, P116, DOI 10.1016/j.jhazmat.2017.02.005; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; Kral'ova K, 2012, ECOL CHEM ENG S, V19, P133, DOI 10.2478/v10216-011-0012-0; Liao HF, 2003, J AGR FOOD CHEM, V51, P7907, DOI 10.1021/jf034729d; Luceri C, 2007, BRIT J NUTR, V97, P458, DOI 10.1017/S0007114507657882; Matkowski A, 2008, BIOTECHNOL ADV, V26, P548, DOI 10.1016/j.biotechadv.2008.07.001; Moreau RA, 2002, PROG LIPID RES, V41, P457, DOI 10.1016/S0163-7827(02)00006-1; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nafea EMA., 2016, J MEDITERR ECOL, V14, P5; Nair RB, 2004, PLANT CELL, V16, P544, DOI 10.1105/tpc.017509; Namdeo A. G., 2007, Pharmacognosy Reviews, V1, P69; Onrubia M, 2013, J PLANT PHYSIOL, V170, P211, DOI 10.1016/j.jplph.2012.09.004; Piotrowska A, 2010, J PLANT GROWTH REGUL, V29, P53, DOI 10.1007/s00344-009-9113-8; Rischer H, 2006, P NATL ACAD SCI USA, V103, P5614, DOI 10.1073/pnas.0601027103; Saeidnia S., 2014, European Journal of Medicinal Plants, V4, P590; Sakai S, 1999, MEDIAT INFLAMM, V8, P173, DOI 10.1080/09629359990513; Satdive RK, 2007, J BIOTECHNOL, V128, P281, DOI 10.1016/j.jbiotec.2006.10.009; Sinapic H., 2014, COMPR REV FOOD SCI F, V13, P34; Sudhop T, 2002, GUT, V51, P860, DOI 10.1136/gut.51.6.860; Suh HW, 2013, PROCESS BIOCHEM, V48, P1581, DOI 10.1016/j.procbio.2013.06.032; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Thiyam U, 2006, EUR J LIPID SCI TECH, V108, P239, DOI 10.1002/ejlt.200500292; Tugizimana F, 2015, PLANT BIOTECHNOL REP, V9, P125, DOI 10.1007/s11816-015-0350-y; TUrker OC, 2017, INT J PHYTOREMEDIAT; Uppalapati SR, 2005, PLANT J, V42, P201, DOI 10.1111/j.1365-313X.2005.02366.x; Vallejo F, 2002, J SCI FOOD AGR, V82, P1293, DOI 10.1002/jsfa.1183; Vasconsuelo A, 2007, PLANT SCI, V172, P861, DOI 10.1016/j.plantsci.2007.01.006; Villasenor IM, 2002, PHYTOTHER RES, V16, P417, DOI 10.1002/ptr.910; Wang L, 2009, J AGRON CROP SCI, V195, P377, DOI 10.1111/j.1439-037X.2009.00378.x; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; Weston LA., 2015, J ALLELOCHEM INTERAC, V2, P15; Weststrate JA, 1998, EUR J CLIN NUTR, V52, P334, DOI 10.1038/sj.ejcn.1600559; Xie ZX, 2008, J PLANT PHYSIOL, V165, P375, DOI 10.1016/j.jplph.2007.06.001; Xie ZX, 2015, J PLANT GROWTH REGUL, V34, P651, DOI 10.1007/s00344-015-9501-1; Yun KJ, 2008, J AGR FOOD CHEM, V56, P10265, DOI 10.1021/jf802095g; Zhang YQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012559; 안영성, 2004, [The Korea Journal of Herbology, 대한본초학회지], V19, P117	53	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							e0187622	10.1371/journal.pone.0187622	http://dx.doi.org/10.1371/journal.pone.0187622			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6TA	29099862	Green Published, Green Submitted, gold			2022-12-26	WOS:000414377900034
J	Stupple, EJN; Pitchford, M; Ball, LJ; Hunt, TE; Steel, R				Stupple, Edward J. N.; Pitchford, Melanie; Ball, Linden J.; Hunt, Thomas E.; Steel, Richard			Slower is not always better: Response-time evidence clarifies the limited role of miserly information processing in the Cognitive Reflection Test	PLOS ONE			English	Article							DUAL-PROCESS THEORIES; INDIVIDUAL-DIFFERENCES; DECISION-MAKING; SELECTION TASK; INSPECTION TIMES; ANALYTIC THINKING; PROCESS MODEL; CONFLICT; BIAS; BELIEF	We report a study examining the role of 'cognitive miserliness' as a determinant of poor performance on the standard three-item Cognitive Reflection Test (CRT). The cognitive miserliness hypothesis proposes that people often respond incorrectly on CRT items because of an unwillingness to go beyond default, heuristic processing and invest time and effort in analytic, reflective processing. Our analysis (N = 391) focused on people's response times to CRT items to determine whether predicted associations are evident between miserly thinking and the generation of incorrect, intuitive answers. Evidence indicated only a weak correlation between CRT response times and accuracy. Item-level analyses also failed to demonstrate predicted response-time differences between correct analytic and incorrect intuitive answers for two of the three CRT items. We question whether participants who give incorrect intuitive answers on the CRT can legitimately be termed cognitive misers and whether the three CRT items measure the same general construct.	[Stupple, Edward J. N.; Hunt, Thomas E.] Univ Derby, Ctr Psychol Res, Derby, England; [Pitchford, Melanie] Univ Bedfordshire, Dept Psychol, Luton, Beds, England; [Ball, Linden J.] Univ Cent Lancashire, Sch Psychol, Preston, Lancs, England; [Steel, Richard] Loughborough Univ Technol, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England	University of Derby; University of Bedfordshire; University of Central Lancashire; Loughborough University	Stupple, EJN (corresponding author), Univ Derby, Ctr Psychol Res, Derby, England.	e.j.n.stupple@derby.ac.uk	Stupple, Edward J N/H-2925-2016	Stupple, Edward J N/0000-0001-8545-9504	University of Derby; Lancaster University	University of Derby; Lancaster University	This work was supported by the University of Derby and Lancaster University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, THINKING DECIDING; Baldi PL, 2013, STUD PSYCHOL, V55, P265; Ball LJ, 2003, Q J EXP PSYCHOL-A, V56, P1053, DOI 10.1080/02724980244000729; Ball LJ, 2000, BEHAV BRAIN SCI, V23, P667, DOI 10.1017/S0140525X00243434; Baron J, 2015, J APPL RES MEM COGN, V4, P265, DOI 10.1016/j.jarmac.2014.09.003; Bonner C, 2010, MEM COGNITION, V38, P186, DOI 10.3758/MC.38.2.186; Bourgeois-Gironde S, 2009, RATIONAL ANIMALS IRR; CACIOPPO JT, 1986, J PERS SOC PSYCHOL, V51, P1032, DOI 10.1037/0022-3514.51.5.1032; Calvillo DP, 2015, JUDGM DECIS MAK, V10, P332; Campitelli G, 2014, MEM COGNITION, V42, P434, DOI 10.3758/s13421-013-0367-9; Campitelli G, 2010, JUDGM DECIS MAK, V5, P182; Cokely ET, 2009, JUDGM DECIS MAK, V4, P20; De Neys W, 2008, COGNITION, V106, P1248, DOI 10.1016/j.cognition.2007.06.002; De Neys W, 2013, PSYCHON B REV, V20, P269, DOI 10.3758/s13423-013-0384-5; De Neys W, 2012, PERSPECT PSYCHOL SCI, V7, P28, DOI 10.1177/1745691611429354; Elqayam S, 2011, BEHAV BRAIN SCI, V34, P233, DOI 10.1017/S0140525X1100001X; EPSTEIN S, 1994, AM PSYCHOL, V49, P709, DOI 10.1037/0003-066X.49.8.709; Erceg N, 2017, J COGN PSYCHOL, V29, P381, DOI 10.1080/20445911.2016.1278004; Evans JST, 2013, PERSPECT PSYCHOL SCI, V8, P223, DOI 10.1177/1745691612460685; Evans JSBT, 2010, Q J EXP PSYCHOL, V63, P434, DOI 10.1080/17470210903398147; Evans JStBT, 2010, THINKING TWICE 2 MIN; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; Gangemi A, 2015, THINK REASONING, V21, P383, DOI 10.1080/13546783.2014.980755; Hoppe EI, 2011, ECON LETT, V110, P97, DOI 10.1016/j.econlet.2010.11.015; Kahneman D., 2011, THINKING FAST SLOW; Kahneman D., 2011, THINKING FAST SLOW; Keren G, 2009, PERSPECT PSYCHOL SCI, V4, P533, DOI 10.1111/j.1745-6924.2009.01164.x; Koehler DJ, 2010, MEM COGNITION, V38, P667, DOI 10.3758/MC.38.6.667; Liberali JM, 2012, J BEHAV DECIS MAKING, V25, P361, DOI 10.1002/bdm.752; Mevel K, 2015, J COGN PSYCHOL, V27, P227, DOI 10.1080/20445911.2014.986487; Meyer A, 2015, J EXP PSYCHOL GEN, V144, pE16, DOI 10.1037/xge0000049; Oechssler J, 2009, J ECON BEHAV ORGAN, V72, P147, DOI 10.1016/j.jebo.2009.04.018; Oldrati V, 2016, NEUROPSYCHOLOGIA, V91, P499, DOI 10.1016/j.neuropsychologia.2016.09.010; Osman M, 2004, PSYCHON B REV, V11, P988, DOI 10.3758/BF03196730; Pennycook G, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00009; Pennycook G, 2015, CURR DIR PSYCHOL SCI, V24, P425, DOI 10.1177/0963721415604610; Perkins D., 1995, OUTSMARTING IQ EMERG; Primi C, 2016, J BEHAV DECIS MAKING, V29, P453, DOI 10.1002/bdm.1883; Quayle JD, 2000, Q J EXP PSYCHOL-A, V53, P1202, DOI 10.1080/02724980050156362; Rand DG, 2012, NATURE, V489, P427, DOI 10.1038/nature11467; Roberts MJ, 1998, Q J EXP PSYCHOL-A, V51, P815, DOI 10.1080/027249898391404; Roberts MJ, 2001, Q J EXP PSYCHOL-A, V54, P1031, DOI 10.1080/02724980143000082; Roberts MJ, 1998, Q J EXP PSYCHOL-A, V51, P781, DOI 10.1080/027249898391387; SCHOOLER JW, 1993, J EXP PSYCHOL GEN, V122, P166, DOI 10.1037/0096-3445.122.2.166; Simonovic B, 2017, J BEHAV DECIS MAKING, V30, P658, DOI 10.1002/bdm.1980; Sinayev A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00532; Stanovich KE, 1997, J EDUC PSYCHOL, V89, P342, DOI 10.1037/0022-0663.89.2.342; Stanovich KE, 2000, BEHAV BRAIN SCI, V23, P645, DOI 10.1017/S0140525X00003435; Stanovich KE., 2012, MIND SOC, V11, P3, DOI [10.1007/s11299-011-0093-6, DOI 10.1007/S11299-011-0093-6]; Stanovich KE, 2016, RATIONALITY QUOTIENT; Stanovich KE, 2007, THINK REASONING, V13, P225, DOI 10.1080/13546780600780796; Stupple E., 2013, P 35 ANN C COGN SCI; Stupple EJN, 2008, THINK REASONING, V14, P168, DOI 10.1080/13546780701739782; Stupple EJN, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01269; Stupple EJN, 2013, THINK REASONING, V19, P54, DOI 10.1080/13546783.2012.735622; Stupple EJN, 2011, J COGN PSYCHOL, V23, P931, DOI 10.1080/20445911.2011.589381; Teovanovic P, 2015, INTELLIGENCE, V50, P75, DOI 10.1016/j.intell.2015.02.008; Thompson VA, 2003, PSYCHON B REV, V10, P184, DOI 10.3758/BF03196483; Thompson VA, 2013, COGNITION, V128, P237, DOI 10.1016/j.cognition.2012.09.012; Thompson VA, 2011, COGNITIVE PSYCHOL, V63, P107, DOI 10.1016/j.cogpsych.2011.06.001; Thomson KS, 2016, JUDGM DECIS MAK, V11, P99; Toplak ME, 2014, THINK REASONING, V20, P147, DOI 10.1080/13546783.2013.844729; Toplak ME, 2011, MEM COGNITION, V39, P1275, DOI 10.3758/s13421-011-0104-1; Travers E, 2016, COGNITION, V150, P109, DOI 10.1016/j.cognition.2016.01.015; Unsworth N, 2005, BEHAV RES METHODS, V37, P498, DOI 10.3758/BF03192720; Weber EU, 2009, ANNU REV PSYCHOL, V60, P53, DOI 10.1146/annurev.psych.60.110707.163633	66	23	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							e0186404	10.1371/journal.pone.0186404	http://dx.doi.org/10.1371/journal.pone.0186404			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL6TA	29099840	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000414377900006
J	Riggio, J; Caro, T				Riggio, Jason; Caro, Tim			Structural connectivity at a national scale: Wildlife corridors in Tanzania	PLOS ONE			English	Article							CONSERVATION; LANDSCAPE; MIGRATION; BARRIERS; ROAD	Wildlife corridors can help maintain landscape connectivity but novel methods must be developed to assess regional structural connectivity quickly and cheaply so as to determine where expensive and time-consuming surveys of functional connectivity should occur. We use least-cost methods, the most accurate and up-to-date land conversion dataset for East Africa, and interview data on wildlife corridors, to develop a single, consistent methodology to systematically assess wildlife corridors at a national scale using Tanzania as a case study. Our research aimed to answer the following questions; (i) which corridors may still remain open (i.e. structurally connected) at a national scale, (ii) which have been potentially severed by anthropogenic land conversion (e.g., agriculture and settlements), (iii) where are other remaining potential wildlife corridors located, and (iv) which protected areas with lower forms of protection (e.g., Forest Reserves and Wildlife Management Areas) may act as stepping-stones linking more than one National Park and/or Game Reserve. We identify a total of 52 structural connections between protected areas that are potentially open to wildlife movement, and in so doing add 23 to those initially identified by other methods in Tanzanian Government reports. We find that the vast majority of corridors noted in earlier reports as "likely to be severed" have actually not been cut structurally (21 of 24). Nonetheless, nearly a sixth of all the wildlife corridors identified in Tanzania in 2009 have potentially been separated by land conversion, and a third now pass across lands likely to be converted to human use in the near future. Our study uncovers two reserves with lower forms of protection (Uvinza Forest Reserve in the west and Wami-Mbiki Wildlife Management Area in the east) that act as apparently crucial stepping-stones between National Parks and/or Game Reserves and therefore require far more serious conservation support. Methods used in this study are readily applicable to other nations lacking detailed data on wildlife movements and plagued by inaccurate land cover datasets. Our results are the first step in identifying wildlife corridors at a regional scale and provide a springboard for ground-based follow-up conservation.	[Riggio, Jason; Caro, Tim] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA	University of California System; University of California Davis	Riggio, J (corresponding author), Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA.	jsriggio@ucdavis.edu	Riggio, Jason/AAT-5937-2020	Riggio, Jason/0000-0002-4988-3794	Explorers Club (Exploration Fund); American Philosophical Society (Lewis amp;amp;amp;amp;amp;amp; Clark Fund); University of California, Davis (Henry A. Jastro Graduate Research Fellowship); University of California, Davis (African Studies Committee Graduate Research Fellowship); University of California, Davis (Department of Wildlife, Fish and Conservation Biologyamp;amp;amp;apos;s Walter); University of California, Davis (Elizabeth Howard Wildlife Management Award); University of California, Davis (Selma Herr Fund for Ornithological Research); American Society of Mammalogists	Explorers Club (Exploration Fund); American Philosophical Society (Lewis amp;amp;amp;amp;amp;amp; Clark Fund); University of California, Davis (Henry A. Jastro Graduate Research Fellowship)(University of California System); University of California, Davis (African Studies Committee Graduate Research Fellowship)(University of California System); University of California, Davis (Department of Wildlife, Fish and Conservation Biologyamp;amp;amp;apos;s Walter); University of California, Davis (Elizabeth Howard Wildlife Management Award); University of California, Davis (Selma Herr Fund for Ornithological Research); American Society of Mammalogists	Research was funded by the Explorers Club (Exploration Fund), American Philosophical Society (Lewis & Clark Fund), University of California, Davis (Henry A. Jastro Graduate Research Fellowship, African Studies Committee Graduate Research Fellowship, and Department of Wildlife, Fish and Conservation Biology's Walter and Elizabeth Howard Wildlife Management Award and Selma Herr Fund for Ornithological Research), and an American Society of Mammalogists Grant-in-Aid of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank TAWIRI, the Wildlife Division, and the Commission for Science and Technology (COSTECH) for permissions (Research Permit # 2013-334-NA-2013-76), and Alex Lobora, Senior Research Officer at TAWIRI, for helpful technical guidance. We thank all of the members of the Wami-Mbiki Society, including Majuka Koira (Chairman), Furaha Mbwilo (Head Protection Officer), Hamadi Mbembe (Driver) and the game scouts and staff stationed at Mkongo Camp; and Jessie Godfrey and four anonymous reviewers for comments on the manuscript. Research was funded by the Explorers Club (Exploration Fund), American Philosophical Society (Lewis & Clark Fund), University of California, Davis (Henry A. Jastro Graduate Research Fellowship, African Studies Committee Graduate Research Fellowship, and Department of Wildlife, Fish and Conservation Biology's Walter and Elizabeth Howard Wildlife Management Award and Selma Herr Fund for Ornithological Research), and an American Society of Mammalogists Grant-in-Aid of Research.	Adriaensen F, 2003, LANDSCAPE URBAN PLAN, V64, P233, DOI 10.1016/S0169-2046(02)00242-6; Bartlam-Brooks HLA, 2011, ORYX, V45, P210, DOI 10.1017/S0030605310000414; Beier P, 2008, CONSERV BIOL, V22, P836, DOI 10.1111/j.1523-1739.2008.00942.x; Beier P, 2009, ECOL APPL, V19, P2067, DOI 10.1890/08-1898.1; Belote RT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154223; Berger J, 2006, BIOL LETT-UK, V2, P528, DOI 10.1098/rsbl.2006.0508; BirdLife International, 2016, COUNTR PROF TANZ; Caro T, 2014, CURR BIOL, V24, pR722, DOI 10.1016/j.cub.2014.07.007; Caro T, 2009, BIOL CONSERV, V142, P2807, DOI 10.1016/j.biocon.2009.06.011; Cozzi G, 2013, J ANIM ECOL, V82, P707, DOI 10.1111/1365-2656.12039; Crooks K. R., 2006, CONNECTIVITY CONSERV; Davis SD, 1994, CENTRES PLANT DIVERS, V1; Dutta T, 2016, REG ENVIRON CHANGE, V16, P53, DOI 10.1007/s10113-015-0877-z; Epps CW, 2013, MOL ECOL, V22, P1574, DOI 10.1111/mec.12198; Fritz S, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/044005; Fritz S, 2010, INT J REMOTE SENS, V31, P2237, DOI 10.1080/01431160902946598; Fynn RWS, 2011, AFR J ECOL, V49, P175, DOI 10.1111/j.1365-2028.2010.01245.x; Gregory AJ, 2014, CONSERV BIOL, V28, P689, DOI 10.1111/cobi.12252; Hannerz F, 2008, INT J REMOTE SENS, V29, P3787, DOI 10.1080/01431160801891762; Hilty J. A., 2006, CORRIDOR ECOLOGY SCI; Holdo RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016370; Jacobson A, 2015, ENVIRON MODELL SOFTW, V72, P1, DOI 10.1016/j.envsoft.2015.06.011; Jones T., 2009, WILDLIFE CORRIDORS T; Jones T, 2012, TROP CONSERV SCI, V5, P463, DOI 10.1177/194008291200500405; Kavanagh D.M., 2011, LINKAGE MAPPER CONNE; Kiffner C, 2016, J NAT CONSERV, V31, P29, DOI 10.1016/j.jnc.2016.02.006; Kiffner C, 2015, AFR J ECOL, V53, P156, DOI 10.1111/aje.12160; Kikoti AP, 2010, PACHYDERM, P57; Krosby M, 2015, LANDSCAPE ECOL, V30, P2121, DOI 10.1007/s10980-015-0235-z; LaPoint S, 2013, LANDSCAPE ECOL, V28, P1615, DOI 10.1007/s10980-013-9910-0; Latham J., 2014, FAO GLOBAL LAND COVE; Lehner B, 2004, J HYDROL, V296, P1, DOI 10.1016/j.jhydrol.2004.03.028; McRae B., 2013, NAT CONSERV; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Mittermeier R.A., 2011, BIODIVERSITY HOTSPOT, V1st ed., P3; Mittermeier RA, 2003, P NATL ACAD SCI USA, V100, P10309, DOI 10.1073/pnas.1732458100; Morrison JC, 2007, J MAMMAL, V88, P1363, DOI 10.1644/06-MAMM-A-124R2.1; Morrison TA, 2016, BIOL CONSERV, V197, P53, DOI 10.1016/j.biocon.2016.02.034; Morrison TA, 2014, ORYX, V48, P613, DOI 10.1017/S0030605313000537; Mpanduji DG, 2009, AFR J ECOL, V47, P257, DOI 10.1111/j.1365-2028.2008.00958.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nabe-Nielsen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008932; Newmark WD, 2008, FRONT ECOL ENVIRON, V6, P321, DOI 10.1890/070003; Ntongani WA, 2010, AFR J ECOL, V48, P880, DOI 10.1111/j.1365-2028.2009.01148.x; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Pinto N, 2009, LANDSCAPE ECOL, V24, P253, DOI 10.1007/s10980-008-9303-y; Proctor MF, 2015, J WILDLIFE MANAGE, V79, P544, DOI 10.1002/jwmg.862; Ramiadantsoa T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132126; Rayfield B, 2010, LANDSCAPE ECOL, V25, P519, DOI 10.1007/s10980-009-9436-7; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102; Roever CL, 2013, BIOL CONSERV, V157, P128, DOI 10.1016/j.biocon.2012.06.025; Rovero Francesco, 2012, Ecological Restoration, V30, P282; Rudnick D.A., 2012, ISSUES ECOL, V16, P1; Sawyer H, 2013, J APPL ECOL, V50, P68, DOI 10.1111/1365-2664.12013; Sawyer SC, 2011, J APPL ECOL, V48, P668, DOI 10.1111/j.1365-2664.2011.01970.x; Shannon G, 2016, BIOL REV, V91, P982, DOI 10.1111/brv.12207; Shepard DB, 2008, ANIM CONSERV, V11, P288, DOI 10.1111/j.1469-1795.2008.00183.x; Silveira L, 2014, LANDSCAPE ECOL, V29, P1213, DOI 10.1007/s10980-014-0057-4; TAWIRI, 2010, TANZANIA ELEPHANT MA; TAWIRI (Tanzania Wildlife Research Institute), 2009, POP AB EST SPAT DIST; Van de Perre F, 2014, AFR J ECOL, V52, P448, DOI 10.1111/aje.12139; Vancutsem C, 2013, REMOTE SENS-BASEL, V5, P19, DOI 10.3390/rs5010019; Wall J, 2006, CURR BIOL, V16, pR527, DOI 10.1016/j.cub.2006.06.049; Wegmann M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0193; Zeller KA, 2012, LANDSCAPE ECOL, V27, P777, DOI 10.1007/s10980-012-9737-0; Zeller KA, 2011, BIOL CONSERV, V144, P892, DOI 10.1016/j.biocon.2010.12.003	66	32	32	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187407	10.1371/journal.pone.0187407	http://dx.doi.org/10.1371/journal.pone.0187407			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095901	gold, Green Published, Green Submitted			2022-12-26	WOS:000414340200081
J	Ehm, MG; Aponte, JL; Chiano, MN; Yerges-Armstrong, LM; Johnson, T; Barker, JN; Cook, SF; Gupta, A; Hinds, DA; Li, L; Nelson, MR; Simpson, MA; Tian, C; McCarthy, LC; Rajpal, DK; Waterworth, DM				Ehm, Margaret G.; Aponte, Jennifer L.; Chiano, Mathias N.; Yerges-Armstrong, Laura M.; Johnson, Toby; Barker, Jonathan N.; Cook, Suzanne F.; Gupta, Akanksha; Hinds, David A.; Li, Li; Nelson, Matthew R.; Simpson, Michael A.; Tian, Chao; McCarthy, Linda C.; Rajpal, Deepak K.; Waterworth, Dawn M.			Phenome-wide association study using research participants' self-reported data provides insight into the Th17 and IL-17 pathway	PLOS ONE			English	Article							SUSCEPTIBILITY LOCI; IDENTIFIES 3; INDIVIDUALS; EFFICACY; MODERATE; RISK	A phenome-wide association study of variants in genes in the Th17 and IL-17 pathway was performed using self-reported phenotypes and genetic data from 521,000 research participants of 23 and Me. Results replicated known associations with similar effect sizes for auto immune traits illustrating self-reported traits can be a surrogate for clinically assessed conditions. Novel associations controlling for a false discovery rate of 5% included the association of the variant encoding p.11e684Ser in TYK2 with increased risk of tonsillectomy, strep throat occurrences and teen acne, the variant encoding p.Arg381GIn in IL23R with a decrease in dandruff frequency, the variant encoding p.AsplOAsn in TRAF3IP2 with risk of male-pattern balding, and the RORC regulatory variant (rs4845604) with protection from allergies. This approach enabled rapid assessment of association with a wide variety of traits and investigation of traits with limited reported associations to overlay meaningful phenotypic context on the range of conditions being considered for drugs targeting this pathway.	[Ehm, Margaret G.; Yerges-Armstrong, Laura M.; Nelson, Matthew R.; Rajpal, Deepak K.; Waterworth, Dawn M.] GlaxoSmithKline, Target Sci, Collegeville, PA 19426 USA; [Aponte, Jennifer L.; Li, Li] PAREXEL Int, Genom Med, Durham, NC USA; [Chiano, Mathias N.; Johnson, Toby; McCarthy, Linda C.] GlaxoSmithKline, Target Sci, Stevenage, Herts, England; [Barker, Jonathan N.; Simpson, Michael A.] Kings Coll London, Fac Life Sci & Med, Div Genet & Mol Med, London, England; [Cook, Suzanne F.] Suzanne F Cook Epidemiol Associates LLC, Chapel Hill, NC USA; [Gupta, Akanksha] GlaxoSmithKline, Dermatol, Res Triangle Pk, NC USA; [Hinds, David A.; Tian, Chao] 23andMe Inc, Stat Genet, Mountain View, CA USA	GlaxoSmithKline; Parexel International; GlaxoSmithKline; University of London; King's College London; GlaxoSmithKline	Ehm, MG (corresponding author), GlaxoSmithKline, Target Sci, Collegeville, PA 19426 USA.	meg.g.ehm@gsk.com	tian, chao/GYD-3462-2022; Simpson, Michael/F-4737-2011	Simpson, Michael/0000-0002-8539-8753	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	MGE, M NC, LMY-A, TJ, AG, MRN, LCM, DKR, DMW are employees of GlaxoSmithKline. JA is an employee of PAREXEL International. SFC is an employee of Suzanne F Cook Epidemiology Associates LLC. DAH and CT are employees of 23andMe. GlaxoSmithKline funded the study. The funder provided support in the form of salaries for authors [MGE, MNC, LMY-A, TJ, AG, MRN, LCM, DKR, DMW], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Bartlett HS, 2015, NAT REV DRUG DISCOV, V14, P11, DOI 10.1038/nrd4518; Bush WS, 2016, NAT REV GENET, V17, P129, DOI 10.1038/nrg.2015.36; Chen JJ, 2010, CANCER CONTROL, V17, P58, DOI 10.1177/107327481001700108; Dendrou CA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1974; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Di Meglio P, 2013, J INVEST DERMATOL, V133, P2381, DOI 10.1038/jid.2013.170; Diogo D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122271; Ellinghaus E, 2010, NAT GENET, V42, P991, DOI 10.1038/ng.689; Eriksson N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000993; Gaulton KJ, 2015, NAT GENET, V47, P1415, DOI 10.1038/ng.3437; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Huffmeier U, 2010, NAT GENET, V42, P996, DOI 10.1038/ng.688; Hyde CL, 2016, NAT GENET, V48, P1031, DOI 10.1038/ng.3623; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Medland SE, 2009, AM J HUM GENET, V85, P750, DOI 10.1016/j.ajhg.2009.10.009; Navarini AA, 2014, J INVEST DERMATOL, V134, pS53; Navarini AA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5020; Nelson MR, 2016, NAT REV GENET, V17, P197, DOI 10.1038/nrg.2016.12; Nelson MR, 2015, NAT GENET, V47, P856, DOI 10.1038/ng.3314; Richards JB, 2008, NAT GENET, V40, P1282, DOI 10.1038/ng.255; Scott RA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad3744; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Targan SR, 2012, GASTROENTEROLOGY, V143, pE26, DOI 10.1053/j.gastro.2012.07.084; Tung JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023473	28	11	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0186405	10.1371/journal.pone.0186405	http://dx.doi.org/10.1371/journal.pone.0186405			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091937	Green Published, gold, Green Submitted			2022-12-26	WOS:000414229700017
J	Kulangara, V; Nair, N; Sivasailam, A; Sasidharan, S; Kollannur, JD; Syam, R				Kulangara, Vinodkumar; Nair, Neetha; Sivasailam, Asok; Sasidharan, Suchithra; Kollannur, Justin Davis; Syam, Radhika			Genotypic and phenotypic beta-lactam resistance and presence of PVL gene in Staphylococci from dry bovine udder	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; PANTON-VALENTINE LEUKOCIDIN; ANTIBIOTIC-RESISTANCE; AUREUS; MASTITIS; IDENTIFICATION; PREVALENCE; MRSA; DIVERSITY; ANIMALS	Dairy cows affected with subclinical mastitis can be sources of virulent, antimicrobial-resistant Staphylococci to humans because of the excretion of the bacteria through their milk. This study focussed on the phenotypic and genotypic antibiotic resistance patterns of Staphylococci isolated from dairy cows in early dry period. Among 96 isolates of Gram positive cocci from 157 cows, 76 were identified as Coagulase Negative Staphylococci and the remaining 20 were Staphylococcus aureus. Typical amplicons of coagulase gene were obtained for all 20 samples of S. aureus with three major coagulase types being identified as giving 627 bp (40%), 910 bp (35%) and 710 bp (25%) long PCR products. The groEL gene was amplified in PCR of all 76 isolates of Coagulase Negative Staphylococci, and incubation of PCR products with restriction enzyme Pvul I yielded three distinct PCR-RFLP fragment patterns bearing resemblance to S. chromogenes and S. hyicus. Highest sensitivity of Coagulase Negative Staphylococci was noted for Azithromycin (92.5%) and the least to Tetracyclines (76.3%), whereas for S. aureus, it was Cefoperazone (95%) and Azithromycin (72.2%) respectively. Phenotypic resistance to Oxacillin (25 isolates), and Cefoxitin (11 isolates) was detected by dilution method with a commercial strip (Ezy MICTM). Genotypic resistance to P-Lactam antibiotics was found in 65 (34 with mecA gene and 31 with blaZ gene) isolates. Eighteen isolates possessed both the genes, with the PVL gene for virulence being detected in five of them. Nine isolates which had mecA gene were phenotypically susceptible to oxacillin while phenotypic resistance to oxacillin was observed in seven isolates that did not have either mecA or blaZ gene. This is the first report of persistent Staphylococcal infections possessing PVL gene and high level of genotypic resistance to p-Lactam antibiotics in small-holder dairy cattle from India.	[Kulangara, Vinodkumar; Nair, Neetha; Sivasailam, Asok; Sasidharan, Suchithra; Kollannur, Justin Davis; Syam, Radhika] Coll Vet & Anim Sci, Dept Vet Epidemiol & Prevent Med, Trichur, Kerala, India; [Sivasailam, Asok] Sree Chithra Tirunal Inst Med Sci & Technol, Dept Biochem, Thiruvananthapuram, Kerala, India	Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST)	Kulangara, V (corresponding author), Coll Vet & Anim Sci, Dept Vet Epidemiol & Prevent Med, Trichur, Kerala, India.	kvinodkuma@gmail.com		Kulangara, Vinodkumar/0000-0001-9643-7976	Department of Animal Husbandry, Kerala State, India [B2/29226/2010]	Department of Animal Husbandry, Kerala State, India	This research work received funding from only one source. Vinodkumar Kulangara received partial funding for the research project from the Department of Animal Husbandry, Kerala State, India as per order No. B2/29226/2010 dtd 31/03/11 of Director of Animal Husbandry, Kerala State, India, Web site http://www.and.kera.gov.in. All funding sources have been mentioned and there has been no additional funding received for this study. We further declare that no individuals employed or contracted by the funders (other than the named authors) played any role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aires-De-Sousa M, 2007, APPL ENVIRON MICROB, V73, P3845, DOI 10.1128/AEM.00019-07; Asfour H. A. E., 2011, Global Veterinaria, V6, P39; Badiou C, 2010, J CLIN MICROBIOL, V48, P1384, DOI 10.1128/JCM.02274-09; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Clinical and Laboratory Standards Institute (CLSI), 2012, M100S22 CLIN LAB S S; Santos OCD, 2008, VET MICROBIOL, V130, P134, DOI 10.1016/j.vetmic.2007.12.009; Ebrahimi A, 2009, IRAN J VET RES, V10, P273; Garcia-Alvarez L, 2012, J ANTIMICROB CHEMOTH, V67, pI37, DOI 10.1093/jac/dks206; Gentilini E, 2000, J DAIRY SCI, V83, P1224, DOI 10.3168/jds.S0022-0302(00)74988-5; Gianneechini R, 2002, ACTA VET SCAND, V43, P221, DOI 10.1186/1751-0147-43-221; Goh SH, 1997, J CLIN MICROBIOL, V35, P3116, DOI 10.1128/JCM.35.12.3116-3121.1997; Haran KP, 2012, J CLIN MICROBIOL, V50, P688, DOI 10.1128/JCM.05214-11; Jones CH, 2006, ANTIMICROB AGENTS CH, V50, P505, DOI 10.1128/AAC.50.2.505-510.2006; Joshi S, 2013, INDIAN J MED RES, V137, P363; Kumar VA, 2013, J CLIN MICROBIOL, V51, P318, DOI 10.1128/JCM.01040-12; Li LP, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0492-8; Loeffler B, 2010, PLOS PATHOG, V6, P1, DOI DOI 10.1371/J0URNAL.PPAT.1000715; Moellering RC, 2012, J ANTIMICROB CHEMOTH, V67, P4, DOI 10.1093/jac/dkr437; Moon JS, 2007, J DAIRY SCI, V90, P1176, DOI 10.3168/jds.S0022-0302(07)71604-1; Morgan M, 2008, J ANTIMICROB CHEMOTH, V62, P1181, DOI 10.1093/jac/dkn405; Olsen JE, 2006, J ANTIMICROB CHEMOTH, V57, P450, DOI 10.1093/jac/dki492; Pajic MJ, 2014, VET ARHIV, V84, P205; Skov R, 2014, J ANTIMICROB CHEMOTH, V69, P133, DOI 10.1093/jac/dkt341; Soares LC, 2012, PESQUI VET BRASIL, V32, P692, DOI 10.1590/S0100-736X2012000800002; Sol J, 2000, J DAIRY SCI, V83, P278, DOI 10.3168/jds.S0022-0302(00)74875-2; Strommenger B, 2003, J CLIN MICROBIOL, V41, P4089, DOI 10.1128/JCM.41.9.4089-4094.2003; Sumathi BR, 2008, VET WORLD, V1, P37; Tomazi T, 2014, J CLIN MICROBIOL, V52, P1658, DOI 10.1128/JCM.03032-13; Torres AH, 2009, J VET DIAGN INVEST, V21, P427, DOI 10.1177/104063870902100403; Turutoglu H, 2006, B VET I PULAWY, V50, P41; Unal N, 2012, TROP ANIM HEALTH PRO, V44, P573, DOI 10.1007/s11250-011-9937-7; Vandendriessche S, 2013, J ANTIMICROB CHEMOTH, V68, P1510, DOI 10.1093/jac/dkt047	32	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187277	10.1371/journal.pone.0187277	http://dx.doi.org/10.1371/journal.pone.0187277			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091956	Green Published, gold, Green Submitted			2022-12-26	WOS:000414229700051
J	Forcella, M; Oldani, M; Epistolio, S; Freguia, S; Monti, E; Fusi, P; Frattini, M				Forcella, Matilde; Oldani, Monica; Epistolio, Samantha; Freguia, Stefania; Monti, Eugenio; Fusi, Paola; Frattini, Milo			Non-small cell lung cancer (NSCLC), EGFR downstream pathway activation and TKI targeted therapies sensitivity: Effect of the plasma membrane-associated NEU3	PLOS ONE			English	Article							FACTOR RECEPTOR MUTATIONS; HUMAN COLON-CANCER; SIALIDASE NEU3; EXPRESSION; ERLOTINIB; INVOLVEMENT; SUPPRESSION; GEFITINIB; SURVIVAL	Adenocarcinoma of Non-Small Cell Lung Cancer (NSCLC) is a severe disease. Patients carrying EGFR mutations may benefit from EGFR targeted therapies (e.g.: gefitinib). Recently, it has been shown that sialidase NEU3 directly interacts and regulates EGFR. In this work, we investigate the effect of sialidase NEU3 overexpression on EGFR pathways activation and EGFR targeted therapies sensitivity, in a series of lung cancer cell lines. NEU3 overexpression, forced after transfection, does not affect NSCLC cell viability. We demonstrate that NEU3 overexpression stimulates the ERK pathway but this activation is completely abolished by gefitinib treatment. The Akt pathway is also hyper-activated upon NEU3 overexpression, but gefitinib is able only to decrease, and not to abolish, such activation. These findings indicate that NEU3 can act directly on the ERK pathway through EGFR and both directly and indirectly with respect to EGFR on the Akt pathway. Furthermore, we provide evidence that a healthy mucosa cell line (with EGFR wild-type gene sequence) is slightly sensitive to gefitinib, especially in the presence of NEU3 overexpression, thus hypothesizing that NEU3 overexpressing patients may benefit from EGFR targeted therapies also in absence of EGFR point mutations. Overall, the expression of NEU3 may be a novel diagnostic marker in NSCLC because, by its ability to stimulate EGFR downstream pathways with direct and indirect mechanisms, it may help in the identification of patients who can profit from EGFR targeted therapies in absence of EGFR activating mutations or from new combinations of EGFR and Akt inhibitors.	[Forcella, Matilde; Oldani, Monica; Fusi, Paola] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy; [Epistolio, Samantha; Freguia, Stefania; Frattini, Milo] Inst Pathol, Lab Mol Pathol, Locarno, Switzerland; [Monti, Eugenio] Univ Brescia, Dept Mol & Translat Med, Brescia, Italy	University of Milano-Bicocca; University of Brescia	Frattini, M (corresponding author), Inst Pathol, Lab Mol Pathol, Locarno, Switzerland.; Monti, E (corresponding author), Univ Brescia, Dept Mol & Translat Med, Brescia, Italy.	eugenio.monti@unibs.it; milo.frattini@ti.ch		MONTI, Eugenio/0000-0002-4742-7445; Fusi, Paola/0000-0002-2746-1742; Epistolio, Samantha/0000-0003-1236-2722; FORCELLA, Matilde/0000-0002-9706-4654	Fondazione Ticinese per la Ricerca contro il Cancro (Tessin Foundation against cancer); Ministero dellIstruzione, dell'Universita e della Ricerca (MIUR) FAR	Fondazione Ticinese per la Ricerca contro il Cancro (Tessin Foundation against cancer); Ministero dellIstruzione, dell'Universita e della Ricerca (MIUR) FAR(Ministry of Education, Universities and Research (MIUR))	This work was supported by Fondazione Ticinese per la Ricerca contro il Cancro (Tessin Foundation against cancer) to MF and partly supported by Ministero dellIstruzione, dell'Universita e della Ricerca (MIUR) FAR and ex-60% funds to PF and EM, respectively. For more information: https://ticino.legacancro.ch/ricerca/, http://hubmiur.pubblica.istruzione.it/web/universita/home.	[Anonymous], 2015, R LANG ENV STAT COMP; Bigi A, 2010, GLYCOBIOLOGY, V20, P148, DOI 10.1093/glycob/cwp156; Cappuzzo F, 2010, LANCET ONCOL, V11, P521, DOI 10.1016/S1470-2045(10)70112-1; Choi YJ, 2010, CANCER CHEMOTH PHARM, V66, P381, DOI 10.1007/s00280-009-1174-7; Coudert B, 2012, ANN ONCOL, V23, P388, DOI 10.1093/annonc/mdr125; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Imai K, 2006, NAT REV CANCER, V6, P714, DOI 10.1038/nrc1913; Jiang ZB, 2016, ONCOL REP; Kakugawa Y, 2002, P NATL ACAD SCI USA, V99, P10718, DOI 10.1073/pnas.152597199; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Minguet J, 2016, INT J CANCER, V138, P2549, DOI 10.1002/ijc.29915; Mitsudomi Tetsuya, 2006, Int J Clin Oncol, V11, P190, DOI 10.1007/s10147-006-0583-4; Monti E, 2000, BIOCHEM J, V349, P343, DOI 10.1042/0264-6021:3490343; Monti E, 2010, ADV CARBOHYD CHEM BI, V64, P403, DOI 10.1016/S0065-2318(10)64007-3; Mozzi A, 2015, GLYCOBIOLOGY, V25, P855, DOI 10.1093/glycob/cwv026; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Osarogiagbon RU, 2015, TRANSL LUNG CANCER R, V4, P465, DOI 10.3978/j.issn.2218-6751.2015.07.17; Osorio F, 2016, HEAVY ROBUST ESTIMAT; Papini N, 2004, J BIOL CHEM, V279, P16989, DOI 10.1074/jbc.M400881200; Rodriguez-Walker M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04488-w; Sasaki A, 2003, J BIOL CHEM, V278, P27896, DOI 10.1074/jbc.M212200200; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Siegelin MD, 2014, LAB INVEST, V94, P129, DOI 10.1038/labinvest.2013.147; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578; Uemura T, 2009, ONCOGENE, V28, P1218, DOI 10.1038/onc.2008.471; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wada T, 2007, ONCOGENE, V26, P2483, DOI 10.1038/sj.onc.1210341; Wang SH, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0268-z; Zanchetti G, 2007, BIOCHEM J, V408, P211, DOI 10.1042/BJ20070503	32	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187289	10.1371/journal.pone.0187289	http://dx.doi.org/10.1371/journal.pone.0187289			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088281	Green Published, gold, Green Submitted			2022-12-26	WOS:000414088900060
J	Ngabonziza, JCS; Diallo, AB; Tagliani, E; Diarra, B; Kadanga, AE; Togo, ACG; Thiam, A; de Rijk, WB; Alagna, R; Houeto, S; Ba, F; Dagnra, AY; Ivan, E; Affolabi, D; Schwoebel, V; Trebucq, A; de Jong, BC; Rigouts, L; Daneau, G				Ngabonziza, Jean Claude Semuto; Diallo, Awa Ba; Tagliani, Elisa; Diarra, Bassirou; Kadanga, Abalo Essosimna; Togo, Antieme Combo George; Thiam, Aliou; de Rijk, Willem Bram; Alagna, Riccardo; Houeto, Sabine; Ba, Fatoumata; Dagnra, Anoumou Yaotse; Ivan, Emil; Affolabi, Dissou; Schwoebel, Valerie; Trebucq, Arnaud; de Jong, Bouke Catherine; Rigouts, Leen; Daneau, Geraldine		Union Short MDR-TB Regimen Study G	Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamide	PLOS ONE			English	Article							ASPARTATE DECARBOXYLASE PAND; PNCA GENE-MUTATIONS; DRUG-RESISTANCE; FLUOROQUINOLONES; SUSCEPTIBILITY; TRANSMISSION; MECHANISMS; DIAGNOSIS; LINEAGE	Background Besides inclusion in 1st line regimens against tuberculosis (TB), pyrazinamide (PZA) is used in 2nd line anti-TB regimens, including in the short regimen for multidrug-resistant TB (MDR-TB) patients. Guidelines and expert opinions are contradictory about inclusion of PZA in case of resistance. Moreover, drug susceptibility testing (DST) for PZA is not often applied in routine testing, and the prevalence of resistance is unknown in several regions, including in most African countries. Methods Six hundred and twenty-three culture isolates from rifampicin-resistant (RR) patients were collected in twelve Sub-Saharan African countries. Among those isolates, 71% were from patients included in the study on the Union short-course regimen for MDR-TB in Benin, Burkina Faso, Burundi, Cameroon, Central Africa Republic, the Democratic Republic of the Congo, Ivory Coast, Niger, and Rwanda PZA resistance, and the rest (29%) were consecutive isolates systematically stored from 2014-2015 in Mali, Rwanda, Senegal, and Togo. Besides national guidelines, the isolates were tested for PZA resistance through pncA gene sequencing. Results Over half of these RR-TB isolates (54%) showed a mutation in the pncA gene, with a significant heterogeneity between countries. Isolates with fluoroquinolone resistance (but not with injectable resistance or XDR) were more likely to have concurrent PZA resistance. The pattern of mutations in the pncA gene was quite diverse, although some isolates with an identical pattern of mutations in pncA and other drug-related genes were isolated from the same reference center, suggesting possible transmission of these strains. Conclusion Similar to findings in other regions, more than half of the patients having RR-TB in West and Central Africa present concomitant resistance to PZA. Further investigations are needed to understand the relation between resistance to PZA and resistance to fluoroquinolones, and whether continued use of PZA in the face of PZA resistance provides clinical benefit to the patients.	[Ngabonziza, Jean Claude Semuto; Ivan, Emil] Rwanda Biomed Ctr, Biomed Serv Dept, Natl Reference Lab Div, Kigali, Rwanda; [Ngabonziza, Jean Claude Semuto; de Rijk, Willem Bram; de Jong, Bouke Catherine; Rigouts, Leen; Daneau, Geraldine] Inst Trop Med, Dept Biomed Sci, Mycobacteriol Unit, Antwerp, Belgium; [Diallo, Awa Ba; Thiam, Aliou] CHNU Aristide le Dantec, Mycobacteriol Unit, Bacteriol Virol Lab, Dakar, Senegal; [Tagliani, Elisa; Alagna, Riccardo] IRCCS San Raffaele Sci Inst, Div Immunol Transplantat & Infect Dis, Emerging Bacterial Pathogens Unit, Milan, Italy; [Diarra, Bassirou; Togo, Antieme Combo George] Univ Sci Tech & Technol Bamako, SEREFO UCRC Program, Bamako, Mali; [Kadanga, Abalo Essosimna; Dagnra, Anoumou Yaotse] Lab Natl Reference Mycobacteries, Lome, Togo; [Houeto, Sabine; Affolabi, Dissou] Lab Reference Mycobacteries, Cotonou, Benin; [Ba, Fatoumata] Lab Reference Mycobacteries, Dakar, Senegal; [Schwoebel, Valerie; Trebucq, Arnaud] Int Union TB & Lung Dis, Paris, France; [Rigouts, Leen] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium; [Daneau, Geraldine] Haute Ecole Francisco Ferrer, Biomed Sect, Brussels, Belgium	Rwanda Biomedical Center; Institute of Tropical Medicine (ITM); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Science & Technology of Bamako; University of Antwerp	Ngabonziza, JCS (corresponding author), Rwanda Biomed Ctr, Biomed Serv Dept, Natl Reference Lab Div, Kigali, Rwanda.; Ngabonziza, JCS (corresponding author), Inst Trop Med, Dept Biomed Sci, Mycobacteriol Unit, Antwerp, Belgium.	cldsemuto@gmail.com	Tagliani, Elisa/AAN-1955-2020; Ngabonziza, Jean Claude Semuto/ABY-9467-2022; Ngabonziza, Jean Claude S./AFW-4109-2022; de Jong, Bouke/A-3636-2013	Ngabonziza, Jean Claude Semuto/0000-0002-6075-5603; Ngabonziza, Jean Claude S./0000-0002-6075-5603; Daneau, Geraldine/0000-0002-2570-0893; Piubello, Alberto/0000-0002-6937-3126; de Jong, Bouke/0000-0002-1017-4675; Diarra, Bassirou/0000-0002-1795-9379; Alagna, Riccardo/0000-0002-8768-8180	OPEC Fund for International Development (OFID); DGD FA3.3 TB network; EDCTP WANETAM; ERC Starting Grant INTERRUPTB [311725]	OPEC Fund for International Development (OFID); DGD FA3.3 TB network; EDCTP WANETAM; ERC Starting Grant INTERRUPTB	This study was supported by funds from the OPEC Fund for International Development (OFID), DGD FA3.3 TB network, the EDCTP WANETAM plus project, and the ERC Starting Grant INTERRUPTB (311725) to Leen Rigouts and Bouke Catherine de Jong.; this study was supported by funds from the OPEC Fund for International Development (OFID), DGD FA3.3 TB network, the EDCTP WANETAM plus project, and the ERC Starting Grant INTERRUPTB (311725) to Leen Rigouts and Bouke Catherine de Jong.	Alame-Emane AK, 2015, INT J TUBERC LUNG D, V19, P679, DOI 10.5588/ijtld.14.0768; Allana S, 2017, EMERG INFECT DIS, V23, P491, DOI 10.3201/eid2303.161034; Aung KJM, 2014, INT J TUBERC LUNG D, V18, P1180, DOI 10.5588/ijtld.14.0100; Bates Matthew, 2016, Int J Mycobacteriol, V5 Suppl 1, pS24, DOI 10.1016/j.ijmyco.2016.10.035; Cabibbe A M, 2016, Int J Mycobacteriol, V5 Suppl 1, pS40, DOI 10.1016/j.ijmyco.2016.09.010; Chang KC, 2011, ANTIMICROB AGENTS CH, V55, P4499, DOI 10.1128/AAC.00630-11; Chiu Y-C, BMC INFECT DIS; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; den Hertog AL, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv037; Dillon NA, 2014, ANTIMICROB AGENTS CH, V58, P7258, DOI 10.1128/AAC.04028-14; Feuerriegel S, 2015, J CLIN MICROBIOL, V53, P1908, DOI 10.1128/JCM.00025-15; Fofana MO, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00498-16; Gopal P, 2017, ACS INFECT DIS, V3, P492, DOI 10.1021/acsinfecdis.7b00017; Jonmalung J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-223; Jureen P, 2008, ANTIMICROB AGENTS CH, V52, P1852, DOI 10.1128/AAC.00110-08; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kendall EA, 2015, LANCET RESP MED, V3, P963, DOI 10.1016/S2213-2600(15)00458-0; Kim HJ, 2012, INT J TUBERC LUNG D, V16, P98, DOI 10.5588/ijtld.10.0739; Miotto P, 2015, CHEST, V147, P1135, DOI 10.1378/chest.14-1286; Miotto P, 2014, MBIO, V5, DOI 10.1128/mBio.01819-14; Napiorkowska A, 2014, INT J TUBERC LUNG D, V18, P454, DOI 10.5588/ijtld.13.0457; Nikolayevskyy V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152926; Njire M, 2016, ADV MED SCI-POLAND, V61, P63, DOI 10.1016/j.advms.2015.09.007; Pankhurst LJ, 2016, LANCET RESP MED, V4, P49, DOI 10.1016/S2213-2600(15)00466-X; Pierre-Audigier C, 2012, INT J TUBERC LUNG D, V16, P221, DOI 10.5588/ijtld.11.0266; Portugal I, 2004, ANTIMICROB AGENTS CH, V48, P2736, DOI 10.1128/AAC.48.7.2736-2738.2004; Ramirez-Busby SM, 2015, ANTIMICROB AGENTS CH, V59, P5267, DOI 10.1128/AAC.00204-15; Said HM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146106; Scorpio A, 1997, ANTIMICROB AGENTS CH, V41, P540, DOI 10.1128/AAC.41.3.540; Shi WL, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.61; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trebucq A., 47 UN WORLD C LUNG H; van Soolingen Dick, 2016, Int J Mycobacteriol, V5 Suppl 1, pS60, DOI 10.1016/j.ijmyco.2016.10.036; Velasquez GE, 2016, ANTIMICROB AGENTS CH, V60, P6766, DOI 10.1128/AAC.00632-16; Verdugo D, 2015, ANTIMICROB AGENTS CH, V59, P6140, DOI 10.1128/AAC.00764-15; Walker TM, 2015, LANCET INFECT DIS, V15, P1193, DOI 10.1016/S1473-3099(15)00062-6; Whitfield MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133869; WHO, 2016, WHO FACT SHEET WORLD; WHO, 2016, SHORT MDR TB REG FEA; Zhang Y, 2015, INT J TUBERC LUNG D, V19, P1276, DOI 10.5588/ijtld.15.0389; Zhang Y, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.18; Zheng XB, 2017, INT J ANTIMICROB AG, V49, P183, DOI 10.1016/j.ijantimicag.2016.10.012; Zignol M, 2016, LANCET INFECT DIS, V16, P1185, DOI 10.1016/S1473-3099(16)30190-6	43	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187211	10.1371/journal.pone.0187211	http://dx.doi.org/10.1371/journal.pone.0187211			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088294	Green Published, Green Submitted, gold			2022-12-26	WOS:000414088900049
J	Vancura, P; Abdelhadi, S; Csicsely, E; Baba, K; Tosini, G; Iuvone, PM; Spessert, R				Vancura, Patrick; Abdelhadi, Shaima; Csicsely, Erika; Baba, Kenkichi; Tosini, Gianluca; Iuvone, P. Michael; Spessert, Rainer			Gnaz couples the circadian and dopaminergic system to G protein-mediated signaling in mouse photoreceptors	PLOS ONE			English	Article							MAMMALIAN RETINA; PERTUSSIS-TOXIN; ALPHA-SUBUNIT; MELATONIN SYNTHESIS; ADENYLYL-CYCLASE; PINEAL-GLAND; CLOCK GENES; RAT RETINA; CELLS; EXPRESSION	The mammalian retina harbors a circadian clockwork that regulates vision and promotes healthiness of retinal neurons, mainly through directing the rhythmic release of the neuro-hormones dopamine-acting on dopamine D-4 receptors-and melatonin-acting on MT1 and MT2 receptors. The gene Gnaz D a unique Gi/o subfamily member D was seen in the present study to be expressed in photoreceptors where its protein product G alpha(z) shows a daily rhythm in its subcellular localization. Apart from subcellular localization, Gnaz displays a daily rhythm in expression-with peak values at night-in preparations of the whole retina, microdissected photoreceptors and photoreceptor-related pinealocytes. In retina, Gnaz rhythmicity was observed to persist under constant darkness and to be abolished in retina deficient for Clock or dopamine D-4 receptors. Furthermore, circadian regulation of Gnaz was disturbed in the db/db mouse, a model of diabetic retinopathy. The data of the present study suggest that Gnaz links the circadian clockwork-via dopamine acting on D-4 receptors D to G protein-mediated signaling in intact but not diabetic retina.	[Vancura, Patrick; Abdelhadi, Shaima; Csicsely, Erika; Spessert, Rainer] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Funct & Clin Anat, Mainz, Germany; [Baba, Kenkichi; Tosini, Gianluca] Morehouse Sch Med, Neurosci Inst, Atlanta, GA 30310 USA; [Baba, Kenkichi; Tosini, Gianluca] Morehouse Sch Med, Dept Pharmacol & Toxicol, Atlanta, GA 30310 USA; [Iuvone, P. Michael] Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA	Johannes Gutenberg University of Mainz; Morehouse School of Medicine; Morehouse School of Medicine; Emory University	Vancura, P (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Funct & Clin Anat, Mainz, Germany.	p.vancura@uni-mainz.de		Csicsely, Erika/0000-0002-9157-5154	National Institutes of Health [R01EY026291, R01EY004864, P30EY006360, R01EY02711]; NATIONAL EYE INSTITUTE [R01EY004864, R01EY026291, P30EY006360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC2GM116760] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded in part by grants from the National Institutes of Health: R01EY026291 to GT, R01EY004864 to PMI, P30EY006360 to PMI, and R01EY02711 to PMI.	Aung MH, 2014, J NEUROSCI, V34, P726, DOI 10.1523/JNEUROSCI.3483-13.2014; Baba K, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004302; Baba K, 2009, P NATL ACAD SCI USA, V106, P15043, DOI 10.1073/pnas.0904400106; Bailey MJ, 2009, J BIOL CHEM, V284, P7606, DOI 10.1074/jbc.M808394200; BLATT C, 1988, P NATL ACAD SCI USA, V85, P7642, DOI 10.1073/pnas.85.20.7642; BOWES C, 1988, EXP EYE RES, V47, P369, DOI 10.1016/0014-4835(88)90049-8; BRANN MR, 1987, SCIENCE, V235, P585, DOI 10.1126/science.3101175; Cameron M, 2008, J GENET, V87, P459, DOI 10.1007/s12041-008-0068-5; Cameron MA, 2008, J BIOL RHYTHM, V23, P489, DOI 10.1177/0748730408325874; Chan ASL, 2002, CELL SIGNAL, V14, P249, DOI 10.1016/S0898-6568(01)00240-6; Cornelissen G, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-16; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Debruyne J, 2008, J GENET, V87, P437, DOI 10.1007/s12041-008-0066-7; Doi M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10583; Dorenbos R, 2007, VISUAL NEUROSCI, V24, P573, DOI 10.1017/S0952523807070538; FONG HKW, 1988, P NATL ACAD SCI USA, V85, P3066, DOI 10.1073/pnas.85.9.3066; Fukuhara C, 2004, J NEUROSCI, V24, P1803, DOI 10.1523/JNEUROSCI.4988-03.2004; Goldmann T, 2006, DIAGN PATHOL, V1, DOI 10.1186/1746-1596-1-2; Gustincich S, 2004, P NATL ACAD SCI USA, V101, P5069, DOI 10.1073/pnas.0400913101; Hastings MH, 2008, J NEUROENDOCRINOL, V20, P812, DOI 10.1111/j.1365-2826.2008.01715.x; HINTON DR, 1990, J NEUROSCI, V10, P2763; Ho MKC, 2001, ONCOGENE, V20, P1615, DOI 10.1038/sj.onc.1204190; Hollborn M, 2011, MOL VIS, V17, P2738; Hultman R, 2014, MOL CELL NEUROSCI, V58, P53, DOI 10.1016/j.mcn.2013.12.004; Hwang CK, 2013, J NEUROSCI, V33, P14989, DOI 10.1523/JNEUROSCI.2039-13.2013; Iuvone PM, 2005, PROG RETIN EYE RES, V24, P433, DOI 10.1016/j.preteyeres.2005.01.003; Jackson CR, 2012, J NEUROSCI, V32, P9359, DOI 10.1523/JNEUROSCI.0711-12.2012; Jackson CR, 2011, EUR J NEUROSCI, V34, P57, DOI 10.1111/j.1460-9568.2011.07734.x; JIANG MS, 1991, P NATL ACAD SCI USA, V88, P3907, DOI 10.1073/pnas.88.9.3907; Kamphuis W, 2005, BIOCHEM BIOPH RES CO, V330, P18, DOI 10.1016/j.bbrc.2005.02.118; Kimple ME, 2008, J BIOL CHEM, V283, P4560, DOI 10.1074/jbc.M706481200; Kimple ME, 2012, J BIOL CHEM, V287, P20344, DOI 10.1074/jbc.M112.359745; Kunst S, 2015, INVEST OPHTH VIS SCI, V56, P6084, DOI 10.1167/iovs.15-17503; Kunst S, 2013, J NEUROCHEM, V124, P757, DOI 10.1111/jnc.12089; Leck KJ, 2006, NEUROPHARMACOLOGY, V51, P597, DOI 10.1016/j.neuropharm.2006.05.002; Maronde E, 2007, TRENDS ENDOCRIN MET, V18, P142, DOI 10.1016/j.tem.2007.03.001; MATSUOKA M, 1988, P NATL ACAD SCI USA, V85, P5384, DOI 10.1073/pnas.85.15.5384; McMahon DG, 2014, PROG RETIN EYE RES, V39, P58, DOI 10.1016/j.preteyeres.2013.12.001; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Nir I, 2002, J NEUROSCI, V22, P2063, DOI 10.1523/JNEUROSCI.22-06-02063.2002; OSBORNE NN, 1984, NEUROSCI LETT, V50, P117, DOI 10.1016/0304-3940(84)90472-5; Pozdeyev N, 2008, EUR J NEUROSCI, V27, P2691, DOI 10.1111/j.1460-9568.2008.06224.x; Rath MF, 2013, NEUROCHEM RES, V38, P1100, DOI 10.1007/s11064-012-0906-y; Refinetti R, 2007, BIOL RHYTHM RES, V38, P275, DOI 10.1080/09291010600903692; Ruan GX, 2006, P NATL ACAD SCI USA, V103, P9703, DOI 10.1073/pnas.0601940103; Ruan GX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038985; Ruan GX, 2008, PLOS BIOL, V6, P2248, DOI 10.1371/journal.pbio.0060249; Sanchez-Blazquez P, 2009, CELL SIGNAL, V21, P1444, DOI 10.1016/j.cellsig.2009.05.003; Sandu C, 2011, EUR J NEUROSCI, V34, P507, DOI 10.1111/j.1460-9568.2011.07772.x; Savaskan E, 2002, J HISTOCHEM CYTOCHEM, V50, P519, DOI 10.1177/002215540205000408; Schneider K, 2010, J NEUROCHEM, V115, P585, DOI 10.1111/j.1471-4159.2010.06953.x; Sengupta A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024483; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; Stitt AW, 2013, CLIN SCI, V125, P1, DOI 10.1042/CS20120588; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Tosini G, 1998, BRAIN RES, V789, P221, DOI 10.1016/S0006-8993(97)01446-7; Tosini G, 2007, FASEB J, V21, P3866, DOI 10.1096/fj.07-8371com; Trojan P, 2008, PROG RETIN EYE RES, V27, P237, DOI 10.1016/j.preteyeres.2008.01.003; van den Buuse M, 2005, PSYCHOPHARMACOLOGY, V183, P358, DOI 10.1007/s00213-005-0181-6; Vancura P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164665; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; Yang J, 2002, J BIOL CHEM, V277, P46035, DOI 10.1074/jbc.M208519200; Yang Q, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/757412	65	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187411	10.1371/journal.pone.0187411	http://dx.doi.org/10.1371/journal.pone.0187411			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088301	gold, Green Submitted, Green Published			2022-12-26	WOS:000414088900081
J	Zhao, YY; Ding, Y; Hou, XY; Li, FY; Hang, WJ; Yun, XJ				Zhao, Yanyun; Ding, Yong; Hou, Xiangyang; Li, Frank Yonghong; Hang, Wenjun; Yun, Xiangjun			Effects of temperature and grazing on soil organic carbon storage in grasslands along the Eurasian steppe eastern transect	PLOS ONE			English	Article							LAND-USE CHANGE; INNER-MONGOLIA; NITROGEN STORAGE; CLIMATE-CHANGE; FOREST SOILS; STOCKS; DYNAMICS; SEQUESTRATION; FERTILIZATION; ECOSYSTEMS	Soil represents the largest terrestrial organic carbon pool. To address global climate change, it is essential to explore the soil organic carbon storage patterns and their controlling factors. We investigated the soil organic carbon density (SOCD) in 48 grassland sites along the Eurasian steppe eastern transect (ESET) region, which covers the Inner Mongolia grassland subregion and Mongolia grasslands subregion. Specifically, we analyzed the SOCD in the top 30 cm soil layer and its relationships with climatic variables, soil texture, grazing intensity and community biomass productivity. The results showed that the average SOCD of the ESET was 4.74 kg/m(2), and the SOCD of the Inner Mongolia grassland subregion (4.11 kg/m(2)) was significantly lower than that of the Mongolia grassland subregion (5.79 kg/m(2)). Significant negative relationships were found between the SOCD and the mean annual temperature (MAT), mean annual precipitation (MAP) and grazing intensity in the ESET region. The MAT and grazing intensity were identified as the major factors influencing the SOCD in the ESET region; the MAP and MAT were the major factors influencing the SOCD in the Inner Mongolia grassland subregion; and the MAT and soil pH were the major factors influencing the SOCD in the Mongolia grassland subregion.	[Zhao, Yanyun; Li, Frank Yonghong] Inner Mongolia Univ, Sch Ecol & Environm, Mongolia Key Lab Grassland Ecol, Hohhot, Peoples R China; [Ding, Yong; Hou, Xiangyang; Hang, Wenjun; Yun, Xiangjun] Chinese Acad Agr Sci, Grassland Res Inst, Key Lab Grassland Ecol & Restorat, Minist Agr, Hohhot, Peoples R China	Inner Mongolia University; Chinese Academy of Agricultural Sciences; Institute of Grassland Research, CAAS; Ministry of Agriculture & Rural Affairs	Hou, XY (corresponding author), Chinese Acad Agr Sci, Grassland Res Inst, Key Lab Grassland Ecol & Restorat, Minist Agr, Hohhot, Peoples R China.	houxy16@126.com	Li, Frank Yonghong/AAN-3093-2020	Li, Frank Yonghong/0000-0002-5137-8017	National Key Technology Support Program [2015BAC02B04]; Natural Science Foundation of Inner Mongolia [2015MS0302]	National Key Technology Support Program(National Key Technology R&D Program); Natural Science Foundation of Inner Mongolia	This study was supported by the National Key Technology Support Program (2015BAC02B04) and the Natural Science Foundation of Inner Mongolia (2015MS0302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This study was supported by the National Key Technology Support Program (2015BAC02B04) and the Natural Science Foundation of Inner Mongolia (2015MS0302).	Akpa SIC, 2016, GEODERMA, V271, P202, DOI 10.1016/j.geoderma.2016.02.021; Asner GP, 2004, ANNU REV ENV RESOUR, V29, P261, DOI 10.1146/annurev.energy.29.062403.102142; Badgery WB, 2013, SOIL RES, V51, P645, DOI 10.1071/SR12358; Batjes NH, 2014, EUR J SOIL SCI, V65, P10, DOI 10.1111/ejss.12114_2; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breulmann M, 2016, SCI TOTAL ENVIRON, V545, P30, DOI 10.1016/j.scitotenv.2015.12.050; Cerri CEP, 2003, SOIL SCI SOC AM J, V67, P1879, DOI 10.2136/sssaj2003.1879; Chang XF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097140; Chen DM, 2015, LANDSCAPE ECOL, V30, P1669, DOI 10.1007/s10980-014-9996-z; Chen JQ, 2015, BIOSCIENCE, V65, P559, DOI 10.1093/biosci/biv050; Chen YP, 2012, ENVIRON MANAGE, V50, P622, DOI 10.1007/s00267-012-9919-1; Dai EF, 2014, J GEOGR SCI, V24, P1035, DOI 10.1007/s11442-014-1136-9; Dlamini P, 2016, AGR ECOSYST ENVIRON, V221, P258, DOI 10.1016/j.agee.2016.01.026; Dulamsuren C, 2016, GLOBAL CHANGE BIOL, V22, P830, DOI 10.1111/gcb.13127; Follett RF, 2012, J SOIL WATER CONSERV, V67, P331, DOI 10.2489/jswc.67.5.331; Goidts E, 2009, GLOBAL CHANGE BIOL, V15, P2981, DOI 10.1111/j.1365-2486.2009.01940.x; Golluscio RA, 2009, ECOSYSTEMS, V12, P686, DOI 10.1007/s10021-009-9252-6; Groisman PY, 2009, B AM METEOROL SOC, V90, P671, DOI 10.1175/2008BAMS2556.1; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Han F, 2016, INT J REMOTE SENS, V37, P5551, DOI 10.1080/01431161.2016.1230286; He NP, 2014, PEDOSPHERE, V24, P391, DOI 10.1016/S1002-0160(14)60025-4; Hedley CB, 2012, SOIL RES, V50, P18, DOI 10.1071/SR11171; Herold N, 2014, BIOGEOCHEMISTRY, V119, P435, DOI 10.1007/s10533-014-9978-x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hobley E, 2015, PLANT SOIL, V390, P111, DOI 10.1007/s11104-015-2380-1; [侯向阳 Hou Xiangyang], 2012, [中国草地学报, Chinese Journal of Grassland], V34, P108; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Jung JY, 2011, GEODERMA, V166, P145, DOI 10.1016/j.geoderma.2011.07.023; Kolbl A, 2011, PLANT SOIL, V340, P35, DOI 10.1007/s11104-010-0473-4; Lal R, 2004, GEODERMA, V123, P1, DOI 10.1016/j.geoderma.2004.01.032; Li CL, 2012, J PLANT NUTR SOIL SC, V175, P339, DOI 10.1002/jpln.201100212; Longbottom TL, 2014, CATENA, V119, P125, DOI 10.1016/j.catena.2014.03.002; Luo CY, 2010, GLOBAL CHANGE BIOL, V16, P1606, DOI 10.1111/j.1365-2486.2009.02026.x; Ma HK, 2016, APPL SOIL ECOL, V108, P128, DOI 10.1016/j.apsoil.2016.08.008; Maillard E, 2017, AGR ECOSYST ENVIRON, V236, P268, DOI 10.1016/j.agee.2016.11.024; Maki A, 2007, J HYDROL, V333, P100, DOI 10.1016/j.jhydrol.2006.07.024; Mao DH, 2015, BIOGEOSCIENCES, V12, P1635, DOI 10.5194/bg-12-1635-2015; Marin-Spiotta E, 2013, GLOBAL ECOL BIOGEOGR, V22, P105, DOI 10.1111/j.1466-8238.2012.00788.x; Martin MP, 2011, BIOGEOSCIENCES, V8, P1053, DOI 10.5194/bg-8-1053-2011; McDonald RP, 2002, PSYCHOL METHODS, V7, P64, DOI 10.1037//1082-989X.7.1.64; Mcsherry ME, 2013, GLOBAL CHANGE BIOL, V19, P1347, DOI 10.1111/gcb.12144; Mulder VL, 2015, GLOBAL BIOGEOCHEM CY, V29, P1210, DOI 10.1002/2015GB005178; Naeem S, 2002, ECOLOGY, V83, P1537, DOI 10.1890/0012-9658(2002)083[1537:ECOBLT]2.0.CO;2; Nosrati K., 2013, Journal of Applied Sciences and Environmental Management, V17, P225; PARTON WJ, 1993, GLOBAL BIOGEOCHEM CY, V7, P785, DOI 10.1029/93GB02042; Rabbi SMF, 2015, SCI REP-UK, V5, DOI 10.1038/srep17866; Rudrappa L, 2006, SOIL TILL RES, V88, P180, DOI 10.1016/j.still.2005.05.008; Scurlock JMO, 1998, GLOBAL CHANGE BIOL, V4, P229, DOI 10.1046/j.1365-2486.1998.00151.x; Senechkin IV, 2014, APPL SOIL ECOL, V73, P148, DOI 10.1016/j.apsoil.2013.09.003; Shary P, 2013, EURASIAN SOIL SCI+, V46, P1076, DOI 10.1134/S1064229313090044; Araujo JKS, 2016, SCI TOTAL ENVIRON, V568, P339, DOI 10.1016/j.scitotenv.2016.06.025; Tavakkoli E, 2015, EUROPEAN J SOIL SCI, V66; Wang J, 2013, LANDSCAPE ECOL, V28, P725, DOI 10.1007/s10980-013-9865-1; Wang SP, 2011, AGR ECOSYST ENVIRON, V142, P329, DOI 10.1016/j.agee.2011.06.002; Wang T, 2016, SOIL TILL RES, V163, P176, DOI 10.1016/j.still.2016.05.015; Wang XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep33190; Wellock ML, 2011, FOREST ECOL MANAG, V262, P1589, DOI 10.1016/j.foreco.2011.07.007; Wu JG, 2015, LANDSCAPE ECOL, V30, P1579, DOI 10.1007/s10980-015-0209-1; Yang YH, 2007, BIOGEOCHEMISTRY, V84, P131, DOI 10.1007/s10533-007-9109-z; Yonekura Y, 2013, PLANT SOIL, V372, P683, DOI 10.1007/s11104-013-1763-4	60	17	17	11	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0186980	10.1371/journal.pone.0186980	http://dx.doi.org/10.1371/journal.pone.0186980			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084243	Green Submitted, Green Published, gold			2022-12-26	WOS:000413910200021
J	Cagnardi, P; Guccione, J; Villa, R; D'Andrea, L; Di Loria, A; Ferrante, MC; Borriello, G; Zicarelli, L; Ciaramella, P				Cagnardi, Petra; Guccione, Jacopo; Villa, Roberto; D'Andrea, Luigi; Di Loria, Antonio; Ferrante, Maria Carmela; Borriello, Giuliano; Zicarelli, Luigi; Ciaramella, Paolo			Clinical efficacy and pharmacokinetics of meloxicam in Mediterranean buffalo calves (Bubalus bubalis)	PLOS ONE			English	Article							DAIRY CALVES; BEEF-CALVES; CASTRATION; PAIN; CATTLE; BEHAVIOR; QUALITY; PLASMA; HEALTH; BULLS	The aims of the investigation were to establish for the first time (i) clinical efficacy and (ii) pharmacokinetic profile of meloxicam intravenously (IV) administered in male Mediterranean buffalo calves after surgical orchiectomy. The study was performed on 10 healthy buffalo calves, between 4 and 5 months old and between 127 and 135 kg of body weight (b.w.). An IV injection of 0.5 mg/kg b.w. of meloxicam was administered in six calves (treated group, TG) immediately after surgery; the other four animals were used as untreated control group (CG). The clinical efficacy of meloxicam was evaluated pre-and post-surgery by monitoring respiratory rate (RR), heart rate (HR), rectal temperature (T degrees C), serum cortisol levels (SCL) and pain score (PS). Significant inter-groups differences were detected at sampling times (T): 4 hour (h) for RR (P<0.05), at T1-4-6-8 h for PS (P<0.05) and at T4-6-8 h for SCL (P < 0.0001). Regarding the mean intra-group values observed pre (T0) and post-surgery (from T15 min to T72 h), significant difference between the groups were found for RR (P<0.01), PS and SCL (P<0.05). The pharmacokinetic profile was best fitted by a two-compartmental model and characterized by a fast distribution half-life and slow elimination half-life (0.09 +/- 0.06 h and 21.51 +/- 6.4 h, respectively) and meloxicam mean concentrations at 96 h was of 0.18 +/- 0.14 mu g/mL. The volume of distribution and clearance values were quite low, but reasonably homogenous among individuals (V-dss 142.31 +/- 55.08 mL/kg and Cl-B 4.38 +/- 0.95 mL/kg/h, respectively). The IV administration of meloxicam in buffalo calves shows encouraging effects represented by significant and prolonged analgesic effects, significant reduction of SCL as well as similar pharmacokinetic profile to bovine calves.	[Cagnardi, Petra; Villa, Roberto] Univ Milan, Dept Hlth Anim Sci & Food Safety, Milan, Italy; [Guccione, Jacopo; D'Andrea, Luigi; Ferrante, Maria Carmela; Borriello, Giuliano; Zicarelli, Luigi; Ciaramella, Paolo] Univ Napoli Federico II, Dept Vet Med & Anim Prod, Naples, Italy; [Di Loria, Antonio] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy	University of Milan; University of Naples Federico II; Magna Graecia University of Catanzaro	Guccione, J (corresponding author), Univ Napoli Federico II, Dept Vet Med & Anim Prod, Naples, Italy.; Di Loria, A (corresponding author), Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy.	jacopo.guccione@unina.it; adiloria@unicz.it		Cagnardi, Petra/0000-0001-6232-4850; GUCCIONE, Jacopo/0000-0002-3390-137X; Borriello, Giuliano/0000-0002-4993-0511; Villa, Roberto/0000-0001-5536-1370				Alberghina D., 2016, Comparative Clinical Pathology, V25, P721, DOI 10.1007/s00580-016-2254-9; ALDughaym AM, 2011, RES J PHARM, V5, P1; [Anonymous], EMACVMPVICH463202200; Busch U, 1998, DRUG METAB DISPOS, V26, P576; Coetzee JF, 2015, J VET PHARMACOL THER, V38, P556, DOI 10.1111/jvp.12215; Coetzee JF, 2012, J ANIM SCI, V90, P1026, DOI 10.2527/jas.2011-4068; Coetzee JF, 2013, VET CLIN N AM-FOOD A, V29, P75, DOI 10.1016/j.cvfa.2012.11.002; Coetzee JF, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-153; Coetzee JF, 2009, VET THER, V10; Coetzee JF, 2011, APPL ANIM BEHAV SCI, V135, P192, DOI 10.1016/j.applanim.2011.10.016; Currah JM, 2009, CAN VET J, V50, P375; De la Vibora JB, 2008, VET ANAESTH ANALG, V35, P501; de Oliveira FA, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0200-0; De Rosa G, 2015, J DAIRY SCI, V98, P6886, DOI 10.3168/jds.2015-9350; DellaRocca G, 2014, SEMIOLOGIA CLIN VET, P494; Deneuche AJ, 2004, VET SURG, V33, P650, DOI 10.1111/j.1532-950X.2004.04088.x; Desrosches A, 2005, ANIMAL PRACTICE, V21, P1; EMA, 2011, EMACVMPVICH463202200; EMA, 1997, EMEAMRL23697FINAL; European Commission, 2002, OFFICIAL J, V221, P8; Gandra JR, 2011, LIVEST SCI, V140, P283, DOI 10.1016/j.livsci.2011.04.005; Gao CS, 2006, INT J PHARMACEUT, V322, P104, DOI 10.1016/j.ijpharm.2006.05.035; Gibaldi M, 1982, PHARMACOKINETICS; Giuffrida-Mendoza M, 2015, MEAT SCI, V106, P44, DOI 10.1016/j.meatsci.2015.03.024; Guccione J, 2014, J DAIRY SCI, V97, P2219, DOI 10.3168/jds.2013-7268; Guccione J, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-0944-4; Guccione J, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0726-4; Guccione J, 2014, J EQUINE VET SCI, V34, P302, DOI 10.1016/j.jevs.2013.07.001; Heinrich A, 2009, J DAIRY SCI, V92, P540, DOI 10.3168/jds.2008-1424; Heinrich A, 2010, J DAIRY SCI, V93, P2450, DOI 10.3168/jds.2009-2813; Jeunesse EC, 2017, J PHARM EXPT THERAPE, V338, P548; Konigsson K, 2002, J VET MED A, V49, P408, DOI 10.1046/j.1439-0442.2002.00461.x; Kreuder AJ, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-85; LAM FC, 1985, J PHARM SCI, V74, P229, DOI 10.1002/jps.2600740229; Lees P, 2004, J VET PHARMACOL THER, V27, P479, DOI 10.1111/j.1365-2885.2004.00617.x; LEES P, 2009, VET PHARM THERAPEUTI, P457; McDougall S, 2009, J DAIRY SCI, V92, P4421, DOI 10.3168/jds.2009-2284; Molony V, 1997, J ANIM SCI, V75, P266; Montgomery AA, 2002, BMC HEALTH SERV RES, V2, DOI 10.1186/1472-6963-2-8; Mosher RA, 2012, J VET PHARMACOL THER, V35, P373, DOI 10.1111/j.1365-2885.2011.01331.x; OCKERMAN HW, 1984, J ANIM SCI, V59, P981, DOI 10.2527/jas1984.594981x; Repenning PE, 2013, J ANIM SCI, V91, P4975, DOI 10.2527/jas.2012-6061; Roberts SL, 2015, J ANIM SCI, V93, P4123, DOI 10.2527/jas.2015-9160; ROBERTSON IS, 1994, RES VET SCI, V56, P8, DOI 10.1016/0034-5288(94)90189-9; Saurit AR, 2002, VET RES COMMUN, V26, P49, DOI 10.1023/A:1013305721813; Stewart M, 2009, J DAIRY SCI, V92, P1512, DOI 10.3168/jds.2008-1578; TAYLOR R, 1990, J DIAGN MED SONOG, V6, P35, DOI 10.1177/875647939000600106; Toutain PL, 2004, AM J VET RES, V65, P1542, DOI 10.2460/ajvr.2004.65.1542; Voloski FLS, 2016, MEAT SCI, V116, P207, DOI 10.1016/j.meatsci.2016.02.020; Weaver AD, 2005, BOVINE SURGERY AND LAMENESS, 2ND EDITION, P168; YAMAOKA K, 1978, J PHARMACOKINET BIOP, V6, P165, DOI 10.1007/BF01117450; Zicarelli L, 2017, BUFFALO (BUBALUS BUBALIS) - PRODUCTION AND RESEARCH, P196	52	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187252	10.1371/journal.pone.0187252	http://dx.doi.org/10.1371/journal.pone.0187252			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077759	Green Submitted, Green Published, gold			2022-12-26	WOS:000413861200056
J	Kok, A; van Middelaar, CE; Mostert, PF; van Knegsel, ATM; Kemp, B; de Boer, IJM; Hogeveen, H				Kok, Akke; van Middelaar, Corina E.; Mostert, Pim F.; van Knegsel, Ariette T. M.; Kemp, Bas; de Boer, Imke J. M.; Hogeveen, Henk			Effects of dry period length on production, cash flows and greenhouse gas emissions of the dairy herd: A dynamic stochastic simulation model	PLOS ONE			English	Article							LIFE-CYCLE ASSESSMENT; TEST-DAY MILK; ENERGY-BALANCE; EARLY-LACTATION; SUBSEQUENT LACTATION; TRANSITION COWS; HOLSTEIN HERDS; PROTEIN YIELD; SHORT 35-D; MANAGEMENT	Shortening or omitting the dry period of dairy cows improves metabolic health in early lactation and reduces management transitions for dairy cows. The success of implementation of these strategies depends on their impact on milk yield and farm profitability. Insight in these impacts is valuable for informed decision-making by farmers. The aim of this study was to investigate how shortening or omitting the dry period of dairy cows affects production and cash flows at the herd level, and greenhouse gas emissions per unit of milk, using a dynamic stochastic simulation model. The effects of dry period length on milk yield and calving interval assumed in this model were derived from actual performance of commercial dairy cows over multiple lactations. The model simulated lactations, and calving and culling events of individual cows for herds of 100 cows. Herds were simulated for 5 years with a dry period of 56 (conventional), 28 or 0 days (n = 50 herds each). Partial cash flows were computed from revenues from sold milk, calves, and culled cows, and costs from feed and rearing young-stock. Greenhouse gas emissions were computed using a life cycle approach. A dry period of 28 days reduced milk production of the herd by 3.0% in years 2 through 5, compared with a dry period of 56 days. A dry period of 0 days reduced milk production by 3.5% in years 3 through 5, after a dip in milk production of 6.9% in year 2. On average, dry periods of 28 and 0 days reduced partial cash flows by 1,249 pound and 1,632 pound per herd per year, and increased greenhouse gas emissions by 0.7% and 0.5%, respectively. Considering the potential for enhancing cow welfare, these negative impacts of shortening or omitting the dry period seem justifiable, and they might even be offset by improved health.	[Kok, Akke; van Middelaar, Corina E.; Mostert, Pim F.; de Boer, Imke J. M.] Wageningen Univ & Res, Anim Prod Syst Grp, Wageningen, Netherlands; [Kok, Akke; van Knegsel, Ariette T. M.; Kemp, Bas] Wageningen Univ & Res, Adaptat Physiol Grp, Wageningen, Netherlands; [Hogeveen, Henk] Wageningen Univ & Res, Business Econ Grp, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Kok, A (corresponding author), Wageningen Univ & Res, Anim Prod Syst Grp, Wageningen, Netherlands.; Kok, A (corresponding author), Wageningen Univ & Res, Adaptat Physiol Grp, Wageningen, Netherlands.	akke.kok@wur.nl	van Knegsel, Ariette/AAA-7304-2020; Kok, Akke/I-6202-2019; de Boer, Imke/P-7107-2014	van Knegsel, Ariette/0000-0003-1959-3363; Kok, Akke/0000-0002-6024-5339; de Boer, Imke/0000-0002-0675-7528; Hogeveen, Henk/0000-0002-9443-1412	DairyNL (Zuivel NL); Dutch Ministry of Economic Affairs, as part of the Sustainable Dairy Chain initiative (Duurzame Zuivelketen)	DairyNL (Zuivel NL); Dutch Ministry of Economic Affairs, as part of the Sustainable Dairy Chain initiative (Duurzame Zuivelketen)	This study is financed by DairyNL (Zuivel NL; organization of the Dutch dairy supply chain) and the Dutch Ministry of Economic Affairs (EZ), as part of the Sustainable Dairy Chain initiative (Duurzame Zuivelketen; http://ww.duurzamezuivelketen.nl/en/about-us). The specific project is Customized Dry period lengths (Droogstand op maat; http://www.verantwoordeveehouderij.nl/show/Droogstand-op-maat.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the participating farmers and CRV for providing the data, and Dr. Niels Rutten and Dr. Jan Dijkstra (Wageningen University) for useful discussions. This study is financed by DairyNL (Zuivel NL; organization of the Dutch dairy supply chain) and the Dutch Ministry of Economic Affairs (EZ), as part of the Sustainable Dairy Chain initiative (Duurzame Zuivelketen).	Andersen JB, 2005, J DAIRY SCI, V88, P3530, DOI 10.3168/jds.S0022-0302(05)73038-1; ARNOLD P. T. DIX, 1936, JOUR DAIRY SCI, V19, P257, DOI 10.3168/jds.S0022-0302(36)93061-8; Butler WR, 2003, LIVEST PROD SCI, V83, P211, DOI 10.1016/S0301-6226(03)00112-X; Capuco AV, 1997, J DAIRY SCI, V80, P477, DOI 10.3168/jds.S0022-0302(97)75960-5; Centraal Bureau voor Statistiek, 2016, GEZ VOLW OUD GGEN CB; Chen J, 2015, THERIOGENOLOGY, V84, P1387, DOI 10.1016/j.theriogenology.2015.07.025; Cheng J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115339; Collard BL, 2000, J DAIRY SCI, V83, P2683, DOI 10.3168/jds.S0022-0302(00)75162-9; CVB, 2012, TAB VEEV 2012 VOED L; De Mol R.M., 2003, EMISSIONS METHANE NI; de Vries JW, 2011, LIFE CYCLE ASSESSMEN; Dong H, 2006, FORESTRY; FrieslandCampina, 2016, JAARV 2016; Garnsworthy PC, 2004, ANIM FEED SCI TECH, V112, P211, DOI 10.1016/j.anifeedsci.2003.10.011; Gerber P.J., 2013, TACKLING CLIMATE CHA, P139; Gumen A, 2005, J DAIRY SCI, V88, P2401, DOI 10.3168/jds.S0022-0302(05)72918-0; Heeren JAH, 2014, LIVEST SCI, V168, P149, DOI 10.1016/j.livsci.2014.08.004; Heuer C, 1999, J DAIRY SCI, V82, P295, DOI 10.3168/jds.S0022-0302(99)75236-7; Inchaisri C, 2010, THERIOGENOLOGY, V74, P835, DOI 10.1016/j.theriogenology.2010.04.008; Ingvartsen KL, 2006, ANIM FEED SCI TECH, V126, P175, DOI 10.1016/j.anifeedsci.2005.08.003; International Dairy Federation, 2015, B INT DAIRY FED, V63; Kopf M, 2014, ANIMAL, V8, P1130, DOI 10.1017/S1751731114001062; Kok A, 2017, J DAIRY SCI, V100, P739, DOI 10.3168/jds.2016-10963; Kok A, 2016, J DAIRY SCI, V99, P2956, DOI 10.3168/jds.2015-10559; Kok A, 2017, APPL ANIM BEHAV SCI, V186, P7, DOI 10.1016/j.applanim.2016.10.017; Kuhn MT, 2005, ANIM RES, V54, P351, DOI 10.1051/animres:2005031; KWIN V, 2014, KWANT INF VEEH 2014; Lesschen JP, 2011, ANIM FEED SCI TECH, V166-67, P16, DOI 10.1016/j.anifeedsci.2011.04.058; Mackenzie SG, 2017, INT J LIFE CYCLE ASS, V22, P128, DOI 10.1007/s11367-016-1161-2; Mostert P F, 2018, Animal, V12, P145, DOI 10.1017/S1751731117001306; Mostert PF, 2017, J CLEAN PRO IN PRESS; Myhre G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P659; Nor NM, 2014, J DAIRY RES, V81, P1, DOI 10.1017/S0022029913000460; Pinedo PJ, 2014, J DAIRY SCI, V97, P2886, DOI 10.3168/jds.2013-7685; R Core Team, 2016, R FDN STAT COMP; Rastani RR, 2005, J DAIRY SCI, V88, P1004, DOI 10.3168/jds.S0022-0302(05)72768-5; Roberts T, 2012, J DAIRY SCI, V95, P3057, DOI 10.3168/jds.2011-4937; Rutten CJ, 2014, J DAIRY SCI, V97, P6869, DOI 10.3168/jds.2014-7948; RVO (Netherlands Enterprise Agency), 2015, HANDR BEDR EXCR MELK; Santschi DE, 2011, J DAIRY SCI, V94, P4734, DOI 10.3168/jds.2010-3596; Santschi DE, 2011, J DAIRY SCI, V94, P2302, DOI 10.3168/jds.2010-3594; SORENSEN JT, 1993, LIVEST PROD SCI, V33, P77, DOI 10.1016/0301-6226(93)90240-I; Steeneveld W, 2013, J DAIRY SCI, V96, P2988, DOI 10.3168/jds.2012-6297; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; TAMMINGA S, 1994, LIVEST PROD SCI, V40, P139, DOI 10.1016/0301-6226(94)90043-4; Van Es A.J.H., 1975, LIVEST PROD SCI, V2, P95, DOI DOI 10.1016/0301-6226(75)90029-9; van Hoeij RJ, 2017, J DAIRY SCI, V100, P5863, DOI 10.3168/jds.2016-11703; van Knegsel ATM, 2014, J DAIRY SCI, V97, P1499, DOI 10.3168/jds.2013-7391; van Knegsel ATM, 2013, VET J, V198, P707, DOI 10.1016/j.tvjl.2013.10.005; van Middelaar CE, 2014, J DAIRY SCI, V97, P5191, DOI 10.3168/jds.2013-7413; van Middelaar CE, 2013, AGR SYST, V121, P9, DOI 10.1016/j.agsy.2013.05.009; Vellinga T. V., 2013, METHODOLOGY USED FEE; Velthof G., 2011, CALCULATION NITROUS; Vonk J., 2016, METHODOLOGY ESTIMATI, DOI [10.18174/383679, DOI 10.18174/]; Wageningen Economic Research, AGR PRIC; Wageningen Economic Research, EC FARM RES; Watters RD, 2009, J DAIRY SCI, V92, P3081, DOI 10.3168/jds.2008-1294; Weiss F, 2012, AGR ECOSYST ENVIRON, V149, P124, DOI 10.1016/j.agee.2011.12.015; WILMINK JBM, 1987, LIVEST PROD SCI, V16, P335, DOI 10.1016/0301-6226(87)90003-0; Zobel G, 2015, J DAIRY SCI, V98, P8263, DOI 10.3168/jds.2015-9617	60	9	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187101	10.1371/journal.pone.0187101	http://dx.doi.org/10.1371/journal.pone.0187101			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077739	Green Submitted, gold, Green Published			2022-12-26	WOS:000413861200043
J	Luo, ZT; Fan, YY; Li, QX; Hang, B; Liu, Y; Li, SB; Qiu, H; Pang, ZW				Luo, Zhiting; Fan, Yingying; Li, Qiuxia; Hang, Bing; Liu, Yang; Li, Shubo; Qiu, Hua; Pang, Zongwen			Isolation, purification and characterization of 5 '-phosphodiesterase from Aspergillus fumigatus	PLOS ONE			English	Article							SAFETY EVALUATION; NUCLEASE P1; HYDROLYSIS; PROTEIN; BARLEY	5'-Phosphodiesterase (5'-PDE) catalyzes the hydrolysis of ribonucleic acid to obtain a mixture of ribonucleotides, such as 5'-guanosine monophosphate and 5'-adenosine monophosphate. In this study, a 5'-PDE was newly isolated and purified from Aspergillus fumigatus. Following purification, this enzyme exhibited a specific activity of 1036.76 U/mg protein, a molecular weight of 9.5 kDa, and an optimal temperature and pH for enzyme activity of 60 degrees C and 5.0, respectively. However, its activity was partially inhibited by Fe3+, Cu2+, and Zn2+, but slightly improved by the presence of K+ and Na+. Additionally, chemical-modification experiments were also applied to investigate the structural information of 5'-PDE, in which the residues containing carboxyl and imidazole groups were essential for enzyme activity based on their localization in the 5'-PDE active site. Furthermore, purified 5'-PDE could specifically catalyze the synthesis of ribonucleotides with a V-max 0.71 mmol/mg.min and a K-M of 13.60 mg/mL.	[Luo, Zhiting; Qiu, Hua] Guangxi Univ, Coll Light Ind & Food Engn, Nanning, Peoples R China; [Fan, Yingying; Li, Qiuxia; Hang, Bing; Liu, Yang; Pang, Zongwen] Guangxi Univ, Coll Life Sci & Technol, Nanning, Peoples R China; [Li, Shubo] Liquor Making Biol Technol & Applicat Key Lab Sic, Zigong, Peoples R China	Guangxi University; Guangxi University	Qiu, H (corresponding author), Guangxi Univ, Coll Light Ind & Food Engn, Nanning, Peoples R China.; Pang, ZW (corresponding author), Guangxi Univ, Coll Life Sci & Technol, Nanning, Peoples R China.	qh0038@163.com; pangzw@gxu.edu.cn			Guangxi Natural Science Foundation [2016GXNSFAA380247]; Liquor Making Biological Technology and Application of key laboratory of Sichuan Province [NJ2016-04]	Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Liquor Making Biological Technology and Application of key laboratory of Sichuan Province	This research was financially supported by the Guangxi Natural Science Foundation (grant NO. 2016GXNSFAA380247), and the Liquor Making Biological Technology and Application of key laboratory of Sichuan Province (NJ2016-04).	Beluhan S, 2003, BIOTECHNOL LETT, V25, P1099, DOI 10.1023/A:1024144215414; BENAIGES MD, 1990, ENZYME MICROB TECH, V12, P86, DOI 10.1016/0141-0229(90)90078-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burdock GA, 2000, FOOD CHEM TOXICOL, V38, P429, DOI 10.1016/S0278-6915(00)00018-1; Davis BG, 2003, CURR OPIN BIOTECH, V14, P379, DOI 10.1016/S0958-1669(03)00098-3; Deoda AJ, 2003, BIORESOURCE TECHNOL, V88, P245, DOI 10.1016/S0960-8524(02)00267-5; GARCIADIAZ M, 1991, EUR J BIOCHEM, V196, P451, DOI 10.1111/j.1432-1033.1991.tb15836.x; Guoqing Ying, 2004, GUANGZHOU FOOD SCI T, V20, P126; He QT, 2011, KOREAN J CHEM ENG, V28, P544, DOI 10.1007/s11814-010-0404-3; Hu Y.-J., 1985, Acta Phytophysiologica Sinica, V11, P155; Krause U, 1996, AM J PHYSIOL-REG I, V270, pR811, DOI 10.1152/ajpregu.1996.270.4.R811; KUNINAKA A, 1961, AGR BIOL CHEM TOKYO, V25, P693, DOI 10.1080/00021369.1961.10857865; Lan TQ, 2013, BIORESOURCE TECHNOL, V133, P175, DOI 10.1016/j.biortech.2013.01.088; Okado N, 2016, FOOD CHEM TOXICOL, V88, P21, DOI 10.1016/j.fct.2015.12.001; Paolucci-Jeanjean D, 2001, J CHEM TECHNOL BIOT, V76, P273, DOI 10.1002/jctb.380; ROBERTO IC, 1991, BIORESOURCE TECHNOL, V36, P271, DOI 10.1016/0960-8524(91)90234-B; Shi LE, 2009, J MEMBRANE SCI, V345, P217, DOI 10.1016/j.memsci.2009.09.001; Soares AM, 2003, BIOCHEM BIOPH RES CO, V302, P193, DOI 10.1016/S0006-291X(03)00155-4; Steensma A, 2004, FOOD CHEM TOXICOL, V42, P935, DOI 10.1016/j.fct.2004.01.017; TAKETO Y, 1974, JPN J EXP MED, V44, P291; TANAKA H, 1985, BIOTECHNOL BIOENG, V27, P890, DOI 10.1002/bit.260270621; Warnecke JM, 2000, NUCLEIC ACIDS RES, V28, P720, DOI 10.1093/nar/28.3.720; Ying GQ, 2006, PROCESS BIOCHEM, V41, P1276, DOI 10.1016/j.procbio.2005.12.028; Ying QQ, 2007, APPL BIOCHEM BIOTECH, V136, P119, DOI 10.1007/BF02685942	24	3	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186011	10.1371/journal.pone.0186011	http://dx.doi.org/10.1371/journal.pone.0186011			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073277	Green Published, gold, Green Submitted			2022-12-26	WOS:000413845400011
J	Mazza, A; Cavallin, F; Cappellari, A; Divisic, A; Grbin, I; Akakpo, J; Moukaila, AR; Trevisanuto, D				Mazza, Alessandro; Cavallin, Francesco; Cappellari, Anita; Divisic, Antuan; Grbin, Ivana; Akakpo, Jean; Moukaila, Abdou Razak; Trevisanuto, Daniele			Effect of a short training on neonatal face-mask ventilation performance in a low resource setting	PLOS ONE			English	Article							RESUSCITATION; GUIDELINES; MORTALITY; BABIES	Background We assessed whether a short training, effective in a high resource country, was able to improve the quality of face-mask ventilation (FMV) in a low resource setting. Methods Local healthcare providers at the Centre Me A dico-Social, Kouve, Togo were asked to ventilate a neonatal leak-free manikin before (time-t(1)) and after (t(2)) a two-minute training session. Immediately after this section, a further two-minute training with participants aware of the data monitor was offered. Finally, a third 1-minute FMV round (t(3)) was performed by each participant. Ventilatory parameters were recorded using a computerized system. Primary outcome was the percentage of breaths with relevant mask leak (>25%). Secondary outcomes were percentages of breaths with a low peak inspiratory pressure (PIP<20 cm H2O), within the recommended PIP (20-35 cm H2O) and with a high PIP (>35 cm H2O). Results Twenty-six subjects participated in the study. The percentage of relevant mask leak significantly decreased (p<0.0001; beta = -0.76, SE = 0.10) from 89.7% (SD 21.5%) at t(1) to 45.4% (SD 27.2%) at t(2) and to 18.3% (SD 20.1%) at t(3). The percentage of breaths within the recommended PIP significantly increased (p<0.0001; beta = +0.54, SE = 0.12). The percentage of breaths with PIP>35 cm H2O was 19.5% (SD 32.8%) at t(1) and 39.2% (SD 37.7%) at t(2) (padj = 0.27; beta = +0.61, SE = 0.36) and significantly decreased (padj = 0.01; beta = -1.61, SE = 0.55) to 6.0% (SD 15.4%) at t(3). Conclusions A 2-minute training on FMV, effective in a high resource country, had a positive effect also in a low resource setting. FMV performance further improved after an extra 2-minute verbal recall plus real time feedback. Although the training was extended, it still does not cost much time and effort. Further studies are needed to establish if these basic skills are transferred in real patients and if they are maintained over time.	[Mazza, Alessandro; Cappellari, Anita; Divisic, Antuan; Grbin, Ivana; Trevisanuto, Daniele] Univ Padua, Azienda Osped Padova, Dept Womens & Childrens Hlth, Padua, Italy; [Akakpo, Jean; Moukaila, Abdou Razak] Ctr Med Social, Maternite, Marie Mere Providence, Kouve, Togo	University of Padua; Azienda Ospedaliera - Universita di Padova	Trevisanuto, D (corresponding author), Univ Padua, Azienda Osped Padova, Dept Womens & Childrens Hlth, Padua, Italy.	daniele.trevisanuto@gmail.com	Divisic, Antuan/AFK-4023-2022; Divisic, Antuan/AAG-2819-2022	Trevisanuto, Daniele/0000-0002-7126-5298	Autonomous Province of Trento; Autonomous Region Trentino-Alto Adige, Italy	Autonomous Province of Trento(Autonomous Province of Trento); Autonomous Region Trentino-Alto Adige, Italy	Autonomous Province of Trento and Autonomous Region Trentino-Alto Adige, Italy, supported the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Autonomous Province of Trento and Autonomous Region Trentino-Alto Adige, Italy that supported the project.	[Anonymous], 2019, R LANG ENV STAT COMP; Kelm M, 2012, J PERINAT MED, V40, P583, DOI 10.1515/jpm-2012-0023; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Lee ACC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S12; Mduma E, 2015, RESUSCITATION, V93, P1, DOI 10.1016/j.resuscitation.2015.04.019; Msemo G, 2013, PEDIATRICS, V131, pE353, DOI 10.1542/peds.2012-1795; Newton O, 2006, T ROY SOC TROP MED H, V100, P899, DOI 10.1016/j.trstmh.2006.02.012; Singhal N, 2006, CLIN PERINATOL, V33, P219, DOI 10.1016/j.clp.2005.11.009; Trevisanuto D, 2015, PLOS ONE, V11, P10; Unicef Levels & Trends in Child Mortality, 2013, LEV TRENDS CHILD MOR; van Vonderen JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109049; WHO, 2014, WORLD HLTH STAT; Wood FE, 2008, ARCH DIS CHILD-FETAL, V93, pF230, DOI 10.1136/adc.2007.117788; Wyckoff MH, 2015, CIRCULATION, V132, pS543, DOI 10.1161/CIR.0000000000000267; Wyllie J, 2015, RESUSCITATION, V95, P249, DOI 10.1016/j.resuscitation.2015.07.029	15	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186731	10.1371/journal.pone.0186731	http://dx.doi.org/10.1371/journal.pone.0186731			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073266	Green Published, gold, Green Submitted			2022-12-26	WOS:000413845400046
J	Shen, ZF; Jiang, X; Yan, LL; Chen, Y; Wang, WW; Shi, Y; Shi, LE; Liu, DX; Zhou, NM				Shen, Zhangfei; Jiang, Xue; Yan, Lili; Chen, Yu; Wang, Weiwei; Shi, Ying; Shi, Liangen; Liu, Dongxiang; Zhou, Naiming			Structural basis for the interaction of diapause hormone with its receptor in the silkworm, Bombyx mori	FASEB JOURNAL			English	Article						GPCR; neuropeptide; signaling; structure-activity relationship	PROTEIN-COUPLED RECEPTOR; NEUROPEPTIDE FAMILY; BIOLOGICAL-ACTIVITY; EMBRYONIC DIAPAUSE; IDENTIFICATION; INSECT; COEVOLUTION; ACTIVATION; INDUCTION; PEPTIDES	Diapause hormone (DH) is a 24-aa amidated neuropeptide that elicits the embryonic diapause of the silkworm, Bombyx mori (Bommo), via sensitive and selective interaction with its receptor, Bommo DH receptor (Bommo-DHR). Previous studies of the structure-activity relationship of Bommo-DH were all based on an in vivo diapause-induction bioassay, which has provided little information on the structure of Bommo-DHR or its iteration with DH. Here, to unveil the interaction of Bommo-DH with its receptor, N-terminally truncated analogs and alanine-scanning mutants of Bommo-DH were chemically synthesized and functionally evaluated by using a Cy5.5-labeled Bommo-DH competitive binding assay and Bommo-DHR-based functional assays, including cAMP assay and Ca2+ mobilization assay. Our study demonstrates that the C-terminal residues of Arg23 and Leu24 of Bommo-DH are essential for the binding and activation of Bommo-DHR, and that Trp19 and Phe20 also contribute to the functional activity of Bommo-DH. In contrast, when Gly21 or Pro22 were replaced with alanine, both mutants exhibited binding and signaling activities that were indistinguishable from the wild-type peptide. Furthermore, our homology modeling and molecular dynamics simulations, together with experimental validations, have identified the residues of Glu89, Phe172, Phe194, and Tyr299 in Bommo-DHR that are critically involved in the interaction with Bommo-DH. These results may deepen our understanding of the interactions of class-AGPCRs with their peptidic ligands, particularly those between pheromone biosynthesis-activating neuropeptide/DH family neuropeptides and their cognate receptors.-Shen, Z., Jiang, X., Yan, L., Chen, Y., Wang, W., Shi, Y., Shi, L., Liu, D., Zhou, N. Structural basis for the interaction of diapause hormone with its receptor in the silkworm, Bombyx mori.	[Shen, Zhangfei; Jiang, Xue; Shi, Liangen] Zhejiang Univ, Coll Anim Sci, Dept Econ Zool, Hangzhou, Zhejiang, Peoples R China; [Yan, Lili; Chen, Yu; Wang, Weiwei; Shi, Ying; Zhou, Naiming] Zhejiang Univ, Coll Life Sci, Inst Biochem, Zijingang Campus, Hangzhou 310058, Zhejiang, Peoples R China; [Liu, Dongxiang] Chinese Acad Sci, Shanghai Inst Mat Med, Dept Pharmacol 3, Shanghai 201203, Peoples R China	Zhejiang University; Zhejiang University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Zhou, NM (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Biochem, Zijingang Campus, Hangzhou 310058, Zhejiang, Peoples R China.; Liu, DX (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Dept Pharmacol 3, Shanghai 201203, Peoples R China.	dxl@mail.shcnc.ac.cn; zhounaiming@zju.edu.cn	Zhou, Naiming/AHC-1121-2022; Chen, Yi/HIR-2608-2022; Chen, Yu/Y-3292-2019	shen, zhangfei/0000-0002-3707-2265	National Natural Science Foundation of China [31272375, 31572462, 21472206, 21672233]; Science and Technology Project of Zhejiang, China [2016C32079]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Zhejiang, China	This work was supported by the National Natural Science Foundation of China (Grants 31272375, 31572462, 21472206, and 21672233) and the Science and Technology Project of Zhejiang, China (Grant 2016C32079). The authors declare no conflicts of interest.	Choi MY, 2007, INSECT BIOCHEM MOLEC, V37, P296, DOI 10.1016/j.ibmb.2006.12.004; Cvejic S, 2004, NAT CELL BIOL, V6, P540, DOI 10.1038/ncb1133; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Darlison MG, 1999, TRENDS NEUROSCI, V22, P81, DOI 10.1016/S0166-2236(98)01333-2; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Fukuda S., 1951, Proceedings of the Japan Academy, V27, P672; Hasegawa K., 1951, Proceedings of the Japan Academy, V27, P667; Homma T, 2006, BIOCHEM BIOPH RES CO, V344, P386, DOI 10.1016/j.bbrc.2006.03.085; Huang HS, 2010, BIOCHEMISTRY-US, V49, P10862, DOI 10.1021/bi1014425; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IKEDA M, 1993, J INSECT PHYSIOL, V39, P889, DOI 10.1016/0022-1910(93)90122-8; IMAI K, 1991, P JPN ACAD B-PHYS, V67, P98, DOI 10.2183/pjab.67.98; Imai K, 1998, BIOSCI BIOTECH BIOCH, V62, P1875, DOI 10.1271/bbb.62.1875; Jiang HB, 2014, SCI REP-UK, V4, DOI 10.1038/srep06800; Jiang X, 2016, INSECT BIOCHEM MOLEC, V75, P78, DOI 10.1016/j.ibmb.2016.06.005; Kawai T, 2014, J BIOL CHEM, V289, P19150, DOI 10.1074/jbc.M113.488999; KITAMURA A, 1989, BIOCHEM BIOPH RES CO, V163, P520, DOI 10.1016/0006-291X(89)92168-2; KUNIYOSHI H, 1992, INSECT BIOCHEM MOLEC, V22, P399, DOI 10.1016/0965-1748(92)90078-S; Li G, 2010, J BIOL CHEM, V285, P22605, DOI 10.1074/jbc.M109.087213; Morita A, 2003, J INSECT PHYSIOL, V49, P1093, DOI 10.1016/j.jinsphys.2003.08.009; NACHMAN RJ, 1993, PEPTIDES, V14, P1043, DOI 10.1016/0196-9781(93)90084-T; NACHMAN RJ, 1991, P NATL ACAD SCI USA, V88, P4518, DOI 10.1073/pnas.88.10.4518; Nusawardani T, 2013, INSECT MOL BIOL, V22, P331, DOI 10.1111/imb.12025; Park Y, 2002, P NATL ACAD SCI USA, V99, P11423, DOI 10.1073/pnas.162276199; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Predel R, 2006, HANDBOOK OF BIOLOGICALLY ACTIVE PEPTIDES, P207, DOI 10.1016/B978-012369442-3/50035-0; SAITO H, 1994, PEPTIDES, V15, P1173, DOI 10.1016/0196-9781(94)90139-2; SATO Y, 1993, P NATL ACAD SCI USA, V90, P3251, DOI 10.1073/pnas.90.8.3251; Sato Y., 2006, P JPN ACAD, V68, P75; Shalev AH, 2015, PEPTIDES, V63, P81, DOI 10.1016/j.peptides.2014.10.014; SHIMIZU I, 1991, JPN J APPL ENTOMOL Z, V35, P83; Shiomi K, 2015, SCI REP-UK, V5, DOI 10.1038/srep15566; SUWAN S, 1994, INSECT BIOCHEM MOLEC, V24, P1001, DOI 10.1016/0965-1748(94)90137-6; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Watanabe K, 2007, MOL CELL ENDOCRINOL, V273, P51, DOI 10.1016/j.mce.2007.05.008; Yamashita O, 1996, J INSECT PHYSIOL, V42, P669, DOI 10.1016/0022-1910(96)00003-0; Yang HP, 2013, INSECT BIOCHEM MOLEC, V43, P1028, DOI 10.1016/j.ibmb.2013.08.011; Yang JW, 2013, J BIOL CHEM, V288, P11662, DOI 10.1074/jbc.M112.441675	39	7	8	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1338	1353		10.1096/fj.201700931R	http://dx.doi.org/10.1096/fj.201700931R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29101222	Bronze			2022-12-26	WOS:000427246000018
J	Schroyer, AL; Stimes, NW; Saab, WFA; Chadee, DN				Schroyer, A. L.; Stimes, N. W.; Saab, W. F. Abi; Chadee, D. N.			MLK3 phosphorylation by ERK1/2 is required for oxidative stress-induced invasion of colorectal cancer cells	ONCOGENE			English	Article							LINEAGE KINASE 3; ACTIVATION LOOP; IN-VIVO; B-RAF; IDENTIFICATION; PROMOTES; MIGRATION; COMPLEX; BINDING; SPRK	Mixed lineage kinase 3 (MLK3) functions in migration and/or invasion of several human cancers; however, the role of MLK3 in colorectal cancer (CRC) invasion is unknown. MLK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAP3K) which activates MAPK pathways through either kinase-dependent or -independent mechanisms. Human colorectal tumors display increased levels of reactive oxygen species (ROS) or oxidative stress. ROS, such as H2O2, are important for carcinogenesis and activate MAPK signaling pathways. In human colorectal carcinoma (HCT116) cells treated with H2O2, extracellular signal-regulated kinases 1 and 2 (ERK1/2) were activated and MLK3 exhibited reduced electrophoretic mobility (shift) in sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), which was eliminated by phosphatase treatment. Pretreatment with the ROS scavenger N-acetyl-L-cysteine, the ERK1/2 inhibitor UO126, or ERK1/2 siRNA knockdown blocked the H2O2-induced shift of MLK3, while MLK3 inhibition with Cep1347 did not. In co-immunoprecipitation experiments performed on H2O2-treated HCT116 cells, endogenous MLK3 associated with endogenous ERK1/2 and B-Raf. Active ERK1 phosphorylated kinase dead FLAG-MLK3 in vitro, whereas ERK1 phosphorylation of kinase dead FLAG-MLK3-S705A-S758A was reduced. Both MLK3 siRNA knockdown and FLAGMLK3-S705A-S758A expression decreased ERK1/2 activation in H2O2-treated cells. Prolonged H2O2 treatment activated ERK1/2 and promoted invasion of colon cancer cells, which was attenuated by MLK3 siRNA knockdown. Furthermore, S705A-S758A-FLAG-MLK3 demonstrated decreased oxidative-stress induced colon cancer cell invasion, but increased interaction with GST-B-Raf as compared with wild-type-FLAG-MLK3 in H2O2-treated cells. These results suggest oxidative stress stimulates an ERK1/2-dependent phosphorylation of MLK3 on Ser(705) and Ser(758), which promotes MLK3-dependent B-Raf and ERK1/2 activation; this positive feedback loop enhances the invasion of colon cancer cells.	[Schroyer, A. L.; Stimes, N. W.; Saab, W. F. Abi; Chadee, D. N.] Univ Toledo, Dept Biol Sci, 2801 West Bancroft St, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Chadee, DN (corresponding author), Univ Toledo, Dept Biol Sci, 2801 West Bancroft St, Toledo, OH 43606 USA.	deborah.chadee@utoledo.edu			National Institutes of Health [R15 CA199164, R15 GM102831]; NATIONAL CANCER INSTITUTE [R15CA199164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM102831] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R15 CA199164 and R15 GM102831 (to DNC).	Blessing NA, 2014, MOL CELL BIOL, V34, P3132, DOI 10.1128/MCB.00296-14; Bock BC, 2000, J BIOL CHEM, V275, P14231, DOI 10.1074/jbc.275.19.14231; BOULTON TG, 1991, BIOCHEMISTRY-US, V30, P278, DOI 10.1021/bi00215a038; Chadee DN, 2006, P NATL ACAD SCI USA, V103, P4463, DOI 10.1073/pnas.0510651103; Chadee DN, 2004, NAT CELL BIOL, V6, P770, DOI 10.1038/ncb1152; Chen J, 2010, ONCOGENE, V29, P4399, DOI 10.1038/onc.2010.198; Chen J, 2012, CANCER RES, V72, P4130, DOI 10.1158/0008-5472.CAN-12-0655; Chien ST, 2011, MOL CELL BIOCHEM, V350, P135, DOI 10.1007/s11010-010-0692-2; Cronan MR, 2012, ONCOGENE, V31, P3889, DOI 10.1038/onc.2011.544; Du Y, 2005, J BIOL CHEM, V280, P42984, DOI 10.1074/jbc.M502671200; GALLO KA, 1994, J BIOL CHEM, V269, P15092; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; ING YL, 1994, ONCOGENE, V9, P1745; Lan T, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-016-0486-9; Lee HS, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005260; Leung IWL, 1998, J BIOL CHEM, V273, P32408, DOI 10.1074/jbc.273.49.32408; Leung IWL, 2001, J BIOL CHEM, V276, P1961, DOI 10.1074/jbc.M004092200; Liu H, 2000, MOL CELL BIOL, V20, P2198, DOI 10.1128/MCB.20.6.2198-2208.2000; Maroney AC, 2001, J BIOL CHEM, V276, P25302, DOI 10.1074/jbc.M011601200; Marusiak AA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4901; Misek SA, 2017, MOL CANC RES; Mishra P, 2010, MOL ENDOCRINOL, V24, P598, DOI 10.1210/me.2009-0387; Partridge J, 2009, JOVE-J VIS EXP, P1475; Perse M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/725710; Rana A, 1996, J BIOL CHEM, V271, P19025, DOI 10.1074/jbc.271.32.19025; Rattanasinchai C, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.44; Schachter KA, 2006, J BIOL CHEM, V281, P19134, DOI 10.1074/jbc.M603324200; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Son Yong, 2011, J Signal Transduct, V2011, P792639, DOI 10.1155/2011/792639; Swenson-Fields KI, 2008, MOL CELL, V32, P43, DOI 10.1016/j.molcel.2008.09.007; Teramoto H, 1996, J BIOL CHEM, V271, P27225, DOI 10.1074/jbc.271.44.27225; Tibbles LA, 1996, EMBO J, V15, P7026, DOI 10.1002/j.1460-2075.1996.tb01094.x; Vacratsis PO, 2002, BIOCHEMISTRY-US, V41, P5613, DOI 10.1021/bi016075c; Velho S, 2010, HUM MOL GENET, V19, P697, DOI 10.1093/hmg/ddp536; Wang CY, 2010, PROTEIN CELL, V1, P871, DOI 10.1007/s13238-010-0111-1; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Wlochowitz D, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00042; Xu ZH, 2005, MOL CELL BIOL, V25, P9949, DOI 10.1128/MCB.25.22.9949-9959.2005; Xu ZH, 2003, EMBO J, V22, P252, DOI 10.1093/emboj/cdg021; Zhan Y, 2012, EXP CELL RES, V318, P1641, DOI 10.1016/j.yexcr.2012.05.002; Zhang J, 2014, CLIN EXP DERMATOL, V39, P376, DOI 10.1111/ced.12286	42	35	35	3	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 22	2018	37	8					1031	1040		10.1038/onc.2017.396	http://dx.doi.org/10.1038/onc.2017.396			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FX2QD	29084209	Green Accepted			2022-12-26	WOS:000425905700006
J	Lee, SG; Jez, JM				Lee, Soon Goo; Jez, Joseph M.			Conformational changes in the di-domain structure of Arabidopsis phosphoethanolamine methyltransferase leads to active-site formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis thaliana; enzyme kinetics; X-ray crystallography; protein structure; S-adenosylmethionine (SAM)	PHOSPHOMETHYLETHANOLAMINE N-METHYLTRANSFERASE; PLASMODIUM-FALCIPARUM; PHOSPHATIDYLCHOLINE SYNTHESIS; PHOSPHOCHOLINE BIOSYNTHESIS; CATALYTIC MECHANISM; CRYSTAL-STRUCTURE; CLONING; METABOLISM; PATHWAY; CHOLINE	Phosphocholine (pCho) is a precursor for phosphatidylcholine and osmoprotectants in plants. In plants, de novo synthesis of pCho relies on the phosphobase methylation pathway. Phosphoethanolamine methyltransferase (PMT) catalyzes the triple methylation of phosphoethanolamine (pEA) to pCho. The plant PMTs are di-domain methyltransferases that divide the methylation of pEA in one domain from subsequent methylations in the second domain. To understand the molecular basis of this architecture, we examined the biochemical properties of three Arabidopsis thaliana PMTs (AtPMT1-3) and determined the X-ray crystal structures of AtPMT1 and AtPMT2. Although each isoform synthesizes pCho from pEA, their physiological roles differ with AtPMT1 essential for normal growth and salt tolerance, whereas AtPMT2 and AtPMT3 overlap functionally. The structures of AtPMT1 and AtPMT2 reveal unique features in each methyltransferase domain, including active sites that use different chemical mechanisms for phosphobase methylation. These structures also show how rearrangements in both the active sites and the di-domain linker form catalytically competent active sites and provide insight on the evolution of the PMTs in plants, nematodes, and apicomplexans. Connecting conformational changes with catalysis in modular enzymes, like the PMT, provides new insights on interdomain communication in biosynthetic systems.	[Lee, Soon Goo; Jez, Joseph M.] Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA	Washington University (WUSTL)	Jez, JM (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	jjez@wustl.edu		Lee, Soon Goo/0000-0002-1541-8587	Department of Energy Office of Biological and Environmental Research [DE-AC02-06CH11357]; National Science Foundation [EPS 0236913, MCB 045531, DBI 0521587]; Kansas Technology Enterprise Corp.; K-IDeA Networks of Biomedical Research Excellence (INBRE) of National Institute of Health [P20RR16475]; Kansas State University; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097119] Funding Source: NIH RePORTER	Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Kansas Technology Enterprise Corp.; K-IDeA Networks of Biomedical Research Excellence (INBRE) of National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kansas State University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Portions of this research were carried out at the Argonne National Laboratory Structural Biology Center of the Advanced Photon Source, a national user facility operated by the University of Chicago for the Department of Energy Office of Biological and Environmental Research under Contract No. DE-AC02-06CH11357. Lipid analysis was performed at the Kansas Lipidomics Research Center Analytical Laboratory, which is supported by National Science Foundation Grants EPS 0236913, MCB 045531, and DBI 0521587; Kansas Technology Enterprise Corp.; and K-IDeA Networks of Biomedical Research Excellence (INBRE) of National Institute of Health Grant P20RR16475, and Kansas State University.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BeGora MD, 2010, J BIOL CHEM, V285, P29147, DOI 10.1074/jbc.M110.112151; Bolognese CP, 2000, PLANT PHYSIOL, V124, P1800, DOI 10.1104/pp.124.4.1800; Brendza KM, 2007, BIOCHEM J, V404, P439, DOI 10.1042/BJ20061815; Charron JBF, 2002, PLANT PHYSIOL, V129, P363, DOI 10.1104/pp.001776; Cruz-Ramirez A, 2004, PLANT CELL, V16, P2020, DOI 10.1105/tpc.103.018648; Dall'Acqua W, 2000, PROTEIN SCI, V9, P1; DATKO AH, 1988, PLANT PHYSIOL, V88, P854, DOI 10.1104/pp.88.3.854; DATKO AH, 1988, PLANT PHYSIOL, V88, P1338, DOI 10.1104/pp.88.4.1338; Devaiah SP, 2006, PHYTOCHEMISTRY, V67, P1907, DOI 10.1016/j.phytochem.2006.06.005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Frueh DP, 2008, NATURE, V454, P903, DOI 10.1038/nature07162; Fu ZJ, 1996, BIOCHEMISTRY-US, V35, P11985, DOI 10.1021/bi961068n; Garg A, 2015, SCI REP-UK, V5, DOI 10.1038/srep09064; Hanson AD, 2001, ANNU REV PLANT PHYS, V52, P119, DOI 10.1146/annurev.arplant.52.1.119; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Horton JR, 2001, STRUCTURE, V9, P837, DOI 10.1016/S0969-2126(01)00643-8; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jost R, 2009, J BIOL CHEM, V284, P31962, DOI 10.1074/jbc.M109.022657; Kanipes M. I., 1997, BIOCHIM BIOPHYS ACTA, V1348, P138; KENT C, 1995, ANNU REV BIOCHEM, V64, P315, DOI 10.1146/annurev.bi.64.070195.001531; Khosla C, 2007, ANNU REV BIOCHEM, V76, P195, DOI 10.1146/annurev.biochem.76.053105.093515; Komoto J, 2004, BIOCHEMISTRY-US, V43, P14385, DOI 10.1021/bi0486785; Lee SG, 2014, TRENDS PARASITOL, V30, P241, DOI 10.1016/j.pt.2014.03.001; Lee SG, 2013, STRUCTURE, V21, P1778, DOI 10.1016/j.str.2013.07.023; Lee SG, 2012, BIOORG MED CHEM LETT, V22, P4990, DOI 10.1016/j.bmcl.2012.06.032; Lee SG, 2012, J BIOL CHEM, V287, P1426, DOI 10.1074/jbc.M111.315267; Lee SG, 2011, J BIOL CHEM, V286, P38060, DOI 10.1074/jbc.M111.290619; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNeil SD, 2001, P NATL ACAD SCI USA, V98, P10001, DOI 10.1073/pnas.171228998; Miller BR, 2014, PROTEINS, V82, P2691, DOI 10.1002/prot.24635; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mou ZL, 2002, PLANT CELL, V14, P2031, DOI 10.1105/tpc.001701; MUDD SH, 1986, PLANT PHYSIOL, V82, P126, DOI 10.1104/pp.82.1.126; Munnik T, 2001, TRENDS PLANT SCI, V6, P227, DOI 10.1016/S1360-1385(01)01918-5; Nuccio ML, 2000, J BIOL CHEM, V275, P14095, DOI 10.1074/jbc.275.19.14095; Palavalli LH, 2006, BIOCHEMISTRY-US, V45, P6056, DOI 10.1021/bi060199d; Pessi G, 2004, P NATL ACAD SCI USA, V101, P6206, DOI 10.1073/pnas.0307742101; Reimer JM, 2016, NATURE, V529, P239, DOI 10.1038/nature16503; Saen-oon S, 2014, J BIOL CHEM, V289, P33815, DOI 10.1074/jbc.M114.611319; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Soriano A, 2006, BIOCHEMISTRY-US, V45, P14917, DOI 10.1021/bi061319k; Subramanian S, 2004, PLANT MOL BIOL, V54, P623, DOI 10.1023/B:PLAN.0000040814.28507.35; Takata Y, 2003, BIOCHEMISTRY-US, V42, P8394, DOI 10.1021/bi034245a; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wang YC, 2011, J AM CHEM SOC, V133, P20684, DOI 10.1021/ja2085993; Wu SW, 2007, MOL BIOTECHNOL, V36, P102, DOI 10.1007/s12033-007-0009-1; Ye CJ, 2005, DNA SEQUENCE, V16, P364, DOI 10.1080/10425170500187791; Zhang YS, 2006, J AM CHEM SOC, V128, P13030, DOI 10.1021/ja0622094	52	14	14	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21690	21702		10.1074/jbc.RA117.000106	http://dx.doi.org/10.1074/jbc.RA117.000106			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29084845	Green Published, hybrid			2022-12-26	WOS:000419013000042
J	Dogan, S; Gurkan, C; Dogan, M; Balkaya, HE; Tunc, R; Demirdov, DK; Ameen, NA; Marjanovic, D				Dogan, Serkan; Gurkan, Cemal; Dogan, Mustafa; Balkaya, Hasan Emin; Tunc, Ramazan; Demirdov, Damla Kanliada; Ameen, Nihad Ahmed; Marjanovic, Damir			A glimpse at the intricate mosaic of ethnicities from Mesopotamia: Paternal lineages of the Northern Iraqi Arabs, Kurds, Syriacs, Turkmens and Yazidis	PLOS ONE			English	Article							Y-CHROMOSOME; POPULATION-DATA; STR HAPLOTYPES; MUTATION-RATE; ANATOLIA; LOCI; LANDSCAPE; DIVERSITY; GENETICS; UPDATE	Widely considered as one of the cradles of human civilization, Mesopotamia is largely situated in the Republic of Iraq, which is also the birthplace of the Sumerian, Akkadian, Assyrian and Babylonian civilizations. These lands were subsequently ruled by the Persians, Greeks, Romans, Arabs, Mongolians, Ottomans and finally British prior to the independence. As a direct consequence of this rich history, the contemporary Iraqi population comprises a true mosaic of different ethnicities, which includes Arabs, Kurds, Turkmens, Assyrians, and Yazidis among others. As such, the genetics of the contemporary Iraqi populations are of anthropological and forensic interest. In an effort to contribute to a better understanding of the genetic basis of this ethnic diversity, a total of 500 samples were collected from Northern Iraqi volunteers belonging to five major ethnic groups, namely: Arabs (n = 102), Kurds (n = 104), Turkmens (n = 102), Yazidis (n = 106) and Syriacs (n = 86). 17-loci Y-STR analyses were carried out using the AmpF/STR Yfiler system, and subsequently in silico haplogroup assignments were made to gain insights from a molecular anthropology perspective. Systematic comparisons of the paternal lineages of these five Northern Iraqi ethnic groups, not only among themselves but also in the context of the larger genetic landscape of the Near East and beyond, were then made through the use of two different genetic distance metric measures and the associated data visualization methods. Taken together, results from the current study suggested the presence of intricate Y-chromosomal lineage patterns among the five ethic groups analyzed, wherein both interconnectivity and independent microvariation were observed in parallel, albeit in a differential manner. Notably, the novel Y-STR data on Turkmens, Syriacs and Yazidis from Northern Iraq constitute the first of its kind in the literature. Data presented herein is expected to contribute to further population and forensic investigations in Northern Iraq in particular and the Near East in general.	[Dogan, Serkan; Dogan, Mustafa; Balkaya, Hasan Emin; Tunc, Ramazan; Marjanovic, Damir] Int Burch Univ, Dept Genet & Bioengn, Sarajevo, Bosnia & Herceg; [Gurkan, Cemal; Demirdov, Damla Kanliada] Turkish Cypriot DNA Lab, Comm Missing Persons Cyprus Turkish Cypriot Membe, Nicosia, North Cyprus, Turkey; [Gurkan, Cemal] Eastern Mediterranean Univ, Dr Fazil Kucuk Fac Med, Famagusta, North Cyprus, Turkey; [Ameen, Nihad Ahmed] Univ Salahaddin, Coll Educ, Dept Biol, Erbil, Iraq; [Marjanovic, Damir] Inst Anthropol Res, Zagreb, Croatia	Eastern Mediterranean University; Salahaddin University; Institute for Anthropological Research Zagreb	Dogan, S (corresponding author), Int Burch Univ, Dept Genet & Bioengn, Sarajevo, Bosnia & Herceg.	serkan.dogan@ibu.edu.ba	Dogan, Serkan/I-1162-2016; Gurkan, Cemal/S-5751-2016	Dogan, Serkan/0000-0001-6932-7165; Gurkan, Cemal/0000-0001-7379-4559; Marjanovic, Damir/0000-0002-7472-4525				Al-Jaeloo N, 2010, EVIDENCE STONE WOOD, P39; Al-Zahery N, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-288; Alakoc YD, 2010, FORENSIC SCI INT-GEN, V4, pE135, DOI 10.1016/j.fsigen.2010.01.016; Athey TW., 2006, J GENET GENEAL, V2, P34; Badro DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054616; Balanovsky O, 2017, HUM GENET, V136, P575, DOI 10.1007/s00439-017-1805-8; Balanovsky O, 2017, HUM GENET, V136, P437, DOI 10.1007/s00439-017-1770-2; Battaglia V, 2009, EUR J HUM GENET, V17, P820, DOI 10.1038/ejhg.2008.249; Brinkmann C, 1999, INT J LEGAL MED, V112, P181, DOI 10.1007/s004140050228; Burgarella C, 2011, EUR J HUM GENET, V19, P70, DOI 10.1038/ejhg.2010.154; Central Intelligence Agency, 2016, WORLD FACTB 2016; Chiaroni J, 2010, EUR J HUM GENET, V18, P348, DOI 10.1038/ejhg.2009.166; Cinnioglu C, 2004, HUM GENET, V114, P127, DOI 10.1007/s00439-003-1031-4; Di Cristofaro J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076748; Dogan S, 2016, HOMO, V67, P471, DOI 10.1016/j.jchb.2016.10.003; Grugni V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041252; Gurkan C, 2017, ANN HUM BIOL, V44, P164, DOI 10.1080/03014460.2016.1207805; Gusmao L, 2006, FORENSIC SCI INT, V157, P187, DOI 10.1016/j.forsciint.2005.04.002; Haber M, 2011, EUR J HUM GENET, V19, P334, DOI 10.1038/ejhg.2010.177; Heraclides A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179474; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Imad HH, 2014, AFRICAN J BIOTECHNOL, V13; Izady M, 2015, KURDS CONCISE HIST F; Kirmanj Sherko, 2013, IDENTITY NATION IRAQ; Kreyenbroek PG, 2006, GOD SHEIKH ADI ARE P; Lashgary Z, 2011, ANN HUM BIOL, V38, P364, DOI 10.3109/03014460.2010.535562; Metz HC, 2004, IRAQ A COUNTRY STUDY; Nasidze I, 2005, ANN HUM GENET, V69, P401, DOI 10.1046/j.1529-8817.2005.00174.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Oguzlu HT, 2001, TURKOMANS IRAQ FACTO; Ozbas-Gerceker F, 2013, INT J HUM GENET, V13, P105, DOI 10.1080/09723757.2013.11886204; Purps J, 2014, FORENSIC SCI INT-GEN, V12, P12, DOI 10.1016/j.fsigen.2014.04.008; Ramirez-Faria C, 2007, CONCISE ENCY WORLD H; Serin A, 2011, CROAT MED J, V52, P703, DOI 10.3325/cmj.2011.52.703; Stansfield G, 2013, IRAQ PEOPLE HIST POL; Stenersen M, 2004, INT CONGR SER, V1261, P185, DOI 10.1016/S0531-5131(03)01823-5; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Terali K, 2014, FORENSIC SCI INT-GEN, V10, pE1, DOI 10.1016/j.fsigen.2014.01.003; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; Voskarides K, 2016, INVESTIG GENET, V7, DOI 10.1186/s13323-016-0032-8; Wang CC, 2015, J GENET GENOMICS, V42, P403, DOI 10.1016/j.jgg.2015.03.008; Wang CC, 2015, INVESTIG GENET, V6, DOI [10.1186/s13323-015-0025-z, 10.1186/2041-2223-5-12]; Willuweit S, 2007, FORENSIC SCI INT-GEN, V1, P83, DOI 10.1016/j.fsigen.2007.01.017; Yepiskoposian L, 2010, IRAN CAUCASUS, V14, P37, DOI 10.1163/157338410X12743419189306; Zerjal T, 2002, AM J HUM GENET, V71, P466, DOI 10.1086/342096; Zhabagin M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03176-z; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911	47	9	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							e0187408	10.1371/journal.pone.0187408	http://dx.doi.org/10.1371/journal.pone.0187408			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6TA	29099847	gold, Green Published, Green Submitted			2022-12-26	WOS:000414377900018
J	Lapmanee, S; Charoenphandhu, J; Teerapornpuntakit, J; Krishnamra, N; Charoenphandhu, N				Lapmanee, Sarawut; Charoenphandhu, Jantarima; Teerapornpuntakit, Jarinthorn; Krishnamra, Nateetip; Charoenphandhu, Narattaphol			Agomelatine, venlafaxine, and running exercise effectively prevent anxiety- and depression-like behaviors and memory impairment in restraint stressed rats	PLOS ONE			English	Article							RECEPTOR MESSENGER-RNA; CENTRAL-NERVOUS-SYSTEM; ELEVATED T-MAZE; MONOAMINE LEVELS; ANTIDEPRESSANT TREATMENT; OVARIECTOMIZED RATS; NEUROTROPHIC FACTOR; PREFRONTAL CORTEX; REGIONAL CHANGES; DENTATE GYRUS	Several severe stressful situations, e.g., natural disaster, infectious disease out break, and mass casualty, are known to cause anxiety, depression and cognitive impairment, and preventive intervention for these stress complications is worth exploring. We have previously reported that the serotonin-norepinephrine-dopamine reuptake inhibitor, venlafaxine, as well as voluntary wheel running are effective in the treatment of anxiety-and depression-like behaviors in stressed rats. But whether they are able to prevent deleterious consequences of restraint stress in rats, such as anxiety/depression-like behaviors and memory impairment that occur afterward, was not known. Herein, male Wistar rats were pre-treated for 4 weeks with anti-anxiety/anti-depressive drugs, agomelatine and venlafaxine, or voluntary wheel running, followed by 4 weeks of restraint-induced stress. During the stress period, rats received neither drug nor exercise intervention. Our results showed that restraint stress induced mixed anxiety-and depression-like behaviors, and memory impairment as determined by elevated plus-maze, elevated T-maze, open field test (OFT), forced swimming test (FST), and Morris water maze (MWM). Both pharmacological pre-treatments and running successfully prevented the anxiety-like behavior, especially learned fear, in stressed rats. MWM test suggested that agomelatine, venlafaxine, and running could prevent stress-induced memory impairment, but only pharmacological treatments led to better novel object recognition behavior and positive outcome in FST. Moreover, western blot analysis demonstrated that venlafaxine and running exercise upregulated brain-derived neurotrophic factor (BDNF) expression in the hippocampus. In conclusion, agomelatine, venlafaxine as well as voluntary wheel running had beneficial effects, i.e., preventing the restraint stress-induced anxiety/depression-like behaviors and memory impairment.	[Lapmanee, Sarawut; Krishnamra, Nateetip; Charoenphandhu, Narattaphol] Mahidol Univ, Dept Physiol, Fac Sci, Bangkok, Thailand; [Lapmanee, Sarawut; Teerapornpuntakit, Jarinthorn; Krishnamra, Nateetip; Charoenphandhu, Narattaphol] Mahidol Univ, Ctr Calcium & Bone Res COCAB, Fac Sci, Bangkok, Thailand; [Charoenphandhu, Jantarima] Thammasat Univ, Physiol Div, Preclin Sci, Fac Med, Pathum Thani, Thailand; [Teerapornpuntakit, Jarinthorn] Naresuan Univ, Dept Physiol, Fac Med Sci, Phitsanulok, Thailand; [Charoenphandhu, Narattaphol] Mahidol Univ, Inst Mol Biosci, Nakhon Pathom, Thailand	Mahidol University; Mahidol University; Thammasat University; Naresuan University; Mahidol University	Charoenphandhu, J (corresponding author), Thammasat Univ, Physiol Div, Preclin Sci, Fac Med, Pathum Thani, Thailand.	pjantari@tu.ac.th		Lapmanee, Sarawut/0000-0002-8890-9109	Faculty of Medicine, Thammasat University; Thailand Research Fund (TRF) Mahidol University through the TRF Senior Research Scholar Grant [RTA5780001, RTA6080007]; TRF International Research Network Program [IRN60W0001]; TRF through the Royal Golden Jubilee Ph.D. Program [PHD/0147/2554]; Graduate Studies of Mahidol University Alumni Association; Embassy of France in Thailand	Faculty of Medicine, Thammasat University; Thailand Research Fund (TRF) Mahidol University through the TRF Senior Research Scholar Grant; TRF International Research Network Program; TRF through the Royal Golden Jubilee Ph.D. Program; Graduate Studies of Mahidol University Alumni Association; Embassy of France in Thailand	This work was supported by grants from the Faculty of Medicine, Thammasat University (to J. Charoenphandhu), the Thailand Research Fund (TRF) Mahidol University through the TRF Senior Research Scholar Grant (RTA5780001 and RTA6080007 to N. Charoenphandhu), TRF International Research Network Program (IRN60W0001 to N. Charoenphandhu), TRF through the Royal Golden Jubilee Ph.D. Program (PHD/0147/2554, to S. Lapmanee), Graduate Studies of Mahidol University Alumni Association (to S. Lapmanee), and the Embassy of France in Thailand (to S. Lapmanee). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANISMAN H, 1986, ANN NY ACAD SCI, V467, P205, DOI 10.1111/j.1749-6632.1986.tb14630.x; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Banasr M, 2006, BIOL PSYCHIAT, V59, P1087, DOI 10.1016/j.biopsych.2005.11.025; Bourke CH, 2011, HORM BEHAV, V60, P112, DOI 10.1016/j.yhbeh.2011.03.011; Bowman RE, 2012, STRESS, V15, P524, DOI 10.3109/10253890.2011.645926; Burghardt PR, 2004, BRAIN RES, V1019, P84, DOI 10.1016/j.brainres.2004.05.086; Carman HM, 2002, NEUROBIOL LEARN MEM, V78, P332, DOI 10.1006/nlme.2002.4062; Charoenphandhu N, 2013, MOL CELL BIOCHEM, V375, P49, DOI 10.1007/s11010-012-1527-0; Chenu F, 2013, NEUROPSYCHOPHARMACOL, V38, P275, DOI 10.1038/npp.2012.140; Clark MS, 1997, MOL BRAIN RES, V48, P346, DOI 10.1016/S0169-328X(97)00106-X; Connor B, 1998, BRAIN RES REV, V27, P1, DOI 10.1016/S0165-0173(98)00004-6; Dagnino-Subiabre A, 2006, J NEUROCHEM, V97, P1279, DOI 10.1111/j.1471-4159.2006.03787.x; Dawson LA, 1999, NEUROPHARMACOLOGY, V38, P1153, DOI 10.1016/S0028-3908(99)00052-0; de Oliveira RA, 2004, PHARMACOL BIOCHEM BE, V79, P499, DOI 10.1016/j.pbb.2004.09.001; DEY S, 1992, PHYSIOL BEHAV, V52, P1095, DOI 10.1016/0031-9384(92)90465-E; Droste SK, 2007, NEUROENDOCRINOLOGY, V86, P26, DOI 10.1159/000104770; Dunn AL, 1996, MED SCI SPORT EXER, V28, P204, DOI 10.1097/00005768-199602000-00008; Engesser-Cesar C, 2007, NEUROSCIENCE, V144, P1033, DOI 10.1016/j.neuroscience.2006.10.016; Ferreira ZS, 2005, J PINEAL RES, V38, P182, DOI 10.1111/j.1600-079X.2004.00191.x; Garner M, 2009, EUR NEUROPSYCHOPHARM, V19, P381, DOI 10.1016/j.euroneuro.2009.01.011; Gasser PJ, 2006, J NEUROSCI, V26, P8758, DOI 10.1523/JNEUROSCI.0570-06.2006; GRAEFF FG, 1993, BRAZ J MED BIOL RES, V26, P67; Greenwood BN, 2005, BIOL PSYCHIAT, V57, P559, DOI 10.1016/j.biopsych.2004.11.025; Greenwood BN, 2003, J NEUROSCI, V23, P2889; Hasselgren P O, 1999, Curr Opin Clin Nutr Metab Care, V2, P201, DOI 10.1097/00075197-199905000-00002; HEFFNER TG, 1980, PHARMACOL BIOCHEM BE, V13, P453, DOI 10.1016/0091-3057(80)90254-3; Higashino K, 2014, EUR J PHARMACOL, V729, P86, DOI 10.1016/j.ejphar.2014.02.012; INOUE T, 1994, PHARMACOL BIOCHEM BE, V49, P911, DOI 10.1016/0091-3057(94)90243-7; Lapmanee S, 2013, BEHAV BRAIN RES, V250, P316, DOI 10.1016/j.bbr.2013.05.018; Lapmanee S, 2012, BEHAV BRAIN RES, V231, P20, DOI 10.1016/j.bbr.2012.02.037; Li JJ, 2011, ACTA NEUROPSYCHIATR, V23, P20, DOI 10.1111/j.1601-5215.2010.00512.x; Liu YF, 2009, J PHYSIOL-LONDON, V587, P3221, DOI 10.1113/jphysiol.2009.173088; Luine Victoria, 1996, Physiology and Behavior, V59, P27, DOI 10.1016/0031-9384(95)02016-0; Mason BL, 2010, ENDOCRINOLOGY, V151, P5294, DOI 10.1210/en.2010-0554; MEIJER OC, 1994, EUR J PHARM-MOLEC PH, V266, P255, DOI 10.1016/0922-4106(94)90134-1; Millan MJ, 2005, PSYCHOPHARMACOLOGY, V177, P448, DOI 10.1007/s00213-004-1962-z; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Naert G, 2011, MOL CELL NEUROSCI, V46, P55, DOI 10.1016/j.mcn.2010.08.006; Nillni YI, 2011, CLIN PSYCHOL REV, V31, P1183, DOI 10.1016/j.cpr.2011.07.006; Paizanis E, 2010, INT J NEUROPSYCHOPH, V13, P759, DOI 10.1017/S1461145709990514; Pandaranandaka J, 2006, PHYSIOL BEHAV, V87, P828, DOI 10.1016/j.physbeh.2006.02.002; Pandaranandaka J, 2009, BEHAV BRAIN RES, V198, P142, DOI 10.1016/j.bbr.2008.10.043; Papp M, 2006, BEHAV PHARMACOL, V17, P9; PERSENGIEV S, 1991, J PINEAL RES, V11, P57, DOI 10.1111/j.1600-079X.1991.tb00456.x; PORSOLT RD, 1979, EUR J PHARMACOL, V57, P431, DOI 10.1016/0014-2999(79)90507-7; Redrobe JP, 2010, FRONT PSYCHIATRY, V1, P146, DOI DOI 10.3389/FPSYT.2010.00146; Sairanen M, 2007, NEUROSCIENCE, V144, P368, DOI 10.1016/j.neuroscience.2006.08.069; Schaaf MJM, 1998, BRAIN RES, V813, P112, DOI 10.1016/S0006-8993(98)01010-5; Strohle A, 2009, J PSYCHIATR RES, V43, P1013, DOI 10.1016/j.jpsychires.2009.02.004; Taylor D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1888; THIERRY AM, 1968, J PHARMACOL EXP THER, V163, P163; Ulrich-Lai YM, 2006, AM J PHYSIOL-ENDOC M, V291, pE965, DOI 10.1152/ajpendo.00070.2006; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368	53	29	29	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							e0187671	10.1371/journal.pone.0187671	http://dx.doi.org/10.1371/journal.pone.0187671			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6TA	29099859	gold, Green Published, Green Submitted			2022-12-26	WOS:000414377900037
J	Choi, JY; Yoo, TK; Seo, JG; Kwak, J; Um, TT; Rim, TH				Choi, Joon Yul; Yoo, Tae Keun; Seo, Jeong Gi; Kwak, Jiyong; Um, Terry Taewoong; Rim, Tyler Hyungtaek			Multi-categorical deep learning neural network to classify retinal images: A pilot study employing small database	PLOS ONE			English	Article							DIABETIC-RETINOPATHY; MACULAR DEGENERATION; AUTOMATED DETECTION; MULTICATEGORY CLASSIFICATION; PREVALENCE; GLAUCOMA; DISCRIMINATION; MACHINE; CANCER	Deep learning emerges as a powerful tool for analyzing medical images. Retinal disease detection by using computer-aided diagnosis from fundus image has emerged as a new method. We applied deep learning convolutional neural network by using MatConvNet for an automated detection of multiple retinal diseases with fundus photographs involved in STructured Analysis of the REtina (STARE) database. Dataset was built by expanding data on 10 categories, including normal retina and nine retinal diseases. The optimal outcomes were acquired by using a random forest transfer learning based on VGG-19 architecture. The classification results depended greatly on the number of categories. As the number of categories increased, the performance of deep learning models was diminished. When all 10 categories were included, we obtained results with an accuracy of 30.5%, relative classifier information (RCI) of 0.052, and Cohen's kappa of 0.224. Considering three integrated normal, background diabetic retinopathy, and dry age-related macular degeneration, the multi-categorical classifier showed accuracy of 72.8%, 0.283 RCI, and 0.577 kappa. In addition, several ensemble classifiers enhanced the multi-categorical classification performance. The transfer learning incorporated with ensemble classifier of clustering and voting approach presented the best performance with accuracy of 36.7%, 0.053 RCI, and 0.225 kappa in the 10 retinal diseases classification problem. First, due to the small size of data-sets, the deep learning techniques in this study were ineffective to be applied in clinics where numerous patients suffering from various types of retinal disorders visit for diagnosis and treatment. Second, we found that the transfer learning incorporated with ensemble classifiers can improve the classification performance in order to detect multi-categorical retinal diseases. Further studies should confirm the effectiveness of algorithms with large datasets obtained from hospitals.	[Choi, Joon Yul] Seoul Natl Univ, Dept Elect & Comp Engn, Seoul, South Korea; [Yoo, Tae Keun; Seo, Jeong Gi; Kwak, Jiyong; Rim, Tyler Hyungtaek] Yonsei Univ, Coll Med, Dept Ophthalmol, Inst Vis Res, Seoul, South Korea; [Um, Terry Taewoong] Univ Waterloo, Dept Elect & Comp Engn, Waterloo, ON, Canada	Seoul National University (SNU); Yonsei University; Yonsei University Health System; University of Waterloo	Yoo, TK; Rim, TH (corresponding author), Yonsei Univ, Coll Med, Dept Ophthalmol, Inst Vis Res, Seoul, South Korea.	fawoo2@yuhs.ac; awaitingyourfeedback@gmail.com	Yoo, Tae Keun/Q-3620-2019	Yoo, Tae Keun/0000-0003-0890-8614; Kwak, Jay Jiyong/0000-0002-7738-9136	faculty research grant of Yonsei University College of Medicine [6-2017-0089]	faculty research grant of Yonsei University College of Medicine	This study was supported by a faculty research grant of Yonsei University College of Medicine for 2017 (6-2017-0089).	Abramoff MD, 2010, EXPERT REV MED DEVIC, V7, P287, DOI 10.1586/ERD.09.76; Abramoff MD, 2016, INVEST OPHTH VIS SCI, V57, P5200, DOI 10.1167/iovs.16-19964; Acharya UR, 2016, COMPUT BIOL MED, V73, P131, DOI 10.1016/j.compbiomed.2016.04.009; Adarsh P, 2013, 2013 INTERNATIONAL CONFERENCE ON COMMUNICATIONS AND SIGNAL PROCESSING (ICCSP), P206, DOI 10.1109/iccsp.2013.6577044; Asaoka R, 2016, OPHTHALMOLOGY, V123, P1974, DOI 10.1016/j.ophtha.2016.05.029; Ben-David A, 2008, EXPERT SYST APPL, V34, P825, DOI 10.1016/j.eswa.2006.10.022; Burlina P, 2016, I S BIOMED IMAGING, P184, DOI 10.1109/ISBI.2016.7493240; Caixinha M, 2017, CURR EYE RES, V42, P1, DOI 10.1080/02713683.2016.1175019; Casanova R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098587; Chan CKW, 2015, OPHTHALMOLOGY, V122, P2278, DOI 10.1016/j.ophtha.2015.06.050; Chen XY, 2015, IEEE ENG MED BIO, P715, DOI 10.1109/EMBC.2015.7318462; Chen XW, 2014, IEEE ACCESS, V2, P514, DOI 10.1109/ACCESS.2014.2325029; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Choi SB, 2014, IEEE ENG MED BIO, P3460, DOI 10.1109/EMBC.2014.6944367; Deng J, 2010, LECT NOTES COMPUT SC, V6315, P71, DOI 10.1007/978-3-642-15555-0_6; Dosovitskiy A, 2015, IEEE I CONF COMP VIS, P2758, DOI 10.1109/ICCV.2015.316; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Ganesan K, 2014, MED BIOL ENG COMPUT, V52, P663, DOI 10.1007/s11517-014-1167-5; Gao XT, 2015, IEEE T BIO-MED ENG, V62, P2693, DOI 10.1109/TBME.2015.2444389; GOLDBAUM MH, 1990, INVEST OPHTH VIS SCI, V31, P617; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; Jain S, 2006, EYE, V20, P471, DOI 10.1038/sj.eye.6701916; Kanagasingam Y, 2014, PROG RETIN EYE RES, V38, P20, DOI 10.1016/j.preteyeres.2013.10.002; Kijsirikul B, 2002, IEEE IJCNN, P980, DOI 10.1109/IJCNN.2002.1005608; Klein R, 2013, INVEST OPHTH VIS SCI, V54, DOI 10.1167/iovs.13-12789; Klein R, 2011, ARCH OPHTHALMOL-CHIC, V129, P75, DOI 10.1001/archophthalmol.2010.318; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lee CS, OPHTHALMOL RETINA; Lin C, 2014, NEUROCOMPUTING, V123, P424, DOI 10.1016/j.neucom.2013.08.004; Liu B, 2017, MOL THER-NUCL ACIDS, V7, P267, DOI 10.1016/j.omtn.2017.04.008; Liu B, 2017, BIOINFORMATICS, V33, P35, DOI [10.1093/bioinformatics/btv604, 10.1093/bioinformatics/btw539]; Liu B, 2014, BIOINFORMATICS, V30, P472, DOI 10.1093/bioinformatics/btt709; Liu M, 2013, SENSOR ACTUAT B-CHEM, V177, P970, DOI 10.1016/j.snb.2012.11.071; Mookiah MRK, 2013, COMPUT BIOL MED, V43, P2136, DOI 10.1016/j.compbiomed.2013.10.007; Oh E, 2015, INVEST OPHTH VIS SCI, V56, P3957, DOI 10.1167/iovs.15-16805; Oh E, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-106; Oquab M, 2014, PROC CVPR IEEE, P1717, DOI 10.1109/CVPR.2014.222; Paul R, 2016, TOMOGRAPHY, V2, P388, DOI 10.18383/j.tom.2016.00211; Pratt H, 2016, PROCEDIA COMPUT SCI, V90, P200, DOI 10.1016/j.procs.2016.07.014; Qi ZQ, 2016, KNOWL-BASED SYST, V107, P54, DOI 10.1016/j.knosys.2016.05.055; Ramani RG, 2012, 2012 INTERNATIONAL CONFERENCE ON MACHINE VISION AND IMAGE PROCESSING (MVIP), P149, DOI 10.1109/MVIP.2012.6428782; Ribeiro E, 2016, COMPUT MATH METHOD M, V2016, DOI 10.1155/2016/6584725; Rogers S, 2010, OPHTHALMOLOGY, V117, P313, DOI [10.1016/j.ophtha.2009.07.017, 10.1016/j.ophtha.2010.01.060]; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Sandhu SS, 2005, BRIT J OPHTHALMOL, V89, P967, DOI 10.1136/bjo.2004.060863; Sindhwani V., 2001, SIAM, P1; Statnikov A, 2005, BIOINFORMATICS, V21, P631, DOI 10.1093/bioinformatics/bti033; Statnikov A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-319; Szegedy C., 2016, P IEEE C COMPUTER VI, P2818, DOI DOI 10.1109/CVPR.2016.308; Phan TV, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/5893601; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Welikala RA, 2014, COMPUT METH PROG BIO, V114, P247, DOI 10.1016/j.cmpb.2014.02.010; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Worrall DE, 2016, LECT NOTES COMPUT SC, V10008, P68, DOI 10.1007/978-3-319-46976-8_8; Zhang XZ, 2010, JAMA-J AM MED ASSOC, V304, P649, DOI 10.1001/jama.2010.1111; Zou Q, 2016, NEUROCOMPUTING, V173, P346, DOI 10.1016/j.neucom.2014.12.123	59	107	109	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187336	10.1371/journal.pone.0187338	http://dx.doi.org/10.1371/journal.pone.0187338			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095872	gold, Green Published, Green Submitted			2022-12-26	WOS:000414340200075
J	Inagaki, K; Yasuda, Y; Ando, M; Kaihan, AB; Hachiya, A; Ozeki, T; Hishida, M; Imaizumi, T; Katsuno, T; Kato, S; Tsuboi, N; Maruyama, S				Inagaki, Koji; Yasuda, Yoshinari; Ando, Masahiko; Kaihan, Ahmad Baseer; Hachiya, Asaka; Ozeki, Takaya; Hishida, Manabu; Imaizumi, Takahiro; Katsuno, Takayuki; Kato, Sawako; Tsuboi, Naotake; Maruyama, Shoichi			Seasonal proteinuria changes in IgA nephropathy patients after proteinuria remission	PLOS ONE			English	Article							IMMUNOGLOBULIN-A NEPHROPATHY; RANDOMIZED CONTROLLED-TRIAL; BLOOD-PRESSURE; RISK-FACTORS; PULSE THERAPY; PROGNOSIS; CLASSIFICATION; FEATURES; DISEASE; DAMAGE	Background Proteinuria is a powerful prognostic factor for end-stage renal disease in IgA nephropathy (IgAN) patients. However, it is not known whether proteinuria exacerbations are related to seasonal changes. Methods We retrospectively enrolled consecutive patients diagnosed with IgAN by kidney biopsy at our hospital between 2002 and 2014. Proteinuria remission was defined as urinary protein<0.3 g/gCr in two consecutive outpatient urinalyses and exacerbation as urinary protein >= 0.75 g/gCr. Four seasons were defined: spring (March-May), summer (June-August), autumn (September-November), and winter (December-February). We performed a multivariate analysis to identify factors associated with the second remission following a proteinuria exacerbation. Results We analyzed 116 patients. Proteinuria remission and exacerbation occurred in 77, and 43 patients, respectively. The incidence of proteinuria exacerbation was significantly higher in autumn and winter than in spring and summer (p = 0.040). The cumulative second remission rate was significantly higher in patients with autumn and winter proteinuria exacerbation than in patients with spring and summer exacerbations (p = 0.0091). In multivariate analyses, exacerbation onset in autumn and winter (hazard ratio [HR], 3.51; 95% confidence interval [Cl], 1.41-8.74) and intensive therapy (HR, 2.26; 95% Cl, 1.05-4.88) were significantly associated with a second proteinuria remission. Conclusion In IgAN patients in proteinuria remission, proteinuria exacerbation frequently occurred in autumn and winter. Exacerbations occurring in autumn and winter tended to remit early.	[Inagaki, Koji; Yasuda, Yoshinari; Kaihan, Ahmad Baseer; Hachiya, Asaka; Ozeki, Takaya; Hishida, Manabu; Imaizumi, Takahiro; Katsuno, Takayuki; Kato, Sawako; Tsuboi, Naotake; Maruyama, Shoichi] Nagoya Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi, Japan; [Ando, Masahiko] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan	Nagoya University; Nagoya University	Inagaki, K (corresponding author), Nagoya Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi, Japan.	inagaki21@med.nagoya-u.ac.jp	Tsuboi, Naotake/L-5960-2019; Kato, Sawako/T-2422-2019	Tsuboi, Naotake/0000-0003-0760-845X; Kato, Sawako/0000-0001-7210-1888	Astellas Pharma; Alexion Pharmaceuticals; Otsuka Pharmaceutical; Kyowa Hakko Kirin; Daiichi-Sankyo; Takeda Pharmaceutical Company; Chugai Pharmaceutical; Dainippon Sumitomo Pharma; Pfizer Japan; Merck Sharp and Dohme; Mochida Pharmaceutical Company; Torii Pharmaceutical; Kissei Pharmaceutical; Novartis Pharma; Kowa Pharmaceutical; Nippon Boehringer Ingelheim; Bristol-Myers Squibb; Mitsubishi Tanabe Pharma Corporation; Teijin Pharma Limited	Astellas Pharma(Astellas Pharmaceuticals); Alexion Pharmaceuticals; Otsuka Pharmaceutical(Otsuka Pharmaceutical); Kyowa Hakko Kirin(Kyowa Kirin Ltd); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Chugai Pharmaceutical; Dainippon Sumitomo Pharma(Dainippon Sumitomo Pharma Co., Ltd.); Pfizer Japan(Pfizer); Merck Sharp and Dohme(Merck & Company); Mochida Pharmaceutical Company; Torii Pharmaceutical; Kissei Pharmaceutical(Kissei Pharmaceutical Co Ltd); Novartis Pharma; Kowa Pharmaceutical; Nippon Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Mitsubishi Tanabe Pharma Corporation(Mitsubishi Tanabe Pharma Corporation); Teijin Pharma Limited(Teijin Pharma Limited)	Nagoya university nephrology is supported by the following funders; Astellas Pharma, Alexion Pharmaceuticals, Otsuka Pharmaceutical, Kyowa Hakko Kirin, Daiichi-Sankyo, Takeda Pharmaceutical Company, Chugai Pharmaceutical, Dainippon Sumitomo Pharma, Pfizer Japan, Merck Sharp and Dohme, Mochida Pharmaceutical Company, Torii Pharmaceutical, Kissei Pharmaceutical, Novartis Pharma, Kowa Pharmaceutical, Nippon Boehringer Ingelheim, Bristol-Myers Squibb, Mitsubishi Tanabe Pharma Corporation, and Teijin Pharma Limited. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MJ, 2005, AM J KIDNEY DIS, V45, P994, DOI 10.1053/j.ajkd.2005.02.015; Berthoux F, 2011, J AM SOC NEPHROL, V22, P752, DOI 10.1681/ASN.2010040355; BRENNAN PJ, 1982, BMJ-BRIT MED J, V285, P919, DOI 10.1136/bmj.285.6346.919; DAMICO G, 1987, Q J MED, V64, P709; Eiro M, 2002, NEPHRON, V90, P432, DOI 10.1159/000054731; Hirano K, 2016, CLIN EXP NEPHROL, V20, P425, DOI 10.1007/s10157-015-1170-7; Kaihan AB, 2017, CLIN EXP NEPHROL; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kawamura T, 2014, NEPHROL DIAL TRANSPL, V29, P1546, DOI 10.1093/ndt/gfu020; Kawamura T, 2013, J NEPHROL, V26, P350, DOI 10.5301/jn.5000151; Kim JK, 2012, CLIN J AM SOC NEPHRO, V7, P427, DOI 10.2215/CJN.04820511; Koyama A, 1997, AM J KIDNEY DIS, V29, P526, DOI 10.1016/S0272-6386(97)90333-4; Le WB, 2012, NEPHROL DIAL TRANSPL, V27, P1479, DOI 10.1093/ndt/gfr527; Lin LR, 2016, ARCH MED RES, V47, P25, DOI 10.1016/j.arcmed.2016.01.001; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Nam KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101935; Pozzi C, 2004, J AM SOC NEPHROL, V15, P157, DOI 10.1097/01.ASN.0000103869.08096.4F; Pozzi C, 1999, LANCET, V353, P883, DOI 10.1016/S0140-6736(98)03563-6; Rauen T, 2015, NEW ENGL J MED, V373, P2225, DOI 10.1056/NEJMoa1415463; Reich HN, 2007, J AM SOC NEPHROL, V18, P3177, DOI 10.1681/ASN.2007050526; Saeki K, 2014, J HYPERTENS, V32, P1582, DOI 10.1097/HJH.0000000000000232; Sugiyama H, 2011, CLIN EXP NEPHROL, V15, P493, DOI 10.1007/s10157-011-0430-4; SUZUKI S, 1994, LANCET, V343, P12, DOI 10.1016/S0140-6736(94)90875-3; Tatematsu M, 2012, CLIN EXP NEPHROL, V16, P883, DOI 10.1007/s10157-012-0644-0; Toyabe S, 2005, PEDIATR NEPHROL, V20, P470, DOI 10.1007/s00467-004-1780-x; Wada Y, 2012, DIABETIC MED, V29, P506, DOI 10.1111/j.1464-5491.2011.03472.x; Zhang L, 2016, RENAL FAILURE, V38, P799, DOI 10.3109/0886022X.2016.1163153	27	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187607	10.1371/journal.pone.0187607	http://dx.doi.org/10.1371/journal.pone.0187607			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095887	Green Published, Green Submitted, gold			2022-12-26	WOS:000414340200123
J	Lee, J; Lee, S; Zhang, HR; Hill, MA; Zhang, CH; Park, Y				Lee, Jonghae; Lee, Sewon; Zhang, Hanrui; Hill, Michael A.; Zhang, Cuihua; Park, Yoonjung			Interaction of IL-6 and TNF-alpha contributes to endothelial dysfunction in type 2 diabetic mouse hearts	PLOS ONE			English	Article							INSULIN-RESISTANCE; NITRIC-OXIDE; INTERLEUKIN-6 IMPAIRS; METABOLIC SYNDROME; OXIDATIVE STRESS; ANGIOTENSIN-II; MICE; OBESITY; RISK; CELLS	Objectives Inflammatory cytokines, such as tumor necrosis factor-a (TNF-alpha) and interleukin-6 (IL-6), are individually considered as important contributors to endothelial dysfunction in obesity and type 2 diabetes (T2D). However, their interactions in coronary arteriole endothelial dysfunction are uncertain. Therefore, this study aimed to determine the effects of TNF-alpha and IL-6 interactions on coronary endothelial dysfunction in experimental T2D. Methods The studies used wild type (WT), diabetic mice (db/db), db/db null for TNF (db(TNF-)/db(TNF-)), and db/db mice treated with neutralizing antibody to IL-6 (anti-IL-6). Endothelium-dependent (acetylcholine [ACh], or luminal flow-induced shear stress) and endothelium-independent (sodium nitroprusside [SNP]) vasodilation of isolated and pressurized coronary arterioles were determined. Quantitative PCR, Western blot, and immunofluorescence staining were utilized for mechanistic studies. Results Relative to WT, arteriolar dilation to both ACh and flow was attenuated in db/db mice and db(TNF-)/db(TNF-). Treatment of db(TNF-)/db(TNF-) and db/db mice with anti-IL-6 improved arteriolar dilation compared to db/db mice. Immunofluorescence staining illustrated localization of IL-6 within the endothelial cells of coronary arterioles. In db/db mice, mRNA and protein expression of IL-6 and superoxide (0 (2)similar to) production were higher, but reduced by anti-IL-6 treatment. Also, in db/db mice, mRNA and protein expression of TNF-alpha suppressed by the anti-IL-6 treatment and the reduced expression of mRNA and protein expression of IL-6 by the genetic deletion of TNF-alpha both supported a reciprocal regulation between TNF-alpha and IL-6. Superoxide dismutase 2 (SOD2) expression and phosphorylation of eNOS (p-eNOS/eNOS) were lower in db/db mice coronary arterioles and were restored in db/db+Anti-IL-6 and db (TNF-)/db (TNF-) mice. Conclusion The interactions between TNF-alpha and IL-6 exacerbate oxidative stress and reduce phosphorylation of eNOS, thereby contributing to coronary endothelial dysfunction in T2D mice.	[Lee, Jonghae; Park, Yoonjung] Univ Houston, Dept Hlth & Human Performance, Houston, TX 77004 USA; [Lee, Sewon; Zhang, Hanrui; Hill, Michael A.; Zhang, Cuihua; Park, Yoonjung] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA; [Lee, Sewon; Zhang, Hanrui; Hill, Michael A.; Zhang, Cuihua] Univ Missouri, Med Pharmacol, Columbia, MO USA; [Lee, Sewon] Incheon Natl Univ, Div Sport Sci, Incheon, South Korea; [Lee, Sewon] Incheon Natl Univ, Sport Sci Inst, Incheon, South Korea; [Zhang, Hanrui] Columbia Univ, Med Ctr, Div Cardiol, Dept Med, New York, NY USA; [Zhang, Cuihua] Univ Missouri, Dept Internal Med, Columbia, MO USA; [Zhang, Cuihua] Univ Missouri, Physiol & Nutr Sci, Columbia, MO USA	University of Houston System; University of Houston; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Incheon National University; Incheon National University; Columbia University; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Park, Y (corresponding author), Univ Houston, Dept Hlth & Human Performance, Houston, TX 77004 USA.; Park, Y (corresponding author), Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA.	ypark10@uh.edu	Hill, Michael/AAV-5350-2020; Lee, Sewon/C-8432-2016	Zhang, Hanrui/0000-0001-8655-938X; Hill, Michael/0000-0002-4455-2072; Lee, Sewon/0000-0002-6179-5156	National Heart, Lung, and Blood Institute (NHLBI) [R01-HL077566, R01-HL085119]; American Heart Association Scientist Development Grant [110350047A]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL130574] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association Scientist Development Grant(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung, and Blood Institute (NHLBI, R01-HL077566) to C.Z (Deceased 2011) and M.A.H (http://dalton.missouri.edu/investigators/hillmi.php); National Heart, Lung, and Blood Institute (NHLBI, R01-HL085119) to C.Z and M.A.H; American Heart Association Scientist Development Grant (110350047A) to C.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADERKA D, 1989, J IMMUNOL, V143, P3517; Andreozzi F, 2007, MOL CELL BIOL, V27, P2372, DOI 10.1128/MCB.01340-06; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Bennet AM, 2003, ATHEROSCLEROSIS, V171, P359, DOI 10.1016/j.atherosclerosis.2003.08.029; Bitar MS, 2005, EUR J PHARMACOL, V511, P53, DOI 10.1016/j.ejphar.2005.01.014; Caballero AE, 2003, OBES RES, V11, P1278, DOI 10.1038/oby.2003.174; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Chen X., 2015, PLOS ONE, V10; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; DiSanto E, 1997, CYTOKINE, V9, P300, DOI 10.1006/cyto.1996.0169; Donato AJ, 2012, AM J PHYSIOL-HEART C, V303, pH672, DOI 10.1152/ajpheart.00271.2012; Duncan BB, 2003, DIABETES, V52, P1799, DOI 10.2337/diabetes.52.7.1799; FATTORI E, 1994, J EXP MED, V180, P1243, DOI 10.1084/jem.180.4.1243; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gao X, 2007, ARTERIOSCL THROM VAS, V27, P1269, DOI 10.1161/ATVBAHA.107.142521; Gao X, 2007, CIRCULATION, V115, P245, DOI 10.1161/CIRCULATIONAHA.106.650671; Gao X, 2008, AM J PHYSIOL-HEART C, V295, pH2242, DOI 10.1152/ajpheart.00587.2008; Heink S, 2017, NAT IMMUNOL, V18, P74, DOI 10.1038/ni.3632; Hossain M., 2010, INT J DIABETES MELLI, V2, P165, DOI [10.1016/j.ijdm.2010.08.004, DOI 10.1016/J.IJDM.2010.08.004]; Hu FB, 2004, DIABETES, V53, P693, DOI 10.2337/diabetes.53.3.693; Klover PJ, 2003, DIABETES, V52, P2784, DOI 10.2337/diabetes.52.11.2784; Klover PJ, 2005, ENDOCRINOLOGY, V146, P3417, DOI 10.1210/en.2004-1468; Koenig W, 2007, ARTERIOSCL THROM VAS, V27, P15, DOI 10.1161/01.ATV.0000251503.35795.4f; Kozak AJ, 2005, PROSTAG LEUKOTR ESS, V72, P105, DOI 10.1016/j.plefa.2004.10.007; Li GL, 2007, ENDOCRINOLOGY, V148, P3356, DOI 10.1210/en.2006-1441; Gamez-Mendez AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138609; Meigs James B, 2010, Diabetes Care, V33, P1865, DOI 10.2337/dc10-0641; Miao L, 2009, FREE RADICAL BIO MED, V47, P344, DOI 10.1016/j.freeradbiomed.2009.05.018; Orshal JM, 2004, AM J PHYSIOL-REG I, V286, pR1013, DOI 10.1152/ajpregu.00729.2003; Park Y, 2008, AM J PHYSIOL-HEART C, V295, pH1982, DOI 10.1152/ajpheart.01261.2007; Park Y, 2012, J PHYSIOL-LONDON, V590, P4255, DOI 10.1113/jphysiol.2012.234856; Park Y, 2011, BASIC RES CARDIOL, V106, P111, DOI 10.1007/s00395-010-0129-9; Pencina MJ, 2009, CIRCULATION, V119, P3078, DOI 10.1161/CIRCULATIONAHA.108.816694; Picchi A, 2006, CIRC RES, V99, P69, DOI 10.1161/01.RES.0000229685.37402.80; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Rao Xiayu, 2013, Biostat Bioinforma Biomath, V3, P71; San Martin A, 2007, AM J PHYSIOL-HEART C, V292, pH2073, DOI 10.1152/ajpheart.00943.2006; Saura M, 2006, J BIOL CHEM, V281, P30057, DOI 10.1074/jbc.M606279200; SCHINDLER R, 1990, BLOOD, V75, P40; Schrader LI, 2007, ARTERIOSCL THROM VAS, V27, P2576, DOI 10.1161/ATVBAHA.107.153080; Tabit CE, 2010, REV ENDOCR METAB DIS, V11, P61, DOI 10.1007/s11154-010-9134-4; Turner NA, 2007, CARDIOVASC RES, V76, P81, DOI 10.1016/j.cardiores.2007.06.003; Vanhoutte PM, 2009, CIRC J, V73, P595, DOI 10.1253/circj.CJ-08-1169; Wassmann S, 2004, CIRC RES, V94, P534, DOI 10.1161/01.RES.0000115557.25127.8D; Yang JY, 2009, AM J PHYSIOL-HEART C, V297, pH1208, DOI 10.1152/ajpheart.00396.2009; Yang JYO, 2009, AM J PHYSIOL-HEART C, V296, pH1850, DOI 10.1152/ajpheart.01199.2008; Zhang CH, 2008, BASIC RES CARDIOL, V103, P398, DOI 10.1007/s00395-008-0733-0	47	52	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187189	10.1371/journal.pone.0187189	http://dx.doi.org/10.1371/journal.pone.0187189			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095915	Green Published, gold, Green Submitted			2022-12-26	WOS:000414340200053
J	Misslin, C; Velasco-Estevez, M; Albert, M; O'Sullivan, SA; Dev, KK				Misslin, Cedric; Velasco-Estevez, Maria; Albert, Marie; O'Sullivan, Sinead A.; Dev, Kumlesh K.			Phospholipase A2 is involved in galactosylsphingosine-induced astrocyte toxicity, neuronal damage and demyelination	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; PROTEIN-KINASE-C; ARACHIDONIC-ACID; CELL-DEATH; CYTOSOLIC PHOSPHOLIPASE-A(2); GENE-EXPRESSION; GLIAL-CELLS; PSYCHOSINE; RECEPTOR; RELEASE	Krabbe disease is a fatal rare inherited lipid storage disorder affecting 1:100,000 births. This illness is caused by mutations in the gale gene encoding for the enzyme galactosylcerami-dase (GALC). Dysfunction of GALC has been linked to the toxic build-up of the galactolipid, galactosylsphingosine (psychosine), which induces cell death of oligodendrocytes. Previous studies show that phospholipase A2 (PLA2) may play a role in psychosine induce cell death. Here, we demonstrate that non-selective inhibition of cPLA2/sPLA2 and selective inhibition of cPLA2, but not sPLA2, also attenuates psychosine-induced cell death of human astrocytes. This study shows that extracellular calcium is required for psychosine induced cell death, but intracellular calcium release, reactive oxygen species or release of soluble factors are not involved. These findings suggest a cell autonomous effect, at least in human astrocytes. Supporting a role for PLA2 in psychosine-induced cell death of oligodendrocytes and astrocytes, the results show inhibition of PLA2 attenuates psychosine-induced decrease in the expression of astrocyte marker vimentin as well as myelin basic protein (MBP), myelin oligodendrocyte glycoprotein (MOG) and the neuronal marker SMI-32 in organotypic slice cultures. These findings provide further mechanistic details of psychosine-induced death of glia and suggest a role for PLA2 in the process. This work also supports the proposal that novel drugs for Krabbe disease may require testing on astrocytes as well as oligodendrocytes for more holistic prediction of pre-clinical and clinical efficacy.	[Misslin, Cedric; Velasco-Estevez, Maria; Albert, Marie; O'Sullivan, Sinead A.; Dev, Kumlesh K.] Trinity Coll Dublin, Sch Med, Drug Dev, Dublin, Ireland; [O'Sullivan, Sinead A.] Univ Chicago, Dept Neurol, 5841 S Maryland Ave, Chicago, IL 60637 USA	Trinity College Dublin; University of Chicago	Dev, KK (corresponding author), Trinity Coll Dublin, Sch Med, Drug Dev, Dublin, Ireland.	devk@tcd.ie	Velasco-Estevez, Maria/AAA-5569-2020	Velasco-Estevez, Maria/0000-0002-2886-122X; Dev, Kumlesh/0000-0003-4274-9119	Trinity College Dublin; Health Research Board; Trinity College Dublin, Ireland; Health Research Board, Ireland; Irish Research Council, Ireland; Irish Research Council;  [GOIPG/2015/2804];  [KEDS-2015-1614];  [HRA-POR-2014-646]	Trinity College Dublin; Health Research Board; Trinity College Dublin, Ireland; Health Research Board, Ireland; Irish Research Council, Ireland; Irish Research Council(Irish Research Council for Science, Engineering and Technology); ; ; 	This work was supported by the Trinity College Dublin, Irish Research Council; GOIPG/2015/2804 (http://research.ie/) and the Health Research Board; KEDS-2015-1614 and HRA-POR-2014-646 (http://www.hrb.ie/home/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported, in part, by Trinity College Dublin, Ireland, the Health Research Board, Ireland, and the Irish Research Council, Ireland. CM. is an M.Sc. scholar of Trinity College Dublin. M.V.E. is an Irish Research Council PhD Fellow. S.O.S. is a PhD scholar of Trinity College Dublin. We would like to thank Dr. Catherine O 'Sullivan (Trinity College Dublin) for aiding CM. in the earlier parts of this study. The authors declare no competing financial interests.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; ABRAMSON SB, 1991, J IMMUNOL, V147, P231; Adam-Vizi V, 2010, J ALZHEIMERS DIS, V20, pS413, DOI 10.3233/JAD-2010-100465; Atsumi G, 2000, J BIOL CHEM, V275, P18248, DOI 10.1074/jbc.M000271200; Becuwe P, 2003, FREE RADICAL BIO MED, V35, P636, DOI 10.1016/S0891-5849(03)00387-3; Benveniste EN, 1997, CHEM IMMUNOL, V69, P31; Bymaster FP, 2001, NEUROPSYCHOPHARMACOL, V25, P871, DOI 10.1016/S0893-133X(01)00298-6; Cao Y, 2000, P NATL ACAD SCI USA, V97, P11280, DOI 10.1073/pnas.200367597; CHARLES AC, 1993, GLIA, V7, P134, DOI 10.1002/glia.440070203; CHIU AY, 1991, GLIA, V4, P11, DOI 10.1002/glia.440040103; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; Elain G, 2014, GLIA, V62, P725, DOI 10.1002/glia.22637; Formichi P, 2007, J CELL PHYSIOL, V212, P737, DOI 10.1002/jcp.21070; Gijon MA, 1999, J LEUKOCYTE BIOL, V65, P330, DOI 10.1002/jlb.65.3.330; Giri S, 2006, J LIPID RES, V47, P1478, DOI 10.1194/jlr.M600084-JLR200; Giri S, 2002, FASEB J, V16, DOI 10.1096/fj.01-0798com; Giri S, 2008, J NEUROCHEM, V105, P1820, DOI 10.1111/j.1471-4159.2008.05279.x; GLOVER S, 1995, J BIOL CHEM, V270, P15359, DOI 10.1074/jbc.270.25.15359; GRIOT C, 1990, FREE RADICAL RES COM, V11, P181, DOI 10.3109/10715769009088915; HANNUN YA, 1987, SCIENCE, V235, P670, DOI 10.1126/science.3101176; Haq E, 2003, J NEUROCHEM, V86, P1428, DOI 10.1046/j.1471-4159.2003.01941.x; HAYAKAWA M, 1993, J BIOL CHEM, V268, P11290; Healy LM, 2013, BRIT J PHARMACOL, V169, P1114, DOI 10.1111/bph.12207; HOECK WG, 1993, P NATL ACAD SCI USA, V90, P4475, DOI 10.1073/pnas.90.10.4475; HOLASH JA, 1993, DEV DYNAM, V197, P14, DOI 10.1002/aja.1001970103; Kim C, 2008, BMB REP, V41, P555, DOI 10.5483/BMBRep.2008.41.8.555; Kinloch RA, 2005, EXPERT OPIN THER TAR, V9, P685, DOI 10.1517/14728222.9.4.685; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; LIDDELOW SA, 2017, PLOS ONE, V46, P957, DOI DOI 10.1016/J.IMMUNI.2017.06.006; LIN LL, 1992, J BIOL CHEM, V267, P23451; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Lin ME, 2012, J BIOL CHEM, V287, P17608, DOI 10.1074/jbc.M111.330183; LUZI P, 1995, GENOMICS, V26, P407, DOI 10.1016/0888-7543(95)80230-J; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Mronga T, 2004, GLIA, V46, P446, DOI 10.1002/glia.20022; Murakami M, 2002, J BIOCHEM, V131, P285, DOI 10.1093/oxfordjournals.jbchem.a003101; Nicholls SJ, 2014, JAMA-J AM MED ASSOC, V311, P252, DOI 10.1001/jama.2013.282836; O'Sullivan C, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0494-x; O'Sullivan C, 2015, J CELL SCI, V128, P3878, DOI 10.1242/jcs.169342; O'Sullivan SA, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0659-7; Ohsawa M, 2013, NEUROSCIENCE, V247, P65, DOI 10.1016/j.neuroscience.2013.05.014; Piomelli D, 1993, CURR OPIN CELL BIOL, V5, P274, DOI 10.1016/0955-0674(93)90116-8; Pritchard AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099444; QIU ZH, 1994, J BIOL CHEM, V269, P19480; Rutkowska A, 2015, GLIA, V63, P341, DOI 10.1002/glia.22757; Scorrano L, 2001, J BIOL CHEM, V276, P12035, DOI 10.1074/jbc.M010603200; SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785; Seno K, 2000, J MED CHEM, V43, P1041, DOI 10.1021/jm9905155; SHEA TB, 1992, J NEUROSCI RES, V31, P309, DOI 10.1002/jnr.490310212; Sheridan GK, 2012, GLIA, V60, P382, DOI 10.1002/glia.22272; Sriram S, 2011, J NEUROIMMUNOL, V239, P13, DOI 10.1016/j.jneuroim.2011.08.012; Sun GY, 2010, NEUROMOL MED, V12, P133, DOI 10.1007/s12017-009-8092-z; Sun GY, 2005, MOL NEUROBIOL, V31, P27, DOI 10.1385/MN:31:1-3:027; Suzuki K, 1998, NEUROCHEM RES, V23, P251, DOI 10.1023/A:1022436928925; Tapasi S, 1998, INDIAN J BIOCHEM BIO, V35, P161; Truini A, 2013, J NEUROL, V260, P351, DOI 10.1007/s00415-012-6579-2; Voccoli V, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.483; WOLBURG H, 1994, J CELL SCI, V107, P1347; Xu JF, 2003, FREE RADICAL BIO MED, V34, P1531, DOI 10.1016/S0891-5849(03)00152-7; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001	60	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187217	10.1371/journal.pone.0187217	http://dx.doi.org/10.1371/journal.pone.0187217			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095858	Green Published, Green Submitted, gold			2022-12-26	WOS:000414340200059
J	Shi, HS; Carion, TW; Jiang, YD; Chahine, A; Steinle, JJ; Berger, EA				Shi, Haoshen; Carion, Thomas W.; Jiang, Youde; Chahine, Adam; Steinle, Jena J.; Berger, Elizabeth A.			A regulatory role for beta-adrenergic receptors regarding the resolvin D1 (RvD1) pathway in the diabetic retina	PLOS ONE			English	Article							ENDOTHELIAL-CELL APOPTOSIS; DOCOSAHEXAENOIC ACID; TNF-ALPHA; MULLER CELLS; EXPRESSION; MICROGLIA; IGFBP-3; MOUSE; PHOSPHORYLATION; 5-LIPOXYGENASE	Diabetic retinopathy is a visually debilitating disease with limited treatment options available. Compound 49b, a beta-adrenergic receptor agonist, has been demonstrated to effectively reduce disease pathogenesis associated with diabetic retinopathy. While the exact mechanisms are not fully understood, previous studies have determined that it reduces the proinflammatory cytokine, TNF-alpha, and inhibits apoptosis of the retinal microvasculture. As inflammation becomes more recognized in driving disease pathogenesis, so does the regulation by pro-resolving pathways as therapeutic points of intervention. The current study sought to explore whether Compound 49b had any influence on pro-resolving pathways, thus contributing to improved disease outcome. Using in vivo (animal model of type 1 diabetes) and in vitro (retinal endothelial cells, Muller cells, neutrophils/PMN) techniques, it was determined that high glucose lowers pro-resolving lipid mediator, resolvin D1 (RvD1) levels and differentially alters required enzymes, 5-lipoxygenase (5-LOX), 15-LOX-1 and 15-LOX-2. RvD1 receptors formyl peptide receptor 2 (ALX/FPR2) and G-protein coupled receptor 32 (GPR32) were also downregulated in response to hyperglycemic conditions. Moreover, it was observed that beta-adrenergic receptor activation restored high glucose-induced decreases in both enzyme activity and RvD1 levels observed in vivo and in vitro. The current study is the first to describe a regulatory role for beta-adrenergic receptors on pro-resolving pathways.	[Shi, Haoshen; Carion, Thomas W.; Jiang, Youde; Chahine, Adam; Steinle, Jena J.; Berger, Elizabeth A.] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Steinle, Jena J.; Berger, Elizabeth A.] Kresge Eye Inst, Dept Ophthalmol, Detroit, MI 48201 USA	Wayne State University	Berger, EA (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA.; Berger, EA (corresponding author), Kresge Eye Inst, Dept Ophthalmol, Detroit, MI 48201 USA.	eberger@med.wayne.edu	Berger, Elizabeth/W-6893-2019	Berger, Elizabeth/0000-0001-5371-1170; Steinle, Jena/0000-0002-7539-2892	NATIONAL EYE INSTITUTE [P30EY004068, R01EY022330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY022330, P30 EY004068] Funding Source: Medline; NIDDK NIH HHS [P30 DK020572] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albano GD, 2015, J ALLERGY CLIN IMMUN, V135, P1144, DOI 10.1016/j.jaci.2015.02.006; Berger EA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003457; Chen WQ, 2005, INVEST OPHTH VIS SCI, V46, P4342, DOI 10.1167/iovs.05-0601; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; Das UN, 2013, NUTRITION, V29, P1, DOI 10.1016/j.nut.2012.02.003; Gubitosi-Klug RA, 2008, DIABETES, V57, P1387, DOI 10.2337/db07-1217; Hellmann J, 2011, FASEB J, V25, P2399, DOI 10.1096/fj.10-178657; Jiang YD, 2014, MOL VIS, V20, P872; Johnson JD, 2013, J NEUROIMMUNOL, V254, P161, DOI 10.1016/j.jneuroim.2012.08.007; Joussen AM, 2009, MOL VIS, V15, P1418; Jung TW, 2014, MOL CELL ENDOCRINOL, V391, P30, DOI 10.1016/j.mce.2014.04.012; Kern TS, 2007, EXP DIABETES RES, DOI 10.1155/2007/95103; Kong Y, 2010, J NEUROSCI, V30, P11848, DOI 10.1523/JNEUROSCI.2985-10.2010; Krishnamoorthy S, 2012, AM J PATHOL, V180, P2018, DOI 10.1016/j.ajpath.2012.01.028; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Lydic TA, 2009, JALA-J LAB AUTOM, V14, P383, DOI 10.1016/j.jala.2009.07.003; Norling LV, 2012, ARTERIOSCL THROM VAS, V32, P1970, DOI 10.1161/ATVBAHA.112.249508; Opreanu M, 2010, INVEST OPHTH VIS SCI, V51, P3253, DOI 10.1167/iovs.09-4731; Panjala SR, 2011, MOL VIS, V17, P1822; Sapieha P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001571; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Steinle JJ, 2007, EXP EYE RES, V84, P118, DOI 10.1016/j.exer.2006.09.006; Strokin M, 2003, BRIT J PHARMACOL, V139, P1014, DOI 10.1038/sj.bjp.0705326; Sun YP, 2007, J BIOL CHEM, V282, P9323, DOI 10.1074/jbc.M609212200; Tang YN, 2013, DIABETES, V62, P618, DOI 10.2337/db12-0684; Walker RJ, 2007, INVEST OPHTH VIS SCI, V48, P5276, DOI 10.1167/iovs.07-0129; Walker RJ, 2011, INVEST OPHTH VIS SCI, V52, P9527, DOI 10.1167/iovs.11-8631; Wang J, 2010, J NEUROIMMUNOL, V223, P77, DOI 10.1016/j.jneuroim.2010.04.006; Werz O, 2002, J BIOL CHEM, V277, P14793, DOI 10.1074/jbc.M111945200; Zhang QH, 2014, MICROVASC RES, V95, P76, DOI 10.1016/j.mvr.2014.07.009; Zhang QH, 2013, INVEST OPHTH VIS SCI, V54, P5376, DOI 10.1167/iovs.13-12497; Zhang QH, 2012, INVEST OPHTH VIS SCI, V53, P3004, DOI 10.1167/iovs.11-8779	32	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0185383	10.1371/journal.pone.0185383	http://dx.doi.org/10.1371/journal.pone.0185383			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095817	gold, Green Published, Green Submitted			2022-12-26	WOS:000414340200005
J	Woo, HY; Han, SY; Heo, J; Kim, DU; Baek, DH; Yoo, SY; Kim, CW; Kim, S; Song, GA; Cho, M; Kang, DH				Woo, Hyun Young; Han, Sung Yong; Heo, Jeong; Kim, Dong Uk; Baek, Dong Hoon; Yoo, So Yong; Kim, Chang Won; Kim, Suk; Song, Geun Am; Cho, Mong; Kang, Dae Hwan			Role of endoscopic biliary drainage in advanced hepatocellular carcinoma with jaundice	PLOS ONE			English	Article							OBSTRUCTIVE-JAUNDICE; COMPLICATIONS; PALLIATION; ERCP	Background Patients with advanced hepatocellular carcinoma (HCC) with jaundice have an extremely poor prognosis. Although biliary drainage can resolve obstructive jaundice, signs of obstruction may not be evident. This study evaluated the role of endoscopic biliary drainage in patients with advanced HCC and obstructive jaundice. Methods From 2010 to 2015, 74 patients underwent endoscopic biliary drainage for obstructive jaundice due to advanced HCC. Jaundice resolution was defined as complete response and total bilirubin concentration below 3 mg/dl. Results The technical success rate in the 74 patients was 92.1 % (70/76). Of the 70 patients who underwent successful biliary drainage, 48 (68.6%) and 22 (31.4%) were Child-Pugh classes B and C, respectively, and 10 (14.3%) and 60 (85.7%) were BCLC stages B and C, respectively. Intrahepatic bile duct (IHD) dilatation was observed in 35 patients (50%). After drainage, the complete response rate was 35.7% (25/70). The mean time to resolution was 17.4 +/- 8.5 days. However, jaundice was re-aggravated in 74.3% (15/25) after a mean 103.5 +/- 96.4 days. Multivariate analysis showed that the absence of ascites, presence of IHD dilatation, normal range of prothrombin time, and lower MELD score were significantly associated with complete response. The overall survival rate was 15.7% (11/70) and the median survival time is 28 days (95% confidence interval 2.6-563 days). Complete response and HCC treatment after drainage were significantly associated with survival. Conclusion Effective endoscopic biliary drainage is an important palliative treatment in patients with advanced HCC and obstructive jaundice, especially those with IHD dilatation and preserved liver function, as determined by ascites, prothrombin time, and MELD score.	[Woo, Hyun Young; Han, Sung Yong; Heo, Jeong; Kim, Dong Uk; Baek, Dong Hoon; Song, Geun Am; Cho, Mong; Kang, Dae Hwan] Pusan Natl Univ, Pusan Natl Univ Hosp, Coll Med, Dept Internal Med, Busan, South Korea; [Woo, Hyun Young; Han, Sung Yong; Heo, Jeong; Kim, Dong Uk; Baek, Dong Hoon; Song, Geun Am; Cho, Mong; Kang, Dae Hwan] Pusan Natl Univ, Pusan Natl Univ Hosp, Med Res Inst, Busan, South Korea; [Woo, Hyun Young; Yoo, So Yong] Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea; [Yoo, So Yong] Pusan Natl Univ, BIO IT Foundry Technol Inst, Busan, South Korea; [Yoo, So Yong] Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yangsan, South Korea; [Kim, Chang Won; Kim, Suk] Pusan Natl Univ, Pusan Natl Univ Hosp, Coll Med, Dept Radiol, Busan, South Korea; [Kim, Chang Won; Kim, Suk] Pusan Natl Univ, Pusan Natl Univ Hosp, Med Res Inst, Busan, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital	Heo, J (corresponding author), Pusan Natl Univ, Pusan Natl Univ Hosp, Med Res Inst, Busan, South Korea.	jheo@pusan.ac.kr	Yoo, So Young/P-1386-2019	Yoo, So Young/0000-0001-8875-9289	Biomedical Research Institute Grant; Busan Cancer Center Grant [2017-05]; Pusan National University Hospital	Biomedical Research Institute Grant; Busan Cancer Center Grant; Pusan National University Hospital(Pusan National University)	This study was supported by the Biomedical Research Institute Grant and Busan Cancer Center Grant (2017-05), Pusan National University Hospital.	Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Choi J, 2013, DIGESTION, V88, P87, DOI 10.1159/000353200; Choi J, 2013, J PALLIAT MED, V16, P1026, DOI 10.1089/jpm.2013.0067; Choi J, 2012, HEPATOB PANCREAT DIS, V11, P636, DOI 10.1016/S1499-3872(12)60237-9; Chung KH, 2015, ENDOSCOPY, V47, P509, DOI 10.1055/s-0034-1391304; Freeman ML, 2004, GASTROINTEST ENDOSC, V59, P845, DOI 10.1016/S0016-5107(04)00353-0; Hong HP, 2008, J VASC INTERV RADIOL, V19, P748, DOI 10.1016/j.jvir.2007.12.455; Horrow MM, 2010, ULTRASOUND Q, V26, P67, DOI 10.1097/RUQ.0b013e3181e17516; Huang JF, 2002, J GASTROEN HEPATOL, V17, P190, DOI 10.1046/j.1440-1746.2002.02677.x; KUBOTA Y, 1993, ABDOM IMAGING, V18, P70, DOI 10.1007/BF00201706; Lai ECH, 2006, ANZ J SURG, V76, P631, DOI 10.1111/j.1445-2197.2006.03794.x; Martin JA, 1999, DIGEST DIS SCI, V44, P1298, DOI 10.1023/A:1026618927885; Matsueda K, 2001, J GASTROENTEROL, V36, P173, DOI 10.1007/s005350170125; Minami Y, 2012, DIGEST DIS, V30, P592, DOI 10.1159/000343087; Nelson DB, 2003, GASTROINTEST ENDOSC, V57, P546, DOI 10.1067/mge.2003.139; Park S, 2014, YONSEI MED J, V55, P1267, DOI 10.3349/ymj.2014.55.5.1267; Qin LX, 2003, WORLD J GASTROENTERO, V9, P385, DOI 10.3748/wjg.v9.i3.385; Sugiyama G, 2014, WORLD J GASTROENTERO, V20, P6968, DOI 10.3748/wjg.v20.i22.6968; Tulassay Z, 1997, NEW ENGL J MED, V336, P963	19	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187469	10.1371/journal.pone.0187469	http://dx.doi.org/10.1371/journal.pone.0187469			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095941	Green Published, gold, Green Submitted			2022-12-26	WOS:000414340200097
J	Omwenga, EO; Hensel, A; Pereira, S; Shitandi, AA; Goycoolea, FM				Omwenga, Eric Omori; Hensel, Andreas; Pereira, Susana; Shitandi, Alfred Anakalo; Goycoolea, Francisco M.			Antiquorum sensing, antibiofilm formation and cytotoxicity activity of commonly used medicinal plants by inhabitants of Borabu sub-county, Nyamira County, Kenya	PLOS ONE			English	Article							BIOFILM FORMATION; GENE-EXPRESSION; QUORUM; COMMUNICATION; DIGUANYLATE; EXTRACTS	Productions of various bacterial traits like production of virulence factors (e.g. toxins, enzymes), biofilm formation, luminescence among others, have been known to be controlled by quorum sensing (QS), a process that is dependent on chemical signals or autoinducers (Als). Bacteria known to rely on such Als are known to be virulent and tend to be resistant against various antimicrobial agents. Therefore, strategies aimed at the inhibition of QS pathways, are regarded as potential novel therapies in managing bacterial virulence hence reducing their ability to induce infections in humans. In the present study, a portfolio of 25 medicinal plant extracts (ethanol 50% v/v) used in southwestern Kenya were assayed against a transformed E. coliTop 10 reporter QS strain. This biosensor responds to the exogenous addition of 3-oxo-N-hexanoyl homoserine lactone (3OC6HSL) expressing green fluorescent protein (GFP). The large majority of the screened medicinal plants seemed to exhibit toxic effects and almost none of them induced antiquorum sensing (AQS) activity. This could be the consequence of the presence of mixed compounds in the extracts. Elaeodendron buchananii Loes and Acacia gerrardii Benth extracts that seemed to show AQS activity were further proved found to possess mild AQS but with defined antimicrobial activities, and no antibiofilm formation inhibition. Asa control, an E. colipBCA9145 jtk2828:: sfGFP strain that produces constitutively GFP was used and confirmed that none of the two extracts quenched the fluorescence of sfGFP. Cytotoxicity assays with mammalian MDCK cells also did indicate that the selected extracts with putative AQS activity, also reduced the cell viability. Therefore, further studies will be needed to separate and re-test the individual compounds especially from the selected two promising plants.	[Omwenga, Eric Omori] Kisii Univ, Sch Hlth Sci, Kisii, Kenya; [Omwenga, Eric Omori; Pereira, Susana; Goycoolea, Francisco M.] Univ Munster, Inst Plant Biotechnol & Biol, Nanobiotechnol Grp, Munster, Germany; [Hensel, Andreas] Univ Munster, Inst Pharmaceut Biol & Phytochem, Munster, Germany; [Shitandi, Alfred Anakalo] Kisii Univ, Fac Sci Appl, Kisii, Kenya; [Goycoolea, Francisco M.] Univ Leeds, Sch Food Sci & Nutr, Leeds, W Yorkshire, England	University of Munster; University of Munster; University of Leeds	Goycoolea, FM (corresponding author), Univ Munster, Inst Plant Biotechnol & Biol, Nanobiotechnol Grp, Munster, Germany.; Goycoolea, FM (corresponding author), Univ Leeds, Sch Food Sci & Nutr, Leeds, W Yorkshire, England.	fm.goycoolea@gmail.com	Goycoolea, Francisco M./Q-5841-2017	Goycoolea, Francisco M./0000-0001-7949-5429	DAAD [A/13/93803]; NACOSTI - Kenya	DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); NACOSTI - Kenya	NACOSTI - Kenya sponsored the fieldwork of this project and 90% of the joint scholarship with DAAD awarded to E00 (grant A/13/93803).	Abraham WR, 2016, ANTIBIOTICS-BASEL, V5, DOI 10.3390/antibiotics5010003; Almasoud A, 2016, LWT-FOOD SCI TECHNOL, V66, P560, DOI 10.1016/j.lwt.2015.11.013; Antunes LCM, 2010, MICROBIOL-SGM, V156, P2271, DOI 10.1099/mic.0.038794-0; Auchtung JM, 2006, J BACTERIOL, V188, P5273, DOI 10.1128/JB.00300-06; Banskota AH, 2000, J ETHNOPHARMACOL, V72, P239, DOI 10.1016/S0378-8741(00)00252-X; Bassler BL, 1999, CURR OPIN MICROBIOL, V2, P582, DOI 10.1016/S1369-5274(99)00025-9; Corral-Lugo A, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaa8271; Even-Tov E, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002386; Gopu V, 2016, RSC ADV, V6, P2592, DOI 10.1039/c5ra20677d; Greenberg EP, 2003, J CLIN INVEST, V112, P1288, DOI 10.1172/JCI200320099; Henke JM, 2004, J BACTERIOL, V186, P6902, DOI 10.1128/JB.186.20.6902-6914.2004; Jung SA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004837; Kaiser M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10048; Kalia VC, 2013, BIOTECHNOL ADV, V31, P224, DOI 10.1016/j.biotechadv.2012.10.004; Kareru PG, 2008, AFR J TRADIT COMPLEM, V5, P51; Kumar VP, 2006, J ETHNOPHARMACOL, V107, P182, DOI 10.1016/j.jep.2006.03.013; Lade H, 2014, INT J BIOL SCI, V10, P547, DOI 10.7150/ijbs.9028; Lewis K, 2006, NAT BIOTECHNOL, V24, P1504, DOI 10.1038/nbt1206-1504; Lu LG, 2005, FOODBORNE PATHOG DIS, V2, P242, DOI 10.1089/fpd.2005.2.242; Luo Jing, 2016, Drug Des Devel Ther, V10, P183, DOI 10.2147/DDDT.S97221; Miller MB, 2002, CELL, V110, P303, DOI 10.1016/S0092-8674(02)00829-2; Moreira CG, 2006, J BACTERIOL, V188, P3952, DOI 10.1128/JB.00177-06; Mwitari PG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065619; Nazzaro F, 2013, INT J MOL SCI, V14, P12607, DOI 10.3390/ijms140612607; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Njeru SN, 2016, J INTERCULT ETHNOPHA, V5, P226, DOI 10.5455/jice.20160416122003; Omwenga EO, 2015, J ETHNOPHARMACOL, V176, P508, DOI 10.1016/j.jep.2015.11.032; Omwenga E. O., 2012, South Asian Journal of Experimental Biology, V2, P217; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Peng L, 2005, COLLOID SURFACE B, V45, P108, DOI 10.1016/j.colsurfb.2005.07.014; Qin X, 2016, COLLOID SURFACE B, V149, P358, DOI DOI 10.1016/J.COLSURFB.2016.10.031; Rajamani S, 2008, MOL PLANT MICROBE IN, V21, P1184, DOI 10.1094/MPMI-21-9-1184; Ram Irez-Castillo ML, 2004, LETT, V26, P1301; Reading NC, 2007, J BACTERIOL, V189, P2468, DOI 10.1128/JB.01848-06; Rezk A, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0860-8; Rios JL, 2005, J ETHNOPHARMACOL, V100, P80, DOI 10.1016/j.jep.2005.04.025; Sambanthamoorthy K, 2012, ANTIMICROB AGENTS CH, V56, P5202, DOI 10.1128/AAC.01396-12; Si XR, 2015, APPL MICROBIOL BIOT, V99, P10861, DOI 10.1007/s00253-015-6943-0; Singh S. A., 2010, Journal of Chemical and Pharmaceutical Research, V2, P304; Spoering AL, 2001, J BACTERIOL, V183, P6746, DOI 10.1128/JB.183.23.6746-6751.2001; Sulaiman G. M., 2013, African Journal of Microbiology Research, V7, P1548; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Truchado P, 2015, TRENDS FOOD SCI TECH, V43, P189, DOI 10.1016/j.tifs.2015.02.009; Vila-Sanjurjo C, 2016, BIORXIV; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001	45	16	16	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0185722	10.1371/journal.pone.0185722	http://dx.doi.org/10.1371/journal.pone.0185722			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091715	Green Published, gold			2022-12-26	WOS:000414229700010
J	Paliwal, D; Joshi, P; Panda, SK				Paliwal, Daizy; Joshi, Prashant; Panda, Subrat Kumar			Hepatitis E Virus (HEV) egress: Role of BST2 (Tetherin) and interferon induced long non coding RNA (IncRNA) BISPR	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; ORF3 PROTEIN; CELL-LINES; IN-VIVO; EXPRESSION; RELEASE; BST-2/TETHERIN; GLYCOSYLATION; LOCALIZATION; CYTOSKELETON	Background The biology of Hepatitis E Virus (HEV), a common cause of epidemic and sporadic hepatitis, is still being explored. HEV exits liver through bile, a process which is essential for its natural transmission by feco-oral route. Though the process of this polarised HEV egress is not known in detail, HEV pORF3 and hepatocyte actin cytoskeleton have been shown to play a role. Methods Our transcriptome analysis in Hepatitis E virus (HEV) replicon transfected Huh7 cells at 24 and 72 hrs indicated that at 24hrs, both LncBISPR and BST2, expressed by a bidirectional promoter were highly upregulated whereas at 72 hrs, BST2 expression was comparatively reduced accompanied by normal levels of BISPR. These findings were confirmed by qPCR analysis. Co-localisation of BST2 and HEV pORF2 was confirmed in HEV transfected Huh7 by confocal microscopy. To investigate the role of BISPR/BST2 in HEV life cycle, particularly virus egress, we generated Huh7 cells with-8kb deletion in BISPR gene using Crispr-Cas9 system. The deletion was confirmed by PCR screening, Sanger sequencing and Real time PCR. Virus egress in BISPR Huh7 and Huh7 cells was compared by measuring HEV positive strand RNA copy numbers in cell lysates and culture supernatants at 24 and 72 hrs post HEV replicon transfection and further validated by western blot for HEV pORF2 capsid protein. Results BISPR Huh7 cells showed-8 fold increase in virus egress at 24 hrs compared to Huh7 cells. No significant difference in virus egress was observed at 72hrs. Immunohistochemistry in histologically normal liver and HEV associated acute liver failure revealed BST2 over expression in HEV infected hepatocytes and a dominant canalicular BST2 distribution in normal liver in addition to the cytoplasmic localisation reported in literature. Conclusions These findings lead us to believe that BISPR and BST2 may regulate egress of HEV virions into bile in vivo. This system may also be used to scale up virus production in vitro.	[Paliwal, Daizy; Joshi, Prashant; Panda, Subrat Kumar] All India Inst Med Sci, Dept Pathol, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Panda, SK (corresponding author), All India Inst Med Sci, Dept Pathol, New Delhi, India.	subrat@gmail.com		Panda, Subrat Kumar/0000-0003-0761-8631	Department of Biotechnology [BT/PR13335/MED/29/959/2015]; J.C. Bose fellowship granted form Department of Science and Technology, Govt. of India [SR/S2/JCB-05/2007]	Department of Biotechnology; J.C. Bose fellowship granted form Department of Science and Technology, Govt. of India	The present work has been funded by Department of Biotechnology (www.dbtindia.nic.in) (BT/PR13335/MED/29/959/2015) and J.C. Bose fellowship (SR/S2/JCB-05/2007) granted form Department of Science and Technology, Govt. of India (www.dstgov.in) to SKP. Both the funding agencies had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.	Barriocanal M, 2015, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00655; Billcliff PG, 2013, J CELL SCI, V126, P1553, DOI 10.1242/jcs.112953; Dave VP, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-128; Devhare PB, 2016, SCI REP-UK, V6, DOI 10.1038/srep26827; Dong C, 2012, HEPATOLOGY, V55, P1324, DOI 10.1002/hep.25530; Douglas JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000913; Dube M, 2011, TRAFFIC, V12, P1714, DOI 10.1111/j.1600-0854.2011.01277.x; Emerson SU, 2004, J VIROL, V78, P4838, DOI 10.1128/JVI.78.9.4838-4846.2004; Erikson E, 2011, P NATL ACAD SCI USA, V108, P13688, DOI 10.1073/pnas.1101684108; Fujita H, 2012, CURR HIV RES, V10, P321, DOI 10.2174/157016212800792522; GOTO T, 1994, BLOOD, V84, P1922; Graff J, 2008, J VIROL, V82, P1185, DOI 10.1128/JVI.01219-07; Gupta P, 2012, J VIRAL HEPATITIS, V19, pE177, DOI 10.1111/j.1365-2893.2011.01498.x; Homann S, 2011, J VIROL, V85, P10659, DOI 10.1128/JVI.05524-11; Jagya N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087835; Kambara H, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00676; Kapur N, 2012, J VIRAL HEPATITIS, V19, P436, DOI 10.1111/j.1365-2893.2011.01559.x; Kenney SP, 2015, VIROLOGY, V486, P198, DOI 10.1016/j.virol.2015.09.012; Lei QS, 2016, VIRAL IMMUNOL, V29, P105, DOI 10.1089/vim.2015.0107; Miyakawa K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000700; Nagashima S, 2011, J GEN VIROL, V92, P2838, DOI 10.1099/vir.0.035378-0; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Pan XB, 2013, ANTIVIR RES, V98, P54, DOI 10.1016/j.antiviral.2013.01.009; Panda SK, 2000, J VIROL, V74, P2430, DOI 10.1128/JVI.74.5.2430-2437.2000; Qi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132503; Rehman S, 2008, VIROLOGY, V370, P77, DOI 10.1016/j.virol.2007.07.036; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; Rollason R, 2009, J CELL BIOL, V184, P721, DOI 10.1083/jcb.200804154; Surjit M, 2007, J VIROL, V81, P3339, DOI 10.1128/JVI.02039-06; Tanaka T, 2007, J GEN VIROL, V88, P903, DOI 10.1099/vir.0.82535-0; Torresi J, 1999, J GEN VIROL, V80, P1185, DOI 10.1099/0022-1317-80-5-1185; Varma SPK, 2011, J GEN VIROL, V92, P572, DOI 10.1099/vir.0.027714-0; Yamada K, 2009, J GEN VIROL, V90, P1880, DOI 10.1099/vir.0.010561-0; Yin X, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8080229; Zafrullah M, 1997, J VIROL, V71, P9045, DOI 10.1128/JVI.71.12.9045-9053.1997; Zafrullah M, 1999, J VIROL, V73, P4074, DOI 10.1128/JVI.73.5.4074-4082.1999	36	8	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187334	10.1371/journal.pone.0187334	http://dx.doi.org/10.1371/journal.pone.0187334			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091957	Green Published, Green Submitted, gold			2022-12-26	WOS:000414229700057
J	Mihelcic, M; Simic, G; Leko, MB; Lavrac, N; Dzeroski, S; Smuc, T				Mihelcic, Matej; Simic, Goran; Leko, Mirjana Babic; Lavrac, Nada; Dzeroski, Saso; Smuc, Tomislav		Alzheimer's Dis Neuroimaging	Using redescription mining to relate clinical and biological characteristics of cognitively impaired and Alzheimer's disease patients	PLOS ONE			English	Article							FAS LIGAND; TESTOSTERONE; BRAIN; METAANALYSIS; CLASSIFICATION; PATHOGENESIS; ASSOCIATION; EXPRESSION; DISORDERS; DISCOVERY	Based on a set of subjects and a collection of attributes obtained from the Alzheimer's Disease Neuroimaging Initiative database, we used redescription mining to find interpretable rules revealing associations between those determinants that provide insights about the Alzheimer's disease (AD). We extended the CLUS-RM redescription mining algorithm to a constraint- based redescription mining (CBRM) setting, which enables several modes of targeted exploration of specific, user-constrained associations. Redescription mining enabled finding specific constructs of clinical and biological attributes that describe many groups of subjects of different size, homogeneity and levels of cognitive impairment. We confirmed some previously known findings. However, in some instances, as with the attributes: testosterone, ciliary neurotrophic factor, brain natriuretic peptide, Fas ligand, the imaging attribute Spatial Pattern of Abnormalities for Recognition of Early AD, as well as the levels of leptin and angiopoietin-2 in plasma, we corroborated previously debatable findings or provided additional information about these variables and their association with AD pathogenesis. Moreover, applying redescription mining on ADNI data resulted with the discovery of one largely unknown attribute: the Pregnancy-Associated Protein-A (PAPP-A), which we found highly associated with cognitive impairment in AD. Statistically significant correlations (p <= 0.01) were found between PAPP-A and clinical tests: Alzheimer's Disease Assessment Scale, Clinical Dementia Rating Sum of Boxes, Mini Mental State Examination, etc. The high importance of this finding lies in the fact that PAPP-A is a metalloproteinase, known to cleave insulin-like growth factor binding proteins. Since it also shares similar substrates with A Disintegrin and the Metalloproteinase family of enzymes that act as a-secretase to physiologically cleave amyloid precursor protein (APP) in the non-amyloidogenic pathway, it could be directly involved in the metabolism of APP very early during the disease course. Therefore, further studies should investigate the role of PAPP-A in the development of AD more thoroughly.	[Mihelcic, Matej; Smuc, Tomislav] Rudjer Boskovic Inst, Div Elect, Zagreb, Croatia; [Mihelcic, Matej; Lavrac, Nada; Dzeroski, Saso] Jozef Stefan Int Postgrad Sch, Ljubljana, Slovenia; [Simic, Goran; Leko, Mirjana Babic] Univ Zagreb, Med Sch, Croatian Inst Brain Res, Dept Neurosci, Zagreb, Croatia; [Lavrac, Nada; Dzeroski, Saso] Jozef Stefan Inst, Dept Knowledge Technol, Ljubljana, Slovenia	Rudjer Boskovic Institute; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Zagreb; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Smuc, T (corresponding author), Rudjer Boskovic Inst, Div Elect, Zagreb, Croatia.	tomislav.smuc@irb.hr	Šimić, Goran/GZA-9931-2022; Babić Leko, Mirjana/C-3514-2018; Mihelčić, Matej/AAJ-2725-2020; Šimić, Goran/A-9262-2013; Dzeroski, Saso/ABH-2758-2021; Babić Leko, Mirjana/ABG-3331-2021	Babić Leko, Mirjana/0000-0003-4223-4190; Mihelčić, Matej/0000-0002-1023-8413; Šimić, Goran/0000-0002-6339-9261; Dzeroski, Saso/0000-0003-2363-712X; Babić Leko, Mirjana/0000-0003-4223-4190; Smuc, Tomislav/0000-0002-9185-9384	Alzheimer's Disease Neuroimaging Initiative (ADNI) [U01 AG024904]; DOD ADNI [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Slovenian Research Agency; Future and Emerging Technologies EU [604102]; European Commission [612944]; Croatian Science Foundation [9623]; TS and Tau protein hyperphosphorylation, aggregation and trans-synaptic transfer in Alzheimer's disease: cerebrospinal fluid analysis and assessment of potential neuroprotective compounds [IP-2014-09-9730]	Alzheimer's Disease Neuroimaging Initiative (ADNI); DOD ADNI(United States Department of Defense); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Slovenian Research Agency(Slovenian Research Agency - Slovenia); Future and Emerging Technologies EU; European Commission(European CommissionEuropean Commission Joint Research Centre); Croatian Science Foundation; TS and Tau protein hyperphosphorylation, aggregation and trans-synaptic transfer in Alzheimer's disease: cerebrospinal fluid analysis and assessment of potential neuroprotective compounds	Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from many private pharmaceutical companies and non-profit organizations. The research was partly funded by the Slovenian Research Agency, the Future and Emerging Technologies EU funded Human Brain Project (HBP, grant agreement no. 604102) - NL, SD, the European Commission funded MAESTRA project (Gr. no. 612944) - TS, SD, the Croatian Science Foundation funded projects: Machine Learning Algorithms for Insightful Analysis of Complex Data Structures (grant. no. 9623) - TS and Tau protein hyperphosphorylation, aggregation and trans-synaptic transfer in Alzheimer's disease: cerebrospinal fluid analysis and assessment of potential neuroprotective compounds (grant. no. IP-2014-09-9730) - GS.	Adaszewski S, 2013, NEUROBIOL AGING, V34, P2815, DOI 10.1016/j.neurobiolaging.2013.06.015; Agrawal Rakesh, 1996, ADV KNOWLEDGE DISCOV, P307, DOI DOI 10.1007/978-3-319-31750-2.; Aho T, 2012, J MACH LEARN RES, V13, P2367; Akter K, 2011, BRIT J CLIN PHARMACO, V71, P365, DOI 10.1111/j.1365-2125.2010.03830.x; ANDERSON TW, 1952, ANN MATH STAT, V23, P193, DOI 10.1214/aoms/1177729437; Arnold SE, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2011.63; Bacher M, 2010, MOL MED, V16, P116, DOI 10.2119/molmed.2009.00123; Bay SD, 2001, DATA MIN KNOWL DISC, V5, P213, DOI 10.1023/A:1011429418057; Blockeel H, 1998, ARTIF INTELL, V101, P285, DOI 10.1016/S0004-3702(98)00034-4; Breiman L., 1984, CLASSIFICATION REGRE; Breskvar M, 2015, P 18 INT INF SOC LIU, P5; Caramelli P, 1999, ACTA NEUROL SCAND, V100, P61, DOI 10.1111/j.1600-0404.1999.tb00724.x; Chang Y.T., 2016, FRONT AGING NEUROSCI, V8, P8; Clarke R, 2014, AM J CLIN NUTR, V100, P657, DOI 10.3945/ajcn.113.076349; Coskun A, 2013, J CARDIOL, V61, P128, DOI 10.1016/j.jjcc.2012.09.007; COX DR, 1957, J AM STAT ASSOC, V52, P543, DOI 10.2307/2281704; Donovan NJ, 2014, AM J GERIAT PSYCHIAT, V22, P1168, DOI 10.1016/j.jagp.2013.03.006; Doraiswamy PM, 2014, MOL PSYCHIATR, V19, P1044, DOI 10.1038/mp.2014.9; Douaud G, 2013, P NATL ACAD SCI USA, V110, P9523, DOI 10.1073/pnas.1301816110; Dukart J, 2013, PSYCHIAT RES-NEUROIM, V212, P230, DOI 10.1016/j.pscychresns.2012.04.007; Ferrer I, 2001, ACTA NEUROPATHOL, V102, P121; Fisher D. H., 1987, Machine Learning, V2, P139, DOI 10.1007/BF00114265; FISHER W, 1958, J AM STAT ASS, V53; Ford AH, 2012, J ALZHEIMERS DIS, V29, P133, DOI 10.3233/JAD-2012-111739; Galbrun Esther, 2012, Statistical Analysis and Data Mining, V5, P284, DOI 10.1002/sam.11145; Galbrun E., 2012, P 18 ACM SIGKDD INT, P1544, DOI DOI 10.1145/2339530.2339776; Galbrun E, 2013, THESIS; Gallo A, 2008, FINDING SUBGROUPS HA, P334; Gamberger D, 2015, LECT NOTES ARTIF INT, V9250, P57, DOI 10.1007/978-3-319-23344-4_6; Gamberger D, 2015, LECT N BIOINFORMAT, V9043, P134, DOI 10.1007/978-3-319-16483-0_13; Gamberger D, 2014, LECT NOTES ARTIF INT, V8777, P87, DOI 10.1007/978-3-319-11812-3_8; Gelernter J, 1997, AM J MED GENET, V74, P497, DOI 10.1002/(SICI)1096-8628(19970919)74:5<497::AID-AJMG8>3.3.CO;2-5; Grammas P, 2011, INT J CLIN EXP PATHO, V4, P616; Grober U, 2013, NUTRIENTS, V5, P5031, DOI 10.3390/nu5125031; Guo LH, 2013, ALZHEIMERS DEMENT, V9, P580, DOI 10.1016/j.jalz.2012.10.002; Heidari Behnam, 2015, Acta Med Iran, V53, P395; Hogervorst E, 2004, EXP GERONTOL, V39, P1633, DOI 10.1016/j.exger.2004.06.019; Hostage CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054483; Hu YS, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0252-z; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Juottonen K, 1998, NEUROBIOL AGING, V19, P15, DOI 10.1016/S0197-4580(98)00007-4; Klosgen W., 1996, ADV KNOWLEDGE DISCOV, P249; Kocev D, 2013, PATTERN RECOGN, V46, P817, DOI 10.1016/j.patcog.2012.09.023; Kolmogorov, 1933, GIORNALE DELLISTITUT, V4, P83; Kondziella D, 2009, NEUROREPORT, V20, P825, DOI 10.1097/WNR.0b013e328326f82f; Kuhn PH, 2016, ELIFE, V5, DOI 10.7554/eLife.12748; Liu X, 2013, NEUROIMAGE, V83, P148, DOI 10.1016/j.neuroimage.2013.06.033; Llano DA, 2013, ALZ DIS ASSOC DIS, V27, P233, DOI 10.1097/WAD.0b013e31826d597a; Lv WS, 2016, MOL NEUROBIOL, V53, P2679, DOI 10.1007/s12035-015-9315-y; Ma C, 2015, BIOMED RES INT, V2015; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Marwarha G, 2014, BBA-MOL BASIS DIS, V1842, P1587, DOI 10.1016/j.bbadis.2014.05.015; Marwarha Gurdeep, 2012, Am J Neurodegener Dis, V1, P245; Marwarha G, 2012, CELL SIGNAL, V24, P484, DOI 10.1016/j.cellsig.2011.09.029; Marwarha G, 2010, J ALZHEIMERS DIS, V19, P1007, DOI 10.3233/JAD-2010-1298; Michalski R. S., 1980, International Journal of Policy Analysis and Information Systems, V4, P219; Mihel M., 2015, P 4 WORKSH NEW FRONT, P86; Mihelcic M, 2017, J INTELL INF SYST, P1, DOI DOI 10.1007/S10844017-04485; Mihelcic M, 2016, LECT NOTES ARTIF INT, V9956, P35, DOI 10.1007/978-3-319-46307-0_3; Mihelcic M, 2017, EXPERT SYST APPL, V68, P196, DOI 10.1016/j.eswa.2016.10.012; Mihelcic M, 2016, LECT NOTES ARTIF INT, V9607, P125, DOI 10.1007/978-3-319-39315-5_9; Papasozomenos SC, 2002, P NATL ACAD SCI USA, V99, P1140, DOI 10.1073/pnas.032646799; Parida L., 2005, REDESCRIPTION MINING, P837; Pearson Karl, 1895, P ROY SOC LONDON, V58, P240, DOI [DOI 10.1098/RSPL.1895.0041, 10.1098/rspl.1895.0041]; Piccart B, 2012, THESIS; Plucinska K, 2016, DIABETES, V65, pA430; R Core Team, 2014, R LANG ENV STAT COMP; Ramakrishnan N., 2004, P 10 ACM SIGKDD INT, DOI DOI 10.1145/1014052.1014083; Risacher SL, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00011; Roberts RO, FRONTIERS NERUOSCIEN, P7; Rosario ER, 2010, BRAIN RES, V1359, P281, DOI 10.1016/j.brainres.2010.08.068; SCHOLZ FW, 1987, J AM STAT ASSOC, V82, P918, DOI 10.2307/2288805; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shipley Sheena M, 2013, Neurol Clin Pract, V3, P305; Simic G, 2016, PROGR NEUROBIOLOGY; SMIRNOV N, 1948, ANN MATH STAT, V19, P279, DOI 10.1214/aoms/1177730256; Smith AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012244; Smith G.E., 2013, MILD COGNITIVE IMPAI; Soares HD, 2012, ARCH NEUROL-CHICAGO, V69, P1310, DOI 10.1001/archneurol.2012.1070; Song F, 2012, PLOS ONE, V7, P1; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Stanley M, 2016, J EXP MED; Stefulj J, 2013, TRANSL NEUROSCI, V4, P349, DOI 10.2478/s13380-013-0136-z; Su JH, 2003, NEUROBIOL DIS, V12, P182, DOI 10.1016/S0969-9961(02)00019-0; Tang SL, 2012, ATHEROSCLEROSIS, V222, P344, DOI 10.1016/j.atherosclerosis.2012.03.005; Thirumangalakudi L, 2006, J ALZHEIMERS DIS, V10, P111; van Leeuwen M, 2015, IEEE T KNOWL DATA EN, V27, P3190, DOI 10.1109/TKDE.2015.2453159; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Watson GS, 2003, CNS DRUGS, V17, P27, DOI 10.2165/00023210-200317010-00003; Weiner Michael W, 2012, Alzheimers Dement, V8, pS1, DOI [10.1016/j.jalz.2013.05.1769, 10.1016/j.jalz.2011.09.172]; Wittert G, 2014, ASIAN J ANDROL, V16, P262, DOI 10.4103/1008-682X.122586; Wrobel S, 1997, LECT NOTES ARTIF INT, V1263, P78; Xu D., 2015, ANN DATA SCI, V2, P165, DOI [10.1007/s40745-015-0040-1, DOI 10.1007/S40745-015-0040-1]; Xu J, 2016, CURR ALZHEIMER RES, V13, P215, DOI 10.2174/1567205013666151218145752; Zaki M.J., 2005, P 11 ACM SIGKDD INT, P364, DOI DOI 10.1145/1081870.1081912; Zhao JV, 2016, SCI REPORTS, P6; Zinchenko T., 2014, THESIS	97	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187364	10.1371/journal.pone.0187364	http://dx.doi.org/10.1371/journal.pone.0187364			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088293	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000414088900074
J	Schmidt, K; Butt, J; Mauter, P; Vogel, K; Erles-Kemna, A; Pawlita, M; Nicklas, W				Schmidt, Katja; Butt, Julia; Mauter, Petra; Vogel, Klaus; Erles-Kemna, Andrea; Pawlita, Michael; Nicklas, Werner			Development of a multiplex serological assay reveals a worldwide distribution of murine astrovirus infections in laboratory mice	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; STRUCTURAL PROTEIN; CHICKEN ASTROVIRUS; DUCK ASTROVIRUS; GUT MICROBIOTA; CAPSID PROTEIN; VIRUS; GASTROENTERITIS; ANTIBODIES; HEPATITIS	Laboratory mice play a tremendous role in biomedical research in studies on immunology, infection, cancer and therapy. In the course of standardization of mice used in animal experiments, health monitoring constitutes an important instrument towards microbiological standardization. Infections with murine astroviruses (MuAstV) were only recently discovered and are, therefore, still relatively unknown in laboratory animal science. In rodent health monitoring viral infections within a population are commonly assessed in terms of specific antibodies by serological testing, as active infection and excretion of virus is often temporary and can easily be missed. So far only ongoing infections with astroviruses can be detected by PCR. The objective of this work was the development of a sensitive and specific MuAstV multiplex serological assay with a high-throughput capability to be used in routine testing of laboratory mice. Four different MuAstV proteins were recombinantly expressed and used as antigens. The best reacting antigen, the capsid spike protein VP27, was selected and tested with a panel of 400 sera of mice from units with a known MuAstV status. Assay sensitivity and specificity resulted in 98.5% and 100%, respectively, compared to RT-PCR results. Eventually this assay was used to test 5529 serum samples in total, during routine diagnostics at the German Cancer Research Center (DKFZ) in Heidelberg between 2015 and 2017. High sero-prevalence rates of up to 98% were detected in units with open cages indicating that the virus is highly infectious and circulates within these populations virtually infecting all animals regardless of the mouse strain. In addition, data collected from 312 mice purchased from commercial breeders and from 661 mice from 58 research institutes in 15 countries worldwide allowed the conclusion that MuAstV is widespread in contemporary laboratory mouse populations.	[Schmidt, Katja; Mauter, Petra; Vogel, Klaus; Erles-Kemna, Andrea; Nicklas, Werner] German Canc Res Ctr, Ctr Preclin Res, Microbiol Diagnost, Heidelberg, Germany; [Butt, Julia; Pawlita, Michael] German Canc Res Ctr, Div Mol Diagnost Oncogen Infect, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Schmidt, K (corresponding author), German Canc Res Ctr, Ctr Preclin Res, Microbiol Diagnost, Heidelberg, Germany.	katja.schmidt@dkfz-heidelberg.de		Schmidt, Katja/0000-0002-4828-7974	CPR of the DKFZ	CPR of the DKFZ	The authors thank Dr. Daniela Hofler for valuable professional input, Claudia Brandel for the technical support with protein expression, Bernhard Berkus, Elsbeth Schneider and Katrin Gotz for assistance in the diagnostic laboratory, necropsy of animals, sample preparation and documentation, and the animal care technicians at CAL and CPR of the DKFZ for their support and sample taking.	Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Appleton H, 1975, Lancet, V1, P1297; ASPLIN FD, 1965, VET REC, V77, P487; Bass DM, 1997, J VIROL, V71, P8666, DOI 10.1128/JVI.71.11.8666-8671.1997; BJORKHOLM M, 1995, INT J HEMATOL, V62, P117; Bleich A, 2012, COMP IMMUNOL MICROB, V35, P81, DOI 10.1016/j.cimid.2011.12.006; Bogdanoff WA, 2017, J VIROL, V91, DOI 10.1128/JVI.01859-16; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Compton SR, 2017, J AM ASSOC LAB ANIM, V56, P402; De Benedictis P, 2011, INFECT GENET EVOL, V11, P1529, DOI 10.1016/j.meegid.2011.07.024; Banos-Lara MD, 2010, VIROLOGY, V401, P322, DOI 10.1016/j.virol.2010.02.028; Dewhirst FE, 1999, APPL ENVIRON MICROB, V65, P3287; Dong JH, 2011, P NATL ACAD SCI USA, V108, P12681, DOI 10.1073/pnas.1104834108; Dryden KA, 2012, J MOL BIOL, V422, P650, DOI 10.1016/j.jmb.2012.06.029; Farkas T, 2012, VIRUS GENES, V45, P518, DOI 10.1007/s11262-012-0803-0; Fu Y, 2009, J GEN VIROL, V90, P1104, DOI 10.1099/vir.0.008599-0; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Geigenmuller U, 2002, J GEN VIROL, V83, P1691, DOI 10.1099/0022-1317-83-7-1691; GOUGH RE, 1984, VET REC, V114, P279, DOI 10.1136/vr.114.11.279-a; Hansen AK, 2014, WORLD J GASTROENTERO, V20, P17727, DOI 10.3748/wjg.v20.i47.17727; HERRMANN JE, 1990, J INFECT DIS, V161, P226, DOI 10.1093/infdis/161.2.226; Hewson KA, 2015, J VIROL METHODS, V221, P106, DOI 10.1016/j.jviromet.2015.04.019; Hsu CC, 2007, LAB ANIMAL, V36, P36, DOI 10.1038/laban0907-36; IMADA T, 1979, AVIAN DIS, V23, P582, DOI 10.2307/1589733; KJELDSBERG E, 1985, ARCH VIROL, V84, P135, DOI 10.1007/BF01310560; Koci MD, 2005, VIRAL IMMUNOL, V18, P11, DOI 10.1089/vim.2005.18.11; Koci MD, 2004, J VIROL, V78, P1564, DOI 10.1128/JVI.78.3.1564-1574.2004; Krishna NK, 2005, VIRAL IMMUNOL, V18, P17, DOI 10.1089/vim.2005.18.17; KURTZ J, 1978, MED MICROBIOL IMMUN, V166, P227, DOI 10.1007/BF02121154; KURTZ JB, 1979, J MED VIROL, V3, P221, DOI 10.1002/jmv.1890030308; Lee A, 2013, AVIAN PATHOL, V42, P434, DOI 10.1080/03079457.2013.822467; MACARTHUR H, 1984, J VIROL, V52, P483, DOI 10.1128/JVI.52.2.483-491.1984; MADELEY CR, 1975, LANCET, V2, P451; MAEDA M, 1979, AVIAN DIS, V23, P589, DOI 10.2307/1589734; Mahler M, 2014, LAB ANIM-UK, V48, P178, DOI 10.1177/0023677213516312; Marvin SA, 2016, J VIROL, V90, P1988, DOI 10.1128/JVI.02367-15; Mendez E, 2004, J VIROL, V78, P8601, DOI 10.1128/JVI.78.16.8601-8608.2004; Mendez E, 2002, J VIROL, V76, P7996, DOI 10.1128/JVI.76.16.7996-8002.2002; Mendez E, 2013, FIELDS VIROLOGY, V1, P609; Mendez E, 2007, J VIROL, V81, P10649, DOI 10.1128/JVI.00785-07; Ng TFF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066937; Phan TG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002218; Pritchett-Corning KR, 2014, J AM ASSOC LAB ANIM, V53, P633; REYNOLDS DL, 1986, AVIAN DIS, V30, P728, DOI 10.2307/1590577; SANCHEZFAUQUIER A, 1994, VIROLOGY, V201, P312, DOI 10.1006/viro.1994.1296; Sehr P, 2001, J IMMUNOL METHODS, V253, P153, DOI 10.1016/S0022-1759(01)00376-3; Skibinska A, 2015, AVIAN PATHOL, V44, P436, DOI 10.1080/03079457.2015.1084411; Tlaskalova-Hogenova H, 2011, CELL MOL IMMUNOL, V8, P110, DOI 10.1038/cmi.2010.67; Wang XY, 2011, J VIROL METHODS, V171, P8, DOI 10.1016/j.jviromet.2010.09.015; Waterboer T, 2006, J IMMUNOL METHODS, V309, P200, DOI 10.1016/j.jim.2005.11.008; Waterboer T, 2005, CLIN CHEM, V51, P1845, DOI 10.1373/clinchem.2005.052381; Yokoyama CC, 2012, J VIROL, V86, P12262, DOI 10.1128/JVI.02018-12; York RL, 2016, J VIROL, V90, P2254, DOI 10.1128/JVI.02666-15	53	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187174	10.1371/journal.pone.0187174	http://dx.doi.org/10.1371/journal.pone.0187174			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088279	Green Submitted, Green Published, gold			2022-12-26	WOS:000414088900044
J	Braun, CK; Kalbitz, M; Halbgebauer, R; Eisele, P; Messerer, DAC; Weckbach, S; Schultze, A; Braumuller, S; Gebhard, F; Huber-Lang, MS				Braun, Christian K.; Kalbitz, Miriam; Halbgebauer, Rebecca; Eisele, Philipp; Messerer, David A. C.; Weckbach, Sebastian; Schultze, Anke; Braumueller, Sonja; Gebhard, Florian; Huber-Lang, Markus S.			Early structural changes of the heart after experimental polytrauma and hemorrhagic shock	PLOS ONE			English	Article							SEPSIS; CARDIOMYOCYTES; CONNEXIN-43; GAP; INFLAMMATION; DYSFUNCTION; EXPRESSION; TRAUMA	Evidence is emerging that systemic inflammation after trauma drives structural and functional impairment of cardiomyocytes and leads to cardiac dysfunction, thus worsening the outcome of polytrauma patients. This study investigates the structural and molecular changes in heart tissue 4 h after multiple injuries with additional hemorrhagic shock using a clinically relevant rodent model of polytrauma. We determined mediators of systemic inflammation (keratinocyte chemoattractant, macrophage chemotactic protein 1), activated complement component C3a and cardiac troponin I in plasma and assessed histological specimen of the mouse heart via standard histomorphology and immunohistochemistry for cellular and subcellular damage and ongoing apoptosis. Further we investigated spatial and quantitative changes of connexin 43 by immunohistochemistry and western blotting. Our results show significantly increased plasma levels of both keratinocyte chemoattractant and cardiac troponin I 4 h after polytrauma and 2 h after induction of hypovolemia. Although we could not detect any morphological changes, immunohistochemical evaluation showed increased level of tissue high-mobility group box 1, which is both a damage-associated molecule and actively released as a danger response signal. Additionally, there was marked lateralization of the cardiac gap-junction protein connexin 43 following combined polytrauma and hemorrhagic shock. These results demonstrate a molecular manifestation of remote injury of cardiac muscle cells in the early phase after polytrauma and hemorrhagic shock with marked disruption of the cardiac gap junction. This disruption of an important component of the electrical conduction system of the heart may lead to arrhythmia and consequently to cardiac dysfunction.	[Braun, Christian K.; Halbgebauer, Rebecca; Eisele, Philipp; Messerer, David A. C.; Schultze, Anke; Braumueller, Sonja; Huber-Lang, Markus S.] Univ Hosp Ulm, Inst Clin & Expt Trauma Immunol, Ulm, Germany; [Kalbitz, Miriam; Gebhard, Florian] Univ Hosp Ulm, Dept Orthoped Trauma Hand Plast & Reconstruct Sur, Ulm, Germany; [Weckbach, Sebastian] Univ Hosp Ulm, Dept Orthoped Surg, Ulm, Germany	Ulm University; Ulm University; Ulm University	Huber-Lang, MS (corresponding author), Univ Hosp Ulm, Inst Clin & Expt Trauma Immunol, Ulm, Germany.	markus.huber-lang@uniklink-ulm.de	Huber-Lang, Markus/AAJ-2209-2020; Braun, Christian K/I-5132-2018; Messerer, David Alexander Christian/AAJ-9965-2021	Braun, Christian K/0000-0002-9854-3251; Messerer, David Alexander Christian/0000-0002-0834-038X; Huber-Lang, Markus/0000-0003-2359-6516	German Research Foundation DFG [CRC 1149]	German Research Foundation DFG(German Research Foundation (DFG))	This study was supported by grants from the German Research Foundation DFG CRC 1149, project A01 and Z02; http://www.dfg.de/en/.	Altmann DR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009017; Asavarut Paladd, 2013, Acta Anaesthesiol Taiwan, V51, P28, DOI 10.1016/j.aat.2013.03.007; Atefi G, 2011, FASEB J, V25, P2500, DOI 10.1096/fj.11-183236; Bian B, 2015, EUR J PHARMACOL, V768, P13, DOI 10.1016/j.ejphar.2015.09.023; Celes MRN, 2013, PATHOBIOLOGY, V80, P70, DOI 10.1159/000341640; Celes MRN, 2007, CRIT CARE MED, V35, P2176, DOI 10.1097/01.CCM.0000281454.97901.01; Cohen MJ, 2009, CRIT CARE, V13, DOI 10.1186/cc8152; Denk S, 2017, SHOCK; Fernandez-Cobo M, 1999, CYTOKINE, V11, P216, DOI 10.1006/cyto.1998.0422; Gawande NB, 2014, SHOCK, V42, P211, DOI 10.1097/SHK.0000000000000194; Hoesel LM, 2007, MOL IMMUNOL, V44, P95, DOI 10.1016/j.molimm.2006.06.009; Kalbitz M, 2016, WORLD J SURG; Korff S, 2006, HEART, V92, P987, DOI 10.1136/hrt.2005.071282; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Martins-Marques T, 2015, BIOCHEM J, V467, P231, DOI 10.1042/BJ20141370; McCain ML, 2012, AM J PHYSIOL-HEART C, V302, pH443, DOI 10.1152/ajpheart.01218.2010; Mehta NJ, 2004, INT J CARDIOL, V95, P13, DOI 10.1016/j.ijcard.2003.02.005; Mokdad AH, 2016, LANCET, V387, P2383, DOI 10.1016/S0140-6736(16)00648-6; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Takasu O, 2013, AM J RESP CRIT CARE, V187, P509, DOI 10.1164/rccm.201211-1983OC; Tao L, 2005, AM J PHYSIOL-HEART C, V288, pH2811, DOI 10.1152/ajpheart.01252.2004; ver Elst KM, 2000, CLIN CHEM, V46, P650; Xia Y, 2009, ACTA PHARMACOL SIN, V30, P928, DOI 10.1038/aps.2009.92; Xu H, 2011, AM J PHYSIOL-HEART C, V300, pH913, DOI 10.1152/ajpheart.00703.2010; Yasui K, 2000, CARDIOVASC RES, V48, P68, DOI 10.1016/S0008-6363(00)00145-0; Yin W, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-S1-S6; Zhang CC, 2014, J MOL CELL CARDIOL, V74, P260, DOI 10.1016/j.yjmcc.2014.06.003	27	25	25	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187327	10.1371/journal.pone.0187327	http://dx.doi.org/10.1371/journal.pone.0187327			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084268	Green Published, Green Submitted, gold			2022-12-26	WOS:000413910200050
J	Perez-Parra, S; Chueca, N; Alvarez, M; Pasquau, J; Omar, M; Collado, A; Vinuesa, D; Lozano, AB; Yebra, G; Garcia, F				Perez-Parra, Santiago; Chueca, Natalia; Alvarez, Marta; Pasquau, Juan; Omar, Mohamed; Collado, Antonio; Vinuesa, David; Belen Lozano, Ana; Yebra, Gonzalo; Garcia, Federico			High prevalence and diversity of HIV-1 non-B genetic forms due to immigration in southern Spain: A phylogeographic approach	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NEWLY-DIAGNOSED PATIENTS; DRUG-RESISTANCE; SPANISH COHORT; SUBTYPE C; TRANSMISSION; SEX; MEN; SURVEILLANCE; EMERGENCE	Phylogenetic studies are a valuable tool to understand viral transmission patterns and the role of immigration in HIV-1 spread. We analyzed the spatio-temporal relationship of different HIV-1 non-B subtype variants over time using phylogenetic analysis techniques. We collected 693 pol (PR+RT) sequences that were sampled from 2005 to 2012 from naive patients in different hospitals in southern Spain. We used REGA v3.0 to classify them into subtypes and recombinant forms, which were confirmed by phylogenetic analysis through maximum likelihood (ML) using RAxML. For the main HIV-1 non-B variants, publicly available, genetically similar sequences were sought using HIV-BLAST. The presence of HIV-1 lineages circulating in our study population was established using ML and Bayesian inference (BEAST v1.7.5) and transmission networks were identified. We detected 165 (23.4%) patients infected with HIV-1 non-B variants: 104 (63%) with recombinant viruses in pol: CRF02_AG (71, 43%), CRF14_BG (8, 4.8%), CRF06_cpx (5, 3%) and nine other recombinant forms (11, 6.7%) and unique recombinants (9, 5.5%). The rest (61, 37%) were infected with non-recombinant subtypes: A1 (30, 18.2%), C (7, [4.2%]), D (3, [1.8%]), F1 (9, 5.5%) and G (12, 7.3%). Most patients infected with HIV-1 non-B variants were men (63%, p < 0.001) aged over 35 (73.5%, p < 0.001), heterosexuals (92.2%, p < 0.001), from Africa (59.5%, p < 0.001) and living in the El Ejido area (62.4%, p < 0.001). We found lineages of epidemiological relevance (mainly within Subtype A1), imported primarily through female sex workers from East Europe. We detected 11 transmission clusters of HIV-1 non-B Sub-types, which included patients born in Spain in half of them. We present the phylogenetic profiles of the HIV-1 non-B variants detected in southern Spain, and explore their putative geographical origins. Our data reveals a high HIV-1 genetic diversity likely due to the import of viral lineages that circulate in other countries. The highly immigrated El Ejido area acts as a gateway through which different subtypes are introduced into other regions, hence the importance of setting up epidemiological control measures to prevent future outbreaks.	[Perez-Parra, Santiago; Chueca, Natalia; Alvarez, Marta; Garcia, Federico] Hosp Univ San Cecilio, Serv Microbiol Clin, Campus Salud, Granada, Spain; [Perez-Parra, Santiago; Chueca, Natalia; Alvarez, Marta; Garcia, Federico] Inst Invest IBS, Granada, Spain; [Pasquau, Juan] Hosp Virgen Nieves, Serv Infecciosas, Granada, Spain; [Omar, Mohamed] Hosp Ciudad Jaen, Serv Infecciosas, Jaen, Spain; [Collado, Antonio] Hosp Torrecardenas, Serv Med Interna, Almeria, Spain; [Vinuesa, David] Hosp Univ San Cecilio, Serv Infecciosas, Granada, Spain; [Belen Lozano, Ana] Hosp Poniente, Serv Infecciosas, Almeria, Spain; [Yebra, Gonzalo] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland	Hospital Universitario San Cecilio; Instituto de Investigacion Biosanitaria IBS Granada; Hospital Universitario Virgen de las Nieves; Hospital Torrecardenas; Hospital Universitario San Cecilio; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Garcia, F (corresponding author), Hosp Univ San Cecilio, Serv Microbiol Clin, Campus Salud, Granada, Spain.; Garcia, F (corresponding author), Inst Invest IBS, Granada, Spain.	fegarcia@ugr.es	Chueca, Natalia/T-9734-2019; Garcia, Federico/AAA-3175-2020	Chueca, Natalia/0000-0002-3420-3290; Garcia, Federico/0000-0001-7611-781X; Yebra, Gonzalo/0000-0002-3472-3667; Pasquau, Juan/0000-0001-9409-9205	National Plan of I+D+i [RD12/0017/006]; General Ministry of Evaluation and European; Fund of Regional Development (FEDER); Health Institute Carlos III (ISCIII) [PI12/01053]; Ministry of Health of Andalusia [AC-0082-2013]	National Plan of I+D+i; General Ministry of Evaluation and European; Fund of Regional Development (FEDER); Health Institute Carlos III (ISCIII); Ministry of Health of Andalusia	This work was supported by National Plan of I+D+i (RD12/0017/006), granted to FGG; General Ministry of Evaluation and European, granted to FGG; Fund of Regional Development (FEDER), granted to FGG; Health Institute Carlos III (ISCIII), PI12/01053, granted to FGG; and Ministry of Health of Andalusia (AC-0082-2013), granted to FGG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaeus A, 1997, AIDS, V11, P859, DOI 10.1097/00002030-199707000-00004; Aldous JL, 2012, CLIN INFECT DIS, V55, P1135, DOI 10.1093/cid/cis612; Alexiev I, 2015, J ANTIMICROB CHEMOTH, V70, P1874, DOI 10.1093/jac/dkv011; Bracho MA, 2014, JAIDS-J ACQ IMM DEF, V65, pE130, DOI 10.1097/01.qai.0000435602.73469.56; Alvarez M, 2003, J MED VIROL, V70, P10, DOI 10.1002/jmv.10368; [Anonymous], TRENDS DRUG RES PREV; Apetrei C, 1998, J VIROL, V72, P3534, DOI 10.1128/JVI.72.5.3534-3538.1998; ARTENSTEIN AW, 1995, J INFECT DIS, V171, P805, DOI 10.1093/infdis/171.4.805; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Brennan CA, 2006, J MED VIROL, V78, pS24, DOI 10.1002/jmv.20603; Brenner BG, 2011, J INFECT DIS, V204, P1115, DOI 10.1093/infdis/jir468; Brown AJL, 2011, J INFECT DIS, V204, P1463, DOI 10.1093/infdis/jir550; de Felipe B, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-416; De Mendoza C, 2009, AIDS RES HUM RETROV, V25, P967, DOI 10.1089/aid.2008.0166; Delgado E, 2014, 6 C NAC GESIDA 8 REU, P12; Delgado E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143325; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Esbjornsson J, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew010; Esbjornsson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017025; Fernandez-Garcia A, 2009, AIDS RES HUM RETROV, V25, P1187, DOI 10.1089/aid.2009.0140; Garcia F, 2011, ANTIVIR RES, V91, P150, DOI 10.1016/j.antiviral.2011.05.010; Gilbert MTP, 2007, P NATL ACAD SCI USA, V104, P18566, DOI 10.1073/pnas.0705329104; Gonzalez-Alba JM, 2011, J VIROL, V85, P10755, DOI 10.1128/JVI.00454-11; Grabowski MK, 2014, CURR OPIN HIV AIDS, V9, P126, DOI 10.1097/COH.0000000000000040; Gray RR, 2009, AIDS, V23, pF9, DOI 10.1097/QAD.0b013e32832faf61; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Holguin A, 2008, CURR HIV RES, V6, P327, DOI 10.2174/157016208785132455; Hue S, 2014, AIDS, V28, P1967, DOI 10.1097/QAD.0000000000000383; Kanki PJ, 1999, J INFECT DIS, V179, P68, DOI 10.1086/314557; Kouyos RD, 2010, J INFECT DIS, V201, P1488, DOI 10.1086/651951; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Miller M.A., 2010, P GAT COMP ENV WORKS; Parekh B, 1999, AIDS RES HUM RETROV, V15, P133, DOI 10.1089/088922299311556; Galindo JAP, 2015, J CLIN VIROL, V69, P146, DOI 10.1016/j.jcv.2015.06.094; Perez-Parra S, 2015, ENFERM INFECC MICROB; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Taniguchi Y, 2002, AIDS RES HUM RETROV, V18, P79, DOI 10.1089/088922202753394745; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Cuevas MT, 2009, JAIDS-J ACQ IMM DEF, V51, P99, DOI 10.1097/QAI.0b013e318199063e; Thomson MM, 2012, JAIDS-J ACQ IMM DEF, V59, pE49, DOI 10.1097/QAI.0b013e3182400fc4; Tscherning C, 1998, VIROLOGY, V241, P181, DOI 10.1006/viro.1997.8980; vanHarmelen J, 1997, AIDS, V11, P81, DOI 10.1097/00002030-199701000-00012; Vega Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125699; Vidal N, 2005, JAIDS-J ACQ IMM DEF, V40, P456, DOI 10.1097/01.qai.0000159670.18326.94; Yebra G, 2010, ANTIVIR RES, V85, P409, DOI 10.1016/j.antiviral.2009.11.010; Yebra G, 2012, J CLIN MICROBIOL, V50, P407, DOI 10.1128/JCM.05798-11; Yebra G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026757	53	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0186928	10.1371/journal.pone.0186928	http://dx.doi.org/10.1371/journal.pone.0186928			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084239	Green Published, Green Submitted, gold			2022-12-26	WOS:000413910200019
J	Piotrowski, C; Lede, V; Butthof, A; Kaiser, N; Hirrlinger, PG; Tschop, MH; Schoneberg, T; Bechmann, I				Piotrowski, Carolin; Lede, Vera; Butthof, Anne; Kaiser, Nicole; Hirrlinger, Petra G.; Tschoep, Matthias H.; Schoeneberg, Torsten; Bechmann, Ingo			Open housing drives the expression of immune response genes in the nasal mucosa, but not the olfactory bulb	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; VIRUS; ENCEPHALITIS; MENINGITIS; INFECTION; SPREAD; BRAIN; LISTS; MICE	Nasal mucosa and olfactory bulb are separated by the cribriform plate which is perforated by olfactory nerves. We have previously demonstrated that the cribriform plate is permissive for T cells and monocytes and that viruses can enter the bulb upon intranasal injection by axonal transportation. Therefore, we hypothesized that nasal mucosa and olfactory bulb are equipped to deal with constant infectious threats. To detect genes involved in this process, we compared gene expression in nasal mucosa and bulb of mice kept under specific pathogen free (SPF) conditions to gene expression of mice kept on non-SPF conditions using RNA deep sequencing. We found massive alterations in the expression of immune-related genes of the nasal mucosa, while the bulb did not respond immunologically. The absence of induction of immune-related genes in the olfactory bulb suggests effective defence mechanisms hindering entrance of environmental pathogens beyond the outer arachnoid layer. The genes detected in this study may include candidates conferring susceptibility to meningitis.	[Piotrowski, Carolin; Kaiser, Nicole; Bechmann, Ingo] Univ Leipzig, Inst Anat, Fac Med, Leipzig, Germany; [Lede, Vera; Butthof, Anne; Schoeneberg, Torsten] Univ Leipzig, Rudolf Schonheimer Inst Biochem, Fac Med, Leipzig, Germany; [Hirrlinger, Petra G.] Univ Leipzig, Med Expt Ctr, Fac Med, Leipzig, Germany; [Tschoep, Matthias H.] Helmholtz Ctr Environm Hlth, Munich, Germany	Leipzig University; Leipzig University; Leipzig University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Piotrowski, C (corresponding author), Univ Leipzig, Inst Anat, Fac Med, Leipzig, Germany.	carolin.piotrowski@medizin.uni-leipzig.de			Helmholtz Alliance ICEMED; Medical Faculty of the Universitat Leipzig	Helmholtz Alliance ICEMED; Medical Faculty of the Universitat Leipzig	This project was supported by the Helmholtz Alliance ICEMED. CP received a scholarship of the Medical Faculty of the Universitat Leipzig to perform this work.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Beura LK, 2016, NATURE, V532, P512, DOI 10.1038/nature17655; CARTWRIGHT KAV, 1987, EPIDEMIOL INFECT, V99, P591, DOI 10.1017/S0950268800066449; Cupovic J, 2016, IMMUNITY, V44, P622, DOI 10.1016/j.immuni.2015.12.022; Detje CN, 2015, J VIROL, V89, P2731, DOI 10.1128/JVI.02044-14; Detje CN, 2009, J IMMUNOL, V182, P2297, DOI 10.4049/jimmunol.0800596; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Goldmann J, 2006, J LEUKOCYTE BIOL, V80, P797, DOI 10.1189/jlb.0306176; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Johswich KO, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003509; Kaminski M, 2012, J LEUKOCYTE BIOL, V92, P31, DOI 10.1189/jlb.0511241; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LEWANDOWSKI G, 1994, J NEUROIMMUNOL, V55, P23, DOI 10.1016/0165-5728(94)90143-0; McIntyre PB, 2012, LANCET, V380, P1703, DOI 10.1016/S0140-6736(12)61187-8; Mueller JE, 2010, INT J INFECT DIS, V14, pE553, DOI 10.1016/j.ijid.2009.08.013; Parra B, 1999, J IMMUNOL, V162, P1641; Perez-Pouchoulen M, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0036-15.2015; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reese TA, 2016, CELL HOST MICROBE, V19, P713, DOI 10.1016/j.chom.2016.04.003; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider MC, 2007, TRENDS MICROBIOL, V15, P233, DOI 10.1016/j.tim.2007.03.005; Sergerie Y, 2007, J INFECT DIS, V196, P853, DOI 10.1086/520094; SHANKAR V, 1992, J VIROL, V66, P992, DOI 10.1128/JVI.66.2.992-998.1992	24	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187192	10.1371/journal.pone.0187192	http://dx.doi.org/10.1371/journal.pone.0187192			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077773	Green Published, Green Submitted, gold			2022-12-26	WOS:000413861200051
J	Kashyap, S; Warner, G; Hu, Z; Gao, F; Osman, M; Al Saiegh, Y; Lien, KR; Nath, K; Grande, JP				Kashyap, Sonu; Warner, Gina; Hu, Zeng; Gao, Feng; Osman, Mazen; Al Saiegh, Yousif; Lien, Karen R.; Nath, Karl; Grande, Joseph P.			Cardiovascular phenotype in Smad3 deficient mice with renovascular hypertension	PLOS ONE			English	Article							ABDOMINAL AORTIC-ANEURYSMS; RENAL-ARTERY STENOSIS; UNILATERAL URETERAL OBSTRUCTION; TARGETED DISRUPTION; GENETIC DEFICIENCY; FIBROSIS; GROWTH; INFLAMMATION; PROTECTS; INJURY	Renovascular hypertension (RVH) has deleterious effects on both the kidney and the heart. TGF-beta signaling through Smad3 directs tissue fibrosis in chronic injury models. In the 2-kidney 1-clip (2K1C) model of RVH, employing mice on the 129 genetic background, Smad3 deficiency (KO) protects the stenotic kidney (STK) from development of interstitial fibrosis. However, these mice have an increased incidence of sudden cardiac death following 2K1C surgery. The purpose of this study was to characterize the cardiovascular phenotype of these mice. Renal artery stenosis (RAS) was established in Wild-type (WT) and Smad3 KO mice (129 genetic background) by placement of a polytetrafluoroethylene cuff on the right renal artery. Mortality was 25.5% for KO mice with RAS, 4.1% for KO sham mice, 1.2% for WT with RAS, and 1.8% for WT sham mice. Myocardial tissue of mice studied at 3 days following surgery showed extensive myocyte necrosis in KO but not WT mice. Myocyte necrosis was associated with a rapid induction of Ccl2 expression, macrophage influx, and increased MMP-9 activity. At later time points, both KO and WT mice developed myocardial fibrosis. No aortic aneurysms or dissections were observed at any time point. Smad3 KO mice were backcrossed to the C57BL/6J strain and subjected to RAS. Sudden death was observed at 10-14 days following surgery in 62.5% of mice; necropsy revealed aortic dissections as the cause of death. As observed in the 129 mice, the STK of Smad3 KO mice on the C57BL/6J background did not develop significant chronic renal damage. We conclude that the cardiovascular manifestations of Smad3 deficient mice are strain-specific, with myocyte necrosis in 129 mice and aortic rupture in C57BL/6J mice. Future studies will define mechanisms underlying this strain-specific effect on the cardiovascular system.	[Kashyap, Sonu; Hu, Zeng; Osman, Mazen; Lien, Karen R.; Grande, Joseph P.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Warner, Gina] Mayo Clin, Dept Anesthesiol, Kogod Aging Ctr, Rochester, MN USA; [Gao, Feng] UT Southwestern Med Sch, Dallas, TX USA; [Al Saiegh, Yousif] Hannover Med Sch, Hannover, Germany; [Nath, Karl; Grande, Joseph P.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; University of Texas System; University of Texas Southwestern Medical Center Dallas; Hannover Medical School; Mayo Clinic	Grande, JP (corresponding author), Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA.; Grande, JP (corresponding author), Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55905 USA.	granda.joseph@mayo.edu	Grande, Joseph P./AAG-2128-2020	Grande, Joseph P./0000-0001-5674-1682	NIH/NIAID [R01 AI100911-01]; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, USA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R25DK101405] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, USA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by NIH/NIAID R01 AI100911-01 (https://projectreporter.nih.gov/project_info_description.cfm?aid=9215631&icde=35145736&ddparam=&ddvalue=&ddsub=&cr=1&csb=default&cs=ASC&pball=) and in part by the Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, USA. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biernacka A, 2015, CIRC-HEART FAIL, V8, P788, DOI 10.1161/CIRCHEARTFAILURE.114.001963; Cardin S, 2014, HYPERTENSION, V64, P1040, DOI 10.1161/HYPERTENSIONAHA.114.04067; Cassis LA, 2009, AM J PHYSIOL-HEART C, V296, pH1660, DOI 10.1152/ajpheart.00028.2009; Chen HJ, 2003, AM J PHYSIOL-HEART C, V284, pH1612, DOI 10.1152/ajpheart.00992.2002; Cheng J., 2009, J ORGAN DYSFUNCTION, V5, P182; Cheng JF, 2002, EXP BIOL MED, V227, P943, DOI 10.1177/153537020222701102; Cheng JF, 2009, AM J PHYSIOL-RENAL, V297, pF1055, DOI 10.1152/ajprenal.90439.2008; Cooper CJ, 2014, NEW ENGL J MED, V370, P13, DOI 10.1056/NEJMoa1310753; Daugherty A, 2004, ARTERIOSCL THROM VAS, V24, P429, DOI 10.1161/01.ATV.0000118013.72016.ea; Derynck R, 1998, CELL, V95, P737, DOI 10.1016/S0092-8674(00)81696-7; Divakaran V, 2009, CIRC-HEART FAIL, V2, P633, DOI 10.1161/CIRCHEARTFAILURE.108.823070; Feinberg MW, 2004, CIRC RES, V94, P601, DOI 10.1161/01.RES.0000119170.70818.4F; Flanders KC, 2004, INT J EXP PATHOL, V85, P47, DOI 10.1111/j.0959-9673.2004.00377.x; Fujimoto M, 2003, BIOCHEM BIOPH RES CO, V305, P1002, DOI 10.1016/S0006-291X(03)00885-4; Grande JP, 2002, EXP BIOL MED, V227, P171, DOI 10.1177/153537020222700304; Huang XR, 2010, HYPERTENSION, V55, P1165, DOI 10.1161/HYPERTENSIONAHA.109.147611; Inazaki K, 2004, KIDNEY INT, V66, P597, DOI 10.1111/j.1523-1755.2004.00779.x; Kalra PA, 2010, KIDNEY INT, V77, P37, DOI 10.1038/ki.2009.406; Kashyap S, 2016, AM J PHYSIOL-RENAL, V310, pF372, DOI 10.1152/ajprenal.00131.2015; Keddis MT, 2010, NEPHROL DIAL TRANSPL, V25, P3615, DOI 10.1093/ndt/gfq269; Kobayashi K, 2005, CIRC RES, V96, P904, DOI 10.1161/01.RES.0000163980.55495.44; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Lucas JA, 2010, AM J PHYSIOL-HEART C, V298, pH424, DOI 10.1152/ajpheart.00529.2009; Nath KA, 2011, AM J PHYSIOL-RENAL, V301, pF436, DOI 10.1152/ajprenal.00162.2011; Police SB, 2009, ARTERIOSCL THROM VAS, V29, P1458, DOI 10.1161/ATVBAHA.109.192658; Pyo R, 2000, J CLIN INVEST, V105, P1641, DOI 10.1172/JCI8931; Rateri DL, 2014, AM J PATHOL, V184, P2586, DOI 10.1016/j.ajpath.2014.05.014; Regalado ES, 2011, CIRC RES, V109, P680, DOI 10.1161/CIRCRESAHA.111.248161; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Tan CK, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000269; Verrecchia F, 2002, J INVEST DERMATOL, V118, P211, DOI 10.1046/j.1523-1747.2002.01641.x; Warner GM, 2012, AM J PHYSIOL-RENAL, V302, pF1455, DOI 10.1152/ajprenal.00645.2011; Weber-Mzell D, 2002, EUR HEART J, V23, P1684, DOI 10.1053/euhj.2002.3314; Yuan WH, 2001, J BIOL CHEM, V276, P38502, DOI 10.1074/jbc.M107081200	34	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187062	10.1371/journal.pone.0187062	http://dx.doi.org/10.1371/journal.pone.0187062			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073282	gold, Green Submitted, Green Published			2022-12-26	WOS:000413845400106
J	Andressen, KW; Ulsund, AH; Krobert, KA; Lohse, MJ; Bunemann, M; Levy, FO				Andressen, Kjetil Wessel; Ulsund, Andrea Hembre; Krobert, Kurt A.; Lohse, Martin J.; Buenemann, Moritz; Levy, Finn Olav			Related GPCRs couple differently to G(s): preassociation between G protein and 5-HT7 serotonin receptor reveals movement of Gas upon receptor activation	FASEB JOURNAL			English	Article						Gnas; precoupling; collision coupling; FRET; FRAP	HETEROTRIMERIC G-PROTEINS; ADRENERGIC-RECEPTOR; ADENYLATE-CYCLASE; SPLICE VARIANTS; ASSOCIATION; PHARMACOLOGY; DYNAMICS; CELL	How GPCRs and G proteins interact is important for their biologic functions and their functions as pharmacologic targets. It is still an open question whether receptors and G proteins are preassembled in a complex or interact only after receptor activation. We compared the propensity of the two G(s)-coupled serotonin (5-HT) receptors 5-HT4 and 5-HT7 to associate with G protein prior to agonist activation. Combining receptor-immobilized fluorescence recovery after photobleaching and fluorescence resonance energy transfer methodologies, we observed that 5-HT7 receptors markedly reduced the diffusion of both G alpha and G beta gamma at the cell surface, which indicated 5-HT7 receptor preassociation with G(s). This is in sharp contrast to the 5-HT4 receptor for which the diffusion of Ga beta gamma was not modified, and agonist activation brought together the receptor and G gamma, which is consistent with interaction by collision coupling. Agonist activation of 5-HT7 dissociated G gamma from the receptor, whereas Gas underwent a rapid conformational change with respect to both G gamma and the receptor, followed by a slower dissociation of G gamma from both G alpha(s) and the receptor. Taken together, these data demonstrate a different propensity among receptors to preassociate with G protein in the absence of ligand and reveals a rapid conformational change in G alpha(s) upon activation by the receptor.	[Andressen, Kjetil Wessel; Ulsund, Andrea Hembre; Krobert, Kurt A.; Levy, Finn Olav] Univ Oslo, Dept Pharmacol, Inst Clin Med, Oslo, Norway; [Andressen, Kjetil Wessel; Ulsund, Andrea Hembre; Krobert, Kurt A.; Levy, Finn Olav] Univ Oslo, Ctr Heart Failure Res, Fac Med, Oslo, Norway; [Andressen, Kjetil Wessel; Ulsund, Andrea Hembre; Krobert, Kurt A.; Levy, Finn Olav] Oslo Univ Hosp, Oslo, Norway; [Lohse, Martin J.] Univ Wurzburg, Inst Pharmacol & Toxicol, Wurzburg, Germany; [Lohse, Martin J.] Univ Wurzburg, Rudolf Virchow Ctr, Wurzburg, Germany; [Buenemann, Moritz] Univ Wurzburg, Comprehens Heart Failure Ctr, Wurzburg, Germany; [Lohse, Martin J.] Max Delbruck Ctr, Berlin, Germany; [Buenemann, Moritz] Philipps Univ Marburg, Inst Pharmacol & Clin Pharm, Marburg, Germany	University of Oslo; University of Oslo; University of Oslo; University of Wurzburg; University of Wurzburg; University of Wurzburg; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Philipps University Marburg	Levy, FO (corresponding author), Univ Oslo, Dept Pharmacol, Fac Med, Sognsvannsveien 20,POB 1057, N-0316 Oslo, Norway.	f.o.levy@medisin.uio.no	Lohse, Martin J/A-7160-2012	Lohse, Martin J/0000-0002-0599-3510; Andressen, Kjetil Wessel/0000-0003-1094-1501	Norwegian Council on Cardiovascular Diseases; Research Council of Norway; Kristian Gerhard Jebsen Foundation; Norwegian Cancer Society; Anders Jahre Foundation for the Promotion of Science; Novo Nordisk Foundation; Family Blix Foundation; University of Oslo; Deutsche Forschungsgemeinschaft [SFB487, TR166, 593]; European Research Council Advanced grant "Topas"; Bundesministerium fur Bildung und Forschung grant "OptiMAR"; COST Action CM1207 (GLISTEN)	Norwegian Council on Cardiovascular Diseases; Research Council of Norway(Research Council of Norway); Kristian Gerhard Jebsen Foundation; Norwegian Cancer Society(Norwegian Cancer Society); Anders Jahre Foundation for the Promotion of Science; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Family Blix Foundation; University of Oslo; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council Advanced grant "Topas"; Bundesministerium fur Bildung und Forschung grant "OptiMAR"(Federal Ministry of Education & Research (BMBF)); COST Action CM1207 (GLISTEN)(European Cooperation in Science and Technology (COST))	The authors thank C. H. Berlot for providing the G alpha<INF>s</INF>-CFP plasmid (20) and N. A. Lambert for providing the G beta gamma-Venus plasmid (21). This work was supported by the Norwegian Council on Cardiovascular Diseases, the Research Council of Norway, the Kristian Gerhard Jebsen Foundation, the Norwegian Cancer Society, the Anders Jahre Foundation for the Promotion of Science, the Novo Nordisk Foundation, the Family Blix Foundation, grants from the University of Oslo, Deutsche Forschungsgemeinschaft (Grants SFB487, 593, and TR166), the European Research Council Advanced grant "Topas," and the Bundesministerium fur Bildung und Forschung grant "OptiMAR" and the COST Action CM1207 (GLISTEN; http://www.glisten-gpcr.eu). The authors declare no conflicts of interest.	Andressen KW, 2015, BRIT J PHARMACOL, V172, P3846, DOI 10.1111/bph.13169; Andressen KW, 2006, MOL PHARMACOL, V69, P207, DOI 10.1124/mol.105.015396; Ayoub MA, 2010, FASEB J, V24, P3522, DOI 10.1096/fj.10-154997; Azpiazu I, 2004, J BIOL CHEM, V279, P27709, DOI 10.1074/jbc.M403712200; Bach T, 2001, N-S ARCH PHARMACOL, V363, P146, DOI 10.1007/s002100000299; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Bockaert J, 2004, CNS NEUROL DISORD-DR, V3, P39, DOI 10.2174/1568007043482615; Bruheim S, 2003, RECEPTOR CHANNEL, V9, P107, DOI 10.1080/10606820308245; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; Damian M, 2015, P NATL ACAD SCI USA, V112, P1601, DOI 10.1073/pnas.1414618112; Dorsch S, 2009, NAT METHODS, V6, P225, DOI [10.1038/NMETH.1304, 10.1038/nmeth.1304]; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; Hynes TR, 2004, J BIOL CHEM, V279, P44101, DOI 10.1074/jbc.M405151200; Kilander MBC, 2014, FASEB J, V28, P2293, DOI 10.1096/fj.13-246363; Krobert KA, 2001, N-S ARCH PHARMACOL, V363, P620, DOI 10.1007/s002100000369; Krobert KA, 2002, BRIT J PHARMACOL, V135, P1563, DOI 10.1038/sj.bjp.0704588; Kvachnina E, 2005, J NEUROSCI, V25, P7821, DOI 10.1523/JNEUROSCI.1790-05.2005; Lohse MJ, 2015, MOL PHARMACOL, V88, P572, DOI 10.1124/mol.115.100248; Matthys A, 2011, MOL NEUROBIOL, V43, P228, DOI 10.1007/s12035-011-8175-3; Nobles M, 2005, P NATL ACAD SCI USA, V102, P18706, DOI 10.1073/pnas.0504778102; ORLY J, 1976, P NATL ACAD SCI USA, V73, P4410, DOI 10.1073/pnas.73.12.4410; Piscitelli CL, 2015, MOL PHARMACOL, V88, P536, DOI 10.1124/mol.115.099663; Qin K, 2008, FASEB J, V22, P2920, DOI 10.1096/fj.08-105775; Qin K, 2011, NAT CHEM BIOL, V7, P740, DOI [10.1038/nchembio.642, 10.1038/NCHEMBIO.642]; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Roka F, 1999, MOL PHARMACOL, V56, P1014, DOI 10.1124/mol.56.5.1014; SKOMEDAL T, 1980, ACTA PHARMACOL TOX, V46, P200; TOLKOVSKY AM, 1978, BIOCHEMISTRY-US, V17, P3795, DOI 10.1021/bi00611a020; Vasquez C, 1999, J NEUROSCI, V19, P9271	33	16	16	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					1059	1069		10.1096/fj.201700486R	http://dx.doi.org/10.1096/fj.201700486R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29079700	Green Submitted, Bronze			2022-12-26	WOS:000425146900044
J	Nitani, A; Muta, H; Adachi, M; So, M; Sasahara, K; Sakurai, K; Chatani, E; Naoe, K; Ogi, H; Hall, D; Goto, Y				Nitani, Ayame; Muta, Hiroya; Adachi, Masayuki; So, Masatomo; Sasahara, Kenji; Sakurai, Kazumasa; Chatani, Eri; Naoe, Kazumitsu; Ogi, Hirotsugu; Hall, Damien; Goto, Yuji			Heparin-dependent aggregation of hen egg white lysozyme reveals two distinct mechanisms of amyloid fibrillation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; fluorescence; protein aggregation; protein crystallization; protein misfolding	PROTEIN AGGREGATION; CONFORMATIONAL STATES; CRYSTAL NUCLEATION; PHASE-DIAGRAM; NEUTRAL PH; SUPERSATURATION; FIBRILS; GLYCOSAMINOGLYCANS; CRYSTALLIZATION; SCRAPIE	Heparin, a biopolymer possessing high negative charge density, is known to accelerate amyloid fibrillation by various proteins. Using hen egg white lysozyme, we studied the effects of heparin on protein aggregation at low pH, raised temperature, and applied ultrasonic irradiation, conditions under which amyloid fibrillation was promoted. Heparin exhibited complex bimodal concentration-dependent effects, either accelerating or inhibiting fibrillation at pH 2.0 and 60 degrees C. At concentrations lower than 20 g/ml, heparin accelerated fibrillation through transient formation of hetero-oligomeric aggregates. Between 0.1 and 10 mg/ml, heparin rapidly induced amorphous heteroaggregation with little to no accompanying fibril formation. Above 10 mg/ml, heparin again induced fibrillation after a long lag time preceded by oligomeric aggregate formation. Compared with studies performed using monovalent and divalent anions, the results suggest two distinct mechanisms of heparin-induced fibrillation. At low heparin concentrations, initial hen egg white lysozyme cluster formation and subsequent fibrillation is promoted by counter ion binding and screening of repulsive charges. At high heparin concentrations, fibrillation is caused by a combination of salting out and macromolecular crowding effects probably independent of protein net charge. Both fibrillation mechanisms compete against amorphous aggregation, producing a complex heparin concentration-dependent phase diagram. Moreover, the results suggest an active role for amorphous oligomeric aggregates in triggering fibrillation, whereby breakdown of supersaturation takes place through heterogeneous nucleation of amyloid on amorphous aggregates.	[Nitani, Ayame; Muta, Hiroya; Adachi, Masayuki; So, Masatomo; Sasahara, Kenji; Hall, Damien; Goto, Yuji] Osaka Univ, Inst Prot Res, Yamadaoka 3-2, Suita, Osaka 5650871, Japan; [Sakurai, Kazumasa] Kindai Univ, Inst Adv Technol, 930 Nishimitani, Kinokawa, Wakayama 6496493, Japan; [Chatani, Eri] Kobe Univ, Grad Sch Sci, Dept Chem, Kobe, Hyogo 6578501, Japan; [Naoe, Kazumitsu] Nara Coll, Natl Inst Technol, Nara 6391080, Japan; [Ogi, Hirotsugu] Grad Sch Engn, Suita, Osaka 5650871, Japan; [Hall, Damien] Australian Natl Univ, Res Sch Chem, Acton, ACT 2601, Australia	Osaka University; Kobe University; Australian National University	Goto, Y (corresponding author), Osaka Univ, Inst Prot Res, Yamadaoka 3-2, Suita, Osaka 5650871, Japan.	gtyj8126@protein.osaka-u.ac.jp	Hall, Damien/AGY-5341-2022; Hall, Damien/D-9927-2012	Hall, Damien/0000-0003-1538-7618; Hall, Damien/0000-0003-1538-7618; Goto, Yuji/0000-0003-1221-1270; So, Masatomo/0000-0002-4815-4995; NAOE, Kazumitsu/0000-0002-3892-7018	Cooperative Research Program for the Institute for Protein, Osaka University [ICR-15-02, CR-16-02, VFCR-16-04]; JSPS [15H04362, 15K14458, 15K07038, 16H00836, 17K07363, 17H06352]; SENTAN from Japan Agency for Medical Research and Development (AMED); Grants-in-Aid for Scientific Research [17K07363, 17H06352] Funding Source: KAKEN	Cooperative Research Program for the Institute for Protein, Osaka University; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); SENTAN from Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was performed under the Cooperative Research Program for the Institute for Protein, Osaka University, ICR-15-02, CR-16-02, and VFCR-16-04 and was supported by JSPS KAKENHI Grants 15H04362, 15K14458, 15K07038, 16H00836, 17K07363, and 17H06352 and by the SENTAN from Japan Agency for Medical Research and Development (AMED). The authors declare that they have no conflicts of interest with the contents of this article.	Adachi M, 2015, J BIOL CHEM, V290, P18134, DOI 10.1074/jbc.M115.648139; Auer S, 2007, HFSP J, V1, P137, DOI 10.2976/1.2760023; Bazar E, 2011, CHEMBIOCHEM, V12, P761, DOI 10.1002/cbic.201000486; Bazar E, 2010, CHEMBIOCHEM, V11, P1997, DOI 10.1002/cbic.201000207; Bemporad F, 2012, CHEM BIOL, V19, P315, DOI 10.1016/j.chembiol.2012.02.003; Bergfors T, 2003, J STRUCT BIOL, V142, P66, DOI 10.1016/S1047-8477(03)00039-X; Blancas-Mejia LM, 2015, J BIOL CHEM, V290, P4953, DOI 10.1074/jbc.M114.615401; Bravo R, 2008, J BIOL CHEM, V283, P32471, DOI 10.1074/jbc.M709870200; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; COLLINS KD, 1985, Q REV BIOPHYS, V18, P323, DOI 10.1017/S0033583500005369; Coquerel G, 2014, CHEM SOC REV, V43, P2286, DOI 10.1039/c3cs60359h; Crespo R, 2010, J APPL CRYSTALLOGR, V43, P1419, DOI 10.1107/S0021889810040951; Doig AJ, 2015, CURR OPIN STRUC BIOL, V30, P50, DOI 10.1016/j.sbi.2014.12.004; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; GOTO Y, 1990, BIOCHEMISTRY-US, V29, P3480, DOI 10.1021/bi00466a009; GOTO Y, 1990, P NATL ACAD SCI USA, V87, P573, DOI 10.1073/pnas.87.2.573; GOTO Y, 1989, BIOCHEMISTRY-US, V28, P945, DOI 10.1021/bi00429a004; GOTO Y, 1990, J MOL BIOL, V214, P803, DOI 10.1016/0022-2836(90)90334-I; GOTO Y, 1991, J MOL BIOL, V218, P387, DOI 10.1016/0022-2836(91)90720-Q; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; HAGIHARA Y, 1993, J MOL BIOL, V231, P180, DOI 10.1006/jmbi.1993.1272; Hall D, 2003, BBA-PROTEINS PROTEOM, V1649, P127, DOI 10.1016/S1570-9639(03)00167-5; Hall D, 2016, ANAL BIOCHEM, V498, P78, DOI 10.1016/j.ab.2015.11.021; Hall D, 2015, FEBS LETT, V589, P672, DOI 10.1016/j.febslet.2015.01.032; Hall D, 2009, BIOPHYS CHEM, V145, P17, DOI 10.1016/j.bpc.2009.08.004; Harano K, 2012, NAT MATER, V11, P877, DOI [10.1038/NMAT3408, 10.1038/nmat3408]; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; LANSBURY PT, 1995, CHEM BIOL, V2, P1, DOI 10.1016/1074-5521(95)90074-8; Levin A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6219; Lin YX, 2014, LANGMUIR, V30, P1845, DOI 10.1021/la403100h; Matsushita Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep17647; Miti T, 2015, BIOMACROMOLECULES, V16, P326, DOI 10.1021/bm501521r; Motamedi-Shad N, 2009, J BIOL CHEM, V284, P29921, DOI 10.1074/jbc.M109.018747; Myers SL, 2006, BIOCHEMISTRY-US, V45, P2311, DOI 10.1021/bi052434i; Nakajima K, 2016, SCI REP-UK, V6, DOI 10.1038/srep22015; Noborn F, 2011, P NATL ACAD SCI USA, V108, P5584, DOI 10.1073/pnas.1101194108; Raman B, 2005, BIOCHEMISTRY-US, V44, P1288, DOI 10.1021/bi048029t; Sipe JD, 2014, AMYLOID, V21, P221, DOI 10.3109/13506129.2014.964858; So M, 2017, PROTEIN SCI, V26, P1024, DOI 10.1002/pro.3149; So M, 2016, CURR OPIN STRUC BIOL, V36, P32, DOI 10.1016/j.sbi.2015.11.009; So M, 2015, LANGMUIR, V31, P9973, DOI 10.1021/acs.langmuir.5b02186; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Tycko R, 2013, ACCOUNTS CHEM RES, V46, P1487, DOI 10.1021/ar300282r; Umemoto A, 2014, J BIOL CHEM, V289, P27290, DOI 10.1074/jbc.M114.569814; Vekilov PG, 2012, NAT MATER, V11, P838, DOI 10.1038/nmat3441; Wallace AF, 2013, SCIENCE, V341, P885, DOI 10.1126/science.1230915; WASHABAUGH MW, 1986, J BIOL CHEM, V261, P2477; Wetzel R, 2006, ACCOUNTS CHEM RES, V39, P671, DOI 10.1021/ar050069h; Yagi H, 2015, BBA-PROTEINS PROTEOM, V1854, P209, DOI 10.1016/j.bbapap.2014.12.014; Yamamoto S, 2004, J AM SOC NEPHROL, V15, P126, DOI 10.1097/01.ASN.0000103228.81623.C7; Yamazaki T, 2017, P NATL ACAD SCI USA, V114, P2154, DOI 10.1073/pnas.1606948114; Yoshimura Y, 2012, P NATL ACAD SCI USA, V109, P14446, DOI 10.1073/pnas.1208228109; Zhao Ran, 2016, Biophys Rev, V8, P445, DOI 10.1007/s12551-016-0233-7	53	23	23	1	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21219	21230		10.1074/jbc.M117.813097	http://dx.doi.org/10.1074/jbc.M117.813097			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29101231	Green Published, hybrid			2022-12-26	WOS:000419013000001
J	Li, DD; Nan, HW; Liang, J; Cheng, XY; Zhao, CZ; Yin, HJ; Yin, CY; Liu, Q				Li, Dandan; Nan, Hongwei; Liang, Jin; Cheng, Xinying; Zhao, ChunZhang; Yin, HuaJun; Yin, ChunYing; Liu, Qing			Responses of nutrient capture and fine root morphology of subalpine coniferous tree Picea asperata to nutrient heterogeneity and competition	PLOS ONE			English	Article							BRANCH ORDER; INTERSPECIFIC COMPETITION; TEMPERATE; CARBON; PLANTS; PLASTICITY; DIVERSITY; PATTERNS; NITROGEN; YIELD	Investigating the responses of trees to the heterogeneous distribution of nutrients in soil and simultaneous presence of neighboring roots could strengthen the understanding of an influential mechanism on tree growth and provide a scientific basis for forest management. Here, we conducted two split-pot experiments to investigate the effects of nutrient heterogeneity and intraspecific competition on the fine root morphology and nutrient capture of Picea asperata. The results showed that P. asperata efficiently captured nutrients by increasing the specific root length (SRL) and specific root area (SRA) of first-and second-order roots and decreasing the tissue density of first-order roots to avoid competition for resources and space with neighboring roots. The nutrient heterogeneity and addition of fertilization did not affect the fine root morphology, but enhanced the P and K concentrations in the fine roots in the absence of a competitor. On the interaction between nutrient heterogeneity and competition, competition decreased the SRL and SRA but enhanced the capture of K under heterogeneous soil compared with under homogeneous soil. Additionally, the P concentration, but not the K concentration, was linearly correlated to root morphology in heterogeneous soil, even when competition was present. The results suggested that root morphological features were only stimulated when the soil nutrients were insufficient for plant growth and the nutrients accumulations by root were mainly affected by the soil nutrients more than the root morphology.	[Li, Dandan; Liang, Jin; Cheng, Xinying; Zhao, ChunZhang; Yin, HuaJun; Yin, ChunYing; Liu, Qing] Chinese Acad Sci, Chengdu Inst Biol, Key Lab Mt Ecol Restorat & Bioresource Utilizat, Chengdu, Sichuan, Peoples R China; [Li, Dandan; Liang, Jin; Cheng, Xinying; Zhao, ChunZhang; Yin, HuaJun; Yin, ChunYing; Liu, Qing] Chinese Acad Sci, Chengdu Inst Biol, Ecol Restorat Biodivers Conservat Key Lab Sichuan, Chengdu, Sichuan, Peoples R China; [Nan, Hongwei] Shanxi Agr Univ, Coll Forestry, Jinzhong, Peoples R China	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Shanxi Agricultural University	Li, DD; Liu, Q (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Key Lab Mt Ecol Restorat & Bioresource Utilizat, Chengdu, Sichuan, Peoples R China.; Li, DD; Liu, Q (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Ecol Restorat Biodivers Conservat Key Lab Sichuan, Chengdu, Sichuan, Peoples R China.	ddli1984@hotmail.com; liuqing@cib.ac.cn		Li, Dandan/0000-0003-4513-8903	National Key R&D Program of China [2017YFC0505002]; National Natural Science Foundation of China [31400424, 31570477, 31370495]; West Light Foundation of the Chinese Academy of Sciences [Y4C2021]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); West Light Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported jointly by the National Key R&D Program of China (2017YFC0505002 to DL), the National Natural Science Foundation of China (31400424 to DL, 31570477 to CZ, 31370495 to CY) and West Light Foundation of the Chinese Academy of Sciences (Y4C2021 to DL). study design: DL data collection: DL CY data analysis: DL, HY, CZ decision to publish: DL preparation of the manuscript: DL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnon, 1950, WATER CULTURE METHOD, V347, DOI DOI 10.1073/PNAS.1211132109; Barber S. A., 1995, SOIL NUTR BIOAVAILAB, P414; Baribault TW, 2011, J ECOL, V99, P1358, DOI 10.1111/j.1365-2745.2011.01862.x; Bolte A, 2006, EUR J FOREST RES, V125, P15, DOI 10.1007/s10342-005-0075-5; Cahill JF, 2010, SCIENCE, V328, P1657, DOI 10.1126/science.1189736; Caldwell M.M., 1994, EXPLOITATION ENV HET; Caldwell MM, 1991, FUNCT ECOL, V5, P756; Coomes DA, 2009, J ECOL, V97, P705, DOI 10.1111/j.1365-2745.2009.01507.x; Day KJ, 2003, FUNCT ECOL, V17, P454, DOI 10.1046/j.1365-2435.2003.00758.x; Duan BL, 2014, FOREST ECOL MANAG, V323, P20, DOI 10.1016/j.foreco.2014.03.036; Fransen B, 2001, ECOLOGY, V82, P2534, DOI 10.1890/0012-9658(2001)082[2534:SNHACB]2.0.CO;2; Fransen B, 1998, OECOLOGIA, V115, P351, DOI 10.1007/s004420050527; Garcia-Palacios P, 2012, J ECOL, V100, P1303, DOI 10.1111/j.1365-2745.2012.02014.x; Grams TEE, 2002, PLANT BIOLOGY, V4, P153, DOI 10.1055/s-2002-25729; Guo DL, 2008, NEW PHYTOL, V180, P673, DOI 10.1111/j.1469-8137.2008.02573.x; Guo DL, 2008, NEW PHYTOL, V177, P443, DOI 10.1111/j.1469-8137.2007.02242.x; Guo DL, 2004, OECOLOGIA, V140, P450, DOI 10.1007/s00442-004-1596-1; Hodge A, 2004, NEW PHYTOL, V162, P9, DOI 10.1111/j.1469-8137.2004.01015.x; Hutchings M. J., 2000, ECOLOGICAL CONSEQUEN; HUTCHINGS MJ, 1994, ADV ECOL RES, V25, P159, DOI 10.1016/S0065-2504(08)60215-9; JACKSON RB, 1993, ECOLOGY, V74, P612, DOI 10.2307/1939320; Janecek S, 2004, FLORA, V199, P3, DOI 10.1078/0367-2530-00127; Lamb EG, 2004, FUNCT ECOL, V18, P836, DOI 10.1111/j.0269-8463.2004.00893.x; Li A, 2010, FUNCT ECOL, V24, P224, DOI 10.1111/j.1365-2435.2009.01603.x; Li JW, 2008, ECOLOGY, V89, P2911, DOI 10.1890/07-1381.1; McNickle GG, 2009, TRENDS ECOL EVOL, V24, P419, DOI 10.1016/j.tree.2009.03.004; Messier C, 2009, J ECOL, V97, P548, DOI 10.1111/j.1365-2745.2009.01500.x; Mommer L, 2012, FUNCT ECOL, V26, P66, DOI 10.1111/j.1365-2435.2011.01916.x; Mommer L, 2011, PLANT SOIL, V344, P347, DOI 10.1007/s11104-011-0752-8; Mommer L, 2010, J ECOL, V98, P1117, DOI 10.1111/j.1365-2745.2010.01702.x; Nan HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065650; NEWMAN EI, 1973, NATURE, V244, P310, DOI 10.1038/244310a0; Pregitzer KS, 2002, ECOL MONOGR, V72, P293, DOI 10.1890/0012-9615(2002)072[0293:FRAONN]2.0.CO;2; Pregitzer KS, 1997, OECOLOGIA, V111, P302, DOI 10.1007/s004420050239; Richard M, 2000, ECOGRAPHY, V23, P231, DOI 10.1111/j.1600-0587.2000.tb00279.x; Robinson D, 1999, P ROY SOC LONDON, P266; Stein A, 1997, SOIL SCI SOC AM J, V61, P861, DOI 10.2136/sssaj1997.03615995006100030021x; TILMAN D, 1988; Visser EJW, 2003, ECOLOGICAL STUDIES; Yin CY, 2014, PLANT SOIL, V380, P249, DOI 10.1007/s11104-014-2090-0	40	8	10	6	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187496	10.1371/journal.pone.0187496	http://dx.doi.org/10.1371/journal.pone.0187496			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095947	gold, Green Published, Green Submitted			2022-12-26	WOS:000414340200103
J	Smage, SB; Brevik, OJ; Frisch, K; Watanabe, K; Duesund, H; Nylund, A				Smage, Sverre Bang; Brevik, Oyvind Jakobsen; Frisch, Kathleen; Watanabe, Kuninori; Duesund, Henrik; Nylund, Are			Concurrent jellyfish blooms and tenacibaculosis outbreaks in Northern Norwegian Atlantic salmon (Salmo salar)farms	PLOS ONE			English	Article							SEA LICE; SP-NOV; FLEXIBACTER; FLAVOBACTERIA; COLONIZATION; MICROBIOME; PATHOGEN; DISEASE	Tenacibaculosis is an increasing problem in the Norwegian Atlantic salmon aquaculture industry causing significant economic losses. In September 2015, two separate outbreaks of suspected tenacibaculosis occurred at two Atlantic salmon farms in Finnmark County in Northern Norway. The events resulted in major losses of smolts newly transferred into sea-water. Prior to, and during the outbreaks, large numbers of small jellyfish, identified as Dipleurosoma typicum (Boeck) were observed in the vicinity of the farms and inside the net-pens. This study investigates the possible link between the jellyfish, Tenacibaculum spp. and the tenacibaculosis outbreaks. Bacteriology, histology, scanning and transmission electron microscopy, and real-time RT-PCR screening were performed on both fish and jellyfish samples. Based on the findings, Tenacibaculum finnmarkense was found to be the dominant bacteria associated with the tenacibaculosis outbreaks at both sites and that D. typicum is unlikely to be a vector for this fish pathogenic bacterium. However, results do show that the jellyfish caused direct damage to the fish's skin and may have exacerbated the bacterial infection by allowing an entry point for bacteria.	[Smage, Sverre Bang; Brevik, Oyvind Jakobsen; Frisch, Kathleen; Duesund, Henrik] Cermaq Grp AS, Dronning Eufemiasgate 16, Oslo, Norway; [Smage, Sverre Bang; Brevik, Oyvind Jakobsen; Frisch, Kathleen; Watanabe, Kuninori; Nylund, Are] Univ Bergen, Dept Biol, Fish Dis Res Grp, Thormohlensgate 55, Bergen, Norway	University of Bergen	Smage, SB (corresponding author), Cermaq Grp AS, Dronning Eufemiasgate 16, Oslo, Norway.; Smage, SB (corresponding author), Univ Bergen, Dept Biol, Fish Dis Res Grp, Thormohlensgate 55, Bergen, Norway.	sverre.smage@cermaq.com			Research Council of Norway (Norges Forskningsrad) [241364]; Cermaq Norway; Cermaq Group AS	Research Council of Norway (Norges Forskningsrad)(Research Council of Norway); Cermaq Norway; Cermaq Group AS	The study was partially funded by the Research Council of Norway (Norges Forskningsrad) (Project number 241364, https://www.forskningsradet.no/prosjektbanken/#!/project/241364/no). This study was also partially funded by Cermaq Norway (www.Cermaq.no). Neither of these funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Cermaq Group AS received this funding. Cermaq Group AS provided support in the form of salaries for authors [SS, KF, OB, HD], and also played a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. Two of the authors [KW, AN] are employed by the University of Bergen (UiB); however UiB had no role in study design, data collection or decision to publish. The specific roles of these authors are articulated in the 'author contributions' section.	Abell GCJ, 2005, FEMS MICROBIOL ECOL, V53, P379, DOI 10.1016/j.femsec.2005.01.008; Alles DL, 2013, MARINE PHYTOPLANKTON; Andersen L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-198; Ardyna M, 2014, GEOPHYS RES LETT, V41, P6207, DOI 10.1002/2014GL061047; Avendano-Herrera R, 2016, TRANSBOUND EMERG DIS, V63, P121, DOI 10.1111/tbed.12464; Bamstedt U, 1998, SARSIA, V83, P79, DOI 10.1080/00364827.1998.10413673; Baxter EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018529; Boeck A, 1866, TILSYNELADENDE BILAT; Boero F, 2008, MAR ECOL PROG SER, V356, P299, DOI 10.3354/meps07368; Bohorquez J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00245; Bosch-Belmar M, 2016, SCI REP-UK, V6, DOI 10.1038/srep27929; Bruno D.W., 1985, Bulletin of the European Association of Fish Pathologists, V5, P64; Buchan A, 2014, NAT REV MICROBIOL, V12, P686, DOI 10.1038/nrmicro3326; Cornelius PFS, 1995, N W EUROPEAN THECA 1; CUNNINGHAM CW, 1993, BIOCHEM SYST ECOL, V21, P57, DOI 10.1016/0305-1978(93)90009-G; Dalpadado P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095273; Delannoy CMJ, 2011, AQUACULTURE, V311, P255, DOI 10.1016/j.aquaculture.2010.11.033; Dinasquet J, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00302; Doyle TK, 2008, J PLANKTON RES, V30, P963, DOI 10.1093/plankt/fbn052; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Eiane Ketil, 2009, P209; Ferguson HW, 2010, J VET DIAGN INVEST, V22, P376, DOI 10.1177/104063871002200305; Fisch C, 2011, BIOL CELL, V103, P249, DOI 10.1042/BC20100139; Fleming NEC, 2013, AQUACULT ENV INTERAC, V4, P263, DOI 10.3354/aei00086; FLINT KP, 1985, J APPL BACTERIOL, V59, P561, DOI 10.1111/j.1365-2672.1985.tb03361.x; Fossa JH, 2003, HAVETS MILJO, P99; Fringuelli E, 2012, J FISH DIS, V35, P579, DOI 10.1111/j.1365-2761.2012.01377.x; Frisch K, 2017, J FISH DIS, DOI 10.1111/jfd.12687; Giovannoni SJ, 1996, P NATL ACAD SCI USA, V93, P7979, DOI 10.1073/pnas.93.15.7979; Gomez-Pereira PR, 2010, ISME J, V4, P472, DOI 10.1038/ismej.2009.142; Habib C, 2014, APPL ENVIRON MICROB, V80, P5503, DOI 10.1128/AEM.01177-14; Hahnke RL, 2013, SYST APPL MICROBIOL, V36, P497, DOI 10.1016/j.syapm.2013.06.006; HANSEN GH, 1992, INT J SYST BACTERIOL, V42, P451, DOI 10.1099/00207713-42-3-451; Haukaas A., 2017, HLTH SITUATION NORWE; Helmholz H, 2010, DEV HYDROBIOL, V212, P223, DOI 10.1007/s10750-010-0216-9; Hoffmann K, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00266; Hosteland LTS, 2016, MATTE SLAKTE ECOMERD; Karlsen C, 2017, J FISH DIS, V40, P1645, DOI 10.1111/jfd.12632; Kintner AH, 2012, HYDROZOAN JELLYFISH; Llewellyn MS, 2017, SCI REP-UK, V7, DOI 10.1038/srep43465; Loeng H., 1991, P PRO MAR S POL MAR, V10, P18; Lokesh J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19707; LOTAN A, 1995, NATURE, V375, P456, DOI 10.1038/375456a0; Marcos-Lopez M, 2016, J FISH DIS, V39, P111, DOI 10.1111/jfd.12267; MARISCAL RN, 1974, Z ZELLFORSCH MIK ANA, V147, P149, DOI 10.1007/BF00582789; MARTIN VJ, 1986, BIOL BULL-US, V171, P116, DOI 10.2307/1541910; Merceron M, 1995, EQUINOXE, V56, P6; Mitchell SO, 2011, J FISH DIS, V34, P411, DOI 10.1111/j.1365-2761.2011.01251.x; Nakagawa Y, 2002, J GEN APPL MICROBIOL, V48, P155, DOI 10.2323/jgam.48.155; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Nilsen A, 2017, AQUACULTURE, V466, P41, DOI 10.1016/j.aquaculture.2016.09.009; NYLUND A, 1995, J FISH DIS, V18, P135, DOI 10.1111/j.1365-2761.1995.tb00271.x; Olsen AB, 2011, DIS AQUAT ORGAN, V94, P189, DOI 10.3354/dao02324; Olsvik PA, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-21; Pinhassi J, 2004, APPL ENVIRON MICROB, V70, P6753, DOI 10.1128/AEM.70.11.6753-6766.2004; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Rahman T, 2014, FISH PATHOL, V49, P121, DOI 10.3147/jsfp.49.121; Riebeek H, 2010, PHYTOPLANKTON BLOOM; Rodger H. D., 2007, Fish Veterinary Journal, P38; Rodger HD, 2011, VET REC, V168, DOI 10.1136/vr.d3020; Rodger HD, 2011, REV FISH BIOL FISHER, V21, P423, DOI 10.1007/s11160-010-9182-6; Russell F.S., 1953, MEDUSAE BRIT ISLES; Rutter T, 2010, MANAGING RISK UNCERT; Schlesinger A, 2009, P ROY SOC B-BIOL SCI, V276, P1063, DOI 10.1098/rspb.2008.1586; Schuett C, 2010, HELGOLAND MAR RES, V64, P205, DOI 10.1007/s10152-009-0179-2; Smage SB, 2016, AQUACULTURE, V464, P178, DOI 10.1016/j.aquaculture.2016.06.030; Smage SB, 2016, ANTON LEEUW INT J G, V109, P273, DOI 10.1007/s10482-015-0630-0; Tamura K., 2013, MEGA6 MOL EVOLUTIONA; Teeling H, 2016, ELIFE, V5, DOI 10.7554/eLife.11888; Teeling H, 2012, SCIENCE, V336, P608, DOI 10.1126/science.1218344; Toranzo AE, 2005, AQUACULTURE, V246, P37, DOI 10.1016/j.aquaculture.2005.01.002; Torud B., 2008, Acta Veterinaria Scandinavica, V50, pS7, DOI 10.1186/1751-0147-50-S1-S7; Viver T, 2017, ENVIRON MICROBIOL, V19, P3039, DOI 10.1111/1462-2920.13763; Vold V., 2014, THESIS; WAKABAYASHI H, 1986, INT J SYST BACTERIOL, V36, P396, DOI 10.1099/00207713-36-3-396	75	21	21	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187476	10.1371/journal.pone.0187476	http://dx.doi.org/10.1371/journal.pone.0187476			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095885	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000414340200100
J	Zheng, XL; Tang, HW; Zhao, XF; Sun, YM; Jiang, YF; Liu, YH				Zheng, Xiaoli; Tang, Hongwei; Zhao, Xiaofeng; Sun, Yamei; Jiang, Yanfang; Liu, Yonghua			Long non-coding RNA FTH1P3 facilitates uveal melanoma cell growth and invasion through miR-224-5p	PLOS ONE			English	Article							GASTRIC-CANCER CELLS; FIZZLED 5 EXPRESSION; LUNG-CANCER; C-MET; HEPATOCELLULAR-CARCINOMA; POOR-PROGNOSIS; PROMOTES; PROLIFERATION; PROGRESSION; MIGRATION	Growing evidences indicated that Long noncoding RNAs (lncRNAs) played important roles in tumor initiation and progression. However, the function and mechnism of lncRNA ferritin heavy chain 1 pseudogene 3 (FTH1P3) remain unknown in uveal melanoma. We showed that the expression level of FTH1P3 was upregulated in uveal melanoma cell lines and tissues. Elevated expression of FTH1P3 promoted uveal melanoma cell proliferation, cell cycle and migration. Moreover, we found that FTH1P3 was a direct target gene of miR-224-5p in uveal melanoma cell. Overexpression of FTH1P3 suppressed miR-224-5p expression and promoted the expression of Rac1 and Fizzled 5, which were the direct target genes of miR-224-5p. Furthermore, we showed that miR-224-5p expression level was downregulated in uveal melanoma cell lines and tissues. FTH1P3 expression was inversely correlated with the miR-224-5p expression in uveal melanoma tissues. Ectopic expression of miR-224-5p decreased uveal melanoma cell proliferation, cell cycle and migration. Elevated expression of FTH1P3 enhanced uveal melanoma cell proliferation and migration by inhibiting miR-224-5p expression. These results suggest that lncRNA FTH1P3 plays a crucial role in uveal melanoma. Investigation of the underlying mechanism may be a target for the treatment of uveal melanoma.	[Zheng, Xiaoli; Tang, Hongwei; Liu, Yonghua] Liaocheng Peoples Hosp, Dept Ophthalmol, Liaocheng, Shandong, Peoples R China; [Zhao, Xiaofeng] Liaocheng Peoples Hosp, Joint Lab Translat Med, Liaocheng, Shandong, Peoples R China; [Sun, Yamei] Shanghai Chinese Acad Sci, Inst Pasteur, Shanghai, Peoples R China; [Jiang, Yanfang] Jilin Univ, Hosp 1, Genet Diag Ctr, Changchun, Jilin, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Jilin University	Zheng, XL (corresponding author), Liaocheng Peoples Hosp, Dept Ophthalmol, Liaocheng, Shandong, Peoples R China.	xiaolizheng1@yeah.net			Jilin Province Science and Technology Agency [20160101037JC, 20170622009JC]	Jilin Province Science and Technology Agency	This study was supported by Jilin Province Science and Technology Agency (No.20160101037JC and 20170622009JC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamopoulos PG, 2015, INT J ONCOL, V46, P849, DOI 10.3892/ijo.2014.2775; Deng L, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0136-7; Di Sanzo M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151359; Economou MA, 2008, ACTA OPHTHALMOL, V86, P930, DOI [10.1111/j.1755-3768.2008.01184.x, 10.1111/j.1755-3768.2008.01185.x, 10.1111/j.1755-3768.2008.01182.x]; Fang J, 2016, BIOCHEM BIOPH RES CO, V478, P811, DOI 10.1016/j.bbrc.2016.08.030; Geng S, 2016, J CELL MOL MED, V20, P1611, DOI 10.1111/jcmm.12852; He AB, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0397-9; Huang MD, 2015, J HEMATOL ONCOL, V8, DOI [10.1186/s13045-015-0146-0, 10.1186/s13045-015-0153-1]; Kam Y, 2014, CANCER LETT, V352, P90, DOI 10.1016/j.canlet.2013.02.014; Li C, 2015, AM J TRANSL RES, V7, P1747; Li JQ, 2016, BIOMED PHARMACOTHER, V83, P905, DOI 10.1016/j.biopha.2016.07.057; Li P, 2016, AM J TRANSL RES, V8, P3522; Ling H, 2016, GUT, V65, P977, DOI 10.1136/gutjnl-2015-309372; Liu CB, 2016, AM J TRANSL RES, V8, P4095; Liu F, 2016, ONCOTARGET, V7, P49130, DOI 10.18632/oncotarget.9734; Liu NN, 2012, ONCOL REP, V28, P961, DOI 10.3892/or.2012.1905; Ma L, 2017, ONCOTARGET, V8, P4125, DOI 10.18632/oncotarget.13670; Mallikarjuna K, 2007, CURR EYE RES, V32, P281, DOI 10.1080/02713680601161220; Nie FQ, 2015, MOL CANCER THER, V14, P268, DOI 10.1158/1535-7163.MCT-14-0492; Patel S, 2013, CURR ONCOL REP, V15, P386, DOI 10.1007/s11912-013-0316-6; Pereira PR, 2013, CLIN OPHTHALMOL, V7, P1669, DOI 10.2147/OPTH.S28863; Qiao HP, 2013, ASIAN PAC J CANCER P, V14, P1077, DOI 10.7314/APJCP.2013.14.2.1077; Qiu JJ, 2015, INT J ONCOL, V46, P2497, DOI 10.3892/ijo.2015.2943; Sato T, 2008, CURR ONCOL REP, V10, P431, DOI 10.1007/s11912-008-0066-z; Singh AD, 2011, OPHTHALMOLOGY, V118, P1881, DOI 10.1016/j.ophtha.2011.01.040; Song P, 2016, AGING-US, V8, P2948, DOI 10.18632/aging.101103; Sun CC, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.94; Sun CC, 2016, ONCOTARGET, V7, P35960, DOI 10.18632/oncotarget.8482; Sun CC, 2016, ONCOTARGET, V7, P51784, DOI 10.18632/oncotarget.10108; Sun L, 2015, FEBS LETT, V589, P2791, DOI 10.1016/j.febslet.2015.08.007; Sun L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124428; Surriga O, 2013, MOL CANCER THER, V12, P2817, DOI 10.1158/1535-7163.MCT-13-0499; Tian ZZ, 2015, INT J CLIN EXP PATHO, V8, P15138; Topcu-Yilmaz P, 2010, MELANOMA RES, V20, P126, DOI 10.1097/CMR.0b013e328335a916; WANG F, 2016, SCI REP-UK, V6, pNIL1, DOI DOI 10.1038/srep33229; Wang JQ, 2014, BIOMED PHARMACOTHER, V68, P557, DOI 10.1016/j.biopha.2014.04.007; Wang LN, 2016, AM J TRANSL RES, V8, P5219; Xia MM, 2016, PHARMAZIE, V71, P460, DOI 10.1691/ph.2016.6580; Yan DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040967; Yang F, 2013, J CANCER RES CLIN, V139, P437, DOI 10.1007/s00432-012-1324-x; Yonekawa Y, 2012, HEMATOL ONCOL CLIN N, V26, P1169, DOI 10.1016/j.hoc.2012.08.004; Yousef YA, 2014, HEMATOL ONCOL STEM C; Yu QY, 2016, AM J TRANSL RES, V8, P5444; Zhang CZ, 2017, GENE, V607, P47, DOI 10.1016/j.gene.2017.01.009; Zhang SC, 2015, ARCH ORAL BIOL, V60, P1581, DOI 10.1016/j.archoralbio.2015.08.003; Zhou X, 2015, SCI REP-UK, V5, DOI 10.1038/srep15972	46	45	45	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0184746	10.1371/journal.pone.0184746	http://dx.doi.org/10.1371/journal.pone.0184746			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095823	gold, Green Published, Green Submitted			2022-12-26	WOS:000414340200003
J	Beckers, KF; Schulz, CJ; Childers, GW				Beckers, Kalie F.; Schulz, Christopher J.; Childers, Gary W.			Rapid regrowth and detection of microbial contaminants in equine fecal microbiome samples	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; OPERON COPY NUMBER; GUT MICROBIOTA; STORAGE-CONDITIONS; LARGE-INTESTINE; BACTERIA; SOIL; COMMUNITIES; NUTRITION; REGIONS	Advances have been made to standardize 16S rRNA gene amplicon based studies for inter study comparisons, yet there are many opportunities for systematic error that may render these comparisons improper and misleading. The fecal microbiome of horses has been examined previously, however, no universal horse fecal collection method and sample processing procedure has been established. This study was initialized in large part to ensure that samples collected by different individuals from different geographical areas (i.e., crowd sourced) were not contaminated due to less than optimal sampling or holding conditions. In this study, we examined the effect of sampling the surface of fecal pellets compared to homogenized fecal pellets, and also the effect of time of sampling after defecation on 'bloom' taxa (bloom taxa refers to microbial taxa that can grow rapidly in horse feces post defecation) using v4 16S rRNA amplicon libraries. A total of 1,440,171 sequences were recovered from 65 horse fecal samples yielding a total of 3,422 OTUs at 97% similarity. Sampling from either surface or homogenized feces had no effect on diversity and little effect on microbial composition. Sampling at various time points (0, 2, 4, 6, 12 h) had a significant effect on both diversity and community composition of fecal samples. Alpha diversity (Shannon index) initially increased with time as regrowth taxa were detected in the amplicon libraries, but by 12 h the diversity sharply decreased as the community composition became dominated by a few bloom families, including Bacillaceae, Planococcaeae, and Enterococcaceae, and other families to a lesser extent. The results show that immediate sampling of horse feces must be done in order to ensure accurate representation of horse fecal samples. Also, several of the bloom taxa found in this study are known to occur in human and cattle feces post defecation. The dominance of these taxa in feces shortly after defecation suggests that the feces is an important habitat for these organisms, and horse fecal samples that were improperly stored can be identified by presence of bloom taxa.	[Beckers, Kalie F.; Schulz, Christopher J.; Childers, Gary W.] Southeastern Louisiana Univ, Dept Biol Sci, Hammond, LA 70402 USA	University of Louisiana System; Southeastern Louisiana University	Schulz, CJ (corresponding author), Southeastern Louisiana Univ, Dept Biol Sci, Hammond, LA 70402 USA.	cschulz@selu.edu						Aitchison J, 2005, MATH GEOL, V37, P829, DOI 10.1007/s11004-005-7383-7; Albertsen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132783; Amir A, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00199-16; Anderson M.J., 2005, PERMUTATIONAL MULTIV; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; ARGENZIO RA, 1974, AM J PHYSIOL, V226, P1043, DOI 10.1152/ajplegacy.1974.226.5.1043; ARGENZIO RA, 1975, CORNELL VET, V65, P303; Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Cardona S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-158; Carroll IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046953; Choo JM, 2015, SCI REP-UK, V5, DOI 10.1038/srep16350; Costa MC, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0335-7; Costa MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041484; Daly K, 2001, FEMS MICROBIOL ECOL, V38, P141, DOI 10.1111/j.1574-6941.2001.tb00892.x; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dicks LMT, 2014, LIVEST SCI, V160, P69, DOI 10.1016/j.livsci.2013.11.025; Dougal K, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01502; Dougal K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087424; Dougal K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077660; Durham AE, 2009, VET CLIN N AM-EQUINE, V25, P67, DOI 10.1016/j.cveq.2008.11.003; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eloe-Fadrosh EA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.32, 10.1038/nmicrobiol.2015.32]; Ericsson AC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166523; Fernandes AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067019; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Fouhy F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119355; Gilbert JA, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0069-1; Gorzelak MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134802; Hale VL, 2015, J MICROBIOL METH, V113, P16, DOI 10.1016/j.mimet.2015.03.021; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hansen Naja C. K., 2015, Microbial Ecology in Health and Disease, V26, P27216, DOI 10.3402/mehd.v26.27216; Hart ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143334; HINTZ HF, 1994, ANNU REV NUTR, V14, P243, DOI 10.1146/annurev.nu.14.070194.001331; Hong HA, 2009, RES MICROBIOL, V160, P375, DOI 10.1016/j.resmic.2009.06.006; Janabi AHD, 2016, J MICROBIOL METH, V129, P14, DOI 10.1016/j.mimet.2016.07.019; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Kurtz ZD, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004226; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lauber CL, 2010, FEMS MICROBIOL LETT, V307, P80, DOI 10.1111/j.1574-6968.2010.01965.x; Liu XF, 2014, CURR MICROBIOL, V68, P657, DOI 10.1007/s00284-014-0528-5; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Marchesi JR, 2016, GUT, V65, P330, DOI 10.1136/gutjnl-2015-309990; de Almeida MLM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167108; Murtagh F, 2011, ARXIV111162852011; Nishimoto Y, 2016, GUT; O' Donnell MM, 2013, LETT APPL MICROBIOL, V57, P492, DOI 10.1111/lam.12137; R Development Core Team, 2008, LANG ENV STAT COMP F; Rhee KJ, 2004, J IMMUNOL, V172, P1118, DOI 10.4049/jimmunol.172.2.1118; Rodriguez C, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0514-5; Roesch Luiz F W, 2009, Open Microbiol J, V3, P40, DOI 10.2174/1874285800903010040; Roller BRK, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.160, 10.1038/nmicrobiol.2016.160]; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Shepherd ML, 2012, FEMS MICROBIOL LETT, V326, P62, DOI 10.1111/j.1574-6968.2011.02434.x; Shrestha PM, 2007, ENVIRON MICROBIOL, V9, P2464, DOI 10.1111/j.1462-2920.2007.01364.x; Song SJ, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00021-16; Steelman SM, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-179; Stewart Colin S., 1997, P142; Tam NKM, 2006, J BACTERIOL, V188, P2692, DOI 10.1128/JB.188.7.2692-2700.2006; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Wong K, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00500; Yang B, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0992-y; Zhao YP, 2016, ASIAN AUSTRAL J ANIM, V29, P1345, DOI 10.5713/ajas.15.0587	66	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11								10.1371/Journal.pone.0187044	http://dx.doi.org/10.1371/Journal.pone.0187044			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091944	Green Published, gold, Green Submitted			2022-12-26	WOS:000414229700040
J	Murao, N; Yokoi, N; Honda, K; Han, GR; Hayami, T; Gheni, G; Takahashi, H; Minami, K; Seino, S				Murao, Naoya; Yokoi, Norihide; Honda, Kohei; Han, Guirong; Hayami, Tomohide; Gheni, Ghupurjan; Takahashi, Harumi; Minami, Kohtaro; Seino, Susumu			Essential roles of aspartate aminotransferase 1 and vesicular glutamate transporters in beta-cell glutamate signaling for incretin-induced insulin secretion	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; PHOSPHATE TRANSPORTER; RELEASE; ISLETS; TARGET; ACTS	Incretins (GLP-1 and GIP) potentiate insulin secretion through cAMP signaling in pancreatic beta-cells in a glucose-dependent manner. We recently proposed a mechanistic model of incretin-induced insulin secretion (IIIS) that requires two critical processes: 1) generation of cytosolic glutamate through the malate-aspartate (MA) shuttle in glucose metabolism and 2) glutamate transport into insulin granules by cAMP signaling to promote insulin granule exocytosis. To directly prove the model, we have established and characterized CRISPR/Cas9-engineered clonal mouse beta-cell lines deficient for the genes critical in these two processes: aspartate aminotransferase 1 (AST1, gene symbol Got1), a key enzyme in the MA shuttle, which generates cytosolic glutamate, and the vesicular glutamate transporters (VGLUT1, VGLUT2, and VGLUT3, gene symbol Slc17a7, Slc17a6, and Slc17a8, respectively), which participate in glutamate transport into secretory vesicles. Got1 knockout (KO) (3 -cell lines were defective in cytosolic glutamate production from glucose and showed impaired IIIS. Unexpectedly, different from the previous finding that global Slc17a7K0 mice exhibited impaired IIIS from pancreatic islets, beta-cell specific Slc17a7 KO mice showed no significant impairment in IIIS, as assessed by pancreas perfusion experiment. Single Slc17a7 KO 13 cell lines also retained IIIS, probably due to compensatory upregulation of Slc17a6. Interestingly, triple KO of Slc17a7, Slc17a6, and Slc17a8 diminished IIIS, which was rescued by exogenously introduced wild-type Slc17a7 or Slc17a6 genes. The present study provides direct evidence for the essential roles of AST1 and VGLUTs in beta-cell glutamate signaling for IIIS and also shows the usefulness of the CRISPR/Cas9 system for studying beta-cells by simultaneous disruption of multiple genes.	[Murao, Naoya; Yokoi, Norihide; Honda, Kohei; Han, Guirong; Hayami, Tomohide; Gheni, Ghupurjan; Takahashi, Harumi; Minami, Kohtaro; Seino, Susumu] Kobe Univ, Grad Sch Med, Div Mol & Metab Med, Dept Physiol & Cell Biol, Kobe, Hyogo, Japan; [Han, Guirong; Hayami, Tomohide] Kansai Elect Power Med Res Inst, Kobe, Hyogo, Japan; [Han, Guirong] Kobe Univ, Div Med Chem, Dept Biophys, Grad Sch Hlth Sci, Kobe, Hyogo, Japan; [Hayami, Tomohide] Aichi Med Univ, Div Diabet, Dept Internal Med, Nagakute, Aichi, Japan	Kobe University; Kobe University; Aichi Medical University	Yokoi, N; Seino, S (corresponding author), Kobe Univ, Grad Sch Med, Div Mol & Metab Med, Dept Physiol & Cell Biol, Kobe, Hyogo, Japan.	yokoi@med.kobe-u.ac.jp; seino@med.kobe-u.ac.jp		Minami, Kohtaro/0000-0003-4698-6250; Yokoi, Norihide/0000-0002-5596-9754	Ministry of Education, Culture, Sports, Science and Technology, Japan; MSD K.K.; Japan Diabetes Foundation; Grants-in-Aid for Scientific Research [15K06800] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MSD K.K.(Merck & Company); Japan Diabetes Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. This study was also supported in part by a research grant from MSD K.K. and a research grant from Japan Diabetes Foundation.	Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Gammelsaeter R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022960; Gheni G, 2014, CELL REP, V9, P661, DOI 10.1016/j.celrep.2014.09.030; Gras C, 2002, J NEUROSCI, V22, P5442; Hayashi M, 2003, J HISTOCHEM CYTOCHEM, V51, P1375, DOI 10.1177/002215540305101014; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Iwasaki M, 2010, J DIABETES INVEST, V1, P137, DOI 10.1111/j.2040-1124.2010.00026.x; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Miki T, 2005, DIABETES, V54, P1056, DOI 10.2337/diabetes.54.4.1056; Miyazaki T, 2003, EUR J NEUROSCI, V17, P2563, DOI 10.1046/j.1460-9568.2003.02698.x; Naylor J, 2016, BIOCHEM J, V473, P2881, DOI 10.1042/BCJ20160476; Omote H, 2011, BIOCHEMISTRY-US, V50, P5558, DOI 10.1021/bi200567k; PRENTKI M, 1987, PHYSIOL REV, V67, P1185, DOI 10.1152/physrev.1987.67.4.1185; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/nmeth.2857, 10.1038/NMETH.2857]; SIEGEL EG, 1985, DIABETOLOGIA, V28, P857, DOI 10.1007/BF00291078; Takamori S, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-22-j0002.2001; Tamura K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126003; WEIR GC, 1989, DIABETES, V38, P338, DOI 10.2337/diabetes.38.3.338; Yokoi N, 2016, J DIABETES INVEST, V7, P38, DOI 10.1111/jdi.12468	26	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187213	10.1371/journal.pone.0187213	http://dx.doi.org/10.1371/journal.pone.0187213			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091932	Green Published, gold, Green Submitted			2022-12-26	WOS:000414229700046
J	Lee, S; Kweon, OK; Kim, WH				Lee, Sungin; Kweon, Oh-Kyeong; Kim, Wan Hee			Associations between serum leptin levels, hyperlipidemia, and cholelithiasis in dogs	PLOS ONE			English	Article							BODY CONDITION SCORE; INSULIN-RESISTANCE; GALLBLADDER MOTILITY; DIABETES-MELLITUS; GALLSTONE DISEASE; BILIARY SLUDGE; RISK-FACTOR; OBESE MICE; EXPRESSION; RECEPTOR	Leptin and its receptor play several physiological roles in the canine gallbladder, and the dysregulation of leptin might play a role in the pathogenesis of gallbladder diseases such as gallbladder mucocele. Previous studies revealed a positive association between hyperlipidemia and gallstones in humans. However, the latter is still unclear in dogs with cholelithiasis. In this study, we examined the differences in leptin, leptin receptor, total cholesterol, and triglyceride levels between healthy dogs and dogs with cholelithiasis, and evaluated the correlation between leptin and hyperlipidemia. Twenty-eight healthy dogs and 34 client-owned dogs with cholelithiasis were enrolled in the study. Leptin concentrations and lipid profiles were determined from sera, and leptin and leptin receptor expression levels were quantified in gallbladder tissue. In dogs with cholelithiasis, serum concentrations of leptin (p < 0.001), total cholesterol (p < 0.001), and triglycerides (p < 0.001) were significantly higher compared with those in healthy dogs. Positive correlations were observed between serum leptin and total cholesterol (95% confidence interval (CI) = 0.61-0.89, r = 0.725, p < 0.001), and between leptin and triglycerides (95% CI = 0.63-0.89, r = 0.782, p < 0.001) in the cholelithiasis group. Hypercholesterolemia (Odds Ratio (OR) = 9.720; 95% CI = 1.148-82.318) and hypertriglyceridemia (OR = 12.913; 95% CI = 1.548-107.722) were shown to be risk factors for gallstone disease. In cholelithiasis patients who underwent cholecystectomy, serum leptin levels were significantly higher than in patients that had not undergone surgery (p < 0.001). Leptin and leptin receptor expression was upregulated in the gallbladder tissues of cholelithiasis patients (p < 0.01 and p < 0.001, respectively). These results indicate that increased serum leptin concentrations and hyperlipidemia (hypercholesterolemia or hypertriglyceridemia) are associated with canine cholelithiasis and that homeostatic imbalance of these parameters might affect the pathogenesis of gallstones.	[Kim, Wan Hee] Seoul Natl Univ, Dept Vet Clin Sci, Coll Vet Med, Seoul, South Korea; Seoul Natl Univ, Res Inst Vet Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, WH (corresponding author), Seoul Natl Univ, Dept Vet Clin Sci, Coll Vet Med, Seoul, South Korea.	whkim@snu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2017R1D1A1B03032499]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2017R1D1A1B03032499) to Wan Hee Kim.	Bohlender J, 2003, J ENDOCRINOL, V178, P217, DOI 10.1677/joe.0.1780217; Cuevas A, 2004, J AM COLL NUTR, V23, P187, DOI 10.1080/07315724.2004.10719360; de Lartigue G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032967; Ettinger SJ., 2017, TXB VET INTERNAL MED, V39, P1483; Fonfara S, 2011, J VET INTERN MED, V25, P1017, DOI 10.1111/j.1939-1676.2011.00782.x; German AJ, 2009, DOMEST ANIM ENDOCRIN, V37, P214, DOI 10.1016/j.domaniend.2009.07.001; Gielkens HAJ, 1998, J HEPATOL, V28, P595, DOI 10.1016/S0168-8278(98)80282-1; Goldblatt MI, 2002, J GASTROINTEST SURG, V6, P438, DOI 10.1016/S1091-255X(01)00046-4; Gonzaga NC, 2014, J PAEDIATR CHILD H, V50, P707, DOI 10.1111/jpc.12610; Gonzalez RR, 2006, J BIOL CHEM, V281, P26320, DOI 10.1074/jbc.M601991200; Graewin SJ, 2008, J AM COLL SURGEONS, V206, P503, DOI 10.1016/j.jamcollsurg.2007.09.015; Greene VR, 2013, J VET INTERN MED, V27, P1278, DOI 10.1111/jvim.12169; Haluzik M, 1999, PHYSIOL RES, V48, P363; Hess RS, 2010, VET CLIN N AM-SMALL, V40, P309, DOI 10.1016/j.cvsm.2009.12.001; Ishioka K, 2007, RES VET SCI, V82, P11, DOI 10.1016/j.rvsc.2006.06.002; Jonkers IJAM, 2003, GUT, V52, P109, DOI 10.1136/gut.52.1.109; Kavazarakis E, 2001, METABOLISM, V50, P1091, DOI 10.1053/meta.2001.25606; Kieffer TJ, 1996, RES COMMUN, V224, P522; Kim AY, 2015, J VET SCI, V16, P333, DOI 10.4142/jvs.2015.16.3.333; Kim Jung Mi, 2007, Korean J Gastroenterol, V50, P183; KIRPENSTEIJN J, 1993, J AM VET MED ASSOC, V202, P1137; Krishnamurthy S, 1997, J NUCL MED, V38, P1824; Kutsunai M, 2014, VET J, V199, P76, DOI 10.1016/j.tvjl.2013.10.019; Laflamme D, 1997, CANINE PRACT, V22, P10; Lahm Jose A, 2016, VET MED INT, V2016; Lee S, 2017, J VET INTERN MED, V31, P36, DOI 10.1111/jvim.14612; LEE SP, 1981, J CLIN INVEST, V67, P1712, DOI 10.1172/JCI110209; LEE SP, 1988, GASTROENTEROLOGY, V94, P170, DOI 10.1016/0016-5085(88)90626-9; LEE SP, 1986, GASTROENTEROLOGY, V90, P677, DOI 10.1016/0016-5085(86)91123-6; Lee S, 2016, ACTA HISTOCHEM, V118, P674, DOI 10.1016/j.acthis.2016.09.002; Lerch MM, 2016, GALLSTONE RELATED PA; Lostao MP, 1998, FEBS LETT, V423, P302, DOI 10.1016/S0014-5793(98)00110-0; MAFFEI M, 1995, P NATL ACAD SCI USA, V92, P6957, DOI 10.1073/pnas.92.15.6957; Mazaki-Tovi M, 2010, VET J, V183, P109, DOI 10.1016/j.tvjl.2008.08.017; Nelson R.W., 2014, SMALL ANIMAL INTERNA, V5, P897; Nishii N, 2010, J VET MED SCI, V72, P809, DOI 10.1292/jvms.09-0481; Park HK, 2015, METABOLISM, V64, P24, DOI 10.1016/j.metabol.2014.08.004; Park HJ, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-113; Piantedosi D, 2016, VET J, V216, P72, DOI 10.1016/j.tvjl.2016.07.002; Rucinsky R, 2010, J AM ANIM HOSP ASSOC, V46, P215, DOI 10.5326/0460215; Sarac S, 2015, J INT MED RES, V43, P385, DOI 10.1177/0300060514561134; Silha JV, 2003, EUR J ENDOCRINOL, V149, P331, DOI 10.1530/eje.0.1490331; Smelt AHM, 2010, CLIN CHIM ACTA, V411, P1625, DOI 10.1016/j.cca.2010.08.003; Swartz-Basile DA, 2007, AM J PHYSIOL-GASTR L, V293, pG84, DOI 10.1152/ajpgi.00389.2006; Sweeney G, 2001, CELL MOL BIOL, V47, P363; Thomas T, 2000, METABOLISM, V49, P1278, DOI 10.1053/meta.2000.9519; Thrall D. E., 2013, TXB VET DIAGNOSTIC R; Tobias K.M., 2013, VET SURG SMALL ANIMA; Tran KQ, 2003, J GASTROINTEST SURG, V7, P857, DOI 10.1016/S1091-255X(03)00146-X; Tran KQ, 2003, J SURG RES, V113, P56, DOI 10.1016/S0022-4804(03)00157-4; Verkest KR, 2011, DOMEST ANIM ENDOCRIN, V41, P24, DOI 10.1016/j.domaniend.2011.02.001; Wang SN, 2006, EUR J CLIN INVEST, V36, P176, DOI 10.1111/j.1365-2362.2006.01611.x	52	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187315	10.1371/journal.pone.0187315	http://dx.doi.org/10.1371/journal.pone.0187315			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088261	Green Published, gold, Green Submitted			2022-12-26	WOS:000414088900065
J	Rovelli, C; Poli, A; Galli, L; Cernuschi, M; Tamburini, AM; Racca, S; Tambussi, G; Rolla, S; Albarello, L; Rosati, R; Lazzarin, A; Castagna, A; Nozza, S				Rovelli, Cristina; Poli, Andrea; Galli, Laura; Cernuschi, Massimo; Tamburini, Andrea Marco; Racca, Sara; Tambussi, Giuseppe; Rolla, Serena; Albarello, Luca; Rosati, Riccardo; Lazzarin, Adriano; Castagna, Antonella; Nozza, Silvia			Presence of multiple genotypes in subjects with HPV-16 infection is highly associated with anal squamous intraepithelial lesions in HIV-1 infected males	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; ANYPLEX II HPV28; ANTIRETROVIRAL THERAPY; RISK-FACTORS; HIV; MEN; SEX; COHORT; PREVALENCE; CANCER	Objectives The aim of the study was to determine the prevalence of abnormal cytological findings, high risk (HR)-HPV genotypes and to identify factors associated with an abnormal cytological findings in a cohort of HIV-infected males. Patients and methods Retrospective observational study on HIV-infected male patients who performed screening in the absence of clinical symptoms. Cytological abnormalities were classified as atypical squamous cells of undetermined significance (ASC-US), low-grade(LSIL) or high high-grade squamous intraepithelial lesion (HSIL). Logistic regression models were used to identify predictors of having LSIL/HSIL. Results Among 875 pts, abnormal cytology findings were observed in 254 (29%, 95% CI: 26.1%-32.1%) subjects: 142 (16%) had LSIL and 49 (6%) HSIL. Overall, 581 (66%, 95% CI: 63.2%-69.5%) subjects had >= 1 HR-HPV type and 269 (31%) had >= 2 HR HPV types. Multivariate logistic regression showed that subjects with multiple HR-HPV genotypes (OR = 1.351, 95% CI: 1.005-2.111) and with HPV-16 type (OR = 2.032, 95% CI: 1.313-3.146) were more likely to have LSIL/HSIL in addition to a lower CD4+/CD8+ ratio, a previous diagnosis of syphilis and a positive viral load. In another multivariate model, the presence of multiple HPV types in subjects with HPV-16 type was associated with the highest adjusted OR of having a LSIL/HSIL (OR = 2.598, 95% CI: 1.460-4.624). Conclusions In HIV-infected men, the prevalence of abnormal cytological findings was of 29% and of HR-HPV was 66%. The concomitant presence of HPV-16 and multiple HR genotypes was associated with an increased risk of abnormal cytological findings. These data highlight the importance of screening multiple HPV genotypes in HIV-infected patients.	[Rovelli, Cristina; Rosati, Riccardo; Lazzarin, Adriano; Castagna, Antonella] Univ Vita Salute San Raffaele, Milan, Italy; [Poli, Andrea; Galli, Laura; Cernuschi, Massimo; Tambussi, Giuseppe; Lazzarin, Adriano; Castagna, Antonella; Nozza, Silvia] Ist Sci San Raffaele, Infect Dis Dept, Milan, Italy; [Tamburini, Andrea Marco; Rosati, Riccardo] Ist Sci San Raffaele, Gastrointestinal Surg, Milan, Italy; [Racca, Sara; Rolla, Serena] Ist Sci San Raffaele, Lab Microbiol, Milan, Italy; [Albarello, Luca] Ist Sci San Raffaele, Dept Pathol, Milan, Italy	Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Nozza, S (corresponding author), Ist Sci San Raffaele, Infect Dis Dept, Milan, Italy.	nozza.silvia@hsr.it	NOZZA, SILVIA/AAC-5445-2022; ALBARELLO, LUCA/AAN-3876-2020; Castagna, Antonella/K-3280-2018; Galli, Laura/B-1161-2016; Tamburini, Andrea/U-2958-2019; LAZZARIN, Adriano/K-3607-2018	ALBARELLO, LUCA/0000-0003-4846-5096; Castagna, Antonella/0000-0002-8338-9714; Tamburini, Andrea/0000-0002-7578-209X; LAZZARIN, Adriano/0000-0003-2551-7754; Galli, Laura/0000-0001-8046-0290; Tambussi, Giuseppe/0000-0002-0604-2960; ROSATI, Riccardo/0000-0002-2608-5749				Berry JM, 2014, INT J CANCER, V134, P1147, DOI 10.1002/ijc.28431; Cancer Research UK, 2014, AN CANC INC STAT; Estrade C, 2014, J CLIN MICROBIOL, V52, P607, DOI 10.1128/JCM.02749-13; Fuchs W, 2016, J EUR ACAD DERMATOL, V30, P995, DOI 10.1111/jdv.13539; Garbuglia AR, 2015, J CLIN VIROL, V72, P49, DOI 10.1016/j.jcv.2015.09.001; Goedert JJ, 1998, LANCET, V351, P1833, DOI 10.1016/S0140-6736(97)09028-4; Gonzalez C, 2013, INT J CANCER, V133, P1164, DOI 10.1002/ijc.28102; Hu YF, 2013, JAIDS-J ACQ IMM DEF, V64, P103, DOI 10.1097/QAI.0b013e31829b6298; Latsuzbaia A, 2016, DIAGN MICR INFEC DIS, V85, P318, DOI 10.1016/j.diagmicrobio.2016.04.011; Muller EE, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1706-9; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Mussini C, 2015, LANCET HIV, V2, pE98, DOI 10.1016/S2352-3018(15)00006-5; Nagata N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137434; Northfelt DW, 1996, HEMATOL ONCOL CLIN N, V10, P1177, DOI 10.1016/S0889-8588(05)70392-0; PALEFSKY JM, 1994, J ACQ IMMUN DEF SYND, V7, P599; Richel O, ONE LESION ONE VIRUS; Sahasrabuddhe VV, 2013, J INFECT DIS, V207, P392, DOI 10.1093/infdis/jis694; Schofield AM, 2016, AIDS, V30, P1375, DOI 10.1097/QAD.0000000000001045; Shen-Gunther J, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3612-y; Su JR, 2011, P 2011 NAT HIV PREV; Torres M, 2013, J CLIN MICROBIOL, V51, P3512, DOI 10.1128/JCM.01405-13; Zeier MD, 2015, AIDS, V29, P59, DOI 10.1097/QAD.0000000000000512	22	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186367	10.1371/journal.pone.0186367	http://dx.doi.org/10.1371/journal.pone.0186367			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088236	gold, Green Published, Green Submitted			2022-12-26	WOS:000414088900010
J	Li, DP; Yu, HF; Lin, QX; Liu, Y				Li, Dongpu; Yu, Hongfei; Lin, Qinxiong; Liu, Yun			Doliroside A from Dolichos falcata Klein suppressing amyloid beta-protein 42 fibrillogenesis: An insight at molecular level	PLOS ONE			English	Article							NEUROTOXICITY; INFLAMMATION; INHIBITORS	A bioactive chemical constituent, doliroside A, from Chinese traditional herbal medicine Dolichos falcata Klein was isolated, purified and identified by 60% ethanol extraction, thin layer chromatography (TLC), high performance liquid chromatography (HPLC) and nuclear magnetic resonance (NMR) spectroscopy. Molecular interaction mechanism between doliroside and amyloid beta 42 protein was evaluated by thioflavin T fluorescence (ThT), circular dichroism (CD), atomic force microscope (AFM), and differential scanning calorimeter (DSC) from the aspects of kinetics, secondary structure, morphology, and thermodynamics, respectively. Results show that the purity of doliroside A is 99.9% by HPLC, and its chemical structure is identified by 1 H-and 13 C-NMR. Doliroside A is observed to be concentrationdependent inhibiting the fibrillation of A beta 42 with the IC50 value of 26.57 +/- 1.6 mu M. CD and DSC results imply that doliroside A can bind to the nuclei and oligomers of A beta 42 to form a stable complex and suppress A beta 42 fibrillation. AFM images show that doliroside A, after bound to the nuclei and oligomers, redirect A beta 42 into off-pathway, amorphous oligomers. These findings not only provide a full insight into the molecular interaction mechanisms between A beta 42 and doliroside A, but also facilitate the development of new native anti-AD drug of doliroside A compound.	[Li, Dongpu] Tianjin Med Univ, Gen Hosp, Tianjin, Peoples R China; [Yu, Hongfei; Liu, Yun] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing Key Lab Bioproc, Beijing, Peoples R China; [Lin, Qinxiong] South Cent Univ Nationalities, Pharmaceut Coll, Wuhan, Peoples R China	Tianjin Medical University; Beijing University of Chemical Technology; South Central Minzu University	Liu, Y (corresponding author), Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing Key Lab Bioproc, Beijing, Peoples R China.	liuyun@mail.buct.edu.cn		Liu, Yun/0000-0002-7521-3831	Ministry of Finance; Ministry of Education of China; Beijing Municipal Natural Science Foundation [5142013]; Fundamental Research Funds for the Central Universities; South-Central University for Nationalities of China [CZY10014]	Ministry of Finance; Ministry of Education of China(Ministry of Education, China); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); South-Central University for Nationalities of China	This work was funded by the Ministry of Finance and the Ministry of Education of China. Additionally, this work was funded by the Beijing Municipal Natural Science Foundation (5142013 to YL) and the Fundamental Research Funds for the Central Universities, South-Central University for Nationalities of China (CZY10014 to QL). DSC equipments were provided by Prof. Zhaofeng Jiang and Dr. Ping Chang in Beijing Union University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.; The authors also acknowledge the long-term subsidy mechanism from the Ministry of Finance and the Ministry of Education of China for supporting AFM experiments. Additionally, this work was funded by the Beijing Municipal Natural Science Foundation (5142013) and the Fundamental Research Funds for the Central Universities, South-Central University for Nationalities of China (CZY10014). DSC equipments were provided by Prof. Zhaofeng Jiang and Dr. Ping Chang in Beijing Union University. The funders had no role in study design, data collection and analysis, decision to publish, or preparationof the manuscript. There was no additional external funding received for this study.	Arosio P, 2015, PHYS CHEM CHEM PHYS, V17, P7606, DOI 10.1039/c4cp05563b; Barnham KJ, 2008, P NATL ACAD SCI USA, V105, P6813, DOI 10.1073/pnas.0800712105; Bieschke J, 2010, P NATL ACAD SCI US; Blanchard BJ, 2004, P NATL ACAD SCI USA, V101, P14326, DOI 10.1073/pnas.0405941101; Chen LY, 2013, J ETHNOPHARMACOL, V150, P545, DOI 10.1016/j.jep.2013.08.063; Churches QI, 2014, BIOORG MED CHEM LETT, V24, P3108, DOI 10.1016/j.bmcl.2014.05.008; Cohen S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.183001; Du BS, 2014, INT IMMUNOPHARMACOL, V20, P221, DOI 10.1016/j.intimp.2014.02.036; Gao JJ, 2013, INTRACTABLE RARE DIS, V2, P3, DOI 10.5582/irdr.2013.v2.1.3; Ge JF, 2012, NEUROCHEM INT, V61, P1192, DOI 10.1016/j.neuint.2012.08.012; Gervais F, 2007, NEUROBIOL AGING, V28, P537, DOI 10.1016/j.neurobiolaging.2006.02.015; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Gunther EC, 2010, J MOL MED, V88, P331, DOI 10.1007/s00109-009-0568-7; Joshi P, 2014, CELL DEATH DIFFER, V21, P582, DOI 10.1038/cdd.2013.180; Kam TI, 2014, CELL MOL LIFE SCI, V71, P4803, DOI 10.1007/s00018-014-1706-0; Khallouki F, 2015, FOOD CHEM, V179, P191, DOI 10.1016/j.foodchem.2015.01.103; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Liang Y, 2010, J AM CHEM SOC, V132, P6306, DOI 10.1021/ja910964c; Lin YF, 2003, CHINESE DAI MED COLO, V6, P126; Liu Y, 2015, RSC ADV, V5, P62402, DOI 10.1039/c5ra09608a; Rajasekhar K, 2016, ACS CHEM NEUROSCI, V7, P1300, DOI 10.1021/acschemneuro.6b00175; Rajasekhar K, 2015, CHEM COMMUN, V51, P13434, DOI 10.1039/c5cc05264e; Rajasekhar K, 2015, SCI REP-UK, V5, DOI 10.1038/srep08139; Ruggeri FS, 2015, ANGEW CHEM INT EDIT, V54, P2462, DOI 10.1002/anie.201409050; Ruszkowski P, 2014, MINI-REV ORG CHEM, V11, P307, DOI 10.2174/1570193X1103140915111559; Shimmyo Y, 2008, J NEUROSCI RES, V86, P368, DOI 10.1002/jnr.21476; State Administration of Traditional Chinese Medicine, 2005, CHIN MAT MED VOL DAI, P37; Tian HY, 2009, INTEGRATION CHINESE, P41; Viet MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079151; Wang SH, 2010, J PHYS CHEM B, V114, P11576, DOI 10.1021/jp1001435; Wei H, 2014, EUR J PHARMACOL, V740, P321, DOI 10.1016/j.ejphar.2014.07.023; Xu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100787; Yu H.C., 2000, J CHIN NATL FOLK MED, V6, P339	33	1	1	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0186590	10.1371/journal.pone.0186590	http://dx.doi.org/10.1371/journal.pone.0186590			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084238	Green Published, Green Submitted, gold			2022-12-26	WOS:000413910200010
J	Lopez, JE; Jaradeh, K; Silva, E; Aminololama-Shakeri, S; Simpson, PC				Lopez, Javier E.; Jaradeh, Katrin; Silva, Emmanuel; Aminololama-Shakeri, Shadi; Simpson, Paul C.			A method to increase reproducibility in adult ventricular myocyte sizing and flow cytometry: Avoiding cell size bias in single cell preparations	PLOS ONE			English	Article							MYOSIN HEAVY-CHAIN; GENE-EXPRESSION; IN-VIVO; CARDIAC-HYPERTROPHY; PRESSURE-OVERLOAD; MOUSE HEART; RAT-HEART; CARDIOMYOCYTES; SUBPOPULATION; ACCUMULATION	Rationale Flow cytometry (FCM) of ventricular myocytes (VMs) is an emerging technology in adult cardiac research that is challenged by the wide variety of VM shapes and sizes. Cellular variability and cytometer flow cell size can affect cytometer performance. These two factors of variance limit assay validity and reproducibility across laboratories. Washing and filtering of ventricular cells in suspension are routinely done to prevent cell clumping and minimize data variability without the appropriate standardization. We hypothesize that washing and filtering arbitrarily biases towards sampling smaller VMs than what actually exist in the adult heart. Objective To determine the impact of washing and filtering on adult ventricular cells for cell sizing and FCM. Methods and results Left ventricular cardiac cells in single-cell suspension were harvested from New Zealand White rabbits and fixed prior to analysis. Each ventricular sample was aliquoted before washing or filtering through a 40, 70, 100 or 200 mu m mesh. The outcomes of the study are VM volume by Coulter Multisizer and light-scatter signatures by FCM. Data are presented as mean +/- SD. Myocyte volumes without washing or filtering (NF) served as the "gold standard" within the sample and ranged from 11,017 to 46,926 mu m(3). Filtering each animal sample through a 200 mu m mesh caused no variation in the post-filtration volume (1.01+0.01 fold vs. NF, n = 4 rabbits, p = 0.999) with an intra-assay coefficient of variation (% CV) of <5% for all 4 samples. Filtering each sample through a 40, 70 or 100 mu m mesh invariably reduced the post-filtration volume by 41 +/- 10%, 9.0 +/- 0.8% and 8.8 +/- 0.8% respectively (n = 4 rabbits, p < 0.0001), and increased the %CV (18% to 1.3%). The high light-scatter signature by FCM, a simple parameter for the identification of ventricular myocytes, was measured after washing and filtering. Washing discarded VMs and filtering cells through a 40 or 100 mu m mesh reduced larger VM by 46% or 11% respectively (n = 6 from 2 rabbits, p < 0.001). Conclusion Washing and filtering VM suspensions through meshes 100 mu m or less biases myocyte volumes to smaller sizes, excludes larger cells, and increases VM variability. These findings indicate that validity and reproducibility across laboratories can be compromised unless cell preparation is standardized. We propose no wash prior to fixation and a 200 mu m mesh for filtrations to provide a reproducible standard for VM studies using FCM.	[Lopez, Javier E.; Jaradeh, Katrin; Silva, Emmanuel; Aminololama-Shakeri, Shadi] Univ Calif Davis, Davis, CA 95616 USA; [Simpson, Paul C.] VA Med Ctr, San Francisco, CA USA; [Simpson, Paul C.] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California Davis; University of California System; University of California San Francisco	Lopez, JE (corresponding author), Univ Calif Davis, Davis, CA 95616 USA.	drjlopez@ucdavis.edu	Silva, Emmanuel/AAI-7244-2021	Silva, Emmanuel/0000-0002-6445-8243	Harold Amos Medical Faculty Development Program from the Robert Wood Johnson Foundation; Harold S. Geneen Charitable Trust Awards Program; National Center for Advancing Translational Sciences, NIH [UL1 TR001860, KL2 TR001859]; NIH [R01 HL31113]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001860, KL2TR001859] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031113] Funding Source: NIH RePORTER; Veterans Affairs [I01BX004314] Funding Source: NIH RePORTER	Harold Amos Medical Faculty Development Program from the Robert Wood Johnson Foundation; Harold S. Geneen Charitable Trust Awards Program; National Center for Advancing Translational Sciences, NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported in part by the Harold Amos Medical Faculty Development Program from the Robert Wood Johnson Foundation (J.E.L.), Harold S. Geneen Charitable Trust Awards Program (J.E.L.), the National Center for Advancing Translational Sciences, NIH, grant number UL1 TR001860 and linked award KL2 TR001859 (J.E.L.), and NIH R01 HL31113 (P.C.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackers-Johnson M, 2016, CIRC RES, V119, P909, DOI 10.1161/CIRCRESAHA.116.309202; Alvarez DF, 2010, AM J PHYSIOL-LUNG C, V298, pL127, DOI 10.1152/ajplung.00313.2009; ARMSTRONG SC, 1992, J MOL CELL CARDIOL, V24, P149, DOI 10.1016/0022-2828(92)93151-9; Baker M, 2016, NATURE, V533, P452, DOI 10.1038/533452a; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; Begley CG, 2015, CIRC RES, V116, P116, DOI 10.1161/CIRCRESAHA.114.303819; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; CAMPBELL SE, 1991, CIRC RES, V68, P984, DOI 10.1161/01.RES.68.4.984; Chen XW, 2016, CIRC RES, V119, P888, DOI 10.1161/CIRCRESAHA.116.309734; Collins FS, 2014, NATURE, P505; DeLaughter DM, 2016, DEV CELL, V39, P480, DOI 10.1016/j.devcel.2016.10.001; Diez C, 1998, CARDIOVASC RES, V40, P530, DOI 10.1016/S0008-6363(98)00189-8; Finak G, 2016, SCI REP-UK, V6, DOI 10.1038/srep20686; Galbraith DW, 2000, FLOW CYTOMETRY CELL, P293; GERDES AM, 1986, ANAT RECORD, V215, P420, DOI 10.1002/ar.1092150414; Guo YX, 2017, CIRC RES, V120, P1874, DOI 10.1161/CIRCRESAHA.116.310283; Kraft T, 2016, CIRC RES, V119, P992, DOI 10.1161/CIRCRESAHA.116.309804; Lopez JE, 2017, J MOL CELL CARDIOL, V111, P114, DOI 10.1016/j.yjmcc.2017.07.012; Lopez JE, 2011, CIRC RES, V109, P629, DOI 10.1161/CIRCRESAHA.111.243410; Louch WE, 2011, J MOL CELL CARDIOL, V51, P288, DOI 10.1016/j.yjmcc.2011.06.012; Malliaras K, 2013, EMBO MOL MED, V5, P191, DOI 10.1002/emmm.201201737; Myagmar BE, 2017, CIRC RES, V120, P1103, DOI 10.1161/CIRCRESAHA.117.310520; NAG AC, 1979, J ANAT, V129, P541; NASH GB, 1979, BIOCHIM BIOPHYS ACTA, V587, P99, DOI 10.1016/0304-4165(79)90224-1; Nosek BA, 2015, SCIENCE, V348, P1422, DOI 10.1126/science.aab2374; Pandya K, 2008, P NATL ACAD SCI USA, V105, P13063, DOI 10.1073/pnas.0805120105; Pandya K, 2006, P NATL ACAD SCI USA, V103, P16864, DOI 10.1073/pnas.0607700103; Picot J, 2012, CYTOTECHNOLOGY, V64, P109, DOI 10.1007/s10616-011-9415-0; Pinto AR, 2016, CIRC RES, V118, P400, DOI 10.1161/CIRCRESAHA.115.307778; Pogwizd SM, 1999, CIRC RES, V85, P1009; POWELL T, 1976, BIOCHEM BIOPH RES CO, V72, P327, DOI 10.1016/0006-291X(76)90997-9; SCHIAFFINO S, 1989, CIRC RES, V64, P937, DOI 10.1161/01.RES.64.5.937; Sirish P, 2013, P NATL ACAD SCI USA, V110, P5618, DOI 10.1073/pnas.1221972110; Sirish P, 2012, J MOL CELL CARDIOL, V52, P264, DOI 10.1016/j.yjmcc.2011.10.012; Strijdom H, 2004, J MOL CELL CARDIOL, V37, P897, DOI 10.1016/j.yjmcc.2004.05.018; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005	36	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0186792	10.1371/journal.pone.0186792	http://dx.doi.org/10.1371/journal.pone.0186792			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084228	Green Published, Green Submitted, gold			2022-12-26	WOS:000413910200013
J	Schomann, T; Mezzanotte, L; De Groot, JCMJ; Rivolta, MN; Hendriks, SH; Frijns, JHM; Huisman, MA				Schomann, Timo; Mezzanotte, Laura; De Groot, John C. M. J.; Rivolta, Marcelo N.; Hendriks, Sanne H.; Frijns, Johan H. M.; Huisman, Margriet A.			Neuronal differentiation of hair-follicle-bulge-derived stem cells co-cultured with mouse cochlear modiolus explants	PLOS ONE			English	Article							NEURAL CREST; EXTRACELLULAR-MATRIX; OTIC PLACODE; INNER-EAR; MIGRATION; NERVE; GROWTH; REPAIR; REGENERATION; EXPRESSION	Stem-cell-based repair of auditory neurons may represent an attractive therapeutic option to restore sensorineural hearing loss. Hair-follicle-bulge-derived stem cells (HFBSCs) are promising candidates for this type of therapy, because they (1) have migratory properties, enabling migration after transplantation, (2) can differentiate into sensory neurons and glial cells, and (3) can easily be harvested in relatively high numbers. However, HFBSCs have never been used for this purpose. We hypothesized that HFBSCs can be used for cellbased repair of the auditory nerve and we have examined their migration and incorporation into cochlear modiolus explants and their subsequent differentiation. Modiolus explants obtained from adult wild-type mice were cultured in the presence of EF1a-copGFP-transduced HFBSCs, constitutively expressing copepod green fluorescent protein (copGFP). Also, modiolus explants without hair cells were co-cultured with DCX-copGFP-transduced HFBSCs, which demonstrate copGFP upon doublecortin expression during neuronal differentiation. Velocity of HFBSC migration towards modiolus explants was calculated, and after two weeks, co-cultures were fixed and processed for immunohistochemical staining. EF1 alpha-copGFP HFBSC migration velocity was fast: 80.5 +/- 6.1 mu m/h. After arrival in the explant, the cells formed a fascicular pattern and changed their phenotype into an ATOH1-positive neuronal cell type. DCX-copGFP HFBSCs became green-fluorescent after integration into the explants, confirming neuronal differentiation of the cells. These results show that HFBSC-derived neuronal progenitors are migratory and can integrate into cochlear modiolus explants, while adapting their phenotype depending on this micro-environment. Thus, HFBSCs show potential to be employed in cell-based therapies for auditory nerve repair.	[Schomann, Timo; De Groot, John C. M. J.; Hendriks, Sanne H.; Frijns, Johan H. M.; Huisman, Margriet A.] Leiden Univ, Med Ctr, Dept Otorhinolaryngol & Head & Neck Surg, Leiden, South Holland, Netherlands; [Mezzanotte, Laura] Erasmus MC, Dept Radiol, Opt Mol Imaging Grp, Rotterdam, South Holland, Netherlands; [Rivolta, Marcelo N.] Univ Sheffield, Dept Biomed Sci, Ctr Stem Cell Biol, Sheffield, S Yorkshire, England	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; University of Sheffield	Huisman, MA (corresponding author), Leiden Univ, Med Ctr, Dept Otorhinolaryngol & Head & Neck Surg, Leiden, South Holland, Netherlands.	M.A.Huisman@lumc.nl	Frijns, Johan H.M./H-6249-2011; Schomann, Timo/P-7294-2018	Frijns, Johan H.M./0000-0002-1180-3314; Schomann, Timo/0000-0002-0948-6209; Hendriks, Sanne H/0000-0002-0974-3666; Mezzanotte, Laura/0000-0001-5592-8904	MED-EL (Innsbruck, Austria)	MED-EL (Innsbruck, Austria)	The project is financially supported by grants from MED-EL (Innsbruck, Austria, http://www.medel.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The project is financially supported by grants from MED-EL (Innsbruck, Austria). The authors have no other funding, financial relationships, or conflicts of interest to disclose. We greatly acknowledge Yuedan Li (Department of Immunohematology and Blood Transfusion, LUMC, Leiden, the Netherlands) for performing transduction of the HFBSCs and Martijn Rabelink (Department of Molecular Cell Biology, LUMC, Leiden, the Netherlands) for the production of the lentivirus.	Amoh Y, 2005, P NATL ACAD SCI USA, V102, P5530, DOI 10.1073/pnas.0501263102; Amoh Y, 2005, P NATL ACAD SCI USA, V102, P17734, DOI 10.1073/pnas.0508440102; Amoh Y, 2004, P NATL ACAD SCI USA, V101, P13291, DOI 10.1073/pnas.0405250101; Amoh Y, 2008, CELL CYCLE, V7, P1865, DOI 10.4161/cc.7.12.6056; Amoh Y, 2009, J CELL BIOCHEM, V107, P1016, DOI 10.1002/jcb.22204; Baraniak PR, 2010, REGEN MED, V5, P121, DOI 10.2217/RME.09.74; Baudoin JP, 2008, DEV NEUROSCI-BASEL, V30, P132, DOI 10.1159/000109858; Bhattacharyya S, 2004, CURR OPIN GENET DEV, V14, P520, DOI 10.1016/j.gde.2004.08.002; Chen W, 2012, NATURE, V490, P278, DOI 10.1038/nature11415; Desban N, 2006, J CELL SCI, V119, P3206, DOI 10.1242/jcs.03057; El Seady R, 2008, BIOCHEM BIOPH RES CO, V376, P358, DOI 10.1016/j.bbrc.2008.08.166; Fournier BP, 2016, EUR CELLS MATER, V31, P40, DOI 10.22203/eCM.v031a04; Gho CG, 2016, CYTOTECHNOLOGY, V68, P1849, DOI 10.1007/s10616-015-9938-x; Groves AK, 2014, DEV BIOL, V389, P2, DOI 10.1016/j.ydbio.2013.11.027; Gu SQ, 2016, NUCLEIC ACIDS RES, V44, P5811, DOI 10.1093/nar/gkw497; Huisman Margriet A, 2012, Front Biosci (Schol Ed), V4, P121; Joo S, 2015, SCI REP-UK, V5, DOI 10.1038/srep13043; Kuriyama S, 2008, PHILOS T R SOC B, V363, P1349, DOI 10.1098/rstb.2007.2252; Ladher RK, 2010, DEVELOPMENT, V137, P1777, DOI 10.1242/dev.040055; Lang HN, 2016, SPRINGER HANDB AUDIT, V52, P229, DOI 10.1007/978-1-4939-3031-9_8; Li LN, 2003, P NATL ACAD SCI USA, V100, P9958, DOI 10.1073/pnas.1733025100; Liu F, 2011, CELL CYCLE, V10, P830, DOI 10.4161/cc.10.5.14969; Ma W, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-90; Martin I, 2012, STEM CELL REV REP, V8, P1178, DOI 10.1007/s12015-012-9387-2; Mattotti M, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/2/026001; Maxwell GD, 1996, P NATL ACAD SCI USA, V93, P13274, DOI 10.1073/pnas.93.23.13274; Mezzanotte L, 2013, CONTRAST MEDIA MOL I, V8, P505, DOI 10.1002/cmmi.1549; Mii S, 2013, J CELL BIOCHEM, V114, P1674, DOI 10.1002/jcb.24509; Nayagam BA, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt135; Sandulache VC, 2007, TISSUE ENG, V13, P2791, DOI 10.1089/ten.2006.0412; Santi PA, 2016, JARO-J ASSOC RES OTO, V17, P159, DOI 10.1007/s10162-016-0562-z; Schiraldi C, 2012, EUR CELLS MATER, V24, P426, DOI 10.22203/eCM.v024a30; Schomann T, 2016, CONTRAST MEDIA MOL I, V11, P550, DOI 10.1002/cmmi.1717; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; Steventon B, 2014, DEV BIOL, V389, P28, DOI 10.1016/j.ydbio.2014.01.021; Streit A, 2002, DEV BIOL, V249, P237, DOI 10.1006/dbio.2002.0739; Su WT, 2013, J BIOMED MATER RES A, V101, P185, DOI 10.1002/jbm.a.34318; Sugawara M, 2007, J COMP NEUROL, V501, P30, DOI 10.1002/cne.21227; Tennstaedt A, 2015, BIOMATERIALS, V44, P143, DOI 10.1016/j.biomaterials.2014.12.038; Theveneau E, 2013, NAT CELL BIOL, V15, P763, DOI 10.1038/ncb2772; Uchugonova A, 2011, J CELL BIOCHEM, V112, P2046, DOI 10.1002/jcb.23122; Uchugonova A, 2011, CELL CYCLE, V10, P2017, DOI 10.4161/cc.10.12.15895; VERWOERD CDA, 1981, ACTA OTO-LARYNGOL, V91, P431, DOI 10.3109/00016488109138524; Wang LY, 2011, JARO-J ASSOC RES OTO, V12, P407, DOI 10.1007/s10162-011-0264-5; Yashiro M, 2015, CELL CYCLE, V14, P2362, DOI 10.1080/15384101.2015.1042633	45	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187183	10.1371/journal.pone.0187183	http://dx.doi.org/10.1371/journal.pone.0187183			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084289	Green Submitted, gold, Green Accepted, Green Published			2022-12-26	WOS:000413910200038
J	Dong, S; Liu, LS; Ye, XM				Dong, Shuai; Liu, Lishuai; Ye, Xuemin			Linear stability analysis of magnetohydrodynamic duct flows with perfectly conducting walls	PLOS ONE			English	Article							HARTMANN LAYER; RECTANGULAR DUCT; CHANNEL FLOW; INSTABILITY; PERTURBATIONS; AMPLIFICATION; TRANSITION	The stability of magnetohydrodynamic flow in a duct with perfectly conducting walls is investigated in the presence of a homogeneous and constant static magnetic field. The temporal growth and spatial distribution of perturbations are obtained by solving iteratively the direct and adjoint governing equations with respect of perturbations, based on nonmodal stability theory. The effect of the applied magnetic field, as well as the aspect ratio of the duct on the stability of the magnetohydrodynamic duct flow is taken into account. The computational results show that, weak jets appear near the sidewalls at a moderate magnetic field and the velocity of the jet increases with the increase of the intensity of the magnetic field. The duct flow is stable at either weak or strong magnetic field, but becomes unstable at moderate intensity magnetic field, and the stability is invariance with the aspect ratio of the duct. The instability of magnetohydrodynamic duct flow is related with the exponential growth of perturbations evolving on the fully developed jets. Transient growth of perturbations is also observed in the computation and the optimal perturbation is found to be in the form of streamwise vortices and localized within the sidewall layers. By contrast, the Hartmann layer perpendicular to the magnetic field is irrelevant to the stability issue of the magnetohydrodynamic duct flow.	[Dong, Shuai; Liu, Lishuai; Ye, Xuemin] North China Elect Power Univ, Dept Power Engn, Baoding 071003, Peoples R China	North China Electric Power University	Dong, S (corresponding author), North China Elect Power Univ, Dept Power Engn, Baoding 071003, Peoples R China.	shuai.dong@ncepu.edu	Dong, Shuai/D-3936-2017	Dong, Shuai/0000-0002-2099-8555	National Natural Science Foundation of China [11302076]; Natural Science Foundation of Hebei Province [A2014502047]; Fundamental Research Funds for the Central Universities [2014MS111]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The authors would like to thank the support of the National Natural Science Foundation of China (No. 11302076) to SD, the Natural Science Foundation of Hebei Province (No. A2014502047) to SD and the Fundamental Research Funds for the Central Universities (No. 2014MS111) to SD.; The authors would like to thank the support of the National Natural Science Foundation of China (No. 11302076), the Natural Science Foundation of Hebei Province (No. A2014502047) and the Fundamental Research Funds for the Central Universities (No. 2014MS111). The work was carried out at National Supercomputer Center in Tianjin, and the calculations were performed on TianHe-1(A).	Airiau C, 2004, PHYS FLUIDS, V16, P2991, DOI 10.1063/1.1765645; Biau D, 2008, J FLUID MECH, V596, P133, DOI 10.1017/S0022112007009536; Braiden L, 2016, EPL-EUROPHYS LETT, V115, DOI 10.1209/0295-5075/115/44002; BRANOVER H., 1978, MAGNETOHYDRODYNAMIC; BUTLER KM, 1992, PHYS FLUIDS A-FLUID, V4, P1637, DOI 10.1063/1.858386; Davidson PA., 2001, INTRO MAGNETOHYDRODY; Dong S, 2017, J APPL FLUID MECH, V10, P1293, DOI 10.18869/acadpub.jafm.73.242.27310; Dong S, 2015, MAGNETOHYDRODYNAMICS, V51, P225, DOI 10.22364/mhd.51.2.6; Dong S, 2016, EUR J MECH B-FLUID, V60, P209, DOI 10.1016/j.euromechflu.2016.06.008; Gerard-Varet D, 2002, PHYS FLUIDS, V14, P1458, DOI 10.1063/1.1456512; Hartmann J., 1937, KGL DAN VIDENSK SELS, V15, P1; HUNT JCR, 1965, J FLUID MECH, V21, P577, DOI 10.1017/S0022112065000344; Kinet M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.154501; Krasnov D, 2010, J FLUID MECH, V653, P273, DOI 10.1017/S0022112010000273; Krasnov DS, 2004, J FLUID MECH, V504, P183, DOI 10.1017/S0022112004008006; LANDAHL MT, 1980, J FLUID MECH, V98, P243, DOI 10.1017/S0022112080000122; Lingwood RJ, 1999, PHYS FLUIDS, V11, P2058, DOI 10.1063/1.870068; MOLOKOV S., 2007, MAGNETOHYDRODYNAMICS; Moresco P, 2004, J FLUID MECH, V504, P167, DOI 10.1017/S0022112004007992; MULLER U., 2001, MAGNETOFLUIDDYNAMICS; MURGATROYD W, 1953, PHILOS MAG, V44, P1348; Orr W. M., 1907, P ROY IRISH ACAD A, V27, P9; Priede J, 2012, J FLUID MECH, V708, P111, DOI 10.1017/jfm.2012.276; Reddy SC, 1998, J FLUID MECH, V365, P269, DOI 10.1017/S0022112098001323; SCHMID P., 2001, STABILITY TRANSITION; Schmid PJ, 2007, ANNU REV FLUID MECH, V39, P129, DOI 10.1146/annurev.fluid.38.050304.092139; SHERCLIFF JA, 1953, P CAMB PHILOS SOC, V49, P136, DOI 10.1017/S0305004100028139; TATSUMI T, 1990, J FLUID MECH, V212, P437, DOI 10.1017/S002211209000204X; Uhlmann M, 2006, J FLUID MECH, V551, P387, DOI 10.1017/S0022112005008487; Zikanov O, 2014, APPL MECH REV, V66, DOI 10.1115/1.4027198	30	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186944	10.1371/journal.pone.0186944	http://dx.doi.org/10.1371/journal.pone.0186944			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077734	Green Published, Green Submitted, gold			2022-12-26	WOS:000413861200028
J	Kaza, N; Raju, SV; Cadillac, JM; Trombley, JA; Rasmussen, L; Tang, LP; Dohm, E; Harrod, KS; Rowe, SM				Kaza, Niroop; Raju, S. Vamsee; Cadillac, Joan M.; Trombley, John A.; Rasmussen, Lawrence; Tang, Liping; Dohm, Erik; Harrod, Kevin S.; Rowe, Steven M.			Use of ferrets for electrophysiologic monitoring of ion transport	PLOS ONE			English	Article							POTENTIAL DIFFERENCE MEASUREMENTS; OBSTRUCTIVE PULMONARY-DISEASE; CYSTIC-FIBROSIS MICE; ANIMAL-MODELS; KNOCKOUT FERRETS; EPITHELIAL-CELLS; CFTR MODULATORS; AIRWAY; ABNORMALITIES; PHENOTYPE	Limited success achieved in translating basic science discoveries into clinical applications for chronic airway diseases is attributed to differences in respiratory anatomy and physiology, poor approximation of pathologic processes, and lack of correlative clinical endpoints between humans and laboratory animal models. Here, we discuss advantages of using ferrets (Mustela putorus furo) as a model for improved understanding of human airway physiology and demonstrate assays for quantifying airway epithelial ion transport in vivo and ex vivo, and establish air-liquid interface cultures of ferret airway epithelial cells as a complementary in vitro model for mechanistic studies. We present data here that establishes the feasibility of measuring these human disease endpoints in ferrets. Briefly, potential difference across the nasal and the lower airway epithelium in ferrets could be consistently assessed, were highly reproducible, and responsive to experimental interventions. Additionally, ferret airway epithelial cells were amenable to primary cell culture methods for in vitro experiments as was the use of ferret tracheal explants as an ex vivo system for assessing ion transport. The feasibility of conducting multiple assessments of disease outcomes supports the adoption of ferrets as a highly relevant model for research in obstructive airway diseases.	[Kaza, Niroop; Raju, S. Vamsee; Rasmussen, Lawrence; Tang, Liping; Rowe, Steven M.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Kaza, Niroop; Raju, S. Vamsee; Rasmussen, Lawrence; Tang, Liping; Rowe, Steven M.] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35487 USA; [Cadillac, Joan M.; Dohm, Erik] Univ Alabama Birmingham, Anim Resources Program, Birmingham, AL USA; [Trombley, John A.; Harrod, Kevin S.] Univ Alabama Birmingham, Dept Anesthesiol, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Rowe, SM (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.; Rowe, SM (corresponding author), Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35487 USA.	smrowe@uab.edu		Harrod, Kevin/0000-0003-0780-9470; Rowe, Steven/0000-0001-9045-0133; Kaza, Niroop/0000-0002-7584-1379; Dohm, Erik/0000-0001-7477-6264	National Institute of Diabetes and Digestive and Kidney Diseases [P30 DK072482]; National Heart, Lung, and Blood Institute [1R01 HL105487, CFF R262]; American Lung Associationm [RG-305752]; Flight Attendants Medical Research Association [YFA130008]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R35HL135816] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Lung Associationm; Flight Attendants Medical Research Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases, Grant P30 DK072482 (SMR), the National Heart, Lung, and Blood Institute grant 1R01 HL105487 (SMR),CFF R262 (SMR), American Lung Associationm, Grant RG-305752 (SVR), Flight Attendants Medical Research Association Grant, Grant YFA130008 (SVR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alton E, 2016, RANDOMISED DOUBLE BL; Bouvier NM, 2015, CURR OPIN VIROL, V13, P101, DOI 10.1016/j.coviro.2015.06.002; CORRALES RJ, 1986, J APPL PHYSIOL, V61, P1065, DOI 10.1152/jappl.1986.61.3.1065; Davies JC, 2005, AM J RESP CRIT CARE, V171, P1015, DOI 10.1164/rccm.200408-1116OC; Dransfield MT, 2013, CHEST, V144, P498, DOI 10.1378/chest.13-0274; Fisher JT, 2013, AM J RESP CELL MOL, V49, P837, DOI 10.1165/rcmb.2012-0433OC; Fisher JT, 2011, METHODS MOL BIOL, V742, P311, DOI 10.1007/978-1-61779-120-8_19; Flisikowska T, 2014, J APPL GENET, V55, P53, DOI 10.1007/s13353-013-0182-9; Fricker M, 2014, EXPERT OPIN DRUG DIS, V9, P629, DOI 10.1517/17460441.2014.909805; Fulcher M Leslie, 2013, Methods Mol Biol, V945, P109, DOI 10.1007/978-1-62703-125-7_8; Gohy ST, 2016, CLIN EXP ALLERGY, V46, P529, DOI 10.1111/cea.12712; Grubb Barbara R., 1999, Physiological Reviews, V79, pS193; GRUBB BR, 1994, AM J PHYSIOL, V267, pC293, DOI 10.1152/ajpcell.1994.267.1.C293; Hoegger MJ, 2014, SCIENCE, V345, P818, DOI 10.1126/science.1255825; Keiser NW, 2011, CURR OPIN PULM MED, V17, P478, DOI 10.1097/MCP.0b013e32834b14c9; Kent G, 1996, PEDIATR RES, V40, P233, DOI 10.1203/00006450-199608000-00008; Mannino DM, 2000, ARCH INTERN MED, V160, P1683, DOI 10.1001/archinte.160.11.1683; Mou HM, 2016, CELL STEM CELL, V19, P217, DOI 10.1016/j.stem.2016.05.012; Neuberger T, 2011, METHODS MOL BIOL, V741, P39, DOI 10.1007/978-1-61779-117-8_4; Nikula KJ, 2000, INHAL TOXICOL, V12, P123, DOI 10.1080/089583700750019549; Plourde JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046605; Pyle LC, 2011, AM J PHYSIOL-LUNG C, V301, pL587, DOI 10.1152/ajplung.00465.2010; Radigan KA, 2015, INFECT DRUG RESIST, V8, P311, DOI 10.2147/IDR.S58551; Raju SV, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87536; Rowe SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066955; Rowe SM, 2013, CHEST, V144, P200, DOI 10.1378/chest.12-2431; Rowe SM, 2011, METHODS MOL BIOL, V741, P69, DOI 10.1007/978-1-61779-117-8_6; Saussereau EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057317; Shah VS, 2016, SCIENCE, V351, P503, DOI 10.1126/science.aad5589; Solomon GM, 2010, CHEST, V138, P919, DOI 10.1378/chest.10-0179; Sun XS, 2014, AM J RESP CELL MOL, V50, P502, DOI 10.1165/rcmb.2013-0261OC; Sun XS, 2010, J CLIN INVEST, V120, P3149, DOI 10.1172/JCI43052; Suprynowicz FA, 2012, P NATL ACAD SCI USA, V109, P20035, DOI 10.1073/pnas.1213241109; Tang XX, 2016, J CLIN INVEST, V126, P879, DOI 10.1172/JCI83922; Tuggle KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091253; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Vlahos R, 2015, EUR J PHARMACOL, V759, P265, DOI 10.1016/j.ejphar.2015.03.029	37	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186984	10.1371/journal.pone.0186984	http://dx.doi.org/10.1371/journal.pone.0186984			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077751	gold, Green Published, Green Submitted			2022-12-26	WOS:000413861200033
J	Trefier, A; Musnier, A; Landomiel, F; Bourquard, T; Boulo, T; Ayoub, MA; Leon, K; Bruneau, G; Chevalier, M; Durand, G; Blache, MC; Inoue, A; Fontaine, J; Gauthier, C; Tesseraud, S; Reiter, E; Poupon, A; Crepieux, P				Trefier, Aurelie; Musnier, Astrid; Landomiel, Flavie; Bourquard, Thomas; Boulo, Thomas; Ayoub, Mohammed Akli; Leon, Kelly; Bruneau, Gilles; Chevalier, Manon; Durand, Guillaume; Blache, Marie-Claire; Inoue, Asuka; Fontaine, Joel; Gauthier, Christophe; Tesseraud, Sophie; Reiter, Eric; Poupon, Anne; Crepieux, Pascale			G protein-dependent signaling triggers a beta-arrestin-scaffolded p70S6K/rpS6 module that controls 5 ' TOP mRNA translation	FASEB JOURNAL			English	Article						GPCR; FSHR; gene regulation	FOLLICLE-STIMULATING-HORMONE; COUPLED RECEPTOR KINASES; TESTIS BARRIER DYNAMICS; CRYSTAL-STRUCTURE; S6 PHOSPHORYLATION; PHOSPHATASE 2A; ACTIVATION; MTOR; RPS6; ERK	Many interaction partners of beta-arrestins intervene in the control of mRNA translation. However, how b-arrestins regulate this cellular process has been poorly explored. In this study, we show that beta-arrestins constitutively assemble a p70S6K/ribosomal protein S6 (rpS6) complex in HEK293 cells and in primary Sertoli cells of the testis. We demonstrate that this interaction is direct, and experimentally validate the interaction interface between beta-arrestin 1 and p70S6K predicted by our docking algorithm. Like most GPCRs, the biological function of follicle-stimulating hormone receptor (FSHR) is transduced by G proteins and beta-arrestins. Upon follicle-stimulating hormone (FSH) stimulation, activation of G protein-dependent signaling enhances p70S6K activity within the beta-arrestin/p70S6K/rpS6 preassembled complex, which is not recruited to the FSHR. In agreement, FSH-induced rpS6 phosphorylation within the beta-arrestin scaffold was decreased in cells depleted of Gas. Integration of the cooperative action of beta-arrestin and G proteins led to the translation of 59 oligopyrimidine track mRNA with high efficacy within minutes of FSH input. Hence, this work highlights new relationships between G proteins and beta-arrestins when acting cooperatively on a common signaling pathway, contrasting with their previously shown parallel action on the ERK MAP kinase pathway. In addition, this study provides insights into how GPCR can exert trophic effects in the cell.	[Trefier, Aurelie; Musnier, Astrid; Landomiel, Flavie; Bourquard, Thomas; Boulo, Thomas; Ayoub, Mohammed Akli; Leon, Kelly; Bruneau, Gilles; Chevalier, Manon; Durand, Guillaume; Fontaine, Joel; Gauthier, Christophe; Reiter, Eric; Poupon, Anne; Crepieux, Pascale] INRA, Biol & Bioinformat Signaling Syst BIOS Grp, Nouzilly, France; [Blache, Marie-Claire] INRA, Unite Physiol Reprod & Comportements, Unite Mixte Rech 85, PIC, Nouzilly, France; [Tesseraud, Sophie] INRA, Unite Rech Avicoles, Unite Rech 83, Metab Birds Qual & Adaptat MOQA Grp, Nouzilly, France; [Trefier, Aurelie; Musnier, Astrid; Landomiel, Flavie; Bourquard, Thomas; Boulo, Thomas; Ayoub, Mohammed Akli; Leon, Kelly; Bruneau, Gilles; Chevalier, Manon; Durand, Guillaume; Blache, Marie-Claire; Fontaine, Joel; Gauthier, Christophe; Reiter, Eric; Poupon, Anne; Crepieux, Pascale] CNRS, Unite Mixte Rech 7247, Nouzilly, France; [Trefier, Aurelie; Musnier, Astrid; Landomiel, Flavie; Bourquard, Thomas; Boulo, Thomas; Ayoub, Mohammed Akli; Leon, Kelly; Bruneau, Gilles; Chevalier, Manon; Durand, Guillaume; Blache, Marie-Claire; Fontaine, Joel; Gauthier, Christophe; Reiter, Eric; Poupon, Anne; Crepieux, Pascale] Univ Tours, Tours, France; [Trefier, Aurelie; Musnier, Astrid; Landomiel, Flavie; Bourquard, Thomas; Boulo, Thomas; Ayoub, Mohammed Akli; Leon, Kelly; Bruneau, Gilles; Chevalier, Manon; Durand, Guillaume; Blache, Marie-Claire; Fontaine, Joel; Gauthier, Christophe; Reiter, Eric; Poupon, Anne; Crepieux, Pascale] IFCE, Nouzilly, France; [Inoue, Asuka] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi, Japan; [Ayoub, Mohammed Akli] United Arab Emirates Univ, Coll Sci, Biol Dept, Al Ain, U Arab Emirates	INRAE; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; INRAE; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; Tohoku University; United Arab Emirates University	Crepieux, P (corresponding author), CNRS, Ctr Rech Val de Loire, UMR7247, F-37380 Nouzilly, France.	Pascale.Crepieux@inra.fr	Crepieux, Pascale/X-3217-2019; Durand, Guillaume/K-6352-2019	Durand, Guillaume/0000-0001-6655-5904; AYOUB, Mohammed Akli/0000-0003-0022-578X; musnier, astrid/0000-0002-9994-3724	Institut National de la Recherche Agronomique PHASE Department; Centre National de la Recherche Scientifique; ANR program GPCRnet; Region Centre	Institut National de la Recherche Agronomique PHASE Department; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); ANR program GPCRnet(French National Research Agency (ANR)); Region Centre(Region Centre-Val de Loire)	The authors thank Professor Robert J. Lefkowitz (Duke University, Durham, NC, USA) for the kind gift of beta-arrestin 1,2 knockout MEFs, Dr. George R. Bousfield (Wichita State University, KS, USA) for the generous gift of highly purified porcine FSH, Professor Jean-Claude Lacaille (Universite de Montreal, QC, Canada) for the gift of the 5 ' TOP-YFP reporter, Dr. Jerome A.J. Becker (UMR PRC, Nouzilly, France) for critical and helpful reading of the manuscript, Isaline Bolard (UMR PRC, Nouzilly, France) for excellent technical assistance, and the staff of UEPAO (Domaine de l'Orfrasiere, Nouzilly, France). This work has benefited from the facilities and expertise of the Plateforme d'imagerie Cellulaire (PIC) of the UMR-PRC. This work was funded by the Institut National de la Recherche Agronomique PHASE Department, by the Centre National de la Recherche Scientifique, by the ANR program GPCRnet and by the Region Centre. The authors declare no conflicts of interest.	Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Alam H, 2004, J BIOL CHEM, V279, P19431, DOI 10.1074/jbc.M401235200; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Biever A, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00075; Biever A, 2015, J NEUROSCI, V35, P4113, DOI 10.1523/JNEUROSCI.3288-14.2015; Boularan C, 2007, P NATL ACAD SCI USA, V104, P18061, DOI 10.1073/pnas.0705550104; Bourquard T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10760; Crepieux P, 2001, ONCOGENE, V20, P4696, DOI 10.1038/sj.onc.1204632; Crepieux P, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00032; CSIBI A, 2010, PLOS ONE, V5; Dennis PB, 1998, J BIOL CHEM, V273, P14845, DOI 10.1074/jbc.273.24.14845; Dewire SM, 2008, J BIOL CHEM, V283, P10611, DOI 10.1074/jbc.M710515200; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Freedman NJ, 1996, RECENT PROG HORM RES, V51, P319; Fritz I B, 1975, Curr Top Mol Endocrinol, V2, P367; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Gloaguen Pauline, 2011, Front Endocrinol (Lausanne), V2, P45, DOI 10.3389/fendo.2011.00045; Gobert D, 2008, J NEUROCHEM, V106, P1160, DOI 10.1111/j.1471-4159.2008.05470.x; GUILLOU F, 1986, BIOCHIM BIOPHYS ACTA, V887, P196, DOI 10.1016/0167-4889(86)90055-8; Hahn K, 2010, CELL METAB, V11, P438, DOI 10.1016/j.cmet.2010.03.015; Han K, 2014, NAT METHODS, V11, P86, DOI [10.1038/NMETH.2729, 10.1038/nmeth.2729]; Heitzler D, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.22; Hohenegger M, 1998, P NATL ACAD SCI USA, V95, P346, DOI 10.1073/pnas.95.1.346; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hou XY, 2010, ENDOCRINOLOGY, V151, P2846, DOI 10.1210/en.2009-1032; Huynh J, 2009, MOL CELL ENDOCRINOL, V302, P118, DOI 10.1016/j.mce.2009.01.002; JEFFERIES HBJ, 1994, P NATL ACAD SCI USA, V91, P4441, DOI 10.1073/pnas.91.10.4441; Johnston H, 2004, ENDOCRINOLOGY, V145, P318, DOI 10.1210/en.2003-1055; Kang DS, 2014, CURR OPIN CELL BIOL, V27, P63, DOI 10.1016/j.ceb.2013.11.005; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Kara E, 2006, MOL ENDOCRINOL, V20, P3014, DOI 10.1210/me.2006-0098; Kendall RT, 2014, J BIOL CHEM, V289, P26155, DOI 10.1074/jbc.M114.595728; Kim YK, 2014, J BIOL CHEM, V289, P3901, DOI 10.1074/jbc.M113.515015; Kitano H, 2005, NAT BIOTECHNOL, V23, P961, DOI 10.1038/nbt1111; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Kristensen AR, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.47; Kruger T, 2007, J CELL BIOL, V177, P573, DOI 10.1083/jcb.200612048; Lecureuil C, 2005, MOL ENDOCRINOL, V19, P1812, DOI 10.1210/me.2004-0289; Lee MH, 2016, NATURE, V531, P665, DOI 10.1038/nature17154; Lefkowitz RJ, 2004, CURR OPIN CELL BIOL, V16, P162, DOI 10.1016/j.ceb.2004.01.001; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Leon K, 2014, J MOL ENDOCRINOL, V52, P373, DOI 10.1530/JME-14-0009; Li B, 2013, FEBS LETT, V587, P410, DOI 10.1016/j.febslet.2013.01.027; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Marion S, 2002, BIOL REPROD, V66, P70, DOI 10.1095/biolreprod66.1.70; Marion S, 2006, J ENDOCRINOL, V190, P341, DOI 10.1677/joe.1.06857; Meyuhas O, 2015, BBA-GENE REGUL MECH, V1849, P801, DOI 10.1016/j.bbagrm.2014.08.015; Meyuhas Oded, 1996, V30, P363; Milano SK, 2006, J BIOL CHEM, V281, P9812, DOI 10.1074/jbc.M512703200; Miller WE, 2001, CURR OPIN CELL BIOL, V13, P139, DOI 10.1016/S0955-0674(00)00190-3; Mok KW, 2015, ENDOCRINOLOGY, V156, P1900, DOI 10.1210/en.2014-1791; Mok KW, 2014, J CELL SCI, V127, P4870, DOI 10.1242/jcs.152231; Mok KW, 2012, ENDOCRINOLOGY, V153, P5036, DOI 10.1210/en.2012-1665; Musnier A, 2012, MOL ENDOCRINOL, V26, P669, DOI 10.1210/me.2011-1267; Musnier A, 2010, CELL SIGNAL, V22, P707, DOI 10.1016/j.cellsig.2009.10.012; Musnier A, 2009, CELL MOL LIFE SCI, V66, P3487, DOI 10.1007/s00018-009-0134-z; Nakamura K, 1998, J BIOL CHEM, V273, P24346, DOI 10.1074/jbc.273.38.24346; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; Reiter E, 2001, BIOCHEM BIOPH RES CO, V282, P71, DOI 10.1006/bbrc.2001.4534; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Rosner M, 2011, ONCOGENE, V30, P4509, DOI 10.1038/onc.2011.165; Rosner M, 2011, AMINO ACIDS, V40, P595, DOI 10.1007/s00726-010-0684-2; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shiina T, 2000, J BIOL CHEM, V275, P29082, DOI 10.1074/jbc.M909757199; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; Son O, 2015, BIOCHEM BIOPH RES CO, V465, P200, DOI 10.1016/j.bbrc.2015.07.150; Stallaert W, 2017, MOL PHARMACOL, V91, P533, DOI 10.1124/mol.116.106419; Sunami T, 2010, J BIOL CHEM, V285, P4587, DOI 10.1074/jbc.M109.040667; Thomsen ARB, 2016, CELL, V166, P907, DOI 10.1016/j.cell.2016.07.004; Tian Xufan, 2014, Handb Exp Pharmacol, V219, P173, DOI 10.1007/978-3-642-41199-1_9; Troispoux C, 1999, MOL ENDOCRINOL, V13, P1599, DOI 10.1210/me.13.9.1599; Wehbi V, 2010, MOL ENDOCRINOL, V24, P561, DOI 10.1210/me.2009-0347; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Wiedemann A, 2016, FASEB J, V30, P4180, DOI 10.1096/fj.201600701R; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Yang M, 2009, BIOCHEM J, V417, P287, DOI 10.1042/BJ20081561; Yu UY, 2010, BMB REP, V43, P263, DOI 10.5483/BMBRep.2010.43.4.263; Zhan XZ, 2011, J MOL BIOL, V406, P467, DOI 10.1016/j.jmb.2010.12.034; Zhang X, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13223	89	19	21	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1154	1169		10.1096/fj.201700763R	http://dx.doi.org/10.1096/fj.201700763R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29084767				2022-12-26	WOS:000427246000005
J	Song, SH; Jeon, MS; Nam, JW; Kang, JK; Lee, YJ; Kang, JY; Kim, HP; Han, SW; Kang, GH; Kim, TY				Song, S. H.; Jeon, M. S.; Nam, J. W.; Kang, J. K.; Lee, Y. J.; Kang, J. Y.; Kim, H. P.; Han, S. W.; Kang, G. H.; Kim, T. Y.			Aberrant GATA2 epigenetic dysregulation induces a GATA2/GATA6 switch in human gastric cancer	ONCOGENE			English	Article							BETA-GLOBIN LOCUS; ACUTE MYELOID-LEUKEMIA; DNA METHYLATION; HELICOBACTER-PYLORI; EMBRYONIC-DEVELOPMENT; LINEAGE-SURVIVAL; POLYCOMB; RISK; DIFFERENTIATION; EXPRESSION	Six GATA transcription factors play important roles in eukaryotic development. Among these, GATA2, an essential factor for the hematopoietic cell lineage, exhibits low expression in human gastric tissues, whereas GATA6, which is crucial for gastrointestinal development and differentiation, is frequently amplified and/or overexpressed in human gastric cancer. Interestingly, we found that GATA6 was overexpressed in human gastric cancer cells only when GATA2 expression was completely absent, thereby showing an inverse correlation between GATA2 and GATA6. In gastric cancer cells that express high GATA6 levels, a GATA2 CpG island is hypermethylated, repressing expression in these cells. In contrast, GATA6 expression is undetectable in GATA2-overexpressing gastric cancer cells, which lack GATA2 DNA methylation. Furthermore, PRC2 complex-mediated transcriptional silencing of GATA6 was observed in the GATA2-overexpressing cells. We also show that the GATA2 and PRC2 complexes are enriched within the GATA6 locus, and that the recruitment of the PRC2 complex is impaired by disrupting GATA2 expression, resulting in GATA6 upregulation. In addition, ectopic GATA2 expression significantly downregulates GATA6 expression, suggesting GATA2 directly represses GATA6. Furthermore, GATA6 downregulation showed antitumor activity by inducing growth arrest. Finally, we show that aberrant GATA2 methylation occurs early during the multistep process of gastric carcinogenesis regardless of Helicobacter pylori infection. Taken together, GATA2 dysregulation by epigenetic modification is associated with unfavorable phenotypes in human gastric cancer cells by allowing GATA6 expression.	[Song, S. H.; Jeon, M. S.; Nam, J. W.; Kang, J. K.; Lee, Y. J.; Kang, J. Y.; Kim, H. P.; Han, S. W.; Kim, T. Y.] Seoul Natl Univ, Canc Res Inst, Canc Genom Res Lab, Seoul, South Korea; [Jeon, M. S.; Nam, J. W.; Kang, J. K.; Lee, Y. J.; Kang, J. Y.; Kim, H. P.; Kim, T. Y.] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea; [Han, S. W.; Kim, T. Y.] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Kang, G. H.] Seoul Natl Univ, Canc Res Inst, Lab Epigenet, Seoul, South Korea; [Kang, G. H.] Seoul Natl Univ, Dept Pathol, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Kim, TY (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea.	kimty@snu.ac.kr	/Y-5959-2019; Kang, Gyeong Hoon/F-1051-2010	Kang, Gyeong Hoon/0000-0003-2380-6675	Korea Health Technology R&D Project through the Korea Health Industry Development Institute; Ministry of Health & Welfare, Republic of Korea [HI14C1277]; Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning, Republic of Korea [NRF-2016M3A9B6026918, NRF-2016M3A9B6026921, 2011-0030049]; NRF - Ministry of Education, Republic of Korea [NRF-2016R1D1A1B03930736]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute; Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning, Republic of Korea(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea); NRF - Ministry of Education, Republic of Korea(Ministry of Education (MOE), Republic of KoreaNational Research Foundation of Korea)	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health & Welfare, Republic of Korea (HI14C1277), by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning, Republic of Korea (NRF-2016M3A9B6026918, NRF-2016M3A9B6026921 and 2011-0030049) and by Basic Science Research Program through the NRF funded by the Ministry of Education, Republic of Korea (NRF-2016R1D1A1B03930736).	Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Beuling E, 2011, GASTROENTEROLOGY, V140, P1219, DOI 10.1053/j.gastro.2011.01.033; Bresnick EH, 2012, NUCLEIC ACIDS RES, V40, P5819, DOI 10.1093/nar/gks281; Bresnick EH, 2010, J BIOL CHEM, V285, P31087, DOI 10.1074/jbc.R110.159079; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Capo-Chichi CD, 2009, MOL CELL BIOL, V29, P4766, DOI 10.1128/MCB.00087-09; Cheung WKC, 2013, CANCER CELL, V23, P725, DOI 10.1016/j.ccr.2013.04.009; Chia NY, 2015, GUT, V64, P707, DOI 10.1136/gutjnl-2013-306596; Deng DJ, 2010, ADV GENET, V71, P125, DOI [10.1016/S0065-2660(10)71005-1, 10.1016/B978-0-12-380864-6.00005-5]; Deng NT, 2012, GUT, V61, P673, DOI 10.1136/gutjnl-2011-301839; Dyson MT, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004158; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; Hattori N, 2014, BIOCHEM BIOPH RES CO, V455, P3, DOI 10.1016/j.bbrc.2014.08.140; Haveri H, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-9; Johnson KD, 2012, J CLIN INVEST, V122, P3692, DOI 10.1172/JCI61623; Kang JY, 2015, ONCOGENE, V34, P5677, DOI 10.1038/onc.2015.17; Kang JY, 2015, AM J PATHOL, V185, P666, DOI 10.1016/j.ajpath.2014.11.022; Kang XL, 2010, MOL CELL, V38, P191, DOI 10.1016/j.molcel.2010.03.005; Kang Y, 2017, BBA-GENE REGUL MECH, V1860, P416, DOI 10.1016/j.bbagrm.2017.01.013; Kang Y, 2015, BBA-GENE REGUL MECH, V1849, P282, DOI 10.1016/j.bbagrm.2014.12.010; Karimi P, 2014, CANCER EPIDEM BIOMAR, V23, P700, DOI 10.1158/1055-9965.EPI-13-1057; Katsumura KR, 2016, CELL REP, V16, P2428, DOI 10.1016/j.celrep.2016.07.058; Kim HP, 2014, ONCOGENE, V33, P5434, DOI 10.1038/onc.2013.490; Ku Ja-Lok, 2005, Cancer Res Treat, V37, P1, DOI 10.4143/crt.2005.37.1.1; Lin L, 2012, P NATL ACAD SCI USA, V109, P4251, DOI 10.1073/pnas.1011989109; Liu ZJ, 2014, CLIN CANCER RES, V20, P4598, DOI 10.1158/1078-0432.CCR-13-3380; Liu-Chittenden Y, 2017, ONCOGENE, V36, P3541, DOI 10.1038/onc.2016.497; Lu R, 2011, J BIOL CHEM, V286, P8425, DOI 10.1074/jbc.M110.202150; Maekita T, 2006, CLIN CANCER RES, V12, P989, DOI 10.1158/1078-0432.CCR-05-2096; Matsusaka K, 2014, WORLD J GASTROENTERO, V20, P3916, DOI 10.3748/wjg.v20.i14.3916; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Moriguchi T, 2014, INT J HEMATOL, V100, P417, DOI 10.1007/s12185-014-1568-0; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Morrisey EE, 1997, DEV BIOL, V183, P21, DOI 10.1006/dbio.1996.8485; Nakajima T, 2006, CANCER EPIDEM BIOMAR, V15, P2317, DOI 10.1158/1055-9965.EPI-06-0436; Pan XQ, 2000, J BIOCHEM, V127, P105, DOI 10.1093/oxfordjournals.jbchem.a022570; Park SY, 2009, J PATHOL, V219, P410, DOI 10.1002/path.2596; Ping N, 2017, LEUKEMIA, V31, P195, DOI 10.1038/leu.2016.162; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shih AH, 2015, CANCER CELL, V27, P502, DOI 10.1016/j.ccell.2015.03.009; Song SH, 2007, MOL CELL, V28, P810, DOI 10.1016/j.molcel.2007.09.025; Song SH, 2011, DRUGS, V71, P2391, DOI 10.2165/11596690-000000000-00000; Sulahian R, 2014, ONCOGENE, V33, P5637, DOI 10.1038/onc.2013.517; Tahara T, 2015, EPIGENOMICS-UK, V7, P475, DOI 10.2217/epi.15.4; Ushijima T, 2012, CLIN CANCER RES, V18, P923, DOI 10.1158/1078-0432.CCR-11-2011; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Yun J, 2016, NUCLEIC ACIDS RES, V44, P558, DOI 10.1093/nar/gkv933	51	17	18	1	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 22	2018	37	8					993	1004		10.1038/onc.2017.397	http://dx.doi.org/10.1038/onc.2017.397			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FX2QD	29106391				2022-12-26	WOS:000425905700003
J	Zhou, XH; DeLucia, M; Hao, CL; Hrecka, K; Monnie, C; Skowronski, J; Ahn, J				Zhou, Xiaohong; DeLucia, Maria; Hao, Caili; Hrecka, Kasia; Monnie, Christina; Skowronski, Jacek; Ahn, Jinwoo			HIV-1 Vpr protein directly loads helicase-like transcription factor (HLTF) onto the CRL4-DCAF1 E3 ubiquitin ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CELL NUCLEAR ANTIGEN; REPLICATION FORK; G(2) ARREST; ACCESSORY PROTEINS; IN-VIVO; DNA; ACTIVATION; COMPLEX; CYCLE	The viral protein R (Vpr) is an accessory virulence factor of HIV-1 that facilitates infection in immune cells. Cellular functions of Vpr are tied to its interaction with DCAF1, a substrate receptor component of the CRL4 E3 ubiquitin ligase. Recent proteomic approaches suggested that Vpr degrades helicase-like transcription factor (HLTF) DNA helicase in a proteasome-dependent manner by redirecting the CRL4-DCAF1 E3 ligase. However, the precise molecular mechanism of Vpr-dependent HLTF depletion is not known. Here, using in vitro reconstitution assays, we show that Vpr mediates polyubiquitination of HLTF, by directly loading it onto the C-terminal WD40 domain of DCAF1 in complex with the CRL4 E3 ubiquitin ligase. Mutational analyses suggest that Vpr interacts with DNA-binding residues in the N-terminal HIRAN domain of HLTF in a manner similar to the recruitment of another target, uracil DNA glycosylase (UNG2), to the CRL4-DCAF1 E3 by Vpr. Strikingly, Vpr also engages a second, adjacent region, which connects the HIRAN and ATPase/helicase domains. Thus, our findings reveal that Vpr utilizes common as well as distinctive interfaces to recruit multiple postreplication DNA repair proteins to the CRL4-DCAF1 E3 ligase for ubiquitin-dependent proteasomal degradation.	[Zhou, Xiaohong; DeLucia, Maria; Monnie, Christina; Ahn, Jinwoo] Univ Pittsburgh, Sch Med, Dept Struct Biol, Pittsburgh, PA 15260 USA; [Zhou, Xiaohong; DeLucia, Maria; Monnie, Christina; Ahn, Jinwoo] Univ Pittsburgh, Sch Med, Pittsburgh Ctr HIV Prot Interact, Pittsburgh, PA 15260 USA; [Hao, Caili; Hrecka, Kasia; Skowronski, Jacek] Case Western Reserve Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Case Western Reserve University	Ahn, J (corresponding author), Biomed Sci Tower 3,Rm 1055,3501 Fifth Ave, Pittsburgh, PA 15260 USA.	jia12@pitt.edu	Zhou, Xiaohong/B-3416-2012	Zhou, Xiaohong/0000-0003-0519-2550	National Institute of Health [P50GM082251, R01GM116642, R01AI100673, R01GM123973]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM123973, R01GM116642, P50GM082251] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of Health Grants P50GM082251 (J. A. and J. S.), R01GM116642 (J. A.), R01AI100673 (J. S.), and R01GM123973 (J. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Achar YJ, 2015, NUCLEIC ACIDS RES, V43, P10277, DOI 10.1093/nar/gkv896; Achar YJ, 2011, P NATL ACAD SCI USA, V108, P14073, DOI 10.1073/pnas.1101951108; Ahn J, 2012, J BIOL CHEM, V287, P12550, DOI 10.1074/jbc.M112.340711; Ahn J, 2011, BIOCHEMISTRY-US, V50, P1359, DOI 10.1021/bi101749s; Ahn J, 2010, J BIOL CHEM, V285, P37333, DOI 10.1074/jbc.M110.133181; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Belzile JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001080; Blastyak A, 2010, MOL CELL BIOL, V30, P684, DOI 10.1128/MCB.00863-09; Chiu RK, 2006, PLOS GENET, V2, P1070, DOI 10.1371/journal.pgen.0020116; Collins DR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003851; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; DeHart JL, 2008, J VIROL, V82, P1066, DOI 10.1128/JVI.01628-07; DeHart JL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-57; DeLucia M, 2013, J BIOL CHEM, V288, P19116, DOI 10.1074/jbc.M113.469007; DePaula-Silva AB, 2015, VIROLOGY, V477, P10, DOI 10.1016/j.virol.2014.12.040; Goh WC, 1998, NAT MED, V4, P65, DOI 10.1038/nm0198-065; Hishiki A, 2015, J BIOL CHEM, V290, P13215, DOI 10.1074/jbc.M115.643643; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Hrecka K, 2016, P NATL ACAD SCI USA, V113, pE3921, DOI 10.1073/pnas.1605023113; Kile AC, 2015, MOL CELL, V58, P1090, DOI 10.1016/j.molcel.2015.05.013; Laguette N, 2014, CELL, V156, P134, DOI 10.1016/j.cell.2013.12.011; Lahouassa H, 2016, P NATL ACAD SCI USA, V113, P5311, DOI 10.1073/pnas.1600485113; Lai MY, 2005, J VIROL, V79, P15443, DOI 10.1128/JVI.79.24.15443-15451.2005; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Motegi A, 2008, P NATL ACAD SCI USA, V105, P12411, DOI 10.1073/pnas.0805685105; Nakagawa T, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-22; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Poon B, 1997, J VIROL, V71, P3961, DOI 10.1128/JVI.71.5.3961-3971.1997; Romani B, 2012, CURR OPIN VIROL, V2, P755, DOI 10.1016/j.coviro.2012.09.010; Roshal M, 2003, J BIOL CHEM, V278, P25879, DOI 10.1074/jbc.M303948200; Simon V, 2015, NAT IMMUNOL, V16, P546, DOI 10.1038/ni.3156; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; Subbramanian RA, 1998, J EXP MED, V187, P1103, DOI 10.1084/jem.187.7.1103; Tan L, 2007, J VIROL, V81, P10822, DOI 10.1128/JVI.01380-07; Unk I, 2008, P NATL ACAD SCI USA, V105, P3768, DOI 10.1073/pnas.0800563105; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Vermeire J, 2016, CELL REP, V17, P413, DOI 10.1016/j.celrep.2016.09.023; Wen XY, 2007, J BIOL CHEM, V282, P27046, DOI 10.1074/jbc.M703955200; Wu Y, 2016, NAT STRUCT MOL BIOL, V23, P933, DOI 10.1038/nsmb.3284; Zhou XH, 2016, J BIOL CHEM, V291, P16936, DOI 10.1074/jbc.M116.721183; Zimmerman ES, 2004, MOL CELL BIOL, V24, P9286, DOI 10.1128/MCB.24.21.9286-9294.2004	44	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					21117	21127		10.1074/jbc.M117.798801	http://dx.doi.org/10.1074/jbc.M117.798801			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29079575	Green Published, hybrid			2022-12-26	WOS:000418453400026
J	Macedo, R; Sales, LP; Yoshida, F; Silva-Abud, LL; Lobo, M				Macedo, Renan; Sales, Lilian Patricia; Yoshida, Fernanda; Silva-Abud, Lidianne Lemes; Lobo Junior, Murillo			Potential worldwide distribution of Fusarium dry root rot in common beans based on the optimal environment for disease occurrence	PLOS ONE			English	Article							F-SP PHASEOLI; INOCULUM DENSITY; CLIMATE-CHANGE; PLANT-PATHOGENS; CROP PESTS; SOLANI; SOIL; RESISTANCE; COMPETITION; POPULATION	Root rots are a constraint for staple food crops and a long-lasting food security problem worldwide. In common beans, yield losses originating from root damage are frequently attributed to dry root rot, a disease caused by the Fusarium solani species complex. The aim of this study was to model the current potential distribution of common bean dry root rot on a global scale and to project changes based on future expectations of climate change. Our approach used a spatial proxy of the field disease occurrence, instead of solely the pathogen distribution. We modeled the pathogen environmental requirements in locations where in-situ inoculum density seems ideal for disease manifestation. A dataset of 2,311 soil samples from commercial farms assessed from 2002 to 2015 allowed us to evaluate the environmental conditions associated with the pathogen's optimum inoculum density for disease occurrence, using a lower threshold as a spatial proxy. We encompassed not only the optimal conditions for disease occurrence but also the optimal pathogen's density required for host infection. An intermediate inoculum density of the pathogen was the best disease proxy, suggesting density-dependent mechanisms on host infection. We found a strong convergence on the environmental requirements of both the host and the disease development in tropical areas, mostly in Brazil, Central America, and African countries. Precipitation and temperature variables were important for explaining the disease occurrence (from 17.63% to 43.84%). Climate change will probably move the disease toward cooler regions, which in Brazil are more representative of small-scale farming, although an overall shrink in total area (from 48% to 49% in 2050 and 26% to 41% in 2070) was also predicted. Understanding pathogen distribution and disease risks in an evolutionary context will therefore support breeding for resistance programs and strategies for dry root rot management in common beans.	[Macedo, Renan; Yoshida, Fernanda; Silva-Abud, Lidianne Lemes] Univ Fed Goias, Escola Agron & Engn Alimentos, Goiania, Go, Brazil; [Sales, Lilian Patricia] Univ Fed Goias, Dept Ecol & Evolucao, Goiania, Go, Brazil; [Lobo Junior, Murillo] Empresa Brasileira Pesquisa Agr Embrapa Arroz & F, Santo Antonio De Goias, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Lobo, M (corresponding author), Empresa Brasileira Pesquisa Agr Embrapa Arroz & F, Santo Antonio De Goias, Go, Brazil.	murillo.lobo@embrapa.br	Lobo Junior, Murillo/C-6349-2013; Sales, Lillian P./C-2300-2016; Macedo, Renan/AAC-1608-2021	Lobo Junior, Murillo/0000-0002-3681-4570; Sales, Lillian P./0000-0003-1159-6412; Macedo, Renan/0000-0002-0860-6168	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado de Golas; CNPq [407844/2013-9]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Golas(Fundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	R.M. was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, http://www.capes.gov.br/. L.L.S-A was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, http://cnpq.br/. L.P.S. was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, http://www.capes.gov.br/. F.Y. was supported by Fundacao de Amparo a Pesquisa do Estado de Golas, http://www.fapeg.go.gov.br/. M.L J. was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, http://cnpq.br/; CNPq grant 407844/2013-9. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abawi GS, 1990, CALL CIAT, V144; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Baker DJ, 2016, GLOBAL CHANGE BIOL, V22, P2392, DOI 10.1111/gcb.13273; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bebber DP, 2014, GLOBAL ECOL BIOGEOGR, V23, P1398, DOI 10.1111/geb.12214; Bebber DP, 2013, NAT CLIM CHANGE, V3, P985, DOI [10.1038/nclimate1990, 10.1038/NCLIMATE1990]; Beebe SE, 2012, IMPROVING RESOURCE U, P1; Bilgi VN, 2008, PLANT DIS, V92, P1197, DOI 10.1094/PDIS-92-8-1197; BLACK MC, 1984, PHYTOPATHOLOGY, V74, P1128, DOI 10.1094/Phyto-74-1128; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; Chakraborty S, 2011, PLANT PATHOL, V60, P2, DOI 10.1111/j.1365-3059.2010.02411.x; Chakraborty S, 2013, GLOBAL CHANGE BIOL, V19, P1985, DOI 10.1111/gcb.12205; Chaudhary S, 2006, PHASEOLUS VULGARIS L, V308, P303; CONAB, COMP NAC AB AC SAFR; Costa R, 2004, PESQUI AGROPECUARIA, V34, P89; Dighton J, 1981, FUNGAL COMMUNITY; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Elith J, 2009, ANN REV ECOL EVOL SY; Garrett KA, 2011, PLANT PATHOL, V60, P15, DOI 10.1111/j.1365-3059.2010.02409.x; Gent PR, 2011, J CLIMATE, V24, P4973, DOI 10.1175/2011JCLI4083.1; Gossen BD, 2016, PLANT DIS, V100, P1965, DOI 10.1094/PDIS-02-16-0184-FE; Gridley HE, 1994, P WORK GROUP M BEAN; Grinnell J, 1924, ECOLOGY, V5, P225, DOI 10.2307/1929447; Hao JJ, 2009, PLANT DIS, V93, P1324, DOI 10.1094/PDIS-93-12-1324; Hijmans R, 2016, PACKAGE RASTER; Hijmans R, 2016, PACKAGE SP; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoberg EP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0553; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jousimo J, 2014, SCIENCE, V344, P1289, DOI 10.1126/science.1253621; Knutti R, 2013, GEOPHYS RES LETT, V40, P1194, DOI 10.1002/grl.50256; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; Lamichhane JR, 2015, AGRON SUSTAIN DEV, V35, P443, DOI 10.1007/s13593-014-0275-9; LENSKI RE, 1994, J THEOR BIOL, V169, P253, DOI 10.1006/jtbi.1994.1146; Li SX, 1998, MYCOLOGIA, V90, P414, DOI 10.2307/3761400; Lira-Noriega A, 2014, J BIOGEOGR; Magrin GO, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1499; Manici LM, 2014, INT J BIOMETEOROL, V58, P2071, DOI 10.1007/s00484-014-0808-6; Martin GM, 2011, GEOSCI MODEL DEV, V4, P723, DOI 10.5194/gmd-4-723-2011; Martinez-Garnica M, 2014, REV FAC AGRON LUZ, V31, P539; MCFADDEN W, 1989, CAN J PLANT PATHOL, V11, P122, DOI 10.1080/07060668909501125; MILLER DE, 1985, PLANT DIS, V69, P324, DOI 10.1094/PD-69-328; Mondal SN, 1998, PHYTOPATHOLOGY, V88, P148, DOI 10.1094/PHYTO.1998.88.2.148; Morin X, 2009, ECOLOGY, V90, P1301, DOI 10.1890/08-0134.1; Narouei-Khandan HA, 2016, EUR J PLANT PATHOL, V144, P655, DOI 10.1007/s10658-015-0804-7; Naseri B, 2015, INT J PEST MANAGE, V61, P60, DOI 10.1080/09670874.2014.993001; Newton MR, 1997, ECOLOGY, V78, P1774; Nicoli A, 2013, TROP PLANT PATHOL, V38, P149, DOI 10.1590/S1982-56762013000200009; Nicoli A, 2012, TROP PLANT PATHOL, V37, P393, DOI 10.1590/S1982-56762012000600003; PAPLOMATAS EJ, 1992, PHYTOPATHOLOGY, V82, P1417, DOI 10.1094/Phyto-82-1417; Rangel TF, 2012, NAT CONSERVACAO, V10, P119, DOI 10.4322/natcon.2012.030; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Reichert JM, 2015, FOOD ENERGY SECUR, V4, P219, DOI 10.1002/fes3.65; Rodriguez M, 2016, NEW PHYTOL, V209, P1781, DOI 10.1111/nph.13713; Schroeder KL, 2008, PHYTOPATHOLOGY, V98, P304, DOI 10.1094/PHYTO-98-3-0304; Schroers HJ, 2016, MYCOLOGIA, V108, P806, DOI 10.3852/15-255; Silva-Abud L. E. B., 2015, COMM BEAN DIS WORK A, V25; Singh SP, 2010, CROP SCI, V50, P2199, DOI 10.2135/cropsci2009.03.0163; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stephens PR, 2016, ECOL LETT, V19, P1159, DOI 10.1111/ele.12644; Summerell BA, 2010, FUNGAL DIVERS, V44, P3, DOI 10.1007/s13225-010-0060-2; Teixeira H, 2015, TROP PLANT PATHOL, V40, P335, DOI 10.1007/s40858-015-0047-3; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Tonnang HEZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135283; Tsoar A, 2007, DIVERS DISTRIB, V13, P397, DOI 10.1111/j.1472-4642.2007.00346.x; van de Pol M, 2016, METHODS ECOL EVOL, V7, P1246, DOI 10.1111/2041-210X.12590; Watanabe M, 2010, J CLIMATE, V23, P6312, DOI 10.1175/2010JCLI3679.1; West JS, 2012, EUR J PLANT PATHOL, V133, P315, DOI 10.1007/s10658-011-9932-x; Zhan JS, 2013, ANNU REV PHYTOPATHOL, V51, P131, DOI 10.1146/annurev-phyto-082712-102302; Ramirez-Cabral NYZ, 2016, AGR FOREST METEOROL, V218, P102, DOI 10.1016/j.agrformet.2015.12.002	75	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187770	10.1371/journal.pone.0187770	http://dx.doi.org/10.1371/journal.pone.0187770			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29107985	Green Published, gold			2022-12-26	WOS:000414424600069
J	Arakelyan, A; Nersisyan, L; Poghosyan, D; Khondkaryan, L; Hakobyan, A; Loffler-Wirth, H; Melanitou, E; Binder, H				Arakelyan, Arsen; Nersisyan, Lilit; Poghosyan, David; Khondkaryan, Lusine; Hakobyan, Anna; Loeffler-Wirth, Henry; Melanitou, Evie; Binder, Hans			Autoimmunity and autoinflammation: A systems view on signaling pathway dysregulation profiles	PLOS ONE			English	Article							ENCODING MEVALONATE KINASE; SJOGRENS-SYNDROME; MULTIPLE-SCLEROSIS; NLRP3 INFLAMMASOME; PAPA SYNDROME; GENE-EXPRESSION; BEHCETS-DISEASE; INNATE IMMUNITY; MOLECULAR-BASIS; HORMONE GNRH	Introduction Autoinflammatory and autoimmune disorders are characterized by aberrant changes in innate and adaptive immunity that may lead from an initial inflammatory state to an organ specific damage. These disorders possess heterogeneity in terms of affected organs and clinical phenotypes. However, despite the differences in etiology and phenotypic variations, they share genetic associations, treatment responses and clinical manifestations. The mechanisms involved in their initiation and development remain poorly understood, however the existence of some clear similarities between autoimmune and autoinflammatory disorders indicates variable degrees of interaction between immune-related mechanisms. Methods Our study aims at contributing to a holistic, pathway-centered view on the inflammatory condition of autoimmune and autoinflammatory diseases. We have evaluated similarities and specificities of pathway activity changes in twelve autoimmune and autoinflammatory disorders by performing meta-analysis of publicly available gene expression datasets generated from peripheral blood mononuclear cells, using a bioinformatics pipeline that integrates Self Organizing Maps and Pathway Signal Flow algorithms along with KEGG pathway topologies. Results and conclusions The results reveal that clinically divergent disease groups share common pathway perturbation profiles. We identified pathways, similarly perturbed in all the studied diseases, such as PI3K-Akt, Toll-like receptor, and NF-kappa B signaling, that serve as integrators of signals guiding immune cell polarization, migration, growth, survival and differentiation. Further, two clusters of diseases were identified based on specifically dysregulated pathways: one gathering mostly autoimmune and the other mainly autoinflammatory diseases. Cluster separation was driven not only by apparent involvement of pathways implicated in adaptive immunity in one case, and inflammation in the other, but also by processes not explicitly related to immune response, but rather representing various events related to the formation of specific pathophysiological environment. Thus, our data suggest that while all of the studied diseases are affected by activation of common inflammatory processes, disease-specific variations in their relative balance are also identified.	[Arakelyan, Arsen; Nersisyan, Lilit; Hakobyan, Anna] Natl Acad Sci RA, Inst Mol Biol, Bioinformat Grp, Yerevan, Armenia; [Arakelyan, Arsen] Russian Armenian Univ, Dept Bioinformat & Bioengn, Yerevan, Armenia; [Nersisyan, Lilit] Amer Univ Armenia, Zaven & Sonia Akian Coll Sci & Engn, Yerevan, Armenia; [Poghosyan, David; Khondkaryan, Lusine] Natl Acad Sci RA, Inst Mol Biol, Grp Immune Response Regulat, Yerevan, Armenia; [Loeffler-Wirth, Henry; Binder, Hans] Univ Leipzig, Interdisciplinary Ctr Bioinformat, Leipzig, Germany; [Melanitou, Evie] Inst Pasteur, Dept Parasitol & Insect Vectors, Paris, France	National Academy of Sciences of Armenia; Institute of Molecular Biology - NAS RA; Russian Armenian Slavonic University; American University of Armenia; National Academy of Sciences of Armenia; Institute of Molecular Biology - NAS RA; Leipzig University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Arakelyan, A (corresponding author), Natl Acad Sci RA, Inst Mol Biol, Bioinformat Grp, Yerevan, Armenia.; Arakelyan, A (corresponding author), Russian Armenian Univ, Dept Bioinformat & Bioengn, Yerevan, Armenia.	aarakelyan@sci.am	Melanitou, Evie/AAG-5224-2020; Binder, Hans/U-5519-2018	Loeffler-Wirth, Henry/0000-0001-8239-440X; Nersisyan, Lilit/0000-0001-8525-420X; Arakelyan, Arsen/0000-0002-6851-1056; Binder, Hans/0000-0002-2242-4678	State Committee of Science MES RA [SCS 13YR-1F0022, 16GE-025, 15T-1F150]; German Federal Ministry of Education and Science (BMBF) [WTZ ARM II-010, 01ZX1304A, FFE-0034]	State Committee of Science MES RA; German Federal Ministry of Education and Science (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was supported by the State Committee of Science MES RA projects no. SCS 13YR-1F0022, 16GE-025, and 15T-1F150 (to AA) and German Federal Ministry of Education and Science (BMBF) WTZ ARM II-010 and 01ZX1304A (to HB) and FFE-0034 (to HL-W).	Aganna E, 2002, ARTHRITIS RHEUM-US, V46, P2445, DOI 10.1002/art.10509; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Arakelyan A., 2013, GENOMICS, P71; Arakelyan A, 2017, ZENODO; Arakelyan A, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00079; Ashjazadeh N, 2003, EXP MOL PATHOL, V74, P17, DOI 10.1016/S0014-4800(03)80004-7; Aziz A, 2009, IN J CLIN RHEUMATOL, V4, P681; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Bashaw GJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001941; Baughman RP, 2014, SEMIN RESP CRIT CARE, V35, P391, DOI 10.1055/s-0034-1376401; BINDER A, 1989, BRIT J RHEUMATOL, V28, P518; Brayer J, 2000, J RHEUMATOL, V27, P1896; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Castiblanco J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-197; Chen HF, 1999, J CLIN ENDOCR METAB, V84, P743, DOI 10.1210/jc.84.2.743; Chimenti MS, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.246; Ciccarelli F, 2014, CURR MED CHEM, V21, P261; Cortesio CL, 2010, ARTHRITIS RHEUM-US, V62, P2556, DOI 10.1002/art.27521; Costenbader KH, 2012, AUTOIMMUN REV, V11, P604, DOI 10.1016/j.autrev.2011.10.022; Covarrubias AJ, 2015, SEMIN IMMUNOL, V27, P286, DOI 10.1016/j.smim.2015.08.001; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; de Seze J, 2001, NEUROLOGY, V57, P1359, DOI 10.1212/WNL.57.8.1359; Demidowich AP, 2012, ARTHRITIS RHEUM-US, V64, P2022, DOI 10.1002/art.34332; Diakos CI, 2014, LANCET ONCOL, V15, pE493, DOI 10.1016/S1470-2045(14)70263-3; Doria A, 2012, AUTOIMMUN REV, V12, P22, DOI 10.1016/j.autrev.2012.07.018; Dorr C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125045; Drenth JPH, 1999, NAT GENET, V22, P178, DOI 10.1038/9696; Eaton WW, 2010, IMMUNOL RES, V47, P228, DOI 10.1007/s12026-009-8153-2; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Favier LA, 2016, APPL CLIN GENET, V9, DOI 10.2147/TACG.S93933; Fitzpatrick MA, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13743; Gallo A., 2012, PLOS ONE, V7; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gavanescu I, 2008, P NATL ACAD SCI USA, V105, P13009, DOI 10.1073/pnas.0806874105; Goldbach-Mansky R, 2009, J ALLERGY CLIN IMMUN, V124, P1141, DOI 10.1016/j.jaci.2009.11.016; Golia E, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0435-z; Gupta P, 2014, VIROLOGY, V450, P336, DOI 10.1016/j.virol.2013.12.026; Hawkins PT, 2015, BBA-MOL CELL BIOL L, V1851, P882, DOI 10.1016/j.bbalip.2014.12.006; Houten SM, 1999, NAT GENET, V22, P175, DOI 10.1038/9691; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Jung SM, 2000, J KOREAN MED SCI, V15, P115, DOI 10.3346/jkms.2000.15.1.115; Kahlenberg JM, 2014, CURR OPIN RHEUMATOL, V26, P475, DOI 10.1097/BOR.0000000000000088; Kahlenberg JM, 2014, ARTHRITIS RHEUMATOL, V66, P152, DOI 10.1002/art.38225; Kambe Naotomo, 2010, Allergology International, V59, P105, DOI 10.2332/allergolint.09-RAI-0160; Kastner DL, 2010, CELL, V140, P784, DOI 10.1016/j.cell.2010.03.002; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kraus S, 2001, ARCH MED RES, V32, P499, DOI 10.1016/S0188-4409(01)00331-9; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lee RW, 2014, SEMIN IMMUNOPATHOL, V36, P581, DOI 10.1007/s00281-014-0433-9; Lerner A, 2015, AUTOIMMUN REV, V14, P1038, DOI 10.1016/j.autrev.2015.07.007; Lerner A, 2015, AUTOIMMUN REV, V14, P479, DOI 10.1016/j.autrev.2015.01.009; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; Lisnevskaia L, 2014, LANCET, V384, P1878, DOI 10.1016/S0140-6736(14)60128-8; Loffler-Wirth H, 2015, BIOINFORMATICS, V31, P3225, DOI 10.1093/bioinformatics/btv342; Lu N, 2014, J IMMUNOL, V192, P1013, DOI 10.4049/jimmunol.1300133; Mackay IR, 2010, J AUTOIMMUN, V35, P199, DOI 10.1016/j.jaut.2010.06.008; Maecker HT, 2012, NAT REV RHEUMATOL, V8, P317, DOI 10.1038/nrrheum.2012.66; Martinon F, 2015, NAT REV RHEUMATOL, V11, P11, DOI 10.1038/nrrheum.2014.158; McDermott MF, 1999, CELL, V97, P133, DOI 10.1016/S0092-8674(00)80721-7; McGonagle D, 2007, SEMIN IMMUNOPATHOL, V29, P303, DOI 10.1007/s00281-007-0084-1; McGonagle D, 2006, PLOS MED, V3, P1242, DOI 10.1371/journal.pmed.0030297; Melanitou E, 2003, J AUTOIMMUN, V21, P93, DOI 10.1016/S0896-8411(03)00097-0; Melanitou E, 2013, GENE, V512, P161, DOI 10.1016/j.gene.2012.09.055; Menon R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018660; Mortimer L, 2016, NAT IMMUNOL, V17, P1176, DOI 10.1038/ni.3538; Mulders-Manders CM, 2015, SEMIN IMMUNOPATHOL, V37, P371, DOI 10.1007/s00281-015-0492-6; Mullenix PS, 2005, ANN VASC SURG, V19, P130, DOI 10.1007/s10016-004-0153-z; Mutez E, 2011, NEUROBIOL AGING, V32, P1839, DOI 10.1016/j.neurobiolaging.2009.10.016; Nersisyan L, 2014, BLOOD COLON CANC INT, V4, P46, DOI DOI 10.4018/IJKDB.2014070104; Nersisyan Lilit, 2015, F1000Res, V4, P480, DOI 10.12688/f1000research.6706.2; Netea MG, 2008, EXPERT OPIN BIOL TH, V8, P1867, DOI [10.1517/14712590802494212, 10.1517/14712590802494212 ]; Neven B, 2004, BLOOD, V103, P2809, DOI 10.1182/blood-2003-07-2531; Palmer C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-115; Park YH, 2016, NAT IMMUNOL, V17, P914, DOI 10.1038/ni.3457; Pradhan Vandana D, 2012, Indian J Hum Genet, V18, P155, DOI 10.4103/0971-6866.100750; Ramos PS, 2015, J HUM GENET, V60, P657, DOI 10.1038/jhg.2015.94; Rodero MP, 2016, J EXP MED, V213, P2527, DOI 10.1084/jem.20161596; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Shin MS, 2013, J IMMUNOL, V190, P1407, DOI 10.4049/jimmunol.1201195; Shoham NG, 2003, P NATL ACAD SCI USA, V100, P13501, DOI 10.1073/pnas.2135380100; Singh D., 2005, J INDIAN RHEUMATOL A, V13, P162; Solomon AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065385; Song GG, 2014, IMMUNOL INVEST, V43, P123, DOI 10.3109/08820139.2013.847457; Stehlik C, 2004, J EXP MED, V200, P551, DOI 10.1084/jem.20032234; Sun SC, 2013, TRENDS IMMUNOL, V34, P282, DOI 10.1016/j.it.2013.01.004; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tektonidou MG, 2011, NAT REV RHEUMATOL, V7, P708, DOI 10.1038/nrrheum.2011.157; Todd JA, 2001, IMMUNITY, V15, P387, DOI 10.1016/S1074-7613(01)00202-3; Trapnell C, 2016, F1000RES, V5, P5; Wang DH, 2013, J BIOL CHEM, V288, P4594, DOI 10.1074/jbc.M112.443077; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wessel A, 2014, J IMMUNOL AMERICAN A, V192; Wilson SP, 2010, POSTGRAD MED, V122, P125, DOI 10.3810/pgm.2010.09.2209; Wirth H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-306; Wise CA, 2002, HUM MOL GENET, V11, P961, DOI 10.1093/hmg/11.8.961; Xie SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094496; Xu H, 2014, NATURE, V513, P237, DOI 10.1038/nature13449; Yu D, 2008, IMMUNOL CELL BIOL, V86, P3, DOI 10.1038/sj.icb.7100123; Zakharyan R, 2014, WORLD J BIOL PSYCHIA, V15, P174, DOI 10.3109/15622975.2013.830774; Zakka LR, 2012, AUTOIMMUNITY, V45, P253, DOI 10.3109/08916934.2011.632454; Zapatero DC, 2008, LOUV MED, P127; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang H, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0911-z; Zhao L, 2014, CLIN EXP IMMUNOL, V177, P212, DOI 10.1111/cei.12330; Zhernakova A, 2013, NAT REV ENDOCRINOL, V9, P646, DOI 10.1038/nrendo.2013.161	108	37	40	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							e0187572	10.1371/journal.pone.0187572	http://dx.doi.org/10.1371/journal.pone.0187572			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6TA	29099860	Green Submitted, Green Published, gold			2022-12-26	WOS:000414377900031
J	Beierfuss, A; Dietrich, H; Kremser, C; Hunjadi, M; Ritsch, A; Rulicke, T; Thome, C; Mern, DS				Beierfuss, Anja; Dietrich, Hermann; Kremser, Christian; Hunjadi, Monika; Ritsch, Andreas; Ruelicke, Thomas; Thome, Claudius; Mern, Demissew Shenegelegn			Knockout of Apolipoprotein E in rabbit promotes premature intervertebral disc degeneration: A new in vivo model for therapeutic approaches of spinal disc disorders	PLOS ONE			English	Article							LOW-BACK-PAIN; CARDIOVASCULAR RISK-FACTORS; MATERNAL HYPERCHOLESTEROLEMIA; MESSENGER-RNA; SERUM-LIPIDS; FOLLOW-UP; ATHEROSCLEROSIS; EXPRESSION; HEALTH; CLASSIFICATION	Intervertebral disc (IVD) degeneration that accelerates the loss of disc structural and functional integrities is recognized as one of the major factors of chronic back pain. Cardiovascular risk factors, such as deficits of apolipoproteins that elevate the levels of cholesterol and triglycerides, are considered critical for the progress of atherosclerosis; notably in the abdominal aorta and its lumbar branching arteries that supply lumbar vertebrae and IVDs. Obstruction of the lumbar arteries by atherosclerosis is presumed to promote lumbar disc degeneration and low back pain. APOE-knockout rabbits have recently been shown to generate hyperlipidemia with increased levels of cholesterol and triglycerides that mimic the symptoms of atherosclerosis in humans. Here, we analysed IVD degeneration in the lumbar spines of ten homozygous APOE-knockout and four wild-type New Zealand White rabbits of matching age to prove accelerated IVD degeneration in APOE-knockout rabbits, since APOE-knockout rabbits could be a beneficial model for therapeutic approaches of degenerative IVD disorders. Experiments were performed using T1/T2-weighted magnetic resonance imaging, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, glucose-oxidase assay, enzyme-linked immunosorbent assay, quantitative reverse transcription PCR and western blot. APOE-knockout lumbar spines showed more advanced IVD degeneration, obstructed lumbar arteries and lower enhancement of contrast agent in IVDs. Moreover, lower concentration of glucose, lower number of viable cells and lower concentrations of aggrecan, collagen II and higher concentration of collagen I were detected in APOE-knockout IVDs (p < 0.0001). APOE-knockout in rabbits could induce structurally deteriorating premature IVD degeneration that mimics the symptoms of accelerated IVD degeneration in humans. APOE-knockout rabbits could be used as beneficial model, as they can bypass the standard surgical interventions that are commonly applied in research animals for the induction of enhanced IVD degeneration. Their parallel use in therapeutic approaches of IVD disorders and atherosclerosis could reduce the number of research animals to be used and contribute to the principles of 3Rs (Replacement, Reduction and Refinement).	[Beierfuss, Anja; Dietrich, Hermann] Med Univ Innsbruck, Cent Lab Anim Facil, Innsbruck, Austria; [Kremser, Christian] Med Univ Innsbruck, Dept Radiol, Innsbruck, Austria; [Hunjadi, Monika; Ritsch, Andreas] Med Univ Innsbruck, Dept Internal Med 1, Innsbruck, Austria; [Ruelicke, Thomas] Univ Vet Med Vienna, Inst Lab Anim Sci, Vet Pl 1, Vienna, Austria; [Thome, Claudius; Mern, Demissew Shenegelegn] Med Univ Innsbruck, Dept Neurosurg, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; University of Veterinary Medicine Vienna; Medical University of Innsbruck	Mern, DS (corresponding author), Med Univ Innsbruck, Dept Neurosurg, Innsbruck, Austria.	demissew.shenegelegn@i-med.ac.at		Ritsch, Andreas/0000-0002-0417-5161; Hunjadi, Monika/0000-0003-4285-2925; Shenegelegn Mern, Demissew/0000-0001-5893-981X	Austrian Science Fund FWF [P 27116] Funding Source: Medline	Austrian Science Fund FWF(Austrian Science Fund (FWF))		Adams MA, 2005, J BIOMECH, V38, P1972, DOI 10.1016/j.jbiomech.2005.03.028; Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; Anderson DG, 2005, SPINE J, V5, P260, DOI DOI 10.1016/J.SPINEE.2005.02.010; Antoniou J, 1998, MAGN RESON MED, V40, P900, DOI 10.1002/mrm.1910400616; Battie MC, 2007, PAIN, V131, P272, DOI 10.1016/j.pain.2007.01.010; Baumgartner C, 2016, PROG BIOPHYS MOL BIO, V121, P131, DOI 10.1016/j.pbiomolbio.2016.05.001; BELLOSTA S, 1995, J CLIN INVEST, V96, P2170, DOI 10.1172/JCI118271; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Bibby SRS, 2004, EUR SPINE J, V13, P695, DOI 10.1007/s00586-003-0616-x; Boos N, 2002, SPINE, V27, P2631, DOI 10.1097/00007632-200212010-00002; BOTTOMLEY PA, 1994, J MAGN RESON SER B, V104, P159, DOI 10.1006/jmrb.1994.1070; BUCKWALTER JA, 1995, SPINE, V20, P1307, DOI 10.1097/00007632-199506000-00022; CHIRAS J, 1979, J NEURORADIOLOGY, V6, P169; CROCK HV, 1976, CLIN ORTHOP RELAT R, P6; DEYO RA, 1991, ANNU REV PUBL HEALTH, V12, P141, DOI 10.1146/annurev.pu.12.050191.001041; Fan JL, 2015, PHARMACOL THERAPEUT, V146, P104, DOI 10.1016/j.pharmthera.2014.09.009; Ferguson SJ, 2003, EUR SPINE J, V12, pS97, DOI 10.1007/s00586-003-0621-0; Hemingway H, 1999, J EPIDEMIOL COMMUN H, V53, P197, DOI 10.1136/jech.53.4.197; Hoy D, 2012, ARTHRITIS RHEUM-US, V64, P2028, DOI 10.1002/art.34347; Hoy D, 2014, ANN RHEUM DIS, V73, P968, DOI 10.1136/annrheumdis-2013-204428; Hoyland JA, 2008, RHEUMATOLOGY, V47, P809, DOI 10.1093/rheumatology/ken056; Jhawar Balraj S, 2006, Spine J, V6, P684, DOI 10.1016/j.spinee.2006.04.016; Ji DN, 2015, TRANSGENIC RES, V24, P227, DOI 10.1007/s11248-014-9834-8; KAUPPILA LI, 1994, ACTA RADIOL, V35, P541; KAUPPILA LI, 1993, J SPINAL DISORD, V6, P124; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leino-Arjas P, 2006, SPINE, V31, P1032, DOI 10.1097/01.brs.0000214889.31505.08; Leino-Arjas P, 2006, SCAND J WORK ENV HEA, V32, P12, DOI 10.5271/sjweh.971; Leino-Arjas P, 2008, ATHEROSCLEROSIS, V197, P43, DOI 10.1016/j.atherosclerosis.2007.07.035; LINLEE YC, 1985, BIOCHEMISTRY-US, V24, P3751, DOI 10.1021/bi00335a050; MABUCHI H, 1989, METABOLISM, V38, P115, DOI 10.1016/0026-0495(89)90249-7; Mahler M, 2014, LAB ANIM-UK, V48, P178, DOI 10.1177/0023677213516312; Mahley RW, 1999, J LIPID RES, V40, P1933; Mahley RW, 1999, J LIPID RES, V40, P1; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MCLEAN JW, 1984, J BIOL CHEM, V259, P6498; Napoli C, 2000, CIRC RES, V87, P946, DOI 10.1161/01.RES.87.10.946; Niimi M, 2016, ATHEROSCLEROSIS, V245, P187, DOI 10.1016/j.atherosclerosis.2015.12.002; OHSHIMA H, 1989, SPINE, V14, P1234, DOI 10.1097/00007632-198911000-00017; Palinski W, 2001, CIRC RES, V89, P991, DOI 10.1161/hh2301.099646; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Roberts S, 1996, SPINE, V21, P415, DOI 10.1097/00007632-199602150-00003; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Russell WMS., 1959, MED J AUSTRALIA; SCHAEFER EJ, 1986, J CLIN INVEST, V78, P1206, DOI 10.1172/JCI112704; SOLBERG LA, 1983, ARTERIOSCLEROSIS, V3, P187, DOI 10.1161/01.ATV.3.3.187; Tannenbaum J, 2015, J AM ASSOC LAB ANIM, V54, P120; Urban JPG, 2004, SPINE, V29, P2700, DOI 10.1097/01.brs.0000146499.97948.52; Urban JPG, 2003, ARTHRITIS RES THER, V5, P120, DOI 10.1186/ar629; URBAN JPG, 1982, CLIN ORTHOP RELAT R, P296; Waddell G, 1996, SPINE, V21, P2820, DOI 10.1097/00007632-199612150-00002; Zhang XJ, 2008, J NUTR, V138, P515, DOI 10.1093/jn/138.3.515; Zhdanov VS, 1999, INT J CARDIOL, V68, P95, DOI 10.1016/S0167-5273(98)00339-8	53	10	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							e0187564	10.1371/journal.pone.0187564	http://dx.doi.org/10.1371/journal.pone.0187564			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6TA	29099857	Green Published, gold, Green Submitted			2022-12-26	WOS:000414377900030
J	Gabriel, BM; Al-Tarrah, M; Alhindi, Y; Kilikevicius, A; Venckunas, T; Gray, SR; Lionikas, A; Ratkevicius, A				Gabriel, Brendan M.; Al-Tarrah, Mustafa; Alhindi, Yosra; Kilikevicius, Audrius; Venckunas, Tomas; Gray, Stuart R.; Lionikas, Arimantas; Ratkevicius, Aivaras			H55N polymorphism is associated with low citrate synthase activity which regulates lipid metabolism in mouse muscle cells	PLOS ONE			English	Article							SKELETAL-MUSCLE; OXIDATION; RESISTANCE; MODEL	The H55N polymorphism in the Cs gene of A/J mice has been linked to low activity of the enzyme in skeletal muscles. The aim of the study was to test this hypothesis and examine effects of low citrate synthase (CS) activity on palmitate metabolism in muscle cells. Results of the study showed that carriers of the wild type (WT) Cs (C57BL/6J and Balb/cByJ mouse strains) had higher CS activity (p< 0.01) than carriers of the A/J variant (B6.A-(rs3676616-D10Utsw1)/KjnB6 and A/J mouse strains) in the heart, liver and gastrocnemius muscle. Furthermore, the recombinant CS protein of WT showed higher CS activity than the A/J variant. In C2C12 muscle cells the shRNA mediated 47% knockdown of CS activity reduced the rate of fatty acid oxidation compared to the control cells. In summary, our results are consistent with the hypothesis that H55N substitution causes a reduction in CS activity. Furthermore, low CS activity interferes with metabolic flexibility of muscle cells.	[Gabriel, Brendan M.; Al-Tarrah, Mustafa; Alhindi, Yosra; Lionikas, Arimantas] Univ Aberdeen, Sch Med Med Sci & Nutr, Aberdeen, Scotland; [Gabriel, Brendan M.] Karolinska Inst, Dept Physiol & Pharmacol, Integrat Physiol, Stockholm, Sweden; [Kilikevicius, Audrius; Venckunas, Tomas; Ratkevicius, Aivaras] Lithuanian Sports Univ, Dept Appl Biol & Rehabil, Kaunas, Lithuania; [Gray, Stuart R.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland	University of Aberdeen; Karolinska Institutet; Lithuanian Sports University; University of Glasgow	Ratkevicius, A (corresponding author), Lithuanian Sports Univ, Dept Appl Biol & Rehabil, Kaunas, Lithuania.	Aivaras.Ratkevicius@lsu.lt	Alhindi, Yosra/AAD-4804-2021; Gabriel, Brendan/AAH-2625-2019; Gray, Stuart/L-2489-2017	Alhindi, Yosra/0000-0002-5725-3522; Gabriel, Brendan/0000-0001-6878-8779; Gray, Stuart/0000-0001-8969-9636	European Social Fund under Global Grant measure Grant [VP1-3.1-SMM-07-K-02-057]; European Foundation for the Study of Diabetes; NHS Grampian Endowment grant; Kuwait Ministry of Health; Saudi Ministry of Higher Education; Wenner-Gren Foundation Postdoctoral Fellowship; Albert Renold Travel Fellowship; Novo Nordisk Foundation Challenge Grant; Saltire scholarship	European Social Fund under Global Grant measure Grant; European Foundation for the Study of Diabetes; NHS Grampian Endowment grant; Kuwait Ministry of Health; Saudi Ministry of Higher Education; Wenner-Gren Foundation Postdoctoral Fellowship; Albert Renold Travel Fellowship; Novo Nordisk Foundation Challenge Grant; Saltire scholarship	This work was supported, in whole or in part, by European Social Fund under the Global Grant measure Grant VP1-3.1-SMM-07-K-02-057 (to A.L.), European Foundation for the Study of Diabetes grant (to T.V.), NHS Grampian Endowment grant (to A.R. and S.R.G.), Kuwait Ministry of Health grant (to M.A.), Saudi Ministry of Higher Education grant (to Y.A.,) as well as Saltire scholarship, Wenner-Gren Foundation Postdoctoral Fellowship, Albert Renold Travel Fellowship and a Novo Nordisk Foundation Challenge Grant (to B.G.).	Blomstrand E, 1997, ACTA PHYSIOL SCAND, V159, P41, DOI 10.1046/j.1365-201X.1997.547327000.x; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Fischer K, 2010, MOL ENDOCRINOL, V24, P1935, DOI 10.1210/me.2010-0005; Galgani JE, 2008, AM J PHYSIOL-ENDOC M, V295, pE1009, DOI 10.1152/ajpendo.90558.2008; Gaster M, 2004, DIABETES, V53, P542, DOI 10.2337/diabetes.53.3.542; Haslbeck M, 2003, J CHROMATOGR B, V786, P127, DOI 10.1016/S1570-0232(02)00716-X; Henique C, 2010, J BIOL CHEM, V285, P36818, DOI 10.1074/jbc.M110.170431; HOLLOSZY JO, 1976, ANNU REV PHYSIOL, V38, P273, DOI 10.1146/annurev.ph.38.030176.001421; Houmard JA, 2008, AM J PHYSIOL-REG I, V294, pR1111, DOI 10.1152/ajpregu.00396.2007; Iommarini L, 2015, MITOCHONDRION, V22, P96, DOI 10.1016/j.mito.2015.01.008; Jacobs RA, 2013, EXP PHYSIOL, V98, P908, DOI 10.1113/expphysiol.2012.070037; Jeukendrup AE, 2002, ANN NY ACAD SCI, V967, P217; Johnson KR, 2012, NEUROBIOL AGING, V33, P1720, DOI 10.1016/j.neurobiolaging.2011.05.009; Kilikevicius A, 2013, SCAND J MED SCI SPOR, V23, P657, DOI 10.1111/j.1600-0838.2012.01451.x; KURZ LC, 1995, BIOCHEMISTRY-US, V34, P13278, DOI 10.1021/bi00041a003; Leibowitz SF, 2005, BRAIN RES, V1047, P137, DOI 10.1016/j.brainres.2005.03.047; Lin CC, 2012, SCI REP-UK, V2, DOI 10.1038/srep00785; Lipina C, 2013, DIABETES, V62, P3426, DOI 10.2337/db13-0264; Martin-Granados C, 2008, INT J BIOCHEM CELL B, V40, P2315, DOI 10.1016/j.biocel.2008.03.021; Ortenblad N, 2005, BBA-MOL BASIS DIS, V1741, P206, DOI 10.1016/j.bbadis.2005.04.001; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POGSON CI, 1966, BIOCHEM J, V100, P683, DOI 10.1042/bj1000683; Powers SK, 2012, AM J PHYSIOL-ENDOC M, V303, pE31, DOI 10.1152/ajpendo.00609.2011; Ratkevicius A, 2010, PHYSIOL GENOMICS, V42A, P96, DOI 10.1152/physiolgenomics.00066.2010; Saha AK, 1999, AM J PHYSIOL-ENDOC M, V276, pE1030, DOI 10.1152/ajpendo.1999.276.6.E1030; Vigelso Andreas, 2014, Int J Physiol Pathophysiol Pharmacol, V6, P84; Watt KI, 2010, MUSCLE NERVE, V41, P624, DOI 10.1002/mus.21573	27	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0185789	10.1371/journal.pone.0185789	http://dx.doi.org/10.1371/journal.pone.0185789			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095821	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000414340200008
J	Schumacher, LL; Huss, AR; Cochrane, RA; Stark, CR; Woodworth, JC; Bai, JF; Poulsen, EG; Chen, Q; Main, RG; Zhang, JQ; Gauger, PC; Ramirez, A; Derscheid, RJ; Magstadt, DM; Dritz, SS; Jones, CK				Schumacher, Loni L.; Huss, Anne R.; Cochrane, Roger A.; Stark, Charles R.; Woodworth, Jason C.; Bai, Jianfa; Poulsen, Elizabeth G.; Chen, Qi; Main, Rodger G.; Zhang, Jianqiang; Gauger, Phillip C.; Ramirez, Alejandro; Derscheid, Rachel J.; Magstadt, Drew M.; Dritz, Steve S.; Jones, Cassandra K.			Characterizing the rapid spread of porcine epidemic diarrhea virus (PEDV) through an animal food manufacturing facility	PLOS ONE			English	Article							UNITED-STATES; FEED MILLS; SURVIVAL; NOROVIRUS; SURFACES; DISEASE; SWINE	New regulatory and consumer demands highlight the importance of animal feed as a part of our national food safety system. Porcine epidemic diarrhea virus (PEDV) is the first viral pathogen confirmed to be widely transmissible in animal food. Because the potential for viral contamination in animal food is not well characterized, the objectives of this study were to 1) observe the magnitude of virus contamination in an animal food manufacturing facility, and 2) investigate a proposed method, feed sequencing, to decrease virus decontamination on animal food-contact surfaces. A U.S. virulent PEDV isolate was used to inoculate 50 kg swine feed, which was mixed, conveyed, and discharged into bags using pilot-scale feed manufacturing equipment. Surfaces were swabbed and analyzed for the presence of PEDV RNA by quantitative real-time polymerase chain reaction (qPCR). Environmental swabs indicated complete contamination of animal food-contact surfaces (0/40 vs. 48/48, positive baseline samples/total baseline samples, positive subsequent samples/total subsequent samples, respectively; P< 0.05) and near complete contamination of non-animal food-contact surfaces (0/24 vs. 16/18, positive baseline samples/total baseline samples, positive subsequent samples/total subsequent samples, respectively; P< 0.05). Flushing animal food-contact surfaces with low-risk feed is commonly used to reduce cross-contamination in animal feed manufacturing. Thus, four subsequent 50 kg batches of virus-free swine feed were manufactured using the same system to test its impact on decontaminating animal food-contact surfaces. Even after 4 subsequent sequences, animal food-contact surfaces retained viral RNA (28/33 positive samples/total samples), with conveying system being more contaminated than the mixer. A bioassay to test infectivity of dust from animal food-contact surfaces failed to produce infectivity. This study demonstrates the potential widespread viral contamination of surfaces in an animal food manufacturing facility and the difficulty of removing contamination using conventional feed sequencing, which underscores the importance for preventing viruses from entering and contaminating such facilities.	[Schumacher, Loni L.; Bai, Jianfa; Poulsen, Elizabeth G.; Dritz, Steve S.] Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA; [Huss, Anne R.; Stark, Charles R.] Kansas State Univ, Dept Grain Sci & Ind, Manhattan, KS 66506 USA; [Cochrane, Roger A.; Woodworth, Jason C.; Jones, Cassandra K.] Kansas State Univ, Dept Anim Sci & Ind, Manhattan, KS 66506 USA; [Chen, Qi; Main, Rodger G.; Zhang, Jianqiang; Gauger, Phillip C.; Ramirez, Alejandro; Derscheid, Rachel J.; Magstadt, Drew M.] Iowa State Univ, Dept Vet Diagnost & Prod Anim Med, Ames, IA USA; [Huss, Anne R.] BioMatrix Int, Princeton, MN USA	Kansas State University; Kansas State University; Kansas State University; Iowa State University	Jones, CK (corresponding author), Kansas State Univ, Dept Anim Sci & Ind, Manhattan, KS 66506 USA.	jonesc@ksu.edu	Derscheid, Rachel/AAV-9043-2021; Bai, Jianfa/M-7830-2019; Gauger, Phillip/AAQ-9806-2021	Bai, Jianfa/0000-0002-0021-3036; Dritz, Steve/0000-0001-6371-0729	National Pork Board [14-273]	National Pork Board	This work was supported by the National Pork Board to JCW, 14-273. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120532; BEAN B, 1982, J INFECT DIS, V146, P47, DOI 10.1093/infdis/146.1.47; Bowman AS, 2015, VET MICROBIOL, V179, P213, DOI 10.1016/j.vetmic.2015.05.027; Chen Q, 2014, J CLIN MICROBIOL, V52, P234, DOI 10.1128/JCM.02820-13; Cochrane R. A, 2015, THESIS; Cochrane RA, 2016, J SWINE HEALTH PROD, V24, P154; Davies PR, 2015, PREV VET MED, V122, P235, DOI 10.1016/j.prevetmed.2015.08.006; de Graaf M, 2016, NAT REV MICROBIOL, V14, P421, DOI 10.1038/nrmicro.2016.48; Dee S, 2014, BMC VET RES, P10; Dee S, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0176-9; Fairchild F, 2005, FEED MANUFACTURING T, P203; GERBA CP, 1984, ADV APPL MICROBIOL, V30, P133, DOI 10.1016/S0065-2164(08)70054-6; Greiner LL, 2016, J SWINE HEALTH PROD, V24, P198; Herrman T., 1995, Kansas State University Swine Day 1995. Report of Progress 746, P127; Huang YW, 2013, MBIO, V4, DOI 10.1128/mBio.00737-13; HURST CJ, 1980, APPL ENVIRON MICROB, V40, P1067, DOI 10.1128/AEM.40.6.1067-1079.1980; HURST CJ, 1980, APPL ENVIRON MICROB, V40, P192, DOI 10.1128/AEM.40.2.192-200.1980; Huss AR, 2015, J FOOD PROTECT, V78, P1682, DOI 10.4315/0362-028X.JFP-15-052; Huss AR, 2016, P MIS SEC AM SOC AN; Huss AR, PLOS ONE, V12; Jung K, 2015, VET J, V204, P134, DOI 10.1016/j.tvjl.2015.02.017; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Lacroix-Gueu P, 2005, CR BIOL, V328, P1065, DOI 10.1016/j.crvi.2005.09.010; Malek Mark, 2009, Clin Infect Dis, V48, P31, DOI 10.1086/594118; McCoy R. A., 2005, FEED MANUFACTURING T, P620; McDaniel GL, 2005, FEED MANUFACTURING T, P238; Nelson J, 2014, 23 INT PIG VET SOC C; Pasick J, 2014, TRANSBOUND EMERG DIS, V61, P397, DOI 10.1111/tbed.12269; Schumacher LL, AM J VET RE IN PRESS; Thomas JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139266; Vasickova P, 2010, FOOD ENVIRON VIROL, V2, P24, DOI 10.1007/s12560-010-9025-6; Vega E, 2008, J FOOD PROTECT, V71, P522, DOI 10.4315/0362-028X-71.3.522; Widdowson MA, 2005, EMERG INFECT DIS, V11, P95, DOI 10.3201/eid1101.040426	33	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187309	10.1371/journal.pone.0187309	http://dx.doi.org/10.1371/journal.pone.0187309			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095859	Green Published, Green Submitted, gold			2022-12-26	WOS:000414340200069
J	Smith, RL; Tan, JME; Jonker, MJ; Jongejan, A; Buissink, T; Veldhuijzen, S; van Kampen, AHC; Brul, S; van der Spek, H				Smith, Reuben L.; Tan, Josephine M. E.; Jonker, Martijs J.; Jongejan, Aldo; Buissink, Thomas; Veldhuijzen, Steve; van Kampen, Antoine H. C.; Brul, Stanley; van der Spek, Hans			Beyond the polymerase-gamma theory: Production of ROS as a mode of NRTI-induced mitochondrial toxicity	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; ANTIVIRAL NUCLEOSIDE ANALOGS; INCREASING OXIDATIVE STRESS; ELEGANS LIFE-SPAN; CAENORHABDITIS-ELEGANS; C. ELEGANS; SUPEROXIDE-PRODUCTION; DNA POLYMERASE; COMPLEX-I; VITAMIN-E	Use of some HIV-1 nucleoside reverse transcriptase inhibitors (NRTI) is associated with severe adverse events. However, the exact mechanisms behind their toxicity has not been fully understood. Mitochondrial dysfunction after chronic exposure to specific NRTIs has predominantly been assigned to mitochondrial polymerase-gamma inhibition by NRTIs. However, an increasing amount of data suggests that this is not the sole mechanism. Many NRTI induced adverse events have been linked to the incurrence of oxidative stress, although the causality of events leading to reactive oxygen species (ROS) production and their role in toxicity is unclear. In this study we show that short-term effects of first generation NRTIs, which are rarely discussed in the literature, include inhibition of oxygen consumption, decreased ATP levels and increased ROS production. Collectively these events affect fitness and longevity of C. elegans through mitohormetic signalling events. Furthermore, we demonstrate that these effects can be normalized by addition of the anti-oxidant N-acetylcysteine (NAC), which suggests that ROS likely influence the onset and severity of adverse events upon drug exposure.	[Smith, Reuben L.; Tan, Josephine M. E.; Buissink, Thomas; Veldhuijzen, Steve; Brul, Stanley; van der Spek, Hans] Univ Amsterdam, SILS, Fac Sci FNWI, Mol Biol & Microbial Food Safety, Amsterdam, Netherlands; [Jonker, Martijs J.] Univ Amsterdam, SILS, Fac Sci FNWI, RNA Biol & Appl Bioinformat, Amsterdam, Netherlands; [Jongejan, Aldo; van Kampen, Antoine H. C.] AMC, Clin Epidemiol Biostat & Bioinformat, Bioinformat Lab, Amsterdam, Netherlands; [van Kampen, Antoine H. C.] Univ Amsterdam, SILS, Fac Sci FNWI, Biosyst Data Anal, Amsterdam, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam	Smith, RL (corresponding author), Univ Amsterdam, SILS, Fac Sci FNWI, Mol Biol & Microbial Food Safety, Amsterdam, Netherlands.	r.l.smith@amc.uva.nl		Tan, Josephine M.E./0000-0003-2534-3029				Allard JP, 1998, AIDS, V12, P1653, DOI 10.1097/00002030-199813000-00013; Ames BN, 2010, MECH AGEING DEV, V131, P473, DOI 10.1016/j.mad.2010.04.005; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Anders S., 2014, BIORXIV; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anderson PL, 2004, CLIN INFECT DIS, V38, P743, DOI 10.1086/381678; Apostolova N, 2011, TRENDS PHARMACOL SCI, V32, P715, DOI 10.1016/j.tips.2011.07.007; Apostolova N, 2011, CURR PHARM DESIGN, V17, P2130, DOI 10.2174/138161211796904731; Back P, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/608478; Ballinger SW, 2000, CIRC RES, V86, P960, DOI 10.1161/01.RES.86.9.960; Bansal A, 2015, P NATL ACAD SCI USA, V112, pE277, DOI 10.1073/pnas.1412192112; Baruah A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004097; Blas-Garcia A, 2011, CURR PHARM DESIGN, V17, P4076, DOI 10.2174/138161211798764951; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Bratic I, 2009, NUCLEIC ACIDS RES, V37, P1817, DOI 10.1093/nar/gkp018; Burns AR, 2010, NAT CHEM BIOL, V6, P549, DOI [10.1038/NCHEMBIO.380, 10.1038/nchembio.380]; Cihlar T, 2010, ANTIVIR RES, V85, P39, DOI 10.1016/j.antiviral.2009.09.014; Cocheme HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200; Cote HCF, 2005, ANTIVIR THER, V10, pM3; Cristina D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000450; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Day Brian J, 2004, Cardiovasc Toxicol, V4, P207, DOI 10.1385/CT:4:3:207; de Boer R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126220; de la Asuncion JG, 2004, LIFE SCI, V76, P47, DOI 10.1016/j.lfs.2004.06.020; Droge W, 1999, Curr Opin Clin Nutr Metab Care, V2, P493, DOI 10.1097/00075197-199911000-00011; Graziewicz MA, 2002, NUCLEIC ACIDS RES, V30, P2817, DOI 10.1093/nar/gkf392; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Hasegawa K, 2007, TOXICOL LETT, V175, P82, DOI 10.1016/j.toxlet.2007.09.013; Holden-Dye L, 2007, ANTHELMINTIC DRUGS; Hosseini SH, 2007, AM J PATHOL, V170, P865, DOI 10.2353/ajpath.2007.060655; Hukezalie KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047505; Jiang B, 2007, TOXICOL APPL PHARM, V224, P60, DOI 10.1016/j.taap.2007.06.010; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kline ER, 2009, CARDIOVASC TOXICOL, V9, P1, DOI 10.1007/s12012-008-9029-8; Lagido Cristina, 2008, BMC Physiology, V8, P7, DOI 10.1186/1472-6793-8-7; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawless J., 2011, STAT MODELS METHODS, P1982; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Lee SJ, 2010, CURR BIOL, V20, P2131, DOI 10.1016/j.cub.2010.10.057; Leiers BR, 2003, FREE RADICAL BIO MED, V34, P1405, DOI 10.1016/S0891-5849(03)00102-3; Lewis W, 2003, NAT REV DRUG DISCOV, V2, P812, DOI 10.1038/nrd1201; Lopez O, 2003, BIOMED PHARMACOTHER, V57, P113, DOI 10.1016/S0753-3322(03)00017-9; Lund KC, 2008, TOXICOL APPL PHARM, V226, P94, DOI 10.1016/j.taap.2007.08.015; Lund Kaleb C, 2004, Cardiovasc Toxicol, V4, P217, DOI 10.1385/CT:4:3:217; Luz AL, 2016, MITOCHONDRION, V30, P255, DOI 10.1016/j.mito.2016.08.014; Mallon PWG, 2005, J INFECT DIS, V191, P1686, DOI 10.1086/429697; Manda KR, 2011, FREE RADICAL BIO MED, V50, P801, DOI 10.1016/j.freeradbiomed.2010.12.029; Mandas A, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/749575; MARTIN JL, 1994, ANTIMICROB AGENTS CH, V38, P2743, DOI 10.1128/AAC.38.12.2743; Mattson MP, 2008, AGEING RES REV, V7, P1, DOI 10.1016/j.arr.2007.08.007; Mehta S, 2007, VITAM HORM, V75, P355, DOI 10.1016/s0083-6729(06)75013-0; Milazzo L, 2010, AIDS RES HUM RETROV, V26, P1207, DOI 10.1089/aid.2010.0024; MITCHELL DH, 1979, J GERONTOL, V34, P28, DOI 10.1093/geronj/34.1.28; Miyako K, 1997, J BIOL CHEM, V272, P9605; Mondal Debasis, 2004, Cardiovasc Toxicol, V4, P287, DOI 10.1385/CT:4:3:287; MUNCHPETERSEN B, 1991, J BIOL CHEM, V266, P9032; Munkacsy E, 2014, EXP GERONTOL, V56, P221, DOI 10.1016/j.exger.2014.03.016; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nazir A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015312; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Oliveira RP, 2009, AGING CELL, V8, P524, DOI 10.1111/j.1474-9726.2009.00501.x; PALMEIRA CM, 1995, BBA-BIOENERGETICS, V1229, P187, DOI 10.1016/0005-2728(94)00202-G; Pan-Zhou XR, 2000, ANTIMICROB AGENTS CH, V44, P496, DOI 10.1128/AAC.44.3.496-503.2000; Patrick L, 1999, Altern Med Rev, V4, P403; Patrick L, 2000, Altern Med Rev, V5, P39; Patrick L, 2000, Altern Med Rev, V5, P290; Pereira LF, 1998, CELL BIOCHEM FUNCT, V16, P173, DOI 10.1002/(SICI)1099-0844(199809)16:3<173::AID-CBF783>3.3.CO;2-W; Pulliam DA, 2013, ANTIOXID REDOX SIGN, V19, P1373, DOI 10.1089/ars.2012.4950; Ristow M, 2014, NAT MED, V20, P709, DOI 10.1038/nm.3624; Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Segref A, 2014, CELL METAB, V19, P642, DOI 10.1016/j.cmet.2014.01.016; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Shen C, 2005, J BIOL CHEM, V280, P20580, DOI 10.1074/jbc.M501894200; Sivitz WI, 2010, ANTIOXID REDOX SIGN, V12, P537, DOI 10.1089/ars.2009.2531; Smith Reuben L., 2013, Frontiers in Genetics, V3, P328, DOI 10.3389/fgene.2012.00328; Stankov MV, 2010, ANTIMICROB AGENTS CH, V54, P280, DOI 10.1128/AAC.00914-09; Sun R, 2014, ANTIMICROB AGENTS CH, V58, P6758, DOI 10.1128/AAC.03613-14; Tarnopolsky MA, 2008, ADV DRUG DELIVER REV, V60, P1561, DOI 10.1016/j.addr.2008.05.001; Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Tsang WY, 2002, BIOCHEM BIOPH RES CO, V291, P8, DOI 10.1006/bbrc.2002.6394; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Valenti D, 2000, INT J MOL MED, V6, P93; Van Raamsdonk JM, 2012, P NATL ACAD SCI USA, V109, P5785, DOI 10.1073/pnas.1116158109; Varghese F, 2015, HUM MOL GENET, P1; Viengchareun S, 2007, ANTIVIR THER, V12, P919; Wang L, 2011, ANTIMICROB AGENTS CH, V55, P2552, DOI 10.1128/AAC.00109-11; Wang XW, 2009, AM J PATHOL, V174, P771, DOI 10.2353/ajpath.2009.080157; Xue SY, 2013, TOXICOL SCI, V134, P323, DOI 10.1093/toxsci/kft105; Yan LJ, 1998, P NATL ACAD SCI USA, V95, P12896, DOI 10.1073/pnas.95.22.12896; Yang W, 2007, GENETICS, V177, P2063, DOI 10.1534/genetics.107.080788; Yang W, 2010, AGING CELL, V9, P433, DOI 10.1111/j.1474-9726.2010.00571.x; Yee C, 2014, CELL, V157, P897, DOI 10.1016/j.cell.2014.02.055	95	20	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187424	10.1371/journal.pone.0187424	http://dx.doi.org/10.1371/journal.pone.0187424			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095935	Green Published, gold, Green Submitted			2022-12-26	WOS:000414340200087
J	Ushiyama, A; Tajima, A; Ishikawa, N; Asano, A				Ushiyama, Ai; Tajima, Atsushi; Ishikawa, Naoto; Asano, Atsushi			Characterization of the functions and proteomes associated with membrane rafts in chicken sperm	PLOS ONE			English	Article							DETERGENT-RESISTANT MEMBRANES; LIPID RAFTS; PLASMA-MEMBRANE; CHOLESTEROL DEPLETION; ANCHORED PROTEINS; TRITON X-100; MOUSE; MOTILITY; BINDING; IDENTIFICATION	Cellular membranes are heterogeneous, and this has a great impact on cellular function. Despite the central role of membrane functions in multiple cellular processes in sperm, their molecular mechanisms are poorly understood. Membrane rafts are specific membrane domains enriched in cholesterol, ganglioside G(M1), and functional proteins, and they are involved in the regulation of a variety of cellular functions. Studies of the functional characterization of membrane rafts in mammalian sperm have demonstrated roles in sperm-egg binding and the acrosomal reaction. Recently, our biochemical and cell biological studies showed that membrane rafts are present and might play functional roles in chicken sperm. In this study, we isolated membrane rafts from chicken sperm as a detergent-resistant membranes (DRM) floating on a density gradient in the presence of 1% Triton X-100, and characterized the function and proteomes associated with these domains. Biochemical comparison of the DRM between fresh and cryopreserved sperm demonstrated that cryopreservation induces cholesterol loss specifically from membrane rafts, indicating the functional connection with reduced post-thaw fertility in chicken sperm. Furthermore, using an avidin-biotin system, we found that sperm DRM is highly enriched in a 60 KDa single protein able to bind to the inner perivitelline layer. To identify possible roles of membrane rafts, quantitative proteomics, combined with a stable isotope dimethyl labeling approach, identified 82 proteins exclusively or relatively more associated with membrane rafts. Our results demonstrate the functional distinctions between membrane domains and provide compelling evidence that membrane rafts are involved in various cellular pathways inherent to chicken sperm.	[Ushiyama, Ai] Univ Tsukuba, Grad Sch Life & Environm Sci, Ibaraki, Japan; [Tajima, Atsushi; Ishikawa, Naoto; Asano, Atsushi] Univ Tsukuba, Fac Life & Environm Sci, Ibaraki, Japan	University of Tsukuba; University of Tsukuba	Asano, A (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Ibaraki, Japan.	asano.atsushi.ft@u.tsukuba.ac.jp			JSPS KAKENHI [15K07761]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	JSPS KAKENHI (Grant number 15K07761 to AA) supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral A, 2014, HUM REPROD UPDATE, V20, P40, DOI 10.1093/humupd/dmt046; Asano A, 2016, J POULT SCI, V53, P233, DOI 10.2141/jpsa.0150160; Asano A, 2013, J BIOL CHEM, V288, P28104, DOI 10.1074/jbc.M113.450981; Asano A, 2010, PROTEOMICS, V10, P3494, DOI 10.1002/pmic.201000002; Asano A, 2009, J CELL PHYSIOL, V218, P537, DOI 10.1002/jcp.21623; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; BURROWS W. H., 1937, POULTRY SCI, V16, P19, DOI 10.3382/ps.0160019; Buttke DE, 2006, BIOL REPROD, V74, P889, DOI 10.1095/biolreprod.105.046219; Caballero J, 2012, J CELL PHYSIOL, V227, P3876, DOI 10.1002/jcp.24099; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Edwards IJ, 2013, J NEUROSCI, V33, P9913, DOI 10.1523/JNEUROSCI.5584-12.2013; Evans JP, 2002, HUM REPROD UPDATE, V8, P297, DOI 10.1093/humupd/8.4.297; Foster Leonard J., 2007, V43, P35, DOI 10.1007/978-1-4020-5943-8_4; Gomez-Mouton C, 2001, P NATL ACAD SCI USA, V98, P9642, DOI 10.1073/pnas.171160298; Gu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019386; Guyonnet B, 2012, MOL CELL PROTEOMICS, V11, P758, DOI 10.1074/mcp.M112.020339; Hansen GH, 2001, J BIOL CHEM, V276, P32338, DOI 10.1074/jbc.M102667200; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Hickey KD, 2012, THERIOGENOLOGY, V77, P1369, DOI 10.1016/j.theriogenology.2011.10.045; HOWARTH B, 1990, POULTRY SCI, V69, P1012, DOI 10.3382/ps.0691012; Hu FZ, 2017, BIOL REPROD, V96, P907, DOI 10.1093/biolre/iox010; Ikawa M, 2010, J CLIN INVEST, V120, P984, DOI 10.1172/JCI41585; Jimenez T, 2011, P NATL ACAD SCI USA, V108, P644, DOI 10.1073/pnas.1016902108; Khalil MB, 2006, DEV BIOL, V290, P220, DOI 10.1016/j.ydbio.2005.11.030; KIDO S, 1988, POULTRY SCI, V67, P476, DOI 10.3382/ps.0670476; Kocak-Toker N, 2002, INT J ANDROL, V25, P180, DOI 10.1046/j.1365-2605.2002.00346.x; Korrodi-Gregorio L, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-15; Kusumi A, 2005, BBA-MOL CELL RES, V1746, P234, DOI 10.1016/j.bbamcr.2005.10.001; Labas V, 2014, DATA BRIEF, V1, P37, DOI 10.1016/j.dib.2014.08.008; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li WP, 2001, J CELL SCI, V114, P1397; Li Y, 2016, J UROLOGY, V195, P1160, DOI 10.1016/j.juro.2015.10.179; Li YC, 2006, AM J PATHOL, V168, P1107, DOI 10.2353/ajpath.2006.050959; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; Maehashi E, 2003, J BIOL CHEM, V278, P42050, DOI 10.1074/jbc.M307493200; Mattei V, 2011, MOL BIOL CELL, V22, P4842, DOI 10.1091/mbc.E11-04-0348; Motoyama K, 2009, EUR J PHARM SCI, V38, P249, DOI 10.1016/j.ejps.2009.07.010; MRSNY RJ, 1981, J CELL BIOL, V91, P77; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nakamura M, 2005, ELECTROPHORESIS, V49, P77, DOI [10.2198/jelectroph.49.77, DOI 10.2198/JELECTROPH.49.77]; Nixon B, 2008, J CELL PHYSL; Nixon B, 2009, J CELL PHYSIOL, V218, P122, DOI 10.1002/jcp.21575; Nixon B, 2011, J CELL PHYSIOL, V226, P2651, DOI 10.1002/jcp.22615; Ohta K, 1999, BIOCHEM BIOPH RES CO, V258, P616, DOI 10.1006/bbrc.1999.0686; Okunande GW, 2004, J BIOL CHEM, V279, P33742, DOI 10.1074/jbc.M404628200; Onodera R, 2013, INT J PHARMACEUT, V452, P116, DOI 10.1016/j.ijpharm.2013.04.071; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Post H, 2010, INT J ANDROL, V33, P775, DOI 10.1111/j.1365-2605.2009.01022.x; Rashid-Doubell F, 2007, PLACENTA, V28, P139, DOI 10.1016/j.placenta.2005.12.005; Reid AT, 2011, ASIAN J ANDROL, V13, P88, DOI 10.1038/aja.2010.74; Sasanami T, 2011, REPRODUCTION, V142, P267, DOI 10.1530/REP-11-0120; Schroeder RJ, 1998, J BIOL CHEM, V273, P1150, DOI 10.1074/jbc.273.2.1150; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Schuh K, 2004, J BIOL CHEM, V279, P28220, DOI 10.1074/jbc.M312599200; Selvaraj V, 2006, J CELL PHYSIOL, V206, P636, DOI 10.1002/jcp.20504; Selvaraj V, 2009, J CELL PHYSIOL, V218, P522, DOI 10.1002/jcp.21624; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Skerget S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140650; Sleight SB, 2005, BIOL REPROD, V73, P721, DOI 10.1095/biolreprod.105.041533; TAJIMA A, 1989, J REPROD FERTIL, V85, P1, DOI 10.1530/jrf.0.0850001; Tanphaichitr N, 2015, ASIAN J ANDROL, V17, P574, DOI 10.4103/1008-682X.152817; Thaler CD, 2006, MOL REPROD DEV, V73, P1541, DOI 10.1002/mrd.20540; Nguyen TMD, 2016, FEBS J, V283, P1902, DOI 10.1111/febs.13710; Tokhtaeva E, 2012, J BIOL CHEM, V287, P26115, DOI 10.1074/jbc.M112.370734; Tsai PS, 2007, MOL MEMBR BIOL, V24, P313, DOI 10.1080/09687860701228692; Urayama S, 2008, J BIOL CHEM, V283, P21725, DOI 10.1074/jbc.M802631200; Ushiyama A, 2017, REPROD FERT DE UNPUB; Ushiyama A, 2016, J POULT SCI; van Gestel RA, 2005, MOL HUM REPROD, V11, P583, DOI 10.1093/molehr/gah200; Wang GG, 2013, J PROTEOMICS, V79, P114, DOI 10.1016/j.jprot.2012.12.008; Wennemuth G, 2003, J GEN PHYSIOL, V122, P115, DOI 10.1085/jgp.200308839; Woo AL, 2000, J BIOL CHEM, V275, P20693, DOI 10.1074/jbc.M002323200; Zheng YZ, 2009, J LIPID RES, V50, P988, DOI 10.1194/jlr.M800658-JLR200	76	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186482	10.1317/journal.pone.0186482	http://dx.doi.org/10.1317/journal.pone.0186482			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095853				2022-12-26	WOS:000414340200018
J	Ballouhey, Q; Richard, L; Fourcade, L; Ben Rhaiem, I; Vallat, JM; Sturtz, F; Bourthoumieu, S				Ballouhey, Quentin; Richard, Laurence; Fourcade, Laurent; Ben Rhaiem, Ines; Vallat, Jean Michel; Sturtz, Franck; Bourthoumieu, Sylvie			Involvement of the enteroendocrine system in intestinal obstruction	PLOS ONE			English	Article							ENTERIC NERVOUS-SYSTEM; SMALL-BOWEL OBSTRUCTION; JEJUNOILEAL ATRESIA; INTERSTITIAL-CELLS; MYENTERIC PLEXUS; ENDOCRINE-CELLS; IMMUNE-SYSTEM; RAT MODEL; GUT; INNERVATION	Introduction Intestinal atresia, a rare congenital condition, is often associated with intestinal motility disorders despite adequate neonatal surgery. Previous studies have focused on changes in the enteric nervous system (ENS). We hypothesized that other components of the digestive tract could be involved in this condition. Material and methods In a rat model of surgically-induced intestinal obstruction, a transcriptome analysis was performed to measure the global gene expression. Then, analyzes were focused on genes expressed in ENS and neuroendocrine cells. Rat fetus small intestines at different developmental stages (ED15, ED17, ED19 and ED21, (n = 22)) were studied as controls and compared to the upper and lower segments of small intestines from rat fetuses with surgically induced obstruction (n = 14; ligature at ED18). The gene expression pattern was confirmed by immunohistochemistry, electron microscopy and RT-qPCR. Results From ED15 to ED21, there was a physiological decrease in the gene expression of ENS markers and an increase in that of neuroendocrine genes. Regarding operated embryos, the changes in global gene expression were significantly higher in the proximal segment compared to the distal segment (18% vs. 9%). More precisely, a decrease in ENS gene expression and an increase in neuroendocrine gene expression were observed in the proximal segment compared to controls, indicating an accelerated maturation pattern. Immun ohistochemistry and electron microscopy confirmed these findings. Conclusion Fetal intestinal obstruction seems to induce an accelerated maturation in the proximal segment. Moreover, neuroendocrine cells undergo significant unexpected changes, suggesting that ENS changes could be associated with other changes to induce intestinal motility disorders.	[Ballouhey, Quentin; Richard, Laurence; Fourcade, Laurent; Ben Rhaiem, Ines; Vallat, Jean Michel; Sturtz, Franck; Bourthoumieu, Sylvie] Univ Med, Peripheral Neuropathy EA6309, Limoges, France; [Ballouhey, Quentin; Fourcade, Laurent] Univ Hosp, Dept Pediat Surg, Limoges, France; [Richard, Laurence; Vallat, Jean Michel] Univ Hosp, Dept Neurol, Limoges, France; [Sturtz, Franck] Univ Hosp, Dept Biochem & Mol Genet, Limoges, France; [Bourthoumieu, Sylvie] Univ Hosp, Dept Histol Cytol & Cytogenet, Limoges, France	CHU Limoges; CHU Limoges; CHU Limoges; CHU Limoges	Ballouhey, Q; Bourthoumieu, S (corresponding author), Univ Med, Peripheral Neuropathy EA6309, Limoges, France.; Ballouhey, Q (corresponding author), Univ Hosp, Dept Pediat Surg, Limoges, France.; Bourthoumieu, S (corresponding author), Univ Hosp, Dept Histol Cytol & Cytogenet, Limoges, France.	qballouhey@gmail.com; sylvie.bourthournieu@unilim.fr		/0000-0001-6428-5162	CHU de Limoges, APREL (Appel a projet Recherche Equipes Emergentes et Labellisees) - ARS Limousin	CHU de Limoges, APREL (Appel a projet Recherche Equipes Emergentes et Labellisees) - ARS Limousin	This work was supported by a grant from CHU de Limoges, APREL (Appel a projet Recherche Equipes Emergentes et Labellisees, 2013), funded by ARS Limousin.	Baglaj SM, 2001, J PEDIATR SURG, V36, P1428, DOI 10.1053/jpsu.2001.26392; Bohorquez DV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089881; Burns AJ, 2006, NEUROGASTROENT MOTIL, V18, P876, DOI 10.1111/j.1365-2982.2006.00806.x; Celli J, 2014, EUR J MED GENET, V57, P424, DOI 10.1016/j.ejmg.2014.06.007; Chang IY, 2001, J PHYSIOL-LONDON, V536, P555, DOI 10.1111/j.1469-7793.2001.0555c.xd; Farge E, 2011, CURR TOP DEV BIOL, V95, P243, DOI 10.1016/B978-0-12-385065-2.00008-6; Fiegel HC, 2006, EUR J PEDIATR SURG, V16, P407, DOI 10.1055/s-2006-924750; Fourcade L, 2009, NEUROSCI LETT, V461, P126, DOI 10.1016/j.neulet.2009.06.009; Fourcade LM, 2010, J PEDIATR SURG, V45, P499, DOI 10.1016/j.jpedsurg.2009.07.031; Fu M, 2004, ANAT EMBRYOL, V208, P33, DOI 10.1007/s00429-003-0371-0; Furness JB, 2000, J AUTONOM NERV SYST, V81, P87, DOI 10.1016/S0165-1838(00)00127-2; Furness JB, 2013, NAT REV GASTRO HEPAT, V10, P729, DOI 10.1038/nrgastro.2013.180; Gaillard D, 1996, PEDIATR PATHOL LAB M, V16, P25, DOI 10.1080/107710496175859; Gershon MD, 1999, HOSP PRACT, V34, P31, DOI 10.3810/hp.1999.07.153; Gfroerer S, 2010, WORLD J GASTROENTERO, V16, P5716, DOI 10.3748/wjg.v16.i45.5716; Goyal RK, 1996, NEW ENGL J MED, V334, P1106, DOI 10.1056/NEJM199604253341707; Hao MM, 2013, DEV BIOL, V382, P365, DOI 10.1016/j.ydbio.2012.12.006; Hao MM, 2009, J CELL MOL MED, V13, P1193, DOI 10.1111/j.1582-4934.2009.00813.x; Harrison E, 2013, CURR OPIN PHARMACOL, V13, P941, DOI 10.1016/j.coph.2013.09.012; Hatch J, 2015, DEV DYNAM, V244, P56, DOI 10.1002/dvdy.24178; Hemming V, 2007, PRENATAL DIAG, V27, P1205, DOI 10.1002/pd.1886; Heuckeroth RO, 2006, DEVELOPMENT, V133, P2287, DOI 10.1242/dev.02418; Khen N, 2004, PEDIATR RES, V56, P975, DOI 10.1203/01.PDR.0000145294.11800.71; Khen-Dunlop N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062292; Latorre R, 2016, NEUROGASTROENT MOTIL, V28, P620, DOI 10.1111/nmo.12754; Masumoto K, 1999, J PEDIATR SURG, V34, P1463, DOI 10.1016/S0022-3468(99)90104-5; McKeown SJ, 2001, CELL TISSUE RES, V303, P301, DOI 10.1007/s004410000303; Obata Y, 2016, GASTROENTEROLOGY, V151, P836, DOI 10.1053/j.gastro.2016.07.044; Ozguner IF, 2005, J PEDIATR SURG, V40, P1232, DOI 10.1016/j.jpedsurg.2005.05.032; Ramachandran P, 2007, PEDIATR SURG INT, V23, P1183, DOI 10.1007/s00383-007-2029-0; Salvi EP, 2004, ANAT EMBRYOL, V209, P143, DOI 10.1007/s00429-004-0435-9; Schoenberg RA, 2002, J PEDIATR SURG, V37, P735, DOI 10.1053/jpsu.2002.32267; Schonhoff SE, 2004, ENDOCRINOLOGY, V145, P2639, DOI 10.1210/en.2004-0051; Stollman TH, 2009, J PEDIATR SURG, V44, P217, DOI 10.1016/j.jpedsurg.2008.10.043; Tander B, 2010, J PEDIATR SURG, V45, P724, DOI 10.1016/j.jpedsurg.2009.11.010; Vaccaro R, 2009, EUR J HISTOCHEM, V53, P143; von Sochaczewski CO, 2017, J SURG RES, V209, P112, DOI 10.1016/j.jss.2016.09.035; Wang XL, 2013, J PEDIATR SURG, V48, P2084, DOI 10.1016/j.jpedsurg.2013.05.025; Watanabe Y, 2001, J PEDIATR SURG, V36, P474, DOI 10.1053/jpsu.2001.21618; Worthington JJ, 2015, BIOCHEM SOC T, V43, P727, DOI 10.1042/BST20150090	40	2	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0186507	10.1371/journal.pone.0186507	http://dx.doi.org/10.1371/journal.pone.0186507			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091949	Green Published, Green Submitted, gold			2022-12-26	WOS:000414229700021
J	Briceno, B; Coville, A; Gertler, P; Martinez, S				Briceno, Bertha; Coville, Aidan; Gertler, Paul; Martinez, Sebastian			Are there synergies from combining hygiene and sanitation promotion campaigns: Evidence from a large-scale cluster-randomized trial in rural Tanzania	PLOS ONE			English	Article							CHILD UNDERNUTRITION; DIARRHEA; COMMUNITY; INDIA; INTERVENTION; BEHAVIOR; HEALTH; HANDS; WATER; RISK	The current evidence on handwashing and sanitation programs suggests limited impacts on health when at-scale interventions have been tested in isolation. However, no published experimental evidence currently exists that tests the interaction effects between sanitation and handwashing. We present the results of two large-scale, government-led handwashing and sanitation promotion campaigns in rural Tanzania, with the objective of tracing the causal chain from hygiene and sanitation promotion to changes in child health outcomes and specifically testing for potential interaction effects of combining handwashing and sanitation interventions. Methods The study is a factorial cluster-randomized control trial where 181 rural wards from 10 districts in Tanzania were randomly assigned to receive sanitation promotion, handwashing promotion, both interventions together or neither (control). Interventions were rolled out from February 2009 to June 2011 and the endline survey was conducted from May to November 2012, approximately one year after program completion. The sample was composed of households with children under 5 years old in the two largest villages in each ward. Masking was not possible due to the nature of the intervention, but enumerators played no part in the intervention and were blinded to treatment status. The primary outcome of interest was 7-day diarrhea prevalence for children under five. Intermediate outcomes of behavior change including improved latrine construction, levels of open defecation and handwashing with soap were also analyzed. Secondary health outcomes included anemia, height-for-age and weight-for-age of children under 5. An intention-to-treat analysis was used to assess the relationship between the interventions and outcomes of interest. Findings One year after the end of the program, ownership of improved latrines increased from 49.7% to 64.8% (95% CI 57.9%-71.7%) and regular open defecation decreased from 23.1% to 11.1% (95% CI 3.5%-18.7%) in sanitation promotion-only wards. Households in hand washing promotion-only wards showed marginal improvements in handwashing behavior related to food preparation but not at other critical junctures. There were no detectable interaction effects for the combined intervention. The associated cost-per-household gaining access to improved sanitation is estimated to be USD $194. Final effects on child health measured through diarrhea, anemia, stunting and wasting were absent in all treatment groups. Interpretation Although statistically significant, the changes in intermediate outcomes achieved through each intervention in isolation were not large enough to generate meaningful health impacts. With no observable signs of interaction, the combined intervention produced similar results. The study highlights the importance of focusing on intermediate outcomes of take up and behavior change as a critical first step in large-scale programs before realizing the changes in health that sanitation and hygiene interventions aim to deliver.	[Briceno, Bertha] Interamer Dev Bank, Knowledge & Learning Sect, Washington, DC USA; [Coville, Aidan] World Bank, Dev Impact Evaluat Unit, 1818 H St NW, Washington, DC 20433 USA; [Gertler, Paul] Univ Calif Berkeley, Haas Sch Business, Berkeley, CA 94720 USA; [Martinez, Sebastian] Interamer Dev Bank, Off Strateg Planning & Dev Effectiveness, Washington, DC USA	Inter-American Development Bank; The World Bank; University of California System; University of California Berkeley; Inter-American Development Bank	Coville, A (corresponding author), World Bank, Dev Impact Evaluat Unit, 1818 H St NW, Washington, DC 20433 USA.	acoville@worldbank.org		Martinez, Sebastian/0000-0002-7651-6674	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by a grant from the Bill & Melinda Gates Foundation to the Water and Sanitation Program. The funder provided support in the form of salaries for BB and AC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	BAQUI AH, 1991, INT J EPIDEMIOL, V20, P1057, DOI 10.1093/ije/20.4.1057; Biran A, 2014, LANCET GLOB HEALTH, V2, pE145, DOI 10.1016/S2214-109X(13)70160-8; Briceno B, 2015, J DEV EFFECT, V7, P423, DOI 10.1080/19439342.2015.1105848; Bruhn M, 2008, WORLD BANK POLICY RE; Cameron LA, 2013, WORLD BANK POLICY RE; Chase C, 2012, WORLD BANK POLICY RE; Clasen T, 2014, LANCET GLOB HEALTH, V2, pE645, DOI 10.1016/S2214-109X(14)70307-9; Crocker J, 2016, ENVIRON SCI TECHNOL, V50, P6517, DOI 10.1021/acs.est.6b01021; Curtis V, 2003, LANCET INFECT DIS, V3, P275, DOI 10.1016/S1473-3099(03)00606-6; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Dreibelbis R, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13010129; Duflo E., 2015, TOILETS CAN WORK SHO; Ejemot R. I., 2009, EVIDENCE BASED CHILD, V4, P893, DOI DOI 10.1002/EBCH.373; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Freeman MC, 2014, TROP MED INT HEALTH, V19, P906, DOI 10.1111/tmi.12339; Fuller JA, 2016, AM J TROP MED HYG, P15; Galiani S, 2015, HLTH EC; Garn J. V., 2016, INT J HYGIENE ENV HL; Guiteras R, 2015, SCIENCE, V348, P903, DOI 10.1126/science.aaa0491; Humphrey JH, 2009, LANCET, V374, P1032, DOI 10.1016/S0140-6736(09)60950-8; Kling JR, 2007, ECONOMETRICA, V75, P83, DOI 10.1111/j.1468-0262.2007.00733.x; Lavelle MJ, 2015, GLOBAL ENVIRON CHANG, V35, P368, DOI 10.1016/j.gloenvcha.2015.09.021; Luby SP, 2004, JAMA-J AM MED ASSOC, V291, P2547, DOI 10.1001/jama.291.21.2547; Patil SR, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001709; Pickering AJ, 2015, LANCET GLOB HEALTH, V3, pE701, DOI 10.1016/S2214-109X(15)00144-8; Ram P., 2010, PRACTICAL GUIDANCE M; Schmidt WP, 2015, LANCET GLOB HEALTH, V3, pE659, DOI 10.1016/S2214-109X(15)00182-5; Schmidt WP, 2009, ENVIRON SCI TECHNOL, V43, P986, DOI 10.1021/es802232w; Schriewer A, 2015, AM J TROP MED HYG, V93, P509, DOI 10.4269/ajtmh.14-0824; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; WHO- Unicef, LEV TRENDS CHILD MOR; World Health Organization (WHO), 2013, HAEM CONC DIAGN AN A	32	28	28	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0186228	10.1371/journal.pone.0186228	http://dx.doi.org/10.1371/journal.pone.0186228			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL4VN	29091726	gold, Green Published, Green Submitted			2022-12-26	WOS:000414229700012
J	Yamaguchi, H; Ishida, Y; Hosomichi, J; Suzuki, JI; Hatano, K; Usumi-Fujita, R; Shimizu, Y; Kaneko, S; Ono, T				Yamaguchi, Hiroyuki; Ishida, Yuji; Hosomichi, Jun; Suzuki, Jun-ichi; Hatano, Kasumi; Usumi-Fujita, Risa; Shimizu, Yasuhiro; Kaneko, Sawa; Ono, Takashi			Ultrasound microbubble-mediated transfection of NF-kappa B decoy oligodeoxynucleotide into gingival tissues inhibits periodontitis in rats in vivo	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; ATTENUATES NEOINTIMAL FORMATION; TRANSCRIPTION FACTOR DECOY; PLASMID DNA; EPITHELIAL-CELLS; ARTERIAL INJURY; GENE-EXPRESSION; BONE-RESORPTION; CONTRAST AGENTS; ALVEOLAR BONE	Periodontitis is a chronic infectious disease for which the fundamental treatment is to reduce the load of subgingival pathogenic bacteria by debridement. However, previous investigators attempted to implement a nuclear factor kappa B (NF-kappa B) decoy oligodeoxynucleotide (ODN) as a suppressor of periodontitis progression. Although we recently reported the effectiveness of the ultrasound-microbubble method as a tool for transfecting the NF-kappa B decoy ODN into healthy rodent gingival tissue, this technique has not yet been applied to the pathological gingiva of periodontitis animal models. Therefore, the aim of this study was to investigate the effectiveness of the technique in transfecting the NF-kappa B decoy ODN into rats with ligature-induced periodontitis. Micro computed tomography (micro-CT) analysis demonstrated a significant reduction in alveolar bone loss following treatment with the NF-kappa B decoy ODN in the experimental group. RT-PCR showed that NF-kappa B decoy ODN treatment resulted in significantly reduced expression of inflammatory cytokine transcripts within rat gingival tissues. Thus, we established a transcutaneous transfection model of NF-kappa B decoy ODN treatment of periodontal tissues using the ultrasound-microbubble technique. Our findings suggest that the NF-kappa B decoy ODN could be used as a significant suppressor of gingival inflammation and periodontal disease progression.	[Yamaguchi, Hiroyuki; Ishida, Yuji; Hosomichi, Jun; Suzuki, Jun-ichi; Hatano, Kasumi; Usumi-Fujita, Risa; Shimizu, Yasuhiro; Kaneko, Sawa; Ono, Takashi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Orthodont Sci, Tokyo, Japan; [Suzuki, Jun-ichi] Univ Tokyo, Grad Sch Med, Dept Adv Clin Sci & Therapeut, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); University of Tokyo	Ishida, Y (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Orthodont Sci, Tokyo, Japan.	yjis.orts@tmd.ac.jp	Ono, Takashi/ABC-4644-2020	Ono, Takashi/0000-0002-8043-660X; YAMAGUCHI, HIROYUKI/0000-0002-3754-6723	Japanese Ministry of Education, Culture, Sports, Science, and Technology (KAKENHI) [24792322]; Grants-in-Aid for Scientific Research [16K20639] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science, and Technology (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was financially supported in part by Grants-in-Aid for Scientific Research (24792322) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (KAKENHI). Yuji Ishida, http://www. isps.go.jp/english/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belibasakis GN, 2007, MICROB PATHOGENESIS, V43, P46, DOI 10.1016/j.micpath.2007.03.001; Bosshardt DD, 2005, J DENT RES, V84, P9, DOI 10.1177/154405910508400102; Brunetti G, 2005, J PERIODONTOL, V76, P1675, DOI 10.1902/jop.2005.76.10.1675; Cheng WC, 2010, J PERIODONTAL RES, V45, P788, DOI 10.1111/j.1600-0765.2010.01301.x; Egashira K, 2008, J GENE MED, V10, P805, DOI 10.1002/jgm.1192; Endoh M, 2002, MOL THER, V5, P501, DOI 10.1006/mthe.2002.0577; Erdemir Ebru Olgun, 2015, Eur J Dent, V9, P60, DOI 10.4103/1305-7456.149644; FECHHEIMER M, 1987, P NATL ACAD SCI USA, V84, P8463, DOI 10.1073/pnas.84.23.8463; Ferrara K, 2007, ANNU REV BIOMED ENG, V9, P415, DOI 10.1146/annurev.bioeng.8.061505.095852; Fujihara R, 2014, J PERIODONTAL RES, V49, P508, DOI 10.1111/jre.12131; Fujihara R, 2013, TUMOR NECROSIS FACTO, V49, P508, DOI DOI 10.1111/JRE.12131; Hatipoglu M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128134; HavemosePoulsen A, 1997, CRIT REV ORAL BIOL M, V8, P217, DOI 10.1177/10454411970080020801; Inagaki H, 2006, J VASC RES, V43, P12, DOI 10.1159/000089103; Inoue H, 2014, ULTRASONICS, V54, P874, DOI 10.1016/j.ultras.2013.10.021; Kornman KS, 1997, PERIODONTOL 2000, V14, P33, DOI 10.1111/j.1600-0757.1997.tb00191.x; Kunugiza Y, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1980; Latanich CA, 2009, J INVEST SURG, V22, P301, DOI 10.1080/08941930903040155; Lee FY, 2011, AAPS PHARMSCITECH, V12, P1110, DOI 10.1208/s12249-011-9681-3; Leow CH, 2015, ULTRASOUND MED BIOL, V41, P2926, DOI 10.1016/j.ultrasmedbio.2015.06.023; LINDHE J, 1984, J CLIN PERIODONTOL, V11, P448, DOI 10.1111/j.1600-051X.1984.tb01344.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/634095; Morishita R, 1997, NAT MED, V3, P894, DOI 10.1038/nm0897-894; Morishita R, 2004, CURR OPIN PHARMACOL, V4, P139, DOI 10.1016/j.coph.2003.10.008; Nakamura H, 2002, GENE THER, V9, P1221, DOI 10.1038/sj.gt.3301724; Nakata T, 2016, BMC ORAL HEALTH, V16, DOI 10.1186/s12903-016-0303-z; Paefgen V, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00197; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; Shimizu H, 2009, ANTIOXID REDOX SIGN, V11, P2065, DOI [10.1089/ars.2008.2355, 10.1089/ARS.2008.2355]; Shirasaki H, 2004, CLIN EXP ALLERGY, V34, P945, DOI 10.1111/j.1365-2222.2004.01964.x; STASHENKO P, 1991, J CLIN PERIODONTOL, V18, P548, DOI 10.1111/j.1600-051X.1991.tb00088.x; Stride E, 2009, ULTRASOUND MED BIOL, V35, P861, DOI 10.1016/j.ultrasmedbio.2008.11.010; Sugano M, 2012, INT J PHARMACEUT, V422, P332, DOI 10.1016/j.ijpharm.2011.11.001; Suzuki J, 2010, J AM COLL CARDIOL, V55, P904, DOI 10.1016/j.jacc.2009.09.054; Takayanagi H, 2009, NAT REV RHEUMATOL, V5, P667, DOI 10.1038/nrrheum.2009.217; Tamai R, 2005, INFECT IMMUN, V73, P6290, DOI 10.1128/IAI.73.10.6290-6298.2005; Taniyama Y, 2002, CIRCULATION, V105, P1233, DOI 10.1161/hc1002.105228; Taniyama Y, 2006, YAKUGAKU ZASSHI, V126, P1039, DOI 10.1248/yakushi.126.1039; Taubman MA, 2005, J PERIODONTOL, V76, P2033, DOI 10.1902/jop.2005.76.11-S.2033; Toker H, 2008, J PERIODONTOL, V79, P1089, DOI [10.1902/jop.2008.070462, 10.1902/jop.2008.070462 ]; Tomita N, 2000, GENE THER, V7, P1326, DOI 10.1038/sj.gt.3301243; VanWinkelhoff AJ, 1996, PERIODONTOL 2000, V10, P45; Vrana JA, 2009, BLOOD, V114, P4957, DOI 10.1182/blood-2009-07-230722; Wee JH, 2017, ALLERGY ASTHMA IMMUN, V9, P61, DOI 10.4168/aair.2017.9.1.61; Xu XC, 2015, MOL MED REP, V12, P3494, DOI 10.3892/mmr.2015.3875; Yamaguchi H, 2017, INT J ORAL SCI, V9, P80, DOI 10.1038/ijos.2017.10	48	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0186264	10.1371/journal.pone.0186264	http://dx.doi.org/10.1371/journal.pone.0186264			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091721	Green Published, Green Submitted, gold			2022-12-26	WOS:000414229700013
J	Hill, LD; Edwards, R; Turner, JR; Argo, YD; Olkhanud, PB; Odsuren, M; Guttikunda, S; Ochir, C; Smith, KR				Hill, L. Drew; Edwards, Rufus; Turner, Jay R.; Argo, Yuma D.; Olkhanud, Purevdorj B.; Odsuren, Munkhtuul; Guttikunda, Sarath; Ochir, Chimedsuren; Smith, Kirk R.			Health assessment of future PM2.5 exposures from indoor, outdoor, and secondhand tobacco smoke concentrations under alternative policy pathways in Ulaanbaatar, Mongolia	PLOS ONE			English	Article							AIR-POLLUTION; SPATIAL VARIABILITY; GLOBAL BURDEN; DISEASE; MORTALITY; RISK; COLD	Introduction Winter air pollution in Ulaanbaatar, Mongolia is among the worst in the world. The health impacts of policy decisions affecting air pollution exposures in Ulaanbaatar were modeled and evaluated under business as usual and two more-strict alternative emissions pathways through 2024. Previous studies have relied on either outdoor or indoor concentrations to assesses the health risks of air pollution, but the burden is really a function of total exposure. This study combined projections of indoor and outdoor concentrations of PM2.5 with population time-activity estimates to develop trajectories of total age-specific PM2.5 exposure for the Ulaanbaatar population. Indoor PM2.5 contributions from secondhand tobacco smoke (SHS) were estimated in order to fill out total exposures, and changes in population and background disease were modeled. The health impacts were derived using integrated exposure-response curves from the Global Burden of Disease Study. Results Annual average population-weighted PM2.5 exposures at baseline (2014) were estimated at 59 mu g/m(3). These were dominated by exposures occurring indoors, influenced considerably by infiltrated outdoor pollution. Under current control policies, exposures increased slightly to 60 mu g/m(3) by 2024; under moderate emissions reductions and under a switch to clean technologies, exposures were reduced from baseline levels by 45% and 80%, respectively. The moderate improvement pathway decreased per capita annual disability-adjusted life year (DALY) and death burdens by approximately 40%. A switch to clean fuels decreased per capita annual DALY and death burdens by about 85% by 2024 with the relative SHS contribution increasing substantially. Conclusion This study demonstrates a way to combine estimated changes in total exposure, background disease and population levels, and exposure-response functions to project the health impacts of alternative policy pathways. The resulting burden analysis highlights the need for aggressive action, including the elimination of residential coal burning and the reduction of current smoking rates.	[Hill, L. Drew; Smith, Kirk R.] Univ Calif Berkeley, Div Environm Hlth Sci, Berkeley, CA 94720 USA; [Edwards, Rufus] Univ Calif Irvine, Dept Epidemiol, Irvine, CA USA; [Turner, Jay R.] Washington Univ, Dept Energy Environm & Chem Engn, St Louis, MO USA; [Argo, Yuma D.; Olkhanud, Purevdorj B.; Odsuren, Munkhtuul; Ochir, Chimedsuren] Mongolian Natl Univ Med Sci, Sch Publ Hlth, Ulaanbaatar, Mongolia; [Olkhanud, Purevdorj B.] NHLBI, Sickle Cell Branch, NIH, Bldg 10, Bethesda, MD 20892 USA; [Guttikunda, Sarath] Desert Res Inst, Div Atmospher Sci, Reno, NV USA	University of California System; University of California Berkeley; University of California System; University of California Irvine; Washington University (WUSTL); Mongolian National University of Medical Sciences; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Nevada System of Higher Education (NSHE); Desert Research Institute NSHE	Hill, LD (corresponding author), Univ Calif Berkeley, Div Environm Hlth Sci, Berkeley, CA 94720 USA.	drew.hill@berkeley.edu	Hill, Drew/AAO-4930-2020; Ochir, Chimedsuren/AAW-7743-2020	Hill, Drew/0000-0001-8929-3556; Ochir, Chimedsuren/0000-0002-7134-5255; Guttikunda, Sarath/0000-0003-4507-5199; Turner, Jay/0000-0001-7787-6244	Mongolian Ministry of Environment and Green Development through the Clean Air Foundation of Ulaanbaatar; NSF SAGE IGERT at the University of California, Berkeley [DGE-1144885]; Berkeley Air Monitoring Group	Mongolian Ministry of Environment and Green Development through the Clean Air Foundation of Ulaanbaatar; NSF SAGE IGERT at the University of California, Berkeley; Berkeley Air Monitoring Group	The Mongolian Ministry of Environment and Green Development provided funding for this study through the Clean Air Foundation of Ulaanbaatar: https://www.mne.mn/. The NSF SAGE IGERT program (DGE-1144885) at the University of California, Berkeley funded L. Drew Hill during part of the write up and analysis phases of this project. For a short period overlapping the beginning of this study, authors YDA, RE, and JT were partially supported as consultants on a separate project for Social Impact. The specific roles of these authors are articulated in the 'author contributions' section. Some of the publicly available data collected as part of the Social Impact project were used in the current study. Social Impact was not otherwise involved in this study.; Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation. The authors are grateful to the National Statistics Office of Mongolia and the Statistics Department of Ulaanbaatar, Health Development Center of the Ministry of Health and Sports which provided access to various demographics and health databases. We are grateful to Social Impact and the Millennium Challenge Corporation for their open access databases of household measurements conducted as part of the impact evaluation of the Energy and Environment Projects. We thank Maria Hernandez, Ajay Pillarisetti, Paul Chung, and Alan Hubbard of the University of California, Berkeley and Nick Lam from the University of Illinois for their advice and generous assistance during the project. We acknowledge Boldkhuu Nanzad of the Ministry of Energy of Mongolia for advocating for our research, and appreciate the Berkeley Air Monitoring Group for facilitating financial arrangements. We also acknowledge that the final analysis benefits from comments made by many participants at a workshop presenting preliminary results conducted as part of the impact evaluation of the Energy and Environment Projects. During the peer-review process, a modified version of this paper was included as a chapter in a doctoral dissertation at the University of California, Berkeley. The full dissertation, which includes five total chapters and is titled "A breath of fresher air: improving methods for PM<INF>2.5</INF> exposure assessment from Mongolia to California" by Lawson Andrew Hill, will eventually be available at ProQuest/UMI or the University of California's online repository, "eScholarship."	Alexeeff SE, 2015, J EXPO SCI ENV EPID, V25, P138, DOI 10.1038/jes.2014.40; Allen RW, 2013, AIR QUAL ATMOS HLTH, V6, P137, DOI 10.1007/s11869-011-0154-3; Amarsaikhan D., 2014, J GEOSCI ENV PROT, V2, P123, DOI [10.4236/gep.2014.22017, DOI 10.4236/GEP.2014.22017]; [Anonymous], 2007, NIH CURR SER S; Balakrishnan K, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-77; Brauer M, 2016, ENVIRON SCI TECHNOL, V50, P79, DOI 10.1021/acs.est.5b03709; Burnett RT, 2014, ENVIRON HEALTH PERSP, V122, P397, DOI 10.1289/ehp.1307049; Cameron T, 2004, ADVISORY COUNCIL CLE; Chilkhaasuren B, 2010, POPULATION EC ACTIVI; Chowdhury Z, 2013, ATMOS ENVIRON, V67, P161, DOI 10.1016/j.atmosenv.2012.10.041; Davy PK, 2011, ATMOS POLLUT RES, V2, P126, DOI 10.5094/APR.2011.017; Demaio AR, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-213; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Dore G, 2006, ENVIRONMENT, V48, P10, DOI 10.3200/ENVT.48.6.10-24; Enkhbat U, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13020214; Environmental Systems Research Institute, 2012, ARCGIS DESKT REL 10; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Greene L., 2014, IMPACT EVALUATION RE; Greene L, 2014, SOCIAL IMPACT 2012 2; Greene L, 2014, MONGOLIA ENERGY ENV; Guttikunda SK, 2013, AIR QUAL ATMOS HLTH, V6, P357, DOI 10.1007/s11869-012-0187-2; HJI Group Corporation, 2011, MONG UL LOW CARB EN; Japan International Cooperation Agency, 2013, CAP DEV PROJ AIR POL; Jerrett M, 2005, EPIDEMIOLOGY, V16, P727, DOI 10.1097/01.ede.0000181630.15826.7d; Kohn M., 2013, BLOOMBERG BUSINESS; Li TX, 2016, SCI TOTAL ENVIRON, V548, P6, DOI 10.1016/j.scitotenv.2016.01.038; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Luo B, 2014, INT J BIOMETEOROL, V58, P185, DOI 10.1007/s00484-013-0641-3; Mongolian Statistical Information Service, 2016, DAT STAT DAT SECT; Nakao M, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3481-x; National Statistics Office of Mongolia, 2012, 2010 POP HOUS CENS M; OpenAQ, 2016, US DIPL POST UL DAT; Pillarisetti A, 2016, BROKEN PUMPS AND PROMISES: INCENTIVIZING IMPACT IN ENVIRONMENTAL HEALTH, P147, DOI 10.1007/978-3-319-28643-3_10; Pinto JP, 2004, J AIR WASTE MANAGE, V54, P440, DOI 10.1080/10473289.2004.10470919; RCore Team, 2020, R LANG ENV STAT COMP; Statistics Department of Ulaanbaatar, 2013, POP HOUS CENS 2012; Ulzii D, 2015, HEAL EFF AIR POLLUT, V1, P67; United Nations Children's Fund, 2016, RED IMP AIR POLL CHI; United Nations Children's Fund Mongolia, 2016, UND ADDR IMP AIR POL; United States Environmental Protection Agency, 1995, EPA454B95003B; United States Environmental Protection Agency, 2006, FED REGISTER, V71, P9866; van der Laan MJ, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1309; van Donkelaar A, 2015, ENVIRON HEALTH PERSP, V123, P135, DOI 10.1289/ehp.1408646; Warburton D, 2013, ENVIRON RES, V124, P65, DOI 10.1016/j.envres.2013.04.002; WHO, 2014, WHO GUID IND AIR QUA; World Bank, 2011, AIR QUAL AN UL IMPR; World Bank Asia Sustainable and Alternative Energy Program, 2009, MONG HEAT POOR PER U; World Health Organization, 2010, MONG STEPS SURV PREV; World Health Organization Western Pacific Region, 2012, SMOK BANS ALL PUBL A	50	26	27	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186834	10.1371/journal.pone.0186834	http://dx.doi.org/10.1371/journal.pone.0186834			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088256	gold, Green Published			2022-12-26	WOS:000414088900025
J	Zhou, SJ; Wang, P; Su, XL; Chen, JX; Chen, HF; Yang, HB; Fang, AP; Xie, LS; Yao, YQ; Yang, JL				Zhou, Shijie; Wang, Ping; Su, Xiaolan; Chen, Jingxia; Chen, Hongfen; Yang, Hanbing; Fang, Aiping; Xie, Linshen; Yao, Yuqin; Yang, Jinliang			High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma	PLOS ONE			English	Article							CARCINOMA; 3Q; OVEREXPRESSION; AMPLIFICATION; RESISTANT	Different subtypes of non-small cell lung cancer (NSCLC) have distinct sites of origin, histologies, genetic and epigenetic changes. In this study, we explored the mechanisms of ECT2 dysregulation and compared its prognostic value in lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC). In addition, we also investigated the enrichment of ECT2 co-expressed genes in KEGG pathways in LUAD and LUSC. Bioinformatic analysis was performed based on data from the Cancer Genome Atlas (TCGA)-LUAD and TCGA-LUSC. Results showed that ECT2 expression was significantly upregulated in both LUAD and LUSC compared with normal lung tissues. ECT2 expression was considerably higher in LUSC than in LUAD. The level of ECT2 DNA methylation was significantly lower in LUSC than in LUAD. ECT2 mutation was observed in 5% of LUAD and in 51% of LUSC cases. Amplification was the predominant alteration. LUAD patients with ECT2 amplification had significantly worse disease-free survival (p = 0.022). High ECT2 expression was associated with unfavorable overall survival (OS) (p<0.0001) and recurrence-free survival (RFS) (p = 0.001) in LUAD patients. Nevertheless, these associations were not observed in patients with LUSC. The following univariate and multivariate analysis showed that the high ECT2 expression was an independent prognostic factor for poor OS (HR: 2.039, 95% CI: 1.457-2.852, p<0.001) and RFS (HR: 1.715, 95% CI: 1.210-2.432, p = 0.002) in LUAD patients, but not in LUSC patients. Among 518 genes co-expressed with ECT2 in LUAD and 386 genes co-expressed with ECT2 in LUSC, there were only 98 genes in the overlapping cluster. Some of the genes related KEGG pathways in LUAD were not observed in LUSC. These differences might help to explain the different prognostic value of ECT2 in LUAD and LUSC, which are also worthy of further studies.	[Zhou, Shijie; Wang, Ping; Fang, Aiping; Xie, Linshen; Yao, Yuqin] Sichuan Univ, West China Teaching Hosp 4, West China Sch Publ Health, Res Ctr Publ Hlth & Prevent Med, Chengdu, Sichuan, Peoples R China; [Zhou, Shijie; Wang, Ping; Su, Xiaolan; Fang, Aiping; Yang, Jinliang] Sichuan Univ, West China Hosp, West China Med Sch, Canc Ctr, Chengdu, Sichuan, Peoples R China; [Chen, Jingxia; Chen, Hongfen; Yang, Hanbing] Weifang Med Univ, Affiliated Hosp, Dept Emergency Med, Weifang, Shandong, Peoples R China	Sichuan University; Sichuan University; Weifang Medical University	Yao, YQ (corresponding author), Sichuan Univ, West China Teaching Hosp 4, West China Sch Publ Health, Res Ctr Publ Hlth & Prevent Med, Chengdu, Sichuan, Peoples R China.	yuqin_yao@scu.edu.cn	Yao, Yuqin/AAG-3879-2020; Yao, Yuqin/W-9673-2018	Yao, Yuqin/0000-0003-2097-6978; Zhou, Shijie/0000-0002-7787-8722	National Science Foundation of China [81402564]; National Natural Science Foundation of China [81773375]; National High Technology Research and Development Program of China [2015AA020904]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by National Science Foundation of China, grant 81402564 to Yuqing Yao; National Natural Science Foundation of China, grant 81773375 to Yuqing Yao; and National High Technology Research and Development Program of China, grant 2015AA020904 to Yuqing Yao.	Balsara BR, 1997, CANCER RES, V57, P2116; Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cline MS, 2013, SCI REP-UK, V3, DOI 10.1038/srep02652; Fields Alan P., 2015, Advances in Biological Regulation, V60, P47, DOI 10.1016/j.jbior.2015.10.009; Fields AP, 2010, ADV ENZYME REGUL, V50, P190, DOI 10.1016/j.advenzreg.2009.10.010; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hirata D, 2009, CLIN CANCER RES, V15, P256, DOI 10.1158/1078-0432.CCR-08-1672; Huff Lauren P, 2013, Genes Cancer, V4, P460, DOI 10.1177/1947601913514851; Justilien V, 2009, ONCOGENE, V28, P3597, DOI 10.1038/onc.2009.217; Justilien V, 2017, CANCER CELL, V31, P256, DOI 10.1016/j.ccell.2016.12.010; Justilien V, 2011, J BIOL CHEM, V286, P8149, DOI 10.1074/jbc.M110.196113; Luo Y, 2015, BIOMED PHARMACOTHER, V73, P135, DOI 10.1016/j.biopha.2015.06.007; Mendez P, 2013, TRANSL LUNG CANCER R, V2, P101, DOI 10.3978/j.issn.2218-6751.2013.03.05; Murata Y, 2014, CANCER SCI, V105, P490, DOI 10.1111/cas.12363; Pasini A, 2012, TRANSL ONCOL, V5, P461, DOI 10.1593/tlo.12256; Pierceall WE, 2012, ANN ONCOL, V23, P2245, DOI 10.1093/annonc/mdr624; Qian J, 2015, GENOM DATA, V5, P272, DOI 10.1016/j.gdata.2015.06.014; Saghaeian Jazi M, 2016, TUMOUR BIOL J INT SO; Schmid-Bindert G, 2013, TARGET ONCOL, V8, P15, DOI 10.1007/s11523-013-0261-1; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sun RF, 2015, TUMOR BIOL, V36, P7195, DOI 10.1007/s13277-015-3361-y; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921	23	29	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187356	10.1371/journal.pone.0187356	http://dx.doi.org/10.1371/journal.pone.0187356			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088286	Green Published, gold, Green Submitted			2022-12-26	WOS:000414088900072
J	Li, J; Yao, ZY; She, C; Li, J; Ten, B; Liu, C; Lin, SB; Dong, QR; Ren, PG				Li, Jian; Yao, Zhen-yu; She, Chang; Li, Jian; Ten, Bin; Liu, Chang; Lin, Shu-bin; Dong, Qi-Rong; Ren, Pei-Gen			Effects of low-dose X-ray irradiation on activated macrophages and their possible signal pathways	PLOS ONE			English	Article							PARTICLE-INDUCED OSTEOLYSIS; IONIZING-RADIATION; TITANIUM PARTICLES; MODEL; SUPPRESSION; ENDOTOXIN; RESPONSES; IMPLANTS; EFFICACY; CULTURES	Low-dose irradiation (LDI) has been used in clinics to treat human diseases, including chronic inflammation. This study assessed the effects of LDI on the inflammatory response of activated mouse primary peritoneal macrophages, and the underlying signal pathways. Primary peritoneal macrophages were isolated from mice and then incubated with lipopolysaccharide (LPS)-coated Ti microparticles (Ti-positive control) with or without brief exposure to LDI (X-ray, 0.5 Gy) 1 h later (Ti-LDI group) or left untreated in culture medium (Ti-negative control). The macrophages were then subjected to qRT-PCR, Western blot, cell viability CCK-8 assay, and ELISA. qRT-PCR analysis revealed the Ti-LDI group expressed significantly lower levels of IL-1 beta, IL-6, and TNF-alpha mRNA than those of the Ti-positive control group, while the ELISA data showed that Ti-LDI group had significantly lower secretion of IL-1 beta, IL-6, and TNF-alpha proteins. The most significant reduction associated with LDI was the secretion TNF-alpha protein, which barely increased from 13 to 25 h after treatment. Western blot data demonstrated that phosphorylation of p65 and ERK was much lower in the Ti-LDI group than in the controls. The data from the current study suggests that LDI of activated mouse macrophages was associated with significantly lower inflammation responses, compared with non-exposed activated macrophages, which was possibly through inhibition of the NF-kappa B and ERK pathways.	[Li, Jian; She, Chang; Lin, Shu-bin; Dong, Qi-Rong] Soochow Univ, Affiliated Hosp 2, Dept Orthoped, Suzhou, Jiangsu, Peoples R China; [Yao, Zhen-yu; Li, Jian; Ten, Bin; Liu, Chang; Ren, Pei-Gen] Chinese Acad Sci, Shenzhen Inst Adv Technol, Dept Translat Med, R&D Ctr, Shenzhen, Guangdong, Peoples R China	Soochow University - China; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Dong, QR (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Orthoped, Suzhou, Jiangsu, Peoples R China.; Ren, PG (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Dept Translat Med, R&D Ctr, Shenzhen, Guangdong, Peoples R China.	dqrszgk@163.com; pg.ren@siat.ac.cn			Suzhou Science and Technology Development Project [SYS201621, SYSD2015084]; natural science foundation of Jiangsu Province [BK20160340]	Suzhou Science and Technology Development Project; natural science foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This study was supported by grants from Suzhou Science and Technology Development Project (Grants NO: SYS201621, SYSD2015084) and the natural science foundation of Jiangsu Province (Grants NO: BK20160340).	Arenas M, 2006, INT J RADIAT ONCOL, V66, P560, DOI 10.1016/j.ijrobp.2006.06.004; Asaithamby A, 2009, NUCLEIC ACIDS RES, V37, P3912, DOI 10.1093/nar/gkp237; Bitar D, 2015, WORLD J ORTHOP, V6, P172, DOI 10.5312/wjo.v6.i2.172; Cerqueira EMM, 2008, DENTOMAXILLOFAC RAD, V37, P398, DOI 10.1259/dmfr/56848097; Dempsey KE, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2201; Ding HF, 2012, J MATER SCI-MATER M, V23, P1055, DOI 10.1007/s10856-012-4574-x; Esteban J, 2008, J CLIN MICROBIOL, V46, P488, DOI 10.1128/JCM.01762-07; Goodman Stuart B, 2013, Instr Course Lect, V62, P201; Joo HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136394; Liebmann A, 2004, STRAHLENTHER ONKOL, V180, P165, DOI 10.1007/s00066-004-1197-2; Lin TH, 2014, ACTA BIOMATER, V10, P3747, DOI 10.1016/j.actbio.2014.04.034; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodermann B, 2012, INT J RADIAT BIOL, V88, P727, DOI 10.3109/09553002.2012.689464; LUCKEY TD, 1982, HEALTH PHYS, V43, P771, DOI 10.1097/00004032-198212000-00001; Magone K, 2015, ARCH ORTHOP TRAUM SU, V135, P683, DOI 10.1007/s00402-015-2196-8; Misharin AV, 2012, J LEUKOCYTE BIOL, V92, P325, DOI 10.1189/jlb.1111560; Ouyang ZX, 2014, BIOCHEM PHARMACOL, V90, P276, DOI 10.1016/j.bcp.2014.06.009; Pajarinen Jukka, 2014, J Long Term Eff Med Implants, V24, P283; Ragab AA, 1999, J ORTHOPAED RES, V17, P803, DOI 10.1002/jor.1100170603; Sangsliwan T, 2008, RADIAT RES, V170, P776, DOI 10.1667/RR1399.1; Schaue D, 2002, INT J RADIAT BIOL, V78, P567, DOI 10.1080/09553000210126457; Schwarz EM, 2003, J ORTHOPAED RES, V21, P1049, DOI 10.1016/S0736-0266(03)00093-7; Seo SW, 2010, BONE, V46, P695, DOI 10.1016/j.bone.2009.10.032; Shao HG, 2015, BIOMATERIALS, V60, P92, DOI 10.1016/j.biomaterials.2015.04.048; She C, 2016, J ORTHOP RES, V34, P1688, DOI 10.1002/jor.23179; Tsukimoto M, 2009, RADIAT RES, V171, P219, DOI 10.1667/RR1351.1; Xu Y, 2014, BIOCHEM BIOPH RES CO, V453, P362, DOI 10.1016/j.bbrc.2014.09.088; Yang HL, 2016, BIOMATERIALS, V80, P1, DOI 10.1016/j.biomaterials.2015.11.046; Zhou XZ, 2009, ARCH ORTHOP TRAUM SU, V129, P125, DOI 10.1007/s00402-008-0634-6	29	6	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0185854	10.1371/journal.pone.0185854	http://dx.doi.org/10.1371/journal.pone.0185854			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077718	gold, Green Published, Green Submitted			2022-12-26	WOS:000413861200007
J	Lee, CC; Chan, OW; Lai, MY; Hsu, KH; Wu, TW; Lim, WH; Wang, YC; Lien, R				Lee, Chien-Chung; Chan, Oi-Wa; Lai, Mei-Yin; Hsu, Kai-Hsiang; Wu, Tai-Wei; Lim, Wai-Ho; Wang, Yu-Cheng; Lien, Reyin			Incidence and outcomes of acute kidney injury in extremely-low-birth-weight infants	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; SERUM CREATININE; RISK-FACTORS; MORTALITY; PRETERM; AKI; EPIDEMIOLOGY; DEFINITION; GESTATION; NEWBORNS	Background Acute kidney injury (AKI) is a common event in the neonatal intensive care unit (NICU), especially in extremely-low-birth-weight (ELBW) infants. This cohort study investigated the incidence of and risk factors for AKI in ELBW infants and their overall survival at the post-menstrual age (PMA) of 36 weeks. Methods All ELBW infants admitted to our NICU between January 2010 and December 2013 were enrolled. Those who died prior to 72 hours of life, had congenital renal abnormality, or had only one datum of the serum creatinine (SCr) level after the first 24 hours of life were excluded. The criteria used for the diagnosis of AKI was set according to the modified neonatal KDIGO AKI definition. Results AKI occurred in 56% of 276 infants. Specifically, stage 1, stage 2, and stage 3 AKI occurred in 30%, 17%, and 9% of ELBW infants, respectively. High-frequency ventilation support (adjusted odds ratio [OR]: 3.4, 95% confidence interval [Cl]: 1.78-6.67, p < 0.001), the presence of patent ductus arteriosus (adjusted OR: 4.3, 95% Cl: 2.25-8.07, p < 0.001), lower gestational age (adjusted OR for gestational age: 0.7, 95% CI: 0.58-0.83, < 0.001), and inotropic agent use (adjusted OR: 2.6, 95% Cl: 1.31-5.21, p = 0.006) were independently associated with AKI. Maternal pre-eclampsia was a protective factor (adjusted OR: 0.4, 95% Cl: 0.14-0.97, p = 0.044). Infants with AKI had higher mortality before the PMA of 36 weeks with an adjusted hazard ratio (HR) of 5.34 (95% Cl: 1.21-23.53, p = 0.027). Additionally, infants with stage 3 AKI had a highest HR of 10.60, 95% CI: 2.09-53.67, p = 0.004). Conclusion AKI was a very common event (56%) in ELBW infants and was associated with a lower GA, high-frequency ventilation support, the presence of PDA, and inotropic agent use. AKI reduced survival of ELBW infants before the PMA of 36 weeks.	[Lee, Chien-Chung; Lai, Mei-Yin; Hsu, Kai-Hsiang; Wu, Tai-Wei; Lim, Wai-Ho; Lien, Reyin] Chang Gung Univ, Sch Med, Chang Gung Mem Hosp, Div Neonatol,Dept Pediat, Taoyuan, Taiwan; [Lee, Chien-Chung; Chan, Oi-Wa; Hsu, Kai-Hsiang] Chang Gung Univ, Grad Inst Clin Med Sci, Sch Med, Taoyuan, Taiwan; [Chan, Oi-Wa] Chang Gung Univ, Sch Med, Chang Gung Mem Hosp, Div Pediat Crit Care Med,Dept Pediat, Taoyuan, Taiwan; [Wang, Yu-Cheng] Ton Yen Gen Hosp, Dept Pediat, Hsinchu, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Lien, R (corresponding author), Chang Gung Univ, Sch Med, Chang Gung Mem Hosp, Div Neonatol,Dept Pediat, Taoyuan, Taiwan.	reyinl@cgmh.org.tw	Wu, Tai-Wei/L-3334-2016	Wu, Tai-Wei/0000-0001-5155-6189; Hsu, Kai-Hsiang/0000-0003-2852-6322; Lee, Chien-Chung/0000-0002-1077-8612				Aggarwal A, 2005, J TROP PEDIATRICS, V51, P295, DOI 10.1093/tropej/fmi017; Agras PI, 2004, RENAL FAILURE, V26, P305, DOI 10.1081/JDI-200026749; Akcan-Arikan A, 2007, KIDNEY INT, V71, P1028, DOI 10.1038/sj.ki.5002231; AlAbbas A, 2013, PEDIATR NEPHROL, V28, P1127, DOI 10.1007/s00467-013-2454-3; Askenazi D, 2015, PEDIATR NEPHROL, V30, P1511, DOI 10.1007/s00467-015-3087-5; Askenazi DJ, 2013, PEDIATR NEPHROL, V28, P661, DOI 10.1007/s00467-012-2369-4; Askenazi DJ, 2011, J PEDIATR-US, V159, P907, DOI 10.1016/j.jpeds.2011.05.045; Askenazi DJ, 2009, PEDIATR NEPHROL, V24, P265, DOI 10.1007/s00467-008-1060-2; Auron A, 2006, J PERINATOL, V26, P755, DOI 10.1038/sj.jp.7211604; Bateman DA, 2015, PEDIATR RES, V77, P696, DOI 10.1038/pr.2015.25; Blinder JJ, 2012, J THORAC CARDIOV SUR, V143, P368, DOI 10.1016/j.jtcvs.2011.06.021; Bolat F, 2013, WORLD J PEDIATR, V9, P323, DOI 10.1007/s12519-012-0371-3; BRENNER BM, 1988, AM J HYPERTENS, V1, P335, DOI 10.1093/ajh/1.4.335; BRENNER BM, 1994, AM J KIDNEY DIS, V23, P171, DOI 10.1016/S0272-6386(12)80967-X; Bruel A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084892; Carmody JB, 2014, CLIN J AM SOC NEPHRO, V9, P2036, DOI 10.2215/CJN.05190514; Carmody JB, 2013, PEDIATRICS, V131, P1168, DOI 10.1542/peds.2013-0009; Cataldi L, 2005, ARCH DIS CHILD-FETAL, V90, pF514, DOI 10.1136/adc.2004.060434; Chowdhary V, 2017, CLIN EXP NEPHROL; Coca SG, 2007, AM J KIDNEY DIS, V50, P712, DOI 10.1053/j.ajkd.2007.07.018; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Cuzzolin L, 2006, PEDIATR NEPHROL, V21, P931, DOI 10.1007/s00467-006-0118-2; Bezerra CTD, 2013, NEPHROL DIAL TRANSPL, V28, P901, DOI 10.1093/ndt/gfs604; Dodd-O JM, 2009, AM J PHYSIOL-LUNG C, V296, pL3, DOI 10.1152/ajplung.00030.2008; Gadepalli SK, 2011, J PEDIATR SURG, V46, P630, DOI 10.1016/j.jpedsurg.2010.11.031; Gallini F, 2000, PEDIATR NEPHROL, V15, P119, DOI 10.1007/s004670000356; Hassoun HT, 2009, AM J PHYSIOL-RENAL, V297, pF125, DOI 10.1152/ajprenal.90666.2008; Hoke TS, 2007, J AM SOC NEPHROL, V18, P155, DOI 10.1681/ASN.2006050494; Jetton JG, 2014, CLIN PERINATOL, V41, P487, DOI 10.1016/j.clp.2014.05.001; Jetton JG, 2012, CURR OPIN PEDIATR, V24, P191, DOI 10.1097/MOP.0b013e32834f62d5; Kaur S, 2011, ANN TROP PAEDIATR, V31, P129, DOI 10.1179/146532811X12925735813922; Koralkar R, 2011, PEDIATR RES, V69, P354, DOI 10.1203/PDR.0b013e31820b95ca; Krawczeski CD, 2011, J PEDIATR-US, V158, P1009, DOI 10.1016/j.jpeds.2010.12.057; Lunn AJF, 2006, ARCH DIS CHILD-FETAL, V91, P388, DOI 10.1136/adc.2005.092023; Mortazavi F, 2009, IRAN J KIDNEY DIS, V3, P136; Rhone ET, 2014, J MATERN-FETAL NEO M, V27, P1485, DOI 10.3109/14767058.2013.860522; Selewski DT, 2015, PEDIATRICS, V136, pE463, DOI 10.1542/peds.2014-3819; Selewski DT, 2013, J PEDIATR-US, V162, P725, DOI 10.1016/j.jpeds.2012.10.002; Singbartl K, 2012, KIDNEY INT, V81, P819, DOI 10.1038/ki.2011.339; Singer E, 2011, KIDNEY INT, V80, P405, DOI 10.1038/ki.2011.41; Stojanovic V, 2014, PEDIATR NEPHROL, V29, P2213, DOI 10.1007/s00467-014-2837-0; Susantitaphong P, 2013, CLIN J AM SOC NEPHRO, V8, P1482, DOI 10.2215/CJN.00710113; Sutherland MR, 2011, J AM SOC NEPHROL, V22, P1365, DOI 10.1681/ASN.2010121266; Thayyil S, 2008, J PERINATOL, V28, P226, DOI 10.1038/sj.jp.7211905; Vachvanichsanong P, 2012, NEPHROL DIAL TRANSPL, V27, P973, DOI 10.1093/ndt/gfr477; Vikse BE, 2008, J AM SOC NEPHROL, V19, P151, DOI 10.1681/ASN.2007020252; Vincent JL, 2013, CRIT CARE, V17, DOI 10.1186/cc13027; Viswanathan S, 2012, PEDIATR NEPHROL, V27, P303, DOI 10.1007/s00467-011-1977-8; Walker MW, 2011, J PERINATOL, V31, P199, DOI 10.1038/jp.2010.82; Walsh MC, 2005, J PEDIATR-US, V146, P798, DOI 10.1016/j.jpeds.2005.01.047; Zhou JJ, 2012, NEPHROLOGY, V17, P330, DOI 10.1111/j.1440-1797.2012.01577.x	51	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187764	10.1371/journal.pone.0187764	http://dx.doi.org/10.1371/journal.pone.0187764			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29108006	Green Published, Green Submitted, gold			2022-12-26	WOS:000414424600068
J	Ebuy, Y; Alemayehu, M; Mitiku, M; Goba, GK				Ebuy, Yirga; Alemayehu, Mussie; Mitiku, Mengistu; Goba, Gelila K.			Determinants of severe anemia among laboring mothers in Mekelle city public hospitals, Tigray region, Ethiopia	PLOS ONE			English	Article								Introduction Anemia is a global public health problem that has affected a significant number of pregnant mothers worldwide. The World Health Organization has estimated the prevalence of anemia in pregnant women at 18% and 56% in developed and developing countries, respectively. This study aimed to identify factors associated with severe anemia among laboring women in Mekelle city public hospitals, Tigray, Ethiopia. Methods This unmatched case-control study involved 264 (88 = cases and 176 = controls) pregnant women who were recruited when they came for delivery service in Mekelle city public hospitals. The data was collected from July to August, 2016. In this study, a systematic sampling technique was used inselecting controls, but the cases were enrolled until the required sample size was reached. Bivariate and multivariate analyses were conducted to find predictors of severe anemia. Statistically significant predictors of severe anemia were identified at Pvalue <0.05 and 95% confidence interval. Results A total of 264 pregnant women who came for delivery services were enrolled in this study. The major predicting variables for the occurrence of severe anemia among laboring women were residency (AOR = 3.28, 95% CI: 1.26-8.48), number of pregnancies (AOR = 2.46, 95% CI: 1.14-5.29), iron folate supplementation (AOR = 3.29, 95% CI: 1.27-8.49), dietary diversification score (AOR = 3.23, 95% CI: 1.19-8.71) and duration of menstrual cycle (AOR = 2.37, 95% CI: 1.10-5.10). The variable 'blood loss during pregnancy' (AOR = 6.63 95% CI: 2.96-14.86) was identified as a strong predictor of the outcome variable, severe anemia. Conclusion This study identified determinants of severe anemia among laboring women in Mekelle city public hospitals, Northern Ethiopia. To reduce anemia, strengthening health education provision related to the importance of birth spacing and consuming diversified and iron-enriched food should be considered. Moreover, screening of pregnant women for state of anemia during their visits to health facilities, as well as de-worming for intestinal parasites infection are needed.	[Ebuy, Yirga] Tigray Field Off, Save Children, Dept Nutr, Mekelle, Ethiopia; [Alemayehu, Mussie; Mitiku, Mengistu] Mekelle Univ, Coll Hlth Sci, Sch Publ Hlth, Mekelle, Ethiopia; [Goba, Gelila K.] Univ Illinois, Dept Obstet & Gynecol, Chicago, IL USA	Save the Children; Mekelle University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Ebuy, Y (corresponding author), Tigray Field Off, Save Children, Dept Nutr, Mekelle, Ethiopia.	Ebuy.yirga@yahoo..com	Alemayehu, Mussie/AAH-3016-2019	Alemayehu, Mussie/0000-0002-0035-631X; Mitiku, Mengistu/0000-0003-2542-2536				Abel G., 2015, J NUTR METABOLISM; Abel G., J NUTR METABOLISM, V2015; Abrehet A., 2014, BMC RES NOTES, V7, P888; [Anonymous], 2015, EFY ANN HLTH REP 201; Ashiry A., 2014, ACTA MEDICA MEDITERR, V30, P1045; Baig-Ansari N, 2008, FOOD NUTR BULL, V29, P132, DOI 10.1177/156482650802900207; Bamlaku T., 2009, DETERMINANT ANEMIA P; Central Statistical Agency (CSA), 2011, ETH DEM HLTH SURV; Chowdhury HA, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0234-x; Cuneyt T., 2015, J TURK GER GYNECOL A, V16, P231; Devi NB, 2015, J MED DENT SCI, V14, P06; Gedefaw L, 2015, ETHIOP J HEALTH SCI, V25, P155, DOI 10.4314/ejhs.v25i2.8; Hylemariam M., 2015, J MED MICROBIOLOGY D, V4, P3; Judith N., 2012, J S ASIA FEDERATION, P64; Jufar AH, 2014, J HEMATOL THROMB DIS, V2, P125, DOI [10.4172/2329-8790.1000125, DOI 10.4172/2329-8790.1000125]; Kayode O., 2012, ANEMIA DEV COUNTRIES; Kefiyalew Filagot, 2014, BMC Res Notes, V7, P771, DOI 10.1186/1756-0500-7-771; Lealem G., 2015, ETHIOP J HLTH SCI, V25; Lelissa D., 2015, CLIN MED RES, V4, P79, DOI [DOI 10.11648/J.CMR.20150403.14, DOI 10.11648/j.cmr.20150403.14, 10.11648/j.cmr.20150403.14]; Meseret A., 2013, J INTERDISCIPLINARY, P137; Million G., 2012, PARASITE VECTOR, V5, P296; Mulambalah S., 2014, SCI J PUBLIC HLTH, P216; Nagaraj K., 2003, Journal of Human Ecology, V14, P237; Okube T., 2016, OPEN J OBSTET GYNECO, P16; Sudhir M., 2015, EUROPEAN J PHARM MED, P973; WHO, 2013, LANCET GLOBAL HLTH, V1; WHO, 2001, IRON DEFICIENCY ANAE; Yaregal A., 2014, DETERMINANT FACTORS; Zeina M., 2012, INT J MED PUBLIC HLT, V43	29	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							e0186724	10.1371/journal.pone.0186724	http://dx.doi.org/10.1371/journal.pone.0186724			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6TA	29099850	Green Submitted, gold, Green Published			2022-12-26	WOS:000414377900009
J	Rueckert, S; Horak, A				Rueckert, Sonja; Horak, Ales			Archigregarines of the English Channel revisited: New molecular data on Selenidium species including early described and new species and the uncertainties of phylogenetic relationships	PLOS ONE			English	Article							GREGARINE PARASITES APICOMPLEXA; SABELLARIA ALVEOLATA L; REVISED CLASSIFICATION; SEQUENCE ALIGNMENT; GENOME-SEQUENCE; N. SP.; ULTRASTRUCTURE; CHECKLIST; LECUDINA; SPOROZOA	Background Gregarines represent an important transition step from free-living predatory (colpodellids s. l.) and/or photosynthetic (Chromera and Vitrella) apicomplexan lineages to the most important pathogens, obligate intracellular parasites of humans and domestic animals such as coccidians and haemosporidians (Plasmodium, Toxoplasma, Eimeria, Babesia, etc.). While dozens of genomes of other apicomplexan groups are available, gregarines are barely entering the molecular age. Among the gregarines, archigregarines possess a unique mixture of ancestral (myzocytosis) and derived (lack of apicoplast, presence of subpellicular microtubules) features. Methodology/Principal findings In this study we revisited five of the early-described species of the genus Selenidium including the type species Selenidium pendula, with special focus on surface ultrastructure and molecular data. We were also able to describe three new species within this genus. All species were characterized at morphological (light and scanning electron microscopy data) and molecular (SSU rDNA sequence data) levels. Gregarine specimens were isolated from polychaete hosts collected from the English Channel near the Station Biologique de Roscoff, France: Selenidium pendula from Scolelepis squamata, S. hollandei and S. sabellariae from Sabellaria alveolata, S. sabellae from Sabella pavonina, Selenidium fallax from Cirriformia tentaculata, S. spiralis sp. n. and S. antevariabilis sp. n. from Amphitritides gracilis, and S. opheliae sp. n. from Ophelia roscoffensis. Molecular phylogenetic analyses of these data showed archigregarines clustering into five separate clades and support previous doubts about their monophyly. Conclusions/Significance Our phylogenies using the extended gregarine sampling show that the archigregarines are indeed not monophyletic with one strongly supported clade of Selenidium sequences around the type species S.pendula. We suggest the revision of the whole archigregarine taxonomy with only the species within this clade remaining in the genus Selenidium, while the other species should be moved into newly erected genera. However, the SSU rDNA phylogenies show very clearly that the tree topology and therefore the inferred relationships within and in between clades are unstable and such revision would be problematic without additional sequence data.	[Rueckert, Sonja] Edinburgh Napier Univ, Sch Appl Sci, Edinburgh, Midlothian, Scotland; [Horak, Ales] Biol Ctr CAS, Inst Parasitol, Ceske Budejovice, Czech Republic; [Horak, Ales] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic	Edinburgh Napier University; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Rueckert, S (corresponding author), Edinburgh Napier Univ, Sch Appl Sci, Edinburgh, Midlothian, Scotland.	s.rueckert@napier.ac.uk	Horak, Ales/H-6723-2012	Horak, Ales/0000-0002-3364-7383; Rueckert, Sonja/0000-0002-8016-1634	ASSEMBLE EU FP7 research infrastructure initiative [EU-RI-227799]; European Union Seventh Framework Programme (FP7) [316304]; Czech Grant Agency [15-17643S]	ASSEMBLE EU FP7 research infrastructure initiative; European Union Seventh Framework Programme (FP7); Czech Grant Agency(Grant Agency of the Czech Republic)	This project was supported by ASSEMBLE EU FP7 research infrastructure initiative (EU-RI-227799) call 7 (2013) and call 9 (2014), the research infrastructure funded from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no 316304 as well as the Czech Grant Agency project No. 15-17643S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cavalier-Smith T, 2004, EUR J PROTISTOL, V40, P185, DOI 10.1016/j.ejop.2004.01.002; Cavalier-Smith T, 2014, EUR J PROTISTOL, V50, P472, DOI 10.1016/j.ejop.2014.07.002; COX FEG, 1994, INT J PARASITOL, V24, P1301, DOI 10.1016/0020-7519(94)90197-X; De Beauchamp P., 1913, ARCH PROTISTENKD, V31, P138; Desportes I, 2013, GREGARINES EARLY BRA; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; GIARD A., 1884, CR ASS FR AVANC SCI, P192; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grasse P.-P., 1953, TRAITE ZOOL, P590; GUNDERSON J, 1986, J PARASITOL, V72, P107, DOI 10.2307/3281801; Henneguy L. F., 1907, Compte Rendu de l'Association Francaise pour l'Avancement des Sciences, V36, P633; HONIGBERG BM, 1964, J PROTOZOOL, V11, P7, DOI 10.1111/j.1550-7408.1964.tb01715.x; Janouskovec J, 2015, P NATL ACAD SCI USA, V112, P10200, DOI 10.1073/pnas.1423790112; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kissinger JC, 2002, NATURE, V419, P490, DOI 10.1038/419490a; Kuvardina Olga N., 2002, Protistology, V2, P169; Lankester ER, 1863, J CELL SCI, Vs2-3, P83; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; LARTILLOT N, 2007, BMC EVOL BIOL S1, V7; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Leander BS, 2007, ZOOL SCR, V36, P213, DOI 10.1111/j.1463-6409.2007.00272.x; Leander BS, 2006, MAR BIOL RES, V2, P178, DOI 10.1080/17451000600724395; Leander BS, 2003, TRENDS ECOL EVOL, V18, P395, DOI 10.1016/S0169-5347(03)00152-6; Leander BS, 2003, INT J SYST EVOL MICR, V53, P345, DOI 10.1099/ijs.0.02284-0; LECOINTRE G, 1993, MOL PHYLOGENET EVOL, V2, P205, DOI 10.1006/mpev.1993.1021; LEVINE ND, 1977, INT J PARASITOL, V7, P101, DOI 10.1016/0020-7519(77)90074-1; LEVINE ND, 1977, J PROTOZOOL, V24, P41, DOI 10.1111/j.1550-7408.1977.tb05279.x; LEVINE ND, 1971, J PROTOZOOL, V18, P704, DOI 10.1111/j.1550-7408.1971.tb03401.x; LEVINE ND, 1976, T AM MICROSC SOC, V95, P695, DOI 10.2307/3225395; MACGREGO.HC, 1965, J PROTOZOOL, V12, P438, DOI 10.1111/j.1550-7408.1965.tb03239.x; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; MELLOR JS, 1980, J EXP BIOL, V87, P149; Perkins F. O., 2000, ILLUSTRATED GUIDE PR, V1, P190; RAY HARENDRA NATH, 1930, PARASITOLOGY, V22, P370; Rotari Yuri M., 2015, Protistology, V9, P50; Rueckert S, 2009, J EUKARYOT MICROBIOL, V56, P428, DOI 10.1111/j.1550-7408.2009.00422.x; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SCHREVEL J, 1970, Protistologica, V6, P389; SCHREVEL J, 1971, Protistologica, V7, P101; SCHREVEL J, 1971, J PROTOZOOL, V18, P448, DOI 10.1111/j.1550-7408.1971.tb03355.x; Schrevel J, 2016, PROTIST, V167, P339, DOI 10.1016/j.protis.2016.06.001; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Templeton TJ, 2010, MOL BIOL EVOL, V27, P235, DOI 10.1093/molbev/msp226; VIVIER E, 1966, J MICROSC-PARIS, V5, P213; VIVIER E, 1970, Protistologica, V6, P127; VIVIER E, 1968, J PROTOZOOL, V15, P230, DOI 10.1111/j.1550-7408.1968.tb02115.x; VIVIER E, 1964, J MICROSC-PARIS, V3, P651; Wakeman KC, 2014, PROTIST, V165, P493, DOI 10.1016/j.protis.2014.05.007; Wakeman KC, 2013, J EUKARYOT MICROBIOL, V60, P514, DOI 10.1111/jeu.12059; Wakeman KC, 2012, J EUKARYOT MICROBIOL, V59, P232, DOI 10.1111/j.1550-7408.2012.00616.x; Woo YH, 2015, ELIFE, V4, DOI 10.7554/eLife.06974	55	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							e0187430	10.1371/journal.pone.0187430	http://dx.doi.org/10.1371/journal.pone.0187430			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6TA	29099876	Green Published, gold, Green Submitted			2022-12-26	WOS:000414377900020
J	Matsubara, S; Shiraishi, A; Sakai, T; Okuda, T; Satake, H				Matsubara, Shin; Shiraishi, Akira; Sakai, Tsubasa; Okuda, Toshimi; Satake, Honoo			Heterodimerization of the prostaglandin E2 receptor EP2 and the calcitonin receptor CTR	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; NATIVE GABA(B) RECEPTORS; CIONA-INTESTINALIS; TRYPSIN DIGESTION; IN-VIVO; PROTOCHORDATE; INTERACTOME; MODULATION; PROTEOMICS; EFFICACY	G protein-coupled receptors (GPCRs) have been found to form heterodimers and modulate or fine-tune the functions of GPCRs. However, the involvement of GPCR heterodimerization and its functional consequences in gonadal tissues, including granulosa cells, have been poorly investigated, mainly due to the lack of efficient method for identification of novel GPCR heterodimers. In this paper, we identified a novel GPCR heterodimer between prostaglandin E2 (PGE2) receptor 2 (EP2) and calcitonin (CT) receptor (CTR). High-resolution liquid chromatography (LC)-tandem mass spectrometry (MS/MS) of protease-digested EP2-coimmunoprecipitates detected protein fragments of CTR in an ovarian granulosa cell line, OV3121. Western blotting of EP2-and CTR-coimmunoprecipitates detected a specific band for EP2-CTR heterodimer. Specific heterodimerization between EP2 and CTR was also observed by fluorescence resonance energy transfer analysis in HEK293MSR cells expressing cyan-and yellow-fluorescent protein-fused EP2 and CTR, respectively. Collectively, these results provided evidence for heterodimerization between EP2 and CTR. Moreover, Ca(2+)mobilization by CT was approximately 40% less potent in HEK293MSR cells expressing an EP2-CTR heterodimer, whereas cAMP production by EP2 or CT was not significantly altered compared with cells expressing EP2-or CTR alone. These functional analyses verified that CTR-mediated Ca(2+)mobilization is specifically decreased via heterodimerization with EP2. Altogether, the present study suggests that a novel GPCR heterodimer, EP2-CTR, is involved in some functional regulation, and paves the way for investigation of novel biological roles of CTR and EP2 in various tissues.	[Matsubara, Shin; Shiraishi, Akira; Sakai, Tsubasa; Okuda, Toshimi; Satake, Honoo] Suntory Fdn Life Sci, Bioorgan Res Inst, Kyoto, Japan	Suntory Holdings Ltd	Satake, H (corresponding author), Suntory Fdn Life Sci, Bioorgan Res Inst, Kyoto, Japan.	satake@sunbor.or.jp		Shiraishi, Akira/0000-0003-3456-3074; Matsubara, Shin/0000-0002-7794-534X	Japan Society for the promotion of Sciences [16K07430]; Grants-in-Aid for Scientific Research [16K07430, 16K18581, 17J10624] Funding Source: KAKEN	Japan Society for the promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by 16K07430, Japan Society for the promotion of Sciences, to Honoo Satake (https://www.jsps.go.jp/english/Index.html). The author received no specific funding for this work.r We thank Dr. Atushi P. Kimura of Hokkaido University for the kind gift of OV3121 cells. We also thank Dr. Takeshi Ishimuzu of Ritsumeikan University for technical advice and Prof. Shi-getada Nakanishi for fruitful discussions. This work was supported in part by the Japan Society for the Promotion of Science (to H.S.)	AbdAlla S, 2001, J BIOL CHEM, V276, P39721, DOI 10.1074/jbc.M105253200; AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; Borroto-Escuela DO, 2014, INT J MOL SCI, V15, P8570, DOI 10.3390/ijms15058570; Chung KY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054942; Cvicek V, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004805; Edelstein SJ, 2016, BIOPHYS J, V111, P902, DOI 10.1016/j.bpj.2016.07.044; El-Nefiawy N, 2005, HISTOL HISTOPATHOL, V20, P825, DOI 10.14670/HH-20.825; Fanelli F, 2011, CHEM REV, V111, pPR438, DOI 10.1021/cr100437t; Feng XY, 2013, ENDOCRINOLOGY, V154, P3925, DOI 10.1210/en.2013-1407; Ferre S, 2014, PHARMACOL REV, V66, P413, DOI 10.1124/pr.113.008052; Fuxe K, 2012, CURR MED CHEM, V19, P356, DOI 10.2174/092986712803414259; Glatter T, 2012, J PROTEOME RES, V11, P5145, DOI 10.1021/pr300273g; Gomes I, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0007.2000; Hizaki H, 1999, P NATL ACAD SCI USA, V96, P10501, DOI 10.1073/pnas.96.18.10501; Hollin T, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2571-z; Jacoby E, 2006, CHEMMEDCHEM, V1, P760, DOI 10.1002/cmdc.200600134; Kawada T, 2011, ENDOCRINOLOGY, V152, P2416, DOI 10.1210/en.2010-1348; Kenakin T, 2013, BRIT J PHARMACOL, V168, P554, DOI 10.1111/j.1476-5381.2012.02223.x; Kieffer BL, 1999, TRENDS PHARMACOL SCI, V20, P19, DOI 10.1016/S0165-6147(98)01279-6; Kobayashi Y, 2016, GEN COMP ENDOCR, V230, P103, DOI 10.1016/j.ygcen.2016.04.008; Lavoie C, 2002, J BIOL CHEM, V277, P35402, DOI 10.1074/jbc.M204163200; Levoye A, 2006, EMBO J, V25, P3012, DOI 10.1038/sj.emboj.7601193; Masuda T, 2008, J PROTEOME RES, V7, P731, DOI 10.1021/pr700658q; Matsubara S, 2016, GEN COMP ENDOCR, V227, P101, DOI 10.1016/j.ygcen.2015.05.010; Milligan G, 2007, TRENDS PHARMACOL SCI, V28, P615, DOI 10.1016/j.tips.2007.11.001; Nemoto W, 2016, PROTEINS, V84, P1224, DOI 10.1002/prot.25071; Ozawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052383; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Rossi S, 2005, AM J CLIN PATHOL, V124, P295, DOI 10.1309/NR8HN08GDPVEMU08; Sakai T, 2012, ENDOCRINOLOGY, V153, P1841, DOI 10.1210/en.2011-1668; Sakai T, 2010, MOL BIOL EVOL, V27, P1097, DOI 10.1093/molbev/msp319; Satake H, 2008, PROTEIN PEPTIDE LETT, V15, P300, DOI 10.2174/092986608783744207; Satake Honoo, 2013, Front Endocrinol (Lausanne), V4, P100, DOI 10.3389/fendo.2013.00100; Schwenk J, 2016, NAT NEUROSCI, V19, P233, DOI 10.1038/nn.4198; Schwenk J, 2010, NATURE, V465, P231, DOI 10.1038/nature08964; Segi E, 2003, BIOL REPROD, V68, P804, DOI 10.1095/biolreprod.102.003590; Sexton PM, 1999, CURR MED CHEM, V6, P1067; Smits AH, 2016, TRENDS BIOTECHNOL, V34, P825, DOI 10.1016/j.tibtech.2016.02.014; Sugimoto Y, 2015, J BIOCHEM, V157, P73, DOI 10.1093/jb/mvu081; Uegaki M, 2010, PLANT BIOTECHNOL, V27, P289, DOI 10.5511/plantbiotechnology.27.289; Valentin-Hansen L, 2015, J BIOL CHEM, V290, P24495, DOI 10.1074/jbc.M115.641944; Vigone G, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-380; Vit O, 2017, J PROTEOMICS, V153, P8, DOI 10.1016/j.jprot.2016.08.006; Waldhoer M, 2005, P NATL ACAD SCI USA, V102, P9050, DOI 10.1073/pnas.0501112102; Wigglesworth K, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.121756; Willmann KL, 2016, J PROTEOME RES, V15, P2900, DOI 10.1021/acs.jproteome.5b01004; Yano T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156716; Zvonok N, 2010, J PROTEOME RES, V9, P1746, DOI 10.1021/pr900870p	48	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187711	10.1371/journal.pone.0187711	http://dx.doi.org/10.1371/journal.pone.0187711			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095955	gold, Green Published, Green Submitted			2022-12-26	WOS:000414340200129
J	Mwesigwa, J; Achan, J; Di Tanna, GL; Affara, M; Jawara, M; Worwui, A; Hamid-Adiamoh, M; Kanuteh, F; Ceesay, S; Bousema, T; Drakeley, C; Grietens, KP; Lindsay, SW; Van Geertruyden, JP; D'Alessandro, U				Mwesigwa, Julia; Achan, Jane; Di Tanna, Gian Luca; Affara, Muna; Jawara, Musa; Worwui, Archibald; Hamid-Adiamoh, Majidah; Kanuteh, Fatoumatta; Ceesay, Sainey; Bousema, Teun; Drakeley, Chris; Grietens, Koen Peeters; Lindsay, Steve W.; Van Geertruyden, Jean-Pierre; D'Alessandro, Umberto			Residual malaria transmission dynamics varies across The Gambia despite high coverage of control interventions	PLOS ONE			English	Article							REAL-TIME PCR; PLASMODIUM-FALCIPARUM; ANOPHELES-GAMBIAE; INSECTICIDE RESISTANCE; PARASITEMIA; DENSITY; IMPACT; INFECTIVITY; CARRIAGE; PATTERNS	Over the last decades, malaria has declined substantially in The Gambia but its transmission has not been interrupted. In order to better target control interventions, it is essential to understand the dynamics of residual transmission. This prospective cohort study was conducted between June 2013 and April 2014 in six pairs of villages across The Gambia. Blood samples were collected monthly during the transmission season (June-December) from all residents aged >6 months (4,194 individuals) and then in April (dry season). Entomological data were collected monthly throughout the malaria transmission season. Ownership of Long-Lasting Insecticidal Nets was 71.5% (2766/3869). Incidence of malaria infection and clinical disease varied significantly across the country, with the highest values in eastern (1.7/PYAR) than in central (0.2/PYAR) and western (0.1/PYAR) Gambia. Malaria infection at the beginning of the transmission season was significantly higher in individuals who slept outdoors (HR = 1.51, 95% Cl: 1.02-2.23, p = 0.04) and in those who had travelled outside the village (HR = 2.47, 95% Cl: 1.83-3.34, p<0.01). Sub-patent infections were more common in older children (HR = 1.35, 95% Cl: 1.04-1.6, p<0.01) and adults (HR = 1.53, 95% Cl: 1.23-1.89, p<0.01) than in younger children. The risk of clinical malaria was significantly higher in households with at least one infected individual at the beginning of the transmission season (HR = 1.76, p<0.01). Vector parity was significantly higher in the eastern part of the country, both in the south (90.7%, 117/129, p<0.01) and the north bank (81.1%, 227/280, p<0.01), than in the western region (41.2%, 341/826), indicating higher vector survival. There is still significant residual malaria transmission across The Gambia, particularly in the eastern region. Additional interventions able to target vectors escaping Long-Lasting Insecticidal Nets and indoor residual spraying are needed to achieve malaria elimination.	[Mwesigwa, Julia; Achan, Jane; Affara, Muna; Jawara, Musa; Worwui, Archibald; Kanuteh, Fatoumatta; Ceesay, Sainey; D'Alessandro, Umberto] Med Res Council Unit Gambia, Banjul, Gambia; [Mwesigwa, Julia; Van Geertruyden, Jean-Pierre] Univ Antwerp, Fac Med & Hlth Sci, Dept Global Hlth, Antwerp, Belgium; [Di Tanna, Gian Luca] Queen Mary Univ London, Ctr Primary Care & Publ Hlth, London, England; [Hamid-Adiamoh, Majidah] Univ Ghana, Dept Biochem Cell & Mol Biol, West African Ctr Cell Biol Infect Pathogens, Accra, Ghana; [Bousema, Teun] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, Nijmegen, Netherlands; [Drakeley, Chris; D'Alessandro, Umberto] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England; [Grietens, Koen Peeters] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Grietens, Koen Peeters] Univ Amsterdam, Amsterdam Inst Social Sci Res, Amsterdam, Netherlands; [Grietens, Koen Peeters] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki, Japan; [Lindsay, Steve W.] Univ Durham, Sch Biol & Biomed Sci, Durham, England	University of London; London School of Hygiene & Tropical Medicine; University of Antwerp; University of London; Queen Mary University London; University of Ghana; Radboud University Nijmegen; University of London; London School of Hygiene & Tropical Medicine; Institute of Tropical Medicine (ITM); University of Amsterdam; Nagasaki University; Durham University	D'Alessandro, U (corresponding author), Med Res Council Unit Gambia, Banjul, Gambia.; D'Alessandro, U (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England.	udalessandro@mrc.gm	Bousema, Teun/N-3574-2014; Peeters Grietens, Koen/G-7028-2019; Van geertruyden, Jean-Pierre/K-6425-2014; Di Tanna, Gian Luca/AAF-2352-2019; Van geertruyden, Jean-Pierre/S-3254-2019	Bousema, Teun/0000-0003-2666-094X; Peeters Grietens, Koen/0000-0001-6570-9887; Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Di Tanna, Gian Luca/0000-0002-5470-3567; Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Mwesigwa, Julia/0000-0003-2452-3677; Lindsay, Steve/0000-0002-3461-9050	UK Medical Research Council (MRC); UK Department for International Development (DFID) under MRC/DFID Concordat [MC_EX_MR/J002364/1]; Medical Research Council [MR/J002364/1] Funding Source: researchfish	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) under MRC/DFID Concordat(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study is funded The UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement. Grant number MC_EX_MR/J002364/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyasingha RR, 2017, GUIDELINES ENTOMOLOG; [Anonymous], 2011, HAEM CONC DIAGN AN A; Babiker HA, 2013, DRUG RESIST UPDATE, V16, P1, DOI 10.1016/j.drup.2013.02.001; Bejon P, 2014, ELIFE, V3, DOI 10.7554/eLife.02130; Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Betson M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-187; Bottius E, 1996, T ROY SOC TROP MED H, V90, P15, DOI 10.1016/S0035-9203(96)90463-0; Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10; Bousema T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014114; Caputo B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-182; Ceesay S, 2017, DETECTION PLASMODIUM; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Ceesay SJ, 2010, CONTINUED DECLINE MA; Chen I, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001942; Cucunuba ZM, 2008, MEM I OSWALDO CRUZ, V103, P668, DOI 10.1590/S0074-02762008000700007; DALESSANDRO U, 1995, LANCET, V345, P479, DOI 10.1016/S0140-6736(95)90582-0; DETINOVA T S, 1962, Monogr Ser World Health Organ, V47, P13; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Durnez L, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P671, DOI 10.5772/55925; Gnanguenon V, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-444; Hamad AA, 2000, PARASITOLOGY, V120, P447, DOI 10.1017/S0031182099005818; IYENGAR R, 1962, B WORLD HEALTH ORGAN, V27, P223; Killeen GF, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-161; Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-330; Kleinschmidt I, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0782-4; Lin JT, 2014, TRENDS PARASITOL, V30, P183, DOI 10.1016/j.pt.2014.02.004; Lindblade KA, 2006, J MED ENTOMOL, V43, P428, DOI 10.1093/jmedent/43.2.428; Lindblade KA, 2013, EXPERT REV ANTI-INFE, V11, P623, DOI [10.1586/eri.13.45, 10.1586/ERI.13.45]; LINDSAY SW, 1993, T ROY SOC TROP MED H, V87, P45, DOI 10.1016/0035-9203(93)90175-P; MABEY DCW, 1987, J INFECT DIS, V155, P1319, DOI 10.1093/infdis/155.6.1319; Males S, 2008, CLIN INFECT DIS, V46, P516, DOI 10.1086/526529; Mwesigwa J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0829-6; Nourein AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016948; Nwakanma D, 2008, INT J PARASITOL, V38, P219, DOI 10.1016/j.ijpara.2007.07.003; Okebe J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110926; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Olotu A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032929; Opondo KO, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1203-z; Ototo EN, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0763-7; Ouedraogo AL, 2015, CLIN INFECT DIS, V60, P357, DOI 10.1093/cid/ciu797; Quinones ML, 1997, MED VET ENTOMOL, V11, P71, DOI 10.1111/j.1365-2915.1997.tb00292.x; Republic of The Gambia, 2014, GAMB NAT HLTH STRAT; RepublicofTheGambia, 2009, MALCONTR GAMB STRAT; RepublicofTheGambia, 2009, MAL CONTR GAMB START; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; Schneider P, 2005, J CLIN MICROBIOL, V43, P402, DOI 10.1128/JCM.43.1.402-405.2005; Sissoko MS, 2015, AM J TROP MED HYG, V93, P790, DOI 10.4269/ajtmh.14-0765; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Tangena JAA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074351; Thomson M, 1996, SOC SCI MED, V43, P101, DOI 10.1016/0277-9536(95)00346-0; THOMSON MC, 1994, T ROY SOC TROP MED H, V88, P638, DOI 10.1016/0035-9203(94)90204-6; Tusting LS, 2014, ADV PARASIT, V84, P151, DOI 10.1016/B978-0-12-800099-1.00003-X; van Eijk AM, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1120-1; Walldorf JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134061; White G B, 1969, BLOOD FEEDING HABITS; WHO, 2016, WORLD MAL REP 2016; WIRTZ RA, 1987, J MED ENTOMOL, V24, P433, DOI 10.1093/jmedent/24.4.433; World Health Organization, 2014, CONTR RES MAL PAR TR	58	36	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187059	10.1371/journal.pone.0187059	http://dx.doi.org/10.1371/journal.pone.0187059			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095834	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000414340200041
J	Yang, D; Krois, CR; Huang, P; Wang, JS; Min, J; Yoo, HS; Deng, YH; Napoli, JL				Yang, Di; Krois, Charles R.; Huang, Priscilla; Wang, Jinshan; Min, Jin; Yoo, Hong Sik; Deng, Yinghua; Napoli, Joseph L.			Raldh1 promotes adiposity during adolescence independently of retinal signaling	PLOS ONE			English	Article							ALDEHYDE DEHYDROGENASE 1A1; DIET-INDUCED OBESITY; ACID RECEPTOR-ALPHA; VITAMIN-A; BINDING-PROTEIN; STEM-CELLS; ADIPOCYTE DIFFERENTIATION; ACTIVATED RECEPTOR; 3T3-F442A CELLS; 3T3-L1 CELLS	All-frans-retinoic acid (RA) inhibits adipogenesis in established preadipocyte cell lines. Dosing pharmacological amounts of RA reduces weight gain in mice fed a high-fat diet, i.e. counteracts diet-induced obesity (DIO). The aldehyde dehydrogenase Raldh1 (Aldhla1) functions as one of three enzymes that converts the retinol metabolite retinal into RA, and one of many proteins that contribute to RA homeostasis. Female Raldh1-ablated mice resist DIO. This phenotype contrasts with ablations of other enzymes and binding-proteins that maintain RA homeostasis, which gain adiposity. The phenotype observed prompted the conclusion that loss of Raldh1 causes an increase in adipose tissue retinal, and therefore, retinal functions independently of RA to prevent DIO. A second deduction proposed that low nM concentrations of RA stimulate adipogenesis, in contrast to higher concentrations. Using peer-reviewed LC/MS/MS assays developed and validated for quantifying tissue RA and retinal, we show that endogenous retinal and RA concentrations in adipose tissues from Raldh1-null mice do not correlate with the phenotype. Moreover, male Raldh1-null mice resist weight gain regardless of dietary fat content. Resistance to weight gain occurs during adolescence in both sexes. We show that RA concentrations as low as 1 nM, i.e. in the sub-physiological range, impair adipogenesis of embryonic fibroblasts from wild-type mice. Embryonic fibroblasts from Raldh1-null mice resist differentiating into adipocytes, but retain ability to generate RA. These fibroblasts remain sensitive to an RA receptor pan-agonist, and are not affected by an RA receptor pan-antagonist. Thus, the data do not support the hypothesis that retinal itself represses weight gain and adipogenesis independently of RA. Instead, the data indicate that Raldh1 functions as a retinal and atRA-independent promoter of adiposity during adolescence, and enhances adiposity through pre-adipocyte cell autonomous actions.	[Yang, Di; Krois, Charles R.; Huang, Priscilla; Wang, Jinshan; Min, Jin; Yoo, Hong Sik; Deng, Yinghua; Napoli, Joseph L.] Univ Calif Berkeley, Grad Program Metab Biol Nutrit Sci & Toxicol, Berkeley, CA 94720 USA; [Krois, Charles R.] Minnesota State Univ, Mankato, MN USA; [Huang, Priscilla] Midwestern Univ, Arizona Coll Osteopath Med, Glendale, AZ USA; [Wang, Jinshan] Bayer Pharmaceut, Berkeley, CA USA; [Min, Jin] Nova Southeastern Univ, Coll Osteopath Med, Oakland, CA USA; [Deng, Yinghua] Hubei Univ Educ, Wuhan, Hubei, Peoples R China	University of California System; University of California Berkeley; Minnesota State Colleges & Universities; Minnesota State University Mankato; Midwestern University; Bayer AG; Bayer Healthcare Pharmaceuticals; Nova Southeastern University; Hubei University Education	Napoli, JL (corresponding author), Univ Calif Berkeley, Grad Program Metab Biol Nutrit Sci & Toxicol, Berkeley, CA 94720 USA.	jna@berkeley.edu	Yoo, Hong Sik/HDN-7624-2022	Napoli, Joseph/0000-0003-3223-4752	National Institutes of Health USA [DK30875, AA30888, DK102014]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK112754, R01DK102014] Funding Source: NIH RePORTER	National Institutes of Health USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health USA, DK30875, JLN; National Institutes of Health USA, AA30888, JLN; National Institutes of Health USA, DK102014, JLN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison WN, 2014, MOL CELL BIOL, V34, P3076, DOI 10.1128/MCB.00185-14; Arnold SLM, 2015, BIOCHEM PHARMACOL, V95, P177, DOI 10.1016/j.bcp.2015.03.001; Bateman OA, 2003, BIOCHEMISTRY-US, V42, P4349, DOI 10.1021/bi027367w; Berry DC, 2012, DIABETES, V61, P1112, DOI 10.2337/db11-1620; Berry DC, 2010, J BIOL CHEM, V285, P15324, DOI 10.1074/jbc.M110.110635; Berry DC, 2009, MOL CELL BIOL, V29, P3286, DOI 10.1128/MCB.01742-08; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Dawson M. I., 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P199, DOI 10.2174/1568011043352975; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; Dupe V, 2003, P NATL ACAD SCI USA, V100, P14036, DOI 10.1073/pnas.2336223100; Everts HB, 2013, J INVEST DERMATOL, V133, P325, DOI 10.1038/jid.2012.393; Green AC, 2017, EXP CELL RES, V350, P284, DOI 10.1016/j.yexcr.2016.12.007; Grunblatt E, 2016, J NEURAL TRANSM, V123, P83, DOI 10.1007/s00702-014-1320-1; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Hisada K, 2013, J BONE MINER METAB, V31, P53, DOI 10.1007/s00774-012-0385-x; Jette C, 2004, J BIOL CHEM, V279, P34397, DOI 10.1074/jbc.M314021200; Jeyakumar SM, 2006, OBESITY, V14, P52, DOI 10.1038/oby.2006.7; KAMEI Y, 1994, LIFE SCI, V55, pPL307, DOI 10.1016/0024-3205(94)90073-6; Kane MA, 2008, ANAL BIOCHEM, V378, P71, DOI 10.1016/j.ab.2008.03.038; Kane MA, 2010, METHODS MOL BIOL, V652, P1, DOI 10.1007/978-1-60327-325-1_1; Kang S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001433; Kedishvili Natalia Y, 2016, Subcell Biochem, V81, P127; Kent T, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.131458; Kim JI, 2015, SCIENCE, V350, P102, DOI 10.1126/science.aac4690; KURIHARCUCH W, 1982, DIFFERENTIATION, V23, P164, DOI 10.1111/j.1432-0436.1982.tb01279.x; Lin SC, 2010, P NATL ACAD SCI USA, V107, P9234, DOI 10.1073/pnas.0910430107; Bonet ML, 2012, BBA-MOL CELL BIOL L, V1821, P177, DOI 10.1016/j.bbalip.2011.06.001; MCCAMMON DK, 1993, MOL CELL ENDOCRINOL, V91, P177, DOI 10.1016/0303-7207(93)90270-T; McLaren DS, 2012, WORLD REV NUTR DIET, V103, P33; Mercader J, 2006, ENDOCRINOLOGY, V147, P5325, DOI 10.1210/en.2006-0760; Moreb JS, 2008, CURR STEM CELL RES T, V3, P237, DOI 10.2174/157488808786734006; Muccio DD, 1996, J MED CHEM, V39, P3625, DOI 10.1021/jm9603126; Muenzner M, 2013, MOL CELL BIOL, V33, P4068, DOI 10.1128/MCB.00221-13; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; Noy N, 2013, ADIPOCYTE, V2, P184, DOI 10.4161/adip.23489; Obrochta KM, 2015, J BIOL CHEM, V290, P7259, DOI 10.1074/jbc.M114.609313; Obrochta KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099435; PAIRAULT J, 1987, J CELL PHYSIOL, V132, P279, DOI 10.1002/jcp.1041320212; Penzes P, 1997, BBA-PROTEIN STRUCT M, V1342, P175, DOI 10.1016/S0167-4838(97)00102-7; PEREIRA F, 1991, BIOCHEM BIOPH RES CO, V175, P831, DOI 10.1016/0006-291X(91)91640-X; POSCH KC, 1992, J BIOL CHEM, V267, P19676; Puigserver P, 1996, BIOCHEM J, V317, P827, DOI 10.1042/bj3170827; Reeves PG, 1997, J NUTR, V127, pS838; Reichert B, 2011, MOL ENDOCRINOL, V25, P799, DOI 10.1210/me.2010-0465; Ribes V, 2006, DEVELOPMENT, V133, P351, DOI 10.1242/dev.02204; Ribot J, 2001, OBES RES, V9, P500, DOI 10.1038/oby.2001.65; Romeo RD, 2016, NEUROSCI BIOBEHAV R, V70, P206, DOI 10.1016/j.neubiorev.2016.05.020; ROSS AC, 1994, ADV EXP MED BIOL, V352, P187; SAFONOVA I, 1994, MOL CELL ENDOCRINOL, V104, P201, DOI 10.1016/0303-7207(94)90123-6; SATO M, 1980, BIOCHEM BIOPH RES CO, V95, P1839, DOI 10.1016/S0006-291X(80)80113-6; Schwarz EJ, 1997, MOL CELL BIOL, V17, P1552, DOI 10.1128/MCB.17.3.1552; Shaw N, 2003, J BIOL CHEM, V278, P41589, DOI 10.1074/jbc.C300368200; Shin DJ, 2012, NUCLEIC ACIDS RES, V40, P11499, DOI 10.1093/nar/gks932; Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004; Sladek NE, 1999, CURR PHARM DESIGN, V5, P607; SOPRANO DR, 1995, ANNU REV NUTR, V15, P111, DOI 10.1146/annurev.nu.15.070195.000551; SOPRANO DR, 1993, TOXICOL APPL PHARM, V122, P159, DOI 10.1006/taap.1993.1183; STONE RL, 1990, DIFFERENTIATION, V45, P119, DOI 10.1111/j.1432-0436.1990.tb00465.x; Sun SY, 2000, J BIOL CHEM, V275, P17149, DOI 10.1074/jbc.M000527200; Tomita H, 2016, ONCOTARGET, V7, P11018, DOI 10.18632/oncotarget.6920; Wang C, 2011, J BIOL CHEM, V286, P6542, DOI 10.1074/jbc.M110.198382; Wang JS, 2015, ANAL BIOCHEM, V484, P162, DOI 10.1016/j.ab.2015.05.016; WILLHITE CC, 1984, TOXICOL APPL PHARM, V74, P397, DOI 10.1016/0041-008X(84)90293-X; YOSHIDA A, 1993, ADV EXP MED BIOL, V328, P37; Zhang M, 2007, FASEB J, V21, P2886, DOI 10.1096/fj.06-7964com; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587	66	10	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187669	10.1371/journal.pone.0187669	http://dx.doi.org/10.1371/journal.pone.0187669			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095919	gold, Green Submitted, Green Published			2022-12-26	WOS:000414340200127
J	Gonias, SL; Karimi-Mostowfi, N; Murray, SS; Mantuano, E; Gilder, AS				Gonias, Steven L.; Karimi-Mostowfi, Nicki; Murray, Sarah S.; Mantuano, Elisabetta; Gilder, Andrew S.			Expression of LDL receptor-related proteins (LRPs) in common solid malignancies correlates with patient survival	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; MYELIN-ASSOCIATED GLYCOPROTEIN; SCAVENGER RECEPTORS; CANCER GENOMICS; BETA-CATENIN; MEGALIN; TUMORIGENESIS; PROGRESSION; ASSOCIATION; METASTASIS	LDL receptor-related proteins (LRPs) are transmembrane receptors involved in endocytosis, cell-signaling, and trafficking of other cellular proteins. Considerable work has focused on LRPs in the fields of vascular biology and neurobiology. How these receptors affect cancer progression in humans remains largely unknown. Herein, we mined provisional data-bases in The Cancer Genome Atlas (TCGA) to compare expression of thirteen LRPs in ten common solid malignancies in patients. Our first goal was to determine the abundance of LRP mRNAs in each type of cancer. Our second goal was to determine whether expression of LRPs is associated with improved or worsened patient survival. In total, data from 4,629 patients were mined. In nine of ten cancers studied, the most abundantly expressed LRP was LRP1; however, a correlation between LRP1 mRNA expression and patient survival was observed only in bladder urothelial carcinoma. In this malignancy, high levels of LRP1 mRNA were associated with worsened patient survival. High levels of LDL receptor (LDLR) mRNA were associated with decreased patient survival in pancreatic adenocarcinoma. High levels of LRP10 mRNA were associated with decreased patient survival in hepatocellular carcinoma, lung adenocarcinoma, and pancreatic adenocarcinoma. LRP2 was the only LRP for which high levels of mRNA expression correlated with improved patient survival. This correlation was observed in renal clear cell carcinoma. Insights into LRP gene expression in human cancers and their effects on patient survival should guide future research.	[Gonias, Steven L.; Karimi-Mostowfi, Nicki; Murray, Sarah S.; Mantuano, Elisabetta; Gilder, Andrew S.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Mantuano, Elisabetta] Sapienza Univ Rome, Dept Expt Med, Rome, Italy	University of California System; University of California San Diego; Sapienza University Rome	Gonias, SL (corresponding author), Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA.	sgonias@ucsd.edu			NIH [R01 HL136395]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded by NIH grant R01 HL136395 to Steven L Gonias. The sponsor had no role in the study design, collection and analysis of data, or the decision to publish.	Andersen RK, 2015, PIGM CELL MELANOMA R, V28, DOI 10.1111/pcmr.12352; Auderset L, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2108495; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Boucher R, 2008, HISTOCHEM CELL BIOL, V130, P315, DOI 10.1007/s00418-008-0436-5; Brodeur J, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-31; Ceccarelli M, 2016, CELL, V164, P550, DOI 10.1016/j.cell.2015.12.028; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen S, 2007, J CELL SCI, V120, P4009, DOI 10.1242/jcs.013946; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; Ettenberg SA, 2010, P NATL ACAD SCI USA, V107, P15473, DOI 10.1073/pnas.1007428107; FARQUHAR MG, 1995, J AM SOC NEPHROL, V6, P35; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Ge S, 2017, AM J CANCER RES, V7, P1540; Gonias SL, 2014, AM J PATHOL, V184, P18, DOI 10.1016/j.ajpath.2013.08.029; Gonias SL, 2011, CURR PHARM DESIGN, V17, P1962; Guillaumond F, 2015, P NATL ACAD SCI USA, V112, P2473, DOI 10.1073/pnas.1421601112; Hoang BH, 2004, INT J CANCER, V109, P106, DOI 10.1002/ijc.11677; Holt SK, 2008, CLIN CANCER RES, V14, P3823, DOI 10.1158/1078-0432.CCR-07-4566; Huang XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044301; Jeong YH, 2010, BIOCHEM BIOPH RES CO, V392, P495, DOI 10.1016/j.bbrc.2010.01.049; Jeong YH, 2010, BIOCHEM BIOPH RES CO, V391, P1110, DOI 10.1016/j.bbrc.2009.12.033; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; Lane-Donovan C, 2017, J LIPID RES, V58, P1036, DOI 10.1194/jlr.R075507; Lee JD, 2016, EXP THER MED, V12, P2974, DOI 10.3892/etm.2016.3722; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Lindner I, 2010, CANCER RES, V70, P277, DOI 10.1158/0008-5472.CAN-09-1462; Lindvall C, 2006, J BIOL CHEM, V281, P35081, DOI 10.1074/jbc.M607571200; Mantuano E, 2016, P NATL ACAD SCI USA, V113, P1369, DOI 10.1073/pnas.1515480113; Mantuano E, 2013, J BIOL CHEM, V288, P34009, DOI 10.1074/jbc.M113.509133; Montel V, 2007, CANCER RES, V67, P9817, DOI 10.1158/0008-5472.CAN-07-0683; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Polakis P, 2000, GENE DEV, V14, P1837; Ren DN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7906; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; SAITO A, 1994, P NATL ACAD SCI USA, V91, P9725, DOI 10.1073/pnas.91.21.9725; Schuetz AN, 2005, J MOL DIAGN, V7, P206, DOI 10.1016/S1525-1578(10)60547-8; Song H, 2009, CANCER RES, V69, P879, DOI 10.1158/0008-5472.CAN-08-3379; Springer TA, 1998, J MOL BIOL, V283, P837, DOI 10.1006/jmbi.1998.2115; Stiles TL, 2013, J CELL SCI, V126, P209, DOI 10.1242/jcs.113191; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; Sugiyama T, 2000, BIOCHEMISTRY-US, V39, P15817, DOI 10.1021/bi001583s; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tomczak Katarzyna, 2015, Contemp Oncol (Pozn), V19, pA68, DOI 10.5114/wo.2014.47136; Van Gool B, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00271; Vasseur S, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1033586; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126	50	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186649	10.1371/journal.pone.0186649	http://dx.doi.org/10.1371/journal.pone.0186649			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088295	Green Submitted, gold, Green Published			2022-12-26	WOS:000414088900019
J	Grasso, G; Deriu, MA; Patrulea, V; Borchard, G; Moller, M; Danani, A				Grasso, Gianvito; Deriu, Marco Agostino; Patrulea, Viorica; Borchard, Gerrit; Moller, Michael; Danani, Andrea			Free energy landscape of siRNA-polycation complexation: Elucidating the effect of molecular geometry, polymer flexibility, and charge neutralization	PLOS ONE			English	Article							DYNAMICS SIMULATIONS; GENE DELIVERY; IN-VIVO; DNA; EXCHANGE; PROTEIN; BINDING; POLY(ETHYLENIMINE); POLYETHYLENIMINE; METADYNAMICS	The success of medical threatments with DNA and silencing interference RNA is strongly related to the design of efficient delivery technologies. Cationic polymers represent an attractive strategy to serve as nucleic-acid carriers with the envisioned advantages of efficient complexation, low cost, ease of production, well-defined size, and low polydispersity index. However, the balance between efficacy and toxicity (safety) of these polymers is a challenge and in need of improvement. With the aim of designing more effective polycationic-based gene carriers, many parameters such as carrier morphology, size, molecular weight, surface chemistry, and flexibility/rigidity ratio need to be taken into consideration. In the present work, the binding mechanism of three cationic polymers (polyarginine, polylysine and polyethyleneimine) to a model siRNA target is computationally investigated at the atomistic level. In order to better understand the polycationic carrier-siRNA interactions, replica exchange molecular dynamic simulations were carried out to provide an exhaustive exploration of all the possible binding sites, taking fully into account the siRNA flexibility together with the presence of explicit solvent and ions. Moreover, well-tempered metadynamics simulations were employed to elucidate how molecular geometry, polycation flexibility, and charge neutralization affect the siRNA-polycations free energy landscape in term of low-energy binding modes and unbinding free energy barriers. Significant differences among polymer binding modes have been detected, revealing the advantageous binding properties of polyarginine and polylysine compared to polyethyleneimine.	[Grasso, Gianvito; Deriu, Marco Agostino; Danani, Andrea] USI, Ist Dalle Molle Studi Sull Intelligenza Artificia, SUPSI, Ctr Galleria 2, Manno, Switzerland; [Patrulea, Viorica; Borchard, Gerrit; Moller, Michael] Univ Geneva, Sch Pharmaceut Sci, Rue Michel Servet 1, Geneva, Switzerland	Universita della Svizzera Italiana; University of Geneva	Danani, A (corresponding author), USI, Ist Dalle Molle Studi Sull Intelligenza Artificia, SUPSI, Ctr Galleria 2, Manno, Switzerland.	andrea.danani@idsia.ch	Patrulea, Viorica/AFM-9063-2022; Deriu, Marco Agostino Agostino/GPW-8179-2022; Patrulea, Viorica/P-4334-2019	Deriu, Marco Agostino Agostino/0000-0003-1918-1772; Patrulea, Viorica/0000-0003-3906-2041; Danani, Andrea/0000-0001-6578-5089; Grasso, Gianvito/0000-0002-7761-222X	Swiss National Foundation [200021_157033]; Swiss National Supercomputing Centre (CSCS)	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Swiss National Supercomputing Centre (CSCS)	This work was supported by the Swiss National Foundation project "Novel micellar drug carrier systems for gene therapies" (project ID 200021_157033). This work was also supported by the Swiss National Supercomputing Centre (CSCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshamsan A, 2009, MOL PHARMACEUT, V6, P121, DOI 10.1021/mp8000815; [Anonymous], 2010, BIOPHYS J, V99, P201; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baker NA, 2004, POISSON BOLTZMANN ME, P94, DOI [10.1016/S0076-6879(04)83005-2, DOI 10.1016/S0076-6879(04)83005-2]; Baptista AM, 2002, J CHEM PHYS, V117, P4184, DOI 10.1063/1.1497164; Barducci A, 2011, WIRES COMPUT MOL SCI, V1, P826, DOI 10.1002/wcms.31; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bergonzo C, 2014, J CHEM THEORY COMPUT, V10, P492, DOI 10.1021/ct400862k; Bertschinger M, 2006, J CONTROL RELEASE, V116, P96, DOI 10.1016/j.jconrel.2006.09.006; Bonomi M, 2009, J COMPUT CHEM, V30, P1615, DOI 10.1002/jcc.21305; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Bumcrot D, 2006, NAT CHEM BIOL, V2, P711, DOI 10.1038/nchembio839; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chen CY, 2011, BIOPHYS J, V101, P1139, DOI 10.1016/j.bpj.2011.07.016; Choosakoonkriang S, 2003, J PHARM SCI-US, V92, P1710, DOI 10.1002/jps.10437; Coletta A, 2013, NUCLEIC ACIDS RES, V41, P9977, DOI 10.1093/nar/gkt790; Denschlag R, 2009, CHEM PHYS LETT, V473, P193, DOI 10.1016/j.cplett.2009.03.053; Deriu MA, 2016, PROTEINS, V84, P666, DOI 10.1002/prot.25017; Deriu MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108677; DeRouchey J, 2013, BIOCHEMISTRY-US, V52, P3000, DOI 10.1021/bi4001408; Di Leva FS, 2014, NUCLEIC ACIDS RES, V42, P5447, DOI 10.1093/nar/gku247; Dlugosz M, 2004, CHEM PHYS, V302, P161, DOI 10.1016/j.chemphys.2004.03.031; Donald JE, 2011, PROTEINS, V79, P898, DOI 10.1002/prot.22927; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elder RM, 2011, BIOMACROMOLECULES, V12, P3870, DOI 10.1021/bm201113y; Furini S, 2014, J PHYS CHEM B, V118, P13059, DOI 10.1021/jp505885j; Godbey WT, 1999, J BIOMED MATER RES, V45, P268, DOI 10.1002/(SICI)1097-4636(19990605)45:3<268::AID-JBM15>3.0.CO;2-Q; Godbey WT, 1999, J CONTROL RELEASE, V60, P149, DOI 10.1016/S0168-3659(99)00090-5; Granata D, 2013, P NATL ACAD SCI USA, V110, P6817, DOI 10.1073/pnas.1218350110; Grasso G, 2017, BIOL DIRECT, V12, DOI 10.1186/s13062-016-0173-y; Grasso G, 2016, PROTEINS, V84, P52, DOI 10.1002/prot.24954; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; HUD NV, 1994, BIOCHEMISTRY-US, V33, P7528, DOI 10.1021/bi00190a005; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Jere D, 2009, EXPERT OPIN DRUG DEL, V6, P827, DOI 10.1517/17425240903029183; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Khandogin J, 2005, BIOPHYS J, V89, P141, DOI 10.1529/biophysj.105.061341; Kondinskaia DA, 2016, J PHYS CHEM B, V120, P6546, DOI 10.1021/acs.jpcb.6b03779; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; Laio A, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/12/126601; Lamiable A, 2016, NUCLEIC ACIDS RES, V44, pW449, DOI 10.1093/nar/gkw329; Lee J, 2014, J CHEM THEORY COMPUT, V10, P2738, DOI 10.1021/ct500175m; Lee MS, 2004, PROTEINS, V56, P738, DOI 10.1002/prot.20128; Lindorff-Larsen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032131; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lingenheil M, 2009, CHEM PHYS LETT, V478, P80, DOI 10.1016/j.cplett.2009.07.039; Liu X, 2014, NANOSCALE; Lu J, 2012, ACS NANO, V6, P944, DOI 10.1021/nn204536e; Luo D, 2000, NAT BIOTECHNOL, V18, P33, DOI 10.1038/71889; Maiti PK, 2006, NANO LETT, V6, P2478, DOI 10.1021/nl061609m; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mongan J, 2005, CURR OPIN STRUC BIOL, V15, P157, DOI 10.1016/j.sbi.2005.02.002; Mongan J, 2004, J COMPUT CHEM, V25, P2038, DOI 10.1002/jcc.20139; Mukherjee G, 2011, J COMPUT CHEM, V32, P893, DOI 10.1002/jcc.21671; Mullen PM, 2000, BBA-GEN SUBJECTS, V1523, P103, DOI 10.1016/S0304-4165(00)00104-5; Nagaya J, 1996, BIOPHYS CHEM, V60, P45, DOI 10.1016/0301-4622(95)00143-3; Navarro G, 2015, MOL PHARMACEUT, V12, P301, DOI 10.1021/mp5007213; Nguyen PH, 2005, PROTEINS, V61, P795, DOI 10.1002/prot.20696; Ouyang DF, 2010, J PHYS CHEM B, V114, P9220, DOI 10.1021/jp911906e; Pavan GM, 2012, CURR MED CHEM, V19, P4929; Pavan Giovanni M, 2011, Curr Drug Discov Technol, V8, P314; Pavan GM, 2011, RSC ADV, V1, P1677, DOI 10.1039/c1ra00472g; Pavan GM, 2010, BIOMACROMOLECULES, V11, P721, DOI 10.1021/bm901298t; Pavan GM, 2009, J AM CHEM SOC, V131, P9686, DOI 10.1021/ja901174k; Perez-Villa A, 2016, NUCLEIC ACIDS RES, V44, P2975, DOI 10.1093/nar/gkv1378; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sousa da Silva Alan W, 2012, BMC Res Notes, V5, P367, DOI 10.1186/1756-0500-5-367; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; SUH J, 1994, BIOORG CHEM, V22, P318, DOI 10.1006/bioo.1994.1025; Sun CB, 2012, J PHYS CHEM B, V116, P2405, DOI 10.1021/jp211716v; Sun CB, 2011, BIOPHYS J, V100, P2754, DOI 10.1016/j.bpj.2011.04.045; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Tomalia DA, 2010, SOFT MATTER, V6, P456, DOI 10.1039/b917370f; Toy R, 2014, NANOMEDICINE-UK, V9, P121, DOI 10.2217/nnm.13.191; Tribello GA, 2014, COMPUT PHYS COMMUN, V185, P604, DOI 10.1016/j.cpc.2013.09.018; Vargiu AV, 2008, NUCLEIC ACIDS RES, V36, P5910, DOI 10.1093/nar/gkn561; Veiseh O, 2011, BIOMATERIALS, V32, P5717, DOI 10.1016/j.biomaterials.2011.04.039; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Wiseman JW, 2003, GENE THER, V10, P1654, DOI 10.1038/sj.gt.3302050; Yoo J, 2016, NUCLEIC ACIDS RES, V44, P2036, DOI 10.1093/nar/gkw081; Zerze GH, 2015, J CHEM THEORY COMPUT, V11, P2776, DOI 10.1021/acs.jctc.5b00047; Zhang Y, 2012, MOL THER, V20, P1298, DOI 10.1038/mt.2012.79; Zhou W, 2006, BRIT J CANCER, V95, P164, DOI 10.1038/sj.bjc.6603234; Zhou YL, 2004, SPECTROCHIM ACTA A, V60, P377, DOI 10.1016/S1386-1425(03)00243-9; Ziebarth J, 2009, BIOPHYS J, V97, P1971, DOI 10.1016/j.bpj.2009.03.069; Ziebarth JD, 2017, J PHYS CHEM B, V121, P1941, DOI 10.1021/acs.jpcb.6b10775; Ziebarth JD, 2010, BIOMACROMOLECULES, V11, P29, DOI 10.1021/bm900842d	91	20	20	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186816	10.1371/journal.pone.0186816	http://dx.doi.org/10.1371/journal.pone.0186816			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088239	Green Submitted, Green Published, gold			2022-12-26	WOS:000414088900022
J	Laurence, J; Elhadad, S; Robison, T; Terry, H; Varshney, R; Woolington, S; Ghafoory, S; Choi, ME; Ahamed, J				Laurence, Jeffrey; Elhadad, Sonia; Robison, Tyler; Terry, Hunter; Varshney, Rohan; Woolington, Sean; Ghafoory, Shahrouz; Choi, Mary E.; Ahamed, Jasimuddin			HIV protease inhibitor-induced cardiac dysfunction and fibrosis is mediated by platelet-derived TGF-beta 1 and can be suppressed by exogenous carbon monoxide	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; OXIDATIVE STRESS; ARTERIAL INFLAMMATION; INSULIN-RESISTANCE; INFECTION; AUTOPHAGY; KIDNEY; ACTIVATION; BETA	Human immunodeficiency virus (HIV) infection is an independent risk factor for cardiovascular disease. This risk is magnified by certain antiretrovirals, particularly the protease inhibitor ritonavir, but the pathophysiology of this connection is unknown. We postulated that a major mechanism for antiretroviral-associated cardiac disease is pathologic fibrosis linked to platelet activation with release and activation of transforming growth factor (TGF)-beta 1, and that these changes could be modeled in a murine system. We also sought to intervene utilizing inhaled carbon monoxide (CO) as proof-of-concept for therapeutics capable of regulating TGF-beta 1 signaling and collagen autophagy. We demonstrate decreased cardiac function indices, including cardiac output, ejection fraction and stroke volume, and prominent cardiac fibrosis, in mice exposed to pharmacological doses of ritonavir. Cardiac output and fibrosis correlated with plasma TGF-beta 1 levels. Mice with targeted deletion of TGF-beta 1 in megakaryocytes/platelets (PF4CreTgfb1(flox/flox)) were partially protected from ritonavir-induced cardiac dysfunction and fibrosis. Inhalation of low dose CO (250ppm), used as a surrogate for upregulation of inducible heme oxygenase/endogenous CO pathways, suppressed ritonavir-induced cardiac fibrosis. This occurred in association with modulation of canonical (Smad2) and non-canonical (p38) TGF-beta 1 signaling pathways. In addition, CO treatment suppressed the M1 pro-inflammatory subset of macrophages and increased M2c regulatory cells in the hearts of RTV-exposed animals. The effects of CO were dependent upon autophagy as CO did not mitigate ritonavir-induced fibrosis in autophagy-deficient LC3(-/-) mice. These results suggest that platelet-derived TGF-beta 1 contributes to ritonavir-associated cardiac dysfunction and fibrosis, extending the relevance of our findings to other antiretrovirals that also activate platelets. The anti-fibrotic effects of CO are linked to alterations in TGF-beta 1 signaling and autophagy, suggesting a proof-of-concept for novel interventions in HIV/antiretroviral therapy-mediated cardiovascular disease.	[Laurence, Jeffrey; Elhadad, Sonia; Terry, Hunter] Weill Cornell Med Coll, Div Hematol & Med Oncol, New York, NY USA; [Robison, Tyler; Varshney, Rohan; Woolington, Sean; Ghafoory, Shahrouz; Ahamed, Jasimuddin] Univ Oklahoma, Hlth Sci Ctr, Cardiovasc Biol Res Program, Dept Biochem & Mol Biol,OMRF, Oklahoma City, OK 73104 USA; [Choi, Mary E.] WCMC, Div Nephrol & Hypertens, New York, NY USA	Cornell University; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center	Ahamed, J (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Cardiovasc Biol Res Program, Dept Biochem & Mol Biol,OMRF, Oklahoma City, OK 73104 USA.	ahamedj@omrf.org	Elhadad, Sonia/GRF-6466-2022	Elhadad, Sonia/0000-0002-0139-6487; Ahamed, Jasimuddin/0000-0001-6455-0296	NIH [R21 HL125044, R01 HL123605]; COBRA; Angelo Donghia Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM114731] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); COBRA; Angelo Donghia Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants R21 HL125044 (J.L. and J.A.) and R01 HL123605 (J.A.), a COBRA grant to OMRF, and the Angelo Donghia Foundation (J.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed J, 2017, ANTIOXIDANT IN PRESS; Ahamed J, 2008, BLOOD, V112, P3650, DOI 10.1182/blood-2008-04-151753; Ahamed J, 2016, AIDS, V30, P535, DOI 10.1097/QAD.0000000000000982; Andre L, 2010, AM J RESP CRIT CARE, V181, P587, DOI 10.1164/rccm.200905-0794OC; Angeles Pajares Maria, 2016, Anales de la Real Academia Nacional de Farmacia, V82, P231; [Anonymous], 2012, NAT REV MOL CELL BIO, V13, P616; Burdo T.H., 2015, J CLIN CELL IMMUNOL, V6, DOI [10.4172/2155-9899.1000333, DOI 10.4172/2155-9899.1000333]; Cipriani S, 2013, CIRCULATION, V127, P2114, DOI 10.1161/CIRCULATIONAHA.113.001278; Ding Y, 2014, J AM SOC NEPHROL, V25, P2835, DOI 10.1681/ASN.2013101068; Duprez DA, 2011, AIDS, V25, P651, DOI 10.1097/QAD.0b013e32834404a1; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Estes JD, 2015, J INFECT DIS, V211, P744, DOI 10.1093/infdis/jiu519; Fakruddin JM, 2003, J BIOL CHEM, V278, P48251, DOI 10.1074/jbc.M304676200; Fernandez D, 2015, AASLD; Freiberg MS, 2017, JAMA CARDIOL, V2, P536, DOI 10.1001/jamacardio.2017.0264; Gaggin HK, 2013, BBA-MOL BASIS DIS, V1832, P2442, DOI 10.1016/j.bbadis.2012.12.014; Gibellini L, 2012, AIDS, V26, P2017, DOI 10.1097/QAD.0b013e328359b8be; Hemkens LG, 2014, EUR HEART J, V35, P1373, DOI 10.1093/eurheartj/eht528; Hsue PY, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.116.004427; Jais A, 2014, CELL, V158, P25, DOI 10.1016/j.cell.2014.04.043; Jerico C, 2006, STROKE, V37, P812, DOI 10.1161/01.STR.0000204037.26797.7f; Kim JH, 2006, J AM SOC NEPHROL, V17, P1373, DOI 10.1681/ASN.2005091001; Kim SI, 2012, J BIOL CHEM, V287, P11677, DOI 10.1074/jbc.M111.308460; Li Gang, 2006, Chinese Medical Sciences Journal, V21, P175; Liovat AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046143; Lipshultz SE, 2013, JAMA PEDIATR, V167, P520, DOI 10.1001/jamapediatrics.2013.1206; Lipson KE, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S24; Loboda A, 2016, CELL MOL LIFE SCI, V73, P3221, DOI 10.1007/s00018-016-2223-0; Lu JY, 2013, KIDNEY INT, V84, P745, DOI 10.1038/ki.2013.135; Lumadue JA, 1996, AM J CLIN PATHOL, V106, P795; Mak IT, 2013, AM J PHYSIOL-REG I, V305, pR1102, DOI 10.1152/ajpregu.00268.2013; Mancini D, TRANSL RES IN PRESS; Marconi VC, 2017, C RETR OPP INF SEATT; Martinez E, 2012, AIDS, V26, P2315, DOI 10.1097/QAD.0b013e328359f29c; Mayne E, 2012, JAIDS-J ACQ IMM DEF, V59, P340, DOI 10.1097/QAI.0b013e3182439355; Meyer A, 2012, BLOOD, V119, P1064, DOI 10.1182/blood-2011-09-377648; Patel K, 2014, CIRCULATION, V129, P1204, DOI 10.1161/CIRCULATIONAHA.113.001978; Peers C, 2012, J MOL CELL CARDIOL, V52, P359, DOI 10.1016/j.yjmcc.2011.05.013; Reyskens KMSE, 2014, BBA-MOL BASIS DIS, V1842, P256, DOI 10.1016/j.bbadis.2013.11.019; Reyskens KMSE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073347; Ryom L, 2017, C RETR OPP INF SEATT; Satchell CS, 2011, J INFECT DIS, V204, P1202, DOI 10.1093/infdis/jir509; Shannon RP, 2000, CIRCULATION, V101, P185, DOI 10.1161/01.CIR.101.2.185; Subramanian S, 2012, JAMA-J AM MED ASSOC, V308, P379, DOI 10.1001/jama.2012.6698; Sureshbabu A, 2016, AM J PHYSIOL-RENAL, V310, pF596, DOI 10.1152/ajprenal.00365.2015; Tannous P, 2008, P NATL ACAD SCI USA, V105, P9745, DOI 10.1073/pnas.0706802105; Tawakol A, 2017, JAMA CARDIOL, V2, P163, DOI 10.1001/jamacardio.2016.4728; Taylor N, 2017, JAIDS-J ACQ IMM DEF, V75, pE13, DOI 10.1097/qai.0000000000001223; van der Heijden WA, 2017, C RETR OPP INF SEATT; WAHL SM, 1991, J EXP MED, V173, P981, DOI 10.1084/jem.173.4.981; Walker JA, 2014, AIDS RES HUM RETROV, V30, P685, DOI [10.1089/AID.2013.0268, 10.1089/aid.2013.0268]; Wang L, 2008, AM J PHYSIOL-RENAL, V294, pF508, DOI 10.1152/ajprenal.00306.2007; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Yin MT, 2010, J CLIN ENDOCR METAB, V95, P620, DOI 10.1210/jc.2009-0708; Zanni MV, 2016, JAMA CARDIOL, V1, P474, DOI 10.1001/jamacardio.2016.0846; Zhou ZH, 2005, AM J PATHOL, V166, P27, DOI 10.1016/S0002-9440(10)62229-8	57	14	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187185	10.1371/journal.pone.0187185	http://dx.doi.org/10.1371/journal.pone.0187185			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088262	Green Published, gold			2022-12-26	WOS:000414088900047
J	Lee, YH; Kweon, SS; Choi, JS; Nam, HS; Park, KS; Choi, SW; Ryu, SY; Oh, SH; Shin, MH				Lee, Young-Hoon; Kweon, Sun-Seog; Choi, Jin-Su; Nam, Hae-Sung; Park, Kyeong-Soo; Choi, Seong-Woo; Ryu, So-Yeon; Oh, Su-Hyun; Shin, Min-Ho			Association of serum vitamin D and parathyroid hormone with subclinical atherosclerotic phenotypes: The Dong-gu Study	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; CARDIOVASCULAR-DISEASE; 25-HYDROXYVITAMIN D; ARTERIAL STIFFNESS; POSTMENOPAUSAL WOMEN; 25-OH-VITAMIN D; D DEFICIENCY; ALL-CAUSE; RISK; EVENTS	Background Although previous studies reported an association between serum vitamin D and parathyroid hormone (PTH) with carotid atherosclerosis or arterial stiffness, these were inconsistent. We examined the independent association between serum vitamin D and PTH with multiple subclinical markers of atherosclerosis. Methods A total of 8,217 subjects who participated in the Dong-gu Study in Korea were included in the final analysis. The carotid artery structure, including intima-media thickness (IMT), plaques, and luminal diameter, was evaluated using a high-resolution B-mode ultrasound. The brachial-ankle pulse wave velocity (baPWV) was determined using an automatic waveform analysis device, and the mean of the left and right baPWV was used. Results The PTH concentration was positively associated with carotid luminal diameter and baPWV, but not with carotid IMT and plaques. The mean carotid luminal diameter of individuals with PTH levels in the second, third, and fourth quartiles was significantly larger compared with those in the first quartile (P-trend < 0.01). The mean baPWV of individuals with PTH levels in the fourth quartile was significantly greater than those with PTH levels in the first quartile (P-trend = 0.01). However, there was no significant association between vitamin D and any atherosclerotic phenotypes, including carotid IMT, plaques, luminal diameter, and baPWV. Conclusion This suggests that PTH might affect the development of atherosclerosis by altering vascular compliance.	[Lee, Young-Hoon] Wonkwang Univ, Sch Med, Dept Prevent Med, Iksan, Jeonbuk, South Korea; [Lee, Young-Hoon] Wonkwang Univ, Sch Med, Inst Wonkwang Med Sci, Iksan, Jeonbuk, South Korea; [Lee, Young-Hoon] Wonkwang Univ Hosp, Reg Cardiocerebrovasc Ctr, Iksan, Jeonbuk, South Korea; [Kweon, Sun-Seog; Choi, Jin-Su; Oh, Su-Hyun; Shin, Min-Ho] Chonnam Natl Univ, Med Sch, Dept Prevent Med, Hwasun, South Korea; [Kweon, Sun-Seog] Chonnam Natl Univ, Jeonnam Reg Canc Ctr, Hwasun Hosp, Hwasun, South Korea; [Nam, Hae-Sung] Chungnam Natl Univ, Sch Med, Dept Prevent Med, Daejeon, South Korea; [Park, Kyeong-Soo] Seonam Univ, Coll Med, Dept Prevent Med, Namwon, Jeonbuk, South Korea; [Choi, Seong-Woo; Ryu, So-Yeon] Chosun Univ, Med Sch, Dept Prevent Med, Gwangju, South Korea	Wonkwang University; Wonkwang University; Wonkwang University; Chonnam National University; Chonnam National University; Chungnam National University; Seonam University; Chosun University	Shin, MH (corresponding author), Chonnam Natl Univ, Med Sch, Dept Prevent Med, Hwasun, South Korea.	mhshinx@paran.com	Kweon, Sun-Seog/AAZ-4732-2021	Kweon, Sun-Seog/0000-0003-2378-8550; Lee, Young-Hoon/0000-0003-1367-025X; Oh, Su-Hyun/0000-0002-6373-8833; Nam, Hae-Sung/0000-0003-0911-4576; Shin, Min-Ho/0000-0002-2217-5624	Wonkwang University [WKU-2017]	Wonkwang University	This study was supported by Wonkwang University in 2017 (WKU-2017).	Al Mheid I, 2011, J AM COLL CARDIOL, V58, P186, DOI 10.1016/j.jacc.2011.02.051; Baldassarre D, 2012, J AM COLL CARDIOL, V60, P1489, DOI 10.1016/j.jacc.2012.06.034; Bjorkman M, 2009, ARCH GERONTOL GERIAT, V48, P160, DOI 10.1016/j.archger.2007.12.005; Blondon M, 2013, ARTERIOSCL THROM VAS, V33, P2639, DOI 10.1161/ATVBAHA.113.301781; Bosworth C, 2013, CLIN ENDOCRINOL, V79, P429, DOI 10.1111/cen.12163; Bots ML, 2005, STROKE, V36, P762, DOI 10.1161/01.STR.0000158924.71069.94; Brondum-Jacobsen P, 2015, INT J EPIDEMIOL, V44, P651, DOI 10.1093/ije/dyv078; Brown Spandana J, 2017, Methodist Debakey Cardiovasc J, V13, P49, DOI 10.14797/mdcj-13-2-49; Carrelli AL, 2011, STROKE, V42, P2240, DOI 10.1161/STROKEAHA.110.608539; Choi HS, 2008, INT J CLIN PRACT, V62, P1352, DOI 10.1111/j.1742-1241.2008.01801.x; CROUSE JR, 1994, STROKE, V25, P1354, DOI 10.1161/01.STR.25.7.1354; Ekmekci H, 2017, DIS MARKERS, V2017; Giallauria F, 2012, J CLIN ENDOCR METAB, V97, P3717, DOI 10.1210/jc.2012-1584; Hagstrom E, 2009, CIRCULATION, V119, P2765, DOI 10.1161/CIRCULATIONAHA.108.808733; Judd SE, 2009, AM J MED SCI, V338, P40, DOI 10.1097/MAJ.0b013e3181aaee91; Kestenbaum B, 2011, J AM COLL CARDIOL, V58, P1433, DOI 10.1016/j.jacc.2011.03.069; Knox S, 2012, ATHEROSCLEROSIS, V223, P437, DOI 10.1016/j.atherosclerosis.2012.05.001; Kruger IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054554; Kweon SS, 2014, INT J EPIDEMIOL, V43, P558, DOI 10.1093/ije/dys244; Labropoulos N, 1998, AM J SURG, V176, P140, DOI 10.1016/S0002-9610(98)00135-4; Leone N, 2008, ARTERIOSCL THROM VAS, V28, P1392, DOI 10.1161/ATVBAHA.108.164582; Lerstad G, 2017, EUR J ENDOCRINOL, V176, P625, DOI 10.1530/EJE-16-1037; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lim S, 2012, J CLIN ENDOCR METAB, V97, P169, DOI 10.1210/jc.2011-1580; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Mannami T, 2000, STROKE, V31, P2958, DOI 10.1161/01.STR.31.12.2958; Matsuoka O, 2005, BIOMED PHARMACOTHER, V59, pS40, DOI 10.1016/S0753-3322(05)80008-3; Meng FB, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004810; Michos ED, 2009, CALCIFIED TISSUE INT, V84, P195, DOI 10.1007/s00223-008-9209-3; Mozos I, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/109275; Nambi V, 2012, EUR HEART J, V33, P183, DOI 10.1093/eurheartj/ehr192; Pirro M, 2012, J ATHEROSCLER THROMB, V19, P924, DOI 10.5551/jat.13128; Prati P, 2008, STROKE, V39, P2470, DOI 10.1161/STROKEAHA.107.511584; Qi L, 2017, ARTERIOSCLER THROMB; Reis JP, 2009, ATHEROSCLEROSIS, V207, P585, DOI 10.1016/j.atherosclerosis.2009.05.030; Semba RD, 2010, EUR J CLIN NUTR, V64, P203, DOI 10.1038/ejcn.2009.140; Slominski AT, 2016, EXP DERMATOL, V25, P231, DOI 10.1111/exd.12872; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Slominski AT, 2015, J STEROID BIOCHEM, V151, P25, DOI 10.1016/j.jsbmb.2014.11.010; Tomaschitz A, 2012, CARDIOVASC RES, V94, P10, DOI 10.1093/cvr/cvs092; Tomiyama H, 2005, CIRC J, V69, P815, DOI 10.1253/circj.69.815; Valcour A, 2012, J CLIN ENDOCR METAB, V97, P3989, DOI 10.1210/jc.2012-2276; van Ballegooijen AJ, 2013, J CLIN ENDOCR METAB, V98, pE638, DOI 10.1210/jc.2012-4007; Veloudi P, 2016, PULSE, V4, P193, DOI 10.1159/000452742; Wang L, 2012, CIRC-CARDIOVASC QUAL, V5, P819, DOI 10.1161/CIRCOUTCOMES.112.967604	45	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186421	10.1371/journal.pone.0186421	http://dx.doi.org/10.1371/journal.pone.0186421			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088221	gold, Green Submitted, Green Published			2022-12-26	WOS:000414088900011
J	Radziwon-Balicka, A; Degn, M; Johansson, SE; Warfvinge, K; Edvinsson, L				Radziwon-Balicka, Aneta; Degn, Matilda; Johansson, Sara E.; Warfvinge, Karin; Edvinsson, Lars			A novel multicolor flow-cytometry application for quantitative detection of receptors on vascular smooth muscle cells	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; TISSUES	There is a need to develop new techniques for quantitative measurement of receptors expression on particular vasculature cells types. Here, we describe and demonstrate a novel method to measure quantitatively and simultaneously the expression of endothelin B receptor (ETB) on vascular smooth muscle cells (VSMC). We isolated cells from male rat tissues such as: brain pial, brain intraparenchymal and retina vessels. To analyze solid tissues, a single-cell suspension was prepared by a combined mechanic and enzymatic process. The cells were stained with Fixable Viability Dye, followed by fixation, permeabilization and antibodies staining. The expression of ETB receptors on VSMC was measured by flow-cytometry and visualized by fluorescence microscopy. We obtained a high percentage of viable cells 87.6% +/- 1.5% pial; 84.6% +/- 4.3% parenchymal and 90.6% +/- 4% retina after isolation of single cells. We performed a quantitative measurement of ETB receptor expression on VSMC and we identified two subpopulations of VSMC based on their expression of smooth muscle cells marker SM22a. The results obtained from pial vessels are statistically significant (38.4% +/- 4% vs 9.8% +/- 3.32%) between the two subpopulations of VSMC. The results obtained from intraparenchymal and retina vessels were not statistically significant. By specific gating on two subpopulations, we were able to quantify the expression of ETB receptors. The two subpopulation expressed the same level of ETB receptor (p = 0.45; p = 0.3; p = 0.42) in pial, parenchymal and retina vessels, respectively. We applied our method to the animals after induction of subarachnoid hemorrhage (SAH). There was statistically significant expression of ETB receptor (p = 0.02) on VSMC between sham 61.4% +/- 4% and SAH 77.4% +/- 4% rats pial vessels. The presented technique is able to quantitatively and selectively measure the level of protein expression on VSMC. The entire technique is optimized for rat tissue; however the protocol can also be adapted for other species.	[Radziwon-Balicka, Aneta; Degn, Matilda; Johansson, Sara E.; Warfvinge, Karin; Edvinsson, Lars] Rigshosp, Glostrup Res Inst, Dept Clin Expt Res, Glostrup, Denmark; [Warfvinge, Karin; Edvinsson, Lars] Lund Univ, Div Expt Vasc Res, Dept Clin Sci, Lund, Sweden	Rigshospitalet; Lund University	Radziwon-Balicka, A (corresponding author), Rigshosp, Glostrup Res Inst, Dept Clin Expt Res, Glostrup, Denmark.	arad0002@regionh.dk	Radziwon-Balicka, Aneta/AAA-3787-2021	Degn, Matilda/0000-0003-3093-3525; Radziwon-Balicka, Aneta/0000-0002-5123-5710; Edvinsson, Lars/0000-0002-1805-1346	Lundbeck Foundation Denmark; Swedish Research Council (Forskningsradet om Halsa, Arbetsliv och Valfard) [5958]; Lundbeck Foundation [R59-2010-5404] Funding Source: researchfish	Lundbeck Foundation Denmark(Lundbeckfonden); Swedish Research Council (Forskningsradet om Halsa, Arbetsliv och Valfard); Lundbeck Foundation(Lundbeckfonden)	This work is supported by a financial support from the Lundbeck Foundation Denmark (Grant of Excellence to LE, 2011-2016) and the Swedish Research Council (Forskningsradet om Halsa, Arbetsliv och Valfard, grant no 5958 to LE).	Adhikari N, 2015, J CARDIOVASC TRANSL, V8, P158, DOI 10.1007/s12265-015-9616-6; Ansar S, 2007, AM J PHYSIOL-HEART C, V293, pH3750, DOI 10.1152/ajpheart.00857.2007; Brindley David, 2011, J Tissue Eng, V2011, P620247, DOI 10.4061/2011/620247; Donnenberg VS, 2013, CYTOM PART A, V83A, P141, DOI 10.1002/cyto.a.22156; Edvinsson L, 2011, ACTA PHYSIOL, V203, P209, DOI 10.1111/j.1748-1716.2010.02227.x; Edvinsson L., 2002, CEREBRAL BLOOD FLOW, V2nd ed; HEAD RJ, 1980, BLOOD VESSELS, V17, P173; Navone SE, 2013, NAT PROTOC, V8, P1680, DOI 10.1038/nprot.2013.107; Povlsen GK, 2015, J CEREBR BLOOD F MET, V35, P329, DOI 10.1038/jcbfm.2014.205; Povlsen GK, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-34; Qasaimeh MA, 2017, SCI REP-UK, V7, DOI 10.1038/srep45681; Saladin K., 2015, UNITY FORM FUNCTION; Schwartz A, 2002, J RES NATL INST STAN, V107, P83, DOI 10.6028/jres.107.009; Spray S, 2016, ACTA PHYSL OXF; van Beijnum JR, 2008, NAT PROTOC, V3, P1085, DOI 10.1038/nprot.2008.71; Weber SC, 2011, PEDIATR RES, V70, P236, DOI 10.1203/PDR.0b013e318225f748	16	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0186504	10.1371/journal.pone.0186504	http://dx.doi.org/10.1371/journal.pone.0186504			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084284	gold, Green Published, Green Submitted			2022-12-26	WOS:000413910200007
J	Nemoto, K; Oka, H; Fukuda, H; Yamakawa, Y				Nemoto, Kiyotaka; Oka, Hiroki; Fukuda, Hiroki; Yamakawa, Yoshinori			MRI-based Brain Healthcare Quotients: A bridge between neural and behavioral analyses for keeping the brain healthy	PLOS ONE			English	Article							BODY-MASS INDEX; VOXEL-BASED MORPHOMETRY; GRAY-MATTER VOLUME; ALZHEIMERS-DISEASE; SOCIAL-STATUS; YOUNG-ADULTS; LATE-LIFE; SCHIZOPHRENIA; METAANALYSIS; FEASIBILITY	Neurological and psychiatric disorders are a burden on social and economic resources. Therefore, maintaining brain health and preventing these disorders are important. While the physiological functions of the brain are well studied, few studies have focused on keeping the brain healthy from a neuroscientific viewpoint. We propose a magnetic resonance imaging (MRI)-based quotient for monitoring brain health, the Brain Healthcare Quotient (BHQ), which is based on the volume of gray matter (GM) and the fractional anisotropy (FA) of white matter (WM). We recruited 144 healthy adults to acquire structural neuro-imaging data, including T1-weighted images and diffusion tensor images, and data associated with both physical (BMI, blood pressure, and daily time use) and social (subjective socioeconomic status, subjective well-being, post-materialism and Epicureanism) factors. We confirmed that the BHQ was sensitive to an age-related decline in GM volume and WM integrity. Further analysis revealed that the BHQ was critically affected by both physical and social factors. We believe that our BHQ is a simple yet highly sensitive, valid measure for brain health research that will bridge the needs of the scientific community and society and help us lead better lives in which we stay healthy, active, and sharp.	[Nemoto, Kiyotaka] Univ Tsukuba, Div Clin Med, Dept Neuropsychiat, Fac Med, Tsukuba, Ibaraki, Japan; [Oka, Hiroki; Fukuda, Hiroki; Yamakawa, Yoshinori] Govt Japan, Cabinet Off, ImPACT Program, Council Sci Technol & Innovat,Chiyoda Ku, Tokyo, Japan	University of Tsukuba	Yamakawa, Y (corresponding author), Govt Japan, Cabinet Off, ImPACT Program, Council Sci Technol & Innovat,Chiyoda Ku, Tokyo, Japan.	yamakawa@bi-lab.org	Nemoto, Kiyotaka/C-4987-2013	Nemoto, Kiyotaka/0000-0001-8623-9829; yamakawa, yoshinori/0000-0002-7995-1794	ImPACT Program of Council for Science, Technology and Innovation (Cabinet Office, Government of Japan)	ImPACT Program of Council for Science, Technology and Innovation (Cabinet Office, Government of Japan)	This work was funded by ImPACT Program of Council for Science, Technology and Innovation (Cabinet Office, Government of Japan).	Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; Alves GS, 2017, CURR ALZHEIMER RES, V14, P61, DOI 10.2174/1567205013666160603010203; Anstey KJ, 2011, OBES REV, V12, pe426, DOI 10.1111/j.1467-789X.2010.00825.x; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bosc M, 1997, EUROPEAN NEUROPSYCHO; Demakakos P, 2008, SOC SCI MED, V67, P330, DOI 10.1016/j.socscimed.2008.03.038; Ecker C, 2015, LANCET NEUROL, V14, P1121, DOI 10.1016/S1474-4422(15)00050-2; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Erickson KI, 2014, NEUROBIOL AGING, V35, pS20, DOI 10.1016/j.neurobiolaging.2014.03.034; Fennema-Notestine C, 2007, NEUROINFORMATICS, V5, P235, DOI 10.1007/s12021-007-9003-9; Gunstad J, 2008, INT J NEUROSCI, V118, P1582, DOI 10.1080/00207450701392282; Hamilton JP, 2012, AM J PSYCHIAT, V169, P693, DOI 10.1176/appi.ajp.2012.11071105; Hollingshead AB, 1965, 2 FACTOR INDEX SOCIA; INGLEHART R, 1971, AM POLIT SCI REV, V65, P991, DOI 10.2307/1953494; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johansen-Berg H, 2010, CURR OPIN NEUROL, V23, P351, DOI 10.1097/WCO.0b013e32833b7631; Kanai R, 2011, CURR BIOL, V21, P677, DOI 10.1016/j.cub.2011.03.017; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Kandel E.R., 2012, PRINCIPLES NEURAL SC; Lewis GJ, 2012, J COGNITIVE NEUROSCI, V24, P1657, DOI 10.1162/jocn_a_00239; Malnick SDH, 2006, QJM-INT J MED, V99, P565, DOI 10.1093/qjmed/hcl085; Meda SA, 2008, SCHIZOPHR RES, V101, P95, DOI 10.1016/j.schres.2008.02.007; Menary K, 2013, INTELLIGENCE, V41, P597, DOI 10.1016/j.intell.2013.07.010; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Noble KG, 2015, NAT NEUROSCI, V18, P773, DOI 10.1038/nn.3983; O'Brien C, 2015, TODAYS GERIATRIC MED, V8, P1; Ogawa W., 2015, HLTH EVAL PROMOT, V42, P301, DOI [10.7143/jhep.42.301, DOI 10.7143/JHEP.42.301]; Ohtani T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112691; Pardoe H, 2008, NEUROIMAGE, V42, P611, DOI 10.1016/j.neuroimage.2008.05.007; Peterson C., 2006, PRIMER POSITIVE PSYC, DOI DOI 10.1016/j.compedu.2004.08.013; Pinkham AE, 2008, SCHIZOPHR RES, V99, P164, DOI 10.1016/j.schres.2007.10.024; Raz N., 2000, HDB AGING COGNITION, V2nd, P1; Segall JM, 2009, SCHIZOPHRENIA BULL, V35, P82, DOI 10.1093/schbul/sbn150; Seligman M., 2002, HDB POSITIVE PSYCHOL, V2, P3; Sheehan D, 1996, INT CLIN PSYCHOPHARM; Shimoji K, 2013, DIABETES CARE, V36, P696, DOI 10.2337/dc12-0666; Smith SM, 2015, NAT NEUROSCI, V18, P1565, DOI 10.1038/nn.4125; Stonnington CM, 2008, NEUROIMAGE, V39, P1180, DOI 10.1016/j.neuroimage.2007.09.066; Swan GE, 1998, NEUROLOGY, V51, P986, DOI 10.1212/WNL.51.4.986; Taki Y, 2008, OBESITY, V16, P119, DOI 10.1038/oby.2007.4; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Ward MA, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-23; Weingarten CP, 2015, NEUROSCI BIOBEHAV R, V59, P16, DOI 10.1016/j.neubiorev.2015.09.007; WHO, WHAT AR NEUR DIS; Yamakawa Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004360; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	47	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187137	10.1371/journal.pone.0187137	http://dx.doi.org/10.1371/journal.pone.0187137			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK9WD	29077756	gold, Green Published, Green Submitted			2022-12-26	WOS:000413861200048
J	Sorensen, BM; Houben, AJHM; Berendschot, TTJM; Schouten, JSAG; Kroon, AA; van der Kallen, CJH; Henry, RMA; Koster, A; Dagnelie, PC; Schaper, NC; Schram, MT; Stehouwer, CDA				Sorensen, Ben M.; Houben, Alfons J. H. M.; Berendschot, Tos T. J. M.; Schouten, Jan S. A. G.; Kroon, Abraham A.; van der Kallen, Carla J. H.; Henry, Ronald M. A.; Koster, Annemarie; Dagnelie, Pieter C.; Schaper, Nicolaas C.; Schram, Miranda T.; Stehouwer, Coen D. A.			Cardiovascular risk factors as determinants of retinal and skin microvascular function: The Maastricht Study	PLOS ONE			English	Article							ENDOTHELIAL DYSFUNCTION; BLOOD-PRESSURE; NITRIC-OXIDE; INSULIN-RESISTANCE; VESSEL DIAMETER; OPTIC-NERVE; AGE; OBESITY; FLOW; PATHOLOGY	Objective Microvascular dysfunction is an important underlying mechanism of microvascular diseases. Determinants (age, sex, hypertension, dyslipidemia, hyperglycemia, obesity, and smoking) of macrovascular diseases affect large-artery endothelial function. These risk factors also associate with microvascular diseases. We hypothesized that they are also determinants of microvascular (endothelial) function. Methods In The Maastricht Study, a type 2 diabetes-enriched population-based cohort study (n = 1991, 51% men, aged 59.7 +/- 8.2 years), we determined microvascular function as flicker light-induced retinal arteriolar %-dilation and heat-induced skin %-hyperemia. Multiple linear regression analyses were used to assess the associations of cardiovascular risk factors (age, sex, waist circumference, total-to-high-density lipoprotein (HDL) cholesterol ratio, fasting plasma glucose (FPG), 24-h systolic blood pressure, and cigarette smoking) with retinal and skin microvascular function. Results In multivariate analyses, age and FPG were inversely associated with retinal and skin microvascular function (regression coefficients per standard deviation (SD) were -0.11SD (95% CI: -0.15;-0.06) and -0.12SD (-0.17;-0.07) for retinal arteriolar %-dilation and -0.10SD (-0.16;-0.05) and -0.11SD (-0.17;-0.06) for skin %-hyperemia, respectively. Men and current smokers had -0.43SD (-0.58;-0.27) and -0.32SD (-0.49;-0.15) lower skin %-hyperemia, respectively. 24-h systolic blood pressure, waist circumference, and total-to-HDL cholesterol ratio were not statistically significantly associated with these microvascular functions. Conclusions Associations between cardiovascular risk factors and retinal and skin microvascular function show a pattern that is partly similar to the associations between cardiovascular risk factors and macrovascular function. Impairment of microvascular function may constitute a pathway through which an adverse cardiovascular risk factor pattern may increase risk of diseases that are partly or wholly of microvascular origin.	[Sorensen, Ben M.; Houben, Alfons J. H. M.; Kroon, Abraham A.; van der Kallen, Carla J. H.; Henry, Ronald M. A.; Dagnelie, Pieter C.; Schaper, Nicolaas C.; Schram, Miranda T.; Stehouwer, Coen D. A.] Maastricht Univ, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands; [Sorensen, Ben M.; Houben, Alfons J. H. M.; Kroon, Abraham A.; van der Kallen, Carla J. H.; Henry, Ronald M. A.; Schaper, Nicolaas C.; Schram, Miranda T.; Stehouwer, Coen D. A.] Maastricht Univ, Dept Internal Med, Med Ctr, Maastricht, Netherlands; [Berendschot, Tos T. J. M.; Schouten, Jan S. A. G.] Maastricht Univ, Univ Eye Clin Maastricht, Med Ctr, Maastricht, Netherlands; [Henry, Ronald M. A.; Schram, Miranda T.] Maastricht Univ, Heart & Vasc Ctr, Med Ctr, Maastricht, Netherlands; [Koster, Annemarie; Dagnelie, Pieter C.; Schaper, Nicolaas C.] Maastricht Univ, CAPHRI Care & Publ Hlth Res Inst, Maastricht, Netherlands; [Koster, Annemarie] Maastricht Univ, Dept Social Med, Maastricht, Netherlands; [Dagnelie, Pieter C.] Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University; Maastricht University; Maastricht University	Stehouwer, CDA (corresponding author), Maastricht Univ, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands.; Stehouwer, CDA (corresponding author), Maastricht Univ, Dept Internal Med, Med Ctr, Maastricht, Netherlands.	cda.stehouwer@mumc.nl	Berendschot, Tos TJM/M-8509-2016; Stehouwer, Coen/AAB-3435-2021; Koster, Annemarie/E-7438-2010; Houben, Alfons J/C-1913-2014; Schaper, Nicolaas C/E-7112-2014	Berendschot, Tos TJM/0000-0002-8101-939X; Koster, Annemarie/0000-0003-1583-7391; Stehouwer, Coen/0000-0001-8752-3223; Schram, Miranda/0000-0001-8113-7604; schaper, nicolaas/0000-0002-2128-8029; Kroon, Abraham/0000-0001-7750-8249; van der Kallen, Carla/0000-0003-1468-8793	European Regional Development Fund via OP-Zuid; Province of Limburg; Dutch Ministry of Economic Affairs [310.041]; Stichting De Weijerhorst (Maastricht, the Netherlands); Pearl String Initiative Diabetes (Amsterdam, the Netherlands); CARIM School for Cardiovascular Diseases (Maastricht, the Netherlands); Stichting Annadal (Maastricht, the Netherlands); Health Foundation Limburg (Maastricht, the Netherlands); Perimed (Jarfalla, Sweden); Janssen-Cilag B.V. (Tilburg, the Netherlands); Novo Nordisk Farma B.V. (Alphen aan den Rijn, the Netherlands); Sanofi-Aventis Netherlands B.V. (Gouda, the Netherlands)	European Regional Development Fund via OP-Zuid; Province of Limburg; Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Stichting De Weijerhorst (Maastricht, the Netherlands)(Netherlands Government); Pearl String Initiative Diabetes (Amsterdam, the Netherlands)(Netherlands Government); CARIM School for Cardiovascular Diseases (Maastricht, the Netherlands); Stichting Annadal (Maastricht, the Netherlands); Health Foundation Limburg (Maastricht, the Netherlands); Perimed (Jarfalla, Sweden); Janssen-Cilag B.V. (Tilburg, the Netherlands); Novo Nordisk Farma B.V. (Alphen aan den Rijn, the Netherlands); Sanofi-Aventis Netherlands B.V. (Gouda, the Netherlands)(Netherlands Government)	This study was supported by the European Regional Development Fund via OP-Zuid, the Province of Limburg, the Dutch Ministry of Economic Affairs (grant 310.041), Stichting De Weijerhorst (Maastricht, the Netherlands), the Pearl String Initiative Diabetes (Amsterdam, the Netherlands), CARIM School for Cardiovascular Diseases (Maastricht, the Netherlands), Stichting Annadal (Maastricht, the Netherlands), Health Foundation Limburg (Maastricht, the Netherlands), Perimed (Jarfalla, Sweden), and by unrestricted grants from Janssen-Cilag B.V. (Tilburg, the Netherlands), Novo Nordisk Farma B.V. (Alphen aan den Rijn, the Netherlands) and Sanofi-Aventis Netherlands B.V. (Gouda, the Netherlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006429; Arora S, 1998, J VASC SURG, V27, P1141, DOI 10.1016/S0741-5214(98)70016-3; Buysschaert M, 2015, ENDOCRINE, V48, P371, DOI 10.1007/s12020-014-0436-2; Caballero AE, 1999, DIABETES, V48, P1856, DOI 10.2337/diabetes.48.9.1856; CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P471, DOI 10.1016/0735-1097(94)90305-0; Chen SM, 2011, HEART VESSELS, V26, P2, DOI 10.1007/s00380-010-0017-0; Cheung N, 2007, HYPERTENSION, V50, P617, DOI 10.1161/HYPERTENSIONAHA.107.091926; Chilelli NC, 2013, NUTR METAB CARDIOVAS, V23, P913, DOI 10.1016/j.numecd.2013.04.004; Cracowski JL, 2011, MICROCIRCULATION, V18, P356, DOI 10.1111/j.1549-8719.2011.00098.x; de Jongh RT, 2004, CIRCULATION, V109, P2529, DOI 10.1161/01.CIR.0000129772.26647.6F; De Silva TM, 2016, CELL MOL NEUROBIOL, V36, P241, DOI 10.1007/s10571-015-0308-1; Falsini B, 2002, INVEST OPHTH VIS SCI, V43, P2309; Fitzmaurice G, 2000, NUTRITION, V16, P313, DOI 10.1016/S0899-9007(99)00293-2; Francischetti EA, 2011, MICROVASC RES, V81, P325, DOI 10.1016/j.mvr.2011.01.002; Fraser-Bell S, 2017, CLIN EXP OPHTHALMOL, V45, P45, DOI 10.1111/ceo.12905; Garhofer G, 2011, MICROVASC RES, V82, P351, DOI 10.1016/j.mvr.2011.07.001; Gupta A, 2015, OMICS, V19, P733, DOI 10.1089/omi.2015.0128; Hashimoto S, 2015, DIABETES, V64, P876, DOI 10.2337/db14-0432; Henriksson P, 2014, MICROCIRCULATION, V21, P587, DOI 10.1111/micc.12137; Houben A, 2017, J AM SOC NEPHROL; IJzerman RG, 2003, EUR J CLIN INVEST, V33, P536, DOI 10.1046/j.1365-2362.2003.01179.x; Ijzerman RG, 2003, CLIN SCI, V104, P247, DOI 10.1042/CS20020318; Irving RJ, 2002, CARDIOVASC RES, V53, P271, DOI 10.1016/S0008-6363(01)00450-3; Jia GH, 2016, DIABETES, V65, P2118, DOI 10.2337/dbi16-0026; Jonk AM, 2007, PHYSIOLOGY, V22, P252, DOI 10.1152/physiol.00012.2007; Kellogg DL, 1999, J APPL PHYSIOL, V86, P1185, DOI 10.1152/jappl.1999.86.4.1185; Knottnerus ILH, 2009, CEREBROVASC DIS, V27, P519, DOI 10.1159/000212672; Kubli S, 2000, J CARDIOVASC PHARM, V36, P640, DOI 10.1097/00005344-200011000-00014; Lacolley P, 2012, CARDIOVASC RES, V95, P194, DOI 10.1093/cvr/cvs135; Lee JF, 2016, HEART, V102, P278, DOI 10.1136/heartjnl-2015-308403; Lim M, 2013, MICROCIRCULATION, V20, P257, DOI 10.1111/micc.12026; Minson CT, 2001, J APPL PHYSIOL, V91, P1619, DOI 10.1152/jappl.2001.91.4.1619; Montero D, 2015, J HYPERTENS, V33, P445, DOI 10.1097/HJH.0000000000000446; Muris DMJ, 2014, J HYPERTENS, V32, P2439, DOI 10.1097/HJH.0000000000000348; Muris DMJ, 2013, REV ENDOCR METAB DIS, V14, P29, DOI 10.1007/s11154-012-9231-7; Nagel E, 2006, OPHTHALMOLOGE, V103, P114, DOI 10.1007/s00347-005-1254-y; Nagel E, 2004, INVEST OPHTH VIS SCI, V45, P1486, DOI 10.1167/iovs.03-0667; Ogueta SB, 1999, INVEST OPHTH VIS SCI, V40, P1906; Parekh A, 2017, HEALTHCARE-BASEL, V5, DOI 10.3390/healthcare5010005; Puissant C, 2014, J Mal Vasc, V39, P47, DOI 10.1016/j.jmv.2013.11.004; Reimann M, 2015, ATHEROSCLEROSIS SUPP, V18, P1, DOI 10.1016/j.atherosclerosissup.2015.02.001; Riva CE, 2005, PROG RETIN EYE RES, V24, P183, DOI 10.1016/j.preteyeres.2004.07.002; Santos M, 2012, J NEUROL SCI, V322, P46, DOI 10.1016/j.jns.2012.05.048; Schram MT, 2014, EUR J EPIDEMIOL, V29, P439, DOI 10.1007/s10654-014-9889-0; Seshadri S, 2016, ACTA OPHTHALMOL, V94, pE35, DOI 10.1111/aos.12786; Seshadri S, 2015, ACTA OPHTHALMOL, V93, pE266, DOI 10.1111/aos.12594; Smith AR, 2006, ARCH BIOCHEM BIOPHYS, V454, P100, DOI 10.1016/j.abb.2006.02.017; Sorensen BM, 2016, CIRCULATION, V134, P1339, DOI 10.1161/CIRCULATIONAHA.116.023446; Tsao CW, 2015, INT J EPIDEMIOL, V44, P1800, DOI 10.1093/ije/dyv337; Wickman C, 2013, SEMIN NEPHROL, V33, P14, DOI 10.1016/j.semnephrol.2012.12.006; Witte DR, 2005, J AM COLL CARDIOL, V45, P1987, DOI 10.1016/j.jacc.2005.02.073; Yang SH, 2005, CNS NEUROL DISORD-DR, V4, P169, DOI 10.2174/1568007053544174; Zafrani L, 2015, AM J KIDNEY DIS, V66, P1083, DOI 10.1053/j.ajkd.2015.06.019	53	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187324	10.1371/journal.pone.0187324	http://dx.doi.org/10.1371/journal.pone.0187324			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077770	Green Submitted, gold, Green Published			2022-12-26	WOS:000413861200058
J	Silvestro, PC; Pignatti, S; Yang, H; Yang, GJ; Pascucci, S; Castaldi, F; Casa, R				Silvestro, Paolo Cosmo; Pignatti, Stefano; Yang, Hao; Yang, Guijun; Pascucci, Simone; Castaldi, Fabio; Casa, Raffaele			Sensitivity analysis of the Aquacrop and SAFYE crop models for the assessment of water limited winter wheat yield in regional scale applications	PLOS ONE			English	Article							GLOBAL SENSITIVITY; DATA ASSIMILATION; SIMULATION-MODEL; SOIL-MOISTURE; UNCERTAINTY; GROWTH; PREDICTIONS; PERFORMANCE; CALIBRATION; VEGETATION	Process-based models can be usefully employed for the assessment of field and regional-scale impact of drought on crop yields. However, in many instances, especially when they are used at the regional scale, it is necessary to identify the parameters and input variables that most influence the outputs and to assess how their influence varies when climatic and environmental conditions change. In this work, two different crop models, able to represent yield response to water, Aquacrop and SAFYE, were compared, with the aim to quantify their complexity and plasticity through Global Sensitivity Analysis (GSA), using Morris and EFAST (Extended Fourier Amplitude Sensitivity Test) techniques, for moderate to strong water limited climate scenarios. Although the rankings of the sensitivity indices was influenced by the scenarios used, the correlation among the rankings, higher for SAFYE than for Aquacrop, assessed by the top-down correlation coefficient (TDCC), revealed clear patterns. Parameters and input variables related to phenology and to water stress physiological processes were found to be the most influential for Aquacrop. For SAFYE, it was found that the water stress could be inferred indirectly from the processes regulating leaf growth, described in the original SAFY model. SAFYE has a lower complexity and plasticity than Aquacrop, making it more suitable to less data demanding regional scale applications, in case the only objective is the assessment of crop yield and no detailed information is sought on the mechanisms of the stress factors affecting its limitations.	[Silvestro, Paolo Cosmo; Castaldi, Fabio; Casa, Raffaele] Univ Tuscia, Dept Agr Forestry & Nat DAFNE, Viterbo, Italy; [Pignatti, Stefano; Pascucci, Simone] CNR, Inst Methodol Environm Anal IMAA, Potenza, Italy; [Yang, Hao; Yang, Guijun] NERCITA, Beijing, Peoples R China	Tuscia University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Metodologie per l'Analisi Ambientale (IMAA-CNR)	Casa, R (corresponding author), Univ Tuscia, Dept Agr Forestry & Nat DAFNE, Viterbo, Italy.	rcasa@unitus.it	Castaldi, Fabio/D-3269-2014; Castaldi, Fabio/AAY-6064-2021; Morano, Stefano Pignatti/A-4640-2008; Pascucci, Simone/I-8172-2019	Castaldi, Fabio/0000-0001-9160-1765; Morano, Stefano Pignatti/0000-0002-0587-8926; Pascucci, Simone/0000-0002-8311-8615; Silvestro, Paolo Cosmo/0000-0001-7375-2906; Yang, Guijun/0000-0002-6425-8321; CASA, Raffaele/0000-0003-3091-7680; Yang, Hao/0000-0001-8506-7295	European Space Agency [4000110311/14/I-BG]; European Space Agency Dragon 3 Project [10448]; Consiglio Nazionale delle Ricerche; China Academy of Science; Chinese National Science and Technology Support Program [2012BAH29B00]; Chinese State Key Basic Project [2013CB733404]; University of Tuscia funding; ESA (European Space Agency) [4000110311/14/I-BG, 10448]; CNR	European Space Agency(European Space AgencyEuropean Commission); European Space Agency Dragon 3 Project; Consiglio Nazionale delle Ricerche(Consiglio Nazionale delle Ricerche (CNR)); China Academy of Science; Chinese National Science and Technology Support Program; Chinese State Key Basic Project; University of Tuscia funding; ESA (European Space Agency)(European Space Agency); CNR(Consiglio Nazionale delle Ricerche (CNR))	PhD scholarship to Paolo Cosmo Silvestro under European Space Agency contract 4000110311/14/I-BG; European Space Agency Dragon 3 Project ID 10448 (https://dragon3.esa.int); Agreement on scientific cooperation between Consiglio Nazionale delle Ricerche and China Academy of Science 2014-2016; Chinese National Science and Technology Support Program grant 2012BAH29B00 to Guijun Yang; Chinese State Key Basic Project grant 2013CB733404 to Hao Yang; University of Tuscia funding to Paolo Cosmo Silvestro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a grant to PCS PhD scholarship under ESA (European Space Agency) Contract No. 4000110311/14/I-BG, in the framework of Dragon 3 Project ID 10448 "Farmland Drought" and by the CNR contribution in the framework of the Agreement on scientific cooperation between CNR and CAS China 2014-2016. The authors would like to thank Dirk Raes for providing the command-line version of Aquacrop and Samuel Buis and other colleagues at INRA Avignon (France) for providing the Matlab code for the GSA.	Allen R.G., 1998, FAO IRRIGATION DRAIN, DOI DOI 10.1016/J.EJA.2010.12.001; Andarzian B, 2011, AGR WATER MANAGE, V100, P1, DOI 10.1016/j.agwat.2011.08.023; Baret F., 1991, Remote Sensing of Environment, V35, P161, DOI 10.1016/0034-4257(91)90009-U; Basso B, 2016, ADV AGRON, V136, P27, DOI 10.1016/bs.agron.2015.11.004; Ben Touhami H, 2013, ECOL MODEL, V266, P42, DOI 10.1016/j.ecolmodel.2013.07.005; Brisson N, 2003, EUR J AGRON, V18, P309, DOI 10.1016/S1161-0301(02)00110-7; BRISTOW KL, 1984, AGR FOREST METEOROL, V31, P159, DOI 10.1016/0168-1923(84)90017-0; Campolongo F, 2007, ENVIRON MODELL SOFTW, V22, P1509, DOI 10.1016/j.envsoft.2006.10.004; Cariboni J, 2007, ECOL MODEL, V203, P167, DOI 10.1016/j.ecolmodel.2005.10.045; Casa R, INT GEOSC REM SENS S, P5925; Casa R, 2009, WATER RESOUR MANAG, V23, P1685, DOI 10.1007/s11269-008-9347-4; Castaneda-Vera A, 2015, EUR J AGRON, V68, P97, DOI 10.1016/j.eja.2015.04.008; Chahbi A, 2014, INT J REMOTE SENS, V35, P1004, DOI 10.1080/01431161.2013.875629; Chen YT, 2014, ECOL MODEL, V290, P165, DOI 10.1016/j.ecolmodel.2014.01.030; Confalonieri R, 2012, ECOL MODEL, V225, P159, DOI 10.1016/j.ecolmodel.2011.11.022; Confalonieri R, 2010, ECOL MODEL, V221, P1897, DOI 10.1016/j.ecolmodel.2010.04.021; Confalonieri R, 2010, ECOL MODEL, V221, P960, DOI 10.1016/j.ecolmodel.2009.12.003; Confalonieri R, 2016, ENVIRON MODELL SOFTW, V85, P332, DOI 10.1016/j.envsoft.2016.09.007; Confalonieri R, 2016, ENVIRON MODELL SOFTW, V81, P165, DOI 10.1016/j.envsoft.2016.04.009; Confalonieri R, 2016, ECOL MODEL, V328, P72, DOI 10.1016/j.ecolmodel.2016.02.013; Confalonieri R, 2009, ECOL MODEL, V220, P1395, DOI 10.1016/j.ecolmodel.2009.02.017; DeJonge KC, 2012, ECOL MODEL, V231, P113, DOI 10.1016/j.ecolmodel.2012.01.024; Diodato N, 2008, CLIM RES, V36, P53, DOI 10.3354/cr00726; Dorigo WA, 2007, INT J APPL EARTH OBS, V9, P165, DOI 10.1016/j.jag.2006.05.003; Duchemin B, 2005, P DEUX C MED RESS EA, P14; Duchemin B, 2008, ENVIRON MODELL SOFTW, V23, P876, DOI 10.1016/j.envsoft.2007.10.003; Foster T, 2017, AGR WATER MANAGE, V181, P18, DOI 10.1016/j.agwat.2016.11.015; IMAN RL, 1987, TECHNOMETRICS, V29, P351, DOI 10.2307/1269344; Ines AVM, 2013, REMOTE SENS ENVIRON, V138, P149, DOI 10.1016/j.rse.2013.07.018; Iqbal MA, 2014, AGR WATER MANAGE, V135, P61, DOI 10.1016/j.agwat.2013.12.012; Irace Z, 2014, THESIS I NAT POL TOU; Jin XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086938; Jin XL, 2017, ISPRS J PHOTOGRAMM, V126, P24, DOI 10.1016/j.isprsjprs.2017.02.001; Kersebaum KC, 2015, ENVIRON MODELL SOFTW, V72, P402, DOI 10.1016/j.envsoft.2015.05.009; Mishra AK, 2010, J HYDROL, V391, P204, DOI 10.1016/j.jhydrol.2010.07.012; Mkhabela MS, 2012, AGR WATER MANAGE, V110, P16, DOI 10.1016/j.agwat.2012.03.009; MONTEITH JL, 1977, PHILOS T ROY SOC B, V281, P277, DOI 10.1098/rstb.1977.0140; MORRIS MD, 1991, TECHNOMETRICS, V33, P161, DOI 10.2307/1269043; Pagani V, 2017, EUR J AGRON, V89, P97, DOI 10.1016/j.eja.2017.06.010; Paleari L, 2016, ECOL MODEL, V340, P57, DOI 10.1016/j.ecolmodel.2016.09.008; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Porter JR, 1999, EUR J AGRON, V10, P23, DOI 10.1016/S1161-0301(98)00047-1; Potgieter A, 2013, CLIMATIC CHANGE, V117, P163, DOI 10.1007/s10584-012-0543-0; Raes D, 2016, AQUACROP VERSION 5 0; Saab MTA, 2015, AGR WATER MANAGE, V147, P21, DOI 10.1016/j.agwat.2014.08.001; Saltelli A, 1999, TECHNOMETRICS, V41, P39, DOI 10.2307/1270993; Saltelli A, 2008, GLOBAL SENSITIVITY A, DOI 10.1002/9780470725184; Shrestha N, 2013, AGR WATER MANAGE, V122, P53, DOI 10.1016/j.agwat.2013.03.003; Silvestro PC, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9050509; Steduto P, 2009, AGRON J, V101, P426, DOI 10.2134/agronj2008.0139s; Stockle CO, 2003, EUR J AGRON, V18, P289, DOI 10.1016/S1161-0301(02)00109-0; Todorovic M, 2009, AGRON J, V101, P509, DOI 10.2134/agronj2008.0166s; Tsakiris G, 2017, WATER RESOUR MANAG, V31, P3083, DOI 10.1007/s11269-017-1698-2; van Keulen H., 1986, SIMULATION MONOGRAPH; Vanuytrecht E, 2014, ENVIRON MODELL SOFTW, V51, P323, DOI 10.1016/j.envsoft.2013.10.017; Varella H, 2010, ENVIRON MODELL SOFTW, V25, P310, DOI 10.1016/j.envsoft.2009.09.012; Wallach D., 2006, WORKING DYNAMIC CROP; Wang XX, 2013, AGR WATER MANAGE, V129, P95, DOI 10.1016/j.agwat.2013.07.010	58	37	38	6	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187485	10.1371/journal.pone.0187485	http://dx.doi.org/10.1371/journal.pone.0187485			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29107963	Green Published, gold, Green Submitted			2022-12-26	WOS:000414424600034
J	de Bekker, C; Will, I; Hughes, DP; Brachmann, A; Merrow, M				de Bekker, Charissa; Will, Ian; Hughes, David P.; Brachmann, Andreas; Merrow, Martha			Daily rhythms and enrichment patterns in the transcriptome of the behavior-manipulating parasite Ophiocordyceps kimflemingiae	PLOS ONE			English	Article							NEUROSPORA CIRCADIAN CLOCK; FEEDBACK LOOP; LIGHT INPUT; BLUE-LIGHT; EXPRESSION; GENES; PAS; OSCILLATOR; DROSOPHILA; INCREASE	Various parasite-host interactions that involve adaptive manipulation of host behavior display time-of-day synchronization of certain events. One example is the manipulated biting behavior observed in Carpenter ants infected with Ophiocordyceps unilateralis sensu lato. We hypothesized that biological clocks play an important role in this and other parasite-host interactions. In order to identify candidate molecular clock components, we used two general strategies: bioinformatics and transcriptional profiling. The bioinformatics approach was used to identify putative homologs of known clock genes. For transcriptional profiling, RNA-Seq was performed on 48 h time courses of Ophiocordyceps kimflemingiae (a recently named species of the O. unilateralis complex), whose genome has recently been sequenced. Fungal blastospores were entrained in liquid media under 24 h light-dark (LD) cycles and were harvested at 4 h intervals either under LD or continuous darkness. Of all O. kimflemingiae genes, 5.3% had rhythmic mRNAs under these conditions (JTK Cycle, <= 0.057 statistical cutoff). Our data further indicates that a significant number of transcription factors have a peaked activity during the light phase (day time). The expression levels of a significant number of secreted enzymes, proteases, toxins and small bioactive compounds peaked during the dark phase or subjective night. These findings support a model whereby this fungal parasite uses its biological clock for phase-specific activity. We further suggest that this may be a general mechanism involved in parasite-host interactions.	[de Bekker, Charissa; Will, Ian] Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA; [de Bekker, Charissa; Will, Ian; Merrow, Martha] Ludwig Maximilians Univ Munchen, Fac Med, Inst Med Psychol, Munich, Germany; [de Bekker, Charissa; Brachmann, Andreas] Ludwig Maximilians Univ Munchen, Fac Biol, Genet, Planegg Martinsried, Germany; [Hughes, David P.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Hughes, David P.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA	State University System of Florida; University of Central Florida; University of Munich; University of Munich; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	de Bekker, C (corresponding author), Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA.; de Bekker, C (corresponding author), Ludwig Maximilians Univ Munchen, Fac Med, Inst Med Psychol, Munich, Germany.; de Bekker, C (corresponding author), Ludwig Maximilians Univ Munchen, Fac Biol, Genet, Planegg Martinsried, Germany.	chanssa.debekker@uct.edu	Brachmann, Andreas/I-2241-2013	Brachmann, Andreas/0000-0001-7980-8173; de Bekker, Charissa/0000-0002-7325-172X; Will, Ian/0000-0002-2396-6778	Marie Curie Actions IOF Project [FP7-299501, 299501]; Alexander von Hum boldt Foundation; LMUs Friedrich Baur Stiftung; Alexander von Humboldt Foundation; Friedrich-Baur-Stiftung of LMU Munich	Marie Curie Actions IOF Project; Alexander von Hum boldt Foundation(Alexander von Humboldt Foundation); LMUs Friedrich Baur Stiftung; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Friedrich-Baur-Stiftung of LMU Munich	This work was supported by Marie Curie Actions IOF Project FP7-299501 (http://ec.europa.eu/research/mariecurieactions), the Alexander von Hum boldt Foundation (http://www.humboldt-foundation.de) and funds from the LMUs Friedrich Baur Stiftung (http://www.klinikum.uni-muenchen.de/Fried rich-Badr-Institut/de/institut/friedrich_baur_stiftung). All funds were made available to CdB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Marie Curie Actions IOF Project 299501, the Alexander von Humboldt Foundation and funds from the Friedrich-Baur-Stiftung of LMU Munich. We would like to thank Michael Hughes for taking the time to discuss our data with us and his invaluable advice on how to analyze the JTK_CYCLE output.	Andersen SB, 2009, AM NAT, V174, P424, DOI 10.1086/603640; Araujo JP, STUDIES IN MYCOLOGY; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; Badie A, 1973, C R SEANCES SOC BIOL, V167, P3; Baker CL, 2012, FEMS MICROBIOL REV, V36, P95, DOI 10.1111/j.1574-6976.2011.00288.x; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Bell-Pedersen D, 2001, MOL MICROBIOL, V41, P897, DOI 10.1046/j.1365-2958.2001.02558.x; BellPedersen D, 1996, P NATL ACAD SCI USA, V93, P13096, DOI 10.1073/pnas.93.23.13096; Bluhm BH, 2010, MYCOLOGIA, V102, P1221, DOI 10.3852/09-041; Blumenstein A, 2005, CURR BIOL, V15, P1833, DOI 10.1016/j.cub.2005.08.061; Botnevik CF, 2016, J PARASITOL, V102, P495, DOI 10.1645/16-53; Buhr Ethan D, 2013, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-25950-0_1; Canessa P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084223; Ceriani MF, 2002, J NEUROSCI, V22, P9305, DOI 10.1523/jneurosci.22-21-09305.2002; Cha J, 2015, BIOCHEMISTRY-US, V54, P150, DOI 10.1021/bi5005624; Cheng P, 2001, EMBO J, V20, P101, DOI 10.1093/emboj/20.1.101; CROSTHWAITE SK, 1995, CELL, V81, P1003, DOI 10.1016/S0092-8674(05)80005-4; Dasgupta A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005215; de Bekker C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12863-w; de Bekker C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1812-x; de Bekker C, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0166-3; de Bekker C, 2014, INTEGR COMP BIOL, V54, P166, DOI 10.1093/icb/icu063; de Bekker C, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r71; Denault DL, 2001, EMBO J, V20, P109, DOI 10.1093/emboj/20.1.109; Deng YZ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004972; Duffield GE, 2003, J NEUROENDOCRINOL, V15, P991, DOI 10.1046/j.1365-2826.2003.01082.x; Dunlap JC, 2007, COLD SH Q B, V72, P57; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Eelderink-Chen Z, 2010, P NATL ACAD SCI USA, V107, P2043, DOI 10.1073/pnas.0907902107; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Froehlich AC, 2005, EUKARYOT CELL, V4, P2140, DOI 10.1128/EC.4.12.2140-2152.2005; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Greene AV, 2003, EUKARYOT CELL, V2, P231, DOI 10.1128/EC.2.2.231-237.2003; Heintzen C, 2001, CELL, V104, P453, DOI 10.1016/S0092-8674(01)00232-X; Henry JT, 2011, ANNU REV MICROBIOL, V65, P261, DOI 10.1146/annurev-micro-121809-151631; Hevia MA, 2015, P NATL ACAD SCI USA, V112, P8744, DOI 10.1073/pnas.1508432112; Hughes David P., 2011, BMC Ecology, V11, P13, DOI 10.1186/1472-6785-11-13; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Hurley JM, 2016, FUNGAL GENET BIOL, V90, P39, DOI 10.1016/j.fgb.2015.10.002; Hurley JM, 2014, P NATL ACAD SCI USA, V111, P16995, DOI 10.1073/pnas.1418963111; Ingram KK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045715; Johnson CH, 2011, ANNU REV BIOPHYS, V40, P143, DOI 10.1146/annurev-biophys-042910-155317; Lakens D, 2014, PERSPECT PSYCHOL SCI, V9, P278, DOI 10.1177/1745691614528520; Lee JE, 2008, CURR BIOL, V18, P195, DOI 10.1016/j.cub.2007.12.054; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Leming MT, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1128; Li JJ, 2015, METHOD ENZYMOL, V551, P349, DOI 10.1016/bs.mie.2014.10.020; Lin JM, 2002, NATURE, V420, P816, DOI 10.1038/nature01235; Llanos A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1224-y; Lone SR, 2010, J INSECT PHYSIOL, V56, P1611, DOI 10.1016/j.jinsphys.2010.05.023; Manga-Gonzalez MY, 2001, PARASITOLOGY, V123, pS91, DOI 10.1017/S0031182001008204; Marcolino-Gomes J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139051; Merrow M, 2001, EMBO J, V20, P307, DOI 10.1093/emboj/20.3.307; Montenegro-Montero A, 2015, ADV GENET, V92, P107, DOI 10.1016/bs.adgen.2015.09.003; Nsa IY, 2015, GENETICS, V199, P233, DOI 10.1534/genetics.114.169441; O'Donnell AJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-372; O'Donnell AJ, 2011, P ROY SOC B-BIOL SCI, V278, P2429, DOI 10.1098/rspb.2010.2457; Page TL, 1985, COMPREHENSIVE INSECT, P577; Ponting CP, 1997, CURR BIOL, V7, pR674, DOI 10.1016/S0960-9822(06)00352-6; Purschwitz J, 2008, CURR BIOL, V18, P255, DOI 10.1016/j.cub.2008.01.061; Rijo-Ferreira F, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.32; Rund SSC, 2011, P NATL ACAD SCI USA, V108, pE421, DOI 10.1073/pnas.1100584108; Sancar C, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0126-4; Saunders DS, 2002, INSECT CLOCKS; Sellke T, 2001, AM STAT, V55, P62, DOI 10.1198/000313001300339950; Sharma VK, 2004, NATURWISSENSCHAFTEN, V91, P386, DOI 10.1007/s00114-004-0544-6; Smith KM, 2010, EUKARYOT CELL, V9, P1549, DOI 10.1128/EC.00154-10; Steinkraus DC, 2017, J INVERTEBR PATHOL, V148, P51, DOI 10.1016/j.jip.2017.05.002; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Talora C, 1999, EMBO J, V18, P4961, DOI 10.1093/emboj/18.18.4961; Tan Y, 2004, CURR BIOL, V14, P433, DOI 10.1016/j.cub.2004.02.035; Traeger S, 2015, G3-GENES GENOM GENET, V5, P2061, DOI 10.1534/g3.115.020461; Wager-Smith K, 2000, NAT GENET, V26, P23, DOI 10.1038/79134; Wang W, 2011, NATURE, V470, P110, DOI 10.1038/nature09766; Wijnen H, 2006, PLOS GENET, V2, P326, DOI 10.1371/journal.pgen.0020039; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2	79	17	17	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							e0187170	10.1371/journal.pone.0187170	http://dx.doi.org/10.1371/journal.pone.0187170			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6TA	29099875	Green Published, gold, Green Submitted			2022-12-26	WOS:000414377900012
J	Forghani, A; Milner, TE				Forghani, Ali; Milner, Theodore E.			Origin of directionally tuned responses in lower limb muscles to unpredictable upper limb disturbances	PLOS ONE			English	Article							AUTOMATIC POSTURAL RESPONSES; PERTURBATIONS; STANCE; ARM; LOCOMOTION; PLACEMENT; AMPLITUDE	Unpredictable forces which perturb balance are frequently applied to the body through interaction between the upper limb and the environment. Lower limb muscles respond rapidly to these postural disturbances in a highly specific manner. We have shown that the muscle activation patterns of lower limb muscles are organized in a direction specific manner which changes with lower limb stability. Ankle muscles change their activity within 80 ms of the onset of a force perturbation applied to the hand which is earlier than the onset of changes in ground reaction force, ankle angle or head motion. The latency of the response is sensitive to the perturbation direction. However, neither the latency nor the magnitude of the response is affected by stiffening the arm even though this alters the magnitude and timing of motion of the body segments. Based on the short latency, insensitivity of the change in ankle muscle activation to motion of the body segments but sensitivity to perturbation direction we reason that changes in ankle muscle activation are most likely triggered by sensory signals originating from cutaneous receptors in the hand. Furthermore, evidence that the latency of changes in ankle muscle activation depends on the number of perturbation directions suggests that the neural pathway is not confined to the spinal cord.	[Forghani, Ali] Univ Virginia, Ctr Appl Biomech, Charlottesville, VA USA; [Forghani, Ali; Milner, Theodore E.] McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ, Canada	University of Virginia; McGill University	Milner, TE (corresponding author), McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ, Canada.	theodore.milner@mcgill.ca		Milner, Theodore/0000-0002-8111-6843	Natural Sciences and Engineering Research Council of Canada [RGPIN-142009-2010]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Natural Sciences and Engineering Research Council of Canada, RGPIN-142009-2010, http://www.nserc-crsng.gc.ca/index_eng.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r Funding for this research was provided by the Natural Sciences and Engineering Research Council of Canada RGPIN-142009-2010.	Aruin AS, 2001, EXP BRAIN RES, V138, P458; CORDO PJ, 1982, J NEUROPHYSIOL, V47, P287, DOI 10.1152/jn.1982.47.2.287; DIENER HC, 1984, EXP BRAIN RES, V56, P126; Drew T, 1996, EXP BRAIN RES, V111, P153; Forghani A, 2017, J ELECTROMYOGR KINES, V35, P30, DOI 10.1016/j.jelekin.2017.05.006; Forghani A, 2017, NEUROSCIENCE, V352, P170, DOI 10.1016/j.neuroscience.2017.03.062; Henry SM, 1998, J NEUROPHYSIOL, V80, P1939, DOI 10.1152/jn.1998.80.4.1939; Henry SM, 2001, J NEUROPHYSIOL, V85, P559, DOI 10.1152/jn.2001.85.2.559; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hodges PW, 1996, ELECTROMYOGR MOTOR C, V101, P511, DOI 10.1016/S0013-4694(96)95190-5; LEE WA, 1990, EXP BRAIN RES, V82, P304; Lowrey CR, 2017, J NEUROPHYSIOL, V117, P1070, DOI 10.1152/jn.01004.2015; MacKinnon CD, 2000, EXP BRAIN RES, V131, P477, DOI 10.1007/s002219900317; MARSDEN CD, 1981, BRAIN, V104, P513, DOI 10.1093/brain/104.3.513; McIlroy WE, 1997, CLIN BIOMECH, V12, P66, DOI 10.1016/S0268-0033(96)00040-X; Milner TE, 2009, MOTOR CONTROL, V13, P454, DOI 10.1123/mcj.13.4.454; Misiaszek JE, 2016, NEUROSCIENCE, V316, P1, DOI 10.1016/j.neuroscience.2015.12.033; MOORE SP, 1988, EXP BRAIN RES, V73, P648, DOI 10.1007/BF00406624; Remaud A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110004; SHIMAMURA M, 1982, BRAIN RES, V231, P51, DOI 10.1016/0006-8993(82)90006-3; Teng BZ, 2017, EXP BRAIN RES, V235, P2235, DOI 10.1007/s00221-017-4963-y; Torres-Oviedo G, 2007, J NEUROPHYSIOL, V98, P2144, DOI 10.1152/jn.01360.2006; TRAUB MM, 1980, BRAIN, V103, P393, DOI 10.1093/brain/103.2.393	23	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187006	10.1371/journal.pone.0187006	http://dx.doi.org/10.1371/journal.pone.0187006			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095888	Green Submitted, Green Published, gold			2022-12-26	WOS:000414340200039
J	Furth, KE; McCoy, AJ; Dodge, C; Walters, JR; Buonanno, A; Delaville, C				Furth, Katrina E.; McCoy, Alex J.; Dodge, Caroline; Walters, Judith R.; Buonanno, Andres; Delaville, Claire			Neuronal correlates of ketamine and walking induced gamma oscillations in the medial prefrontal cortex and mediodorsal thalamus	PLOS ONE			English	Article							NMDA RECEPTOR BLOCKADE; FREQUENCY OSCILLATIONS; COGNITIVE CONTROL; BRAIN RHYTHMS; SCHIZOPHRENIA; CONNECTIVITY; NETWORK; RAT; ANTAGONIST; MEMORY	Alterations in the function of the medial prefrontal cortex (mPFC) and its major thalamic source of innervation, the mediodorsal (MD) thalamus, have been hypothesized to contribute to the symptoms of schizophrenia. The NMDAR antagonist ketamine, used to model schizophrenia, elicits a brain state resembling early stage schizophrenia characterized by cognitive deficits and increases in cortical low gamma (40-70 Hz) power. Here we sought to determine how ketamine differentially affects spiking and gamma local field potential (LFP) activity in the rat mPFC and MD thalamus. Additionally, we investigated the ability of drugs targeting the dopamine D4 receptor (D4R) to modify the effects of ketamine on gamma activity as a measure of potential cognitive therapeutic efficacy. Rats were trained to walk on a treadmill to reduce confounds related to hyperactivity after ketamine administration (10 mg/kg s.c.) while recordings were obtained from electrodes chronically implanted in the mPFC and MD thalamus. Ketamine increased gamma LFP power in mPFC and MD thalamus in a similar frequency range, yet did not increase thalamocortical synchronization. Ketamine also increased firing rates and spike synchronization to gamma oscillations in the mPFC but decreased both measures in MD thalamus. Conversely, walking alone increased both firing rates and spike-gamma LFP correlations in both mPFC and MD thalamus. The D4R antagonist alone (L-745,870) had no effect on gamma LFP power during treadmill walking, although it reversed increases induced by the D4R agonist (A-412997) in both mPFC and MD thalamus. Neither drug altered ketamine-induced changes in gamma power or firing rates in the mPFC. However, in MD thalamus, the D4R agonist increased ketamine-induced gamma power and prevented ketamine's inhibitory effect on firing rates. Results provide new evidence that ketamine differentially modulates spiking and gamma power in MD thalamus and mPFC, supporting a potential role for both areas in contributing to ketamine-induced schizophrenia-like symptoms.	[Furth, Katrina E.; McCoy, Alex J.; Dodge, Caroline; Walters, Judith R.; Delaville, Claire] NINDS, Neurophysiol Pharmacol Sect, NIH, Bethesda, MD 20892 USA; [Furth, Katrina E.] Boston Univ, Grad Program Neurosci, Boston, MA 02215 USA; [Furth, Katrina E.; Buonanno, Andres] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Neurobiol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Boston University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Furth, KE (corresponding author), NINDS, Neurophysiol Pharmacol Sect, NIH, Bethesda, MD 20892 USA.; Furth, KE (corresponding author), Boston Univ, Grad Program Neurosci, Boston, MA 02215 USA.; Furth, KE (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Neurobiol, NIH, Bethesda, MD 20892 USA.	kfurth@bu.edu			Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [ZIA-HD000711]; National Institute of Neurological Disorders and Stroke (NINDS), intramural research programs; Office of Behavioral and Social Sciences Research (OBSSR) Bench-to-Bedside award [NHD15003]; Boston University Graduate Program for Neuroscience; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003117] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Neurological Disorders and Stroke (NINDS), intramural research programs; Office of Behavioral and Social Sciences Research (OBSSR) Bench-to-Bedside award; Boston University Graduate Program for Neuroscience; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors are grateful for the generous support from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD; ZIA-HD000711) and the National Institute of Neurological Disorders and Stroke (NINDS), intramural research programs, and the Office of Behavioral and Social Sciences Research (OBSSR) Bench-to-Bedside award (NHD15003). K.E.F. was supported by university training fellowships from the Boston University Graduate Program for Neuroscience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors are grateful for the generous support from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD; ZIA-HD000711) and the National Institute of Neurological Disorders and Stroke (NINDS), intramural research programs, and the Office of Behavioral and Social Sciences Research (OBSSR) Bench-to-Bedside award (NHD15003). The authors also thank Dr. Detlef Vullhorst for his insightful comments on the manuscript. K.E.F. was supported by university training fellowships from the Boston University Graduate Program for Neuroscience.	Abdallah CG, 2015, ANNU REV MED, V66, P509, DOI 10.1146/annurev-med-053013-062946; Alcaraz F, 2016, EUR J NEUROSCI, V44, P1972, DOI 10.1111/ejn.13316; Anderson PM, 2014, INT J NEUROPSYCHOPH, V17, P1895, DOI 10.1017/S1461145714000959; Anderson PM, 2016, CEREB CORTEX; Andersson R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040906; Andersson RH, 2012, P NATL ACAD SCI USA, V109, P13118, DOI 10.1073/pnas.1201011109; Anticevic A, 2017, BIOL PSYCHIAT, V81, P818, DOI 10.1016/j.biopsych.2016.12.006; Anticevic A, 2015, BIOL PSYCHIAT, V77, P569, DOI 10.1016/j.biopsych.2014.07.022; Anticevic A, 2014, CEREB CORTEX, V24, P3116, DOI 10.1093/cercor/bht165; Anticevic A, 2014, SCHIZOPHRENIA BULL, V40, P1227, DOI 10.1093/schbul/sbu100; Arnsten AFT, 2000, NEUROPSYCHOPHARMACOL, V23, P405, DOI 10.1016/S0893-133X(00)00133-0; Avila I, 2010, EXP NEUROL, V221, P307, DOI 10.1016/j.expneurol.2009.11.016; Azouz R, 1997, CEREB CORTEX, V7, P534, DOI 10.1093/cercor/7.6.534; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Becker R, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.53; Benchenane K, 2011, CURR OPIN NEUROBIOL, V21, P475, DOI 10.1016/j.conb.2011.01.004; Bernaerts P, 2003, BEHAV BRAIN RES, V142, P41, DOI 10.1016/S0166-4328(02)00371-6; Bokil H, 2007, J NEUROSCI METH, V159, P337, DOI 10.1016/j.jneumeth.2006.07.011; Bolkan SS, 2017, NAT NEUROSCI, V20, P987, DOI 10.1038/nn.4568; Brazhnik E, 2016, J NEUROSCI, V36, P4196, DOI 10.1523/JNEUROSCI.3582-15.2016; Brazhnik E, 2012, J NEUROSCI, V32, P7869, DOI 10.1523/JNEUROSCI.0943-12.2012; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Cannon J, 2014, EUR J NEUROSCI, V39, P705, DOI 10.1111/ejn.12453; Celada P, 2013, INT J NEUROPSYCHOPH, V16, P2145, DOI 10.1017/S1461145713000643; CHO AK, 1991, PHARMACOL BIOCHEM BE, V39, P947, DOI 10.1016/0091-3057(91)90058-A; Cho RY, 2006, P NATL ACAD SCI USA, V103, P19878, DOI 10.1073/pnas.0609440103; Clinton SM, 2004, SCHIZOPHR RES, V69, P237, DOI 10.1016/j.schres.2003.09.017; Cohen IV, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01590-x; Cronenwett WJ, 2010, CURR TOP BEHAV NEURO, V4, P509, DOI 10.1007/7854_2010_55; Dawson N, 2014, NEUROPSYCHOPHARMACOL, V39, P1786, DOI 10.1038/npp.2014.26; Dawson N, 2013, SCHIZOPHRENIA BULL, V39, P366, DOI 10.1093/schbul/sbr144; de la Sallel S, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00348; Delaville C, 2015, J NEUROSCI, V35, P6918, DOI 10.1523/JNEUROSCI.0587-15.2015; Demiralp T, 2007, CEREB CORTEX, V17, P1007, DOI 10.1093/cercor/bhl011; Dorph-Petersen KA, 2017, SCHIZOPHR RES, V180, P28, DOI 10.1016/j.schres.2016.08.007; Driesen NR, 2013, NEUROPSYCHOPHARMACOL, V38, P2613, DOI 10.1038/npp.2013.170; Dupre KB, 2016, NEUROBIOL DIS, V86, P1, DOI 10.1016/j.nbd.2015.11.009; Ehrlichman RS, 2009, NEUROSCIENCE, V158, P705, DOI 10.1016/j.neuroscience.2008.10.031; Frohlich J, 2014, J PSYCHOPHARMACOL, V28, P287, DOI 10.1177/0269881113512909; Furth KE, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00102; Gasca-Martinez D, 2010, NEUROSCIENCE, V169, P1672, DOI 10.1016/j.neuroscience.2010.05.048; Gilmour G, 2012, NEUROPHARMACOLOGY, V62, P1401, DOI 10.1016/j.neuropharm.2011.03.015; Giraldo-Chica M, 2017, SCHIZOPHR RES, V180, P58, DOI 10.1016/j.schres.2016.08.005; Gonzalez-Burgos G, 2015, BIOL PSYCHIAT, V77, P1031, DOI 10.1016/j.biopsych.2015.03.010; Govindaiah G, 2010, J NEUROPHYSIOL, V104, P2757, DOI 10.1152/jn.00361.2010; Guidi M, 2015, NEUROBIOL LEARN MEM, V125, P36, DOI 10.1016/j.nlm.2015.07.015; Hakami T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006755; Hoeflich A, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyv040; Homayoun H, 2007, J NEUROSCI, V27, P11496, DOI 10.1523/JNEUROSCI.2213-07.2007; Hong LE, 2010, NEUROPSYCHOPHARMACOL, V35, P632, DOI 10.1038/npp.2009.168; Hudson MR, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.51; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; Jackson ME, 2004, P NATL ACAD SCI USA, V101, P8467, DOI 10.1073/pnas.0308455101; Jadi M. P., 2015, BIOL PSYCHIAT; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V142, P78, DOI 10.1007/s002130050865; Jones EG, 1997, SCHIZOPHRENIA BULL, V23, P483, DOI 10.1093/schbul/23.3.483; Jones NC, 2014, INT J NEUROPSYCHOPH, V17, P1671, DOI 10.1017/S1461145714000492; Jones NC, 2012, INT J NEUROPSYCHOPH, V15, P657, DOI 10.1017/S1461145711000848; Kiss Tamas, 2011, Front Psychiatry, V2, P14, DOI 10.3389/fpsyt.2011.00014; Kocsis B, 2014, BRAIN STRUCT FUNCT, P1; Kocsis B, 2013, CNS NEUROSCI THER, V19, P437, DOI 10.1111/cns.12081; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Krystal JH, 2017, BIOL PSYCHIAT, V81, P874, DOI 10.1016/j.biopsych.2017.01.004; Kulikova SP, 2012, EUR J NEUROSCI, V36, P3407, DOI 10.1111/j.1460-9568.2012.08263.x; Lazarewicz MT, 2010, J COGNITIVE NEUROSCI, V22, P1452, DOI 10.1162/jocn.2009.21305; Lee S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00869; Lener MS, 2017, BIOL PSYCHIAT, V81, P886, DOI 10.1016/j.biopsych.2016.05.005; Lisman JE, 2013, NEURON, V77, P1002, DOI 10.1016/j.neuron.2013.03.007; Lodge D, 2015, BRIT J PHARMACOL, V172, P4254, DOI 10.1111/bph.13222; Lowet E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146443; McGinley MJ, 2015, NEURON, V87, P1143, DOI 10.1016/j.neuron.2015.09.012; Miller OH, 2016, NEUROPHARMACOLOGY, V100, P17, DOI 10.1016/j.neuropharm.2015.07.028; Minzenberg MJ, 2010, NEUROPSYCHOPHARMACOL, V35, P2590, DOI 10.1038/npp.2010.150; Mitchell AS, 2015, NEUROSCI BIOBEHAV R, V54, P76, DOI 10.1016/j.neubiorev.2015.03.001; Mitchell AS, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00037; Moghaddam B, 1997, J NEUROSCI, V17, P2921; Molina LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085842; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; Mrzljak L, 1996, NATURE, V381, P245, DOI 10.1038/381245a0; Murai T, 2014, BEHAV BRAIN RES, V261, P26, DOI 10.1016/j.bbr.2013.11.036; Nakazawa S, 2015, PSYCHOPHARMACOLOGY, V232, P3287, DOI 10.1007/s00213-015-3978-y; Nayak S, 2003, PROG NEURO-PSYCHOPH, V27, P441, DOI 10.1016/S0278-5846(03)00031-9; Niell CM, 2010, NEURON, V65, P472, DOI 10.1016/j.neuron.2010.01.033; Parnaudeau S, 2013, NEURON, V77, P1151, DOI 10.1016/j.neuron.2013.01.038; Pergola G, 2015, NEUROSCI BIOBEHAV R, V54, P57, DOI 10.1016/j.neubiorev.2015.01.013; Pinault D, 1998, J COMP NEUROL, V391, P180, DOI 10.1002/(SICI)1096-9861(19980209)391:2<180::AID-CNE3>3.0.CO;2-Z; Pinault D, 2008, BIOL PSYCHIAT, V63, P730, DOI 10.1016/j.biopsych.2007.10.006; Pinault D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7040034; Pittman-Polletta BR, 2015, BIOL PSYCHIAT, V77, P1020, DOI 10.1016/j.biopsych.2015.02.005; Popken GJ, 2000, P NATL ACAD SCI USA, V97, P9276, DOI 10.1073/pnas.150243397; Rivolta D, 2015, SCHIZOPHRENIA BULL, V41, P1105, DOI 10.1093/schbul/sbv051; Rondou P, 2010, CELL MOL LIFE SCI, V67, P1971, DOI 10.1007/s00018-010-0293-y; Rosen ZB, 2015, NAT NEUROSCI, V18, P1763, DOI 10.1038/nn.4152; ROSENBERG JR, 1989, PROG BIOPHYS MOL BIO, V53, P1, DOI 10.1016/0079-6107(89)90004-7; Sakurai T, 2015, PROG NEUROBIOL, V134, P178, DOI 10.1016/j.pneurobio.2015.09.010; SALT TE, 1988, BRIT J PHARMACOL, V94, P443, DOI 10.1111/j.1476-5381.1988.tb11546.x; Salt TE, 1996, PROG NEUROBIOL, V48, P55, DOI 10.1016/0301-0082(95)00047-X; Santana N, 2011, BIOL PSYCHIAT, V69, P918, DOI 10.1016/j.biopsych.2010.10.030; Shaw AD, 2015, EUR NEUROPSYCHOPHARM, V25, P1136, DOI 10.1016/j.euroneuro.2015.04.012; Sherman SM, 2016, NAT NEUROSCI, V19, P533, DOI 10.1038/nn.4269; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Swanson JM, 1998, MOL PSYCHIATR, V3, P38, DOI 10.1038/sj.mp.4000354; Troyano-Rodriguez E, 2014, BIOL PSYCHIAT, V76, P937, DOI 10.1016/j.biopsych.2014.05.019; Vinck M, 2015, NEURON, V86, P740, DOI 10.1016/j.neuron.2015.03.028; Walther S, 2012, NEUROPSYCHOBIOLOGY, V66, P77, DOI 10.1159/000339456; Watis L, 2008, J NEURAL TRANSM, V115, P493, DOI 10.1007/s00702-007-0859-5; WILSON FAW, 1994, P NATL ACAD SCI USA, V91, P4009, DOI 10.1073/pnas.91.9.4009; Womelsdorf T, 2014, NAT NEUROSCI, V17, P1031, DOI 10.1038/nn.3764; Wood J, 2012, J NEUROSCI, V32, P3022, DOI 10.1523/JNEUROSCI.6377-11.2012; Woodward ND, 2016, BIOL PSYCHIAT, V79, P1016, DOI 10.1016/j.biopsych.2015.06.026; Woodward ND, 2012, AM J PSYCHIAT, V169, P1092, DOI 10.1176/appi.ajp.2012.12010056; Woolley ML, 2008, BEHAV PHARMACOL, V19, P765, DOI 10.1097/FBP.0b013e32831c3b06; Zanos P, 2016, NATURE; Zhang YC, 2014, SCHIZOPHR RES, V153, P129, DOI 10.1016/j.schres.2014.01.023	114	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186732	10.1371/journal.pone.0186732	http://dx.doi.org/10.1371/journal.pone.0186732			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL6FI	29095852	Green Published, gold, Green Submitted			2022-12-26	WOS:000414340200022
J	Zhao, LL; Ru, YF; Liu, M; Tang, JN; Zheng, JF; Wu, B; Gu, YH; Shi, HJ				Zhao, Li-lin; Ru, Yan-fei; Liu, Miao; Tang, Jia-nan; Zheng, Ju-fen; Wu, Bin; Gu, Yi-hua; Shi, Hui-juan			Reproductive effects of cadmium on sperm function and early embryonic development in vitro	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; INDUCED APOPTOSIS; DAMAGE; RAT; EXPOSURE; ZINC; LEAD; FERTILIZATION; DYSFUNCTION; EXPRESSION	Cadmium is a major environmental toxicant that is released into the atmosphere, water and soil in the form of cadmium oxide, cadmium chloride, or cadmium sulfide via industrial activities, such as the manufacturing of batteries and pigments, metal smelting and refining and municipal waste incineration. In the present study, we investigated the effects of cadmium exposure on sperm quality parameters, fertilization capacity and early embryonic development. Our study showed that in vitro incubation of human or mouse sperms with cadmium for a long time (up to 24 hours) could significantly decreased sperm motility in a concentration-and time-dependent manner. Exposure to cadmium in the environment for a short term (30 min) did not affect sperm motility but significantly reduced in vitro fertilization rate. We also evaluated the effects of cadmium at concentrations of 0.625 mu g/ml, and 1.25 mu g/ml on early embryonic development in vitro and observed that the blastocyst formation rate dramatically decreased with increasing cadmium concentration. This finding emphasizes the hazardous effects of cadmium on sperm quality as well as on natural embryo development and raises greater concerns regarding cadmium pollution.	[Zhao, Li-lin; Ru, Yan-fei; Liu, Miao; Tang, Jia-nan; Zheng, Ju-fen; Wu, Bin; Gu, Yi-hua; Shi, Hui-juan] Fudan Univ, Reprod & Dev Inst, SIPPR, Key Lab Reprod Regulat NPFPC, Shanghai, Peoples R China; [Shi, Hui-juan] Shanghai Jiao Tong Univ, Shanghai Key Lab Reprod Med, Shanghai, Peoples R China	Fudan University; Shanghai Jiao Tong University	Gu, YH; Shi, HJ (corresponding author), Fudan Univ, Reprod & Dev Inst, SIPPR, Key Lab Reprod Regulat NPFPC, Shanghai, Peoples R China.; Shi, HJ (corresponding author), Shanghai Jiao Tong Univ, Shanghai Key Lab Reprod Med, Shanghai, Peoples R China.	gu_yihua@hotmail.com; shihuijuan2011@163.com			Ministry of Science and Technology of China [2014CB943104]; Shanghai Municipal Commission of 415 Health and Family Planning [201440002]; Family Planning Project	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Shanghai Municipal Commission of 415 Health and Family Planning; Family Planning Project	This work was supported by the Ministry of Science and Technology of China (2014CB943104) and Family Planning Project, Shanghai Municipal Commission of 415 Health and Family Planning (201440002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by the Ministry of Science and Technology of China (2014CB943104) and Family Planning Project, Shanghai Municipal Commission of 415 Health and Family Planning (201440002). We thank the Shanghai JIAI Genetics & IVF Institute for their valuable comments on this study.	Abdelrazek HMA, 2016, REPROD BIOL, V16, P300, DOI 10.1016/j.repbio.2016.11.001; Adamkovicova M, 2016, REPROD BIOL ENDOCRIN, V14, DOI 10.1186/s12958-016-0177-6; Adedara IA, 2010, HUM EXP TOXICOL, V29, P801, DOI 10.1177/0960327109360115; Amara S, 2008, J REPROD DEVELOP, V54, P129, DOI 10.1262/jrd.18110; Benoff S, 2000, HUM REPROD UPDATE, V6, P107, DOI 10.1093/humupd/6.2.107; Benoff Susan, 2008, Fertil Steril, V89, pe73, DOI 10.1016/j.fertnstert.2007.12.035; Cheng CY, 2012, PHARMACOL REV, V64, P16, DOI 10.1124/pr.110.002790; Cilenk KT, 2016, EXP MOL PATHOL, V101, P207, DOI 10.1016/j.yexmp.2016.08.004; Correia S, 2017, J APPL TOXICOL, V37, P159, DOI 10.1002/jat.3333; Da Costa R, 2016, ANDROLOGIA, V48, P464, DOI 10.1111/and.12466; de Freitas ML, 2012, J TOXICOL SCI, V37, P899, DOI 10.2131/jts.37.899; Dorostghoal M, 2017, ANDROLOGIA, V49, DOI 10.1111/and.12762; Gu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070112; Herak-Kramberger CM, 2000, BIOL REPROD, V63, P599, DOI 10.1095/biolreprod63.2.599; Phuc HD, 2017, J APPL TOXICOL, V37, P1046, DOI 10.1002/jat.3455; Huang XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050465; Jelks K, 2001, REPROD TOXICOL, V15, P11; Kim J, 2009, TOXICOL LETT, V188, P45, DOI 10.1016/j.toxlet.2009.03.006; Kim K, 2010, J ASSIST REPROD GEN, V27, P463, DOI 10.1007/s10815-010-9437-0; Kudo C, 2004, J NEUROCHEM, V88, P1416, DOI 10.1046/j.1471-4159.2003.02270.x; Lamas CD, 2017, INT J EXP PATHOL, V98, P86, DOI 10.1111/iep.12227; Li XH, 2016, TOXICOLOGY, V357, P52, DOI 10.1016/j.tox.2016.06.003; Liu W, 2014, TOXICOL LETT, V224, P1, DOI 10.1016/j.toxlet.2013.10.009; Lorenzetti S, 2011, ANN I SUPER SANITA, V47, P429, DOI 10.4415/ANN_11_04_16; Martino NA, 2017, REPROD TOXICOL, V69, P132, DOI 10.1016/j.reprotox.2017.02.005; Olszowski T, 2012, ACTA BIOCHIM POL, V59, P475; Oteiza PI, 1999, TOXICOLOGY, V137, P13, DOI 10.1016/S0300-483X(99)00067-0; Pant N, 2015, ANDROLOGIA, V47, P887, DOI 10.1111/and.12342; PARIZEK J, 1957, J ENDOCRINOL, V15, P56, DOI 10.1677/joe.0.0150056; PARIZEK J, 1956, NATURE, V177, P1036; SATO M, 1993, FREE RADICAL BIO MED, V14, P325, DOI 10.1016/0891-5849(93)90029-T; SAXENA DK, 1989, RES COMMUN CHEM PATH, V64, P317; Seok SM, 2006, TOXICOL LETT, V165, P212, DOI 10.1016/j.toxlet.2006.04.007; Stojanov T, 1999, MOL HUM REPROD, V5, P116, DOI 10.1093/molehr/5.2.116; Tinkov AA, 2017, SCI TOTAL ENVIRON, V601, P741, DOI 10.1016/j.scitotenv.2017.05.224; Vine MF, 1996, INT J ANDROL, V19, P323, DOI 10.1111/j.1365-2605.1996.tb00523.x; Wang Y.J., 2016, HUM EXP TOXICOL; Yang SH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101703; Yari A, 2016, ANDROLOGIA, V48, P1244, DOI 10.1111/and.12568	39	50	53	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186727	10.1371/journal.pone.0186727	http://dx.doi.org/10.1371/journal.pone.0186727			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095856	gold, Green Published, Green Submitted			2022-12-26	WOS:000414340200021
J	Adjei, DN; Stronks, K; Adu, D; Snijder, MB; Modesti, PA; Peters, RJG; Vogt, L; Agyemang, C				Adjei, David N.; Stronks, Karien; Adu, Dwomoa; Snijder, Marieke B.; Modesti, Pietro A.; Peters, Ron J. G.; Vogt, Liffert; Agyemang, Charles			Relationship between educational and occupational levels, and Chronic Kidney Disease in a multi-ethnic sample-The HELIUS study	PLOS ONE			English	Article							STAGE RENAL-DISEASE; SOCIOECONOMIC-STATUS; UNITED-STATES; CARDIOVASCULAR-DISEASE; RACIAL-DIFFERENCES; AFRICAN-AMERICAN; ADULT HEALTH; EXCESS RISK; LOW-INCOME; POPULATION	Background Ethnic minority groups in high-income countries are disproportionately affected by Chronic Kidney Disease (CKD) for reasons that are unclear. We assessed the association of educational and occupational levels with CKD in a multi-ethnic population. Furthermore, we assessed to what extent ethnic inequalities in the prevalence of CKD were accounted for by educational and occupational levels. Methods Cross-sectional analysis of baseline data from the Healthy Life in an Urban Setting (HELIUS) study of 21,433 adults (4,525 Dutch, 3,027 South-Asian Surinamese, 4,105 African Surinamese, 2,314 Ghanaians, 3,579 Turks, and 3,883 Moroccans) aged 18 to 70 years living in Amsterdam, the Netherlands. Three CKD outcomes were considered using the 2012 KDIGO (Kidney Disease: Improving Global Outcomes) severity of CKD classification. Comparisons between educational and occupational levels were made using logistic regression analyses. Results After adjustment for sex and age, low-level and middle-level education were significantly associated with higher odds of high to very high-risk of CKD in Dutch (Odds Ratio (OR) 2.10, 95% C.I., 1.37-2.95; OR 1.55, 95% C.I., 1.03-2.34). Among ethnic minority groups, low-level education was significantly associated with higher odds of high to very-high-risk CKD but only in South -Asian Surinamese (OR 1.58, 95% C.I., 1.06-2.34). Similar results were found for the occupational level in relation to CKD risk. Conclusion The lower educational and occupational levels of ethnic minority groups partly accounted for the observed ethnic inequalities in CKD. Reducing CKD risk in ethnic minority populations with low educational and occupational levels may help to reduce ethnic inequalities in CKD and its related complications.	[Adjei, David N.; Stronks, Karien; Snijder, Marieke B.; Agyemang, Charles] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Amsterdam, Netherlands; [Adjei, David N.] Univ Ghana, Dept Med Lab Sci, Sch Biomed & Allied Hlth Sci, Coll Hlth Sci, Accra, Ghana; [Adu, Dwomoa] Univ Ghana, Dept Med, Sch Med & Dent, Accra, Ghana; [Adu, Dwomoa] Korle Bu Teaching Hosp, Accra, Ghana; [Modesti, Pietro A.] Univ Florence, Dept Clin & Expt Med, Florence, Italy; [Peters, Ron J. G.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, Amsterdam, Netherlands; [Vogt, Liffert] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Sect Nephrol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Ghana; University of Ghana; University of Florence; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Adjei, DN (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Amsterdam, Netherlands.; Adjei, DN (corresponding author), Univ Ghana, Dept Med Lab Sci, Sch Biomed & Allied Hlth Sci, Coll Hlth Sci, Accra, Ghana.	dna@chs.edu.gh	Vogt, Liffert/C-3168-2018; Modesti, Pietro Amedeo/B-2638-2012; Nana, David Adjei/AAV-8319-2020	Vogt, Liffert/0000-0002-4585-7505; Modesti, Pietro Amedeo/0000-0002-9511-2173; Nana, David Adjei/0000-0003-2306-5723; Stronks, Karien/0000-0002-0921-2232	Dutch Heart Foundation; Netherlands Organization for Health Research and Development (ZonMw); European Union (Seventh Framework Program [FP7])	Dutch Heart Foundation(Netherlands Heart Foundation); Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); European Union (Seventh Framework Program [FP7])	This work was supported by the Dutch Heart Foundation, the Netherlands Organization for Health Research and Development (ZonMw), and the European Union (Seventh Framework Program [FP7]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyemang C, 2015, AM J KIDNEY DIS; Agyemang C, 2016, AM J KIDNEY DIS, V67, P391, DOI 10.1053/j.ajkd.2015.07.023; Agyemang C, 2010, INT J CARDIOL, V141, P266, DOI 10.1016/j.ijcard.2008.12.023; Alebiosu CO, 2005, ETHNIC DIS, V15, P418; Bailey PK, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-240; Banks J, 2006, JAMA-J AM MED ASSOC, V295, P2037, DOI 10.1001/jama.295.17.2037; Bello AK, 2008, CLIN J AM SOC NEPHRO, V3, P1316, DOI 10.2215/CJN.00680208; Bruce MA, 2010, AM J KIDNEY DIS, V55, P1001, DOI 10.1053/j.ajkd.2010.01.016; Crews DC, 2012, AM J KIDNEY DIS, V60, P779, DOI 10.1053/j.ajkd.2012.05.010; DiAngelantonio E, 2007, RENAL FUNCTION RISK; Drey N, 2003, AM J KIDNEY DIS, V42, P677, DOI 10.1016/S0272-6386(03)00916-8; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Fine L, 2005, CARDIOVASCULAR DISOR, P563; Fored CM, 2003, NEPHROL DIAL TRANSPL, V18, P82, DOI 10.1093/ndt/18.1.82; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Geyer S, 2000, J EPIDEMIOL COMMUN H, V54, P299, DOI 10.1136/jech.54.4.299; Klag MJ, 1997, JAMA-J AM MED ASSOC, V277, P1293, DOI 10.1001/jama.277.16.1293; Krop JS, 1999, ARCH INTERN MED, V159, P1777, DOI 10.1001/archinte.159.15.1777; Levey AS, 2010, AM J KIDNEY DIS, V55, P622, DOI 10.1053/j.ajkd.2010.02.337; Levin A, 2002, POSTGRAD MED, V111, P53, DOI 10.3810/pgm.2002.04.1168; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Lynch JW, 1997, SOC SCI MED, V44, P809, DOI 10.1016/S0277-9536(96)00191-8; Lysaght MJ, 2002, J AM SOC NEPHROL, V13, pS37; Mackenbach JP, 1997, LANCET, V349, P1655, DOI 10.1016/S0140-6736(96)07226-1; Mackenbach JP, 2000, EUR HEART J, V21, P1141, DOI 10.1053/euhj.1999.1990; McCullough PA, 2010, AM J KIDNEY DIS, V55, pS1, DOI 10.1053/j.ajkd.2009.12.017; McKay L., 2003, MIGRATION HLTH REV I; Merkin SS, 2007, SOC SCI MED, V65, P809, DOI 10.1016/j.socscimed.2007.04.011; Norris K, 2008, J AM SOC NEPHROL, V19, P1261, DOI 10.1681/ASN.2008030276; NUYTS GD, 1995, LANCET, V346, P7, DOI 10.1016/S0140-6736(95)92648-8; Peralta CA, 2006, J AM SOC NEPHROL, V17, P3491, DOI 10.1681/ASN.2006050493; PERNEGER TV, 1995, ARCH INTERN MED, V155, P1201, DOI 10.1001/archinte.155.11.1201; Richter M, 2009, SOC SCI MED, V69, P396, DOI 10.1016/j.socscimed.2009.05.023; Seligman HK, 2010, J NUTR, V140, P304, DOI 10.3945/jn.109.112573; Shoham DA, 2005, ADV CHRONIC KIDNEY D, V12, P56, DOI 10.1053/j.ackd.2004.10.007; STENGEL B, 1995, INT J EPIDEMIOL, V24, P427, DOI 10.1093/ije/24.2.427; Stronks K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-402; Stronks K, 2009, ETHNIC HEALTH, V14, P255, DOI 10.1080/13557850802509206; Tarver-Carr ME, 2002, J AM SOC NEPHROL, V13, P2363, DOI 10.1097/01.ASN.0000026493.18542.6A; van de Mheen H, 1998, INT J EPIDEMIOL, V27, P431, DOI 10.1093/ije/27.3.431; Vart P, 2013, CLIN J AM SOC NEPHRO; Volkova N, 2008, J AM SOC NEPHROL, V19, P356, DOI 10.1681/ASN.2006080934; Ward FL, 2015, HEMODIALYSIS INT; Wedeen RP, 1997, SEMIN NEPHROL; Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8; White SL, 2008, AM J PUBLIC HEALTH, V98, P1306, DOI 10.2105/AJPH.2007.116020; YOUNG EW, 1994, KIDNEY INT, V45, P907, DOI 10.1038/ki.1994.120	47	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0186460	10.1371/journal.pone.0186460	http://dx.doi.org/10.1371/journal.pone.0186460			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL4VN	29091928	gold, Green Published			2022-12-26	WOS:000414229700019
J	Rosato, M; Alvarez, I; Feliner, GN; Rossello, JA				Rosato, Marcela; Alvarez, Ines; Nieto Feliner, Gonzalo; Rossello, Josep A.			High and uneven levels of 45S rDNA site-number variation across wild populations of a diploid plant genus (Anacyclus, Asteraceae)	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; GENOME ORGANIZATION; REPETITIVE DNA; EVOLUTION; LOCUS; REARRANGEMENTS; RECOMBINATION; SYSTEMATICS; SPECIATION; AEGILOPS	The nuclear genome harbours hundreds to several thousand copies of ribosomal DNA. Despite their essential role in cellular ribogenesis few studies have addressed intrapopulation, interpopulation and interspecific levels of rDNA variability in wild plants. Some studies have assessed the extent of rDNA variation at the sequence and copy-number level with large sampling in several species. However, comparable studies on rDNA site number variation in plants, assessed with extensive hierarchical sampling at several levels (individuals, populations, species) are lacking. In exploring the possible causes for ribosomal loci dynamism, we have used the diploid genus Anacyclus (Asteraceae) as a suitable system to examine the evolution of ribosomal loci. To this end, the number and chromosomal position of 45S rDNA sites have been determined in 196 individuals from 47 populations in all Anacyclus species using FISH. The 45S rDNA site-number has been assessed in a significant sample of seed plants, which usually exhibit rather consistent features, except for polyploid plants. In contrast, the level of rDNA site-number variation detected in Anacyclus is outstanding in the context of angiosperms particularly regarding populations of the same species. The number of 45S rDNA sites ranged from four to 11, accounting for 14 karyological ribosomal phenotypes. Our results are not even across species and geographical areas, and show that there is no clear association between the number of 45S rDNA loci and the life cycle in Anacyclus. A single rDNA phenotype was detected in several species, but a more complex pattern that included intra-specific and intra-population polymorphisms was recorded in A. homogamos, A. clavatus and A. valentinus, three weedy species showing large and overlapping distribution ranges. It is likely that part of the cytogenetic changes and inferred dynamism found in these species have been triggered by genomic rearrangements resulting from contemporary hybridisation.	[Rosato, Marcela; Rossello, Josep A.] Univ Valencia, Jardin Bot, ICBIBE, Unidad Asociada,CSIC, Valencia, Spain; [Alvarez, Ines; Nieto Feliner, Gonzalo] Real Jardin Bot CSIC, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid	Rossello, JA (corresponding author), Univ Valencia, Jardin Bot, ICBIBE, Unidad Asociada,CSIC, Valencia, Spain.	rossello@uv.es		Nieto Feliner, Gonzalo/0000-0002-7469-4733; Alvarez, Ines/0000-0002-5982-5424	Spanish Ministry of Economy and Competitiveness [CGL2013-49097-C2-1-P]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by funds from the Spanish Ministry of Economy and Competitiveness (Project CGL2013-49097-C2-1-P). The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez I., 2017, FLORA BERIC IN PRESS, V16; Belyayev A, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-6; Bennetzen JL, 1996, TRENDS MICROBIOL, V4, P347, DOI 10.1016/0966-842X(96)10042-1; Borgen L, 2003, BOT J LINN SOC, V141, P491, DOI 10.1046/j.1095-8339.2003.00147.x; Bustamante FO, 2014, CROP SCI, V54, P617, DOI 10.2135/cropsci2013.05.0325; CARMONA MJ, 1984, PLANT SYST EVOL, V146, P1, DOI 10.1007/BF00984050; Cerbah M, 1999, MOL PLANT MICROBE IN, V12, P947, DOI 10.1094/MPMI.1999.12.11.947; Cronn RC, 1996, J MOL EVOL, V42, P685, DOI 10.1007/BF02338802; Datson PM, 2006, CHROMOSOME RES, V14, P845, DOI 10.1007/s10577-006-1092-z; EHRENDORFER F, 1977, TAXON, V26, P387, DOI 10.2307/1220037; FLAVELL RB, 1986, PHILOS T R SOC B, V312, P227, DOI 10.1098/rstb.1986.0004; Galian JA, 2014, ANN BOT-LONDON, V114, P243, DOI 10.1093/aob/mcu115; Garcia S, 2012, CHROMOSOMA, V121, P389, DOI 10.1007/s00412-012-0368-7; Garnatje T, 2012, GENOME, V55, P529, DOI [10.1139/G2012-041, 10.1139/g2012-041]; GERLACH WL, 1979, NUCLEIC ACIDS RES, V7, P1869, DOI 10.1093/nar/7.7.1869; Hanson RE, 1996, CHROMOSOMA, V105, P55, DOI 10.1007/BF02510039; Huang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002167; HUMPHRIES C. J., 1981, NORD J BOT, V1, P83, DOI [DOI 10.1111/J.1756-1051.1981.TB01038.X, 10.1111/j.1756-1051.1981.tb01038.x]; Humphries CJ, 1979, B BRIT MUS NAT HIST, V7, P83; Kalendar R, 2000, P NATL ACAD SCI USA, V97, P6603, DOI 10.1073/pnas.110587497; KING LM, 1989, EVOLUTION, V43, P1117, DOI 10.1111/j.1558-5646.1989.tb02557.x; Kobayashi T, 2005, SCIENCE, V309, P1581, DOI 10.1126/science.1116102; Kovarik A, 2008, ANN BOT-LONDON, V101, P815, DOI 10.1093/aob/mcn019; Lai Z, 2005, GENETICS, V171, P291, DOI 10.1534/genetics.105.042242; Lan H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151512; MAGGINI F, 1978, CHROMOSOMA, V66, P173, DOI 10.1007/BF00295138; Oberprieler Christoph, 2004, Willdenowia, V34, P39, DOI 10.3372/wi.34.34102; Olanj N, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0564-8; Pedrosa-Harand A, 2006, THEOR APPL GENET, V112, P924, DOI 10.1007/s00122-005-0196-8; Pontes O, 2004, P NATL ACAD SCI USA, V101, P18240, DOI 10.1073/pnas.0407258102; Raskina O, 2008, CYTOGENET GENOME RES, V120, P351, DOI 10.1159/000121084; Raskina O, 2004, P NATL ACAD SCI USA, V101, P14818, DOI 10.1073/pnas.0405817101; Raskina O, 2004, CHROMOSOME RES, V12, P153, DOI 10.1023/B:CHRO.0000013168.61359.43; Reeves A, 2001, GENOME, V44, P439, DOI 10.1139/gen-44-3-439; Roa F, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-225; Rosato M, 2008, ANN BOT-LONDON, V102, P15, DOI 10.1093/aob/mcn055; SCHUBERT I, 1985, CHROMOSOMA, V92, P143, DOI 10.1007/BF00328466; SCHWEIZER D, 1976, PLANT SYST EVOL, V126, P107, DOI 10.1007/BF00981668; SOLTIS PS, 1993, MOL PHYLOGENET EVOL, V2, P166, DOI 10.1006/mpev.1993.1017; Torices R, 2013, AN JARDIN BOT MADRID, V70, P48, DOI 10.3989/ajbm.2351; Tsang E, 2008, DNA REPAIR, V7, P1613, DOI 10.1016/j.dnarep.2008.06.010; Zhong XB, 1996, PLANT MOL BIOL REP, V14, P232, DOI 10.1007/BF02671658	42	20	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187131	10.1371/journal.pone.0187131	http://dx.doi.org/10.1371/journal.pone.0187131			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088249	gold, Green Published, Green Submitted			2022-12-26	WOS:000414088900043
J	Campbell, JR; Johnston, JC; Sadatsafavi, M; Cook, VJ; Elwood, RK; Marra, F				Campbell, Jonathon R.; Johnston, James C.; Sadatsafavi, Mohsen; Cook, Victoria J.; Elwood, R. Kevin; Marra, Fawziah			Cost-effectiveness of post-landing latent tuberculosis infection control strategies in new migrants to Canada	PLOS ONE			English	Article							LOW-INCIDENCE COUNTRIES; TREATMENT COMPLETION; UNITED-STATES; RANDOMIZED-TRIAL; HEALTH; RIFAMPIN; RISK; DIAGNOSIS; REACTIVATION; IMMIGRANTS	Background The majority of tuberculosis in migrants to Canada occurs due to reactivation of latent TB infection. Risk of tuberculosis in those with latent tuberculosis infection can be significantly reduced with treatment. Presently, only 2.4% of new migrants are flagged for post-landing surveillance, which may include latent tuberculosis infection screening; no other migrants receive routine latent tuberculosis infection screening. To aid in reducing the tuberculosis burden in new migrants to Canada, we determined the cost-effectiveness of using different latent tuberculosis infection interventions in migrants under post-arrival surveillance and in all new migrants. Methods A discrete event simulation model was developed that focused on a Canadian permanent resident cohort after arrival in Canada, utilizing a ten-year time horizon, healthcare system perspective, and 1.5% discount rate. Latent tuberculosis infection interventions were evaluated in the population under surveillance (N = 6100) and the total cohort (N = 260,600). In all evaluations, six different screening and treatment combinations were compared to the base case of tuberculin skin test screening followed by isoniazid treatment only in the population under surveillance. Quality adjusted life years, incident tuberculosis cases, and costs were recorded for each intervention and incremental cost-effectiveness ratios were calculated in relation to the base case. Results In the population under surveillance (N = 6100), using an interferon-gamma release assay followed by rifampin was dominant compared to the base case, preventing 4.90 cases of tuberculosis, a 4.9% reduction, adding 4.0 quality adjusted life years, and saving $353,013 over the ensuing ten-years. Latent tuberculosis infection screening in the total population (N = 260,600) was not cost-effective when compared to the base case, however could potentially prevent 21.8% of incident tuberculosis cases. Conclusions Screening new migrants under surveillance with an interferon-gamma release assay and treating with rifampin is cost saving, but will not significantly impact TB incidence. Universal latent tuberculosis infection screening and treatment is cost-prohibitive. Research into using risk factors to target screening post-landing may provide alternate solutions.	[Campbell, Jonathon R.; Sadatsafavi, Mohsen; Marra, Fawziah] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada; [Johnston, James C.; Cook, Victoria J.; Elwood, R. Kevin] Univ British Columbia, Div Resp Med, Fac Med, Vancouver, BC, Canada; [Johnston, James C.; Cook, Victoria J.; Elwood, R. Kevin] British Columbia Ctr Dis Control, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Marra, F (corresponding author), Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada.	fawziah@mail.ubc.ca	Sadatsafayi, Mohsen/AAZ-1593-2020; Campbell, Jonathon/AAN-4252-2021	Sadatsafayi, Mohsen/0000-0002-0419-7862; Campbell, Jonathon/0000-0003-2341-2166; , Fawziah/0000-0002-1266-1901				Aldridge RW, 2016, LANCET, V388, P2510, DOI 10.1016/S0140-6736(16)31008-X; Alexander DC, 2009, J CLIN MICROBIOL, V47, P2651, DOI 10.1128/JCM.01946-08; Alsdurf H, 2016, LANCET INFECT DIS, V16, P1269, DOI 10.1016/S1473-3099(16)30216-X; [Anonymous], 2015, CAN FACTS FIG IMM OV; [Anonymous], 2017, GUID EC EV HLTH TECH; [Anonymous], 2017, BCG WORLD ATLAS; [Anonymous], 2016, LIF TABL CAN PROV TE; Ara R, 2010, VALUE HEALTH, V13, P509, DOI 10.1111/j.1524-4733.2010.00700.x; Aspler A, 2010, THORAX, V65, P582, DOI 10.1136/thx.2009.125054; Auguste P, 2016, TUBERCULOSIS, V99, P81, DOI 10.1016/j.tube.2016.04.007; Bauer M, 2015, QUAL LIFE RES, V24, P1337, DOI 10.1007/s11136-014-0858-6; Bettache N, 2012, AM J RESP CRIT CARE, V185, pA6507; Campbell JR, 2015, APPL HEALTH ECON HEA, V13, P325, DOI 10.1007/s40258-015-0183-4; Campbell JR, 2015, MOL DIAGN THER, V19, P107, DOI 10.1007/s40291-015-0135-6; Campbell JR, 2015, MOL DIAGN THER, V19, P9, DOI 10.1007/s40291-014-0125-0; Chan IHY, 2017, LANCET INFECT DIS; Chin DP, 1998, AM J RESP CRIT CARE, V158, P1797, DOI 10.1164/ajrccm.158.6.9804029; COMSTOCK GW, 1974, AM J EPIDEMIOL, V99, P131, DOI 10.1093/oxfordjournals.aje.a121593; COMSTOCK GW, 1966, AM REV RESPIR DIS, V93, P171; Dasgupta K, 2000, AM J RESP CRIT CARE, V162, P2079, DOI 10.1164/ajrccm.162.6.2001111; EDWARDS LB, 1971, ARCH ENVIRON HEALTH, V22, P106, DOI 10.1080/00039896.1971.10665820; Fassbender K, 2009, J PAIN SYMPTOM MANAG, V38, P75, DOI 10.1016/j.jpainsymman.2009.04.007; FEREBEE SH, 1963, AM REV RESPIR DIS, V88, P161; FEREBEE SH, 1970, BIBL TUBERC MED THOR, V17, P28; Guo N, 2008, VALUE HEALTH, V11, P1154, DOI 10.1111/j.1524-4733.2008.00355.x; Holland DP, 2009, AM J RESP CRIT CARE, V179, P1055, DOI 10.1164/rccm.200901-0153OC; Horsburgh CR, 2010, AM J RESP CRIT CARE, V182, P420, DOI 10.1164/rccm.200909-1355OC; Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667; Jasmer RM, 2004, AM J RESP CRIT CARE, V170, P1360, DOI 10.1164/rccm.200408-1081OC; Khan K, 2002, NEW ENGL J MED, V347, P1850, DOI 10.1056/NEJMsa021099; Khan K, 2015, CAN MED ASSOC J, V187, pE473, DOI 10.1503/cmaj.150011; Lardizabal A, 2006, CHEST, V130, P1712, DOI 10.1378/chest.130.6.1712; LAUPACIS A, 1992, CAN MED ASSOC J, V146, P473; Linas BP, 2011, AM J RESP CRIT CARE, V184, P590, DOI 10.1164/rccm.201101-0181OC; Long R, 2002, INT J TUBERC LUNG D, V6, P615; Marra CA, 2008, CHEST, V133, P396, DOI 10.1378/chest.07-1494; Marra F, 2008, INT J TUBERC LUNG D, V12, P1414; Marseille E, 2015, B WORLD HEALTH ORGAN, V93, P118, DOI 10.2471/BLT.14.138206; Menzies D, 2004, AM J RESP CRIT CARE, V170, P445, DOI 10.1164/rccm.200404-478OC; Menzies D, 2008, CAN J PUBLIC HEALTH, V99, P391, DOI 10.1007/BF03405248; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Menzies D, 2011, INDIAN J MED RES, V133, P257; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Oxlade O, 2007, INT J TUBERC LUNG D, V11, P16; Page KR, 2006, ARCH INTERN MED, V166, P1863, DOI 10.1001/archinte.166.17.1863; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; PALMER CE, 1957, AM REV TUBERC PULM, V76, P517; Patel AR, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015108; Pina JM, 2013, EUR J CLIN MICROBIOL, V32, P647, DOI 10.1007/s10096-012-1788-2; Public Health Agency of Canada Canadian Thoracic Society and the Canadian Lung Association, 2013, CANADIAN TUBERCULOSI; Reichman LB, 2004, AM J RESP CRIT CARE, V170, P832, DOI 10.1164/rccm.200405-584PP; Roth D, 2012, BC MED J, V54, P387; Roth DZ, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01546-2016; SALPETER SR, 1993, WESTERN J MED, V159, P560; Sanders GD, 2016, JAMA-J AM MED ASSOC, V316, P1093, DOI 10.1001/jama.2016.12195; Shea KM, 2014, AM J EPIDEMIOL, V179, P216, DOI 10.1093/aje/kwt246; Tan MC, 2008, VALUE HEALTH, V11, P842, DOI 10.1111/j.1524-4733.2008.00334.x; THOMPSON NJ, 1982, B WORLD HEALTH ORGAN, V60, P555; Walter ND, 2014, AM J RESP CRIT CARE, V189, P88, DOI 10.1164/rccm.201308-1480OC; WHO-UNICEF, 2017, WHO UNICEF EST BCG C; Zammarchi L, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1045-3	61	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0186778	10.1371/journal.pone.0186778	http://dx.doi.org/10.1371/journal.pone.0186778			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084227	Green Published, Green Submitted, gold			2022-12-26	WOS:000413910200012
J	Chng, WBA; Koch, R; Li, XX; Kondo, S; Nagoshi, E; Lemaitre, B				Chng, Wen-bin Alfred; Koch, Rafael; Li, Xiaoxue; Kondo, Shu; Nagoshi, Emi; Lemaitre, Bruno			Transforming Growth Factor beta/Activin signaling in neurons increases susceptibility to starvation	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; DROSOPHILA; SUGAR; EXPRESSION; FRUCTOSE; GLUCOSE; OBESITY	Animals rely on complex signaling network to mobilize its energy stores during starvation. We have previously shown that the sugar-responsive TGF beta/Activin pathway, activated through the TGF beta ligand Dawdle, plays a central role in shaping the post-prandial digestive competence in the Drosophila midgut. Nevertheless, little is known about the TGF beta/Activin signaling in sugar metabolism beyond the midgut. Here, we address the importance of Dawdle (Daw) after carbohydrate ingestion. We found that Daw expression is coupled to dietary glucose through the evolutionarily conserved Mio-Mlx transcriptional complex. In addition, Daw activates the TGF beta/Activin signaling in neuronal populations to regulate triglyceride and glycogen catabolism and energy homeostasis. Loss of those neurons depleted metabolic reserves and rendered flies susceptible to starvation.	[Chng, Wen-bin Alfred; Li, Xiaoxue; Lemaitre, Bruno] Ecole Polytech Fed Lausanne, Global Hlth Inst, Sch Life Sci, Lausanne, Switzerland; [Koch, Rafael; Nagoshi, Emi] Univ Geneva, Dept Genet & Evolut, Sci 3, Geneva, Switzerland; [Kondo, Shu] Natl Inst Genet, Invertebrate Genet Lab, Genet Strains Res Ctr, Mishima, Shizuoka, Japan	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Geneva; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Chng, WBA; Lemaitre, B (corresponding author), Ecole Polytech Fed Lausanne, Global Hlth Inst, Sch Life Sci, Lausanne, Switzerland.	chng.alfred@gmail.com; bruno.lemaitre@epfl.ch	Lemaitre, Bruno/T-8146-2019; Kondo, Shu/AAH-8921-2020	Lemaitre, Bruno/0000-0001-7970-1667; Kondo, Shu/0000-0002-4625-8379; Koch, Rafael/0000-0001-6105-2638; Nagoshi, Emi/0000-0002-6365-4074	Swiss National Fund [3100A0-12079/1]; SNSF [3100A0-12079/1]	Swiss National Fund(Swiss National Science Foundation (SNSF)); SNSF(Swiss National Science Foundation (SNSF))	The work is funded by the Swiss National Fund (3100A0-12079/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfa RW, 2015, CELL METAB, V21, P323, DOI 10.1016/j.cmet.2015.01.006; Awasaki T, 2011, NAT NEUROSCI, V14, P821, DOI 10.1038/nn.2833; Bai H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003941; Ball GDC, 2005, CAN J DIET PRACT RES, V66, P162, DOI 10.3148/66.3.2005.162; Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Brummel T, 1999, GENE DEV, V13, P98, DOI 10.1101/gad.13.1.98; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Chng WA, TRENDENDOCRINOLOGY, V28, P131; Chng WBA, 2014, CELL REP, V9, P336, DOI 10.1016/j.celrep.2014.08.064; Collings PJ, 2013, AM J CLIN NUTR, V97, P1020, DOI 10.3945/ajcn.112.045088; Garrido D, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004995; Gesualdi SC, 2007, FLY, V1, P212, DOI 10.4161/fly.5116; Ghosh AC, 2014, P NATL ACAD SCI USA, V111, P5729, DOI 10.1073/pnas.1319116111; Havula E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003438; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Jourjine N, 2016, CELL, V166, P855, DOI 10.1016/j.cell.2016.06.046; KANAREK RB, 1982, J NUTR, V112, P1546, DOI 10.1093/jn/112.8.1546; Keller KB, 2003, AM J CRIT CARE, V12, P167, DOI 10.4037/ajcc2003.12.2.167; Kim SK, 2004, NATURE, V431, P316, DOI 10.1038/nature02897; Kondo S, 2013, GENETICS, V195, P715, DOI 10.1534/genetics.113.156737; Mattila J, 2015, CELL REP, V13, P350, DOI 10.1016/j.celrep.2015.08.081; Musselman LP, 2013, J BIOL CHEM, V288, P8028, DOI 10.1074/jbc.M112.371047; Park S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004555; Pfeiffenberger Cory, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5518; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Serpe M, 2006, DEVELOPMENT, V133, P4969, DOI 10.1242/dev.02711; Veenstra JA, 2008, CELL TISSUE RES, V334, P499, DOI 10.1007/s00441-008-0708-3; Weber K, 2005, GENETICS, V169, P1461, DOI 10.1534/genetics.104.027748; Zheng XY, 2003, CELL, V112, P303, DOI 10.1016/S0092-8674(03)00072-2; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	31	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187054	10.1371/journal.pone.0187054	http://dx.doi.org/10.1371/journal.pone.0187054			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084242	Green Submitted, gold, Green Published			2022-12-26	WOS:000413910200028
J	Houshmand-Oeregaard, A; Hjort, L; Kelstrup, L; Hansen, NS; Broholm, C; Gillberg, L; Clausen, TD; Mathiesen, ER; Damm, P; Vaag, A				Houshmand-Oeregaard, Azadeh; Hjort, Line; Kelstrup, Louise; Hansen, Ninna S.; Broholm, Christa; Gillberg, Linn; Clausen, Tine D.; Mathiesen, Elisabeth R.; Damm, Peter; Vaag, Allan			DNA methylation and gene expression of TXNIP in adult offspring of women with diabetes in pregnancy	PLOS ONE			English	Article							SUBCUTANEOUS ADIPOSE-TISSUE; EPIGENOME-WIDE ASSOCIATION; IN-UTERO; MELLITUS; PPARGC1A; GLUCOSE; MUSCLE; BLOOD	Background Fetal exposure to maternal diabetes increases the risk of type 2 diabetes (T2DM), possibly mediated by epigenetic mechanisms. Low blood TXNIP DNA methylation has been associated with elevated glucose levels and risk of T2DM, and increased skeletal muscle TXNIP gene expression was reported in subjects with impaired glucose metabolism or T2DM. Subcutaneous adipose tissue (SAT) and skeletal muscle play a key role in the control of whole body glucose metabolism and insulin action. The extent to which TXNIP DNA methylation levels are decreased and/or gene expression levels increased in SAT or skeletal muscle of a developmentally programmed at-risk population is unknown. Objective and methods The objective of this study was to investigate TXNIP DNA methylation and gene expression in SAT and skeletal muscle, and DNA methylation in blood, from adult offspring of women with gestational diabetes (O-GDM, n = 82) or type 1 diabetes (O-T1DM, n = 67) in pregnancy compared with offspring of women from the background population (O-BP, n = 57). Results SAT TXNIP DNA methylation was increased (p = 0.032) and gene expression decreased (p = 0.001) in O-GDM, but these differences were attenuated after adjustment for confounders. Neither blood/muscle TXNIP DNA methylation nor muscle gene expression differed between groups. Conclusion We found no evidence of decreased TXNIP DNA methylation or increased gene expression in metabolic target tissues of offspring exposed to maternal diabetes. Further studies are needed to confirm and understand the paradoxical SAT TXNIP DNA methylation and gene expression changes in O-GDM subjects.	[Houshmand-Oeregaard, Azadeh; Kelstrup, Louise; Mathiesen, Elisabeth R.; Damm, Peter] Rigshosp, Ctr Pregnant Women Diabet, Dept Obstet, Copenhagen, Denmark; [Houshmand-Oeregaard, Azadeh; Hjort, Line; Hansen, Ninna S.; Broholm, Christa; Gillberg, Linn; Vaag, Allan] Rigshosp, Dept Endocrinol, Diabet & Metab, Copenhagen, Denmark; [Houshmand-Oeregaard, Azadeh; Hjort, Line; Kelstrup, Louise; Hansen, Ninna S.; Clausen, Tine D.; Mathiesen, Elisabeth R.; Damm, Peter; Vaag, Allan] Univ Copenhagen, Inst Clin Med, Fac Hlth & Med Sci, Copenhagen, Denmark; [Hjort, Line; Hansen, Ninna S.] Danish Diabet Acad, Danish PhD Sch Mol Metab, Odense, Denmark; [Clausen, Tine D.] Univ Copenhagen, Nordsjaellands Hosp, Dept Gynecol & Obstet, Hillerod, Denmark; [Mathiesen, Elisabeth R.] Rigshosp, Ctr Pregnant Women Diabet, Dept Endocrinol, Copenhagen, Denmark; [Houshmand-Oeregaard, Azadeh] Novo Nordisk AS, Basgvaerd, Denmark; [Vaag, Allan] AstraZeneca, Molndal, Sweden	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Novo Nordisk; AstraZeneca	Houshmand-Oeregaard, A (corresponding author), Rigshosp, Ctr Pregnant Women Diabet, Dept Obstet, Copenhagen, Denmark.; Houshmand-Oeregaard, A (corresponding author), Rigshosp, Dept Endocrinol, Diabet & Metab, Copenhagen, Denmark.; Houshmand-Oeregaard, A (corresponding author), Univ Copenhagen, Inst Clin Med, Fac Hlth & Med Sci, Copenhagen, Denmark.; Houshmand-Oeregaard, A (corresponding author), Novo Nordisk AS, Basgvaerd, Denmark.	a.houshmand.oregaard@gmail.com	Gillberg, Linn/A-1417-2017; Clausen, Tine Dalsgaard/X-3720-2019	Gillberg, Linn/0000-0003-0588-1663; Kelstrup, Louise/0000-0003-3994-0377; Damm, Peter/0000-0002-2067-5246; Clausen, Tine Dalsgaard/0000-0001-5585-2153; Hjort, Line/0000-0003-4673-4176; Vaag, Allan Arthur/0000-0002-3690-2191	Danish Council for Strategic Research; Novo Nordisk Foundation; Danish Diabetes Academy; Augustinus Foundation; Danish Diabetes Association; Novo Nordisk Fonden [NNF14OC0009275] Funding Source: researchfish	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Diabetes Academy; Augustinus Foundation; Danish Diabetes Association; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the Danish Council for Strategic Research, the Novo Nordisk Foundation, Danish Diabetes Academy, Augustinus Foundation, Danish Diabetes Association, The A.P. Moller Foundation for the Advancement of Medical Science, European Foundation for the Study of Diabetes (EFSD), and The Research Fund of Rigshospitalet. ERM has received honorarium from Novo Nordisk A/S for talks. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Al Muftah WA, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0177-6; [Anonymous], 2006, DEFINITION DIAGNOSIS; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Brons C, 2010, J CLIN ENDOCR METAB, V95, P3048, DOI 10.1210/jc.2009-2413; Chambers JC, 2015, LANCET DIABETES ENDO, V3, P526, DOI 10.1016/S2213-8587(15)00127-8; Chen JQ, 2008, FASEB J, V22, P3581, DOI 10.1096/fj.08-111690; Chong CR, 2014, CARDIOVASC DRUG THER, V28, P347, DOI 10.1007/s10557-014-6538-5; Chutkow WA, 2010, DIABETES, V59, P1424, DOI 10.2337/db09-1212; Clausen TD, 2008, DIABETES CARE, V31, P340, DOI 10.2337/dc07-1596; Clausen TD, 2009, J CLIN ENDOCR METAB, V94, P2464, DOI 10.1210/jc.2009-0305; Dabelea D, 2000, J Matern Fetal Med, V9, P83, DOI 10.1002/(SICI)1520-6661(200001/02)9:1<83::AID-MFM17>3.0.CO;2-O; DAMM P, 1992, AM J OBSTET GYNECOL, V167, P607, DOI 10.1016/S0002-9378(11)91559-2; Damm P, 1998, DAN MED BULL, V45, P495; Dayeh T, 2016, EPIGENETICS-US, V11, P482, DOI 10.1080/15592294.2016.1178418; El Hajj N, 2014, REPRODUCTION, V148, pR111, DOI 10.1530/REP-14-0334; Florath I, 2015, DIABETOLOGIA; Gillberg L, 2014, METABOLISM, V63, P263, DOI 10.1016/j.metabol.2013.10.003; Gluckman PD, 2009, NAT REV ENDOCRINOL, V5, P401, DOI 10.1038/nrendo.2009.102; Houshmand-Oeregaard A, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0338-2; Kelstrup L, 2016, DIABETES, V65, P2900, DOI 10.2337/db16-0227; Koenen TB, 2011, DIABETES, V60, P517, DOI 10.2337/db10-0266; Kulkarni H, 2015, HUM MOL GENET, V24, P5330, DOI 10.1093/hmg/ddv232; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; PETTITT DJ, 1988, DIABETES, V37, P622, DOI 10.2337/diabetes.37.5.622; Ruchat SM, 2013, NUTR REV, V71, pS88, DOI 10.1111/nure.12057; Schulze PC, 2004, J BIOL CHEM, V279, P30369, DOI 10.1074/jbc.M400549200; Shalev A, 2014, MOL ENDOCRINOL, V28, P1211, DOI 10.1210/me.2014-1095; Sobngwi E, 2003, LANCET, V361, P1861, DOI 10.1016/S0140-6736(03)13505-2; Soriano-Tarraga C, 2016, HUM MOL GENET, V25, P609, DOI 10.1093/hmg/ddv493; West Nancy A, 2013, Immunometabolism, V1, P1; Zheng J, 2014, BRIT J NUTR, V112, P1850, DOI 10.1017/S0007114514002827	33	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187038	10.1371/journal.pone.0187038	http://dx.doi.org/10.1371/journal.pone.0187038			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077742	Green Published, gold, Green Submitted			2022-12-26	WOS:000413861200038
J	Chen, SY; Li, X; Liu, L; Liu, C; Han, X				Chen, Siyu; Li, Xiao; Liu, Li; Liu, Chang; Han, Xiao			Ophiopogonin D alleviates high-fat diet-induced metabolic syndrome and changes the structure of gut microbiota in mice	FASEB JOURNAL			English	Article						saponin compound; obesity; intestinal bacteria; transplantation; pyrosequence	GLUCAGON-LIKE PEPTIDE-1; AQUEOUS EXTRACT; COMPOUND K; OBESITY; HEALTH; HOST; INFLAMMATION; JAPONICUS; POLYSACCHARIDE; EPIDEMIOLOGY	Gut dysbiosis is believed to play a critical role in the pathogenesis of metabolic diseases, including obesity. Ophiopogonin D (OP-D), a steroidal glycoside and an active component extracted from the root of the plant Ophiopogon japonicus (also known as radix ophiopogonis), can regulate multiple physiologic processes. Here we show that OP-D administration reduces body weight, hyperglycemia, hyperlipidemia, and insulin resistance in male mice fed a high-fat diet (HFD). Pyrosequencing of the V4 regions of 16S rRNA genes in mouse feces revealed a deviation of the gut microbiota in response to OP-D treatment. In particular, the decreased Firmicutes-to-Bacteroidetes ratios and endotoxin-bearing Proteobacteria levels indicated that OP-D reversed HFD-induced gut dysbiosis. More importantly, the effects of OP-D on modulation of obesity and microbiota were transferable via horizontal feces transfer from OP-D-treated mice to HFD-fed mice. Taken together, our results suggest that OP-D may be used as a prebiotic agent to treat obesity-associated gut dysbiosis and metabolic syndrome.	[Chen, Siyu; Han, Xiao] Nanjing Med Univ, Key Lab Human Funct Genom Jiangsu Prov, Dept Biochem & Mol Biol, 101 Longmian Ave, Nanjing 211166, Jiangsu, Peoples R China; [Chen, Siyu; Liu, Chang] China Pharmaceut Univ, Sch Life Sci, 639 Longmian Ave, Nanjing 211198, Jiangsu, Peoples R China; [Li, Xiao] Nanjing Med Univ, Affiliated Hosp 1, Dept Pathol, Nanjing, Jiangsu, Peoples R China; [Liu, Li] Nanjing Med Univ, Affiliated Hosp 1, Dept Geriatr, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; China Pharmaceutical University; Nanjing Medical University; Nanjing Medical University	Han, X (corresponding author), Nanjing Med Univ, Key Lab Human Funct Genom Jiangsu Prov, Dept Biochem & Mol Biol, 101 Longmian Ave, Nanjing 211166, Jiangsu, Peoples R China.; Liu, C (corresponding author), China Pharmaceut Univ, Sch Life Sci, 639 Longmian Ave, Nanjing 211198, Jiangsu, Peoples R China.	changliu@cpu.edu.cn; hanxiao@njmu.edu.cn		Chen, Siyu/0000-0002-3809-1062	National Natural Science Foundation of China (NSF) [81420108007, 31422028]; National Key Research and Development Program of China [2016YFC1304804]; NSF of Jiangsu Province of China [BK20140041]; Jiangsu Postdoctoral Research Funding Plan [1601020A]	National Natural Science Foundation of China (NSF)(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; NSF of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Jiangsu Postdoctoral Research Funding Plan	This work was supported by research grants from the National Natural Science Foundation of China (NSF; 81420108007 to X.H., 31422028 to C.L.) and the National Key Research and Development Program of China (2016YFC1304804 to X.H.), NSF of Jiangsu Province of China (BK20140041 to C.L.), and the Jiangsu Postdoctoral Research Funding Plan (1601020A to S.C.). X.H. and C.L. are fellows at the Collaborative Innovation Center for Cardiovascular Disease Translational Medicine and Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The authors have declared that no competing interests exist.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Borody Thomas J, 2013, Curr Gastroenterol Rep, V15, P337, DOI 10.1007/s11894-013-0337-1; Campos P, 2006, INT J EPIDEMIOL, V35, P55, DOI 10.1093/ije/dyi254; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cartwright TH, 2002, J CLIN ONCOL, V20, P160, DOI 10.1200/JCO.20.1.160; Chang CJ, 2015, NAT COMMUN, V6, DOI [10.1038/ncomms8489, 10.1038/ncomms8216]; CHEN M, 1990, ACTA PHARM SINIC, V11, P161; Chen SY, 2014, DIABETES, V63, P2073, DOI 10.2337/db13-0788; Chen XM, 2013, CARBOHYD POLYM, V94, P378, DOI 10.1016/j.carbpol.2013.01.037; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; DeMinicis S, 2014, HEPATOLOGY, V59, P1738, DOI 10.1002/hep.26695; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ge X, 2015, INT J MOL SCI, V16, P28180, DOI 10.3390/ijms161226093; Guo JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24197; LeBlanc JG, 2013, CURR OPIN BIOTECH, V24, P160, DOI 10.1016/j.copbio.2012.08.005; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Huang Q, 2015, BONE, V74, P18, DOI 10.1016/j.bone.2015.01.002; Hur KY, 2015, DIABETES METAB J, V39, P198, DOI 10.4093/dmj.2015.39.3.198; Hwang I, 2015, FASEB J, V29, P2397, DOI 10.1096/fj.14-265983; Ichikawa H, 2003, AM J CHINESE MED, V31, P509, DOI 10.1142/S0192415X03001193; Ishibashi H, 2001, BRIT J PHARMACOL, V132, P461, DOI 10.1038/sj.bjp.0703818; Jia W, 2008, NAT REV DRUG DISCOV, V7, P123, DOI 10.1038/nrd2505; Jia WP, 2010, BIOMED ENVIRON SCI, V23, P4, DOI 10.1016/S0895-3988(10)60025-6; Jiang MM, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-350; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Kameyama K, 2014, MICROBES ENVIRON, V29, P427, DOI 10.1264/jsme2.ME14054; Kang KA, 2013, INT J ONCOL, V43, P1907, DOI 10.3892/ijo.2013.2129; Kim KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062409; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Kou JP, 2005, BIOL PHARM BULL, V28, P1234, DOI 10.1248/bpb.28.1234; Kou J, 2006, BIOL PHARM BULL, V29, P1267, DOI 10.1248/bpb.29.1267; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Liu C, 2013, J ENDOCRINOL, V217, P185, DOI 10.1530/JOE-12-0502; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; McChesney James D, 2002, P R Health Sci J, V21, P91; Million M, 2013, CLIN MICROBIOL INFEC, V19, P305, DOI 10.1111/1469-0691.12172; Moayyedi P, 2008, DIGEST DIS SCI, V53, P2293, DOI 10.1007/s10620-008-0410-z; Neyrinck AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020944; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Pachikian BD, 2013, MOL NUTR FOOD RES, V57, P347, DOI 10.1002/mnfr.201200364; Qian JC, 2010, J ETHNOPHARMACOL, V128, P438, DOI 10.1016/j.jep.2010.01.031; Raman M, 2013, CLIN GASTROENTEROL H, V11, P868, DOI 10.1016/j.cgh.2013.02.015; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Smith KB, 2016, PRIMARY CARE, V43, P121, DOI 10.1016/j.pop.2015.10.001; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Ueyama J, 2005, EUR J PHARMACOL, V510, P127, DOI 10.1016/j.ejphar.2005.01.025; Villanueva-Millan MJ, 2015, J PHYSIOL BIOCHEM, V71, P509, DOI 10.1007/s13105-015-0390-3; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952; Yang Z, 2012, DRUG METAB DISPOS, V40, P1538, DOI 10.1124/dmd.111.044008; Zang QQ, 2016, J INTEGR MED-JIM, V14, P51, DOI 10.1016/S2095-4964(16)60238-8; Zhan S.Y., 2014, ARCH PHARM RES; Zhang S, 2017, ANAEROBE, V48, P184, DOI 10.1016/j.anaerobe.2017.08.017; Zhang W, 2017, EUR J DRUG METAB PH, V42, P669, DOI 10.1007/s13318-016-0384-8; Zhang X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040320, 10.1371/journal.pone.0042529]; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071108; Zhang YY, 2015, J PHARMACOL EXP THER, V352, P166, DOI 10.1124/jpet.114.219261; Zhao LP, 2013, NAT REV MICROBIOL, V11, P639, DOI 10.1038/nrmicro3089; Zhao LP, 2010, J BIOTECHNOL, V149, P183, DOI 10.1016/j.jbiotec.2010.02.008	70	27	34	4	41	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1139	1153		10.1096/fj.201700741RR	http://dx.doi.org/10.1096/fj.201700741RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29084766				2022-12-26	WOS:000427246000004
J	Maclean, KN; Jiang, H; Aivazidis, S; Kim, E; Shearn, CT; Harris, PS; Petersen, DR; Allen, RH; Stabler, SP; Roede, JR				Maclean, Kenneth N.; Jiang, Hua; Aivazidis, Stefanos; Kim, Eugene; Shearn, Colin T.; Harris, Peter S.; Petersen, Dennis R.; Allen, Robert H.; Stabler, Sally P.; Roede, James R.			Taurine treatment prevents derangement of the hepatic gamma-glutamyl cycle and methylglyoxal metabolism in a mouse model of classical homocystinuria: regulatory crosstalk between thiol and sulfinic acid metabolism	FASEB JOURNAL			English	Article						cystathionine; beta-synthase; glutathione; ophthalmate	SYNTHASE-DEFICIENT HOMOCYSTINURIA; GLUTATHIONE-RELATED ENZYMES; TRANSCRIPTION FACTOR NRF2; INDUCED OXIDATIVE STRESS; SUBUNIT GENE-EXPRESSION; NECROSIS-FACTOR-ALPHA; APOPTOTIC CELL-DEATH; GLYOXALASE-I; ENDOTHELIAL DYSFUNCTION; ANTIOXIDATIVE ENZYMES	Cystathionine beta-synthase-deficient homocystinuria (HCU) is a poorly understood, life-threatening inborn error of sulfur metabolism. Analysis of hepatic glutathione (GSH) metabolism in a mouse model of HCU demonstrated significant depletion of cysteine, GSH, and GSH disulfide independent of the block in trans-sulfuration compared with wild-type controls. HCU induced the expression of the catalytic and regulatory subunits of gamma-glutamyl ligase, GSH synthase (GS), gamma-glutamyl transpeptidase 1, 5-oxoprolinase (OPLAH), and the GSH-dependent methylglyoxal detoxification enzyme, glyoxalase-1. Multiple components of the transcription factor nuclear factor (erythroid-derived 2)-like 2 (Nrf2)-mediated antioxidant-response regulatory axis were induced without any detectable activation of Nrf2. Metabolomic analysis revealed the accumulation of multiple gamma-glutamyl amino acids and that plasma ophthalmate levels could serve as a noninvasive marker for hepatic redox stress. Neither cysteine, nor betaine treatment was able to reverse the observed enzyme inductions. Taurine treatment normalized the expression levels of gamma-glutamyl ligase C/M, GS, OPLAH, and glyoxalase-1, and reversed HCU-induced deficits in protein glutathionylation by acting to double GSH levels relative to controls. Collectively, our data indicate that the perturbation of the gamma-glutamyl cycle could contribute to multiple sequelae in HCU and that taurine has significant therapeutic potential for both HCU and other diseases for which GSH depletion is a critical pathogenic factor.-Maclean, K.N., Jiang, H., Aivazidis, S., Kim, E., Shearn, C.T., Harris, P.S., Petersen, D.R., Allen, R.H., Stabler, S. P., Roede, J. R. Taurine treatment prevents derangement of the hepatic gamma-glutamyl cycle and methylglyoxal metabolism in a mouse model of classical homocystinuria: regulatory crosstalk between thiol and sulfinic acid metabolism.	[Maclean, Kenneth N.; Jiang, Hua; Kim, Eugene] Univ Colorado, Hlth Sci Ctr, Dept Pediat, Aurora, CO 80045 USA; [Aivazidis, Stefanos; Shearn, Colin T.; Harris, Peter S.; Petersen, Dennis R.; Roede, James R.] Univ Colorado, Hlth Sci Ctr, Dept Pharmaceut Sci, Aurora, CO 80045 USA; [Allen, Robert H.; Stabler, Sally P.] Univ Colorado, Hlth Sci Ctr, Dept Med, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Maclean, KN (corresponding author), Univ Colorado, Sch Med, Dept Pediat, UCHSC, Mail Stop 8313,POB 6511, Aurora, CO 80045 USA.	ken.maclean@UCdenver.edu		Aivazids, Stefanos/0000-0003-0421-1473; Kim, Eugene/0000-0003-3409-4124	William R. Hummel Homocystinuria Research Fund; Ehst-Hummel-Kaufmann Family Endowed Chair in Inherited Metabolic Disease; Skaggs School of Pharmacy and Pharmaceutical Sciences (Aurora, CO, USA); Children's Hospital of Colorado (Aurora, CO, USA) Summer Child Health Research Internship	William R. Hummel Homocystinuria Research Fund; Ehst-Hummel-Kaufmann Family Endowed Chair in Inherited Metabolic Disease; Skaggs School of Pharmacy and Pharmaceutical Sciences (Aurora, CO, USA); Children's Hospital of Colorado (Aurora, CO, USA) Summer Child Health Research Internship	K.N.M. gratefully acknowledges financial support from the William R. Hummel Homocystinuria Research Fund and holds the Ehst-Hummel-Kaufmann Family Endowed Chair in Inherited Metabolic Disease. Additional funding for this work was provided by a faculty start-up package from the Skaggs School of Pharmacy and Pharmaceutical Sciences (Aurora, CO, USA; to J.R.R.). E.K. gratefully acknowledges support from a Children's Hospital of Colorado (Aurora, CO, USA) Summer Child Health Research Internship. The authors declare no conflicts of interest.	Akhand AA, 2001, FREE RADICAL BIO MED, V31, P20, DOI 10.1016/S0891-5849(01)00550-0; Aquilano Katia, 2011, Commun Integr Biol, V4, P477, DOI 10.4161/cib.4.4.15654; Aquilano K, 2011, J CELL SCI, V124, P1043, DOI 10.1242/jcs.077149; Arai RJ, 2008, TOXICOL APPL PHARM, V233, P227, DOI 10.1016/j.taap.2008.07.023; Bachhawat AK, 2013, BBA-GEN SUBJECTS, V1830, P3154, DOI 10.1016/j.bbagen.2012.11.018; BALLATORI N, 1994, J BIOL CHEM, V269, P19731; Bardag-Gorce F, 2011, EXP MOL PATHOL, V90, P123, DOI 10.1016/j.yexmp.2010.10.013; Briviba K, 1999, METHOD ENZYMOL, V301, P301; Broadhead GK, 2011, J BIOL CHEM, V286, P8786, DOI 10.1074/jbc.M110.149724; Brouwers O, 2014, DIABETOLOGIA, V57, P224, DOI 10.1007/s00125-013-3088-5; BUHL R, 1989, LANCET, V2, P1294; Cacciatore I, 2010, MOLECULES, V15, P1242, DOI 10.3390/molecules15031242; Cai JX, 1997, BIOCHEM J, V326, P167, DOI 10.1042/bj3260167; Chun HJ, 2016, NEUROTOX RES, V29, P419, DOI 10.1007/s12640-015-9588-y; CLIFFE EE, 1961, BIOCHEM J, V79, P475, DOI 10.1042/bj0790475; DEQUAY B, 1992, AIDS, V6, P815, DOI 10.1097/00002030-199208000-00008; DIILIO C, 1995, CANCER LETT, V96, P189, DOI 10.1016/0304-3835(95)03928-P; Forman HJ, 2009, MOL ASPECTS MED, V30, P1, DOI 10.1016/j.mam.2008.08.006; Garcia-Ruiz C, 2007, J GASTROEN HEPATOL, V22, pS38, DOI 10.1111/j.1440-1746.2006.04644.x; Go YM, 2005, CIRCULATION, V111, P2973, DOI 10.1161/CIRCULATIONAHA.104.515155; Griffith OW, 1999, ADV ENZYMOL RAMB, V73, P209, DOI 10.1002/9780470123195.ch7; GRIFFITH OW, 1979, P NATL ACAD SCI USA, V76, P5606, DOI 10.1073/pnas.76.11.5606; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; Gu F, 2013, FREE RADICAL BIO MED, V65, P488, DOI 10.1016/j.freeradbiomed.2013.07.021; Gupta S, 2014, FASEB J, V28, P781, DOI 10.1096/fj.13-240770; Habib GM, 2000, HEPATOLOGY, V32, P556, DOI 10.1053/jhep.2000.9715; Hanssen NMJ, 2014, EUR HEART J, V35, P1137, DOI 10.1093/eurheartj/eht402; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Helbling B, 1996, EUR J CLIN INVEST, V26, P38, DOI 10.1046/j.1365-2362.1996.88237.x; HUANG CS, 1993, J BIOL CHEM, V268, P19675; HUANG CS, 1993, J BIOL CHEM, V268, P20578; Huang ZZ, 1998, HEPATOLOGY, V27, P147, DOI 10.1002/hep.510270123; Huseby NE, 2016, FREE RADICAL RES, V50, P1, DOI 10.3109/10715762.2015.1100730; Jacob C, 2012, CHEM RES TOXICOL, V25, P588, DOI 10.1021/tx200342b; Janaky R, 2000, NEUROSCIENCE, V95, P617; Jiang H, 2015, BIOL OPEN, V4, P1154, DOI 10.1242/bio.013433; Jiang H, 2014, FASEB J, V28, P4044, DOI 10.1096/fj.14-253633; Jiang H, 2012, MOL GENET METAB, V107, P55, DOI 10.1016/j.ymgme.2012.04.025; Jones DP, 2006, ANTIOXID REDOX SIGN, V8, P1865, DOI 10.1089/ars.2006.8.1865; Jones DP, 1998, CLIN CHIM ACTA, V275, P175, DOI 10.1016/S0009-8981(98)00089-8; Kalish BT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059653; Kanaoka Y, 1997, CELL, V90, P1085, DOI 10.1016/S0092-8674(00)80374-8; Keating AK, 2011, MOL GENET METAB, V103, P330, DOI 10.1016/j.ymgme.2011.04.012; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kwak MK, 2001, MOL MED, V7, P135, DOI 10.1007/BF03401947; Lee TD, 2005, BIOCHEM J, V390, P521, DOI 10.1042/BJ20050439; Lieberman MW, 1996, P NATL ACAD SCI USA, V93, P7923, DOI 10.1073/pnas.93.15.7923; LU SC, 1992, J CLIN INVEST, V90, P524, DOI 10.1172/JCI115890; LU SC, 1992, AM J PHYSIOL, V263, pC1181, DOI 10.1152/ajpcell.1992.263.6.C1181; Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Luo JL, 1998, AM J PHYSIOL-ENDOC M, V275, pE359, DOI 10.1152/ajpendo.1998.275.2.E359; Luperchio S, 1996, FREE RADICAL BIO MED, V21, P513, DOI 10.1016/0891-5849(96)00219-5; Maclean KN, 2012, J BIOL CHEM, V287, P31994, DOI 10.1074/jbc.M112.355172; Maclean KN, 2012, MOL GENET METAB, V105, P395, DOI 10.1016/j.ymgme.2011.11.190; Maclean KN, 2010, MOL GENET METAB, V101, P153, DOI 10.1016/j.ymgme.2010.06.010; Maclean KN, 2010, MOL GENET METAB, V101, P163, DOI 10.1016/j.ymgme.2010.06.007; Maclean KN, 2002, HUM MUTAT, V19, P641, DOI 10.1002/humu.10089; Mannervik B, 1981, Methods Enzymol, V77, P297; Martin JA, 2001, JAMA-J AM MED ASSOC, V285, P1444, DOI 10.1001/jama.285.11.1444; Maynard L. A., 1962, ANIMAL NUTRITION, P283; MEISTER A, 1988, J BIOL CHEM, V263, P17205; MEISTER A, 1974, LIFE SCI, V15, P177, DOI 10.1016/0024-3205(74)90206-9; Moinova HR, 1999, BIOCHEM BIOPH RES CO, V261, P661, DOI 10.1006/bbrc.1999.1109; Mosharov E, 2000, BIOCHEMISTRY-US, V39, P13005, DOI 10.1021/bi001088w; MUDD SH, 1985, AM J HUM GENET, V37, P1; ORLOWSKI M, 1970, P NATL ACAD SCI USA, V67, P1248, DOI 10.1073/pnas.67.3.1248; ORLOWSKI M, 1971, J BIOL CHEM, V246, P7095; Pompella A, 2007, CURR OPIN PHARMACOL, V7, P360, DOI 10.1016/j.coph.2007.04.004; Pullin CH, 2002, J INHERIT METAB DIS, V25, P107, DOI 10.1023/A:1015672625913; RACKER E, 1951, J BIOL CHEM, V190, P685; Rahman I, 1998, FEBS LETT, V427, P129, DOI 10.1016/S0014-5793(98)00410-4; Rahman I, 1996, FEBS LETT, V396, P21, DOI 10.1016/0014-5793(96)01027-7; Sengupta R, 2013, ANTIOXID REDOX SIGN, V18, P259, DOI 10.1089/ars.2012.4716; Siitonen T, 1999, ANN ONCOL, V10, P1361, DOI 10.1023/A:1008382912096; SILBER PM, 1986, ANAL BIOCHEM, V158, P68, DOI 10.1016/0003-2697(86)90590-7; SNOKE JE, 1953, J BIOL CHEM, V201, P573; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; STABLER SP, 1993, BLOOD, V81, P3404; Steullet P, 2006, NEUROSCIENCE, V137, P807, DOI 10.1016/j.neuroscience.2005.10.014; Stiborova M, 2008, TOXICOLOGY, V247, P11, DOI 10.1016/j.tox.2008.01.018; Stipanuk MH, 2011, J INHERIT METAB DIS, V34, P17, DOI 10.1007/s10545-009-9006-9; Sun WM, 1996, BIOCHEM J, V320, P321, DOI 10.1042/bj3200321; TATEISHI N, 1974, J BIOCHEM, V75, P93, DOI 10.1093/oxfordjournals.jbchem.a130387; TESHIGAWARA M, 1995, RES EXP MED, V195, P55, DOI 10.1007/BF02576774; Thornalley Paul J., 2008, Drug Metabolism and Drug Interactions, V23, P125; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; Urata Y, 1996, J BIOL CHEM, V271, P15146, DOI 10.1074/jbc.271.25.15146; URSINI F, 1995, METHOD ENZYMOL, V252, P38; VANDERWE.P, 1973, P NATL ACAD SCI USA, V70, P759; Wild AC, 1999, J BIOL CHEM, V274, P33627, DOI 10.1074/jbc.274.47.33627; Yan CC, 1996, BIOCHEM PHARMACOL, V51, P375, DOI 10.1016/0006-2952(95)02189-2; Yang G, 2016, CELL REP, V17, P1022, DOI 10.1016/j.celrep.2016.09.067; Yang HP, 2005, BIOCHEM J, V391, P399, DOI 10.1042/BJ20050795; Zhang HQ, 2006, FREE RADICAL BIO MED, V40, P1281, DOI 10.1016/j.freeradbiomed.2005.11.005	95	13	13	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1265	1280		10.1096/fj.201700586R	http://dx.doi.org/10.1096/fj.201700586R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29101223				2022-12-26	WOS:000427246000013
J	Wiley, SZ; Sriram, K; Liang, WJ; Chang, SE; French, R; McCann, T; Sicklick, J; Nishihara, H; Lowy, AM; Insel, PA				Wiley, Shu Z.; Sriram, Krishna; Liang, Wenjing; Chang, Sarah E.; French, Randall; McCann, Thalia; Sicklick, Jason; Nishihara, Hiroshi; Lowy, Andrew M.; Insel, Paul A.			GPR68, a proton-sensing GPCR, mediates interaction of cancer-associated fibroblasts and cancer cells	FASEB JOURNAL			English	Article						GPCR signaling pathway; pancreatic cancer; cyclic AMP; tumor microenvironment	PROTEIN-COUPLED RECEPTORS; PANCREATIC STELLATE CELLS; GENE-EXPRESSION; IN-VIVO; INHIBITOR; CYTOKINES; PH; MYOFIBROBLASTS; ANGIOGENESIS; REPERTOIRE	The microenvironment of pancreatic ductal adenocarcinoma (PDAC) is characterized by a dense fibrotic stroma (desmoplasia) generated by pancreatic cancer-associated fibroblasts (CAFs) derived from pancreatic stellate cells (PSCs) and pancreatic fibroblasts (PFs). Using an unbiased GPCRomic array approach, we identified 82 G-protein-coupled receptors (GPCRs) commonly expressed by CAFs derived from 5 primary PDAC tumors. Compared with PSCs and PFs, CAFs have increased expression of GPR68 (a proton-sensing GPCR), with the results confirmed by immunoblotting, The Cancer Genome Atlas data, and immunohistochemistry of PDAC tumors. Coculture of PSCs with PDAC cells, or incubation with TNF-alpha, induced GPR68 expression. GPR68 activation (by decreasing the extracellular pH) enhanced IL-6 expression via a cAMP/PKA/cAMP response element binding protein signaling pathway. Knockdown of GPR68 by short interfering RNA diminished low pH-induced production of IL-6 and enhancement of PDAC cell proliferation by CAF conditioned media. CAFs from other gastrointestinal cancers also express GPR68. PDAC cells thus induce expression by CAFs of GPR68, which senses the acidic microenvironment, thereby increasing production of fibrotic markers and IL-6 and promoting PDAC cell proliferation. CAF-expressed GPR68 is a mediator of low-pH-promoted regulation of the tumor microenvironments, in particular to PDAC cell-CAF interaction and may be a novel therapeutic target for pancreatic and perhaps other types of cancers.	[Wiley, Shu Z.; Sriram, Krishna; Liang, Wenjing; Chang, Sarah E.; McCann, Thalia; Insel, Paul A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Insel, Paul A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [French, Randall; Sicklick, Jason; Lowy, Andrew M.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Sicklick, Jason; Lowy, Andrew M.] Univ Calif San Diego, Div Surg Oncol, Dept Surg, La Jolla, CA 92093 USA; [Liang, Wenjing] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Jinan, Shandong, Peoples R China; [Nishihara, Hiroshi] Hokkaido Canc Ctr, Div Clin Canc Genom, Shiroishi Ku, Sapporo, Hokkaido, Japan	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Shandong University	Insel, PA (corresponding author), Univ Calif San Diego, 9500 Gilman Dr,BSB 3076,MC 0636, La Jolla, CA 92093 USA.	pinsel@ucsd.edu	Liang, Wenjing/AAC-1434-2020		National Cancer Institute (NCI) Therapeutic Training Grant [5T32CA121938]; NIH/NCI [R21 CA189477, R01 CA155620]; NIH/NCI; American Society for Pharmacology and Experimental Therapeutics (ASPET)-David Lehr Research Award; U.S. National Institutes of Health (NIH); NATIONAL CANCER INSTITUTE [R01CA155620, K08CA168999, T32CA121938, R21CA189477] Funding Source: NIH RePORTER	National Cancer Institute (NCI) Therapeutic Training Grant; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Society for Pharmacology and Experimental Therapeutics (ASPET)-David Lehr Research Award; U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Jing Zhang (University of California, San Diego) for assisting us with statistical analysis. This work was supported by U.S. National Institutes of Health (NIH), National Cancer Institute (NCI) Therapeutic Training Grant 5T32CA121938, NIH/NCI Research Grants R21 CA189477, R01 CA155620, and Padres Pedal the Cause PTC2017, and by an American Society for Pharmacology and Experimental Therapeutics (ASPET)-David Lehr Research Award. The authors declare no conflicts of interest.	[Anonymous], 2017, CANC FACTS FIG 2017, P1; Apte MV, 2013, GASTROENTEROLOGY, V144, P1210, DOI 10.1053/j.gastro.2012.11.037; Apte MV, 1999, GUT, V44, P534, DOI 10.1136/gut.44.4.534; ARAFAT HA, 2007, J AM COLL SURGEONS, V204, P1005; Arafat HA, 2007, J AM COLL SURGEONS, V204, P996, DOI 10.1016/j.jamcollsurg.2007.01.067; Bellone G, 2006, J IMMUNOL, V177, P3448, DOI 10.4049/jimmunol.177.5.3448; Bjarnadottir TK, 2006, GENOMICS, V88, P263, DOI 10.1016/j.ygeno.2006.04.001; Damaghi M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00370; de Valliere C, 2016, CELL MOL GASTROENTER, V2, P796, DOI 10.1016/j.jcmgh.2016.06.003; de Valliere C, 2015, INFLAMM BOWEL DIS, V21, P1269, DOI 10.1097/MIB.0000000000000375; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Duluc C, 2015, EMBO MOL MED, V7, P735, DOI 10.15252/emmm.201404346; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Erkan M, 2008, CLIN GASTROENTEROL H, V6, P1155, DOI 10.1016/j.cgh.2008.05.006; Erkan M, 2012, NAT REV GASTRO HEPAT, V9, P454, DOI 10.1038/nrgastro.2012.115; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; GILLIES RJ, 1994, AM J PHYSIOL, V267, pC195, DOI 10.1152/ajpcell.1994.267.1.C195; Guha S, 2005, CANCER RES, V65, P2738, DOI 10.1158/0008-5472.CAN-04-3197; Haqq J, 2014, EUR J CANCER, V50, P2570, DOI 10.1016/j.ejca.2014.06.021; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Huang XP, 2015, NATURE, V527, P477, DOI 10.1038/nature15699; Huang Y, 2008, MOL CELL BIOCHEM, V308, P133, DOI 10.1007/s11010-007-9621-4; Insel PA, 2015, MOL PHARMACOL, V88, P181, DOI 10.1124/mol.115.098129; Ke N, 2007, MOL CANCER THER, V6, P1840, DOI 10.1158/1535-7163.MCT-07-0066; Kleger A, 2014, ANN ONCOL, V25, P1260, DOI 10.1093/annonc/mdu013; Kordes C, 2005, PANCREAS, V31, P156, DOI 10.1097/01.mpa.0000168222.05591.a0; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Li BBX, 2009, CHEMBIOCHEM, V10, P2721, DOI 10.1002/cbic.200900552; Li Jing, 2013, J Mol Signal, V8, P6, DOI 10.1186/1750-2187-8-6; Li M., 2010, CANCER SCI, V99, P2218; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lu D, 2013, MOL PHARMACOL, V84, P787, DOI 10.1124/mol.113.087742; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Matsuo Y, 2009, INT J CANCER, V125, P1027, DOI 10.1002/ijc.24383; Mogi C, 2005, J PHARMACOL SCI, V99, P160, DOI 10.1254/jphs.FP0050599; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; Ozdemir BC, 2015, CANCER CELL, V28, P831, DOI 10.1016/j.ccell.2015.11.002; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Ohlund D, 2017, J EXP MED, V214, P579, DOI 10.1084/jem.20162024; Okada S, 1998, JPN J CLIN ONCOL, V28, P12, DOI 10.1093/jjco/28.1.12; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pilon-Thomas S, 2017, CANCER RES, V77, P2552, DOI 10.1158/0008-5472.CAN-17-0559; Pilon-Thomas S, 2016, CANCER RES, V76, P1381, DOI 10.1158/0008-5472.CAN-15-1743; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roshani R, 2014, CANCER LETT, V345, P157, DOI 10.1016/j.canlet.2013.07.014; Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198; Ryder NM, 2001, J CELL PHYSIOL, V186, P53, DOI 10.1002/1097-4652(200101)186:1<53::AID-JCP1004>3.0.CO;2-Q; Segerstolpe A, 2016, CELL METAB, V24, P593, DOI 10.1016/j.cmet.2016.08.020; Sherman MH, 2014, CELL, V159, P80, DOI 10.1016/j.cell.2014.08.007; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Singh LS, 2007, JNCI-J NATL CANCER I, V99, P1313, DOI 10.1093/jnci/djm107; Snead AN, 2012, FASEB J, V26, P4540, DOI 10.1096/fj.12-213496; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; van Sluis R, 1999, MAGN RESON MED, V41, P743, DOI 10.1002/(SICI)1522-2594(199904)41:4<743::AID-MRM13>3.0.CO;2-Z; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Walter K, 2008, CANCER BIOL THER, V7, P882, DOI 10.4161/cbt.7.6.5869; Wehr AY, 2011, PANCREAS, V40, P557, DOI 10.1097/MPA.0b013e318214efaf; Xie FC, 2015, J MED CHEM, V58, P5075, DOI 10.1021/acs.jmedchem.5b00468; Zhou Honglei, 2014, Oncoscience, V1, P765	65	54	55	2	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1170	1183		10.1096/fj.201700834R	http://dx.doi.org/10.1096/fj.201700834R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29092903	Green Published			2022-12-26	WOS:000427246000006
J	Capogrosso, RF; Mantuano, P; Uaesoontrachoon, K; Cozzoli, A; Giustino, A; Dow, T; Srinivassane, S; Filipovic, M; Bell, C; Vandermeulen, J; Massari, AM; De Bellis, M; Conte, E; Pierno, S; Camerino, GM; Liantonio, A; Nagaraju, K; De Luca, A				Capogrosso, Roberta Francesca; Mantuano, Paola; Uaesoontrachoon, Kitipong; Cozzoli, Anna; Giustino, Arcangela; Dow, Todd; Srinivassane, Sadish; Filipovic, Marina; Bell, Christina; Vandermeulen, Jack; Massari, Ada Maria; De Bellis, Michela; Conte, Elena; Pierno, Sabata; Camerino, Giulia Maria; Liantonio, Antonella; Nagaraju, Kanneboyina; De Luca, Annamaria			Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy	FASEB JOURNAL			English	Article						skeletal muscle; Duchenne muscular dystrophy; preclinical drug testing; murine model; rycals	DUCHENNE MUSCULAR-DYSTROPHY; STANDARD OPERATING PROCEDURES; SKELETAL-MUSCLE; MOUSE MODEL; IN-VIVO; CALCIUM HOMEOSTASIS; ENZYME-RELEASE; KATP CHANNELS; EXERCISE; REGENERATION	Muscle fibers lacking dystrophin undergo a long-term alteration of Ca2+ homeostasis, partially caused by a leaky Ca2+ release ryanodine (RyR) channel. S48168/ARM210, an RyR calcium release channel stabilizer (a Rycal compound), is expected to enhance the rebinding of calstabin to the RyR channel complex and possibly alleviate the pathologic Ca2+ leakage in dystrophin-deficient skeletal and cardiac muscle. This study systematically investigated the effect of S48168/ARM210 on the phenotype of mdx mice by means of a first proof-of-concept, short (4 wk), phase 1 treatment, followed by a 12-wk treatment (phase 2) performed in parallel by 2 independent laboratories. The mdx mice were treated with S48168/ARM210 at two different concentrations (50 or 10 mg/kg/d) in their drinking water for 4 and 12 wk, respectively. The mice were subjected to treadmill sessions twice per week (12 m/min for 30 min) to unmask the mild disease. This testing was followed by in vivo forelimb and hindlimb grip strength and fatigability measurement, ex vivo extensor digitorum longus (EDL) and diaphragm (DIA) force contraction measurement and histologic and biochemical analysis. The treatments resulted in functional (grip strength, ex vivo force production in DIA and EDL muscles) as well as histologic improvement after 4 and 12 wk, with no adverse effects. Furthermore, levels of cellular biomarkers of calcium homeostasis increased. Therefore, these data suggest that S48168/ARM210 may be a safe therapeutic option, at the dose levels tested, for the treatment of Duchenne muscular dystrophy (DMD).	[Capogrosso, Roberta Francesca; Mantuano, Paola; Cozzoli, Anna; Giustino, Arcangela; Massari, Ada Maria; De Bellis, Michela; Conte, Elena; Pierno, Sabata; Camerino, Giulia Maria; Liantonio, Antonella; De Luca, Annamaria] Univ Bari, Dept Pharm Drug Sci, Pharmacol Unit, Bari, Italy; [Uaesoontrachoon, Kitipong; Dow, Todd; Srinivassane, Sadish; Filipovic, Marina; Bell, Christina; Vandermeulen, Jack; Nagaraju, Kanneboyina] Agada Biosci Inc, Halifax, NS, Canada; [Nagaraju, Kanneboyina] SUNY Binghamton, Sch Pharm & Pharmaceut Sci, Binghamton, NY 13902 USA	Universita degli Studi di Bari Aldo Moro; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Nagaraju, K (corresponding author), SUNY Binghamton, Dept Pharmaceut Sci, Sch Pharm & Pharmaceut Sci, AB-G34,POB 6000, Binghamton, NY 13902 USA.; De Luca, A (corresponding author), Univ Bari Aldo Moro, Dept Pharm Drug Sci, Sect Pharmacol, Orabona 4 Campus, I-70125 Bari, Italy.	nagaraju@binghamton.edu; annamaria.deluca@uniba.it	Conte, Elena/AAV-3153-2020; Nagaraju, Kanneboyina/ABA-6525-2021; Conte, Elena/AAF-4055-2019; Nagaraju, Kanneboyina/AAV-7684-2021; Mantuano, Paola/AAG-9696-2019; De Bellis, Michela/ABE-2595-2020	Conte, Elena/0000-0001-8571-5125; Mantuano, Paola/0000-0001-6339-2222; Camerino, Giulia Maria/0000-0003-1410-6327; Dow, Todd/0000-0001-9607-5071	Muscular Dystrophy Association [228338]; U.S. National Institutes of Health [K26OD011171]; Dutch Duchenne Parent Project (NL-DPP); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K26OD011171] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Duchenne Parent Project (NL-DPP); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Dr. Deborah McClellan for editing the manuscript. The compound used for this study was provided by Servier (Suresnes, France) and Armgo Pharma (Tarrytown, NY, USA), who are jointly developing S48168/ARM210 for indications including DMD. This study was supported in part by funds from Muscular Dystrophy Association Grant 228338 (Chicago, IL, USA); by U.S. National Institutes of Health Grant K26OD011171 (to K.N.); and by funds from the Dutch Duchenne Parent Project (NL-DPP) (to A.D.L.). K.N. and A.D.L. are senior coauthors. K.N. is a cofounder of Reveragen Biopharma, which is engaged in the development of therapeutic products for DMD. The remaining authors declare no conflicts of interest.	ARMSTRONG RB, 1990, MED SCI SPORT EXER, V22, P429; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; Burdi R, 2006, NEUROMUSCULAR DISORD, V16, P237, DOI 10.1016/j.nmd.2006.01.013; Burdi R, 2009, J APPL PHYSIOL, V106, P1311, DOI 10.1152/japplphysiol.90985.2008; Camerino GM, 2014, HUM MOL GENET, V23, P5720, DOI 10.1093/hmg/ddu287; Capogrosso RF, 2017, J APPL PHYSIOL, V122, P828, DOI 10.1152/japplphysiol.00776.2015; Capogrosso RF, 2016, PHARMACOL RES, V106, P101, DOI 10.1016/j.phrs.2016.02.016; CARLSON BM, 1973, AM J ANAT, V137, P119, DOI 10.1002/aja.1001370202; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Cozzoli A, 2014, AM J PHYSIOL-CELL PH, V307, pC634, DOI 10.1152/ajpcell.00372.2013; Dahlqvist JR, 2014, MUSCLE NERVE, V49, P261, DOI 10.1002/mus.23909; De Luca A, 2005, AM J PATHOL, V166, P477, DOI 10.1016/S0002-9440(10)62270-5; De Luca A, 2003, J PHARMACOL EXP THER, V304, P453, DOI 10.1124/jpet.102.041343; De Luca A, 2008, NEUROBIOL DIS, V32, P243, DOI 10.1016/j.nbd.2008.07.009; Deconinck N, 2007, PEDIATR NEUROL, V36, P1, DOI 10.1016/j.pediatrneurol.2006.09.016; Duan DS, 2016, J CARDIOVASC TRANSL, V9, P85, DOI 10.1007/s12265-015-9669-6; EMERY AEH, 1980, BRIT MED J, V280, P355, DOI 10.1136/bmj.280.6211.355; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; Fauconnier J, 2010, P NATL ACAD SCI USA, V107, P1559, DOI 10.1073/pnas.0908540107; FONG P, 1990, SCIENCE, V250, P673, DOI 10.1126/science.2173137; Fraysse B, 2004, NEUROBIOL DIS, V17, P144, DOI 10.1016/j.nbd.2004.06.002; Friden J, 2001, SCAND J MED SCI SPOR, V11, P126, DOI 10.1034/j.1600-0838.2001.011002126.x; Gailly P, 2002, BBA-PROTEINS PROTEOM, V1600, P38, DOI 10.1016/S1570-9639(02)00442-9; Goonasekera SA, 2011, J CLIN INVEST, V121, P1044, DOI 10.1172/JCI43844; Grange RW, 2002, AM J PHYSIOL-CELL PH, V283, pC1090, DOI 10.1152/ajpcell.00450.2001; Grefte S, 2007, STEM CELLS DEV, V16, P857, DOI 10.1089/scd.2007.0058; Grounds MD, 2008, NEUROBIOL DIS, V31, P1, DOI 10.1016/j.nbd.2008.03.008; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1991, MOL ASPECTS MED, V12, P175, DOI 10.1016/0098-2997(91)90001-3; HUTTER OF, 1991, J MUSCLE RES CELL M, V12, P585, DOI 10.1007/BF01738447; KOMULAINEN J, 1994, PFLUG ARCH EUR J PHY, V428, P346, DOI 10.1007/BF00724517; Malerba A, 2011, MOL THER, V19, P345, DOI 10.1038/mt.2010.261; Mele A, 2014, BIOCHEM PHARMACOL, V91, P266, DOI 10.1016/j.bcp.2014.06.023; MENKE A, 1991, NATURE, V349, P69, DOI 10.1038/349069a0; MENKE A, 1995, J CELL SCI, V108, P727; OHLENDIECK K, 1991, J CELL BIOL, V115, P1685, DOI 10.1083/jcb.115.6.1685; Pal R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5425; PASTERNAK C, 1995, J CELL BIOL, V128, P355, DOI 10.1083/jcb.128.3.355; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Pierno S, 2014, AGE, V36, P73, DOI 10.1007/s11357-013-9544-9; Pierno S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065167; Robert V, 2001, J BIOL CHEM, V276, P4647, DOI 10.1074/jbc.M006337200; Rolland JF, 2006, NEUROBIOL DIS, V24, P466, DOI 10.1016/j.nbd.2006.08.010; ROSES AD, 1975, NATURE, V254, P350, DOI 10.1038/254350a0; Sali A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034204; Sharp PS, 2011, MOL THER, V19, P165, DOI 10.1038/mt.2010.213; SPENCER MJ, 1995, J BIOL CHEM, V270, P10909, DOI 10.1074/jbc.270.18.10909; Spurney CF, 2009, MUSCLE NERVE, V39, P591, DOI 10.1002/mus.21211; Terrill JR, 2012, NEUROMUSCULAR DISORD, V22, P427, DOI 10.1016/j.nmd.2011.11.007; Tricarico D, 2012, J PHARMACOL EXP THER, V340, P266, DOI 10.1124/jpet.111.185835; TURNER PR, 1988, NATURE, V335, P735, DOI 10.1038/335735a0; TURNER PR, 1991, J CELL BIOL, V115, P1701, DOI 10.1083/jcb.115.6.1701; Uaesoontrachoon K, 2014, HUM MOL GENET, V23, P3239, DOI 10.1093/hmg/ddu033; VANDERMEULEN JH, 1991, J APPL PHYSIOL, V71, P999, DOI 10.1152/jappl.1991.71.3.999; Wacker SJ, 2012, CHEMMEDCHEM, V7, P1775, DOI 10.1002/cmdc.201100600; Wang QL, 2015, J MOL CELL CARDIOL, V89, P177, DOI 10.1016/j.yjmcc.2015.11.009; Wang X, 2005, NAT CELL BIOL, V7, P525, DOI 10.1038/ncb1254; Waning DL, 2015, NAT MED, V21, P1262, DOI 10.1038/nm.3961; Whitehead NP, 2008, J PHYSIOL-LONDON, V586, P2003, DOI 10.1113/jphysiol.2007.148338; Whitehead NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015354; Willmann Raffaella, 2015, J Neuromuscul Dis, V2, P113; Willmann R, 2012, NEUROMUSCULAR DISORD, V22, P43, DOI 10.1016/j.nmd.2011.04.012; Willmann R, 2009, NEUROMUSCULAR DISORD, V19, P241, DOI 10.1016/j.nmd.2008.11.015	63	32	33	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					1025	1043		10.1096/fj.201700182RRR	http://dx.doi.org/10.1096/fj.201700182RRR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29097503	Green Published, hybrid			2022-12-26	WOS:000425146900042
J	Wei, PC; Song, GJ; Shi, MY; Zhou, YF; Liu, Y; Lei, J; Chen, P; Yin, L				Wei, Pengcheng; Song, Guangji; Shi, Mengyang; Zhou, Yafei; Liu, Yang; Lei, Jun; Chen, Peng; Yin, Lei			Substrate analog interaction with MCR-1 offers insight into the rising threat of the plasmid-mediated transferable colistin resistance	FASEB JOURNAL			English	Article						X-ray crystallography; antibiotic resistance; template for drug design	PHOSPHOETHANOLAMINE TRANSFERASE; GENE MCR-1; ANTIBIOTIC-RESISTANCE; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; POLYMYXIN; MECHANISMS; SOFTWARE; TOOLS	Colistin is considered a last-resort antibiotic against most gram-negative bacteria. Recent discoveries of a plasmid-mediated, transferable mobilized colistin-resistance gene (mcr-1) on all continents have heralded the imminent emergence of pan-drug-resistant superbacteria. The inner-membrane protein MCR-1 can catalyze the transfer of phosphoethanolamine (PEA) to lipid A, resulting in colistin resistance. However, little is known about the mechanism, and few drugs exist to address this issue. We present crystal structures revealing the MCR-1 catalytic domain (cMCR-1) as a monozinc metalloprotein with ethanolamine (ETA) and d-glucose, respectively, thus highlighting 2 possible substrate-binding pockets in the MCR-1-catalyzed PEA transfer reaction. Mutation of the residues involved in ETA and d-glucose binding impairs colistin resistance in recombinant Escherichia coli containing full-length MCR-1. Partial analogs of the substrate are used for cocrystallization with cMCR-1, providing valuable information about the family of PEA transferases. One of the analogs, ETA, causes clear inhibition of polymyxin B resistance, highlighting its potential for drug development. These data demonstrate the crucial role of the PEA- and lipid A-binding pockets and provide novel insights into the structure-based mechanisms, important drug-target hot spots, and a drug template for further drug development to combat the urgent, rising threat of MCR-1-mediated antibiotic resistance.	[Wei, Pengcheng; Song, Guangji; Shi, Mengyang; Zhou, Yafei; Liu, Yang; Lei, Jun; Chen, Peng; Yin, Lei] Wuhan Univ, Dept Biochem & Mol Biol, Coll Life Sci, State Key Lab Virol,Hubei Key Lab Cell Homeostasi, Luojia Hill, Wuhan 430072, Hubei, Peoples R China	Wuhan University	Yin, L (corresponding author), Wuhan Univ, Dept Biochem & Mol Biol, Coll Life Sci, State Key Lab Virol,Hubei Key Lab Cell Homeostasi, Luojia Hill, Wuhan 430072, Hubei, Peoples R China.	yinlei@whu.edu.cn	Wei, Pengcheng/ABH-2631-2020	Liu, Yang/0000-0002-2420-2606; yin, lei/0000-0001-5203-2766; Wei, Pengcheng/0000-0003-0002-9439	National Basic Research Program of China [2014CB910103]; National Natural Science Foundation of China [31470738]; National Thousand (Young) Talents Program from the Office of Global Experts Recruitment in China	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Thousand (Young) Talents Program from the Office of Global Experts Recruitment in China	The authors thank Na Yang and the staff of the Protein Research Core Facility at the Institute of Biophysics, Chinese Academy of Sciences; and Hengjiang Cong and the X-ray facility at the College of Chemistry and Molecular Sciences, Wuhan University, for their technical support during crystals testing. The authors also thank the staff from BL17U1/BL19U1 Beamline of the National Center for Protein Sciences Shanghai at the Shanghai Synchrotron Radiation Facility, for assistance during data collection. This work was supported by the National Basic Research Program of China (Grant 2014CB910103 to L.Y.) and the National Natural Science Foundation of China (Grant 31470738 to L.Y.). L.Y. received scholarships from the National Thousand (Young) Talents Program from the Office of Global Experts Recruitment in China. The authors declare no conflicts of interest.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Anandan A, 2017, P NATL ACAD SCI USA, V114, P2218, DOI 10.1073/pnas.1612927114; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biswas S, 2012, EXPERT REV ANTI-INFE, V10, P917, DOI [10.1586/eri.12.78, 10.1586/ERI.12.78]; Blair JMA, 2015, NAT REV MICROBIOL, V13, P42, DOI 10.1038/nrmicro3380; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Fage CD, 2014, ACTA CRYSTALLOGR D, V70, P2730, DOI 10.1107/S1399004714017623; Falgenhauer L, 2016, LANCET INFECT DIS, V16, P282, DOI 10.1016/S1473-3099(16)00009-8; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Gao RS, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005957; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hinchliffe P, 2017, SCI REP-UK, V7, DOI 10.1038/srep39392; Hu ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep38793; Hu YF, 2016, LANCET INFECT DIS, V16, P146, DOI 10.1016/S1473-3099(15)00533-2; Jiang XL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15784; Kelesidis T, 2015, EXPERT OPIN DRUG SAF, V14, P1687, DOI 10.1517/14740338.2015.1088520; Kieffer N, 2017, ANTIMICROB AGENTS CH, V61; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Liu T, 2017, P NATL ACAD SCI USA, V114, P7683, DOI 10.1073/pnas.1621486114; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; Ma GX, 2016, SCI REP-UK, V6, DOI 10.1038/srep39540; Malhotra-Kumar S, 2016, LANCET INFECT DIS, V16, P283, DOI 10.1016/S1473-3099(16)00012-8; Martinez JL, 2008, SCIENCE, V321, P365, DOI 10.1126/science.1159483; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGann P, 2016, ANTIMICROB AGENTS CH, V60, P4420, DOI 10.1128/AAC.01103-16; Mulvey MR, 2016, LANCET INFECT DIS, V16, P289, DOI [10.1016/S1473-3099(16)00067-0, 10.1016/S1473-3099(15)00540-X]; Needham BD, 2013, NAT REV MICROBIOL, V11, P467, DOI 10.1038/nrmicro3047; Nei M., 2000, MOL EVOLUTION PHYLOG; Norimatsu Y, 2017, NATURE, V545, P193, DOI 10.1038/nature22357; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Palmer AC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5296; Poirel L, 2017, CLIN MICROBIOL REV, V30, P557, DOI 10.1128/CMR.00064-16; Rosay T, 2015, MBIO, V6, DOI 10.1128/mBio.01033-15; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schwarz S, 2016, J ANTIMICROB CHEMOTH, V71, P2066, DOI 10.1093/jac/dkw274; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sprenger M, 2016, SCIENCE, V351, P1264, DOI 10.1126/science.aad9450; Stojanoski V, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0303-0; STORM DR, 1977, ANNU REV BIOCHEM, V46, P723, DOI 10.1146/annurev.bi.46.070177.003451; Sun J, 2017, MBIO, V8, DOI 10.1128/mBio.00625-17; Suzuki S, 2016, LANCET INFECT DIS, V16, P284, DOI 10.1016/S1473-3099(16)00008-6; Trimble M. J., 2016, COLD SPRING HARB PER, V6; Velkov T, 2013, FUTURE MICROBIOL, V8, P711, DOI [10.2217/FMB.13.39, 10.2217/fmb.13.39]; Wanty C, 2013, J MOL BIOL, V425, P3389, DOI 10.1016/j.jmb.2013.06.029; WESTERHOFF HV, 1989, P NATL ACAD SCI USA, V86, P6597, DOI 10.1073/pnas.86.17.6597; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wright GD, 2011, CHEM COMMUN, V47, P4055, DOI 10.1039/c0cc05111j; Xavier B. B., 2016, EURO SURVEILL, V21; Yang L, 2000, BIOPHYS J, V79, P2002, DOI 10.1016/S0006-3495(00)76448-4; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	58	23	25	0	23	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2018	32	2					1085	1098		10.1096/fj.201700705R	http://dx.doi.org/10.1096/fj.201700705R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FW2PS	29079699	Bronze			2022-12-26	WOS:000425146900046
J	Honda, A; Usui, H; Sakimura, K; Igarashi, M				Honda, Atsuko; Usui, Hiroshi; Sakimura, Kenji; Igarashi, Michihiro			Rufy3 is an adapter protein for small GTPases that activates a Rac guanine nucleotide exchange factor to control neuronal polarity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RUN DOMAIN; GROWTH; IDENTIFICATION; AXONS; GENE; SUPPRESSES; OUTGROWTH; CORTEX; FASCIN; RAFTS	RUN and FYVE domain-containing 3 (Rufy3) is an adapter protein for small GTPase proteins and is bound to activated Rap2, a Ras family protein in the developing neuron. Previously, we reported the presence of a rapid cell polarity determination mechanism involving Rufy3, which is likely required for in vivo neuronal development. However, the molecular details of this mechanism are unclear. To this end, here we produced Rufy3 knock-out (Rufy3-KO) mice to study the role of Rufy3 in more detail. Examining Rufy3-KO neurons, we found that Rufy3 is recruited via glycoprotein M6A to detergent-resistant membrane domains, which are biochemically similar to lipid rafts. We also clarified that Rufy3, as a component of a ternary complex, induces the assembly of Rap2 in the axonal growth cone, whereas in the absence of Rufy3, the accumulation of a Rac guanine nucleotide exchange factor, T-cell lymphoma invasion and metastasis 2 (Tiam2/STEF), is inhibited downstream of Rap2. We also found that Rufy3 regulates the cellular localization of Rap2 and Tiam2/STEF. Taken together, we conclude that Rufy3 is a physiological adapter for Rap2 and activates Tiam2/STEF in glycoprotein M6A-regulated neuronal polarity and axon growth.	[Honda, Atsuko; Igarashi, Michihiro] Niigata Univ, Inst Brain Res, Dept Neurochem & Mol Cell Biol, Chou Ku, Niigata 9518510, Japan; [Honda, Atsuko; Igarashi, Michihiro] Niigata Univ, Inst Brain Res, Transdisciplinary Res Program, Chou Ku, Niigata 9518510, Japan; [Usui, Hiroshi; Sakimura, Kenji] Niigata Univ, Inst Brain Res, Dept Cellular Neurobiol, Chou Ku, Niigata 9518510, Japan	Niigata University; Niigata University; Niigata University	Igarashi, M (corresponding author), Niigata Univ, Inst Brain Res, Dept Neurochem & Mol Cell Biol, Chou Ku, Niigata 9518510, Japan.; Igarashi, M (corresponding author), Niigata Univ, Inst Brain Res, Transdisciplinary Res Program, Chou Ku, Niigata 9518510, Japan.	tarokaja@med.niigata-u.ac.jp			TOGO-NO and HOKATSU-NO (Comprehensive Brain Science Network) on Innovative Areas; Niigata University; Uehara Memorial Science Promoting Foundation; RIKEN BioResource Center; KAKENHI [17023019, 22240040, 24111515]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [15K06770, 24700319]; Japan Society for the Promotion of Science; MEXT of Japan; Tsukada Milk Co.; Novartis Pharma Ltd.; Takeda Foundation; Grants-in-Aid for Scientific Research [16H06276, 17K19444] Funding Source: KAKEN	TOGO-NO and HOKATSU-NO (Comprehensive Brain Science Network) on Innovative Areas; Niigata University; Uehara Memorial Science Promoting Foundation; RIKEN BioResource Center; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tsukada Milk Co.; Novartis Pharma Ltd.; Takeda Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by TOGO-NO and HOKATSU-NO (Comprehensive Brain Science Network) on Innovative Areas (to M. I.); project-promoting grants from Niigata University; Uehara Memorial Science Promoting Foundation (to M. I.); RIKEN BioResource Center grants for gene targeting in production of mice (to M. I.); KAKENHI Grants 17023019, 22240040, and 24111515 (to M. I.) and 15K06770 and 24700319 (to A. H.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and Japan Society for the Promotion of Science; the Platform of Advanced Animal Model Support from MEXT of Japan (to M. I. and K. S.); grants from Tsukada Milk Co. and Novartis Pharma Ltd. (to A. H.); and a Takeda Foundation research grant (to Y. I.). The authors declare that they have no conflicts of interest with the contents of this article.	Caceres A, 2012, CURR OPIN CELL BIOL, V24, P547, DOI 10.1016/j.ceb.2012.05.011; Cromm PM, 2015, ANGEW CHEM INT EDIT, V54, P13516, DOI 10.1002/anie.201504357; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Fukuda M, 2011, CELL STRUCT FUNCT, V36, P155, DOI 10.1247/csf.11001; Fuse T, 2004, BIOCHEM BIOPH RES CO, V318, P665, DOI 10.1016/j.bbrc.2004.04.076; Honda A, 2017, J NEUROSCI, V37, P4046, DOI 10.1523/JNEUROSCI.3319-16.2017; Hoshinoso M, 1999, J BIOL CHEM, V274, P17837, DOI 10.1074/jbc.274.25.17837; Igarashi M, 2014, NEUROSCI RES, V88, P1, DOI 10.1016/j.neures.2014.07.005; Janoueix-Lerosey I, 1998, EUR J BIOCHEM, V252, P290, DOI 10.1046/j.1432-1327.1998.2520290.x; Kitagishi Y, 2013, INT J MOL SCI, V14, P6487, DOI 10.3390/ijms14036487; Kukimoto-Niino M, 2006, J BIOL CHEM, V281, P31843, DOI 10.1074/jbc.M604960200; Matsuo N, 2002, J BIOL CHEM, V277, P2860, DOI 10.1074/jbc.M106186200; Mishina M, 2007, NEUROSCI RES, V58, P105, DOI 10.1016/j.neures.2007.01.004; Miyamoto Y, 2006, P NATL ACAD SCI USA, V103, P10444, DOI 10.1073/pnas.0603914103; Mori T, 2007, J BIOL CHEM, V282, P19884, DOI 10.1074/jbc.M700770200; Nakazawa H, 2012, J NEUROSCI, V32, P12712, DOI 10.1523/JNEUROSCI.0989-12.2012; Namba T, 2015, PHYSIOL REV, V95, P995, DOI 10.1152/physrev.00025.2014; Namba T, 2014, NEURON, V81, P814, DOI 10.1016/j.neuron.2013.12.015; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; Nozumi M, 2017, CELL REP, V18, P2203, DOI 10.1016/j.celrep.2017.02.008; Nozumi M, 2009, P NATL ACAD SCI USA, V106, P17211, DOI 10.1073/pnas.0904092106; Sasaki Y, 1996, J NEUROCHEM, V66, P980; Shah B, 2016, BIOL CHEM, V397, P1055, DOI 10.1515/hsz-2016-0165; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Stankiewicz TR, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00314; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Villarroel-Campos D, 2016, CYTOSKELETON, V73, P498, DOI 10.1002/cm.21303; Wei Z, 2014, J NEUROCHEM, V130, P678, DOI 10.1111/jnc.12740	28	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					20936	20946		10.1074/jbc.M117.809541	http://dx.doi.org/10.1074/jbc.M117.809541			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29089386	Green Published, hybrid			2022-12-26	WOS:000418453400011
J	Museyko, O; Gerner, B; Engelke, K				Museyko, Oleg; Gerner, Bastian; Engelke, Klaus			A new method to determine cortical bone thickness in CT images using a hybrid approach of parametric profile representation and local adaptive thresholds: Accuracy results	PLOS ONE			English	Article							QUANTITATIVE COMPUTED-TOMOGRAPHY; THIN STRUCTURES; CLINICAL CT; DENSITY; SEGMENTATION; RESOLUTION; QCT; HIP	Motivation Cortical bone is an important contributor to bone strength and is pivotal to understand the etiology of osteoporotic fractures and the specific mechanisms of antiosteoporotic treatment regimen. 3D computed tomography (CT) can be used to measure cortical thickness, density, and mass in the proximal femur, lumbar vertebrae, and distal forearm. However, the spatial resolution of clinical whole body CT scanners is limited by radiation exposure; partial volume artefacts severely impair the accurate assessment of cortical parameters, in particular in locations where the cortex is thin such as in the lumbar vertebral bodies or in the femoral neck. Method Model-based deconvolution approaches recover the cortical thickness by numerically deconvolving the image along 1 D profiles using an estimated scanner point spread function (PSF) and a hypothesized uniform cortical bone mineral density (reference density). In this work we provide a new essentially analytical unique solution to the model-based cortex recovery problem using few characteristics of the measured profile and thus eliminate the non-linear optimization step for deconvolution. Also, the proposed approach allows to get rid of the PSF in the model and reduces sensitivity to errors in the reference density. Additionally, run-time and memory effective computation of cortical thickness was achieved with the help of a lookup table. Results The method accuracy and robustness was validated and compared to that of a deconvolution approach recently proposed for cortical bone and of the 50% relative threshold technique: in a simulated environment with noise and various error levels in the reference density and using CT acquisitions of the European Forearm Phantom (EFP II), a modification of a widely used anthropomorphic standard of cortical and trabecular bone compartments that was scanned with various scan protocols. Conclusion Results of simulations and of phantom data analysis verified the following properties of the new method: 1) Robustness against errors in the reference density. 2) Excellent accuracy on ground truth data with various noise levels. 3) Very fast computation using a lookup table.	[Museyko, Oleg; Gerner, Bastian; Engelke, Klaus] Univ Erlangen Nurnberg, Inst Med Phys, Henkestr 91, Erlangen, Germany	University of Erlangen Nuremberg	Museyko, O (corresponding author), Univ Erlangen Nurnberg, Inst Med Phys, Henkestr 91, Erlangen, Germany.	oleg.museyko@imp.uni-eriangen.de						Acosta O, 2009, MED IMAGE ANAL, V13, P730, DOI 10.1016/j.media.2009.07.003; Buie HR, 2007, BONE, V41, P505, DOI 10.1016/j.bone.2007.07.007; Davis KA, 2007, CALCIFIED TISSUE INT, V81, P364, DOI 10.1007/s00223-007-9076-3; Engelke K, 2015, J CLIN DENSITOM, V18, P338, DOI 10.1016/j.jocd.2015.06.012; Hangartner T. N., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P9; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; Holzer G, 2009, J BONE MINER RES, V24, P468, DOI 10.1359/JBMR.081108; Kang Y, 2003, IEEE T MED IMAGING, V22, P586, DOI 10.1109/TMI.2003.812265; Museyko O, 2015, 3 MICCAI WORKSH CHAL, P66; Nawathe S, 2015, J BIOMECH, V48, P816, DOI 10.1016/j.jbiomech.2014.12.022; Prevrhal S, 1999, PHYS MED BIOL, V44, P751, DOI 10.1088/0031-9155/44/3/017; Treece GM, 2015, MED IMAGE ANAL, V20, P249, DOI 10.1016/j.media.2014.11.012; Treece GM, 2012, MED IMAGE ANAL, V16, P952, DOI 10.1016/j.media.2012.02.008; Treece GM, 2010, MED IMAGE ANAL, V14, P276, DOI 10.1016/j.media.2010.01.003; Yezzi A, 2002, LECT NOTES COMPUT SC, V2353, P575	18	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187097	10.1371/journal.pone.0187097	http://dx.doi.org/10.1371/journal.pone.0187097			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29107950	gold, Green Submitted, Green Published			2022-12-26	WOS:000414424600013
J	Wang, C; Pakhomova, S; Newcomer, ME; Christner, BC; Luo, BH				Wang, Chen; Pakhomova, Svetlana; Newcomer, Marcia E.; Christner, Brent C.; Luo, Bing-Hao			Structural basis of antifreeze activity of a bacterial multi-domain antifreeze protein	PLOS ONE			English	Article							ICE-BINDING PROTEIN; ANTARCTIC BACTERIUM; THERMAL HYSTERESIS; GROWTH-INHIBITION; CRYSTAL-STRUCTURE; CLATHRATE WATERS; WINTER FLOUNDER; ARCTIC YEAST; MECHANISM; FISHES	Antifreeze proteins (AFPs) enhance the survival of organisms inhabiting cold environments by affecting the formation and/or structure of ice. We report the crystal structure of the first multi-domain AFP that has been characterized. The two ice binding domains are structurally similar. Each consists of an irregular beta-helix with a triangular cross-section and a long alpha-helix that runs parallel on one side of the beta-helix. Both domains are stabilized by hydrophobic interactions. A flat plane on the same face of each domain's P-helix was identified as the ice binding site. Mutating any of the smaller residues on the ice binding site to bulkier ones decreased the antifreeze activity. The bulky side chain of Leu174 in domain A sterically hinders the binding of water molecules to the protein backbone, partially explaining why antifreeze activity by domain A is inferior to that of domain B. Our data provide a molecular basis for understanding differences in antifreeze activity between the two domains of this protein and general insight on how structural differences in the ice-binding sites affect the activity of AFPs.	[Wang, Chen; Pakhomova, Svetlana; Newcomer, Marcia E.; Christner, Brent C.; Luo, Bing-Hao] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Christner, Brent C.] Univ Florida, Dept Microbiol & Cell Sci, Biodivers Inst, Gainesville, FL 32611 USA	Louisiana State University System; Louisiana State University; State University System of Florida; University of Florida	Luo, BH (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	luo@lsu.edu		Wang, Chen/0000-0001-5769-2077; Luo, Bing-Hao/0000-0001-8602-4019	U.S. Department of Energy [DE-AC02-98CH10886]	U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by the U.S. Department of Energy (DE-AC02-98CH10886). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achberger AM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00255; Baardsnes J, 1999, FEBS LETT, V463, P87, DOI 10.1016/S0014-5793(99)01588-4; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brown Jennifer R, 2014, Biotechnol Rep (Amst), V3, P60, DOI 10.1016/j.btre.2014.06.005; Celik Y, 2010, P NATL ACAD SCI USA, V107, P5423, DOI 10.1073/pnas.0909456107; Chao HM, 1997, BIOCHEMISTRY-US, V36, P14652, DOI 10.1021/bi970817d; Cheng J, 2016, BIOCH J; Davies PL, 2014, TRENDS BIOCHEM SCI, V39, P548, DOI 10.1016/j.tibs.2014.09.005; DEVRIES AL, 1970, J BIOL CHEM, V245, P2901; DEVRIES AL, 1983, ANNU REV PHYSIOL, V45, P245, DOI 10.1146/annurev.ph.45.030183.001333; DEVRIES AL, 1969, SCIENCE, V163, P1073, DOI 10.1126/science.163.3871.1073; Do H, 2014, ACTA CRYSTALLOGR D, V70, P1061, DOI 10.1107/S1399004714000996; Drori R, 2015, LANGMUIR, V31, P5805, DOI 10.1021/acs.langmuir.5b00345; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fletcher GL, 2001, ANNU REV PHYSIOL, V63, P359, DOI 10.1146/annurev.physiol.63.1.359; Garnham CP, 2011, P NATL ACAD SCI USA, V108, P7363, DOI 10.1073/pnas.1100429108; Gilbert JA, 2005, FEMS MICROBIOL LETT, V245, P67, DOI 10.1016/j.femsle.2005.02.022; Graether SP, 2000, NATURE, V406, P325, DOI 10.1038/35018610; Graham LA, 1997, NATURE, V388, P727, DOI 10.1038/41908; Griffith M, 2004, TRENDS PLANT SCI, V9, P399, DOI 10.1016/j.tplants.2004.06.007; Hakim A, 2013, J BIOL CHEM, V288, P12295, DOI 10.1074/jbc.M113.450973; Hanada Y, 2014, FEBS J, V281, P3576, DOI 10.1111/febs.12878; Haymet ADJ, 1998, FEBS LETT, V430, P301, DOI 10.1016/S0014-5793(98)00652-8; HOWLIN B, 1993, J APPL CRYSTALLOGR, V26, P622, DOI 10.1107/S0021889893002729; Jia ZC, 2002, TRENDS BIOCHEM SCI, V27, P101, DOI 10.1016/S0968-0004(01)02028-X; Kajava AV, 2006, ADV PROTEIN CHEM, V73, P55, DOI 10.1016/S0065-3233(06)73003-0; KNIGHT CA, 1986, CRYOBIOLOGY, V23, P256, DOI 10.1016/0011-2240(86)90051-9; KNIGHT CA, 1993, BIOPHYS J, V64, P252, DOI 10.1016/S0006-3495(93)81361-4; Knight CA, 2000, NATURE, V406, P249, DOI 10.1038/35018671; KNIGHT CA, 1989, SCIENCE, V245, P505, DOI 10.1126/science.245.4917.505; KNIGHT CA, 1984, NATURE, V308, P295, DOI 10.1038/308295a0; Ko TP, 2003, BIOPHYS J, V84, P1228, DOI 10.1016/S0006-3495(03)74938-8; Kondo H, 2012, P NATL ACAD SCI USA, V109, P9360, DOI 10.1073/pnas.1121607109; Kristiansen E, 2005, CRYOBIOLOGY, V51, P262, DOI 10.1016/j.cryobiol.2005.07.007; Lee JH, 2012, J BIOL CHEM, V287, P11460, DOI 10.1074/jbc.M111.331835; Leinala EK, 2002, J BIOL CHEM, V277, P33349, DOI 10.1074/jbc.M205575200; Liou YC, 2000, NATURE, V406, P322, DOI 10.1038/35018604; Liu Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000548; Loewen MC, 1999, BIOCHEMISTRY-US, V38, P4743, DOI 10.1021/bi982602p; Marshall CB, 2002, FEBS LETT, V529, P261, DOI 10.1016/S0014-5793(02)03355-0; MAZUR P, 1970, SCIENCE, V168, P939, DOI 10.1126/science.168.3934.939; Meister K, 2014, P NATL ACAD SCI USA, V111, P17732, DOI 10.1073/pnas.1414188111; Middleton AJ, 2012, J MOL BIOL, V416, P713, DOI 10.1016/j.jmb.2012.01.032; Nada H, 2012, POLYM J, V44, P690, DOI 10.1038/pj.2012.13; Nutt DR, 2008, J AM CHEM SOC, V130, P13066, DOI 10.1021/ja8034027; OTWINOWSKI Z, MACROMOLECULAR CRYST, P307; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Park KS, 2012, CRYOBIOLOGY, V64, P286, DOI 10.1016/j.cryobiol.2012.02.014; Pentelute BL, 2008, J AM CHEM SOC, V130, P9695, DOI 10.1021/ja8013538; Price PB, 2000, P NATL ACAD SCI USA, V97, P1247, DOI 10.1073/pnas.97.3.1247; Raymond JA, 2008, EXTREMOPHILES, V12, P713, DOI 10.1007/s00792-008-0178-2; Roberts E, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-382; Schrodinger LLC, PYMOL MOLECULAR GRAP; SICHERI F, 1995, NATURE, V375, P427, DOI 10.1038/375427a0; Smolin N, 2008, J PHYS CHEM B, V112, P6193, DOI 10.1021/jp710546e; Sonnichsen FD, 1996, STRUCTURE, V4, P1325, DOI 10.1016/S0969-2126(96)00140-2; Sun TJ, 2014, SCIENCE, V343, P795, DOI 10.1126/science.1247407; Wang C, 2016, BIOCHEMISTRY-US, V55, P3975, DOI 10.1021/acs.biochem.6b00323; Yang C, 2004, BIOPHYS CHEM, V109, P137, DOI 10.1016/j.bpc.2003.10.024; Yeh Y, 1996, CHEM REV, V96, P601, DOI 10.1021/cr950260c; Zhang W, 1998, J BIOL CHEM, V273, P34806, DOI 10.1074/jbc.273.52.34806	61	11	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187169	10.1371/journal.pone.0187169	http://dx.doi.org/10.1371/journal.pone.0187169			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29108002	Green Published, Green Submitted, gold			2022-12-26	WOS:000414424600017
J	Kim, H; Park, CM; Keam, B; Park, SJ; Kim, M; Kim, TM; Kim, DW; Heo, DS; Goo, JM				Kim, Hyungjin; Park, Chang Min; Keam, Bhumsuk; Park, Sang Joon; Kim, Miso; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog; Goo, Jin Mo			The prognostic value of CT radiomic features for patients with pulmonary adenocarcinoma treated with EGFR tyrosine kinase inhibitors	PLOS ONE			English	Article							CELL LUNG-CANCER; TUMOR HETEROGENEITY; TEXTURE ANALYSIS; NSCLC PATIENTS; FREE SURVIVAL; TOMOGRAPHY; GEFITINIB; NODULES; RESISTANCE; PREDICTION	Purpose To determine if the radiomic features on CT can predict progression-free survival (PFS) in epidermal growth factor receptor (EGFR) mutant adenocarcinoma patients treated with first-line EGFR tyrosine kinase inhibitors (TKIs) and to identify the incremental value of radiomic features over conventional clinical factors in PFS prediction. Methods In this institutional review board - approved retrospective study, pretreatment contrast-enhanced CT and first follow-up CT after initiation of TKIs were analyzed in 48 patients (M:F = 23: 25; median age: 61 years). Radiomic features at baseline, at 1st first follow-up, and the percentage change between the two were determined. A Cox regression model was used to predict PFS with nonredundant radiomic features and clinical factors, respectively. The incremental value of radiomic features over the clinical factors in PFS prediction was also assessed by way of a concordance index. Results Roundness (HR: 3.91; 95% CI: 1.72, 8.90; P = 0.001) and grey-level nonuniformity (HR: 3.60; 95% CI: 1.80, 7.18; P<0.001) were independent predictors of PFS. For clinical factors, patient age (HR: 2.11; 95% CI: 1.01, 4.39; P = 0.046), baseline tumor diameter (HR: 1.03; 95% CI: 1.01, 1.05; P = 0.002), and treatment response (HR: 0.46; 95% CI: 0.24, 0.87; P = 0.017) were independent predictors. The addition of radiomic features to clinical factors significantly improved predictive performance (concordance index; combined model = 0.77, clinical-only model = 0.69, P<0.001). Conclusions Radiomic features enable PFS estimation in EGFR mutant adenocarcinoma patients treated with first-line EGFR TKIs. Radiomic features combined with clinical factors provide significant improvement in prognostic performance compared with using only clinical factors.	[Kim, Hyungjin; Park, Chang Min; Park, Sang Joon; Goo, Jin Mo] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Park, Chang Min; Goo, Jin Mo] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea; [Park, Chang Min; Keam, Bhumsuk; Park, Sang Joon; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog; Goo, Jin Mo] Seoul Natl Univ, Canc Res Instr, Seoul, South Korea; [Keam, Bhumsuk; Kim, Miso; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Park, CM (corresponding author), Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea.; Park, CM (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea.; Park, CM; Keam, B (corresponding author), Seoul Natl Univ, Canc Res Instr, Seoul, South Korea.; Keam, B (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea.	cmpark.morphius@gmail.com; bhumsuk@snu.a.c.kr	Kim, Dong-Wan/J-5391-2012	Park, Chang Min/0000-0003-1884-3738	Seoul National University Hospital Research Fund [05-2016-0050]	Seoul National University Hospital Research Fund	This study was supported by grant no. 05-2016-0050 from the Seoul National University Hospital Research Fund. http://www.scuh.org/pub/. CMP received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4789; Ahn SY, 2015, INVEST RADIOL, V50, P719, DOI 10.1097/RLI.0000000000000174; Benz MR, 2011, J NUCL MED, V52, P1684, DOI 10.2967/jnumed.111.095257; Budczies J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051862; Bullard JW, 2013, POWDER TECHNOL, V249, P241, DOI 10.1016/j.powtec.2013.08.015; Chae HD, 2014, RADIOLOGY, V273, P285, DOI 10.1148/radiol.14132187; Cook GJR, 2015, RADIOLOGY, V276, P883, DOI 10.1148/radiol.2015141309; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fave X, 2015, COMPUT MED IMAG GRAP, V44, P54, DOI 10.1016/j.compmedimag.2015.04.006; Fried DV, 2016, RADIOLOGY, V278, P214, DOI 10.1148/radiol.2015142920; Fu WJJ, 2005, BIOINFORMATICS, V21, P1979, DOI 10.1093/bioinformatics/bti294; Ganeshan B, 2012, EUR RADIOL, V22, P796, DOI 10.1007/s00330-011-2319-8; Harrell FE, 2001, REGRESSION MODELING; Huang YQ, 2016, RADIOLOGY, V281, P947, DOI 10.1148/radiol.2016152234; Keam B, 2015, J THORAC ONCOL, V10, P1189, DOI 10.1097/JTO.0000000000000569; Keam B, 2014, CANCER RES TREAT, V46, P323, DOI 10.4143/crt.2013.120; Keam B, 2013, CANCER RES TREAT, V45, P178, DOI 10.4143/crt.2013.45.3.178; Kim H, 2016, INVEST RADIOL, V51, P569, DOI 10.1097/RLI.0000000000000267; Lee JH, 2016, CANCER IMAGING, V16, DOI 10.1186/s40644-016-0063-7; Lin YX, 2014, AM J CANCER RES, V4, P411; Mackin D, 2015, INVEST RADIOL, V50, P757, DOI 10.1097/RLI.0000000000000180; Nishino M, 2013, J THORAC ONCOL, V8, P1059, DOI 10.1097/JTO.0b013e318294c909; Park S, 2015, CANCER RES TREAT, V47, P630, DOI 10.4143/crt.2014.244; Ravanelli M, 2013, EUR RADIOL, V23, P3450, DOI 10.1007/s00330-013-2965-0; Scheffler M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053081; Solomon J, 2016, RADIOLOGY, V279, P185, DOI 10.1148/radiol.2015150892; Song YS, 2014, RADIOLOGY, V273, P276, DOI 10.1148/radiol.14132324; Stewart EL, 2015, TRANSL LUNG CANCER R, V4, P67, DOI 10.3978/j.issn.2218-6751.2014.11.06; Suh KJ, 2016, CLIN LUNG CANCER, V17, P245, DOI 10.1016/j.cllc.2015.11.012; Sundaresan TK, 2016, CLIN CANCER RES, V22, P1103, DOI 10.1158/1078-0432.CCR-15-1031; Takeda M, 2014, J THORAC ONCOL, V9, P200, DOI 10.1097/JTO.0000000000000053; Win T, 2013, CLIN CANCER RES, V19, P3591, DOI 10.1158/1078-0432.CCR-12-1307; Wu YC, 2015, EUR RADIOL, V25, P1801, DOI 10.1007/s00330-014-3579-x; Yoon SH, 2016, RADIOLOGY, V280, P940, DOI 10.1148/radiol.2016151367; Zander T, 2011, J CLIN ONCOL, V29, P1701, DOI 10.1200/JCO.2010.32.4939; Zhao BS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23428; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	37	12	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							e0187500	10.1371/journal.pone.0187500	http://dx.doi.org/10.1371/journal.pone.0187500			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6TA	29099855	Green Submitted, gold, Green Published			2022-12-26	WOS:000414377900025
J	Martis, MM; Tarbiat, B; Tyden, E; Jansson, DS; Hoglund, J				Martis, Mihaela M.; Tarbiat, Behdad; Tyden, Eva; Jansson, Desiree S.; Hoglund, Johan			RNA-Seqde novo assembly and differential transcriptome analysis of the nematode Ascaridia galli in relation to in vivo exposure to flubendazole	PLOS ONE			English	Article							BETA-TUBULIN GENE; BENZIMIDAZOLE-RESISTANCE; HAEMONCHUS-CONTORTUS; MUTATION; GENOMICS; DIVERSITY; SELECTION; REVEALS; VITRO; LIFE	The nematode Ascaridia galli (order Ascaridida) is an economically important intestinal parasite responsible for increased food consumption, reduced performance and elevated mortality in commercial poultry production. This roundworm is an emerging problem in several European countries on farms with laying hens, as a consequence of the recent European Union (EU) ban on conventional battery cages. As infection is associated with slow development of low levels of acquired protective immunity, parasite control relies on repeated use of dewormers (anthelmintics). Benzimidazoles (BZ) are currently the only anthelmintic registered in the EU for use in controlling A. galli and there is an obvious risk of overuse of one drug class, selecting for resistance. Thus we developed a reference transcriptome of A. galli to investigate the response in gene expression before and after exposure to the BZ drug flubendazole (FLBZ). Transcriptional variations between treated and untreated A. galli showed that transcripts annotated as mitochondrial glutamate dehydrogenase and cytochrome P450 were significantly down-regulated in treated worms, whereas transcripts homologous to heat shock proteins (HSP), catalase, phosphofructokinase, and a multidrug resistance Pglycoprotein (PGP1) were significantly up-regulated in treated worms. Investigation of candidate transcripts responsible for anthelmintic resistance in livestock nematodes led to identification of several tubulins, including six new isoforms of beta-tubulin, and several ligandgated ionotropic receptors and ABC-transporters. We discovered several transcripts associated with drug binding and processing genes, but further characterisation using a larger set of worms exposed to BZs in functional assays is required to determine how these are involved in drug binding and metabolism.	[Martis, Mihaela M.] Linkoping Univ, Div Cell Biol, Dept Clin & Expt Med, NBIS, Linkoping, Sweden; [Tarbiat, Behdad; Tyden, Eva; Hoglund, Johan] Swedish Univ Agr Sci SLU, Dept Biomed Sci & Vet Publ Hlth, Sect Parasitol, Uppsala, Sweden; [Jansson, Desiree S.] Natl Vet Inst SVA, Dept Anim Hlth & Antimicrobial Strategies, Uppsala, Sweden	Linkoping University; Swedish University of Agricultural Sciences; National Veterinary Institute SVA	Hoglund, J (corresponding author), Swedish Univ Agr Sci SLU, Dept Biomed Sci & Vet Publ Hlth, Sect Parasitol, Uppsala, Sweden.	johan.hoglund@slu.de	Tyden, Eva/C-1615-2015; Höglund, Johan/AAN-8047-2020; Jansson, Desiree/AAO-6266-2021	Tyden, Eva/0000-0001-6958-2692; Höglund, Johan/0000-0002-1129-6615; Martis, Mihaela-Maria/0000-0001-7509-2446	Formas [FORMAS 2013-665]; SNIC through Uppsala Multidisciplinary Centre for Advanced Computational Science (UPPMAX) [b2014242]	Formas(Swedish Research Council Formas); SNIC through Uppsala Multidisciplinary Centre for Advanced Computational Science (UPPMAX)	Funding was provided by Formas (FORMAS 2013-665), http://www.formas.se/en/. Resources were also provided by SNIC through Uppsala Multidisciplinary Centre for Advanced Computational Science (UPPMAX) under Project b2014242. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The computations were performed using resources provided by SNIC through Uppsala Multidisciplinary Centre for Advanced Computational Science (UPPMAX) under Project b2014242.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Anderson R. C., 2000, Nematode parasites of vertebrates: their development and transmission., DOI 10.1079/9780851994215.0000; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; DAUM G, 1986, BIOCHEM BIOPH RES CO, V139, P215, DOI 10.1016/S0006-291X(86)80101-2; Demeler J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070212; Elard L, 1999, PARASITOL RES, V85, P452, DOI 10.1007/s004360050577; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Ghisi M, 2007, VET PARASITOL, V144, P313, DOI 10.1016/j.vetpar.2006.10.003; Gilleard JS, 2006, INT J PARASITOL, V36, P1227, DOI 10.1016/j.ijpara.2006.06.010; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hanser E, 2003, PARASITOL RES, V89, P63, DOI 10.1007/s00436-002-0668-6; Hoglund J, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-97; James CE, 2009, TRENDS PARASITOL, V25, P328, DOI 10.1016/j.pt.2009.04.004; Jansson DS, 2010, AVIAN PATHOL, V39, P525, DOI 10.1080/03079457.2010.527923; JONES DT, 1994, FEBS LETT, V339, P269, DOI 10.1016/0014-5793(94)80429-X; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kaplan RM, 2004, TRENDS PARASITOL, V20, P477, DOI 10.1016/j.pt.2004.08.001; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kotze AC, 2012, INT J PARASITOL-DRUG, V2, P92, DOI 10.1016/j.ijpddr.2012.02.003; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KWA MSG, 1994, MOL BIOCHEM PARASIT, V63, P299, DOI 10.1016/0166-6851(94)90066-3; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Laing R, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r88; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leroy S, 2003, MOL BIOCHEM PARASIT, V128, P91, DOI 10.1016/S0166-6851(03)00023-9; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567; Mitreva M, 2005, TRENDS GENET, V21, P573, DOI 10.1016/j.tig.2005.08.003; Muhamad N, 2012, COMPARATIVE BIOCH PH, V159, P71; Niedermaier J, 2000, CHROMOSOMA, V109, P439, DOI 10.1007/s004120000104; Njue AI, 2003, PARASITOLOGY, V127, P579, DOI 10.1017/S0031182003004086; O'Neill M, 2016, INT J PARASITOL-DRUG, V6, P288, DOI 10.1016/j.ijpddr.2016.09.005; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; R?delsperger C., 2013, STRUCTURE FUNCTION E; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rufener L, 2009, MOL BIOCHEM PARASIT, V168, P120, DOI 10.1016/j.molbiopara.2009.07.002; Saunders GI, 2013, INT J PARASITOL, V43, P465, DOI 10.1016/j.ijpara.2012.12.011; Schwarz EM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r89; Sherwin CM, 2013, BRIT POULTRY SCI, V54, P12, DOI 10.1080/00071668.2012.757577; Silvestre A, 2002, INT J PARASITOL, V32, P921, DOI 10.1016/S0020-7519(02)00032-2; Silvestre A, 2002, MOL BIOCHEM PARASIT, V120, P297, DOI 10.1016/S0166-6851(01)00455-8; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Skuce P, 2010, INT J PARASITOL, V40, P1247, DOI 10.1016/j.ijpara.2010.03.016; Smith-Unna R, 2016, GENOME RES, V26, P1134, DOI 10.1101/gr.196469.115; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Tarbiat B, 2016, VET PARASITOL, V218, P66, DOI 10.1016/j.vetpar.2016.01.012; Tarbiat B, 2015, VET PARASITOL, V209, P101, DOI 10.1016/j.vetpar.2015.01.024; Tsang WY, 2003, BBA-MOL BASIS DIS, V1638, P91, DOI 10.1016/S0925-4439(03)00079-6; Tyden E, 2013, MOL BIOCHEM PARASIT, V190, P38, DOI 10.1016/j.molbiopara.2013.05.003; Waller PJ, 2006, ANIM FEED SCI TECH, V126, P277, DOI 10.1016/j.anifeedsci.2005.08.007	56	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							0185182	10.1371/journal.pone.0185182	http://dx.doi.org/10.1371/journal.pone.0185182			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6TA	29099835	Green Submitted, Green Published, gold			2022-12-26	WOS:000414377900002
J	Chen, SH; Chao, PM				Chen, Szu-Han; Chao, Pei-Min			Prenatal PPAR alpha activation by clofibrate increases subcutaneous fat browning in male C57BL/6J mice fed a high-fat diet during adulthood	PLOS ONE			English	Article							WHITE ADIPOSE-TISSUE; OXIDIZED FRYING OIL; GENE-EXPRESSION; THERMOGENIC ACTIVATION; ADIPOCYTE DEVELOPMENT; POSTNATAL-DEVELOPMENT; BEIGE ADIPOCYTES; PREGNANT MICE; IN-VIVO; OBESITY	We tested the hypothesis that prenatal administration of PPAR alpha agonist clofibrate may permanently increase browning capacity of developing white adipose tissue (WAT). Pregnant C57BL/6J mice were fed a basal diet, without (C) or with 0.5% clofibrate (CF, a PPAR alpha agonist) throughout pregnancy. After parturition, only male offspring were used; all suckled their mothers (who were eating the C diet) and after weaning, they ate a standard chow diet for 4 wk, followed by a high-fat diet (HFD) for 5 wk. Administration of CF up-regulated serum concentrations and hepatic expression of FGF21 in fetuses, with a return to basal levels after CF withdrawal. At postnatal day 84 (P84), CF-offspring had significantly higher expression of thermogenic genes (Ucp1, Cidea, Ppara Ppargc1a, Cpt1b) and UCP1 protein levels in response to HFD in inguinal fat, but not in retroperitoneal (combined with perirenal) or epididymal fat. Based on UCP1 levels in inguinal fat on P7, P14, and P21, appearance of the transient brown-adipocyte phenotype seemed to be hastened by CF exposure. We concluded that giving CF to pregnant mice programmed greater HFD-induced WAT browning in subcutaneous, but not in visceral fat, in their male offspring at adulthood.	[Chen, Szu-Han; Chao, Pei-Min] China Med Univ, Inst Nutr, Taichung, Taiwan	China Medical University Taiwan	Chao, PM (corresponding author), China Med Univ, Inst Nutr, Taichung, Taiwan.	pmchao@mail.cmu.edu.tw	chao, P/GSD-8001-2022; Chao, Pei-Min/L-8157-2013	Chao, Pei-Min/0000-0002-4846-3245	Ministry of Science and Technology, Taiwan [MOST 104-2320-B-039-028]; China Medical University, Taiwan [CMU104-S-40]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); China Medical University, Taiwan(China Medical University)	Financial support for this study was by the Ministry of Science and Technology, Taiwan [grant number grant number MOST 104-2320-B-039-028] and the China Medical University, Taiwan [grant number CMU104-S-40]".	Bartness TJ, 2007, J LIPID RES, V48, P1655, DOI 10.1194/jlr.R700006-JLR200; Berry DC, 2016, TRENDS ENDOCRIN MET, V27, P574, DOI 10.1016/j.tem.2016.05.001; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Bogacka I, 2007, DIABETES CARE, V30, P1179, DOI 10.2337/dc06-1962; Bonet ML, 2013, BBA-MOL CELL BIOL L, V1831, P969, DOI 10.1016/j.bbalip.2012.12.002; Chabowska-Kita A, 2016, OBESITY, V24, P283, DOI 10.1002/oby.21376; Chabowska-Kita A, 2015, FASEB J, V29, P3238, DOI 10.1096/fj.15-271395; Chao PM, 2001, J NUTR, V131, P3166, DOI 10.1093/jn/131.12.3166; Chuang HC, 2013, J NUTR, V143, P267, DOI 10.3945/jn.112.168948; Cinti S, 2002, J ENDOCRINOL INVEST, V25, P823, DOI 10.1007/BF03344046; Claycombe KJ, 2016, J NUTR BIOCHEM, V31, P113, DOI 10.1016/j.jnutbio.2016.01.008; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; COUSIN B, 1992, J CELL SCI, V103, P931; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; de Jong JMA, 2015, AM J PHYSIOL-ENDOC M, V308, pE1085, DOI 10.1152/ajpendo.00023.2015; Ding XS, 2012, CELL METAB, V16, P387, DOI 10.1016/j.cmet.2012.08.002; Fischer AW, 2017, AM J PHYSIOL-ENDOC M, V312, pE72, DOI 10.1152/ajpendo.00284.2016; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Garcia RA, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0081-2; Garcia-Ruiz E, 2015, INT J OBESITY, V39, P1619, DOI 10.1038/ijo.2015.112; Giordano A, 2014, EUR J ENDOCRINOL, V170, pR159, DOI 10.1530/EJE-13-0945; Giralt M, 2015, MOL CELL ENDOCRINOL, V418, P66, DOI 10.1016/j.mce.2015.09.018; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; Hondares E, 2011, J BIOL CHEM, V286, P43112, DOI 10.1074/jbc.M111.252775; Hondares E, 2010, CELL METAB, V11, P206, DOI 10.1016/j.cmet.2010.02.001; Huang CF, 2014, J NUTR BIOCHEM, V25, P549, DOI 10.1016/j.jnutbio.2014.01.005; Jeffery E, 2015, NAT CELL BIOL, V17, P376, DOI 10.1038/ncb3122; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kozak LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030392; KUNIEDA T, 1992, BIOL REPROD, V46, P692, DOI 10.1095/biolreprod46.4.692; Lasar D, 2013, BBA-MOL CELL BIOL L, V1831, P960, DOI 10.1016/j.bbalip.2013.01.016; Lee YH, 2015, FASEB J, V29, P286, DOI 10.1096/fj.14-263038; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Loft A, 2015, GENE DEV, V29, P7, DOI 10.1101/gad.250829.114; Morrison SF, 2000, J NEUROSCI, V20, P9264; Garcia AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017313; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Rachid TL, 2015, MOL CELL ENDOCRINOL, V402, P86, DOI 10.1016/j.mce.2014.12.027; Rakhshandehroo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006796; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Sacks H, 2013, DIABETES, V62, P1783, DOI 10.2337/db12-1430; Simpson AECM, 1996, DRUG METAB DISPOS, V24, P547; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200; Zou TD, 2017, J PHYSIOL-LONDON, V595, P1547, DOI 10.1113/JP273478	50	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187507	10.1371/journal.pone.0187507	http://dx.doi.org/10.1371/journal.pone.0187507			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095960	Green Published, Green Submitted, gold			2022-12-26	WOS:000414340200106
J	Fryer, TD; Ejaz, S; Jensen-Kondering, U; Williamson, DJ; Sitnikov, S; Sawiak, SJ; Aigbirhio, FI; Hong, YT; Baron, JC				Fryer, Tim D.; Ejaz, Sohail; Jensen-Kondering, Ulf; Williamson, David J.; Sitnikov, Sergey; Sawiak, Stephen J.; Aigbirhio, Franklin I.; Hong, Young T.; Baron, Jean-Claude			Effects of hyperoxia on F-18-fluoro-misonidazole brain uptake and tissue oxygen tension following middle cerebral artery occlusion in rodents: Pilot studies	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ACUTE ISCHEMIC-STROKE; SPONTANEOUSLY HYPERTENSIVE-RAT; SELECTIVE NEURONAL LOSS; ELECTRON-PARAMAGNETIC-RESONANCE; NORMOBARIC HYPEROXIA; HYPOXIC TISSUE; FOCAL ISCHEMIA; BLOOD-FLOW; CARBON-DIOXIDE	Purpose Mapping brain hypoxia is a major goal for stroke diagnosis, pathophysiology and treatment monitoring. F-18-fluoro-misonidazole (FMISO) positron emission tomography (PET) is the gold standard hypoxia imaging method. Normobaric hyperoxia (NBO) is a promising therapy in acute stroke. In this pilot study, we tested the straightforward hypothesis that NBO would markedly reduce FMISO uptake in ischemic brain in Wistar and spontaneously hypertensive rats (SHRs), two rat strains with distinct vulnerability to brain ischemia, mimicking clinical heterogeneity. Methods Thirteen adult male rats were randomized to distal middle cerebral artery occlusion under either 30% O-2 or 100% O-2. FMISO was administered intravenously and PET data acquired dynamically for 3hrs, after which magnetic resonance imaging (MRI) and tetrazolium chloride (TTC) staining were carried out to map the ischemic lesion. Both FMISO tissue uptake at 2-3hrs and FMISO kinetic rate constants, determined based on previously published kinetic modelling, were obtained for the hypoxic area. In a separate group (n = 9), tissue oxygen partial pressure (PtO2) was measured in the ischemic tissue during both control and NBO conditions. Results As expected, the FMISO PET, MRI and TTC lesion volumes were much larger in SHRs than Wistar rats in both the control and NBO conditions. NBO did not appear to substantially reduce FMISO lesion size, nor affect the FMISO kinetic rate constants in either strain. Likewise, MRI and TTC lesion volumes were unaffected. The parallel study showed the expected increases in ischemic cortex PtO2 under NBO, although these were small in some SHRs with very low baseline PtO2. Conclusions Despite small samples, the apparent lack of marked effects of NBO on FMISO uptake suggests that in permanent ischemia the cellular mechanisms underlying FMISO trapping in hypoxic cells may be disjointed from PtO2. Better understanding of FMISO trapping processes will be important for future applications of FMISO imaging.	[Fryer, Tim D.; Jensen-Kondering, Ulf; Williamson, David J.; Sawiak, Stephen J.; Aigbirhio, Franklin I.; Hong, Young T.] Univ Cambridge, Dept Clin Neurosci, Wolfson Brain Imaging Ctr, Cambridge, England; [Ejaz, Sohail; Jensen-Kondering, Ulf; Sitnikov, Sergey; Baron, Jean-Claude] Univ Cambridge, Dept Clin Neurosci, Stroke Res Grp, Cambridge, England; [Jensen-Kondering, Ulf] Univ Med Ctr Schleswig Holstein, Dept Radiol & Neuroradiol, Kiel, Germany; [Baron, Jean-Claude] Univ Paris 05, Hop St Anne Hosp, Dept Neurol, NSERM,U894, Paris, France	University of Cambridge; University of Cambridge; University of Kiel; Schleswig Holstein University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Baron, JC (corresponding author), Univ Cambridge, Dept Clin Neurosci, Stroke Res Grp, Cambridge, England.; Baron, JC (corresponding author), Univ Paris 05, Hop St Anne Hosp, Dept Neurol, NSERM,U894, Paris, France.	jean-claucle.baron@inserm.fr	Sawiak, Stephen/I-8944-2012	Sawiak, Stephen/0000-0003-4210-9816; baron, jean-claude/0000-0002-5264-2588	European Union Grant EUSTROKE [Health-F2-2008-2022131]; Medical Research Council [G0600986]; Deutsche Forschungsgemeinschaft [Je 598/1-1]; state of Schleswig-Holstein within the funding programme "Open Access Publikationsfonds"; Medical Research Council [G0001237, G0500874] Funding Source: researchfish; MRC [G0500874, G0001237, G0600986] Funding Source: UKRI	European Union Grant EUSTROKE; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); state of Schleswig-Holstein within the funding programme "Open Access Publikationsfonds"; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	European Union Grant (https://europa.eu) EUSTROKE Health-F2-2008-2022131 provided funding for experiments, consumables, and salaries for S. Ejaz and S. Sitnikov. Medical Research Council (www.mrc.ac.uk) collaborative grant (G0600986) provided funding for DJ Williamson salary, and Deutsche Forschungsgemeinschaft (www.dfg.de): grant Je 598/1-1 provided funding for Ulf Jensen-Kondering fellowship. We acknowledge the financial support by the state of Schleswig-Holstein within the funding programme "Open Access Publikationsfonds".	Alawneh JA, 2014, EUR J NUCL MED MOL I, V41, P736, DOI 10.1007/s00259-013-2581-x; Amenta Francesco, 2010, Italian Journal of Anatomy and Embryology, V115, P13; ANDERSON TW, 1954, J AM STAT ASSOC, V49, P765, DOI 10.2307/2281537; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; Baron JC, 1999, CEREBROVASC DIS, V9, P193, DOI 10.1159/000015955; BARONE FC, 1992, NEUROSCI BIOBEHAV R, V16, P219, DOI 10.1016/S0149-7634(05)80182-4; Bartlett RM, 2012, J NUCL MED, V53, P1608, DOI 10.2967/jnumed.112.103523; Baskerville TA, 2011, J CEREBR BLOOD F MET, V31, P1799, DOI 10.1038/jcbfm.2011.65; Baskin A, 2015, CURR VASC PHARMACOL, V13, P209, DOI 10.2174/15701611113116660167; Beynon C, 2007, NEUROSCI LETT, V425, P141, DOI 10.1016/j.neulet.2007.07.009; BRINT S, 1988, J CEREBR BLOOD F MET, V8, P474, DOI 10.1038/jcbfm.1988.88; Brown A T, 2014, Open Neurol J, V8, P27, DOI 10.2174/1874205X01408010027; BUCHAN AM, 1992, STROKE, V23, P273, DOI 10.1161/01.STR.23.2.273; Chan SL, 2016, STROKE, V47, P1618, DOI 10.1161/STROKEAHA.116.013392; COYLE P, 1986, STROKE, V17, P520, DOI 10.1161/01.STR.17.3.520; COYLE P, 1991, BLOOD VESSELS, V28, P183; CROCKARD HA, 1976, J NEUROL SCI, V27, P29, DOI 10.1016/0022-510X(76)90232-X; Dijkhuizen RM, 2001, P NATL ACAD SCI USA, V98, P12766, DOI 10.1073/pnas.231235598; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; DIROCCO RJ, 1993, J CEREBR BLOOD F MET, V13, P755, DOI 10.1038/jcbfm.1993.96; Dohmen C, 2003, STROKE, V34, P2152, DOI 10.1161/01.STR.0000083624.74929.32; DUVERGER D, 1988, J CEREBR BLOOD F MET, V8, P449, DOI 10.1038/jcbfm.1988.86; Ejaz S, 2016, BRAIN, V139, P751, DOI 10.1093/brain/awv391; Ejaz S, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00064; Ejaz S, 2015, STROKE, V46, P1084, DOI 10.1161/STROKEAHA.114.007581; Ejaz S, 2013, NEUROBIOL DIS, V51, P120, DOI 10.1016/j.nbd.2012.11.002; Esposito E, 2013, EXP NEUROL, V249, P33, DOI 10.1016/j.expneurol.2013.08.005; Falcao ALE, 2004, ANN NEUROL, V56, P695, DOI 10.1002/ana.20265; Flynn EP, 2002, ANN NEUROL, V52, P566, DOI 10.1002/ana.10322; Fujiwara N, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-79; Gratton JA, 1998, STROKE, V29, P690, DOI 10.1161/01.STR.29.3.690; HARRIS RJ, 1987, J CEREBR BLOOD F MET, V7, P599, DOI 10.1038/jcbfm.1987.111; Henninger N, 2007, J CEREBR BLOOD F MET, V27, P1632, DOI 10.1038/sj.jcbfm.9600463; Henninger N, 2013, STROKE, V44, P61, DOI 10.1161/STROKEAHA.112.679084; Henninger N, 2009, J CEREBR BLOOD F MET, V29, P119, DOI 10.1038/jcbfm.2008.104; Hirano T, 1999, NEUROLOGY, V53, P2179, DOI 10.1212/WNL.53.9.2179; HOFFMAN JM, 1987, STROKE, V18, P168, DOI 10.1161/01.STR.18.1.168; Hoffman WE, 1996, SURG NEUROL, V46, P75, DOI 10.1016/0090-3019(96)00049-3; Hoffman WE, 1999, SURG NEUROL, V51, P654, DOI 10.1016/S0090-3019(99)00011-7; Hom S, 2007, AM J PHYSIOL-REG I, V292, pR1881, DOI 10.1152/ajpregu.00761.2005; Hong YT, 2011, J CEREBR BLOOD F MET, V31, P648, DOI 10.1038/jcbfm.2010.141; Hou HH, 2007, PHYSIOL MEAS, V28, P963, DOI 10.1088/0967-3334/28/8/017; Hughes JL, 2012, NEUROIMAGE, V59, P2007, DOI 10.1016/j.neuroimage.2011.10.060; Hughes JL, 2010, NEUROIMAGE, V49, P19, DOI 10.1016/j.neuroimage.2009.08.047; Iadecola C, 2008, CELL METAB, V7, P476, DOI 10.1016/j.cmet.2008.03.010; Jensen-Kondering U, 2017, INT J STROKE, V12, P752, DOI 10.1177/1747493017706221; Jin XC, 2013, EXP NEUROL, V240, P9, DOI 10.1016/j.expneurol.2012.11.018; JONES TH, 1981, J NEUROSURG, V54, P773, DOI 10.3171/jns.1981.54.6.0773; Kang BT, 2014, NEUROSCIENCE, V269, P223, DOI 10.1016/j.neuroscience.2014.03.031; Kim HY, 2005, ANN NEUROL, V57, P571, DOI 10.1002/ana.20430; KINAHAN PE, 1989, IEEE T NUCL SCI, V36, P964, DOI 10.1109/23.34585; Lee GH, 2015, J NEUROIMAGING, V25, P652, DOI 10.1111/jon.12180; Leoni RF, 2011, NEUROIMAGE, V58, P75, DOI 10.1016/j.neuroimage.2011.06.030; Letourneur A, 2012, EXP NEUROL, V233, P264, DOI 10.1016/j.expneurol.2011.10.014; Liang J, 2015, STROKE, V46, P1344, DOI 10.1161/STROKEAHA.114.008599; Liu CS, 2012, STROKE, V43, P220, DOI 10.1161/STROKEAHA.111.625756; Liu SM, 2006, J CEREBR BLOOD F MET, V26, P1274, DOI 10.1038/sj.jcbfm.9600277; Liu SM, 2004, J CEREBR BLOOD F MET, V24, P343, DOI 10.1097/01.WCB.0000110047.43905.01; Markus R, 2004, BRAIN, V127, P1427, DOI 10.1093/brain/awh162; Markus R, 2003, STROKE, V34, P2646, DOI 10.1161/01.STR.0000094422.74023.FF; Markus R, 2002, NEUROIMAGE, V16, P425, DOI 10.1006/nimg.2002.1056; McCabe C, 2009, STROKE, V40, P3864, DOI 10.1161/STROKEAHA.109.559021; Mies G, 1999, J CEREBR BLOOD F MET, V19, P1238, DOI 10.1097/00004647-199911000-00008; Miyamoto O, 2000, NEUROLOGY, V54, P362, DOI 10.1212/WNL.54.2.362; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Paxinos G., 1996, RAT BRAIN STEREOTAXI; Piert M, 2000, NUCL MED BIOL, V27, P693, DOI 10.1016/S0969-8051(00)00151-7; Piert M, 1999, EUR J NUCL MED, V26, P95, DOI 10.1007/s002590050365; Poli S, 2009, CURR MOL MED, V9, P227, DOI 10.2174/156652409787581619; Read SJ, 2000, ANN NEUROL, V48, P228, DOI 10.1002/1531-8249(200008)48:2<228::AID-ANA13>3.3.CO;2-2; Read SJ, 1998, NEUROLOGY, V51, P1617, DOI 10.1212/WNL.51.6.1617; Reid E, 2012, J CEREBR BLOOD F MET, V32, P1765, DOI 10.1038/jcbfm.2012.69; Rewell SSJ, 2017, J CEREBR BLOOD F MET, V37, P3380, DOI 10.1177/0271678X16688704; Rojas S, 2011, MOL IMAGING BIOL, V13, P558, DOI 10.1007/s11307-010-0371-4; Saita K, 2004, STROKE, V35, P975, DOI 10.1161/01.STR.0000121647.01941.ba; Sarrafzadeh AS, 2010, J CEREBR BLOOD F MET, V30, P36, DOI 10.1038/jcbfm.2009.199; Schirrmacher R, 2016, CEREBROVASC DIS, V41, P139, DOI 10.1159/000442997; Seiffge DJ, 2012, EXP NEUROL, V237, P18, DOI 10.1016/j.expneurol.2012.06.007; Shin HK, 2007, BRAIN, V130, P1631, DOI 10.1093/brain/awm071; Shin HK, 2014, J NEUROSCI, V34, P15200, DOI 10.1523/JNEUROSCI.1110-14.2014; Singhal AB, 2005, STROKE, V36, P797, DOI 10.1161/01.STR.0000158914.66827.2e; Singhal AB, 2002, NEUROLOGY, V58, P945, DOI 10.1212/WNL.58.6.945; Singhal AB, 2007, NEUROL RES, V29, P173, DOI 10.1179/016164107X181815; Spratt NJ, 2006, STROKE, V37, P1862, DOI 10.1161/01.STR.0000226908.93295.9d; Spratt NJ, 2011, J CEREBR BLOOD F MET, V31, P934, DOI 10.1038/jcbfm.2010.174; Spratt NJ, 2009, BRAIN RES, V1288, P135, DOI 10.1016/j.brainres.2009.06.102; Sun L, 2008, STROKE, V39, P1000, DOI 10.1161/STROKEAHA.107.490599; Takasawa M, 2008, STROKE, V39, P1629, DOI 10.1161/STROKEAHA.107.485938; Takasawa M, 2007, J CEREBR BLOOD F MET, V27, P679, DOI 10.1038/sj.jcbfm.9600405; Takasawa M, 2011, EXP NEUROL, V229, P251, DOI 10.1016/j.expneurol.2011.02.005; von Bornstadt D, 2015, NEURON, V85, P1117, DOI 10.1016/j.neuron.2015.02.007; Weaver J, 2014, J CEREBR BLOOD F MET, V34, P890, DOI 10.1038/jcbfm.2014.35; Werner P, 2015, J CEREBR BLOOD F MET, V35, P1421, DOI 10.1038/jcbfm.2015.158; Williamson DJ, 2013, NUCL MED BIOL, V40, P338, DOI 10.1016/j.nucmedbio.2012.11.012	94	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187087	10.1371/journal.pone.0187087	http://dx.doi.org/10.1371/journal.pone.0187087			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091934	gold, Green Submitted, Green Published			2022-12-26	WOS:000414229700042
J	Tesovnik, T; Cizelj, I; Zorc, M; Citar, M; Bozic, J; Glavan, G; Narat, M				Tesovnik, Tanja; Cizelj, Ivanka; Zorc, Minja; Citar, Manuela; Bozic, Janko; Glavan, Gordana; Narat, Mojca			Immune related gene expression in worker honey bee (Apis mellifera carnica) pupae exposed to neonicotinoid thiamethoxam and Varroa mites (Varroa destructor)	PLOS ONE			English	Article							DEFORMED-WING VIRUS; LARVAE; PESTICIDES; PATHOGEN	Varroa destructor is one of the most common parasites of honey bee colonies and is considered as a possible co-factor for honey bee decline. At the same time, the use of pesticides in intensive agriculture is still the most effective method of pest control. There is limited information about the effects of pesticide exposure on parasitized honey bees. Larval ingestion of certain pesticides could have effects on honey bee immune defense mechanisms, development and metabolic pathways. Europe and America face the disturbing phenomenon of the disappearance of honey bee colonies, termed Colony Collapse Disorder (CCD). One reason discussed is the possible suppression of honey bee immune system as a consequence of prolonged exposure to chemicals. In this study, the effects of the neonicotinoid thiamethoxam on honey bee, Apis mellifera carnica, pupae infested with Varroa destructor mites were analyzed at the molecular level. Varroa-infested and non-infested honey bee colonies received protein cakes with or without thiamethoxam. Nurse bees used these cakes as a feed for developing larvae. Samples of white-eyed and brown-eyed pupae were collected. Expression of 17 immune-related genes was analyzed by real-time PCR. Relative gene expression in samples exposed only to Varroa or to thiamethoxam or simultaneously to both Varroa and thiamethoxam was compared. The impact from the consumption of thiamethoxam during the larval stage on honey bee immune related gene expression in Varroa-infested white-eyed pupae was reflected as down-regulation of spaetzle, AMPs abaecin and defensin-1 and up-regulation of lysozyme-2. In brown-eyed pupae up-regulation of PPOact, spaetzle, hopscotch and basket genes was detected. Moreover, we observed a major difference in immune response to Varroa infestation between white-eyed pupae and brown-eyed pupae. The majority of tested immune-related genes were upregulated only in brown-eyed pupae, while in white-eyed pupae they were downregulated.	[Tesovnik, Tanja; Cizelj, Ivanka; Zorc, Minja; Citar, Manuela; Narat, Mojca] Univ Ljubljana, Biotech Fac, Dept Anim Sci, Domzale, Slovenia; [Bozic, Janko; Glavan, Gordana] Univ Ljubljana, Dept Biol, Biotech Fac, Ljubljana, Slovenia	University of Ljubljana; University of Ljubljana	Narat, M (corresponding author), Univ Ljubljana, Biotech Fac, Dept Anim Sci, Domzale, Slovenia.	mojca.narat@bf.uni-lj.si	Zorc, Minja/AGD-6914-2022	Zorc, Minja/0000-0003-3330-7909	Slovenian Research agency (ARRS); Slovenian Ministry of Agriculture, Forestry and Food [L4-5522]	Slovenian Research agency (ARRS)(Slovenian Research Agency - Slovenia); Slovenian Ministry of Agriculture, Forestry and Food	This study was supported by the Slovenian Research agency (ARRS) and Slovenian Ministry of Agriculture, Forestry and Food grant No L4-5522.	Aggarwal K, 2008, BMB REP, V41, P267, DOI 10.5483/BMBRep.2008.41.4.267; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Aronstein K, 2012, AM BEE J, V152, P789; Badiou-Beneteau A, 2012, ECOTOX ENVIRON SAFE, V82, P22, DOI 10.1016/j.ecoenv.2012.05.005; Balasubramanyam MV, 2014, J CHEM BIO PHYS SCI, V4, P361; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Boncristiani H, 2012, J INSECT PHYSIOL, V58, P613, DOI 10.1016/j.jinsphys.2011.12.011; Chen YP, 2007, ADV VIRUS RES, V70, P33, DOI 10.1016/S0065-3527(07)70002-7; Cizelj I, 2016, PESTIC BIOCHEM PHYS, V128, P68, DOI 10.1016/j.pestbp.2015.09.015; Decourtye A, 2003, PEST MANAG SCI, V59, P269, DOI 10.1002/ps.631; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Di Prisco G, 2016, P NATL ACAD SCI USA, V113, P3203, DOI 10.1073/pnas.1523515113; Doublet V, 2015, ENVIRON MICROBIOL, V17, P969, DOI 10.1111/1462-2920.12426; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Evans JD, 2006, J INVERTEBR PATHOL, V93, P135, DOI 10.1016/j.jip.2006.04.004; Evans JD, 2004, J INVERTEBR PATHOL, V85, P105, DOI 10.1016/j.jip.2004.02.004; Francis RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057540; Gregorc A, 2012, J INSECT PHYSIOL, V58, P1042, DOI 10.1016/j.jinsphys.2012.03.015; Gregory PG, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.7; Hillyer JF, 2016, DEV COMP IMMUNOL, V58, P102, DOI 10.1016/j.dci.2015.12.006; Human H, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.10; Ilyasov RA, 2012, J APIC SCI, V56, P115, DOI 10.2478/v10289-012-0013-y; Jefferson JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054097; Kevan PG, 1999, AGR ECOSYST ENVIRON, V74, P373, DOI 10.1016/S0167-8809(99)00044-4; Koleoglu G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169669; Kuster RD, 2014, J EXP BIOL, V217, P1710, DOI 10.1242/jeb.097766; Kutmon M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004085; Lenth RV, 2016, LEAST SQUARES MEANS, V69, P33, DOI [DOI 10.18637/JSS.V069.I01, DOI 10.1016/j.envexpbot.2017.10.014]; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Nauen R, 2003, PESTIC BIOCHEM PHYS, V76, P55, DOI 10.1016/S0048-3575(03)00065-8; Navajas M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-301; Nazzi F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002735; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Novomestky F, 2015, MOMENTS CUMULANTS SK; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pilling E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077193; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Ryabov EV, 2016, PEERJ, V4, DOI 10.7717/peerj.1591; Schluns H, 2007, INSECT MOL BIOL, V16, P753, DOI 10.1111/j.1365-2583.2007.00768.x; Shen MQ, 2005, VIROLOGY, V342, P141, DOI 10.1016/j.virol.2005.07.012; Tavares DA, 2015, CHEMOSPHERE, V135, P370, DOI 10.1016/j.chemosphere.2015.04.090; Valanne S, 2007, DEV COMP IMMUNOL, V31, P991, DOI 10.1016/j.dci.2007.01.004; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Villa S, 2000, ECOTOXICOLOGY, V9, P287, DOI 10.1023/A:1026522112328; Wang Y, 2009, EXP PARASITOL, V123, P6, DOI 10.1016/j.exppara.2009.05.017; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilson-Rich N, 2008, J INSECT PHYSIOL, V54, P1392, DOI 10.1016/j.jinsphys.2008.07.016; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102; Yue C, 2005, J GEN VIROL, V86, P3419, DOI 10.1099/vir.0.81401-0	50	28	31	4	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187079	10.1371/journal.pone.0187079	http://dx.doi.org/10.1371/journal.pone.0187079			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088251	Green Published, Green Submitted, gold			2022-12-26	WOS:000414088900039
J	Ee, CC; Thuraisingam, S; Pirotta, MV; French, SD; Xue, CC; Teede, HJ				Ee, Carolyn C.; Thuraisingam, Sharmala; Pirotta, Marie V.; French, Simon D.; Xue, Charlie C.; Teede, Helena J.			Expectancy after the first treatment and response to acupuncture for menopausal hot flashes	PLOS ONE			English	Article							MIDDLE-AGED WOMEN; ALTERNATIVE MEDICINE; PLACEBO-RESPONSE; CONTROLLED-TRIAL; NIGHT SWEATS; HEALTH; FLUSHES; COMPLEMENTARY; TRANSITION; PRACTITIONER	Background Evidence on the impact of expectancy on acupuncture treatment response is conflicting. Objectives This secondary analysis of a randomized sham-controlled trial on acupuncture for menopausal hot flashes investigated whether treatment expectancy score was associated with hot flash score at end-of-treatment. Secondary analyses investigated whether there were associations between other pre-specified factors and hot flash score. Study design Women experiencing moderately-severe hot flashes were randomized to receive 10 sessions of real or sham acupuncture over eight weeks. Hot flash score was collected using a seven-day hot flash diary, and expectancy using the modified Credibility and Expectancy Questionnaire immediately after the first treatment. Linear mixed-effects models with random intercepts were used to identify associations between expectancy score and hot flash score at end-of-treatment. Regression was also used to identify associations between prespecified factors of interest and hot flash score. Because there was no difference between real and sham acupuncture for the primary outcome of hot flash score, both arms were combined in the analysis. Results 285 women returned the Credibility and Expectancy Questionnaire, and 283 women completed both expectancy measures. We found no evidence for an association between expectancy and hot flash score at end-of-treatment for individual cases in either acupuncture or sham group. Hot flash scores at end-of-treatment were 8.1 (95% CI, 3.0 to 13.2; P = 0.002) points lower in regular smokers compared to those who had never smoked, equivalent to four fewer moderate hot flashes a day. Conclusion In our study of acupuncture for menopausal hot flashes, higher expectancy after the first treatment did not predict better treatment outcomes. Future research may focus on other determinants of outcomes in acupuncture such as therapist attention. The relationship between smoking and hot flashes is poorly understood and needs further exploration.	[Ee, Carolyn C.] Western Sydney Univ, Natl Inst Complementary Med, Sydney, NSW, Australia; [Ee, Carolyn C.; Thuraisingam, Sharmala; Pirotta, Marie V.] Univ Melbourne, Dept Gen Practice, Melbourne, Vic, Australia; [French, Simon D.] Queens Univ, Sch Rehabil Therapy, Kingston, ON, Canada; [French, Simon D.] Macquarie Univ, Dept Chiropract, Fac Sci & Engn, N Ryde, NSW, Australia; [Xue, Charlie C.] RMIT Univ, Sch Hlth & Biomed Sci, Melbourne, Vic, Australia; [Teede, Helena J.] Monash Univ, Monash Ctr Hlth Res & Implementat, Melbourne, Vic, Australia	Western Sydney University; University of Melbourne; Queens University - Canada; Macquarie University; Royal Melbourne Institute of Technology (RMIT); Monash University	Ee, CC (corresponding author), Western Sydney Univ, Natl Inst Complementary Med, Sydney, NSW, Australia.; Ee, CC (corresponding author), Univ Melbourne, Dept Gen Practice, Melbourne, Vic, Australia.	c.ee@westernsydney.edu.au	Xue, Charlie C/F-1244-2014; Ee, Carolyn/V-5070-2019	Ee, Carolyn/0000-0002-3363-9199; Xue, Charlie/0000-0001-6937-9088; French, Simon/0000-0002-7061-7706	NHMRC; National Health and Medical Research Council, Australia [1004006]; Canadian Chiropractic Research Foundation	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Canadian Chiropractic Research Foundation	CE was supported by an NHMRC Postgraduate Scholarship, HT by an NHMRC Practitioner Fellowship, MP by an NHMRC Career Development Fellowship. The main study was funded by a Project Grant 1004006 from the National Health and Medical Research Council, Australia (www.nhmrc.gov.au). SDF is supported by a Canadian Chiropractic Research Foundation Professorship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CE was supported by an NHMRC Postgraduate Scholarship, HT by an NHMRC Practitioner Fellowship, MP by an NHMRC Career Development Fellowship. SDF is supported by a Canadian Chiropractic Research Foundation Professorship.	Armour M, 2016, EVID-BASED COMPL ALT, V2016; Avis NE, 2009, MENOPAUSE, V16, P860, DOI 10.1097/gme.0b013e3181a3cdaf; Bair YA, 2008, MENOPAUSE, V15, P32, DOI 10.1097/gme.0b013e31813429d6; Bauml Joshua, 2014, Journal of the National Cancer Institute Monographs, P302, DOI 10.1093/jncimonographs/lgu029; Borud EK, 2009, MENOPAUSE, V16, P484, DOI 10.1097/gme.0b013e31818c02ad; Col NF, 2009, MENOPAUSE, V16, P453, DOI 10.1097/gme.0b013e31818d414e; Colagiuri B, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/857804; Colquhoun D, 2013, ANESTH ANALG, V116, P1360, DOI 10.1213/ANE.0b013e31828f2d5e; Devilly GJ, 2000, J BEHAV THER EXP PSY, V31, P73, DOI 10.1016/S0005-7916(00)00012-4; Dodin S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007410.pub2; Duffy OK, 2013, MENOPAUSE, V20, P383, DOI 10.1097/gme.0b013e31827655cf; Ee C, 2016, ANN INTERN MED, V164, P146, DOI 10.7326/M15-1380; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Freeman EW, 2015, PSYCHOSOM MED, V77, P167, DOI 10.1097/PSY.0000000000000143; Greendale GA, 2005, AM J MED, V118, P1411, DOI 10.1016/j.amjmed.2005.10.026; Herber-Gast GCM, 2013, MENOPAUSE, V20, P953, DOI [10.1097/GME.0b013e3182844a7c, 10.1097/gme.0b013e3182844a7c]; Hrobjartsson A, 2011, J CLIN EPIDEMIOL, V64, P1223, DOI 10.1016/j.jclinepi.2011.01.008; Hrobjartsson A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003974.pub3; Hunter MS, 2012, BJOG-INT J OBSTET GY, V119, P40, DOI 10.1111/j.1471-0528.2011.03166.x; Kaptchuk TJ, 2009, CULT MED PSYCHIAT, V33, P382, DOI 10.1007/s11013-009-9141-7; Kim KH, 2010, MENOPAUSE, V17, P269, DOI 10.1097/gme.0b013e3181bfac3b; Kumari M, 2005, J CLIN EPIDEMIOL, V58, P719, DOI 10.1016/j.jclinepi.2004.09.016; Linde K, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-75; Linde K, 2010, FORSCH KOMPLEMENTMED, V17, P259, DOI 10.1159/000320374; Lund Irene, 2009, Chin Med, V4, P1, DOI 10.1186/1749-8546-4-1; Lundeberg T, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep049; Lundeberg T, 2008, ACUPUNCT MED, V26, P239, DOI 10.1136/aim.26.4.239; MacPherson H, 2003, J ALTERN COMPLEM MED, V9, P869, DOI 10.1089/107555303771952226; MacPherson H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093739; Madsen MV, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3115; Mishra GD, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e402; Nedrow A, 2006, ARCH INTERN MED, V166, P1453, DOI 10.1001/archinte.166.14.1453; Nir Y, 2007, MATURITAS, V56, P383, DOI 10.1016/j.maturitas.2006.11.001; Paterson Charlotte, 2010, Complement Ther Clin Pract, V16, P3, DOI 10.1016/j.ctcp.2009.08.001; Pirotta M, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-224; Prady SL, 2015, COMPLEMENT THER MED, V23, P185, DOI 10.1016/j.ctim.2015.01.007; Price DD, 2008, ANNU REV PSYCHOL, V59, P565, DOI 10.1146/annurev.psych.59.113006.095941; Price S, 2006, PATIENT EDUC COUNS, V63, P239, DOI 10.1016/j.pec.2005.11.006; Rutherford BR, 2013, AM J PSYCHIAT, V170, P723, DOI 10.1176/appi.ajp.2012.12040474; Rutherford BR, 2010, CURR PSYCHIATRY REV, V6, P1, DOI 10.2174/157340010790596571; Sackett DL, 2007, INT J EPIDEMIOL, V36, P664, DOI 10.1093/ije/dym088; Sloan JA, 2001, J CLIN ONCOL, V19, P4280, DOI 10.1200/JCO.2001.19.23.4280; Stefanopoulou E, 2014, AM J HUM BIOL, V26, P389, DOI 10.1002/ajhb.22530; Thurston RC, 2011, OBSTET GYN CLIN N AM, V38, P489, DOI 10.1016/j.ogc.2011.05.006; van der Sluijs CP, 2007, MENOPAUSE, V14, P397, DOI 10.1097/01.gme.0000236937.36078.f4; van Die MD, 2009, MENOPAUSE, V16, P792, DOI [10.1097/gme.0b013e318199d5e6, 10.1097/GME.0b013e318199d5e6]; Vase L, 2013, PAIN, V154, P1659, DOI 10.1016/j.pain.2013.05.008; White P, 2012, PAIN, V153, P455, DOI 10.1016/j.pain.2011.11.007; Zhang CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140825	49	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186966	10.1371/journal.pone.0186966	http://dx.doi.org/10.1371/journal.pone.0186966			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077767	Green Published, gold, Green Submitted			2022-12-26	WOS:000413861200031
J	Langer, EM; Kendsersky, ND; Daniel, CJ; Kuziel, GM; Pelz, C; Murphy, KM; Capecchi, MR; Sears, RC				Langer, E. M.; Kendsersky, N. D.; Daniel, C. J.; Kuziel, G. M.; Pelz, C.; Murphy, K. M.; Capecchi, M. R.; Sears, R. C.			ZEB1-repressed microRNAs inhibit autocrine signaling that promotes vascular mimicry of breast cancer cells	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MIR-200 FAMILY; ENDOTHELIAL DIFFERENTIATION; PROTEASE NEXIN-1; STEM-CELLS; PDGFR-BETA; EXPRESSION; SERPINE2; ZEB1; ANGIOGENESIS	During normal tumor growth and in response to some therapies, tumor cells experience acute or chronic deprivation of nutrients and oxygen and induce tumor vascularization. While this occurs predominately through sprouting angiogenesis, tumor cells have also been shown to directly contribute to vessel formation through vascular mimicry (VM) and/or endothelial transdifferentiation. The extrinsic and intrinsic mechanisms underlying tumor cell adoption of endothelial phenotypes, however, are not well understood. Here we show that serum withdrawal induces mesenchymal breast cancer cells to undergo VM and that knockdown of the epithelial-to-mesenchymal transition (EMT) regulator, Zinc finger E-box binding homeobox 1 (ZEB1), or overexpression of the ZEB1-repressed microRNAs (miRNAs), miR-200c, miR-183, miR-96 and miR-182 inhibits this process. We find that secreted proteins Fibronectin 1 (FN1) and serine protease inhibitor (serpin) family E member 2 (SERPINE2) are essential for VM in this system. These secreted factors are upregulated in mesenchymal cells in response to serum withdrawal, and overexpression of VM-inhibiting miRNAs abrogates this upregulation. Intriguingly, the receptors for these secreted proteins, low-density lipoprotein receptor-related protein 1 (LRP1) and Integrin beta 1 (ITGB1), are also targets of the VM-inhibiting miRNAs, suggesting that autocrine signaling stimulating VM is regulated by ZEB1-repressed miRNA clusters. Together, these data provide mechanistic insight into the regulation of VM and suggest that miRNAs repressed during EMT, in addition to suppressing migratory and stem-like properties of tumor cells, also inhibit endothelial phenotypes of breast cancer cells adopted in response to a nutrient-deficient microenvironment.	[Langer, E. M.; Kendsersky, N. D.; Daniel, C. J.; Kuziel, G. M.; Sears, R. C.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, 2730 SW Moody Ave, Portland, OR 97201 USA; [Pelz, C.] Oregon Hlth & Sci Univ, Div Bioinformat & Computat Biol, Portland, OR 97201 USA; [Murphy, K. M.; Capecchi, M. R.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Murphy, K. M.] Washington Univ, Dept Pathol & Immunol, St Louis, MO USA; [Capecchi, M. R.] Univ Utah, Dept Human Genet, Salt Lake City, UT USA; [Sears, R. C.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Howard Hughes Medical Institute; Washington University (WUSTL); Utah System of Higher Education; University of Utah; Oregon Health & Science University	Langer, EM; Sears, RC (corresponding author), Oregon Hlth & Sci Univ, Dept Mol & Med Genet, 2730 SW Moody Ave, Portland, OR 97201 USA.	langere@ohsu.edu; searsr@ohsu.edu			American Cancer Society [118795-PF-10-022-01-CSM]; NCI [CA100855, CA196228]; Knight NCI Cancer Center Support Grant [5P30CA069533]; National Institutes of Health [U54 HG008100]; National Cancer Institute [5P30CA069533]; Susan G Komen Foundation [SAC110]; NATIONAL CANCER INSTITUTE [P30CA069533, R01CA100855, R01CA196228] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG008100] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Knight NCI Cancer Center Support Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G Komen Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was supported by a postdoctoral fellowship from the American Cancer Society 118795-PF-10-022-01-CSM (EML), as well as philanthropic gifts from the Colson Family Foundation and the Prospect Creek Foundation, and R01s from the NCI CA100855 and CA196228 (RCS). Flow Cytometry was performed in the Oregon Health & Science University (OHSU) Flow Cytometry Shared Resource, hematoxylin and eosin and PAS staining as well as CD31 IHC was performed by the OHSU Histopathology Shared Resource, and short read sequencing assays (RNA-seq) were performed by the OHSU Massively Parallel Sequencing Shared Resource. These OHSU Shared Resources are supported by the Knight NCI Cancer Center Support Grant 5P30CA069533. We thank Dr Sen Wu for providing the PB-CAG-GFP-iNeo plasmid. We thank Dr Joe Gray for providing cell lines supported by the National Institutes of Health grant U54 HG008100, National Cancer Institute grant 5P30CA069533 and by the Susan G Komen Foundation SAC110. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health nor does it reflect the position or the policy of the Government, and no official endorsement should be inferred.	Arnold HK, 2009, EMBO J, V28, P500, DOI 10.1038/emboj.2008.279; Buchholz M, 2003, CANCER RES, V63, P4945; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Candia BJ, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-16; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Chang YS, 2000, P NATL ACAD SCI USA, V97, P14608, DOI 10.1073/pnas.97.26.14608; Choi YC, 2011, MOL CELLS, V32, P77, DOI 10.1007/s10059-011-1042-2; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Conley SJ, 2012, P NATL ACAD SCI USA, V109, P2784, DOI 10.1073/pnas.1018866109; Cseh B, 2010, J CELL SCI, V123, P3989, DOI 10.1242/jcs.073346; D'Ippolito E, 2016, CANCER RES, V76, P5562, DOI 10.1158/0008-5472.CAN-16-0140; Dyballa Nadine, 2012, Methods Mol Biol, V893, P47, DOI 10.1007/978-1-61779-885-6_4; Fanti Z, 2011, DEV NEUROBIOL, V71, P870, DOI 10.1002/dneu.20866; Fardin P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-185; Farrell AS, 2013, MOL CELL BIOL, V33, P2930, DOI 10.1128/MCB.01455-12; Fayard B, 2009, CANCER RES, V69, P5690, DOI 10.1158/0008-5472.CAN-08-4573; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Francescone RA, 2011, JOVE-J VIS EXP, DOI 10.3791/3040; Francois D, 2014, LAB INVEST, V94, P1237, DOI 10.1038/labinvest.2014.111; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gill JG, 2012, STEM CELLS DEV, V21, P167, DOI 10.1089/scd.2011.0194; Gill JG, 2011, STEM CELLS, V29, P764, DOI 10.1002/stem.628; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Harrell JC, 2014, CLIN EXP METASTAS, V31, P33, DOI 10.1007/s10585-013-9607-4; Heiser LM, 2012, P NATL ACAD SCI USA, V109, P2724, DOI 10.1073/pnas.1018854108; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Howe EN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2867; Jalvy-Delvaille S, 2012, NUCLEIC ACIDS RES, V40, P1356, DOI 10.1093/nar/gkr843; Karroum A, 2012, EUR J PHARMACOL, V685, P1, DOI 10.1016/j.ejphar.2012.04.004; Korpal M, 2011, NAT MED, V17, P1101, DOI 10.1038/nm.2401; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Li GR, 2010, J BIOL CHEM, V285, P5461, DOI 10.1074/jbc.M109.037127; Li XL, 2014, MOL CELL BIOL, V34, P533, DOI 10.1128/MCB.01043-13; Liu TJ, 2013, ONCOGENE, V32, P544, DOI 10.1038/onc.2012.85; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Mense SM, 2006, PHYSIOL GENOMICS, V25, P435, DOI 10.1152/physiolgenomics.00315.2005; Nagahara A, 2010, BIOCHEM BIOPH RES CO, V391, P1641, DOI 10.1016/j.bbrc.2009.12.105; Ong YS, 2010, J CELL BIOL, V190, P331, DOI 10.1083/jcb.201003005; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pecot CV, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3427; Plantamura I, 2014, MOL ONCOL, V8, P968, DOI 10.1016/j.molonc.2014.03.015; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Qi JF, 2010, CANCER CELL, V18, P23, DOI 10.1016/j.ccr.2010.05.024; Quesada AR, 2010, CURR PHARM DESIGN, V16, P3932; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Schliekelman MJ, 2011, CANCER RES, V71, P7670, DOI 10.1158/0008-5472.CAN-11-0964; Schoenfeld Jonathan, 2004, Angiogenesis, V7, P143, DOI 10.1007/s10456-004-1677-0; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Soda Y, 2011, P NATL ACAD SCI USA, V108, P4274, DOI 10.1073/pnas.1016030108; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wagenblast E, 2015, NATURE, V520, P358, DOI 10.1038/nature14403; Wang K, 2015, J CANCER RES CLIN, V141, P805, DOI 10.1007/s00432-014-1858-1; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Wong CM, 2015, ONCOTARGET, V6, P13658, DOI 10.18632/oncotarget.3700; Xu CL, 2017, P NATL ACAD SCI USA, V114, P722, DOI 10.1073/pnas.1615735114; Xu Y, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-16; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Zhang L, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-108; Zhou XM, 2008, GENE DEV, V22, P1231, DOI 10.1101/gad.1643308; Zhu M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15471	63	34	35	0	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 22	2018	37	8					1005	1019		10.1038/onc.2017.356	http://dx.doi.org/10.1038/onc.2017.356			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FX2QD	29084210	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000425905700004
J	Ma, D; Chen, X; Zhang, PY; Zhang, H; Wei, LJ; Hu, S; Tang, JZ; Zhou, MT; Xie, C; Ou, R; Xu, Y; Tang, KF				Ma, D.; Chen, X.; Zhang, P-Y; Zhang, H.; Wei, L-J; Hu, S.; Tang, J-Z; Zhou, M-T; Xie, C.; Ou, R.; Xu, Y.; Tang, K-F			Upregulation of the ALDOA/DNA-PK/p53 pathway by dietary restriction suppresses tumor growth	ONCOGENE			English	Article							CANCER-CELL PROLIFERATION; DEPENDENT PROTEIN-KINASE; CATALYTIC SUBUNIT; MODEL ORGANISMS; DNA-DAMAGE; ALDOLASE; PHOSPHORYLATION; ACTIVATION; EXPRESSION; INTERACTS	Dietary restriction (DR) delays the incidence and decreases the growth of various types of tumors; however, the mechanisms responsible for DR-mediated antitumor effects have not been unequivocally identified. Here, we report that DR suppresses xenograft tumor growth by upregulating a novel signaling pathway. DR led to upregulated aldolase A (ALDOA) expression in xenograft tumors. ALDOA physically interacted with the catalytic subunit of DNA-dependent protein kinase (DNA-PK) and promoted DNA-PK activation. Activated DNA-PK phosphorylated p53 and increased its activity. Although ALDOA can function as an oncogene in cultured cells, it can also activate the tumor suppressor p53. Thus, ALDOA overexpression in the presence of p53 suppressed xenograft tumor growth; however, when p53 was suppressed, ALDOA overexpression promoted xenograft tumor growth. Moreover, we demonstrated that p53 suppression inhibited the antitumor effects of DR. Our results indicate that upregulation of the ALDOA/DNA-PK/p53 pathway is a mechanism accounting for the antitumor effects of DR.	[Ma, D.; Chen, X.; Zhang, P-Y; Zhang, H.; Wei, L-J; Tang, K-F] Wenzhou Med Univ, Affiliated Hosp 1, Digest Canc Ctr, Wenzhou 325015, Zhejiang, Peoples R China; [Ma, D.; Chen, X.; Zhang, P-Y; Zhang, H.; Wei, L-J; Xu, Y.; Tang, K-F] Wenzhou Med Univ, Affiliated Hosp 1, Inst Translat Med, Wenzhou, Peoples R China; [Hu, S.] Wenzhou Med Univ, Inst Genom Med, Wenzhou, Peoples R China; [Tang, J-Z] Third Mil Med Univ, Daping Hosp, Res Inst Surg, Chongqing, Peoples R China; [Zhou, M-T] Wenzhou Med Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Wenzhou, Peoples R China; [Xie, C.] Wenzhou Med Univ, Affiliated Hosp 1, Dept Radiat Oncol, Wenzhou, Zhejiang, Peoples R China; [Ou, R.] Wenzhou Med Univ, Affiliated Hosp 1, Dept Gynecol, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Army Medical University; Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Tang, KF (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Digest Canc Ctr, Wenzhou 325015, Zhejiang, Peoples R China.	tang_kaifu@wmu.edu.cn		Zhou, Meng-Tao/0000-0002-0613-1656; Zhou, Mengtao/0000-0002-2455-250X; Hu, Shanshan/0000-0003-4904-0583; Tang, Kai-Fu/0000-0002-2657-4163; Chen, Xiao/0000-0001-6155-6035; Tang, Kai-Fu/0000-0002-6892-1207	National Natural Science Foundation of China [81572780]; Zhejiang Provincial Natural Sciences Foundation [LZ16H160004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Sciences Foundation	We thank Bin Tan (Chongqing Medical University, Chongqing, China), as well as Guiling Li, Tongke Chen and Yixiang Han (Wenzhou Medical University, Wenzhou, China), for providing technical assistance. This work was supported by the National Natural Science Foundation of China (Grant No. 81572780) and the Zhejiang Provincial Natural Sciences Foundation (Grant No. LZ16H160004).	Anzo M, 2008, CANCER RES, V68, P3342, DOI 10.1158/0008-5472.CAN-07-3165; Buscaglia CA, 2006, J BIOL CHEM, V281, P1324, DOI 10.1074/jbc.M506346200; Caspi M, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-164; Concepcion J, 2009, COMB CHEM HIGH T SCR, V12, P791, DOI 10.2174/138620709789104915; Curry NL, 2013, CANCER DISCOV, V3, P908, DOI 10.1158/2159-8290.CD-12-0507; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Du S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085804; Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020; Goodwin JF, 2014, CANCER DISCOV, V4, P1126, DOI 10.1158/2159-8290.CD-14-0358; Hakvoort TBM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.216986; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Kao AW, 1999, J BIOL CHEM, V274, P17742, DOI 10.1074/jbc.274.25.17742; Kim JH, 2002, BIOCHEMISTRY-US, V41, P3414, DOI 10.1021/bi015700a; Kim K, 2012, ONCOGENE, V31, P4290, DOI 10.1038/onc.2011.605; Lee C, 2011, ONCOGENE, V30, P3305, DOI 10.1038/onc.2011.91; Lessa RC, 2013, HEAD NECK-J SCI SPEC, V35, P1475, DOI 10.1002/hed.23169; Lew CR, 2012, J BIOL CHEM, V287, P42554, DOI 10.1074/jbc.M112.405969; Lincet H, 2015, ONCOGENE, V34, P3751, DOI 10.1038/onc.2014.320; Longo VD, 2014, CELL METAB, V19, P181, DOI 10.1016/j.cmet.2013.12.008; Meynet O, 2014, TRENDS MOL MED, V20, P419, DOI 10.1016/j.molmed.2014.05.001; Moreschi C, 1909, Z IMMUNITATSFORSCH, V2, P651; PENHOET E, 1966, P NATL ACAD SCI USA, V56, P1275, DOI 10.1073/pnas.56.4.1275; POGSON CI, 1967, NATURE, V216, P156, DOI 10.1038/216156a0; Rous P, 1914, J EXP MED, V20, P433, DOI 10.1084/jem.20.5.433; SCHAPIRA F, 1966, ENZYMOL BIOL CLIN, V7, P98, DOI 10.1159/000457208; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; SIBLEY JA, 1955, CANCER RES, V15, P306; Spindler SR, 2001, ANN NY ACAD SCI, V928, P296; Tang KF, 2008, J CELL BIOL, V182, P233, DOI 10.1083/jcb.200801169; TANNENBAUM A, 1953, CANCER RES, V13, P532; WEINDRUCH R, 1982, SCIENCE, V215, P1415, DOI 10.1126/science.7063854; Wu JM, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.289; Wu JM, 2012, CARCINOGENESIS, V33, P519, DOI 10.1093/carcin/bgr304; Zhang PY, 2016, NUCLEIC ACIDS RES, V44, P3629, DOI 10.1093/nar/gkv1504	36	27	28	4	21	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 22	2018	37	8					1041	1048		10.1038/onc.2017.398	http://dx.doi.org/10.1038/onc.2017.398			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FX2QD	29084207				2022-12-26	WOS:000425905700007
J	Bart, AG; Scott, EE				Bart, Aaron G.; Scott, Emily E.			Structural and functional effects of cytochrome b(5) interactions with human cytochrome P450 enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; BACULOVIRUS EXPRESSION; MICROSOMAL CYTOCHROME; 17,20-LYASE ACTIVITY; MASS-SPECTROMETRY; BINDING-SITE; HUMAN LIVER; 2E1; PURIFICATION; REDUCTASE	The small heme-containing protein cytochrome b(5) can facilitate, inhibit, or have no effect on cytochrome P450 catalysis, often in a P450-dependent and substrate-dependent manner that is not well understood. Herein, solution NMR was used to identify b(5) residues interacting with different human drug-metabolizing P450 enzymes. NMR results revealed that P450 enzymes bound to either b(5) alpha 4-5 (CYP2A6 and CYP2E1) or this region and alpha 2-3 (CYP2D6 and CYP3A4) and suggested variation in the affinity for b(5). Mutations of key b(5) residues suggest not only that different b(5) surfaces are responsible for binding different P450 enzymes, but that these different complexes are relevant to the observed effects on P450 catalysis.	[Bart, Aaron G.; Scott, Emily E.] Univ Michigan, Biophys Program, Ann Arbor, MI 48109 USA; [Scott, Emily E.] Univ Michigan, Dept Med Chem, 428 Church St, Ann Arbor, MI 48109 USA; [Scott, Emily E.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Scott, EE (corresponding author), Univ Michigan, Dept Med Chem, 428 Church St, Ann Arbor, MI 48109 USA.	scottee@umich.edu			National Institutes of Health Grants [F37 GM076343, T32 GM008545]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM076343, T32GM008545] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants F37 GM076343 (to E.E.S.) and T32 GM008545. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahuja S, 2013, J BIOL CHEM, V288, P22080, DOI 10.1074/jbc.M112.448225; Bridges A, 1998, J BIOL CHEM, V273, P17036, DOI 10.1074/jbc.273.27.17036; Chen WQ, 1996, ARCH BIOCHEM BIOPHYS, V335, P123, DOI 10.1006/abbi.1996.0489; Chen WQ, 1998, CHEM RES TOXICOL, V11, P295, DOI 10.1021/tx9701687; Dehal SS, 1997, CANCER RES, V57, P3402; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeVore NM, 2008, DRUG METAB DISPOS, V36, P2582, DOI 10.1124/dmd.108.023770; Estrada DF, 2014, J BIOL CHEM, V289, P14310, DOI 10.1074/jbc.M114.560144; Estrada DF, 2013, J BIOL CHEM, V288, P17008, DOI 10.1074/jbc.M113.468926; Fukami T, 2008, CHEM RES TOXICOL, V21, P720, DOI 10.1021/tx700325f; Gao QX, 2006, J BIOL CHEM, V281, P20404, DOI 10.1074/jbc.M601785200; GILLAM EMJ, 1994, ARCH BIOCHEM BIOPHYS, V312, P59, DOI 10.1006/abbi.1994.1280; GORSKY LD, 1986, DRUG METAB DISPOS, V14, P89; GRUENKE LD, 1995, J BIOL CHEM, V270, P24707, DOI 10.1074/jbc.270.42.24707; Guengerich F.P., 2015, CYTOCHROME P450 STRU, P523, DOI [10.1007/978-3-319-12108-6, DOI 10.1007/978-3-319-12108-6]; Henderson CJ, 2015, MOL PHARMACOL, V87, P733, DOI 10.1124/mol.114.097394; KATAGIRI M, 1995, ARCH BIOCHEM BIOPHYS, V317, P343, DOI 10.1006/abbi.1995.1173; Mulrooney SB, 2000, PROTEIN EXPRES PURIF, V19, P173, DOI 10.1006/prep.2000.1228; Naffin-Olivos JL, 2006, BIOCHEMISTRY-US, V45, P755, DOI 10.1021/bi051623y; Nunez M, 2010, J BIOMOL NMR, V47, P289, DOI 10.1007/s10858-010-9428-6; OPRIAN DD, 1982, J BIOL CHEM, V257, P8935; Peng HM, 2016, BIOCHEMISTRY-US, V55, P4356, DOI 10.1021/acs.biochem.6b00532; Peng HM, 2014, ARCH BIOCHEM BIOPHYS, V541, P53, DOI 10.1016/j.abb.2013.11.001; Peng HM, 2013, BIOCHEMISTRY-US, V52, P210, DOI 10.1021/bi301384n; Porubsky PR, 2008, J BIOL CHEM, V283, P33698, DOI 10.1074/jbc.M805999200; Schenkman JB, 2003, PHARMACOL THERAPEUT, V97, P139, DOI 10.1016/S0163-7258(02)00327-3; Shimada T, 2005, ARCH BIOCHEM BIOPHYS, V435, P207, DOI 10.1016/j.abb.2004.12.008; Soucek P, 1999, ARCH BIOCHEM BIOPHYS, V370, P190, DOI 10.1006/abbi.1999.1388; STRITTMATTER P, 1956, J BIOL CHEM, V221, P253; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TAMBURINI PP, 1985, J BIOL CHEM, V260, P4007; Tan YZ, 1997, ARCH BIOCHEM BIOPHYS, V342, P82, DOI 10.1006/abbi.1997.9995; Wang A, 2012, J BIOL CHEM, V287, P10834, DOI 10.1074/jbc.M111.307918; Waskell L., 2015, CYTOCHROME P450 STRU, P33, DOI [DOI 10.1007/978-3-319-12108-6, DOI 10.1007/978-3-319-12108-6_9]; Wester MR, 2002, METHOD ENZYMOL, V357, P73; Yamazaki H, 1997, ARCH BIOCHEM BIOPHYS, V342, P329, DOI 10.1006/abbi.1997.0125; Yamazaki H, 1996, BIOCHEM PHARMACOL, V52, P301, DOI 10.1016/0006-2952(96)00208-0; Yamazaki H, 2002, PROTEIN EXPRES PURIF, V24, P329, DOI 10.1006/prep.2001.1578; Yamazaki H, 2001, J BIOL CHEM, V276, P30885, DOI 10.1074/jbc.M105011200; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200; Yu AM, 2001, DRUG METAB DISPOS, V29, P1362; Yun CH, 2005, J BIOL CHEM, V280, P12279, DOI 10.1074/jbc.M411019200; Zhang HM, 2007, J BIOL CHEM, V282, P29766, DOI 10.1074/jbc.M703845200; Zhang M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08392; Zhao CS, 2012, BIOCHEMISTRY-US, V51, P9488, DOI 10.1021/bi301069r	45	30	30	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					20818	20833		10.1074/jbc.RA117.000220	http://dx.doi.org/10.1074/jbc.RA117.000220			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29079577	Green Published, hybrid			2022-12-26	WOS:000418453400002
J	Li, PT; Wang, ZF; Chu, IT; Kuan, YM; Li, MH; Huang, MC; Chiang, PC; Chang, TC; Chen, CT				Li, Pei-Tzu; Wang, Zi-Fu; Chu, I. -Te; Kuan, Yen-Min; Li, Ming-Hao; Huang, Mu-Ching; Chiang, Pei-Chi; Chang, Ta-Chau; Chen, Chin-Tin			Expression of the human telomerase reverse transcriptase gene is modulated by quadruplex formation in its first exon due to DNA methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTER-DOT-G; G-C REPEATS; SECONDARY STRUCTURES; PROMOTER REGION; HTERT PROMOTER; HUMAN GENOME; CANCER; CTCF; NMR; DEMETHYLATION	DNA secondary structures and methylation are two well-known mechanisms that regulate gene expression. The catalytic subunit of telomerase, human telomerase reverse transcriptase (hTERT), is overexpressed in similar to 90% of human cancers to maintain telomere length for cell immortalization. Binding of CCCTC-binding factor (CTCF) to the first exon of the hTERT gene can down-regulate its expression. However, DNA methylation in the first exon can prevent CTCF binding in most cancers, but the molecular mechanism is unknown. The NMR analysis showed that a stretch of guanine-rich sequence in the first exon of hTERT and located within the CTCF-binding region can form two secondary structures, a hairpin and a quadruplex. A key finding was that the methylation of cytosine at the specific CpG dinucleotides will participate in quartet formation, causing the shift of the equilibrium from the hairpin structure to the quadruplex structure. Of further importance was the finding that the quadruplex formation disrupts CTCF protein binding, which results in an increase in hTERT gene expression. Our results not only identify quadruplex formation in the first exon promoted by CpG dinucleotide methylation as a regulator of hTERT expression but also provide a possible mechanistic insight into the regulation of gene expression via secondary DNA structures.	[Li, Pei-Tzu; Kuan, Yen-Min; Huang, Mu-Ching; Chiang, Pei-Chi; Chen, Chin-Tin] Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei 10617, Taiwan; [Chu, I. -Te; Chang, Ta-Chau] Natl Taiwan Univ, Dept Chem, Taipei 10617, Taiwan; [Wang, Zi-Fu; Chu, I. -Te; Li, Ming-Hao; Chang, Ta-Chau] Acad Sinica, Inst Atom & Mol Sci, Taipei 10617, Taiwan	National Taiwan University; National Taiwan University; Academia Sinica - Taiwan	Chen, CT (corresponding author), Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei 10617, Taiwan.; Chang, TC (corresponding author), Natl Taiwan Univ, Dept Chem, Taipei 10617, Taiwan.; Chang, TC (corresponding author), Acad Sinica, Inst Atom & Mol Sci, Taipei 10617, Taiwan.	tcchang@po.iams.sinica.edu.tw; chintin@ntu.edu.tw	Chang, Ta-Chau/F-7921-2012; Hsiao, Wei-Hung/B-9931-2013	Chang, Ta-Chau/0000-0001-5878-8556; Chu, I-Te/0000-0002-2235-3275; CHEN, CHIN-TIN/0000-0002-7439-8774	Academia Sinica [AS-102-TPA07]; Ministry of Science and Technology of the Republic of China [MOST-103-2113-M-001-017-MY3, MOST105-2320-B-002-056]; National Taiwan University; Academia Sinica Innovative Joint Program Grant [NTU-SINICA-105R104510]	Academia Sinica(Academia Sinica - Taiwan); Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University); Academia Sinica Innovative Joint Program Grant	This work was supported by Academia Sinica Grant AS-102-TPA07, Ministry of Science and Technology of the Republic of China Grants MOST-103-2113-M-001-017-MY3 (to T.C.C.) and MOST105-2320-B-002-056 (to C.T.C.), and National Taiwan University and Academia Sinica Innovative Joint Program Grant NTU-SINICA-105R104510.	Armanios M, 2012, NAT REV GENET, V13, P693, DOI 10.1038/nrg3246; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; de Jesus BB, 2013, TRENDS GENET, V29, P513, DOI 10.1016/j.tig.2013.06.007; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Bouaziz S, 1998, J MOL BIOL, V282, P637, DOI 10.1006/jmbi.1998.2031; Chambers VS, 2015, NAT BIOTECHNOL, V33, P877, DOI 10.1038/nbt.3295; Chiba K, 2015, ELIFE, V4, DOI 10.7554/eLife.07918; Choi JH, 2010, BIOCHEM BIOPH RES CO, V391, P449, DOI 10.1016/j.bbrc.2009.11.078; Cogoi S, 2006, NUCLEIC ACIDS RES, V34, P2536, DOI 10.1093/nar/gkl286; Dai JX, 2006, NUCLEIC ACIDS RES, V34, P5133, DOI 10.1093/nar/gkl610; De S, 2011, NAT STRUCT MOL BIOL, V18, P950, DOI 10.1038/nsmb.2089; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; FRY M, 1994, P NATL ACAD SCI USA, V91, P4950, DOI 10.1073/pnas.91.11.4950; Gao YW, 2013, CELL STEM CELL, V12, P453, DOI 10.1016/j.stem.2013.02.005; Gray RD, 2008, NUCLEIC ACIDS RES, V36, P4191, DOI 10.1093/nar/gkn379; Guo K, 2008, NUCLEIC ACIDS RES, V36, P4598, DOI 10.1093/nar/gkn380; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Halder R, 2010, MOL BIOSYST, V6, P2439, DOI 10.1039/c0mb00009d; HARDIN CC, 1993, BIOCHEMISTRY-US, V32, P5870, DOI 10.1021/bi00073a021; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Huang WC, 2015, NUCLEIC ACIDS RES, V43, P10102, DOI 10.1093/nar/gkv1061; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Kaas GA, 2013, NEURON, V79, P1086, DOI 10.1016/j.neuron.2013.08.032; Kang HJ, 2016, J AM CHEM SOC, V138, P13673, DOI 10.1021/jacs.6b07598; Kettani A, 1998, J MOL BIOL, V282, P619, DOI 10.1006/jmbi.1998.2030; KETTANI A, 1995, J MOL BIOL, V254, P638, DOI 10.1006/jmbi.1995.0644; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; KLENOVA EM, 1993, MOL CELL BIOL, V13, P7612, DOI 10.1128/MCB.13.12.7612; Kocman V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6831; Kuo MHJ, 2015, J AM CHEM SOC, V137, P210, DOI 10.1021/ja5089327; Kyo S, 2008, CANCER SCI, V99, P1528, DOI 10.1111/j.1349-7006.2008.00878.x; Li T, 2008, MOL CELL BIOL, V28, P6473, DOI 10.1128/MCB.00204-08; Lim KW, 2010, J AM CHEM SOC, V132, P12331, DOI 10.1021/ja101252n; Lim KW, 2009, NUCLEIC ACIDS RES, V37, P6239, DOI 10.1093/nar/gkp630; Lin J, 2013, BIOCHEM BIOPH RES CO, V433, P368, DOI 10.1016/j.bbrc.2012.12.040; Maizels N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003468; Palumbo SL, 2009, J AM CHEM SOC, V131, P10878, DOI 10.1021/ja902281d; Phan AT, 2002, J AM CHEM SOC, V124, P1160, DOI 10.1021/ja011977m; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; PLATEAU P, 1982, J AM CHEM SOC, V104, P7310, DOI 10.1021/ja00389a067; Rankin S, 2005, J AM CHEM SOC, V127, P10584, DOI 10.1021/ja050823u; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P1245, DOI 10.1093/nar/gkl1125; Renaud S, 2005, NUCLEIC ACIDS RES, V33, P6850, DOI 10.1093/nar/gki989; Rigo R, 2017, BBA-GEN SUBJECTS, V1861, P1399, DOI 10.1016/j.bbagen.2016.12.024; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Vinagre J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3185; Vincent JJ, 2013, CELL STEM CELL, V12, P470, DOI 10.1016/j.stem.2013.01.016; Wang JM, 2014, J BIOL CHEM, V289, P14612, DOI 10.1074/jbc.M114.548230; Wang ZF, 2014, NUCLEIC ACIDS RES, V42, P4723, DOI 10.1093/nar/gku083	52	20	20	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					20859	20870		10.1074/jbc.M117.808022	http://dx.doi.org/10.1074/jbc.M117.808022			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29084850	Green Published, hybrid			2022-12-26	WOS:000418453400005
J	Bagnis, CI; Pieroni, L; Inaoui, R; Maksud, P; Lallauret, S; Valantin, MA; Tubiana, R; Katlama, C; Deray, G; Courbebaisse, M; Tourret, J; du Montcel, ST				Bagnis, Corinne Isnard; Pieroni, Laurence; Inaoui, Rachida; Maksud, Philippe; Lallauret, Stephanie; Valantin, Marc-Antoine; Tubiana, Roland; Katlama, Christine; Deray, Gilbert; Courbebaisse, Marie; Tourret, Jerome; du Montcel, Sophie Tezenas			Impact of lean mass and bone density on glomerular filtration rate estimation in people living with HIV/AIDS	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CYSTATIN C; ESTIMATING EQUATIONS; SERUM CREATININE; RENAL-DISEASE; EPIDEMIOLOGY COLLABORATION; COCKCROFT-GAULT; PERFORMANCE; DIET; ASSOCIATION	Context Chronic kidney disease is a frequent complication in persons living with HIV/AIDS. Although previous studies have suggested that the CKD-EPI formula is appropriate to estimate glomerular filtration rate (GFR) in HIV-positive adults with normal kidney function, the optimal way to estimate GFR in those with Stage 3 chronic kidney disease is not known. Moreover, the impact of muscle mass on creatinine level and GFR estimation is unknown. Aim and methods Our study aimed to evaluate the accuracy of different diagnostic tests available compared to the gold standard measurement of GFR. A group of 44 HIV-1 patients with an estimated GFR between 60 and 30 ml/min/1.73 m(2) were included in a single-center cross-sectional study. Serum creatinine and cystatin C were measured. GFR was estimated using Cock-croft-Gault, MDRD, sMDRD, CKD-EPI, CKD-EPIcyst, and CKD-EPIcyst/creat formulae and was measured using isotopic Chrome(51)EDTA clearance. Bone density and muscle mass were measured by DXA scan. Results Mean age was 62 +/- 10 years. Mean BMI was 23 +/- 4 kg/m(2). Prevalence of diabetes was 30% and of hypertension was 47%. Viral load was <40 copies/ml for 90% of the patients, and mean CD4 count was 446 +/- 191 cells/mm(3). Mean measured GFR was 63.4 +/- 16.5 ml/min/1.73 m(2). All formulae under-estimated GFR. The best relative precision and accuracy were provided by the CKP-EPI formula. sMDRD, CKD-EPIcyst, and CKD-EPIcyst/creat performed worse than the CKD-EPI formula. Body composition did not significantly influence accuracy or precision of GFR estimation. Conclusion In HIV-infected patients in stable immunovirologic conditions with CKD stage 3 and high prevalence of metabolic associated conditions, the CKD-EPI formula performed best, although all formulae under estimate GFR.	[Bagnis, Corinne Isnard; Deray, Gilbert; Tourret, Jerome] Grp Hosp Pitie Salpetriere, AP HP, Nephrol, Paris, France; [Bagnis, Corinne Isnard; Pieroni, Laurence; Inaoui, Rachida; Maksud, Philippe; Deray, Gilbert; Tourret, Jerome] Univ Paris 06, Paris, France; [Pieroni, Laurence] Grp Hosp Pitie Salpetriere, AP HP, Biochem Dept, Paris, France; [Inaoui, Rachida] Grp Hosp Pitie Salpetriere, AP HP, Rhumatol, Paris, France; [Maksud, Philippe] Grp Hosp Pitie Salpetriere, AP HP, Nucl Med, Paris, France; [Lallauret, Stephanie; du Montcel, Sophie Tezenas] Grp Hosp Pitie Salpetriere, AP HP, Biostat Unit, Paris, France; [Lallauret, Stephanie; du Montcel, Sophie Tezenas] Grp Hosp Pitie Salpetriere, AP HP, Clin Res Unit, Paris, France; [Valantin, Marc-Antoine; Tubiana, Roland; Katlama, Christine] Grp Hosp Pitie Salpetriere, AP HP, Infect Dis, Paris, France; [Courbebaisse, Marie] Hop Europeen Georges Pompidou, Physiol Dept, Paris, France; [Courbebaisse, Marie] INSERM, Paris, France; [du Montcel, Sophie Tezenas] UPMC Univ Paris 06, UMR S1136, Sorbonne Univ, Paris, France; [du Montcel, Sophie Tezenas] Inst Pierre Louis EPIdemiol & Sante Publ, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Bagnis, CI (corresponding author), Grp Hosp Pitie Salpetriere, AP HP, Nephrol, Paris, France.; Bagnis, CI (corresponding author), Univ Paris 06, Paris, France.	corinne.bagnis@aphp.fr	Tezenas du Montcel, Sophie/A-6207-2012; Pieroni, Laurence/AAA-4583-2019; Bagnis, corinne/AAY-1034-2020	Tezenas du Montcel, Sophie/0000-0002-2866-4330; Bagnis, corinne/0000-0002-1048-6636	SIDACTION; Institution Assistance Publique-Hopitaux de Paris	SIDACTION; Institution Assistance Publique-Hopitaux de Paris	The study was funded by an institutional grant from SIDACTION and sponsored by our Institution Assistance Publique-Hopitaux de Paris.	Agence Nationnale de la Securite du Medicament et des produits de sante (ANSM), 2014, AN VENT MED FRANC 20; Ando Minoru, 2015, World J Nephrol, V4, P388, DOI 10.5527/wjn.v4.i3.388; Barraclough K, 2009, NEPHRON CLIN PRACT, V111, pC39, DOI 10.1159/000178978; Beringer PM, 2010, PHARMACOTHERAPY, V30, P1004, DOI 10.1592/phco.30.10.1004; Bhasin B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082028; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Neto LFDP, 2016, BRAZ J INFECT DIS, V20, P99, DOI 10.1016/j.bjid.2015.10.003; Dabrowska MM, 2011, AIDS RES HUM RETROV, V27, P809, DOI [10.1089/AID.2010.0233, 10.1089/aid.2010.0233]; Delanaye P, 2014, J NEPHROL, V27, P467, DOI 10.1007/s40620-014-0087-7; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; Fosbol MO, 2015, CLIN PHYSIOL FUNCT I, V35, P81, DOI 10.1111/cpf.12152; Gagneux-Brunon A, 2013, AIDS, V27, P1573, DOI 10.1097/QAD.0b013e32835fac30; Gagneux-Brunon A, 2012, NEPHROL DIAL TRANSPL, V27, P1305, DOI 10.1093/ndt/gfs001; Gupta SK, 2014, OPEN FORUM INFECT DI, V2014, P1, DOI DOI 10.1093/0FID/0FU003; Inker LA, 2012, JAIDS-J ACQ IMM DEF, V61, P302, DOI 10.1097/QAI.0b013e31826a6c4f; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Levey AS, 2016, AM J KIDNEY DIS, V67, P9, DOI 10.1053/j.ajkd.2015.09.014; Levey AS, 2015, JAMA-J AM MED ASSOC, V313, P837, DOI 10.1001/jama.2015.0602; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lucas GM, 2014, CLIN INFECT DIS, V59, pE96, DOI 10.1093/cid/ciu617; Luo J, 2015, CLIN CHIM ACTA, V450, P39, DOI 10.1016/j.cca.2015.07.016; Margolick JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086311; Mialich MS, 2017, J CLIN DENSITOM, V20, P73, DOI 10.1016/j.jocd.2016.06.007; Mocroft A, 2014, HIV MED, V15, P144, DOI 10.1111/hiv.12095; Onopiuk A, 2015, ADV CLIN CHEM, V68, P57, DOI 10.1016/bs.acc.2014.11.007; Rosenberg AZ, 2015, NAT REV NEPHROL, V11, P150, DOI 10.1038/nrneph.2015.9; Stevens LA, 2007, J AM SOC NEPHROL, V18, P2749, DOI 10.1681/ASN.2007020199; Stevens LA, 2009, J AM SOC NEPHROL, V20, P2305, DOI 10.1681/ASN.2009020171; Stohr W, 2008, ANTIVIR THER, V13, P761; Thibault R, 2012, ANN NUTR METAB, V60, P6, DOI 10.1159/000334879; Wyatt Christina M, 2012, Top Antivir Med, V20, P106; Wyatt CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069601	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186410	10.1371/journal.pone.0186410	http://dx.doi.org/10.1371/journal.pone.0186410			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29096403	Green Submitted, gold, Green Published			2022-12-26	WOS:000414340200016
J	Le Reste, JY; Nabbe, P; Grasset, AB; Le Floch, B; Grall, P; Derriennic, J; Odorico, M; Lalande, S; le Goff, D; Barais, M; Chiron, B; Lingner, H; Guillou, M; Barraine, P				Le Reste, Jean Yves; Nabbe, Patrice; Grasset, Alice Billot; Le Floch, Bernard; Grall, Pauline; Derriennic, Jeremy; Odorico, Michele; Lalande, Sophie; le Goff, Delphine; Barais, Marie; Chiron, Benoit; Lingner, Heidrun; Guillou, Morgane; Barraine, Pierre			Multimorbid outpatients: A high frequency of FP appointments and/or family difficulties, should alert FPs to the possibility of death or acute hospitalization occurring within six months; A primary care feasibility study	PLOS ONE			English	Article							LONG-TERM-CARE; CHRONIC DISEASES; HEALTH; DEFINITION; PREVALENCE; MEDICINE; LIFE	Background The European General Practitioners Research Network (EGPRN) designed and validated a comprehensive definition of multimorbidity using a systematic literature review and qualitative research throughout Europe. This definition was tested as a model to assess death or acute hospitalization in multimorbid outpatients. ObjectiveTo assess which criteria in the EGPRN concept of multimorbidity could detect outpatients at risk of death or acute hospitalization in a primary care cohort at a 6-month follow-up and to assess whether a large scale cohort with FPs would be feasible. Method Family Physicians included a random sample of multimorbid patients who attended appointments in their offices from July to December 2014. Inclusion criteria were those of the EGPRN definition of Multimorbidity. Exclusion criteria were patients under legal protection and those unable to complete the 2-year follow-up. Statistical analysis was undertaken with uni-and multivariate analysis at a 6-month follow-up using a combination of approaches including both automatic classification and expert decision making. A Multiple Correspondence Analysis (MCA) completed the process with a projection of illustrative variables. A logistic regression was finally performed in order to identify and quantify risk factors for decompensation. Results 19 FPs participated in the study. 96 patients were analyzed. 3 different clusters were identified. MCA showed the central function of psychosocial factors and peaceful versus conflictual relationships with relatives in all clusters. While taking into account the limit of a small cohort, age, frequency of family physician visits and extent of family difficulties were the factors which predicted death or acute hospitalization. Conclusion A large scale cohort seems feasible in primary care. A sense of alarm should be triggered to prevent death or acute hospitalization in multimorbid older outpatients who have frequent family physician visits and who experience family difficulties.	[Le Reste, Jean Yves; Nabbe, Patrice; Grasset, Alice Billot; Le Floch, Bernard; Grall, Pauline; Derriennic, Jeremy; Odorico, Michele; Lalande, Sophie; le Goff, Delphine; Barais, Marie; Chiron, Benoit; Guillou, Morgane; Barraine, Pierre] Univ Bretagne Occidentale, SPURBO, Dept Gen Practice, EA 7479, Brest, France; [Lingner, Heidrun] Allgemein Med Hsch Hannover, Hannover, Germany	Universite de Bretagne Occidentale	Le Reste, JY; Nabbe, P (corresponding author), Univ Bretagne Occidentale, SPURBO, Dept Gen Practice, EA 7479, Brest, France.	lereste@univ-brest.fr; nabbep@univ-brest.fr	barais, marie/H-2888-2018	le reste, jean yves/0000-0003-0883-3595				Almirall Jose, 2013, J Comorb, V3, P4; Bongue Bienvenu, 2016, Soins Gerontol, V21, P24, DOI 10.1016/j.sger.2016.05.006; Brandlmeier P, 1976, ZFA (Stuttgart), V52, P1269; Diederichs C, 2011, J GERONTOL A-BIOL, V66, P301, DOI 10.1093/gerona/glq208; DRESS, 2016, COMP INT DEP HOSP; European Academy of Teachers in General Practice (Network within Wonca Europe), 2002, EUR DEF GEN PRACT ME; Fortin M, 2006, QUAL LIFE RES, V15, P83, DOI 10.1007/s11136-005-8661-z; Fortin M, 2012, ANN FAM MED, V10, P142, DOI 10.1370/afm.1337; Galvin R, 2016, AGE AGEING; Garrido-Elustondo S, 2016, ATEN PRIMARIA; Huber Machteld, 2011, BMJ, V343, pd4163, DOI 10.1136/bmj.d4163; Hummers-Pradier E, 2010, EUR J GEN PRACT, V16, P174, DOI 10.3109/13814788.2010.504982; Kaufman L, 2005, FINDING GROUPS ORDIN; Le Reste JY, 2016, EUR J GEN PRACT, V22, P159, DOI 10.3109/13814788.2015.1136619; Le Reste JY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115796; Le Reste JY, 2013, J AM MED DIR ASSOC, V14, P319, DOI 10.1016/j.jamda.2013.01.001; Le Reste JY, 2013, J AM MED DIR ASSOC, V14, P132, DOI 10.1016/j.jamda.2012.07.017; Le Reste J, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0337-3; Lee L, 2015, CAN FAM PHYSICIAN, V61, pE148; Lussier MT, 2016, PATIENT EDUC COUNS, V99, P530, DOI 10.1016/j.pec.2015.11.007; Muth C, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0223-1; Muth C, 2014, EUR J GEN PRACT, V20, P139, DOI 10.3109/13814788.2013.839651; Onder G, 2015, EUR J INTERN MED, V26, P157, DOI 10.1016/j.ejim.2015.02.020; PETO V, 1993, FAM PRACT, V10, P207, DOI 10.1093/fampra/10.2.207; SPEECHLEY M, 1991, J AM GERIATR SOC, V39, P46, DOI 10.1111/j.1532-5415.1991.tb05905.x; van den Akker M, 1996, EUR J GEN PRACT, V2, P65, DOI [DOI 10.3109/13814789609162146, 10.3109/13814789609162146]; van den Bussche H, 2013, J CLIN EPIDEMIOL, V66, P209, DOI 10.1016/j.jclinepi.2012.07.019; van den Bussche H, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-101; Violan C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-251; WHO, 2008, PHARMAFORUM 0121; Wicke FS, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-62; WINOGRAD C H, 1991, Journal of the American Geriatrics Society, V39, p25S	32	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186931	10.1371/journal.pone.0186931	http://dx.doi.org/10.1371/journal.pone.0186931			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL6FI	29095849	Green Submitted, Green Published, gold			2022-12-26	WOS:000414340200033
J	Rannou, F; Scotet, V; Marcorelles, P; Monnoyer, R; Le Marechal, C				Rannou, Fabrice; Scotet, Virginie; Marcorelles, Pascale; Monnoyer, Roxane; Le Marechal, Cedric			Effects of AMPD1 common mutation on the metabolic-chronotropic relationship: Insights from patients with myoadenylate deaminase deficiency	PLOS ONE			English	Article							HEART-FAILURE; MAXIMAL EXERCISE; SKELETAL-MUSCLE; MUTANT ALLELE; ADENOSINE; GENE; VARIANT; POLYMORPHISM; SURVIVAL; DISEASE	Purpose Current evidence indicates that the common AMPD1 gene variant is associated with improved survival in patients with advanced heart failure. Whilst adenosine has been recognized to mediate the cardioprotective effect of C34T AMPD1, the precise pathophysiologic mechanism involved remains undefined to date. To address this issue, we used cardio-pulmonary exercise testing data (CPX) from subjects with myoadenylate deaminase (MAD) defects. Methods From 2009 to 2013, all the patients referred in our laboratory to perform a metabolic exercise testing, i.e. a CPX with measurements of muscle metabolites in plasma during and after exercise testing, were prospectively enrolled. Subjects that also underwent an open muscle biopsy for diagnosis purpose were finally included. The metabolic-chronotropic response was assessed by calculating the slope of the linear relationship between the percent heart rate reserve and the percent metabolic reserve throughout exercise. MAD activity was measured using the Fishbein's technique in muscle biopsy sample. The common AMPD1 mutation was genotyped and the AMPD1 gene was sequenced to screen rare variants from blood DNA. Results Sixty-seven patients were included in the study; 5 had complete MAD deficiency, 11 had partial MAD deficiency, and 51 had normal MAD activity. Compared with normal MAD activity subjects, MAD deficient subjects appeared to have a lower-than-expected metabolic-chronotopic response during exercise. The metabolic-chronotropic relationship is more closely correlated with MAD activity in skeletal muscle (Rs = 0.57, p = 5.93E-7, Spearman correlation) than the presence of the common AMPD1 gene variant (Rs = 0.34, p = 0.005). Age-predicted O-2 pulse ratio is significantly increased in MAD deficient subjects, indicating a greater efficiency of the cardiovascular system to deliver O-2 (p< 0.01, Scheffe's post hoc test). Conclusion The metabolic-chronotropic response is decreased in skeletal muscle MAD deficiency, suggesting a biological mechanism by which AMPD1 gene exerts cardiac effect.	[Rannou, Fabrice] CHRU Cavale Blanche, Physiol Dept, EA 4324, Brest, France; [Scotet, Virginie; Monnoyer, Roxane; Le Marechal, Cedric] Inst Natl Sante & Rech Med, UMR 1078, Brest, France; [Marcorelles, Pascale] CHRU Morvan, Dept Pathol, EA LNB 4685, Brest, France	CHU Brest; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Brest	Rannou, F (corresponding author), CHRU Cavale Blanche, Physiol Dept, EA 4324, Brest, France.	fabrice.rannou@chu-brest.fr	Rannou, Fabrice/AAI-1924-2021	Scotet, Virginie/0000-0002-5447-4207; le marechal, cedric/0000-0002-5575-5131; Rannou, Fabrice/0000-0002-6643-0527				Anderson JL, 2000, J AM COLL CARDIOL, V36, P1248, DOI 10.1016/S0735-1097(00)00850-0; Bader DS, 2000, AM J CARDIOL, V85, P767, DOI 10.1016/S0002-9149(99)00859-0; Camarda Sérgio Ricardo de Abreu, 2008, Arq. Bras. Cardiol., V91, P311, DOI 10.1590/S0066-782X2008001700005; Darvish A, 1996, AM J PHYSIOL-HEART C, V271, pH2162, DOI 10.1152/ajpheart.1996.271.5.H2162; DIMARCO JP, 1983, CIRCULATION, V68, P1254, DOI 10.1161/01.CIR.68.6.1254; Drury AN, 1929, J PHYSIOL-LONDON, V68, P213, DOI 10.1113/jphysiol.1929.sp002608; Feng AF, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0608-0; Fischer S, 2005, CLIN NEUROPATHOL, V24, P77; FISHBEIN WN, 1984, ANN NEUROL, V15, P271, DOI 10.1002/ana.410150312; Fishbein WN, 1999, ANN NEUROL, V45, P547, DOI 10.1002/1531-8249(199904)45:4<547::AID-ANA25>3.0.CO;2-L; FISHBEIN WN, 1978, SCIENCE, V200, P545, DOI 10.1126/science.644316; FISHBEIN WN, 1985, BIOCHEM MED METAB B, V33, P158, DOI 10.1016/0006-2944(85)90024-9; Grealy R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145171; Gross M, 2002, NEUROMUSCULAR DISORD, V12, P558, DOI 10.1016/S0960-8966(02)00008-1; Hanisch F, 2008, J NEUROL, V255, P318, DOI 10.1007/s00415-008-0530-6; JONES NL, 1985, AM REV RESPIR DIS, V131, P700; Kalsi KK, 2003, CARDIOVASC RES, V59, P678, DOI 10.1016/S0008-6363(03)00497-8; Kirchhof P, 2003, AM J PHYSIOL-HEART C, V285, pH145, DOI 10.1152/ajpheart.01036.2002; Kolek MJ, 2005, J CARD FAIL, V11, P677, DOI 10.1016/j.cardfail.2005.06.437; LEE HT, 1993, AM J PHYSIOL, V265, pH1916, DOI 10.1152/ajpheart.1993.265.6.H1916; Loh E, 1999, CIRCULATION, V99, P1422, DOI 10.1161/01.CIR.99.11.1422; MORISAKI T, 1992, P NATL ACAD SCI USA, V89, P6457, DOI 10.1073/pnas.89.14.6457; MOSER GH, 1989, AM J PHYSIOL, V256, pC799, DOI 10.1152/ajpcell.1989.256.4.C799; Oliveira RB, 2011, CLINICS, V66, P203, DOI 10.1590/S1807-59322011000200004; Rannou F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132972; Richard P, 2006, J AM COLL CARDIOL, V48, pA79, DOI 10.1016/j.jacc.2006.09.014; SABINA RL, 1984, J CLIN INVEST, V73, P720, DOI 10.1172/JCI111265; SHUMATE JB, 1979, MUSCLE NERVE, V2, P213, DOI 10.1002/mus.880020309; Sommerschild HT, 2000, ACTA ANAESTH SCAND, V44, P1038, DOI 10.1034/j.1399-6576.2000.440903.x; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Tarnopolsky MA, 2006, APPL PHYSIOL NUTR ME, V31, P21, DOI 10.1139/H05-008; Tarnopolsky MA, 2001, J PHYSIOL-LONDON, V533, P881, DOI 10.1111/j.1469-7793.2001.t01-1-00881.x; Toyama K, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013151; VALEN PA, 1987, ARTHRITIS RHEUM, V30, P661, DOI 10.1002/art.1780300609; Wasserman K, 2005, PRINCIPLES EXERCISE, P160; Wilkoff Bruce L., 1992, Cardiology Clinics, V10, P705; Yamaya Y, 2002, J APPL PHYSIOL, V92, P162, DOI 10.1152/japplphysiol.00409.2001; Yazaki Y, 2004, J CARD FAIL, V10, P316, DOI 10.1016/j.cardfail.2003.10.008	39	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187266	10.1371/journal.pone.0187266	http://dx.doi.org/10.1371/journal.pone.0187266			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095874	Green Submitted, Green Published, gold			2022-12-26	WOS:000414340200064
J	Radchenko, T; Brink, A; Siegrist, Y; Kochansky, C; Bateman, A; Fontaine, F; Morettoni, L; Zamora, I				Radchenko, Tatiana; Brink, Andreas; Siegrist, Yves; Kochansky, Christopher; Bateman, Alison; Fontaine, Fabien; Morettoni, Luca; Zamora, Ismael			Software-aided approach to investigate peptide structure and metabolic susceptibility of amide bonds in peptide drugs based on high resolution mass spectrometry	PLOS ONE			English	Article							IDENTIFICATION; FUTURE; STABILITY; FRAGMENT; MSE	Interest in using peptide molecules as therapeutic agents due to high selectivity and efficacy is increasing within the pharmaceutical industry. However, most peptide-derived drugs cannot be administered orally because of low bioavailability and instability in the gastrointestinal tract due to protease activity. Therefore, structural modifications peptides are required to improve their stability. For this purpose, several in-silico software tools have been developed such as PeptideCutter or PoPS, which aim to predict peptide cleavage sites for different proteases. Moreover, several databases exist where this information is collected and stored from public sources such as MEROPS and ExPASy ENZYME databases. These tools can help design a peptide drug with increased stability against proteolysis, though they are limited to natural amino acids or cannot process cyclic peptides, for example. We worked to develop a new methodology to analyze peptide structure and amide bond metabolic stability based on the peptide structure (linear/cyclic, natural/unnatural amino acids). This approach used liquid chromatography / high resolution, mass spectrometry to obtain the analytical data from in vitro incubations. We collected experimental data for a set (linear/cyclic, natural/unnatural amino acids) of fourteen peptide drugs and four substrate peptides incubated with different proteolytic media: trypsin, chymotrypsin, pepsin, pancreatic elastase, dipeptidyl peptidase-4 and neprilysin. Mass spectrometry data was analyzed to find metabolites and determine their structures, then all the results were stored in a chemically aware manner, which allows us to compute the peptide bond susceptibility by using a frequency analysis of the metabolic-liable bonds. In total 132 metabolites were found from the various in vitro conditions tested resulting in 77 distinct cleavage sites. The most frequent observed cleavage sites agreed with those reported in the literature. The main advantages of the developed approach are the abilities to elucidate metabolite structure of cyclic peptides and those containing unnatural amino acids, store processed information in a searchable format within a database leading to frequency analysis of the labile sites for the analyzed peptides. The presented algorithm may be useful to optimize peptide drug properties with regards to cleavage sites, stability, metabolism and degradation products in drug discovery.	[Radchenko, Tatiana; Zamora, Ismael] Pompeu Fabra Univ, Barcelona, Spain; [Radchenko, Tatiana; Fontaine, Fabien; Zamora, Ismael] Lead Mol Design SL, Sant Cugat Del Valles, Spain; [Brink, Andreas; Siegrist, Yves] F Hoffmann La Roche Ltd, Roche Innovat Ctr Basel, Pharma Res & Early Dev, Basel, Switzerland; [Kochansky, Christopher; Bateman, Alison] Merck & Co Inc, Pharmacokinet Pharmacodynam & Drug Metab, West Point, PA USA; [Morettoni, Luca] Mol Discovery Ltd, London, England	Pompeu Fabra University; Roche Holding; Merck & Company	Radchenko, T; Zamora, I (corresponding author), Pompeu Fabra Univ, Barcelona, Spain.; Radchenko, T; Zamora, I (corresponding author), Lead Mol Design SL, Sant Cugat Del Valles, Spain.	tatiana.radchenko01@estudiant.upf.edu; ismael.zamora@leadmolecular.com		Brink, Andreas/0000-0001-6927-8252; Zamora, Ismael/0000-0002-7700-0354	Amb el suport de la Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya; La ayuda a Doctorados Industrial del Gobierno de la Generalitat de Catalunya	Amb el suport de la Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya(Generalitat de Catalunya); La ayuda a Doctorados Industrial del Gobierno de la Generalitat de Catalunya(Generalitat de Catalunya)	Amb el suport de la Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya. La ayuda a Doctorados Industrial del Gobierno de la Generalitat de Catalunya (http://doctoratsindustrials.gencat.cat/es) funded all travel expenses related to this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Andreas Brink and Yves Siergist are employed by F.Hoffmann-La Roche Ltd. Christopher Kochansky and Alison Bateman are employed by Merck & Co., Inc.. Luca Morettoni is employed by Molecular Discovery Ltd. F. Hoffmann-La Roche Ltd, Merck & Co., Inc., and Molecular Discovery Ltd provided support in the form of salaries for authors AB, YS, CK, AB and LM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'dauthor contributions' section.	Ahlqvist M, 2015, RAPID COMMUN MASS SP, V29, P2083, DOI 10.1002/rcm.7364; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304; Bayden AS, 2015, BIOPOLYMERS, V104, P775, DOI 10.1002/bip.22711; Bonn B, 2010, RAPID COMMUN MASS SP, V24, P3127, DOI 10.1002/rcm.4753; Boyd Sarah E., 2005, Journal of Bioinformatics and Computational Biology, V3, P551, DOI 10.1142/S021972000500117X; Brink A, 2016, P 64 ASMS C MASS SPE; Brink A., 2013, DRUG DISCOV TODAY TE, V10, pe207; Brink A, 2014, RAPID COMMUN MASS SP, V28, P2695, DOI 10.1002/rcm.7062; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; Cruciani C, 2000, J MOL STRUC-THEOCHEM, V503, P17, DOI 10.1016/S0166-1280(99)00360-7; Di L, 2015, AAPS J, V17, P134, DOI 10.1208/s12248-014-9687-3; Fontaine F, 2009, CHEMMEDCHEM, V4, P427, DOI 10.1002/cmdc.200800355; Fosgerau K, 2015, DRUG DISCOV TODAY, V20, P122, DOI 10.1016/j.drudis.2014.10.003; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Igarashi Y, 2007, NUCLEIC ACIDS RES, V35, pD546, DOI 10.1093/nar/gkl813; Kaspar AA, 2013, DRUG DISCOV TODAY, V18, P807, DOI 10.1016/j.drudis.2013.05.011; Katsila T, 2012, MASS SPECTROM REV, V31, P110, DOI 10.1002/mas.20340; Klingler D, 2012, PROTEOMICS, V12, P587, DOI 10.1002/pmic.201100399; Malm-Erjefalt M, 2010, DRUG METAB DISPOS, V38, P1944, DOI 10.1124/dmd.110.034066; Manning MC, 2010, PHARM RES-DORDR, V27, P544, DOI 10.1007/s11095-009-0045-6; Meier JJ, 2012, NAT REV ENDOCRINOL, V8, P728, DOI 10.1038/nrendo.2012.140; Niedermeyer THJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044913; Cece-Esencan EN, 2016, RAPID COMMUN MASS SP, V30, P301, DOI 10.1002/rcm.7429; Paiva AA, 2017, BIOANALYSIS, V9, P541, DOI 10.4155/bio-2016-0299; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Song JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033747; Tsomaia N, 2015, EUR J MED CHEM, V94, P459, DOI 10.1016/j.ejmech.2015.01.014; Uhlig T., 2014, EUPA OPEN PROTEOMICS, V4, P58, DOI [10.1016/j.euprot.2014.05.003, DOI 10.1016/J.EUPROT.2014.05.003]; Verspurten J, 2009, TRENDS BIOCHEM SCI, V34, P319, DOI 10.1016/j.tibs.2009.04.001; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Xu CX, 2006, DRUG DISCOV TODAY, V11, P595, DOI 10.1016/j.drudis.2006.05.011; Zamora Ismael, 2013, Drug Discov Today Technol, V10, pe199, DOI 10.1016/j.ddtec.2012.10.015; Zelesky V, 2013, BIOANALYSIS, V5, P1165, DOI [10.4155/BIO.13.89, 10.4155/bio.13.89]	35	12	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0186461	10.1371/journal.pone.0186461	http://dx.doi.org/10.1371/journal.pone.0186461			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091918	Green Submitted, Green Published, gold			2022-12-26	WOS:000414229700020
J	Jang, H; Choi, Y; Yoo, I; Han, J; Hong, JS; Kim, YY; Ka, H				Jang, Hwanhee; Choi, Yohan; Yoo, Inkyu; Han, Jisoo; Hong, Jin Su; Kim, Yoo Yong; Ka, Hakhyun			Vitamin D-metabolic enzymes and related molecules: Expression at the maternal-conceptus interface and the role of vitamin D in endometrial gene expression in pigs	PLOS ONE			English	Article							UTERINE ENDOMETRIUM; PORCINE UTERUS; D-RECEPTOR; 1,25-DIHYDROXYVITAMIN D-3; 25-HYDROXYVITAMIN D-3; CYP24A1 EXPRESSION; D 24-HYDROXYLASE; FETAL INTERFACE; HUMAN-PREGNANCY; DECIDUAL CELLS	Vitamin D is a secosteroid hormone with many varied functions including regulation of blood calcium levels, cell proliferation, immunity, and reproduction in mammals. Vitamin D is activated by 25-hydroxylase (CYP2R1) and 1-alpha-hydroxylase (CYP27B1) and is degraded by 24-hydroxylase (CYP24A1). Vitamin D is transported by vitamin D-binding protein (group-specific component, GC) through the bloodstream and regulates cellular actions by binding to vitamin D receptor (VDR). In this study, we determined the expression and regulation of vitamin D-related molecules and the role of vitamin D at the maternal-conceptus interface in pigs. Vitamin D-metabolizing enzymes CYP2R1, CYP27B1, and CYP24A1, vitamin D binding protein GC, and vitamin D receptor VDR were expressed in the endometrium in a pregnancy stage-specific manner as well as in conceptus and chorioallantoic tissues during pregnancy. VDR protein was localized to endometrial and trophoblastic cells. Concentrations of calcitriol, the active form of vitamin D, in the endometrial tissues were higher during early pregnancy than in mid-to late pregnancy, while plasma concentrations of calcitriol were highest during late pregnancy. Furthermore, calcitriol affected the expression of several genes related to conceptus implantation, vitamin D metabolism, calcium ion regulation, PG metabolism, and calcium-binding proteins in endometrial tissue explants. These results show that CYP2R1, CYP27B1, CYP24A1, GC, and VDR were expressed at the maternal-conceptus interface, endometrial calcitriol levels were regulated during pregnancy, and calcitriol modulated the expression of endometrial genes, suggesting that calcitriol may play an important role in the establishment and maintenance of pregnancy by regulating endometrial function in pigs.	[Jang, Hwanhee; Choi, Yohan; Yoo, Inkyu; Han, Jisoo; Ka, Hakhyun] Yonsei Univ, Dept Biol Sci & Technol, Wonju, South Korea; [Hong, Jin Su; Kim, Yoo Yong] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea	Yonsei University; Seoul National University (SNU)	Ka, H (corresponding author), Yonsei Univ, Dept Biol Sci & Technol, Wonju, South Korea.	hka@yonsei.ac.kr		Hong, Jinsu/0000-0002-3401-3024	Rural Development Administration [PJ01119103]; National Research Foundation - Korean Government, Republic of Korea [NRF-2015R1D1A1A01058356]	Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); National Research Foundation - Korean Government, Republic of Korea	This work was supported by the BioGreen 21 Program (#PJ01119103), Rural Development Administration, and by the National Research Foundation Grant funded by the Korean Government (#NRF-2015R1D1A1A01058356), Republic of Korea.; This work was supported by the BioGreen 21 Program (#PJ01119103), Rural Development Administration, and by the National Research Foundation Grant funded by the Korean Government (#NRF-2015R1D1A1A01058356), Republic of Korea.	Agic A, 2007, REPROD SCI, V14, P486, DOI 10.1177/1933719107304565; Baeke F, 2010, CURR OPIN PHARMACOL, V10, P482, DOI 10.1016/j.coph.2010.04.001; Barrett H, 2010, BEST PRACT RES CL EN, V24, P527, DOI 10.1016/j.beem.2010.05.010; Bazer FW, 2014, DIFFERENTIATION, V87, P52, DOI 10.1016/j.diff.2013.11.005; Bergada L, 2014, LAB INVEST, V94, P608, DOI 10.1038/labinvest.2014.57; Bikle D, 2009, J CLIN ENDOCR METAB, V94, P26, DOI 10.1210/jc.2008-1454; Braissant O, 1998, BIOCHEMICA, V1, P16; Choi Y, 2014, DOMEST ANIM ENDOCRIN, V47, P1, DOI 10.1016/j.domaniend.2013.12.005; Choi Y, 2012, ASIAN AUSTRAL J ANIM, V25, P44, DOI 10.5713/ajas.2011.11305; Choi Y, 2009, BIOL REPROD, V81, P1122, DOI 10.1095/biolreprod.109.076703; DELVIN EE, 1985, J CLIN ENDOCR METAB, V60, P880, DOI 10.1210/jcem-60-5-880; Diaz L, 2000, J CLIN ENDOCR METAB, V85, P2543, DOI 10.1210/jc.85.7.2543; Du HL, 2005, MOL ENDOCRINOL, V19, P2222, DOI 10.1210/me.2004-0336; El-Atifi M, 2015, NEUROREPORT, V26, P245, DOI 10.1097/WNR.0000000000000328; Evans KN, 2006, BIOL REPROD, V75, P816, DOI 10.1095/biolreprod.106.054056; Evans KN, 2004, J SOC GYNECOL INVEST, V11, P263, DOI 10.1016/j.jsgi.2004.02.002; Garlow JE, 2002, BIOL REPROD, V66, P718, DOI 10.1095/biolreprod66.3.718; GEISERT RD, 1982, BIOL REPROD, V27, P957, DOI 10.1095/biolreprod27.4.957; Han J, 2017, BIOL REPROD, V97, P69, DOI 10.1093/biolre/iox074; Haussler MR, 2008, NUTR REV, V66, pS98, DOI 10.1111/j.1753-4887.2008.00093.x; Jensen MB, 2014, NAT REV ENDOCRINOL, V10, P175, DOI 10.1038/nrendo.2013.262; Joyce MM, 2007, ENDOCRINOLOGY, V148, P4420, DOI 10.1210/en.2007-0505; Ka H, 2001, ENDOCRINOLOGY, V142, P2303, DOI 10.1210/en.142.6.2303; Ka H, 2009, MOL REPROD DEV, V76, P75, DOI 10.1002/mrd.20935; KACHKACHE M, 1993, FEBS LETT, V333, P83, DOI 10.1016/0014-5793(93)80379-9; Kaeoket K, 2003, J VET MED A, V50, P169, DOI 10.1046/j.1439-0442.2003.00532.x; Kim M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143436; KUMAR R, 1979, J CLIN INVEST, V63, P342, DOI 10.1172/JCI109308; Kwak-Kim J, 2010, AM J REPROD IMMUNOL, V63, P611, DOI 10.1111/j.1600-0897.2010.00847.x; LIN H, 1993, J IMMUNOL, V151, P4562; Liu NQ, 2012, ARCH BIOCHEM BIOPHYS, V523, P37, DOI 10.1016/j.abb.2011.11.018; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma R, 2012, AM J PHYSIOL-ENDOC M, V303, pE928, DOI 10.1152/ajpendo.00279.2012; Mizwicki MT, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.275re4; NESTLER JE, 1987, ENDOCRINOLOGY, V120, P1996, DOI 10.1210/endo-120-5-1996; Norman AW, 2008, AM J CLIN NUTR, V88, p491S, DOI 10.1093/ajcn/88.2.491S; Novakovic B, 2009, J BIOL CHEM, V284, P14838, DOI 10.1074/jbc.M809542200; O'Brien KO, 2014, J CLIN ENDOCR METAB, V99, P1348, DOI 10.1210/jc.2013-1366; Pike JW, 2012, ARCH BIOCHEM BIOPHYS, V523, P2, DOI 10.1016/j.abb.2011.12.003; Seo H, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.114926; Seo H, 2008, ENDOCRINOLOGY, V149, P6166, DOI 10.1210/en.2008-0354; Shahbazi M, 2011, PLACENTA, V32, P657, DOI 10.1016/j.placenta.2011.06.013; Shin JS, 2010, PLACENTA, V31, P1027, DOI 10.1016/j.placenta.2010.08.015; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Slominski AT, 2015, J STEROID BIOCHEM, V151, P25, DOI 10.1016/j.jsbmb.2014.11.010; Slominski AT, 2014, MOL CELL ENDOCRINOL, V383, P181, DOI 10.1016/j.mce.2013.12.012; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Song G, 2009, ENDOCRINOLOGY, V150, P936, DOI 10.1210/en.2008-1026; Spencer TE, 2008, REPRODUCTION, V135, P165, DOI 10.1530/REP-07-0327; Sundaram K, 2014, HORM CANCER-US, V5, P90, DOI 10.1007/s12672-014-0170-5; Tamblyn JA, 2015, J ENDOCRINOL, V224, pR107, DOI 10.1530/JOE-14-0642; Vigano P, 2006, J MOL ENDOCRINOL, V36, P415, DOI 10.1677/jme.1.01946; Vigano P, 2003, PLACENTA, V24, pS56, DOI 10.1016/S0143-4004(03)00137-1; WEISMAN Y, 1979, NATURE, V281, P317, DOI 10.1038/281317a0; White FJ, 2005, BIOL REPROD, V73, P1294, DOI 10.1095/biolreprod.105.045153; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391; Zarnani AH, 2010, FERTIL STERIL, V93, P2738, DOI 10.1016/j.fertnstert.2009.09.045	57	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187221	10.1371/journal.pone.0187221	http://dx.doi.org/10.1371/journal.pone.0187221			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088291	Green Submitted, Green Published, gold			2022-12-26	WOS:000414088900050
J	Smith, AN; Creighton, JC; Belk, MC				Smith, Ashlee N.; Creighton, J. Curtis; Belk, Mark C.			Why does it take two to tango? Lifetime fitness consequences of parental care in a burying beetle	PLOS ONE			English	Article							NICROPHORUS-VESPILLOIDES COLEOPTERA; REPRODUCTIVE BENEFITS; BIPARENTAL CARE; PATERNAL CARE; BROOD SIZE; BODY-SIZE; COMPETITION; ORBICOLLIS; EVOLUTION; SILPHIDAE	In species that require parental care, each parent can either care for their offspring or leave them in the care of the other parent. For each parent this creates three possible parental care strategies: biparental care, uniparental (male or female) care, and uniparental desertion by either the male or female. The burying beetle, Nicrophorus orbicollis, typically exhibits biparental care of offspring, and thus provides a unique system that allows us to compare the fitness benefits of these parental care strategies in an unconfounded way. In this study, we assess the lifetime fitness of biparental care, uniparental care, and uniparental desertion strategies in both male and female N. orbicollis. Specifically, we tested for increased fitness of the biparental care strategy compared to uniparental care strategies. Second, we test for equality of fitness between uniparental care and uniparental desertion strategies. Surprisingly, biparental care yields lower lifetime fitness for both parents compared to the other two strategies. Also, uniparental care and uniparental desertion strategies yielded equal fitness. The evolution of biparental care in this system is not consistent with the expectation of a mutual fitness benefit. We discuss other potential explanations for the evolution of biparental care in this system.	[Smith, Ashlee N.; Belk, Mark C.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Creighton, J. Curtis] Purdue Univ Calumet, Dept Biol Sci, Hammond, LA 47907 USA	Brigham Young University; Purdue University System; Purdue University	Smith, AN (corresponding author), Brigham Young Univ, Dept Biol, Provo, UT 84602 USA.	ashleens@byu.edu		Smith, Ashlee/0000-0001-8941-8574	Purdue University Graduate Studies Department; Department of Biological Sciences at Purdue University Northwest	Purdue University Graduate Studies Department; Department of Biological Sciences at Purdue University Northwest	ANS received funding for this research from the Purdue University Graduate Studies Department through a Graduate Research Grant (http://webs. purduecal.edu/gradschool/graduate-research-awards/). JCC received funding for this research from the Department of Biological Sciences at Purdue University Northwest (https:// academics.pnw.edu/biology/).	BARTLETT J, 1988, BEHAV ECOL SOCIOBIOL, V23, P297, DOI 10.1007/BF00300576; BARTLETT J, 1988, BEHAV ECOL SOCIOBIOL, V22, P429, DOI 10.1007/BF00294981; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Benowitz KM, 2016, BIOL J LINN SOC, V119, P1082, DOI 10.1111/bij.12830; BERTRAM BCR, 1975, J ZOOL, V177, P463; Boncoraglio G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031713; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Cockburn A, 2006, P ROY SOC B-BIOL SCI, V273, P1375, DOI 10.1098/rspb.2005.3458; Creighton JC, 2015, BEHAV ECOL SOCIOBIOL, V69, P265, DOI 10.1007/s00265-014-1839-z; Creighton JC, 2005, BEHAV ECOL, V16, P1031, DOI 10.1093/beheco/ari084; EGGERT AK, 1992, BEHAV ECOL, V3, P243, DOI 10.1093/beheco/3.3.243; Eggert AK, 2008, P ROY SOC B-BIOL SCI, V275, P2521, DOI 10.1098/rspb.2008.0661; Eggert AK, 2011, ANIM BEHAV, V82, P1227, DOI 10.1016/j.anbehav.2011.09.001; Gross MR, 2005, Q REV BIOL, V80, P37, DOI 10.1086/431023; Hopwood PE, 2015, J EVOLUTION BIOL, V28, P1394, DOI 10.1111/jeb.12664; Hopwood PE, 2013, FUNCT ECOL, V27, P1350, DOI 10.1111/1365-2435.12137; HRDY SB, 1974, FOLIA PRIMATOL, V22, P19; Kvarnemo C, 2006, BEHAV ECOL, V17, P144, DOI 10.1093/beheco/ari097; Lee VE, 2014, BEHAV ECOL, V25, P172, DOI 10.1093/beheco/art101; Muller JK, 2007, BEHAV ECOL, V18, P196, DOI 10.1093/beheco/arl073; Muller JK, 1998, ECOL ENTOMOL, V23, P195, DOI 10.1046/j.1365-2311.1998.00119.x; MULLER JK, 1990, ANIM BEHAV, V40, P491, DOI 10.1016/S0003-3472(05)80529-9; MULLER JK, 1990, BEHAV ECOL SOCIOBIOL, V27, P11, DOI 10.1007/BF00183307; OTRONEN M, 1988, ANN ZOOL FENN, V25, P191; Parker DJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9449; REZNICK D, 1992, TRENDS ECOL EVOL, V7, P42, DOI 10.1016/0169-5347(92)90104-J; Royle NJ, 2016, CURR OPIN BEHAV SCI, V12, P30, DOI 10.1016/j.cobeha.2016.08.004; Safryn SA, 2000, J INSECT BEHAV, V13, P291, DOI 10.1023/A:1007700601095; Scott MP, 1998, ANNU REV ENTOMOL, V43, P595, DOI 10.1146/annurev.ento.43.1.595; SCOTT MP, 1989, J INSECT BEHAV, V2, P133, DOI 10.1007/BF01053623; SCOTT MP, 1990, BEHAV ECOL SOCIOBIOL, V26, P31, DOI 10.1007/BF00174022; Smiseth PT, 2005, ANIM BEHAV, V69, P551, DOI 10.1016/j.anbehav.2004.06.004; Smith AN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143762; Smith AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109165; Thomas LK, 2005, ANIM BEHAV, V69, P275, DOI 10.1016/j.anbehav.2004.03.009; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; TRUMBO ST, 1991, BEHAVIOUR, V117, P82, DOI 10.1163/156853991X00139; TRUMBO ST, 1990, BEHAV ECOL SOCIOBIOL, V27, P269, DOI 10.1007/BF00164899; Trumbo ST, 2006, ANIM BEHAV, V72, P1159, DOI 10.1016/j.anbehav.2006.05.004	39	1	1	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186466	10.1371/journal.pone.0186466	http://dx.doi.org/10.1371/journal.pone.0186466			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088220	Green Published, gold, Green Submitted			2022-12-26	WOS:000414088900014
J	Wang, MQ; Lee, RJ; Bi, Y; Li, LL; Yan, GD; Lu, JH; Meng, QF; Teng, LS; Xie, J				Wang, Mengqiao; Lee, Robert J.; Bi, Ye; Li, Lianlian; Yan, Guodong; Lu, Jiahui; Meng, Qingfan; Teng, Lesheng; Xie, Jing			Transferrin-conjugated liposomes loaded with novel dihydroquinoline derivatives as potential anticancer agents	PLOS ONE			English	Article							CELLS; DELIVERY; TUMOR	A series of 1,2-dihydroquinoline derivatives were synthesized and evaluated for cytotoxicity in HeLa, Hep G2 and 6HEK-293T cell lines. EEDQ2 was identified as a promising anti-cancer agent with low IC50 in HeLa (18.55 mu g/ml) and Hep G2 (14.53 mu g/ml) cells. For improving the antitumor activity and tumor selectivity of EEDQ2, we prepared transferrin (Tf)-modified liposomes (LPs) to deliver EEDQ2. When HeLa and Hep G2 cells were treated with LP-delivered EEDQ2, the ROS level was significantly enhanced, and mitochondrial membrane potential was reversed. Tf-LPs improved cell uptake of EEDQ2 by about 3.7 times compared with non-targeted LPs. These data suggest that Tf-LPs delivering EEDQ2 is a promising strategy to treat cancer.	[Wang, Mengqiao; Lee, Robert J.; Bi, Ye; Li, Lianlian; Yan, Guodong; Lu, Jiahui; Meng, Qingfan; Teng, Lesheng; Xie, Jing] Jilin Univ, Coll Life Sci, Changchun, Jilin, Peoples R China; [Lee, Robert J.] Ohio State Univ, Coll Pharm, Div Pharmaceut, 500 W 12Th Ave, Columbus, OH 43210 USA	Jilin University; University System of Ohio; Ohio State University	Teng, LS; Xie, J (corresponding author), Jilin Univ, Coll Life Sci, Changchun, Jilin, Peoples R China.	tenglesheng@jlu.edu.cn; xiejing@jlu.edu.cn		Teng, Lesheng/0000-0003-1623-5384	National Natural Science Foundation of China [81502999]; Jilin Province Science and Technology Development Program [20170414039GH]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin Province Science and Technology Development Program	This research was supported by the National Natural Science Foundation of China (grant no. 81502999) and Jilin Province Science and Technology Development Program (grant no. 20170414039GH).; The work was funded by National Natural Science Foundation of China (No. 81502999) and Jilin Province Science and Technology Development Program (No. 20170414039GH).	Bekhit AA, 2010, EUR J MED CHEM, V45, P6027, DOI 10.1016/j.ejmech.2010.10.001; Bi Y, 2016, CURR DRUG METAB, V17, P763, DOI 10.2174/1389200217666160619191853; Bondock S, 2007, EUR J MED CHEM, V42, P948, DOI 10.1016/j.ejmech.2006.12.025; Chiu SJ, 2006, J CONTROL RELEASE, V112, P199, DOI 10.1016/j.jconrel.2006.02.011; Ding YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122128; Dressler C, 2006, J FLUORESC, V16, P689, DOI 10.1007/s10895-006-0110-z; Engel A, 2003, PHARM RES-DORDR, V20, P51, DOI 10.1023/A:1022294624256; Eswaran R, 2016, J INORG BIOCHEM, V155, P1, DOI 10.1016/j.jinorgbio.2015.11.007; Gomes CRB, 2010, LETT DRUG DES DISCOV, V7, P353; Hossen MN, 2010, J CONTROL RELEASE, V147, P261, DOI 10.1016/j.jconrel.2010.07.100; Lee HH, 2013, INT J ONCOL, V42, P1036, DOI 10.3892/ijo.2013.1762; Li Z, 2014, COLLOID SURFACE B, V122, P630, DOI 10.1016/j.colsurfb.2014.07.042; Ma XY, 2016, CHEM RES CHINESE U, V32, P634, DOI 10.1007/s40242-016-5481-3; Ma XY, 2016, ANTICANCER RES, V36, P2105; Maitani Y, 2001, J LIPOSOME RES, V11, P115, DOI 10.1081/LPR-100103174; Omar K, 2010, BIOORGAN MED CHEM, V18, P426, DOI 10.1016/j.bmc.2009.10.041; Ottana R, 2005, BIOORG MED CHEM LETT, V15, P3930, DOI 10.1016/j.bmcl.2005.05.093; Panwar P, 2010, INT J NANOMED, V5, P101; Przybylo M, 2016, EUR J PHARM SCI, V85, P39, DOI 10.1016/j.ejps.2016.01.028; Raja DS, 2013, EUR J MED CHEM, V64, P148, DOI 10.1016/j.ejmech.2013.03.040; Rekhert JM, 2008, DRUG DISCOV TODAY, V13, P30, DOI 10.1016/j.drudis.2007.09.003; Szilagyi G, 2006, NEUROSCI LETT, V399, P206, DOI 10.1016/j.neulet.2006.01.071; Ulrich AS, 2002, BIOSCIENCE REP, V22, P129, DOI 10.1023/A:1020178304031; Xu M, 2014, CHROMATOGRAPHIA, V77, P223, DOI 10.1007/s10337-013-2591-7; Yang YH, 2016, J CELL PHYSIOL, V231, P2570, DOI 10.1002/jcp.25349; Zhao CK, 2015, LIFE SCI, V137, P37, DOI 10.1016/j.lfs.2015.07.019; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	27	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186821	10.1371/journal.pone.0186821	http://dx.doi.org/10.1371/journal.pone.0186821			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088257	gold, Green Published, Green Submitted			2022-12-26	WOS:000414088900023
J	Subsomwong, P; Miftahussurur, M; Uchida, T; Vilaichone, R; Ratanachu-ek, T; Mahachai, V; Yamaoka, Y				Subsomwong, Phawinee; Miftahussurur, Muhammad; Uchida, Tomohisa; Vilaichone, Rathakorn; Ratanachu-ek, Thawee; Mahachai, Varocha; Yamaoka, Yoshio			Prevalence, risk factors, and virulence genes of Helicobacter pylori among dyspeptic patients in two different gastric cancer risk regions of Thailand	PLOS ONE			English	Article							ENDONUCLEASE-REPLACING GENE; ENCODING GLYCOSYLTRANSFERASES; CLINICAL-RELEVANCE; CAGA; INFECTION; METAANALYSIS; JAPANESE; VACA; HRGA; ADENOCARCINOMA	Gastric cancer risk is varied among different regions of Thailand. We examined the characteristics of Helicobacter pylori infection in two regions of Thailand. The H. pylori status of 273 dyspeptic patients (136 from the South and 137 from the North; a low and high incidence of gastric cancer region, respectively) was evaluated, and virulence genotypes (cagA, vacA, hrgA and jhp0562-positive/beta-(1,3) galT) were determined. The overall H. pylori infection rate was 34.1% (93/273). The prevalence was higher in the North than in the South (50.4% vs. 17.6%, P < 0.001) and was significantly higher among individuals with the following characteristics: low income, birthplace in the Northeast or North regions, agricultural employment, or consumption of alcohol or unboiling water. Among these socio-demographic determinants, region was an independent risk factor for H. pylori infection (odds ratio = 6.37). Patients including both H. pylori infected and uninfected cases who lived in the North had significantly more severe histological scores than those in the South. In contrast, among H. pylori-positive cases, patients in the South had significantly more severe histological scores than those in the North. Of the 74 strains cultured, 56.8% carried Western-type cagA, with a higher proportion in the South than in the North (76.2% vs. 49.1%, P = 0.05). In disagreement with the current consensus, patients infected with the Western-type cagA strains had more severe inflammation scores in the antrum than those infected with the East Asian-type cagA strains (P = 0.027). Moreover, Western-type cagA strains induced more severe histological scores in patients from the South than those of either genotype from the North. Other virulence genes had no influence on histological scores. The incidence of gastric cancer in Thailand was different among regions and corresponded to differences in the prevalence of H. pylori infection. More careful follow- up for patients in the South will be required, even if they are infected with H. pylori carrying Western-type cagA.	[Subsomwong, Phawinee; Miftahussurur, Muhammad; Yamaoka, Yoshio] Oita Univ, Fac Med, Dept Environm & Prevent Med, Yufu, Japan; [Miftahussurur, Muhammad] Univ Airlangga, Dr Soetomo Teaching Hosp, Fac Med, Gastroenterohepatol Div,Dept Internal Med,Inst Tr, Surabaya, Indonesia; [Miftahussurur, Muhammad; Yamaoka, Yoshio] Baylor Coll Med, Dept Gastroenterol & Hepatol, Houston, TX 77030 USA; [Miftahussurur, Muhammad; Yamaoka, Yoshio] Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA; [Uchida, Tomohisa] Oita Univ, Fac Med, Dept Mol Pathol, Hasama Machi, Yufu City, Oita, Japan; [Vilaichone, Rathakorn] Thammasat Univ Hosp, Dept Med, Gastroenterol Unit, Pathum Thani, Thailand; [Ratanachu-ek, Thawee] Rajavithi Hosp, Dept Surg, Bangkok, Thailand; [Mahachai, Varocha] Bangkok Med Ctr, GI & Liver Ctr, Bangkok, Thailand	Oita University; Airlangga University; Baylor College of Medicine; Baylor College of Medicine; Oita University; Thammasat University; Rajavithi Hospital	Yamaoka, Y (corresponding author), Oita Univ, Fac Med, Dept Environm & Prevent Med, Yufu, Japan.; Yamaoka, Y (corresponding author), Baylor Coll Med, Dept Gastroenterol & Hepatol, Houston, TX 77030 USA.; Yamaoka, Y (corresponding author), Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA.	yyamaoka@oita-u.ac.jp	Miftahussurur, Muhammad/AAB-6151-2021; Vilaichone, Ratha-korn/ABA-1118-2020	Miftahussurur, Muhammad/0000-0003-1415-6033; Subsomwong, Phawinee/0000-0002-9961-9350; Yamaoka, Yoshio/0000-0002-1222-5819	Ministry of Education, Culture, Sports, Science and Technology [25293104, 26640114, 15H02657, 16H05191, 211S0002]; National Institutes of Health [DK62813]; Ministry of Research, Technology and Higher Education of Indonesia for World Class Professor Program [105/D2.3/KP/2017]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Research, Technology and Higher Education of Indonesia for World Class Professor Program	This work was supported by Ministry of Education, Culture, Sports, Science and Technology (25293104, 26640114, 15H02657, 16H05191 and 211S0002) to Yoshio Yamaoka, National Institutes of Health (DK62813) to Yoshio Yamaoka and Ministry of Research, Technology and Higher Education of Indonesia for World Class Professor Program (no. 105/D2.3/KP/2017) to Muhammad Miftahussurur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aftab H, 2016, J INFECT DEV COUNTR, V10, P245, DOI 10.3855/jidc.7713; Ando T, 2002, CANCER RES, V62, P2385; ATHERTON JC, 1995, J BIOL CHEM, V270, P17771, DOI 10.1074/jbc.270.30.17771; Atisook K, 2003, HELICOBACTER, V8, P132, DOI 10.1046/j.1523-5378.2003.00134.x; Bakhti SZ, 2015, HELICOBACTER; Basiri Z, 2014, ASIAN PAC J CANCER P, V15, P1575, DOI 10.7314/APJCP.2014.15.4.1575; BLASER MJ, 1995, CANCER RES, V55, P2111; CORREA P, 1992, CANCER RES, V52, P6735; D'Elia L, 2012, CLIN NUTR, V31, P489, DOI 10.1016/j.clnu.2012.01.003; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Elitsur Y, 2009, J CLIN GASTROENTEROL, V43, P147, DOI 10.1097/MCG.0b013e318157e4e7; Figueiredo C, 2002, J NATL CANCER I, V94, P1680, DOI 10.1093/jnci/94.22.1680; Goh KL, 2011, HELICOBACTER, V16, P1, DOI 10.1111/j.1523-5378.2011.00874.x; Goh KL, 1997, J GASTROEN HEPATOL, V12, pS29, DOI 10.1111/j.1440-1746.1997.tb00455.x; Graham DY, 2005, GUT, V54, P735, DOI 10.1136/gut.2004.056549; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Higashi H, 2002, P NATL ACAD SCI USA, V99, P14428, DOI 10.1073/pnas.222375399; Jones KR, 2009, J CLIN MICROBIOL, V47, P959, DOI 10.1128/JCM.02330-08; Kim J, 2011, CANCER SCI, V102, P231, DOI 10.1111/j.1349-7006.2010.01770.x; Kodaman N, 2014, P NATL ACAD SCI USA, V111, P1455, DOI 10.1073/pnas.1318093111; KUIPERS EJ, 1995, J NATL CANCER I, V87, P1777, DOI 10.1093/jnci/87.23.1777; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Ladeiras-Lopes R, 2008, CANCER CAUSE CONTROL, V19, P689, DOI 10.1007/s10552-008-9132-y; Loh YH, 2011, AM J CLIN NUTR, V93, P1053, DOI 10.3945/ajcn.111.012377; Lu H, 2004, DIGEST DIS SCI, V49, P1551, DOI 10.1023/B:DDAS.0000042263.18541.ec; Ma KP, 2017, J PLANT ECOL, V10, P1, DOI 10.1093/jpe/rtw129; Matsuda M, 2011, J GASTROEN HEPATOL, V26, P1451, DOI 10.1111/j.1440-1746.2011.06779.x; Matsuhisa T, 2015, WORLD J GASTROENTERO, V21, P8408, DOI 10.3748/wjg.v21.i27.8408; Matsunari O, 2012, J CLIN MICROBIOL, V50, P876, DOI 10.1128/JCM.05562-11; Miftahussurur M, 2015, EPIDEMIOL INFECT, V143, P986, DOI 10.1017/S095026881400154X; Miftahussurur M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134216; Mitacek EJ, 2008, NUTR CANCER, V60, P196, DOI 10.1080/01635580701649636; Nguyen LT, 2010, EUR J CLIN MICROBIOL, V29, P651, DOI 10.1007/s10096-010-0909-z; Nguyen TL, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-114; Ogiwara H, 2009, J CLIN MICROBIOL, V47, P3493, DOI 10.1128/JCM.00887-09; Oleastro M, 2010, J CLIN MICROBIOL, V48, P2885, DOI 10.1128/JCM.00401-10; Ren SM, 2006, J BIOL CHEM, V281, P32344, DOI 10.1074/jbc.M606172200; Rhead JL, 2007, GASTROENTEROLOGY, V133, P926, DOI 10.1053/j.gastro.2007.06.056; Rugge M, 2007, GUT, V56, P631, DOI 10.1136/gut.2006.106666; Sahara S, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-223; Shiota S, 2014, J MED MICROBIOL, V63, P1189, DOI 10.1099/jmm.0.075275-0; Shiota S, 2010, EXPERT REV GASTROENT, V4, P149, DOI [10.1586/egh.10.7, 10.1586/EGH.10.7]; Sicinschi LA, 2010, CLIN MICROBIOL INFEC, V16, P369, DOI 10.1111/j.1469-0691.2009.02811.x; Suwanrungruang K, 2008, ASIAN PAC J CANCER P, V9, P71; Tanaka M, 2012, HEPATO-GASTROENTEROL, V59, P304, DOI 10.5754/hge10364; Uchida T, 2007, CANCER SCI, V98, P521, DOI 10.1111/j.1349-7006.2007.00415.x; Uchida T, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-175; Vilaichone RK, 2013, WORLD J GASTROENTERO, V19, P2806, DOI 10.3748/wjg.v19.i18.2806; Vilaichone RK, 2004, HELICOBACTER, V9, P453, DOI 10.1111/j.1083-4389.2004.00260.x; Xia YL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007736; Yamaoka Y, 1999, GASTROENTEROLOGY, V117, P342, DOI 10.1053/gast.1999.0029900342; Yamaoka Y, 2014, FUTURE ONCOL, V10, P1487, DOI [10.2217/fon.14.29, 10.2217/FON.14.29]; Yamazaki S, 2005, J CLIN MICROBIOL, V43, P3906, DOI 10.1128/JCM.43.8.3906-3916.2005; Zhang XS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004621	54	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187113	10.1371/journal.pone.0187113	http://dx.doi.org/10.1371/journal.pone.0187113			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084246	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000413910200031
J	Ingala, MR; Ravenelle, RE; Monro, JJ; Frank, CL				Ingala, Melissa R.; Ravenelle, Rebecca E.; Monro, Johanna J.; Frank, Craig L.			The effects of epidermal fatty acid profiles, 1-oleoglycerol, and triacylglycerols on the susceptibility of hibernating bats to Pseudogymnoascus destructans	PLOS ONE			English	Article							WHITE-NOSE SYNDROME; SELECTIVE MOBILIZATION; SYNDROME FUNGUS; ADIPOSE-TISSUE; PATHOGEN; ECOLOGY; LIPIDS	White Nose Syndrome (WNS) greatly increases the over-winter mortality of little brown (Myotis lucifugus), Indiana (M. sodalis), northern (M. septentrionalis), and tricolored (Perimyotis subflavus) bats, and is caused by cutaneous infections with Pseudogymnoascus destructans (Pd). Big brown bats (Eptesicus fuscus) are highly resistant to Pd infections. Seven different fatty acids (myristic, pentadecanoic, palmitic, palmitoleic, oleic, and, linoleic acids) occur in the wing epidermis of both M. lucifugus and E. fuscus, 4 of which (myristic, palmitoleic, oleic, and, linoleic acids) inhibit Pd growth. The amounts of myristic and linoleic acids in the epidermis of M. lucifugus decrease during hibernation, thus we predicted that the epidermal fatty acid profile of M. lucifugus during hibernation has a reduced ability to inhibit Pd growth. Laboratory Pd growth experiments were conducted to test this hypothesis. The results demonstrated that the fatty acid profile of M. lucifugus wing epidermis during hibernation has a reduced ability to inhibit the growth of Pd. Additional Pd growth experiments revealed that: a) triacylglycerols composed of known anti-Pd fatty acids do not significantly affect growth, b) pentadecanoic acid inhibits Pd growth, and c) 1-oleoglycerol, which is found in the wing epidermis of E. fuscus, also inhibits the growth of this fungus. Analyses of white adipose from M. lucifugus also revealed the selective retention of oleic and linoleic acids in this tissue during hibernation.	[Ingala, Melissa R.; Ravenelle, Rebecca E.; Frank, Craig L.] Fordham Univ, Dept Biol Sci, Louis Calder Ctr, Armonk, NY 10504 USA; [Monro, Johanna J.] Fordham Univ, Environm Sci Program, Bronx, NY 10458 USA	Fordham University; Fordham University	Frank, CL (corresponding author), Fordham Univ, Dept Biol Sci, Louis Calder Ctr, Armonk, NY 10504 USA.	frank@fordham.edu	Frank, Craig/AFQ-3761-2022	Ingala, Melissa/0000-0002-9866-5646; Frank, Craig/0000-0002-4340-4422	National Science Foundation (US) [IOS-0818222]; NSF [IOS-0818222]	National Science Foundation (US)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	This work was supported by National Science Foundation (US), www.nsf.gov, IOS-0818222.; We thank A. Hicks, C. Herzog, and R.J. Rudd for their generous assistance. A. Davis provided valuable comments and guidance throughout the course of this study. This study was supported by NSF grant IOS-0818222 awarded to C.L.F.	Altieri C, 2009, INT J FOOD SCI TECH, V44, P242, DOI 10.1111/j.1365-2621.2007.01639.x; Ben-Hamo M, 2016, P R SOC B; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; BRACK V, 1985, J MAMMAL, V66, P308, DOI 10.2307/1381243; BUCKNER JS, 1993, INSECT LIPIDS: CHEMISTRY, BIOCHEMISTRY AND BIOLOGY, P227; Camera E, 2010, J LIPID RES, V51, P3377, DOI 10.1194/jlr.D008391; Chaturvedi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010783; Christie WW., 1992, ADV LIPID METHODOLOG; Dark J, 2005, ANNU REV NUTR, V25, P469, DOI 10.1146/annurev.nutr.25.050304.092514; Feingold KR, 2007, J LIPID RES, V48, P2531, DOI 10.1194/jlr.R700013-JLR200; Fischer CL, 2014, BBA-MOL CELL BIOL L, V1841, P319, DOI 10.1016/j.bbalip.2013.08.012; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frank CL, 2002, J MAMMAL, V83, P1013, DOI 10.1644/1545-1542(2002)083&lt;1013:STVIDF&gt;2.0.CO;2; Frank C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095175; Frank CL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153535; Frank Craig L., 2012, P271; Gunstone F.D., 1996, FATTY ACID LIPID CHE; Iverson SJ, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P281, DOI 10.1007/978-0-387-89366-2_12; Kellner Amanda M.E., 2005, Northwestern Naturalist, V86, P45, DOI 10.1898/1051-1733(2005)086[0045:DOBICR]2.0.CO;2; KUNZ TH, 1974, ECOLOGY, V55, P693, DOI 10.2307/1934408; Langwig KE, 2015, EMERG INFECT DIS, V21, P1023, DOI 10.3201/eid2106.150123; Leopardi S, 2015, CURR BIOL, V25, pR217, DOI 10.1016/j.cub.2015.01.047; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Mead J. F., 1986, LIPIDS CHEM BIOCH NU; Pannkuk EL, 2014, LIPIDS, V49, P1143, DOI 10.1007/s11745-014-3951-2; Pannkuk EL, 2013, CHEM BIODIVERS, V10, P2122, DOI 10.1002/cbdv.201300319; Price ER, 2013, PHYSIOL BIOCHEM ZOOL, V86, P205, DOI 10.1086/668892; RACLOT T, 1995, J LIPID RES, V36, P2164; Raclot T, 2001, J LIPID RES, V42, P2049; Reeder DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038920; Reynolds DS, 2000, ECOSCIENCE, V7, P10; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Shimozuru M, 2016, COMP BIOCHEM PHYS B, V196, P38, DOI 10.1016/j.cbpb.2016.02.001; Thomas DW, 1995, SYM ZOOL S, P233; Urich K., 1994, COMP ANIMAL BIOCH; Verant ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046280; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109	37	6	6	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187195	10.1371/journal.pone.0187195	http://dx.doi.org/10.1371/journal.pone.0187195			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077745	gold, Green Submitted, Green Published			2022-12-26	WOS:000413861200052
J	Jayatilaka, H; Giri, A; Karl, M; Aifuwa, I; Trenton, NJ; Phillip, JM; Khatau, S; Wirtz, D				Jayatilaka, Hasini; Giri, Anjil; Karl, Michelle; Aifuwa, Ivie; Trenton, Nicholaus J.; Phillip, Jude M.; Khatau, Shyam; Wirtz, Denis			EB1 and cytoplasmic dynein mediate protrusion dynamics for efficient 3-dimensional cell migration	FASEB JOURNAL			English	Article						RhoA; paclitaxel; microtubule	MICROTUBULE PLUS ENDS; EXTRACELLULAR-MATRIX; PERICELLULAR PROTEOLYSIS; RHO-GTPASES; CANCER; ACTIVATION; PROTEINS; COLLAGEN; MOTILITY; RAC1	Microtubules have long been implicated to play an integral role in metastatic disease, for which a critical step is the local invasion of tumor cells into the 3-dimensional (3D) collagen-rich stromal matrix. Here we show that cell migration of human cancer cells uses the dynamic formation of highly branched protrusions that are composed of a microtubule core surrounded by cortical actin, a cytoskeletal organization that is absent in cells on 2-dimensional (2D) substrates. Microtubule plus-end tracking protein End-binding 1 and motor protein dynein subunits light intermediate chain 2 and heavy chain 1, which do not regulate 2D migration, critically modulate 3D migration by affecting RhoA and thus regulate protrusion branching through differential assembly dynamics of microtubules. An important consequence of this observation is that the commonly used cancer drug paclitaxel is 100-fold more effective at blocking migration in a 3D matrix than on a 2D matrix. This work reveals the central role that microtubule dynamics plays in powering cell migration in a more pathologically relevant setting and suggests further testing of therapeutics targeting microtubules to mitigate migration.	[Jayatilaka, Hasini; Giri, Anjil; Karl, Michelle; Aifuwa, Ivie; Khatau, Shyam; Wirtz, Denis] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Jayatilaka, Hasini; Giri, Anjil; Karl, Michelle; Aifuwa, Ivie; Wirtz, Denis] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD 21218 USA; [Trenton, Nicholaus J.] Rice Univ, Dept Bioengn, Houston, TX USA; [Wirtz, Denis] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD USA; [Wirtz, Denis] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD USA; [Wirtz, Denis] Johns Hopkins Sch Med, Sydney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Phillip, Jude M.] Weill Cornell Med, Dept Med, Div Hematol & Oncol, New York, NY USA	Johns Hopkins University; Johns Hopkins University; Rice University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Cornell University	Wirtz, D (corresponding author), Johns Hopkins Univ, 3400 North Charles St,Maryland Hall 221, Baltimore, MD 21218 USA.	wirtz@jhu.edu	Phillip, Jude/AAR-6240-2020	Karl, Michelle/0000-0003-3306-701X	U.S. National Institutes of Health, National Cancer Institute [U54CA143868, R01CA174388]; NATIONAL CANCER INSTITUTE [R01CA174388, U54CA143868] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by U.S. National Institutes of Health, National Cancer Institute Grants U54CA143868 and R01CA174388. The authors declare no conflicts of interest.	Applegate KT, 2011, J STRUCT BIOL, V176, P168, DOI 10.1016/j.jsb.2011.07.009; ASOKAN R, 1993, MOL CELL BIOCHEM, V120, P25, DOI 10.1007/BF00925981; Buey RM, 2011, MOL BIOL CELL, V22, P2912, DOI 10.1091/mbc.E11-01-0017; Chang YC, 2008, MOL BIOL CELL, V19, P2147, DOI 10.1091/mbc.E07-12-1269; Chitaley K, 2001, MED HYPOTHESES, V56, P381, DOI 10.1054/mehy.2000.1207; Courtheoux T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13487; Duellberg C, 2013, TRENDS CELL BIOL, V23, P54, DOI 10.1016/j.tcb.2012.10.003; Dujardin DL, 2003, J CELL BIOL, V163, P1205, DOI 10.1083/jcb.200310097; Fraley SI, 2015, SCI REP-UK, V5, DOI 10.1038/srep14580; Fraley SI, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1711; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Gierke S, 2012, CURR BIOL, V22, P753, DOI 10.1016/j.cub.2012.02.069; Giri A, 2013, FASEB J, V27, P4089, DOI 10.1096/fj.12-224352; HALL J, 1985, HUM PATHOL, V16, P439, DOI 10.1016/S0046-8177(85)80080-0; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Jayatilaka H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15584; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Katoh H, 2006, J CELL SCI, V119, P56, DOI 10.1242/jcs.02720; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Kutys ML, 2014, NAT CELL BIOL, V16, P909, DOI 10.1038/ncb3026; Machesky LM, 1998, NATURE, V394, P125, DOI 10.1038/28039; Matov A, 2010, NAT METHODS, V7, P761, DOI 10.1038/nmeth.1493; Mimori-Kiyosue Y, 2005, J CELL BIOL, V168, P141, DOI 10.1083/jcb.200405094; Nalbant P, 2004, SCIENCE, V305, P1615, DOI 10.1126/science.1100367; Netti PA, 2000, CANCER RES, V60, P2497; Pluen A, 2001, P NATL ACAD SCI USA, V98, P4628, DOI 10.1073/pnas.081626898; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ridley AJ, 2001, J CELL SCI, V114, P2713; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ridley AJ, 2015, CURR OPIN CELL BIOL, V36, P103, DOI 10.1016/j.ceb.2015.08.005; Roberts AJ, 2013, NAT REV MOL CELL BIO, V14, P713, DOI 10.1038/nrm3667; Rogers SL, 2004, CURR BIOL, V14, P1827, DOI 10.1016/j.cub.2004.09.078; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Schober JM, 2012, BIOCHEM BIOPH RES CO, V417, P67, DOI 10.1016/j.bbrc.2011.11.056; Shields MA, 2012, BIOCHEM J, V441, P541, DOI 10.1042/BJ20111240; Slattum G, 2009, J CELL BIOL, V186, P693, DOI 10.1083/jcb.200903079; Takesono A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008774; Tirnauer JS, 2000, J CELL BIOL, V149, P761, DOI 10.1083/jcb.149.4.761; Vaughan KT, 2005, J CELL BIOL, V171, P197, DOI 10.1083/jcb.200509150; Vladar EK, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002964; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Worthylake RA, 2003, J BIOL CHEM, V278, P13578, DOI 10.1074/jbc.M211584200; Wu PH, 2015, NAT PROTOC, V10, DOI 10.1038/nprot.2015.030; Wu PH, 2014, P NATL ACAD SCI USA, V111, P3949, DOI 10.1073/pnas.1318967111; Zaoui K, 2008, J CELL BIOL, V183, P401, DOI 10.1083/jcb.200805107; Zhang G, 2014, J BIOL CHEM, V289, P23112, DOI 10.1074/jbc.M114.549550; Zhou XM, 2008, GENE DEV, V22, P1231, DOI 10.1101/gad.1643308	55	15	15	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1207	1221		10.1096/fj.201700444RR	http://dx.doi.org/10.1096/fj.201700444RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29097501	hybrid, Green Published			2022-12-26	WOS:000427246000009
J	Frenzel, T; Hoffmann, B; Schmitz, R; Bethge, A; Schumacher, U; Wedemann, G				Frenzel, Thorsten; Hoffmann, Bertin; Schmitz, Ruediger; Bethge, Anja; Schumacher, Udo; Wedemann, Gero			Radiotherapy and chemotherapy change vessel tree geometry and metastatic spread in a small cell lung cancer xenograft mouse tumor model	PLOS ONE			English	Article							GROWTH; SIMULATION; INSIGHTS	Background Tumor vasculature is critical for tumor growth, formation of distant metastases and efficiency of radio-and chemotherapy treatments. However, how the vasculature itself is affected during cancer treatment regarding to the metastatic behavior has not been thoroughly investigated. Therefore, the aim of this study was to analyze the influence of hypofractionated radiotherapy and cisplatin chemotherapy on vessel tree geometry and metastasis formation in a small cell lung cancer xenograft mouse tumor model to investigate the spread of malignant cells during different treatments modalities. Methods The biological data gained during these experiments were fed into our previously developed computer model "Cancer and Treatment Simulation Tool" (CaTSiT) to model the growth of the primary tumor, its metastatic deposit and also the influence on different therapies. Furthermore, we performed quantitative histology analyses to verify our predictions in xenograft mouse tumor model. Results According to the computer simulation the number of cells engrafting must vary considerably to explain the different weights of the primary tumor at the end of the experiment. Once a primary tumor is established, the fractal dimension of its vasculature correlates with the tumor size. Furthermore, the fractal dimension of the tumor vasculature changes during treatment, indicating that the therapy affects the blood vessels' geometry. We corroborated these findings with a quantitative histological analysis showing that the blood vessel density is depleted during radiotherapy and cisplatin chemotherapy. The CaTSiT computer model reveals that chemotherapy influences the tumor's therapeutic susceptibility and its metastatic spreading behavior. Conclusion Using a system biological approach in combination with xenograft models and computer simulations revealed that the usage of chemotherapy and radiation therapy determines the spreading behavior by changing the blood vessel geometry of the primary tumor.	[Frenzel, Thorsten; Schmitz, Ruediger; Schumacher, Udo] Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr, Dept Anat & Expt Morphol, Ctr Expt Med, Hamburg, Germany; [Frenzel, Thorsten] Univ Hosp Hamburg Eppendorf, Ambulatory Ctr, Dept Radiat Oncol, Hamburg, Germany; [Hoffmann, Bertin; Bethge, Anja; Wedemann, Gero] Univ Appl Sci Stralsund, Inst Appl Comp Sci, Competence Ctr Bioinformat, Stralsund, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Wedemann, G (corresponding author), Univ Appl Sci Stralsund, Inst Appl Comp Sci, Competence Ctr Bioinformat, Stralsund, Germany.	gero.wedemann@nochschule-stralsund.de	Wedemann, Gero/A-6384-2009; Hoffmann, Bertin/T-6580-2017	Wedemann, Gero/0000-0001-7869-774X; Hoffmann, Bertin/0000-0001-5019-2221	Studienstiftung des deutschen Volkes (German National Academic Foundation); Gunther Elin Krempel Foundation; UKE UCCH Drittelstipendium	Studienstiftung des deutschen Volkes (German National Academic Foundation); Gunther Elin Krempel Foundation; UKE UCCH Drittelstipendium	Rudiger Schmitz gratefully acknowledges funding by the Studienstiftung des deutschen Volkes (German National Academic Foundation) and the Gunther Elin Krempel Foundation. Thorsten Frenzel gratefully acknowledges funding by the UKE UCCH Drittelstipendium.	[Anonymous], 2015, MATHWORKS EXAMPLES M; Arthur D, 2007, PROCEEDINGS OF THE EIGHTEENTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P1027; Bethge A, 2014, CATSIT COMPUTER SIMU; Bethge A, 2015, J BIOMED INFORM, V57, P74, DOI 10.1016/j.jbi.2015.07.011; Bethge A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035689; Brown JM, 1998, CANCER RES, V58, P1408; Campbell R, FILE EXCHANGE MATLAB; Cardenas-Navia LI, 2007, FRONT BIOSCI-LANDMRK, V12, P4061, DOI 10.2741/2372; Frenzel T, 2014, Z MED PHYS, V24, P352, DOI 10.1016/j.zemedi.2014.02.002; GAZDAR AF, 1980, CANCER RES, V40, P3502; Gazit Y, 1997, MICROCIRCULATION-LON, V4, P395, DOI 10.3109/10739689709146803; Hardee ME, 2009, CURR MOL MED, V9, P435, DOI 10.2174/156652409788167122; HART IR, 1992, LANCET, V339, P1453, DOI 10.1016/0140-6736(92)92039-I; Hoffmann B, CANC BIOINF IN PRESS; Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758; Iwata K, 2000, J THEOR BIOL, V203, P177, DOI 10.1006/jtbi.2000.1075; Jain RK, 2014, CANCER CELL, V26, P605, DOI 10.1016/j.ccell.2014.10.006; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jurczyszyn K, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/793291; Lange T, 2014, CLIN CANCER RES, V20, P1791, DOI 10.1158/1078-0432.CCR-13-2308; Lange T, 2012, CLIN CANCER RES, V18, P1364, DOI 10.1158/1078-0432.CCR-11-2900; Ma JG, 2001, CANCER RES, V61, P5491; Nehmann N, 2010, ACTA HISTOCHEM, V112, P489, DOI 10.1016/j.acthis.2009.05.004; Song C, 2016, INT J RADIAT ONCOL, V95, P1022, DOI 10.1016/j.ijrobp.2016.01.064; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Valentiner U, SHRNA CD44 INHIBITS; Vogelstein B, 2015, NEW ENGL J MED, V373, P1895, DOI 10.1056/NEJMp1508811; Wedemann G, 2014, METHODS MOL BIOL, V1070, P107, DOI 10.1007/978-1-4614-8244-4_8; Weinberg RA, 2006, GARLAND SCI, P25	29	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187144	10.1371/journal.pone.0187144	http://dx.doi.org/10.1371/journal.pone.0187144			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29107953	gold, Green Published, Green Submitted			2022-12-26	WOS:000414424600015
J	Sales, MAF; Schultz, CL				Sales, Marcos A. F.; Schultz, Cesar L.			Spinosaur taxonomy and evolution of craniodental features: Evidence from Brazil	PLOS ONE			English	Article							ISOLATED THEROPOD TEETH; SANTANA FORMATION; DINOSAURIA THEROPODA; NORTHEASTERN BRAZIL; ALCANTARA FORMATION; PREDATORY DINOSAUR; BEHAVIOR; SKULL; INFORMATION; VERTEBRATES	Fossil sites from Brazil have yielded specimens of spinosaurid theropods, among which the most informative include the cranial remains of Irritator, Angaturama, and Oxalaia. In this work some of their craniodental features are reinterpreted, providing new data for taxonomic and evolutionary issues concerning this particular clade of dinosaurs. The mesial-most tooth of the left maxilla of the holotype of Irritatoris regarded as representing the third tooth position, which is also preserved in the holotype of Angaturama. Thus, both specimens cannot belong to the same individual, contrary to previous assumptions, although they could have been the same taxon. In addition, the position of the external nares of Irritatoris more comparable to those of Baryonyx and Suchomimus instead of other spinosaurine spinosaurids. In fact, with regards to some craniodental features, Brazilian taxa represent intermediate conditions between Baryonychinae and Spinosaurinae. Such a scenario is corroborated by our cladistic results, which also leave open the possibility of the former subfamily being non-monophyletic. Furthermore, the differences between spinosaurids regarding the position and size of the external nares might be related to distinct feeding habits and degrees of reliance on olfaction. Other issues concerning the evolution and taxonomy of Spinosauridae require descriptions of additional material for their clarification.	[Sales, Marcos A. F.; Schultz, Cesar L.] Univ Fed Rio Grande do Sul, Inst Geociencias, Programa Posgrad Geociencias, Porto Alegre, RS, Brazil; [Sales, Marcos A. F.] Inst Fed Educ Ciencia & Tecnol Ceara IFCE, Fortaleza, Ceara, Brazil; [Schultz, Cesar L.] Univ Fed Rio Grande do Sul, Inst Geociencias, Dept Paleontol & Estratig, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Instituto Federal do Ceara (IFCE); Universidade Federal do Rio Grande do Sul	Sales, MAF (corresponding author), Univ Fed Rio Grande do Sul, Inst Geociencias, Programa Posgrad Geociencias, Porto Alegre, RS, Brazil.; Sales, MAF (corresponding author), Inst Fed Educ Ciencia & Tecnol Ceara IFCE, Fortaleza, Ceara, Brazil.	marcos.paleo@yahoo.com.br	Schultz, Cesar/I-4127-2013	Schultz, Cesar/0000-0001-7121-0409; Fontenele Sales, Marcos Andre/0000-0002-2292-578X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [141268/2013-1]; Deutscher Akademischer Austauschdienst [57130097]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD))	The first author received a Ph.D. grant from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Grant 141268/2013-1) and a short-term research grant from the Deutscher Akademischer Austauschdienst (Grant 57130097). The informed funders provided support for data collection throught visits to scientific paleontological collections in Brazil and Europe.; We would like to thank Juliana M. Leme (USP), Alexander W. A. Kellner, Luciana B. de Carvalho, and Sergio A. K. Azevedo (MN), Rainer Schoch (SMNS), Ronan Allain (MNHN), and Cristiano Dal Sasso (MSNM) for the access to specimens under their care. We also extend our gratitude to Deisi D. R. Henriques and Lilian Cruz for their help during the visits to MN. Rainer Schoch also provided priceless support during the stay of the first author at SMNS. His great heart will never be forgotten. Sandra Chapman (Natural History Museum, London, UK) kindly sent photographs of Baryonyx. Ronan Allain, Oliver Rauhut (Bayerische Staatssammlung fur Palaontologie und Geologie, Munich, Germany), Felipe L. Pinheiro (Universidade Federal do Pampa, Sao Gabriel, Brazil), and Paul Sereno (University of Chicago, Chicago, USA) helped us to get some important papers. Renata F. Cunha (Universidade Federal do Parana, Curitiba, Brazil) provided the scientific artwork of Fig 11. Felipe L. Pinheiro, Agustin G. Martinelli (UFRGS), Renato R. Medeiros (University of Michigan, Ann Arbor, USA), Stephen L. Brusatte and Michela Johnson (University of Edinburgh, Edinburgh, UK), and two anonymous reviewers gave valuable advices that improved this manuscript. We also acknowledge the Willi Hennig Society for the free access to the software TNT v. 1.5. Finally, the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico and the Deutscher Akademischer Austauschdienst provided a Ph.D. scholarship (Grant 141268/2013-1) and a short-term research grant (Grant 57130097), respectively, to the first author.	Ali F, 2008, J VERTEBR PALEONTOL, V28, P123, DOI 10.1671/0272-4634(2008)28[123:HOTECO]2.0.CO;2; Allain R, 2012, NATURWISSENSCHAFTEN, V99, P369, DOI 10.1007/s00114-012-0911-7; Amiot R, 2010, GEOLOGY, V38, P139, DOI 10.1130/G30402.1; Assine M.l., 1992, BRAZ J GEOL, V22, P289, DOI DOI 10.25249/0375-7536.1992289300; Assine ML., 2007, B GEOCIENCIAS PETROB, V15, P371; Barrett PM, 2011, BIOL LETTERS, V7, P933, DOI 10.1098/rsbl.2011.0466; BEURLEN K, 1971, AN ACAD BRAS CIENC, V43, P411; Bittencourt JS, 2011, AN ACAD BRAS CIENC, V83, P23, DOI 10.1590/S0001-37652011000100003; Bittencourt JS., 2004, ARQ MUS NAC, V62, P309; Buffetaut E, 2004, NATURE, V430, P33, DOI 10.1038/430033a; Buffetaut E, 2002, B SOC GEOL FR, V173, P415, DOI 10.2113/173.5.415; Buffetaut E., 1986, Revue de Paleobiologie, V5, P217; Buffetaut E., 1989, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1989, P79; Buffetaut E., 2009, INT C VERT PAL CONT, P18; Buffetaut E, 2011, ORYCTOS, V10, P1; Buffetaut E, 2008, GEOL MAG, V145, P745, DOI 10.1017/S0016756808005360; Buffetaut E, 2007, GEOL MAG, V144, P1021, DOI 10.1017/S0016756807003883; Buffetaut E, 2010, GEOL SOC SPEC PUBL, V343, P175, DOI 10.1144/SP343.10; Carrano MT, 2012, J SYST PALAEONTOL, V10, P211, DOI 10.1080/14772019.2011.630927; CHARIG AJ, 1986, NATURE, V324, P359, DOI 10.1038/324359a0; Charig Alan J., 1997, Bulletin of the Natural History Museum Geology Series, V53, P11; Cuff AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065295; Dal Sasso C, 2005, J VERTEBR PALEONTOL, V25, P888, DOI 10.1671/0272-4634(2005)025[0888:NIOTSO]2.0.CO;2; [David W.E.HONE 洪大卫], 2010, [古脊椎动物学报, Vertebrata Palasiatica], V48, P19; Evers S, 2015, PEERJ, V3, DOI 10.7717/peerj.1323; Fara E, 2005, PALAEOGEOGR PALAEOCL, V218, P145, DOI 10.1016/j.palaeo.2004.12.012; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Goloboff PA, 2016, CLADISTICS, V32, P221, DOI 10.1111/cla.12160; Hendrickx C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144695; Hendrickx C, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2015.982797; Hendrickx C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088905; Hendrickx C, 2014, ZOOTAXA, V 3759, P1, DOI 10.11646/zootaxa.3759.1.1; HOLTZ M., 2002, ELEMENTOS FUNDAMENTA; Holtz TR, 1998, SCIENCE, V282, P1276, DOI 10.1126/science.282.5392.1276; Hone DWE, 2017, ACTA GEOL SIN-ENGL, V91, P1120, DOI 10.1111/1755-6724.13328; Ibrahim Nizar, 2017, Memoires de la Societe Geologique de France, V180, P249; Ibrahim N, 2014, SCIENCE, V345, P1613, DOI 10.1126/science.1258750; Kellner Alexander W.A., 2003, Geological Society Special Publication, V217, P105, DOI 10.1144/GSL.SP.2003.217.01.10; Kellner AWA, 2011, AN ACAD BRAS CIENC, V83, P99, DOI 10.1590/S0001-37652011000100006; Kellner Alexander W. A., 2001, Journal of Vertebrate Paleontology, V21, p67A; Kellner Alexander W.A., 2004, Natura Nascosta, V29, P37; Kellner Alexander W.A., 1996, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V199, P151; Kellner Alexander W. A., 1996, Memoirs of the Queensland Museum, V39, P611; Machado E., 2010, THESIS; Machado E. B., 2005, GEOCIENCIAS, V28, P158; Machado E. B., 2007, PALEONTOLOGIA CENARI, V1, P291; Machado EB, 2005, 2 C LAT PAL VERT 200, P161; Machado E, 2008, J VERTEBR PALEONTOL, V28, p109A; Machutchon AG, 1998, URSUS-SERIES, V10, P539; Maisey JG, 1991, SANTANA FOSSILS ILLU; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; Martill D., 1990, S BACIA ARARIPE BACI, P241; Martill DM, 1996, J GEOL SOC LONDON, V153, P5, DOI 10.1144/gsjgs.153.1.0005; McFeeters B, 2013, CAN J EARTH SCI, V50, P636, DOI 10.1139/cjes-2012-0129; Medeiros MA, 2001, CRETACEO BACIA SAO L, V1, P209; Medeiros Manuel Alfredo, 2006, REVISTA BRASILEIRA DE PALEONTOLOGIA, V9, P333; Medeiros Manuel Alfredo, 2002, Arquivos do Museu Nacional Rio de Janeiro, V60, P155; Medeiros MA, 2014, J S AM EARTH SCI, V53, P50, DOI 10.1016/j.jsames.2014.04.002; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Porfiri JD, 2014, CRETACEOUS RES, V51, P35, DOI 10.1016/j.cretres.2014.04.007; Rayfield EJ, 2007, J VERTEBR PALEONTOL, V27, P892, DOI 10.1671/0272-4634(2007)27[892:FMOSCD]2.0.CO;2; Reimchen TE, 1998, CAN FIELD NAT, V112, P446; Richter U, 2013, PALAEONTOL Z, V87, P291, DOI 10.1007/s12542-012-0153-1; Rosas FCW, 1999, BIOTROPICA, V31, P502, DOI 10.1111/j.1744-7429.1999.tb00393.x; Rossetti D.F., 1997, B MUSEU PARAENSE EMI, V9, P29; Rossetti D. F., 2001, CRETACEO BACIA SAO L, P31; Russell Dale A., 1996, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V18, P349; Sales MAF, 2017, J S AM EARTH SCI, V74, P83, DOI 10.1016/j.jsames.2016.10.005; Sales MAF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147031; Sanchez-Hernandez B, 2007, PALAEOGEOGR PALAEOCL, V249, P180, DOI 10.1016/j.palaeo.2007.01.009; Sereno PC, 1998, SCIENCE, V282, P1298, DOI 10.1126/science.282.5392.1298; Serrano-Martinez A, 2016, ACTA PALAEONTOL POL, V61, P403, DOI 10.4202/app.00101.2014; Serrano-Martinez A, 2015, P GEOLOGIST ASSOC, V126, P107, DOI 10.1016/j.pgeola.2014.10.005; Shealer David A., 2002, P137; Smith JB, 2003, J VERTEBR PALEONTOL, V23, P1, DOI 10.1671/0272-4634(2003)23[1:APFAST]2.0.CO;2; Smith JB, 2006, J PALEONTOL, V80, P400, DOI 10.1666/0022-3360(2006)080[0400:NIRTHO]2.0.CO;2; Soares D, 2002, NATURE, V417, P241, DOI 10.1038/417241a; Stromer E, 1915, ABHANDLUNGEN KONIGLI, V28, P1; Stromer E., 1934, ABH BAYER AKAD WISS, V22, P1; Sues HD, 2002, J VERTEBR PALEONTOL, V22, P535, DOI 10.1671/0272-4634(2002)022[0535:ICASDT]2.0.CO;2; TAQUET P, 1984, CR ACAD SCI II, V299, P217; Taquet P, 1998, CR ACAD SCI II A, V327, P347, DOI 10.1016/S1251-8050(98)80054-2; Therrien F, 2005, LIFE O PAST, P179; Therrien F, 2007, J VERTEBR PALEONTOL, V27, P108, DOI 10.1671/0272-4634(2007)27[108:MTIBTY]2.0.CO;2; Unwin David M., 2003, Geological Society Special Publication, V217, P139, DOI 10.1144/GSL.SP.2003.217.01.11; Valenca L. M. M., 2003, Geologica Acta, V1, P261; Vullo R, 2016, ACTA PALAEONTOL POL, V61, P825, DOI 10.4202/app.00284.2016; Witmer LM, 2009, ANAT REC, V292, P1266, DOI 10.1002/ar.20983; Witmer LM, 2003, NATURE, V425, P950, DOI 10.1038/nature02048; Witmer LM, 2001, SCIENCE, V293, P850, DOI 10.1126/science.1062681; Xing LD, 2013, CHINESE SCI BULL, V58, P1931, DOI 10.1007/s11434-013-5765-7	91	21	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e087070	10.1371/journal.pone.0187070	http://dx.doi.org/10.1371/journal.pone.0187070			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29107966	gold, Green Published, Green Submitted			2022-12-26	WOS:000414424600012
J	Pertusa, JAG; Leon-Quinto, T; Berna, G; Tejedo, JR; Hmadcha, A; Bedoya, FJ; Martin, F; Soria, B				Pertusa, Jose A. G.; Leon-Quinto, Trinidad; Berna, Genoveva; Tejedo, Juan R.; Hmadcha, Abdelkrim; Bedoya, Francisco J.; Martin, Franz; Soria, Bernat			Zn2+ chelation by serum albumin improves hexameric Zn2+-insulin dissociation into monomers after exocytosis	PLOS ONE			English	Article							MOUSE PANCREATIC-ISLETS; SUBCUTANEOUS INSULIN ABSORPTION; BETA-CELLS; PULMONARY ENDOTHELIUM; SELF-ASSOCIATION; PHASE-3 TRIAL; NITRIC-OXIDE; RINM5F CELLS; ZINC; SECRETION	beta-cells release hexameric Zn2+-insulin into the extracellular space, but monomeric Zn2+-free insulin appears to be the only biologically active form. The mechanisms implicated in dissociation of the hexamer remain unclear, but they seem to be Zn2+ concentration-dependent. In this study, we investigate the influence of albumin binding to Zn2+ on Zn2+-insulin dissociation into Zn2+-free insulin and its physiological, methodological and therapeutic relevance. Glucose and K+-induced insulin release were analyzed in isolated mouse islets by static incubation and perifusion experiments in the presence and absence of albumin and Zn2+ chelators. Insulin tolerance tests were performed in rats using different insulin solutions with and without Zn2+ and/or albumin. Albumin-free buffer does not alter quantification by RIA of Zn2+-free insulin but strongly affects RIA measurements of Zn2+-insulin. In contrast, accurate determination of Zn2+-insulin was obtained only when bovine serum albumin or Zn2+ chelators were present in the assay buffer solution. Albumin and Zn2+ chelators do not modify insulin release but do affect insulin determination. Preincubation with albumin or Zn2+ chelators promotes the conversion of "slow" Zn2+-insulin into "fast" insulin. Consequently, insulin diffusion from large islets is ameliorated in the presence of Zn2+ chelators. These observations support the notion that the Zn2+-binding properties of albumin improve the dissociation of Zn2+-insulin into subunits after exocytosis, which may be useful in insulin determination, insulin pharmacokinetic assays and islet transplantation.	[Pertusa, Jose A. G.; Leon-Quinto, Trinidad] Univ Miguel Hernandez Elche, Inst Bioingn, Alicante, Spain; [Berna, Genoveva; Tejedo, Juan R.; Hmadcha, Abdelkrim; Bedoya, Francisco J.; Martin, Franz; Soria, Bernat] Univ Seville, Univ Pablo de Olavide, Andalusian Ctr Mol Biol & Regenerat Med, Dept Cell Regenerat & Adv Therapies,CSIC,CABIMER, Seville, Spain; [Berna, Genoveva; Tejedo, Juan R.; Bedoya, Francisco J.; Martin, Franz; Soria, Bernat] Inst Salud Carlos III, Biomed Res Network Diabet & Related Metab Dis, CIBERDEM, Madrid, Spain; [Berna, Genoveva; Tejedo, Juan R.; Bedoya, Francisco J.; Martin, Franz] UPO, Dept Mol Biol & Biochem Engn, Seville, Spain	Universidad Miguel Hernandez de Elche; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Universidad Pablo de Olavide	Martin, F; Soria, B (corresponding author), Univ Seville, Univ Pablo de Olavide, Andalusian Ctr Mol Biol & Regenerat Med, Dept Cell Regenerat & Adv Therapies,CSIC,CABIMER, Seville, Spain.; Martin, F; Soria, B (corresponding author), Inst Salud Carlos III, Biomed Res Network Diabet & Related Metab Dis, CIBERDEM, Madrid, Spain.; Martin, F (corresponding author), UPO, Dept Mol Biol & Biochem Engn, Seville, Spain.	fmarber@upo.es; bernat.soria@cabimer.es	Martin, Franz/K-4197-2014; Bedoya, Francisco J/R-4871-2018; Tejedo, Juan R/I-9336-2017; Berna, Genoveva/K-4562-2014; Berna, Genoveva/AAG-7849-2020; Tejedo, Juan R./AAN-8865-2021; Bedoya, Francisco/AAX-8812-2021; , Bernat/AAL-6470-2021; Hmadcha, Abdelkrim/T-1173-2019	Martin, Franz/0000-0002-5745-8704; Bedoya, Francisco J/0000-0003-0262-7029; Tejedo, Juan R/0000-0002-8434-7516; Berna, Genoveva/0000-0001-8185-8428; Berna, Genoveva/0000-0001-8185-8428; Tejedo, Juan R./0000-0002-8434-7516; Bedoya, Francisco/0000-0003-0262-7029; Hmadcha, Abdelkrim/0000-0002-4105-3702; Soria, Bernat/0000-0002-2356-0380	Fondos FEDER; Institute de Salud Carlos III (CIBERDEM) [CB07/08/0006, FIS PI14/010015, Red TerCel RD/0012/0028]; Junta de Andalucia [PAI-BI0311, CTS-576, CTS 11-727]	Fondos FEDER(European Commission); Institute de Salud Carlos III (CIBERDEM); Junta de Andalucia(Junta de Andalucia)	Our research is supported by Fondos FEDER and the Institute de Salud Carlos III (CIBERDEM, CB07/08/0006; FIS PI14/010015 and Red TerCel RD/0012/0028 to BS and FM) and Junta de Andalucia (PAI-BI0311 (to FM), CTS-576 (to FB) and CTS 11-727). The funders had no role in study design, data collection and analysis,	Andersson A, 2004, CELL BIOCHEM BIOPHYS, P55; ARQUILLA ER, 1978, BIOCHEM J, V175, P289, DOI 10.1042/bj1750289; Aspinwall CA, 1999, J BIOL CHEM, V274, P6360, DOI 10.1074/jbc.274.10.6360; Aspinwall CA, 1997, J BIOL CHEM, V272, P31308, DOI 10.1074/jbc.272.50.31308; Bernal PJ, 2011, AM J PHYSIOL-LUNG C, V300, pL874, DOI 10.1152/ajplung.00328.2010; BLUNDELL TL, 1972, DIABETES, V21, P492, DOI 10.2337/diab.21.2.S492; Cahuana GM, 2004, EXP CELL RES, V293, P22, DOI 10.1016/j.yexcr.2003.10.004; CARPENTER FH, 1966, AM J MED, V40, P750, DOI 10.1016/0002-9343(66)90156-2; DEPAEPE ME, 1992, DIABETOLOGIA, V35, P1118, DOI 10.1007/BF00401364; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Eisenberg D, 1979, PHYS CHEM APPL TO LI; FERRER R, 1984, AM J PHYSIOL, V246, pC520, DOI 10.1152/ajpcell.1984.246.5.C520; FOSTER MC, 1993, BIOPHYS J, V64, P525, DOI 10.1016/S0006-3495(93)81397-3; FRANK BH, 1972, DIABETES, V21, P486, DOI 10.2337/diab.21.2.S486; GAMMELTOFT S, 1984, PHYSIOL REV, V64, P1321, DOI 10.1152/physrev.1984.64.4.1321; GHAFGHAZI T, 1981, DIABETES, V30, P341, DOI 10.2337/diabetes.30.4.341; Giuliani M, 2005, CELL TRANSPLANT, V14, P67, DOI 10.3727/000000005783983287; GOLD G, 1984, EXPERIENTIA, V40, P1105, DOI 10.1007/BF01971458; HELMERHORST E, 1986, ARCH BIOCHEM BIOPHYS, V245, P238, DOI 10.1016/0003-9861(86)90210-9; Hering BJ, 2016, DIABETES CARE, V39, P1230, DOI 10.2337/dc15-1988; HURLEY LS, 1969, AM J CLIN NUTR, V22, P1332; Ishihara H, 2003, NAT CELL BIOL, V5, P330, DOI 10.1038/ncb951; JEFFREY PD, 1966, BIOCHEMISTRY-US, V5, P489, DOI 10.1021/bi00866a014; KANG S, 1991, DIABETES CARE, V14, P942, DOI 10.2337/diacare.14.11.942; Komatsu H, 2017, OXYGEN ENV ISLET SIZ, V12; Kragh-Hansen U, 2002, BIOL PHARM BULL, V25, P695, DOI 10.1248/bpb.25.695; KROLL J, 1993, SCAND J IMMUNOL, V37, P381, DOI 10.1111/j.1365-3083.1993.tb02568.x; KURTZHALS P, 1995, DIABETES, V44, P1381, DOI 10.2337/diabetes.44.12.1381; Lepore M, 2000, DIABETES, V49, P2142, DOI 10.2337/diabetes.49.12.2142; LERNMARK A, 1974, DIABETOLOGIA, V10, P431, DOI 10.1007/BF01221634; Li HH, 2010, ANN NY ACAD SCI, V1203, P73, DOI 10.1111/j.1749-6632.2010.05558.x; Li YV, 2014, ENDOCRINE, V45, P178, DOI 10.1007/s12020-013-0032-x; Martin F, 1999, DIABETES, V48, P1954, DOI 10.2337/diabetes.48.10.1954; PARISI AF, 1970, BIOCHEMISTRY-US, V9, P2421, DOI 10.1021/bi00814a005; PULLEN RA, 1976, NATURE, V259, P369, DOI 10.1038/259369a0; Ricordi C, 2016, DIABETES, V65, P3418, DOI 10.2337/db16-0234; SINDELKA G, 1994, DIABETOLOGIA, V37, P377, DOI 10.1007/BF00408474; Stewart AJ, 2003, P NATL ACAD SCI USA, V100, P3701, DOI 10.1073/pnas.0436576100; Tejedo J, 1999, FEBS LETT, V459, P238, DOI 10.1016/S0014-5793(99)01255-7; Thambiayya Kalidasan, 2012, Pulm Circ, V2, P443, DOI 10.4103/2045-8932.105032; VALDEOLMILLOS M, 1993, DIABETES, V42, P1210, DOI 10.2337/diabetes.42.8.1210; ZALEWSKI PD, 1993, BIOCHEM J, V296, P403, DOI 10.1042/bj2960403	42	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							e0187547	10.1371/journal.pone.0187547	http://dx.doi.org/10.1371/journal.pone.0187547			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6TA	29099856	Green Published, Green Submitted, gold			2022-12-26	WOS:000414377900028
J	Ajima, R; Suzuki, E; Saga, Y				Ajima, Rieko; Suzuki, Emiko; Saga, Yumiko			Pofut1 point-mutations that disrupt O-fucosyltransferase activity destabilize the protein and abolish Notch1 signaling during mouse somitogenesis	PLOS ONE			English	Article							DELTA INTERACTIONS; LIGAND-BINDING; FRINGE; O-FUCOSYL-TRANSFERASE-1; GLYCOSYLATION; SEGMENTATION; ENDOCYTOSIS; DROSOPHILA; RECEPTOR; PATHWAY	The segmental pattern of the vertebrate body is established via the periodic formation of somites from the presomitic mesoderm (PSM). This periodical process is controlled by the cyclic and synchronized activation of Notch signaling in the PSM. Protein O-fucosyltransfer-ase1 (Pofut1), which transfers O-fucose to the EGF domains of the Notch1 receptor, is indispensable for Notch signaling activation. The Drosophila homologue Ofut1 was reported to control Notch localization via two different mechanisms, working as a chaperone for Notch or as a regulator of Notch endocytosis. However, these were found to be independent of O-fucosyltransferase activity because the phenotypes were rescued by Ofut1 mutants lacking O-fucosyltransferase activity. Pofut1 may also be involved in the Notch receptor localization in mice. However, the contribution of enzymatic activity of Pofut1 to the Notch receptor dynamics remains to be elucidated. In order to clarify the importance of the O-fucosyltransferase activity of Pofut1 for Notch signaling activation and the protein localization in the PSM, we established mice carrying point mutations at the 245th a.a. or 370-372th a.a., highly conserved amino-acid sequences whose mutations disrupt the O-fucosyltransferase activity of both Drosophila Ofut1 and mammalian Pofut1, with the CRISPR/Cas9 mediated genome-engineering technique. Both mutants displayed the same severely perturbed somite formation and Notch1 subcellular localization defects as the Pofut1 null mutants. In the mutants, Pofut1 protein, but not RNA, became undetectable by E9.5. Furthermore, both wild-type and mutant Pofut1 proteins were degraded through lysosome dependent machinery. Pofut1 protein loss in the point mutant embryos caused the same phenotypes as those observed in Pofut1 null embryos.	[Ajima, Rieko; Saga, Yumiko] Natl Inst Genet, Genet Strains Res Ctr, Mammalian Dev Lab, Mishima, Shizuoka, Japan; [Ajima, Rieko; Saga, Yumiko] Natl Inst Genet, Mouse Res Supporting Unit, Mishima, Shizuoka, Japan; [Ajima, Rieko; Suzuki, Emiko; Saga, Yumiko] SOKENDAI, Dept Genet, Mishima, Shizuoka, Japan; [Suzuki, Emiko] Natl Inst Genet, Struct Biol Ctr, Gene Network Lab, Mishima, Shizuoka, Japan; [Saga, Yumiko] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Tokyo	Ajima, R; Saga, Y (corresponding author), Natl Inst Genet, Genet Strains Res Ctr, Mammalian Dev Lab, Mishima, Shizuoka, Japan.; Ajima, R; Saga, Y (corresponding author), Natl Inst Genet, Mouse Res Supporting Unit, Mishima, Shizuoka, Japan.; Ajima, R; Saga, Y (corresponding author), SOKENDAI, Dept Genet, Mishima, Shizuoka, Japan.; Saga, Y (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo, Japan.	rajima@nig.ac.jp; ysaga@nig.ac.jp		Suzuki, Emiko/0000-0002-4005-0542	Transdisciplinary Research Integration Center of the Research Organization of Information and Systems	Transdisciplinary Research Integration Center of the Research Organization of Information and Systems	This work was supported by Transdisciplinary Research Integration Center of the Research Organization of Information and Systems (YS).r We thank the Mouse Research Supporting Unit at the National Institute of Genetics for establishing all mutant mice in this study. We are particularly thankful to Dr. Yoshiaki Okamura, Makoto Kiso and Akane Ohishi (National Institute of Genetics, Japan) for technical support. We are grateful to Dr. Yasuyuki Kurihara for generating the monoclonal antibodies used in this study. We are grateful to Dr. Hitoshi Niwa and Dr. Ryoichiro Kageyama for providing reagents. We are grateful to Danelle Wright for editing this manuscript. This work was supported by funding from the Transdisciplinary Research Integration Center of the Research Organization of Information and Systems.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Araki K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007526; Breton C, 1998, J BIOCHEM, V123, P1000; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Chapman G, 2011, HUM MOL GENET, V20, P905, DOI 10.1093/hmg/ddq529; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Furthauer M, 2009, TRAFFIC, V10, P792, DOI 10.1111/j.1600-0854.2009.00914.x; Ge CH, 2008, P NATL ACAD SCI USA, V105, P1539, DOI 10.1073/pnas.0702846105; Haines N, 2003, NAT REV MOL CELL BIO, V4, P786, DOI 10.1038/nrm1228; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hashimoto M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11315; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hubaud A, 2014, NAT REV MOL CELL BIO, V15, P709, DOI 10.1038/nrm3891; Ishio A, 2015, J BIOL CHEM, V290, P505, DOI 10.1074/jbc.M114.616847; Jehn BM, 2002, J BIOL CHEM, V277, P8033, DOI 10.1074/jbc.M108552200; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jorissen E, 2010, CURR TOP DEV BIOL, V92, P201, DOI 10.1016/S0070-2153(10)92006-1; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kuwahara S, 2006, BIOL REPROD, V75, P352, DOI 10.1095/biolreprod.106.051136; Ladi E, 2005, J CELL BIOL, V170, P983, DOI 10.1083/jcb.200503113; Le Borgne R, 2006, CURR OPIN CELL BIOL, V18, P213, DOI 10.1016/j.ceb.2006.02.011; Le Bras S, 2011, TRAFFIC, V12, P149, DOI 10.1111/j.1600-0854.2010.01126.x; Lira-Navarrete E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025365; Luca VC, 2017, SCIENCE, V355, P1320, DOI 10.1126/science.aaf9739; Luca VC, 2015, SCIENCE, V347, P847, DOI 10.1126/science.1261093; Luo Y, 2005, J BIOL CHEM, V280, P11289, DOI 10.1074/jbc.M414574200; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Moretti J, 2013, INT J MOL SCI, V14, P6359, DOI 10.3390/ijms14036359; Muller J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088571; Musse AA, 2012, SEMIN CELL DEV BIOL, V23, P429, DOI 10.1016/j.semcdb.2012.01.011; Okajima T, 2003, J BIOL CHEM, V278, P42340, DOI 10.1074/jbc.M308687200; Okajima T, 2005, SCIENCE, V307, P1599, DOI 10.1126/science.1108995; Okajima T, 2002, CELL, V111, P893, DOI 10.1016/S0092-8674(02)01114-5; Okajima T, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-1; Okamura Y, 2008, MECH DEVELOP, V125, P663, DOI 10.1016/j.mod.2008.04.007; Okubo Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2133; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Panin VM, 2002, J BIOL CHEM, V277, P29945, DOI 10.1074/jbc.M204445200; Rampal R, 2007, CURR MOL MED, V7, P427, DOI 10.2174/156652407780831593; Saga Y, 2012, CURR OPIN GENET DEV, V22, P331, DOI 10.1016/j.gde.2012.05.004; Sasamura T, 2003, DEVELOPMENT, V130, P4785, DOI 10.1242/dev.00679; Sasamura T, 2007, DEVELOPMENT, V134, P1347, DOI 10.1242/dev.02811; Serth K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123776; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Shifley ET, 2008, DEVELOPMENT, V135, P899, DOI 10.1242/dev.006742; Stahl M, 2008, J BIOL CHEM, V283, P13638, DOI 10.1074/jbc.M802027200; Stanley P, 2010, CURR TOP DEV BIOL, V92, P131, DOI 10.1016/S0070-2153(10)92004-8; SUZUKI E, 1994, J ELECTRON MICROSC, V43, P183; Suzuki E, 1995, CELL TECHNOLOGY, V14, P456; Takeuchi H, 2014, BIOCHEM BIOPH RES CO, V453, P235, DOI 10.1016/j.bbrc.2014.05.115; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Yamamoto S, 2010, CURR TOP DEV BIOL, V92, P165, DOI 10.1016/S0070-2153(10)92005-X	56	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187248	10.1371/journal.pone.0187248	http://dx.doi.org/10.1371/journal.pone.0187248			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095923	Green Published, gold, Green Submitted			2022-12-26	WOS:000414340200061
J	Graf, L; Kim, YJ; Cho, GY; Miller, KA; Yoon, HS				Graf, Louis; Kim, Yae Jin; Cho, Ga Youn; Miller, Kathy Ann; Yoon, Hwan Su			Plastid and mitochondrial genomes of Coccophora langsdorfii (Fucales, Phaeophyceae) and the utility of molecular markers	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; SARGASSUM-HORNERI SARGASSACEAE; BROWN-ALGAE; PHYLOGENETIC-RELATIONSHIPS; FUNCTION PREDICTION; CHLOROPLAST GENOME; GENETIC DIVERSITY; PROTEIN-STRUCTURE; COMPLETE SEQUENCE; I-TASSER	Coccophora langsdorfii (Turner) Greville (Fucales) is an intertidal brown alga that is endemic to Northeast Asia and increasingly endangered by habitat loss and climate change. We sequenced the complete circular plastid and mitochondrial genomes of C. langsdorfii. The circular plastid genome is 124,450 bp and contains 139 protein-coding, 28 tRNA and 6 rRNA genes. The circular mitochondrial genome is 35,660 bp and contains 38 protein-coding, 25 tRNA and 3 rRNA genes. The structure and gene content of the C langsdorfii plastid genome is similar to those of other species in the Fucales. The plastid genomes of brown algae in other orders share similar gene content but exhibit large structural recombination. The large in-frame insert in the cox2 gene in the mitochondrial genome of C langsdorfii is typical of other brown algae. We explored the effect of this insertion on the structure and function of the cox2 protein. We estimated the usefulness of 135 plastid genes and 35 mitochondrial genes for developing molecular markers. This study shows that 29 organellar genes will prove efficient for resolving brown algal phylogeny. In addition, we propose a new molecular marker suitable for the study of intraspecific genetic diversity that should be tested in a large survey of populations of C. langsdorfii.	[Graf, Louis; Kim, Yae Jin; Yoon, Hwan Su] Sungkyunkwan Univ, Dept Biol Sci, Suwon, South Korea; [Cho, Ga Youn] Natl Inst Biol Resources, Incheon, South Korea; [Miller, Kathy Ann] Univ Calif Berkeley, Univ Herbarium, Berkeley, CA 94720 USA	Sungkyunkwan University (SKKU); National Institute of Biological Resources; University of California System; University of California Berkeley	Yoon, HS (corresponding author), Sungkyunkwan Univ, Dept Biol Sci, Suwon, South Korea.	hsyoon2011@skku.edu	Yoon, Hwan Su/A-2974-2013; Yoon, Hwan Su/ABD-7011-2020	Graf, Louis/0000-0001-8276-1687; Yoon, Hwan Su/0000-0001-9507-0105	National Institute of Biological Resources - Ministry of Environment; Collaborative Genome Program - Ministry of Oceans and Fisheries, Korea [20140428]	National Institute of Biological Resources - Ministry of Environment; Collaborative Genome Program - Ministry of Oceans and Fisheries, Korea	This work was supported by the grants from National Institute of Biological Resources funded by the Ministry of Environment and the Collaborative Genome Program (20140428) funded by the Ministry of Oceans and Fisheries, Korea to HSY.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Adams KL, 2001, MOL BIOL EVOL, V18, P2289, DOI 10.1093/oxfordjournals.molbev.a003775; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bi Y, 2015, MITOCHONDRIAL DNA, V1-2; Brodie J, 2009, PHYCOLOGIA, V48, P423, DOI 10.2216/09-21.1; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; Burger G, 2000, J MOL BIOL, V297, P365, DOI 10.1006/jmbi.2000.3529; Charif D., 2007, SEQINR 10 2 CONTRIBU, P207, DOI [10.1007/978-3-540-35306-5_10, DOI 10.1007/978-3-540-35306-5_10]; Chevreux B., 1999, GERMAN C BIOINFORMAT, V99, P45; Cho GY, 2006, PHYCOLOGIA, V45, P512, DOI 10.2216/05-48.1; Cho GY, 2004, J PHYCOL, V40, P921, DOI 10.1111/j.1529-8817.2004.03160.x; Cho SM, 2012, BOT MAR, V55, P473, DOI 10.1515/bot-2012-0109; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; de Graaf RM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-514; Funes S, 2002, SCIENCE, V298, P2155, DOI 10.1126/science.1076003; Gawryluk Ryan M R, 2009, BMC Res Notes, V2, P16, DOI 10.1186/1756-0500-2-16; Guy L, 2010, BIOINFORMATICS, V26, P2334, DOI 10.1093/bioinformatics/btq413; Henry RJ, 2013, MOL MARKERS PLANTS, P3; Hilker R, 2012, BIOINFORMATICS, V28, P2509, DOI 10.1093/bioinformatics/bts440; Jackson C, 2017, J PHYCOL, V53, P1, DOI 10.1111/jpy.12465; Janouskovec J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059001; KADENBACH B, 1991, J BIOENERG BIOMEMBR, V23, P321, DOI 10.1007/BF00762225; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Le Corguille G, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-253; Lee J, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0299-5; Li TY, 2015, MITOCHONDR DNA, V26, P953, DOI 10.3109/19401736.2013.865172; Liu F, 2015, MITOCHONDRIAL DNA, V1-3; Liu Fang, 2014, Biomed Res Int, V2014, P170289, DOI 10.1155/2014/170289; Liu F, 2016, J APPL PHYCOL, V28, P1419, DOI 10.1007/s10811-015-0609-2; Liu F, 2016, MITOCHONDRIAL DNA A, V27, P1468, DOI 10.3109/19401736.2014.953096; Liu F, 2015, CURR GENET, V61, P621, DOI 10.1007/s00294-015-0488-8; Liu F, 2016, MITOCHONDRIAL DNA A, V27, P1158, DOI 10.3109/19401736.2014.936417; Liu F, 2016, MITOCHONDRIAL DNA A, V27, P1129, DOI 10.3109/19401736.2014.933333; Liu F, 2015, J APPL PHYCOL, V27, P1021, DOI 10.1007/s10811-014-0386-3; Liu F, 2015, J APPL PHYCOL, V27, P469, DOI 10.1007/s10811-014-0295-5; Ministry of Environment, 2015, STAT DISTR END SPEC, P344; Oak J.H., 2010, ALGAL FLORA KOREA, P111; Oudot-le Secq MP, 2002, EUR J PHYCOL, V37, P163, DOI 10.1017/S0967026202003542; Oudot-Le Secq MP, 2001, J MOL EVOL, V53, P80, DOI 10.1007/s002390010196; Pecina P, 2004, PHYSIOL RES, V53, pS213; Perez-Martinez X, 2001, J BIOL CHEM, V276, P11302, DOI 10.1074/jbc.M010244200; Qu JQ, 2015, MITOCHONDR DNA, V26, P919, DOI 10.3109/19401736.2013.863290; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sahu Sunil Kumar, 2012, ISRN Mol Biol, V2012, P205049, DOI 10.5402/2012/205049; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Secq MPO, 2006, CURR GENET, V49, P47, DOI 10.1007/s00294-005-0031-4; Silberfeld T, 2014, CRYPTOGAMIE ALGOL, V35, P117, DOI 10.7872/crya.v35.iss2.2014.117; Silberfeld T, 2010, MOL PHYLOGENET EVOL, V56, P659, DOI 10.1016/j.ympev.2010.04.020; Smith DR, 2015, GENOME BIOL EVOL, V7, P1227, DOI 10.1093/gbe/evv069; Song HJ, 2016, ALGAE-SEOUL, V31, P137, DOI 10.4490/algae.2016.31.6.5; Stephens TG, 2016, PEERJ, V4, DOI 10.7717/peerj.2038; Szafranski P, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3626-5; Titlyanov E.A., 2016, USEFUL MARINE PLANTS; Uwai SY, 2006, PHYCOLOGIA, V45, P687, DOI 10.2216/05-66.1; Uwai S, 2009, MAR BIOL, V156, P901, DOI 10.1007/s00227-009-1136-y; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Voisin M, 2005, P NATL ACAD SCI USA, V102, P5432, DOI 10.1073/pnas.0501754102; Waller RF, 2006, GENE, V383, P33, DOI 10.1016/j.gene.2006.07.003; Wang S, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON SIGNAL PROCESSING, COMMUNICATIONS AND COMPUTING (ICSPCC), P1, DOI 10.1109/INTMAG.2015.7156812; Wang XL, 2013, MAR GENOM, V10, P1, DOI 10.1016/j.margen.2012.12.002; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Wynne MJ, 2014, PHYCOLOGIA, V53, P513, DOI 10.2216/14-055.1; Yang EC, 2012, PROTIST, V163, P217, DOI 10.1016/j.protis.2011.08.001; Yang JH, 2016, MAR GENOM, V28, P17, DOI 10.1016/j.margen.2016.03.003; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yoon HS, 2001, MOL PHYLOGENET EVOL, V21, P231, DOI 10.1006/mpev.2001.1009; Yoshida T., 1998, MARINE ALGAE JAPAN; Yotsukura N, 2010, J APPL PHYCOL, V22, P243, DOI 10.1007/s10811-009-9452-7; Zhang J, 2013, J APPL PHYCOL, V25, P1247, DOI 10.1007/s10811-012-9915-0; Zhang Jing, 2011, Journal of Ocean University of China, V10, P351, DOI 10.1007/s11802-011-1856-8; Zhang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140144; Zhang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139366; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	81	7	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187104	10.1371/journal.pone.0187104	http://dx.doi.org/10.1371/journal.pone.0187104			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095864	Green Published, Green Submitted, gold			2022-12-26	WOS:000414340200046
J	Jonsson, J; Westman, A; Bruchfeld, J; Sturegard, E; Gaines, H; Schon, T				Jonsson, Jerker; Westman, Anna; Bruchfeld, Judith; Sturegard, Erik; Gaines, Hans; Schon, Thomas			A borderline range for Quantiferon Gold In-Tube results	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; HEALTH-CARE WORKERS; TUBERCULOSIS INFECTION; PLUS; VARIABILITY	Objective Interferon gamma release assays like Quantiferon Gold In-Tube (QFT) are used to identify individuals infected with Mycobacterium tuberculosis. A dichotomous cut-off (0.35 IU/ml) defines a positive QFT without considering test variability. Our objective was to evaluate the introduction of a borderline range under routine conditions. Methods Results of routine QFT samples from Sweden (2009-2014) were collected. A borderline range (0.20-0.99 IU/ml) was introduced in 2010 recommending a follow-up sample. The association between borderline results and incident active TB within 3 to 24 months was investigated through linkage with the national TB-register. Results Using the recommended QFT cut-off, 75.1 % tests were negative, 21.4% positive and 3.5% indeterminate. In total, 9% (3656/40773) were within the borderline range. In follow-up samples, individuals with initial results between 0.20-0.34 IU/ml and 0.35-0.99 IU/ml displayed negative results below the borderline range (<0.20 IU/ml) in 66.1% (230/348) and 42.5% (285/671) respectively, and none developed incident TB. Among 6712 individuals with a positive initial test >0.99 IU/ml, 65 (0.97%) developed incident TB within 3-24 months. Conclusions We recommend retesting of subjects with QFT results in the range 0.20-0.99 IU/ml to enhance reliability and validity of the test. Half of the subjects in the borderline range will be negative at a level<0.20 IU/ml when retested and have a very low risk of developing incident active TB.	[Jonsson, Jerker; Gaines, Hans] Publ Hlth Agcy Sweden, Solna, Sweden; [Jonsson, Jerker; Bruchfeld, Judith; Gaines, Hans] Karolinska Inst, Unit Infect Dis, Dept Med, Stockholm, Sweden; [Westman, Anna] Danderyd Hosp, Dept Infect Dis, Stockholm, Sweden; [Westman, Anna] Karolinska Univ Hosp Lab, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden; [Bruchfeld, Judith; Gaines, Hans] Karolinska Univ Hosp Solna, Dept Infect Dis, Stockholm, Sweden; [Sturegard, Erik] Lund Univ, Dept Translat Med, Infect Dis Res Unit, Lund, Sweden; [Schon, Thomas] Kalmar Cty Hosp, Dept Clin Microbiol & Infect Dis, Kalmar, Sweden; [Schon, Thomas] Linkoping Univ, Dept Clin & Expt Res, Div Med Microbiol, Linkoping, Sweden	Public Health Agency of Sweden; Karolinska Institutet; Danderyds Hospital; Karolinska Institutet; Karolinska University Hospital; Lund University; Linkoping University	Schon, T (corresponding author), Kalmar Cty Hosp, Dept Clin Microbiol & Infect Dis, Kalmar, Sweden.; Schon, T (corresponding author), Linkoping Univ, Dept Clin & Expt Res, Div Med Microbiol, Linkoping, Sweden.	tschon@hotmail.com	Jonsson, Jerker/O-6675-2019	Jonsson, Jerker/0000-0003-1383-6176; Schon, Thomas/0000-0003-4849-1286	Swedish Research council [201602043]; Swedish Heart and Lung Foundation (Oscar II Jubilee foundation) [20150236, 20150237]	Swedish Research council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation (Oscar II Jubilee foundation)	This study was funded (all granted to Thomas Schon) by the Swedish Research council, grant 201602043 (www.vr.se) and the Swedish Heart and Lung Foundation (Oscar II Jubilee foundation) grants 20150236 and 20150237 (www3.hjart-lungfonden.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banaei Niaz, 2016, J Clin Microbiol, V54, P845, DOI 10.1128/JCM.02803-15; Barcellini L, 2016, EUR RESPIR J, V48, P1411, DOI 10.1183/13993003.00510-2016; Diel R, 2012, CHEST, V142, P63, DOI 10.1378/chest.11-3157; Dorman SE, 2014, AM J RESP CRIT CARE, V189, P77, DOI 10.1164/rccm.201302-0365OC; Gamsky TE, 2016, ANN AM THORAC SOC, V13, P660, DOI 10.1513/AnnalsATS.201508-532OC; Getahun H, 2015, NEW ENGL J MED, V372, P2127, DOI 10.1056/NEJMra1405427; Hermansen TS, 2016, THORAX, V71, P652, DOI 10.1136/thoraxjnl-2015-208228; Hoffmann H, 2016, CLIN MICROBIOL INFEC, V22, P701, DOI 10.1016/j.cmi.2016.05.006; Joshi Manish, 2014, Ann Am Thorac Soc, V11, P296, DOI 10.1513/AnnalsATS.201310-378OC; Knierer J, 2017, J OCCUP MED TOXICOL, V12, DOI 10.1186/s12995-016-0148-z; Lewinsohn DM, 2016, CLIN INFECT DIS, P1; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Metcalfe JZ, 2013, AM J RESP CRIT CARE, V187, P206, DOI 10.1164/rccm.201203-0430OC; Nienhaus A, 2014, J OCCUP MED TOXICOL, V9, DOI 10.1186/1745-6673-9-9; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Pai M, 2014, CLIN MICROBIOL REV, V27, P3, DOI 10.1128/CMR.00034-13; Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9; Schablon A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115322; Simpson T, 2012, HEART LUNG, V41, P553, DOI 10.1016/j.hrtlng.2012.06.005; Tagmouti Saloua, 2014, Ann Am Thorac Soc, V11, P1267, DOI 10.1513/AnnalsATS.201405-188OC; Thanassi W, 2016, INFECT CONT HOSP EP, V37, P478, DOI 10.1017/ice.2015.324; Welfare TSNBfHa, 2013, NATL SWEDISH RECOMME; Yi LN, 2016, SCI REP-UK, V6, DOI 10.1038/srep30617	23	35	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187313	10.1371/journal.pone.0187313	http://dx.doi.org/10.1371/journal.pone.0187313			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095918	gold, Green Published, Green Submitted			2022-12-26	WOS:000414340200071
J	Terrill, JR; Pinniger, GJ; Nair, KV; Grounds, MD; Arthur, PG				Terrill, Jessica R.; Pinniger, Gavin J.; Nair, Keshav V.; Grounds, Miranda D.; Arthur, Peter G.			Beneficial effects of high dose taurine treatment in juvenile dystrophic mdx mice are offset by growth restriction	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; MOUSE MODEL; CYSTEINE DIOXYGENASE; OXIDATIVE STRESS; AMINO-ACIDS; MUSCLE; SUPPLEMENTATION; DYSTROPATHOLOGY; DEFICIENCY; BIOMARKERS	Duchenne Muscular Dystrophy (DMD) is a fatal muscle wasting disease manifested in young boys, for which there is no current cure. We have shown that the amino acid taurine is safe and effective at preventing dystropathology in the mdx mouse model for DMD. This study aimed to establish if treating growing mdx mice with a higher dose of taurine was more effective at improving strength and reducing inflammation and oxidative stress. Mice were treated with a dose of taurine estimated to be 16g/kg/day, in drinking water from 1-6 weeks of age, after which in vivo and ex vivo muscle strength was assessed, as were measures of inflammation, oxidative stress and taurine metabolism. While the dose did decrease inflammation and protein oxidation in dystrophic muscles, there was no improvement in muscle strength (in contrast with benefits observed with the lower dose) and growth of the young mice was significantly restricted. We present novel data that a high taurine dose increases the cysteine content of both mdx liver and plasma, a possible result of down regulation of the taurine synthesis pathway in the liver (which functions to dispose of excess cysteine, which is toxic). These data caution that a high dose of taurine can have adverse effects and may be less efficacious than lower taurine doses. Therefore, monitoring of taurine dosage needs to be considered in future pre-clinical trials, in anticipation of using taurine as a clinical therapy for growing DMD boys (and other conditions).	[Terrill, Jessica R.; Arthur, Peter G.] Univ Western Australia, Sch Mol Sci, Perth, WA, Australia; [Pinniger, Gavin J.; Nair, Keshav V.; Grounds, Miranda D.] Univ Western Australia, Sch Human Sci, Perth, WA, Australia	University of Western Australia; University of Western Australia	Terrill, JR (corresponding author), Univ Western Australia, Sch Mol Sci, Perth, WA, Australia.	jessica.terrill@uwa.edu.au	Arthur, Peter/H-8765-2014; Arthur, Peter/AAD-4594-2020; Pinniger, Gavin/F-1421-2013	Arthur, Peter/0000-0002-1257-8200; Arthur, Peter/0000-0002-1257-8200; Pinniger, Gavin/0000-0002-4400-0817; Terrill, Jessica/0000-0001-5484-5373; Grounds, Miranda/0000-0002-4530-9402	National Health and Medical Research Council (NHMRC) of Australia [APP1065829]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This research was funded by the National Health and Medical Research Council of Australia (https://www.nhmrc.gov.au), grant number APP1065829 (PGA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This research was supported by funding from the National Health and Medical Research Council (NHMRC) of Australia.	BAGLEY PJ, 1995, J NUTR, V125, P933; Bella DL, 2000, ADV EXP MED BIOL, V483, P71; Biggar WD, 2006, PEDIATR REV, V27, P83, DOI 10.1542/pir.27-3-83; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Capogrosso RF, 2016, PHARMACOL RES, V106, P101, DOI 10.1016/j.phrs.2016.02.016; Cozzoli A, 2011, NEUROPATH APPL NEURO, V37, P243, DOI 10.1111/j.1365-2990.2010.01106.x; De Luca A, 2003, J PHARMACOL EXP THER, V304, P453, DOI 10.1124/jpet.102.041343; De Luca A, 2001, BRIT J PHARMACOL, V132, P1047, DOI 10.1038/sj.bjp.0703907; De Luca A, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0610-1; De Luca Annamaria, 2012, Acta Myol, V31, P40; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Eppler B, 2001, BIOCHEM PHARMACOL, V62, P29, DOI 10.1016/S0006-2952(01)00647-5; Grounds MD, 2008, CELL MOL LIFE SCI, V65, P1621, DOI 10.1007/s00018-008-7574-8; Grounds MD, 2011, BIOESSAYS, V33, P458, DOI 10.1002/bies.201000136; Hakim CH, 2013, JOVE-J VIS EXP, DOI 10.3791/50183; HARPER AE, 1970, PHYSIOL REV, V50, P428, DOI 10.1152/physrev.1970.50.3.428; HAYES KC, 1980, J NUTR, V110, P2058, DOI 10.1093/jn/110.10.2058; Horvath DM, 2016, AMINO ACIDS, P1; Hu JM, 2000, J VET MED SCI, V62, P693, DOI 10.1292/jvms.62.693; Huxtable R., 2002, TAURINE, V4, P1; JERKINS AA, 1991, AM J PHYSIOL, V261, pE551, DOI 10.1152/ajpendo.1991.261.5.E551; Jerkins AA, 1998, J NUTR, V128, P1890, DOI 10.1093/jn/128.11.1890; Johnson RB, 2015, AQUACULTURE, V445, P79, DOI 10.1016/j.aquaculture.2015.03.030; Kharraz Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/965631; Lapidos KA, 2004, CIRC RES, V94, P1023, DOI 10.1161/01.RES.0000126574.61061.25; Liu Y, 2014, LIVEST SCI, V168, P109, DOI 10.1016/j.livsci.2014.08.014; Manzur AY, 2008, COCHRANE DB SYST REV, V3; Marcinkiewicz J, 2014, AMINO ACIDS, V46, P7, DOI 10.1007/s00726-012-1361-4; Matthews E, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003725.pub4; Murphy RM, 2013, J PHYSIOL-LONDON, V591, P5823, DOI 10.1113/jphysiol.2013.263251; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Radley HG, 2007, INT J BIOCHEM CELL B, V39, P469, DOI 10.1016/j.biocel.2006.09.009; Radley-Crabb HG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089277; Ramsey KA, 2010, MUSCLE NERVE, V42, P769, DOI 10.1002/mus.21744; Schuller-Levis GB, 2004, NEUROCHEM RES, V29, P117, DOI 10.1023/B:NERE.0000010440.37629.17; Shao A, 2008, REGUL TOXICOL PHARM, V50, P376, DOI 10.1016/j.yrtph.2008.01.004; Shimizu-Motohashi Y, 2016, AM J TRANSL RES, V8, P2471; Stipanuk MH, 2006, J NUTR, V136, p1652S, DOI 10.1093/jn/136.6.1652S; Stipanuk MH, 2004, NEUROCHEM RES, V29, P105, DOI 10.1023/B:NERE.0000010438.40376.c9; Strehle EM, 2015, ARCH DIS CHILD, V100, P1173, DOI 10.1136/archdischild-2014-307962; Terrill JR, 2016, REDOX BIOL, V9, P276, DOI 10.1016/j.redox.2016.08.016; Terrill JR, 2016, J PHYSIOL-LONDON, V594, P3095, DOI 10.1113/JP271418; Terrill JR, 2015, INT J BIOCHEM CELL B, V66, P141, DOI 10.1016/j.biocel.2015.07.016; Terrill JR, 2013, INT J BIOCHEM CELL B, V45, P2097, DOI 10.1016/j.biocel.2013.07.009; Terrill JRP, 2016, PLOS CURR, V8; Ueki I, 2008, CURR PROTOC TOXICOL, V38; Winterbourn CC, 2000, FREE RADICAL BIO MED, V29, P403, DOI 10.1016/S0891-5849(00)00204-5; Winterbourn CC, 2002, TOXICOLOGY, V181, P223, DOI 10.1016/S0300-483X(02)00286-X	48	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187317	10.1371/journal.pone.0187317	http://dx.doi.org/10.1371/journal.pone.0187317			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095865	Green Published, gold, Green Submitted			2022-12-26	WOS:000414340200072
J	Vinnard, C; Ravimohan, S; Tamuhla, N; Pasipanodya, J; Srivastava, S; Modongo, C; Zetola, NM; Weissman, D; Gumbo, T; Bisson, GP				Vinnard, Christopher; Ravimohan, Shruthi; Tamuhla, Neo; Pasipanodya, Jotam; Srivastava, Shashikant; Modongo, Chawangwa; Zetola, Nicola M.; Weissman, Drew; Gumbo, Tawanda; Bisson, Gregory P.			Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation	PLOS ONE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; HUMAN-IMMUNODEFICIENCY-VIRUS; IN-VITRO; ANTIRETROVIRAL THERAPY; TUBERCULOSIS PATIENTS; DRUG CONCENTRATIONS; HIV-INFECTION; T-CELLS; PHARMACOKINETICS; IMPACT	Pyrazinamide is the main driver of sterilizing effect in the standard regimen in adults and older children, and this effect is concentration-dependent. Tuberculosis patients co-infected with human immunodeficiency virus (HIV) have an increased risk for poor tuberculosis treatment outcomes and adverse drug events. We sought to determine whether measures of systemic immune activation were related to pyrazinamide pharmacokinetics among HIV/tuberculosis patients. We conducted a prospective cohort study of pyrazinamide pharmacokinetics in HIV/tuberculosis patients in Gaborone, Botswana. Patients underwent intensive pharmacokinetic sampling before and after the initiation of antiretroviral therapy, which can increase immune activation in HIV/tuberculosis. Compartmental pharmacokinetic modeling was performed to determine whether variability in systemic immune activation was related to variability in pyrazinamide pharmacokinetic parameters. Forty HIV/tuberculosis patients completed the first pharmacokinetic sampling visit, and 24 patients returned for a second visit following antiretroviral therapy initiation. The pyrazinamide plasma concentration-versus-time data were best explained by a one-compartment model with first-order elimination, and a combined additive and proportional residual error model. Pyrazinamide clearance was higher in men than women. Expression of CD38 and HLA-DR on CD8+T cells, a measure of HIV-associated immune activation, was inversely related to pyrazinamide clearance, with increasing immune activation associated with decreasing pyrazinamide clearance. Future studies should verify this finding in larger numbers of tuberculosis patients with and without HIV co-infection.	[Vinnard, Christopher] Univ Med & Dent New Jersey, Publ Hlth Res Inst, Newark, NJ 07103 USA; [Ravimohan, Shruthi; Weissman, Drew; Bisson, Gregory P.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Tamuhla, Neo; Modongo, Chawangwa; Zetola, Nicola M.] Botswana UPenn Partnership, Gaborone, Botswana; [Pasipanodya, Jotam; Srivastava, Shashikant; Gumbo, Tawanda] Baylor Univ, Med Ctr, Baylor Res Inst, Ctr Infect Dis Res & Expt Therapeut, Dallas, TX USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Pennsylvania; Pennsylvania Medicine; Baylor Scott & White Health; Baylor University; Baylor University Medical Center	Vinnard, C (corresponding author), Univ Med & Dent New Jersey, Publ Hlth Res Inst, Newark, NJ 07103 USA.	christopher.vinnard@njms.rutgers.edu	Srivastava, Shashikant/I-4704-2019; Srivastava, Shashikant/D-5311-2013	Srivastava, Shashikant/0000-0002-8786-8851; Gumbo, Tawanda/0000-0001-7592-8012	NIAID [R21AI104441, K23AI102639]; Public Health Research Institute, Rutgers; State University of New Jersey; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI102639] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Public Health Research Institute, Rutgers; State University of New Jersey; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID (R21AI104441 to Dr. Bisson, K23AI102639 to Dr. Vinnard). Dr. Vinnard receives internal support from the Public Health Research Institute, Rutgers, The State University of New Jersey. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064622; Araujo-Mariz C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157725; Breen RAM, 2006, THORAX, V61, P791, DOI 10.1136/thx.2006.058867; Chideya S, 2009, CLIN INFECT DIS, V48, P1685, DOI 10.1086/599040; Chigutsa E, 2015, ANTIMICROB AGENTS CH, V59, P38, DOI 10.1128/AAC.03931-14; Chirehwa MT, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/aac.00490-17, 10.1128/AAC.00490-17]; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; El-Sadr WM, 2001, CLIN INFECT DIS, V32, P623, DOI 10.1086/318706; Ette EI, 2007, PHARMACOMETRICS SCI, P265; GIORGI JV, 1993, J ACQ IMMUN DEF SYND, V6, P904; Gumbo T, 2009, ANTIMICROB AGENTS CH, V53, P3197, DOI 10.1128/AAC.01681-08; Harvey RD, 2014, CLIN PHARMACOL THER, V96, P449, DOI 10.1038/clpt.2014.143; HEIFETS L, 1992, AM REV RESPIR DIS, V145, P1223, DOI 10.1164/ajrccm/145.5.1223; Khan FA, 2010, CLIN INFECT DIS, V50, P1288, DOI 10.1086/651686; Kim TH, 2011, FEBS J, V278, P2307, DOI 10.1111/j.1742-4658.2011.08148.x; Korenromp EL, 2003, CLIN INFECT DIS, V37, P101, DOI 10.1086/375220; KRAEMER MJ, 1982, PEDIATRICS, V69, P476; Kumar AKH, 2016, INT J TUBERC LUNG D, V20, P1236, DOI 10.5588/ijtld.16.0048; LACROIX C, 1990, ARZNEIMITTELFORSCH, V40-1, P76; Laureillard D, 2013, AIDS, V27, P2577, DOI 10.1097/01.aids.0000432456.14099.c7; Liptrott NJ, 2009, BRIT J PHARMACOL, V156, P497, DOI 10.1111/j.1476-5381.2008.00050.x; Liu ZY, 1997, J ACQ IMMUN DEF SYND, V16, P83, DOI 10.1097/00042560-199710010-00003; Mallory KF, 2000, INT J TUBERC LUNG D, V4, P455; McIlleron H, 2012, ANTIMICROB AGENTS CH, V56, P3232, DOI 10.1128/AAC.05526-11; Pasipanodya JG, 2013, J INFECT DIS, V208, P1464, DOI 10.1093/infdis/jit352; Pasipanodya JG, 2010, ANTIMICROB AGENTS CH, V54, P2847, DOI 10.1128/AAC.01567-09; Ravimohan S, 2015, LANCET INFECT DIS, V15, P429, DOI 10.1016/S1473-3099(15)70008-3; Shih TY, 2013, ANTIMICROB AGENTS CH, V57, P1685, DOI 10.1128/AAC.01866-12; Swaminathan S, 2016, CLIN INFECT DIS, V63, pS63, DOI 10.1093/cid/ciw471; Tostmann A, 2008, INT J ANTIMICROB AG, V31, P577, DOI 10.1016/j.ijantimicag.2008.01.022; Tostmann A, 2010, DRUG CHEM TOXICOL, V33, P325, DOI 10.3109/01480540903449715; Via LE, 2015, ACS INFECT DIS, V1, P203, DOI 10.1021/id500028m; Vinnard C, 2017, BRIT J CLIN PHARMACO, V83, P801, DOI 10.1111/bcp.13172; World Health Organization, TREATM TUB GUID, V4th	34	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187624	10.1371/journal.pone.0187624	http://dx.doi.org/10.1371/journal.pone.0187624			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095954	Green Published, gold, Green Submitted			2022-12-26	WOS:000414340200125
J	Auracher, J				Auracher, Jan			Sound iconicity of abstract concepts: Place of articulation is implicitly associated with abstract concepts of size and social dominance	PLOS ONE			English	Article							FORMANT FREQUENCIES; FACIAL EXPRESSIONS; SYMBOLISM; EMOTION; COMMUNICATION; SHAPE; CORRESPONDENCES; PERCEPTION; PHONEMES; SADNESS	The concept of sound iconicity implies that phonemes are intrinsically associated with non acoustic phenomena, such as emotional expression, object size or shape, or other perceptual features. In this respect, sound iconicity is related to other forms of cross -modal associations in which stimuli from different sensory modalities are associated with each other due to the implicitly perceived correspondence of their primal features. One prominent example is the association between vowels, categorized according to their place of articulation, and size, with back vowels being associated with bigness and front vowels with smallness. However, to date the relative influence of perceptual and conceptual cognitive processing on this association is not clear. To bridge this gap, three experiments were conducted in which associations between nonsense words and pictures of animals or emotional body postures were tested. In these experiments participants had to infer the relation between visual stimuli and the notion of size from the content of the pictures, while directly perceivable features did not support or even contradicted the predicted association. Results show that implicit associations between articulatory -acoustic characteristics of phonemes and pictures are mainly influenced by semantic features, i.e., the content of a picture, whereas the influence of perceivable features, i.e., size or shape, is overridden. This suggests that abstract semantic concepts can function as an interface between different sensory modalities, facilitating cross -modal associations.	[Auracher, Jan] Max Planck Inst Empir Aesthet, Dept Language & Literature, Frankfurt, Germany		Auracher, J (corresponding author), Max Planck Inst Empir Aesthet, Dept Language & Literature, Frankfurt, Germany.	jan.auracher@aesthetics.mpg.de	Auracher, Jan/ABB-5166-2021	Auracher, Jan/0000-0002-4357-8350	Japanese Society for the Promotion of Science (JSPS) [24520481]	Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japanese Society for the Promotion of Science (JSPS, , research project No. 24520481, https://www.isps.go.jp/english/); Researcher: Jan Auracher. Funding was used for technical equipment, software licenses and to pay allowance for participants.	Allott R., 1995, LANGUAGE WURM GLACIA, P15; Amorim MCP, 2005, ANIM BEHAV, V69, P595, DOI 10.1016/j.anbehav.2004.06.016; Aryani A, 2016, PSYCHOL AESTHET CREA, V10, P191, DOI 10.1037/aca0000033; Asano M, 2015, CORTEX, V63, P196, DOI 10.1016/j.cortex.2014.08.025; Auracher J, 2011, DISCOURSE PROCESS, V48, P1, DOI 10.1080/01638531003674894; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BECKER JA, 1988, AM J PSYCHOL, V101, P51, DOI 10.2307/1422792; BIRCH D, 1958, J GEN PSYCHOL, V58, P291, DOI 10.1080/00221309.1958.9920401; Blasi DE, 2016, P NATL ACAD SCI USA, V113, P10818, DOI 10.1073/pnas.1605782113; Colleye O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049179; de Gelder B, 2015, WIRES COGN SCI, V6, P149, DOI 10.1002/wcs.1335; De Houwer J, 2009, PSYCHOL BULL, V135, P347, DOI 10.1037/a0014211; Dingemanse M, 2015, TRENDS COGN SCI, V19, P603, DOI 10.1016/j.tics.2015.07.013; Eitan Z, 2010, COGNITION, V114, P405, DOI 10.1016/j.cognition.2009.10.013; Elliot AJ, 2013, EMOT REV, V5, P308, DOI 10.1177/1754073913477517; Feinberg DR, 2011, BEHAV ECOL, V22, P1320, DOI 10.1093/beheco/arr134; FONAGY I, 1961, WORD, V17, P194, DOI 10.1080/00437956.1961.11659754; Fox J., 2018, R COMPANION APPL REG, VThird; French P. L., 1977, WORD, V28, P305, DOI [DOI 10.1080/00437956.1977.11435647, 10.1080/00437956.1977.11435647]; Gao XQ, 2010, J EXP CHILD PSYCHOL, V105, P98, DOI 10.1016/j.jecp.2009.09.001; Gawronski B, 2006, CONSCIOUS COGN, V15, P485, DOI 10.1016/j.concog.2005.11.007; Greenberg J. H., 1966, WORD, V22, P207, DOI [10.1080/00437956.1966.11435451, DOI 10.1080/00437956.1966.11435451]; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Gregory SW, 2002, SOC PSYCHOL QUART, V65, P298; Gregory SW, 1996, J PERS SOC PSYCHOL, V70, P1231, DOI 10.1037/0022-3514.70.6.1231; Hinton L., 1994, SOUND SYMBOLISM, P1; Hodges-Simeon CR, 2010, HUM NATURE-INT BIOS, V21, P406, DOI 10.1007/s12110-010-9101-5; Imai M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0298; Imai M, 2008, COGNITION, V109, P54, DOI 10.1016/j.cognition.2008.07.015; Jack RE, 2014, CURR BIOL, V24, P187, DOI 10.1016/j.cub.2013.11.064; Jacobs AM, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00186; Jakobson R., 1960, STYLE LANG, P350; Kanero J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097905; Kantartzis K, 2011, COGNITIVE SCI, V35, P575, DOI 10.1111/j.1551-6709.2010.01169.x; Klink R. R., 2000, MARKET LETT, V11, P5, DOI DOI 10.1023/A:1008184423824; Knutson B, 1996, J NONVERBAL BEHAV, V20, P165, DOI 10.1007/BF02281954; Kovic V, 2010, COGNITION, V114, P19, DOI 10.1016/j.cognition.2009.08.016; Kraxenberger M, 2014, RIV ITAL FILOS LINGU, V8, P10, DOI 10.4396/20140603; LINDAUER MS, 1990, B PSYCHONOMIC SOC, V28, P151; LINDAUER MS, 1991, METAPHOR SYMB ACT, V6, P183, DOI 10.1207/s15327868ms0603_3; Lockwood G, 2016, J EXP PSYCHOL LEARN, V42, P1274, DOI 10.1037/xlm0000235; Lockwood G, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01246; Marks L.E., 1996, METAPHOR SYMBOL, V11, P39, DOI [DOI 10.1207/S15327868MS1101_3, 10.1207/s15327868ms1101_3]; MARKS LE, 1974, AM J PSYCHOL, V87, P173, DOI 10.2307/1422011; Marks LE, 1978, UNITY SENSES INTERRE, VXI; Martino G, 2000, PERCEPTION, V29, P745, DOI 10.1068/p2984; Maurer D, 2006, DEVELOPMENTAL SCI, V9, P316, DOI 10.1111/j.1467-7687.2006.00495.x; Menninghaus W, 2014, PSYCHOL AESTHET CREA, V8, P71, DOI 10.1037/a0035309; Miall DS, 2001, POETICS, V29, P55, DOI 10.1016/S0304-422X(00)00025-5; MIRON MS, 1961, J ABNORM SOC PSYCH, V62, P623, DOI 10.1037/h0045212; Monaghan P, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0299; Mondloch CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073605; Newman SS, 1933, AM J PSYCHOL, V45, P53, DOI 10.2307/1414186; Nosek BA, 2005, PERS SOC PSYCHOL B, V31, P166, DOI 10.1177/0146167204271418; Nuckolls JB, 1999, ANNU REV ANTHROPOL, V28, P225, DOI 10.1146/annurev.anthro.28.1.225; Nygaard LC, 2009, COGNITION, V112, P181, DOI 10.1016/j.cognition.2009.04.001; Obermeier C, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00010; OHALA JJ, 1984, PHONETICA, V41, P1, DOI 10.1159/000261706; Ohala John J., 1994, SOUND SYMBOLISM, P325; Oyama T, 1963, PSYCHOLOGIA, V6, P131; Ozturk O, 2013, J EXP CHILD PSYCHOL, V114, P173, DOI 10.1016/j.jecp.2012.05.004; Parise CV, 2012, EXP BRAIN RES, V220, P319, DOI 10.1007/s00221-012-3140-6; Pena M, 2011, PSYCHOL SCI, V22, P1419, DOI 10.1177/0956797611421791; Perry LK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137147; PLUTCHIK R., 1994, PSYCHOL BIOL EMOTION; Puts DA, 2007, EVOL HUM BEHAV, V28, P340, DOI 10.1016/j.evolhumbehav.2007.05.002; Puts DA, 2006, EVOL HUM BEHAV, V27, P283, DOI 10.1016/j.evolhumbehav.2005.11.003; Ramachandran V, 2001, J CONSCIOUSNESS STUD, V8, P3; Reay IE, 1994, ENCY LANGUAGE LINGUI, V8, P4064; Revill KP, 2014, BRAIN LANG, V128, P18, DOI 10.1016/j.bandl.2013.11.002; Rubin DC, 2009, MEMORY, V17, P802, DOI 10.1080/09658210903130764; RUSSELL JA, 1977, J RES PERS, V11, P273, DOI 10.1016/0092-6566(77)90037-X; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Sapir E, 1929, J EXP PSYCHOL, V12, P225, DOI 10.1037/h0070931; SCHLOSBERG H, 1954, PSYCHOL REV, V61, P81, DOI 10.1037/h0054570; Schmidtke DS, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00080; Shrum LJ, 2012, INT J RES MARK, V29, P275, DOI 10.1016/j.ijresmar.2012.03.002; Shrum LJ, 2007, PSYCHOLINGUISTIC PHE, P39; Spence C, 2011, ATTEN PERCEPT PSYCHO, V73, P971, DOI 10.3758/s13414-010-0073-7; Sucevic J, 2015, BRAIN LANG, V145, P11, DOI [10.1016/j.bandl.2015.03.011, 10.1016/j.band1.2015.03.011]; Thayer R. E, 1990, BIOPSYCHOLOGY MOOD A; Tiedens LZ, 2001, J PERS SOC PSYCHOL, V80, P86, DOI 10.1037//0022-3514.80.1.86; Tracy JL, 2015, CURR OPIN BEHAV SCI, V3, P25, DOI 10.1016/j.cobeha.2015.01.001; Tsur R, 2006, J PRAGMATICS, V38, P905, DOI 10.1016/j.pragma.2005.12.002; Ultan R., 1978, UNIVERSALS HUMAN LAN, P525; Vannoni E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003113; von Hornbostel EM, 1931, PFLUG ARCH GES PHYS, V227, P517; WALKER P, 1984, PERCEPTION, V13, P75, DOI 10.1068/p130075; Wallbott HG, 1998, EUR J SOC PSYCHOL, V28, P879, DOI 10.1002/(SICI)1099-0992(1998110)28:6<879::AID-EJSP901>3.0.CO;2-W; WATSON D, 1985, PSYCHOL BULL, V98, P219, DOI 10.1037/0033-2909.98.2.219; Westbury C, 2005, BRAIN LANG, V93, P10, DOI 10.1016/j.bandl.2004.07.006; Whissell C, 1999, PERCEPT MOTOR SKILL, V89, P19, DOI 10.2466/PMS.89.5.19-48; Whissell C, 2000, PERCEPT MOTOR SKILL, V91, P617, DOI 10.2466/PMS.91.6.617-648; Wiseman M., 2003, ROMAN JAKOBSONS GEDI, P277; Wolff SE, 2010, BEHAV ECOL SOCIOBIOL, V64, P1673, DOI 10.1007/s00265-010-0981-5	96	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187196	10.1371/journal.pone.0187196	http://dx.doi.org/10.1371/journal.pone.0187196			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	FL4VN	29091943	Green Submitted, Green Published, gold			2022-12-26	WOS:000414229700045
J	Bertin, Y; Habouzit, C; Duniere, L; Laurier, M; Durand, A; Duchez, D; Segura, A; Thevenot-Sergentet, D; Baruzzi, F; Chaucheyras-Durand, F; Forano, E				Bertin, Yolande; Habouzit, Chloe; Duniere, Lysiane; Laurier, Marie; Durand, Alexandra; Duchez, David; Segura, Audrey; Thevenot-Sergentet, Delphine; Baruzzi, Federico; Chaucheyras-Durand, Frederique; Forano, Evelyne			Lactobacillus reuteri suppresses E-coli 0157: H7 in bovine ruminal fluid: Toward a pre-slaughter strategy to improve food safety?	PLOS ONE			English	Article							LACTIC-ACID; IN-VITRO; BEEF-CATTLE; GLYCEROL; O157H7; RUMEN; 3-HYDROXYPROPIONALDEHYDE; BACTERIA; SHEEP; DIGESTIBILITY	The bovine gastrointestinal tract (GIT) is the main reservoir for enterohaemorrhagic Escherichia coli (EHEC) responsible for food-borne infections. Therefore, it is crucial to develop strategies, such as EHEC suppression by antagonistic microorganisms, to reduce EHEC survival in the GIT of cattle and to limit shedding and food contamination. Most human derived Lactobacillus reuteri strains produce hydroxypropionaldehyde (HPA), an antimicrobial compound, during anaerobic reduction of glycerol. The capacity of L. reuteriLB1-7, a strain isolated from raw bovine milk, to produce HPA and its antimicrobial activity against an 0157:H7 EHEC strain (FCH6) were evaluated in bovine rumen fluid (RF) under strict anaerobiosis. EHEC was totally suppressed when incubated in RF inoculated with L. reuteri LB1-7 and supplemented with 80 mM glycerol (RF-Glyc80). The addition of LB1-7 or glycerol alone did not modify EHEC survival in RF. Glycerol was converted to HPA (up to 14 mM) by LB1-7 during incubation in RF-Glyc80, and HPA production appeared to be responsible for EHEC suppression. The bactericidal activity of L. reuteriLB1-7, the concentration of glycerol required and the level of HPA produced depended on physiological and ecological environments. In vitro experiments also showed that EHEC inoculated in rumen fluid and exposed to L. reuteri and glycerol had a very limited growth in rectal contents. However, L. reuteri exerted an antimicrobial activity against the rumen endogenous microbiota and perturbed feedstuff degradation in the presence of glycerol. The potential administration of L. reuteri and glycerol in view of application to finishing beef cattle at the time of slaughter is discussed. Further in vivo studies will be important to confirm the efficiency of L. reuteri and glycerol supplementation against EHEC shedding in ruminants.	[Bertin, Yolande; Habouzit, Chloe; Duniere, Lysiane; Laurier, Marie; Durand, Alexandra; Segura, Audrey; Chaucheyras-Durand, Frederique; Forano, Evelyne] Univ Clermont Auvergne, INRA, MEDIS, Clermont Ferrand, France; [Duniere, Lysiane; Chaucheyras-Durand, Frederique] Lallemand SAS, Blagnac, France; [Duchez, David] Univ Blaise Pascal, Polytech Clermont Ferrand, Inst Pascal Axe GePEB, Aubiere, France; [Thevenot-Sergentet, Delphine] VetAgro Sup, Res Grp Bacterial Opportunist Pathogens & Environ, UMR, Ecol Microbienne,CNRS,INRA, Villeurbanne, France; [Thevenot-Sergentet, Delphine] Univ Lyon 1, Villeurbanne, France; [Thevenot-Sergentet, Delphine] VetAgro Sup, Lab Etud Microorganismes Pathogenes, French Lab Shiga Toxin Producing Escherichia Coli, Campus Vet, Marcy Letoile, France; [Baruzzi, Federico] Natl Res Council Italy, Inst Sci Food Prod, Bari, Italy	INRAE; Universite Clermont Auvergne (UCA); Lallemand - France; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Consiglio Nazionale delle Ricerche (CNR); Istituto Scienze delle Produzioni Alimentari (ISPA-CNR)	Bertin, Y (corresponding author), Univ Clermont Auvergne, INRA, MEDIS, Clermont Ferrand, France.	yolande.bertin@inra.fr	Baruzzi, Federico/I-7276-2013; FORANO, Evelyne/C-9976-2009	FORANO, Evelyne/0000-0002-7450-3466; BARUZZI, FEDERICO/0000-0002-3586-2140	Fonds unique interministeriel [OSEO F1010011M]; European Regional Development Fund [33577]	Fonds unique interministeriel; European Regional Development Fund(European Commission)	This work was supported by Fonds unique interministeriel (OSEO F1010011M) (EF); http://competitivite.gouv.fr/le-lancement-du-10e-appel-a-projets-de-r-d-du-fu/les-resultats-du-10e-appal-a-projets-701.html; European Regional Development Fund (33577) (EF); http:///www.europe-en-auvergne.eu/programme-massif-central.html; Conseil Regional d'Auvergne (CPER T2ANSH) (EF); http://enseignementsup-recherche.gouv.fr/cid72550/le-contrat-de-projets-etat-region-auvergne-2007-2013.html; LALLEMAND SAS provided support in the form of salaries for authors FCD and LD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesogan AT, 2005, ANIM FEED SCI TECH, V119, P333, DOI 10.1016/i.anifeedsci.2004.09.012; Baruzzi F, 2011, APPL MICROBIOL BIOT, V90, P331, DOI 10.1007/s00253-011-3133-6; Bertin Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098367; Bertin Y, 2013, ENVIRON MICROBIOL, V15, P610, DOI 10.1111/1462-2920.12019; Biebl H, 1999, APPL MICROBIOL BIOT, V52, P289, DOI 10.1007/s002530051523; Bohle LA, 2010, APPL ENVIRON MICROB, V76, P7306, DOI 10.1128/AEM.01423-10; Brashears MM, 2017, MEAT SCI, V132, P59, DOI 10.1016/j.meatsci.2017.03.015; Brown CA, 1997, APPL ENVIRON MICROB, V63, P27, DOI 10.1128/AEM.63.1.27-32.1997; Caprioli A, 2005, VET RES, V36, P289, DOI 10.1051/vetres:2005002; Chancey CC, 2013, J FOOD PROTECT, V76, P1778, DOI 10.4315/0362-028X.JFP-12-566; Chaucheyras-Durand F, 2010, BENEF MICROBES, V1, P3, DOI 10.3920/BM2008.1002; Chaucheyras-Durand F, 2006, APPL ENVIRON MICROB, V72, P4136, DOI 10.1128/AEM.02600-05; Damiran D, 2008, ANIM FEED SCI TECH, V141, P15, DOI 10.1016/j.anifeedsci.2007.04.007; Danielsson R, 2014, J DAIRY SCI, V97, P5729, DOI 10.3168/jds.2014-7929; Donkin SS, 2009, J DAIRY SCI, V92, P5111, DOI 10.3168/jds.2009-2201; Eaton KA, 2011, INFECT IMMUN, V79, P185, DOI 10.1128/IAI.00880-10; Elramady MG, 2013, FOODBORNE PATHOG DIS, V10, P661, DOI 10.1089/fpd.2012.1420; Gaggia F, 2010, INT J FOOD MICROBIOL, V141, pS15, DOI 10.1016/j.ijfoodmicro.2010.02.031; GARTON GA, 1961, J GEN MICROBIOL, V25, P215, DOI 10.1099/00221287-25-2-215; Goering H.K., 1970, AGR HDB USDA; Gruber SL, 2010, J ANIM SCI, V88, P1148, DOI 10.2527/jas.2009-2183; Heilig HGHJ, 2002, APPL ENVIRON MICROB, V68, P114, DOI 10.1128/AEM.68.1.114-123.2002; HOBSON PN, 1961, J GEN MICROBIOL, V25, P227, DOI 10.1099/00221287-25-2-227; HOOVER WH, 1991, VET CLIN N AM-FOOD A, V7, P311, DOI 10.1016/S0749-0720(15)30801-X; Jami E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033306; Keen JE, 2010, APPL ENVIRON MICROB, V76, P5278, DOI 10.1128/AEM.00400-10; Law D, 2000, J APPL MICROBIOL, V88, P729, DOI 10.1046/j.1365-2672.2000.01031.x; Lomander H, 2012, J DAIRY SCI, V95, P2397, DOI 10.3168/jds.2011-4535; Luongo D, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-298; Luthi-Peng Q, 2002, APPL MICROBIOL BIOT, V60, P73, DOI 10.1007/s00253-002-1099-0; McSweeney S, 2012, 61 FAO; Mosoni P, 2007, J APPL MICROBIOL, V103, P2676, DOI 10.1111/j.1365-2672.2007.03517.x; Naylor SW, 2003, INFECT IMMUN, V71, P1505, DOI 10.1128/IAI.71.3.1505-1512.2003; Ogawa M, 2001, INT J FOOD MICROBIOL, V68, P135, DOI 10.1016/S0168-1605(01)00465-2; Pandey V, 2015, J INT SOC PREV COMMU, V5, P81, DOI 10.4103/2231-0762.155726; REMOND D, 1993, J ANIM SCI, V71, P2529, DOI 10.2527/1993.7192529x; Rivas L, 2010, APPL ENVIRON MICROB, V76, P7210, DOI 10.1128/AEM.01530-10; Schaefer L, 2010, MICROBIOL-SGM, V156, P1589, DOI 10.1099/mic.0.035642-0; Sperandio V, 2010, GUT MICROBES, V1, P432, DOI 10.4161/gmic.1.6.14177; Spinler JK, 2008, ANAEROBE, V14, P166, DOI 10.1016/j.anaerobe.2008.02.001; Stern MD, 1997, J ANIM SCI, V75, P2256; TALARICO TL, 1989, ANTIMICROB AGENTS CH, V33, P674, DOI 10.1128/AAC.33.5.674; Vaidyanathan H, AMB EXPRESS, P1; Vollenweider S, 2003, J AGR FOOD CHEM, V51, P3287, DOI 10.1021/jf021086d; Vollenweider S, 2010, J AGR FOOD CHEM, V58, P10315, DOI 10.1021/jf1010897; Walker C, 2010, FOODBORNE PATHOG DIS, V7, P249, DOI 10.1089/fpd.2009.0410; White BA, 2014, ANNU REV MICROBIOL, V68, P279, DOI 10.1146/annurev-micro-092412-155618; Wisener LV, 2015, ZOONOSES PUBLIC HLTH, V62, P75, DOI 10.1111/zph.12112	48	16	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187229	10.1371/journal.pone.0187229	http://dx.doi.org/10.1371/journal.pone.0187229			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091926	Green Published, Green Submitted, gold			2022-12-26	WOS:000414229700047
J	Johnson, KM; Taslim, C; Saund, RS; Lessnick, SL				Johnson, Kirsten M.; Taslim, Cenny; Saund, Ranajeet S.; Lessnick, Stephen L.			Identification of two types of GGAA-microsatellites and their roles in EWS/FLI binding and gene regulation in Ewing sarcoma	PLOS ONE			English	Article							DNA-BINDING; FUSION PROTEIN; TRANSCRIPTION FACTOR; MOLECULAR-DYNAMICS; ETS DOMAIN; MECHANISM; ELEMENTS; FAMILY; FLI-1; READ	Ewing sarcoma is a bone malignancy of children and young adults, frequently harboring the EWS/FLI chromosomal translocation. The resulting fusion protein is an aberrant transcription factor that uses highly repetitive GGAA-containing elements (microsatellites) to activate and repress thousands of target genes mediating oncogenesis. However, the mechanisms of EWS/FLI interaction with microsatellites and regulation of target gene expression is not clearly understood. Here, we profile genome-wide protein binding and gene expression. Using a combination of unbiased genome-wide computational and experimental analysis, we define GGAA-microsatellites in a Ewing sarcoma context. We identify two distinct classes of GGAA-microsatellites and demonstrate that EWS/FLI responsiveness is dependent on microsatellite length. At close range "promoter-like" microsatellites, EWS/FLI binding and subsequent target gene activation is highly dependent on number of GGAA-motifs. "Enhancer-like" microsatellites demonstrate length-dependent EWS/FLI binding, but minimal correlation for activated and none for repressed targets. Our data suggest EWS/FLI binds to "promoter-like" and "enhancer-like" microsatellites to mediate activation and repression of target genes through different regulatory mechanisms. Such characterization contributes valuable insight to EWS/FLI transcription factor biology and clarifies the role of GGAA-microsatellites on a global genomic scale. This may provide unique perspective on the role of non-coding DNA in cancer susceptibility and therapeutic development.	[Johnson, Kirsten M.; Lessnick, Stephen L.] Ohio State Univ, Coll Med, Med Scientist Training Program, Columbus, OH 43210 USA; [Johnson, Kirsten M.; Lessnick, Stephen L.] Ohio State Univ, Coll Med, Biomed Sci Grad Program, Columbus, OH 43210 USA; [Johnson, Kirsten M.; Taslim, Cenny; Saund, Ranajeet S.; Lessnick, Stephen L.] Nationwide Childrens Hosp, Res Inst, Ctr Childhood Canc & Blood Dis, Columbus, OH 43205 USA; [Lessnick, Stephen L.] Ohio State Univ, Coll Med, Div Pediat Hematol Oncol BMT, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Lessnick, SL (corresponding author), Ohio State Univ, Coll Med, Med Scientist Training Program, Columbus, OH 43210 USA.; Lessnick, SL (corresponding author), Ohio State Univ, Coll Med, Biomed Sci Grad Program, Columbus, OH 43210 USA.; Lessnick, SL (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Childhood Canc & Blood Dis, Columbus, OH 43205 USA.; Lessnick, SL (corresponding author), Ohio State Univ, Coll Med, Div Pediat Hematol Oncol BMT, Columbus, OH 43210 USA.	stephen.lessnick@nationwidechildrens.org		Johnson, Kirsten/0000-0003-2388-0621; SAUND, RANAJEET/0000-0001-5501-4387	National Cancer Institute [R01 CA140394, R01 CA183776, F30 CA21058]; High Performance Computing Facility at the Research Institute at Nationwide Children's Hospital; NATIONAL CANCER INSTITUTE [P30CA016058, R01CA183776, R01CA140394, F30CA210588] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); High Performance Computing Facility at the Research Institute at Nationwide Children's Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funds awarded to S.L.L. from the National Cancer Institute [Grant R01 CA140394 and R01 CA183776], and funds awarded to K.M.J. from the National Cancer Institute [Grant F30 CA21058. This research was supported in part by the High Performance Computing Facility at the Research Institute at Nationwide Children's Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Joanna Groden and Melody Davis for critical reading of the manuscript and members of the laboratory of S.L.L. for helpful discussions. This research was supported in part by the High Performance Computing Facility at the Research Institute at Nationwide Children's Hospital.	BAILLY RA, 1994, MOL CELL BIOL, V14, P3230, DOI 10.1128/MCB.14.5.3230; Boulay G, 2017, CELL, V171, P163, DOI 10.1016/j.cell.2017.07.036; BRAUN BS, 1995, MOL CELL BIOL, V15, P4623; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Gangwal K, 2008, CELL CYCLE, V7, P3127, DOI 10.4161/cc.7.20.6892; Gangwal K, 2008, P NATL ACAD SCI USA, V105, P10149, DOI 10.1073/pnas.0801073105; Gangwal Kunal, 2010, Genes Cancer, V1, P177; Gel B, 2016, BIOINFORMATICS, V32, P289, DOI 10.1093/bioinformatics/btv562; Guillon N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004932; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Hu-Lieskovan S, 2005, CANCER RES, V65, P4633, DOI 10.1158/0008-5472.CAN-04-2857; Johnson KM, 2017, P NATL ACAD SCI USA, V114, P9870, DOI 10.1073/pnas.1701872114; Kennedy AL, 2015, ONCOTARGET, V6, P30178, DOI 10.18632/oncotarget.4903; Kolde R., 2015, PHEATMAP PRETTY HEAT; Lamber EP, 2008, EMBO J, V27, P2006, DOI 10.1038/emboj.2008.117; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lessnick SL, 2002, CANCER CELL, V1, P393, DOI 10.1016/S1535-6108(02)00056-9; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LIANG H, 1994, NAT STRUCT BIOL, V1, P871, DOI 10.1038/nsb1294-871; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MAO XH, 1994, J BIOL CHEM, V269, P18216; Monument MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104378; Monument MJ, 2012, GENES-BASEL, V3, P444, DOI 10.3390/genes3030444; Morgan M, 2016, BIOCPARALLEL BIOCOND; Obika S, 2003, J MOL BIOL, V331, P345, DOI 10.1016/S0022-2836(03)00726-5; OHNO T, 1993, CANCER RES, V53, P5859; Pages H, 2016, R PACKAGE; Pages H., 2016, BIOSTRINGS STRING OB; Pott S, 2015, NAT GENET, V47, P8, DOI 10.1038/ng.3167; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; Riggi N, 2014, CANCER CELL, V26, P668, DOI 10.1016/j.ccell.2014.10.004; Sankar S, 2013, ONCOGENE, V32, P5089, DOI 10.1038/onc.2012.525; Sankar Savita, 2013, Genes Cancer, V4, P213, DOI 10.1177/1947601913489569; Sawaya S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054710; Slattery M, 2014, TRENDS BIOCHEM SCI, V39, P381, DOI 10.1016/j.tibs.2014.07.002; Sorensen PHB, 1996, SEMIN CANCER BIOL, V7, P3, DOI 10.1006/scbi.1996.0002; Szymczyna BR, 2000, J BIOL CHEM, V275, P28363, DOI 10.1074/jbc.M004294200; Tomazou EM, 2015, CELL REP, V10, P1082, DOI 10.1016/j.celrep.2015.01.042; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; ZHU LJ, 2010, BIOMED CENTRAL, V11, DOI DOI 10.1186/1471-2105-11-237	45	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0186275	10.1371/journal.pone.0186275	http://dx.doi.org/10.1371/journal.pone.0186275			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091716	Green Published, Green Submitted, gold			2022-12-26	WOS:000414229700014
J	Choi, M; Ghammraoui, B; Badano, A				Choi, Mina; Ghammraoui, Bahaa; Badano, Aldo			Small-angle X-ray scattering characteristics of mouse brain: Planar imaging measurements and tomographic imaging simulations	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; ALZHEIMERS-DISEASE; DIFFRACTION; MYELIN; DIFFUSION; TRANSPORT; TISSUES; MRI	Small-angle x-ray scattering (SAXS) imaging can differentiate tissue types based on their nanoscale molecular structure. However, characterization of the coherent scattering cross-section profile of relevant tissues is needed to optimally design SAXS imaging techniques for a variety of biomedical applications. Reported measured nervous tissue x-ray scattering cross sections under a synchrotron source have had limited agreement. We report a set of x-ray cross-section measurements obtained from planar SAXS imaging of 1 mm thick mouse brain (APP/PS1 wild-type) coronal slices using an 8 keV laboratory x-ray source. Two characteristic peaks were found at 0.96 and 1.60 nm(-1) attributed to myelin. The peak intensities varied by location in the slice. We found that regions of gray matter, white matter, and corpus callosum could be segmented by their increasing intensities of myelin peaks respectively. Measured small-angle x-ray scattering cross sections were then used to define brain tissue scattering properties in a GPU-accelerated Monte Carlo simulation of SAXS computed tomography (CT) using a higher monochromatic x-ray energy (20 keV) to study design trade-offs for noninvasive in vivo SAXS imaging on a small-animal head including radiation dose, signal-to-noise ratio (SNR), and the effect of skull presence on the previous two metrics. Simulation results show the estimated total dose to the mouse head for a single SAXS-CT slice was 149.4 mGy. The pixel SNR was approximately 30.8 for white matter material whether or not a skull was present. In this early-stage proof-of-principle work, we have demonstrated our brain cross-section data and simulation tools can be used to assess optimal instrument parameters for dedicated small-animal SAXS-CT prototypes.	[Choi, Mina; Badano, Aldo] Univ Maryland, Fischell Dept Bioengineering, College Pk, MD 20742 USA; [Choi, Mina; Ghammraoui, Bahaa; Badano, Aldo] CDRH USFDA, Div Imaging Diagnost & Software Reliabil, Off Sci & Engn Labs, Silver Spring, MD 20993 USA	University System of Maryland; University of Maryland College Park	Badano, A (corresponding author), Univ Maryland, Fischell Dept Bioengineering, College Pk, MD 20742 USA.; Badano, A (corresponding author), CDRH USFDA, Div Imaging Diagnost & Software Reliabil, Off Sci & Engn Labs, Silver Spring, MD 20993 USA.	aldo.badano@fda.hhs.gov	Badano, Aldo/G-7786-2012	Badano, Aldo/0000-0003-3712-6670; CHOI, MINA/0000-0002-1695-2271	University of Maryland	University of Maryland	M.C. acknowledges funding by the Fischell Fellowship in Biomedical Engineering at University of Maryland and was also supported by an appointment to the Research Participation Program at the Center for Devices and Radiological Health (CDRH) administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S.Department of Energy and the U.S. Food and Drug Administration (FDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Drs. Hey-Kyoung Lee at Johns Hopkins University and Christen Welle in DBP/OSEL/CDRH/FDA for supplying mouse brain tissue samples, Christopher Gorini for providing mouse skull samples, and Beom Koo for providing training on the vibratome. M.C. acknowledges funding by the Fischell Fellowship in Biomedical Engineering at University of Maryland and was also supported by an appointment to the Research Participation Program at the Center for Devices and Radiological Health (CDRH) administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and the U.S. Food and Drug Administration (FDA). The mention of commercial products herein is not to be construed as either an actual or implied endorsement of such products by the Department of Health and Human Services. This is a contribution of the US Food and Drug Administration and is not subject to copyright.	Badal A, 2009, MED PHYS, V36, P4878, DOI 10.1118/1.3231824; Bernhardt M, 2017, NEW J PHYS, V19, DOI 10.1088/1367-2630/19/1/013012; Blanton TN, 1995, POWDER DIFFR, V10, P91, DOI DOI 10.1017/S0885715600014421; Choi M, 2017, APPL PHYS LETT, V110, DOI 10.1063/1.4980133; Choi M, 2016, SPIE MED IMAGING; Choi M, 2016, PROC SPIE, V9788, DOI 10.1117/12.2217408; Choi M, 2016, J APPL CRYSTALLOGR, V49, P188, DOI 10.1107/S1600576715023924; Christ A, 2010, PHYS MED BIOL, V55, pN23, DOI 10.1088/0031-9155/55/2/N01; Dahal E, 2017, PHYS BIOL, V14, DOI 10.1088/1478-3975/aa776a; De Felici M, 2008, PHYS MED BIOL, V53, P5675, DOI 10.1088/0031-9155/53/20/007; Eichner T, 2011, MOL CELL, V43, P8, DOI 10.1016/j.molcel.2011.05.012; Ghammraoui B, 2017, PHYS MED BIOL, V62, P1192, DOI 10.1088/1361-6560/aa5187; Ghammraoui B, 2014, PHYS MED BIOL, V59, P3501, DOI 10.1088/0031-9155/59/13/3501; Gourrier A, 2007, J APPL CRYSTALLOGR, V40, pS78, DOI 10.1107/S0021889807006693; Guiner A., 1955, SMALL ANGLE SCATTERI; HARDING G, 1987, MED PHYS, V14, P515, DOI 10.1118/1.596063; Harding G., 2006, P SPIE; Hubbell JH, 1975, PHYS CHEM REF DATA, V4, P471; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; Jensen TH, 2011, NEUROIMAGE, V57, P124, DOI 10.1016/j.neuroimage.2011.04.013; Jensen TH, 2011, PHYS MED BIOL, V56, P1717, DOI 10.1088/0031-9155/56/6/012; Kleuker U, 1998, PHYS MED BIOL, V43, P2911, DOI 10.1088/0031-9155/43/10/017; Langkilde AE, 2009, FEBS LETT, V583, P2600, DOI 10.1016/j.febslet.2009.05.040; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Menzel H.-G., 2014, J ICRU, V14, P1, DOI [10.1093/jicru/ndx006, DOI 10.1093/JICRU/NDX006]; Paris O, 2008, BIOINTERPHASES, V3, pFB16, DOI 10.1116/1.2955443; Pauw BR, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/38/383201; Salvat F, 2006, NUCL EN AG WORKSH P; Schroer CG, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2196062; Silverman DHS, 2002, J NUCL MED, V43, P253; Siu KKW, 2005, NUCL INSTRUM METH A, V548, P140, DOI 10.1016/j.nima.2005.03.081; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Stapulionis R, 2008, J IMMUNOL, V180, P3946, DOI 10.4049/jimmunol.180.6.3946; Tartari A, 2002, PHYS MED BIOL, V47, P163, DOI 10.1088/0031-9155/47/1/312; Wilkinson SJ, 2007, PHYS MED BIOL, V52, P2409, DOI 10.1088/0031-9155/52/9/006; Yagi N, 2011, J PHYS CONF SER, V272, DOI 10.1088/1742-6596/272/1/012009; Zhang F, 2010, METALL MATER TRANS A, V41A, P1151, DOI 10.1007/s11661-009-9950-x	39	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186451	10.1371/journal.pone.0186451	http://dx.doi.org/10.1371/journal.pone.0186451			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088259	Green Published, Green Submitted, gold			2022-12-26	WOS:000414088900012
J	Rashedi, I; Talele, N; Wang, XH; Hinz, B; Radisic, M; Keating, A				Rashedi, Iran; Talele, Nilesh; Wang, Xing-Hua; Hinz, Boris; Radisic, Milica; Keating, Armand			Collagen scaffold enhances the regenerative properties of mesenchymal stromal cells	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; STEM-CELLS; MECHANICAL STIMULATION; HEART-FAILURE; DIFFERENTIATION; PHENOTYPE; CARDIOMYOCYTES; TISSUE; MSCS; METAANALYSIS	MSCs are widely applied to regenerate heart tissue in myocardial diseases but when grown in standard two-dimensional (2D) cultures exhibit limited potential for cardiac repair and develop fibrogenic features with increasing culture time. MSCs can undergo partial cardiomyogenic differentiation, which improves their cardiac repair capacity. When applied to collagen patches they may improve cardiac tissue regeneration but the mechanisms remain elusive. Here, we investigated the regenerative properties of MSCs grown in a collagen scaffold as a three-dimensional (3D) culture system, and performed functional analysis using an engineered heart tissue (EHT) model. We showed that the expression of cardiomyocyte-specific proteins by MSCs co-cultured with rat neonatal cardiomyocytes was increased in collagen patches versus conventional cultures. MSCs in 3D collagen patches were less fibrogenic, secreted more cardiotrophic factors, retained anti-apoptotic and immunomodulatory function, and responded less to TLR4 ligand lipopolysaccharide (LPS) stimulation. EHT analysis showed no effects by MSCs on cardiomyocyte function, whereas control dermal fibroblasts abrogated the beating of cardiac tissue constructs. We conclude that 3D collagen scaffold improves the cardioprotective effects of MSCs by enhancing the production of trophic factors and modifying their immune modulatory and fibrogenic phenotype. The improvement in myocardial function by MSCs after acquisition of a partial cardiac cell-like phenotype is not due to enhanced MSC contractility. A better understanding of the mechanisms of MSC-mediated tissue repair will help to further enhance the therapeutic potency of MSCs.	[Rashedi, Iran; Radisic, Milica; Keating, Armand] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Rashedi, Iran; Wang, Xing-Hua; Keating, Armand] Univ Hlth Network, Cell Therapy Program, Toronto, ON, Canada; [Talele, Nilesh; Hinz, Boris] Univ Toronto, Lab Tissue Repair & Regenerat, Matrix Dynam Grp, Fac Dent, Toronto, ON, Canada; [Wang, Xing-Hua; Keating, Armand] Univ Hlth Network, Krembil Res Inst, Arthrit Program, Toronto, ON, Canada; [Keating, Armand] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Rashedi, I (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.; Rashedi, I (corresponding author), Univ Hlth Network, Cell Therapy Program, Toronto, ON, Canada.	i.rashedi@utoronto.ca	Talele, Nilesh Prakash/GRE-5860-2022	Talele, Nilesh Prakash/0000-0003-2758-8599; Keating, Armand/0000-0002-7676-6059	University Health Network; Gloria and Seymour Epstein Chair in Cell Therapy and Transplantation	University Health Network; Gloria and Seymour Epstein Chair in Cell Therapy and Transplantation	This work was supported in part by the Cell Therapy Program at University Health Network and by the Gloria and Seymour Epstein Chair in Cell Therapy and Transplantation to AK.	Astudillo P, 2014, CURR MOL MED, V14, P209, DOI 10.2174/1566524014666140128105352; Balestrini JL, 2012, INTEGR BIOL-UK, V4, P410, DOI 10.1039/c2ib00149g; Bartosh TJ, 2010, P NATL ACAD SCI USA, V107, P13724, DOI 10.1073/pnas.1008117107; Bartunek J, 2013, J AM COLL CARDIOL, V61, P2329, DOI 10.1016/j.jacc.2013.02.071; Behfar A, 2010, J AM COLL CARDIOL, V56, P721, DOI 10.1016/j.jacc.2010.03.066; Bhana B, 2010, BIOTECHNOL BIOENG, V105, P1148, DOI 10.1002/bit.22647; Chachques JC, 2008, ANN THORAC SURG, V85, P901, DOI 10.1016/j.athoracsur.2007.10.052; Dayan V, 2011, BASIC RES CARDIOL, V106, P1299, DOI 10.1007/s00395-011-0221-9; Dengler J, 2011, BIOTECHNOL BIOENG, V108, P704, DOI 10.1002/bit.22987; Duggal S, 2009, TISSUE ENG PT A, V15, P1763, DOI 10.1089/ten.tea.2008.0306; Figeac F, 2014, STEM CELLS, V32, P216, DOI 10.1002/stem.1560; Fisher SA, 2015, CIRC RES, V116, P1361, DOI 10.1161/CIRCRESAHA.116.304386; Follin B., 2016, TISSUE ENG B; Frith JE, 2010, TISSUE ENG PART C-ME, V16, P735, DOI 10.1089/ten.TEC.2009.0432; Gaebel R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015652; Guan JJ, 2011, BIOMATERIALS, V32, P5568, DOI 10.1016/j.biomaterials.2011.04.038; Guo L, 2014, STEM CELLS DEV, V23, P978, DOI 10.1089/scd.2013.0338; Gyongyosi M, 2015, CIRC RES, V116, P1346, DOI 10.1161/CIRCRESAHA.116.304346; Hahn JY, 2008, J AM COLL CARDIOL, V51, P933, DOI 10.1016/j.jacc.2007.11.040; Jung JP, 2016, BIORESEARCH OPEN ACC, V5, P37, DOI 10.1089/biores.2015.0044; Kang K, J AM COLL CARDIOLOGY; Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015; Kim DH, 2009, J BIOSCI BIOENG, V108, P63, DOI 10.1016/j.jbiosc.2009.02.008; Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004; Koninckx R, 2009, CYTOTHERAPY, V11, P778, DOI 10.3109/14653240902988818; Li CX, 2017, NAT MATER, V16, P379, DOI [10.1038/nmat4780, 10.1038/NMAT4780]; Lin X, 2013, CELL TISSUE RES, V352, P523, DOI 10.1007/s00441-013-1576-z; Majd H, 2009, STEM CELLS, V27, P200, DOI 10.1634/stemcells.2008-0674; Maureira P, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-93; Modarressi A, 2010, J INVEST DERMATOL, V130, P2818, DOI 10.1038/jid.2010.224; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Nguyen LT, ENHANCED OSTEOGENIC; Okura H, 2010, TISSUE ENG PART C-ME, V16, P417, DOI [10.1089/ten.tec.2009.0362, 10.1089/ten.TEC.2009.0362]; Potapova IA, 2008, AM J PHYSIOL-HEART C, V295, pH2257, DOI 10.1152/ajpheart.00219.2008; Quevedo HC, 2009, P NATL ACAD SCI USA, V106, P14022, DOI 10.1073/pnas.0903201106; Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101; Rangappa S, 2003, J THORAC CARDIOV SUR, V126, P124, DOI 10.1016/S0022-5223(03)00074-6; Rashedi I, 2017, STEM CELLS, V35, P265, DOI 10.1002/stem.2485; Rose RA, 2008, STEM CELLS, V26, P2884, DOI 10.1634/stemcells.2008-0329; Serrao GW, 2012, TISSUE ENG PT A, V18, P1322, DOI [10.1089/ten.tea.2011.0278, 10.1089/ten.TEA.2011.0278]; Shafy A, 2013, EUR J CARDIO-THORAC, V43, P1211, DOI 10.1093/ejcts/ezs480; Shah N, 2014, CELL BIOCHEM FUNCT, V32, P309, DOI 10.1002/cbf.3027; Song H, 2010, P NATL ACAD SCI USA, V107, P3329, DOI 10.1073/pnas.0905729106; Talele NP, 2015, STEM CELL REP, V4, P1016, DOI 10.1016/j.stemcr.2015.05.004; Tang YL, 2004, REGUL PEPTIDES, V117, P3, DOI 10.1016/j.regpep.2003.09.005; Wang WJ, 2009, BIOMATERIALS, V30, P2705, DOI 10.1016/j.biomaterials.2009.01.030; Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088; Yannarelli G, 2014, STEM CELL REV REP, V10, P304, DOI 10.1007/s12015-013-9483-y; Yeh HY, 2012, BIOMATERIALS, V33, P8943, DOI 10.1016/j.biomaterials.2012.08.069; Ylostalo JH, 2012, STEM CELLS, V30, P2283, DOI 10.1002/stem.1191; Yoon J, 2005, ACTA CARDIOL, V60, P277, DOI 10.2143/AC.60.3.2005005; Young PP, 2015, TRANSFUSION, V55, P441, DOI 10.1111/trf.12826; Yuan T, 2011, J BIOMED MATER RES A, V98A, P332, DOI 10.1002/jbm.a.33121; Zhao XY, 2014, STEM CELLS, V32, P521, DOI 10.1002/stem.1543	54	38	40	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187348	10.1371/journal.pone.0187348	http://dx.doi.org/10.1371/journal.pone.0187348			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088264	gold, Green Published, Green Submitted			2022-12-26	WOS:000414088900070
J	Lin, GHY; Chai, V; Lee, V; Dodge, K; Truong, T; Wong, M; Johnson, LD; Linderoth, E; Pang, XL; Winston, J; Petrova, PS; Uger, RA; Viller, NN				Lin, Gloria H. Y.; Chai, Vien; Lee, Vivian; Dodge, Karen; Truong, Tran; Wong, Mark; Johnson, Lisa D.; Linderoth, Emma; Pang, Xinli; Winston, Jeff; Petrova, Penka S.; Uger, Robert A.; Viller, Natasja N.			TTI-621 (SIRP alpha Fc), a CD47-blocking cancer immunotherapeutic, triggers phagocytosis of lymphoma cells by multiple polarized macrophage subsets	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; HIGH-AFFINITY IGG; GAMMA-RI; LUNG-CANCER; RECEPTOR; ACTIVATION; SURVIVAL; BINDING; PROGRESSION; ANTIBODY	Tumor-associated macrophages (TAMs) are heterogeneous and can adopt a spectrum of activation states between pro-inflammatory and pro-tumorigenic in response to the microenvironment. We have previously shown that TTI-621, a soluble SIRP alpha Fc fusion protein that blocks the CD47 "do-not-eat" signal, promotes tumor cell phagocytosis by IFN-gamma-primed macrophages. To assess the impact of CD47 blockade on diverse types of macrophages that are found within the tumor microenvironment, six different polarized human macrophage subsets (M(-), M(IFN gamma), M(IFN-gamma+LPS), M(IL-4), M(HAGG+IL-1 beta), M(IL-10 + TGF beta)) with distinct cell surface markers and cytokine profiles were generated. Blockade of CD47 using TTI-621 significantly increased phagocytosis of lymphoma cells by all macrophage subsets, with M(IFN-gamma), M(IFN-gamma+LPS) and M(IL-10 + TGF beta) macrophages having the highest phagocytic response. TTI-621-mediated phagocytosis involves macrophage expression of both the low-and high-affinity Fc gamma receptors II (CD32) and I (CD64), respectively. Moreover, macrophages with lower phagocytic capabilities (M(-), M(IL-4), M(HAGG + IL-1 beta)) could readily be re-polarized into highly phagocytic macrophages using various cytokines or TLR agonists. In line with the in vitro study, we further demonstrate that TTI-621 can trigger phagocytosis of tumor cells by diverse subsets of isolated mouse TAMs ex vivo. These data suggest that TTI-621 may be efficacious in triggering the destruction of cancer cells by a diverse population of TAMs found in vivo and support possible combination approaches to augment the activity of CD47 blockade.	[Lin, Gloria H. Y.; Chai, Vien; Lee, Vivian; Dodge, Karen; Truong, Tran; Wong, Mark; Johnson, Lisa D.; Linderoth, Emma; Pang, Xinli; Winston, Jeff; Petrova, Penka S.; Uger, Robert A.; Viller, Natasja N.] Trillium Therapeut Inc, Mississauga, ON, Canada		Uger, RA (corresponding author), Trillium Therapeut Inc, Mississauga, ON, Canada.	bob@trilliumtherapeutics.com	Johnson, Lisa DS/E-4218-2013	Johnson, Lisa DS/0000-0002-2019-6560	Trillium Therapeutics Inc.	Trillium Therapeutics Inc.	The authors received no specific funding for this work. Trillium Therapeutics Inc. provided support in the form of salaries for GHYL, VC, VL, KD, TT, MW, LDJ, EL, XP, JW, PSP, RAU and NNV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Barclay AN, 2014, ANNU REV IMMUNOL, V32, P25, DOI 10.1146/annurev-immunol-032713-120142; Bevaart L, 2006, CANCER RES, V66, P1261, DOI 10.1158/0008-5472.CAN-05-2856; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; Chao MP, 2012, CURR OPIN IMMUNOL, V24, P225, DOI 10.1016/j.coi.2012.01.010; Chen JJW, 2005, J CLIN ONCOL, V23, P953, DOI 10.1200/JCO.2005.12.172; DOUGHERTY GJ, 1987, EUR J IMMUNOL, V17, P1453, DOI 10.1002/eji.1830171011; Erdman LK, 2009, J IMMUNOL, V183, P6452, DOI 10.4049/jimmunol.0901374; Farinha P, 2005, BLOOD, V106, P2169, DOI 10.1182/blood-2005-04-1565; Feng MY, 2015, P NATL ACAD SCI USA, V112, P2145, DOI 10.1073/pnas.1424907112; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Kim DW, 2008, BRIT J CANCER, V98, P1118, DOI 10.1038/sj.bjc.6604256; Koning N, 2010, J INNATE IMMUN, V2, P195, DOI 10.1159/000252803; KURLANDER RJ, 1983, J IMMUNOL, V131, P140; Leidi M, 2009, J IMMUNOL, V182, P4415, DOI 10.4049/jimmunol.0713732; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nagelkerke SQ, 2014, BLOOD, V124, P3709, DOI 10.1182/blood-2014-05-576835; Nagorsen D, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-62; Petrova PS, 2017, CLIN CANCER RES, V23, P1068, DOI 10.1158/1078-0432.CCR-16-1700; Pricop L, 2001, J IMMUNOL, V166, P531, DOI 10.4049/jimmunol.166.1.531; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Quatromoni JG, 2012, AM J TRANSL RES, V4, P376; Redlich S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-71; Ribes S, 2010, INFECT IMMUN, V78, P865, DOI 10.1128/IAI.01110-09; Ryder M, 2008, ENDOCR-RELAT CANCER, V15, P1069, DOI 10.1677/ERC-08-0036; Sato T, 2011, IMMUNOL RES, V51, P170, DOI 10.1007/s12026-011-8262-6; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Squadrito ML, 2011, MOL ASPECTS MED, V32, P123, DOI 10.1016/j.mam.2011.04.005; Staples KJ, 2012, J ALLERGY CLIN IMMUN, V130, P1404, DOI 10.1016/j.jaci.2012.07.023; van der Poel CE, 2011, J IMMUNOL, V186, P2699, DOI 10.4049/jimmunol.1003526; van der Poel CE, 2010, BLOOD, V116, P5327, DOI 10.1182/blood-2010-04-280214; Varin A, 2010, BLOOD, V115, P353, DOI 10.1182/blood-2009-08-236711; Zhang M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153550; Zizzo G, 2012, J IMMUNOL, V189, P3508, DOI 10.4049/jimmunol.1200662	35	35	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187262	10.1371/journal.pone.0187262	http://dx.doi.org/10.1371/journal.pone.0187262			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084248	Green Published, gold, Green Submitted			2022-12-26	WOS:000413910200044
J	Liu, HW; Zhang, L; Meng, AH; Zhang, JB; Xie, MM; Qin, YH; Faulk, DC; Zhang, BH; Yang, SS; Qiu, L				Liu, Huawei; Zhang, Lei; Meng, Aihua; Zhang, Junbiao; Xie, Miaomiao; Qin, Yaohong; Faulk, Dylan Chase; Zhang, Baohong; Yang, Shushen; Qiu, Li			Isolation and molecular identification of endophytic diazotrophs from seeds and stems of three cereal crops	PLOS ONE			English	Article							LENGTH-POLYMORPHISM ANALYSIS; SP-NOV; GENES; AMPLIFICATION; BACTERIUM; RHIZOBIA; SEQUENCE; STRAINS; RATES	Ten strains of endophytic diazotroph were isolated and identified from the plants collected from three different agricultural crop species, wheat, rice and maize, using the nitrogen-free selective isolation conditions. The nitrogen-fixing ability of endophytic diazotroph was verified by the nifH-PCR assay that showed positive nitrogen fixation ability. These identified strains were classified by 879F-RAPD and 16S rRNA sequence analysis. RAPD analyses revealed that the 10 strains were clustered into seven 879F-RAPD groups, suggesting a clonal origin. 16S rRNA sequencing analyses allowed the assignment of the 10 strains to known groups of nitrogen-fixing bacteria, including organisms from the genera Paenibacillus, Enterobacter, Klebsiella and Pantoea. These representative genus are not endophytic diazotrophs in the conventional sense. They may have obtained nitrogen fixation ability through lateral gene transfer, however, the evolutionary forces of lateral gene transfer are not well known. Molecular identification results from 16S rRNA analyses were also confirmed by morphological and biochemical data. The test strains SH6A and MZB showed positive effect on the growth of plants.	[Liu, Huawei; Meng, Aihua; Zhang, Junbiao; Xie, Miaomiao; Qin, Yaohong; Yang, Shushen] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Zhang, Lei; Qiu, Li] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China; [Faulk, Dylan Chase; Zhang, Baohong] East Carolina Univ, Dept Biol, Greenville, NC USA	Northwest A&F University - China; Northwest A&F University - China; University of North Carolina; East Carolina University	Yang, SS (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.; Qiu, L (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China.	yangshushen2002@163.com; qiuli525@nwsuaf.edu.cn			National Natural Science Foundation of China [31071870, 30700489]; International Cooperation and Exchanges Project of Shaanxi Province [2015KW-028]; Northwest AF University [2452015033]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation and Exchanges Project of Shaanxi Province; Northwest AF University	This work was partially supported by National Natural Science Foundation of China (31071870,30700489), International Cooperation and Exchanges Project of Shaanxi Province (2015KW-028), and Fundamental Research Funds of Northwest A&F University (2452015033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partially supported by National Natural Science Foundation of China (31071870,30700489), International Cooperation and Exchanges Project of Shaanxi Province (2015KW-028), and Fundamental Research Funds of Northwest A&F University (2452015033).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bakhoum N, 2015, MICROB ECOL, V69, P641, DOI 10.1007/s00248-014-0507-1; Baldani JI, 1997, SOIL BIOL BIOCHEM, V29, P911, DOI 10.1016/S0038-0717(96)00218-0; Balows A, 1992, HDB BIOL BACTERIA EC; Bellagamba F, 2001, J AGR FOOD CHEM, V49, P3775, DOI 10.1021/jf0010329; Bezdicek DF, 1988, MICROORGANISMS ACTIO; BROSIUS J, 1978, P NATL ACAD SCI USA, V75, P4801, DOI 10.1073/pnas.75.10.4801; Chanway CP, 2014, ADVANCES IN BIOLOGY AND ECOLOGY OF NITROGEN FIXATION, P3, DOI 10.5772/57532; Cleenwerck I, 2002, INT J SYST EVOL MICR, V52, P1551, DOI 10.1099/00207713-52-5-1551; Davidson E., 2007, REACTIVE NITROGEN EN; Diouf D, 2010, J APPL MICROBIOL, V108, P818, DOI 10.1111/j.1365-2672.2009.04500.x; James EK, 1998, CRIT REV PLANT SCI, V17, P77, DOI 10.1016/S0735-2689(98)00357-8; Janarthine SRS, 2011, AFR J MICROBIOL RES, V5, P4455, DOI 10.5897/AJMR10.188; JOSEY DP, 1979, J APPL BACTERIOL, V46, P343, DOI 10.1111/j.1365-2672.1979.tb00830.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; LAGUERRE G, 1994, APPL ENVIRON MICROB, V60, P56, DOI 10.1128/AEM.60.1.56-63.1994; Oldroyd GED, 2013, NAT REV MICROBIOL, V11, P252, DOI 10.1038/nrmicro2990; Patil BS, 2015, CATAL TODAY, V256, P49, DOI 10.1016/j.cattod.2015.05.005; Peng GX, 2009, INT J SYST EVOL MICR, V59, P1650, DOI 10.1099/ijs.0.65484-0; Rivas R, 2006, PLANT SOIL, V287, P23, DOI 10.1007/s11104-006-9062-y; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Valverde A, 2006, INT J SYST EVOL MICR, V56, P2631, DOI 10.1099/ijs.0.64402-0; VANROSSUM D, 1995, APPL ENVIRON MICROB, V61, P1599, DOI 10.1128/AEM.61.4.1599-1609.1995; VINCENT J. M., 1970, A Manual for the Practical Study of the Root- Bacteria.; Vos M, 2015, TRENDS MICROBIOL, V23, P598, DOI 10.1016/j.tim.2015.07.006; Wang GCY, 1997, APPL ENVIRON MICROB, V63, P4645, DOI 10.1128/AEM.63.12.4645-4650.1997; ZEHR JP, 1989, APPL ENVIRON MICROB, V55, P2522, DOI 10.1128/AEM.55.10.2522-2526.1989	30	14	15	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187383	10.1371/journal.pone.0187383	http://dx.doi.org/10.1371/journal.pone.0187383			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084254	Green Published, Green Submitted, gold			2022-12-26	WOS:000413910200055
J	Miura, N; Omodaka, K; Kimura, K; Matsumoto, A; Kikawa, T; Takahashi, S; Takada, N; Takahashi, H; Maruyama, K; Akiba, M; Yuasa, T; Nakazawa, T				Miura, Naoki; Omodaka, Kazuko; Kimura, Koudai; Matsumoto, Akiko; Kikawa, Tsutomu; Takahashi, Seri; Takada, Naoko; Takahashi, Hidetoshi; Maruyama, Kazuichi; Akiba, Masahiro; Yuasa, Tetsuya; Nakazawa, Toru			Evaluation of retinal nerve fiber layer defect using wide-field en-face swept-source OCT images by applying the inner limiting membrane flattening	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; FREE FUNDUS PHOTOGRAPHY; NORMAL-TENSION GLAUCOMA; OPEN-ANGLE GLAUCOMA; PROGRESSION; THICKNESS; DAMAGE; WORLDWIDE; PEOPLE; NUMBER	Purpose The assessment of retinal nerve fiber layer defects (RNFLDs) is a useful part of glaucoma care. Here, we obtained en-face images of retinal layers below the inner limiting membrane (ILM) with swept source-optical coherence tomography (SS-OCT), and measured RNFLD angle with new software. Methods This study included 105 eyes of 105 normal tension glaucoma (NTG) patients (age, 59.8 +/- 13.2). Exclusion criteria were best-corrected visual acuity < 0.5, axial length > 28 mm, nonglaucoma ocular disease, and systemic disease affecting the visual field. We obtained 12 x 9 mm 3D volume scans centered on the macula with SS-OCT (DRI OCT-1, Topcon), and from these scans, created 3 averaged en-face images, each comprising 7 horizontal enface images (total thickness: 18.2 mu m). We labeled these averaged images, according to their depth below the ILM, as en-face images 1 (shallowest), 2 (middle) and 3 (deepest). In each image, a circle was drawn centered on the disc, with a radius of half the distance between the centers of the disc and macula. The investigator marked points where the edge of the RNFLD intersected this circle, and RNFLD angle (RNFLDA) was calculated with new software. Finally, we analyzed the association between RNFLDA, cpRNFLT, weighted RGC count (wrgc) and Humphrey field analyzer (HFA)-measured mean deviation (MD) and hemifield total deviation (TD), both overall and in each hemifield. Results En-face image 2 had the highest interclass reproducibility for measuring RNFLDA (intrarater intraclass correlation coefficient (ICC): 0.988, inter-rater ICC: 0.962). The correlation coefficients with RNFLDA were: HFA MD, -0.60; superior TD, -0.73; inferior TD, -0.69; overall cpRNFLT, -0.27; superior hemifield cpRNFLT, -0.39; and inferior hemifield cpRNFLT, -0.53 (all p< 0.001). Conclusions RNFLDA measured in SS-OCT images had high reproducibility and was correlated to glaucoma severity. Our new method may be a valuable future part of glaucoma care.	[Miura, Naoki; Omodaka, Kazuko; Takahashi, Seri; Takada, Naoko; Takahashi, Hidetoshi; Maruyama, Kazuichi; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi, Japan; [Kimura, Koudai; Yuasa, Tetsuya] Yamagata Univ, Grad Sch Sci & Engn, Yamagata, Japan; [Matsumoto, Akiko; Kikawa, Tsutomu; Akiba, Masahiro] Topcon Corp, Tokyo, Japan; [Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Retinal Dis Control, Ophthalmol, Sendai, Miyagi, Japan; [Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Adv Ophthalm Med, Sendai, Miyagi, Japan	Tohoku University; Yamagata University; Topcon Corporation; Tohoku University; Tohoku University	Nakazawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi, Japan.; Nakazawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Retinal Dis Control, Ophthalmol, Sendai, Miyagi, Japan.; Nakazawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Adv Ophthalm Med, Sendai, Miyagi, Japan.	ntoru@oph.med.tohoku.ac.jp	Maruyama, Kazuichi/GRX-8129-2022	Maruyama, Kazuichi/0000-0001-6283-5466	joint research fund of Topcon Corporation; JST grants from JSPS KAKENHI [26293372, 26670751]; JST Center for Revitalization Promotion	joint research fund of Topcon Corporation; JST grants from JSPS KAKENHI; JST Center for Revitalization Promotion	Tsutomu Kikawa, Akiko Matsumoto, and Masahiro Akiba are employed by Topcon Corporation, a commercial entity. This paper was supported in part by joint research fund of Topcon Corporation, JST grants from JSPS KAKENHI Grants-in-Aid for Scientific Research (B) (T.N. 26293372), and for Exploratory Research (T.N. 26670751), and by the JST Center for Revitalization Promotion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR., 1999, AUTOMATED STATIC PER; Badala F, 2007, AM J OPHTHALMOL, V144, P724, DOI 10.1016/j.ajo.2007.07.010; Budenz DL, 2007, OPHTHALMOLOGY, V114, P1046, DOI 10.1016/j.ophtha.2006.08.046; Harwerth RS, 2010, PROG RETIN EYE RES, V29, P249, DOI 10.1016/j.preteyeres.2010.02.001; Hood DC, 2015, INVEST OPHTH VIS SCI, V56, P6208, DOI 10.1167/iovs.15-17259; Hood DC, 2014, INVEST OPHTH VIS SCI, V55, P632, DOI 10.1167/iovs.13-13130; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Hwang JM, 2006, J GLAUCOMA, V15, P223, DOI 10.1097/01.ijg.0000212218.96932.f7; Hwang YH, 2014, CURR EYE RES, V39, P1099, DOI 10.3109/02713683.2014.900805; Jeong JH, 2014, ACTA OPHTHALMOL, V92, pE185, DOI 10.1111/aos.12277; Leung CKS, 2012, OPHTHALMOLOGY, V119, P1858, DOI 10.1016/j.ophtha.2012.03.044; Mardin CY, 2001, CURR OPIN OPHTHALMOL, V12, P100, DOI 10.1097/00055735-200104000-00004; Medeiros FA, 2012, AM J OPHTHALMOL, V154, P814, DOI 10.1016/j.ajo.2012.04.022; Medeiros FA, 2012, INVEST OPHTH VIS SCI, V53, P6939, DOI 10.1167/iovs.12-10345; Naithani P, 2007, INVEST OPHTH VIS SCI, V48, P3138, DOI 10.1167/iovs.06-1407; Nitta K, 2011, J GLAUCOMA, V20, P189, DOI 10.1097/IJG.0b013e3181e0799c; Omodaka K, 2015, CURR EYE RES, V40, P744, DOI 10.3109/02713683.2014.956371; Omodaka K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122347; Park HY Lopilly, 2013, AM J OPHTHALMOL; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; QUIGLEY HA, 1992, OPHTHALMOLOGY, V99, P19; Resnikoff S, 2002, B WORLD HEALTH ORGAN, V82, P844; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P77, DOI 10.1001/archopht.1991.01080010079037; Suzuki Y, 2006, OPHTHALMOLOGY, V113, P1613, DOI 10.1016/j.ophtha.2006.03.059; TUULONEN A, 1993, OPHTHALMOLOGY, V100, P587; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0	27	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0185573	10.1371/journal.pone.0185573	http://dx.doi.org/10.1371/journal.pone.0185573			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077716	gold, Green Submitted, Green Published			2022-12-26	WOS:000413861200006
J	Huang, JB; Zhou, YB; Wan, B; Wang, QS; Wan, XC				Huang, Jinbao; Zhou, Yibin; Wan, Bei; Wang, Qiushi; Wan, Xiaochun			Green tea polyphenols alter lipid metabolism in the livers of broiler chickens through increased phosphorylation of AMP-activated protein kinase	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN-1C; HEPATIC STELLATE CELLS; RECEPTOR-ALPHA; ENERGY-METABOLISM; GENE-EXPRESSION; ADIPOSE-TISSUE; X-RECEPTOR; BLACK TEA; MICE; RATS	Our previous results showed that green tea polyphenols (GTPs) significantly altered the expression of lipid-metabolizing genes in the liver of chickens. However, the underlying mechanism was not elucidated. In this study, we further characterized how GTPs influence AMP-activated protein kinase (AMPK) in the regulation of hepatic fat metabolism. Thirty-six male chickens were fed GTPs at a daily dose of 0, 80 or 160 mg/kg of body weight for 4 weeks. The results demonstrated that oral administration of GTPs significantly reduced hepatic lipid content and abdominal fat mass, enhanced the phosphorylation levels of AMPK alpha and ACACA, and altered the mRNA levels and enzymatic activities of lipid-metabolizing enzymes in the liver. These results suggested that the activation of AMPK is a potential mechanism by which GTPs regulate hepatic lipid metabolism in such a way that lipid synthesis is reduced and fat oxidation is stimulated.	[Huang, Jinbao; Zhou, Yibin; Wan, Bei; Wang, Qiushi; Wan, Xiaochun] Anhui Agr Univ, Sch Tea & Food Sci & Technol, State Key Lab Tea Plant Biol & Utilizat, Hefei, Anhui, Peoples R China; [Huang, Jinbao; Wan, Xiaochun] Anhui Agr Univ, Int Joint Res Lab Tea Chem & Hlth Effects, Hefei, Anhui, Peoples R China	Anhui Agricultural University; Anhui Agricultural University	Wan, XC (corresponding author), Anhui Agr Univ, Sch Tea & Food Sci & Technol, State Key Lab Tea Plant Biol & Utilizat, Hefei, Anhui, Peoples R China.; Wan, XC (corresponding author), Anhui Agr Univ, Int Joint Res Lab Tea Chem & Hlth Effects, Hefei, Anhui, Peoples R China.	xcwan@ahau.edu.cn	Huang, Jinbao/N-3391-2018	Huang, Jinbao/0000-0003-2272-933X	Anhui Major Demonstration Project for Leading Talent Team on Tea Chemistry and Health; Natural Science Foundation of Anhui province, China [1608085MC54]; Natural Science Foundation of the Anhui Higher Education Institutions of China [KJ2015A060]; Youth Science Foundation of Anhui Agricultural University [2014zr009]; Talent Foundation of Anhui Agricultural University [yj2015-19]	Anhui Major Demonstration Project for Leading Talent Team on Tea Chemistry and Health; Natural Science Foundation of Anhui province, China(Natural Science Foundation of Anhui Province); Natural Science Foundation of the Anhui Higher Education Institutions of China; Youth Science Foundation of Anhui Agricultural University; Talent Foundation of Anhui Agricultural University	This work was supported, in whole or in part, by Anhui Major Demonstration Project for Leading Talent Team on Tea Chemistry and Health (www.ahedu.gov.cn); the Natural Science Foundation of Anhui province, China (Grant No. 1608085MC54, www.ahkjt.gov.cn); the Natural Science Foundation of the Anhui Higher Education Institutions of China (Key project, Grant No. KJ2015A060, www.ahedu.gov.cn), Youth Science Foundation of Anhui Agricultural University (Grant No. 2014zr009, www.ahau.edu.cn), Talent Foundation of Anhui Agricultural University (Grant No. yj2015-19, www.ahau.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameen C, 2004, AM J PHYSIOL-ENDOC M, V287, pE1039, DOI 10.1152/ajpendo.00059.2004; Banerjee S, 2012, NUTR RES, V32, P985, DOI 10.1016/j.nutres.2012.10.005; Barger PM, 2000, TRENDS CARDIOVAS MED, V10, P238, DOI 10.1016/S1050-1738(00)00077-3; Bergen WG, 2005, J NUTR, V135, P2499, DOI 10.1093/jn/135.11.2499; Braissant O, 1998, ENDOCRINOLOGY, V139, P2748, DOI 10.1210/en.139.6.2748; Chen N, 2009, NUTR RES, V29, P784, DOI 10.1016/j.nutres.2009.10.003; Diot C, 1999, POULTRY SCI, V78, P1198, DOI 10.1093/ps/78.8.1198; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Gondret F, 2001, J LIPID RES, V42, P106; Hardie DG, 2011, BIOCHEM SOC T, V39, P1, DOI 10.1042/BST0390001; Higuchi N, 2008, HEPATOL RES, V38, P1122, DOI 10.1111/j.1872-034X.2008.00382.x; Huang HC, 2012, FOOD FUNCT, V3, P170, DOI 10.1039/c1fo10157a; Huang J, 2014, EUR J CLIN NUTR, V68, P1075, DOI 10.1038/ejcn.2014.143; Huang JB, 2013, J AGR FOOD CHEM, V61, P8565, DOI 10.1021/jf402004x; Kandhro A, 2008, FOOD CHEM, V109, P207, DOI 10.1016/j.foodchem.2007.12.029; Kim SB, 2000, NUTR CANCER, V37, P41, DOI 10.1207/S15327914NC3701_5; Klaus S, 2005, INT J OBESITY, V29, P615, DOI 10.1038/sj.ijo.0802926; Kohjima M, 2008, INT J MOL MED, V21, P507; Lee MS, 2009, ANN NUTR METAB, V54, P151, DOI 10.1159/000214834; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Murase T, 2009, BIOCHEM PHARMACOL, V78, P78, DOI 10.1016/j.bcp.2009.03.021; Ni Q, 2014, BIOCHEM BIOPH RES CO, V446, P574, DOI 10.1016/j.bbrc.2014.03.001; Nogalska A, 2005, METABOLISM, V54, P1041, DOI 10.1016/j.metabol.2005.03.007; Pawlak M, 2015, J HEPATOL, V62, P720, DOI 10.1016/j.jhep.2014.10.039; Pollak M, 2014, NAT MED, V20, P591, DOI 10.1038/nm.3596; Sa C, 2015, EVID-BASED COMPL ALT, V2015, DOI DOI 10.1155/2015/647832; Sae-Tan S, 2011, PHARMACOL RES, V64, P146, DOI 10.1016/j.phrs.2010.12.013; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shrestha S, 2009, J NUTR, V139, P640, DOI 10.3945/jn.108.103341; Suganuma M, 1998, CARCINOGENESIS, V19, P1771, DOI 10.1093/carcin/19.10.1771; Yan KF, 2012, MOL MED, V18, P10, DOI 10.2119/molmed.2011.00243; Yang CS, 2013, ANNU REV NUTR, V33, P161, DOI 10.1146/annurev-nutr-071811-150717; Zhai XG, 2013, BRIT J PHARMACOL, V169, P197, DOI 10.1111/bph.12114; Zhang C, 2012, TOXICOL LETT, V212, P229, DOI 10.1016/j.toxlet.2012.06.002	35	15	18	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187061	10.1371/journal.pone.0187061	http://dx.doi.org/10.1371/journal.pone.0187061			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073281	Green Published, gold, Green Submitted			2022-12-26	WOS:000413845400105
J	Peng, F; Wang, JH; Fan, WJ; Meng, YT; Li, MM; Li, TT; Cui, B; Wang, HF; Zhao, Y; An, F; Guo, T; Liu, XF; Zhang, L; Lv, L; Lv, DK; Xu, LZ; Xie, JJ; Lin, WX; Lam, EWF; Xu, J; Liu, Q				Peng, F.; Wang, J-H; Fan, W-J; Meng, Y-T; Li, M-M; Li, T-T; Cui, B.; Wang, H-F; Zhao, Y.; An, F.; Guo, T.; Liu, X-F; Zhang, L.; Lv, L.; Lv, D-K; Xu, L-Z; Xie, J-J; Lin, W-X; Lam, E. W-F; Xu, J.; Liu, Q.			Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia	ONCOGENE			English	Article							PYRUVATE-DEHYDROGENASE KINASE; OXIDATIVE-PHOSPHORYLATION; LUNG-CANCER; DICHLOROACETATE; LONG; GLIOBLASTOMA; METABOLISM; ACTIVATION; PROGRESSION; GENERATION	Glycolysis is critical for cancer stem cell reprogramming; however, the underlying regulatory mechanisms remain elusive. Here, we show that pyruvate dehydrogenase kinase 1 (PDK1) is enriched in breast cancer stem cells (BCSCs), whereas depletion of PDK1 remarkably diminishes ALDH(+) subpopulations, decreases stemness-related transcriptional factor expression, and inhibits sphere-formation ability and tumor growth. Conversely, high levels of PDK1 enhance BCSC properties and are correlated with poor overall survival. In mouse xenograft tumor, PDK1 is accumulated in hypoxic regions and activates glycolysis to promote stem-like traits. Moreover, through screening hypoxia-related long non-coding RNAs (lncRNAs) in PDK1-positive tissue, we find that lncRNA H19 is responsible for glycolysis and BCSC maintenance. Furthermore, H19 knockdown decreases PDK1 expression in hypoxia, and ablation of PDK1 counteracts H19-mediated glycolysis and self-renewal ability in vitro and in vivo. Accordingly, H19 and PDK1 expression exhibits strong correlations in primary breast carcinomas. H19 acting as a competitive endogenous RNA sequesters miRNA let-7 to release Hypoxia-inducible factor 1 alpha, leading to an increase in PDK1 expression. Lastly, aspirin markedly attenuates glycolysis and cancer stem-like characteristics by suppressing both H19 and PDK1. Thus, these novel findings demonstrate that the glycolysis gatekeeper PDK1 has a critical role in BCSC reprogramming and provides a potential therapeutic strategy for breast malignancy.	[Peng, F.; Fan, W-J; Meng, Y-T; Li, M-M; Li, T-T; Cui, B.; Wang, H-F; An, F.; Liu, X-F; Zhang, L.; Lv, D-K; Xu, L-Z; Xie, J-J; Xu, J.; Liu, Q.] Dalian Med Univ, Inst Canc Stem Cell, Dalian, Peoples R China; [Peng, F.; Fan, W-J; Meng, Y-T; Li, M-M; Liu, Q.] Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Wang, J-H; Zhao, Y.] Dalian Med Univ, Affiliated Hosp 1, Dept Oncol, Dalian, Peoples R China; [Guo, T.] Dalian Med Univ, Affiliated Hosp 1, Dept Thorac Surg, Dalian, Peoples R China; [Lv, L.] Dalian Med Univ, Affiliated Hosp 2, Dept Pathol, Dalian, Peoples R China; [Xu, L-Z] Dalian Med Univ, Affiliated Hosp 2, Internal Med Dept Oncol, Dalian, Peoples R China; [Lin, W-X] Dalian Maternal & Child Care Serv Ctr, Dalian, Liaoning, Peoples R China; [Lin, W-X] Imperial Coll London, Dept Surg & Canc, London, England	Dalian Medical University; State Key Lab Oncology South China; Sun Yat Sen University; Dalian Medical University; Dalian Medical University; Dalian Medical University; Dalian Medical University; Imperial College London	Xu, J; Liu, Q (corresponding author), Dalian Med Univ, Inst Canc Stem Cell, Western Sect 9, Lvshun South St, Dalian 116044, Liaoning, Peoples R China.	xujie@dmu.edu.cn; liuq9@mail.sysu.edu.cn	Fan, Wenjun/GLV-2107-2022; Lam, Eric W-F/AAW-8566-2020	Fan, Wenjun/0000-0002-5432-4524; Lam, Eric W-F/0000-0003-1274-3576; Peng, Fei/0000-0003-0772-0273	Innovative Research Team in University of Ministry of Education of China [IRT13049]; National Natural Science Foundation of China [81630005, 81573025, 81201686, 81602588, 81502579, 81602585]; Liaoning high-level talent innovation program [NSF2014029102, NSF 2015020264, 201601231]; Dalian high-level talent innovation program [2016RD12]; CRUK [A12011]; Breast Cancer Now [PR070, PhD016]; MRC [MR/N012097/1] Funding Source: UKRI; Cancer Research UK [12011] Funding Source: researchfish; Medical Research Council [MR/N012097/1] Funding Source: researchfish	Innovative Research Team in University of Ministry of Education of China(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Liaoning high-level talent innovation program; Dalian high-level talent innovation program; CRUK(Cancer Research UK); Breast Cancer Now; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Quentin Liu's lab members for their critical commends and technical support. This work is supported by Innovative Research Team in University of Ministry of Education of China (No. IRT13049), National Natural Science Foundation of China (No. 81630005 and No. 81573025 to QL, No. 81201686 to JX, No. 81602588 to L-ZX, No. 81502579 to Z-JH, No. 81602585 to F-MZ), the Liaoning (NSF2014029102 to QL, NSF 2015020264 to JX, 201601231 to L-ZX), Dalian high-level talent innovation program (2016RD12 to QL). Eric W-F Lam's work is supported by CRUK (A12011) and Breast Cancer Now (2012 May PR070; 2012 Nov PhD016).	Amabile G, 2009, TRENDS MOL MED, V15, P59, DOI 10.1016/j.molmed.2008.12.003; Bhat-Nakshatri P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-411; Chae YC, 2016, CANCER CELL, V30, P257, DOI 10.1016/j.ccell.2016.07.004; Chang YN, 2016, GENE, V575, P1, DOI 10.1016/j.gene.2015.08.049; Chen CL, 2016, CELL METAB, V23, P206, DOI 10.1016/j.cmet.2015.12.004; Choudhry H, 2015, ONCOGENE, V34, P4482, DOI 10.1038/onc.2014.378; Choudhry H, 2016, MOL ASPECTS MED, V47-48, P35, DOI 10.1016/j.mam.2016.01.003; Cuesta E, 2005, EUR J PHARMACOL, V517, P158, DOI 10.1016/j.ejphar.2005.05.024; Denise C, 2015, ONCOTARGET, V6, P41706, DOI 10.18632/oncotarget.5991; Deshmukh A, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0555-x; Dong CF, 2013, CANCER CELL, V23, P316, DOI 10.1016/j.ccr.2013.01.022; Dupuy F, 2015, CELL METAB, V22, P577, DOI 10.1016/j.cmet.2015.08.007; Feng WG, 2014, STEM CELLS, V32, P1734, DOI 10.1002/stem.1662; Feuerecker B, 2015, AM J CANCER RES, V5, P812; Fiorillo M, 2016, ONCOTARGET, V7, P34084, DOI 10.18632/oncotarget.9122; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105; Goswami CP, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-970; Guo H, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0892-5; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ho N, 2015, EXP CELL RES, V331, P73, DOI 10.1016/j.yexcr.2014.12.006; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Janiszewska M, 2012, GENE DEV, V26, P1926, DOI 10.1101/gad.188292.112; Jeoung NH, 2015, DIABETES METAB J, V39, P188, DOI 10.4093/dmj.2015.39.3.188; Jiang ZF, 2017, BIOCHEM BIOPH RES CO, V483, P32, DOI 10.1016/j.bbrc.2017.01.015; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Korkaya H, 2007, BIODRUGS, V21, P299, DOI 10.2165/00063030-200721050-00002; Kornfeld JW, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00057; Lagadinou ED, 2013, CELL STEM CELL, V12, P329, DOI 10.1016/j.stem.2012.12.013; Li ZK, 2014, CANCER SCI, V105, P951, DOI 10.1111/cas.12461; Lin AF, 2016, NAT CELL BIOL, V18, P213, DOI 10.1038/ncb3295; Liu PP, 2014, CELL DEATH DIFFER, V21, P124, DOI 10.1038/cdd.2013.131; Ma X. Y., 2014, NAT COMMUN, V5; Michelakis ED, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000677; Paldino E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/859871; Palorini R, 2014, J CELL BIOCHEM, V115, P368, DOI 10.1002/jcb.24671; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Prigione A, 2014, STEM CELLS, V32, P364, DOI 10.1002/stem.1552; Qin LJ, 2016, ONCOTARGET, V7, P1395, DOI 10.18632/oncotarget.6366; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Roche TE, 2001, PROG NUCLEIC ACID RE, V70, P33, DOI 10.1016/S0079-6603(01)70013-X; Ruggieri V, 2015, ONCOTARGET, V6, P1217, DOI 10.18632/oncotarget.2721; Rupaimoole R, 2015, CELL REP, V13, P2395, DOI 10.1016/j.celrep.2015.11.047; Saha S, 2016, CANCER RES, V76, P2000, DOI 10.1158/0008-5472.CAN-15-1360; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sancho P, 2016, BRIT J CANCER, V114, P1305, DOI 10.1038/bjc.2016.152; Sancho P, 2015, CELL METAB, V22, P590, DOI 10.1016/j.cmet.2015.08.015; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Shen YA, 2015, CELL CYCLE, V14, P86, DOI 10.4161/15384101.2014.974419; Sun RC, 2010, BREAST CANCER RES TR, V120, P253, DOI 10.1007/s10549-009-0435-9; Sutendra G, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00038; Tordonato C, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00072; Velpula KK, 2013, CANCER RES, V73, P7277, DOI 10.1158/0008-5472.CAN-13-1868; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; Wang TH, 2016, ONCOTARGET, V7, P43588, DOI 10.18632/oncotarget.9635; Wang Y, 2013, DEV CELL, V25, P69, DOI 10.1016/j.devcel.2013.03.002; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Xie H, 2014, CELL METAB, V19, P795, DOI 10.1016/j.cmet.2014.03.003; Yang F, 2014, MOL CELL, V53, P88, DOI 10.1016/j.molcel.2013.11.004; Ye XQ, 2011, INT J CANCER, V129, P820, DOI 10.1002/ijc.25944; Zhang K, 2014, GENE, V547, P1, DOI 10.1016/j.gene.2014.06.043; Zhang SL, 2016, J MED CHEM, V59, P3562, DOI 10.1021/acs.jmedchem.5b01828; Zhang Y, 2015, ONCOTARGET, V6, P9999, DOI 10.18632/oncotarget.3171; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60; Zhou ML, 2016, STEM CELLS, V34, P55, DOI 10.1002/stem.2219; Zhou YF, 2011, J BIOL CHEM, V286, P32843, DOI 10.1074/jbc.M111.260935	69	131	139	8	34	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 22	2018	37	8					1062	1074		10.1038/onc.2017.368	http://dx.doi.org/10.1038/onc.2017.368			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FX2QD	29106390	hybrid, Green Published			2022-12-26	WOS:000425905700009
J	Houliston, RS; Lemak, A; Iqbal, A; Ivanochko, D; Duan, SL; Kaustov, L; Ong, MS; Fan, LX; Senisterra, G; Brown, PJ; Wang, YX; Arrowsmith, CH				Houliston, R. Scott; Lemak, Alexander; Iqbal, Aman; Ivanochko, Danton; Duan, Shili; Kaustov, Lilia; Ong, Michelle S.; Fan, Lixin; Senisterra, Guillermo; Brown, Peter J.; Wang, Yun-Xing; Arrowsmith, Cheryl H.			Conformational dynamics of the TTD-PHD histone reader module of the UHRF1 epigenetic regulator reveals multiple histone-binding states, allosteric regulation, and druggability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACKBONE DYNAMICS; CHEMICAL PROBE; TUDOR DOMAIN; RECOGNITION; NMR; RESOLUTION; PROTEINS; MACROMOLECULES; PREDICTION; SCATTERING	UHRF1 is a key mediator of inheritance of epigenetic DNA methylation patterns during cell division and is a putative target for cancer therapy. Recent studies indicate that interdomain interactions critically influence UHRF1's chromatin-binding properties, including allosteric regulation of its histone binding. Here, using an integrative approach that combines small angle X-ray scattering, NMR spectroscopy, and molecular dynamics simulations, we characterized the dynamics of the tandem tudor domain-plant homeodomain (TTD-PHD) histone reader module, including its 20-residue interdomain linker. We found that the apo TTD-PHD module in solution comprises a dynamic ensemble of conformers, approximately half of which are compact conformations, with the linker lying in the TTD peptide-binding groove. These compact conformations are amenable to cooperative, high-affinity histone binding. In the remaining conformations, the linker position was in flux, and the reader adopted both extended and compact states. Using a small-molecule fragment screening approach, we identified a compound, 4-benzylpiperidine-1-carboximidamide, that binds to the TTD groove, competes with linker binding, and promotes open TTD-PHD conformations that are less efficient at H3K9me3 binding. Our work reveals a mechanism by which the dynamic TTD-PHD module can be allosterically targeted with small molecules to modulate its histone reader function for therapeutic or experimental purposes.	[Houliston, R. Scott; Lemak, Alexander; Ivanochko, Danton; Duan, Shili; Kaustov, Lilia; Ong, Michelle S.; Arrowsmith, Cheryl H.] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada; [Houliston, R. Scott; Lemak, Alexander; Ivanochko, Danton; Duan, Shili; Kaustov, Lilia; Ong, Michelle S.; Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Iqbal, Aman; Ong, Michelle S.; Senisterra, Guillermo; Brown, Peter J.; Arrowsmith, Cheryl H.] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Fan, Lixin] Leidos Biomed Res Inc, Small Angle Xray Scattering Core Facil, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Wang, Yun-Xing] NCI, NIH, Frederick, MD 21702 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; Structural Genomics Consortium; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Arrowsmith, CH (corresponding author), Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada.; Arrowsmith, CH (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada.; Arrowsmith, CH (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada.	carrow@uhnresearch.ca		Kaustov, Lilia/0000-0002-8474-559X; Brown, Peter/0000-0002-8454-0367; Arrowsmith, Cheryl/0000-0002-4971-3250	Princess Margaret Cancer Centre of the University Health Network; Argonne National Laboratory [DE-AC02-06CH11357]; AbbVie; Bayer Pharma AG; Boehringer Ingelheim; Canada Foundation for Innovation; Eshelman Institute for Innovation; Genome Canada through Ontario Genomics Institute [OGI-055]; Innovative Medicines Initiative (EU/EFPIA) (ULTRA-DD Grant) [115766]; Janssen; Merck Co.; Novartis Pharma AG; Ontario Ministry of Research, Innovation and Science; Pfizer; Sao Paulo Research Foundation-FAPESP; Takeda; Wellcome Trust	Princess Margaret Cancer Centre of the University Health Network(University of Toronto); Argonne National Laboratory(United States Department of Energy (DOE)); AbbVie(AbbVie); Bayer Pharma AG; Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Eshelman Institute for Innovation; Genome Canada through Ontario Genomics Institute(Genome Canada); Innovative Medicines Initiative (EU/EFPIA) (ULTRA-DD Grant); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck Co.(Merck & Company); Novartis Pharma AG; Ontario Ministry of Research, Innovation and Science; Pfizer(Pfizer); Sao Paulo Research Foundation-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission)	The operation of the Arrowsmith NMR facility is supported by the Princess Margaret Cancer Centre of the University Health Network. The shared Beamline 12-ID-B resource was allocated under Agreement PUP-24152 between the National Cancer Institute and the Argonne National Laboratory. Use of the Advanced Photon Source, a U.S. Department of Energy Office of Science User Facility, was operated by the Argonne National Laboratory under Contract DE-AC02-06CH11357. The Structural Genomics Consortium is a registered charity (Number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute (Grant OGI-055), Innovative Medicines Initiative (EU/EFPIA) (ULTRA-DD Grant 115766), Janssen, Merck & Co., Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science, Pfizer, Sao Paulo Research Foundation-FAPESP, Takeda, and the Wellcome Trust. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alhosin M, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0453-5; Arita K, 2012, P NATL ACAD SCI USA, V109, P12950, DOI 10.1073/pnas.1203701109; Berlin K, 2013, J AM CHEM SOC, V135, P16595, DOI 10.1021/ja4083717; Bronner C, 2007, PHARMACOL THERAPEUT, V115, P419, DOI 10.1016/j.pharmthera.2007.06.003; Cheng JD, 2013, J BIOL CHEM, V288, P1329, DOI 10.1074/jbc.M112.415398; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fang J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11197; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Feigin L.A., 1987, STRUCTURE ANAL SMALL; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gelato KA, 2014, MOL CELL, V54, P905, DOI 10.1016/j.molcel.2014.04.004; Goddard T.D., 2004, SPARKY 3; Harrison JS, 2016, ELIFE, V5, DOI 10.7554/eLife.17101; He YP, 2017, NAT CHEM BIOL, V13, P389, DOI 10.1038/nchembio.2306; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; James LI, 2013, NAT CHEM BIOL, V9, P184, DOI [10.1038/NCHEMBIO.1157, 10.1038/nchembio.1157]; Kazimierczuk K, 2011, ANGEW CHEM INT EDIT, V50, P5556, DOI 10.1002/anie.201100370; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lallous N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027599; Lemak A, 2008, J BIOMOL NMR, V41, P29, DOI 10.1007/s10858-008-9238-2; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Myrianthopoulos V, 2016, EUR J MED CHEM, V114, P390, DOI 10.1016/j.ejmech.2016.02.043; Nady N, 2011, J BIOL CHEM, V286, P24300, DOI 10.1074/jbc.M111.234104; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Onufriev A, 2000, J PHYS CHEM B, V104, P3712, DOI 10.1021/jp994072s; Orekhov VY, 2003, J BIOMOL NMR, V27, P165, DOI 10.1023/A:1024944720653; Peters MB, 2010, J CHEM THEORY COMPUT, V6, P2935, DOI 10.1021/ct1002626; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rajakumara E, 2011, MOL CELL, V43, P275, DOI 10.1016/j.molcel.2011.07.006; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rezaei-Ghaleh N, 2015, BIOINFORMATICS, V31, P1319, DOI 10.1093/bioinformatics/btu824; Rezaei-Ghaleh N, 2013, ANGEW CHEM INT EDIT, V52, P11410, DOI 10.1002/anie.201305094; Rothbart SB, 2012, NAT STRUCT MOL BIOL, V19, P1155, DOI 10.1038/nsmb.2391; Stuckey JI, 2016, NAT CHEM BIOL, V12, P180, DOI 10.1038/nchembio.2007; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tauber M, 2015, NUCLEUS-PHILA, V6, P123, DOI 10.1080/19491034.2015.1026022; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Trotzier MA, 2004, BIOCHEM BIOPH RES CO, V319, P590, DOI 10.1016/j.bbrc.2004.05.028; Unoki M, 2011, RECENT PAT ANTI-CANC, V6, P116, DOI 10.2174/157489211793980024; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang F, 2012, ANN SURG ONCOL, V19, P2753, DOI 10.1245/s10434-011-2194-1; Xie S, 2012, J MOL BIOL, V415, P318, DOI 10.1016/j.jmb.2011.11.012; Yang J, 2017, ONCOGENE, V36, P4828, DOI 10.1038/onc.2017.96; Zhang ZM, 2015, CELL REP, V12, P1400, DOI 10.1016/j.celrep.2015.07.046; Zhou L, 2015, CANCER BIOL THER, V16, P1241, DOI 10.1080/15384047.2015.1056411	47	25	25	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					20947	20959		10.1074/jbc.M117.799700	http://dx.doi.org/10.1074/jbc.M117.799700			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29074623	Green Published, hybrid			2022-12-26	WOS:000418453400012
J	Schneider, DJ; Speth, JM; Penke, LR; Wettlaufer, SH; Swanson, JA; Peters-Golden, M				Schneider, Daniel J.; Speth, Jennifer M.; Penke, Loka R.; Wettlaufer, Scott H.; Swanson, Joel A.; Peters-Golden, Marc			Mechanisms and modulation of microvesicle uptake in a model of alveolar cell communication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; TUMOR-DERIVED MICROVESICLES; COATED VESICLE FORMATION; CIGARETTE-SMOKE EXTRACT; EPIDERMAL-GROWTH-FACTOR; ACUTE LUNG INJURY; EXTRACELLULAR VESICLES; OXIDATIVE STRESS; EPITHELIAL-CELLS; MYOFIBROBLAST DIFFERENTIATION	Extracellular vesicles, including exosomes and shed microvesicles (MVs), can be internalized by recipient cells to modulate function. Although the mechanism by which extracellular vesicles are internalized is incompletely characterized, it is generally considered to involve endocytosis and an initial surface-binding event. Furthermore, modulation of uptake by microenvironmental factors is largely unstudied. Here, we used flow cytometry, confocal microscopy, and pharmacologic and molecular targeting to address these gaps in knowledge in a model of pulmonary alveolar cell-cell communication. Alveolar macrophage-derived MVs were fully internalized by alveolar epithelial cells in a time-, dose-, and temperature-dependent manner. Uptake was dependent on dynamin and actin polymerization. However, it was neither saturable nor dependent on clathrin or receptor binding. Internalization was enhanced by extracellular proteins but was inhibited by cigarette smoke extract via oxidative disruption of actin polymerization. We conclude that MV internalization occurs via a pathway more consistent with fluid-phase than receptor-dependent endocytosis and is subject to bidirectional modulation by relevant pathologic perturbations.	[Schneider, Daniel J.; Speth, Jennifer M.; Penke, Loka R.; Wettlaufer, Scott H.; Peters-Golden, Marc] Univ Michigan, Sch Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Swanson, Joel A.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Swanson, Joel A.; Peters-Golden, Marc] Univ Michigan, Sch Med, Grad Program Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Peters-Golden, M (corresponding author), 6301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	petersm@umich.edu	PENKE, LOKA RAGHU KUMAR/L-7255-2016; Swanson, Joel A/P-4362-2014	Swanson, Joel A/0000-0003-0900-8212; Schneider, Daniel/0000-0002-0344-2811; Speth, Jennifer/0000-0002-7724-6995; PENKE, LOKA RAGHU KUMAR/0000-0002-2780-7950	National Institutes of Health [R01 HL-125555, NIH RO1 HL-94311, T32 HL-774923, UL1TR000433, R01-GM 101189, R01-GM110215]; American Heart Association [15POST25280003]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000433] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007749, R01HL125555, R01HL094311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101189, R01GM110215] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 HL-125555 and NIH RO1 HL-94311 (to M.P.-G.), T32 HL-774923 (to D.J.S. and J.M.S.), UL1TR000433(to J.M.S.), R01-GM 101189 and R01-GM110215 (to J.A.S.), and from the American Heart Association 15POST25280003 (to L.R.P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilar-Gaytan R, 2003, BIOCHEM BIOPH RES CO, V305, P510, DOI 10.1016/S0006-291X(03)00796-4; Al-Nedawi K, 2009, P NATL ACAD SCI USA, V106, P3794, DOI 10.1073/pnas.0804543106; Atay S, 2011, AM J REPROD IMMUNOL, V66, P259, DOI 10.1111/j.1600-0897.2011.00995.x; Baba T, 1995, COLD SPRING HARB SYM, V60, P235, DOI 10.1101/SQB.1995.060.01.027; Ballweg K, 2014, AM J PHYSIOL-LUNG C, V307, pL895, DOI 10.1152/ajplung.00180.2014; Barres C, 2010, BLOOD, V115, P696, DOI 10.1182/blood-2009-07-231449; Barth K, 2005, HISTOCHEM CELL BIOL, V124, P453, DOI 10.1007/s00418-005-0048-2; Blanchard N, 2002, J IMMUNOL, V168, P3235, DOI 10.4049/jimmunol.168.7.3235; Bourdonnay E, 2015, J EXP MED, V212, P729, DOI 10.1084/jem.20141675; Buchackert Y, 2012, J PHYSIOL-LONDON, V590, P5167, DOI 10.1113/jphysiol.2012.233403; Buschow SI, 2009, TRAFFIC, V10, P1528, DOI 10.1111/j.1600-0854.2009.00963.x; Cao H, 2010, MOL CELL BIOL, V30, P781, DOI 10.1128/MCB.00330-09; Cheng J, 2006, CELL BIOCHEM BIOPHYS, V45, P177, DOI 10.1385/CBB:45:2:177; Christianson HC, 2013, P NATL ACAD SCI USA, V110, P17380, DOI 10.1073/pnas.1304266110; Chung JJ, 2015, J CLIN INVEST, V125, P2307, DOI 10.1172/JCI79641; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Escrevente C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-108; Fitzner D, 2011, J CELL SCI, V124, P447, DOI 10.1242/jcs.074088; Grassart A, 2014, J CELL BIOL, V205, P721, DOI 10.1083/jcb.201403041; HAIGLER HT, 1979, J CELL BIOL, V83, P82, DOI 10.1083/jcb.83.1.82; Happonen KE, 2016, J BIOL CHEM, V291, P10586, DOI 10.1074/jbc.M115.699058; Hasday JD, 1999, CHEST, V115, P829, DOI 10.1378/chest.115.3.829; Herzog Erica L, 2008, Proc Am Thorac Soc, V5, P778, DOI 10.1513/pats.200803-028HR; HOLT PG, 1987, THORAX, V42, P241, DOI 10.1136/thx.42.4.241; Idone V, 2008, J CELL BIOL, V180, P905, DOI 10.1083/jcb.200708010; Ismail N, 2013, BLOOD, V121, P984, DOI 10.1182/blood-2011-08-374793; Kanj RS, 2005, J TOXICOL ENV HEAL A, V68, P185, DOI 10.1080/15287390590890509; Kim KJ, 2003, AM J PHYSIOL-LUNG C, V284, pL458, DOI 10.1152/ajplung.00237.2002; Kim SY, 2011, J BIOL CHEM, V286, P31932, DOI 10.1074/jbc.M111.267633; Kosmider B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026059; LANNAN S, 1994, AM J PHYSIOL, V266, pL92, DOI 10.1152/ajplung.1994.266.1.L92; Lee J, 2012, J DENT RES, V91, P142, DOI 10.1177/0022034511421200; Lener T, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.30087; Li XY, 1998, AM J RESP CRIT CARE, V157, P1027, DOI 10.1164/ajrccm.157.4.9605080; Lima LG, 2009, CANCER LETT, V283, P168, DOI 10.1016/j.canlet.2009.03.041; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Matthay MA, 2005, AM J RESP CELL MOL, V33, P319, DOI 10.1165/rcmb.F305; MILLER YE, 1989, EXP LUNG RES, V15, P635, DOI 10.3109/01902148909069623; Minematsu N, 2011, AM J RESP CELL MOL, V44, P474, DOI 10.1165/rcmb.2009-0463OC; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Monteil C, 1999, TOXICOLOGY, V133, P129, DOI 10.1016/S0300-483X(99)00015-3; Mooren OL, 2012, ANNU REV BIOCHEM, V81, P661, DOI 10.1146/annurev-biochem-060910-094416; Mougeolle A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122654; Mulcahy LA, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24641; Nakase I, 2015, SCI REP-UK, V5, DOI 10.1038/srep10300; Noda N, 2013, INT IMMUNOL, V25, P643, DOI 10.1093/intimm/dxt033; Nolte-'t Hoen ENM, 2013, J LEUKOCYTE BIOL, V93, P395, DOI 10.1189/jlb.0911480; Obregon C, 2006, AM J PATHOL, V169, P2127, DOI 10.2353/ajpath.2006.060453; Oosthuyzen W, 2016, J AM SOC NEPHROL, V27, P3345, DOI 10.1681/ASN.2015050568; Palmer SE, 2015, CURR BIOL, V25, P868, DOI 10.1016/j.cub.2015.01.061; Parolini I, 2009, J BIOL CHEM, V284, P34211, DOI 10.1074/jbc.M109.041152; Parry SN, 2008, KIDNEY BLOOD PRESS R, V31, P16, DOI 10.1159/000112921; Penke LRK, 2014, J BIOL CHEM, V289, P17151, DOI 10.1074/jbc.M114.558130; Phipps JC, 2010, INFECT IMMUN, V78, P1214, DOI 10.1128/IAI.00963-09; Pitt JM, 2016, J CLIN INVEST, V126, P1139, DOI 10.1172/JCI87316; RACOOSIN EL, 1989, J EXP MED, V170, P1635, DOI 10.1084/jem.170.5.1635; Rana S, 2012, INT J BIOCHEM CELL B, V44, P1574, DOI 10.1016/j.biocel.2012.06.018; Raposo G, 1997, MOL BIOL CELL, V8, P2631, DOI 10.1091/mbc.8.12.2631; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Robbins PD, 2016, J CLIN INVEST, V126, P1173, DOI 10.1172/JCI81131; Sauvonnet N, 2005, J CELL BIOL, V168, P155, DOI 10.1083/jcb.200406174; Schorey JS, 2016, J CLIN INVEST, V126, P1181, DOI 10.1172/JCI81132; Sever S, 2000, J CELL BIOL, V150, P1137, DOI 10.1083/jcb.150.5.1137; Severgnini M, 2004, AM J PHYSIOL-LUNG C, V286, pL1282, DOI 10.1152/ajplung.00349.2003; Sohrab S, 2009, FASEB J, V23, P3149, DOI 10.1096/fj.09-129304; Speth JM, 2016, J IMMUNOL, V196, P5112, DOI 10.4049/jimmunol.1502153; SUNDQVIST T, 1993, ACTA PHYSIOL SCAND, V149, P127, DOI 10.1111/j.1748-1716.1993.tb09604.x; Takano M, 2012, LUNG, V190, P651, DOI 10.1007/s00408-012-9413-9; Tian T, 2014, J BIOL CHEM, V289, P22258, DOI 10.1074/jbc.M114.588046; Valapala M, 2011, J BIOL CHEM, V286, P30911, DOI 10.1074/jbc.M111.271155; Wang Y, 2009, NAT MED, V15, P319, DOI 10.1038/nm.1922; Ward JR, 2010, J BIOL CHEM, V285, P23145, DOI 10.1074/jbc.M109.072793; Xu R, 2016, J CLIN INVEST, V126, P1152, DOI 10.1172/JCI81129; Yamada H, 2016, NEUROSCI LETT, V628, P179, DOI 10.1016/j.neulet.2016.06.030; Yumoto R, 2006, AM J PHYSIOL-LUNG C, V290, pL946, DOI 10.1152/ajplung.00173.2005; Yumoto R, 2012, DRUG METAB PHARMACOK, V27, P336, DOI 10.2133/dmpk.DMPK-11-RG-127; Zhu JW, 2005, J CELL SCI, V118, P807, DOI 10.1242/jcs.01668	77	51	52	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					20897	20910		10.1074/jbc.M117.792416	http://dx.doi.org/10.1074/jbc.M117.792416			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29101235	Green Published, hybrid			2022-12-26	WOS:000418453400008
J	Rochman, CM; Parnis, JM; Browne, MA; Serrato, S; Reiner, EJ; Robson, M; Young, T; Diamond, ML; Teh, SJ				Rochman, Chelsea M.; Parnis, J. Mark; Browne, Mark A.; Serrato, Sebastian; Reiner, Eric J.; Robson, Matthew; Young, Thomas; Diamond, Miriam L.; Teh, Swee J.			Direct and indirect effects of different types of microplastics on freshwater prey (Corbicula fluminea) and their predator (Acipenser transmontanus)	PLOS ONE			English	Article							ORGANIC CONTAMINANTS; GREAT-LAKES; FOOD-WEB; POLLUTANTS; SEDIMENTS; POLLUTION; DEBRIS; POLYETHYLENE; ZEBRAFISH; PARTICLES	We examined whether environmentally relevant concentrations of different types of microplastics, with or without PCBs, directly affect freshwater prey and indirectly affect their predators. Asian clams (Corbicula fluminea) were exposed to environmentally relevant concentrations of polyethylene terephthalate (PET), polyethylene, polyvinylchloride (PVC) or polystyrene with and without polychlorinated biphenyls (PCBs) for 28 days. Their predators, white sturgeon (Acipenser transmontanus), were exposed to clams from each treatment for 28 days. In both species, we examined bioaccumulation of PCBs and effects (i.e., immunohistochemistry, histology, behavior, condition, mortality) across several levels of biological organization. PCBs were not detected in prey or predator, and thus differences in bioaccumulation of PCBs among polymers and biomagnification in predators could not be measured. One of the main objectives of this study was to test the hypothesis that bioaccumulation of PCBs would differ among polymer types. Because we could not answer this question experimentally, a bioaccumulation model was run and predicted that concentrations of PCBs in clams exposed to polyethylene and polystyrene would be greater than PET and PVC. Observed effects, although subtle, seemed to be due to microplastics rather than PCBs alone. For example, histopathology showed tubular dilation in clams exposed to microplastics with PCBs, with only mild effects in clams exposed to PCBs alone.	[Rochman, Chelsea M.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Rochman, Chelsea M.; Serrato, Sebastian; Teh, Swee J.] Univ Calif Davis, Sch Vet Med, Aquat Hlth Program, Davis, CA 95616 USA; [Parnis, J. Mark] Trent Univ, Dept Chem, Chem Properties Res Grp, Peterborough, ON, Canada; [Browne, Mark A.] Univ New South Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia; [Reiner, Eric J.; Robson, Matthew] Ontario Minist Environm & Climate Change, Toronto, ON, Canada; [Young, Thomas] Univ Calif Davis, Dept Civil & Environm Engn, One Shields Ave, Davis, CA 95616 USA; [Diamond, Miriam L.] Univ Toronto, Dept Earth Sci, Toronto, ON, Canada	University of Toronto; University of California System; University of California Davis; Trent University; University of New South Wales Sydney; University of California System; University of California Davis; University of Toronto	Rochman, CM (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada.; Rochman, CM (corresponding author), Univ Calif Davis, Sch Vet Med, Aquat Hlth Program, Davis, CA 95616 USA.	chelsea.rochman@utoronto.ca	Diamond, Miriam/D-1770-2013	Diamond, Miriam/0000-0001-6296-6431; Browne, Mark Anthony/0000-0002-7508-1015	NOAA Marine Debris Program [NA13NOS4630061]; Smith Postdoctoral Fellowship	NOAA Marine Debris Program; Smith Postdoctoral Fellowship	This work was funded by the NOAA Marine Debris Program (https://marinedebris.noaa.gov/) under grant Award # NA13NOS4630061 to Swee Teh. NOAA had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NOAA did read a draft of the manuscript prior to submission. Rochman was funded by a Smith Postdoctoral Fellowship (http://conbio.org/mini-sites/smith-fellows) during the majority of this work. The Smith Fellowship had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batel A, 2016, ENVIRON TOXICOL CHEM, V35, P1656, DOI 10.1002/etc.3361; Browne MA, 2008, ENVIRON SCI TECHNOL, V42, P5026, DOI 10.1021/es800249a; Browne MA, 2013, CURR BIOL, V23, P2388, DOI 10.1016/j.cub.2013.10.012; Castaneda RA, 2014, CAN J FISH AQUAT SCI, V71, P1767, DOI 10.1139/cjfas-2014-0281; Deng DF, 2010, TOXICON, V55, P787, DOI 10.1016/j.toxicon.2009.11.012; Eerkes-Medrano D, 2015, WATER RES, V75, P63, DOI 10.1016/j.watres.2015.02.012; Eriksen M, 2013, MAR POLLUT BULL, V77, P177, DOI 10.1016/j.marpolbul.2013.10.007; Ferguson MM, 1997, ENVIRON BIOL FISH, V48, P299, DOI 10.1023/A:1007367818353; Free CM, 2014, MAR POLLUT BULL, V85, P156, DOI 10.1016/j.marpolbul.2014.06.001; Gall SC, 2015, MAR POLLUT BULL, V92, P170, DOI 10.1016/j.marpolbul.2014.12.041; Goldstein MC, 2012, BIOL LETTERS, V8, P817, DOI 10.1098/rsbl.2012.0298; Hamer J, 2014, ENVIRON SCI TECHNOL, V48, P13451, DOI 10.1021/es501385y; Imhof HK, 2013, CURR BIOL, V23, pR867, DOI 10.1016/j.cub.2013.09.001; Jambeck JR, 2015, SCIENCE, V347, P768, DOI 10.1126/science.1260352; Jemec A, 2016, ENVIRON POLLUT, V219, P201, DOI 10.1016/j.envpol.2016.10.037; Jepson PD, 2016, SCIENCE, V352, P1388, DOI 10.1126/science.aaf9075; Khan FR, 2015, ENVIRON POLLUT, V206, P73, DOI 10.1016/j.envpol.2015.06.009; Klein S, 2015, ENVIRON SCI TECHNOL, V49, P6070, DOI 10.1021/acs.est.5b00492; Ko FC, 2012, SCI TOTAL ENVIRON, V416, P410, DOI 10.1016/j.scitotenv.2011.11.042; Koelmans AA, 2013, ENVIRON SCI TECHNOL, V47, P7812, DOI 10.1021/es401169n; Kuhn S, 2015, MARINE ANTHROPOGENIC LITTER, P75, DOI 10.1007/978-3-319-16510-3_4; Lechner A, 2014, ENVIRON POLLUT, V188, P177, DOI 10.1016/j.envpol.2014.02.006; Lee H, 2014, SCI TOTAL ENVIRON, V470, P1545, DOI 10.1016/j.scitotenv.2013.08.023; Li JN, 2016, ENVIRON POLLUT, V214, P177, DOI 10.1016/j.envpol.2016.04.012; Li JN, 2015, ENVIRON POLLUT, V207, P190, DOI 10.1016/j.envpol.2015.09.018; Lithner D, 2011, SCI TOTAL ENVIRON, V409, P3309, DOI 10.1016/j.scitotenv.2011.04.038; Lohmann R, 2012, ENVIRON SCI TECHNOL, V46, P606, DOI 10.1021/es202702y; Marranca JM, 2015, RESTOR ECOL, V23, P455, DOI 10.1111/rec.12200; Marvin CH, 2002, ENVIRON TOXICOL CHEM, V21, P1908, DOI 10.1897/1551-5028(2002)021<1908:PDPDAD>2.0.CO;2; MCCABE GT, 1993, NORTHWEST SCI, V67, P170; Megson D, 2016, ANAL CHEM, V88, P11406, DOI 10.1021/acs.analchem.6b01550; Melymuk L, 2014, ENVIRON SCI TECHNOL, V48, P3732, DOI 10.1021/es403209z; Metcalfe TL, 1997, SCI TOTAL ENVIRON, V201, P245, DOI 10.1016/S0048-9697(97)84061-2; MILLS EL, 1993, J GREAT LAKES RES, V19, P1, DOI 10.1016/S0380-1330(93)71197-1; Morrison SA, 2016, TALANTA, V146, P16, DOI 10.1016/j.talanta.2015.08.021; Ocean Conservancy, 2016, OC TRASH IND; Ogata Y, 2009, MAR POLLUT BULL, V58, P1437, DOI 10.1016/j.marpolbul.2009.06.014; Plastics Europe, 2015, PLAST FACTS 2015; Rehse S, 2016, CHEMOSPHERE, V153, P91, DOI 10.1016/j.chemosphere.2016.02.133; Rochman CM, 2016, ECOLOGY, V97, P302, DOI 10.1890/14-2070.1; Rochman CM, 2015, SCI REP-UK, V5, DOI 10.1038/srep14340; Rochman CM, 2014, SCI TOTAL ENVIRON, V493, P656, DOI 10.1016/j.scitotenv.2014.06.051; Rochman CM, 2013, SCI REP-UK, V3, DOI 10.1038/srep03263; Rochman CM, 2013, ENVIRON SCI TECHNOL, V47, P1646, DOI 10.1021/es303700s; Song YK, 2014, ENVIRON SCI TECHNOL, V48, P9014, DOI 10.1021/es501757s; Su L, 2016, ENVIRON POLLUT, V216, P711, DOI 10.1016/j.envpol.2016.06.036; Sussarellu R, 2016, P NATL ACAD SCI USA, V113, P2430, DOI 10.1073/pnas.1519019113; TANABE S, 1987, ENVIRON POLLUT, V47, P147, DOI 10.1016/0269-7491(87)90044-3; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Watts AJR, 2015, ENVIRON SCI TECHNOL, V49, P14597, DOI 10.1021/acs.est.5b04026; Watts AJR, 2014, ENVIRON SCI TECHNOL, V48, P8823, DOI 10.1021/es501090e; Wright SL, 2013, ENVIRON POLLUT, V178, P483, DOI 10.1016/j.envpol.2013.02.031	52	75	77	12	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187664	10.1371/journal.pone.0187664	http://dx.doi.org/10.1371/journal.pone.0187664			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29108004	gold, Green Published			2022-12-26	WOS:000414424600055
J	Suzuki, T; Kinugasa, R; Fukashiro, S				Suzuki, Takahito; Kinugasa, Ryuta; Fukashiro, Senshi			Activation of plantar flexor muscles is constrained by multiple muscle synergies rather than joint torques	PLOS ONE			English	Article							SPINAL-CORD; MOTOR BEHAVIORS; HUMAN WALKING; COORDINATION; CONSTRUCTION; OPTIMIZATION; COMBINATIONS; PREDICTION; LOCOMOTION; MOVEMENT	Behavioral evidence has suggested that a small number of muscle synergies may be responsible for activating a variety of muscles. Nevertheless, such dimensionality reduction may also be explained using the perspective of alternative hypotheses, such as predictions based on linear combinations of joint torques multiplied by corresponding coefficients. To compare the explanatory capacity of these hypotheses for describing muscle activation, we enrolled 12 male volunteers who performed isometric plantar flexor contractions at 10-100% of maximum effort. During each plantar flexor contraction, the knee extensor muscles were isometrically contracted at 0%, 50%, or 100% of maximum effort. Electromyographic activity was recorded from the vastus lateralis, medial gastrocnemius (MG), lateral gastrocnemius (LG), and soleus muscles and quantified using the average rectified value (ARV). At lower plantar flexion torque, regression analysis identified a clear linear relationship between the MG and soleus ARVs and between the MG and LG ARVs, suggesting the presence of muscle synergy (r(2) > 0.65). The contraction of the knee extensor muscles induced a significant change in the slope of this relationship for both pairs of muscles (MG x soleus, P=0.002; MG x LG, P=0.006). Similarly, the slope of the linear relationship between the plantar flexion torque and the ARV of the MG or soleus changed significantly with knee extensor contraction (P=0.031 and P=0.041, respectively). These results suggest that muscle synergies characterized by non-mechanical constraints are selectively recruited according to whether contraction of the knee extensor muscles is performed simultaneously, which is relatively consistent with the muscle synergy hypothesis.	[Suzuki, Takahito; Kinugasa, Ryuta] Kanagawa Univ, Dept Human Sci, Yokohama, Kanagawa, Japan; [Fukashiro, Senshi] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan	Kanagawa University; University of Tokyo	Suzuki, T (corresponding author), Kanagawa Univ, Dept Human Sci, Yokohama, Kanagawa, Japan.	takahito.suzuki.hg@alum.riken.jp		Kinugasa, Ryuta/0000-0002-4164-7981; Suzuki, Takahito/0000-0002-2314-001X	Japan Society for the Promotion of Science KAKENHI [25560330, 17K13155]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work was supported by the Japan Society for the Promotion of Science KAKENHI (25560330 and 17K13155; URL: https://www.jsps.go.jp/j-grantsinaid/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akima H, 2004, EUR J APPL PHYSIOL, V91, P7, DOI 10.1007/s00421-003-0942-z; Anderson FC, 2001, J BIOMECH ENG-T ASME, V123, P381, DOI 10.1115/1.1392310; Bernstein N, 1967, COORDINATION REGULAT; BOUISSET S, 1977, ELECTROEN CLIN NEURO, V42, P543, DOI 10.1016/0013-4694(77)90218-8; BUCHANAN TS, 1986, J NEUROPHYSIOL, V56, P1225, DOI 10.1152/jn.1986.56.5.1225; Cappellini G, 2006, J NEUROPHYSIOL, V95, P3426, DOI 10.1152/jn.00081.2006; Clark DJ, 2010, J NEUROPHYSIOL, V103, P844, DOI 10.1152/jn.00825.2009; CROWNINSHIELD RD, 1981, J BIOMECH, V14, P793, DOI 10.1016/0021-9290(81)90035-X; d'Avella A, 2005, P NATL ACAD SCI USA, V102, P3076, DOI 10.1073/pnas.0500199102; d'Avella A, 2003, NAT NEUROSCI, V6, P300, DOI 10.1038/nn1010; d'Avella A, 2006, J NEUROSCI, V26, P7791, DOI 10.1523/JNEUROSCI.0830-06.2006; De Groote F, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00115; de Rugy A, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00019; Disselhorst-Klug C, 2009, CLIN BIOMECH, V24, P225, DOI 10.1016/j.clinbiomech.2008.08.003; Dominici N, 2011, SCIENCE, V334, P997, DOI 10.1126/science.1210617; Federative Committee on Anatomical Terminology, 1998, TERM AN INT AN TERM; Hagio S, 2014, J NEUROPHYSIOL, V112, P316, DOI 10.1152/jn.00109.2014; Hirashima M, 2016, NEUROSCI RES, V104, P80, DOI 10.1016/j.neures.2015.12.008; Ivanenko YP, 2004, J PHYSIOL-LONDON, V556, P267, DOI 10.1113/jphysiol.2003.057174; Kargo WJ, 2008, J NEUROSCI, V28, P2409, DOI 10.1523/JNEUROSCI.3229-07.2008; KAUFMAN KR, 1991, NEUROSCIENCE, V40, P793, DOI 10.1016/0306-4522(91)90013-E; Kutch JJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002434; LEE WA, 1984, J MOTOR BEHAV, V16, P135; Nozaki D, 2005, J NEUROPHYSIOL, V93, P2614, DOI 10.1152/jn.00960.2004; Nozaki D, 2005, J APPL PHYSIOL, V99, P1093, DOI 10.1152/japplphysiol.00365.2005; Papaiordanidou M, 2016, MUSCLE NERVE, V53, P626, DOI 10.1002/mus.24895; Roh J, 2011, J NEUROPHYSIOL, V106, P1363, DOI 10.1152/jn.00842.2010; Santuz A, 2017, INT J NEURAL SYST, V27, DOI 10.1142/S0129065717500071; Sherrington C.S., 1906, INTEGRATIVE ACTION N, Vfirst, DOI 10.1037/13798-000; Suzuki T, 2014, HUM MOVEMENT SCI, V36, P35, DOI 10.1016/j.humov.2014.04.009; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Torres-Oviedo G, 2006, J NEUROPHYSIOL, V96, P1530, DOI 10.1152/jn.00810.2005; Tresch MC, 2009, CURR OPIN NEUROBIOL, V19, P601, DOI 10.1016/j.conb.2009.09.002; Tresch MC, 1999, NAT NEUROSCI, V2, P162, DOI 10.1038/5721; Tresch MC, 2006, J NEUROPHYSIOL, V95, P2199, DOI 10.1152/jn.00222.2005; ZAJAC FE, 1989, CRIT REV BIOMED ENG, V17, P359	36	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187587	10.1371/journal.pone.0187587	http://dx.doi.org/10.1371/journal.pone.0187587			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29107958	Green Submitted, Green Published, gold			2022-12-26	WOS:000414424600046
J	Diallo, AO; Soeters, HM; Yameogo, I; Sawadogo, G; Ake, F; Lingani, C; Wang, X; Bita, A; Fall, A; Sangare, L; Ouedraogo-Traore, R; Medah, I; Bicaba, B; Novak, RT				Diallo, Alpha Oumar; Soeters, Heidi M.; Yameogo, Issaka; Sawadogo, Guetawende; Ake, Flavien; Lingani, Clement; Wang, Xin; Bita, Andre; Fall, Amadou; Sangare, Lassana; Ouedraogo-Traore, Rasmata; Medah, Isaie; Bicaba, Brice; Novak, Ryan T.		MenAfriNet Consortium	Bacterial meningitis epidemiology and return of Neisseria meningitidis serogroup A cases in Burkina Faso in the five years following MenAfriVac mass vaccination campaign	PLOS ONE			English	Article							MENINGOCOCCAL CONJUGATE VACCINE; REAL-TIME PCR; PSA-TT; SURVEILLANCE; CARRIAGE; IMPACT; ASSAYS; NIGER; BELT	Background Historically, Neisseria meningitidis serogroup A (NmA) caused large meningitis epidemics in sub-Saharan Africa. In 2010, Burkina Faso became the first country to implement a national meningococcal serogroup A conjugate vaccine (MACV) campaign. We analyzed nationwide meningitis surveillance data from Burkina Faso for the 5 years following MACV introduction. Methods We examined Burkina Faso's aggregate reporting and national laboratory-confirmed case-based meningitis surveillance data from 2011-2015. We calculated incidence (cases per 100,000 persons), and described reported NmA cases. Results In 2011-2015, Burkina Faso reported 20,389 cases of suspected meningitis. A quarter (4,503) of suspected meningitis cases with cerebrospinal fluid specimens were laboratory-confirmed as either S. pneumoniae (57%), N. meningitidis (40%), or H. influenzae (2%). Average adjusted annual national incidence of meningococcal meningitis was 3.8 (range: 2.0-10.2 annually) and was highest among infants aged<1 year (8.4). N. meningitidis serogroup W caused the majority (64%) of meningococcal meningitis among all age groups. Only six confirmed NmA cases were reported in 2011-2015. Five cases were in children who were too young (n = 2) or otherwise not vaccinated (n = 3) during the 2010 MACV mass vaccination campaign; one case had documented MACV receipt, representing the first documented MACV failure. Conclusions Meningococcal meningitis incidence in Burkina Faso remains relatively low following MACV introduction. However, a substantial burden remains and NmA transmission has persisted. MACV integration into routine childhood immunization programs is essential to ensure continued protection.	[Diallo, Alpha Oumar; Soeters, Heidi M.; Wang, Xin; Novak, Ryan T.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Soeters, Heidi M.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA; [Yameogo, Issaka; Sawadogo, Guetawende; Medah, Isaie; Bicaba, Brice] Minist Sante, Direct Lutte Maladie, Ouagadougou, Burkina Faso; [Ake, Flavien] CDC Fdn, Ouagadougou, Burkina Faso; [Lingani, Clement; Bita, Andre; Fall, Amadou] AFRO Intercountry Support Team West Afr, World Hlth Org, Ouagadougou, Burkina Faso; [Sangare, Lassana] Ctr Hosp Univ Yalgado Ouedraogo, Ouagadougou, Burkina Faso; [Ouedraogo-Traore, Rasmata] Ctr Hosp Univ Pediat Charles Gaulle, Ouagadougou, Burkina Faso	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; World Health Organization	Diallo, AO; Soeters, HM (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA.; Soeters, HM (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA.	adiallo@cdc.gov; hmsoeters@cdc.gov	Soeters, Heidi/H-3271-2019	Soeters, Heidi/0000-0002-9415-9340; Diallo, Alpha Oumar/0000-0002-4819-0806	Bill & Melinda Gates Foundation [OPP1084298]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Bill & Melinda Gates Foundation, Grant Number OPP1084298. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali O, 2015, J INFECT DIS, V212, P1298, DOI 10.1093/infdis/jiv211; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P57; [Anonymous], 2014, Wkly Epidemiol Rec, V89, P561; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Centers for Disease Control and Prevention (U.S.) World Health Organization, 2011, LAB METHODS DIAGNOSI; Colombini A, 2015, CLIN INFECT DIS, V61, pS473, DOI 10.1093/cid/civ600; Daugla DM, 2014, LANCET, V383, P40, DOI 10.1016/S0140-6736(13)61612-8; Djingarey MH, 2015, CLIN INFECT DIS, V61, pS434, DOI 10.1093/cid/civ551; Djingarey MH, 2012, VACCINE, V30, pB40, DOI 10.1016/j.vaccine.2011.12.073; Funk Anna, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.b50c2aaf1032b3ccade0fca0b63ee518; Greenwood B, 1999, T ROY SOC TROP MED H, V93, P341, DOI 10.1016/S0035-9203(99)90106-2; Idoko OT, 2015, CLIN INFECT DIS, V61, pS416, DOI 10.1093/cid/civ596; Kambire D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166384; Karachaliou A, 2015, CLIN INFECT DIS, V61, pS594, DOI 10.1093/cid/civ508; Kretz CB, 2016, EMERG INFECT DIS, V22, P1762, DOI 10.3201/eid2210.160468; Kristiansen PA, 2013, CLIN INFECT DIS, V56, P354, DOI 10.1093/cid/cis892; LaForce FM, 2017, HUMAN VACCIN IMMUNOT; Lingani C, 2015, CLIN INFECT DIS, V61, pS410, DOI 10.1093/cid/civ597; MacNeil JR, 2014, EMERG INFECT DIS, V20, P394, DOI 10.3201/eid2003.131407; Mothershed EA, 2004, J CLIN MICROBIOL, V42, P320, DOI 10.1128/JCM.42.1.320-328.2004; Novak RT, 2012, LANCET INFECT DIS, V12, P757, DOI 10.1016/S1473-3099(12)70168-8; PATH, 2017, MAP AFR MEN BELT; Sambo L, 2015, CLIN INFECT DIS, V61, pS387, DOI 10.1093/cid/civ490; Sidikou F, 2016, LANCET INFECT DIS, V16, P1288, DOI 10.1016/S1473-3099(16)30253-5; Tapia MD, 2015, CLIN INFECT DIS, V61, pS514, DOI 10.1093/cid/civ672; Tartof S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063605; Wang X, 2012, J CLIN MICROBIOL, V50, P702, DOI 10.1128/JCM.06087-11; WHO, 1998, WHO PRACT GUID; [World Health Organization Africa WHOIST-W], 2016, MENINGITIS WEEKLY B; World Health Organization, 2010, TECHN GUID INT DIS S	30	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187466	10.1371/journal.pone.0187466	http://dx.doi.org/10.1371/journal.pone.0187466			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095907	gold, Green Published, Green Submitted			2022-12-26	WOS:000414340200096
J	Kim, BR; Kwon, YW; Park, GT; Choi, EJ; Seo, JK; Jang, IH; Kim, SC; Ko, HC; Lee, SC; Kim, JH				Kim, Ba Reun; Kwon, Yang Woo; Park, Gyu Tae; Choi, Eun Jung; Seo, Jeong Kon; Jang, Il Ho; Kim, Seung-Chul; Ko, Hyun-Chang; Lee, Sang Chul; Kim, Jae Ho			Identification of a novel angiogenic peptide from periostin	PLOS ONE			English	Article							BREAST-CANCER; FASCICLIN-I; GROWTH; EXPRESSION; CELL; PROTEIN; DOMAIN; MODEL	Angiogenic peptides have therapeutic potential for the treatment of chronic ischemic diseases. Periostin, an extracellular matrix protein expressed in injured tissues, promotes angiogenesis and tissue repair. We previously reported that in vivo administration of both recombinant full-length protein and the first FAS I domain of periostin alleviated peripheral artery occlusive disease by stimulating the migration of humane endothelial colony forming cells (ECFCs) and subsequent angiogenesis. In the present study, we ascertained the peptide sequence responsible for the periostin-induced angiogenesis. By serial deletion mapping of the first FAS I domain, we identified a peptide sequence (amino acids 142-151) of periostin for stimulation of chemotactic migration, adhesion, proliferation and endothelial tube formation of human ECFCs in vitro. Chemotactic migration of ECFCs induced by the periostin peptide was blocked by pre-incubation with an anti-beta 5 integrin neutralizing antibody. Treatment of ECFCs with the periostin peptide led to phosphorylation of both AKT and ERK, and pretreatment of ECFCs with the MEK-ERK pathway inhibitor U0126 or the PI3K-AKT pathway inhibitors, LY294002 or Wortmannin, blocked the periostin peptide-stim-ulated migration of ECFCs. These results suggest that the synthetic periostin peptide can be applied for stimulating angiogenic and therapeutic potentials of ECFCs.	[Kim, Ba Reun; Kwon, Yang Woo; Park, Gyu Tae; Choi, Eun Jung; Kim, Jae Ho] Pusan Natl Univ, Sch Med, Dept Physiol, Yangsan, South Korea; [Seo, Jeong Kon] Ulsan Natl Inst Sci & Technol, UNIST Cent Res Facil, Ulsan, South Korea; [Jang, Il Ho] Pusan Natl Univ, Sch Dent, Dept Oral Biochem & Mol Biol, Yangsan, South Korea; [Kim, Seung-Chul] Pusan Natl Univ, Sch Med, Dept Obstet & Gynecol, Yangsan, South Korea; [Ko, Hyun-Chang] Pusan Natl Univ, Sch Med, Dept Dermatol, Yangsan, South Korea; [Lee, Sang Chul] KRIBB, Funct Genom Res Ctr, Daejeon, South Korea; [Kim, Jae Ho] Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yangsan, South Korea	Pusan National University; Pusan National University Hospital; Ulsan National Institute of Science & Technology (UNIST); Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Pusan National University; Pusan National University Hospital	Kim, JH (corresponding author), Pusan Natl Univ, Sch Med, Dept Physiol, Yangsan, South Korea.; Kim, JH (corresponding author), Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yangsan, South Korea.	jhkimst@pusan.ac.kr	Ko, Hyun-chang/ABF-7418-2021; Kim, Seung-Chul/D-9216-2018	Ko, Hyun-chang/0000-0002-3459-5474; Kim, Seung-Chul/0000-0002-8174-9931; Kim, Jae Ho/0000-0003-4323-4790; Jang, Il Ho/0000-0002-0820-3035	MRC program [NRF-2015R1A5A2009656]; programs of the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2012M3A9C7050184, NRF-2015M3A9C6030280]	MRC program(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); programs of the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This research was supported by the MRC program (NRF-2015R1A5A2009656) and by the programs of the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2012M3A9C7050184;NRF-2015M3A9C6030280). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; ARNOLD F, 1991, PHARMACOL THERAPEUT, V52, P407, DOI 10.1016/0163-7258(91)90034-J; Braund Rhiannon, 2007, Current Drug Delivery, V4, P195; Buchwald H, 2014, SURG OBES RELAT DIS, V10, P780, DOI 10.1016/j.soard.2014.01.032; Field S, 2016, INT J CANCER, V138, P1959, DOI 10.1002/ijc.29946; Fosgerau K, 2015, DRUG DISCOV TODAY, V20, P122, DOI 10.1016/j.drudis.2014.10.003; Gillan L, 2002, CANCER RES, V62, P5358; Giordano C, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00063; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kim BR, 2014, BBA-MOL BASIS DIS, V1842, P1324, DOI 10.1016/j.bbadis.2014.05.004; Kudo A, 2011, CELL MOL LIFE SCI, V68, P3201, DOI 10.1007/s00018-011-0784-5; Kudo Y, 2007, HISTOL HISTOPATHOL, V22, P1167, DOI 10.14670/HH-22.1167; Lee YJ, 2013, MOL THER, V21, P1004, DOI 10.1038/mt.2013.30; Li GH, 2010, ATHEROSCLEROSIS, V208, P358, DOI 10.1016/j.atherosclerosis.2009.07.046; Padhi A, 2014, TUBERCULOSIS, V94, P363, DOI 10.1016/j.tube.2014.03.011; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Robinson SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087648; ROESEL JF, 1995, J SURG RES, V58, P449, DOI 10.1006/jsre.1995.1071; Ruan K, 2009, CELL MOL LIFE SCI, V66, P2219, DOI 10.1007/s00018-009-0013-7; Shao R, 2004, MOL CELL BIOL, V24, P3992, DOI 10.1128/MCB.24.9.3992-4003.2004; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; Zhu M, 2010, GYNECOL ONCOL, V119, P337, DOI 10.1016/j.ygyno.2010.07.008	23	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187464	10.1371/journal.pone.0187464	http://dx.doi.org/10.1371/journal.pone.0187464			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095886	Green Published, Green Submitted, gold			2022-12-26	WOS:000414340200095
J	Silva, FH; Veiga, FJR; Mora, AG; Heck, RS; De Oliveira, CC; Gambero, A; Franco-Penteado, CF; Antunes, E; Gardner, JD; Priviero, FBM; Claudino, MA				Silva, Fabio Henrique; Reis Veiga, Frederico Jose; Mora, Aline Goncalves; Heck, Rodrigo Sader; De Oliveira, Caroline Candida; Gambero, Alessandra; Franco-Penteado, Carla Fernanda; Antunes, Edson; Gardner, Jason D.; Marinho Priviero, Fernanda Bruschi; Claudino, Mario Angelo			A novel experimental model of erectile dysfunction in rats with heart failure using volume overload	PLOS ONE			English	Article							EXTRACELLULAR-SUPEROXIDE DISMUTASE; SYMPATHETIC-NERVOUS-SYSTEM; NITRIC-OXIDE SYNTHASE; OXIDATIVE STRESS; ENDOTHELIAL DYSFUNCTION; CORPUS CAVERNOSUM; PENILE ERECTION; SMOOTH-MUSCLE; UP-REGULATION; EXPRESSION	Background Patients with heart failure (HF) display erectile dysfunction (ED). However, the pathophysiology of ED during HF remains poorly investigated. Objective This study aimed to characterize the aortocaval fistula (ACF) rat model associated with HF as a novel experimental model of ED. We have undertaken molecular and functional studies to evaluate the alterations of the nitric oxide (NO) pathway, autonomic nervous system and oxidative stress in the penis. Methods Male rats were submitted to ACF for HF induction. Intracavernosal pressure in anesthetized rats was evaluated. Concentration-response curves to contractile (phenylephrine) and relaxant agents (sodium nitroprusside; SNP), as well as to electrical field stimulation (EFS), were obtained in the cavernosal smooth muscle (CSM) strips from sham and HF rats. Protein expression of endothelial NO synthase (eNOS) and neuronal NO synthase (nNOS) and phosphodiestarese-5 in CSM were evaluated, as well as NOX2 (gp91 (phox)) and superoxide dismutase (SOD) mRNA expression. SOD activity and thiobarbituric acid reactive substances (TBARs) were also performed in plasma. Results HF rats display erectile dysfunction represented by decreased ICP responses compared to sham rats. The neurogenic contractile responses elicited by EFS were greater in CSM from the HF group. Likewise, phenylephrine-induced contractions were greater in CSM from HF rats. Nitrergic response induced by EFS were decreased in the cavernosal tissue, along with lower eNOS, nNOS and phosphodiestarese-5 protein expressions. An increase of NOX2 and SOD mRNA expression in CSM and plasma TBARs of HF group were detected. Plasma SOD activity was decreased in HF rats. Conclusion ED in HF rats is associated with decreased NO bioavailability in erectile tissue due to eNOS/nNOS dowregulation and NOX2 upregulation, as well as hypercontractility of the penis. This rat model of ACF could be a useful tool to evaluate the molecular alterations of ED associated with HF.	[Silva, Fabio Henrique; Franco-Penteado, Carla Fernanda] Univ Estadual Campinas, Fac Med Sci, Hematol & Hemotherapy Ctr, Campinas, SP, Brazil; [Reis Veiga, Frederico Jose; Mora, Aline Goncalves; Heck, Rodrigo Sader; De Oliveira, Caroline Candida; Gambero, Alessandra; Marinho Priviero, Fernanda Bruschi; Claudino, Mario Angelo] Sao Francisco Univ, Med Sch, Lab Multidisciplinary Res, Braganca Paulista, SP, Brazil; [Antunes, Edson] Univ Estadual Campinas, Fac Med Sci, Dept Pharmacol, Campinas, SP, Brazil; [Gardner, Jason D.] Louisiana State Univ, Hlth Sci Ctr, Dept Physiol, Baton Rouge, LA 70803 USA	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Louisiana State University System; Louisiana State University; Louisiana State University Health Sciences Center at Shreveport	Claudino, MA (corresponding author), Sao Francisco Univ, Med Sch, Lab Multidisciplinary Res, Braganca Paulista, SP, Brazil.	mario.claudino@usf.edu.br	Priviero, Fernanda/E-2193-2012; SILVA, FABIO HENRIQUE/AAZ-8140-2020; Claudino, Mário A/D-5367-2014; Silva, Fábio/D-5412-2013	Priviero, Fernanda/0000-0002-6022-2081; Silva, Fábio/0000-0003-3374-5570; Claudino, Mario Angelo/0000-0002-3590-9607; Gambero, Alessandra/0000-0002-4862-4328	Sao Paulo Research Foundation (FAPESP) [2011/21095-4]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106392] Funding Source: NIH RePORTER	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Sao Paulo Research Foundation (FAPESP) (www.fapesp.br), Grant number: 2011/21095-4.	Abassi ZA, 1997, CIRCULATION, V96, P3655; Abassi Z, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/729497; Alcaino H, 2008, EUR J HEART FAIL, V10, P646, DOI 10.1016/j.ejheart.2008.05.008; Andersson KE, 2011, PHARMACOL REV, V63, P811, DOI 10.1124/pr.111.004515; Bivalacqua TJ, 2003, J ANDROL, V24, pS17; Bohm M, 2010, CIRCULATION, V121, P1439, DOI 10.1161/CIRCULATIONAHA.109.864199; Bradley JM, 2013, J APPL PHYSIOL, V115, P1099, DOI 10.1152/japplphysiol.00343.2013; Burnett Arthur L, 2006, J Clin Hypertens (Greenwich), V8, P53; Carneiro FS, 2010, J SEX MED, V7, P3620, DOI 10.1111/j.1743-6109.2010.02000.x; Champion HC, 2005, P NATL ACAD SCI USA, V102, P1661, DOI 10.1073/pnas.0407183102; Chirinos JA, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004133; Cho KI, 2014, INT J MOL SCI, V15, P14803, DOI 10.3390/ijms150814803; Claudino MA, 2011, LIFE SCI, V88, P272, DOI 10.1016/j.lfs.2010.11.018; Claudino MA, 2010, UROLOGY, V75, P961, DOI 10.1016/j.urology.2009.05.098; da Silva FH, 2013, INT J IMPOT RES, V25, P69, DOI 10.1038/ijir.2012.35; Del Rio D, 2005, NUTR METAB CARDIOVAS, V15, P316, DOI 10.1016/j.numecd.2005.05.003; DROLLER MJ, 1993, JAMA-J AM MED ASSOC, V270, P83; Dworakowski R, 2008, J AM COLL CARDIOL, V51, P1349, DOI 10.1016/j.jacc.2007.12.033; Francis B, 2004, J CARDIOVASC PHARM, V44, pS54, DOI 10.1097/01.fjc.0000166214.42791.f2; Frey RS, 2009, ANTIOXID REDOX SIGN, V11, P791, DOI [10.1089/ars.2008.2220, 10.1089/ARS.2008.2220]; Gardner JD, 2010, AM J PHYSIOL-HEART C, V298, pH497, DOI 10.1152/ajpheart.00336.2009; Hebert K, 2008, INT J IMPOT RES, V20, P507, DOI 10.1038/ijir.2008.35; Hebert K, 2010, J SEX MED, V7, P3991, DOI 10.1111/j.1743-6109.2010.01954.x; Heymes C, 2003, J AM COLL CARDIOL, V41, P2164, DOI 10.1016/S0735-1097(03)00471-6; Ho CY, 2010, NEW ENGL J MED, V363, P552, DOI 10.1056/NEJMoa1002659; Hurt KJ, 2012, P NATL ACAD SCI USA, V109, P16624, DOI 10.1073/pnas.1213790109; Jaarsma T, 1996, HEART LUNG, V25, P262, DOI 10.1016/S0147-9563(96)80061-6; Jin LM, 2008, J SEX MED, V5, P544, DOI 10.1111/j.1743-6109.2007.00733.x; KOWALUK EA, 1992, J PHARMACOL EXP THER, V262, P916; Koyama T, 2010, HYPERTENS RES, V33, P485, DOI 10.1038/hr.2010.48; Landmesser U, 2002, CIRCULATION, V106, P3073, DOI 10.1161/01.CIR.0000041431.57222.AF; Leite LN, 2017, EUR J PHARMACOL, V804, P82, DOI 10.1016/j.ejphar.2017.03.024; Lin CS, 2002, INT J IMPOT RES, V14, P15, DOI 10.1038/sj.ijir.3900802; Lynch SM, 1997, ARTERIOSCL THROM VAS, V17, P2975, DOI 10.1161/01.ATV.17.11.2975; Metra M, 2017, LANCET LOND ENGL; Musicki B, 2017, ANDROLOGY-US, V5, P294, DOI 10.1111/andr.12313; Musicki B, 2016, ANDROLOGY-US, V4, P977, DOI 10.1111/andr.12218; Musicki B, 2015, J SEX MED, V12, P2233, DOI 10.1111/jsm.13069; Nagalla KT, 2012, EXP BIOL MED, V237, P24, DOI 10.1258/ebm.2011.011180; Parajuli N, 2014, CLIN SCI, V127, P331, DOI 10.1042/CS20130787; Patel KP, 1996, BRAIN RES, V734, P109, DOI 10.1016/S0006-8993(96)00620-8; PIERUZZI F, 1995, CIRCULATION, V92, P3105, DOI 10.1161/01.CIR.92.10.3105; Polidori MC, 2002, FREE RADICAL BIO MED, V32, P148, DOI 10.1016/S0891-5849(01)00782-1; Rodrigues FL, 2016, LIFE SCI, V145, P9, DOI 10.1016/j.lfs.2015.12.005; Sharma NM, 2011, CARDIOVASC RES, V92, P348, DOI 10.1093/cvr/cvr217; Silva FH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166291; Silva FH, 2014, AM J PHYSIOL-HEART C, V307, pH1393, DOI 10.1152/ajpheart.00708.2013; Silva FH, 2013, J SEX MED, V10, P960, DOI 10.1111/jsm.12063; Silva FH, 2016, J PHARM EXP THER; Toque HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072277; Triposkiadis F, 2009, J AM COLL CARDIOL, V54, P1747, DOI 10.1016/j.jacc.2009.05.015; Tsutsui H, 2011, AM J PHYSIOL-HEART C, V301, pH2181, DOI 10.1152/ajpheart.00554.2011; Westlake C, 1999, J HEART LUNG TRANSPL, V18, P1133, DOI 10.1016/S1053-2498(99)00084-4; Zhang DY, 2014, CARDIOL CLIN, V32, P33, DOI 10.1016/j.ccl.2013.09.010; Zhang Q, 2011, INT J ANDROL, V34, P225, DOI 10.1111/j.1365-2605.2010.01083.x; Zhou R, 2017, CARDIOVASC THER, V35, DOI 10.1111/1755-5922.12241	56	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187083	10.1371/journaL.pone.0187083	http://dx.doi.org/10.1371/journaL.pone.0187083			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095897	gold, Green Published, Green Submitted			2022-12-26	WOS:000414340200045
J	Wilunda, C; Dall'Oglio, G; Scanagatta, C; Segafredo, G; Lukhele, BW; Takahashi, R; Putoto, G; Manenti, F; Betran, AP				Wilunda, Calistus; Dall'Oglio, Giovanni; Scanagatta, Chiara; Segafredo, Giulia; Lukhele, Bhekumusa Wellington; Takahashi, Risa; Putoto, Giovanni; Manenti, Fabio; Betran, Ana Pilar			Changing the role of traditional birth attendants in Yirol West County, South Sudan	PLOS ONE			English	Article							INTERVIEWS; PERSPECTIVE; ENOUGH	Effective from May 2014, community-based traditional birth attendants (TBAs) in Yirol West County, South Sudan, were directed to start referring all women in labour to health facilities for childbirth instead of assisting them in the villages. This study aimed to understand the degree of integration of TBAs in the health system, to reveal the factors influencing the integration, and to explore the perceived solutions to the challenges faced by TBAs. A qualitative study utilising 11 focus group discussions with TBAs, 6 focus group discussions with women, and 18 key informant interviews with members of village health committees, staff of health facilities, and staff of the County Health Department was conducted. Data were analysed using qualitative content analysis. The study found that many TBAs were referring women to health facilities for delivery, but some were still attending to deliveries at home. Facilitators of the adoption of the new role by TBAs were: acceptance of the new TBAs' role by the community, women and TBAs, perceptions about institutional childbirth and risks of home childbirth, personal commitment and motivation by some TBAs, a good working relationship between community-based TBAs and health facility staff, availability of incentives for women at health facilities, and training of TBAs. Challenges of integrating TBAs in the health system included, among others, communication problems between TBAs and health care facilities, delays in seeking care by women, insecurity, lack of materials and supplies for TBAs, health system constraints, insufficient incentives for TBAs, long distances to health facilities and transportation problems. This study has revealed encouraging developments in TBAs' integration in the formal health system in Yirol West. However, there is need to address the challenges faced by TBAs in assuming their new role in order to sustain the integration.	[Wilunda, Calistus] Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Pharmacoepidemiol, Kyoto, Japan; [Dall'Oglio, Giovanni] Doctors Africa CUAMM, Rumbek, South Sudan; [Scanagatta, Chiara; Segafredo, Giulia; Putoto, Giovanni; Manenti, Fabio] Doctors Africa CUAMM, Padua, Italy; [Lukhele, Bhekumusa Wellington] Kyoto Univ, Grad Sch Med, Dept Global Hlth & Socioepidemiol, Kyoto, Japan; [Lukhele, Bhekumusa Wellington] Kyoto Univ, Sch Publ Hlth, Kyoto, Japan; [Takahashi, Risa] Tenri Hlth Care Univ, Fac Hlth Care, Dept Nursing Sci, Tenri, Nara, Japan; [Betran, Ana Pilar] WHO, UNDP UNFPA UNICEF WHO World Bank Special Programm, Dept Reprod Hlth & Res, Geneva, Switzerland	Kyoto University; Kyoto University; Kyoto University; The World Bank; United Nations Population Fund; World Health Organization	Wilunda, C (corresponding author), Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Pharmacoepidemiol, Kyoto, Japan.	calistuswilunda@yahoo.co.uk	Dangal, Ganesh/O-1989-2017; Putoto, Giovanni/ABG-2069-2020	Dangal, Ganesh/0000-0002-5834-5525; Wilunda, Calistus/0000-0002-6606-6534; Lukhele, Bhekumusa Wellington/0000-0001-6429-638X	Doctors with Africa CUAMM	Doctors with Africa CUAMM	This study was funded by Doctors with Africa CUAMM as part of a project to improve maternal health services in Yirol West County, South Sudan.	Bisika Thomas, 2008, East Afr J Public Health, V5, P103; Byrne A, 2011, INT J GYNECOL OBSTET, V115, P127, DOI 10.1016/j.ijgo.2011.06.019; Coenen M, 2012, QUAL LIFE RES, V21, P359, DOI 10.1007/s11136-011-9943-2; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Gabrysch S, 2009, B WORLD HEALTH ORGAN, V87, P724, DOI 10.2471/BLT.08.057794; Glenton C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010414.pub2; Green A, 2014, LANCET, V384, P1252, DOI 10.1016/S0140-6736(14)61755-4; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Guest G, 2017, FIELD METHOD, V29, P3, DOI 10.1177/1525822X16639015; Hagaman AK, 2017, FIELD METHOD, V29, P23, DOI 10.1177/1525822X16640447; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Kirchberger I, 2009, DIABETIC MED, V26, P700, DOI 10.1111/j.1464-5491.2009.02762.x; Kitui JE, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1307-7; Kruske S, 2004, J MIDWIFERY WOM HEAL, V49, P306, DOI 10.1016/j.jmwh.2004.01.005; Low LK, 2006, MIDWIFERY, V22, P78, DOI 10.1016/j.midw.2005.03.005; Ministry of Health, 2009, BAS PACK HLTH NUTR S; Mullany LC, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000317; Pyone T, 2014, INT J GYNECOL OBSTET, V127, P41, DOI 10.1016/j.ijgo.2014.04.009; Saravanan S, 2010, J HEALTH MANAG, V12, P93, DOI 10.1177/097206341001200201; Sibley L, 2004, SOC SCI MED, V59, P1757, DOI 10.1016/j.socscimed.2004.02.009; Sibley LM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005460; Sibley LM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005460.pub3; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; UNICEF, 2015, TRACK PROGR MAT NEWB; UNICEF WHO and the World Bank Group, 2020, LEVELS TRENDS CHILD; United Nations Department of Economic and Social Affairs, 2015, SUST DEV GOALS KNOWL; WHO, 2004, MAK PREGN SAF CRIT R; WHO, 2010, REPR HLTH STRAT ACC; Wilunda C, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-259; World Health Organization, 2012, WHO REC OPT HLTH WOR; World Health Organization, 1992, TRAD BORTH ATT JOINT; YADAV H, 1987, SMJ Singapore Medical Journal, V28, P520	32	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0185726	10.1371/journal.pone.0185726	http://dx.doi.org/10.1371/journal.pone.0185726			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL6FI	29095824	Green Published, gold, Green Submitted			2022-12-26	WOS:000414340200007
J	Neubauer, G; Pilacka, L; Zielinski, P; Gromadzka, J				Neubauer, Grzegorz; Pilacka, Lucyna; Zielinski, Piotr; Gromadzka, Jadwiga			Population-level body condition correlates with productivity in an arctic wader, the dunlin Calidris alpina, during post-breeding migration	PLOS ONE			English	Article							RED KNOTS; FUEL DEPOSITION; HABITAT QUALITY; SHOREBIRDS; INCUBATION; ARRIVAL; LATITUDES; PATTERNS; WEATHER; SEGREGATION	Weather and predation constitute the two main factors affecting the breeding success of those Arctic waders whose productivity is highly variable over the years. We tested whether reproductive success is associated with the post-breeding condition of adults, in which in `good' years (with warm weather, plentiful food and low predation pressure) the condition of breeders and their productivity is high. To verify this hypothesis, we used a 10-year dataset comprising 20,792 dunlins Calidris alpina, trapped during migration at a stopover site on the southern Baltic Sea shore. Males were consistently in a slightly worse condition than females, likely due to male-biased parental investment in brood rearing. Annual productivity indices were positively correlated with the respective condition indices of breeders from the Eurasian Arctic, indicating that in 'good' years, despite great effort spent on reproduction, breeders leave the breeding grounds in better condition. The pattern did not hold for 1992: productivity was low, but the average condition of adults during migration was the highest noted over the decade. We suggest that the delayed effect of the Mount Pinatubo eruption in the Philippines in 1991, could be responsible for the unexpected high condition of Arctic breeders in 1992. High population-level average condition, coupled with the low productivity could stem from severe weather caused by the volcano eruption a year before and strong predation pressure, which in turn lead to a reduced investment in reproduction. The importance of large-scale episodic phenomena, like this volcano eruption, may blur the statistical associations of wildlife with local environmental drivers.	[Neubauer, Grzegorz; Pilacka, Lucyna; Zielinski, Piotr; Gromadzka, Jadwiga] Polish Acad Sci, Museum & Inst Zool, Ornithol Stn, Nadwislanska 108, Gdansk, Poland; [Neubauer, Grzegorz] Wroclaw Univ, Lab Forest Biol, Ul Sienkiewicza 21, Wroclaw, Poland	Polish Academy of Sciences; Museum & Institute of Zoology of the Polish Academy of Sciences; University of Wroclaw	Pilacka, L (corresponding author), Polish Acad Sci, Museum & Inst Zool, Ornithol Stn, Nadwislanska 108, Gdansk, Poland.	pilacka@miiz.waw.pl		Neubauer, Grzegorz/0000-0003-2123-0780	Research Grants of National Science Centre (Poland) [NCN2012/07/B/NZ8/02810 LP GN PZ]; Museum and Institute of Zoology, Polish Academy of Sciences JG	Research Grants of National Science Centre (Poland); Museum and Institute of Zoology, Polish Academy of Sciences JG	This work was supported by Research Grants of National Science Centre (Poland) no. NCN2012/07/B/NZ8/02810 LP GN PZ, https://www.ncn.gov.pli?language=en;Ornithological Station, Museum and Institute of Zoology, Polish Academy of Sciences JG, http://www.stornit.gda.pi/index_en.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon-Rotman Y, 2015, OIKOS, V124, P861, DOI 10.1111/oik.01730; Baker AJ, 2004, P ROY SOC B-BIOL SCI, V271, P875, DOI 10.1098/rspb.2003.2663; Barton K., 2015, MUMIN MULTIMODEL INF; Battley PF, 2002, THESIS; Beale CM, 2006, IBIS, V148, P405, DOI 10.1111/j.1474-919X.2006.00556.x; Blomqvist S, 2002, OECOLOGIA, V133, P146, DOI 10.1007/s00442-002-1017-2; Borowik OA, 1999, AUK, V116, P1107, DOI 10.2307/4089689; Boyd H, 2001, ARDEA, V89, P301; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Choi CY, 2011, J FIELD ORNITHOL, V82, P202, DOI 10.1111/j.1557-9263.2011.00323.x; Choi CY, 2009, ARDEA, V97, P61, DOI 10.5253/078.097.0108; Clark Jacquie A., 2004, Wader Study Group Bulletin, V104, P51; Cramp S, 1983, HDB BIRDS EUROPE MID, V3; del Hoyo J, 1996, HDB BIRDS WORLD, P3; Duriez O, 2012, OIKOS, V121, P862, DOI 10.1111/j.1600-0706.2012.20326.x; Engelmoer M., 1998, GEOGRAPHICAL VARIATI, DOI DOI 10.1007/978-94-011-5016-3; Ganter B, 2000, ARCTIC, V53, P289; Gill JA, 2001, NATURE, V412, P436, DOI 10.1038/35086568; GREENWOOD J G, 1984, Ringing and Migration, V5, P35; Gromadzka J., 1998, International Wader Studies, V10, P88; Gromadzka J., 1986, Var Fagelvarld Supplement, P51; Gromadzka J., 1985, Wader Study Group Bulletin, P32; GROMADZKA J, 1989, ORNIS SCAND, V20, P132, DOI 10.2307/3676881; Gromadzka J., 1998, WADER STUDY GR B, V10, P85; Gunnarsson TG, 2006, J ANIM ECOL, V75, P1119, DOI 10.1111/j.1365-2656.2006.01131.x; Gunnarsson TG, 2017, IBIS, V159, P467, DOI 10.1111/ibi.12449; Harrison XA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077783; Harrison XA, 2011, J ANIM ECOL, V80, P4, DOI 10.1111/j.1365-2656.2010.01740.x; HOLMES RT, 1966, CONDOR, V68, P3, DOI 10.2307/1365173; Jamieson SE, 2011, J ORNITHOL, V152, P1013, DOI 10.1007/s10336-011-0691-4; JEHL JR, 1970, ECOLOGY, V52, P169; Klaassen M, 2001, NATURE, V413, P794, DOI 10.1038/35101654; Klaassen M, 2003, AVIAN MIGRATION, P237; Labocha MK, 2012, J ORNITHOL, V153, P1, DOI 10.1007/s10336-011-0706-1; Lappo E.G., 1998, International Wader Studies, V10, P152; Lehikoinen A, 2016, ORNIS FENNICA, V93, P31; Lopes RJ, 2008, DIVERS DISTRIB, V14, P732, DOI 10.1111/j.1472-4642.2008.00480.x; Lopes RJ, 2006, J ORNITHOL, V147, P385, DOI 10.1007/s10336-005-0048-y; Marthinsen G, 2007, BIOL J LINN SOC, V92, P713, DOI 10.1111/j.1095-8312.2007.00931.x; Meissner W., 2007, WADER STUDY GR B, V115, P16; Meissner Wlodzimierz, 1995, Notatki Ornitologiczne, V36, P205; Meissner W, 2015, ARDEOLA, V62, P335; Meissner W, 2015, J ORNITHOL, V156, P47, DOI 10.1007/s10336-014-1132-y; Meissner Wlodzimierz, 2009, Wader Study Group Bulletin, V116, P35; Meissner Wlodzimierz, 2006, Ring, V28, P33; Meissner Wlodzimierz, 2005, Wader Study Group Bulletin, V108, P53; Meissner W, 2008, ORNIS FENNICA, V85, P135; Meltofte H., 2007, MEDDELELSER GRONLAND, V59; Monaghan P, 1997, TRENDS ECOL EVOL, V12, P270, DOI 10.1016/S0169-5347(97)01094-X; Morrison RIG, 2005, CONDOR, V107, P449, DOI 10.1650/7614; Morrison RIG, 2004, AUK, V121, P333, DOI 10.1642/0004-8038(2004)121[0333:UOBSIS]2.0.CO;2; Morrissette M, 2010, OIKOS, V119, P1181, DOI 10.1111/j.1600-0706.2009.18079.x; Newton I, 2006, J ORNITHOL, V147, P146, DOI 10.1007/s10336-006-0058-4; Newton I, 2010, MIGRATION ECOLOGY BI; Nol E, 1997, CONDOR, V99, P389, DOI 10.2307/1369945; Norris DR, 2005, OIKOS, V109, P178, DOI 10.1111/j.0030-1299.2005.13671.x; O'Connor CM, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00388.1; Ockendon N, BIOL LET, V2013; PIENKOWSKI MW, 1979, BIRD STUDY, V26, P134, DOI 10.1080/00063657909476632; Piersma T, 2002, INTEGR COMP BIOL, V42, P51, DOI 10.1093/icb/42.1.51; Prater AJ, 1977, GUIDE IDENTIFICATION, P380; Reneerkens Jeroen, 2005, Wader Study Group Bulletin, V106, P12; Robinson Robert A., 2005, Wader Study Group Bulletin, V106, P17; Sandercock BK, 1998, J FIELD ORNITHOL, V69, P235; Schamel D, 2003, W SANDP WORKSH JAN; Shepherd PCF, 2001, CONDOR, V103, P352, DOI 10.1650/0010-5422(2001)103[0352:SRODWA]2.0.CO;2; Smith PA, 2010, J AVIAN BIOL, V41, P292, DOI 10.1111/j.1600-048X.2009.04815.x; SOIKKELI M, 1967, Annales Zoologici Fennici, V4, P158; Soloviev MY, 1997, J ORNITHOL, V138, P271, DOI 10.1007/BF01651552; Stearns S.C., 1992, pi; SUMMERS RW, 1987, BIRD STUDY, V34, P161, DOI 10.1080/00063658709476955; Thomson DL, 1998, BIOL REV, V73, P293, DOI 10.1017/S0006323198005180; Tomkovich Pavel S., 1994, Wader Study Group Bulletin, V75, P20; Tulp I, 2006, J AVIAN BIOL, V37, P207, DOI 10.1111/j.2006.0908-8857.03519.x; Tulp I, 2002, IBIS, V144, P122, DOI 10.1046/j.0019-1019.2001.00014.x; Tulp I, 2008, ARCTIC, V61, P48; Tulp I, 2009, AUK, V126, P155, DOI 10.1525/auk.2009.07181; Tulp I, 2009, POLAR BIOL, V32, P481, DOI 10.1007/s00300-008-0543-8; Wennerberg L, 2001, MOL ECOL, V10, P1111, DOI 10.1046/j.1365-294X.2001.01256.x; Wennerberg L, 1999, IBIS, V141, P391, DOI 10.1111/j.1474-919X.1999.tb04408.x; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Zuur A. F., 2014, BEGINNERS GUIDE GEN; Zuur AF, BEGINNERS GUIDE GEN, V2; Zuur Alain F., 2009, P1	85	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187370	10.1371/journal.pone.0187370	http://dx.doi.org/10.1371/journal.pone.0187370			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091970	Green Submitted, Green Published, gold			2022-12-26	WOS:000414229700061
J	Christie, MP; Hu, SH; Whitten, AE; Rehman, A; Jarrott, RJ; King, GJ; Collins, BM; Martin, JL				Christie, Michelle P.; Hu, Shu-Hong; Whitten, Andrew E.; Rehman, Asma; Jarrott, Russell J.; King, Gordon J.; Collins, Brett M.; Martin, Jennifer L.			Revisiting interaction specificity reveals neuronal and adipocyte Munc18 membrane fusion regulatory proteins differ in their binding interactions with partner SNARE Syntaxins	PLOS ONE			English	Article							SYNAPTIC VESICLE DOCKING; N-PEPTIDE; COMPLEX; MODE	The efficient delivery of cellular cargo relies on the fusion of cargo-carrying vesicles with the correct membrane at the correct time. These spatiotemporal fusion events occur when SNARE proteins on the vesicle interact with cognate SNARE proteins on the target membrane. Regulatory Munc18 proteins are thought to contribute to SNARE interaction specificity through interaction with the SNARE protein Syntaxin. Neuronal Munc18a interacts with Syntaxin1 but not Syntaxin4, and adipocyte Munc18c interacts with Syntaxin4 but not Syntaxin1. Here we show that this accepted view of specificity needs revision. We find that Munc18c interacts with both Syntaxin4 and Syntaxin1, and appears to bind "noncognate" Syntaxin1 a little more tightly than Syntaxin4. Munc18a binds Syntaxin1 and Syntaxin4, though it interacts with its cognate Syntaxin1 much more tightly. We also observed that when bound to non-cognate Munc18c, Syntaxin1 captures its neuronal SNARE partners SNAP25 and VAMP2, and Munc18c can bind to pre-formed neuronal SNARE ternary complex. These findings reveal that Munc18a and Munc18c bind Syntaxins differently. Munc18c relies principally on the Syntaxin N-peptide interaction for binding Syntaxin4 or Syntaxin1, whereas Munc18a can bind Syntaxin1 tightly whether or not the Syntaxin1 N-peptide is present. We conclude that Munc18a and Munc18c differ in their binding interactions with Syntaxins: Munc18a has two tight binding modes/sites for Syntaxins as defined previously but Munc18c has just one that requires the N-peptide. These results indicate that the interactions between Munc18 and Syntaxin proteins, and the consequences for in vivo function, are more complex than can be accounted for by binding specificity alone.	[Christie, Michelle P.; Hu, Shu-Hong; Whitten, Andrew E.; Rehman, Asma; Jarrott, Russell J.; King, Gordon J.; Martin, Jennifer L.] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, St Lucia, Qld, Australia; [Collins, Brett M.] Univ Queensland, Inst Mol Biosci, Div Cell Biol & Mol Med, St Lucia, Qld, Australia; [Martin, Jennifer L.] Griffith Univ, Griffith Inst Drug Discovery, Nathan, Qld, Australia; [Christie, Michelle P.] St Vincents Inst, Fitzroy, Vic, Australia; [Hu, Shu-Hong; Jarrott, Russell J.] Griffith Univ, Griffith Inst Drug Discovery, Nathan, Qld, Australia; [Whitten, Andrew E.] Australian Nucl Sci & Technol Org, Lucas Heights, NSW, Australia; [Rehman, Asma] Dulbecco Telethon Inst, Genoa, Italy	University of Queensland; University of Queensland; Griffith University; St. Vincent's Institute of Medical Research; Griffith University; Australian Nuclear Science & Technology Organisation; Fondazione Telethon; Dulbecco Telethon Institute (DTI)	Christie, MP; Martin, JL (corresponding author), Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, St Lucia, Qld, Australia.; Christie, MP (corresponding author), St Vincents Inst, Fitzroy, Vic, Australia.	mchristie@svi.edu.au; jlm@griffith.edu.au	Martin, Jennifer L./A-6039-2010; Rehman, Asma/X-4632-2018; Collins, Brett/J-1563-2014	Martin, Jennifer L./0000-0002-9225-8863; Whitten, Andrew/0000-0001-8856-3120; Christie, Michelle/0000-0002-7001-3400; Rehman, Asma/0000-0002-0653-9053; Collins, Brett/0000-0002-6070-3774; Jarrott, Russell/0000-0003-4326-1203	Australian National Health and Medical Research Council (NHMRC) [535921]; NHMRC Peter Doherty Fellowship [569864]; NHMRC Career Development Fellowship [APP1061574]; Australian Research Council Laureate Fellowship [FL0992138]; NHMRC Fellowship [455829];  [1066069];  [1080995]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Peter Doherty Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Laureate Fellowship(Australian Research Council); NHMRC Fellowship(National Health and Medical Research Council (NHMRC) of Australia); ; 	This work was supported by the Australian National Health and Medical Research Council (NHMRC, www.nhmrc.gov.au) through program grant 535921 (to JLM) and then project grants 1066069 and 1080995 (to AEW and JLM). AEW was supported by an NHMRC Peter Doherty Fellowship (569864); BMC by an NHMRC Career Development Fellowship (APP1061574); JLM by an Australian Research Council (www.arc.gov.au) Laureate Fellowship (FL0992138) and then NHMRC Fellowship (455829). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bracher A, 2002, EMBO J, V21, P6114, DOI 10.1093/emboj/cdf608; Brandie FM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004074; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Burkhardt P, 2011, P NATL ACAD SCI USA, V108, P15264, DOI 10.1073/pnas.1106189108; Carpp LN, 2006, J CELL BIOL, V173, P927, DOI 10.1083/jcb.200512024; Christie MP, 2012, P NATL ACAD SCI USA, V109, P9816, DOI 10.1073/pnas.1116975109; Colbert KN, 2013, P NATL ACAD SCI USA, V110, P12637, DOI 10.1073/pnas.1303753110; de Wit H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000126; Deak F, 2009, J CELL BIOL, V184, P751, DOI 10.1083/jcb.200812026; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Genc O, 2014, ELIFE, V3, DOI 10.7554/eLife.01715; Han GYA, 2011, MOL BIOL CELL, V22, P4134, DOI 10.1091/mbc.E11-02-0135; Han L, 2009, MOL BIOL CELL, V20, P4962, DOI 10.1091/mbc.E09-08-0712; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Hu SH, 2007, P NATL ACAD SCI USA, V104, P8773, DOI 10.1073/pnas.0701124104; Hu SH, 2011, P NATL ACAD SCI USA, V108, P1040, DOI 10.1073/pnas.0914906108; Kanda H, 2005, J CLIN INVEST, V115, P291, DOI 10.1172/JCI200522681; Latham CF, 2006, TRAFFIC, V7, P1408, DOI 10.1111/j.1600-0854.2006.00474.x; Li YS, 2017, WIREL COMMUN MOB COM, P1, DOI 10.1155/2017/8056126; Lou XC, 2015, J BIOL CHEM, V290, P10535, DOI 10.1074/jbc.M114.631341; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Oh E, 2009, DIABETES, V58, P1165, DOI 10.2337/db08-1059; Peng RW, 2002, J CELL BIOL, V157, P645, DOI 10.1083/jcb.200202006; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; Rathore SS, 2010, P NATL ACAD SCI USA, V107, P22399, DOI 10.1073/pnas.1012997108; Rehman A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183366; Rehman A, 2014, IUCRJ, V1, P505, DOI 10.1107/S2052252514020727; Rehman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083499; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Spessott WA, 2017, P NATL ACAD SCI USA, V114, pE2176, DOI 10.1073/pnas.1617981114; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tamori Y, 1998, J BIOL CHEM, V273, P19740, DOI 10.1074/jbc.273.31.19740; Tellam JT, 1997, J BIOL CHEM, V272, P6179, DOI 10.1074/jbc.272.10.6179; TELLAM JT, 1995, J BIOL CHEM, V270, P5857, DOI 10.1074/jbc.270.11.5857; Togneri J, 2006, P NATL ACAD SCI USA, V103, P17730, DOI 10.1073/pnas.0605448103; Toonen RFG, 2003, TRENDS CELL BIOL, V13, P177, DOI 10.1016/S0962-8924(03)00031-X; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Weimer RM, 2003, NAT NEUROSCI, V6, P1023, DOI 10.1038/nn1118; Xu Y, 2010, BIOCHEMISTRY-US, V49, P1568, DOI 10.1021/bi9021878; Yu HJ, 2013, P NATL ACAD SCI USA, V110, pE3271, DOI 10.1073/pnas.1311232110; Zhang YX, 2015, J BIOL CHEM, V290, P10518, DOI 10.1074/jbc.M114.630772	44	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187302	10.1371/journal.pone.0187302	http://dx.doi.org/10.1371/journal.pone.0187302			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088285	Green Published, gold, Green Submitted			2022-12-26	WOS:000414088900063
J	Barrett, AN; Xiong, L; Tana, TZ; Advani, HV; Hua, R; Laureano-Asibal, C; Soong, R; Biswas, A; Nagarajan, N; Choolani, M				Barrett, Angela N.; Xiong, Li; Tana, Tuan Z.; Advani, Henna V.; Hua, Rui; Laureano-Asibal, Cecille; Soong, Richie; Biswas, Arijit; Nagarajan, Niranjan; Choolani, Mahesh			Measurement of fetal fraction in cell-free DNA from maternal plasma using a panel of insertion/deletion polymorphisms	PLOS ONE			English	Article							NONINVASIVE PRENATAL-DIAGNOSIS; DIGITAL PCR; MONOGENIC DISEASES; ANEUPLOIDY; MUTATIONS; REVEALS; MARKER	Objective Cell-free DNA from maternal plasma can be used for non-invasive prenatal testing for aneuploidies and single gene disorders, and also has applications as a biomarker for monitoring high-risk pregnancies, such as those at risk of pre-eclampsia. On average, the fractional cell-free fetal DNA concentration in plasma is approximately 15%, but can vary from less than 4% to greater than 30%. Although quantification of cell-free fetal DNA is straightforward in the case of a male fetus, there is no universal fetal marker; in a female fetus measurement is more challenging. We have developed a panel of multiplexed insertion/deletion polymorphisms that can measure fetal fraction in all pregnancies in a simple, targeted sequencing reaction. Methods A multiplex panel of primers was designed for 35 indels plus a ZFX/ZFY amplicon. cfDNA was extracted from plasma from 157 pregnant women, and maternal genomic DNA was extracted for 20 of these samples for panel validation. Sixty-one samples from pregnancies with a male fetus were subjected to whole genome sequencing on the Ion Proton sequencing platform, and fetal fraction derived from Y chromosome counts was compared to fetal fraction measured using the indel panel. A total of 157 cell-free DNA samples were sequenced using the indel panel, and informativity was assessed, along with the proportion of fetal DNA. Results Using gDNA we optimised the indel panel, removing amplicons giving rise to PCR bias. Good correlation was found between fetal fraction using indels and using whole genome sequencing of the Y chromosome (Spearmans r = 0.69). A median of 12 indels were informative per sample. The indel panel was informative in 157/157 cases (mean fetal fraction 14.4% (+/- 0.58%)). Conclusions Using our targeted next generation sequencing panel we can readily assess the fetal DNA percentage in male and female pregnancies.	[Barrett, Angela N.; Xiong, Li; Advani, Henna V.; Hua, Rui; Laureano-Asibal, Cecille; Biswas, Arijit; Choolani, Mahesh] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore, Singapore; [Xiong, Li; Hua, Rui] Soothern Med Univ, Nanfang Hosp, Dept Gynecol & Obstet, Guangzhou, Guangdong, Peoples R China; [Tana, Tuan Z.; Soong, Richie] Natl Univ Singapore, Canc Sci Inst, Singapore, Singapore; [Nagarajan, Niranjan] Genome Inst Singapore, Singapore, Singapore	National University of Singapore; Southern Medical University - China; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Barrett, AN; Choolani, M (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore, Singapore.	obganb@nus.edu.sg; obgmac@nus.edu.sg		Nagarajan, Niranjan/0000-0003-0850-5604	National Medical Research Council/Clinician Scientist Award [NMRC/CSA/0059/2014]	National Medical Research Council/Clinician Scientist Award	We acknowledge the National Medical Research Council/Clinician Scientist Award (NMRC/CSA/0059/2014) for supporting our work. The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberry MS, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.07.063; Barrett AN, 2012, CLIN CHEM, V58, P1026, DOI 10.1373/clinchem.2011.178939; Bianchi DW, 2012, OBSTET GYNECOL, V119, P890, DOI 10.1097/AOG.0b013e31824fb482; Canick JA, 2013, PRENATAL DIAG, V33, P667, DOI 10.1002/pd.4126; Chan KCA, 2006, CLIN CHEM, V52, P2211, DOI 10.1373/clinchem.2006.074997; Chan KCA, 2016, P NATL ACAD SCI USA, V113, pE8159, DOI 10.1073/pnas.1615800113; Chiu RWK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7401; De Vlaminck I, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007803; Dugoff L, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.02.009; Fernando MR, 2010, PRENATAL DIAG, V30, P418, DOI 10.1002/pd.2484; Hidestrand M, 2012, FETAL DIAGN THER, V31, P122, DOI 10.1159/000335020; Hudecova I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088484; Jiang PY, 2016, NPJ GENOM MED, V1, DOI 10.1038/npjgenmed.2016.13; Jiang PY, 2012, BIOINFORMATICS, V28, P2883, DOI 10.1093/bioinformatics/bts549; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim SK, 2015, PRENATAL DIAG, V35, P810, DOI 10.1002/pd.4615; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; Lam KWG, 2012, CLIN CHEM, V58, P1467, DOI 10.1373/clinchem.2012.189589; Lench N, 2013, PRENATAL DIAG, V33, P555, DOI 10.1002/pd.4124; Lo KK, 2014, BIOINFORMATICS, V30, P2965, DOI 10.1093/bioinformatics/btu419; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lun FMF, 2008, CLIN CHEM, V54, P1664, DOI 10.1373/clinchem.2008.111385; Lun FMF, 2013, CLIN CHEM, V59, P1583, DOI 10.1373/clinchem.2013.212274; Lun FMF, 2008, P NATL ACAD SCI USA, V105, P19920, DOI 10.1073/pnas.0810373105; Martin A, 2014, PRENATAL DIAG, V34, P685, DOI 10.1002/pd.4416; Miura K, 2006, CLIN CHEM, V52, P2121, DOI 10.1373/clinchem.2006.075697; Nygren AOH, 2010, CLIN CHEM, V56, P1627, DOI 10.1373/clinchem.2010.146290; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Peng XL, INT J MOL SCI, V18, pE453; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Rozen S, 2000, Methods Mol Biol, V132, P365; Samango-Sprouse C, 2013, PRENATAL DIAG, V33, P643, DOI 10.1002/pd.4159; Shih DQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016090; Snyder TM, 2011, P NATL ACAD SCI USA, V108, P6229, DOI 10.1073/pnas.1013924108; Sparks AB, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.030; Straver R, 2016, PRENATAL DIAG, V36, P614, DOI 10.1002/pd.4816; Tabor A, 2010, FETAL DIAGN THER, V27, P1, DOI 10.1159/000271995; Takoudes T, 2015, ULTRASOUND OBST GYN, V45, P112, DOI 10.1002/uog.14715; Taly V, 2013, CLIN CHEM, V59, P1722, DOI 10.1373/clinchem.2013.206359; Tsui NBY, 2011, BLOOD, V117, P3684, DOI 10.1182/blood-2010-10-310789; van Beek DM, 2017, PRENATAL DIAG, V37, P769, DOI 10.1002/pd.5079; Wataganara T, 2016, BJOG-INT J OBSTET GY, V123, P31, DOI 10.1111/1471-0528.14197; Weber JL, 2002, AM J HUM GENET, V71, P854, DOI 10.1086/342727; Yu SCY, 2014, P NATL ACAD SCI USA, V111, P8583, DOI 10.1073/pnas.1406103111; Zhong Q, 2011, LAB CHIP, V11, P2167, DOI 10.1039/c1lc20126c; Zimmermann B, 2012, PRENATAL DIAG, V32, P1233, DOI 10.1002/pd.3993	46	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0186771	10.1371/journal.pone.0186771	http://dx.doi.org/10.1371/journal.pone.0186771			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084245	Green Published, gold, Green Submitted			2022-12-26	WOS:000413910200011
J	Sato, T; Usui, M; Konishi, N; Kai, A; Matsui, H; Hanaki, H; Tamura, Y				Sato, Tomomi; Usui, Masaru; Konishi, Noriko; Kai, Akemi; Matsui, Hidehito; Hanaki, Hideaki; Tamura, Yutaka			Closely related methicillin-resistant Staphylococcus aureus isolates from retail meat, cows with mastitis, and humans in Japan	PLOS ONE			English	Article							MULTIPLEX PCR; STRAINS; EPIDEMIOLOGY; IDENTIFICATION; OUTBREAK; SEQUENCE; MILK; INFECTIONS; PRODUCTS; PATTERNS	Methicillin-resistant Staphylococcus aureus (MRSA) is a pervasive healthcare-acquired (HA) pathogen with recent emergence as a community-acquired (CA) pathogen. To elucidate whether meat mediates MRSA transmission between animals and humans in Japan, this study examined MRSA isolates from retail meat (n = 8), cows with mastitis (n = 7), and humans (HA-MRSA = 46 and CA-MRSA = 54) by molecular typing, virulence gene analyses, and antimicrobial susceptibility testing. MRSA isolates from retail meat were classified into sequence type (ST) 8/spa type t1767 (n = 4), ST8/t4133 (n = 1), ST59/t3385 (n = 1), ST88/t375 (n = 1), and ST509/t375 (n = 1). All seven MRSA isolates from cows with mastitis were ST8/t1767. 46 HA-MRSA were clonal complex (CC) 5, divided into t002 (n = 30), t045 (n = 12), and t7455 (n = 4). 54 CA-MRSA were classified into 6 different CCs: CC1 (n = 14), CC5 (n = 7), CC8 (n = 29), CC45 (n = 1), CC89 (n = 1), CC509 (n = 1), and into 16 different spa types including newly identified t17177, t17193, and t17194. The majority were CC8/t1767 (n = 16). CC of one CA-MRSA isolate (spa type t1767) was not classified. Among 41 CC8 MRSA (five from meat, seven from cows with mastitis, and 29 CA-MRSA), 14 ST8/SCCmec IVl isolates (three from meat, one from a cow with mastitis, and 10 CA-MRSA) had identical pulsed-field gel electrophoresis patterns and similar spa type (t1767, t4133, and t17177), and were typed as CA-MRSA/J (ST8/SCCmec IVl, positive for sec + sel + tst but negative for Panton-Valentine leukocidin and the arginine catabolic mobile element). These results suggest that there is a transmission cycle of CA-MRSA/J among meat, cows, and humans in Japan, although it is unclear whether the origin is cow.	[Sato, Tomomi; Usui, Masaru; Tamura, Yutaka] Rakuno Gakuen Univ, Sch Vet Med, Dept Hlth & Environm Sci, Lab Food Microbiol & Food Safety, Ebetsu, Hokkaido, Japan; [Konishi, Noriko] Tokyo Metropolitan Inst Publ Hlth, Dept Microbiol, Shinjuku Ku, Tokyo, Japan; [Kai, Akemi] Tokyo Med Univ, Dept Microbiol, Shinjuku Ku, Tokyo, Japan; [Matsui, Hidehito; Hanaki, Hideaki] Kitasato Univ, Infect Control Res Ctr, Minato Ku, Tokyo, Japan	Rakuno Gakuen University; Tokyo Medical University; Kitasato University	Tamura, Y (corresponding author), Rakuno Gakuen Univ, Sch Vet Med, Dept Hlth & Environm Sci, Lab Food Microbiol & Food Safety, Ebetsu, Hokkaido, Japan.	tamuray@rakuno.ac.jp						Al-Talib H, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-113; Asao T, 2003, EPIDEMIOL INFECT, V130, P33, DOI 10.1017/S0950268802007951; Baba K, 2010, INT J ANTIMICROB AG, V36, P352, DOI 10.1016/j.ijantimicag.2010.06.040; Chen CJ, 2011, J CLIN MICROBIOL, V49, P131, DOI 10.1128/JCM.01774-10; Chuang YY, 2015, INT J ANTIMICROB AG, V45, P334, DOI 10.1016/j.ijantimicag.2014.12.007; Cremonesi P, 2005, MOL CELL PROBE, V19, P299, DOI 10.1016/j.mcp.2005.03.002; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Deiters C, 2015, INT J MED MICROBIOL, V305, P110, DOI 10.1016/j.ijmm.2014.11.007; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Hata E, 2016, J VET DIAGN INVEST, V28, P291, DOI 10.1177/1040638716643126; Hata E, 2010, J CLIN MICROBIOL, V48, P2130, DOI 10.1128/JCM.01940-09; Hennekinne JA, 2012, FEMS MICROBIOL REV, V36, P815, DOI 10.1111/j.1574-6976.2011.00311.x; Iwaki M, 2011, YAKUGAKU ZASSHI, V131, P1653, DOI 10.1248/yakushi.131.1653; Iwao Y, 2012, J INFECT CHEMOTHER, V18, P96, DOI 10.1007/s10156-011-0348-5; Juhasz-kaszanyitzky E, 2007, EMERG INFECT DIS, V13, P3; Kitai S, 2005, J VET MED SCI, V67, P107, DOI 10.1292/jvms.67.107; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kluytmans JAJW, 2010, CLIN MICROBIOL INFEC, V16, P11, DOI 10.1111/j.1469-0691.2009.03110.x; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Mediavilla JR, 2012, CURR OPIN MICROBIOL, V15, P588, DOI 10.1016/j.mib.2012.08.003; Mehrotra M, 2000, J CLIN MICROBIOL, V38, P1032, DOI 10.1128/JCM.38.3.1032-1035.2000; Molla B, 2012, J CLIN MICROBIOL, V50, P3687, DOI 10.1128/JCM.01971-12; Mulvey MR, 2001, J CLIN MICROBIOL, V39, P3481, DOI 10.1128/JCM.39.10.3481-3485.2001; Murakami K, 2002, JAPANESE J FOOD MICR, V19, P127; Nimmo GR, 2008, INT J ANTIMICROB AG, V31, P401, DOI 10.1016/j.ijantimicag.2007.08.011; Ogata K, 2012, APPL ENVIRON MICROB, V78, P2797, DOI 10.1128/AEM.07470-11; Pantosti A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00127; Rodriguez-Lazaro D, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01344; Sato T, 2015, J GLOB ANTIMICROB RE, V3, P283, DOI 10.1016/j.jgar.2015.07.009; Sheng WH, 2009, DIAGN MICR INFEC DIS, V63, P309, DOI 10.1016/j.diagmicrobio.2008.11.014; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Suzuki M, 2009, J APPL MICROBIOL, V107, P1367, DOI 10.1111/j.1365-2672.2009.04321.x; Verhegghe M., 2015, International Journal of Food Contamination, V2, DOI 10.1186/s40550-015-0013-3; Wayne P, 2014, M100S24 CLIN LAB S S; Yamamoto T, 2010, J INFECT CHEMOTHER, V16, P225, DOI 10.1007/s10156-010-0045-9	38	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187319	10.1371/journal.pone.0187319	http://dx.doi.org/10.1371/journal.pone.0187319			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084288	Green Submitted, Green Published, gold			2022-12-26	WOS:000413910200049
J	Kim, DH; Park, J; Kahng, B				Kim, Do-Hyun; Park, Jinha; Kahng, Byungnam			Enhanced storage capacity with errors in scale-free Hopfield neural networks: An analytical study	PLOS ONE			English	Article							SMALL-WORLD; CONNECTIVITY; MODEL; HUBS	The Hopfield model is a pioneering neural network model with associative memory retrieval. The analytical solution of the model in mean field limit revealed that memories can be retrieved without any error up to a finite storage capacity of O( N), where N is the system size. Beyond the threshold, they are completely lost. Since the introduction of the Hopfield model, the theory of neural networks has been further developed toward realistic neural networks using analog neurons, spiking neurons, etc. Nevertheless, those advances are based on fully connected networks, which are inconsistent with recent experimental discovery that the number of connections of each neuron seems to be heterogeneous, following a heavytailed distribution. Motivated by this observation, we consider the Hopfield model onscalefree networks and obtain a different pattern of associative memory retrieval from that obtained on the fully connected network: the storage capacity becomes tremendously enhanced but with some error in the memory retrieval, which appears as the heterogeneity of the connections is increased. Moreover, the error rates are also obtained on several real neural networks and are indeed similar to that on scale-free model networks.	[Kim, Do-Hyun] Sogang Univ, Dept Phys, Seoul, South Korea; [Park, Jinha; Kahng, Byungnam] Seoul Natl Univ, CCSS, CTP, Seoul, South Korea; [Park, Jinha; Kahng, Byungnam] Seoul Natl Univ, Dept Phys & Astron, Seoul, South Korea	Sogang University; Seoul National University (SNU); Seoul National University (SNU)	Kim, DH (corresponding author), Sogang Univ, Dept Phys, Seoul, South Korea.; Kahng, B (corresponding author), Seoul Natl Univ, CCSS, CTP, Seoul, South Korea.; Kahng, B (corresponding author), Seoul Natl Univ, Dept Phys & Astron, Seoul, South Korea.	dohyunkim@sogang.ac.kr; bkahng@snu.ac.kr		Kim, Do-Hyun/0000-0002-8384-668X	National Research Foundation of Korea [2014R1A3A2069005, 2015R1A5A7037676]; Sogang University [201610033.01, 201710066.01]; NRF of Korea [2014R1A3A2069005, 2015R1A5A7037676]	National Research Foundation of Korea(National Research Foundation of Korea); Sogang University; NRF of Korea	This work was supported by the National Research Foundation of Korea (http://www.nrf.re.kr): Grant Nos. 2014R1A3A2069005 and 2015R1A5A7037676 to B. Kahng and by Sogang University (http://www.sogang.ac.kr): Grant No. 201610033.01 and 201710066.01 to D.-H. Kim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the NRF of Korea (Grant Nos. 2014R1A3A2069005 and 2015R1A5A7037676) and Sogang University (Grant Nos. 201610033.01 and 201710066.01). We would like to express our appreciation toward S.-H. Lee and Joonwon Lee.	Achard S, 2012, P NATL ACAD SCI USA, V109, P20608, DOI 10.1073/pnas.1208933109; AMIT DJ, 1985, PHYS REV LETT, V55, P1530, DOI 10.1103/PhysRevLett.55.1530; AMIT DJ, 1987, ANN PHYS-NEW YORK, V173, P30, DOI 10.1016/0003-4916(87)90092-3; Amit DJ, 1989, MODELING BRAIN FUNCT; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bartol TM, 2015, ELIFE, V4, DOI 10.7554/eLife.10778; BOLLOBAS B., 2001, RANDOM GRAPHS, V73, DOI 10.1017/CBO9780511814068.008; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Castillo IP, 2004, J PHYS A-MATH GEN, V37, P8789, DOI 10.1088/0305-4470/37/37/002; Cho YS, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.135702; Chung F., 2002, ANN COMB, V6, P125, DOI [10.1007/PL00012580, 10.1007/PL00012580.pdf, DOI 10.1007/PL00012580.PDF]; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; ERDOS P, 1960, B INT STATIST INST, V38, P343; Gallos LK, 2012, P NATL ACAD SCI USA, V109, P2825, DOI 10.1073/pnas.1106612109; Goh KI, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.278701; Hebb Donald O., 1949, ORG BEHAV; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Josselyn SA, 2015, NAT REV NEUROSCI, V16, P521, DOI 10.1038/nrn4000; Kandel ER, 2013, PRINCIPLES NEURAL SC, V5; Kim DH, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056115; Kim DH, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.022803; Lee JS, 2006, EUR PHYS J B, V49, P231, DOI 10.1140/epjb/e2006-00051-y; Mezard M., 1987, WORLD SCI LECT NOT P, V9; Nishimori H., 2001, STAT PHYS SPIN GLASS; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Rubinov Mikail, 2013, Dialogues Clin Neurosci, V15, P339; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Stauffer D, 2003, EUR PHYS J B, V32, P395, DOI 10.1140/epjb/e2003-00114-7; Steullet P, 2014, SCHIZOPHR RES; Torres JJ, 2004, NEUROCOMPUTING, V58, P229, DOI 10.1016/j.neucom.2004.01.048; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel MP, 2013, TRENDS COGN SCI, V17, P683, DOI 10.1016/j.tics.2013.09.012	32	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0184683	10.1371/journal.pone.0184683	http://dx.doi.org/10.1371/journal.pone.0184683			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077721	Green Published, gold, Green Submitted			2022-12-26	WOS:000413861200001
J	Rao, A; Padhy, D; Sahay, P; Pradhan, A; Sarangi, S; Das, G; Raj, N				Rao, Aparna; Padhy, Debananda; Sahay, Prity; Pradhan, Amiya; Sarangi, Sarada; Das, Gopinath; Raj, Niranjan			Clinical spectrum of pseudoexfoliation syndrome-An electronic records audit	PLOS ONE			English	Article							SOUTH INDIAN POPULATION; EXFOLIATION SYNDROME; GLAUCOMA; PREVALENCE; PATHOGENESIS; EYE	Purpose To evaluate different clinical variants of pseudoexfoliation syndrome and their risk of developing ocular hypertension (OHT) or glaucoma (PXG) Design Cross sectional hospital based study. Setting All patients seen at glaucoma services of a tertiary eye care center in east India. Methods Electronic medical records search of hospital database including consecutive new and old cases seen during April 2013 to March 2015 was done to retrieve case sensitive words including pseudoexfoliation, PXF, PEX, PXG and pseudoexfoliative glaucoma over any part of the clinical electronic sheet of the patient. All demographic and clinical details including laterality, the pattern of deposits, need for medicines and disc damage at presentation was compared in eyes with radial pigmentary, classical or combined forms of PXF phenotypes. Results Of 110313 PXF patients seen during the period of 2013-2015, a total of 2297 eyes of 1150 PXF patients were identified including 525 unilateral PXF (meaning a total of 1775 PXF eyes with 625 patients having bilateral disease, n = 1250 eyes, other clinically normal eye, n = 522) at presentation. Of 525 unilateral PXF eyes, 105 had OHT and 131 had glaucoma while bilateral cases had more > 50% (675 eyes of 1250 eyes) with glaucoma. Glaucoma with significant changes in IOP with or without disc damage was seen in 32% of pigmentary and 39% of classical PXF forms with eyes with combined forms of PXF having around 50% with glaucoma at presentation compared to other forms, p< 0.001. Conclusion Different phenotypic variants of PXF in this Indian cohort was associated with 30-50% risk of OHT or glaucoma respectively. Adequate care is required while examining the pattern of PXF in each case to prognosticate each patient/eye.	[Rao, Aparna; Padhy, Debananda; Sahay, Prity; Pradhan, Amiya; Sarangi, Sarada; Das, Gopinath; Raj, Niranjan] LV Prasad Eye Inst, Glaucoma Serv, Bhubaneswar, Odisha, India	L. V. Prasad Eye Institute	Rao, A (corresponding author), LV Prasad Eye Inst, Glaucoma Serv, Bhubaneswar, Odisha, India.	aparna@lvpei.org		rao, Aparna/0000-0001-8120-8740	DBT Wellcome Trust grant [IA/CPHI/15/1/502031]	DBT Wellcome Trust grant(Wellcome Trust DBT India Alliance)	This work was funded in part by the DBT Wellcome Trust grant, ref no IA/CPHI/15/1/502031. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboobakar IF, 2017, EXP EYE RES, V154, P88, DOI 10.1016/j.exer.2016.11.011; Al-Saleh SA, 2015, SAUDI MED J, V36, P108, DOI 10.15537/smj.2015.1.9121; Anastasopoulos E, 2015, CURR OPIN OPHTHALMOL, V26, P82, DOI 10.1097/ICU.0000000000000132; Anastasopoulos E, 2011, J GLAUCOMA, V20, P160, DOI 10.1097/IJG.0b013e3181d9d8bd; Arnarsson A, 2009, AM J OPHTHALMOL, V148, P291, DOI 10.1016/j.ajo.2009.03.021; Founti P, 2015, ANN HUM GENET, V79, P431, DOI 10.1111/ahg.12128; Gunes A, 2016, SEMINOPHTHALMOL, V21, P1; HENKE V, 1987, KLIN MONATSBL AUGENH, V190, P173, DOI 10.1055/s-2008-1050350; Konstas Anastasios G P, 2006, Compr Ophthalmol Update, V7, P131; Landers J, 2012, CLIN EXP OPHTHALMOL, V40, P454, DOI 10.1111/j.1442-9071.2011.02696.x; LAYDEN WE, 1974, AM J OPHTHALMOL, V78, P835, DOI 10.1016/0002-9394(74)90307-9; Miglior S, 2015, PROG BRAIN RES, V221, P233, DOI 10.1016/bs.pbr.2015.06.007; Mitchell P, 1999, ARCH OPHTHALMOL-CHIC, V117, P1319, DOI 10.1001/archopht.117.10.1319; Naumann GOH, 1998, OPHTHALMOLOGY, V105, P951, DOI 10.1016/S0161-6420(98)96020-1; Olawoye OO, 2014, INT OPHTHALMOL, V34, P1165, DOI 10.1007/s10792-014-9953-5; OSTENFELDAKERBLOM A, 1988, ACTA OPHTHALMOL, V66, P467; Padhy B, 2014, EXP EYE RES, V127, P69, DOI 10.1016/j.exer.2014.07.005; Parrish RK, 2009, AM J OPHTHALMOL, V148, P482, DOI 10.1016/j.ajo.2009.07.005; Puska PM, 2002, J GLAUCOMA, V11, P517, DOI 10.1097/00061198-200212000-00012; Rao A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113329; Rao V, 2015, ASIA-PAC J OPHTHALMO, V4, P121, DOI 10.1097/APO.0b013e3182a0af43; Ren RJ, 2015, ASIA-PAC J OPHTHALMO, V4, P86, DOI 10.1097/APO.0000000000000106; Schlotzer-Schrehardt U, 2012, OPHTHALMOLOGE, V109, P944, DOI 10.1007/s00347-012-2531-1; SOOD NN, 1968, ACTA OPHTHALMOL, V46, P211; Vazquez Luis E, 2014, Int Ophthalmol Clin, V54, P1, DOI 10.1097/IIO.0000000000000047; Vesti E, 2000, PROG RETIN EYE RES, V19, P345, DOI 10.1016/S1350-9462(99)00019-1; Vijaya L, 2016, J GLAUCOMA, V25, pE596, DOI 10.1097/IJG.0000000000000276; Vijaya L, 2015, OPHTHALMOLOGY, V122, P1158, DOI 10.1016/j.ophtha.2015.02.007	28	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0185373	10.1371/journal.pone.0185373	http://dx.doi.org/10.1371/journal.pone.0185373			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077713	Green Published, Green Submitted, gold			2022-12-26	WOS:000413861200003
J	Wall, EC; Mukaka, M; Denis, B; Mlozowa, VS; Msukwa, M; Kasambala, K; Nyrienda, M; Allain, TJ; Faragher, B; Heyderman, RS; Lalloo, DG				Wall, Emma C.; Mukaka, Mavuto; Denis, Brigitte; Mlozowa, Veronica S.; Msukwa, Malango; Kasambala, Khumbo; Nyrienda, Mulinda; Allain, Theresa J.; Faragher, Brian; Heyderman, Robert S.; Lalloo, David G.			Goal directed therapy for suspected acute bacterial meningitis in adults and adolescents in sub-Saharan Africa	PLOS ONE			English	Article							SURVIVING SEPSIS CAMPAIGN; MENINGOCOCCAL DISEASE; SEPTIC SHOCK; INTERNATIONAL GUIDELINES; COMPLEX INTERVENTIONS; MANAGEMENT; CHILDREN; DIAGNOSIS; CARE; RESUSCITATION	Background Mortality from acute bacterial meningitis (ABM) in sub-Saharan African adults and adolescents exceeds 50%. We tested if Goal Directed Therapy (GDT) was feasible for adults and adolescents with clinically suspected ABM in Malawi. Materials and methods Sequential patient cohorts of adults and adolescents with clinically suspected ABM were recruited in the emergency department of a teaching hospital in Malawi using a before/after design. Routine care was monitored in year one (P1). In year two (P2), nurses delivered protocolised GDT (rapid antibiotics, airway support, oxygenation, seizure control and fluid resuscitation) to a second cohort. The primary endpoint was composite mean number of clinical goals attained. Secondary endpoints were individual goals attained and death or disability from proven or probable ABM at day 40. Results 563 patients with suspected ABM were enrolled in the study; 273 were monitored in P1; 290 patients with suspected ABM received GDT in P2. 61% were male, median age 33 years and 90% were HIV co-infected. ABM was proven or probable in 132 (23%) patients. GDT attained more clinical goals compared to routine care: composite mean number of goals in P1 was 0.55 vs. 1.57 in P2 GDT (p<0.001); Death or disability by day 40 from proven or probable ABM occurred in 29/57 (51%) in P1 and 38/60 (63%) in P2 (p = 0.19). Conclusion Nurse-led GDT in a resource-constrained setting was associated with improved delivery of protocolised care. Outcome was unaffected.	[Wall, Emma C.; Mukaka, Mavuto; Denis, Brigitte; Mlozowa, Veronica S.; Msukwa, Malango; Kasambala, Khumbo; Heyderman, Robert S.] Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Wall, Emma C.; Faragher, Brian; Lalloo, David G.] Univ Liverpool Liverpool Sch Trop Med, Pembroke Pl, Liverpool, Merseyside, England; [Wall, Emma C.; Heyderman, Robert S.] UCL, Div Infect & Immun, London, England; [Mukaka, Mavuto] Mahidol Oxford Trop Med Res Unit MORU, Bangkok, Thailand; [Mukaka, Mavuto] Univ Oxford, Nuffield Dept Med Res Bldg, Oxford Ctr Trop Med & Global Hlth, Oxford, England; [Nyrienda, Mulinda] Minist Hlth, Adult Emergency & Trauma Ctr, Queen Elizabeth Cent Hosp, Blantyre, Malawi; [Allain, Theresa J.] Coll Med, Dept Med, Blantyre, Malawi	University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; University of London; University College London; Mahidol Oxford Tropical Medicine Research Unit (MORU); University of Oxford; University of Malawi; University of Malawi	Wall, EC (corresponding author), Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi.; Wall, EC (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Pembroke Pl, Liverpool, Merseyside, England.; Wall, EC (corresponding author), UCL, Div Infect & Immun, London, England.	emma.wall@doctors.org.uk		Heyderman, Robert/0000-0003-4573-449X; Lalloo, David/0000-0001-7680-2200; Wall, Emma/0000-0003-2732-4497	Wellcome Trust [086971/B/09/Z]; Academy of Medical Sciences (AMS) [SGL016\\1009] Funding Source: researchfish; National Institute for Health Research [CL-2014-18-002] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by The Wellcome Trust in a personal Clinical PhD Fellowship in Global Health EW #086971/B/09/Z. The funding body had no role in study design, data collection, analysis of data, manuscript preparation or the decision to publish. The corresponding author takes full responsibility for the integrity of the data.	Ajdukiewicz KMB, 2011, LANCET INFECT DIS, V11, P293, DOI 10.1016/S1473-3099(10)70317-0; Andrews B, 2014, CRIT CARE MED, V42, P2315, DOI 10.1097/CCM.0000000000000541; Arnold RC, 2008, SHOCK; Baker T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144801; Barochia AV, 2010, CRIT CARE MED, V38, P668, DOI 10.1097/CCM.0b013e3181cb0ddf; Booy R, 2001, ARCH DIS CHILD, V85, P386, DOI 10.1136/adc.85.5.386; Brouwer MC, 2012, LANCET, V380, P1684, DOI 10.1016/S0140-6736(12)61185-4; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Campbell NC, 2007, BMJ-BRIT MED J, V334, P455, DOI 10.1136/bmj.39108.379965.BE; Council MR., 2008, DEV EVALUATING COMPL; Council UR, 2010, ADV LIF SUPP GUID 20; Dellinger RP, 2013, INTENS CARE MED, V39, P165, DOI [10.1007/s00134-012-2769-8, 10.1097/CCM.0b013e31827e83af]; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Edmond K, 2010, LANCET INFECT DIS, V10, P317, DOI 10.1016/S1473-3099(10)70048-7; Fitch MT, 2007, LANCET INFECT DIS, V7, P191, DOI 10.1016/S1473-3099(07)70050-6; Gans J. de, 2002, New England Journal of Medicine, V347, P1549, DOI 10.1056/NEJMoa021334; Glimaker M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091976; Harnden A, 2006, BRIT MED J, V332, P1295, DOI 10.1136/bmj.38789.723611.55; Heyderman RS, 2005, J INFECTION, V50, P373, DOI 10.1016/j.jinf.2005.04.002; Jacob ST, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-107; Jacob ST, 2012, CRIT CARE MED, V40, P2050, DOI 10.1097/CCM.0b013e31824e65d7; Kalil AC, 2017, CRIT CARE MED, V45, P607, DOI 10.1097/CCM.0000000000002235; Lee WK, 2016, YONSEI MED J, V57, P1260, DOI 10.3349/ymj.2016.57.5.1260; Lepur D, 2007, INFECTION, V35, P225, DOI 10.1007/s15010-007-6202-0; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Maitland K, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-90; McGill F, 2016, J INFECTION, V72, P405, DOI 10.1016/j.jinf.2016.01.007; Molyneux AJ, 2006, CLIN NEUROL NEUROSUR, V108, P115, DOI 10.1016/j.clineuro.2005.10.015; Molyneux EM, 2014, PEDIATR INFECT DIS J, V33, P214, DOI 10.1097/INF.0000000000000122; Molyneux EM, 2002, LANCET, V360, P211, DOI 10.1016/S0140-6736(02)09458-8; Mouncey PR, 2015, NEW ENGL J MED, V372, P1301, DOI 10.1056/NEJMoa1500896; Nguyen HB, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1288-3; Ninis N, 2005, BRIT MED J, V330, P1475, DOI 10.1136/bmj.330.7506.1475; Okike IO, 2014, LANCET INFECT DIS, V14, P301, DOI 10.1016/S1473-3099(13)70332-3; party BSoACBw, BSAC DISC DIFF METH; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Peltola H, 2001, CLIN INFECT DIS, V32, P64, DOI 10.1086/317534; RANKIN J, 1957, Scott Med J, V2, P254; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Scarborough M, 2007, NEW ENGL J MED, V357, P2441, DOI 10.1056/NEJMoa065711; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Townsend SR, 2008, CLIN CHEST MED, V29, P721, DOI 10.1016/j.ccm.2008.06.011; Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; Wall EC, 2016, CLIN INFECT DIS OFFI; Wall EC, 2017, CLIN INFECT DIS, V64, P413, DOI 10.1093/cid/ciw779; Wall EC, 2014, J INFECTION, V69, P440, DOI 10.1016/j.jinf.2014.06.011; Wall EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069783; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602; Yu H, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008330	52	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186687	10.1371/journal.pone.0186687	http://dx.doi.org/10.1371/journal.pone.0186687			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077720	Green Published, Green Accepted, gold			2022-12-26	WOS:000413861200017
J	Morgan, MT; Nguyen, LAH; Hancock, HL; Fahrni, CJ				Morgan, M. Thomas; Nguyen, Lily Anh H.; Hancock, Haylie L.; Fahrni, Christoph J.			Glutathione limits aquacopper(I) to sub-femtomolar concentrations through cooperative assembly of a tetranuclear cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						copper; metal homeostasis; peptides; spectroscopy; thermodynamics; phosphorescence; potentiometry	SYNTHETIC FLUORESCENT-PROBES; X-RAY-ABSORPTION; PROTEIN INTERACTIONS; COPPER(I) COMPLEXES; THIOLATE CLUSTERS; CU(I); REDOX; SPECIATION; CRYSTAL; CELL	The tripeptide glutathione (GSH) is a crucial intracellular reductant and radical scavenger, but it may also coordinate the soft Cu(I) cation and thereby yield pro-oxidant species. The GSH-Cu(I) interaction is thus a key consideration for both redox and copper homeostasis in cells. However, even after nearly four decades of investigation, the nature and stability of the GSH-Cu(I) complexes formed under biologically relevant conditions remain controversial. Here, we revealed the unexpected predominance of a tetranuclear [Cu-4(GS)(6)] cluster that is sufficiently stable to limit the effective free aquacopper(I) concentration to the sub-femtomolar regime. Combined spectrophotometric-potentiometric titrations at biologically realistic GSH/Cu(I) ratios, enabled by our recently developed Cu(I) affinity standards and corroborated by low-temperature phosphorescence studies, established cooperative assembly of [Cu-4(GS)(6)] as the dominant species over a wide pH range, from 5.5 to 7.5. Our robust model for the glutathione-Cu(I) equilibrium system sets a firm upper limit on the thermodynamic availability of intracellular copper that is 3 orders of magnitude lower than previously estimated. Taking into account their ability to catalyze the production of deleterious superoxide, the formation of Cu(I)-glutathione complexes might be avoided under normal physiological conditions. The actual intracellular Cu(I) availability may thus be regulated a further 3 orders of magnitude below the GSH/Cu(I) affinity limit, consistent with the most recent affinity determinations of Cu(I) chaperones.	[Morgan, M. Thomas; Nguyen, Lily Anh H.; Hancock, Haylie L.; Fahrni, Christoph J.] Georgia Inst Technol, Sch Chem & Biochem, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Fahrni, CJ (corresponding author), Sch Chem & Biochem, 901 Atlantic Dr, Atlanta, GA 30332 USA.; Fahrni, CJ (corresponding author), Petit Inst Bioengn & Biosci, 315 Ferst Dr, Atlanta, GA 30332 USA.	fahrni@chemistry.gatech.edu		Morgan, Michael Thomas/0000-0003-3308-1567	National Institutes of Health [GM067169]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067169] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM067169. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alderighi L, 1999, COORDIN CHEM REV, V184, P311, DOI 10.1016/S0010-8545(98)00260-4; Allen S, 2012, BIOCHEMISTRY-US, V51, P1439, DOI 10.1021/bi201370r; [Anonymous], 2004, NIST STANDARD REFERE; Bagchi P, 2013, J AM CHEM SOC, V135, P18549, DOI 10.1021/ja408827d; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; BAUMGARTNER M, 1993, J SOLID STATE CHEM, V107, P63, DOI 10.1006/jssc.1993.1324; Benitez JJ, 2008, J AM CHEM SOC, V130, P2446, DOI 10.1021/ja7107867; Benitez JJ, 2011, FARADAY DISCUSS, V148, P71, DOI 10.1039/c004913a; Binstead R. A., 2001, SPECFIT GLOBAL ANAL; Brugger J, 2007, COMPUT GEOSCI-UK, V33, P248, DOI 10.1016/j.cageo.2006.06.011; Coppola S, 2000, BIOCHEM SOC T, V28, P56, DOI 10.1042/bst0280056; Corazza A, 1996, EUR J BIOCHEM, V236, P697, DOI 10.1111/j.1432-1033.1996.0697d.x; Cotgreave IA, 1998, BIOCHEM BIOPH RES CO, V242, P1, DOI 10.1006/bbrc.1997.7812; Cotruvo JA, 2015, CHEM SOC REV, V44, P4400, DOI 10.1039/c4cs00346b; DANCE IG, 1978, AUST J CHEM, V31, P2195, DOI 10.1071/CH9782195; DANCE IG, 1983, POLYHEDRON, V2, P1031, DOI 10.1016/S0277-5387(00)81450-3; Fahrni CJ, 2013, CURR OPIN CHEM BIOL, V17, P656, DOI 10.1016/j.cbpa.2013.05.019; Faller P, 2010, FEBS J, V277, P2921, DOI 10.1111/j.1742-4658.2010.07717.x; Fujisawa K, 1998, INORG CHEM, V37, P168, DOI 10.1021/ic971317b; Hatori Y, 2016, ANTIOXIDANTS-BASEL, V5, DOI 10.3390/antiox5030025; Henkel G, 2004, CHEM REV, V104, P801, DOI 10.1021/cr020620d; Johnson DK, 2015, DALTON T, V44, P16494, DOI 10.1039/c5dt02689j; Keller AM, 2012, J AM CHEM SOC, V134, P8934, DOI 10.1021/ja3018835; Konigsberger LC, 2015, DALTON T, V44, P20413, DOI 10.1039/c5dt02129d; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Maiti BK, 2007, EUR J INORG CHEM, P5548, DOI 10.1002/ejic.200700784; Martell A. E., 1974, CRITICAL STABILITY C; Maryon EB, 2013, AM J PHYSIOL-CELL PH, V304, pC768, DOI 10.1152/ajpcell.00417.2012; Menon SG, 2007, ONCOGENE, V26, P1101, DOI 10.1038/sj.onc.1209895; Meyer AJ, 2005, PHOTOSYNTH RES, V86, P435, DOI 10.1007/s11120-005-8425-1; Morgan MT, 2016, CHEM SCI, V7, P1468, DOI [10.1039/c5sc03643g, 10.1039/C5SC03643G]; Newton GL, 2009, NAT CHEM BIOL, V5, P625, DOI 10.1038/nchembio.189; Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996; Ohrvika H, 2013, P NATL ACAD SCI USA, V110, pE4279, DOI 10.1073/pnas.1311749110; OSTERBERG R, 1979, J INORG BIOCHEM, V10, P341, DOI 10.1016/S0162-0134(00)80200-7; Pastore A, 2003, CLIN CHIM ACTA, V333, P19, DOI 10.1016/S0009-8981(03)00200-6; Poger D, 2008, J BIOL INORG CHEM, V13, P1239, DOI 10.1007/s00775-008-0408-1; POUNTNEY DL, 1994, BIOCHEMISTRY-US, V33, P9699, DOI 10.1021/bi00198a040; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Pushkar Y, 2013, AGING CELL, V12, P823, DOI 10.1111/acel.12112; Roschitzki B, 2002, J BIOL INORG CHEM, V7, P611, DOI 10.1007/s00775-002-0339-1; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Scheller JS, 2017, METALLOMICS, V9, P447, DOI 10.1039/c7mt00041c; Shen C, 2015, METALLOMICS, V7, P56, DOI 10.1039/c4mt00288a; Speisky H, 2008, BIOORGAN MED CHEM, V16, P6568, DOI 10.1016/j.bmc.2008.05.026; Vita N, 2015, NATURE, V525, P140, DOI 10.1038/nature14854; Walsh MJ, 2013, J INORG BIOCHEM, V128, P112, DOI 10.1016/j.jinorgbio.2013.07.012; Wegner SV, 2011, CHEM COMMUN, V47, P2571, DOI 10.1039/c0cc04292g; Xiao ZG, 2011, J BIOL CHEM, V286, P11047, DOI 10.1074/jbc.M110.213074	49	41	40	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21558	21567		10.1074/jbc.M117.817452	http://dx.doi.org/10.1074/jbc.M117.817452			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29101230	Green Published, hybrid			2022-12-26	WOS:000419013000030
J	Peeler, JC; Schedin-Weiss, S; Soula, M; Kazmi, MA; Sakmar, TP				Peeler, Jennifer C.; Schedin-Weiss, Sophia; Soula, Mariluz; Kazmi, Manija A.; Sakmar, Thomas P.			Isopeptide and ester bond ubiquitination both regulate degradation of the human dopamine receptor 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dopamine receptor; G protein-coupled receptor (GPCR); proteasome; protein degradation; ubiquitylation (ubiquitination)	NON-LYSINE UBIQUITINATION; ENDOPLASMIC-RETICULUM; ADRENERGIC-RECEPTOR; E3 LIGASE; PROTEIN; RESIDUES; PROTEASOME; COMPLEX; SERINE; UBIQUITYLATION	How an optimal level of human dopamine D4 receptor (hD4R) is maintained in synaptic membranes is not known. We show here that hD4R is ubiquitinated in primary neurons. We go on to show that ubiquitin is attached to hD4R through isopeptide and ester bonds. When lysine (Lys) residues of the hD4R are substituted with arginine (Arg) residues, cellular hD4R protein levels increase. A synergistic effect on hD4R levels is noted when cytoplasmic serine (Ser) and threonine (Thr) residues are mutated. Chloroquine, an inhibitor of lysosomal degradation, did not have an effect on hD4R protein levels. However, treatment with bortezomib, an inhibitor of the 20S proteasome, caused a dose-dependent increase in hD4R protein levels. The effect of bortezomib was attenuated in the receptor variants that lacked Lys or Ser/Thr residues, and the hD4R mutant that lacked 17 cytoplasmic Lys, Ser, and Thr residues was nearly insensitive to bortezomib treatment. We conclude that both isopeptide and ester bond ubiquitination regulate proteasomal degradation of hD4R.	[Peeler, Jennifer C.; Soula, Mariluz; Kazmi, Manija A.; Sakmar, Thomas P.] Rockefeller Univ, Lab Chem Biol & Signal Transduct, 1230 York Ave,Box 187, New York, NY 10065 USA; [Schedin-Weiss, Sophia; Sakmar, Thomas P.] Karolinska Inst, Div Neurogeriatr, Dept Neurobiol Care Sci & Soc, Ctr Alzheimer Res, S-14157 Huddinge, Sweden	Rockefeller University; Karolinska Institutet	Sakmar, TP (corresponding author), Rockefeller Univ, Lab Chem Biol & Signal Transduct, 1230 York Ave,Box 187, New York, NY 10065 USA.	sakmar@rockefeller.edu		Schedin Weiss, Sophia/0000-0003-2143-7052	National Science Foundation Graduate Research Fellowships Program [DGE-1325261]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM083688] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowships Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by the National Science Foundation Graduate Research Fellowships Program under Grant DGE-1325261.	Andersson RH, 2012, P NATL ACAD SCI USA, V109, P13118, DOI 10.1073/pnas.1201011109; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Bhandari D, 2009, MOL BIOL CELL, V20, P1324, DOI 10.1091/mbc.E08-03-0308; Boban M, 2015, J BIOL CHEM, V290, P2489, DOI 10.1074/jbc.M114.600593; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Chang FM, 1996, HUM GENET, V98, P91, DOI 10.1007/s004390050166; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Domingues C, 2012, CELL DEATH DIFFER, V19, P470, DOI 10.1038/cdd.2011.116; Fath T, 2009, NAT PROTOC, V4, P78, DOI 10.1038/nprot.2008.199; Furth KE, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00102; Gilkerson J, 2015, PLANT PHYSIOL, V168, P708, DOI 10.1104/pp.15.00402; Golnik R, 2016, J BIOL CHEM, V291, P8805, DOI 10.1074/jbc.M115.705178; Ishikura S, 2010, J BIOL CHEM, V285, P23916, DOI 10.1074/jbc.M110.127936; Kazmi MA, 2000, BIOCHEMISTRY-US, V39, P3734, DOI 10.1021/bi992354c; Kocsis B, 2014, BRAIN STRUCT FUNCT, V219, P2173, DOI 10.1007/s00429-013-0607-6; LICHTER JB, 1993, HUM MOL GENET, V2, P767, DOI 10.1093/hmg/2.6.767; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; Marchese A, 2001, J BIOL CHEM, V276, P45509, DOI 10.1074/jbc.C100527200; Nikolaidis A, 2010, SOC COGN AFFECT NEUR, V5, P188, DOI 10.1093/scan/nsp049; Palombella VJ, 1998, P NATL ACAD SCI USA, V95, P15671, DOI 10.1073/pnas.95.26.15671; Petaja-Repo UE, 2001, J BIOL CHEM, V276, P4416, DOI 10.1074/jbc.M007151200; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rondou P, 2008, J BIOL CHEM, V283, P11083, DOI 10.1074/jbc.M708473200; Schedin-Weiss S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063962; Shimizu Y, 2010, MOL CELL, V40, P917, DOI 10.1016/j.molcel.2010.11.033; Skieterska K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18050923; Skieterska K, 2016, CELL SIGNAL, V28, P1001, DOI 10.1016/j.cellsig.2016.05.003; Skieterska K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145654; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Spooren A, 2010, CELL SIGNAL, V22, P600, DOI 10.1016/j.cellsig.2009.11.013; Tokarev AA, 2011, J VIROL, V85, P51, DOI 10.1128/JVI.01795-10; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; VANTOL HHM, 1991, NATURE, V350, P610, DOI 10.1038/350610a0; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063	34	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21623	21630		10.1074/jbc.M116.758961	http://dx.doi.org/10.1074/jbc.M116.758961			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29101232	Green Published, hybrid			2022-12-26	WOS:000419013000036
J	Warner, MD; Azmi, IF; Kang, S; Zhao, YD; Bell, SP				Warner, Megan D.; Azmi, Ishara F.; Kang, Sukhyun; Zhao, Yanding; Bell, Stephen P.			Replication origin-flanking roadblocks reveal origin-licensing dynamics and altered sequence dependence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases associated with diverse cellular activities (AAA); cell cycle; DNA helicase; DNA replication; DNA-protein interaction; nucleosome; Saccharomyces cerevisiae; cdt1; helicase loading; origin of replication	DNA-REPLICATION; RECOGNITION COMPLEX; BUDDING YEAST; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL ELEMENTS; CMG HELICASE; BINDING-SITE; ORC; INITIATION; CHROMOSOME	In eukaryotes, DNA replication initiates from multiple origins of replication for timely genome duplication. These sites are selected by origin licensing, during which the core enzyme of the eukaryotic DNA replicative helicase, the Mcm2-7 (minichromosome maintenance) complex, is loaded at each origin. This origin licensing requires loading two Mcm2-7 helicases around origin DNA in a head-to-head orientation. Current models suggest that the origin-recognition complex (ORC) and cell-division cycle 6 (Cdc6) proteins recognize and encircle origin DNA and assemble an Mcm2-7 double-hexamer around adjacent double-stranded DNA. To test this model and assess the location of Mcm2-7 initial loading, we placed DNA-protein roadblocks at defined positions adjacent to the essential ORC-binding site within Saccharomyces cerevisiae origin DNA. Roadblocks were made either by covalent cross-linking of the HpaII methyltransferase to DNA or through binding of a transcription activator-like effector (TALE) protein. Contrary to the sites of Mcm2-7 recruitment being precisely defined, only single roadblocks that inhibited ORC-DNA binding showed helicase loading defects. We observed inhibition of helicase loading without inhibition of ORC-DNA binding only when roadblocks were placed on both sides of the origin to restrict sliding of a helicase-loading intermediate. Consistent with a sliding helicase-loading intermediate, when either one of the flanking roadblocks was eliminated, the remaining roadblock had no effect on helicase loading. Interestingly, either origin-flanking nucleosomes or roadblocks resulted in helicase loading being dependent on an additional origin sequence known to be a weaker ORC-DNA-binding site. Together, our findings support a model in which sliding helicase-loading intermediates increase the flexibility of the DNA sequence requirements for origin licensing.	[Warner, Megan D.; Azmi, Ishara F.; Kang, Sukhyun; Bell, Stephen P.] MIT, Howard Hughes Med Inst, Dept Biol, Rm 68-630,77 Massachusetts Ave, Cambridge, MA 02139 USA; [Zhao, Yanding] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; [Kang, Sukhyun] Inst Basic Sci, Ctr Genom Integr, Ulsan 44919, South Korea; [Zhao, Yanding] Geisel Sch Med Dartmouth, Dept Mol & Syst Biol, Hanover, NH 03755 USA; [Bell, Stephen P.] Howard Hughes Med Inst, Cambridge, MA USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Brandeis University; Institute for Basic Science - Korea (IBS); Dartmouth College; Howard Hughes Medical Institute	Bell, SP (corresponding author), MIT, Howard Hughes Med Inst, Dept Biol, Rm 68-630,77 Massachusetts Ave, Cambridge, MA 02139 USA.	spbell@mit.edu		Kang, Sukhyun/0000-0002-7567-0231; Bell, Stephen/0000-0002-2876-610X	Koch Institute Support Grant from the NCI, National Institutes of Health [P30-CA14051]; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER	Koch Institute Support Grant from the NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Koch Institute Support Grant P30-CA14051 from the NCI, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Azmi IF, 2017, ELIFE, V6, DOI 10.7554/eLife.22512; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Bell SP, 2016, GENETICS, V203, P1027, DOI 10.1534/genetics.115.186452; Berbenetz NM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001092; Bleichert F, 2015, NATURE, V519, P321, DOI 10.1038/nature14239; Bleichert F, 2013, ELIFE, V2, DOI 10.7554/eLife.00882; BROACH JR, 1982, COLD SPRING HARB SYM, V47, P1165, DOI 10.1101/SQB.1983.047.01.132; Chang F, 2008, MOL CELL BIOL, V28, P5071, DOI 10.1128/MCB.00206-08; Chang FJ, 2011, NUCLEIC ACIDS RES, V39, P6523, DOI 10.1093/nar/gkr301; CHEN L, 1991, BIOCHEMISTRY-US, V30, P11018, DOI 10.1021/bi00110a002; Chen SY, 2011, GENE DEV, V25, P363, DOI 10.1101/gad.2011511; Coster G, 2017, SCIENCE, V357, P314, DOI 10.1126/science.aan0063; Crampton A, 2008, MOL CELL, V30, P156, DOI 10.1016/j.molcel.2008.02.019; DIFFLEY JFX, 1988, P NATL ACAD SCI USA, V85, P2120, DOI 10.1073/pnas.85.7.2120; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Duxin JP, 2014, CELL, V159, P346, DOI 10.1016/j.cell.2014.09.024; Eaton ML, 2010, GENE DEV, V24, P748, DOI 10.1101/gad.1913210; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Frigola J, 2013, NATURE, V495, P339, DOI 10.1038/nature11920; Fu YV, 2011, CELL, V146, P930, DOI 10.1016/j.cell.2011.07.045; Georgescu R, 2017, P NATL ACAD SCI USA, V114, pE697, DOI 10.1073/pnas.1620500114; HUANG RY, 1993, EMBO J, V12, P4521, DOI 10.1002/j.1460-2075.1993.tb06141.x; Kang S, 2014, MOL CELL, V55, P655, DOI 10.1016/j.molcel.2014.06.033; Lee DG, 1997, MOL CELL BIOL, V17, P7159, DOI 10.1128/MCB.17.12.7159; Liachko I, 2013, GENOME RES, V23, P698, DOI 10.1101/gr.144659.112; Lin S, 1997, MOL CELL BIOL, V17, P5473, DOI 10.1128/MCB.17.9.5473; Lipford JR, 2001, MOL CELL, V7, P21, DOI 10.1016/S1097-2765(01)00151-4; Long DT, 2014, MOL CELL, V56, P174, DOI 10.1016/j.molcel.2014.08.012; MARAHRENS Y, 1992, SCIENCE, V255, P817, DOI 10.1126/science.1536007; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; RAO H, 1994, MOL CELL BIOL, V14, P7643, DOI 10.1128/MCB.14.11.7643; RAO H, 1995, P NATL ACAD SCI USA, V92, P2224, DOI 10.1073/pnas.92.6.2224; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; ROWLEY A, 1995, EMBO J, V14, P2631, DOI 10.1002/j.1460-2075.1995.tb07261.x; SIMPSON RT, 1990, NATURE, V343, P387, DOI 10.1038/343387a0; Speck C, 2005, NAT STRUCT MOL BIOL, V12, P965, DOI 10.1038/nsmb1002; Sun JC, 2014, GENE DEV, V28, P2291, DOI 10.1101/gad.242313.114; Sun JC, 2013, NAT STRUCT MOL BIOL, V20, P944, DOI 10.1038/nsmb.2629; THEIS JF, 1994, MOL CELL BIOL, V14, P7652, DOI 10.1128/MCB.14.11.7652; Ticau S, 2017, NAT STRUCT MOL BIOL, V24, P309, DOI 10.1038/nsmb.3375; Ticau S, 2015, CELL, V161, P513, DOI 10.1016/j.cell.2015.03.012; Tocilj A, 2017, ELIFE, V6, DOI 10.7554/eLife.20818; Wilmes GM, 2002, P NATL ACAD SCI USA, V99, P101, DOI 10.1073/pnas.012578499; Xu WH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-276; Yuan ZN, 2017, NAT STRUCT MOL BIOL, V24, P316, DOI 10.1038/nsmb.3372; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000	47	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21417	21430		10.1074/jbc.M117.815639	http://dx.doi.org/10.1074/jbc.M117.815639			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29074622	Green Published, hybrid			2022-12-26	WOS:000419013000018
J	Henderson, JC; Herrera, CM; Trent, MS				Henderson, Jeremy C.; Herrera, Carmen M.; Trent, M. Stephen			AlmG, responsible for polymyxin resistance in pandemic Vibrio cholerae, is a glycyltransferase distantly related to lipid A late acyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; LIPOTEICHOIC ACID; TEICHOIC-ACID; D-ALANINE; LIPOPOLYSACCHARIDE; MUTANT; GENES; LPS; IDENTIFICATION; BIOSYNTHESIS	Cationic antimicrobial peptides (CAMPs), such as polymyxins, are used as a last-line defense in treatment of many bacterial infections. However, some bacteria have developed resistance mechanisms to survive these compounds. Current pandemic O1 Vibrio cholerae biotype El Tor is resistant to polymyxins, whereas a previous pandemic strain of the biotype Classical is polymyxin-sensitive. The almEFG operon found in El Tor V. cholerae confers >100-fold resistance to antimicrobial peptides through aminoacylation of lipopolysaccharide (LPS), expected to decrease the negatively charged surface of the V. cholerae outer membrane. This Gram-negative system bears striking resemblance to a related Gram-positive cell-wall remodeling strategy that also promotes CAMP resistance. Mutants defective in AlmEF-dependent LPS modification exhibit reduced fitness in vivo. Here, we present investigation of AlmG, the hitherto uncharacterized member of the AlmEFG pathway. Evidence for AlmG glycyl to lipid substrate transferase activity is demonstrated in vivo by heterologous expression of V. cholerae pathway enzymes in a specially engineered Escherichia coli strain. Development of a minimal keto-deoxyoctulosonate (Kdo)-lipidAdomain in E. coli was necessary to facilitate chemical structure analysis and to produce a mimetic Kdo-lipid A domain AlmG substrate to that synthesized by V. cholerae. Our biochemical studies support a uniquely nuanced pathway of Gram-negative CAMPs resistance and provide a more detailed description of an enzyme of the pharmacologically relevant lysophosphospholipid acyltransferase (LPLAT) superfamily.	[Henderson, Jeremy C.; Herrera, Carmen M.; Trent, M. Stephen] Univ Georgia, Coll Vet Med, Ctr Vaccines & Immunol, Dept Infect Dis, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Trent, MS (corresponding author), Univ Georgia, Coll Vet Med, Ctr Vaccines & Immunol, Dept Infect Dis, Athens, GA 30602 USA.	strent@uga.edu		Henderson, Jeremy/0000-0001-6509-0842	National Institute of Health [RO1 AI076322]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076322] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Health Grant RO1 AI076322 (to M. S. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427; Bilecen K, 2015, INFECT IMMUN, V83, P1199, DOI 10.1128/IAI.02700-14; Boll JM, 2015, MBIO, V6, DOI 10.1128/mBio.00478-15; Brabetz W, 1997, EUR J BIOCHEM, V247, P716, DOI 10.1111/j.1432-1033.1997.00716.x; Brown S, 2012, P NATL ACAD SCI USA, V109, P18909, DOI 10.1073/pnas.1209126109; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; Clements A, 2007, J BIOL CHEM, V282, P15569, DOI 10.1074/jbc.M701454200; Clementz T, 1996, J BIOL CHEM, V271, P12095, DOI 10.1074/jbc.271.20.12095; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dovala D, 2016, P NATL ACAD SCI USA, V113, pE6064, DOI 10.1073/pnas.1610746113; Dzieciatkowska M, 2007, BIOCHEMISTRY-US, V46, P14704, DOI 10.1021/bi701229k; Engskog MKR, 2011, CARBOHYD RES, V346, P1241, DOI 10.1016/j.carres.2011.04.030; Ernst R, 2016, J MOL BIOL, V428, P4776, DOI 10.1016/j.jmb.2016.08.013; Hankins JV, 2012, P NATL ACAD SCI USA, V109, P8722, DOI 10.1073/pnas.1201313109; Hankins JV, 2011, MOL MICROBIOL, V81, P1313, DOI 10.1111/j.1365-2958.2011.07765.x; Hankins JV, 2009, J BIOL CHEM, V284, P25804, DOI 10.1074/jbc.M109.022772; Heath RJ, 1998, J BACTERIOL, V180, P1425, DOI 10.1128/JB.180.6.1425-1430.1998; Henderson JC, 2014, ACS CHEM BIOL, V9, P2382, DOI 10.1021/cb500438x; Henderson JC, 2013, JOVE-J VIS EXP, DOI 10.3791/50623; Herrera CM, 2017, MOL MICROBIOL, V106, P582, DOI 10.1111/mmi.13835; Herrera CM, 2014, MBIO, V5, DOI 10.1128/mBio.02283-14; Herrera CM, 2010, MOL MICROBIOL, V76, P1444, DOI 10.1111/j.1365-2958.2010.07150.x; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Hug LA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.48, 10.1038/nmicrobiol.2016.48]; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Liu J, 2011, VIROLOGY, V417, P304, DOI 10.1016/j.virol.2011.06.005; Molinaro A, 2008, GLYCOBIOLOGY, V18, P260, DOI 10.1093/glycob/cwm140; Needham BD, 2013, NAT REV MICROBIOL, V11, P467, DOI 10.1038/nrmicro3047; Needham BD, 2013, P NATL ACAD SCI USA, V110, P1464, DOI 10.1073/pnas.1218080110; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Oger PM, 2015, SUBCELL BIOCHEM, V72, P383, DOI 10.1007/978-94-017-9918-8_19; Pasquina LW, 2013, CURR OPIN MICROBIOL, V16, P531, DOI 10.1016/j.mib.2013.06.014; Percy MG, 2014, ANNU REV MICROBIOL, V68, P81, DOI 10.1146/annurev-micro-091213-112949; PEREGO M, 1995, J BIOL CHEM, V270, P15598, DOI 10.1074/jbc.270.26.15598; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Reichmann NT, 2013, MICROBIOL-SGM, V159, P1868, DOI 10.1099/mic.0.069898-0; Rottig A, 2013, MICROBIOL MOL BIOL R, V77, P277, DOI 10.1128/MMBR.00010-13; Rubin EJ, 2014, MOL MICROBIOL, V91, P887, DOI 10.1111/mmi.12501; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Six DA, 2008, BIOCHEMISTRY-US, V47, P8623, DOI 10.1021/bi800873n; Tran AX, 2005, J BIOL CHEM, V280, P28186, DOI 10.1074/jbc.M505020200; Vorachek-Warren MK, 2002, J BIOL CHEM, V277, P14186, DOI 10.1074/jbc.M200408200; Wang JL, 2014, MAR DRUGS, V12, P1495, DOI 10.3390/md12031495; Yildiz F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086751; Yilmaz P, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01524; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839	51	23	23	1	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					21205	21215		10.1074/jbc.RA117.000131	http://dx.doi.org/10.1074/jbc.RA117.000131			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29101229	Green Published, hybrid			2022-12-26	WOS:000418453400034
J	Ludolph, N; Ploger, J; Giese, MA; Lig, W				Ludolph, Nicolas; Ploeger, Jannis; Giese, Martin A.; Ilg, Winfried			Motor expertise facilitates the accuracy of state extrapolation in perception	PLOS ONE			English	Article							CEREBELLUM; ADAPTATION; PREDICTION; MOTION; CONSEQUENCES; NETWORKS	Predicting the behavior of objects in the environment is an important requirement to overcome latencies in the sensorimotor system and realize precise actions in rapid situations. Internal forward models that were acquired during motor training might not only be used for efficiently controlling fast motor behavior but also to facilitate extrapolation performance in purely perceptual tasks. In this study, we investigated whether preceding virtual cart-pole balancing training facilitates the ability to extrapolate the virtual pole motion. Specifically, subjects had to report the expected pole orientation after an occlusion of the pole of 900ms duration. We compared a group of 10 subjects, proficient in performing the virtual cart-pole balancing task, to 10 naive subjects without motor experience in cart-pole balancing task. Our results demonstrate that preceding motor training increases the accuracy of pole movement extrapolation, although extrapolation is not trained explicitly. Additionally, we modelled subjects' behaviors and show that the difference in extrapolation performance can be explained by individual differences in the accuracy of internal forward models. When subjects are provided with feedback about the true orientation of the pole after the occlusion in a second phase of the experiment, both groups improve rapidly. The results indicate that the perceptual capability to extrapolate the state of the cart-pole system accurately is implicitly trained during motor learning. We discuss these results in the context of shared representations and action-perception transfer.	[Ludolph, Nicolas; Ploeger, Jannis; Giese, Martin A.; Ilg, Winfried] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cognit Neurol, Sect Computat Sensomotor, Tubingen, Germany; [Ludolph, Nicolas; Ploeger, Jannis; Giese, Martin A.; Ilg, Winfried] Univ Tubingen, Ctr Integrat Neurosci, Tubingen, Germany; [Ludolph, Nicolas] Int Max Planck Res Sch Cognit & Syst Neurosci, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen	Ludolph, N (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cognit Neurol, Sect Computat Sensomotor, Tubingen, Germany.; Ludolph, N (corresponding author), Univ Tubingen, Ctr Integrat Neurosci, Tubingen, Germany.; Ludolph, N (corresponding author), Int Max Planck Res Sch Cognit & Syst Neurosci, Tubingen, Germany.	nicolas.ludolph@uni-tuebingen.de		Ilg, Winfried/0000-0002-1537-1336	German National Academic Foundation; German Research Foundation [DFG GZ: KA 1258/15-1]; European Union Seventh Framework Programme [CogIMon H2020 ICT- 644727]; Human Frontiers Science Program [HFSP RGP0036/2016]; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of the University of Tubingen	German National Academic Foundation; German Research Foundation(German Research Foundation (DFG)); European Union Seventh Framework Programme(European Commission); Human Frontiers Science Program(Human Frontier Science Program); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of the University of Tubingen	NL would like to thank the German National Academic Foundation for granting a doctoral student fellowship. Financial support for this study has been received from the German Research Foundation (DFG GZ: KA 1258/15-1), European Union Seventh Framework Programme (CogIMon H2020 ICT- 644727) and the Human Frontiers Science Program (HFSP RGP0036/2016). We acknowledge the support by the Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of the University of Tubingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; BARTO AG, 1983, IEEE T SYST MAN CYB, V13, P834, DOI 10.1109/TSMC.1983.6313077; Blakemore SJ, 2003, EXP BRAIN RES, V153, P239, DOI 10.1007/s00221-003-1597-z; Blakemore SJ, 2001, NEUROREPORT, V12, P3741, DOI 10.1097/00001756-200112040-00027; Bohil CJ, 2011, NAT REV NEUROSCI, V12, P752, DOI 10.1038/nrn3122; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Casile A, 2006, CURR BIOL, V16, P69, DOI 10.1016/j.cub.2005.10.071; Christensen A, 2014, J NEUROSCI, V34, P6707, DOI 10.1523/JNEUROSCI.3276-13.2014; Deluca C, 2014, CORTEX, V58, P52, DOI 10.1016/j.cortex.2014.04.017; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Dingwell JB, 2002, J NEUROPHYSIOL, V88, P222, DOI 10.1152/jn.2002.88.1.222; Donchin O, 2012, J NEUROPHYSIOL, V107, P134, DOI 10.1152/jn.00007.2011; Engel A, 2008, EUR J NEUROSCI, V27, P2294, DOI 10.1111/j.1460-9568.2008.06200.x; Franklin DW, 2011, NEURON, V72, P425, DOI 10.1016/j.neuron.2011.10.006; Graf M, 2007, NEUROIMAGE, V36, pT22, DOI 10.1016/j.neuroimage.2007.03.017; Grush R., 2004, BEHAV BRAIN SCI, V27; Hasson CJ, 2012, J NEUROPHYSIOL, V108, P1349, DOI 10.1152/jn.00019.2012; Hecht H, 2001, PSYCHOL RES-PSYCH FO, V65, P3, DOI 10.1007/s004260000043; Higuchi S, 2007, CORTEX, V43, P350, DOI 10.1016/S0010-9452(08)70460-X; Ivry RB, 2002, ANN NY ACAD SCI, V978, P302, DOI 10.1111/j.1749-6632.2002.tb07576.x; Kleiner M., 2007, WHATS NEW PSYCHTOOLB; La Scaleia B, 2015, J NEUROPHYSIOL, V114, P1577, DOI 10.1152/jn.00475.2015; Ludolph N, 2017, SCI REP, V7, P325; Mehta B, 2002, J NEUROPHYSIOL, V88, P942, DOI 10.1152/jn.2002.88.2.942; Nagengast AJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000419; O'Reilly JX, 2008, J NEUROSCI, V28, P2252, DOI 10.1523/JNEUROSCI.2742-07.2008; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PRABLANC C, 1975, PERCEPT PSYCHOPHYS, V17, P325, DOI 10.3758/BF03203218; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Roth MJ, 2013, CURR BIOL, V23, P930, DOI 10.1016/j.cub.2013.04.027; Schubotz RI, 2007, TRENDS COGN SCI, V11, P211, DOI 10.1016/j.tics.2007.02.006; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Synofzik M, 2008, CURR BIOL, V18, P814, DOI 10.1016/j.cub.2008.04.071; Vahdat S, 2014, J NEUROSCI, V34, P2451, DOI 10.1523/JNEUROSCI.4291-13.2014; Vahdat S, 2011, J NEUROSCI, V31, P16907, DOI 10.1523/JNEUROSCI.2737-11.2011; Wolpert DM, 2011, NAT REV NEUROSCI, V12, P739, DOI 10.1038/nrn3112; Wolpert DM, 1998, NAT NEUROSCI, V1, P529, DOI 10.1038/2245; Yarrow K, 2009, NAT REV NEUROSCI, V10, P585, DOI 10.1038/nrn2672; Zago M, 2009, EXP BRAIN RES, V192, P571, DOI 10.1007/s00221-008-1691-3	40	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187666	10.1371/journal.pone.0187666	http://dx.doi.org/10.1371/journal.pone.0187666			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL7JU	29107970	Green Submitted, Green Published, gold			2022-12-26	WOS:000414424600056
J	Savira, F; Cao, LX; Wang, I; Yang, WD; Huang, K; Hua, Y; Jucker, BM; Willette, RN; Huang, L; Krum, H; Li, ZL; Fu, T; Wang, BH				Savira, Feby; Cao, Longxing; Wang, Ian; Yang, Wendi; Huang, Kevin; Hua, Yue; Jucker, Beat M.; Willette, Robert N.; Huang, Li; Krum, Henry; Li, Zhiliang; Fu, Tang; Wang, Bing Hui			Apoptosis signal-regulating kinase 1 inhibition attenuates cardiac hypertrophy and cardiorenal fibrosis induced by uremic toxins: Implications for cardiorenal syndrome	PLOS ONE			English	Article							ORGANIC ANION TRANSPORTERS; P-CRESYL SULFATE; NF-KAPPA-B; INDOXYL SULFATE; GROWTH-FACTOR; CARDIOVASCULAR-DISEASE; ANGIOTENSIN RECEPTOR; PROTEIN; EXPRESSION; INDUCTION	Intracellular accumulation of protein-bound uremic toxins in the setting of cardiorenal syndrome leads to adverse effects on cardiorenal cellular functions, where cardiac hypertrophy and cardiorenal fibrosis are the hallmarks. In this study, we sought to determine if Apoptosis Signal-Regulated Kinase 1 (ASKI), an upstream regulator of cellular stress response, mediates cardiac hypertrophy and cardiorenal fibrosis induced by indoxyl sulfate (IS) and p-cresol sulfate (PCS) in vitro, and whether ASK1 inhibition is beneficial to ameliorate these cellular effects. PCS augmented cardiac myocyte hypertrophy and fibroblast collagen synthesis (as determined by H-3-leucine and H-3-proline incorporation, respectively), similar to our previous finding with IS. IS and PCS also increased collagen synthesis of proximal tubular cells and renal mesangial cells. Pro-hypertrophic (alpha-skeletal muscle actin and beta-MHC) and pro-fibrotic genes (TGF-beta 1 and ctg) were induced by both IS and PCS. Western blot analyses revealed the activation of ASKI and downstream mitogen activated protein kinases (MAPKs) (p38MAPK and ERK1/2) as well as nuclear factor-kappa B (NF-kappa B) by IS and PCS. ASKI, OAT1/3, ERK1/2 and p38MAPK inhibitors suppressed all these effects. In summary, IS and PCS exhibit pro-hypertrophic and pro-fibrotic properties, at least in part, via the activation of ASKI and its downstream pathways. ASK1 inhibitor is an effective therapeutic agent to alleviate protein-bound uremic toxin-induced cardiac hypertrophy and cardiorenal fibrosis in vitro, and may be translated further for cardiorenal syndrome therapy.	[Savira, Feby; Cao, Longxing; Wang, Ian; Yang, Wendi; Huang, Kevin; Hua, Yue; Huang, Li; Krum, Henry; Fu, Tang; Wang, Bing Hui] Monash Univ, Ctr Cardiovasc Res & Educ Therapeut, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Cao, Longxing; Li, Zhiliang; Fu, Tang] Southern Med Univ, Zhujiang Hosp, Sch Med, Guangzhou, Guangdong, Peoples R China; [Hua, Yue] Southern Med Univ, Sch Tradit Chinese Med, Guangzhou, Guangdong, Peoples R China; [Jucker, Beat M.; Willette, Robert N.] GlaxoSmithKline, Heart Failure Discovery Performance Unit, King Of Prussia, PA USA	Monash University; Southern Medical University - China; Southern Medical University - China; GlaxoSmithKline	Wang, BH (corresponding author), Monash Univ, Ctr Cardiovasc Res & Educ Therapeut, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia.	bing.wang@monash.edu	Savira, Feby/AFU-5538-2022	Savira, Feby/0000-0002-0383-812X; Wang, Bing/0000-0001-9580-2548	National Health and Medical Research Council of Australia [546272, 1092642, 1087355]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by National Health and Medical Research Council of Australia [Program Grants 546272 and 1092642 (to HK) and Project Grant 1087355 (to BHW)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by National Health and Medical Research Council of Australia (Program Grants 546272 and 1092642 and Project Grant 1087355).	Accornero F, 2015, MOL CELL BIOL, V35, P2154, DOI 10.1128/MCB.00199-15; Castro NE, 2014, J BIOL CHEM, V289, P29001, DOI 10.1074/jbc.M114.600783; Colombo PC, 2012, HEART FAIL REV, V17, P177, DOI 10.1007/s10741-011-9261-3; Driesen RB, 2009, J CELL MOL MED, V13, P896, DOI 10.1111/j.1582-4934.2008.00523.x; Efstratiadis G, 2009, HIPPOKRATIA, V13, P224; Ehler E, 2013, JOVE-J VIS EXP, DOI 10.3791/50154; Enomoto A, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000022017.96399.B2; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Frangogiannis NG, 2008, PHARMACOL RES, V58, P88, DOI 10.1016/j.phrs.2008.06.007; Gerczuk PZ, 2012, J CARDIOVASC PHARM, V60, P276, DOI 10.1097/FJC.0b013e31825ea0fa; Gomez-Guerrero Carmen, 2005, Current Drug Targets - Inflammation and Allergy, V4, P341, DOI 10.2174/1568010054022169; Han H, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001852; Hefti MA, 1997, J MOL CELL CARDIOL, V29, P2873, DOI 10.1006/jmcc.1997.0523; Hoppensack A, 2014, TISSUE ENG PART C-ME, V20, P599, DOI [10.1089/ten.tec.2013.0446, 10.1089/ten.TEC.2013.0446]; Ito S, 2014, TOXINS, V6, P665, DOI 10.3390/toxins6020665; Kawarazaki Y, 2014, EXPERT OPIN THER TAR, V18, P651, DOI 10.1517/14728222.2014.896903; Kompa AR, 2013, INT J CARDIOL, V167, P210, DOI 10.1016/j.ijcard.2011.12.062; Koniari K, 2010, INT J NEPHROL, V2011; Lekawanvijit S, 2015, CIRC J, V79, P2088, DOI 10.1253/circj.CJ-15-0749; Lekawanvijit S, 2015, J RENAL NUTR, V25, P149, DOI 10.1053/j.jrn.2014.10.009; Lekawanvijit S, 2014, J PHYSIOL-LONDON, V592, P3969, DOI 10.1113/jphysiol.2014.273078; Lekawanvijit S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083687; Lekawanvijit S, 2010, EUR HEART J, V31, P1771, DOI 10.1093/eurheartj/ehp574; Lin CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132589; Lin HH, 2015, TOXICOL LETT, V234, P20, DOI 10.1016/j.toxlet.2015.02.003; Liu M, 2014, EUR REV MED PHARMACO, V18, P2918; Liu S, 2012, INT J CARDIOL, V158, P457, DOI 10.1016/j.ijcard.2012.05.022; Ma FY, 2014, AM J PHYSIOL-RENAL, V307, pF1263, DOI 10.1152/ajprenal.00211.2014; McCullough PA, 2011, WORLD J CARDIOL, V3, P1, DOI 10.4330/wjc.v3.i1.1; Meijers BKI, 2011, NEPHROL DIAL TRANSPL, V26, P759, DOI 10.1093/ndt/gfq818; Mochida Y, 2000, J BIOL CHEM, V275, P32747, DOI 10.1074/jbc.M003042200; Motojima M, 2003, KIDNEY INT, V63, P1671, DOI 10.1046/j.1523-1755.2003.00906.x; Muhlberger I, 2012, OMICS, V16, P105, DOI 10.1089/omi.2011.0121; Ronco C, 2008, J AM COLL CARDIOL, V52, P1527, DOI 10.1016/j.jacc.2008.07.051; Saito S, 2014, ENDOCRINOLOGY, V155, P1899, DOI 10.1210/en.2013-1937; SIMPSON P, 1985, CIRC RES, V56, P884, DOI 10.1161/01.RES.56.6.884; Thomas WG, 2002, CIRC RES, V90, P135, DOI 10.1161/hh0202.104109; Viaene L, 2013, BIOPHARM DRUG DISPOS, V34, P165, DOI 10.1002/bdd.1834; von Lueder TG, 2015, CIRC-HEART FAIL, V8, P71, DOI 10.1161/CIRCHEARTFAILURE.114.001785; Wadsworth SA, 1999, J PHARMACOL EXP THER, V291, P680; Wang YG, 2003, J MOL CELL CARDIOL, V35, P1083, DOI 10.1016/S0022-2828(03)00200-1; Watanabe H, 2014, CLIN EXP NEPHROL, V18, P814, DOI 10.1007/s10157-013-0902-9; Woodcock EA, 2002, J BIOL CHEM, V277, P22734, DOI 10.1074/jbc.M110405200; Zhao XW, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0046302, 10.1371/journal.pone.0029935]	44	21	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187459	10.1371/journal.pone.0187459	http://dx.doi.org/10.1371/journal.pone.0187459			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29107962	Green Published, Green Submitted, gold			2022-12-26	WOS:000414424600030
J	Wuerth, KC; Falsafi, R; Hancock, REW				Wuerth, Kelli C.; Falsafi, Reza; Hancock, Robert E. W.			Synthetic host defense peptide IDR-1002 reduces inflammation in Pseudomonas aeruginosa lung infection	PLOS ONE			English	Article							CYSTIC-FIBROSIS; ANTIMICROBIAL PEPTIDES; NOSOCOMIAL INFECTIONS; CATIONIC PEPTIDE; IMMUNE-RESPONSE; RAT MODEL; EPIDEMIOLOGY; MORBIDITY; STRAINS; GROWTH	Pseudomonas aeruginosa is a frequent cause of lung infections, particularly in chronic infections in cystic fibrosis patients. However, treatment is challenging due to P. aeruginosa evasion of the host immune system and the rise of antibiotic resistant strains. Host defense peptides (HDPs) and synthetic derivatives called innate defense regulators (IDRs) have shown promise in several infection models as an alternative to antibiotic treatment. Here we tested peptide IDR-1 002 against P. aeruginosa in vitro and in vivo. Treatment of bronchial epithelial cells and macrophages with IDR-1 002 or in combination with live P. aeruginosa or its LPS led to the reduction of agonist-induced cytokines and chemokines and limited cell killing by live P. aeruginosa. In an in vivo model using P. aeruginosa combined with alginate to mimic a chronic model, IDR-1 002 did not reduce the bacterial burden in the lungs, but IDR-1 002 mice showed a significant decrease in IL-6 in the lungs and in gross pathology of infection, while histology revealed that IDR-1 002 treated mice had reduced alveolar macrophage infiltration around the site of infection and reduced inflammation. Overall, these results indicate that IDR-1002 has promise for combating P. aeruginosa lung infections and their resulting inflammation.	[Wuerth, Kelli C.; Falsafi, Reza; Hancock, Robert E. W.] Univ British Columbia, Ctr Microbial Dis & Immun Res, Dept Microbiol & Immunol, Vancouver, BC, Canada	University of British Columbia	Hancock, REW (corresponding author), Univ British Columbia, Ctr Microbial Dis & Immun Res, Dept Microbiol & Immunol, Vancouver, BC, Canada.	bob@hancocklab.com	Hancock, Robert E. W./E-1145-2013	Hancock, Robert E. W./0000-0001-5989-8503; Wuerth, Kelli/0000-0001-5260-9166	Canadian Institutes for Health Research [MOP-74493]; Cystic Fibrosis Canada	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Canada	This research was supported by the Canadian Institutes for Health Research (MOP-74493). KCW was supported by a Cystic Fibrosis Canada doctoral studentship while REWH received a Canada Research Chair in Health and Genomics and is a UBC Killam Professor.	Achtman AH, 2012, SCI TRANSL MED, V4; Al-Aloul M, 2004, THORAX, V59, P334, DOI 10.1136/thx.2003.014258; Aloush V, 2006, ANTIMICROB AGENTS CH, V50, P43, DOI 10.1128/AAC.50.1.43-48.2006; Barlow PG, 2010, AM J RESP CELL MOL, V43, P692, DOI 10.1165/rcmb.2009-0250OC; Bartlett KH, 2003, ANTIMICROB AGENTS CH, V47, P3901, DOI 10.1128/AAC.47.12.3901-3906.2003; CDC, 2013, ANTIBIOTIC RESISTANC; Chen YX, 2006, CHEM BIOL DRUG DES, V67, P162, DOI 10.1111/j.1747-0285.2006.00349.x; Cheng K, 1996, LANCET, V348, P639, DOI 10.1016/S0140-6736(96)05169-0; Choe H, 2015, CLIN ORTHOP RELAT R, V473, P2898, DOI 10.1007/s11999-015-4301-2; DARVEAU RP, 1983, J BACTERIOL, V155, P831, DOI 10.1128/JB.155.2.831-838.1983; Dunzendorfer S, 2004, J IMMUNOL, V173, P1166, DOI 10.4049/jimmunol.173.2.1166; Emerson J, 2002, PEDIATR PULM, V34, P91, DOI 10.1002/ppul.10127; FITZSIMMONS SC, 1993, J PEDIATR-US, V122, P1, DOI 10.1016/S0022-3476(05)83478-X; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; Gellatly SL, 2013, PATHOG DIS, V67, P159, DOI 10.1111/2049-632X.12033; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hilchie AL, 2013, NAT CHEM BIOL, V9, P761, DOI [10.1038/NCHEMBIO.1393, 10.1038/nchembio.1393]; Hilpert K, 2005, NAT BIOTECHNOL, V23, P1008, DOI 10.1038/nbt1113; Hilpert K, 2006, CHEM BIOL, V13, P1101, DOI 10.1016/j.chembiol.2006.08.014; Hoffmann N, 2005, INFECT IMMUN, V73, P2504, DOI 10.1128/IAI.73.4.2504-2514.2005; Hoffmann N, 2007, ANTIMICROB AGENTS CH, V51, P3677, DOI 10.1128/AAC.01011-06; Huante-Mendoza A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00533; Kukavica-Ibrulj I, 2008, LAB ANIM-UK, V42, P389, DOI 10.1258/la.2007.06014e; Kukavica-Ibrulj I, 2008, J BACTERIOL, V190, P2804, DOI 10.1128/JB.01572-07; Mardirossian M, 2016, AMINO ACIDS, V48, P2253, DOI 10.1007/s00726-016-2266-4; Mayhall CG, 2003, CLIN INFECT DIS, V37, P543, DOI 10.1086/376993; Mittal Rahul, 2009, J Infect Public Health, V2, P101, DOI 10.1016/j.jiph.2009.08.003; Mohamed MF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07440-0; Nijnik A, 2010, J IMMUNOL, V184, P2539, DOI 10.4049/jimmunol.0901813; Obritsch MD, 2005, PHARMACOTHERAPY, V25, P1353, DOI 10.1592/phco.2005.25.10.1353; Ray A, 2010, J VIS EXP; Reffuveille F, 2014, ANTIMICROB AGENTS CH, V58, P5363, DOI 10.1128/AAC.03163-14; Rivas-Santiago B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059119; Sabet M, 2009, ANTIMICROB AGENTS CH, V53, P3923, DOI 10.1128/AAC.00268-09; Schilbach K, 2008, J IMMUNOTHER, V31, P896, DOI 10.1097/CJI.0b013e31818955ad; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; Song ZJ, 2005, ANTIMICROB AGENTS CH, V49, P3868, DOI 10.1128/AAC.49.9.3868-3874.2005; Steinstraesser L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039373; van Heeckeren AM, 2002, LAB ANIM-UK, V36, P291, DOI 10.1258/002367702320162405; Vandamme D, 2012, CELL IMMUNOL, V280, P22, DOI 10.1016/j.cellimm.2012.11.009; WHO, 2017, ANT RES PRIOR PATH L; Wieczorek M, 2010, CHEM BIOL, V17, P970, DOI 10.1016/j.chembiol.2010.07.007; Winstanley C, 2009, GENOME RES, V19, P12, DOI 10.1101/gr.086082.108; Wu MH, 1999, ANTIMICROB AGENTS CH, V43, P1274, DOI 10.1128/AAC.43.5.1274; Zhang LJ, 2005, ANTIMICROB AGENTS CH, V49, P2921, DOI 10.1128/AAC.49.7.2921-2927.2005	45	19	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187565	10.1371/journal.pone.0187565	http://dx.doi.org/10.1371/journal.pone.0187565			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29107983	Green Published, gold, Green Submitted			2022-12-26	WOS:000414424600042
J	Dibattista, M; Lobasso, S; Stramaglia, S; Corcelli, A				Dibattista, Michele; Lobasso, Simona; Stramaglia, Sebastiano; Corcelli, Angela			Assessing olfactory functions in patients with Barth syndrome	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; ODOR IDENTIFICATION; CARDIOLIPIN; TASTE; DISCRIMINATION; LEUKOCYTES; BEHAVIOR	Barth syndrome is a rare X-linked disease affecting less than 200 individuals worldwide. Several comorbidities have been associated with the pathology and, among those, cardiac myopathy and neutropenia are the most life threatening. The appropriate nutritive support is important to sustain the everyday life of Barth syndrome patients given the chronic fatigue they experience. Since they often prefer salty and fried food, and avoid vegetables and fruits, their eating habit and food preferences do not always provide the proper amount of vitamins and amino acids. It has been indeed reported that Barth syndrome patients have altered taste sensitivity. As olfaction also contributes to food consumption and flavor perception, we decided to investigate their olfactory abilities using the "Sniffin' sticks' extended test". We found no significant difference in any of the tested olfactory abilities between the group of Barth syndrome patients and the healthy controls. In summary, altered food preference of Barth boys could not be easily explained with an altered olfactory perception.	[Dibattista, Michele; Lobasso, Simona; Corcelli, Angela] Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy; [Stramaglia, Sebastiano] Univ Bari Aldo Moro, Dept Phys, Bari, Italy; [Stramaglia, Sebastiano] INFN, Sez Bari, Bari, Italy; [Corcelli, Angela] IPCF CNR Sez Bari, Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Istituto Nazionale di Fisica Nucleare (INFN)	Corcelli, A (corresponding author), Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy.; Corcelli, A (corresponding author), IPCF CNR Sez Bari, Bari, Italy.	angela.corcelli@uniba.it	LOBASSO, SIMONA/AAN-9109-2020; DIBATTISTA, Michele/AAC-7621-2022	LOBASSO, SIMONA/0000-0003-3566-4547; DIBATTISTA, Michele/0000-0002-3955-4663; Corcelli, Angela/0000-0001-9658-8520	Italian Ministry of Education, University, and Research "Rita Levi Montalcini Award" [DM100915_685]; Regione Puglia Future in Research; University of Bari	Italian Ministry of Education, University, and Research "Rita Levi Montalcini Award"; Regione Puglia Future in Research; University of Bari	This study was supported by grants from Italian Ministry of Education, University, and Research "Rita Levi Montalcini Award" (DM100915_685 to M. Dibattista), Regione Puglia Future in Research (to S. Lobasso) and University of Bari (to A. Corcelli). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini R, 2015, J LIPID RES, V56, P1787, DOI 10.1194/jlr.D059824; BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; Barth PG, 1999, J INHERIT METAB DIS, V22, P555, DOI 10.1023/A:1005568609936; BEAUCHAMP GK, 1994, DEV PSYCHOBIOL, V27, P353, DOI 10.1002/dev.420270604; Boesveldt S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085977; Bowron A, 2013, J INHERIT METAB DIS, V36, P741, DOI 10.1007/s10545-012-9552-4; Cenedese V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116483; Clarke SLN, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-23; Croy I, 2014, CHEM SENSES, V39, P185, DOI 10.1093/chemse/bjt072; Dalton P, 2011, LARYNGOSCOPE, V121, P1843, DOI 10.1002/lary.21928; Di Bartolomeo M, 2017, C PROC SOC EXP MECH, P1, DOI 10.1007/978-3-319-15221-9_1; Donaldson LF, 2009, AM J CLIN NUTR, V90, p800S, DOI 10.3945/ajcn.2009.27462Q; GOODSPEED RB, 1987, POSTGRAD MED, V81, P251, DOI 10.1080/00325481.1987.11699680; Houtkooper RH, 2009, ANAL BIOCHEM, V387, P230, DOI 10.1016/j.ab.2009.01.032; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Lipchock SV, 2011, CLIN PERINATOL, V38, P627, DOI 10.1016/j.clp.2011.08.008; MENNELLA JA, 1993, PEDIATR RES, V34, P805, DOI 10.1203/00006450-199312000-00022; Mennella JA, 1998, NUTR REV, V56, P205, DOI 10.1111/j.1753-4887.1998.tb01749.x; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Mura CV, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0379-7; Nishizaki K, 2010, RHINOLOGY, V48, P228, DOI 10.4193/Rhin09.100; Olfaction Boesveldt S., 2017, SPRINGER HDB ODOR, P109; Reynolds Stacey, 2015, J Rare Disord, V3, P1; Reynolds S, 2015, J MULTIDISCIP HEALTH, V8, P345, DOI 10.2147/JMDH.S54802; Sala-Rabanal M, 2017, J BIOL CHEM, V292, P9164, DOI 10.1074/jbc.M117.788232; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Solaroglu I, 2007, FRONT BIOSCI-LANDMRK, V12, P712, DOI 10.2741/2095; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Stevenson RJ, 2010, CHEM SENSES, V35, P3, DOI 10.1093/chemse/bjp083; Tirindelli R, 2009, PHYSIOL REV, V89, P921, DOI 10.1152/physrev.00037.2008; Whited K, 2013, HUM MOL GENET, V22, P483, DOI 10.1093/hmg/dds447; Xu FY, 2010, BBA-BIOMEMBRANES, V1798, P1577, DOI 10.1016/j.bbamem.2010.04.007	33	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							e0187619	10.1371/journal.pone.0187619	http://dx.doi.org/10.1371/journal.pone.0187619			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6TA	29099864	Green Published, gold, Green Submitted			2022-12-26	WOS:000414377900033
J	Lei, XY; Huang, S				Lei, Xiaoyun; Huang, Shi			Enrichment of minor allele of SNPs and genetic prediction of type 2 diabetes risk in British population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COMPLEX TRAITS; VARIANTS; SMOKING; SCORE	Type 2 diabetes (T2D) is a complex disorder characterized by high blood sugar, insulin resistance, and relative lack of insulin. The collective effects of genome wide minor alleles of common SNPs, or the minor allele content (MAC) in an individual, have been linked with quantitative variations of complex traits and diseases. Here we studied MAC in T2D using previously published SNP datasets and found higher MAC in cases relative to matched controls. A set of 357 SNPs was found to have the best predictive accuracy in a British population. A weighted risk score calculated by using this set produced an area under the curve (AUC) score of 0.86, which is comparable to risk models built by phenotypic markers. These results identify a novel genetic risk element in T2D susceptibility and provide a potentially useful genetic method to identify individuals with high risk of T2D.	[Lei, Xiaoyun; Huang, Shi] Cent S Univ, Xiangya Med Sch, Sch Life Sci, Lab Med Genet, Changsha, Hunan, Peoples R China	Central South University	Huang, S (corresponding author), Cent S Univ, Xiangya Med Sch, Sch Life Sci, Lab Med Genet, Changsha, Hunan, Peoples R China.	huangshi@sklmg.edu.cn			National Natural Science Foundation of China [81171880]; National Basic Research Program of China [2011C1351001]; Central South University of China [2017zzts375]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Central South University of China	This work was supported by the National Natural Science Foundation of China [S.H. received the funding and grant number was 81171880]; the National Basic Research Program of China [S.H. received the funding and grant number was 2011C1351001]; and the research grant for postgraduate students provided by the Central South University of China [X.L. received the funding and grant number was 2017zzts375]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali O, 2013, WORLD J DIABETES, V4, P114, DOI 10.4239/wjd.v4.i4.114; Bao W, 2013, AM J EPIDEMIOL, V178, P1197, DOI 10.1093/aje/kwt123; Boyle EA, 2017, CELL, V169, P1177, DOI 10.1016/j.cell.2017.05.038; Brady MJ, 2004, J CLIN INVEST, V114, P886, DOI 10.1172/JC1200423108; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cornelis MC, 2009, ANN INTERN MED, V150, P541, DOI 10.7326/0003-4819-150-8-200904210-00008; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Euesden J, 2015, BIOINFORMATICS, V31, P1466, DOI 10.1093/bioinformatics/btu848; Forouhi Nita Gandhi, 2014, Medicine (Abingdon), V42, P698; Fuchsberger C, 2016, NATURE, V536, P41, DOI 10.1038/nature18642; Hagenaars SP, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006594; He P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12104-0; Hosmer DW, 1997, STAT MED, V16, P965; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang S., NAT P; Huang Shi, 2008, J Comput Sci Syst Biol, V1, P92; Huang S, 2016, GENOMICS, V108, P3, DOI 10.1016/j.ygeno.2016.01.008; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Jostins L, 2011, HUM MOL GENET, V20, pR182, DOI 10.1093/hmg/ddr378; Kang J, 2011, HUM MOL GENET, V20, P2435, DOI 10.1093/hmg/ddr116; Kapoor D, 2005, EUR J ENDOCRINOL, V152, P491, DOI 10.1530/eje.1.01867; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Lei DY Xiaoyun, 2017, 106864 BIORXIV; Lyssenko V, 2013, DIABETES CARE, V36, pS120, DOI 10.2337/dcS13-2009; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Okbay A, 2016, NATURE, V533, P539, DOI 10.1038/nature17671; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Talmud PJ, 2015, DIABETES, V64, P1830, DOI 10.2337/db14-1504; Talmud PJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4838; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Vassy JL, 2012, BEST PRACT RES CL EN, V26, P189, DOI 10.1016/j.beem.2011.09.002; Vazquez G, 2007, EPIDEMIOL REV, V29, P115, DOI 10.1093/epirev/mxm008; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yuan DJ, 2014, SCI CHINA LIFE SCI, V57, P876, DOI 10.1007/s11427-014-4704-4; Yuan XL Dejian, 2017, BIORXIV101410; Zhu ZB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133421	41	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							e0187644	10.1371/journal.pone.0187644	http://dx.doi.org/10.1371/journal.pone.0187644			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6TA	29099854	Green Submitted, gold, Green Published			2022-12-26	WOS:000414377900035
J	McLeod, A; Mosleth, EF; Rud, I; dos Santos, FB; Snipen, L; Liland, KH; Axelsson, L				McLeod, Anette; Mosleth, Ellen F.; Rud, Ida; dos Santos, Filipe Branco; Snipen, Lars; Liland, Kristian Hovde; Axelsson, Lars			Effects of glucose availability in Lactobacillus sakei; metabolic change and regulation of the proteome and transcriptome	PLOS ONE			English	Article							ARGININE DEIMINASE PATHWAY; ANAEROBIC GENE-EXPRESSION; OXIDATIVE STRESS-RESPONSE; CURVATUS ABO-ELNAGA; REPRESSOR REX; LACTATE-DEHYDROGENASE; STAPHYLOCOCCUS-AUREUS; STREPTOCOCCUS-MUTANS; EMENDED DESCRIPTIONS; CALORIC RESTRICTION	Effects of glucose availability were investigated in Lactobacillus sakei strains 23K and LS25 cultivated in anaerobic, glucose-limited chemostats set at high (D = 0.357 h(-1)) and low (D = 0.045 h(-1)) dilution rates. We observed for both strains a shift from homolactic towards more mixed acid fermentation when comparing high to low growth rates. However, this change was more pronounced for LS25 than for 23K, where dominating products were lactate > formate > acetate >= ethanol at both conditions. A multivariate approach was used for analyzing proteome and transcriptome data from the bacterial cultures, where the predictive power of the omics data was used for identifying features that can explain the differences in the end-product profiles. We show that the different degree of response to the same energy restriction revealed interesting strain specific regulation. An elevated formate production level during slow growth, more for LS25 than for 23K, was clearly reflected in correlating pyruvate formate lyase expression. With stronger effect for LS25, differential expression of the Rex transcriptional regulator and NADH oxidase, a target of Rex, indicated that maintainance of the cell redox balance, in terms of the NADH/NAD(+) ratio, may be a key process during the metabolic change. The results provide a better understanding of different strategies that cells may deploy in response to changes in substrate availability.	[McLeod, Anette; Mosleth, Ellen F.; Rud, Ida; Liland, Kristian Hovde; Axelsson, Lars] Nofima AS, Norwegian Inst Food Fisheries & Aquaculture Res, As, Norway; [dos Santos, Filipe Branco] Univ Amsterdam, Fac Sci, Swammerdam Inst Life Sci, Mol Microbial Physiol Grp, Amsterdam, Netherlands; [Snipen, Lars] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway	Nofima; University of Amsterdam; Norwegian University of Life Sciences	Axelsson, L (corresponding author), Nofima AS, Norwegian Inst Food Fisheries & Aquaculture Res, As, Norway.	lars.axelsson@nofima.no	Liland, Kristian Hovde/I-5871-2012	Liland, Kristian Hovde/0000-0001-6468-9423; Branco dos Santos, Filipe/0000-0002-4268-8080; McLeod, Anette/0000-0001-7350-1330	Foundation for Research Lew on Agricultural Products (Norway); National Program for Research in Functional Genomics (FUGE) of the Research Council of Norway	Foundation for Research Lew on Agricultural Products (Norway); National Program for Research in Functional Genomics (FUGE) of the Research Council of Norway	This work was funded by Foundation for Research Lew on Agricultural Products (Norway). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Kristina Vagonyte-Hallan for excellent technical assistance. The sequencing service and the mass spectrometry analysis were provided by the Norwegian Sequencing Centre hosted by University of Oslo (www.sequencing.uio.no) and the Proteomics Unit at the University of Bergen (www.uib.no/rg/probe), respectively, both national technology platforms supported by the National Program for Research in Functional Genomics (FUGE) of the Research Council of Norway.	Bachmann H, 2017, FEMS MICROBIOL REV, V41, pS201, DOI 10.1093/femsre/fux024; Barger JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120738; Berthier F, 1996, MICROBIOL-UK, V142, P1273, DOI 10.1099/13500872-142-5-1273; Bitoun JP, 2011, FEMS MICROBIOL LETT, V320, P110, DOI 10.1111/j.1574-6968.2011.02293.x; BREIMAN L, 1995, TECHNOMETRICS, V37, P373, DOI 10.2307/1269730; Chaillou S, 2005, NAT BIOTECHNOL, V23, P1527, DOI 10.1038/nbt1160; Champomier-Verges MC, 2002, RES MICROBIOL, V153, P115, DOI 10.1016/S0923-2508(01)01296-7; Fadda S, 1999, APPL ENVIRON MICROB, V65, P578; Fiedler T, 2011, APPL ENVIRON MICROB, V77, P612, DOI 10.1128/AEM.01838-10; Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020; Fuchs S, 2007, J BACTERIOL, V189, P4275, DOI 10.1128/JB.00081-07; Goel A, 2015, MOL MICROBIOL, V97, P77, DOI 10.1111/mmi.13012; Goel A, 2012, BIOTECHNOL LETT, V34, P2147, DOI 10.1007/s10529-012-1038-9; Green J, 2004, NAT REV MICROBIOL, V2, P954, DOI 10.1038/nrmicro1022; Hagen BF, 2000, MEAT SCI, V55, P161, DOI 10.1016/S0309-1740(99)00138-2; Hagopian K, 2005, FEBS LETT, V579, P2009, DOI 10.1016/j.febslet.2005.02.062; Hagopian K, 2003, EXP GERONTOL, V38, P267, DOI 10.1016/S0531-5565(02)00202-4; Huberts DHEW, 2012, FEMS YEAST RES, V12, P118, DOI 10.1111/j.1567-1364.2011.00767.x; Jonsson M, 2009, APPL ENVIRON MICROB, V75, P4901, DOI 10.1128/AEM.00344-09; Klein G, 1996, INT J SYST BACTERIOL, V46, P367, DOI 10.1099/00207713-46-2-367; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Langsrud O, 2002, J ROY STAT SOC D-STA, V51, P305, DOI 10.1111/1467-9884.00320; Lauret R, 1996, APPL ENVIRON MICROB, V62, P1922, DOI 10.1128/AEM.62.6.1922-1927.1996; Lipson DA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00615; Luo HZ, 2017, TRENDS ENDOCRIN MET, V28, P449, DOI 10.1016/j.tem.2017.02.008; McLeod A., 2013, GENOME ANNOUNC, V1; McLeod A, 2008, SYST APPL MICROBIOL, V31, P393, DOI 10.1016/j.syapm.2008.06.002; McLeod A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-145; McLeod A, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-120; Mehmeti I, 2012, APPL ENVIRON MICROB, V78, P170, DOI 10.1128/AEM.06604-11; Mehmeti I, 2011, APPL ENVIRON MICROB, V77, P2406, DOI 10.1128/AEM.02485-10; MONTEL MC, 1987, APPL ENVIRON MICROB, V53, P2683, DOI 10.1128/AEM.53.11.2683-2685.1987; Neyman J., 1937, PHILOS T R SOC S-A, V236, P333, DOI DOI 10.1098/RSTA.1937.0005; NOVICK A, 1950, SCIENCE, V112, P715, DOI 10.1126/science.112.2920.715; Nyquist OL, 2011, MOL GENET GENOMICS, V285, P297, DOI 10.1007/s00438-011-0608-1; Pagels M, 2010, MOL MICROBIOL, V76, P1142, DOI 10.1111/j.1365-2958.2010.07105.x; Ravcheev DA, 2012, J BACTERIOL, V194, P1145, DOI 10.1128/JB.06412-11; Rimaux T, 2012, APPL ENVIRON MICROB, V78, P4874, DOI 10.1128/AEM.07724-11; Rimaux T, 2011, APPL ENVIRON MICROB, V77, P6539, DOI 10.1128/AEM.00498-11; Rimaux T, 2011, FOOD MICROBIOL, V28, P597, DOI 10.1016/j.fm.2010.11.016; Rimaux T, 2013, RES MICROBIOL, V164, P216, DOI 10.1016/j.resmic.2012.11.004; Rud I, 2011, MICROB BIOTECHNOL, V4, P345, DOI 10.1111/j.1751-7915.2010.00223.x; Ruetenik A, 2015, BBA-BIOENERGETICS, V1847, P1434, DOI 10.1016/j.bbabio.2015.05.005; Sanz Y, 1999, INT J FOOD MICROBIOL, V53, P115, DOI 10.1016/S0168-1605(99)00134-8; Sauer U, 2005, FEMS MICROBIOL REV, V29, P765, DOI 10.1016/j.femsre.2004.11.002; TAKAHASHI S, 1982, J BACTERIOL, V149, P1034, DOI 10.1128/JB.149.3.1034-1040.1982; THOMAS TD, 1981, APPL ENVIRON MICROB, V41, P1289, DOI 10.1128/AEM.41.6.1289-1294.1981; THOMAS TD, 1979, J BACTERIOL, V138, P109, DOI 10.1128/JB.138.1.109-117.1979; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Torriani S, 1996, INT J SYST BACTERIOL, V46, P1158, DOI 10.1099/00207713-46-4-1158; van Hoek MJA, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-22; Vaudel M, 2011, PROTEOMICS, V11, P996, DOI 10.1002/pmic.201000595; Verges MCC, 1999, FEMS MICROBIOL LETT, V180, P297, DOI 10.1016/S0378-1097(99)00492-9; Von Wright A, 2012, LACTIC ACID BACTERIA: MICROBIOLOGICAL AND FUNCTIONAL ASPECTS, 4TH EDITION, P1; Wang E, 2008, MOL MICROBIOL, V69, P466, DOI 10.1111/j.1365-2958.2008.06295.x; WEINDRUCH R, 1988, J GERONTOL, V43, pB40, DOI 10.1093/geronj/43.2.B40; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; Zuniga M, 1998, J BACTERIOL, V180, P4154; Zuniga M, 2002, APPL ENVIRON MICROB, V68, P6051, DOI 10.1128/AEM.68.12.6051-6058.2002	59	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							e0187542	10.1371/journal.pone.0187542	http://dx.doi.org/10.1371/journal.pone.0187542			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6TA	29099858	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000414377900027
J	Phillips, HN; Heins, BJ; Delate, K; Turnbull, R				Phillips, Hannah N.; Heins, Bradley J.; Delate, Kathleen; Turnbull, Robert			Impact of grazing dairy steers on winter rye (Secale cereale) versus winter wheat (Triticum aestivum) and effects on meat quality, fatty acid and amino acid profiles, and consumer acceptability of organic beef	PLOS ONE			English	Article							SUBCUTANEOUS ADIPOSE-TISSUE; ABERDEEN ANGUS BREEDS; CARCASS CHARACTERISTICS; ANIMAL PERFORMANCE; PRODUCTION SYSTEMS; FEEDING SYSTEMS; BELGIAN BLUE; CATTLE; BULLS; PASTURE	Meat from Holstein and crossbred organic dairy steers finished on winter rye and winter wheat pastures was evaluated and compared for meat quality, fatty acid and amino acid profiles, and consumer acceptability. Two adjacent 4-ha plots were established with winter rye or winter wheat cover crops in September 2015 at the University of Minnesota West Central Research and Outreach Center (Morris, MN). During spring of 2015, 30 steers were assigned to one of three replicate breed groups at birth. Breed groups were comprised of: Holstein (HOL; n = 10), crossbreds comprised of Montbeliarde, Viking Red, and HOL (MVH; n = 10), and crossbreds comprised of Normande, Jersey, and Viking Red (NJV; n = 10). Dairy steers were maintained in their respective replicate breed group from three days of age until harvest. After weaning, steers were fed an organic total mixed ration of organic corn silage, alfalfa silage, corn, soybean meal, and minerals until spring 2016. Breed groups were randomly assigned to winter rye or winter wheat and rotationally grazed from spring until early summer of 2016. For statistical analysis, independent variables were fixed effects of breed, forage, and the interaction of breed and forage, with replicated group as a random effect. Specific contrast statements were used to compare HOL versus crossbred steers. Fat from crossbreds had 13% greater omega-3 fatty acids than HOL steers. Furthermore, the omega-6/3 ratio was 14% lower in fat from crossbreds than HOL steers. For consumer acceptability, steaks from steers grazed on winter wheat had greater overall liking than steers grazed on winter rye. Steak from crossbreeds had greater overall liking than HOL steers. The results suggest improvement in fatty acids and sensory attributes of beef from crossbred dairy steers compared to HOL steers, as well as those finished on winter wheat compared to winter rye.	[Phillips, Hannah N.; Heins, Bradley J.] Univ Minnesota, West Cent Res & Outreach Ctr, Morris, MN 56267 USA; [Phillips, Hannah N.; Heins, Bradley J.] Univ Minnesota, Dept Anim Sci, St Paul, MN 55108 USA; [Delate, Kathleen; Turnbull, Robert] Iowa State Univ, Dept Agron, Ames, IA USA; [Delate, Kathleen; Turnbull, Robert] Iowa State Univ, Dept Hort, Ames, IA USA	University of Minnesota System; University of Minnesota Morris; University of Minnesota System; University of Minnesota Twin Cities; Iowa State University; Iowa State University	Heins, BJ (corresponding author), Univ Minnesota, West Cent Res & Outreach Ctr, Morris, MN 56267 USA.; Heins, BJ (corresponding author), Univ Minnesota, Dept Anim Sci, St Paul, MN 55108 USA.	hein0106@umn.edu		Phillips, Hannah/0000-0003-3059-5765; Heins, Bradley/0000-0003-2186-9082	Organic Research and Extension Initiative from the USDA National Institute of Food and Agriculture [2014-51300-22541]	Organic Research and Extension Initiative from the USDA National Institute of Food and Agriculture	This work is supported by the Organic Research and Extension Initiative, grant no. 2014-51300-22541 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaia CPM, 2009, FOOD CHEM, V114, P939, DOI 10.1016/j.foodchem.2008.10.041; [Anonymous], [No title captured]; AOAC, 2002, 99606 AOAC INT; AOAC International, 2005, 99412 AOAC INT; Bjorklund EA, 2014, J DAIRY SCI, V97, P1828, DOI 10.3168/jds.2013-6984; Bjorklund EA, 2014, J DAIRY SCI, V97, P1817, DOI 10.3168/jds.2013-6983; Bonny SPF, 2016, ANIMAL, V10, P987, DOI 10.1017/S175173111500292X; Christensen M, 2011, MEAT SCI, V87, P61, DOI 10.1016/j.meatsci.2010.09.003; Clapham WM, 2005, J AGR FOOD CHEM, V53, P10068, DOI 10.1021/jf0517039; Covington MB, 2004, AM FAM PHYSICIAN, V70, P133; Cox RB, 2006, J FOOD SCI, V71, pS542, DOI 10.1111/j.1750-3841.2006.00124.x; Cuvelier C, 2006, MEAT SCI, V74, P522, DOI 10.1016/j.meatsci.2006.04.032; Cuvelier C, 2006, ANIM SCI, V82, P125, DOI 10.1079/ASC20057; Dabney SM, 2001, COMMUN SOIL SCI PLAN, V32, P1221, DOI 10.1081/CSS-100104110; Daley CA, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-10; Descalzo AM, 2005, MEAT SCI, V70, P35, DOI 10.1016/j.meatsci.2004.11.018; Destefanis G, 2000, MEAT SCI, V56, P255, DOI 10.1016/S0309-1740(00)00050-4; Dimitri C, 2009, ECONOMIC RES B, V58; Duckett SK, 2013, J ANIM SCI, V91, P1454, DOI 10.2527/jas.2012-5914; Gagaoua M, 2016, J INTEGR AGR, V15, P1550, DOI 10.1016/S2095-3119(16)61340-0; Garcia PT, 2008, MEAT SCI, V79, P500, DOI 10.1016/j.meatsci.2007.10.019; Gwin L, 2009, J SUSTAIN AGR, V33, P189, DOI 10.1080/10440040802660095; Leheska JM, 2008, J ANIM SCI, V86, P3575, DOI 10.2527/jas.2007-0565; Marley CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086259; McNamee A, 2015, LIVEST SCI, V173, P95, DOI 10.1016/j.livsci.2014.12.009; McNamee A, 2014, AGR FOOD SCI, V23, P266, DOI 10.23986/afsci.46431; Monson F, 2005, MEAT SCI, V71, P471, DOI 10.1016/j.meatsci.2005.04.026; Noci F, 2005, J ANIM SCI, V83, P1167; North American Meat Processors Association (NAMP), 2007, MEAT BUYERS GUID BEE; Nuernberg K, 2005, LIVEST PROD SCI, V94, P137, DOI 10.1016/j.livprodsci.2004.11.036; Patel M, 2016, GRASSL SCI EUR, V21, P369; Ponnampalam EN, 2006, ASIA PAC J CLIN NUTR, V15, P21; Razminowicz RH, 2006, MEAT SCI, V73, P351, DOI 10.1016/j.meatsci.2005.12.013; Realini CE, 2004, MEAT SCI, V66, P567, DOI 10.1016/S0309-1740(03)00160-8; Robertson A.R., 1977, COLOR RES APPL, V2, P5; SAS Institute Inc, 2014, SAS STAT SOFTW; Schmidt JR, 2013, J ANIM SCI, V91, P4451, DOI 10.2527/jas.2012-5405; Scollan N, 2006, MEAT SCI, V74, P17, DOI 10.1016/j.meatsci.2006.05.002; USDA-AMS, 2017, THE PROGR HDB; Zapletal D, 2009, LIVEST SCI, V123, P28, DOI 10.1016/j.livsci.2008.10.002	40	7	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							e0187686	10.1371/journal.pone.0187686	http://dx.doi.org/10.1371/journal.pone.0187686			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6TA	29099863	Green Published, Green Submitted, gold			2022-12-26	WOS:000414377900038
J	Platonova, N; Parravicini, C; Sensi, C; Paoli, A; Colombo, M; Neri, A; Eberini, I; Chiaramonte, R				Platonova, Natalia; Parravicini, Chiara; Sensi, Cristina; Paoli, Alessandro; Colombo, Michela; Neri, Antonino; Eberini, Ivano; Chiaramonte, Raffaella			Identification of small molecules uncoupling the Notch:: Jagged interaction through an integrated high-throughput screening	PLOS ONE			English	Article							CAUSES SPONDYLOCOSTAL DYSOSTOSIS; SQUAMOUS-CELL CARCINOMA; MULTIPLE-MYELOMA; UBIQUITIN LIGASE; SELF-RENEWAL; PROGRESSION; HUMANS; ADENOCARCINOMA; OVEREXPRESSION; PHENOTYPE	Notch signaling plays an important role in several cellular functions including growth, differentiation, cell fate determination and stemness. Increased Notch activity has been linked to several types of cancers. Activation of Notch signaling is triggered by the interaction of Notch receptors (Notch1-4) with 5 different ligands (Jagged1-2 and Dll1-3-4) expressed on the neighbouring cells. Currently, indirect approaches to inhibit Notch signalling are based on the inhibition of the key step of Notch activation catalyzed by the gamma-Secretase and thereby affect several different.-Secretase substrates; conversely direct strategies get advantage of antibody-based drugs. The evidence that Jagged-mediated Notch activation plays a key role in cancer cell biology and the interplay with the surrounding microenvironment prompted us to develop a strategy to directly inhibit Notch activation by uncoupling its interaction with the Jagged, using an unprecedented approach based on small molecules. We set-up a screening strategy based on: protein:: protein docking of crystallographic structures of Notch1 with Jagged1; comparative modelling of the Notch2: Jagged2 complex, based on the Notch1:: Jagged1 complex; in silico high-throughput screening directed to Notch2 interaction surface of a virtual chemical library containing a large variety of molecules commercially available. The predicted pharmacological activity of the selected compounds was validated in vitro by a gene reporter and a viability assay. This approach led to the successful identification of two candidates with different anti-proliferative potency and efficacy. This represents the first step towards the rational identification of candidate molecules for the development of entirely novel drugs directed to inhibit Notch signaling in cancer.	[Platonova, Natalia; Paoli, Alessandro; Colombo, Michela; Chiaramonte, Raffaella] Univ Milan, Dept Hlth Sci, Milan, Italy; [Parravicini, Chiara] Univ Pisa, Dept Pharm, Pisa, Italy; [Sensi, Cristina; Eberini, Ivano] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy; [Neri, Antonino] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy; [Neri, Antonino] Fdn Ca Granda IRCCS Policlin, Hematol, Milan, Italy	University of Milan; University of Pisa; University of Milan; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico	Eberini, I (corresponding author), Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy.	ivano.eberini@unimi.it	Neri, Antonino/I-9690-2014; Colombo, Michela/K-7879-2016	Neri, Antonino/0000-0001-9047-5912; Colombo, Michela/0000-0003-2252-1424	National Cancer Institute [NCI 1R21CA194679-01]; Universita degli Studi di Milano (Transition Grant Linea 1A "UNIMI partenariati H") [2016-FDA-0058]; Universita degli Studi di Milano; Fondazione Umberto Veronesi; Associazione Italiana Ricerca sul Cancro [IG 10136]; Associazione Italiana per la Ricerca sul Cancro [18013]; University of Milano as temporary research associate	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Universita degli Studi di Milano (Transition Grant Linea 1A "UNIMI partenariati H"); Universita degli Studi di Milano; Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); University of Milano as temporary research associate	This study was supported by grants from the National Cancer Institute (NCI 1R21CA194679-01) and Universita degli Studi di Milano (Transition Grant Linea 1A "UNIMI partenariati H2020" 2016-FDA-0058) to RC; Universita degli Studi di Milano (Intramural grant for young researchers - Fondo di sviluppo UNIMI Linea B) to IE; Fondazione Umberto Veronesi to NP (post-doctoral fellowship); Associazione Italiana Ricerca sul Cancro to AN (IG 10136); Associazione Italiana per la Ricerca sul Cancro to MC (post-doctoral fellowship 18013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by grants from the National Cancer Institute (NCI 1R21CA194679-01) and University degli Studi di Milano to RC (Transition Grant) and to IE (Fondo di sviluppo UNIMI Linea B); Associazione Italiana Ricerca sul Cancro to AN (IG 10136); Fondazione Italiana per la Ricerca sul Cancro to MC (post-doctoral fellowship 18013). NP and CP were sponsored by the post -doctoral program of the University of Milano as temporary research associate.	Ascano JM, 2003, J BIOL CHEM, V278, P8771, DOI 10.1074/jbc.M211427200; Bednarz-Knoll N, 2016, CLIN CHEM, V62, P378, DOI 10.1373/clinchem.2015.246686; Berenstein R, 2015, MOL CARCINOG; Borggrefe T, 2009, CELL MOL LIFE SCI, V66, P1631, DOI 10.1007/s00018-009-8668-7; Chiron D, 2012, BLOOD CELL MOL DIS, V48, P247, DOI 10.1016/j.bcmd.2012.01.006; Colombo M, 2016, ONCOTARGET, V7, P56013, DOI 10.18632/oncotarget.10820; Colombo M, 2015, ONCOTARGET, V6, P26826, DOI 10.18632/oncotarget.5025; Colombo M, 2014, ONCOTARGET, V5, P10393, DOI 10.18632/oncotarget.2084; Cordle J, 2008, NAT STRUCT MOL BIOL, V15, P849, DOI 10.1038/nsmb.1457; Eberini I, 2011, J COMPUT AID MOL DES, V25, P743, DOI 10.1007/s10822-011-9455-8; Ghoshal P, 2009, CANCER RES, V69, P4380, DOI 10.1158/0008-5472.CAN-08-3467; Houde C, 2004, BLOOD, V104, P3697, DOI 10.1182/blood-2003-12-4114; Hu W, 2014, CANCER RES, V74, P3282, DOI 10.1158/0008-5472.CAN-13-2066; Huang TT, 2015, ONCOTARGET, V6, P18012, DOI 10.18632/oncotarget.4000; Hubmann R, 2002, BLOOD, V99, P3742, DOI 10.1182/blood.V99.10.3742; Jundt F, 2004, BLOOD, V103, P3511, DOI 10.1182/blood-2003-07-2254; Kangsamaksin T, 2015, CANCER DISCOV, V5, P182, DOI 10.1158/2159-8290.CD-14-0650; Kato H, 1997, DEVELOPMENT, V124, P4133; Kawaguchi K, 2016, AM J PATHOL, V186, P2055, DOI 10.1016/j.ajpath.2016.04.011; Kiel MJ, 2012, J EXP MED, V209, P1553, DOI 10.1084/jem.20120910; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Labute P., 2001, J CHEM COMPUTING GRO; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; Labute P, 2009, PROTEINS, V75, P187, DOI 10.1002/prot.22234; Lee H, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-334; Lee SH, 2012, BIOCHEM BIOPH RES CO, V424, P58, DOI 10.1016/j.bbrc.2012.06.065; Mazur PK, 2010, P NATL ACAD SCI USA, V107, P13438, DOI 10.1073/pnas.1002423107; Mimae T, 2012, CLIN CANCER RES, V18, P945, DOI 10.1158/1078-0432.CCR-11-1946; Naim M, 2007, J CHEM INF MODEL, V47, P122, DOI 10.1021/ci600406v; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; Platonova N, 2017, CURR PHARM DESIGN, V23, P108, DOI 10.2174/1381612822666161006160524; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Rutten JW, 2013, HUM MUTAT, V34, P1486, DOI 10.1002/humu.22432; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Sparrow DB, 2006, AM J HUM GENET, V78, P28, DOI 10.1086/498879; Sparrow DB, 2008, HUM MOL GENET, V17, P3761, DOI 10.1093/hmg/ddn272; Takeuchi T, 2005, AM J PATHOL, V166, P1817, DOI 10.1016/S0002-9440(10)62491-1; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; van Stralen E, 2009, EXP HEMATOL, V37, P78, DOI 10.1016/j.exphem.2008.08.006; Wang C, 2016, SCI REP-UK, V6, DOI 10.1038/srep25722; Wang ZW, 2009, CANCER LETT, V279, P8, DOI 10.1016/j.canlet.2008.09.030; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Whittock NV, 2004, AM J HUM GENET, V74, P1249, DOI 10.1086/421053; Wojciechowski M, 2004, J PHYS CHEM B, V108, P18368, DOI 10.1021/jp046748b; Wu WR, 2016, ONCOL REP, V36, P181, DOI 10.3892/or.2016.4831; Xu DH, 2012, BIOCHEM BIOPH RES CO, V428, P518, DOI 10.1016/j.bbrc.2012.10.071; Yu HP, 2015, MOL MED REP, V11, P734, DOI 10.3892/mmr.2014.2747; Zhang XY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0088075, 10.1371/journal.pone.0101532]	49	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							e0182640	10.1371/journal.pone.0182640	http://dx.doi.org/10.1371/journal.pone.0182640			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6TA	29099834	Green Published, gold			2022-12-26	WOS:000414377900001
J	Clarencon, F; Bardinet, E; Martinerie, J; Pelbarg, V; Champfleur, NMD; Gupta, R; Tollard, E; Soto-Ares, G; Ibarrola, D; Schmitt, E; Tourdias, T; Degos, V; Yelnik, J; Dormont, D; Puybasset, L; Galanaud, D				Clarencon, Frederic; Bardinet, Eric; Martinerie, Jacques; Pelbarg, Vincent; Champfleur, Nicolas Menjot dDe; Gupta, Rajiv; Tollard, Eleonore; Soto-Ares, Gustavo; Ibarrola, Danielle; Schmitt, Emmanuelle; Tourdias, Thomas; Degos, Vincent; Yelnik, Jerome; Dormont, Didier; Puybasset, Louis; Galanaud, Damien		Neuro Imaging Coma Emergence	Lesions in deep gray nuclei after severe traumatic brain injury predict neurologic outcome	PLOS ONE			English	Article							VEGETATIVE STATE; AXONAL INJURY; PROGNOSTIC VALUE; BASAL GANGLIA; HEAD-INJURY; CORPUS-CALLOSUM; WHITE-MATTER; MRI; STEM; NEUROPATHOLOGY	Purpose This study evaluates the correlation between injuries to deep gray matter nuclei, as quanti-tated by lesions in these nuclei on MR T2 Fast Spin Echo (T2 FSE) images, with 6-month neurological outcome after severe traumatic brain injury (TBI). Materials and methods Ninety-five patients (80 males, mean age = 36.7y) with severe TBI were prospectively enrolled. All patients underwent a MR scan within the 45 days after the trauma that included a T2 FSE acquisition. A 3D deformable atlas of the deep gray matter was registered to this sequence; deep gray matter lesions (DGML) were evaluated using a semi-quantitative classification scheme. The 6-month outcome was dichotomized into unfavorable (death, vegetative or minimally conscious state) or favorable (minimal or no neurologic deficit) outcome. Results Sixty-six percent of the patients (63/95) had both satisfactory registration of the 3D atlas on T2 FSE and available clinical follow-up. Patients without DGML had an 89% chance (P = 0.0016) of favorable outcome while those with bilateral DGML had an 80% risk of unfavorable outcome (P = 0.00008). Multivariate analysis based on DGML accurately classified patients with unfavorable neurological outcome in 90.5% of the cases. Conclusion Lesions in deep gray matter nuclei may predict long-term outcome after severe TBI with high sensitivity and specificity.	[Clarencon, Frederic; Dormont, Didier; Galanaud, Damien] Hop La Pitie Salpetriere, Dept Neuroradiol, Paris, France; [Clarencon, Frederic; Degos, Vincent; Dormont, Didier; Puybasset, Louis; Galanaud, Damien] Paris VI Univ Pierre & Marie Curie, Paris, France; [Bardinet, Eric; Martinerie, Jacques] CNRS, UMR 7225, Inst Cerveau & Moelle Epiniere ICM, Paris, France; [Pelbarg, Vincent] Brain & Spine Inst ICM, IHU A ICM, Bioinformat & Biostat Plateform, Paris, France; [Champfleur, Nicolas Menjot dDe] Guy de Chauliac Univ Hosp, Dept Neuroradiol, Montpellier, France; [Gupta, Rajiv] Massachusetts Gen Hosp, Dept Neuroradiol, Boston, MA 02114 USA; [Tollard, Eleonore] Rouen Univ Hosp, Dept Neuroradiol, Rouen, France; [Soto-Ares, Gustavo] Roger Salengro Hosp, Dept Neuroradiol, Lille, France; [Ibarrola, Danielle] Pierre Wertheimer Neurol & Neurosurg Hosp, CERMEP, Bron, France; [Schmitt, Emmanuelle] Nancy Univ Hosp, Dept Neuroradiol, Nancy, France; [Tourdias, Thomas] Bordeaux Univ Hosp, Dept Neuroradiol, Bordeaux, France; [Degos, Vincent; Puybasset, Louis] Paris VI Univ, Pitie Salpetriere Hosp, Neurosurg Intens Care Unit, Paris, France; [Yelnik, Jerome] Paris VI Univ, Pitie Salpetriere Hosp, INSERM, U679, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Universite de Montpellier; Harvard University; Massachusetts General Hospital; CHU de Rouen; Universite de Lille - ISITE; CHU Lille; CHU de Nancy; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Clarencon, F (corresponding author), Hop La Pitie Salpetriere, Dept Neuroradiol, Paris, France.; Clarencon, F (corresponding author), Paris VI Univ Pierre & Marie Curie, Paris, France.	fredclare5@msn.com	Tourdias, Thomas/K-1209-2019; IBARROLA, Danielle/GRR-7305-2022	Tourdias, Thomas/0000-0002-7151-6325; IBARROLA, Danielle/0000-0001-8999-8740; PUYBASSET, Louis/0000-0002-6849-1825; YELNIK, Jerome/0000-0003-4814-708X	Projet Hospitalier de Recherche Clinique (PHRC) [P051061]	Projet Hospitalier de Recherche Clinique (PHRC)	This work has been funded by the Projet Hospitalier de Recherche Clinique (PHRC) #P051061.	Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Comoglu S, 2001, Australas Radiol, V45, P357, DOI 10.1046/j.1440-1673.2001.00937.x; de la Cueva L, 2006, Rev Esp Med Nucl, V25, P89, DOI 10.1157/13086250; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Galanaud D, 2012, ANESTHESIOLOGY, V117, P1300, DOI 10.1097/ALN.0b013e3182755558; Graham DI, 2005, PROG BRAIN RES, V150, P445, DOI 10.1016/S0079-6123(05)50031-1; Graham DI, 2005, NEUROPSYCHOL REHABIL, V15, P198, DOI 10.1080/09602010443000452; Hopkins RO, 2006, BRAIN INJURY, V20, P273, DOI 10.1080/02699050500488181; JENNETT B, 1975, LANCET, V1, P480; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; Kampfl A, 1998, J NEUROSURG, V88, P809, DOI 10.3171/jns.1998.88.5.0809; Kouloulas EJ, 2013, INT J REHABIL RES, V36, P260, DOI 10.1097/MRR.0b013e32835fd99a; Laouchedi M, 2015, J NEURORADIOLOGY, V42, P202, DOI 10.1016/j.neurad.2014.03.001; Masuzawa H, 1997, NEUROL SURG TOKYO, V25, P689; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Moen KG, 2016, J NEUROSCI RES, V94, P623, DOI 10.1002/jnr.23728; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Parvizi J, 2003, BRAIN, V126, P1524, DOI 10.1093/brain/awg166; Patrick PD, 2007, BRAIN INJURY, V21, P63, DOI 10.1080/02699050601111401; Rosi J, 2017, J CLIN NEUROSCI, V42, P122, DOI 10.1016/j.jocn.2017.03.012; Schaltenbrand G., 1977, ATLAS STEREOTAXY HUM; Shakir A, 2016, J NEUROIMAGING, V26, P103, DOI 10.1111/jon.12286; Shibata Y, 2000, CLIN NEUROL NEUROSUR, V102, P124, DOI 10.1016/S0303-8467(00)00095-0; Su E, 2016, FRONTIERS NEUROSCIEN; Uzan M, 2003, J NEUROL NEUROSUR PS, V74, P33, DOI 10.1136/jnnp.74.1.33; Vapnik V., 1998, STAT LEARNING THEORY; Wedekind C, 2002, BRIT J NEUROSURG, V16, P256, DOI 10.1080/02688690220148842; Weiss N, 2007, CRIT CARE, V11, DOI 10.1186/cc6107; Xu WW, 2016, WORLD NEUROSURG, V94, P167, DOI 10.1016/j.wneu.2016.06.123; Yelnik J, 2007, NEUROIMAGE, V34, P618, DOI 10.1016/j.neuroimage.2006.09.026; Young L, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00089; Yuan L, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20150129	33	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186641	10.1371/journal.pone.0186641	http://dx.doi.org/10.1371/journal.pone.0186641			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095850	Green Submitted, gold, Green Published			2022-12-26	WOS:000414340200019
J	del Priore, L; Pigozzi, MI				del Priore, Lucia; Ines Pigozzi, Maria			Broad-scale recombination pattern in the primitive bird Rhea americana (Ratites, Palaeognathae)	PLOS ONE			English	Article							MEIOTIC RECOMBINATION; CROSSING-OVER; SYNAPTONEMAL COMPLEXES; EQUAL RECOMBINATION; AXIAL EQUALIZATION; AVIAN GENOME; ZEBRA FINCH; CHROMOSOMES; EVOLUTION; NODULES	Birds have genomic and chromosomal features that make them an attractive group to analyze the evolution of recombination rate and the distribution of crossing over. Yet, analyses are biased towards certain species, especially domestic poultry and passerines. Here we analyze for the first time the recombination rate and crossover distribution in the primitive ratite bird, Rhea americana (Rheiformes, Palaeognathae). Using a cytogenetic approach for in situ mapping of crossovers we found that the total genetic map is 3050 cM with a global recombination rate of 2.1 cM/Mb for female rheas. In the five largest macrobivalents there were 3 or more crossovers in most bivalents. Recombination rates for macrobivalents ranges between 1.8-2.1 cM/Mb and the physical length of their synaptonemal complexes is highly predictive of their genetic lengths. The crossover rate at the pseudoautosomal region is 2.1 cM/Mb, similar to those of autosomal pairs 5 and 6 and only slightly higher compared to other macroautosomes. It is suggested that the presence of multiple crossovers on the largest macrobivalents is a feature common to many avian groups, irrespective of their position throughout phylogeny. These data provide new insights to analyze the heterogeneous recombination landscape of birds.	[del Priore, Lucia; Ines Pigozzi, Maria] Univ Buenos Aires, INBIOMED Inst Invest Biomed UBA CONICET, Fac Med, Buenos Aires, DF, Argentina	University of Buenos Aires	Pigozzi, MI (corresponding author), Univ Buenos Aires, INBIOMED Inst Invest Biomed UBA CONICET, Fac Med, Buenos Aires, DF, Argentina.	mpigozzi@fmed.uba.ar	Pigozzi, Maria/AAT-1751-2020	Pigozzi, Maria/0000-0002-3105-0073	Universidad de Buenos Aires, UBACyT [003]; ANPCyT, BID-PICT [0059]	Universidad de Buenos Aires, UBACyT(University of Buenos Aires); ANPCyT, BID-PICT	This study was supported by Universidad de Buenos Aires, UBACyT 2014-2017 No 003 (http://www.uba.ar/secyt/) and ANPCyT, BID-PICT 2013 No 0059 (http://www.agencia.mincyt.gob.ar/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LK, 2003, GENETICS, V165, P849; Anderson LK, 1999, GENETICS, V151, P1569; Anderson LK, 2014, P NATL ACAD SCI USA, V111, P13415, DOI 10.1073/pnas.1406846111; Backstroem N, 2008, MOL ECOL, V17, P964, DOI 10.1111/j.1365-294X.2007.03551.x; Backstrom N, 2010, GENOME RES, V20, P485, DOI 10.1101/gr.101410.109; Barlow AL, 1998, EUR J HUM GENET, V6, P350, DOI 10.1038/sj.ejhg.5200200; Basheva EA, 2008, CHROMOSOME RES, V16, P709, DOI 10.1007/s10577-008-1221-y; Calderon PL, 2006, CHROMOSOME RES, V14, P605, DOI 10.1007/s10577-006-1059-0; Capilla L, 2016, CYTOGENET GENOME RES, V150, P1, DOI 10.1159/000452822; Christidis L., 1990, ANIMAL CYTOGENETICS; Coop G, 2007, NAT REV GENET, V8, P23, DOI 10.1038/nrg1947; de Villena FPM, 2001, MAMM GENOME, V12, P318, DOI 10.1007/s003350020005; del Priore L, 2016, GENETICA, V144, P625, DOI 10.1007/s10709-016-9922-1; del Priore L, 2015, CHROMOSOME RES, V23, P199, DOI 10.1007/s10577-014-9448-2; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Dumont BL, 2008, EVOLUTION, V62, P276, DOI 10.1111/j.1558-5646.2007.00278.x; Dumont BL, 2017, GENETICS, V205, P155, DOI 10.1534/genetics.116.192690; Duroc Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004674; Elferink MG, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-11; Ellegren H, 2013, ANNU REV ECOL EVOL S, V44, P239, DOI 10.1146/annurev-ecolsys-110411-160327; Ellegren H, 2010, TRENDS ECOL EVOL, V25, P283, DOI 10.1016/j.tree.2009.12.004; Froenicke L, 2002, AM J HUM GENET, V71, P1353, DOI 10.1086/344714; Grelon M, 2016, CR BIOL, V339, P247, DOI 10.1016/j.crvi.2016.04.003; Griffin DK, 2007, CYTOGENET GENOME RES, V117, P64, DOI 10.1159/000103166; Groenen MAM, 2009, GENOME RES, V19, P510, DOI 10.1101/gr.086538.108; Hansson B, 2010, HEREDITY, V104, P67, DOI 10.1038/hdy.2009.107; Hulten M, 2006, GENETIC MAPS DIRECT; Hulten M, 2001, GENETIC MAPPING COMP; Jaari S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-1; Janes DE, 2009, J HERED, V100, P125, DOI 10.1093/jhered/esn065; Kawakami T, 2017, MOL ECOL, P1; Kawakami T, 2014, MOL ECOL, V23, P4035, DOI 10.1111/mec.12810; Link J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003261; Maceira NO, 2016, PEQUENAS CADENAS VAL; Mary N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099123; Mezard C, 2015, TRENDS GENET, V31, P393, DOI 10.1016/j.tig.2015.03.008; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Nishida-Umehara C, 2007, CHROMOSOME RES, V15, P721, DOI 10.1007/s10577-007-1157-7; Pigozzi MI, 2016, CYTOGENET GENOME RES, V150, P128, DOI 10.1159/000453541; Pigozzi MI, 2005, CHROMOSOMA, V114, P403, DOI 10.1007/s00412-005-0025-5; Pigozzi MI, 1999, GENOME, V42, P308, DOI 10.1139/gen-42-2-308; Pigozzi MI, 2001, CYTOGENET CELL GENET, V95, P129, DOI 10.1159/000059334; Pigozzi MI, 1997, CHROMOSOME RES, V5, P421, DOI 10.1023/A:1018404610973; Pigozzi MI, 1999, GENOME, V42, P315, DOI 10.1139/gen-42-2-315; Pigozzi MI, 2016, CYTOGENETIC GENOME R; RAHN MI, 1986, CYTOGENET CELL GENET, V43, P187, DOI 10.1159/000132319; Rodionov AV, 1992, GENETIKA, V28; Schmid M, 2005, CYTOGENET GENOME RES, V109, P415, DOI 10.1159/000084205; Schmid M, 2017, CYTOGENET GENOME RES, V151, P216, DOI 10.1159/000464268; Segura J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1945; Singhal S, 2015, SCIENCE, V350, P928, DOI 10.1126/science.aad0843; SOLARI AJ, 1993, CYTOGENET CELL GENET, V64, P268, DOI 10.1159/000133591; SOLARI AJ, 1992, CYTOGENET CELL GENET, V59, P52, DOI 10.1159/000133199; Stack SM, 2017, GENETICS, V205, P1101, DOI 10.1534/genetics.116.196089; STOCK AD, 1982, CYTOGENET CELL GENET, V34, P136, DOI 10.1159/000131802; Sumner AT., 2003, CHROMOSOMES ORG FUNC; Sun F, 2004, AM J HUM GENET, V74, P521, DOI 10.1086/382138; Torgasheva AA, 2017, CYTOGENET GENOME RES, V151, P27, DOI 10.1159/000458741; van Oers K, 2014, HEREDITY, V112, P307, DOI 10.1038/hdy.2013.107; Yazdi HP, 2014, MOL BIOL EVOL, V31, P1444, DOI 10.1093/molbev/msu101; Zhang LX, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003608; Zhou Q, 2014, SCIENCE, V346, P1332, DOI 10.1126/science.1246338; Zlotina A, 2012, CHROMOSOME RES, V20, P1017, DOI 10.1007/s10577-012-9319-7	63	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187549	10.1371/journal.pone.0187549	http://dx.doi.org/10.1371/journal.pone.0187549			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095930	Green Published, gold, Green Submitted			2022-12-26	WOS:000414340200116
J	Lee, CK; Ma, KT; Hong, YJ; Kim, CY				Lee, Chang Kyu; Ma, Kyoung Tak; Hong, Young Jae; Kim, Chan Yun			Long-term clinical outcomes of Ahmed valve implantation in patients with refractory glaucoma	PLOS ONE			English	Article							DIFFERENT BIOMATERIALS; CONGENITAL GLAUCOMA; PEDIATRIC GLAUCOMA; DRAINAGE DEVICES; FOLLOW-UP; SURGERY; TRABECULECTOMY; EXPERIENCE; MANAGEMENT; SILICONE	Purpose To evaluate the long-term efficacy of intraocular pressure (IOP) reduction and complications of Ahmed Glaucoma Valve (AGV) implantation in patients with refractory glaucoma. Design Retrospective study. Subjects The study involved 302 refractory glaucoma patients who underwent AGV implantation and had a minimum follow-up of 6 months between March 1995 and December 2013. Methods An operation was defined as successful when (1) the postoperative IOP remained between 5 and 21 mmHg and was reduced 30% compared to the baseline IOP with or without medication, (2) there was no loss of light perception or vision-threatening severe complications, and (3) no additional filtering or aqueous drainage surgery was required. Clinical records were reviewed. Main outcome measures IOP, anti-glaucoma medications, and complications Results The mean follow-up period was 62.25 months (range, 6 to 190 months). The cumulative probability of success was 89% at 6 months, 81 % at 1 year, 66% at 3 years, 44% at 10 years, and 26% at 15 years. IOP was reduced from a mean of 32.2 +/- 10.5 mmHg to 18.6 +/- 9.1 mmHg at 1 month, 15.2 +/- 7.0 mmHg at 6 months, and 14.2 +/- 3.5 mmHg at 15 years. Surgical failures were significantly increased when preoperative IOP was high, and when severe complications occurred after AGV implantation (P< 0.05). Conclusion AGV implantation was successful for IOP control in patients with refractive glaucoma in the long term. However, the success rate of surgery decreased over time. Preoperative high IOP and severe complications related to the operation were significant risk factors for failure.	[Lee, Chang Kyu] Univ Ulsan, Coll Med, Dept Ophthalmol, Ulsan Univ Hosp, Ulsan, South Korea; [Ma, Kyoung Tak] Jeil Eye Clin, Suwon, South Korea; [Hong, Young Jae] Nune Eye Hosp, Seoul, South Korea; [Kim, Chan Yun] Yonsei Univ, Inst Vis Res, Dept Ophthalmol, Coll Med, Seoul, South Korea	University of Ulsan; Ulsan University Hospital; Yonsei University; Yonsei University Health System	Kim, CY (corresponding author), Yonsei Univ, Inst Vis Res, Dept Ophthalmol, Coll Med, Seoul, South Korea.	kcyeye@yuhs.ac		Lee, Chang Kyu/0000-0002-4023-232X; Kim, Chan Yun/0000-0002-8373-9999				Ayyala RS, 1998, OPHTHALMOLOGY, V105, P1968, DOI 10.1016/S0161-6420(98)91049-1; Ayyala RS, 2002, OPHTHALMIC SURG LAS, V33, P94; Ayyala RS, 2000, ARCH OPHTHALMOL-CHIC, V118, P1081, DOI 10.1001/archopht.118.8.1081; Ayyala RS, 1999, ARCH OPHTHALMOL-CHIC, V117, P233; COLEMAN AL, 1995, AM J OPHTHALMOL, V120, P23, DOI 10.1016/S0002-9394(14)73755-9; Da Mata A, 1999, OPHTHALMOLOGY, V106, P2168, DOI 10.1016/S0161-6420(99)90500-6; Das JC, 2005, EYE, V19, P183, DOI 10.1038/sj.eye.6701447; Gedde SJ, 2010, AM J OPHTHALMOL, V149, P875, DOI 10.1016/j.ajo.2010.02.016; Gedde SJ, 2009, AM J OPHTHALMOL, V148, P670, DOI 10.1016/j.ajo.2009.06.018; Heuer DK, 2001, J GLAUCOMA, V10, P493, DOI 10.1097/00061198-200112000-00010; Huang MC, 1999, AM J OPHTHALMOL, V127, P27, DOI 10.1016/S0002-9394(98)00394-8; Ishida K, 2006, OPHTHALMOLOGY, V113, P1320, DOI 10.1016/j.ophtha.2006.04.020; Law SK, 2005, OPHTHALMOLOGY, V112, P1514, DOI 10.1016/j.ophtha.2005.04.012; Lee EK, 2009, AM J OPHTHALMOL, V148, P361, DOI 10.1016/j.ajo.2009.04.016; Lima FE, 2004, J GLAUCOMA, V13, P233, DOI 10.1097/00061198-200406000-00011; Mandal AK, 1997, OPHTHALMOLOGY, V104, P996, DOI 10.1016/S0161-6420(97)30195-X; Minckler DS, 2008, OPHTHALMOLOGY, V115, P1089, DOI 10.1016/j.ophtha.2008.03.031; Morad Y, 2003, AM J OPHTHALMOL, V135, P821, DOI 10.1016/S0002-9394(02)02274-2; Nguyen QH, 2009, CURR OPIN OPHTHALMOL, V20, P122, DOI 10.1097/ICU.0b013e32831da828; Nouri-Mahdavi K, 2003, AM J OPHTHALMOL, V136, P1001, DOI 10.1016/S0002-9394(03)00630-5; Ou Y, 2009, ARCH OPHTHALMOL-CHIC, V127, P1436, DOI 10.1001/archophthalmol.2009.267; Schwartz Kenneth, 2004, Curr Opin Ophthalmol, V15, P119, DOI 10.1097/00055735-200404000-00011; Souza C, 2007, AM J OPHTHALMOL, V144, P893, DOI 10.1016/j.ajo.2007.07.035; Syed HM, 2004, J GLAUCOMA, V13, P38, DOI 10.1097/00061198-200402000-00008; Tanimoto SA, 2006, CURR OPIN OPHTHALMOL, V17, P132, DOI 10.1097/01.icu.0000193091.60185.27; Topouzis F, 1999, AM J OPHTHALMOL, V128, P198, DOI 10.1016/S0002-9394(99)00080-X; Tsai JC, 2003, OPHTHALMOLOGY, V110, P1814, DOI 10.1016/S0161-6420(03)00574-8; Wilson MR, 2003, AM J OPHTHALMOL, V136, P464, DOI 10.1016/S0002-9394(03)00239-3; Zhu YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121608	29	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187533	10.1371/journal.pone.0187533	http://dx.doi.org/10.1371/journal.pone.0187533			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095931	Green Published, gold, Green Submitted			2022-12-26	WOS:000414340200113
J	Abir, T; Ogbo, FA; Stevens, GJ; Page, AN; Milton, AH; Agho, KE				Abir, Tanvir; Ogbo, Felix Akpojene; Stevens, Garry John; Page, Andrew Nicolas; Milton, Abul Hasnat; Agho, Kingsley Emwinyore			The impact of antenatal care, iron-folic acid supplementation and tetanus toxoid vaccination during pregnancy on child mortality in Bangladesh	PLOS ONE			English	Article							NEONATAL-MORTALITY; RURAL BANGLADESH; INFANT-MORTALITY; INTERVENTIONS; IMMUNIZATION; STILLBIRTHS; OUTCOMES; TRENDS	Background Appropriate antenatal care (ANC) is an important preventive public health intervention to ensure women's and newborn health outcomes. The study aimed to investigate the impact of ANC, iron folic acid (IFA) supplementation and tetanus toxoid (TT) vaccination during pregnancy on child mortality in Bangladesh. Method A cross-sectional study of three datasets from the Bangladesh Demographic and Health Surveys for the years 2004, 2007 and 2011 were pooled and used for the analyses. A total weighted sample of 16,721 maternal responses (5,364 for 2004; 4,872 for 2007 and 6,485 for 2011) was used. Multivariate logistic models that adjusted for cluster and sampling weights were used to examine the impact of ANC, IFA supplementation and TT vaccination during pregnancy on the death of a child aged 0-28 days (neonatal), 1-11 months (post neonatal) and 12-59 months (child). Results Multivariable analyses revealed that the odds of postnatal and under -5 mortality was lower in mothers who had ANC [Odds Ratio (OR) = 0.60, 95% confidence interval (95% CI): 0.43-0.85], IFA supplementation [OR = 0.66, 95% CI: (0.45-0.98)] and >= 2 TT vaccinations (OR = 0.43, 95% CI: 0.49-0.78) for post -natal mortality; and for under -5 mortality, any form of ANC (OR = 0.69, 95% CI: 0.51-0.93), IFA supplementation (OR = 0.67, 95% CI: 0.48-0.94) and >= 2 TT vaccinations (OR = 0.50, 95% CI: 0.36-0.69). When combined, TT vaccination with IFA supplementation, and TT vaccination without IFA supplementation were protective across all groups. Conclusion The study found that ANC, IFA supplementation, and TT vaccination during pregnancy reduced the likelihood of child mortality in Bangladesh. The findings suggest that considerable gains in improving child survival could be achieved through ensuring universal coverage of ANC, promoting TT vaccination during pregnancy and IFA supplementation among pregnant women in Bangladesh.	[Abir, Tanvir; Agho, Kingsley Emwinyore] Western Sydney Univ, Sch Sci & Hlth, Penrith, NSW, Australia; [Ogbo, Felix Akpojene; Page, Andrew Nicolas] Western Sydney Univ, Sch Med, THRI, Penrith, NSW, Australia; [Stevens, Garry John] Western Sydney Univ, Sch Social Sci & Psychol, HADRI, Penrith, NSW, Australia; [Milton, Abul Hasnat] Univ Newcastle, Fac Hlth & Med, Sch Med & Publ Hlth, CCEB, Callaghan, NSW, Australia	Western Sydney University; Western Sydney University; Western Sydney University; University of Newcastle	Agho, KE (corresponding author), Western Sydney Univ, Sch Sci & Hlth, Penrith, NSW, Australia.	k.agho@westernsydeny.edu.au	Agho, Kingsley/AAW-5622-2021; ABIR, TANVIR/AAG-4161-2021; Agho, Kingsley/AAE-9971-2020	Agho, Kingsley/0000-0003-4111-3207; Stevens, Garry/0000-0002-3556-4098				Abir T, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006722; Alam N, 2000, J BIOSOC SCI, V32, P229, DOI 10.1017/S0021932000002297; [Anonymous], 2001, IRON DEFICIENCY ANAE; [Anonymous], 2017, SUST DEV KNOWL PLATF; Basinga P, 2011, LANCET, V377, P1421, DOI 10.1016/S0140-6736(11)60177-3; BLACK RE, 1980, B WORLD HEALTH ORGAN, V58, P927; Blencowe H, 2010, INT J EPIDEMIOL, V39, P102, DOI 10.1093/ije/dyq027; Chai F, 2004, INT J EPIDEMIOL, V33, P551, DOI 10.1093/ije/dyh073; Curtis SL, 1995, ASSESSMENT QUALITY D, P1459; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Ezeh OK, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006779; Gitta Sheba N, 2006, MMWR Suppl, V55, P25; Hill K, 2006, DEMOGR RES, V14, P429, DOI 10.4054/DemRes.2006.14.18; Hyder AA, 2014, J HEALTH POPUL NUTR, V32, P564; Jin Jing, 2008, Ther Clin Risk Manag, V4, P269; Jokhio AH, 2005, NEW ENGL J MED, V352, P2091, DOI 10.1056/NEJMsa042830; Khan AA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-322; Lamberti LM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S15; Mahy M., 2003, CHILDHOOD MORTALITY; Martin Leslie R, 2005, Ther Clin Risk Manag, V1, P189; *MIN HLTH FAM WELF, 2015, SUCC FACT WOM CHILDR; Mosley WH, 1984, POPUL DEV REV, V10, P25, DOI 10.2307/2807954; National Institute of population Research and training (NIPORT), 2009, BANGL DEM HLTH SURV; NIPORT Mitra and Associates and ICF International, 2013, BANGL DEM HLTH SURV; NIPORT Mitra and Associates ORC Macro, 2005, BANGL DEM HLTH SURV; Nutrition International, WOM NEWB SURV HLTH B; Ogbo FA, 2016, PAEDIATR PERINAT EP, V30, P346, DOI 10.1111/ppe.12293; Pervin J, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-111; Rahman AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112308; Rahman A, 2017, J HEALTH POPUL NUTR, V36, DOI 10.1186/s41043-016-0078-5; Ronsmans C, 2008, PAEDIATR PERINAT EP, V22, P269, DOI 10.1111/j.1365-3016.2008.00939.x; Singh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048891; STEWART MA, 1995, CAN MED ASSOC J, V152, P1423; TALL F, 1991, B SOC PATHOL EXOT, V84, P558; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Titaley CR, 2010, B WORLD HEALTH ORGAN, V88, P500, DOI 10.2471/BLT.09.065813; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Wang HD, 2016, LANCET, V388, P1725, DOI 10.1016/S0140-6736(16)31575-6; West KP, 2014, JAMA-J AM MED ASSOC, V312, P2649, DOI 10.1001/jama.2014.16819; World Health Organisation, 2005, WORLD HLTH REP MAK E; Zeng L, 2008, BMJ-BRIT MED J, P337	42	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187090	10.1371/journal.pone.0187090	http://dx.doi.org/10.1371/journal.pone.0187090			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091923	Green Submitted, Green Published, gold			2022-12-26	WOS:000414229700043
J	Matias, WR; Julceus, FE; Abelard, C; Mayo-Smith, LM; Franke, MF; Harris, JB; Ivers, LC				Matias, Wilfredo R.; Julceus, Fabrice E.; Abelard, Cademil; Mayo-Smith, Leslie M.; Franke, Molly F.; Harris, Jason B.; Ivers, Louise C.			Laboratory evaluation of immunochromatographic rapid diagnostic tests for cholera in Haiti	PLOS ONE			English	Article							VIBRIO-CHOLERAE; DIPSTICK TEST; KIT; OUTBREAK; DIARRHEA	Background Rapid diagnostic tests (RDT) for cholera are promising tools for detecting cholera in areas with limited laboratory infrastructure. However, evidence on the characteristics of the many available RDTs is scarce, and their use has been limited by suboptimal performance. We evaluated the performance characteristics of three cholera RDTs from Span Diagnostics, Artron Laboratories, and Standard Diagnostics in a regional laboratory in Haiti. Methodology/Principal findings We retrospectively reviewed records from May 2014 to October 2015 of a laboratory-based surveillance program for Vibrio cholerae atHipital Saint-Nicolas in Saint-Marc, Haiti. We compared the results of 511 Crystal VC, 129 Artron and 451 SD Bioline RDTs to bacterial culture as the gold standard. Of 905 cultures, 477 (52.7%) were positive for V. cholerae 01, of which 27.7% were serotype Inaba. No cultures grew V. cholerae 0139. Sensitivity and specificity of Crystal VC were 98.6% (95%Cl: 96.5%-99.6%) and 71.1% (95%Cl: 64.7%76.9%), respectively. Artron demonstrated a sensitivity of 98.6% (95%Cl: 92.7%-100%) and specificity of 69.1% (95%Cl: 55.2%-80.9%). SD Bioline demonstrated a sensitivity of 81.1% (95%Cl: 75.6%-85.8%) and specificity of 92.8% (95%Cl: 88.4%-95.9%). Crystal VC and Artron frequently showed false positive O139 bands, whereas none were seen with SD Bioline. Conclusions/Significance There is significant variation in the performance of different cholera diagnostic RDTs. Artron and Crystal VC RDTs have high sensitivity and low specificity, while SD Bioline RDT has low to moderate sensitivity and high specificity when performed by laboratory technicians in Haiti. Study limitations included its retrospective design. The suboptimal characteristics of these tests limit their use as clinical point-of-care tests; however, they may be useful in outbreak response, surveillance, and research in resource-limited settings.	[Matias, Wilfredo R.; Franke, Molly F.; Ivers, Louise C.] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA USA; [Matias, Wilfredo R.; Ivers, Louise C.] Partners Hlth, Boston, MA USA; [Julceus, Fabrice E.; Abelard, Cademil] Zanmi Lasante, Pont Tambour, St Marc, Haiti; [Mayo-Smith, Leslie M.; Harris, Jason B.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Harris, Jason B.] Harvard Med Sch, Dept Pediat, Boston, MA USA; [Ivers, Louise C.] Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Partners Healthcare System; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Matias, WR; Ivers, LC (corresponding author), Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA USA.; Matias, WR; Ivers, LC (corresponding author), Partners Hlth, Boston, MA USA.; Ivers, LC (corresponding author), Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA.	vmatias@partners.org; livers@pih.org	Matias, Wilfredo/AAD-5159-2019; Ivers, Louise C/Q-4164-2018; Franke, Molly/AAK-7559-2020; Harris, Jason/ABF-2684-2020	Ivers, Louise C/0000-0003-2314-9230; Franke, Molly/0000-0002-4890-5728; Harris, Jason/0000-0003-3642-5126; Julceus, Emmanuel Fabrice/0000-0001-6505-9159; Matias, Wilfredo/0000-0002-5371-1354	National Institutes of Health [NIAID R01 A1099243]; Abundance Foundation (LCI); Global Health Research Core of the Department of Global Health and Social Medicine (MFF); Madison Enteric Diseases Laboratory fund; Doris Duke Charitable Foundation through a grant supporting the Doris Duke International Clinical Research Fellows Program at Harvard Medical School; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abundance Foundation (LCI); Global Health Research Core of the Department of Global Health and Social Medicine (MFF); Madison Enteric Diseases Laboratory fund; Doris Duke Charitable Foundation through a grant supporting the Doris Duke International Clinical Research Fellows Program at Harvard Medical School; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grants from the National Institutes of Health, (NIAID R01 A1099243; to JBH, LCI and MFF), the Abundance Foundation (LCI), the Global Health Research Core of the Department of Global Health and Social Medicine (MFF), and the Madison Enteric Diseases Laboratory fund. WRM was supported in part by the Doris Duke Charitable Foundation through a grant supporting the Doris Duke International Clinical Research Fellows Program at Harvard Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005045; Alam M, 2010, J CLIN MICROBIOL, V48, P3918, DOI 10.1128/JCM.00616-10; ALBERT MJ, 1995, J CLIN MICROBIOL, V33, P3119, DOI 10.1128/JCM.33.12.3119-3123.1995; Ali M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003832; Ansaruzzaman M, 1999, J MED MICROBIOL, V48, P873, DOI 10.1099/00222615-48-9-873; Boncy J, 2013, DIAGN MICR INFEC DIS, V76, P521, DOI 10.1016/j.diagmicrobio.2013.03.010; Chen WX, 2014, CLIN BIOCHEM, V47, P448, DOI 10.1016/j.clinbiochem.2013.12.022; Debes AK, 2016, AM J TROP MED HYG, V94, P537, DOI 10.4269/ajtmh.15-0496; Dick MH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001845; George CM, 2014, TROP MED INT HEALTH, V19, P301, DOI 10.1111/tmi.12252; Harris JR, 2009, TROP MED INT HEALTH, V14, P1117, DOI 10.1111/j.1365-3156.2009.02335.x; HASAN JAK, 1995, J CLIN MICROBIOL, V33, P2935, DOI 10.1128/JCM.33.11.2935-2939.1995; HASAN JAK, 1994, J CLIN MICROBIOL, V32, P249, DOI 10.1128/JCM.32.1.249-252.1994; Kalluri P, 2006, TROP MED INT HEALTH, V11, P49, DOI 10.1111/j.1365-3156.2005.01539.x; Keddy KH, 2013, J INFECT DIS, V208, pS23, DOI 10.1093/infdis/jit196; Koski-Karell V, 2016, RISK MANAG HEALTHC P, V9, DOI 10.2147/RMHP.S75919; Lesmana M, 1997, J CLIN MICROBIOL, V35, P1856, DOI 10.1128/JCM.35.7.1856-1858.1997; Ley B, 2012, PLOS ONE, V7, P3; Mukherjee P, 2010, JPN J INFECT DIS, V63, P234; Ontweka LN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168257; Page AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037360; QADRI F, 1995, J CLIN MICROBIOL, V33, P732, DOI 10.1128/JCM.33.3.732-734.1995; Sinha A, 2012, INDIAN J MED RES, V135, P523; Steenland MW, 2013, AM J TROP MED HYG, V89, P641, DOI 10.4269/ajtmh.13-0307; WHO, 2013, PREV CONTR CHOL OUTB; World Health Organization, 2016, INT HLTH REG, V3, P1	26	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11								10.1371/journal.pone.0186710	http://dx.doi.org/10.1371/journal.pone.0186710			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091945	Green Submitted, gold, Green Published			2022-12-26	WOS:000414229700028
J	Heffner, MA; Genetos, DC; Christiansen, BA				Heffner, Mollie A.; Genetos, Damian C.; Christiansen, Blaine A.			Bone adaptation to mechanical loading in a mouse model of reduced peripheral sensory nerve function	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; FEMALE C57BL/6 MICE; IN-VIVO; SUBSTANCE-P; CORTICAL BONE; CAPSAICIN; NEURONS; RESORPTION; RAT; INNERVATION	Underlying mechanisms contributing to the imbalance in bone turnover during osteoporosis remain only partially explained. Reduced sensory nerve function may contribute to this imbalance, as sensory neuropeptides affect the activity of osteoblasts and osteoclasts in vivo, especially during bone adaptation. In this study, we investigated bone adaptation in mice following two weeks of tibial compression (peak magnitude 3 N or 7 N). To induce decreased sensory nerve function, mice were treated with capsaicin as neonates. We hypothesized that decreased sensory nerve function would diminish the adaptation of bone to mechanical loading, assessed with mu CT and dynamic histomorphometry. We found that tibial compression induced significant changes in cortical microarchitecture that depended on compression magnitude and location along the length of the tibia; in contrast, there was no effect of loading on trabecular bone of the tibial metaphysis. Tibial compression significantly increased periosteal, and decreased endosteal, bone formation. Contrary to our initial hypothesis, capsaicin-treated mice generally displayed a similar, if not larger, adaptive response to mechanical loading, including greater increases in bone mineral content and mineral apposition rate. To integrate mechanical loading of bone with sensory nerve activation, we examined whether concentration of the neuropeptides calcitonin gene-related peptide (CGRP) and substance P (SP) in bone were affected following 1 or 5 days of 5 N tibial compression or hindlimb unloading. We found that 1 day of tibial compression significantly increased CGRP concentrations in bone, and hindlimb unloading also exhibited a trend toward increased CGRP in bone. These results may suggest a role of sensory nerves in the bone adaptation response to the mechanical environment, though this remains unclear.	[Heffner, Mollie A.] Univ Calif Davis, Mouse Biol Program, Davis, CA 95616 USA; [Genetos, Damian C.] Univ Calif Davis, Sch Vet Med, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA; [Christiansen, Blaine A.] Univ Calif Davis, Med Ctr, Dept Orthopaed Surg, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Christiansen, BA (corresponding author), Univ Calif Davis, Med Ctr, Dept Orthopaed Surg, Sacramento, CA 95817 USA.	bchristiansen@ucdavis.edu	Genetos, Damian C/A-6480-2012; Genetos, Damian/AAF-5953-2021	Genetos, Damian/0000-0002-8599-2867; Christiansen, Blaine/0000-0002-0105-6458	Department of Defense Congressionally Directed Medical Research Programs [PR110178]	Department of Defense Congressionally Directed Medical Research Programs(United States Department of Defense)	Research reported in this publication was supported by the Department of Defense Congressionally Directed Medical Research Programs, under Award Number PR110178. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldock PA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008415; Baron R, 1983, PROCESSING UNDECALCI, P13; Brodt M. D, 2010, J BONE MINER RES; Carriero A, 2014, J BIOMECH, V47, P2490, DOI 10.1016/j.jbiomech.2014.03.035; Christiansen BA, 2012, OSTEOARTHR CARTILAGE, V20, P773, DOI 10.1016/j.joca.2012.04.014; De Souza RL, 2005, BONE, V37, P810, DOI 10.1016/j.bone.2005.07.022; DSOUZA SM, 1986, ENDOCRINOLOGY, V119, P58, DOI 10.1210/endo-119-1-58; Elefteriou F, 2005, CELL MOL LIFE SCI, V62, P2339, DOI 10.1007/s00018-005-5175-3; Fritton JC, 2005, BONE, V36, P1030, DOI 10.1016/j.bone.2005.02.013; Fukuda T, 2013, NATURE, V497, P490, DOI 10.1038/nature12115; Guo TZ, 2014, J PAIN, V15, P1033, DOI 10.1016/j.jpain.2014.07.004; HaraIrie F, 1996, BONE, V18, P29, DOI 10.1016/8756-3282(95)00425-4; Heffner MA, 2014, J MUSCULOSKEL NEURON, V14, P1; HILL EL, 1991, NEUROSCIENCE, V44, P747, DOI 10.1016/0306-4522(91)90094-5; HOLZER P, 1991, PHARMACOL REV, V43, P143; Imai S, 1997, J ORTHOP RES, V15, P133, DOI 10.1002/jor.1100150120; JANCSO G, 1977, NATURE, V270, P741, DOI 10.1038/270741a0; Jimenez-Andrade JM, 2009, NEUROSCIENCE, V162, P1244, DOI 10.1016/j.neuroscience.2009.05.065; Jones Kevin B, 2004, Iowa Orthop J, V24, P123; KAR S, 1989, CELL TISSUE RES, V255, P451; Karl T, 2003, EXP TOXICOL PATHOL, V55, P69, DOI 10.1078/0940-2993-00301; Konttinen YT, 1996, ACTA ORTHOP SCAND, V67, P632, DOI 10.3109/17453679608997772; Mach DB, 2002, NEUROSCIENCE, V113, P155, DOI 10.1016/S0306-4522(02)00165-3; Main RP, 2010, J BIOMECH, V43, P2689, DOI 10.1016/j.jbiomech.2010.06.019; Mihara K, 2004, BRIT J DERMATOL, V151, P335, DOI 10.1111/j.1365-2133.2004.06036.x; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; Mori T, 1999, BIOCHEM BIOPH RES CO, V262, P418, DOI 10.1006/bbrc.1999.1220; NAGY JI, 1983, J NEUROSCI, V3, P399; Nakano T, 2008, ACTA DERM-VENEREOL, V88, P449, DOI 10.2340/00015555-0479; Offley SC, 2005, J BONE MINER RES, V20, P257, DOI 10.1359/JBMR.041108; Patel TK, 2014, J BIOMECH, V47, P451, DOI 10.1016/j.jbiomech.2013.10.052; Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721; ROOS BA, 1986, ENDOCRINOLOGY, V118, P46, DOI 10.1210/endo-118-1-46; Sample SJ, 2008, J BONE MINER RES, V23, P1372, DOI [10.1359/jbmr.080407, 10.1359/JBMR.080407]; SCADDING JW, 1980, J ANAT, V131, P471; Serre CM, 1999, BONE, V25, P623, DOI 10.1016/S8756-3282(99)00215-X; Spencer GJ, 2004, FEBS LETT, V559, P6, DOI 10.1016/S0014-5793(04)00053-5; Sugiyama T, 2010, BONE, V46, P314, DOI 10.1016/j.bone.2009.08.054; TAMURA T, 1992, J CELL PHYSIOL, V153, P6, DOI 10.1002/jcp.1041530103; TIPPINS JR, 1984, NEUROPEPTIDES, V4, P425, DOI 10.1016/0143-4179(84)90118-5; Wang LP, 2009, BONE, V45, P309, DOI 10.1016/j.bone.2009.04.203; Willie BM, 2013, BONE, V55, P335, DOI 10.1016/j.bone.2013.04.023; Wright NC, 2014, J BONE MINER RES, V29, P2520, DOI 10.1002/jbmr.2269; YAMAMOTO I, 1986, CALCIFIED TISSUE INT, V38, P339, DOI 10.1007/BF02555747	44	18	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187354	10.1371/journal.pone.0187354	http://dx.doi.org/10.1371/journal.pone.0187354			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088267	Green Published, Green Submitted, gold			2022-12-26	WOS:000414088900071
J	Lee, H; Chung, H; Ko, H; Jeong, C; Noh, SE; Kim, C; Lee, J				Lee, Hooseok; Chung, Heewon; Ko, Hoon; Jeong, Changwon; Noh, Se-Eung; Kim, Chul; Lee, Jinseok			Dedicated cardiac rehabilitation wearable sensor and its clinical potential	PLOS ONE			English	Article							MAXIMAL HEART-RATE; FUNCTIONAL-CAPACITY; INTERVENTION; ELECTRONICS; ADHERENCE; AGE	We describe a wearable sensor developed for cardiac rehabilitation (CR) exercise. To effectively guide CR exercise, the dedicated CR wearable sensor (DCRW) automatically recommends the exercise intensity to the patient by comparing heart rate (HR) measured in real time with a predefined target heart rate zone (THZ) during exercise. The CR exercise includes three periods: pre-exercise, exercise with intensity guidance, and post-exercise. In the pre-exercise period, information such as THZ, exercise type, exercise stage order, and duration of each stage are set up through a smartphone application we developed for iPhones and Android devices. The set-up information is transmitted to the DCRW via Bluetooth communication. In the period of exercise with intensity guidance, the DCRW continuously estimates HR using a reflected pulse signal in the wrist. To achieve accurate HR measurements, we used multichannel photo sensors and increased the chances of acquiring a clean signal. Subsequently, we used singular value decomposition (SVD) for de-noising. For the median and variance of RMSEs in the measured HRs, our proposed method with DCRW provided lower values than those from a single channel-based method and template-based multiple-channel method for the entire exercise stage. In the post-exercise period, the DCRW transmits all the measured HR data to the smartphone application via Bluetooth communication, and the patient can monitor his/her own exercise history.	[Lee, Hooseok; Chung, Heewon; Ko, Hoon; Jeong, Changwon; Lee, Jinseok] Wonkwang Univ, Dept Biomed Engn, Coll Med, Iksan, South Korea; [Noh, Se-Eung] Wonkwang Univ, Dept Rehabil Med, Coll Med, Iksan, South Korea; [Kim, Chul] Inje Univ, Med Coll, Sanggye Paik Hosp, Dept Rehabil Med, Seoul, South Korea	Wonkwang University; Wonkwang University; Inje University	Lee, J (corresponding author), Wonkwang Univ, Dept Biomed Engn, Coll Med, Iksan, South Korea.	gonasago@wku.ac.kr	Lee, Jinseok/AAV-7182-2021; Lee, Jinseok/GRR-6086-2022; Ko, Hoon/J-4612-2013	Lee, Jinseok/0000-0002-8580-490X; Lee, Jinseok/0000-0002-8580-490X; Ko, Hoon/0000-0002-4604-1735	National Research Foundation of Korea (NRF) - Ministry of Science, ICT Future Planning [NRF-2016R1D1A1B03934938, NRF-2015M3A9D7067215]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT Future Planning	This study was partially supported by a by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT &Future Planning: NRF-2016R1D1A1B03934938 and NRF-2015M3A9D7067215. (J.L both). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboy M, 2005, IEEE T BIO-MED ENG, V52, P1662, DOI 10.1109/TBME.2005.855725; Allen Jerilyn K, 2003, J Cardiovasc Nurs, V18, P150; [Anonymous], 1952, EXPT STUDIES PHYS WO; Arena R, 2012, CIRCULATION, V125, P1321, DOI 10.1161/CIR.0b013e318246b1e5; Arrigo I, 2008, EUR J CARDIOV PREV R, V15, P306, DOI 10.1097/HJR.0b013e3282f40e01; Baldasseroni S, 2016, J AM GERIATR SOC, V64, P1640, DOI 10.1111/jgs.14239; Blackwell D., 2015, TABLES SUMMARY HLTH; de la Cuerda RC, 2012, REV ESP CARDIOL, V65, P72, DOI [10.1016/j.recesp.2011.07.016, 10.1016/j.rec.2011.07.015]; Chang JS, 2017, IEEE J EM SEL TOP C, V7, P7, DOI 10.1109/JETCAS.2017.2673863; Cheng T, 2015, ADV MATER, V27, P3349, DOI 10.1002/adma.201405864; Chung H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161268; Dalal HM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5631; Gellish RL, 2007, MED SCI SPORT EXER, V39, P822, DOI 10.1097/mss.0b013e31803349c6; Giallauria F, 2016, MONALDI ARCH CHEST D, V66; Gulati M, 2010, CIRCULATION, V122, P130, DOI 10.1161/CIRCULATIONAHA.110.939249; JETTE M, 1990, CLIN CARDIOL, V13, P555, DOI 10.1002/clc.4960130809; Jolly K, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11350; Lavie CJ, 2009, EXERCISE TRAINING CA, P373; Lee J, 2013, IEEE T BIO-MED ENG, V60, P203, DOI 10.1109/TBME.2012.2208112; Lewinter C, 2015, EUR J PREV CARDIOL, V22, P1504, DOI 10.1177/2047487314559853; Mackinnon LT, 2003, XERCISE MANAGEMENT C; Maddison R, 2015, EUR J PREV CARDIOL, V22, P701, DOI 10.1177/2047487314535076; Medicine ACoS, 2013, ACSMS GUID EX TEST P; Noonan V, 2000, PHYS THER, V80, P782, DOI 10.1093/ptj/80.8.782; Pasquali SK, 2003, AM HEART J, V145, P445, DOI 10.1067/mhj.2003.172; Roy SJ, 2009, VALIDATION MAXIMAL H; Sarela A, 2009, HOME BASED CARE MODE, P1; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Warren KM, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16030342; Whaley M H, 1997, J Cardiopulm Rehabil, V17, P261, DOI 10.1097/00008483-199707000-00007; WHO, CARD DIS CVDS	31	12	14	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187108	10.1371/journal.pone.0187108	http://dx.doi.org/10.1371/journal.pone.0187108			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088260	gold, Green Published, Green Submitted			2022-12-26	WOS:000414088900040
J	Guazzo, RA; Helble, TA; D'Spain, GL; Weller, DW; Wiggins, SM; Hildebrand, JA				Guazzo, Regina A.; Helble, Tyler A.; D'Spain, Gerald L.; Weller, David W.; Wiggins, Sean M.; Hildebrand, John A.			Migratory behavior of eastern North Pacific gray whales tracked using a hydrophone array	PLOS ONE			English	Article							ESCHRICHTIUS-ROBUSTUS; HUMPBACK WHALES; PATTERNS; SOUNDS; SEA	Eastern North Pacific gray whales make one of the longest annual migrations of any mammal, traveling from their summer feeding areas in the Bering and Chukchi Seas to their wintering areas in the lagoons of Baja California, Mexico. Although a significant body of knowledge on gray whale biology and behavior exists, little is known about their vocal behavior while migrating. In this study, we used a sparse hydrophone array deployed offshore of central California to investigate how gray whales behave and use sound while migrating. We detected, localized, and tracked whales for one full migration season, a first for gray whales. We verified and localized 10,644 gray whale M3 calls and grouped them into 280 tracks. Results confirm that gray whales are acoustically active while migrating and their swimming and acoustic behavior changes on daily and seasonal time scales. The seasonal timing of the calls verifies the gray whale migration timing determined using other methods such as counts conducted by visual observers. The total number of calls and the percentage of calls that were part of a track changed significantly over both seasonal and daily time scales. An average calling rate of 5.7 calls/whale/day was observed, which is significantly greater than previously reported migration calling rates. We measured a mean speed of 1.6 m/s and quantified heading, direction, and water depth where tracks were located. Mean speed and water depth remained constant between night and day, but these quantities had greater variation at night. Gray whales produce M3 calls with a root mean square source level of 156.9 dB re 1 mu Pa at 1 m. Quantities describing call characteristics were variable and dependent on site-specific propagation characteristics.	[Guazzo, Regina A.; D'Spain, Gerald L.; Wiggins, Sean M.; Hildebrand, John A.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Helble, Tyler A.] SPAWAR Syst Ctr Pacific, San Diego, CA USA; [Weller, David W.] NOAA, Southwest Fisheries Sci Ctr, La Jolla, CA USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Naval Information Warfare Center Pacific; National Oceanic Atmospheric Admin (NOAA) - USA	Guazzo, RA (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	rguazzo@ucsd.edu	Guazzo, Regina/S-5372-2019	Guazzo, Regina/0000-0002-6482-2965; Hildebrand, John/0000-0002-5418-9799	Science, Mathematics and Research for Transformation Defense Scholarship for Service Program - ASD/R&E (Assistant Secretary of Defense for Research and Education) [PE0601120D8Z, N00244-09-1-0081]; U.S. Army Corps of Engineers by the U.S. Navy's Pacific Fleet through the Cooperative Ecosystem Studies Units;  [W9126G-15-2-003]	Science, Mathematics and Research for Transformation Defense Scholarship for Service Program - ASD/R&E (Assistant Secretary of Defense for Research and Education); U.S. Army Corps of Engineers by the U.S. Navy's Pacific Fleet through the Cooperative Ecosystem Studies Units; 	RAG received a fellowship from the Science, Mathematics and Research for Transformation Defense Scholarship for Service Program funded by ASD/R&E (Assistant Secretary of Defense for Research and Education), Defense - Wide / PE0601120D8Z National Defense Education Program (NDEP) / BA-1, Basic Research, Grant Number N00244-09-1-0081 (https://smart.asee.org/). JAH received a grant from the U.S. Army Corps of Engineers using funds provided by the U.S. Navy's Pacific Fleet through the Cooperative Ecosystem Studies Units. The authors would specifically like to thank Chip Johnson from Pacific Fleet. Grant Number W9126G-15-2-003. (http://vwfw.cesu.psu.edu/). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Au WWL, 2006, J ACOUST SOC AM, V120, P1103, DOI 10.1121/1.2211547; Au WWL, 2000, MAR MAMMAL SCI, V16, P530, DOI 10.1111/j.1748-7692.2000.tb00949.x; Crane NL, 1996, J ACOUST SOC AM, V100, P1878, DOI 10.1121/1.416006; CUMMINGS WC, 1968, J ACOUST SOC AM, V44, P1278, DOI 10.1121/1.1911259; Dalheim ME, 1987, BIOACOUSTICS GRAY WH; Durban JW, 2017, SCA17GW06 INT WHAL C; FISH JF, 1974, MAR FISH REV, V36, P38; Gilmore RM, 1960, SPECIAL SCI REPORTS, V342, piv; Helble TA, 2015, J ACOUST SOC AM, V137, P11, DOI 10.1121/1.4904505; Helble TA, 2013, J ACOUST SOC AM, V134, P2556, DOI 10.1121/1.4816581; Helble TA, 2012, J ACOUST SOC AM, V131, P2682, DOI 10.1121/1.3685790; HUBBS CL, 1967, CALIF FISH GAME, V53, P23; Laake JL, 2009, NMFSAFSC203 US DEP C; Mate B, 2010, SC62BRG21 INT WHAL C; Mate Bruce R., 2003, Journal of Cetacean Research and Management, V5, P155; Moore SE, 2001, MAR MAMMAL SCI, V17, P954, DOI 10.1111/j.1748-7692.2001.tb01310.x; Munger LM, 2008, MAR MAMMAL SCI, V24, P795, DOI 10.1111/j.1748-7692.2008.00219.x; Parks SE, 2011, BIOL LETTERS, V7, P33, DOI 10.1098/rsbl.2010.0451; Perryman WL, 1999, MAR MAMMAL SCI, V15, P426, DOI 10.1111/j.1748-7692.1999.tb00811.x; Perryman WL, 2002, MAR MAMMAL SCI, V18, P121, DOI 10.1111/j.1748-7692.2002.tb01023.x; Perryman WL, 2010, SC62BRG1 INT WHAL CO; PETROCHENKO SP, 1991, SOV PHYS ACOUST+, V37, P622; Poole M.M., 1984, P389; Reilly SB, 2008, IUCN RED LIST THREAT; Rice D. W. W., 1971, AM SOC MAMMAL, DOI DOI 10.5962/BHL.TITLE.39537; Rugh D.J., 1984, P225; Rugh DJ, 2008, MAR MAMMAL SCI, V24, P864, DOI 10.1111/j.1748-7692.2008.00215.x; RUGH DJ, 1990, MAR MAMMAL SCI, V6, P109, DOI 10.1111/j.1748-7692.1990.tb00233.x; Scammon C.M., 1874, MARINE MAMMALS N W C; Shelden Kim E. W., 2002, Journal of Cetacean Research and Management, V4, P53; Sumich J., 2014, E ROBUSTUS BIOL HUMA; SUMICH JL, 1983, CAN J ZOOL, V61, P647, DOI 10.1139/z83-086; Urick R. J., 1967, PRINCIPLES UNDERWATE; Wiggins Sean M., 2007, International Symposium on Underwater Technology 2007. International Workshop on Scientific Use of Submarine Cables and Related Technologies 2007, P551; Wiggins Sean M., 2005, Aquatic Mammals, V31, P161, DOI 10.1578/AM.31.2.2005.161; Woodward PM, 1964, INT SERIES MONOGRAPH, V3	36	20	20	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0185585	10.1371/journal.pone.0185585	http://dx.doi.org/10.1371/journal.pone.0185585			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084266	Green Submitted, Green Published, gold			2022-12-26	WOS:000413910200002
J	Meyer-Rath, G; Johnson, LF; Pillay, Y; Blecher, M; Brennan, AT; Long, L; Moultrie, H; Sanne, I; Fox, MP; Rosen, S				Meyer-Rath, Gesine; Johnson, Leigh F.; Pillay, Yogan; Blecher, Mark; Brennan, Alana T.; Long, Lawrence; Moultrie, Harry; Sanne, Ian; Fox, Matthew P.; Rosen, Sydney			Changing the South African national antiretroviral therapy guidelines: The role of cost modelling	PLOS ONE			English	Article							OUTCOMES	Background We were tasked by the South African Department of Health to assess the cost implications to the largest ART programme in the world of adopting sets of ART guidelines issued by the World Health Organization between 2010 and 2016. Methods Using data from large South African ART clinics (n = 24,244 patients), projections of patients in need of ART, and cost data from bottom-up cost analyses, we constructed a populationlevel health-state transition model with 6-monthly transitions between health states depending on patients' age, CD4 cell count/percentage, and, for adult first-line ART, time on treatment. Findings For each set of guidelines, the modelled increase in patient numbers as a result of prevalence and uptake was substantially more than the increase resulting from additional eligibility. Under each set of guidelines, the number of people on ART was projected to increase by 31 -133% over the next seven years, and cost by 84-175%, while increased eligibility led to 1 - 26% more patients, and 1-17% higher cost. The projected increases in treatment cost due to the 2010 and the 2015 WHO guidelines could be offset in their entirety by the introduction of cost-saving measures such as opening the drug tenders for international competition and task-shifting. Under universal treatment, annual costs of the treatment programme will decrease for the first time from 2024 onwards. Conclusions Annual budgetary requirements for ART will continue to increase in South Africa until universal treatment is taken to full scale. Model results were instrumental in changing South African ART guidelines, more than tripling the population on treatment between 2009 and 2017, and reducing the per-patient cost of treatment by 64%.	[Meyer-Rath, Gesine; Brennan, Alana T.; Fox, Matthew P.; Rosen, Sydney] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA; [Meyer-Rath, Gesine; Brennan, Alana T.; Long, Lawrence; Sanne, Ian; Fox, Matthew P.; Rosen, Sydney] Univ Witwatersrand, HE2RO, Dept Med, Fac Hlth Sci, Johannesburg, South Africa; [Johnson, Leigh F.] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, Cape Town, South Africa; [Pillay, Yogan] Natl Dept Hlth, Pretoria, South Africa; [Blecher, Mark] Natl Treasury, Pretoria, South Africa; [Moultrie, Harry] Univ Witwatersrand, Wits RHI, Fac Hlth Sci, Johannesburg, South Africa; [Sanne, Ian] Univ Witwatersrand, Fac Hlth Sci, Dept Med, Clin HIV Res Unit, Johannesburg, South Africa; [Fox, Matthew P.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Boston University; University of Witwatersrand; University of Cape Town; University of Witwatersrand; University of Witwatersrand; Boston University	Meyer-Rath, G (corresponding author), Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA.; Meyer-Rath, G (corresponding author), Univ Witwatersrand, HE2RO, Dept Med, Fac Hlth Sci, Johannesburg, South Africa.	gesine@bu.edu	Sanne, Ian/ABH-2231-2020; Fox, Matthew/K-2004-2019; Moultrie, Harry/AFV-0903-2022; Moultrie, Harry/H-1842-2014	Moultrie, Harry/0000-0001-9722-0699; Moultrie, Harry/0000-0001-9722-0699; Rosen, Sydney/0000-0002-6560-2964; Long, Lawrence/0000-0003-4986-4988; Brennan, Alana/0000-0002-7746-0668	American people through the United States Agency for International Development (USAID) [674-A-00-09-00018-00, GHS-A-00-03-00020, AID 674-A-12-00029, 674-A-00-02-00018]; National Institute of Allergy and Infectious Diseases [K01A1083097]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI083097] Funding Source: NIH RePORTER	American people through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was made possible by the generous support of the American people through the United States Agency for International Development (USAID) under the terms of Associate Cooperative Agreement No. 674-A-00-09-00018-00 under Country Research Activity Leader Award No. GHS-A-00-03-00020 and under award number AID 674-A-12-00029 (G.M.-R.'s, L. L.'s and S.R.'s time), and Cooperative Agreement 674-A-00-02-00018 to Right to Care (A.B.'s and M. F.'s time). M.F. was also supported by K01A1083097 from the National Institute of Allergy and Infectious Diseases. We are grateful for the support of the members of the original Costing Task Team convened by the South African National Department of Health, the staff of the two sites providing cohort data, and to staff at USAID South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, S AFRICA GLOBAL AIDS; [Anonymous], 2010, COUNTR PROGR REP DEC; [Anonymous], 2011, STAT M S AFR NAT AID; [Anonymous], 2016, HLTH DEP BUDG VOT 20; Bango F, TROP MED INT HLTH, V21, P1115; Bolton-Moore C, 2007, JAMA-J AM MED ASSOC, V298, P1888, DOI 10.1001/jama.298.16.1888; Cleary S, 2009, 5 INT AIDS SOC C 200; Department of Health, 2010, CLIN GUID MAN HIV AI; Department of Health & South African National AIDS Council, 2016, S AFR HIV TB INV CAS; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Leisegang R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000189; Long L, 2010, AIDS, V24, P915, DOI 10.1097/QAD.0b013e3283360976; Meyer-Rath G, 2013, JAIDS-J ACQ IMM DEF, V62, P322, DOI 10.1097/QAI.0b013e31827e8785; Rosen S, 2008, TROP MED INT HEALTH, V13, P1005, DOI 10.1111/j.1365-3156.2008.02114.x; South African National Department of Health, 2018, GUIDELINES IMPLEMENT; WHO, 2010, ANT THER HIV INF AD; WHO, 2016, CONGUID UANT DRU; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2009, RAP ADV ANT THER HIV	19	38	39	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0186557	10.1371/journal.pone.0186557	http://dx.doi.org/10.1371/journal.pone.0186557			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084275	Green Published, gold, Green Submitted			2022-12-26	WOS:000413910200008
J	Chen, MC; Kunselman, AR; Stetter, CM; Hannush, SB; Roberts, BW				Chen, Michael C.; Kunselman, Allen R.; Stetter, Christy M.; Hannush, Sadeer B.; Roberts, Benjamin W.			Corneal transplantation at Tenwek Hospital, Kenya, East Africa: Analysis of outcomes and associated patient socioeconomic characteristics	PLOS ONE			English	Article							PENETRATING KERATOPLASTY; GRAFT-SURVIVAL	Purpose To review the graft survival rate, visual outcomes, and patient demographics of primary penetrating keratoplasty performed at Tenwek Hospital, a mission hospital in rural Kenya. Methods A retrospective review was performed of the clinical records of patients who underwent primary penetrating keratoplasty for optical purposes from January 2012 to October 2014. The graft survival rates were constructed using the Kaplan-Meier method, and the effect of clinical and socioeconomic characteristics on time to graft failure were examined using Cox regression models. Results 118 patients met the inclusion criteria. The most common indication for surgery was keratoconus (66.1%), followed by corneal scar (22.0%). Despite all patients giving a verbal commitment to do so, 40 patients (33.9%) failed to make it to followup one year postoperatively. Graft survival at one year, inclusive of all indications, was 85.8%. Of the different indications, keratoconus had the highest one-year graft survival rate of 89.9%. Compared to the preoperative uncorrected visual acuity, 85.3% achieved an improvement at one year. Compared to patients who had completed college or university, the risk of developing graft failure was 4.7 times higher among patients with less education (P = 0.01). Conclusions Corneal transplantation at Tenwek Hospital can be performed with a reasonable chance of success at one year, particularly in cases of keratoconus and in patients with higher educational backgrounds. Adherence to followup recommendations proves to be a challenge in this patient population. Additional studies of larger patient populations with longer follow up periods in similar settings may be helpful in informing appropriate patient selection and maximizing successful outcomes of corneal transplantation in low-resource settings.	[Chen, Michael C.] Penn State Coll Med, Penn State Eye Ctr, Hershey, PA 17033 USA; [Chen, Michael C.; Roberts, Benjamin W.] Tenwek Hosp, Bomet, Bomet County, Kenya; [Kunselman, Allen R.; Stetter, Christy M.] Penn State Coll Med, Dept Publ Hlth Sci, Hershey, PA USA; [Hannush, Sadeer B.] Wills Eye Hosp & Res Inst, Philadelphia, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Jefferson University	Chen, MC (corresponding author), Penn State Coll Med, Penn State Eye Ctr, Hershey, PA 17033 USA.; Chen, MC (corresponding author), Tenwek Hosp, Bomet, Bomet County, Kenya.	mchen3@pennstatehealth.psu.edu		Chen, Michael/0000-0001-5178-4632				CAMERON JA, 1989, OPHTHALMOLOGY, V96, P1615; Chua PY, 2013, OPHTHALMOLOGY, V120, P2436, DOI 10.1016/j.ophtha.2013.07.050; Dandona L, 1997, BRIT J OPHTHALMOL, V81, P726, DOI 10.1136/bjo.81.9.726; Dandona L, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-7; De Smedt S, 2011, AM J TROP MED HYG, V85, P711, DOI 10.4269/ajtmh.2011.11-0291; Education Policy and Data Center, 2014, 360 FHI ED POL DAT C; Gain P, 2016, JAMA OPHTHALMOL, V134, P167, DOI 10.1001/jamaophthalmol.2015.4776; Hayilu D, 2016, BMC OPHTHALMOL, V16, DOI 10.1186/s12886-016-0345-7; Huang C, 2009, CORNEA, V28, P1003, DOI 10.1097/ICO.0b013e3181a186c0; International Labour Office, 2012, INT STANDARD CLASSIF; Joshi SA, 2012, INDIAN J OPHTHALMOL, V60, P15, DOI 10.4103/0301-4738.91337; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Mukhtar S, 2017, INT OPHTHALMOL; Oliva MS, 2012, INDIAN J OPHTHALMOL, V60, P423, DOI 10.4103/0301-4738.100540; Pascolini D, 2010, BR J OPHTHALMOL, V96, P614, DOI DOI 10.1136/BJ0PHTHALM0L-2011-300539; Pineda R, 2015, CORNEA, V34, pS35, DOI 10.1097/ICO.0000000000000567; Rashid ZA, 2016, MIDDLE EAST AFR J OP, V23, P283, DOI 10.4103/0974-9233.194074; ROSNER B, 1982, BIOMETRICS, V38, P105, DOI 10.2307/2530293; Tabin GC, 2004, CORNEA, V23, P589, DOI 10.1097/01.ico.0000121712.36593.0d; Tan DTH, 2008, OPHTHALMOLOGY, V115, P975, DOI 10.1016/j.ophtha.2007.08.049; Wagoner MD, 2009, CORNEA, V28, P882, DOI 10.1097/ICO.0b013e31819b00d8; WILLIAMS KA, 1992, OPHTHALMOLOGY, V99, P403; Yorston D, 1996, BRIT J OPHTHALMOL, V80, P890, DOI 10.1136/bjo.80.10.890	23	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187026	10.1371/journal.pone.0187026	http://dx.doi.org/10.1371/journal.pone.0187026			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077728	Green Submitted, Green Published, gold			2022-12-26	WOS:000413861200036
J	Zhang, JH; Sun, XQ; Zhu, R; Li, M; Miao, W				Zhang, Jiang-Hua; Sun, Xiao-Qing; Zhu, Rui; Li, Ming; Miao, Wang			Solving an emergency rescue materials problem under the joint reserves mode of government and framework agreement suppliers	PLOS ONE			English	Article							LOCATION	Emergency rescue material reserves are vital for the success of emergency rescue activities. In this study, we consider a situation where a government owned distribution center and framework agreement suppliers jointly store emergency rescue materials. Using a scenario-based approach to represent demand uncertainty, we propose a comprehensive transportation pattern for the following supply chain: "suppliers-government distribution center-disaster area." Using a joint reserves model that includes the government and framework agreement suppliers, we develop a non-linear mathematic model that determines the choices of the framework suppliers, the corresponding optimal commitment quantities, and the quantity of materials that are stored at a government distribution center. Finally, we use IBM ILOG CPLEX to solve the numerical examples to verify the effectiveness of the mode and perform sensitivity analyses on the relevant parameters.	[Zhang, Jiang-Hua; Sun, Xiao-Qing; Zhu, Rui; Li, Ming] Shandong Univ, Sch Management, Jinan, Shandong, Peoples R China; [Miao, Wang] Qilu Univ Technol, Sch Business Adm, Jinan, Shandong, Peoples R China	Shandong University; Qilu University of Technology	Zhang, JH (corresponding author), Shandong Univ, Sch Management, Jinan, Shandong, Peoples R China.; Miao, W (corresponding author), Qilu Univ Technol, Sch Business Adm, Jinan, Shandong, Peoples R China.	zhangjianghua@sdu.edu.cn; Miao2015sd@glu.edu.cn	Zhang, Jianghua/AAL-4343-2021	Zhang, Jianghua/0000-0002-6734-3492	National Natural Science Foundation of China (NSFC) [71571111, 71201093]; Shandong Provincial Water Conservancy Research and Technology Extension Project [SDSLKY201604]; Independent Innovation Foundation of Shandong University; Fundamental Research Funds of Shandong University; Qilu Young Scholars of Shandong University; Tang Scholars of Shandong University	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shandong Provincial Water Conservancy Research and Technology Extension Project; Independent Innovation Foundation of Shandong University; Fundamental Research Funds of Shandong University; Qilu Young Scholars of Shandong University; Tang Scholars of Shandong University	This paper was partially supported by the National Natural Science Foundation of China (NSFC) (Grant No. 71571111, 71201093), Shandong Provincial Water Conservancy Research and Technology Extension Project (Grant No. SDSLKY201604), and the Independent Innovation Foundation of Shandong University and the Fundamental Research Funds of Shandong University. The authors also would like to thank the Qilu Young Scholars and Tang Scholars of Shandong University for financial and technical support.	Alfredsson P, 1999, MANAGE SCI, V45, P1416, DOI 10.1287/mnsc.45.10.1416; Balcik B, 2008, INT J LOGIST-RES APP, V11, P101, DOI 10.1080/13675560701561789; Balcik B, 2014, PROD OPER MANAG, V23, P1028, DOI 10.1111/poms.12098; Beamon B.M., 2006, INT J LOGIST-RES APP, V9, P1, DOI DOI 10.1080/13675560500453667; Campbell AM, 2011, EUR J OPER RES, V209, P156, DOI 10.1016/j.ejor.2010.08.029; Das R, 2014, EUR J OPER RES, V235, P616, DOI 10.1016/j.ejor.2013.12.042; Davis LB, 2013, INT J PROD ECON, V141, P561, DOI 10.1016/j.ijpe.2012.09.012; Dekle J, 2005, INTERFACES, V35, P133, DOI 10.1287/inte.1050.0127; Ertem MA, 2010, INT J PHYS DISTR LOG, V40, P202, DOI 10.1108/09600031011035092; Garrido RA, 2015, TRANSPORT RES E-LOG, V75, P18, DOI 10.1016/j.tre.2014.12.002; Lang TE, 2016, ADV OPER RES, V2016, DOI 10.1155/2016/1285406; Lee YH, 2007, INT J PROD ECON, V106, P115, DOI 10.1016/j.ijpe.2006.05.007; Mohammadi R, 2015, APPL MATH MODELLING; Ozbay K, 2007, TRANSP RES RECORD, P63, DOI 10.3141/2022-08; Ozguven EE, 2013, TRANSPORT RES C-EMER, V29, P171, DOI 10.1016/j.trc.2011.08.012; Perez-Rodriguez N, 2016, TRANSPORT SCI, V50, P1261, DOI 10.1287/trsc.2014.0565; Qiu BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139132; Rawls CG, 2010, TRANSPORT RES B-METH, V44, P521, DOI 10.1016/j.trb.2009.08.003; Sheu JB, 2007, TRANSPORT RES E-LOG, V43, P687, DOI 10.1016/j.tre.2006.04.004; Tagaras G, 2002, PROD OPER MANAG, V11, P183, DOI 10.1111/j.1937-5956.2002.tb00490.x; Taskin S, 2010, INT J PROD ECON, V126, P66, DOI 10.1016/j.ijpe.2009.10.008; TOREGAS C, 1971, OPER RES, V19, P1363, DOI 10.1287/opre.19.6.1363; Ukkusuri SV, 2008, TRANSPORT RES REC, P18, DOI 10.3141/2089-03; Wang J, 2009, OPT EXPRESS, V17, P10573, DOI 10.1364/OE.17.010573; Widener MJ, 2011, J TRANSP GEOGR, V19, P821, DOI 10.1016/j.jtrangeo.2010.10.006	25	7	8	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186747	10.1371/journal.pone.0186747	http://dx.doi.org/10.1371/journal.pone.0186747			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK9WD	29077722	Green Submitted, gold, Green Published			2022-12-26	WOS:000413861200020
J	Miliu, A; Lebrun, M; Braun-Breton, C; Lamarque, MH				Miliu, Alexandra; Lebrun, Maryse; Braun-Breton, Catherine; Lamarque, Mauld H.			Shelph2, a bacterial-like phosphatase of the malaria parasite Plasmodium falciparum, is dispensable during asexual blood stage	PLOS ONE			English	Article							PROTEIN-KINASE; CELL INVASION; TYROSINE; PHOSPHORYLATION; EGRESS; CYCLE	During the erythrocytic cycle of the malaria parasite Plasmodium falciparum, egress and invasion are essential steps finely controlled by reversible phosphorylation. In contrast to the growing number of kinases identified as key regulators, phosphatases have been poorly studied, and calcineurin is the only one identified so far to play a role in invasion. PfShelph2, a bacterial-like phosphatase, is a promising candidate to participate in the invasion process, as it was reported to be expressed late during the asexual blood stage and to reside within an apical compartment, yet distinct from rhoptry bulb, micronemes, or dense granules. It was also proposed to play a role in the control of the red blood cell membrane deformability at the end of the invasion process. However, genetic studies are still lacking to support this hypothesis. Here, we take advantage of the CRISPR-Cas9 technology to tag shelph2 genomic locus while retaining its endogenous regulatory regions. This new strain allows us to follow the endogenous PfShelph2 protein expression and location during asexual blood stages. We show that PfShelph2 apical location is also distinct from the rhoptry neck or exonemes. We further demonstrate PfShelph2 dispensability during the asexual blood stage by generating PfShelph2-KO parasites using CRISPR-Cas9 machinery. Analyses of the mutant during the course of the erythrocytic development indicate that there are no detectable phenotypic consequences of Pfshelph2 genomic deletion. As this lack of phenotype might be due to functional redundancy, we also explore the likelihood of PfShelph1 (PfShelph2 paralog) being a compensatory phosphatase. We conclude that despite its cyclic expression profile, PfShelph2 is a dispensable phosphatase during the Plasmodium falciparum asexual blood stage, whose function is unlikely substituted by PfShelph1.	[Miliu, Alexandra; Lebrun, Maryse; Braun-Breton, Catherine; Lamarque, Mauld H.] Univ Montpellier, CNRS, DIMNP, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Lamarque, MH (corresponding author), Univ Montpellier, CNRS, DIMNP, Montpellier, France.	mauld.lamarque@umontpellier.fr	Lebrun, Maryse/I-7728-2016	Lebrun, Maryse/0000-0002-0962-0156; Miliu, Alexandra/0000-0002-1363-8658	Laboratoire d'Excellence (LabEx) (ParaFrap) [ANR-11-LABX-0024, ANR-10-LABX-12-01]	Laboratoire d'Excellence (LabEx) (ParaFrap)	This research was supported by the Laboratoire d'Excellence (LabEx) (ParaFrap ANR-11-LABX-0024 and ANR-10-LABX-12-01)-ML and CBB received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8285; Andreeva AV, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-47; Aniweh Y, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12747; [Anonymous], 2016, WORLD MALARIA REPORT; Billker O, 2009, CELL HOST MICROBE, V5, P612, DOI 10.1016/j.chom.2009.05.017; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Brochet M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001806; Collins CR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003344; Crabb BS, 1996, P NATL ACAD SCI USA, V93, P7289, DOI 10.1073/pnas.93.14.7289; Doerig C, 2009, PARASITE, V16, P169, DOI 10.1051/parasite/2009163169; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; Fernandez-Pol S, 2013, EUKARYOT CELL, V12, P1179, DOI 10.1128/EC.00027-13; Ferru E, 2011, BLOOD, V117, P5998, DOI 10.1182/blood-2010-11-317024; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Guttery DS, 2014, CELL HOST MICROBE, V16, P128, DOI 10.1016/j.chom.2014.05.020; Guttery DS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002948; Harris PK, 2005, PLOS PATHOG, V1, P241, DOI 10.1371/journal.ppat.0010029; Hopp CS, 2012, MICROBES INFECT, V14, P831, DOI 10.1016/j.micinf.2012.04.011; Hu GA, 2010, NAT BIOTECHNOL, V28, P91, DOI 10.1038/nbt.1597; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Ito D, 2011, PARASITOL INT, V60, P132, DOI 10.1016/j.parint.2011.01.001; Kato N, 2008, NAT CHEM BIOL, V4, P347, DOI 10.1038/nchembio.87; Koch M, 2017, P NATL ACAD SCI USA, V114, P4225, DOI 10.1073/pnas.1620843114; Kutuzov MA, 2012, FUNCT INTEGR GENOMIC, V12, P11, DOI 10.1007/s10142-011-0254-z; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lasonder E, 2012, J PROTEOME RES, V11, P5323, DOI 10.1021/pr300557m; Pantaleo A, 2010, PROTEOMICS, V10, P3469, DOI 10.1002/pmic.201000269; Pantaleo A, 2010, J PROTEOMICS, V73, P445, DOI 10.1016/j.jprot.2009.08.011; PASVOL G, 1978, ANN TROP MED PARASIT, V72, P87, DOI 10.1080/00034983.1978.11719283; Patzewitz EM, 2013, CELL REP, V3, P622, DOI 10.1016/j.celrep.2013.01.032; Paul AS, 2015, CELL HOST MICROBE, V18, P49, DOI 10.1016/j.chom.2015.06.003; Przyborski JM, 2005, EMBO J, V24, P2306, DOI 10.1038/sj.emboj.7600720; ROGER N, 1988, MOL BIOCHEM PARASIT, V27, P135, DOI 10.1016/0166-6851(88)90033-3; Santos JM, 2017, CELL HOST MICROBE, V21, P731, DOI 10.1016/j.chom.2017.05.006; SAUL A, 1982, B WORLD HEALTH ORGAN, V60, P755; Sisquella X, 2017, ELIFE, V6, DOI [10.7554/eLife.21083, 10.7554/elife.21083]; Solyakov L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1558; Taylor HM, 2010, EUKARYOT CELL, V9, P37, DOI 10.1128/EC.00186-09; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; Tsuruta H, 1999, J BIOCHEM-TOKYO, V125, P690, DOI 10.1093/oxfordjournals.jbchem.a022338; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Wilkes JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-412; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049; Zhao X, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-490; Zuccala ES, 2016, SCI REP-UK, V6, DOI 10.1038/srep19766	47	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0187073	10.1371/journal.pone.0187073	http://dx.doi.org/10.1371/journal.pone.0187073			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073264	Green Published, gold, Green Submitted			2022-12-26	WOS:000413845400108
J	Stranava, M; Man, P; Skalova, T; Kolenko, P; Blaha, J; Fojtikova, V; Martinek, V; Dohnalek, J; Lengalova, A; Rosulek, M; Shimizu, T; Martinkova, M				Stranava, Martin; Man, Petr; Skalova, Tereza; Kolenko, Petr; Blaha, Jan; Fojtikova, Veronika; Martinek, Vaclav; Dohnalek, Jan; Lengalova, Alzbeta; Rosulek, Michal; Shimizu, Toru; Martinkova, Marketa			Coordination and redox state-dependent structural changes of the heme-based oxygen sensor AfGcHK associated with intraprotein signal transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CONFORMATIONAL-CHANGES; TRANSCRIPTION ACTIVATOR COOA; COUPLED HISTIDINE KINASE; CRYSTAL-STRUCTURE; DIGUANYLATE CYCLASE; BACILLUS-SUBTILIS; MYCOBACTERIUM-TUBERCULOSIS; BRADYRHIZOBIUM-JAPONICUM; LIGAND DISCRIMINATION; RESPONSE REGULATOR	The heme-based oxygen sensor histidine kinase AfGcHK is part of a two-component signal transduction system in bacteria. O-2 binding to the Fe(II) heme complex of its N-terminal globin domain strongly stimulates autophosphorylation at His(183) in its C-terminal kinase domain. The 6-coordinate heme Fe(III)-OH- and -CN- complexes of AfGcHK are also active, but the 5-coordinate heme Fe(II) complex and the heme-free apo-form are inactive. Here, we determined the crystal structures of the isolated dimeric globin domains of the active Fe(III)-CN- and inactive 5-coordinate Fe(II) forms, revealing striking structural differences on the heme-proximal side of the globin domain. Using hydrogen/deuterium exchange coupled with mass spectrometry to characterize the conformations of the active and inactive forms of full-length AfGcHK in solution, we investigated the intramolecular signal transduction mechanisms. Major differences between the active and inactive forms were observed on the heme-proximal side (helix H5), at the dimerization interface (helices H6 and H7 and loop L7) of the globin domain and in the ATP-binding site (helices H9 and H11) of the kinase domain. Moreover, separation of the sensor and kinase domains, which deactivates catalysis, increased the solvent exposure of the globin domain-dimerization interface (helix H6) as well as the flex ibility and solvent exposure of helix H11. Together, these results suggest that structural changes at the heme-proximal side, the globin domain-dimerization interface, and the ATP-binding site are important in the signal transduction mechanism of AfGcHK. We conclude that AfGcHK functions as an ensemble of molecules sampling at least two conformational states.	[Stranava, Martin; Man, Petr; Blaha, Jan; Fojtikova, Veronika; Martinek, Vaclav; Lengalova, Alzbeta; Rosulek, Michal; Shimizu, Toru; Martinkova, Marketa] Charles Univ Prague, Fac Sci, Dept Biochem, Hlavova Albertov 2030-8, Prague 12843 2, Czech Republic; [Man, Petr; Rosulek, Michal] Czech Acad Sci, Inst Microbiol, Vvi, Biocev, Vestec 25250, Czech Republic; [Skalova, Tereza; Kolenko, Petr; Dohnalek, Jan] Czech Acad Sci, Inst Biotechnol, Vvi, Biocev, Vestec 25250, Czech Republic; [Kolenko, Petr] Czech Tech Univ, Fac Nucl Sci & Phys Engn, Dept Solid State Engn, Brehova 7, Prague 11519 1, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Czech Technical University Prague	Martinkova, M (corresponding author), Charles Univ Prague, Fac Sci, Dept Biochem, Hlavova Albertov 2030-8, Prague 12843 2, Czech Republic.	marketa.martinkova@natur.cuni.cz	Man, Petr/H-2451-2014; Bláha, Jan/P-7642-2019; Martinkova, Marketa/E-3748-2012; Rosulek, Michal/L-6752-2017; Rosulek, Michal/R-8927-2019; Skalova, Tereza/G-6422-2014; Martinek, Vaclav/E-6710-2011; Lengalova, Alzbeta/G-9148-2017; Kolenko, Petr/G-5732-2014	Man, Petr/0000-0002-1485-2197; Bláha, Jan/0000-0003-4221-3162; Martinkova, Marketa/0000-0002-0865-8785; Rosulek, Michal/0000-0002-2426-7928; Rosulek, Michal/0000-0002-2426-7928; Skalova, Tereza/0000-0003-3186-2431; Martinek, Vaclav/0000-0003-3321-4526; Lengalova, Alzbeta/0000-0002-8386-9363; Kolenko, Petr/0000-0002-4619-9276; Shimizu, Toru/0000-0002-3950-5554; Dohnalek, Jan/0000-0002-8083-7980	Charles University Grant [UNCE 204025/2012]; Grant Agency of the Czech Republic [15-19883S]; Grant Agency of Charles University [362115, 704217]; Ministry of Education, Youth, and Sports of the Czech Republic of COST Action CA15126 MOBIEU [LM2015043, LTC17065]; ERDF fund Grants [CZ.02.1.01/0.0/0.0/16_013/0001776, CZ.1.05/1.1.00/02.0109]; Grant Agency of the Czech Technical University in Prague [SGS16/246/OHK4/3T/14]; Instruct, part of the European Strategy Forum on Research Infrastructures (ESFRI)	Charles University Grant; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Grant Agency of Charles University; Ministry of Education, Youth, and Sports of the Czech Republic of COST Action CA15126 MOBIEU; ERDF fund Grants; Grant Agency of the Czech Technical University in Prague; Instruct, part of the European Strategy Forum on Research Infrastructures (ESFRI)	This work was supported in part by Charles University Grant UNCE 204025/2012; Grant Agency of the Czech Republic Grant 15-19883S; Grant Agency of Charles University Grants 362115 and 704217; Ministry of Education, Youth, and Sports of the Czech Republic Grant LM2015043 CIISB, Biocev Crystallization, Diffraction and LTC17065 in frame of COST Action CA15126 MOBIEU; ERDF fund Grants CZ.02.1.01/0.0/0.0/16_013/0001776 and CZ.1.05/1.1.00/02.0109; and Grant Agency of the Czech Technical University in Prague Grant SGS16/246/OHK4/3T/14. This work was also partly funded by Instruct, part of the European Strategy Forum on Research Infrastructures (ESFRI) and supported by national member subscriptions.	Abriata LA, 2017, ACCOUNTS CHEM RES, V50, P1359, DOI 10.1021/acs.accounts.6b00593; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; Aono S, 2002, J BIOL CHEM, V277, P13528, DOI 10.1074/jbc.M112256200; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho HY, 2009, J BIOL CHEM, V284, P13057, DOI 10.1074/jbc.M808905200; Cunningham KA, 2009, MOL MICROBIOL, V71, P659, DOI 10.1111/j.1365-2958.2008.06554.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engen JR, 2003, ANALYST, V128, P623, DOI 10.1039/b212800b; Fojtikova V, 2015, BIOCHEMISTRY-US, V54, P5017, DOI 10.1021/acs.biochem.5b00517; Gong WM, 2000, BIOCHEMISTRY-US, V39, P3955, DOI 10.1021/bi992346w; Gushchin I, 2017, SCIENCE, V356, DOI 10.1126/science.aah6345; Hao B, 2002, BIOCHEMISTRY-US, V41, P12952, DOI 10.1021/bi020144l; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Igarashi J, 2008, J BIOL CHEM, V283, P18782, DOI 10.1074/jbc.M801400200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kadek A, 2017, BBA-GEN SUBJECTS, V1861, P157, DOI 10.1016/j.bbagen.2016.11.016; Keedy DA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004507; Kitanishi K, 2011, J BIOL CHEM, V286, P35522, DOI 10.1074/jbc.M111.274811; Komori H, 2007, J MOL BIOL, V367, P864, DOI 10.1016/j.jmb.2007.01.043; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kurokawa H, 2004, J BIOL CHEM, V279, P20186, DOI 10.1074/jbc.M314199200; Lanzilotta WN, 2000, NAT STRUCT BIOL, V7, P876; Martinkova M, 2013, J BIOL CHEM, V288, P27702, DOI 10.1074/jbc.R113.473249; Nakajima K, 2012, J INORG BIOCHEM, V108, P163, DOI 10.1016/j.jinorgbio.2011.09.019; Park HJ, 2004, BIOCHEMISTRY-US, V43, P2738, DOI 10.1021/bi035980p; Pesce A, 2009, J MOL BIOL, V386, P246, DOI 10.1016/j.jmb.2008.12.023; Podust LM, 2008, BIOCHEMISTRY-US, V47, P12523, DOI 10.1021/bi8012356; Rao MX, 2017, BIOCHEMISTRY-US, V56, P1274, DOI 10.1021/acs.biochem.6b01133; Rezabkova L, 2011, J BIOL CHEM, V286, P43527, DOI 10.1074/jbc.M111.273573; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shimizu T, 2015, CHEM REV, V115, P6491, DOI 10.1021/acs.chemrev.5b00018; Skalova T, 2005, J MOL BIOL, V353, P282, DOI 10.1016/j.jmb.2005.08.028; SPRINGER BA, 1994, CHEM REV, V94, P699, DOI 10.1021/cr00027a007; Stranava M, 2016, PROTEINS, V84, P1375, DOI 10.1002/prot.25083; Tarnawski M, 2015, ACTA CRYSTALLOGR D, V71, P2158, DOI 10.1107/S139900471501545X; Trcka F, 2014, J BIOL CHEM, V289, P9887, DOI 10.1074/jbc.M113.526046; Underbakke ES, 2014, STRUCTURE, V22, P602, DOI 10.1016/j.str.2014.01.008; Vagin A, 2015, ACTA CRYSTALLOGR A, V71, pS19, DOI 10.1107/S2053273315099672; Willett JW, 2017, MOL MICROBIOL, V103, P197, DOI 10.1111/mmi.13525; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamada S, 2007, ANAL BIOCHEM, V360, P160, DOI 10.1016/j.ab.2006.10.005; Yukl ET, 2008, BIOCHEMISTRY-US, V47, P12532, DOI 10.1021/bi801234w; Zhang W, 2005, BIOPHYS J, V88, P2801, DOI 10.1529/biophysj.104.047936; Zhang W, 2003, STRUCTURE, V11, P1097, DOI 10.1016/S0969-2126(03)00169-2; Zschiedrich CP, 2016, J MOL BIOL, V428, P3752, DOI 10.1016/j.jmb.2016.08.003	47	15	15	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					20921	20935		10.1074/jbc.M117.817023	http://dx.doi.org/10.1074/jbc.M117.817023			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29092908	hybrid, Green Published			2022-12-26	WOS:000418453400010
J	Cohen, SP; Liu, HX; Argues, CT; Pereira, A; Cruz, CV; Verdier, V; Leach, JE				Cohen, Stephen P.; Liu, Hongxia; Argues, Cristiana T.; Pereira, Andy; Cruz, Casiana Vera; Verdier, Valerie; Leach, Jan E.			RNA-Seq analysis reveals insight into enhanced rice Xa7-mediated bacterial blight resistance at high temperature	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; ORYZAE PV ORYZAE; ABSCISIC-ACID; XANTHOMONAS-ORYZAE; DISEASE RESISTANCE; ABIOTIC STRESS; HEAT-STRESS; GENE-EXPRESSION; ARABIDOPSIS-THALIANA; DROUGHT STRESS	Plant disease is a major challenge to agriculture worldwide, and it is exacerbated by abiotic environmental factors. During some plant-pathogen interactions, heat stress allows pathogens to overcome host resistance, a phenomenon which could severely impact crop productivity considering the global warming trends associated with climate change. Despite the importance of this phenomenon, little is known about the underlying molecular mechanisms. To better understand host plant responses during simultaneous heat and pathogen stress, we conducted a transcriptomics experiment for rice plants (cultivar IRBB61) containing Xa7, a bacterial blight disease resistance (R) gene, that were infected with Xanthomonas oryzae, the bacterial blight pathogen of rice, during high temperature stress. Xa7-mediated resistance is unusual relative to resistance mediated by other Rgenes in that it functions better at high temperatures. Using RNA-Seq technology, we identified 8,499 differentially expressed genes as temperature responsive in rice cultivar IRBB61 experiencing susceptible and resistant interactions across three time points. Notably, genes in the plant hormone abscisic acid biosynthesis and response pathways were up-regulated by high temperature in both mock-treated plants and plants experiencing a susceptible interaction and were suppressed by high temperature in plants exhibiting Xa7-mediated resistance. Genes responsive to salicylic acid, an important plant hormone for disease resistance, were down-regulated by high temperature during both the susceptible and resistant interactions, suggesting that enhanced Xa7-mediated resistance at high temperature is not dependent on salicylic acid signaling. A DNA sequence motif similar to known abscisic acid-responsive cis-regulatory elements was identified in the promoter region upstream of genes up-regulated in susceptible but down-regulated in resistant interactions. The results of our study suggest that the plant hormone abscisic acid is an important node for cross-talk between plant transcriptional response pathways to high temperature stress and pathogen attack. Genes in this pathway represent an important focus for future study to determine how plants evolved to deal with simultaneous abiotic and biotic stresses.	[Cohen, Stephen P.; Liu, Hongxia; Argues, Cristiana T.; Verdier, Valerie; Leach, Jan E.] Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA; [Cohen, Stephen P.] Colorado State Univ, Cell & Mol Biol Grad Program, Ft Collins, CO 80523 USA; [Liu, Hongxia] Chinese Acad Agr Sci, Inst Crop Sci, Beijing, Peoples R China; [Pereira, Andy] Univ Arkansas, Dept Crop Soil & Environm Sci, Fayetteville, AR 72701 USA; [Cruz, Casiana Vera] Int Rice Res Inst, Plant Breeding Genet & Biotechnol Div, Los Banos, Philippines; [Verdier, Valerie] Univ Montpellier, IPME, Cirad, IRD, Montpellier, France	Colorado State University; Colorado State University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; University of Arkansas System; University of Arkansas Fayetteville; CGIAR; International Rice Research Institute (IRRI); CIRAD; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Leach, JE (corresponding author), Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA.	Jan.Leach@colostate.edu	Pereira, Andy/AAF-4781-2020; Verdier, Valerie/K-1004-2016; Cohen, Stephen/AAG-6118-2020	Pereira, Andy/0000-0003-1378-4273; Verdier, Valerie/0000-0001-5425-9454; Cohen, Stephen/0000-0002-0748-0401; Leach, Jan/0000-0001-7252-4397	Marie Curie International Outgoing Fellowship within the 7th European Community Framework Program [235457-RXOMics]; National Natural Science Foundation of China NSFC [31471492]; Colorado State University Infectious Diseases Supercluster; United States Agency for International Development Linkage Project; Colorado Agricultural Experiment Station; Direct For Biological Sciences [1444511] Funding Source: National Science Foundation	Marie Curie International Outgoing Fellowship within the 7th European Community Framework Program; National Natural Science Foundation of China NSFC(National Natural Science Foundation of China (NSFC)); Colorado State University Infectious Diseases Supercluster; United States Agency for International Development Linkage Project(United States Agency for International Development (USAID)); Colorado Agricultural Experiment Station; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project received funding from the Marie Curie International Outgoing Fellowship within the 7th European Community Framework Program under grant agreement No. 235457-RXOMics (VV), National Natural Science Foundation of China NSFC Grant No. 31471492 (HXL), grants from the Colorado State University Infectious Diseases Supercluster, the United States Agency for International Development Linkage Project (JEL and CVC), and the Colorado Agricultural Experiment Station (SPC, JEL and CTA). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Barnabas B, 2008, PLANT CELL ENVIRON, V31, P11, DOI 10.1111/j.1365-3040.2007.01727.x; Baron KN, 2012, PLANT SCI, V188, P48, DOI 10.1016/j.plantsci.2012.03.001; Berger S, 2007, J EXP BOT, V58, P4019, DOI 10.1093/jxb/erm298; Cruz CMV, 2000, P NATL ACAD SCI USA, V97, P13500, DOI 10.1073/pnas.250271997; de Jong CF, 2002, MOL PLANT MICROBE IN, V15, P1040, DOI 10.1094/MPMI.2002.15.10.1040; Dossa GS, 2017, EUR J PLANT PATHOL, V147, P115, DOI 10.1007/s10658-016-0985-8; Dossa GS, 2016, AGR ECOSYST ENVIRON, V233, P282, DOI 10.1016/j.agee.2016.09.017; Nguyen D, 2016, PLANT MOL BIOL, V91, P727, DOI 10.1007/s11103-016-0481-8; Garg R, 2012, PLANT SIGNAL BEHAV, V7, P951, DOI 10.4161/psb.20910; Gomez-Porras JL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-260; Gordon A, 2010, FASTX TOOLKIT FASTQA; Gregory R., 2016, COMPREHENSIVE R ARCH; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; HOPKINS CM, 1992, MOL PLANT MICROBE IN, V5, P451, DOI 10.1094/MPMI-5-451; Hu XL, 2008, PLANT GROWTH REGUL, V55, P183, DOI 10.1007/s10725-008-9272-9; Jiang CJ, 2010, MOL PLANT MICROBE IN, V23, P791, DOI 10.1094/MPMI-23-6-0791; Karganilla A., 1973, Philippine Agriculturist, V57, P141; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lee SH, 2015, J INTEGR PLANT BIOL, V57, P562, DOI 10.1111/jipb.12276; Li W, 2016, BIOCHEM BIOPH RES CO, V470, P163, DOI 10.1016/j.bbrc.2016.01.015; Lim CW, 2015, INT J MOL SCI, V16, P15251, DOI 10.3390/ijms160715251; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu G, 2009, PLANTA, V229, P605, DOI 10.1007/s00425-008-0857-3; Madgwick JW, 2011, EUR J PLANT PATHOL, V130, P117, DOI 10.1007/s10658-010-9739-1; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Mang HG, 2012, PLANT CELL, V24, P1271, DOI 10.1105/tpc.112.096198; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Mittler R, 2006, TRENDS PLANT SCI, V11, P15, DOI 10.1016/j.tplants.2005.11.002; Mohr PG, 2003, FUNCT PLANT BIOL, V30, P461, DOI 10.1071/FP02231; Narsai R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-93; O'Hara NB, 2016, EVOLUTION, V70, P241, DOI 10.1111/evo.12833; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Prasch CM, 2013, PLANT PHYSIOL, V162, P1849, DOI 10.1104/pp.113.221044; R Core Team, 2016, R A LANGUAGE AND ENV; REDDY APK, 1979, PHYTOPATHOLOGY, V69, P967, DOI 10.1094/Phyto-69-967; REIMERS PJ, 1991, PHYSIOL MOL PLANT P, V38, P39, DOI 10.1016/S0885-5765(05)80141-9; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Scholthof KBG, 2007, NAT REV MICROBIOL, V5, P152, DOI 10.1038/nrmicro1596; Shigenaga AM, 2016, SEMIN CELL DEV BIOL, V56, P174, DOI 10.1016/j.semcdb.2016.06.005; Suh JP, 2013, RICE, V6, DOI 10.1186/1939-8433-6-5; Suzuki N, 2016, PLOS ONE, V11; Thanh TL, 2017, J PLANT INTERACT, V12, P108, DOI 10.1080/17429145.2017.1291859; Triplett LR, 2011, APPL ENVIRON MICROB, V77, P3930, DOI 10.1128/AEM.00028-11; Triplett LR, 2016, PLANT J, V87, P472, DOI 10.1111/tpj.13212; Tuteja N, 2007, PLANT SIGNAL BEHAV, V2, P135, DOI 10.4161/psb.2.3.4156; Verdier V, 2012, NEW PHYTOL, V196, P1197, DOI 10.1111/j.1469-8137.2012.04367.x; Verma V, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0771-y; Webb KM, 2010, NEW PHYTOL, V185, P568, DOI 10.1111/j.1469-8137.2009.03076.x; Whitham S, 1996, P NATL ACAD SCI USA, V93, P8776, DOI 10.1073/pnas.93.16.8776; Xiong LZ, 2003, PLANT CELL, V15, P745, DOI 10.1105/tpc.008714; Xu JB, 2013, IEEE PHOTON CONF, P10, DOI 10.1109/IPCon.2013.6656340; Xu J, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0411-3; Yasuda M, 2008, PLANT CELL, V20, P1678, DOI 10.1105/tpc.107.054296; Zandalinas SI, 2016, J EXP BOT, V67, P5381, DOI 10.1093/jxb/erw299; Zhang Y, 2005, J EXP BOT, V56, P897, DOI 10.1093/jxb/eri082; Zhao FF, 2016, J PLANT BIOL, V59, P293, DOI 10.1007/s12374-016-0035-2; Zhu Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000844	61	36	39	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187625	10.1371/journal.pone.0187625	http://dx.doi.org/10.1371/journal.pone.0187625			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29107972	Green Published, gold, Green Submitted			2022-12-26	WOS:000414424600049
J	Jung, SI; Rodriguez, N; Irrizary, J; Liboro, K; Bogarin, T; Macias, M; Eivers, E; Porter, E; Fillers, SG; Park, H				Jung, Sook-In; Rodriguez, Natalie; Irrizary, Jihyun; Liboro, Karl; Bogarin, Thania; Macias, Marlene; Eivers, Edward; Porter, Edith; Fillers, Scott G.; Park, Hyunsook			Yeast casein kinase 2 governs morphology, biofilm formation, cell wall integrity, and host cell damage of Candida albicans	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATOR; SIGNALING PATHWAYS; SACCHAROMYCES-CEREVISIAE; HYPHAL DEVELOPMENT; ENDOTHELIAL-CELLS; EXPRESSION; GROWTH; GENE; ALS3; UME6	The regulatory networks governing morphogenesis of a pleomorphic fungus, Candida albicans are extremely complex and remain to be completely elucidated. This study investigated the function of C. albicans yeast casein kinase 2 (CaYck2p). The yck2 Delta/yck2 Delta strain displayed constitutive pseudohyphae in both yeast and hyphal growth conditions, and formed enhanced biofilm under non-biofilm inducing condition. This finding was further supported by gene expression analysis of the yck2 Delta/yck2 Delta strain which showed significant upregulation of UME6, a key transcriptional regulator of hyphal transition and biofilm formation, and cell wall protein genes ALS3, HWP1, and SUN41, all of which are associated with morphogenesis and biofilm architecture. The yck2 Delta/yck2 Delta strain was hypersensitive to cell wall damaging agents and had increased compensatory chitin deposition in the cell wall accompanied by an upregulation of the expression of the chitin synthase genes, CHS2, CHS3, and CHS8. Absence of CaYck2p also affected fungal-host interaction; the yck2 Delta/yck2 Delta strain had significantly reduced ability to damage host cells. However, the yck2 Delta/yck2 Delta strain had wild-type susceptibility to cyclosporine and FK506, suggesting that CaYck2p functions independently from the Ca+/calcineurin pathway. Thus, in C. albicans, Yck2p is a multifunctional kinase that governs morphogenesis, biofilm formation, cell wall integrity, and host cell interactions.	[Jung, Sook-In] Chonnam Natl Univ, Med Sch, Div Infect Dis, Gwangju, South Korea; [Rodriguez, Natalie; Irrizary, Jihyun; Liboro, Karl; Bogarin, Thania; Macias, Marlene; Eivers, Edward; Porter, Edith; Park, Hyunsook] Calif State Univ Los Angeles, Dept Biol Sci, Los Angeles, CA 90032 USA; [Fillers, Scott G.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Dept Med, Div Infect Dis, Torrance, CA 90509 USA; [Fillers, Scott G.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Chonnam National University; California State University System; California State University Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Park, H (corresponding author), Calif State Univ Los Angeles, Dept Biol Sci, Los Angeles, CA 90032 USA.	hpark8@calstatela.edu	Park, Hyunsook/AAA-3815-2021	Park, Hyunsook/0000-0002-8065-1625	National Institutes of Health [GM611331, SC3 GM103699, SC1 GM096916, R01 DE022600]; National Research Foundation of Korea [NRF-2013R1A1A3010554]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI124566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE026600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health, URL: https://www.nih.gov, grant numbers: GM611331, SC3 GM103699, SC1 GM096916, R01 DE022600; and National Research Foundation of Korea, URL: https://www.nrf.re.kr/ index, grant number: NRF-2013R1A1A3010554. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendrup MC, 2010, CURR OPIN CRIT CARE, V16, P445, DOI 10.1097/MCC.0b013e32833e84d2; Argimon S, 2007, EUKARYOT CELL, V6, P682, DOI 10.1128/EC.00340-06; Babu P, 2002, J CELL SCI, V115, P4957, DOI 10.1242/jcs.00203; Banerjee M, 2008, MOL BIOL CELL, V19, P1354, DOI 10.1091/mbc.E07-11-1110; Banerjee M, 2013, EUKARYOT CELL, V12, P224, DOI 10.1128/EC.00163-12; Blankenship JR, 2006, CURR OPIN MICROBIOL, V9, P588, DOI 10.1016/j.mib.2006.10.003; Blankenship JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000752; Boorsma A, 2004, YEAST, V21, P413, DOI 10.1002/yea.1109; Braun BR, 2000, GENETICS, V155, P57; Braun BR, 1997, SCIENCE, V277, P105, DOI 10.1126/science.277.5322.105; Brown AJP, 1999, TRENDS MICROBIOL, V7, P333, DOI 10.1016/S0966-842X(99)01556-5; Brown V, 2009, CURR BIOL, V19, P436, DOI 10.1016/j.cub.2009.01.056; Bruno VM, 2006, PLOS PATHOG, V2, P204, DOI 10.1371/journal.ppat.0020021; Carlisle PL, 2013, MOL BIOL CELL, V24, P246, DOI 10.1091/mbc.E12-01-0065; Carlisle PL, 2010, EUKARYOT CELL, V9, P1320, DOI 10.1128/EC.00046-10; Carlisle PL, 2009, P NATL ACAD SCI USA, V106, P599, DOI 10.1073/pnas.0804061106; Chaffin WL, 1998, MICROBIOL MOL BIOL R, V62, P130, DOI 10.1128/MMBR.62.1.130-180.1998; Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001; Cheong JK, 2011, INT J BIOCHEM CELL B, V43, P465, DOI 10.1016/j.biocel.2010.12.004; Childers DS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122775; Davidson G, 2010, CELL CYCLE, V9, P1667, DOI 10.4161/cc.9.9.11595; Desai JV, 2015, PATHOGENS, V4, P573, DOI 10.3390/pathogens4030573; Desai JV, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a019729; Desai JV, 2013, MBIO, V4, DOI 10.1128/mBio.00637-12; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Dwivedi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016218; Eisman B, 2006, EUKARYOT CELL, V5, P347, DOI 10.1128/EC.5.2.347-358.2006; Espinel-Ingroff A, 2009, J CLIN MICROBIOL, V47, P2766, DOI 10.1128/JCM.00654-09; Fan Y, 2013, MYCOPATHOLOGIA, V176, P329, DOI 10.1007/s11046-013-9684-6; Fanning S, 2012, MOL MICROBIOL, V86, P284, DOI 10.1111/j.1365-2958.2012.08193.x; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; FILLER SG, 1995, INFECT IMMUN, V63, P976, DOI 10.1128/IAI.63.3.976-983.1995; Finkel JS, 2011, NAT REV MICROBIOL, V9, P109, DOI 10.1038/nrmicro2475; Fu Y, 2013, INFECT IMMUN, V81, P2528, DOI 10.1128/IAI.00013-13; Gow NAR, 2002, CURR OPIN MICROBIOL, V5, P366, DOI 10.1016/S1369-5274(02)00338-7; Gow NAR, 2012, CURR OPIN MICROBIOL, V15, P406, DOI 10.1016/j.mib.2012.04.005; Gow NAR, 2012, NAT REV MICROBIOL, V10, P112, DOI 10.1038/nrmicro2711; Hiller E, 2007, EUKARYOT CELL, V6, P2056, DOI 10.1128/EC.00285-07; Ho S, 1996, CLIN IMMUNOL IMMUNOP, V80, pS40, DOI 10.1006/clin.1996.0140; Inglis DO, 2013, EUKARYOT CELL, V12, P1316, DOI 10.1128/EC.00094-13; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jin Y, 2003, J CLIN MICROBIOL, V41, P2961, DOI 10.1128/JCM.41.7.2961-2967.2003; Kadosh D, 2005, MOL BIOL CELL, V16, P2903, DOI 10.1091/mbc.E05-01-0073; KEARNEY PH, 1994, BIOCHEM BIOPH RES CO, V203, P231, DOI 10.1006/bbrc.1994.2172; Koyano T, 2015, GENES CELLS, V20, P1046, DOI 10.1111/gtc.12309; Kumamoto CA, 2005, CELL MICROBIOL, V7, P1546, DOI 10.1111/j.1462-5822.2005.00616.x; Lagorce A, 2003, J BIOL CHEM, V278, P20345, DOI 10.1074/jbc.M211604200; Liu YP, 2011, EUKARYOT CELL, V10, P168, DOI 10.1128/EC.00279-10; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Moriya H, 2004, P NATL ACAD SCI USA, V101, P1572, DOI 10.1073/pnas.0305901101; Mukherjee PK, 2006, INFECT IMMUN, V74, P3804, DOI 10.1128/IAI.00161-06; Munro CA, 2007, MOL MICROBIOL, V63, P1399, DOI 10.1111/j.1365-2958.2007.05588.x; NAVARROGARCIA F, 1995, MOL CELL BIOL, V15, P2197; Nobile CJ, 2005, CURR BIOL, V15, P1150, DOI 10.1016/j.cub.2005.05.047; Nobile CJ, 2006, EUKARYOT CELL, V5, P1604, DOI 10.1128/EC.00194-06; Panek HR, 1997, EMBO J, V16, P4194, DOI 10.1093/emboj/16.14.4194; Park H, 2005, CELL MICROBIOL, V7, P499, DOI 10.1111/j.1462-5822.2004.00476.x; Park H, 2009, EUKARYOT CELL, V8, P1498, DOI 10.1128/EC.00165-09; Pfaller MA, 2010, CRIT REV MICROBIOL, V36, P1, DOI 10.3109/10408410903241444; Phan QT, 2000, INFECT IMMUN, V68, P3485, DOI 10.1128/IAI.68.6.3485-3490.2000; Phan QT, 2013, MBIO, V4, DOI 10.1128/mBio.00542-13; Phan QT, 2007, PLOS BIOL, V5, P543, DOI 10.1371/journal.pbio.0050064; Ramage G, 2005, EUKARYOT CELL, V4, P633, DOI 10.1128/EC.4.4.633-638.2005; Rauceo JM, 2008, MOL BIOL CELL, V19, P2741, DOI 10.1091/mbc.E08-02-0191; Richard ML, 2005, EUKARYOT CELL, V4, P1493, DOI 10.1128/EC.4.8.1493-1502.2005; Robinson LC, 1999, MOL BIOL CELL, V10, P1077, DOI 10.1091/mbc.10.4.1077; ROBINSON LC, 1992, P NATL ACAD SCI USA, V89, P28, DOI 10.1073/pnas.89.1.28; Sanchez AA, 2004, INFECT IMMUN, V72, P598, DOI 10.1128/IAI.72.1.598-601.2004; Saputo S, 2014, EUKARYOT CELL, V13, P1169, DOI 10.1128/EC.00148-14; Saraswati S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015521; Shimada M, 2009, BIOCHEM BIOPH RES CO, V388, P529, DOI 10.1016/j.bbrc.2009.08.030; Staab JF, 1999, SCIENCE, V283, P1535, DOI 10.1126/science.283.5407.1535; Stevens DA, 2006, ANTIMICROB AGENTS CH, V50, P3160, DOI 10.1128/AAC.00563-06; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; Valdivia RH, 2003, P NATL ACAD SCI USA, V100, P10287, DOI 10.1073/pnas.1834246100; Walker LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000040; Walker LA, 2013, J CELL SCI, V126, P2668, DOI 10.1242/jcs.118885; WANG PC, 1992, MOL BIOL CELL, V3, P275, DOI 10.1091/mbc.3.3.275; Wang YN, 2011, EUKARYOT CELL, V10, P1455, DOI 10.1128/EC.05207-11; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Xu L, 2016, INT J ONCOL, V48, P1175, DOI 10.3892/ijo.2016.3337; Zeidler U, 2009, FEMS YEAST RES, V9, P126, DOI 10.1111/j.1567-1364.2008.00459.x; Zhao XM, 2004, MICROBIOL-SGM, V150, P2415, DOI 10.1099/mic.0.26943-0	85	12	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187721	10.1371/journal.pone.0187721	http://dx.doi.org/10.1371/journal.pone.0187721			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29107946	gold, Green Published, Green Submitted			2022-12-26	WOS:000414424600066
J	Seyedsadjadi, N; Berg, J; Bilgin, AA; Tung, C; Grant, R				Seyedsadjadi, Neda; Berg, Jade; Bilgin, Ayse A.; Tung, Chin; Grant, Ross			Significant relationships between a simple marker of redox balance and lifestyle behaviours; Relevance to the Framingham risk score	PLOS ONE			English	Article							TOTAL ANTIOXIDANT CAPACITY; OXIDATIVE STRESS; LIPID-PEROXIDATION; DENSITY-LIPOPROTEIN; PLASMA; QUESTIONNAIRE; CANCER; MALONDIALDEHYDE; OVEREXPRESSION; MORTALITY	Oxidative stress has been closely linked to the progressive cell damage associated with emerging non-communicable disease (NODs). Early detection of these biochemical abnormalities before irreversible cell damage occurs may therefore be useful in identifying disease risk at an individual level. In order to test this hypothesis, this study assessed the relationship between a simple measure of redox status and lifestyle risk factors for NODs, and the population-based risk score of Framingham. In a cross-sectional study design, 100 apparently healthy middle-aged males (n = 48) and females (n = 52) were asked to complete a comprehensive lifestyle assessment questionnaire, followed by body fat percentage and blood pressure measurements, and blood collection. The ratio of plasma total antioxidant capacity to hydroperoxide (TAG/HPX) was used as an index of redox balance. One-way ANOVA and multiple linear regression analysis were performed to analyse the association between TAO/HPX, lifestyle components and other plasma biomarkers. The TAO/HPX ratio was higher in males compared to females (t(96) = 2.34, P = 0.021). TAC/HPX was also lower in participants with poor sleep quality (t(93) = 2.39, P = 0.019), with high sleep apnoea risk (t(62.2) = 3.32, P = 0.002), with high caffeine (F(2, 93) = 3.97, P = 0.022) and red meat intake (F(2, 93) = 5.55, P = 0.005). These associations were independent of gender. Furthermore, the TAC/HPX ratio decreased with increasing body fat percentage (F(2, 95) = 4.74, P = 0.011) and depression score (t(94) = 2.38, P = 0.019), though these associations were dependent on gender. Importantly, a negative association was observed between TAO/HPX levels and the Framingham risk score in both males (r(45) = -0.39, P = 0.008) and females (r(50) = -0.33, P = 0.019) that was independent of other Framingham risk score components. Findings from this study suggests that a relatively simple measure of redox balance such as the TAO/HPX ratio may be a sensitive indicator of redox stress, and may therefore serve as a useful biomarker for assessing an individual's specific NOD risk linked to unhealthy lifestyle practices.	[Seyedsadjadi, Neda; Grant, Ross] Univ New South Wales, Sch Med Sci, Fac Med, Sydney, NSW, Australia; [Berg, Jade; Tung, Chin; Grant, Ross] Sydney Adventist Hosp, Australasian Res Inst, Sydney, NSW, Australia; [Bilgin, Ayse A.] Macquarie Univ, Dept Stat, Sydney, NSW, Australia; [Grant, Ross] Univ Sydney, Sydney Adventist Hosp, Clin Sch, Sydney, NSW, Australia	University of New South Wales Sydney; Sydney Adventist Hospital; Macquarie University; Sydney Adventist Hospital; University of Sydney	Grant, R (corresponding author), Univ New South Wales, Sch Med Sci, Fac Med, Sydney, NSW, Australia.; Grant, R (corresponding author), Sydney Adventist Hosp, Australasian Res Inst, Sydney, NSW, Australia.; Grant, R (corresponding author), Univ Sydney, Sydney Adventist Hosp, Clin Sch, Sydney, NSW, Australia.	Ross.Grant@sah.org.au		Bilgin, Ayse/0000-0001-8760-5763	Australasian Research Institute; University of New South Wales	Australasian Research Institute; University of New South Wales	This study was funded by internal funding from the Australasian Research Institute (received by RG) and student allocated funding from the University of New South Wales (received by NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson KJ, 2004, AM J CLIN NUTR, V79, P40; Arendt BM, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-33; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; Azizbeigi K, 2015, KINESIOLOGY, V47, P139; Baek SE, 2016, PSYCHIAT INVEST, V13, P222, DOI 10.4306/pi.2016.13.2.222; Bazzocchi A, 2013, CLIN NUTR, V32, P569, DOI 10.1016/j.clnu.2012.10.004; Bellanti F, 2013, REDOX BIOL, V1, P340, DOI 10.1016/j.redox.2013.05.003; BOWRY VW, 1992, P NATL ACAD SCI USA, V89, P10316, DOI 10.1073/pnas.89.21.10316; Brigelius-Flohe R, 1997, BIOCHEM J, V328, P199, DOI 10.1042/bj3280199; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cervellati C, 2014, SCAND J CLIN LAB INV, V74, P102, DOI 10.3109/00365513.2013.860618; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dato S, 2013, INT J MOL SCI, V14, P16443, DOI 10.3390/ijms140816443; de Campos HH, 2006, CLIMACTERIC, V9, P312, DOI 10.1080/13697130600871947; de Oliveira MC, 2010, BRAZ ARCH BIOL TECHN, V53, P1333, DOI 10.1590/S1516-89132010000600009; Eisele HJ, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/608438; Fraga CG, 2014, BBA-GEN SUBJECTS, V1840, P931, DOI 10.1016/j.bbagen.2013.06.030; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Fukui T, 2011, HYPERTENS RES, V34, P1041, DOI 10.1038/hr.2011.76; Ghiselli A, 2000, FREE RADICAL BIO MED, V29, P1106, DOI 10.1016/S0891-5849(00)00394-4; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Gomez-Cabrera MC, 2008, FREE RADICAL BIO MED, V44, P126, DOI 10.1016/j.freeradbiomed.2007.02.001; Gonenc A, 2001, J CLIN PHARM THER, V26, P141, DOI 10.1046/j.1365-2710.2001.00334.x; Guest J, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/741612; Huang HL, 2008, DIS MARKERS, V24, P341, DOI 10.1155/2008/371314; Ireland P, 1994, Asia Pac J Clin Nutr, V3, P19; Kvaavik E, 2010, ARCH INTERN MED, V170, P711, DOI 10.1001/archinternmed.2010.76; Lavie L, 2004, SLEEP, V27, P123; Lewis NA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149927; Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158; Liehr JG, 1997, ENVIRON HEALTH PERSP, V105, P565, DOI 10.2307/3433371; Lim S H, 2012, Malays J Nutr, V18, P345; Lovibond SH, 1995, MANUAL DEPRESSION AN, V2nd; Mainous AG, 2004, ANN FAM MED, V2, P139, DOI 10.1370/afm.82; Mates JM, 2012, ARCH TOXICOL, V86, P1649, DOI 10.1007/s00204-012-0906-3; Mazereeuw G, 2015, NEUROPSYCH DIS TREAT, V11, P2479, DOI 10.2147/NDT.S89922; Mohieldein AH, 2015, DIABETES METAB SYND, V9, P287, DOI 10.1016/j.dsx.2014.04.017; Moreto F, 2015, DIABETES METAB SYND, V9, P218, DOI 10.1016/j.dsx.2015.04.008; Moriel P, 2000, BIOL RES, V33, P105; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; NISKANEN LK, 1995, DIABETIC MED, V12, P802, DOI 10.1111/j.1464-5491.1995.tb02083.x; Nova P, 2012, SLEEP MED, V13, P362, DOI 10.1016/j.sleep.2011.11.011; Parkash J, 2006, BIOCHEMISTRY-US, V45, P2872, DOI 10.1021/bi051855x; Pellegrini N, 2007, J NUTR, V137, P93, DOI 10.1093/jn/137.1.93; REIMUND E, 1994, MED HYPOTHESES, V43, P231, DOI 10.1016/0306-9877(94)90071-X; Romeu M, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-102; Shishehbor MH, 2006, FREE RADICAL BIO MED, V41, P1678, DOI 10.1016/j.freeradbiomed.2006.09.001; SIES H, 1991, AM J MED, V91, pS31, DOI 10.1016/0002-9343(91)90281-2; Stephens JW, 2009, ATHEROSCLEROSIS, V202, P321, DOI 10.1016/j.atherosclerosis.2008.06.006; Torres A, 2015, REV CLIN ESP, V215, P486, DOI 10.1016/j.rce.2015.07.002; Wagner KH, 2012, PREV MED, V54, pS38, DOI 10.1016/j.ypmed.2011.11.012; Wassmann S, 2004, CIRC RES, V94, P534, DOI 10.1161/01.RES.0000115557.25127.8D; Weber MA, 2014, J CLIN HYPERTENS, V16, P14, DOI 10.1111/jch.12237; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yarows SA, 2001, BLOOD PRESS MONIT, V6, P145, DOI 10.1097/00126097-200106000-00005; Yeo WW, 2001, DIABETIC MED, V18, P341, DOI 10.1046/j.1464-5491.2001.00510.x; Zeraatpishe A, 2015, ASIAN J SPORTS MED, V6	58	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187713	10.1371/journal.pone.0187713	http://dx.doi.org/10.1371/journal.pone.0187713			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29107974	Green Published, Green Submitted, gold			2022-12-26	WOS:000414424600063
J	Haramura, T; Crossland, MR; Takeuchi, H; Shine, R				Haramura, Takashi; Crossland, Michael R.; Takeuchi, Hirohiko; Shine, Richard			Methods for invasive species control are transferable across invaded areas	PLOS ONE			English	Article							CANE TOAD; SEXUAL SELECTION; FEMALE CHOICE; RHINELLA-MARINA; MATE CHOICE; EVOLUTION; FROG; BEHAVIOR; STRATEGIES; CHEMICALS	Cane Toads (Rhinella marina) are invasive pests in many parts of the world, including the Japanese island of Ishigaki. Extensive research in Australia has identified promising new methods for control, but also has shown that toads exhibit geographic variation in many traits (suggesting that methods developed in one location may not work in another). Can the approaches developed in Australia play a useful role for controlling this invasive species in Japan? Our experimental trials on Ishigaki Island suggest that these new methods can be successfully applied to Japan. First, Cane Toad embryos exposed to chemical cues of conspecific tadpoles exhibited a reduction in viability (subsequent growth and development). This response appears to be species-specific, with native frog embryos not being affected by exposure to cues from toad tadpoles, and Cane Toad embryos not being affected by exposure to cues from native frog tadpoles. Second, Cane Toad tadpoles were attracted to traps containing water from conspecific eggs, and toxin from adult conspecifics. Third, adult Cane Toads were attracted to acoustic cues of calling males, with sex differences in rates of attraction to specific versions of a synthetic call (males were attracted to choruses whereas females were attracted to low-frequency calls). Our results suggest that the methods developed by Australian researchers are applicable to controlling invasive Cane Toads in Japan.	[Haramura, Takashi] Kyoto Univ, Hakubi Ctr Adv Res, Sakyo Ku, Kyoto, Japan; [Haramura, Takashi; Takeuchi, Hirohiko] Kyoto Univ, Field Sci Educ & Res Ctr, Wakayama, Japan; [Crossland, Michael R.; Shine, Richard] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia; [Takeuchi, Hirohiko] Nihon Univ, Coll Bioresource Sci, 1866 Kameino Fujisawa, Kanagawa, Japan	Kyoto University; Kyoto University; University of Sydney; Nihon University	Haramura, T (corresponding author), Kyoto Univ, Hakubi Ctr Adv Res, Sakyo Ku, Kyoto, Japan.; Haramura, T (corresponding author), Kyoto Univ, Field Sci Educ & Res Ctr, Wakayama, Japan.	haramura.takashi.2n@kyoto-u.an.jp	Crossland, Michael R/G-1091-2012	Crossland, Michael R/0000-0001-9967-7158	Hakubi Center, Kyoto University; Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [4RF-1402]; Australian Research Council	Hakubi Center, Kyoto University; Environment Research and Technology Development Fund of the Ministry of the Environment, Japan(Ministry of the Environment, Japan); Australian Research Council(Australian Research Council)	This work was supported by an internal grant from The Hakubi Center, Kyoto University, the Environment Research and Technology Development Fund (4RF-1402) of the Ministry of the Environment, Japan, and the Australian Research Council.	Alford R., 1995, WETLAND RES WET DRY, P173; Alford RA, 2009, WILDLIFE RES, V36, P23, DOI 10.1071/WR08021; Allendorf FW., 2009, CONSERV GENET; Andersson Malte, 1994; [Anonymous], 1984, OR VERS 4; [Anonymous], JMP VERS 9 0; ARAK A, 1983, NATURE, V306, P261, DOI 10.1038/306261a0; Banks PB, 1998, J WILDLIFE MANAGE, V62, P766, DOI 10.2307/3802353; Bee MA, 2007, BEHAV ECOL SOCIOBIOL, V61, P955, DOI 10.1007/s00265-006-0324-8; Bernal XE, 2009, P R SOC B, V276, P1323, DOI 10.1098/rspb.2008.0935; Bowcock H, 2009, COPEIA, P29, DOI 10.1643/CE-08-036; Brown GP, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1385; Castellano S, 1998, ANIM BEHAV, V56, P275, DOI 10.1006/anbe.1998.0784; Clarke GS, 2016, ECOL APPL, V26, P463, DOI 10.1890/14-2365; Cox GW, 2004, ALIEN SPECIES EVOLUT; Crossland MR, 2012, P ROY SOC B-BIOL SCI, V279, P3436, DOI 10.1098/rspb.2012.0821; Crossland MR, 2012, BIOL LETTERS, V8, P226, DOI 10.1098/rsbl.2011.0794; Crossland MR, 2011, OIKOS, V120, P327, DOI 10.1111/j.1600-0706.2010.18911.x; DAVIES NB, 1978, NATURE, V274, P683, DOI 10.1038/274683a0; Ducatez S, 2016, J EVOLUTION BIOL, V29, P335, DOI 10.1111/jeb.12785; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Felton A, 2006, BEHAV ECOL SOCIOBIOL, V59, P786, DOI 10.1007/s00265-005-0124-6; Forester DC, 1998, BEHAVIOUR, V135, P99, DOI 10.1163/156853998793066375; GERHARDT HC, 1991, ANIM BEHAV, V42, P615, DOI 10.1016/S0003-3472(05)80245-3; GERHARDT HC, 1994, ANNU REV ECOL SYST, V25, P293, DOI 10.1146/annurev.es.25.110194.001453; GERHARDT HC, 1988, J COMP PHYSIOL A, V163, P795, DOI 10.1007/BF00604056; Gosner K. L., 1960, Herpetologica, V16, P183; Halliday Tim, 1995, Amphibian Biology, V2, P419; HOWARD RD, 1978, EVOLUTION, V32, P850, DOI 10.1111/j.1558-5646.1978.tb04639.x; Hudson CM, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160687; Kidera Noriko, 2008, Current Herpetology, V27, P23, DOI 10.3105/1345-5834(2008)27[23:CETTKN]2.0.CO;2; LEVER C., 2001, CANE TOAD HIST ECOLO; Llewelyn J, 2010, OECOLOGIA, V162, P343, DOI 10.1007/s00442-009-1471-1; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Marquez R, 1990, HERPETOLOGICA, V46, P172; Masunaga G, 2005, B HERPETOL SOC JAPAN, V2005, P173; Nakajima T, 2005, B HERPETOL SOC JAPAN, V2005, P179; OLDHAM RS, 1967, ECOLOGY, V48, P477, DOI 10.2307/1932683; Ota H, 1999, PROBLEM SNAKE MANAGEMENT, P439; Ota Hidetoshi, 2004, Global Environmental Research, V8, P133; Pallister J, 2007, J VIROL METHODS, V146, P419, DOI 10.1016/j.jviromet.2007.08.016; Peacock T., 2007, COMMUNITY GROUND CAN; Pfennig KS, 2000, BEHAV ECOL SOCIOBIOL, V48, P69, DOI 10.1007/s002650000205; Phillips BL, 2010, J EVOLUTION BIOL, V23, P2595, DOI 10.1111/j.1420-9101.2010.02118.x; Phillips BL, 2006, NATURE, V439, P803, DOI 10.1038/439803a; Pramuk JB, 2006, ZOOL J LINN SOC-LOND, V146, P407, DOI 10.1111/j.1096-3642.2006.00212.x; R Core Team, 2021, R LANGUAGE ENV STAT; Richardson C, 2010, BEHAVIOUR, V147, P1737, DOI 10.1163/000579510X530221; RYAN MJ, 1983, EVOLUTION, V37, P261, DOI 10.1111/j.1558-5646.1983.tb05536.x; RYAN MJ, 1981, BEHAV ECOL SOCIOBIOL, V8, P273, DOI 10.1007/BF00299526; Schwarzkopf L, 2007, WILDLIFE RES, V34, P366, DOI 10.1071/WR06173; Schwarzkopf L, 1996, FUNCT ECOL, V10, P193, DOI 10.2307/2389843; Semlitsch RD, 2008, J WILDLIFE MANAGE, V72, P260, DOI 10.2193/2007-082; Shine R, 2010, Q REV BIOL, V85, P253, DOI 10.1086/655116; Somaweera R, 2012, ANIM CONSERV, V15, P152, DOI 10.1111/j.1469-1795.2011.00500.x; Sullivan Brian K., 1995, Amphibian Biology, V2, P469; Tingley Reid, 2017, Q Rev Biol, V92, P123, DOI 10.1086/692167; Tyler MJ, 1975, REPORT VERMIN NOXIOU; WAGNER WE, 1995, ANIM BEHAV, V49, P305, DOI 10.1006/anbe.1995.0044; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Wells KD., 2007, ECOLOGY BEHAV AMPHIB; Yasumiba K, 2016, SCI REP-UK, V6, DOI 10.1038/srep28158; Yasumiba K, 2015, ANIM BEHAV, V109, P141, DOI 10.1016/j.anbehav.2015.08.015; Yeager A, 2014, J PEST SCI, V87, P323, DOI 10.1007/s10340-014-0555-9; Zar JH, BIOSTATISTICAL ANAL; ZIMMERMAN BL, 1983, HERPETOLOGICA, V39, P235	66	2	2	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							e0187265	10.1371/journal.pone.0187265	http://dx.doi.org/10.1371/journal.pone.0187265			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6TA	29099851	Green Published, Green Submitted, gold			2022-12-26	WOS:000414377900016
J	Huang, YS; Koo, M; Chen, JC; Hwang, JH				Huang, Yung-Sung; Koo, Malcolm; Chen, Jin-Cherng; Hwang, Juen-Haur			The association between tinnitus and the risk of ischemic cerebrovascular disease in young and middle-aged patients: A secondary case-control analysis of a nationwide, population-based health claims database	PLOS ONE			English	Article							SALICYLATE-INDUCED TINNITUS; HEARING-LOSS; STROKE; DIAGNOSIS; STIFFNESS; JAPANESE; GENES; BRAIN	Background Tinnitus and ischemic cerebrovascular disease (ICVD) may share common pathophysiologic mechanisms. Nevertheless, no studies have investigated whether tinnitus is associated with a higher risk of ICVD. The aim of this study was to evaluate the risk of ICVD among young and middle-aged patients with tinnitus. Methods Using the Taiwan's National Health Insurance Research Database, we identified 3,474 patients 20-45 years old with incident ICVD diagnosed between January 1, 2000 and December 31, 2010 and 17,370 controls, frequency matched on age interval, sex, and year of the index date. Risk of ICVD associated with tinnitus was assessed using multiple logistic regression analyses. Results Tinnitus was significantly associated with a higher risk of incident ICVD among young and middle-aged patients (adjusted odds ratio [OR] 1.66, 95% confidence interval [CI] 1.34-2.04), adjusting for sex, age, and comorbidities. In addition, sex-stratified analysis showed that the associations were significant in both male (adjusted OR 1.55, 95% CI 1.16-2.07) and female patients (adjusted OR 1.77, 95% CI 1.30-2.41). Furthermore, tinnitus was significantly associated with a higher risk of ICVD in the 20.0-29.9 years (adjusted OR 4.11, 95% CI 1.98-8.52) and 30.0-39.9 years (adjusted OR 2.19, 95% CI 1.57-3.05) age groups, but for this work. Competing interests: The authors have declared that no competing interests exist. not in the 40.0-45.0 years age group. Conclusions Tinnitus could be a novel risk factor or clinical indicator for young ischemic stroke, and further investigations are warranted.	[Huang, Yung-Sung] Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Neurol, Chiayi, Taiwan; [Koo, Malcolm] Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Med Res, Chiayi, Taiwan; [Koo, Malcolm] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Chen, Jin-Cherng] Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Neurosurg, Chiayi, Taiwan; [Chen, Jin-Cherng; Hwang, Juen-Haur] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Hwang, Juen-Haur] Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Otolaryngol, Chiayi, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; University of Toronto; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital	Hwang, JH (corresponding author), Tzu Chi Univ, Sch Med, Hualien, Taiwan.; Hwang, JH (corresponding author), Dalin Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Otolaryngol, Chiayi, Taiwan.	juenhaur@ms96.url.com.tw	Koo, Malcolm/AAE-5822-2020	Koo, Malcolm/0000-0002-9242-9167				Abanoz Y, 2017, NEUROL SCI; Arnold M, 2009, J NEUROL NEUROSUR PS, V80, P171, DOI 10.1136/jnnp.2008.155226; Baguley D, 2013, LANCET, V382, P1600, DOI 10.1016/S0140-6736(13)60142-7; Bayraktar C, 2017, EUR ARCH OTO-RHINO-L, V274, P2125, DOI 10.1007/s00405-016-4440-4; Benjaminsen E, 2016, CASE REP NEUROL MED, V2016, DOI 10.1155/2016/8736248; Biller J, 2014, STROKE, V45, P3155, DOI 10.1161/STR.0000000000000016; Borghi C, 2005, CURR THER RES CLIN E, V66, P420, DOI 10.1016/j.curtheres.2005.10.001; Chiang CY, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0109-x; Choi EJ, 2013, EVID-BASED COMPL ALT, V2013; Cohen JE, 2010, NEUROL RES, V32, P1027, DOI 10.1179/016164110X12767786356273; Ding X, 2014, INT J NEUROSCI, V124, P834, DOI 10.3109/00207454.2013.879580; Gaspar L, 2011, BRATISL MED J, V112, P63; Gopinath B, 2009, STROKE, V40, P1496, DOI 10.1161/STROKEAHA.108.535682; Hughes JW, 2016, J DIABETES COMPLICAT, V30, P1640, DOI 10.1016/j.jdiacomp.2016.08.004; Hwang JJ, 2017, DENTOMAXILLOFAC RAD, V46, DOI 10.1259/dmfr.20170006; Hwang JH, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0682-4; Hwang JH, 2015, AUDIOL NEURO-OTOL, V20, P322, DOI 10.1159/000381934; Hwang JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058215; Hwang JH, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-30; Hwang JH, 2011, LARYNGOSCOPE, V121, P361, DOI 10.1002/lary.21283; Ikegami-Takada T, 2012, AURIS NASUS LARYNX, V39, P244, DOI 10.1016/j.anl.2011.07.015; Karadas Omer, 2011, Kulak Burun Bogaz Ihtis Derg, V21, P237, DOI 10.5606/kbbihtisas.2011.034; Kazmierczak H, 2001, Int Tinnitus J, V7, P54; Kefi A, 2017, INT J NEUROSCI, V127, P314, DOI 10.1080/00207454.2016.1214131; Kehrle HM, 2016, ANN OTO RHINOL LARYN, V125, P185, DOI 10.1177/0003489415606445; Kim HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127578; Kim JS, 2012, STROKE, V43, P3313, DOI 10.1161/STROKEAHA.112.658500; Koo M, 2016, LARYNGOSCOPE; Lee TH, 2002, STROKE, V33, P1950, DOI 10.1161/01.STR.0000021409.16314.16; Li Y, 2017, NEUROL RES, V39, P30, DOI 10.1080/01616412.2016.1250856; Malm J, 1999, CEREBROVASC DIS, V9, P282, DOI 10.1159/000015979; Mazurek B, 2006, MED HYPOTHESES, V67, P892, DOI 10.1016/j.mehy.2006.03.040; Michikawa T, 2013, PREV MED, V56, P333, DOI 10.1016/j.ypmed.2013.01.016; Patel RR, 2012, CARDIOL REV, V20, P145, DOI 10.1097/CRD.0b013e318247cd15; Pinto PCL, 2014, J LARYNGOL OTOL, V128, P660, DOI 10.1017/S0022215114001030; Renna R, 2014, J STROKE CEREBROVASC, V23, pE221, DOI 10.1016/j.jstrokecerebrovasdis.2013.10.008; Schecklmann M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/461090; Smajlovic D, 2015, VASC HEALTH RISK MAN, V11, P157, DOI 10.2147/VHRM.S53203; Sugiura S, 2008, ACTA OTO-LARYNGOL, V128, P525, DOI 10.1080/00016480701558930; van Sloten TT, 2015, J AM COLL CARDIOL, V66, P2116, DOI 10.1016/j.jacc.2015.08.888	40	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187474	10.1371/journal.pone.0187474	http://dx.doi.org/10.1371/journal.pone.0187474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095920	Green Published, Green Submitted, gold			2022-12-26	WOS:000414340200098
J	Kruse, KE; Batten, J; Constantine, ML; Kache, S; Magnus, D				Kruse, Katherine E.; Batten, Jason; Constantine, Melissa L.; Kache, Saraswati; Magnus, David			Challenges to code status discussions for pediatric patients	PLOS ONE			English	Article							OF-LIFE CARE; PALLIATIVE CARE; FAMILY PERSPECTIVES; RESUSCITATE ORDERS; INTENSIVE-CARE; ATTITUDES; CHILDREN; COMMUNICATION; PHYSICIANS; QUALITY	Objectives In the context of serious or life-limiting illness, pediatric patients and their families are faced with difficult decisions surrounding appropriate resuscitation efforts in the event of a cardiopulmonary arrest. Code status orders are one way to inform end-of-life medical decision making. The objectives of this study are to evaluate the extent to which pediatric providers have knowledge of code status options and explore the association of provider role with (1) knowledge of code status options, (2) perception of timing of code status discussions, (3) perception of family receptivity to code status discussions, and (4) comfort carrying out code status discussions. Design Nurses, trainees (residents and fellows), and attending physicians from pediatric units where code status discussions typically occur completed a short survey questionnaire regarding their knowledge of code status options and perceptions surrounding code status discussions. Setting Single center, quaternary care children's hospital. Measurements and main results 203 nurses, 31 trainees, and 29 attending physicians in 4 high-acuity pediatric units responded to the survey (N = 263, 90% response rate). Based on an objective knowledge measure, providers demonstrate poor understanding of available code status options, with only 22% of providers able to enumerate more than two of four available code status options. In contrast, provider groups self-report high levels of familiarity with available code status options, with attending physicians reporting significantly higher levels than nurses and trainees (p = 0.0125). Nurses and attending physicians show significantly different perception of code status discussion timing, with majority of nurses (63.4%) perceiving discussions as occurring "too late" or "much too late" and majority of attending physicians (55.6%) perceiving the timing as "about right" (p<0.0001). Attending physicians report significantly higher comfort having code status discussions with families than do nurses or trainees (p<0.0001). Attending physicians and trainees perceive families as more receptive to code status discussions than nurses (p<0.0001 and p = 0.0018, respectively). Conclusions Providers have poor understanding of code status options and differ significantly in their comfort having code status discussions and their perceptions of these discussions. These findings may reflect inherent differences among providers, but may also reflect discordant visions of appropriate care and function as a potential source of moral distress. Lack of knowledge of code status options and differences in provider perceptions are likely barriers to quality communication surrounding end-of-life options.	[Kruse, Katherine E.; Batten, Jason; Magnus, David] Stanford Univ, Sch Med, Stanford Ctr Biomed Eth, Stanford, CA 94305 USA; [Kruse, Katherine E.; Kache, Saraswati] Stanford Univ, Dept Pediat, Sch Med, Div Pediat Crit Care Med, Stanford, CA 94305 USA; [Constantine, Melissa L.] Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, Minneapolis, MN USA	Stanford University; Stanford University; University of Minnesota System; University of Minnesota Twin Cities	Kruse, KE (corresponding author), Stanford Univ, Sch Med, Stanford Ctr Biomed Eth, Stanford, CA 94305 USA.; Kruse, KE (corresponding author), Stanford Univ, Dept Pediat, Sch Med, Div Pediat Crit Care Med, Stanford, CA 94305 USA.	kruse575@gmail.com			Jackson Vaughan Critical Care Research Award	Jackson Vaughan Critical Care Research Award	Dr. Kruse received grant support from the Jackson Vaughan Critical Care Research Award. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Anderson WG, 2011, J GEN INTERN MED, V26, P359, DOI 10.1007/s11606-010-1568-6; Auerbach AD, 2008, J HOSP MED, V3, P437, DOI 10.1002/jhm.369; Austin W, 2005, HEC FORUM, V17, P33, DOI 10.1007/s10730-005-4949-1; Contro N, 2002, ARCH PEDIAT ADOL MED, V156, P14, DOI 10.1001/archpedi.156.1.14; Contro NA, 2004, PEDIATRICS, V114, P1248, DOI 10.1542/peds.2003-0857-L; Dellon EP, 2010, J PAIN SYMPTOM MANAG, V40, P821, DOI 10.1016/j.jpainsymman.2010.03.021; Dillman D.A., 2014, INTERNET PHONE MAIL, V4th ed.; Dube CE, 2003, AMBUL PEDIATR, V3, P137, DOI 10.1367/1539-4409(2003)003<0137:SOCSPA>2.0.CO;2; Hakim RB, 1996, ANN INTERN MED, V125, P284, DOI 10.7326/0003-4819-125-4-199608150-00005; Hamric AB, 2012, AJOB PRIM RES, V3, P1, DOI [10.1080/21507716.2011.652337, DOI 10.1080/21507716.2011.652337]; Henrich NJ, 2016, J CRIT CARE, V35, P57, DOI 10.1016/j.jcrc.2016.04.033; Heyland DK, 2006, CHEST, V130, P419, DOI 10.1378/chest.130.2.419; Hilden JM, 2001, J CLIN ONCOL, V19, P205, DOI 10.1200/JCO.2001.19.1.205; Hinds Pamela S, 2005, J Palliat Med, V8 Suppl 1, pS70, DOI 10.1089/jpm.2005.8.s-70; JARRETT N, 1995, J ADV NURS, V22, P72, DOI 10.1046/j.1365-2648.1995.22010072.x; Khaneja S, 1998, ARCH PEDIAT ADOL MED, V152, P909; Kolarik RC, 2006, PEDIATRICS, V117, P1949, DOI 10.1542/peds.2005-1111; Kraemer HC, 1987, MANY SUBJECTS STAT P; Mack JW, 2007, J CLIN ONCOL, V25, P5636, DOI 10.1200/JCO.2007.12.6110; McCallum DE, 2000, J PAIN SYMPTOM MANAG, V20, P417, DOI 10.1016/S0885-3924(00)00212-8; Michelson KN, 2013, PEDIATR CRIT CARE ME, V14, pE34, DOI 10.1097/PCC.0b013e31826e7408; Mirza Ayoub, 2005, Am J Hosp Palliat Care, V22, P20, DOI 10.1177/104990910502200107; Sanderson A, 2013, JAMA PEDIATR, V167, P954, DOI 10.1001/jamapediatrics.2013.2204; Serwint JR, 2004, J PEDIATR-US, V145, P229, DOI 10.1016/j.jpeds.2004.04.055; Solomon MZ, 2005, PEDIATRICS, V116, P872, DOI 10.1542/peds.2004-0905; Sulmasy DP, 2008, CRIT CARE MED, V36, P1817, DOI 10.1097/CCM.0b013e31817c79fe; Vazirani RM, 2000, CRIT CARE MED, V28, P3740, DOI 10.1097/00003246-200011000-00036; WEBSTER GC, 1991, CAN J ANAESTH, V38, P553, DOI 10.1007/BF03008184; Wolfe J, 2000, JAMA-J AM MED ASSOC, V284, P2469, DOI 10.1001/jama.284.19.2469	29	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187375	10.1371/journal.pone.0187375	http://dx.doi.org/10.1371/journal.pone.0187375			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095938	Green Published, Green Submitted, gold			2022-12-26	WOS:000414340200079
J	Kucharova, K; Stallcup, WB				Kucharova, Karolina; Stallcup, William B.			Distinct NG2 proteoglycan-dependent roles of resident microglia and bone marrow-derived macrophages during myelin damage and repair	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; OLIGODENDROCYTE PROGENITORS; CNS REMYELINATION; HL-60 CELLS; EXPRESSION; RECEPTOR; DIFFERENTIATION; PROLIFERATION; PERICYTES; AXONS	We used a bone marrow transplantation approach to distinguish the activities of bone marrow-derived macrophages from the activities of central nervous system-resident microglia in phenomena associated with axon demyelination and remyelination. We transplanted wild type or germline NG2 null beta-actin-EGFP expressing bone marrow into irradiated wild type or NG2 null recipient mice, followed by analysis of lysolecithin-induced spinal cord demyelination and remyelination and quantification of lba-1(+)/F4/80(+)/EGFP(+)macrophages and lba-1 (+)/F4/80(+)/EGFP(-) microglia. One week after microinjection of 1 % lysolecithin into the spinal cord, wild type recipients receiving NG2 null bone marrow exhibit greatly reduced infiltration of macrophages into lesions, compared to wild type recipients receiving wild type bone marrow. Wild type bone marrow recipients also exhibit larger numbers of demyelinated axons than NG2 null recipients, indicative of macrophage participation in the initial myelin damage. However, wild type bone marrow recipients also exhibit superior myelin repair at 6 weeks post-injury, compared to NG2 null bone marrow recipients, demonstrating the additional importance of macrophages in remyelination. Incompletely repaired lesions in NG2 null bone marrow recipients at 6 weeks post-injury retain elevated numbers of macrophages, in contrast to lower numbers of macrophages in more completely repaired lesions in wild type bone marrow recipients. This suggests that NG2 expression renders macrophages more effective in myelin repair and less likely to promote chronic inflammation. Effective macrophage involvement in myelin repair is due in part to effects on the proliferation and/or recruitment of oligodendrocyte progenitor cells. Reduced numbers of oligodendrocyte progenitors are seen in lesions in NG2 null bone marrow recipients, likely due to deficits in macrophage production of oligodendrocyte progenitor-relevant mitogens and in phagocytosis of inhibitory myelin debris. Microglia also appear to be important for clearance of myelin debris, as indicated by reduced phagocytosis in NG2 null recipients receiving wild type bone marrow.	[Kucharova, Karolina; Stallcup, William B.] Sanford Burnham Prebys Med Discovery Inst, Tumor Microenvironm & Canc Immunol Program, Canc Ctr, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Stallcup, WB (corresponding author), Sanford Burnham Prebys Med Discovery Inst, Tumor Microenvironm & Canc Immunol Program, Canc Ctr, La Jolla, CA 92037 USA.	stallcup@SBPDiscovery.org		Kucharova, Karolina/0000-0002-3196-748X	National Institutes of Health, National Cancer Institute [R01 CA095287]; Sanford Burnham Prebys Medical Discovery Institute, Lab Funding Initiative; NIH [R01 CA095287]; Sanford Burnham Prebys Lab Funding Initiative; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Sanford Burnham Prebys Medical Discovery Institute, Lab Funding Initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sanford Burnham Prebys Lab Funding Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health, National Cancer Institute, R01 CA095287 (WBS); and Sanford Burnham Prebys Medical Discovery Institute, Lab Funding Initiative (WBS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank Ms. Regina Kapono for her help in preparing the manuscript, Ms. Adriana Char-bono for assistance with animal care, and Dr. Pilar Cejudo-Martin for expertise with flow cytometric determination of bone marrow engraftment efficiency. This work was supported by NIH grant R01 CA095287 and by Sanford Burnham Prebys Lab Funding Initiative to WBS.	Atkins HL, 2016, LANCET, V388, P576, DOI 10.1016/S0140-6736(16)30169-6; Bu J, 2001, GLIA, V34, P296, DOI 10.1002/glia.1063; Cejudo-Martin Pilar, 2016, Trends Cell Mol Biol, V11, P55; de Castro R, 2005, EXP NEUROL, V192, P299, DOI 10.1016/j.expneurol.2004.11.027; Gao Q, 2010, NEUROSCIENCE, V165, P386, DOI 10.1016/j.neuroscience.2009.10.022; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; Gibby K, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3174; Grako KA, 1999, J CELL SCI, V112, P905; Hinks GL, 1999, MOL CELL NEUROSCI, V14, P153, DOI 10.1006/mcne.1999.0771; Holley JE, 2010, NEUROSCI LETT, V470, P65, DOI 10.1016/j.neulet.2009.12.059; Jones LL, 2002, J NEUROSCI, V22, P2792, DOI 10.1523/JNEUROSCI.22-07-02792.2002; Keirstead HS, 1999, ADV EXP MED BIOL, V468, P183; Kirk S, 2004, J NEUROL SCI, V217, P125, DOI 10.1016/j.jns.2003.10.016; Kitic M, 2017, ACTA NEUROPATHOL, V134, P325, DOI 10.1007/s00401-017-1735-5; Kucharova K, 2010, NEUROSCIENCE, V166, P185, DOI 10.1016/j.neuroscience.2009.12.014; Kucharova K, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0385-6; Kucharova K, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-158; Larsen PH, 2003, J NEUROSCI, V23, P11127, DOI 10.1523/jneurosci.23-35-11127.2003; Mensah-Brown EP, 2011, J NEUROIMMUNOL, V232, P68, DOI 10.1016/j.jneuroim.2010.10.010; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Moransard M, 2011, BRAIN, V134, P1315, DOI 10.1093/brain/awr070; Ozerdem U, 2001, DEV DYNAM, V222, P218, DOI 10.1002/dvdy.1200; Reiterer G, 2008, FEBS LETT, V582, P2508, DOI 10.1016/j.febslet.2008.06.016; Reiterer G, 2007, CANCER RES, V67, P7765, DOI 10.1158/0008-5472.CAN-07-0014; Stallcup WB, 2016, MICROCIRCULATION, V23, P122, DOI 10.1111/micc.12251; Tigges U, 2008, DEVELOPMENT, V135, P523, DOI 10.1242/dev.002071; Trebst C, 2008, MULT SCLER, V14, P728, DOI 10.1177/1352458508089359; Yong VW, 2010, NEUROSCIENTIST, V16, P408, DOI 10.1177/1073858410371379; Yotsumoto F, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2014.1001204	29	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187530	10.1371/journal.pone.0187530	http://dx.doi.org/10.1371/journal.pone.0187530			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095924	Green Published, gold, Green Submitted			2022-12-26	WOS:000414340200112
J	Nedoszytko, B; Sieminska, A; Strapagiel, D; Dabrowski, S; Slomka, M; Sobalska-Kwapis, M; Marciniak, B; Wierzba, J; Skokowski, J; Fijalkowski, M; Nowicki, R; Kalinowski, L				Nedoszytko, Boguslaw; Sieminska, Alicja; Strapagiel, Dominik; Dabrowski, Slawomir; Slomka, Marcin; Sobalska-Kwapis, Marta; Marciniak, Blazej; Wierzba, Jolanta; Skokowski, Jaroslaw; Fijalkowski, Marcin; Nowicki, Roman; Kalinowski, Leszek			High prevalence of carriers of variant c.1528G > C of HADHA gene causing long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD) in the population of adult Kashubians from North Poland	PLOS ONE			English	Article							MITOCHONDRIAL TRIFUNCTIONAL PROTEIN; ACUTE FATTY LIVER; MUTATIONAL ANALYSIS; POLISH PATIENTS; PREGNANCY; IDENTIFICATION; METAANALYSIS; ASSOCIATION; SMOKING	Background/Objectives The mitochondrial (5-oxidation of fatty acids is a complex catabolic pathway. One of the enzymes of this pathway is the heterooctameric mitochondrial trifunctional protein (MTP), composed of four a-and (5-subunits. Mutations in MTP genes (HADHA and HADHB), both located on chromosome 2p23, cause MTP deficiency, a rare autosomal recessive metabolic disorder characterized by decreased activity of MTP. The most common MTP mutation is long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency caused by the c.1528G>C (rs137852769, p.Glu510Gln) substitution in exon 15 of the HADHA gene. Subjects/Methods We analyzed the frequency of genetic variants in the HADHA gene in the adults of Kashubian origin from North Poland and compared this data in other Polish provinces. Results We found a significantly higher frequency of HDHA c.1528G>C(rs137852769, p.Glu510Gln) carriers among Kashubians (1/57) compared to subjects from other regions of Poland (1/187). We found higher frequency of c.652G>C (rs71441018, pVal218Leu) polymorphism in the HADHA gene within population of Silesia, southern Poland (1/107) compared to other regions. Conclusion Our study indicate described high frequency of c.1528G>C variant of HADHAgene in Kashubian population, suggesting the founder effect. For the first time we have found high frequency of rs71441018 in the South Poland Silesian population.	[Nedoszytko, Boguslaw; Nowicki, Roman] Med Univ Gdansk, Dept Dermatol Venereol & Allergol, Gdansk, Poland; [Sieminska, Alicja] Med Univ Gdansk, Dept Pneumonol & Allergol, Gdansk, Poland; [Strapagiel, Dominik; Slomka, Marcin; Sobalska-Kwapis, Marta; Marciniak, Blazej] Univ Lodz, Fac Biol & Environm Protect, Dept Mol Biophys, Biobank Lab, Lodz, Poland; [Strapagiel, Dominik; Slomka, Marcin; Sobalska-Kwapis, Marta; Marciniak, Blazej; Skokowski, Jaroslaw; Kalinowski, Leszek] BBMRI Pl Consortium, Wroclaw, Poland; [Dabrowski, Slawomir] A&A Biotechnol Sc, Gdynia, Poland; [Wierzba, Jolanta] Med Univ Gdansk, Dept Pediat Hematol & Oncol, Gdansk, Poland; [Skokowski, Jaroslaw] Med Univ Gdansk, Dept Surg Oncol, Gdansk, Poland; [Fijalkowski, Marcin] Med Univ Gdansk, Dept Cardiol 1, Gdansk, Poland; [Kalinowski, Leszek] Med Univ Gdansk, Cent Bank Frozen Tissues & Genet Specimens, Dept Med Lab Diagnost, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; University of Lodz; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk	Nedoszytko, B (corresponding author), Med Univ Gdansk, Dept Dermatol Venereol & Allergol, Gdansk, Poland.; Strapagiel, D (corresponding author), Univ Lodz, Fac Biol & Environm Protect, Dept Mol Biophys, Biobank Lab, Lodz, Poland.; Strapagiel, D (corresponding author), BBMRI Pl Consortium, Wroclaw, Poland.	bned@gumed.edu.pl; dominik.strapagiel@biol.uni.lodz.pl	Kalinowski, Leszek/N-3076-2019; Nedoszytko, Boguslaw/AAY-5079-2020; Nowicki, Roman J./U-3148-2018; Strapagiel, Dominik/AAD-4351-2020; Sieminska, Alicja/S-9604-2018	Kalinowski, Leszek/0000-0001-7270-1592; Nowicki, Roman J./0000-0003-4768-1387; Strapagiel, Dominik/0000-0001-9752-4270; Marciniak, Blazej/0000-0003-1571-1473; Sobalska-Kwapis, Marta/0000-0003-1982-2621; Fijalkowski, Marcin/0000-0002-2913-5457; Skokowski, Jaroslaw/0000-0002-3079-3502; Sieminska, Alicja/0000-0002-4415-7566; Wierzba, Jolanta/0000-0003-0290-1243; Nedoszytko, Boguslaw/0000-0002-6286-0693; Slomka, Marcin/0000-0002-7906-5549	Polish Ministry of Science and Higher Education [02-0066/07/253, DIR/WK/2017/01]; Polish POIG Grant from European Regional Development Fund [01.01.02-10-005/08]; A&A Biotechnology s.c.	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Polish POIG Grant from European Regional Development Fund; A&A Biotechnology s.c.	The study is financed by Polish Ministry of Science and Higher Education grant 02-0066/07/253 and DIR/WK/2017/01. POPULOUS collection was financed by the Polish POIG Grant 01.01.02-10-005/08 TESTOPLEK from the European Regional Development Fund. Stawomir Dabrowski received salaries from A&A Biotechnology s.c. The funder provided support in the form of salaries for Stawomir Dabrowski, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The study was approved by the local research ethics committee of the Medical University of Gdansk and local research ethics committee of the University of Lodz. The study was financed by the Polish Ministry of Science and Higher Education grant 02-0066/07/253 and DIR/WK/2017/01. The POPULOUS collection was financed by the Polish POIG Grant 01.01.02-10-005/08 TESTOPLEK from the European Regional Development Fund. Slawomir Dabrowski received salaries from A&A Biotechnology s.c. The funder provided support in the form of salaries for SD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, BAS INF REL SOC POL; Bendl J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003440; Boutron A, 2011, MOL GENET METAB, V103, P341, DOI 10.1016/j.ymgme.2011.04.006; Chen LS, 2012, GENET EPIDEMIOL, V36, P340, DOI 10.1002/gepi.21627; Chmara M, 2010, J APPL GENET, V51, P95, DOI 10.1007/BF03195716; Choi JH, 2007, INT J MOL MED, V19, P81; Das AM, 2006, CLIN CHEM, V52, P530, DOI 10.1373/clinchem.2005.062000; den Boer MEJ, 2002, PEDIATRICS, V109, P99, DOI 10.1542/peds.109.1.99; Den Boer MEJ, 2000, PEDIATR RES, V48, P151, DOI 10.1203/00006450-200008000-00006; Gregersen N, 2010, J INHERIT METAB DIS, V33, P547, DOI 10.1007/s10545-010-9046-1; HAGENFELDT L, 1995, J INHERIT METAB DIS, V18, P245, DOI 10.1007/BF00711779; Ibdah JA, 1999, J INHERIT METAB DIS, V22, P811, DOI 10.1023/A:1005506024055; Ijlst L, 1996, J CLIN INVEST, V98, P1028, DOI 10.1172/JCI118863; Janik M., 2015, INVENTORMETHOD DETER; Joost K, 2012, JIMD REP, V2, P79, DOI 10.1007/8904_2011_51; KAMIJO T, 1994, BIOCHEM BIOPH RES CO, V199, P818, DOI 10.1006/bbrc.1994.1302; Kita-Milczarska K, 2016, MED SCI MONITOR, V22, P1442, DOI 10.12659/MSM.895907; Kushniarevich A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135820; Lindner M, 2010, J INHERIT METAB DIS, V33, P521, DOI 10.1007/s10545-010-9076-8; Lipska-Zietkiewicz BS, 2013, J APPL GENET, V54, P327, DOI 10.1007/s13353-013-0147-z; Mielnik-Sikorska M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054360; Orii KE, 1997, HUM MOL GENET, V6, P1215, DOI 10.1093/hmg/6.8.1215; Pastinen T, 2001, HUM MOL GENET, V10, P2961, DOI 10.1093/hmg/10.26.2961; Piekutowska-Abramczuk D, 2010, J INHERIT METAB DIS, V33, pS373, DOI 10.1007/s10545-010-9190-7; Purevsuren J, 2009, MOL GENET METAB, V98, P372, DOI 10.1016/j.ymgme.2009.07.011; Rebala K, 2013, EUR J HUM GENET, V21, P415, DOI 10.1038/ejhg.2012.190; Sander J, 2005, MOL GENET METAB, V85, P108, DOI 10.1016/j.ymgme.2005.02.002; Shahrokhi M, 2017, ARCH IRAN MED, V20, P22, DOI 0172001/AIM.006; Sieminska A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1455-5; SIMS HF, 1995, P NATL ACAD SCI USA, V92, P841, DOI 10.1073/pnas.92.3.841; Sobalska-Kwapis M, PLOS ONE, V12; Specjalski K, 2013, RHEUMATOL INT, V33, P3043, DOI 10.1007/s00296-012-2575-1; Spiekerkoetter U, 2003, HUM MUTAT, V21, P598, DOI 10.1002/humu.10211; Strapagiel D., 2016, POLAND OPEN J BIORES, V3, pe6, DOI DOI 10.5334/OJB.22; TREEM WR, 1994, HEPATOLOGY, V19, P339; Tyni T, 1999, ACTA PAEDIATR, V88, P237, DOI 10.1080/08035259950169954; WANDERS RJA, 1989, LANCET, V2, P52, DOI 10.1016/S0140-6736(89)90300-0; Ware JJ, 2011, NICOTINE TOB RES, V13, P1167, DOI 10.1093/ntr/ntr118; WILCKEN B, 1993, LANCET, V341, P407, DOI 10.1016/0140-6736(93)92993-4; Witon M, 2017, BIOPRESERV BIOBANK; Wozniak M, 2010, AM J PHYS ANTHROPOL, V142, P540, DOI 10.1002/ajpa.21253; Zhu Jin-ming, 2005, Beijing Da Xue Xue Bao Yi Xue Ban, V37, P72	42	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187365	10.1371/journal.pone.0187365	http://dx.doi.org/10.1371/journal.pone.0187365			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095929	Green Published, Green Submitted, gold			2022-12-26	WOS:000414340200077
J	Heimann, AS; Gupta, A; Gomes, I; Rayees, R; Schlessinger, A; Ferro, ES; Unterwald, EM; Devi, LA				Heimann, Andrea S.; Gupta, Achla; Gomes, Ivone; Rayees, Rahman; Schlessinger, Avner; Ferro, Emer S.; Unterwald, Ellen M.; Devi, Lakshmi A.			Generation of G protein-coupled receptor antibodies differentially sensitive to conformational states	PLOS ONE			English	Article								The N-terminal region of G protein-coupled receptors can be efficiently targeted for the generation of receptor-selective antibodies. These antibodies are useful for the biochemical characterization of the receptors. In this study, we developed a set of criteria to select the optimal epitope and applied them to generate antibodies to the N-terminal region of 34 different G protein-coupled receptors. The antibody characterization revealed that a subset of antibodies exhibited increased recognition of the receptor following agonist treatment and this increase could be blocked by treatment with the receptor antagonist. An analysis of the epitopes showed that those antibodies that exhibit increased recognition are on average twelve residues long, have an overall net negative charge and are enriched in aspartic and glutamic acids. These antibodies are useful since they facilitate studies examining dose dependent increases in recognition of receptors in heterologous cells as well as in native tissue. Another interesting use of these antibodies is that they facilitate measuring changes in receptor recognition in brain following peripheral drug administration; for example, systemic administration of cocaine, a blocker of dopamine transporter that increases local dopamine levels at the synapse, was found to lead to increases in antibody recognition of dopamine receptors in the brain. Taken together these studies, in addition to describing novel tools to study native receptors, provide a framework for the generation of antibodies to G protein coupled receptors that can detect ligand-induced conformational changes.	[Heimann, Andrea S.] Proteimax Biotechnol LTDA, Av Corifeu Azevedo Marques, Sao Paulo, SP, Brazil; [Gupta, Achla; Gomes, Ivone; Rayees, Rahman; Schlessinger, Avner; Devi, Lakshmi A.] Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA; [Ferro, Emer S.] Univ Sao Paulo, Biomed Sci Inst, Dept Pharmacol, Sao Paulo, SP, Brazil; [Unterwald, Ellen M.] Temple Univ, Dept Pharmacol, Sch Med, Philadelphia, PA 19122 USA	Icahn School of Medicine at Mount Sinai; Universidade de Sao Paulo; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Heimann, AS (corresponding author), Proteimax Biotechnol LTDA, Av Corifeu Azevedo Marques, Sao Paulo, SP, Brazil.; Devi, LA (corresponding author), Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA.	andrea@proteimaxnet.com.br; lakshmi.devi@mssm.edu	Ferro, Emer S/D-3908-2012; Devi P, Lakshmi/GXM-5982-2022	Ferro, Emer S/0000-0003-1651-9192; Devi P, Lakshmi/0000-0001-9274-4776	National Institutes of Health [DA008863, NS026880, DA013429, DA018326, GM108911];  [T32 GM062754]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108911, T32GM062754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA008863, R37DA008863, R01DA018326, R56DA008863, P30DA013429] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health awards DA008863 and NS026880 to LAD, DA013429 and DA018326 to EMU, GM108911 to AS; RR was supported by T32 GM062754.	Ferreira DN, 2010, J NUTR, V140, P1742, DOI 10.3945/jn.109.117473; Fontenele-Neto JD, 2001, J COMP NEUROL, V438, P399, DOI 10.1002/cne.1323; Gomes I, 2003, METH MOLEC MED, V84, P157; Gomes I, 2013, NEUROPEPTIDE RECEPTO, P1; Gupta A, 2015, BRIT J PHARMACOL, V172, P704, DOI 10.1111/bph.12833; Gupta A, 2008, J BIOL CHEM, V283, P10735, DOI 10.1074/jbc.M709454200; Gupta A, 2007, J BIOL CHEM, V282, P5116, DOI 10.1074/jbc.M609254200; Gupta A, 2006, MT SINAI J MED, V73, P673; Hinkle Patricia M., 2003, V237, P127; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Jiang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047016; Kallal L, 2000, TRENDS PHARMACOL SCI, V21, P175, DOI 10.1016/S0165-6147(00)01477-2; Machado FC, 2014, BRIT J PHARMACOL, V171, P961, DOI 10.1111/bph.12488; Mika S, 2003, NUCLEIC ACIDS RES, V31, P3789, DOI 10.1093/nar/gkg620; Milligan G, 1999, BRIT J PHARMACOL, V128, P501, DOI 10.1038/sj.bjp.0702824; Rozenfeld R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029239; Schlessinger A, 2005, PROTEINS, V61, P115, DOI 10.1002/prot.20587; Unterwald EM, 2001, BRAIN RES, V900, P103, DOI 10.1016/S0006-8993(01)02269-7; Yachdav G, 2014, NUCLEIC ACIDS RES, V42, pW337, DOI 10.1093/nar/gku366	19	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187306	10.1371/journal.pone.0187306	http://dx.doi.org/10.1371/journal.pone.0187306			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091950	gold, Green Published, Green Submitted			2022-12-26	WOS:000414229700053
J	Rios, M; Sanchez, IM; Morales, J				Rios, Maria; Sanchez, Israel M.; Morales, Jorge			A new giraffid (Mammalia, Ruminantia, Pecora) from the late Miocene of Spain, and the evolution of the sivathere-samothere lineage	PLOS ONE			English	Article							MIDDLE MIOCENE; PHYLOGENY; MOSCHIDAE; ARTIODACTYLA; CHARACTERS	Giraffids include the only living giraffomorph ruminants and are diagnosed by the presence of bi-lobed canines and a special type of epiphyseal cranial appendages called ossicones. The family Giraffidae ranges from the latest early Miocene until today. However they are currently extant relics with only two living representatives, the African genera Okapia and Giraffa. Giraffids were much more diverse and widespread in the past, with more than 30 fossil species described. For the past decades a number of studies intended to resolve the phylogenetic relationships of the family, but due to the lack of really good cranial material no clear consensus was reached regarding the phylogenetic relationships amongst the different members of the group. The exceptionally complete remains of a new large giraffid from the late Miocene of Spain, Decennatherium rexsp. nov., allows us to improve and reassess giraffid systematics, offering a lot of new data, both anatomic and phylogenetic, on the large late Miocene giraffids of Eurasia. The results of our cladistic analysis show Decennatherium as a basal offshoot of a Glade containing the gigantic samotheres and sivatheres, characterized by the presence of a Sivatherium-like ossicone-plan among other features. Decennatherium thus offers the most ancient evidence of this Sivatherium-plan and firmly establishes the early morphological patterns of evolution of a sivathere / samothere-clade that is defined as the less inclusive Glade that contains Decennatherium and Sivatherium. Finally, this large group of four-ossiconed giraffids evolutionarily links Miocene Europe and Africa indicating vicariance / migration processes among the giraffid genetic pools separated by the Mediterranean Sea.	[Rios, Maria; Morales, Jorge] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, Madrid, Spain; [Sanchez, Israel M.] Inst Catala Paleontol Miguel Crusafont, Dept Faunas Neogeno & Cuaternario, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Institut Catala de Paleontologia Miquel Crusafont (ICP)	Rios, M (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, Madrid, Spain.	maria.rios.iba@gmail.com		Sanchez, Israel M./0000-0003-2151-7693; Rios, Maria/0000-0001-7242-1259	FPI predoctoral grant (Spanish Government MINECO) [BES-2012-052589, EEBB-I-14-07947, EEBB-I-15-09349, EEBB-I-16-10617]; EEBB-FPI grant program; Spanish Ministerio de Economia y Competitividad [CGL2016-76431-P, CGL2011-25754, CGL2015-68333-P]	FPI predoctoral grant (Spanish Government MINECO); EEBB-FPI grant program; Spanish Ministerio de Economia y Competitividad(Spanish Government)	MR acknowledges a FPI predoctoral grant (2012-2016) (Spanish Government MINECO http://www.mineco.gob.es/ codes: BES-2012-052589, EEBB-I-14-07947, EEBB-I-15-09349, EEBB-I-16-10617) as well as the EEBB-FPI grant program 2013, 2014 and 2015. IMS acknowledges the CERCA Program (Generalitat de Catalunya) and the CGL2016-76431-P research project by the Spanish Ministerio de Economia y Competitividad (http://www.mineco.gob.es/). This study was supported by the Spanish Ministerio de Economia y Competitividad (research projects CGL2011-25754 (2012-2015) and CGL2015-68333-P (2016-2019), http://www.mineco.gob.esi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcala A L, 1994, MACROMAMIFEROS NEOGE; Alcala L., 1994, Estudios Geologicos (Madrid), V50, P127; [Anonymous], 1942, PALAEONTOGR ABT A, V94, P43; [Anonymous], 1994, B MUS NAT HIST NAT C, V16, P159; [Anonymous], 1856, CR HEBD ACAD SCI; Azanza Asensio Beatriz, 2000, Memorias del Museo Paleontologico de la Universidad de Zaragoza, V8, P1; Basu C, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0940; Bohlin B., 1926, Palaeontologia Sinica Series C, V4, P1; Bohlin B., 1935, Bulletin of the Geological Society of China, V14, P83; BRUNET M, 1983, PALAEOGEOGR PALAEOCL, V44, P283, DOI 10.1016/0031-0182(83)90107-4; BUBENIK AB, 1975, 1 INT REIND CAR S CO, P9; Calvo JP, 2013, SEDIMENTOLOGY, V60, P1681, DOI 10.1111/sed.12048; Campione NE, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-60; Cantalapiedra JL, 2015, EVOLUTION, V69, P2941, DOI 10.1111/evo.12787; Cautley, 1836, J ASIATIC SOC BENGAL, V5, P38; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Churcher C.S., 1978, P509; Churcher C.S., 1990, P180; Churcher C.S., 1970, FOSSIL VERTEBRATES A, V2, P1; Clauss M, 2014, ANN ZOOL FENN, V51, P80, DOI 10.5735/086.051.0210; Crusafont M., 1952, JIRAFIDOS FOSILES DI; Crusafont-Pairo M., 1966, Notas y Comunicaciones del Instituto Geologico y Minero de Espana, V85, P61; Damian A., 2013, VET MED-US, V58, P90; Danowitz M, 2016, PALAEOGEOGR PALAEOCL, V449, P194, DOI 10.1016/j.palaeo.2016.02.026; Danowitz M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150521; Danowitz M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150393; Danowitz M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136552; De Mecquenem R, 1924, ANN PALEONTOL, V13-14, P135; deBonis L, 1997, PALAEONTOLOGY, V40, P121; Dietrich W.O., 1937, WISSENSCHAFTLICHE ER, V1913, P106; Domingo L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063739; DURANTHON F, 1995, CR ACAD SCI II A, V321, P339; ESTES RD, 1991, APPL ANIM BEHAV SCI, V29, P403, DOI 10.1016/0168-1591(91)90264-X; Falconer, 1845, Q J GEOL SOC LOND, V1, P356, DOI DOI 10.1144/GSL.JGS.1845.001.01.80; Fennessy J, 2016, CURR BIOL, V26, P2543, DOI 10.1016/j.cub.2016.07.036; Gaudry, 1861, CR HEBD ACAD SCI, V51, P802; Gentry A.W., 1994, Historical Biology, V7, P115; GERAADS D, 1985, Palaeontologische Zeitschrift, V59, P311; GERAADS D, 1986, GEOBIOS-LYON, V19, P465, DOI 10.1016/S0016-6995(86)80004-3; Geraads D, 1978, GEOLOGIE MEDITERRANE, V5, P269; Geraads D, 2009, GEODIVERSITAS, V31, P893, DOI 10.5252/g2009n4a893; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gray J.E., 1821, LONDON MED REPOSITOR, V15, P297; Grossman Ari, 2013, Zitteliana Reihe B, V31, P24; Groves C, 2011, UNGULATE TAXONOMY; HAMILTON W R, 1973, Bulletin of the British Museum (Natural History) Geology, V21, P73; HAMILTON WR, 1978, PHILOS T R SOC B, V283, P165, DOI 10.1098/rstb.1978.0019; HARRIS J M, 1974, Annals of the South African Museum, V65, P189; HARRIS J M, 1976, Annals of the South African Museum, V69, P325; Harris J.M., 1976, P264; HARRIS JM, 1991, KOOBI FORA RES PROJE, V3; HEINTZ E, 1981, CR ACAD SCI II, V292, P423; HENDEY Q B, 1970, Annals of the South African Museum, V56, P75; Hopwood A. T., 1934, Annals & Magazine of Natural History Series 10, V14, P546; Hou Sukuan, 2014, Zitteliana Reihe B, V32, P91; Janis C.M., 1987, Journal of Vertebrate Paleontology, V7, P200; Killgus H., 1923, Palaeontologische Zeitschrift Berlin, V5, P251; Kohler Meike, 1993, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V25, P1; Kostopoulos Dimitris S., 1996, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V239, P61; Kostopoulos Dimitris S., 2009, Beitraege zur Palaeontologie, V31, P345; Leakey L. S. B., 1965, OLDUVAI GORGE 1951 1; Levin NE, 2006, P NATL ACAD SCI USA, V103, P11201, DOI 10.1073/pnas.0604719103; Linnaeus C, 1758, HOLMIAE LAUR SALVIUS, V10, P424; Lopez-Antonanzas R, 2010, ZOOL J LINN SOC-LOND, V160, P725, DOI 10.1111/j.1096-3642.2010.00618.x; Lydekker BA, 1876, MEM GEOL SURV INDIA, V1, P19; Major CF, 1888, GISEMENT OSSEMENTS F; Melentis IK, 1974, SCI EPETIRIS ISSUED, V14, P65; Montgelard C, 1997, MOL BIOL EVOL, V14, P550, DOI 10.1093/oxfordjournals.molbev.a025792; MONTOYA P, 1991, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V13, P177; Montoya P., 1994, THESIS; MORALES J, 1987, GEOBIOS-LYON, V20, P441, DOI 10.1016/S0016-6995(87)80080-3; Morales J., 2008, Publicaciones del Seminario de Paleontologia de Zaragoza, V8, P41; O'Brien HD, 2016, PEERJ, V4, DOI 10.7717/peerj.1696; O'Gara B.W., 1990, P231; Paraskevaidis I., 1940, NEUES JB MINERALOGIE, V83, P363; Pilgrim G.E., 1911, MEM GEOL SURV INDIA, V4, P1; Pomel, 1892, CR HEBD ACAD SCI, V115, P100; Pozo M., 2004, CUENCA MADRID GEOGAC, V35, P143; QIU ZX, 1985, VERTEBRAT PALASIATIC, V23, P173; Quiralte MV, 2011, THESIS; Rios M, 2016, PAL ELECT, V19, P1, DOI [10.26879/653, DOI 10.26879/653]; Rios M, 2016, J VERTEBR PALEONTOL; Robinson CA, 2011, VERTEBR PALEOBIOL PA, P339, DOI 10.1007/978-90-481-9962-4_14; Rodler A, 1890, DENKSCHRIFTEN KAISER, V57, P753; Sanchez IM, 2008, J VERTEBR PALEONTOL, V28, P873, DOI 10.1671/0272-4634(2008)28[873:MASNRM]2.0.CO;2; Sanchez IM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143034; Sanchez IM, 2010, PALAEONTOLOGY, V53, P1023, DOI 10.1111/j.1475-4983.2010.00992.x; Sanchez IM, 2010, J VERTEBR PALEONTOL, V30, P1306, DOI 10.1080/02724634.2010.483555; Sanchez IM, 2009, J VERTEBR PALEONTOL, V29, P567, DOI 10.1671/039.029.0223; Savy, 1873, ANIMAUX FOSSILES MON, P5; Schlosser M., 1903, ABHANDLUNGEN BAYERIS, V2, P1; Sclater P. L., 1901, Proceedings of the Zoological Society of London, Vi, P50; Scopoli G.A., 1777, INTRO HIST NATURALEM; SINGER RONALD, 1960, ANN S AFRICAN MUS, V45, P375; Domingo MS, 2011, PALAIOS, V26, P55, DOI 10.2110/palo.2010.p10-047r; SOLOUNIAS N, 1993, J MAMMAL, V74, P1059, DOI 10.2307/1382445; SOLOUNIAS N, 1988, PALAEOGEOGR PALAEOCL, V65, P149, DOI 10.1016/0031-0182(88)90021-1; Solounias N., 1988, PALEOBIOLOGY, V69, P845; Solounias N, 2016, PALAEOBIO PALAEOENV, V96, P489, DOI 10.1007/s12549-016-0230-7; Solounias Nikos, 2000, P84; Solounias Nikos, 2007, P257; Valenciano A, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2014.934570; WEBB S D, 1980, Bulletin of the American Museum of Natural History, V167, P117	103	20	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0185378	10.1371/journal.pone.0185378	http://dx.doi.org/10.1371/journal.pone.0185378			59	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091914	Green Published, Green Submitted, gold			2022-12-26	WOS:000414229700006
J	Chiu, PY; Hsu, MH; Wang, CW; Tsai, CT; Pai, MC				Chiu, Pai-Yi; Hsu, Min-Hsien; Wang, Chein-Wei; Tsai, Chun-Tang; Pai, Ming-Chyi			Visual hallucinations in Alzheimer's disease is significantly associated with clinical diagnostic features of dementia with Lewy bodies	PLOS ONE			English	Article							NEUROPSYCHIATRIC SYMPTOMS; PSYCHOSIS; GUIDELINES; CONSORTIUM; MORTALITY; AUTOPSY; DECLINE	Visual hallucinations (VHs) are among the most striking features of dementia with Lewy bodies (DLB). Given that Lewy body pathology is frequently observed in the brains of patients with AD, we aimed to study factors associated with VHs in AD and examine their association with DLB features. This cross-sectional study enrolled a consecutive series of AD patients who visited the dementia clinic of a regional hospital. Clinically diagnosed possible or probable DLB cases were excluded. VH frequency and associated factors including age, sex, education, disease severity, DLB features, vascular risk factors, cognitive function, and neuropsychiatric symptoms were compared between AD patients with VHs (VH+) and those without VHs (VH-). Among a total of 295 patients analyzed, 42 (14.2%) had VHs. After adjusting for age, sex, and disease severity, DLB features including fluctuations in cognition scores, rapid-eye-movement behavioral disorder (RBD), and severe neuroleptic sensitivity were more frequent in the VH+ group. Furthermore, depression score, total Neuropsychiatric Inventory (NPI) score, and total caregiver burden score as assessed by the NPI were higher in the VH+ group. Among neuropsychiatric symptoms, delusions, hallucinations in the non-visual domains, anxiety, and disinhibition were more frequent in the VH+ group. Conversely, none of the vascular risk factors (VRFs) or cognitive domains of the Cognitive Abilities Screening Instrument (CASI) was associated with VHs in AD. In summary, VHs, albeit occurring at a low rate, had a high impact on AD. Diagnostic features of DLB, including fluctuations, RBD, and severe neuroleptic sensitivity were significantly associated with VHs in AD. AD patients with VHs tended to have more severe neuropsychiatric symptoms and greater caregiver burden.	[Chiu, Pai-Yi; Hsu, Min-Hsien] Show Chwan Mem Hosp, Dept Neurol, Changhua, Taiwan; [Wang, Chein-Wei] Lin Shin Hosp, Dept Neurol, Taichung, Taiwan; [Tsai, Chun-Tang] Natl Changhua Univ Educ, Dept Guidance & Counseling, Changhua, Taiwan; [Pai, Ming-Chyi] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Div Behav Neurol,Dept Neurol, Tainan, Taiwan; [Pai, Ming-Chyi] Natl Cheng Kung Univ Hosp, Alzheimers Dis Res Ctr, Tainan, Taiwan; [Pai, Ming-Chyi] Natl Cheng Kung Univ, Coll Med, Inst Gerontol, Tainan, Taiwan	Show Chwan Memorial Hospital; National Changhua University of Education; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University	Pai, MC (corresponding author), Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Div Behav Neurol,Dept Neurol, Tainan, Taiwan.; Pai, MC (corresponding author), Natl Cheng Kung Univ Hosp, Alzheimers Dis Res Ctr, Tainan, Taiwan.; Pai, MC (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Gerontol, Tainan, Taiwan.	pair@mail.ncku.edu.tw		Pai, Ming-Chyi/0000-0003-0475-4515				American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; Assal F, 2002, CURR OPIN NEUROL, V15, P445, DOI 10.1097/00019052-200208000-00007; Ballard C, 1997, Int Psychogeriatr, V9, P381, DOI 10.1017/S1041610297004523; Ballard C, 1999, AM J PSYCHIAT, V156, P1039; Ballard CG, 2004, AM J PSYCHIAT, V161, P843, DOI 10.1176/appi.ajp.161.5.843; Bjoerke-Bertheussen J, 2012, DEMENT GERIATR COGN, V34, P1, DOI 10.1159/000339590; Caputo M, 2008, ACTA PSYCHIAT SCAND, V117, P455, DOI 10.1111/j.1600-0447.2008.01175.x; Chapman FM, 1999, AM J PSYCHIAT, V156, P1983; Chiu Pai-Yi, 2006, Acta Neurol Taiwan, V15, P21; Chiu PY, 2015, TAIWANESE J PSYCHIAT, V29, P29; Christie D, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-62; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; El Haj M, 2015, COGN NEUROPSYCHIATRY, V20, P281, DOI 10.1080/13546805.2015.1023392; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galvin JE, 2007, NEUROLOGY, V68, P1895, DOI 10.1212/01.wnl.0000263131.80945.ad; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HOLROYD S, 1995, AM J GERIAT PSYCHIAT, V3, P198, DOI 10.1097/00019442-199522330-00003; Knopman DS, 2001, NEUROLOGY, V56, P1143, DOI 10.1212/WNL.56.9.1143; Lee DR, 2013, INT J GERIATR PSYCH, V28, P135, DOI 10.1002/gps.3799; Leroi I, 2003, AM J GERIAT PSYCHIAT, V11, P83, DOI 10.1176/appi.ajgp.11.1.83; Lin SH, 2006, CLIN IMAG, V30, P388, DOI 10.1016/j.clinimag.2006.09.025; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Schneider JA, 2012, BRAIN, V135, P3005, DOI 10.1093/brain/aws234; Sinforiani E, 2007, NEUROL SCI, V28, P96, DOI 10.1007/s10072-007-0794-0; Suarez-Gonzalez A, 2014, INT PSYCHOGERIATR, V26, P453, DOI 10.1017/S1041610213002068; Teng E L, 1994, Int Psychogeriatr, V6, P45, DOI 10.1017/S1041610294001602; Tsuang D, 2009, AM J GERIAT PSYCHIAT, V17, P317, DOI 10.1097/JGP.0b013e3181953b9a; Vilalta-Franch J, 2013, AM J GERIAT PSYCHIAT, V21, P1135, DOI 10.1016/j.jagp.2013.01.051; Wilson RS, 2005, AM J GERIAT PSYCHIAT, V13, P984, DOI 10.1176/appi.ajgp.13.11.984; Wilson RS, 2000, J NEUROL NEUROSUR PS, V69, P172, DOI 10.1136/jnnp.69.2.172	34	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186886	10.1371/journal.pone.0186886	http://dx.doi.org/10.1371/journal.pone.0186886			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL2ZD	29088240	Green Published, Green Submitted, gold			2022-12-26	WOS:000414088900029
J	Marcos-Vadillo, E; Garcia-Sanchez, A; Sanz, C; Davila, I; Isidoro-Garcia, M				Marcos-Vadillo, Elena; Garcia-Sanchez, Asuncio; Sanz, Catalina; Davila, Ignacio; Isidoro-Garcia, Maria			PTGDR gene expression and response to dexamethasone treatment in an in vitro model	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ETS TRANSCRIPTION FACTORS; GLUCOCORTICOID-RECEPTOR; INHALED CORTICOSTEROIDS; ASTHMATIC-CHILDREN; ALLERGIC RHINITIS; POLYMORPHISM; PROMOTER; LUNG; INFLAMMATION	Asthma is a multifactorial pathology influenced by environmental and genetic factors. Glucocorticoid treatment decreases symptoms by regulating genes involved in the inflammatory process through binding to specific DNA sequences. Polymorphisms located in the promoter region of the Prostaglandin D Receptor (PTGDR) gene have been related to asthma. We aimed to analyze the effect of PTGDR promoter haplotypes on gene expression and response to corticosteroid therapy. A549 lung epithelial cells were transfected with vectors carrying four different PTGDR haplotypes (CTCT, CCCC, CCCT and TCCT), and treated with dexamethasone. Different approaches to study the promoter activity (Dual Luciferase Reporter System), gene expression levels (qPCR) and cytokine secretion (Multiplexed Bead-based Flow Cytometric) were used. In addition, in silico analysis was also performed. Cells carrying the TCCT haplotype showed the lowest promoter activity (p-value < 0.05) and mRNA expression levels in basal conditions. After dexamethasone treatment, cells carrying the wild-type variant CTCT showed the highest response, and those carrying the TCCT variant the lowest (p-value < 0.05) in luciferase assays. Different transcription factor binding patterns were identified in silico. Moreover, differences in cytokine secretion were also found among different promoter haplotypes. Polymorphisms of PTGDR gene influence basal promoter activity and gene expression, as well as the cytokine secretory pattern. Furthermore, an association between these positions and response to corticoid treatment was observed.	[Marcos-Vadillo, Elena; Garcia-Sanchez, Asuncio; Sanz, Catalina; Davila, Ignacio; Isidoro-Garcia, Maria] IBSAL, Inst Biomed Res, Salamanca, Spain; [Garcia-Sanchez, Asuncio; Davila, Ignacio] Univ Salamanca, Dept Biomed & Diagnost Sci, Salamanca, Spain; [Sanz, Catalina] Univ Salamanca, Dept Genet & Microbiol, Salamanca, Spain; [Davila, Ignacio] Univ Hosp Salamanca, Dept Allergy, Salamanca, Spain; [Isidoro-Garcia, Maria] Univ Hosp Salamanca, Dept Clin Biochem, Salamanca, Spain; [Isidoro-Garcia, Maria] Univ Salamanca, Dept Med, Salamanca, Spain	University of Salamanca; University of Salamanca; University of Salamanca; University of Salamanca; University of Salamanca	Davila, I (corresponding author), IBSAL, Inst Biomed Res, Salamanca, Spain.; Davila, I (corresponding author), Univ Salamanca, Dept Biomed & Diagnost Sci, Salamanca, Spain.; Davila, I (corresponding author), Univ Hosp Salamanca, Dept Allergy, Salamanca, Spain.	idg@usal.es	Garcia-Sanchez, Asuncion/AAE-8611-2019; Dávila, Ignacio/K-4453-2012; Sanz Lozano, Catalina S/H-6759-2015	Garcia-Sanchez, Asuncion/0000-0002-9655-4918; Dávila, Ignacio/0000-0001-8485-5513; ISIDORO-GARCIA, MARIA/0000-0002-9013-9422; Sanz Lozano, Catalina S/0000-0003-2974-0873; Marcos-Vadillo, Elena/0000-0003-1016-8395	Institute de Salud Carlos III [PI13/00564]; Institute de Salud Carlos III (RETICS ARADyAL) [RD16/0006/0019]	Institute de Salud Carlos III(Instituto de Salud Carlos III); Institute de Salud Carlos III (RETICS ARADyAL)	This work was supported by the Institute de Salud Carlos III (grant PI13/00564 and RETICS ARADyAL RD16/0006/0019) to ID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Instituto de Salud Carlos III (grant PI13/00564 and RETICS ARADyAL RD16/0006/0019).	Almawi WY, 2002, J MOL ENDOCRINOL, V28, P69, DOI 10.1677/jme.0.0280069; Arima Masafumi, 2011, Korean Journal of Internal Medicine, V26, P8, DOI 10.3904/kjim.2011.26.1.8; Awasthi S, 2015, INDIAN J PEDIATR, V82, P781, DOI 10.1007/s12098-015-1702-x; Badorrek P, 2015, ANN ALLERG ASTHMA IM, V115, P325, DOI 10.1016/j.anai.2015.07.016; Baiula M, 2014, DRUG DES DEV THER, V8, P745, DOI 10.2147/DDDT.S62659; Beck IME, 2009, ENDOCR REV, V30, P830, DOI 10.1210/er.2009-0013; Berce V, 2013, PHARMACOGENOMICS J, V13, P523, DOI 10.1038/tpj.2012.36; Berce V, 2010, BIOMARKERS, V15, P158, DOI 10.3109/13547500903384318; Berger WE, 2015, ANN ALLERG ASTHMA IM, V115, P130, DOI 10.1016/j.anai.2015.05.012; Chihara J, 1997, J ALLERGY CLIN IMMUN, V100, pS52, DOI 10.1016/S0091-6749(97)70005-8; Clark AR, 2012, PHARMACOL THERAPEUT, V134, P54, DOI 10.1016/j.pharmthera.2011.12.004; Corrigan CJ, 1999, CLIN EXP IMMUNOL, V116, P1; DeKoter RP, 2007, J BIOL CHEM, V282, P14194, DOI 10.1074/jbc.M700377200; Dijkstra A, 2011, EUR RESPIR J, V38, P1036, DOI 10.1183/09031936.00182410; Gallant S, 2006, ARCH IMMUNOL THER EX, V54, P149, DOI 10.1007/s00005-006-0017-z; Garcia-Sanchez A, 2016, J INVEST ALLERG CLIN, V26, P249, DOI 10.18176/jiaci.0042; Garcia-Solaesa V, 2014, ALLERGOL IMMUNOPATH, V42, P64, DOI 10.1016/j.aller.2012.12.002; Gong XM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181466; Grenningloh R, 2006, J IMMUNOL, V176, P5161, DOI 10.4049/jimmunol.176.9.5161; Hakonarson H, 2005, P NATL ACAD SCI USA, V102, P14789, DOI 10.1073/pnas.0409904102; Hakonarson H, 2002, AM J HUM GENET, V71, P483, DOI 10.1086/342205; Hejazi ME, 2016, J RES PHARM PRACT, V5, P7, DOI 10.4103/2279-042X.176542; Hosoki K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126035; Huang GX, 2016, J CELL MOL MED, V20, P1276, DOI 10.1111/jcmm.12809; Isidoro-Garcia M, 2011, ALLERGY, V66, P1553, DOI 10.1111/j.1398-9995.2011.02685.x; Jin HL, 2017, MOL BIOL REP, V44, P243, DOI 10.1007/s11033-017-4106-3; Keranen T, 2017, INFLAMM RES, V66, P441, DOI 10.1007/s00011-017-1028-4; Kim MH, 2013, KOREAN J INTERN MED, V28, P708, DOI 10.3904/kjim.2013.28.6.708; Kim V, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0103-2; Krystel-Whittemore M, 2016, FRONT IMMUNOL, P6; Lee SH, 2009, J STEROID BIOCHEM, V115, P30, DOI 10.1016/j.jsbmb.2009.02.013; Livak K, 2004, APPL BIOSYSTEMS; Lopert A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02915; Luhadia S K, 2014, J Assoc Physicians India, V62, P38; Maneechotesuwan K, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000076; Mansur AH, 2004, THORAX, V59, P876, DOI 10.1136/thx.2003.014092; Marcos-Vadillo E, 2016, METHODS MOL BIOL, V1434, P169, DOI 10.1007/978-1-4939-3652-6_12; Medoff BD, 2002, J IMMUNOL, V168, P5278, DOI 10.4049/jimmunol.168.10.5278; Necela Brian M, 2004, Proc Am Thorac Soc, V1, P239, DOI 10.1513/pats.200402-005MS; Nicolaides NC, 2010, STEROIDS, V75, P1, DOI 10.1016/j.steroids.2009.09.002; Oguma T, 2004, NEW ENGL J MED, V351, P1752, DOI 10.1056/NEJMoa031785; Pascussi JM, 2000, MOL PHARMACOL, V58, P1441, DOI 10.1124/mol.58.6.1441; Pascussi JM, 2003, MOL ENDOCRINOL, V17, P42, DOI 10.1210/me.2002-0244; Pease James E., 2001, Current Opinion in Pharmacology, V1, P248, DOI 10.1016/S1471-4892(01)00044-3; Roberts JK, 2013, F1000RESEARCH, P2; Sanz C, 2006, ALLERGY, V61, P543, DOI 10.1111/j.1398-9995.2006.01025.x; Sanz C, 2009, PEDIAT ALLERG IMM-UK, V20, P151, DOI 10.1111/j.1399-3038.2008.00772.x; Sato M, 2011, RESPIROLOGY, V16, P124, DOI 10.1111/j.1440-1843.2010.01886.x; Shah S, 2014, J BIOL CHEM, V289, P13667, DOI 10.1074/jbc.M113.540799; Thu Kelsie L, 2014, Oncoscience, V1, P326; Ungvari I, 2012, PLOS ONE, P7; van Aalderen WMC, 2011, EUR J PEDIATR, V170, P709, DOI 10.1007/s00431-010-1319-z; Vijverberg SJH, 2015, CLIN EXP ALLERGY, V45, P1051, DOI 10.1111/cea.12492; Wu JH, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-28; Yang H, 2014, PROTEIN CELL, V5, P113, DOI 10.1007/s13238-013-0013-0; Zhang J, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-4	56	1	1	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186957	10.1371/journal.pone.0186957	http://dx.doi.org/10.1371/journal.pone.0186957			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088248	Green Submitted, Green Published, gold			2022-12-26	WOS:000414088900033
J	Roswall, N; Bidstrup, PE; Reaschou-Nielsen, O; Jensen, SS; Overvad, K; Halkjaer, J; Sorensen, M				Roswall, Nina; Bidstrup, Pernille Envold; Reaschou-Nielsen, Ole; Jensen, Steen Solvang; Overvad, Kim; Halkjaer, Jytte; Sorensen, Mette			Residential road traffic noise exposure and colorectal cancer survival - A Danish cohort study	PLOS ONE			English	Article							CIRCADIAN-RHYTHM; BREAST-CANCER; EXPRESSION; MELATONIN; GENES; PREDICTOR; MORTALITY; DISEASE; QUALITY; SLEEP	Background Residential traffic noise exposure may entail sleep disruption and compromised circadian functioning; two factors which have been associated with a poor colorectal cancer (CRC) prognosis. Hence, the aim of the present study was to investigate the association between residential road traffic noise and CRC survival. Methods and materials Road traffic noise was calculated for all residential addresses from 1987 to February 2012 for incident CRC cases (n = 1,234) in a cohort of 57,053 Danes. We used Cox Proportional Hazard Models to investigate the association between residential road traffic noise at different time-windows, and overall and CRC-specific mortality. Furthermore, we investigated interaction with sex, age, prognostic factors, and comorbidity. Mortality Rate Ratios (MRR) were calculated in unadjusted models, and adjusted for railway noise, lifestyle factors, and socioeconomic variables. Results During a median follow-up of 4 years, 594 patients died; 447 from CRC. We found no association between road traffic noise exposure and overall (MRR 1.00 (0.88-1.13) per 10 dB) or CRC-specific mortality (MRR 0.98 (0.85-1.13) per 10 dB) over the entire follow-up period, or 1 year preceding death. Results did not differ when examining colon and rectal cancer separately. Interaction analyses suggested that patients with less clinically advanced disease could be more susceptible to harmful effects of traffic noise. Conclusion The present study suggests no overall association between residential road traffic noise and concurrent mortality in CRC patients. As it is the first study of its kind, with relatively limited power, further studies are warranted.	[Roswall, Nina; Bidstrup, Pernille Envold; Reaschou-Nielsen, Ole; Halkjaer, Jytte; Sorensen, Mette] Danish Canc Soc, Res Ctr, Copenhagen, Denmark; [Jensen, Steen Solvang] Aarhus Univ, Dept Environm Sci, Roskilde, Denmark; [Overvad, Kim] Aarhus Univ, Sect Epidemiol, Dept Publ Hlth, Aarhus, Denmark	Danish Cancer Society; Aarhus University; Aarhus University	Roswall, N (corresponding author), Danish Canc Soc, Res Ctr, Copenhagen, Denmark.	roswall@cancer.dk	Jensen, Steen Solvang/AAM-2945-2021; Raaschou-Nielsen, Ole/GOK-0338-2022; Roswall, Nina/AAJ-6700-2020	Raaschou-Nielsen, Ole/0000-0002-1223-0909; Roswall, Nina/0000-0003-3071-1658; Sorensen, Mette/0000-0002-7302-4789; Overvad, Kim/0000-0001-6429-7921; Bidstrup, Pernille/0000-0002-9704-6800; Jensen, Steen Solvang/0000-0001-5923-8441	European Research Council [281760]	European Research Council(European Research Council (ERC)European Commission)	This work received support from the European Research Council, grant number 281760, https://erc.europa.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Basner M, 2014, LANCET, V383, P1325, DOI 10.1016/S0140-6736(13)61613-X; Bendtsen H, 1999, SCI TOTAL ENVIRON, V235, P331, DOI 10.1016/S0048-9697(99)00216-8; Boyle T, 2013, BRIT J CANCER, V109, P814, DOI 10.1038/bjc.2013.310; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cleeland CS, 2012, NAT REV CLIN ONCOL, V9, P471, DOI 10.1038/nrclinonc.2012.99; Cos S, 1998, CANCER RES, V58, P4383; Danish Colorectal Cancer Group, 2016, NAT ARS RAPP 2014; Davies JM, 2011, SEMIN ONCOL, V38, P552, DOI 10.1053/j.seminoncol.2011.05.009; Egeberg R, 2008, EUR J CANCER, V44, P1978, DOI 10.1016/j.ejca.2008.06.020; Esposito E, 2010, CURR NEUROPHARMACOL, V8, P228, DOI 10.2174/157015910792246155; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Frederiksen BL, 2009, EUR J CANCER, V45, P1248, DOI 10.1016/j.ejca.2008.11.035; Goines L, 2007, SOUTH MED J, V100, P287, DOI 10.1097/SMJ.0b013e3180318be5; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; Hanninen O, 2014, ENVIRON HEALTH PERSP, V122, P439, DOI 10.1289/ehp.1206154; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; Ingeholm P, 2016, CLIN EPIDEMIOL, V8, P465, DOI 10.2147/CLEP.S99481; Innominato PF, 2015, SLEEP MED, V16, P391, DOI 10.1016/j.sleep.2014.10.022; Innominato PF, 2012, INT J CANCER, V131, P2684, DOI 10.1002/ijc.27574; Innominato PF, 2009, CANCER RES, V69, P4700, DOI 10.1158/0008-5472.CAN-08-4747; Jensen SS, 2009, GIS BASED NATL ROAD; Karantanos T, 2014, WORLD J GASTROENTERO, V20, P1986, DOI 10.3748/wjg.v20.i8.1986; Karantanos T, 2013, INT J BIOL MARKER, V28, P280, DOI [10.5301/JBM.5000033, 10.5301/jbm.5000033]; Kelleher FC, 2014, CANCER LETT, V342, P9, DOI 10.1016/j.canlet.2013.09.040; Kerkhof GA, 2010, PROG BRAIN RES, V185, P181, DOI 10.1016/B978-0-444-53702-7.00011-7; Kim SE, 2015, WORLD J GASTROENTERO, V21, P5167, DOI 10.3748/wjg.v21.i17.5167; Larsen SB, 2012, EUR J EPIDEMIOL, V27, P837, DOI 10.1007/s10654-012-9739-x; Levi F, 2014, CHRONOBIOL INT, V31, P891, DOI 10.3109/07420528.2014.924523; Liu R, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-1; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Mazzoccoli G, 2011, CHRONOBIOL INT, V28, P841, DOI 10.3109/07420528.2011.615182; Miedema Henk M E, 2007, Behav Sleep Med, V5, P1, DOI 10.1207/s15402010bsm0501_1; Oshima T, 2011, ONCOL REP, V25, P1439, DOI 10.3892/or.2011.1207; Palesh O, 2012, NAT SCI SLEEP, V4, P151, DOI 10.2147/NSS.S18895; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Roosli M, 2014, NOISE HEALTH, V16, P197, DOI 10.4103/1463-1741.137036; Roswall N, 2017, CANC CAUSES IN PRESS; Roswall N, 2016, ENVIRON RES, V151, P814, DOI 10.1016/j.envres.2016.09.016; Schoenberg MH, 2016, VISC MED, V32, P199, DOI 10.1159/000446492; Sephton S, 2003, BRAIN BEHAV IMMUN, V17, P321, DOI 10.1016/S0889-1591(03)00078-3; Sorensen M, 2013, ENVIRON HEALTH PERSP, V121, P217, DOI 10.1289/ehp.1205503; Storm HH, 1997, DAN MED BULL, V44, P535; Tamas K, 2015, CANCER TREAT REV, V41, P671, DOI 10.1016/j.ctrv.2015.06.007; Tan DX, 2007, J PINEAL RES, V42, P28, DOI 10.1111/j.1600-079X.2006.00407.x; Tjonneland A, 2007, SCAND J PUBLIC HEALT, V35, P432, DOI 10.1080/14034940601047986; Vienneau D, 2015, ENVIRON RES, V138, P372, DOI 10.1016/j.envres.2015.02.023; World Cancer Research Fund / American Institute for Cancer Research, 2011, CONT UPD PROJ REP FO; World Health Organization, 2009, NOGHT NOIS GUID EUR; Zeman M, 2008, MOL MED REP, V1, P599; Zhou F, 2012, CANCER-AM CANCER SOC, V118, P937, DOI 10.1002/cncr.26348	51	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187161	10.1371/journal.pone.0187161	http://dx.doi.org/10.1371/journal.pone.0187161			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084272	Green Published, Green Submitted, gold			2022-12-26	WOS:000413910200036
J	Eckl, J; Sima, S; Marcus, K; Lindemann, C; Richter, K				Eckl, Julia; Sima, Siyuan; Marcus, Katrin; Lindemann, Claudia; Richter, Klaus			Hsp90-downregulation influences the heat-shock response, innate immune response and onset of oocyte development in nematodes	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; ENDOPLASMIC-RETICULUM; QUANTITATIVE-ANALYSIS; TRANSCRIPTION FACTOR; C. ELEGANS; HSP90; INFECTION; PROTEINS; PATHWAY	Hsp90 is a molecular chaperone involved in the regulation and maturation of kinases and transcription factors. In Caenorhabditis elegans, it contributes to the development of fertility, maintenance of muscle structure, the regulation of heat-shock response and dauer state. To understand the consequences of Hsp90-depletion, we studied Hsp90 RNAi-treated nematodes by DNA microarrays and mass spectrometry. We find that upon development of phenotypes the levels of chaperones and Hsp90 cofactors are increased, while specific proteins related to the innate immune response are depleted. In microarrays, we further find many differentially expressed genes related to gonad and larval development. These genes form an expression cluster that is regulated independently from the immune response implying separate pathways of Hsp90-involvement. Using fluorescent reporter strains for the differentially expressed immune response genes skr-5, dod-24 and clec-60 we observe that their activity in intestinal tissues is influenced by Hsp90-depletion. Instead, effects on the development are evident in both gonad arms. After Hsp90-depletion, changes can be observed in early embryos and adults containing fluorescence-tagged versions of SEPA-1, CAV-1 or PUD-1, all of which are downregulated after Hsp90-depletion. Our observations identify molecular events for Hsp90-RNAi induced phenotypes during development and immune responses, which may help to separately investigate independent Hsp90-influenced processes that are relevant during the nematode's life and development.	[Eckl, Julia; Sima, Siyuan; Richter, Klaus] Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci, Lichtenbergstr, Garching, Germany; [Marcus, Katrin; Lindemann, Claudia] Ruhr Univers Bochum, Med Proteom Ctr, Funct Prote, Univ Str, Bochum, Germany	Technical University of Munich; Ruhr University Bochum	Richter, K (corresponding author), Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci, Lichtenbergstr, Garching, Germany.	klaus.richter@tum.de	Richter, Klaus/A-2673-2010	Richter, Klaus/0000-0002-8952-9642	P.U.R.E. (Protein Unit for Research in Europe - German federal state North Rhine-Westphalia); DFG [RI1873/1-3]; German Research Foundation (DFG); Technical University of Munich within the funding programme Open Access Publishing	P.U.R.E. (Protein Unit for Research in Europe - German federal state North Rhine-Westphalia); DFG(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); Technical University of Munich within the funding programme Open Access Publishing	The work was supported by P.U.R.E. (Protein Unit for Research in Europe, funded by the German federal state North Rhine-Westphalia). Klaus Richter is funded by the research grant DFG grant RI1873/1-3. This work was supported by the German Research Foundation (DFG) and the Technical University of Munich within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bar-Lavan Y, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006531; Barash Y, 2004, BIOINFORMATICS, V20, P839, DOI 10.1093/bioinformatics/btg487; Beers M, 2006, DEVELOPMENT, V133, P3745, DOI 10.1242/dev.02544; Birnby DA, 2000, GENETICS, V155, P85; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Bolz DD, 2010, J BIOL CHEM, V285, P10832, DOI 10.1074/jbc.M109.091629; Ceron J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-30; Dehner A, 2003, CHEMBIOCHEM, V4, P870, DOI 10.1002/cbic.200300658; Devaney E, 2005, INT J PARASITOL, V35, P627, DOI 10.1016/j.ijpara.2005.01.007; Ding W, 2015, CELL METAB, V22, P633, DOI 10.1016/j.cmet.2015.07.013; Ding YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067158; Dong MQ, 2007, SCIENCE, V317, P660, DOI 10.1126/science.1139952; Ermolaeva MA, 2013, NATURE, V501, P416, DOI 10.1038/nature12452; Evans EA, 2008, AGING CELL, V7, P879, DOI 10.1111/j.1474-9726.2008.00435.x; Gaiser AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025485; Gaiser AM, 2009, J MOL BIOL, V391, P621, DOI 10.1016/j.jmb.2009.06.051; Geillinger KE, 2012, J PROTEOME RES, V11, P4594, DOI 10.1021/pr300385v; Gillan V, 2009, INT J PARASITOL, V39, P1071, DOI 10.1016/j.ijpara.2009.02.024; Guisbert E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003466; Hall JA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177432; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Haslbeck V, 2013, J MOL BIOL, V425, P2922, DOI 10.1016/j.jmb.2013.05.019; Hibbs MA, 2007, BIOINFORMATICS, V23, P2692, DOI 10.1093/bioinformatics/btm403; Irazoqui JE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000982; JebaMercy G, 2013, MICROBES INFECT, V15, P550, DOI 10.1016/j.micinf.2013.03.009; Kakihara Y, 2012, BBA-MOL CELL RES, V1823, P101, DOI 10.1016/j.bbamcr.2011.08.016; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Lotz GP, 2008, J CELL SCI, V121, P717, DOI 10.1242/jcs.015610; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Marudhupandiyan S, 2017, IMMUNOL RES, V65, P609, DOI 10.1007/s12026-016-8879-6; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; Miyata S, 2008, GENETICS, V178, P903, DOI 10.1534/genetics.107.083923; Mochii M, 1999, P NATL ACAD SCI USA, V96, P15020, DOI 10.1073/pnas.96.26.15020; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; O'Rourke D, 2006, GENOME RES, V16, P1005, DOI 10.1101/gr.50823006; Obayashi T, 2013, NUCLEIC ACIDS RES, V41, pD1014, DOI 10.1093/nar/gks1014; Papsdorf K, 2016, MICROBIAL CELL; Papsdorf K, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1831-7; Safra M, 2014, CELL METAB, V20, P870, DOI 10.1016/j.cmet.2014.09.006; Sahu SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038200; Sato K, 2006, MOL BIOL CELL, V17, P3085, DOI 10.1091/mbc.E06-03-0211; Schulenburg H, 2008, IMMUNOBIOLOGY, V213, P237, DOI 10.1016/j.imbio.2007.12.004; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Shivers RP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000892; Singh V, 2009, J BIOL CHEM, V284, P35580, DOI 10.1074/jbc.M109.060905; Sivamaruthi BS, 2014, INDIAN J MICROBIOL, V54, P52, DOI 10.1007/s12088-013-0424-x; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stiernagle Theresa, 2006, WormBook, P1; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Teixeira MC, 2014, NUCLEIC ACIDS RES, V42, pD161, DOI 10.1093/nar/gkt1015; Tenge VR, 2015, EUKARYOT CELL, V14, P55, DOI 10.1128/EC.00170-14; Tepper RG, 2013, CELL, V154, P676, DOI 10.1016/j.cell.2013.07.006; THOMAS JH, 1993, GENETICS, V134, P1105; Tian Y, 2010, CELL, V141, P1042, DOI 10.1016/j.cell.2010.04.034; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; van Oosten-Hawle P, 2013, CELL, V153, P1366, DOI 10.1016/j.cell.2013.05.015; VENOLIA L, 1990, GENETICS, V126, P345; VOWELS JJ, 1994, GENETICS, V138, P303; Walker AK, 2011, CELL, V147, P840, DOI 10.1016/j.cell.2011.09.045; Yamanaka A, 2002, CURR BIOL, V12, P267, DOI 10.1016/S0960-9822(02)00657-7; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Yunger E, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006577; Zhang Y, 2016, MOL CELL BIOL, V36, P2374, DOI 10.1128/MCB.00131-16; Zhang YX, 2009, CELL, V136, P308, DOI 10.1016/j.cell.2008.12.022; Zhu Q, 2015, NAT METHODS, V12, P211, DOI [10.1038/NMETH.3249, 10.1038/nmeth.3249]	69	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186386	10.1371/journal.pone.0186386	http://dx.doi.org/10.1371/journal.pone.0186386			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29078207	Green Published, gold, Green Submitted			2022-12-26	WOS:000413861200011
J	Chaturvedi, S; Rao, ALN				Chaturvedi, Sonali; Rao, A. L. N.			Riboproteomics: A versatile approach for the identification of host protein interaction network in plant pathogenic noncoding RNAs	PLOS ONE			English	Article							CUCUMBER-MOSAIC-VIRUS; SATELLITE RNA; CAPSID PROTEIN; REPLICATION; BROMODOMAIN	Pathogenic or non-pathogenic small (17 to 30 nt) and long (>200 nt) non-coding RNAs (ncRNAs) have been implicated in the regulation of gene expression at transcriptional, post-transcriptional and epigenetic level by interacting with host proteins. However, lack of suitable experimental system precludes the identification and evaluation of the functional significance of host proteins interacting with ncRNAs. In this study, we present a first report on the application of riboproteomics to identify host proteins interacting with small, highly pathogenic, noncoding satellite RNA (sat-RNA) associated with Cucumber mosaic virus, the helper virus (HV). RNA affinity beads containing sat-RNA transcripts of (+) or (-)-sense covalently coupled to cyanogen bromide activated sepharose beads were incubated with total protein extracts from either healthy or HV-infected Nicotiana benthamiana leaves. RNA-protein complexes bound to the beads were eluted and subjected to MudPIT analysis. Bioinformatics programs PANTHER classification and WoLF-PSORT were used to further classify the identified host proteins in each case based on their functionality and subcellular distribution. Finally, we observed that the host protein network interacting with plus and minus-strand transcripts of sat-RNA, in the presence or absence of HV is distinct, and the global interactome of host proteins interacting with satRNA in either of the orientations is very different.	[Chaturvedi, Sonali; Rao, A. L. N.] Univ Calif Riverside, Dept Microbiol & Plant Pathol, Riverside, CA 92521 USA; [Chaturvedi, Sonali] Univ Calif San Francisco, Gladstone Inst Virol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California Riverside; University of California System; University of California San Francisco; The J David Gladstone Institutes	Rao, ALN (corresponding author), Univ Calif Riverside, Dept Microbiol & Plant Pathol, Riverside, CA 92521 USA.	arao@ucr.edu		Chaturvedi, Sonali/0000-0002-9175-8110	University of California Agricultural Experimental Station Mission Funding Program [19900]	University of California Agricultural Experimental Station Mission Funding Program	This study was partly funded by a grant from University of California Agricultural Experimental Station Mission Funding Program (19900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partly funded by a grant from University of California Agricultural Experimental Station Mission Funding Program (19900).	Annamalai P., 2006, CURRENT PROTOCOLS MI; Bamunusinghe D, 2013, J VIROL, V87, P8982, DOI 10.1128/JVI.01253-13; Chaturvedi S, 2016, VIROLOGY, V494, P47, DOI 10.1016/j.virol.2016.04.001; Chaturvedi S, 2016, J PROTEOMICS, V131, P1, DOI 10.1016/j.jprot.2015.09.030; Chaturvedi S, 2014, VIROLOGY, V464, P67, DOI 10.1016/j.virol.2014.06.030; Chaturvedi S, 2014, J VIROL, V88, P1890, DOI 10.1128/JVI.03082-13; Chaturvedi S, 2012, JOVE-J VIS EXP, DOI 10.3791/3645; Choi SH, 2012, J VIROL, V86, P4823, DOI 10.1128/JVI.00018-12; de Wispelaere M, 2009, VIROLOGY, V384, P179, DOI 10.1016/j.virol.2008.10.023; de Wispelaere M, 2011, VIROLOGY, V419, P17, DOI 10.1016/j.virol.2011.07.016; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hu CC, 2009, VIRUSES-BASEL, V1, P1325, DOI 10.3390/v1031325; Kwon SJ, 2014, VIROLOGY, V450, P222, DOI 10.1016/j.virol.2013.12.008; MARSH LE, 1991, VIROLOGY, V182, P76, DOI 10.1016/0042-6822(91)90650-Z; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Nagy PD, 2006, VIROLOGY, V344, P211, DOI 10.1016/j.virol.2005.09.017; Nagy PD, 2012, NAT REV MICROBIOL, V10, P137, DOI 10.1038/nrmicro2692; PIAZZOLLA P, 1982, VIROLOGY, V122, P147, DOI 10.1016/0042-6822(82)90384-1; Rao ALN, 2015, VIROLOGY, V479, P627, DOI 10.1016/j.virol.2015.02.018; Rao ALN, 2014, CURR OPIN VIROL, V9, P61, DOI 10.1016/j.coviro.2014.09.008; Rao A.L.N., 2015, VIRUS RES; Seo JK, 2013, VIROLOGY, V435, P214, DOI 10.1016/j.virol.2012.10.031; Seo JK, 2009, VIROLOGY, V383, P248, DOI 10.1016/j.virol.2008.10.033; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Vashist S, 2012, J VIROL, V86, P11977, DOI 10.1128/JVI.00432-12; Wang AM, 2015, ANNU REV PHYTOPATHOL, V53, P45, DOI 10.1146/annurev-phyto-080614-120001	26	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186703	10.1371/journal.pone.0186703	http://dx.doi.org/10.1371/journal.pone.0186703			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073276	Green Published, gold			2022-12-26	WOS:000413845400042
J	Blummel, AS; Drepper, F; Knapp, B; Eimer, E; Warscheid, B; Muller, M; Frobel, J				Bluemmel, Anne-Sophie; Drepper, Friedel; Knapp, Bettina; Eimer, Ekaterina; Warscheid, Bettina; Mueller, Matthias; Froebel, Julia			Structural features of the TatC membrane protein that determine docking and insertion of a twin-arginine signal peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Escherichia coli (E; coli); mass spectrometry (MS); membrane protein; protein cross-linking; protein export; protein targeting; Dicyclohexylcarbodiimide (DCCD; DCC); TatC; twin-arginine translocation	ESCHERICHIA-COLI; TRANSPORT-SYSTEM; PRECURSOR PROTEINS; BINDING-SITE; TRANSLOCATION SYSTEM; BACILLUS-SUBTILIS; FOLDED PROTEINS; COMPONENT; COMPLEX; SUBUNIT	Twin-arginine translocation (Tat) systems transport folded proteins across cellular membranes with the concerted action of mostly three membrane proteins: TatA, TatB, and TatC. Hetero-oligomers of TatB and TatC form circular substrate-receptor complexes with a central binding cavity for twin-arginine-containing signal peptides. After binding of the substrate, energy from an electro-chemical proton gradient is transduced into the recruitment of TatA oligomers and into the actual translocation event. We previously reported that Tat-dependent protein translocation into membrane vesicles of Escherichia coli is blocked by the compound N,N-dicyclohexylcarbodiimide (DCCD, DCC). We have now identified a highly conserved glutamate residue in the transmembrane region of E. coli TatC, which when modified by DCCD interferes with the deep insertion of a Tat signal peptide into the TatBC receptor complex. Our findings are consistent with a hydrophobic binding cavity formed by TatB and TatC inside the lipid bilayer. Moreover, we found that DCCD mediates discrete intramolecular cross-links of E. coli TatC involving both its N- and C-tails. These results confirm the close proximity of two distant sequence sections of TatC proposed to concertedly function as the primary docking site for twin-arginine signal peptides.	[Bluemmel, Anne-Sophie; Eimer, Ekaterina; Mueller, Matthias; Froebel, Julia] Univ Freiburg, Fac Med, ZBMZ, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Bluemmel, Anne-Sophie] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, D-79104 Freiburg, Germany; [Bluemmel, Anne-Sophie; Eimer, Ekaterina] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Drepper, Friedel; Knapp, Bettina; Warscheid, Bettina] Univ Freiburg, Fac Biol, Inst Biol 2, Biochem Funct Prote, D-79104 Freiburg, Germany; [Drepper, Friedel; Warscheid, Bettina] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg	Muller, M (corresponding author), Univ Freiburg, Fac Med, ZBMZ, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany.	matthias.mueller@biochemie.uni-freiburg.de		Warscheid, Bettina/0000-0001-5096-1975; Drepper, Friedel/0000-0002-2043-5795	Deutsche Forschungsgemeinschaft [SFB 746, FOR 1905]; Excellence Initiative of the German Federal & State Governments [GSC-4, EXC-294]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal & State Governments	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB 746 and Grant FOR 1905 and the Excellence Initiative of the German Federal & State Governments (GSC-4, Spemann Graduate School, and EXC-294, BIOSS). The authors declare that they have no conflicts of interest with the contents of this article.	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Alcock F, 2016, ELIFE, V5, DOI 10.7554/eLife.20718; Alcock F, 2013, P NATL ACAD SCI USA, V110, pE3650, DOI 10.1073/pnas.1306738110; Aldridge C, 2014, J CELL BIOL, V205, P51, DOI 10.1083/jcb.201311057; Aldridge C, 2012, J BIOL CHEM, V287, P34752, DOI 10.1074/jbc.M112.385666; Behrendt J, 2014, BIOCHEMISTRY-US, V53, P2344, DOI 10.1021/bi500169s; Berks BC, 2014, CURR OPIN STRUC BIOL, V27, P32, DOI 10.1016/j.sbi.2014.03.003; Blummel AS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8234; Bolhuis A, 2001, J BIOL CHEM, V276, P20213, DOI 10.1074/jbc.M100682200; Bruser T, 2003, MICROBIOL RES, V158, P7, DOI 10.1078/0944-5013-00176; Buchanan G, 2002, MOL MICROBIOL, V43, P1457, DOI 10.1046/j.1365-2958.2002.02853.x; Chan A, 2016, EUR J CELL BIOL, V95, P585, DOI 10.1016/j.ejcb.2016.10.004; Cleon F, 2015, MOL MICROBIOL, V98, P111, DOI 10.1111/mmi.13106; Cline K, 2001, J CELL BIOL, V154, P719, DOI 10.1083/jcb.200105149; Cline K, 2015, J BIOL CHEM, V290, P16530, DOI 10.1074/jbc.R114.626820; Eimer E, 2015, J BIOL CHEM, V290, P29281, DOI 10.1074/jbc.M115.696005; Frobel J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2308; Frobel J, 2012, PHILOS T R SOC B, V367, P1029, DOI 10.1098/rstb.2011.0202; Frobel J, 2011, J BIOL CHEM, V286, P43679, DOI 10.1074/jbc.M111.292565; Gerard F, 2006, J BIOL CHEM, V281, P6130, DOI 10.1074/jbc.M512733200; Goosens VJ, 2014, BBA-MOL CELL RES, V1843, P1698, DOI 10.1016/j.bbamcr.2013.10.008; HASSINEN IE, 1993, BIOCHIM BIOPHYS ACTA, V1144, P107, DOI 10.1016/0005-2728(93)90164-B; Holzapfel E, 2007, BIOCHEMISTRY-US, V46, P2892, DOI 10.1021/bi062205b; Hu YF, 2010, J AM CHEM SOC, V132, P15942, DOI 10.1021/ja1053785; Huang Q, 2017, P NATL ACAD SCI USA, V114, pE1958, DOI 10.1073/pnas.1615056114; Kreutzenbeck P, 2007, J BIOL CHEM, V282, P7903, DOI 10.1074/jbc.M610126200; Lausberg F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039867; LESLEY SA, 1991, J BIOL CHEM, V266, P2632; Ma XY, 2013, PLANT CELL, V25, P999, DOI 10.1105/tpc.112.107409; Maurer C, 2010, MOL BIOL CELL, V21, P4151, DOI 10.1091/mbc.E10-07-0585; Moser Michael, 2007, V390, P63; MULLER M, 1987, EMBO J, V6, P3855, DOI 10.1002/j.1460-2075.1987.tb02723.x; MUSSER SM, 1993, BIOPHYS J, V65, P2348, DOI 10.1016/S0006-3495(93)81309-2; Palmer T, 2012, NAT REV MICROBIOL, V10, P483, DOI 10.1038/nrmicro2814; Panahandeh S, 2008, J BIOL CHEM, V283, P33267, DOI 10.1074/jbc.M804225200; Patel R, 2014, BBA-MOL CELL RES, V1843, P1620, DOI 10.1016/j.bbamcr.2014.02.013; Ramasamy S, 2013, STRUCTURE, V21, P777, DOI 10.1016/j.str.2013.03.004; Reimann L, 2017, MOL CELL PROTEOMICS, V16, P346, DOI 10.1074/mcp.M116.065425; Rodriguez F, 2013, P NATL ACAD SCI USA, V110, pE1092, DOI 10.1073/pnas.1219486110; Rollauer SE, 2012, NATURE, V492, P210, DOI 10.1038/nature11683; Rose P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069488; Simone D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078742; Strauch EM, 2007, J MOL BIOL, V374, P283, DOI 10.1016/j.jmb.2007.09.050; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Ulfig A, 2017, J BIOL CHEM, V292, P10865, DOI 10.1074/jbc.M117.788950; Valeur E, 2009, CHEM SOC REV, V38, P606, DOI 10.1039/b701677h; Walther TH, 2010, J AM CHEM SOC, V132, P15945, DOI 10.1021/ja106963s; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Zhang Y, 2014, BBA-BIOMEMBRANES, V1838, P1881, DOI 10.1016/j.bbamem.2014.03.015; Zoufaly S, 2012, J BIOL CHEM, V287, P13430, DOI 10.1074/jbc.M112.343798	50	5	6	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21320	21329		10.1074/jbc.M117.812560	http://dx.doi.org/10.1074/jbc.M117.812560			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29089385	Green Published, hybrid			2022-12-26	WOS:000419013000009
J	Casey, AK; Moehlman, AT; Zhang, JM; Servage, KA; Kramer, H; Orth, K				Casey, Amanda K.; Moehlman, Andrew T.; Zhang, Junmei; Servage, Kelly A.; Kramer, Helmut; Orth, Kim			Fic-mediated deAMPylation is not dependent on homodimerization and rescues toxic AMPylation in flies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; GLUTAMINE-SYNTHETASE; DROSOPHILA-MELANOGASTER; DEADENYLYLATION; ADENYLYLATION; MUTATIONS; BINDING; DOMAIN; SITE	Protein chaperones play a critical role in proteostasis. The activity of the major endoplasmic reticulum chaperone BiP (GRP78) is regulated by Fic-mediated AMPylation during resting states. By contrast, during times of stress, BiP is deAMPylated. Here, we show that excessive AMPylation by a constitutively active FicE247G mutant is lethal in Drosophila. This lethality is cell-autonomous, as directed expression of the mutant FicE247G to the fly eye does not kill the fly but rather results in a rough and reduced eye. Lethality and eye phenotypes are rescued by the deAMPylation activity of wild-type Fic. Consistent with Fic acting as a deAMPylation enzyme, its activity was both time-and concentration-dependent. Furthermore, Fic deAMPylation activity was sufficient to suppress the AMPylation activity mediated by the constitutively active FicE247G mutant in Drosophila S2 lysates. Further, we show that the dual enzymatic activity of Fic is, in part, regulated by Fic dimerization, as loss of this dimerization increases AMPylation and reduces deAMPylation of BiP.	[Casey, Amanda K.; Zhang, Junmei; Servage, Kelly A.; Orth, Kim] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, 6000 Harry Hines Blvd,Rm NA5-120F, Dallas, TX 75390 USA; [Moehlman, Andrew T.; Kramer, Helmut] Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Zhang, Junmei; Servage, Kelly A.; Orth, Kim] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Orth, Kim] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Orth, K (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, 6000 Harry Hines Blvd,Rm NA5-120F, Dallas, TX 75390 USA.	Kim.Orth@UTSouthwestern.edu	Orth, Kim/AAV-4421-2021	Orth, Kim/0000-0002-0678-7620	National Institutes of Health (NIH) [R01 GM115188]; Welch Foundation [I-1561]; Once Upon a Time Foundation; NIH [EY010199, EY021922]; National Science Foundation [1000176311]; NATIONAL EYE INSTITUTE [R01EY021922, R01EY010199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115188] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Once Upon a Time Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by National Institutes of Health (NIH) Grant R01 GM115188, Welch Foundation Grant I-1561, and Once Upon a Time... Foundation (to K. O.), NIH Grants EY010199 and EY021922 (to H. K.), and National Science Foundation Graduate Research Fellowship 1000176311 (to A. T. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ANDERSON WB, 1970, BIOCHEM BIOPH RES CO, V41, P704, DOI 10.1016/0006-291X(70)90070-7; BROWN MS, 1971, P NATL ACAD SCI USA, V68, P2949, DOI 10.1073/pnas.68.12.2949; Bunney TD, 2014, STRUCTURE, V22, P1831, DOI 10.1016/j.str.2014.10.007; Ceriani M Fernanda, 2007, Methods Mol Biol, V362, P415; Engel P, 2012, NATURE, V482, P107, DOI 10.1038/nature10729; Garcia-Pino A, 2014, TRENDS BIOCHEM SCI, V39, P121, DOI 10.1016/j.tibs.2014.01.001; GAUT JR, 1993, J BIOL CHEM, V268, P7248; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Ham H, 2014, J BIOL CHEM, V289, P36059, DOI 10.1074/jbc.M114.612515; Hao YH, 2011, J BIOTECHNOL, V151, P251, DOI 10.1016/j.jbiotec.2010.12.013; Harms A, 2016, ANNU REV MICROBIOL, V70, P341, DOI 10.1146/annurev-micro-102215-095245; KINGDON HS, 1967, P NATL ACAD SCI USA, V58, P1703, DOI 10.1073/pnas.58.4.1703; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Kramer H, 1996, J CELL BIOL, V133, P1205, DOI 10.1083/jcb.133.6.1205; Nandi N, 2014, J CELL BIOL, V207, P253, DOI 10.1083/jcb.201404028; Preissler S, 2017, NAT STRUCT MOL BIOL, V24, P23, DOI 10.1038/nsmb.3337; Preissler S, 2015, ELIFE, V4, DOI 10.7554/eLife.12621; Preissler S, 2015, ELIFE, V4, DOI 10.7554/eLife.08961; Rahman M, 2012, NAT NEUROSCI, V15, P871, DOI 10.1038/nn.3102; Ray M, 2015, J GENET, V94, P407, DOI 10.1007/s12041-015-0535-8; Roy CR, 2015, NAT REV MICROBIOL, V13, P631, DOI 10.1038/nrmicro3520; Sanyal A, 2015, J BIOL CHEM, V290, P8482, DOI 10.1074/jbc.M114.618348; Truttmann MC, 2017, P NATL ACAD SCI USA, V114, pE152, DOI 10.1073/pnas.1619234114; Truttmann MC, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006023; Vasudevan D, 2016, METHODS MOL BIOL, V1491, P131, DOI 10.1007/978-1-4939-3581-9_11; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Wolff Tanya, 2011, Cold Spring Harb Protoc, V2011, P1383, DOI 10.1101/pdb.prot066506; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382	28	18	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					21193	21204		10.1074/jbc.M117.799296	http://dx.doi.org/10.1074/jbc.M117.799296			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29089387	hybrid, Green Published			2022-12-26	WOS:000418453400033
J	Ansari, S; Kabamba, ET; Shrestha, PK; Aftab, H; Myint, T; Tshering, L; Sharma, RP; Ni, N; Aye, TT; Sahanmwong, P; Uchida, T; Ratanachu-Ek, T; Vilaichone, RK; Mahachai, V; Matsumoto, T; Akada, J; Yamaoka, Y				Ansari, Shamshul; Kabamba, Evariste Tshibangu; Shrestha, Pradeep Krishna; Aftab, Hafeza; Myint, Thein; Tshering, Lotay; Sharma, Rabi Prakash; Ni, Nwe; Aye, Than Than; Sahanmwong, Phawinee; Uchida, Tomohisa; Ratanachu-ek, Thawee; Vilaichone, Ratha-korn; Mahachai, Varocha; Matsumoto, Takashi; Akada, Junko; Yamaoka, Yoshio			Helicobacter pylori bab characterization in clinical isolates from Bhutan, Myanmar, Nepal and Bangladesh	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; GASTRIC-CANCER; VIRULENCE FACTORS; DUODENAL-ULCER; INFECTION; GENE; DISEASE; PREVALENCE; EXPRESSION; BINDING	Background Helicobacter pylori BabA is an important outer membrane protein that involves in the attachment to the gastric mucosa and enhances the virulence property of the bacterium. This study was aimed to characterize the bab genotypes, to evaluate its association with cagA, vacA and clinical diseases as well as degree of gastric inflammation. Methods H. pylor isolates from four countries were subjected for the characterization of bab. The locus specific forward and bab specific reverse primers were used to get the specific products by PCR, which could distinguish the three locus (A, B and C). The histological activities were evaluated according to the Updated Sydney system. Result In patients from high risk countries (Bhutan and Myanmar) relatively higher frequencies of strains with babA-positivity (91.8% and 90.7%, respectively), babA at locus A (98% and 91.2%, respectively) and with single babA (96.8% and 91.2%, respectively) were found. Strains with two loci occupied were the most prevalent in Bhutan (84.6%), Myanmar (74.7%), Nepal (58.3%) and Bangladesh (56.9%). The genotype babA at locus A/babB at locus B/bab-negative at locus C (babA/babB/-) was the most common genotype isolated from Bhutan (82.7%), Myanmar (58.7%), Nepal (32%) and Bangladesh (31.4%) among all genotypes assessed. This genotype was also associated with the peptic ulcer disease (P = 0.013) when compared to gastritis. babA-positive characteristics and the genotype babA/babB/-exhibited the enhanced histological activities. Conclusions The higher prevalence of virulence associated babA-positive characteristics and enhanced histological activities in Bhutan than in Myanmar, Nepal and Bangladesh might partly explain why the peoples in Bhutan are at higher risk for developing severe gastric complications.	[Ansari, Shamshul; Kabamba, Evariste Tshibangu; Sahanmwong, Phawinee; Matsumoto, Takashi; Akada, Junko; Yamaoka, Yoshio] Oita Univ, Fac Med, Dept Environm & Prevent Med, Yufu, Japan; [Shrestha, Pradeep Krishna; Sharma, Rabi Prakash] Tribhuvan Univ, Teaching Hosp, Gastroenterol Dept, Maharajgunj Med Campus, Kathmandu, Nepal; [Aftab, Hafeza] Dhaka Med Coll & Hosp, Dept Gastroenterol, Dhaka, Bangladesh; [Myint, Thein] Yangon Gen Hosp, Dept Gastroenterol, Yangon, Myanmar; [Tshering, Lotay] Jigme Dorji VVangchuck Natl Referral Hosp, Dept Surg, Thimphu, Bhutan; [Ni, Nwe] Mandalay Gen Hosp, Dept Gastroenterol, Mandalay, Myanmar; [Ni, Nwe] Univ Med Mandalay, Mandalay, Myanmar; [Aye, Than Than] Thingangyun Sanpya Gen Hosp, Dept Gastroenterol, Thingangyun, Myanmar; [Aye, Than Than] Univ Med 2, Thingangyun, Myanmar; [Uchida, Tomohisa] Oita Univ, Fac Med, Dept Mol Pathol, Hasama Machi, Yufu City, Oita, Japan; [Ratanachu-ek, Thawee] Rajavithi Hosp, Dept Surg, Bangkok, Thailand; [Vilaichone, Ratha-korn] Thammasat Univ Hosp, Dept Med, Gastroenterol Unit, Pathum Thani, Thailand; [Mahachai, Varocha] Bangkok Med Ctr, GI & Liver Ctr, Bangkok, Thailand; [Yamaoka, Yoshio] Baylor Coll Med, Dept Med Gastroenterol, Houston, TX 77030 USA	Oita University; Tribhuvan University; Institute of Medicine (IoM) - Nepal; Dhaka Medical College; Oita University; Rajavithi Hospital; Thammasat University; Baylor College of Medicine	Yamaoka, Y (corresponding author), Oita Univ, Fac Med, Dept Environm & Prevent Med, Yufu, Japan.; Yamaoka, Y (corresponding author), Baylor Coll Med, Dept Med Gastroenterol, Houston, TX 77030 USA.	yyamaoka@olta-u.ac.jp	Ansari, Shamshul/T-6962-2019; Vilaichone, Ratha-korn/ABA-1118-2020; Tshibangu-Kabamba, Evariste/AHB-8078-2022	Tshibangu-Kabamba, Evariste/0000-0002-4339-229X; Subsomwong, Phawinee/0000-0002-9961-9350; Ansari, Shamshul/0000-0003-1846-1377; Yamaoka, Yoshio/0000-0002-1222-5819	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [26640114, 15H02657, 16H05191]; National Institutes of Health [DK62813]; Japanese Government (MEXT); MEXT	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japanese Government (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (26640114, 15H02657 and 16H05191) (Y.Y.) and National Institutes of Health grants DK62813 (Y.Y.). SA and TEK are PhD students supported by the Japanese Government (MEXT) Scholarship Program for 2015 and 2016, respectively. PS was PhD student also supported by the MEXT Scholarship Program for 2013.	Abadi ATB, 2013, INTERN EMERG MED, V8, P497, DOI 10.1007/s11739-011-0631-6; Aftab H, 2016, J INFECT DEV COUNTR, V10, P245, DOI 10.3855/jidc.7713; Andersen PL, 2001, HELICOBACTER PYLORI; Ansari S, 2017, WORLD J GASTROENTERO, V23, P4158, DOI 10.3748/wjg.v23.i23.4158; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; Chomvarin C, 2008, INT J INFECT DIS, V12, P30, DOI 10.1016/j.ijid.2007.03.012; Colbeck JC, 2006, INFECT IMMUN, V74, P4375, DOI 10.1128/IAI.00485-06; CORREA P, 1992, CANCER RES, V52, P6735; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Dorer MS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000544; Forsberg M, 2003, J LEUKOCYTE BIOL, V74, P611, DOI 10.1189/jlb.1102525; Fujimoto S, 2007, CLIN GASTROENTEROL H, V5, P49, DOI 10.1016/j.cgh.2006.09.015; Gerhard M, 1999, P NATL ACAD SCI USA, V96, P12778, DOI 10.1073/pnas.96.22.12778; Ghosh P, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-015-0083-z; Hennig EE, 2006, INFECT IMMUN, V74, P3046, DOI 10.1128/IAI.74.5.3046-3051.2006; Hofman VJ, 2007, MODERN PATHOL, V20, P974, DOI 10.1038/modpathol.3800930; Hooi JKY, 2017, GASTROENTEROLOGY, V153, P420, DOI 10.1053/j.gastro.2017.04.022; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; International Agency for Research on Cancer, GLOBOCAN 2012; Karabiber H, 2014, J PEDIATR GASTR NUTR, V58, P608, DOI 10.1097/MPG.0000000000000273; Kim A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137078; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; Matteo MJ, 2011, INT J MOL EPIDEMIOL, V2, P286; Miftahussurur M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134216; Miwa H, 2002, AM J GASTROENTEROL, V97, P1106, DOI 10.1111/j.1572-0241.2002.05663.x; Moonens K, 2016, CELL HOST MICROBE, V19, P55, DOI 10.1016/j.chom.2015.12.004; Myint T, 2015, WORLD J GASTROENTERO, V21, P629, DOI 10.3748/wjg.v21.i2.629; Nguyen TL, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-114; Olfat FO, 2005, FEMS IMMUNOL MED MIC, V44, P151, DOI 10.1016/j.femsim.2004.10.010; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Pride DT, 2002, J MOL BIOL, V316, P629, DOI 10.1006/jmbi.2001.5311; Rugge M, 2007, GUT, V56, P631, DOI 10.1136/gut.2006.106666; Trang TTH, 2016, EPIDEMIOL INFECT, V144, P234, DOI 10.1017/S0950268815001430; Uchida T, 2007, CANCER SCI, V98, P521, DOI 10.1111/j.1349-7006.2007.00415.x; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Vilaichone RK, 2013, WORLD J GASTROENTERO, V19, P2806, DOI 10.3748/wjg.v19.i18.2806; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10; Yamaoka Y, 2006, GUT, V55, P775, DOI 10.1136/gut.2005.083014; Yamaoka Y, 2000, P NATL ACAD SCI USA, V97, P7533, DOI 10.1073/pnas.130079797; Yamaoka Y, 2002, J CLIN MICROBIOL, V40, P2244, DOI 10.1128/JCM.40.6.2244-2246.2002; Yamaoka Y, 2008, WORLD J GASTROENTERO, V14, P4265, DOI 10.3748/wjg.14.4265; Yamaoka Y, 2010, NAT REV GASTRO HEPAT, V7, P629, DOI 10.1038/nrgastro.2010.154	43	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187225	10.1371/journal.pone.0187225	http://dx.doi.org/10.1371/journal.pone.0187225			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29107979	Green Published, Green Submitted, gold			2022-12-26	WOS:000414424600020
J	Gupta, A; Singh, J; Dufort, I; Robert, C; Dias, FCF; Anzar, M				Gupta, Alisha; Singh, Jaswant; Dufort, Isabelle; Robert, Claude; Dias, Fernanda Caminha Faustino; Anzar, Muhammad			Transcriptomic difference in bovine blastocysts following vitrification and slow freezing at morula stage	PLOS ONE			English	Article							DIFFERENT DEVELOPMENTAL-STAGES; IN-VITRO; GENE-EXPRESSION; MAMMALIAN EMBRYOS; CATTLE EMBRYOS; CRYOPRESERVATION; MOUSE; APOPTOSIS; VIABILITY; SURVIVAL	Cryopreservation is known for its marked deleterious effects on embryonic health. Bovine compact morulae were vitrified or slow-frozen, and post-warm morulae were cultured to the expanded blastocyst stage. Blastocysts developed from vitrified and slow-frozen morulae were subjected to microarray analysis and compared with blastocysts developed from unfrozen control morulae for differential gene expression. Morula to blastocyst conversion rate was higher (P< 0.05) in control (72%) and vitrified (77%) than in slow-frozen (34%) morulae. Total 20 genes were upregulated and 44 genes were downregulated in blastocysts developed from vitrified morulae (fold change >+/- 2, P< 0.05) in comparison with blastocysts developed from control morulae. In blastocysts developed from slow-frozen morulae, 102 genes were upregulated and 63 genes were downregulated (fold change >+/- 1.5, P< 0.05). Blastocysts developed from vitrified morulae exhibited significant changes in gene expression mainly involving embryo implantation (PTGS2, CALB1), lipid peroxidation and reactive oxygen species generation (HSD3B1, AKR1B1, APOA1) and cell differentiation (KRT19, CLDN23). However, blastocysts developed from slow-frozen morulae showed changes in the expression of genes related to cell signaling (SPP1), cell structure and differentiation (DCLK2, JAM2 and VIM), and lipid metabolism (PLA2R1 and SMPD3). In silico comparison between blastocysts developed form vitrified and slow-frozen morulae revealed similar changes in gene expression as between blastocysts developed from vitrified and control morulae. In conclusion, blastocysts developed form vitrified morulae demonstrated better post-warming survival than blastocysts developed from slow-frozen morulae but their gene expression related to lipid metabolism, steroidogenesis, cell differentiation and placentation changed significantly (>2 fold). Slow freezing method killed more morulae than vitrification but those which survived up to blastocyst stage did not express >2 fold change in their gene expression as compared with blastocysts from control morulae.	[Gupta, Alisha; Anzar, Muhammad] Saskatoon Res & Dev Ctr, Agr & Agrifood, Saskatoon, SK, Canada; [Gupta, Alisha; Singh, Jaswant; Dias, Fernanda Caminha Faustino; Anzar, Muhammad] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Biomed Sci, Saskatoon, SK, Canada; [Dufort, Isabelle; Robert, Claude] Local 2742 Univ Laval, Fac Sci Agr Alimentat Pavillon INAF, Ctr Rech Biol Reprod, Quebec City, PQ, Canada	University of Saskatchewan; Laval University	Anzar, M (corresponding author), Saskatoon Res & Dev Ctr, Agr & Agrifood, Saskatoon, SK, Canada.; Anzar, M (corresponding author), Univ Saskatchewan, Western Coll Vet Med, Dept Vet Biomed Sci, Saskatoon, SK, Canada.	anzarm@agr.gc.ca		Robert, Claude/0000-0001-9690-8088; Singh, Jaswant/0000-0002-6439-7831; Dias, Fernanda/0000-0001-7944-8518; Anzar, Muhammad/0000-0001-8379-8852	Natural Sciences and Engineering Research Council of Canada (NSERC); Agriculture and Agri-food Canada	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Agriculture and Agri-food Canada(Agriculture & Agri Food Canada)	This study was funded by Natural Sciences and Engineering Research Council of Canada (NSERC), and Agriculture and Agri-food Canada to MA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This study was funded by Natural Sciences and Engineering Research Council of Canada (NSERC), and Agriculture and Agri-food Canada. Authors are thankful to Dr. Kosala Rajapaksha for his technical help in this study	Abe H, 2002, MOL REPROD DEV, V61, P57, DOI 10.1002/mrd.1131; Abumrad N A, 2000, Curr Opin Clin Nutr Metab Care, V3, P255, DOI 10.1097/00075197-200007000-00003; Aksu DA, 2012, MOL REPROD DEV, V79, P613, DOI 10.1002/mrd.22068; Antunes G, 2010, REPROD DOMEST ANIM, V45, P26, DOI 10.1111/j.1439-0531.2008.01131.x; Anzar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114801; Boisvert WA, 1999, ARTERIOSCL THROM VAS, V19, P525, DOI 10.1161/01.ATV.19.3.525; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bondioli K, 2015, BOVINE REPRODUCTION, P718; BRACKETT BG, 1975, BIOL REPROD, V12, P260, DOI 10.1095/biolreprod12.2.260; Breuiller-Fouche M, 2010, BIOL REPROD, V83, P155, DOI 10.1095/biolreprod.109.080390; Cagnone GLM, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094391; Carter F, 2010, BIOL REPROD, V83, P707, DOI 10.1095/biolreprod.109.082354; Carvalho RV, 1996, THERIOGENOLOGY, V45, P489, DOI 10.1016/0093-691X(95)00385-L; CHARPIGNY G, 1988, FEBS LETT, V228, P12, DOI 10.1016/0014-5793(88)80574-X; DELOOS F, 1989, GAMETE RES, V24, P197, DOI 10.1002/mrd.1120240207; Dhali A, 2007, THERIOGENOLOGY, V68, P1292, DOI 10.1016/j.theriogenology.2007.08.030; Dias FCF, 2013, REPRODUCTION, V146, P181, DOI 10.1530/REP-13-0114; Eberhardt DM, 1999, BIOL REPROD, V60, P1483, DOI 10.1095/biolreprod60.6.1483; El-Sayed A, 2006, PHYSIOL GENOMICS, V28, P84, DOI 10.1152/physiolgenomics.00111.2006; FAHY GM, 1984, CRYOBIOLOGY, V21, P407, DOI 10.1016/0011-2240(84)90079-8; Gendelman M, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.092882; Gilbert I, 2012, REPRODUCTION, V143, P735, DOI 10.1530/REP-11-0460; Godkin JD, 1997, AM J REPROD IMMUNOL, V37, P137; Gupta A, 2016, ANIM REPROD SCI, V164, P162, DOI 10.1016/j.anireprosci.2015.11.026; Kuwayama M, 2007, THERIOGENOLOGY, V67, P73, DOI 10.1016/j.theriogenology.2006.09.014; Leach L, 2000, PLACENTA, V21, P547, DOI 10.1053/plac.2000.0541; Leao B.C.S., 2014, ZYGOTE, DOI [10.1017/S0967199414000380, DOI 10.1017/S0967199414000380]; Leese HJ, 2002, BIOESSAYS, V24, P845, DOI 10.1002/bies.10137; LEHNJENSEN H, 1983, THERIOGENOLOGY, V19, P263, DOI 10.1016/0093-691X(83)90013-4; Leibo SP, 2008, THERIOGENOLOGY, V69, P37, DOI 10.1016/j.theriogenology.2007.10.006; Leibo SP, 2011, FERTIL STERIL, V96, P269, DOI 10.1016/j.fertnstert.2011.06.065; Leibo S. P., 1981, New technologies in animal breeding, P127; LEIBO SP, 1978, CRYOBIOLOGY, V15, P257, DOI 10.1016/0011-2240(78)90036-6; Li LF, 2012, MOL REPROD DEV, V79, P229, DOI 10.1002/mrd.22018; Maddox-Hyttel P, 2003, REPRODUCTION, V125, P607, DOI 10.1530/rep.0.1250607; Martino NA, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-27; MAZUR P, 1970, SCIENCE, V168, P939, DOI 10.1126/science.168.3934.939; Mohan M, 2001, MOL REPROD DEV, V60, P289, DOI 10.1002/mrd.1090; Morato R, 2010, REPROD FERT DEVELOP, V22, P1141, DOI 10.1071/RD10013; Mucci N, 2006, THERIOGENOLOGY, V65, P1551, DOI 10.1016/j.theriogenology.2005.08.020; Nedambale TL, 2004, THERIOGENOLOGY, V62, P437, DOI 10.1016/j.theriogenology.2003.10.020; Nedambale TL, 2004, BIOL REPROD, V71, P1671, DOI 10.1095/biolreprod.104.027987; PARRISH JJ, 1995, THERIOGENOLOGY, V44, P859, DOI 10.1016/0093-691X(95)00271-9; POLLARD JW, 1994, THERIOGENOLOGY, V41, P101, DOI 10.1016/S0093-691X(05)80054-8; Prentice JR, 2011, THERIOGENOLOGY, V75, P602, DOI 10.1016/j.theriogenology.2010.09.027; Proskuryakov SY, 2003, EXP CELL RES, V283, P1, DOI 10.1016/S0014-4827(02)00027-7; RALL WF, 1985, NATURE, V313, P573, DOI 10.1038/313573a0; Rekik W, 2011, MOL REPROD DEV, V78, P226, DOI 10.1002/mrd.21286; Rigotti A, 1999, NEW ENGL J MED, V341, P2011, DOI 10.1056/NEJM199912233412612; Robert C, 2011, MOL REPROD DEV, V78, P651, DOI 10.1002/mrd.21364; ROSENKRANS CF, 1993, BIOL REPROD, V49, P459, DOI 10.1095/biolreprod49.3.459; Saenz-de-Juano MD, 2014, REPROD DOMEST ANIM, V49, P505, DOI 10.1111/rda.12320; Sanchez-Gomez FJ, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00237; Sharkey A, 1998, REV REPROD, V3, P52, DOI 10.1530/revreprod/3.1.52; Shemesh M, 1992, J Physiol Pharmacol, V43, P153; Stinshoff H, 2011, THERIOGENOLOGY, V76, P1433, DOI 10.1016/j.theriogenology.2011.06.013; Sudano MJ, 2011, THERIOGENOLOGY, V75, P1211, DOI 10.1016/j.theriogenology.2010.11.033; Turksen K, 2001, DEV DYNAM, V222, P292, DOI 10.1002/dvdy.1174; Vaiman D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065498; Vajta G, 2006, THERIOGENOLOGY, V65, P236, DOI 10.1016/j.theriogenology.2005.09.026; Vajta G, 2006, REPROD BIOMED ONLINE, V12, P779, DOI 10.1016/S1472-6483(10)61091-7; vanWagtendonkdeLeeuw AM, 1997, THERIOGENOLOGY, V48, P1071, DOI 10.1016/S0093-691X(97)00340-3; Vicente JS, 2013, CRYOBIOLOGY, V67, P321, DOI 10.1016/j.cryobiol.2013.09.165; Vigneault C, 2004, BIOL REPROD, V70, P1701, DOI 10.1095/biolreprod.103.022970; Watson AJ, 2001, FRONT BIOSCI-LANDMRK, V6, pD708, DOI 10.2741/Watson; WILMUT I, 1972, J REPROD FERTIL, V31, P513; Yao JB, 2004, PHYSIOL GENOMICS, V19, P84, DOI 10.1152/physiolgenomics.00123.2004; Zander-Fox D, 2013, J ASSIST REPROD GEN, V30, P1091, DOI 10.1007/s10815-013-0056-4	68	20	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187268	10.1371/journal.pone.0187268	http://dx.doi.org/10.1371/journal.pone.0187268			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095916	Green Published, Green Submitted, gold			2022-12-26	WOS:000414340200065
J	Rothschild, BM; Naples, V				Rothschild, Bruce M.; Naples, Virginia			Apparent sixth sense in theropod evolution: The making of a Cretaceous weathervane	PLOS ONE			English	Article							DINOSAURIA; BRAIN; MAGNETORECEPTION; MORPHOLOGY; PHYLOGENY; OSTEOLOGY; REPTILIA; ORGANS	Objective Two separate and distinctive skills are necessary to find prey: Detection of its presence and determination of its location. Surface microscopy of the dentary of albertosaurines revealed a previously undescribed sensory modification, as will be described here. While dentary "foramina" were previously thought to contain tactile sensory organs, the potential function of this theropod modification as a unique localizing system is explored in this study. Method Dentary surface perforations were examined by surface epi-illumination microscopy in tyr-annosaurine and albertosaurine dinosaurs to characterize their anatomy. Fish lateral lines were examined as potentially comparable structures. Result In contrast to the subsurface vascular bifurcation noted in tyrannosaurines (which lack a lateral dentary surface groove), the area subjacent to the apertures in albertosaurine grooves has the appearance of an expanded chamber. That appearance seemed to be indistinguishable from the lateral line of fish. Conclusion Dentary groove apertures in certain tyrannosaurid lines (specifically albertosaurines) not only have a unique appearance, but one with significant functional and behavior implications. The appearance of the perforations in the dentary groove of albertosaurines mirrors that previously noted only with specialized neurologic structures accommodating derived sensory functions, as seen in the lateral line of fish. The possibility that this specialized morphology could also represent a unique function in albertosaurine theropods for interacting with the environment or facilitating prey acquisition cannot be ignored. It is suggested that these expanded chambers function in perceiving and aligning the body relative to the direction of wind, perhaps a Cretaceous analogue of the contemporary midwestern weathervane.	[Rothschild, Bruce M.] West Virginia Univ, Coll Med, Dept Med, Morgantown, WV 26506 USA; [Rothschild, Bruce M.] Carnegie Museum, Pittsburgh, PA 15213 USA; [Naples, Virginia] NE Illinois Univ, De Kalb, IL USA	West Virginia University	Rothschild, BM (corresponding author), West Virginia Univ, Coll Med, Dept Med, Morgantown, WV 26506 USA.; Rothschild, BM (corresponding author), Carnegie Museum, Pittsburgh, PA 15213 USA.	spondylair@gmail.com		Rothschild, Bruce/0000-0003-1327-6615				Allain R, 2002, J VERTEBR PALEONTOL, V22, P548, DOI 10.1671/0272-4634(2002)022[0548:DOMDTI]2.0.CO;2; Benson RBJ, 2010, J SYST PALAEONTOL, V8, P131, DOI 10.1080/14772011003603515; Brady J, 1995, PHYSIOL ENTOMOL, V20, P293, DOI 10.1111/j.1365-3032.1995.tb00818.x; Brusatte SL, 2016, P NATL ACAD SCI USA, V113, P3447, DOI 10.1073/pnas.1600140113; Brusatte SL, 2012, ACTA PALAEONTOL POL, V57, P65, DOI 10.4202/app.2010.0125; BUDELMANN BU, 1988, J COMP PHYSIOL A, V164, P1, DOI 10.1007/BF00612711; Buschuter D, 2008, NEUROIMAGE, V42, P498, DOI 10.1016/j.neuroimage.2008.05.004; Caprio J, 2014, SCIENCE, V344, P1154, DOI 10.1126/science.1252697; Carr TD, 2017, SCI REP-UK, V7, DOI 10.1038/srep44942; Carrano MT, 2002, J VERTEBR PALEONTOL, V22, P510, DOI 10.1671/0272-4634(2002)022[0510:TOOMKA]2.0.CO;2; Catania KC, 2010, J EXP BIOL, V213, P359, DOI 10.1242/jeb.039685; Conover MR, 2007, PREDATION PREY DYNAM; Crowe-Riddell JM, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160054; Dehnhardt G, 2001, SCIENCE, V293, P102, DOI 10.1126/science.1060514; DEMAINE C, 1985, NEUROSCI LETT, V62, P119, DOI 10.1016/0304-3940(85)90294-0; Di-Poi N, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-19; Eder SHK, 2012, P NATL ACAD SCI USA, V109, P12022, DOI 10.1073/pnas.1205653109; Endres CS, 2009, J EXP BIOL, V212, P3823, DOI 10.1242/jeb.033068; EVANS WG, 1964, NATURE, V202, P211, DOI 10.1038/202211a0; Farlow JO, 2002, HIST BIOL, V16, P21, DOI DOI 10.1080/0891296031000154687; Foffa D, 2014, NATURWISSENSCHAFTEN, V101, P453, DOI 10.1007/s00114-014-1173-3; Ford T.L, 2015, 75 ANN M SOC VERT PA, P125; Gardiner JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093036; Ghysen A, 2004, CURR OPIN NEUROBIOL, V14, P67, DOI 10.1016/j.conb.2004.01.012; Godfrey-Smith D, EFFECTIVE USE DOGS S; GOPALAKRISHNAKONE P, 1984, Snake, V16, P33; GREEN SR, 1995, AGR FOREST METEOROL, V74, P205, DOI 10.1016/0168-1923(94)02191-L; Hanzlik M, 2000, BIOMETALS, V13, P325, DOI 10.1023/A:1009214526685; Hart V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051100; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P111; Josberger EE, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600112; Kane A, 2016, AM NATURALIST; Kear BP, 2005, ZOOL J LINN SOC-LOND, V145, P583, DOI 10.1111/j.1096-3642.2005.00199.x; Leitch DB, 2012, J EXP BIOL, V215, P4217, DOI 10.1242/jeb.076836; Liems KF, 2001, FUNCTIONAL ANATOMY V; Mehlhorn J, 2009, NATURWISSENSCHAFTEN, V96, P1011, DOI 10.1007/s00114-009-0560-7; Molenaar G.J., 1992, P367; Mora CV, 2004, NATURE, V432, P508, DOI 10.1038/nature03077; MURLIS J, 1992, ANNU REV ENTOMOL, V37, P505, DOI 10.1146/annurev.en.37.010192.002445; NAKAMURA K, 1976, APPL ENTOMOL ZOOL, V11, P312; Pack CC, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002271; Pan J, 2016, HYPOXIA, V4, P69, DOI 10.2147/HP.S103957; Peach MB, 2000, J MAR BIOL ASSOC UK, V80, P155, DOI 10.1017/S0025315499001678; Pennisi E, 2015, SCIENCE, V350, P146, DOI 10.1126/science.350.6257.146; Rehkamper G, 2008, BRAIN BEHAV EVOLUT, V71, P115, DOI 10.1159/000111458; REHKAMPER G, 1988, BRAIN BEHAV EVOLUT, V31, P141, DOI 10.1159/000116581; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Rothschild BM, 2013, ANAT REC, V296, P580, DOI 10.1002/ar.22673; Schmerge JD, 2016, CRETACEOUS RES, V65, P238, DOI 10.1016/j.cretres.2016.04.015; Schmerge JD, 2016, CRETACEOUS RES, V61, P26, DOI 10.1016/j.cretres.2015.12.016; Schumacher BA, 2013, J VERTEBR PALEONTOL, V33, P613, DOI 10.1080/02724634.2013.722576; Shatz LF, 2008, J ACOUST SOC AM, V123, P2918, DOI 10.1121/1.2902181; Shatz LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054876; Soares D, 2002, NATURE, V417, P241, DOI 10.1038/417241a; Stokstad E, 2005, SCIENCE, V310, P966, DOI 10.1126/science.310.5750.966; Suli A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029727; von During M., 1974, Zeitschrift Anat Entwickl-gesch, V145, P299; Webb JF, 2016, 11 INT C VERT MORPH; Wieskotten S, 2011, J EXP BIOL, V214, P1922, DOI 10.1242/jeb.053926; Wiltschko W, 2005, J COMP PHYSIOL A, V191, P675, DOI 10.1007/s00359-005-0627-7; Witmer LM, 2009, ANAT REC, V292, P1266, DOI 10.1002/ar.20983; Witschko R, 1995, MAGNETIC ORIENTATION; Zelenitsky DK, 2009, P ROY SOC B-BIOL SCI, V276, P667, DOI 10.1098/rspb.2008.1075	63	1	1	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187064	10.1371/journal.pone.0187064	http://dx.doi.org/10.1371/journal.pone.0187064			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095949	Green Published, gold			2022-12-26	WOS:000414340200042
J	Stetz, G; Tse, A; Verkhivker, GM				Stetz, Gabrielle; Tse, Amanda; Verkhivker, Gennady M.			Ensemble-based modeling and rigidity decomposition of allosteric interaction networks and communication pathways in cyclin-dependent kinases: Differentiating kinase clients of the Hsp90-Cdc37 chaperone	PLOS ONE			English	Article							HSP90 MOLECULAR CHAPERONE; STRUCTURAL BASIS; PROTEIN-KINASES; COMMUNITY STRUCTURE; WEB SERVER; CONFORMATIONAL DYNAMICS; REGULATORY MECHANISMS; CRYSTAL-STRUCTURE; CDK9/CYCLIN T1; CELL-CYCLE	The overarching goal of delineating molecular principles underlying differentiation of protein kinase clients and chaperone-based modulation of kinase activity is fundamental to understanding activity of many oncogenic kinases that require chaperoning of Hsp70 and Hsp90 systems to attain a functionally competent active form. Despite structural similarities and common activation mechanisms shared by cyclin-dependent kinase (CDK) proteins, members of this family can exhibit vastly different chaperone preferences. The molecular determinants underlying chaperone dependencies of protein kinases are not fully understood as structurally similar kinases may often elicit distinct regulatory responses to the chaperone. The regulatory divergences observed for members of CDK family are of particular interest as functional diversification among these kinases may be related to variations in chaperone dependencies and can be exploited in drug discovery of personalized therapeutic agents. In this work, we report the results of a computational investigation of several members of CDK family (CDK5, CDK6, CDK9) that represented a broad repertoire of chaperone dependencies-from nonclient CDK5, to weak client CDK6, and strong client CDK9. By using molecular simulations of multiple crystal structures we characterized conformational ensembles and collective dynamics of CDK proteins. We found that the elevated dynamics of CDK9 can trigger imbalances in cooperative collective motions and reduce stability of the active fold, thus creating a cascade of favorable conditions for chaperone intervention. The ensemble-based modeling of residue interaction networks and community analysis determined how differences in modularity of allosteric networks and topography of communication pathways can be linked with the client status of CDK proteins. This analysis unveiled depleted modularity of the allosteric network in CDK9 that alters distribution of communication pathways and leads to impaired signaling in the client kinase. According to our results, these network features may uniquely define chaperone dependencies of CDK clients. The perturbation response scanning and rigidity decomposition approaches identified regulatory hotspots that mediate differences in stability and cooperativity of allosteric interaction networks in the CDK structures. By combining these synergistic approaches, our study revealed dynamic and network signatures that can differentiate kinase clients and rationalize subtle divergences in the activation mechanisms of CDK family members. The therapeutic implications of these results are illustrated by identifying structural hotspots of pathogenic mutations that preferentially target regions of the increased flexibility to enable modulation of activation changes. Our study offers a network-based perspective on dynamic kinase mechanisms and drug design by unravelling relationships between protein kinase dynamics, allosteric communications and chaperone dependencies.	[Stetz, Gabrielle; Tse, Amanda; Verkhivker, Gennady M.] Chapman Univ, Schmid Coll Sci & Technol, Dept Computat & Data Sci, Orange, CA 92866 USA; [Verkhivker, Gennady M.] Chapman Univ, Sch Pharm, Dept Biomed & Pharmaceut Sci, Irvine, CA 92618 USA	Chapman University System; Chapman University; Chapman University System; Chapman University	Verkhivker, GM (corresponding author), Chapman Univ, Schmid Coll Sci & Technol, Dept Computat & Data Sci, Orange, CA 92866 USA.; Verkhivker, GM (corresponding author), Chapman Univ, Sch Pharm, Dept Biomed & Pharmaceut Sci, Irvine, CA 92618 USA.	verkhivk@chapman.edu	Verkhivker, Gennady/V-9404-2018	Verkhivker, Gennady/0000-0002-4507-4471				Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Aguilar D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041430; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Arif A, 2012, BIOCHEM PHARMACOL, V84, P985, DOI 10.1016/j.bcp.2012.06.027; Asamitsu K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171727; Asamitsu K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119451; Atilgan AR, 2004, BIOPHYS J, V86, P85, DOI 10.1016/S0006-3495(04)74086-2; Atilgan C, 2010, BIOPHYS J, V99, P933, DOI 10.1016/j.bpj.2010.05.020; Atilgan C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000544; Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Bahar I, 2010, ANNU REV BIOPHYS, V39, P23, DOI 10.1146/annurev.biophys.093008.131258; Bartova I, 2005, PROTEIN SCI, V14, P445, DOI 10.1110/ps.04959705; Bartova I, 2004, PROTEIN SCI, V13, P1449, DOI 10.1110/ps.03578504; Bartova I, 2008, PROTEIN SCI, V17, P22, DOI 10.1110/ps.072951208; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Baumli S, 2008, EMBO J, V27, P1907, DOI 10.1038/emboj.2008.121; Baumli S, 2012, STRUCTURE, V20, P1788, DOI 10.1016/j.str.2012.08.011; Besker N, 2014, J BIOMOL STRUCT DYN, V32, P1929, DOI 10.1080/07391102.2013.844080; Bhattacharya D, 2016, NUCLEIC ACIDS RES, V44, pW406, DOI 10.1093/nar/gkw336; Bhattacharya D, 2013, PROTEINS, V81, P119, DOI 10.1002/prot.24167; Boczek EE, 2015, P NATL ACAD SCI USA, V112, pE3189, DOI 10.1073/pnas.1424342112; Bres V, 2008, CURR OPIN CELL BIOL, V20, P334, DOI 10.1016/j.ceb.2008.04.008; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; Brown NR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7769; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Brown NR, 1999, J BIOL CHEM, V274, P8746, DOI 10.1074/jbc.274.13.8746; Bukhtiyarova M, 2007, BIOCHEMISTRY-US, V46, P5687, DOI 10.1021/bi0622221; Camps J, 2009, BIOINFORMATICS, V25, P1709, DOI 10.1093/bioinformatics/btp304; Cao RF, 2017, NUCLEIC ACIDS RES, V45, pD827, DOI 10.1093/nar/gkw1096; Changeux JP, 2012, ANNU REV BIOPHYS, V41, P103, DOI 10.1146/annurev-biophys-050511-102222; Cheung ZH, 2012, TRENDS CELL BIOL, V22, P169, DOI 10.1016/j.tcb.2011.11.003; Christensen NJ, 2013, J CHEM THEORY COMPUT, V9, P3210, DOI 10.1021/ct4002152; Chubynsky MV, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.041135; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; D'Abramo M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00128; Dahiyat BI, 1997, PROTEIN SCI, V6, P1333, DOI 10.1002/pro.5560060622; Day PJ, 2009, P NATL ACAD SCI USA, V106, P4166, DOI 10.1073/pnas.0809645106; De Falco G, 2002, ONCOGENE, V21, P7464, DOI 10.1038/sj.onc.1205967; De Vivo M, 2006, PROTEINS, V62, P89, DOI 10.1002/prot.20697; del Sol A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100063; Di Giovanni C, 2016, EXPERT OPIN INV DRUG, V25, P1215, DOI 10.1080/13543784.2016.1234603; Dutta A, 2015, STRUCTURE, V23, P1692, DOI 10.1016/j.str.2015.07.002; Echalier A, 2014, ACS CHEM BIOL, V9, P1251, DOI 10.1021/cb500135f; Echalier A, 2010, BBA-PROTEINS PROTEOM, V1804, P511, DOI 10.1016/j.bbapap.2009.10.002; Eckl JM, 2015, J BIOL CHEM, V290, P30843, DOI 10.1074/jbc.M115.693150; Emperador A, 2008, BIOPHYS J, V95, P2127, DOI 10.1529/biophysj.107.119115; Emperador A, 2017, J CHEM THEORY COMPUT, V13, P1454, DOI 10.1021/acs.jctc.6b01153; Endicott JA, 2013, BIOCHEM SOC T, V41, P1008, DOI 10.1042/BST20130097; Endicott JA, 2012, ANNU REV BIOCHEM, V81, P587, DOI 10.1146/annurev-biochem-052410-090317; Eyal E, 2015, BIOINFORMATICS, V31, P1487, DOI 10.1093/bioinformatics/btu847; Felts S.J., 2007, SCI STKE, V2007, pe22, DOI [DOI 10.1126/STKE.3852007PE22, DOI 10.1126/stke.3852007pe22]; Ferguson KM, 2008, ANNU REV BIOPHYS, V37, P353, DOI 10.1146/annurev.biophys.37.032807.125829; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD364, DOI 10.1093/nar/gkt1210; Floquet N, 2015, BIOPHYS J, V109, P1179, DOI 10.1016/j.bpj.2015.07.003; FLOYD RW, 1962, COMMUN ACM, V5, P345, DOI 10.1145/367766.368168; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Foster SA, 2016, CANCER CELL, V29, P477, DOI 10.1016/j.ccell.2016.02.010; Gajiwala KS, 2013, STRUCTURE, V21, P209, DOI 10.1016/j.str.2012.11.014; Garriga J, 2003, MOL CELL BIOL, V23, P5165, DOI 10.1128/MCB.23.15.5165-5173.2003; General IJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003624; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gu JY, 2014, CELL CYCLE, V13, DOI 10.4161/cc.28756; Han YM, 2014, BIOMED REP, V2, P775, DOI 10.3892/br.2014.322; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Hespenheide BM, 2002, J MOL GRAPH MODEL, V21, P195, DOI 10.1016/S1093-3263(02)00146-8; Hilser VJ, 2012, ANNU REV BIOPHYS, V41, P585, DOI 10.1146/annurev-biophys-050511-102319; Hu J, 2015, MOL CELL BIOL, V35, P264, DOI 10.1128/MCB.00943-14; Hydbring P, 2016, NAT REV MOL CELL BIO, V17, P280, DOI 10.1038/nrm.2016.27; Jackson SE, 2013, TOP CURR CHEM, V328, P155, DOI 10.1007/128_2012_356; Jacobs DJ, 2001, PROTEINS, V44, P150, DOI 10.1002/prot.1081; Jacobs DJ, 1997, J COMPUT PHYS, V137, P346, DOI 10.1006/jcph.1997.5809; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Jura N, 2011, MOL CELL, V42, P9, DOI 10.1016/j.molcel.2011.03.004; Kannan N, 2005, J MOL BIOL, V351, P956, DOI 10.1016/j.jmb.2005.06.057; Keramisanou D, 2016, MOL CELL, V62, P260, DOI 10.1016/j.molcel.2016.04.005; Kiel C, 2016, ELIFE, V5, DOI 10.7554/eLife.12814; Kiernan RE, 2001, MOL CELL BIOL, V21, P7956, DOI 10.1128/MCB.21.23.7956-7970.2001; Kim J, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600663; Kobayashi H, 2014, J BIOL CHEM, V289, P19627, DOI 10.1074/jbc.M113.501148; Kornev AP, 2008, P NATL ACAD SCI USA, V105, P14377, DOI 10.1073/pnas.0807988105; Kornev AP, 2015, TRENDS BIOCHEM SCI, V40, P628, DOI 10.1016/j.tibs.2015.09.002; Kruger DM, 2013, NUCLEIC ACIDS RES, V41, pW340, DOI 10.1093/nar/gkt292; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; Lange OF, 2006, PROTEINS, V62, P1053, DOI 10.1002/prot.20784; Lange OF, 2006, J PHYS CHEM B, V110, P22842, DOI 10.1021/jp062548j; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Li HC, 2016, NUCLEIC ACIDS RES, V44, pD415, DOI 10.1093/nar/gkv1236; Li Jing, 2013, Biomed J, V36, P106, DOI 10.4103/2319-4170.113230; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Lolli G, 2010, CELL CYCLE, V9, P1551, DOI 10.4161/cc.9.8.11195; Lombardi LE, 2016, BIOINFORMATICS, V32, P1235, DOI 10.1093/bioinformatics/btv740; Luo Q, 2017, SCI REP-UK, V7, DOI 10.1038/srep43996; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Maragakis P, 2005, J MOL BIOL, V352, P807, DOI 10.1016/j.jmb.2005.07.031; Buslje CM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000978; McClendon CL, 2014, P NATL ACAD SCI USA, V111, pE4623, DOI 10.1073/pnas.1418402111; Meharena HS, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001680; Meireles L, 2011, PROTEIN SCI, V20, P1645, DOI 10.1002/pro.711; Mohanty S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005885; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; O'Keeffe B, 2000, J BIOL CHEM, V275, P279, DOI 10.1074/jbc.275.1.279; O'Leary B, 2016, NAT REV CLIN ONCOL, V13, P417, DOI 10.1038/nrclinonc.2016.26; Oruganty K, 2013, P NATL ACAD SCI USA, V110, P924, DOI 10.1073/pnas.1207104110; Oruganty K, 2012, PHILOS T R SOC B, V367, P2529, DOI 10.1098/rstb.2012.0015; Paladino A, 2015, J CHEM INF MODEL, V55, P1377, DOI 10.1021/acs.jcim.5b00270; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Palmieri L, 2013, DRUG DISCOV TODAY, V18, P407, DOI 10.1016/j.drudis.2012.11.009; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pearl LH, 2016, BIOPOLYMERS, V105, P594, DOI 10.1002/bip.22835; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Penkler D, 2017, J CHEM INF MODEL, V57, P1359, DOI 10.1021/acs.jcim.6b00775; Pfleger C, 2013, J CHEM INF MODEL, V53, P1007, DOI 10.1021/ci400044m; Pisani P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154066; Poon RYC, 1997, J BIOL CHEM, V272, P5703, DOI 10.1074/jbc.272.9.5703; Prince T, 2004, J BIOL CHEM, V279, P39975, DOI 10.1074/jbc.M406882200; Prodromou C, 2016, BIOCHEM J, V473, P2439, DOI 10.1042/BCJ20160005; Prodromou C, 2012, BBA-MOL CELL RES, V1823, P614, DOI 10.1016/j.bbamcr.2011.07.020; Rader AJ, 2002, P NATL ACAD SCI USA, V99, P3540, DOI 10.1073/pnas.062492699; Radestock S, 2011, PROTEINS, V79, P1089, DOI 10.1002/prot.22946; Rathi PC, 2012, J BIOTECHNOL, V159, P135, DOI 10.1016/j.jbiotec.2012.01.027; Rathi PC, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004754; Rivalta I, 2012, P NATL ACAD SCI USA, V109, pE1428, DOI 10.1073/pnas.1120536109; Rohl A, 2013, TRENDS BIOCHEM SCI, V38, P253, DOI 10.1016/j.tibs.2013.02.003; Roskoski R, 2016, PHARMACOL RES, V107, P249, DOI 10.1016/j.phrs.2016.03.012; Roskoski R, 2016, PHARMACOL RES, V103, P26, DOI 10.1016/j.phrs.2015.10.021; Roskoski R, 2015, PHARMACOL RES, V100, P1, DOI 10.1016/j.phrs.2015.07.010; Rotkiewicz P, 2008, J COMPUT CHEM, V29, P1460, DOI 10.1002/jcc.20906; Russo AA, 1996, NAT STRUCT BIOL, V3, P696, DOI 10.1038/nsb0896-696; Schulze-Gahmen U, 2002, NAT STRUCT BIOL, V9, P177, DOI 10.1038/nsb756; Schulze-Gahmen U, 2013, ELIFE, V2, DOI 10.7554/eLife.00327; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Sethi A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003046; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Shao H, 2013, J MED CHEM, V56, P640, DOI 10.1021/jm301475f; Sharma P, 1999, P NATL ACAD SCI USA, V96, P11156, DOI 10.1073/pnas.96.20.11156; Shirvanyants D, 2012, J PHYS CHEM B, V116, P8375, DOI 10.1021/jp2114576; Simonetti FL, 2013, NUCLEIC ACIDS RES, V41, pW8, DOI 10.1093/nar/gkt427; Sogabe S, 2013, ACS MED CHEM LETT, V4, P201, DOI 10.1021/ml300327z; Srivastava AK, 2014, STRUCTURE, V22, P1735, DOI 10.1016/j.str.2014.09.010; Stetz G, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005299; Stetz G, 2016, J CHEM INF MODEL, V56, P1490, DOI 10.1021/acs.jcim.5b00755; Stetz G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143752; Strong TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028100; Tahirov TH, 2010, NATURE, V465, P747, DOI 10.1038/nature09131; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Takaki T, 2009, P NATL ACAD SCI USA, V106, P4171, DOI 10.1073/pnas.0809674106; Tarricone C, 2001, MOL CELL, V8, P657, DOI 10.1016/S1097-2765(01)00343-4; Taylor SS, 2012, PHILOS T R SOC B, V367, P2517, DOI 10.1098/rstb.2012.0054; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Teppa E, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-235; Tobi D, 2005, P NATL ACAD SCI USA, V102, P18908, DOI 10.1073/pnas.0507603102; Tsai CJ, 2009, MOL BIOSYST, V5, P207, DOI 10.1039/b819720b; Tse A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130203; Van Durme J, 2011, BIOINFORMATICS, V27, P1711, DOI 10.1093/bioinformatics/btr254; VanWart AT, 2012, J CHEM THEORY COMPUT, V8, P2949, DOI 10.1021/ct300377a; Verba KA, 2016, SCIENCE, V352, P1542, DOI 10.1126/science.aaf5023; Verma S, 2016, BIOCHIMIE, V127, P227, DOI 10.1016/j.biochi.2016.05.018; Vijayabaskar MS, 2010, BIOPHYS J, V99, P3704, DOI 10.1016/j.bpj.2010.08.079; Wu P, 2015, PHARMACOL THERAPEUT, V156, P59, DOI 10.1016/j.pharmthera.2015.10.002; Wu P, 2015, TRENDS PHARMACOL SCI, V36, P422, DOI 10.1016/j.tips.2015.04.005; Wu ZX, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.016675; Yang L, 2008, STRUCTURE, V16, P321, DOI 10.1016/j.str.2007.12.011; Yang LW, 2005, STRUCTURE, V13, P893, DOI 10.1016/j.str.2005.03.015; Yao XQ, 2016, J BIOL CHEM, V291, P4742, DOI 10.1074/jbc.M115.702605; Zhang L, 2015, SCI REP-UK, V5, DOI 10.1038/srep10115	172	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186089	10.1371/journal.pone.0186089	http://dx.doi.org/10.1371/journal.pone.0186089			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095844	Green Published, Green Submitted, gold			2022-12-26	WOS:000414340200012
J	Vieira, T; Botter, A; Gastaldi, L; Sacco, ICN; Martelli, F; Giacomozzi, C				Vieira, Taian; Botter, Alberto; Gastaldi, Laura; Sacco, Isabel C. N.; Martelli, Francesco; Giacomozzi, Claudia			Textured insoles affect the plantar pressure distribution while elite rowers perform on an indoor rowing machine	PLOS ONE			English	Article							FORCE PRODUCTION; JUNIOR ROWERS; BIOMECHANICS; ADULTS; GAIT; ASYMMETRY; SYMMETRY; FEEDBACK; SYSTEM	Introduction During rowing, foot positioning on the foot stretcher is critical to optimise muscle force transmission and boat propulsion. Following the beneficial effects of textured insoles on gait and balance, this study aims at investigating whether passive stimulation of foot mechanoreceptors induced by these insoles may contribute to improving foot loading pattern and symmetry during indoor rowing. Methods Eleven elite rowers were assessed during controlled training on a standard rowing machine while wearing control, low-density or high-density textured insoles. Plantar pressure and knee and trunk kinematics were measured; performance data were recorded from the machine. Insole effect on kinematic parameters, peak and average values of foot force, contact area and position of centre of pressure was assessed with ANOVA and Bonferroni correction for pair-wise comparisons. Results A main effect was observed for force and contact area, with the high-density insoles providing greatest values (P<0.035). No interaction was observed between side and insole (P>0.190), even though symmetry was higher with high-density insoles. Kinematics (P = 0.800) and rowing performance were not affected by insole type; a consistent though not statistically significant increase in mean travelled distance was observed for denser insoles (P>0.21). Conclusion The high-density textured insoles affected foot loading distribution during indoor rowing. Rowers applied greater foot force and over a greater foot stretcher area with the high-density than the low-density and control insoles. These findings and the methodology applied may be relevant for the understanding and monitoring of rowing performance.	[Vieira, Taian; Botter, Alberto] Politecn Torino, Dept Elect & Telecommun, Lab Engn Neuromuscular Syst & Motor Rehabil, Turin, Italy; [Gastaldi, Laura] Politecn Torino, Dept Mech & Aerosp Engn, Turin, Italy; [Sacco, Isabel C. N.] Univ Sao Paulo, Sch Med, Lab Biomech Human Movement & Posture, Dept Phys Therapy,Speech,Occupat Therapy, Sao Paulo, Brazil; [Martelli, Francesco; Giacomozzi, Claudia] Italian Natl Inst Hlth, Dept Cardiovasc Dysmetabol & Aging Associated Dis, Rome, Italy	Polytechnic University of Turin; Polytechnic University of Turin; Universidade de Sao Paulo; Istituto Superiore di Sanita (ISS)	Giacomozzi, C (corresponding author), Italian Natl Inst Hlth, Dept Cardiovasc Dysmetabol & Aging Associated Dis, Rome, Italy.	c_giacomozzi@yahoo.com	Sacco, Isabel/T-2630-2019; Vieira, Taian M/A-3818-2013; Botter, Alberto/I-3466-2016; Sacco, Isabel/D-7172-2011; Giacomozzi, Claudia/AAH-1640-2021; Martelli, Francesco/D-8864-2012	Sacco, Isabel/0000-0003-1254-0007; Vieira, Taian M/0000-0002-6239-7301; Botter, Alberto/0000-0002-4797-0667; Sacco, Isabel/0000-0003-1254-0007; Giacomozzi, Claudia/0000-0001-6950-4934; Martelli, Francesco/0000-0002-6963-8331				Aruin AS, 2013, EXP BRAIN RES, V231, P201, DOI 10.1007/s00221-013-3685-z; Barrow JD, 2010, AM J PHYS, V78, P728, DOI 10.1119/1.3318808; Baudouin A, 2002, BRIT J SPORT MED, V36, P396, DOI 10.1136/bjsm.36.6.396; Bourgois J, 2000, BRIT J SPORT MED, V34, P213, DOI 10.1136/bjsm.34.3.213; Buckeridge EM, 2015, SCAND J MED SCI SPOR, V25, pe176, DOI 10.1111/sms.12264; Buckeridge EM, 2014, SPORT BIOMECH, V13, P47, DOI 10.1080/14763141.2013.861013; Busch AC, 2009, COMPUT METH PROG BIO, V94, P15, DOI 10.1016/j.cmpb.2008.08.008; Christiansen E, 1997, SCAND J MED SCI SPOR, V7, P49; Cuijpers LS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133527; Elliott B, 2001, SPORT BIOMECH, V1, P1; Evans G, 2016, BRIT J SPORT MED, V50, P266, DOI 10.1136/bjsports-2015-095126; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fohanno V, 2015, SPORT BIOMECH, V14, P310, DOI 10.1080/14763141.2015.1060252; Giacomozzi C, 2010, GAIT POSTURE, V32, P141, DOI 10.1016/j.gaitpost.2010.03.014; Godi M, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-95; Hase K, 2002, JSME INT J C-MECH SY, V45, P1073, DOI 10.1299/jsmec.45.1073; Hatton AL, 2012, J FOOT ANKLE RES, V5, DOI 10.1186/1757-1146-5-11; Hoch MC, 2012, MED SCI SPORT EXER, V44, P666, DOI 10.1249/MSS.0b013e3182390212; Hurkmans HLP, 2006, GAIT POSTURE, V23, P118, DOI 10.1016/j.gaitpost.2005.05.008; JOHANSSON RS, 1979, J PHYSIOL-LONDON, V286, P283, DOI 10.1113/jphysiol.1979.sp012619; Kalron A, 2015, PM&R, V7, P17, DOI 10.1016/j.pmrj.2014.08.942; Kennedy PM, 2002, J PHYSIOL-LONDON, V538, P995, DOI 10.1113/jphysiol.2001.013087; Lebel K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118361; Longman D, 2011, INT J SPORTS MED, V32, P606, DOI 10.1055/s-0031-1275301; Ma CC, 2016, GAIT POSTURE, V49, P190, DOI 10.1016/j.gaitpost.2016.07.010; Maurer M, 2011, AM J SPORT MED, V39, P392, DOI 10.1177/0363546510381365; McGregor AH, 2004, INT J SPORTS MED, V25, P465, DOI 10.1055/s-2004-820936; Qiu F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083309; Qu XD, 2015, APPL ERGON, V46, P38, DOI 10.1016/j.apergo.2014.06.005; Readi NG, 2015, J MED SCI SPORT, V25; Ritchie C, 2011, GAIT POSTURE, V33, P576, DOI 10.1016/j.gaitpost.2011.01.012; Schaffert N, 2015, J SPORT SCI, V33, P411, DOI 10.1080/02640414.2014.946438; Smith RM, 2002, J SPORT SCI, V20, P783, DOI 10.1080/026404102320675639; Smith TB, 2011, MED SCI SPORT EXER, V43, P2155, DOI 10.1249/MSS.0b013e31821d3f8e; Smoljanovic T, 2009, AM J SPORT MED, V37, P1193, DOI 10.1177/0363546508331205; Soper C, 2004, SPORTS MED, V34, P825, DOI 10.2165/00007256-200434120-00003; Stutchfield BM, 2006, EUR J SPORT SCI, V6, P255, DOI 10.1080/17461390601012678; Trapp R.G., 2004, BASIC CLIN BIOSTATIS, V4th; van Soest AJK, 2016, J SPORTS SCI, P1; Waddington G, 2003, BRIT J SPORT MED, V37, P170, DOI 10.1136/bjsm.37.2.170; Waddington G, 2000, TEXTURED INSOLE EFFE; WATANABE I, 1981, ANN NY ACAD SCI, V374, P855, DOI 10.1111/j.1749-6632.1981.tb30926.x	42	5	5	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187202	10.1371/journal.pone.0187202	http://dx.doi.org/10.1371/journal.pone.0187202			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095908	Green Published, gold, Green Submitted			2022-12-26	WOS:000414340200055
J	Garbus, I; Romero, JR; Selva, JP; Pasten, MC; Chinestra, C; Carballo, J; Zappacosta, DC; Echenique, V				Garbus, Ingrid; Rodolfo Romero, Jose; Pablo Selva, Juan; Cielo Pasten, Maria; Chinestra, Carolina; Carballo, Jose; Carlos Zappacosta, Diego; Echenique, Viviana			De novo transcriptome sequencing and assembly from apomictic and sexual Eragrostis curvula genotypes	PLOS ONE			English	Article							GENE-EXPRESSION; APOMIXIS; APOSPORY; MARKERS; DISCOVERY; NUCLEAR; RNA	A long-standing goal in plant breeding has been the ability to confer apomixis to agriculturally relevant species, which would require a deeper comprehension of the molecular basis of apomictic regulatory mechanisms. Eragrostis curvula (Schrad.) Nees is a perennial grass that includes both sexual and apomictic cytotypes. The availability of a reference transcriptome for this species would constitute a very important tool toward the identification of genes controlling key steps of the apomictic pathway. Here, we used Roche/454 sequencing technologies to generate reads from inflorescences of E. curvula apomictic and sexual genotypes that were de novo assembled into a reference transcriptome. Near 90% of the 49568 assembled isotigs showed sequence similarity to sequences deposited in the public databases. A gene ontology analysis categorized 27448 isotigs into at least one of the three main GO categories. We identified 11475 SSRs, and several of them were assayed in E curvula germoplasm using SSR-based primers, providing a valuable set of molecular markers that could allow direct allele selection. The differential contribution to each library of the spliced forms of several transcripts revealed the existence of several isotigs produced via alternative splicing of single genes. The reference transcriptome presented and validated in this work will be useful for the identification of a wide range of gene(s) related to agronomic traits of E. curvula, including those controlling key steps of the apomictic pathway in this species, allowing the extrapolation of the findings to other plant species.	[Garbus, Ingrid; Rodolfo Romero, Jose; Pablo Selva, Juan; Cielo Pasten, Maria; Chinestra, Carolina; Carballo, Jose; Carlos Zappacosta, Diego; Echenique, Viviana] Univ Nacl Sur, CONICET, Ctr Recursos Nat Renovables Zona Semiarida CERZOS, Bahia Blanca, Buenos Aires, Argentina; [Garbus, Ingrid] Univ Nacl Sur, Dept Ciencias Salud, Bahia Blanca, Buenos Aires, Argentina; [Pablo Selva, Juan] Univ Nacl Sur, Dept Biol Bioquim & Farm, Bahia Blanca, Buenos Aires, Argentina; [Carlos Zappacosta, Diego; Echenique, Viviana] Univ Nacl Sur, Dept Agron, Bahia Blanca, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South; National University of the South; National University of the South; National University of the South	Echenique, V (corresponding author), Univ Nacl Sur, CONICET, Ctr Recursos Nat Renovables Zona Semiarida CERZOS, Bahia Blanca, Buenos Aires, Argentina.; Echenique, V (corresponding author), Univ Nacl Sur, Dept Agron, Bahia Blanca, Buenos Aires, Argentina.	echeniq@criba.edu.ar	Echenique, Viviana/GRX-7389-2022	Echenique, Viviana/0000-0003-3755-9062; Garbus, Ingrid/0000-0001-9646-689X; Carballo, Jose/0000-0002-3592-6466	Agenda Nacional de Promocion Cientifica y Tecnologica [PICT 2013 2029]; European Union [645674]; Agencia Nacional de PromociOn Cientifica y Tecnologica (ANPCyT) [PICT 2013-2029, PICT Raices 2014-1243]; Universidad Nacional del Sur (PGI TIR) [CSU-142/14, PGI 24/A199]; CONICET [11220150100963]	Agenda Nacional de Promocion Cientifica y Tecnologica; European Union(European Commission); Agencia Nacional de PromociOn Cientifica y Tecnologica (ANPCyT)(ANPCyT); Universidad Nacional del Sur (PGI TIR); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	Funded by Agenda Nacional de Promocion Cientifica y Tecnologica, (http://www.agencia.mincyt.gob.ar/frontendiagencia/fondo/foncyt):) PICT 2013 2029 to I.G. and PICT Ralces 2014 1243 to V.E): Involved in study design, data collection and analysis, experiments development, decision to publish, preparation of the manuscript. Secretaria General de Ciencia y Tecnologia, Universidad Nacional del Sur, (http://www.uns.edu.aricenten id es/40/480#proyectos-grupos-deinvestigacion): PGI - TIR, CSU-142/14 and PGI 24/A199 to V.E: Involved in study design, data collection and analysis, experiments development, decision to publish, preparation of the manuscript. Consejo Nacional de Investigaciones Cientificas y Tecnicas (http://convocatorias.contcet.gov.ar/proyectos-pip/): PIP 11220110100767 to V.E and 11220150100963 to I.G: Involved in study design, data collection and analysis, experiments development, decision to publish, preparation of the manuscript. European Union's Horizon 2020 Research and Innovation Programme (htips://ec europleuiprogram.mes/horizon2020/en/h2020section/fp arie-sklodowska-curieactions) under the Marie Skfodowska-Curie Grant Agreement No 645674: Involved in study design, data collection and ana; Jose Rodolfo Romero passed away before the submission of the final version of this manuscript. Viviana Echenique accepts responsibility for the integrity and validity of the data collected and analyzed. This work was granted by the Agencia Nacional de PromociOn Cientifica y Tecnologica (ANPCyT, PICT 2013-2029 to I.G. and PICT Raices 2014-1243 to V.E), Universidad Nacional del Sur (PGI TIR, CSU-142/14 and PGI 24/A199 to V.E), CONICET (PIPlysis, experiments development, decision to publish, preparation of the manuscript. 11220110100767 to V.E and 11220150100963 to I.G) and the European Union's Horizon 2020 Research and Innovation Programme under the Marie Sklodowska-Curie Grant Agreement No 645674.	Albertini E, 2001, SEX PLANT REPROD, V14, P213, DOI 10.1007/s00497-001-0116-2; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barcaccia G, 2013, PLANT REPROD, V26, P159, DOI 10.1007/s00497-013-0222-y; BEKELE E, 1981, ANN BOT-LONDON, V48, P717, DOI 10.1093/oxfordjournals.aob.a086178; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENNETT MD, 1972, PROC R SOC SER B-BIO, V181, P109, DOI 10.1098/rspb.1972.0042; Cannarozzi G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-581; Carman JG, 1997, BIOL J LINN SOC, V61, P51, DOI 10.1006/bijl.1996.0118; Catanach AS, 2006, P NATL ACAD SCI USA, V103, P18650, DOI 10.1073/pnas.0605588103; Cervigni GDL, 2008, PLANT MOL BIOL, V67, P1, DOI 10.1007/s11103-007-9282-4; Chen CX, 2014, MOL GENET GENOMICS, V289, P1147, DOI 10.1007/s00438-014-0875-8; Chen WH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-320; Ochogavia AC, 2011, SEX PLANT REPROD, V24, P231, DOI 10.1007/s00497-011-0165-0; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conner JA, 2013, PLANTA, V238, P51, DOI 10.1007/s00425-013-1873-5; Covas G., 1991, PASTO LLORON BIOL MA, P1; Crane C., 2001, FLOWERING APOMIXIS M, P168; Da Maia LC, 2008, INT J PLANT GENOMICS; Galla G, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1439-y; Grimanelli D, 1998, HEREDITY, V80, P40, DOI 10.1046/j.1365-2540.1998.00264.x; Grossniklaus U, 2001, PLANT CELL, V13, P1491, DOI 10.1105/tpc.13.7.1491; Hand ML, 2014, GENETICS, V197, P441, DOI 10.1534/genetics.114.163105; Horandl E, 2010, SEX PLANT REPROD, V23, P73, DOI 10.1007/s00497-009-0122-3; Jiang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071054; Jones AL, 1998, EMBO J, V17, P6385, DOI 10.1093/emboj/17.21.6385; Koltunow A.M., 2013, SEED GENOMICS, P83; Koltunow AM, 2003, ANNU REV PLANT BIOL, V54, P547, DOI 10.1146/annurev.arplant.54.110901.160842; Rodrigo JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175852; Meier M, 2011, AUST J BOT, V59, P253, DOI 10.1071/BT10267; Mundry M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031410; Noyes RD, 2000, GENETICS, V155, P379; Ortiz JPA, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3700-z; Ozias-Akins P, 2007, ANNU REV GENET, V41, P509, DOI 10.1146/annurev.genet.40.110405.090511; Ravishankar KV, 2015, PLANT BREEDING, V134, P247, DOI 10.1111/pbr.12238; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Romero J, 2016, BIOL PLANTARUM, V60, P55, DOI 10.1007/s10535-015-0569-z; Roodt-Wilding R, 2006, SYST BIODIVERS, V4, P401, DOI 10.1017/S1477200006002131; Saha MC, 2006, THEOR APPL GENET, V113, P1449, DOI 10.1007/s00122-006-0391-2; Schallau A, 2010, PLANT J, V62, P773, DOI 10.1111/j.1365-313X.2010.04188.x; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Selva J. P., 2012, American Journal of Plant Sciences, V3, P403, DOI 10.4236/ajps.2012.33049; Sharbel TF, 2010, PLANT CELL, V22, P655, DOI 10.1105/tpc.109.072223; Toledo-Silva G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070781; Van Dijk PJ, 1999, HEREDITY, V83, P715, DOI 10.1038/sj.hdy.6886200; Voigt P., 2004, WARM SEASON C4 GRASS, V45, P1027; VOIGT PW, 1976, CROP SCI, V16, P803, DOI 10.2135/cropsci1976.0011183X001600060017x; VOIGT PW, 1971, CROP SCI, V11, P424, DOI 10.2135/cropsci1971.0011183X001100030034x; Watson L., 1992, The grass genera of the world.; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Zappacosta D, 2011, PHYTON-INT J EXP BOT, V80, P211; Zappacosta DC, 2014, SCI REP-UK, V4, DOI 10.1038/srep04423	53	13	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0185595	10.1371/journal.pone.0185595	http://dx.doi.org/10.1371/journal.pone.0185595			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091722	Green Published, Green Submitted, gold			2022-12-26	WOS:000414229700008
J	Rozenbaum, AG; Gelband, DS; Stein, M; Mienis, HK; Rabinovich, R				Rozenbaum, Alexis Gabriel; Gelband, Dotan Shaked; Stein, Mordechai; Mienis, Henk K.; Rabinovich, Rivka			First evidence of "ancient deer" (cervid) in the late Miocene Bira Formation, Northern Israel	PLOS ONE			English	Article							EARLY PLIOCENE; MAMMALIA; FRAGMENTATION; ARTIODACTYLA; EVOLUTION; GALILEE; RIFT	Despite the extensive geological and paleontological searches in the south Levant, no terrestrial fauna of late Neogene age was yet reported. Here, we report the first evidence of "ancient deer"-cervid in the late Miocene (Tortonian) lacustrine section of the Bira Formation at Hagal Stream, Jordan Valley, northern Israel. The section comprises rich assemblage of macrofauna fossils, mostly freshwater mollusks. The mammalian bone was discovered among the macrofauna fossils, and is described as an almost complete left humerus of an adult animal identified as an artiodactyls element probably of a cervid. This terrestrial mammal shares similar paleoenvironmental conditions with other contemporaneous localities, where cervids prevailed with bovids and other taxa. It appears that the freshwater lakes provided favorite habitat for the development of the cervids and possibly other mammals. The specific conditions of preservation of the cervid illuminate the role of post depositional processes (taphonomic constrains) in masking terrestrial fauna remains in the region. Accordingly, further efforts will be devoted to unveil the mute part of the southern Levant-east Mediterranean terrestrial faunistic realm at the end of the Miocene.	[Rozenbaum, Alexis Gabriel; Gelband, Dotan Shaked; Stein, Mordechai] Geol Survey Israel, 30 Malkhe Israel, Jerusalem, Israel; [Rozenbaum, Alexis Gabriel; Gelband, Dotan Shaked; Stein, Mordechai; Rabinovich, Rivka] Hebrew Univ Jerusalem, Inst Earth Sci, Edmond J Safra Campus, Jerusalem, Israel; [Mienis, Henk K.; Rabinovich, Rivka] Hebrew Univ Jerusalem, Nat Hist Collect, Edmond J Safra Campus, Jerusalem, Israel	Geological Survey Israel; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Rozenbaum, AG (corresponding author), Geol Survey Israel, 30 Malkhe Israel, Jerusalem, Israel.; Rozenbaum, AG (corresponding author), Hebrew Univ Jerusalem, Inst Earth Sci, Edmond J Safra Campus, Jerusalem, Israel.	alexis.rozenbaum@mail.huji.ac.il	Stein, Mordechai/AAJ-3200-2020	Stein, Mordechai/0000-0002-3126-416X; Rabinovich, Rivka/0000-0002-1343-3134	Israel Science Foundation [683/09]; Ministry of National Infrastructures, Energy and Water Resources grant [213/17/09]	Israel Science Foundation(Israel Science Foundation); Ministry of National Infrastructures, Energy and Water Resources grant	The research was supported by the Israel Science Foundation grant 683/09 and the Ministry of National Infrastructures, Energy and Water Resources grant 213/17/09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Amir Sandler and Dr. Ezra Zilberman from the Geological Survey of Israel and Yossi Morag of Gesher Quarries who guided us to the Hagal section. Special thanks to Gali Beiner (ACR), the conservator of The Natural History Collections of the Hebrew University that had speared no effort to expose this unique find and Uzzan who took the photos of the bone. Field assistance by Yaakov Rephael of the Geological Survey of Israel was crucial to the success of this study. We acknowledge Prof. Abraham Starinsky of the Institute of Earth Sciences of the Hebrew University for field discussions. The research was supported by the Israel Science Foundation grant 683/09 and the Ministry of National Infrastructures, Energy and Water Resources grant 213/17/09.	Abbazzi L, 2001, RIV ITAL PALEONTOL S, V107, P107, DOI 10.13130/2039-4942/5426; ABBOTT R. TUCKER, 1958, PROC ACAD NAT SCI PHILADELPHIA, V110, P213; Amr Z.S., 2004, Denisia, V14, P221; Amson E, 2016, SCI NAT-HEIDELBERG, V103, DOI 10.1007/s00114-016-1379-7; Ataabadi MM, 2016, PALAEOBIO PALAEOENV, V96, P339, DOI 10.1007/s12549-016-0242-3; AZANZA B, 1995, J PALEONTOL, V69, P1163, DOI 10.1017/S0022336000038142; Azanza B, 2013, PALAEOBIO PALAEOENV, V93, P217, DOI 10.1007/s12549-013-0118-8; Blondel J, 2009, PHYS GEOGRAPHY MEDIT, P139; Bouvrain G, 2007, ANN PALEONTOL, V93, P121, DOI 10.1016/j.annpal.2007.03.001; Boyer DL, 2004, PALAIOS, V19, P372, DOI 10.1669/0883-1351(2004)019<0372:ESOLTS>2.0.CO;2; Braun D, 1992, THESIS; BRETT C E, 1986, Palaios, V1, P207, DOI 10.2307/3514686; Clarke KR, 1994, CHANGE MARINE COMMUN; Cohen A., 1997, GSI297 MIN NAT INFR; Croitor R, 2017, NEUES JAHRB GEOL P-A, V283, P85, DOI 10.1127/njgpa/2017/0630; Dicker T., 1969, J EARTH SCI, V18, P39; Edelman-Furstenberg Y, 2008, PALAEOGEOGR PALAEOCL, V261, P58, DOI 10.1016/j.palaeo.2008.01.004; Flecker R, 2015, EARTH-SCI REV, V150, P365, DOI 10.1016/j.earscirev.2015.08.007; Fortelius M, 2006, PALAEOGEOGR PALAEOCL, V238, P219, DOI 10.1016/j.palaeo.2006.03.042; FREUND R, 1970, PHILOS T R SOC S-A, V267, P107, DOI 10.1098/rsta.1970.0027; FURSICH FT, 1978, LETHAIA, V11, P243, DOI 10.1111/j.1502-3931.1978.tb01231.x; FURSICH FT, 1993, LETHAIA, V26, P327, DOI 10.1111/j.1502-3931.1993.tb01540.x; GARFUNKEL Z, 1989, ISRAEL J EARTH SCI, V38, P51; GARFUNKEL Z, 1981, TECTONOPHYSICS, V80, P81, DOI 10.1016/0040-1951(81)90143-8; Garfunkel Z., 1988, ZOOGEOGRAPHY ISRAEL, P7; Geraads D, 2013, ACTA ZOOL BULGAR, V65, P381; Heintz E., 1970, Memoires Mus natn Hist nat Paris (Sci Terre), V22, P1; Horowitz A., 1974, LATE CENOZOIC STRATI; Horowitz A., 2001, JORDAN RIFT VALLEY; HSU KJ, 1973, NATURE, V242, P240, DOI 10.1038/242240a0; HUDSON J D, 1980, Proceedings of the Geologists' Association, V91, P99; Kafri Uri, 2002, Israel Journal of Earth Sciences, V51, P79, DOI 10.1560/WH4Y-3NNT-TQ2W-1D9D; KANGAS P, 1978, ESTUAR COAST MAR SCI, V6, P409, DOI 10.1016/0302-3524(78)90131-7; Kidwell S.M., 1991, Topics in Geobiology, V9, P115; KIDWELL S M, 1991, Palaios, V6, P426, DOI 10.2307/3514967; Kostopoulos DS, 2006, PALAEONTOGR ABT A, V276, P151; Koufos George D., 2003, Deinsea (Rotterdam), V10, P343; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; Lopez-Antonanzas R, 2015, SCI REP-UK, V5, DOI 10.1038/srep12871; MALEZ M, 1989, GEOBIOS-LYON, V22, P665, DOI 10.1016/S0016-6995(89)80119-6; MARCUS E, 1985, ISRAEL J EARTH SCI, V34, P1; Marcus E. J, 8411 OIL EXPL INV LT; Pillay D, 2009, J EXP MAR BIOL ECOL, V380, P47, DOI 10.1016/j.jembe.2009.08.016; Pitra C, 2004, MOL PHYLOGENET EVOL, V33, P880, DOI 10.1016/j.ympev.2004.07.013; Raab M, 1997, CARBONATE EVAPORITE, V12, P296, DOI 10.1007/BF03175424; Rabinovich R, 2012, VERTEBR PALEOBIOL PA, P1, DOI 10.1007/978-94-007-2159-3; Remane A, 1971, BIOL BRACKISH WATER; Rogl F, 1999, GEOL CARPATH, V50, P339; Rogl F., 1984, GEOL J, P171; ROSENFELD A, 1981, ISRAEL J EARTH SCI, V30, P113; Roveri M, 2008, TERRA NOVA, V20, P483, DOI 10.1111/j.1365-3121.2008.00842.x; Rozenbaum AG, 2016, GEOL SOC AM BULL, V128, P1383, DOI 10.1130/B31239.1; Rozenbaum A.G., 2017, THESIS; SCHULMAN N., 1959, BULL RES COUNC ISRAEL SECT G GEO SCI, V8G, P63; Schulman N., 1962, THESIS; Segev A, 2000, TECTONOPHYSICS, V325, P257, DOI 10.1016/S0040-1951(00)00122-0; Shaked-Gelband D, 2017, UNPUB; Shaked-Gelband D, 2012, GSI372012 MIN EN WAT; Shaliv G, 1991, THESIS; Sneh A., 1998, GEOLOGICAL MAP ISRAE; STEIN M, 1992, EARTH PLANET SC LETT, V114, P193, DOI 10.1016/0012-821X(92)90161-N; Stein M, 2014, MOD APPR SOL EARTH S, V6, P279, DOI 10.1007/978-94-017-8872-4_10; Steininger FF, TETHYAN OCEAN PARATE; Tchernov E., 1988, ZOOGEOGRAPHY ISRAEL, P159; Wald R., 2016, THESIS; Zak I., 1967, THESIS; Zilberman E., 2013, ISR GEOL SOC ANN M F, P18; Zuschin M, 2003, EARTH-SCI REV, V63, P33, DOI 10.1016/S0012-8252(03)00014-X	68	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0185268	10.1371/Journal.pone.0185268	http://dx.doi.org/10.1371/Journal.pone.0185268			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091714	Green Published, Green Submitted, gold			2022-12-26	WOS:000414229700005
J	Scott, AJ; Song, EK; Bagby, S; Purkey, A; McCarter, M; Gajdos, C; Quackenbush, KS; Cross, B; Pitts, TM; Tan, AC; Eckhardt, SG; Fenton, H; Arcaroli, J; Messersmith, WA				Scott, Aaron J.; Song, Eun-Kee; Bagby, Stacey; Purkey, Alicia; McCarter, Martin; Gajdos, Csaba; Quackenbush, Kevin S.; Cross, Benjamin; Pitts, Todd M.; Tan, Aik Choon; Eckhardt, S. Gail; Fenton, Hubert; Arcaroli, John; Messersmith, Wells A.			Evaluation of the efficacy of dasatinib, a Src/Abl inhibitor, in colorectal cancer cell lines and explant mouse model	PLOS ONE			English	Article							NEGATIVE BREAST-CANCER; HUMAN-COLON-CARCINOMA; SRC KINASE-ACTIVITY; GROWTH-FACTOR; C-SRC; TYROSINE KINASES; PHASE-I; ACTIVATION; RECEPTOR; BIOMARKERS	Background Dysregulation of the Src pathway has been shown to be important at various stages of cancer. Dasatinib is a potent Src/Abl inhibitor and has demonstrated to have anti-proliferative and anti-invasive activity in many preclinical models. The objective of this study was to determine the anti-tumor activity of dasatinib using in vitro and in vivo preclinical colorectal (CRC) models. Methods CRC cell lines and patient-derived tumor explant (PDX) models were used to investigate the efficacy of dasatinib. We treated 50 CRC cell lines with dasatinib for 72 hours and proliferation was assayed by a sulforhodamine B (SRB) assay; an IC50 <= 0.08 mu mol/L was considered sensitive. We treated 17 patient-derived CRC explants with dasatinib (50 mg/kg/day, administered once-daily) for 28 days to determine in vivo efficacy. Tumor growth inhibition (TGI) >= 50% was considered sensitive. Results We found that 8 out of 50 CRC cell lines reached an IC50 <= 0.08 mu mol/L with dasatinib treatment. In addition, of 17 CRC explants grown in the xenograft mouse model, 2 showed sensitivity to dasatinib. The anti -tumor effects observed in this study were a result of G1 cell cycle arrest as the dasatinib sensitive CRC cell lines exhibited G1 inhibition. Moreover, those CRC cell lines that were responsive (0.08 mu mol/L) to treatment demonstrated a significant baseline increase in Src and FAK gene expression. Conclusion Dasatinib demonstrated significant anti-proliferative activity in a subset of CRC cell lines in vitro, especially in those with increased Src expression at baseline, but only showed modest efficacy in CRC explants. Dasatinib is currently being studied in combination with chemotherapy in patients with advanced CRC, as its use as a single agent appears limited.	[Scott, Aaron J.] Banner Univ, Arizona Canc Ctr, Div Med Oncol, Tucson, AZ 85724 USA; [Song, Eun-Kee] Chonbuk Natl Univ, Med Sch, Jeonju, South Korea; [Bagby, Stacey; Purkey, Alicia; Quackenbush, Kevin S.; Cross, Benjamin; Pitts, Todd M.; Tan, Aik Choon; Arcaroli, John; Messersmith, Wells A.] Univ Colorado Denver, Div Med Oncol, Anschutz Med Campus, Aurora, CO USA; [Bagby, Stacey; Purkey, Alicia; McCarter, Martin; Gajdos, Csaba; Quackenbush, Kevin S.; Cross, Benjamin; Pitts, Todd M.; Tan, Aik Choon; Fenton, Hubert; Arcaroli, John; Messersmith, Wells A.] Univ Colorado, Canc Ctr, Aurora, CO USA; [McCarter, Martin; Gajdos, Csaba] Univ Colorado Denver, Dept Surg, Anschutz Med Campus, Aurora, CO USA; [Eckhardt, S. Gail] Univ Texas Austin, Div Med Oncol, Austin, TX 78712 USA; [Fenton, Hubert] Univ Colorado Denver, Dept Pathol, Anschutz Med Campus, Aurora, CO USA	Arizona Center Cancer Care; Jeonbuk National University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Texas System; University of Texas Austin; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Scott, AJ (corresponding author), Banner Univ, Arizona Canc Ctr, Div Med Oncol, Tucson, AZ 85724 USA.	ajscott@email.arizona.edu	Tan, Aik Choon/A-3135-2011	Tan, Aik Choon/0000-0003-2955-8369; Purkey, Alicia/0000-0002-1865-1421	National Cancer Institute grant [1R01CA152303-01]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER	National Cancer Institute grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute grant 1R01CA152303-01. Authors who received funding included WAM, JA. (https://www.cancer.gov/grants-training/grants/funding-opportunities). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcaroli JJ, 2010, CLIN CANCER RES, V16, P4165, DOI 10.1158/1078-0432.CCR-10-0066; Bagby S, 2016, JOVE-J VIS EXP, DOI 10.3791/54393; BOLEN JB, 1987, ONCOGENE RES, V1, P149; CARTWRIGHT CA, 1990, P NATL ACAD SCI USA, V87, P558, DOI 10.1073/pnas.87.2.558; COURTNEIDGE SA, 1993, DEVELOPMENT, P57; Demetri GD, 2009, CLIN CANCER RES, V15, P6232, DOI 10.1158/1078-0432.CCR-09-0224; Dunn EF, 2011, ONCOGENE, V30, P561, DOI 10.1038/onc.2010.430; Ellis LM, 1998, J BIOL CHEM, V273, P1052, DOI 10.1074/jbc.273.2.1052; Finn RS, 2011, CLIN CANCER RES, V17, P6905, DOI 10.1158/1078-0432.CCR-11-0288; Herold CI, 2011, CLIN CANCER RES, V17, P6061, DOI 10.1158/1078-0432.CCR-11-1071; Howlander N, 1975, SEER CANC STAT REV; Kopetz S, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-660; Kopetz S, 2009, CANCER RES, V69, P3842, DOI 10.1158/0008-5472.CAN-08-2246; LaVallee TM, 1998, J CELL BIOL, V141, P1647, DOI 10.1083/jcb.141.7.1647; Levitzki A, 1996, ANTI-CANCER DRUG DES, V11, P175; Lieu C, 2010, J CLIN ONCOLOGY OFFI; LUTTRELL DK, 1994, P NATL ACAD SCI USA, V91, P83, DOI 10.1073/pnas.91.1.83; Mao WG, 1997, ONCOGENE, V15, P3083, DOI 10.1038/sj.onc.1201496; MARTIN GS, 1970, NATURE, V227, P1021, DOI 10.1038/2271021a0; PARK JS, 1993, ONCOGENE, V8, P2627; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Perez M, 2016, ONCOTARGET, V7, P33111, DOI 10.18632/oncotarget.8880; Peterson JE, 1996, J BIOL CHEM, V271, P31562, DOI 10.1074/jbc.271.49.31562; Rahimi N, 1998, J BIOL CHEM, V273, P33714, DOI 10.1074/jbc.273.50.33714; Rous P, 1911, J EXP MED, V13, P397, DOI 10.1084/jem.13.4.397; Serrels A, 2006, MOL CANCER THER, V5, P3014, DOI 10.1158/1535-7163.MCT-06-0382; Sharma MR, 2012, INVEST NEW DRUG, V30, P1211, DOI 10.1007/s10637-011-9681-x; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Song LX, 2006, CANCER RES, V66, P5542, DOI 10.1158/0008-5472.CAN-05-4620; Strickler JH, 2014, INVEST NEW DRUG, V32, P330, DOI 10.1007/s10637-013-0042-9; TALAMONTI MS, 1993, J CLIN INVEST, V91, P53, DOI 10.1172/JCI116200; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; Tsao AS, 2007, MOL CANCER THER, V6, P1962, DOI 10.1158/1535-7163.MCT-07-0052; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zheng X, 2008, INT J CANCER, V122, P1999, DOI 10.1002/ijc.23321	35	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187173	10.1371/journal.pone.0187173	http://dx.doi.org/10.1371/journal.pone.0187173			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091939	Green Published, gold, Green Submitted			2022-12-26	WOS:000414229700044
J	Kuo, BJ; Vaca, SD; Vissoci, JRN; Staton, CA; Xu, L; Muhumuza, M; Ssenyonjo, H; Mukasa, J; Kiryabwire, J; Nanjula, L; Muhumuza, C; Rice, HE; Grant, GA; Haglund, MM				Kuo, Benjamin J.; Vaca, Silvia D.; Vissoci, Joao Ricardo Nickenig; Staton, Catherine A.; Xu, Linda; Muhumuza, Michael; Ssenyonjo, Hussein; Mukasa, John; Kiryabwire, Joel; Nanjula, Lydia; Muhumuza, Christine; Rice, Henry E.; Grant, Gerald A.; Haglund, Michael M.			A prospective neurosurgical registry evaluating the clinical care of traumatic brain injury patients presenting to Mulago National Referral Hospital in Uganda	PLOS ONE			English	Article							LOW-INCOME; BURDEN; IMPACT; OUTCOMES	Background Traumatic Brain Injury (TBI) is disproportionally concentrated in low-and middle-income countries (LMICs), with the odds of dying from TBI in Uganda more than 4 times higher than in high income countries (HICs). The objectives of this study are to describe the processes of care and determine risk factors predictive of poor outcomes for TBI patients presenting to Mulago National Referral Hospital (MNRH), Kampala, Uganda. Methods We used a prospective neurosurgical registry based on Research Electronic Data Capture (REDCap) to systematically collect variables spanning 8 categories. Univariate and multivariate analysis were conducted to determine significant predictors of mortality. Results 563 TBI patients were enrolled from 1 June-30 November 2016. 102 patients (18%) received surgery, 29 patients (5.1%) intended for surgery failed to receive it, and 251 patients (45%) received non-operative management. Overall mortality was 9.6%, which ranged from 4.7% for mild and moderate TBI to 55% for severe TBI patients with GCS 3-5. Within each TBI severity category, mortality differed by management pathway. Variables predictive of mortality were TBI severity, more than one intracranial bleed, failure to receive surgery, high dependency unit admission, ventilator support outside of surgery, and hospital arrival delayed by more than 4 hours. Conclusions The overall mortality rate of 9.6% in Uganda for TBI is high, and likely underestimates the true TBI mortality. Furthermore, the wide-ranging mortality (3-82%), high ICU fatality, and negative impact of care delays suggest shortcomings with the current triaging practices. Lack of surgical intervention when needed was highly predictive of mortality in TBI patients. Further research into the determinants of surgical interventions, quality of step-up care, and prolonged care delays are needed to better understand the complex interplay of variables that affect patient outcome. These insights guide the development of future interventions and resource allocation to improve patient outcomes.	[Kuo, Benjamin J.; Vissoci, Joao Ricardo Nickenig; Staton, Catherine A.; Haglund, Michael M.] Duke Univ, Div Global Neurosurg & Neurol, Durham, NC 27708 USA; [Kuo, Benjamin J.; Vissoci, Joao Ricardo Nickenig; Staton, Catherine A.; Rice, Henry E.; Haglund, Michael M.] Duke Univ, Global Hlth Inst, Durham, NC 27708 USA; [Kuo, Benjamin J.] Duke Natl Univ Singapore, Med Sch, Singapore, Singapore; [Vaca, Silvia D.] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; [Vaca, Silvia D.; Xu, Linda; Grant, Gerald A.] Stanford Ctr Innovat Global Hlth, Palo Alto, CA USA; [Vissoci, Joao Ricardo Nickenig; Staton, Catherine A.] Duke Univ, Med Ctr, Dept Emergency Med, Durham, NC USA; [Xu, Linda; Grant, Gerald A.] Stanford Univ, Med Ctr, Dept Neurosurg, Palo Alto, CA 94304 USA; [Muhumuza, Michael; Ssenyonjo, Hussein; Mukasa, John; Kiryabwire, Joel; Nanjula, Lydia] Mulago Hosp, Dept Neurosurg, Kampala, Uganda; [Muhumuza, Christine] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Rice, Henry E.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Haglund, Michael M.] Duke Univ, Dept Neurosurg, Med Ctr, Durham, NC 27708 USA	Duke University; Duke University; National University of Singapore; Stanford University; Duke University; Stanford University; Mulago National Referral Hospital; Makerere University; Duke University; Duke University	Haglund, MM (corresponding author), Duke Univ, Div Global Neurosurg & Neurol, Durham, NC 27708 USA.; Haglund, MM (corresponding author), Duke Univ, Global Hlth Inst, Durham, NC 27708 USA.; Haglund, MM (corresponding author), Duke Univ, Dept Neurosurg, Med Ctr, Durham, NC 27708 USA.	michael.haglund@dm.duke.edu		Staton, Catherine/0000-0002-6468-2894; Kuo, Benjamin/0000-0002-3074-2123	Duke Department of Neurosurgery; Duke Division of Global Neurosurgery and Neurology; Duke Global Health Institute; Duke-NUS Medical School; Stanford Medical Scholars Program; FOGARTY INTERNATIONAL CENTER [K01TW010000] Funding Source: NIH RePORTER	Duke Department of Neurosurgery; Duke Division of Global Neurosurgery and Neurology; Duke Global Health Institute; Duke-NUS Medical School; Stanford Medical Scholars Program; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Funding was provided by the Duke Department of Neurosurgery, Duke Division of Global Neurosurgery and Neurology, Duke Global Health Institute, Duke-NUS Medical School, and Stanford Medical Scholars Program. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelgadir J, 2017, WORLD NEUROSURG, V101, P651, DOI 10.1016/j.wneu.2017.02.048; Bhalla K, 2009, INJURY PREV, V15, P150, DOI 10.1136/ip.2008.020826; Bhalla K, 2009, PLOS MED, V6, P22, DOI 10.1371/journal.pmed.1000001; CDC, 2016, TRAUMATIC BRAIN INJU; Chandran A, 2010, EPIDEMIOL REV, V32, P110, DOI 10.1093/epirev/mxq009; Demyttenaere SV, 2009, CAN J SURG, V52, pE146; Di Saverio S, 2014, LANGENBECK ARCH SURG, V399, P109, DOI 10.1007/s00423-013-1143-9; Gagne M, 2017, J TRAUMA ACUTE CARE, V82, P374, DOI 10.1097/TA.0000000000001319; Gupta D, 2016, WORLD NEUROSURG, V89, P169, DOI 10.1016/j.wneu.2015.12.097; Hofman K, 2005, AM J PUBLIC HEALTH, V95, P13, DOI 10.2105/AJPH.2004.039354; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jayaraman S, 2011, WORLD J SURG, V35, P505, DOI 10.1007/s00268-010-0871-z; Kim YJ, 2011, J EMERG NURS, V37, P328, DOI 10.1016/j.jen.2010.04.017; Krishnamoorthy V, 2015, J INTENSIVE CARE, P1; Kwizera Arthur, 2012, BMC Res Notes, V5, P475, DOI 10.1186/1756-0500-5-475; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mwita CC, 2016, J NEUROSCI RURAL PRA, V7, P97, DOI 10.4103/0976-3147.165390; Opondo EA, 2009, ANN AFRICAN SURG, P1; Selassie AW, 2011, J TRAUMA, V71, P1226, DOI 10.1097/TA.0b013e318226ecfc; Staton CA, 2015, INT J INJ CONTROL SA, P1; Tobi KU, 2016, SOUTH AFR J ANAESTH, V22, P135, DOI 10.1080/22201181.2016.1206293; Tran TM, 2015, WORLD NEUROSURG, V83, P269, DOI 10.1016/j.wneu.2014.12.028; Ubos. Uganda National Household Survey 2009/ 2010, 2010, UGAUBOSUBOS2012V01, P222; World Health Organization, 2015, INJURY PREV, P318	25	34	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0182285	10.1371/journal.pone.0182285	http://dx.doi.org/10.1371/journal.pone.0182285			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL2ZD	29088217	gold, Green Submitted, Green Published			2022-12-26	WOS:000414088900001
J	Sullivan, TJ; Neigel, JE				Sullivan, Timothy J.; Neigel, Joseph E.			Differential host mortality explains the effect of high temperature on the prevalence of a marine pathogen	PLOS ONE			English	Article							CRAB CALLINECTES-SAPIDUS; DINOFLAGELLATE HEMATODINIUM-PEREZI; BLUE-CRAB; INFECTIOUS-DISEASES; THERMAL TOLERANCE; CLIMATE-CHANGE; CORAL DISEASE; SALINITY; ECOLOGY; OCEAN	Infectious diseases threaten marine populations, and the extent of their impacts is often assessed by prevalence of infection (the proportion of infected individuals). Changes in prevalence are often attributed to altered rates of transmission, although the rates of birth, recovery, and mortality also determine prevalence. The parasitic dinoflagellate Hematodinium perezi causes a severe, often fatal disease in blue crabs. It has been speculated that decreases in prevalence associated with high temperatures result from lower rates of infection. We used field collections, environmental sensor data, and high-temperature exposure experiments to investigate the factors that change prevalence of infections in blue crab megalopae (post-larvae). These megalopae migrate from offshore waters, where temperatures are moderate, to marshes where temperatures may be extremely high. Within a few days of arriving in the marsh, the megalopae metamorphose into juvenile crabs. We found a strong negative association between prevalence of Hematodinium infection in megalopae and the cumulative time water temperatures in the marsh exceeded 34 degrees C over the preceding two days. Temperatures this high are known to be lethal for blue crabs, suggesting that higher mortality of infected megalopae could be the cause of reduced prevalence. Experimental exposure of megalopae from the marsh to a temperature of 34 degrees C resulted in higher mortality for infected than uninfected individuals, and decreased the prevalence of infection among survivors from 18% to 3%.	[Sullivan, Timothy J.; Neigel, Joseph E.] Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA; [Sullivan, Timothy J.] Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA	University of Louisiana Lafayette; University of Arkansas System; University of Arkansas Fayetteville	Sullivan, TJ (corresponding author), Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA.; Sullivan, TJ (corresponding author), Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA.	tsulli1988@gmail.com	sullivan, Timothy/AAG-3677-2020		Gulf of Mexico Research Initiative [GRI-013, GoMRI2012-11-523]; University of Louisiana Doctoral Fellowship	Gulf of Mexico Research Initiative; University of Louisiana Doctoral Fellowship	This research was funded by grants from The Gulf of Mexico Research Initiative (gulfresearchinitiative.org) (GRI-013 and GoMRI2012-11-523) awarded to JEN and by a University of Louisiana Doctoral Fellowship to TJS. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Bree Yednock for sample collection, Jeffery Shields and Joe Pitula for providing DNA from H. perezi, and Ed Chesney for providing lab space, supplies, and guidance for the thermal stress experiments. This research was made possible by grants from The Gulf of Mexico Research Initiative (GRI-013 and GoMRI2012-II-523) and by a University of Louisiana Doctoral Fellowship to T. Sullivan.	Altizer S, 2013, SCIENCE, V341, P514, DOI 10.1126/science.1239401; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; ANDERSON RM, 1981, PHILOS T R SOC B, V291, P451, DOI 10.1098/rstb.1981.0005; Bates AE, 2009, DIS AQUAT ORGAN, V86, P245, DOI 10.3354/dao02125; Coffey AH, 2012, J PARASITOL, V98, P536, DOI 10.1645/GE-2971.1; COSTLOW JD, 1967, HELGOLAND WISS MEER, V15, P84, DOI 10.1007/BF01618611; COSTLOW JD, 1959, BIOL BULL, V116, P373, DOI 10.2307/1538947; Egan S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00991; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; Ford SE, 2007, MAR BIOL, V151, P119, DOI 10.1007/s00227-006-0454-6; Forward RB, 2005, J SHELLFISH RES, V24, P587; Friedman CS, 2009, 623 AL N PAC RES BOA; Gandy R, 2015, DIS AQUAT ORGAN, V113, P235, DOI 10.3354/dao02841; Groner M, 2015, SCIENCE, V347, P1210, DOI 10.1126/science.347.6227.1210-a; Groner ML, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0364; Hallegraeff Gustaaf M., 1997, Aquatic Ecology, V31, P47, DOI 10.1023/A:1009972931195; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Harvell D, 2004, FRONT ECOL ENVIRON, V2, P375, DOI 10.1890/1540-9295(2004)002[0375:TRTOOD]2.0.CO;2; Hirazawa N, 2003, AQUACULTURE, V223, P1, DOI 10.1016/S0044-8486(03)00167-4; Holland Jr JS, 1971, THESIS; Huchin-Mian JP, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3185-y; Lafferty KD, 2004, ANNU REV ECOL EVOL S, V35, P31, DOI 10.1146/annurev.ecolsys.35.021103.105704; Lafferty KD, 2014, MARINE COMMUNITY ECOLOGY AND CONSERVATION, P85; LEFFLER CW, 1972, MAR BIOL, V14, P104, DOI 10.1007/BF00373209; Li CW, 2011, PARASITOLOGY, V138, P1924, DOI 10.1017/S0031182011001405; Lycett KA, 2017, DIS AQUAT ORGAN, V124, P169, DOI 10.3354/dao03112; McCallum HI, 2004, TRENDS ECOL EVOL, V19, P585, DOI 10.1016/j.tree.2004.08.009; Messick GA, 2000, DIS AQUAT ORGAN, V43, P139, DOI 10.3354/dao043139; Metcalf KS, 1995, B MAR SCI, V57, P781; Nugues MM, 2004, ECOL LETT, V7, P919, DOI 10.1111/j.1461-0248.2004.00651.x; POWELL EN, 1992, MAR ECOL-P S Z N I, V13, P243, DOI 10.1111/j.1439-0485.1992.tb00354.x; Ruiz-Morenol D, 2012, DIS AQUAT ORGAN, V100, P249, DOI 10.3354/dao02488; Shields JD, 2000, FISH B-NOAA, V98, P139; Shields JD, 2007, BLUE CRAB CALLINECTE, P299; Shields JD, 2007, DIS AQUAT ORGAN, V77, P61, DOI 10.3354/dao01825; Steyer GD, 2003, PROPOSED COAST WIDE, P107; Sullivan TJ, 2016, DIS AQUAT ORGAN, V120, P83, DOI 10.3354/dao03004; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; TAGATZ ME, 1969, T AM FISH SOC, V98, P713, DOI 10.1577/1548-8659(1969)98[713:SROTAA]2.0.CO;2; vanMontfrans J, 1995, B MAR SCI, V57, P834; Ward JR, 2004, PLOS BIOL, V2, P542, DOI 10.1371/journal.pbio.0020120	42	3	3	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187128	10.1371/journal.pone.0187128	http://dx.doi.org/10.1371/journal.pone.0187128			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084257	Green Submitted, Green Published, gold			2022-12-26	WOS:000413910200033
J	Xie, JD; Chen, SR; Pan, HL				Xie, Jing-Dun; Chen, Shao-Rui; Pan, Hui-Lin			Presynaptic mGluR5 receptor controls glutamatergic input through protein kinase C-NMDA receptors in paclitaxel-induced neuropathic pain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glutamate receptor; microtubule; neurophysiology; neuroscience; neurotransmitter; pain; synaptic plasticity; tubulin	ROOT GANGLIA NEURONS; SPINAL-CORD; SUBSTANTIA-GELATINOSA; CHLORIDE HOMEOSTASIS; NERVE INJURY; DORSAL-HORN; RAT; ACTIVATION; HYPERSENSITIVITY; PHARMACOLOGY	Chemotherapeutic drugs such as paclitaxel cause painful peripheral neuropathy in many cancer patients and survivors. Although NMDA receptors (NMDARs) at primary afferent terminals are known to be critically involved in chemotherapy-induced chronic pain, the upstream signaling mechanism that leads to presynaptic NMDAR activation is unclear. Group I metabotropic glutamate receptors (mGluRs) play a role in synaptic plasticity and NMDAR regulation. Here we report that the Group I mGluR agonist (S)-3,5-dihydroxyphenylglycine (DHPG) significantly increased the frequency of miniature excitatory postsynaptic currents (EPSCs) and the amplitude of monosynaptic EPSCs evoked from the dorsal root. DHPG also reduced the paired-pulse ratio of evoked EPSCs in spinal dorsal horn neurons. These effects were blocked by the selective mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP), but not by an mGluR1 antagonist. MPEP normalized the frequency of miniature EPSCs and the amplitude of evoked EPSCs in paclitaxel-treated rats but had no effect in vehicle-treated rats. Furthermore, mGluR5 protein levels in the dorsal root ganglion and spinal cord synaptosomes were significantly higher in paclitaxel- than in vehicle-treated rats. Inhibiting protein kinase C (PKC) or blocking NMDARs abolished DHPG-induced increases in the miniature EPSC frequency of spinal dorsal horn neurons in vehicle- and paclitaxel-treated rats. Moreover, intrathecal administration of MPEP reversed pain hypersensitivity caused by paclitaxel treatment. Our findings suggest that paclitaxel-induced painful neuropathy is associated with increased presynaptic mGluR5 activity at the spinal cord level, which serves as upstream signaling for PKC-mediated tonic activation of NMDARs. mGluR5 is therefore a promising target for reducing chemotherapy-induced neuropathic pain.	[Xie, Jing-Dun; Chen, Shao-Rui; Pan, Hui-Lin] Univ Texas MD Anderson Canc Ctr, Ctr Neurosci & Pain Res, Dept Anesthesiol & Perioperat Med, Houston, TX 77030 USA; [Xie, Jing-Dun] Sun Yat Sen Univ, Ctr Canc, Dept Anesthesiol, Guangzhou 510060, Guangdong, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; Sun Yat Sen University	Pan, HL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Unit 110, 1515 Holcombe Blvd, Houston, TX 77030 USA.	huilinpan@mdanderson.org		Pan, Hui-Lin/0000-0001-8444-3770	National Institutes of Health [GM120844, NS101880]; N. G. and Helen T. Hawkins Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS101880] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); N. G. and Helen T. Hawkins Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants GM120844 and NS101880 and a grant from the N. G. and Helen T. Hawkins Endowment (to H.-L. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Angulo MC, 2004, J NEUROSCI, V24, P6920, DOI 10.1523/JNEUROSCI.0473-04.2004; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen SR, 2014, J BIOL CHEM, V289, P31111, DOI 10.1074/jbc.M114.600320; Chen SR, 2014, J PHARMACOL EXP THER, V350, P301, DOI 10.1124/jpet.114.215855; Chen SR, 2014, J PHYSIOL-LONDON, V592, P215, DOI 10.1113/jphysiol.2013.263814; Chen SR, 2011, J PHARMACOL EXP THER, V337, P285, DOI 10.1124/jpet.110.176586; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Crawford JH, 2000, NEUROPHARMACOLOGY, V39, P621, DOI 10.1016/S0028-3908(99)00167-7; Gasparini F, 1999, NEUROPHARMACOLOGY, V38, P1493, DOI 10.1016/S0028-3908(99)00082-9; Grisold W, 2012, NEURO-ONCOLOGY, V14, P45, DOI 10.1093/neuonc/nos203; Huang H, 2007, J NEUROSCI, V27, P11560, DOI 10.1523/JNEUROSCI.2147-07.2007; Inquimbert P, 2012, PAIN, V153, P2422, DOI 10.1016/j.pain.2012.08.011; Kotecha SA, 2003, J BIOL CHEM, V278, P27742, DOI 10.1074/jbc.M301946200; Li DP, 2014, J NEUROSCI, V34, P4309, DOI 10.1523/JNEUROSCI.4295-13.2014; Li DP, 2002, J PHYSIOL-LONDON, V543, P807, DOI 10.1113/jphysiol.2002.020644; Li JQ, 2010, J NEUROCHEM, V112, P162, DOI 10.1111/j.1471-4159.2009.06437.x; Li LY, 2016, CELL REP, V15, P1376, DOI 10.1016/j.celrep.2016.04.039; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Pan YZ, 2004, J NEUROPHYSIOL, V91, P2413, DOI 10.1152/jn.01242.2003; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; Polomano RC, 2001, PAIN, V94, P293, DOI 10.1016/S0304-3959(01)00363-3; Santos SFA, 2007, J PHYSIOL-LONDON, V581, P241, DOI 10.1113/jphysiol.2006.126912; SCHOEPP DD, 1994, J NEUROCHEM, V63, P769; Serge A, 2003, J CELL SCI, V116, P5015, DOI 10.1242/jcs.00822; Sisignano M, 2014, NAT REV NEUROL, V10, P694, DOI 10.1038/nrneurol.2014.211; Theiss C, 2000, CELL TISSUE RES, V299, P213, DOI 10.1007/s004419900120; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Valerio A, 1997, NEUROSCI RES, V28, P49, DOI 10.1016/S0168-0102(97)01175-9; Werner CG, 2007, EUR J NEUROSCI, V25, P3597, DOI 10.1111/j.1460-9568.2007.05614.x; Xie JD, 2017, NEUROPHARMACOLOGY, V123, P477, DOI 10.1016/j.neuropharm.2017.06.027; Xie JD, 2016, J BIOL CHEM, V291, P19364, DOI 10.1074/jbc.M116.732347; YOSHIMURA M, 1990, J PHYSIOL-LONDON, V430, P315, DOI 10.1113/jphysiol.1990.sp018293; Zhao YL, 2012, J BIOL CHEM, V287, P25073, DOI 10.1074/jbc.M112.378737; Zhou HY, 2007, J NEUROPHYSIOL, V97, P871, DOI 10.1152/jn.00964.2006; Zhou HY, 2012, J BIOL CHEM, V287, P33853, DOI 10.1074/jbc.M112.395830; Zhou HY, 2010, J NEUROSCI, V30, P4460, DOI 10.1523/JNEUROSCI.5857-09.2010	36	29	31	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	2017	292	50					20644	20654		10.1074/jbc.M117.818476	http://dx.doi.org/10.1074/jbc.M117.818476			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ3OR	29074619	hybrid, Green Published			2022-12-26	WOS:000418267000024
J	Santoyo-Zedillo, M; Portillo, W; Paredes, RG				Santoyo-Zedillo, Marianela; Portillo, Wendy; Paredes, Raul G.			Neurogenesis in the olfactory bulb induced by paced mating in the female rat is opioid dependent	PLOS ONE			English	Article							MEDIAL PREOPTIC AREA; NEURAL STEM-CELLS; SEXUAL-BEHAVIOR; VAGINAL STIMULATION; NORWAY RATS; ENDOGENOUS OPIOIDS; MESSENGER-RNA; MU; RECEPTORS; ACTIVATION	The possibility to control the rate of sexual stimulation that the female rat receives during a mating encounter (pacing) increases the number of newborn neurons that reach the granular layer of the accessory olfactory bulb (AOB). If females mate repeatedly, the increase in the number of neurons is observed in other regions of the AOB and in the main olfactory bulb (MOB). It has also been shown that paced mating induces a reward state mediated by opioids. There is also evidence that opioids modulate neurogenesis. In the present study, we evaluated whether the opioid receptor antagonist naloxone (NX) could reduce the increase in neurogenesis in the AOB induced by paced mating. Ovariectomized female rats were randomly divided in 5 different groups: 1) Control (not mated) treated with saline, 2) control (not mated) treated with naloxone, 3) females that mated without controlling the sexual interaction (no-pacing), 4) females injected with saline before pacing the sexual interaction and 5) females injected with NX before a paced mating session. We found, as previously described, that paced mating induced a higher number of new cells in the granular layer of the AOB. The administration of NX before paced mating, blocked the increase in the number of newborn cells and prevented these cells from differentiating into neurons. These data suggest that opioid peptides play a fundamental role in the neurogenesis induced by paced mating in female rats.	[Santoyo-Zedillo, Marianela; Portillo, Wendy; Paredes, Raul G.] Univ Nacl Autonoma Mexico, Inst Neurobiol, Campus Juriquilla, Queretaro, Mexico	Universidad Nacional Autonoma de Mexico	Paredes, RG (corresponding author), Univ Nacl Autonoma Mexico, Inst Neurobiol, Campus Juriquilla, Queretaro, Mexico.	rparedes@unam.mx		Portillo, Wendy/0000-0002-5651-4815; Paredes, Raul/0000-0002-3032-3527	CONACYT [253631, 252756]; UNAM-DGAPA [IN210215, IN203615]; Fronteras [374]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); UNAM-DGAPA(Universidad Nacional Autonoma de Mexico); Fronteras	Research supported by: CONACYT: 253631, 252756 and Fronteras 374; UNAM-DGAPA: IN210215 and IN203615.; We thank Marie Bedos, Francisco Camacho, Deisy Gasca, Alejandra Castilla, Alejandra Pardo, Leonor Casanova, Omar Gonzalez, Ma. De Lourdes Lara, Martin Garcia, Francisco Javier Valles and Elsa Nydia Hernandez for their excellent technical assistance. Research supported by: CONACYT: 253631, 252756 and Fronteras 374; UNAM-DGAPA: IN210215 and IN203615	Acosta-Martinez M, 2002, HORM BEHAV, V41, P88, DOI 10.1006/hbeh.2001.1741; AGMO A, 1988, PHARMACOL BIOCHEM BE, V30, P1021, DOI 10.1016/0091-3057(88)90135-9; AGMO A, 1993, BEHAV NEUROSCI, V107, P812, DOI 10.1037/0735-7044.107.5.812; AGMO A, 1990, BEHAV NEUROSCI, V104, P177, DOI 10.1037/0735-7044.104.1.177; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Arzate DM, 2013, NEUROSCIENCE, V232, P151, DOI 10.1016/j.neuroscience.2012.12.014; CHIBA T, 1985, BRAIN RES BULL, V14, P261, DOI 10.1016/0361-9230(85)90091-7; Coolen LM, 2004, NEUROSCIENCE, V124, P11, DOI 10.1016/j.neuroscience.2003.10.045; Corona R, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00048; Corona R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019380; CROWLEY WR, 1977, PSYCHOPHARMACOLOGY, V54, P223, DOI 10.1007/BF00426567; ERSKINE MS, 1992, J NEUROENDOCRINOL, V4, P173, DOI 10.1111/j.1365-2826.1992.tb00156.x; Erskine MS, 2004, BEHAV BRAIN RES, V153, P295, DOI 10.1016/j.bbr.2004.01.026; ERSKINE MS, 1989, HORM BEHAV, V23, P473, DOI 10.1016/0018-506X(89)90037-8; FORSBERG G, 1987, NEUROSCI LETT, V81, P151, DOI 10.1016/0304-3940(87)90356-9; Garcia-Horsman SP, 2008, HORM BEHAV, V54, P709, DOI 10.1016/j.yhbeh.2008.07.011; Hahn JW, 2010, J NEUROCHEM, V112, P1431, DOI 10.1111/j.1471-4159.2009.06479.x; HILL RG, 1981, PHARMACOL BIOCHEM BE, V14, P631, DOI 10.1016/0091-3057(81)90123-4; JANIK J, 1992, J NEUROENDOCRINOL, V4, P701, DOI 10.1111/j.1365-2826.1992.tb00221.x; KAPOOR R, 1991, NEUROPEPTIDES, V19, P231, DOI 10.1016/0143-4179(91)90089-2; Khurshid N, 2010, FASEB J, V24, P3681, DOI 10.1096/fj.09-146746; KOMISARUK BR, 1977, BRAIN RES, V137, P85, DOI 10.1016/0006-8993(77)91014-9; Larsen CM, 2008, HORM BEHAV, V53, P509, DOI 10.1016/j.yhbeh.2007.11.020; Leslie FM, 1998, CAN J PHYSIOL PHARM, V76, P284, DOI 10.1139/cjpp-76-3-284; Leuner B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011597; Mak GK, 2007, NAT NEUROSCI, V10, P1003, DOI 10.1038/nn1928; Martinez I, 2001, HORM BEHAV, V40, P510, DOI 10.1006/hbeh.2001.1712; Martinez-Marcos A, 1999, EUR J NEUROSCI, V11, P3789, DOI 10.1046/j.1460-9568.1999.00797.x; MCCLINTOCK MK, 1982, ANIM BEHAV, V30, P398, DOI 10.1016/S0003-3472(82)80051-1; MCCLINTOCK MK, 1982, ANIM BEHAV, V30, P410, DOI 10.1016/S0003-3472(82)80052-3; MCCLINTOCK MK, 1978, BEHAVIOUR, V67, P67, DOI 10.1163/156853978X00260; MESSING RB, 1979, BRAIN RES BULL, V4, P615, DOI 10.1016/0361-9230(79)90102-3; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Ochi T, 2016, BRAIN RES, V1636, P118, DOI 10.1016/j.brainres.2016.01.046; Paredes RG, 2014, PHARMACOL BIOCHEM BE, V121, P124, DOI 10.1016/j.pbb.2013.11.004; Paredes RG, 1999, BEHAV BRAIN RES, V105, P117, DOI 10.1016/S0166-4328(99)00087-X; PAREDES RG, 1992, BEHAV BRAIN RES, V52, P175, DOI 10.1016/S0166-4328(05)80228-1; Paredes RG, 1997, BEHAV NEUROSCI, V111, P123, DOI 10.1037/0735-7044.111.1.123; Paredes RG, 2001, BEHAV NEUROSCI, V115, P1363, DOI 10.1037//0735-7044.115.6.1363; Parra-Gamez L, 2013, BRAIN RES, V1517, P36, DOI 10.1016/j.brainres.2013.04.004; Parra-Gamez L, 2009, PHYSIOL BEHAV, V97, P98, DOI 10.1016/j.physbeh.2009.02.004; Persson AI, 2003, EUR J NEUROSCI, V17, P1159, DOI 10.1046/j.1460-9568.2003.02538.x; PFAUS JG, 1987, NEUROSCI BIOBEHAV R, V11, P1, DOI 10.1016/S0149-7634(87)80002-7; Portillo W, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00025; Sargeant TJ, 2007, BRAIN RES, V1175, P28, DOI 10.1016/j.brainres.2007.07.091; Seri B, 2002, CLIN NEUROSCI RES, V2, P11, DOI 10.1016/S1566-2772(02)00004-X; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; SIMERLY RB, 1988, J COMP NEUROL, V270, P209, DOI 10.1002/cne.902700205; Sinchak K, 2001, J NEUROSCI, V21, P5723, DOI 10.1523/JNEUROSCI.21-15-05723.2001; STEINMAN JL, 1983, PAIN, V16, P155, DOI 10.1016/0304-3959(83)90205-1; Sugai T, 2006, NEUROREPORT, V17, P1663, DOI 10.1097/01.wnr.0000239950.14954.59; SZECHTMAN H, 1981, EUR J PHARMACOL, V70, P279, DOI 10.1016/0014-2999(81)90161-8; Unda NM, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00065; Willner D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103043; Zhang HN, 2006, EUR J NEUROSCI, V23, P984, DOI 10.1111/j.1460-9568.2006.04621.x	55	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0186335	10.1371/journal.pone.0186335	http://dx.doi.org/10.1371/journal.pone.0186335			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29107945	gold, Green Published, Green Submitted			2022-12-26	WOS:000414424600003
J	Dicks, N; Bohrer, RC; Gutierrez, K; Michalak, M; Agellon, LB; Bordignon, V				Dicks, Naomi; Bohrer, Rodrigo C.; Gutierrez, Karina; Michalak, Marek; Agellon, Luis B.; Bordignon, Vilceu			Relief of endoplasmic reticulum stress enhances DNA damage repair and improves development of pre-implantation embryos	PLOS ONE			English	Article							CELL NUCLEAR TRANSFER; GENERATED IN-VITRO; BOVINE EMBRYOS; EARLY CLEAVAGE; 1ST CLEAVAGE; BLASTOCYST STAGE; UNFOLDED PROTEIN; COMPETENCE; ACTIVATION; MATURATION	Early-cleaving embryos are known to have better capacity to reach the blastocyst stage and produce better quality embryos compared to late-cleaving embryos. To investigate the significance of endoplasmic reticulum (ER) stress on early embryo cleavage kinetics and development, porcine embryos produced in vitro were separated into early- and late-cleaving groups and then cultured in the absence or presence of the ER stress inhibitor tauroursodeoxycholic acid (TUDCA). Developing embryos were collected at days 3 to 7 of culture for assessment of ER stress status, incidence of DNA double-strand breaks (DSBs), development and total cell number. In the absence of TUDCA treatment, late-cleaving embryos exhibited ER stress, higher incidence of DNA DSBs, as well as reductions in development to the blastocyst stage and total embryo cell numbers. Treatment of late-cleaving embryos with TUDCA mitigated these effects and markedly improved embryo quality and development. These results demonstrate the importance of stress coping responses in early developing embryos, and that reduction of ER stress is a potential means to improve embryo quality and developmental competence.	[Dicks, Naomi; Bohrer, Rodrigo C.; Gutierrez, Karina; Bordignon, Vilceu] McGill Univ, Dept Anim Sci, Ste Anne De Bellevue, PQ, Canada; [Michalak, Marek] Univ Alberta, Dept Biochem, Edmonton, AB, Canada; [Agellon, Luis B.] McGill Univ, Sch Human Nutr, Ste Anne De Bellevue, PQ, Canada	McGill University; University of Alberta; McGill University	Bordignon, V (corresponding author), McGill Univ, Dept Anim Sci, Ste Anne De Bellevue, PQ, Canada.; Agellon, LB (corresponding author), McGill Univ, Sch Human Nutr, Ste Anne De Bellevue, PQ, Canada.	luis.agellon@mcgill.ca; vilceu.bordignon@mcgill.ca	Bohrer, Rodrigo/I-7725-2013	Bohrer, Rodrigo/0000-0002-0726-7643; Bordignon, Vilceu/0000-0001-7076-7707; Gutierrez, Karina/0000-0001-9112-1542	Natural Sciences and Engineering Research Council of Canada (NSERC) [262085-2011, 2015-04390]; Science Without Borders Program Scholarships from the Brazilian Council of Scientific and Technological Development; Alexander Graham Bell Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Science Without Borders Program Scholarships from the Brazilian Council of Scientific and Technological Development; Alexander Graham Bell Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada	This study is supported by grants (262085-2011 to V.B. and 2015-04390 to L.B.A.) from the Natural Sciences and Engineering Research Council of Canada (NSERC). K.G. and R.C.B. are recipients of Science Without Borders Program Scholarships from the Brazilian Council of Scientific and Technological Development. N.D. is a recipient of an Alexander Graham Bell Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Olymel S.E.C./L.P of Saint-Esprit, QC, Canada for providing porcine ovaries for use in these experiments, as well as Eliza Komninou, Gustavo Ilha and Werner Glanzner for oocyte collection and maturation, Monique Rovani for qPCR analyses, Joao Ricardo Souza for embryo immunofluorescence staining. K.G. and R.C.B. are recipients of Science Without Borders Program Scholarships from the Brazilian Council of Scientific and Technological Development. N.D. is a recipient of an Alexander Graham Bell Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada.	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Adam S, 2014, EXP CELL RES, V329, P148, DOI 10.1016/j.yexcr.2014.07.017; Argemi J, 2017, GASTROENTEROLOGY, V152, P1203, DOI 10.1053/j.gastro.2016.12.040; Audouard C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017109; Bastos GM, 2008, MOL REPROD DEV, V75, P282, DOI 10.1002/mrd.20798; Bohrer RC, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.130542; Bohrer RC, 2014, CELL CYCLE, V13, P2138, DOI 10.4161/cc.29215; Booth PJ, 2007, BIOL REPROD, V77, P765, DOI 10.1095/biolreprod.107.062802; Brevini TAL, 2002, MOL REPROD DEV, V63, P510, DOI 10.1002/mrd.10191; Che L, 2007, THERIOGENOLOGY, V67, P1297, DOI 10.1016/j.theriogenology.2007.02.006; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Coutinho ARS, 2011, MOL REPROD DEV, V78, P673, DOI 10.1002/mrd.21368; Dang-Nguyen TQ, 2010, J REPROD DEVELOP, V56, P593, DOI 10.1262/jrd.10-038M; Dicks N, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00011; Diskin MG, 2012, REPROD FERT DEVELOP, V24, P244, DOI 10.1071/RD11914; EDWARDS R G, 1984, Journal of In Vitro Fertilization and Embryo Transfer, V1, P3, DOI 10.1007/BF01129615; Fair T, 2004, MOL REPROD DEV, V67, P136, DOI 10.1002/mrd.10385; Grenier L, 2012, TOXICOL SCI, V127, P555, DOI 10.1093/toxsci/kfs120; Groenendyk J, 2013, ANNU REV PHYSIOL, V75, P49, DOI 10.1146/annurev-physiol-030212-183707; Groenendyk J, 2010, CIRC RES, V107, P1185, DOI 10.1161/CIRCRESAHA.110.227033; Hao LP, 2009, BIOL REPROD, V80, P944, DOI 10.1095/biolreprod.108.072546; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Isom SC, 2012, MOL REPROD DEV, V79, P197, DOI 10.1002/mrd.22013; Iwawaki T, 2009, P NATL ACAD SCI USA, V106, P16657, DOI 10.1073/pnas.0903775106; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kim JS, 2012, REPROD DOMEST ANIM, V47, P791, DOI 10.1111/j.1439-0531.2011.01969.x; Kirkegaard K, 2015, FERTIL STERIL, V103, P323, DOI 10.1016/j.fertnstert.2014.11.003; Lechniak D, 2008, REPROD BIOLOGY, V8, P23, DOI 10.1016/S1642-431X(12)60002-3; Lee YSL, 2015, HUM REPROD, V30, P543, DOI 10.1093/humrep/deu334; Leroy JLMR, 2015, REPROD FERT DEVELOP, V27, P693, DOI 10.1071/RD14363; Lin T, 2016, REPROD BIOL; Lonergan P, 1999, J REPROD FERTIL, V117, P159, DOI 10.1530/jrf.0.1170159; Luo SZ, 2006, MOL CELL BIOL, V26, P5688, DOI 10.1128/MCB.00779-06; MCKIERNAN SH, 1994, HUM REPROD, V9, P2123, DOI 10.1093/oxfordjournals.humrep.a138403; McManus KJ, 2005, MOL BIOL CELL, V16, P5013, DOI 10.1091/mbc.E05-01-0065; Meseguer M, 2011, HUM REPROD, V26, P2658, DOI 10.1093/humrep/der256; Michalak Marek, 2015, Clin Exp Reprod Med, V42, P1, DOI 10.5653/cerm.2015.42.1.1; Mourot M, 2006, MOL REPROD DEV, V73, P1367, DOI 10.1002/mrd.20585; Paramio MT, 2014, REPROD DOMEST ANIM, V49, P37, DOI 10.1111/rda.12334; Pontes JHF, 2011, THERIOGENOLOGY, V75, P1640, DOI 10.1016/j.theriogenology.2010.12.026; Sakkas D, 1998, HUM REPROD, V13, P182, DOI 10.1093/humrep/13.1.182; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Song BS, 2014, REPROD FERT DEVELOP, V26, P432, DOI 10.1071/RD12336; Sugimura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036627; Sunderam S, 2015, MMWR SURVEILL SUMM, V64, P1; Swain JE, 2016, FERTIL STERIL, V105, P571, DOI 10.1016/j.fertnstert.2016.01.035; Totey SM, 1996, THERIOGENOLOGY, V45, P521, DOI 10.1016/0093-691X(95)00388-O; Vega H, 2016, IUBMB LIFE, V68, P943, DOI 10.1002/iub.1576; Vinson RK, 2002, MUTAT RES-FUND MOL M, V509, P79, DOI 10.1016/S0027-5107(02)00223-3; Wong CC, 2010, NAT BIOTECHNOL, V28, P1115, DOI 10.1038/nbt.1686; Wrenzycki C, 2013, REPROD DOMEST ANIM, V48, P38, DOI 10.1111/rda.12204; YADAV BR, 1993, MOL REPROD DEV, V36, P434, DOI 10.1002/mrd.1080360405; Zhang C, 2012, PLOS ONE, V7; Zhang JY, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095059	54	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							e0187717	10.1371/journal.pone.0187717	http://dx.doi.org/10.1371/journal.pone.0187717			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6TA	29099865	Green Submitted, Green Published, gold			2022-12-26	WOS:000414377900040
J	Niccoli, S; Boreham, DR; Phenix, CP; Lees, SJ				Niccoli, Sarah; Boreham, Douglas R.; Phenix, Christopher P.; Lees, Simon J.			Non-radioactive 2-deoxy-2-fluoro-D-glucose inhibits glucose uptake in xenograft tumours and sensitizes HeLa cells to doxorubicin in vitro	PLOS ONE			English	Article							CANCER-CELLS; OXIDATIVE STRESS; AEROBIC GLYCOLYSIS; ANTITUMOR-ACTIVITY; DOSE-ESCALATION; 2-DEOXY-D-GLUCOSE; METABOLISM; ADRIAMYCIN; EFFICACY; 2-DEOXYGLUCOSE	A glucose analog called 2-deoxy-D-glucose (2DG) has been successfully used to sensitize cancer cells to ROS-inducing cancer treatments such as ionizing radiation, through the inhibition of glycolysis. However, the use of 2DG can be limited by several factors such as availability, non-specific cytotoxicity, and chemoresistance under hypoxic conditions. The purpose of this study was to investigate the use of non-radioactive 2-deoxy-2-fluoro-D-glucose ((19)FDG), a drug that potentially addresses current limitations of 2DG. The effectiveness of using either 2DG or (19)FDG in combination with doxorubicin (Dox) in HeLa cells was determined in both normoxia and hypoxia. We have also shown that under both oxygen conditions, (19)FDG-treated cells produce less lactate than 2DG-treated cells, an important finding that suggests improved inhibition of glycolysis, the preferential pathway for cancerous cells. When used in combination with Dox, we have demonstrated a significant decrease in the number of viable cells, with the effect of (19)FDG remaining stable across both normoxic and hypoxic conditions. Moreover, the assessment of apoptosis and necrosis revealed that (19)FDG maintained its ability to sensitize HeLa cells to Dox in hypoxia, but 2DG was only effective under normoxic conditions. The retained effectiveness of (19)FDG in combination with Dox under hypoxic conditions, suggests that (19)FDG may be efficacious for sensitizing hypoxic regions of solid tumour masses. Importantly, the ability of (19)FDG to inhibit glucose uptake in vivo was also confirmed using positron emission tomography (PET) of xenograft tumours. The results displayed here suggest (19)FDG is a promising combination therapy, which may lead to decreased ROS scavenging via glycolysis, and enhanced treatment success.	[Niccoli, Sarah; Lees, Simon J.] Lakehead Univ, Fac Med, Med Sci, Thunder Bay, ON, Canada; [Boreham, Douglas R.; Lees, Simon J.] Northern Ontario Sch Med, Med Sci Div, Thunder Bay, ON, Canada; [Phenix, Christopher P.] Univ Saskatchewan, Chem, Saskatoon, SK, Canada; [Phenix, Christopher P.] Thunder Bay Reg Hlth Res Inst, Thunder Bay, ON, Canada; [Lees, Simon J.] Lakehead Univ, Biol, Thunder Bay, ON, Canada	Lakehead University; Northern Ontario School of Medicine; University of Saskatchewan; Northern Ontario School of Medicine; Lakehead University	Lees, SJ (corresponding author), Lakehead Univ, Fac Med, Med Sci, Thunder Bay, ON, Canada.; Lees, SJ (corresponding author), Northern Ontario Sch Med, Med Sci Div, Thunder Bay, ON, Canada.; Lees, SJ (corresponding author), Lakehead Univ, Biol, Thunder Bay, ON, Canada.	simon.lees@nosm.ca	Phenix, Christopher P/O-5028-2018	Phenix, Christopher P/0000-0001-8392-5268	Northern Ontario Academic Medicine Association [A-15-02]; Northern Ontario School of Medicine Research Development Fund	Northern Ontario Academic Medicine Association; Northern Ontario School of Medicine Research Development Fund	This work was supported by the Northern Ontario Academic Medicine Association (A-15-02) SJL, (http://www.noama.ca/site/) and the Northern Ontario School of Medicine Research Development Fund SJL, (http://www.nosm.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloj L, 1999, CANCER RES, V59, P4709; BALCH CM, 1990, CANCER, V65, P604, DOI 10.1002/1097-0142(19900201)65:3+<604::AID-CNCR2820651303>3.0.CO;2-8; Baselga J, 1998, CANCER RES, V58, P2825; Bouayed J, 2010, OXID MED CELL LONGEV, V3, P228, DOI 10.4161/oxim.3.4.12858; BROWN J, 1962, METABOLISM, V11, P1098; BURANT CF, 1992, BIOCHEMISTRY-US, V31, P10414, DOI 10.1021/bi00157a032; BUSTAMANTE E, 1977, P NATL ACAD SCI USA, V74, P3735, DOI 10.1073/pnas.74.9.3735; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Cheong JH, 2011, MOL CANCER THER, V10, P2350, DOI 10.1158/1535-7163.MCT-11-0497; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; Desagher S, 1997, J NEUROSCI, V17, P9060; Dwarukanath BS, 2004, CANCER BIOL THER, V3, P864, DOI 10.4161/cbt.3.9.1040; FLORIDI A, 1981, J NATL CANCER I, V66, P497; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Goldberg L, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.24; Gonzalez-Lima F, 1992, ADV METABOLIC MAPPIN, Vxxiv; Gorovits N, 2003, BIOCHEM MOL BIOL EDU, V31, P163, DOI 10.1002/bmb.2003.494031030227; Gottschalk S, 2004, CLIN CANCER RES, V10, P6661, DOI 10.1158/1078-0432.CCR-04-0039; Guillaumond F, 2013, P NATL ACAD SCI USA, V110, P3919, DOI 10.1073/pnas.1219555110; Gupta S, 2005, CANCER BIOL THER, V4, P87; Hybertson BM, 2011, MOL ASPECTS MED, V32, P234, DOI 10.1016/j.mam.2011.10.006; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kostakoglu L, 2003, RADIOGRAPHICS, V23, P315, DOI 10.1148/rg.232025705; KOVAC P, 1986, CARBOHYD RES, V153, P168, DOI 10.1016/S0008-6215(00)90209-X; Kuerer HM, 1999, J CLIN ONCOL, V17, P460, DOI 10.1200/JCO.1999.17.2.460; Kurtoglu M, 2007, MOL CANCER THER, V6, P3049, DOI 10.1158/1535-7163.MCT-07-0310; Lampidis TJ, 2006, CANCER CHEMOTH PHARM, V58, P725, DOI 10.1007/s00280-006-0207-8; Lee YJ, 1998, J BIOL CHEM, V273, P5294, DOI 10.1074/jbc.273.9.5294; LEFRAK EA, 1973, CANCER-AM CANCER SOC, V32, P302, DOI 10.1002/1097-0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2; Maher JC, 2007, MOL CANCER THER, V6, P732, DOI 10.1158/1535-7163.MCT-06-0407; Malm SW, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0147-4; Manning G, 2014, MUTAT RES-FUND MOL M, V770, P29, DOI 10.1016/j.mrfmmm.2014.09.002; Marin-Hernandez A, 2017, J CELL PHYSIOL, V232, P1346, DOI 10.1002/jcp.25617; Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294; May MS, 2012, EUR J NUCL MED MOL I, V39, P1712, DOI 10.1007/s00259-012-2201-1; Moreno-Sanchez R, 2014, INT J BIOCHEM CELL B, V50, P10, DOI 10.1016/j.biocel.2014.01.025; Muggia FM, 1997, J CLIN ONCOL, V15, P987, DOI 10.1200/JCO.1997.15.3.987; Nogueira V, 2013, CLIN CANCER RES, V19, P4309, DOI 10.1158/1078-0432.CCR-12-1424; Patra KC, 2014, TRENDS BIOCHEM SCI, V39, P347, DOI 10.1016/j.tibs.2014.06.005; Purohit BS, 2014, INSIGHTS IMAGING, V5, P585, DOI 10.1007/s13244-014-0349-x; Raez LE, 2013, CANCER CHEMOTH PHARM, V71, P523, DOI 10.1007/s00280-012-2045-1; Rempel A, 1996, CANCER RES, V56, P2468; Rodriguez-Enriquez S, 2010, INT J BIOCHEM CELL B, V42, P1744, DOI 10.1016/j.biocel.2010.07.010; Schwarzer R, 1969, Zentralbl Chir, V94, P1259; Singal P, 2000, MOL CELL BIOCHEM, V207, P77, DOI 10.1023/A:1007094214460; Singh DH, 2005, STRAHLENTHER ONKOL, V181, P507, DOI 10.1007/s00066-005-1320-z; Singh KK, 2004, ANN NY ACAD SCI, V1019, P260, DOI 10.1196/annals.1297.043; Takeuchi R, 2015, BIOORG MED CHEM LETT, V25, P5500, DOI 10.1016/j.bmcl.2015.10.068; Thorn CF, 2011, PHARMACOGENET GENOM, V21, P440, DOI 10.1097/FPC.0b013e32833ffb56; Wang X, 2007, BRAIN RES, V1132, P1, DOI 10.1016/j.brainres.2006.11.032; WICK AN, 1957, J BIOL CHEM, V224, P963; WILS JA, 1991, J CLIN ONCOL, V9, P827, DOI 10.1200/JCO.1991.9.5.827; Xu RH, 2005, CANCER RES, V65, P613; Zhang FJ, 2009, J CANCER RES THER, V5, P41, DOI 10.4103/0973-1482.55140; Zhu AZ, 2011, SEMIN ONCOL, V38, P55, DOI 10.1053/j.seminoncol.2010.11.012; Zu XL, 2004, BIOCHEM BIOPH RES CO, V313, P459, DOI 10.1016/j.bbrc.2003.11.136	57	9	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187584	10.1371/journal.pone.0187584	http://dx.doi.org/10.1371/journal.pone.0187584			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095925	gold, Green Published, Green Submitted			2022-12-26	WOS:000414340200121
J	Wen, GP; Ringseis, R; Eder, K				Wen, Gaiping; Ringseis, Robert; Eder, Klaus			Endoplasmic reticulum stress inhibits expression of genes involved in thyroid hormone synthesis and their key transcriptional regulators in FRTL-5 thyrocytes	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ELEMENT-BINDING PROTEINS; CONGENITAL HYPOTHYROID GOITER; COENZYME-A REDUCTASE; CYCLIC-AMP; THYROGLOBULIN SYNTHESIS; SREBP-1C ACTIVATION; EPITHELIAL-CELLS; STORAGE DISEASE; THYROTROPIN	Endoplasmic reticulum (ER) stress is characterized by the accumulation of misfolded proteins due to an impairment of ER quality control pathways leading to the activation of a defense system, called unfolded protein response (UPR). While thyrocytes are supposed to be highly susceptible to environmental conditions that cause ER stress due to the synthesis of large amounts of secretory proteins required for thyroid hormone synthesis, systematic investigations on the effect of ER stress on expression of key genes of thyroid hormone synthesis and their transcriptional regulators are lacking. Since the aim of the ER stress-induced UPR is to restore ER homeostasis and to facilitate cell survival through transient shutdown of ribosomal protein translation, we hypothesized that the expression of genes involved in thyroid hormone synthesis and their transcriptional regulators, all of which are not essential for cell survival, are down-regulated in thyrocytes during ER stress, while sterol regulatory element-binding proteins (SREBPs) are activated during ER stress in thyrocytes. Treatment of FRTL-5 thyrocytes with the ER stress inducer tunicamycin (TM) dose-dependently increased the mRNA and/or protein levels of known UPR target genes, stimulated phosphorylation of the ER stress sensor protein kinase RNA-like ER kinase (PERK) and of the PERK target protein eukaryotic initiation factor 2 alpha (elF2 alpha) and caused splicing of the ER stress-sensitive transcription factor X-box binding protein (XBP-1) (P< 0.05). The mRNA levels and/or protein levels of genes involved in thyroid hormone synthesis, sodium/iodide symporter (NIS), thyroid peroxidase (TPO) and thyroglobulin (TG), their transcriptional regulators and thyrotropin (TSH) receptor and the uptake of Na(125)l were reduced at the highest concentration of TM tested (0.1 mu g/mL; P< 0.05). Proteolytic activation of the SREBP-1c pathway was not observed in FRTL-5 cells treated with TM, whereas TM reduced proteolytic activation of the SREBP-2 pathway at 0.1 mu g TM/mL (P< 0.05). In conclusion, the expression of key genes involved in thyroid hormone synthesis and their critical regulators and of the TSH receptor as well as the uptake of iodide is attenuated in thyrocytes during mild ER stress. Down-regulation of NIS, TPO and TG during ER stress is likely the consequence of impaired TSH/TSHR signaling in concert with reduced expression of critical transcriptional regulators of these genes.	[Wen, Gaiping; Ringseis, Robert; Eder, Klaus] Justus Liebig Univ Giessen, Inst Anim Nutr & Nutr Physiol, Giessen, Germany	Justus Liebig University Giessen	Ringseis, R (corresponding author), Justus Liebig Univ Giessen, Inst Anim Nutr & Nutr Physiol, Giessen, Germany.	robert.ringseis@ernaehrung.uni-giessen.de	Ringseis, Robert/AAH-1509-2021					ALOJ SM, 1990, MOL ENDOCRINOL, V4, P611, DOI 10.1210/mend-4-4-611; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMBESIIMPIOMBATO FS, 1980, P NATL ACAD SCI-BIOL, V77, P3455, DOI 10.1073/pnas.77.6.3455; Baryshev M, 2004, J MOL ENDOCRINOL, V32, P903, DOI 10.1677/jme.0.0320903; BIFULCO M, 1995, J BIOL CHEM, V270, P15231, DOI 10.1074/jbc.270.25.15231; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Cangul H, 2014, ENDOCRINE, V45, P206, DOI 10.1007/s12020-013-0027-7; Chevronnay HPG, 2015, ENDOCRINOLOGY, V156, P2349, DOI 10.1210/en.2014-1672; Chiappisi E, 2017, J DAIRY SCI, V100, P6689, DOI 10.3168/jds.2016-12406; Choi YJ, 2014, LAB INVEST, V94, P1114, DOI 10.1038/labinvest.2014.98; Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010; Colgan SM, 2007, INT J BIOCHEM CELL B, V39, P1843, DOI 10.1016/j.biocel.2007.05.002; CONSIGLIO E, 1987, J BIOL CHEM, V262, P10304; Damante G, 2001, PROG NUCLEIC ACID RE, V66, P307; de Virgilio M, 1999, MOL BIOL CELL, V10, P4059, DOI 10.1091/mbc.10.12.4059; EDWARDS HH, 1976, BIOCHEM J, V158, P477, DOI 10.1042/bj1580477; Endo T, 1997, MOL ENDOCRINOL, V11, P1747, DOI 10.1210/me.11.11.1747; Esposito C, 1998, BIOCHEM J, V331, P37, DOI 10.1042/bj3310037; GRIECO D, 1990, J BIOL CHEM, V265, P19343; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Kambe F, 1996, MOL ENDOCRINOL, V10, P801, DOI 10.1210/me.10.7.801; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Keller J, 2012, ANIMAL, V6, P70, DOI 10.1017/S1751731111001327; Kim PS, 1996, J CELL BIOL, V133, P517, DOI 10.1083/jcb.133.3.517; LAMAS L, 1972, ENDOCRINOLOGY, V90, P1417, DOI 10.1210/endo-90-6-1417; LAURENT E, 1987, MOL CELL ENDOCRINOL, V52, P273, DOI 10.1016/0303-7207(87)90055-4; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee JN, 2004, J BIOL CHEM, V279, P45257, DOI 10.1074/jbc.M408235200; Lee SJ, 2011, HORM METAB RES, V43, P331, DOI 10.1055/s-0030-1269907; Leonardi A, 2002, ENDOCRINOLOGY, V143, P2169, DOI 10.1210/en.143.6.2169; Lombardi A, 2015, J CLIN ENDOCR METAB, V100, pE1, DOI 10.1210/jc.2014-2745; Ma SG, 2015, SCAND J CLIN LAB INV, V75, P633, DOI 10.3109/00365513.2015.1055789; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Maurel M, 2014, TRENDS BIOCHEM SCI, V39, P245, DOI 10.1016/j.tibs.2014.02.008; MedeirosNeto G, 1996, J CLIN INVEST, V98, P2838, DOI 10.1172/JCI119112; Nicola JP, 2011, J CLIN ENDOCR METAB, V96, pE1100, DOI 10.1210/jc.2011-0349; Pagliassotti MJ, 2012, ANNU REV NUTR, V32, P17, DOI 10.1146/annurev-nutr-071811-150644; Rauer C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091265; Ringseis R, 2013, MOL ENDOCRINOL, V27, P781, DOI 10.1210/me.2012-1269; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rozen S, 2000, Methods Mol Biol, V132, P365; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Shoulders MD, 2013, CELL REP, V3, P1279, DOI 10.1016/j.celrep.2013.03.024; SINCLAIR AJ, 1990, EUR J BIOCHEM, V193, P311, DOI 10.1111/j.1432-1033.1990.tb19339.x; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Vali M, 2000, Rev Endocr Metab Disord, V1, P69, DOI 10.1023/A:1010016520778; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANHERLE AJ, 1979, NEW ENGL J MED, V301, P239, DOI 10.1056/NEJM197908023010504; VANSANDE J, 1990, MOL CELL ENDOCRINOL, V74, pR1, DOI 10.1016/0303-7207(90)90209-Q; Welihinda AA, 1999, GENE EXPRESSION, V7, P293; Wen G, 2016, J DAIRY SCI, V99, P9211, DOI 10.3168/jds.2016-11174; Wen GP, 2016, BBA-GENE REGUL MECH, V1859, P994, DOI 10.1016/j.bbagrm.2016.06.004; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Xavier ACW, 2016, ARCH ENDOCRIN METAB, V60, P66, DOI 10.1590/2359-3997000000103; Yu YJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003266; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200	59	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187561	10.1371/journal.pone.0187561	http://dx.doi.org/10.1371/journal.pone.0187561			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095946	gold, Green Submitted, Green Published			2022-12-26	WOS:000414340200118
J	Zhang, JM; Wang, JK; An, TT; Wei, D; Chi, FQ; Zhou, BK				Zhang, Jiuming; Wang, Jingkuan; An, Tingting; Wei, Dan; Chi, Fengqin; Zhou, Baoku			Effects of long-term fertilization on soil humic acid composition and structure in Black Soil	PLOS ONE			English	Article							DISSOLVED ORGANIC-MATTER; FLUORESCENCE; SUBSTANCES; SPECTROSCOPY; FRACTIONS; COMPOSTS	The composition and structure of humic acid (HA) can be affected by fertilization, but the short-term effects are difficult to detect using traditional analysis methods. Using a 35-year long-term experiment in Black Soil, the molecular structure of HA was analyzed with Fourier transform infrared spectroscopy (FTIR), C-13 nuclear magnetic resonance spectroscopy (NMR), and fluorescence spectroscopy. Variation in HA was analyzed after long-term fertilization, including fertilization with manure (M), inorganic N, P and K fertilizer (NPK), manure combined with inorganic N, P, and K fertilizer (MNPK), and a no-fertilizer control (CK). The application of each fertilizer treatment increased crop yields compared with the CK treatment, and the MNPK treatment increased crop yield the most. The ratio of main IR absorption peak of HA at 2,920 cm(-1) compared with the peak at 2,850 cm(-1) (2920/2850) was higher in the NPK and MNPK treatments compared with the CK treatment. The application of manure (MNPK and M treatments) increased the ratio of hydrogen to carbon (H/C) in HA, and raised the ratio of the main IR absorption peak of HA at 2920 cm(-1) to that at 1720 cm(-1) (2920/1720). Manure treatments also raised the ratio of aliphatic carbon (C) to aromatic C, alkyl C to alkoxy C and hydrophobic C to hydrophilic C and the fluorescence index (f 450/500), but decreased the degree of aromatization of HA, when compared with the CK treatment. The ratio between each type of C in HA was similar among all the fertilizer treatments, but NPK had a lower ratio of H/C and a lower content of aliphatic C compared with the CK treatment. These results indicated that the molecular structure of HA in Black Soil tends to be aliphatic, simpler, and younger after the application of manure. While the application of inorganic fertilizers increased in the degree of condensation of HA and made HA structure complicated. The application of manure alone or combined with inorganic fertilizers may be an effective way to increase crop yield and improve the structure of soil organic matter.	[Zhang, Jiuming; Wang, Jingkuan; An, Tingting] Shenyang Agr Univ, Coll Land & Environm, Shenyang, Liaoning, Peoples R China; [Zhang, Jiuming; Wei, Dan; Chi, Fengqin; Zhou, Baoku] Heilongjiang Acad Agr Sci, Soil Fertilizer & Environm Resources Inst, Key Lab Soil Environm & Plant Nutr Harbin, Harbin, Heilongjiang, Peoples R China	Shenyang Agricultural University; Heilongjiang Academy of Agricultural Sciences	Wang, JK; An, TT (corresponding author), Shenyang Agr Univ, Coll Land & Environm, Shenyang, Liaoning, Peoples R China.	j-kwang@163.com; atting@126.com	An, Tingting/V-9666-2017	An, Tingting/0000-0002-5263-7375	Youth Fund of Heilongjiang Province [QC2014C042]; National Science and Technology Support Program [2013BAD07B01]; National Natural Science Foundation of China [41771284]; Public Welfare Industry (agriculture) Research Project [201303126]	Youth Fund of Heilongjiang Province; National Science and Technology Support Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Welfare Industry (agriculture) Research Project	The study was supported by the Youth Fund of Heilongjiang Province (Grant No. QC2014C042), National Science and Technology Support Program (Grant No. 2013BAD07B01), National Natural Science Foundation of China (41771284), and the Public Welfare Industry (agriculture) Research Project (Grant No. 201303126) supported this study.r The study was supported by the Youth Fund of Heilongjiang Province (Grant No. QC2014C042), National Science and Technology Support Program (Grant No. 2013BAD07B01), the Public Welfare Industry (agriculture) Research Project (Grant No. 201303126), and National Natural Science Foundation of China (41771284) supported this study.	Amir S, 2010, J HAZARD MATER, V177, P524, DOI 10.1016/j.jhazmat.2009.12.064; Baldock J., 2000, SOIL ORGANIC MATTER; Bertoncini EI, 2008, BIORESOURCE TECHNOL, V99, P4972, DOI 10.1016/j.biortech.2007.09.024; Chien SWC, 2006, J AGR FOOD CHEM, V54, P6790, DOI 10.1021/jf061275m; Dou S, 2008, EUR J SOIL SCI, V59, P532, DOI 10.1111/j.1365-2389.2007.01012.x; Dou S., 2010, SOIL ORGANIC MATTERS; Dou Sen, 1999, Journal of Jilin Agricultural University, V21, P43; Ellerbrock RH, 2016, SOIL TILL RES, V156, P209, DOI 10.1016/j.still.2015.08.014; Galantini J, 2006, SOIL TILL RES, V87, P72, DOI 10.1016/j.still.2005.02.032; HALL KJ, 1974, WATER RES, V8, P239, DOI 10.1016/0043-1354(74)90161-4; [姜杰 Jiang Jie], 2012, [环境化学, Environmental Chemistry], V31, P2002; LEVESQUE M, 1972, SOIL SCI, V113, P346, DOI 10.1097/00010694-197205000-00008; Li L, 2002, CHINESE J ANAL CHEM, V30, P1303; Luce MS, 2014, GEODERMA, P232; McKnight DM, 2001, LIMNOL OCEANOGR, V46, P38, DOI 10.4319/lo.2001.46.1.0038; Mylotte R, 2016, ORG GEOCHEM, V98, P155, DOI 10.1016/j.orggeochem.2016.05.011; PARKINSON JA, 1975, COMMUN SOIL SCI PLAN, V6, P1, DOI 10.1080/00103627509366539; Plaza C, 2002, J AGR FOOD CHEM, V50, P4867, DOI 10.1021/jf020195p; Rezacova V, 2007, FOLIA MICROBIOL, V52, P415, DOI 10.1007/BF02932097; Sanchez-Monedero MA, 2002, BIODEGRADATION, V13, P361, DOI 10.1023/A:1022888231982; SENESI N, 1991, SOIL SCI, V152, P259, DOI 10.1097/00010694-199110000-00004; Tan KH, 2014, BOOKS SOIL PLANT ENV, P1, DOI 10.1201/b17037; Wei ZM, 2016, INT BIODETER BIODEGR, V113, P187, DOI 10.1016/j.ibiod.2016.03.010; Wei ZM, 2014, CHEMOSPHERE, V95, P261, DOI 10.1016/j.chemosphere.2013.08.087; Wen B, 2007, ENVIRON SCI TECHNOL, V41, P3165, DOI 10.1021/es062262s; Wolfe AP, 2002, ENVIRON SCI TECHNOL, V36, P3217, DOI 10.1021/es011215r; Wu JG, 1998, SPECTROSC SPECT ANAL, V18, P52; Zhang JJ, 2009, CHINESE AGR SCI, V42, P2223; Zhao Y, 2017, ECOL INDIC, V72, P473, DOI 10.1016/j.ecolind.2016.08.051; Zhuo SN, 1994, ADV SOIL SCI, V22, P6	30	26	28	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186918	10.1371/journal.pone.0186918	http://dx.doi.org/10.1371/journal.pone.0186918			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095840	Green Submitted, gold, Green Published			2022-12-26	WOS:000414340200031
J	Zheteyeva, Y; Rainey, JJ; Gao, HJ; Jacobson, EU; Adhikari, BB; Shi, JR; Mpofu, JJ; Bhavnani, D; Dobbs, T; Uzicanin, A				Zheteyeva, Yenlik; Rainey, Jeanette J.; Gao, Hongjiang; Jacobson, Evin U.; Adhikari, Bishwa B.; Shi, Jianrong; Mpofu, Jonetta J.; Bhavnani, Darlene; Dobbs, Thomas; Uzicanin, Amra			Unintended costs and consequences of school closures implemented in preparation for Hurricane Isaac in Harrison County School District, Mississippi, August-September 2012	PLOS ONE			English	Article							PANDEMIC INFLUENZA	Introduction School closures, while an effective measure against the spread of disease during a pandemic, may carry unintended social and economic consequences for students and families. We evaluated these costs and consequences following a 4-day school closure in Mississippi's Harrison County School District (HCSD). Methods In a survey of all households with students enrolled in HCSD, we collected information on difficulties related to the school closure, including interruption of employment and pay, loss of access to subsidized school meals, and arrangement of alternative childcare. We analyzed this information in the context of certain demographic characteristics of the survey respondents and households, such as race, level of education, and income. We also estimated the average number of lost work days and documented the childcare alternatives chosen by households affected by the school closure. Results We received 2,229 (28.4%) completed surveys from an estimated 7,851 households eligible to participate. About half (1,082 [48.5%]) of the households experienced at least some difficulty during the closure, primarily in three areas: uncertainty about duration of the closure, lost income, and the effort of arranging alternate childcare. Adults working outside the home, particularly the major wage earner in the household, were more likely to suffer lost income while schools were closed, an effect mitigated by paid leave benefits. Difficulty arranging childcare was reported most frequently by respondents with lower levels of education and households with younger children. Beyond the top three concerns expressed by households in HCSD, the survey also shed light on the issue of food insecurity when subsidized school meals are not available. Reported by 17.9% of households participating in the subsidized school lunch program, difficulty providing meals during the closure was associated with higher numbers of dependent children, selection of "other" as the race of the household respondent, and lower levels of education. Conclusion To help prevent undue financial hardship in families of school children, public health authorities and school administrators should provide recommendations for childcare alternatives and paid leave or remote work options during prolonged school closures, particularly to households in which all adults work outside of the home.	[Zheteyeva, Yenlik; Rainey, Jeanette J.; Gao, Hongjiang; Shi, Jianrong; Bhavnani, Darlene; Uzicanin, Amra] US Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA 30333 USA; [Jacobson, Evin U.] US Ctr Dis Control & Prevent, Off Publ Hlth Preparedness & Response, Atlanta, GA USA; [Adhikari, Bishwa B.] US Ctr Dis Control & Prevent, Div Preparedness & Emerging Infect, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Mpofu, Jonetta J.] US Ctr Dis Control & Prevent, Div Reprod Hlth Chron Dis Prevent & Promot, Atlanta, GA USA; [Mpofu, Jonetta J.] US Ctr Dis Control & Prevent, Epidem Intelligence Serv, Off Workforce & Career Dev, Atlanta, GA USA; [Bhavnani, Darlene] Council State & Terr Epidemiologists Appl, Atlanta, GA USA; [Dobbs, Thomas] Mississippi Dept Hlth, Jackson, MS USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Zheteyeva, Y (corresponding author), US Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA 30333 USA.	igg0@cdc.gov		Dobbs, Thomas/0000-0001-6199-5337	United States Centers for Disease Control and Prevention	United States Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was supported by the United States Centers for Disease Control and Prevention (http://www.cdc.gov). Karna, LLC provided support in the form of a salary for Jianrong Shi, but did not have any other role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	[Anonymous], 2008, AM COMM SURV 5 YEAR; Berg R., 2012, TROPICAL CYCLONE REP; Berkman BE, 2008, J PUBLIC HEALTH MAN, V14, P372, DOI 10.1097/01.PHH.0000324566.72533.0b; Blendon RJ, 2008, EMERG INFECT DIS, V14, P778, DOI 10.3201/eid1405.071437; Centers for Disease Control and Prevention, 2012, GUID COMM PREV SERV; Jarquin VG, 2011, EMERG INFECT DIS, V17, P751, DOI [10.3201/eid1704.100906, 10.3201/eid1706.100906]; Johnson AJ, 2008, EMERG INFECT DIS, V14, P1024, DOI 10.3201/eid1407.080096; Laughlin L., 2011, CHILD CARE ARRANGEME; Qualls N, 2017, MMWR RECOMM REP, V66, P1, DOI 10.15585/mmwr.rr6601a1; Steelfisher GK, 2010, MMWR-MORBID MORTAL W, V59, P2000; Timperio C. G., 2009, Morbidity and Mortality Weekly Report, V58, P1405; United States Department of Agriculture, FOOD NUTR SERV SCH M; United States Department of Agriculture, 2009, PAND SUPPL NUTR ASS; United States Department of Labor, 2012, EMPL CHAR FAM; Wong KK, 2014, PLOS ONE, V9, P2011, DOI DOI 10.1371/J0URNAL.P0NE.0113755	15	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0184326	10.1371/journal.pone.0184326	http://dx.doi.org/10.1371/journal.pone.0184326			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091717	gold, Green Published			2022-12-26	WOS:000414229700002
J	Huang, SH; Hart, MA; Wade, M; Cozart, MR; McGrath, SL; Kobryn, K				Huang, Shu Hui; Hart, Madison A.; Wade, Matthew; Cozart, McKayla R.; McGrath, Siobhan L.; Kobryn, Kerri			Biochemical characterization of Borrelia burgdorferi's RecA protein	PLOS ONE			English	Article							ESCHERICHIA-COLI RECA; SINGLE-STRANDED-DNA; LYME-DISEASE SPIROCHETE; BINDING PROTEIN; YEAST RAD51; ANTIGENIC VARIATION; TELOMERE RESOLVASE; ATP HYDROLYSIS; SSB PROTEIN; RECOMBINATION	RecA plays key roles in DNA recombination, replication and repair. Mutation of recA in the Lyme disease spirochete, Borrelia burgdorferi, fails to produce some of the phenotypes expected from study of recA mutation in other organisms. 'Missing' recA phenotypes include a lack of growth or viability effects, including in the presence of DNA damage, and a lack of a role in vlsE antigenic variation and infectivity. We present a purification and biochemical characterization of recombinant B. burgdorferi RecA protein. We find that B. burgdorferi RecA displays the expected properties of being a DNA-dependent ATPase, of having an intrinsic binding preference for ssDNA over dsDNA enhanced by ATP binding, of promoting DNA pairing and strand exchange reactions and of having a detectable coprotease activity with E. coli LexA repressor. DNA pairing and strand exchange reactions promoted by B. burgdorferi RecA show an unusually strong dependence upon the presence of the cognate ssDNA binding protein (SSB) but are very sensitive to inhibition by SSB when the ssDNA was prebound by SSB. This indicates B. burgdorferi RecA may have an enhanced requirement for recombinational mediators to promote RecA-SSB exchange, despite the absence of homologues of the RecF pathway proteins that normally play this role in eubacteria. Finally, we do not find any unusual, intrinsic properties of B. burgdorferi's RecA protein to explain the unusual phenotype of recA mutation and suggest that there may be alternative recombinase functions that could explain the 'missing' phenotypes.	[Huang, Shu Hui; Hart, Madison A.; Wade, Matthew; Cozart, McKayla R.; McGrath, Siobhan L.; Kobryn, Kerri] Univ Saskatchewan, Coll Med, Dept Microbiol & Immunol, Acad Hlth Sci Bldg, Saskatoon, SK, Canada; [Wade, Matthew] CHUL, Quebec City, PQ, Canada	University of Saskatchewan; Laval University	Kobryn, K (corresponding author), Univ Saskatchewan, Coll Med, Dept Microbiol & Immunol, Acad Hlth Sci Bldg, Saskatoon, SK, Canada.	kerri.kobryn@usask.ca			Natural Sciences and Engineering Council of Canada [RGPIN 04382-2017]	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by grant #RGPIN 04382-2017 from the Natural Sciences and Engineering Council of Canada. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianco P R, 1998, Front Biosci, V3, pD570; Black CG, 1998, GENE, V208, P61, DOI 10.1016/S0378-1119(97)00653-7; Butala M, 2009, CELL MOL LIFE SCI, V66, P82, DOI 10.1007/s00018-008-8378-6; Chenail AM, 2012, J BACTERIOL, V194, P4570, DOI 10.1128/JB.00661-12; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; CLARK AJ, 1965, P NATL ACAD SCI USA, V53, P451, DOI 10.1073/pnas.53.2.451; Courcelle J, 2003, ANNU REV GENET, V37, P611, DOI 10.1146/annurev.genet.37.110801.142616; Dresser AR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000680; Eggers CH, 1999, J BACTERIOL, V181, P7308, DOI 10.1128/JB.181.23.7308-7313.1999; Eggers CH, 2001, J BACTERIOL, V183, P4771, DOI 10.1128/JB.183.16.4771-4778.2001; Eggler AL, 2002, J BIOL CHEM, V277, P39280, DOI 10.1074/jbc.M204328200; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Hardy PO, 2013, J BACTERIOL, V195, P2220, DOI 10.1128/JB.00043-13; HOWARDFLANDERS P, 1984, COLD SPRING HARB SYM, V49, P571, DOI 10.1101/SQB.1984.049.01.064; Huang SH, 2016, NUCLEIC ACIDS RES, V44, P5288, DOI 10.1093/nar/gkw344; Iyer LM, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-8; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P97, DOI 10.1016/0022-2836(87)90630-9; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; LAVERY PE, 1992, J BIOL CHEM, V267, P9315; Lin T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000679; LITTLE JW, 1984, P NATL ACAD SCI-BIOL, V81, P1375, DOI 10.1073/pnas.81.5.1375; LITTLE JW, 1980, P NATL ACAD SCI-BIOL, V77, P3225, DOI 10.1073/pnas.77.6.3225; Liu J, 2006, J BIOL CHEM, V281, P26308, DOI 10.1074/jbc.M604349200; Liu J, 2011, CRIT REV BIOCHEM MOL, V46, P240, DOI 10.3109/10409238.2011.576007; Liveris D, 2004, J BACTERIOL, V186, P2275, DOI 10.1128/JB.186.8.2275-2280.2004; Liveris D, 2008, INFECT IMMUN, V76, P4009, DOI 10.1128/IAI.00027-08; Luo Y, 2001, CELL, V106, P585, DOI 10.1016/S0092-8674(01)00479-2; Mazin AV, 1996, P NATL ACAD SCI USA, V93, P10673, DOI 10.1073/pnas.93.20.10673; Mazin AV, 1998, EMBO J, V17, P1161, DOI 10.1093/emboj/17.4.1161; McIlwraith MJ, 2001, J MOL BIOL, V305, P23, DOI 10.1006/jmbi.2000.4268; MENETSKI JP, 1985, J MOL BIOL, V181, P281, DOI 10.1016/0022-2836(85)90092-0; MENETSKI JP, 1990, P NATL ACAD SCI USA, V87, P21, DOI 10.1073/pnas.87.1.21; Mir T, 2013, NUCLEIC ACIDS RES, V41, P10438, DOI 10.1093/nar/gkt832; MUNIYAPPA K, 1984, P NATL ACAD SCI-BIOL, V81, P2757, DOI 10.1073/pnas.81.9.2757; Norris SJ, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MDNA3-0038-2014; Petukhova G, 1998, NATURE, V393, P91, DOI 10.1038/30037; PUGH BF, 1988, J BIOL CHEM, V263, P76; PUGH BF, 1987, J BIOL CHEM, V262, P1326; Putteet-Driver AD, 2004, J BACTERIOL, V186, P2266, DOI 10.1128/JB.186.8.2266-2274.2004; Rehrauer WM, 1996, J BIOL CHEM, V271, P11996, DOI 10.1074/jbc.271.20.11996; REHRAUER WM, 1993, J BIOL CHEM, V268, P1292; Rice KP, 2001, J BIOL CHEM, V276, P38570, DOI 10.1074/jbc.M105678200; Shan Q, 1996, J BIOL CHEM, V271, P5712, DOI 10.1074/jbc.271.10.5712; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; SHIBATA T, 1979, P NATL ACAD SCI USA, V76, P1638, DOI 10.1073/pnas.76.4.1638; Solinger JA, 2001, P NATL ACAD SCI USA, V98, P8447, DOI 10.1073/pnas.121009898; Solinger JA, 2001, J MOL BIOL, V307, P1207, DOI 10.1006/jmbi.2001.4555; Steffen SE, 2002, J BIOL CHEM, V277, P14493, DOI 10.1074/jbc.M112444200; Stohl EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017101; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Sung P, 1996, J BIOL CHEM, V271, P27983, DOI 10.1074/jbc.271.45.27983; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Wang X, 2004, PLOS BIOL, V2, P104, DOI 10.1371/journal.pbio.0020021; Zhang JR, 1997, CELL, V89, P275, DOI 10.1016/S0092-8674(00)80206-8	54	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187382	10.1371/journal.pone.0187382	http://dx.doi.org/10.1371/journal.pone.0187382			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088268	gold, Green Published, Green Submitted			2022-12-26	WOS:000414088900080
J	Pedersen, MO; Gang, AO; Brown, P; Pedersen, M; Knudsen, H; Nielsen, SL; Poulsen, T; Klausen, TW; Hogdall, E; Norgaard, P				Pedersen, Mette Olgod; Gang, Anne Ortved; Brown, Peter; Pedersen, Michael; Knudsen, Helle; Nielsen, Signe Ledou; Poulsen, Tim; Klausen, Tobias Wirenfeldt; Hogdall, Estrid; Norgaard, Peter			Real world data on young patients with high-risk diffuse large B-cell lymphoma treated with R-CHOP or R-CHOEP - MYC, BCL2 and BCL6 as prognostic biomarkers	PLOS ONE			English	Article							RITUXIMAB PLUS CYCLOPHOSPHAMIDE; SINGLE CENTERS EXPERIENCE; NON-HODGKINS-LYMPHOMA; POOR-PROGNOSIS; CLINICAL-FEATURES; GERMINAL CENTER; PHASE-II; TRANSLOCATIONS; REARRANGEMENTS; EXPRESSION	Background Double expression of MYC and BCL2 proteins (DE) and double-hit MYC+BCL2/BCL6 translocations (DH) were established as important biomarkers in patients with diffuse large B-cell lymphoma (DLBCL) by the 2016 revision of the World Health Organization classification of lymphoid neoplasms. Whether this applies to the subgroup of young patients with high risk DLBCL is not known. We previously found that in a uniform retrospective population-based cohort of patients aged 18-60 years with high-risk DLBCL, the addition of etoposide to R-CHOP chemotherapy (R-CHOEP) resulted in improved survival mainly in patients with germinal center B-cell like (GCB) immunophenotype. The aim of this study was to investigate the prognostic and predictive value of DE and DH in this patient cohort. Methods Data on all young Danish patients diagnosed with de novo high-risk DLBCL 2004-2008 and treated with R-CHOP or R-CHOEP were obtained from the Danish Lymphoma database (n = 159). Tumor samples were available from 103 patients. MYC and BCL2 proteins were analyzed with quantitative immunohistochemistry (IHC) using different cut off values. MYC-, BCL2-and BCL6-translocations were examined with fluorescent in situ hybridization (FISH). Results DE with MYC > 75% and BCL2 > 85% was an independent negative prognostic marker of progression free survival (PFS) in patients treated with R-CHOP but not R-CHOEP (p < 0.001), also after exclusion of patients with DH. A predictive effect of DE for response (PFS) to R-CHOEP vs. R-CHOP was almost significant (p = 0.07). DH was not prognostic in this patient cohort. Conclusion In young patients with high-risk DLBCL, treatment with R-CHOEP may overcome the negative prognostic impact of DE observed in patients treated with R-CHOP.	[Pedersen, Mette Olgod; Knudsen, Helle; Nielsen, Signe Ledou; Poulsen, Tim; Hogdall, Estrid; Norgaard, Peter] Herlev & Gentofte Hosp, Dept Pathol, Herlev, Denmark; [Gang, Anne Ortved; Klausen, Tobias Wirenfeldt] Herlev & Gentofte Hosp, Dept Hematol, Herlev, Denmark; [Brown, Peter; Pedersen, Michael] Rigshosp, Dept Hematol, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Pedersen, MO (corresponding author), Herlev & Gentofte Hosp, Dept Pathol, Herlev, Denmark.	Mette-pedersen@dadlnet.dk		Hogdall, Estrid/0000-0003-4689-5658; Brown, Peter de Nully/0000-0002-6522-4086; Poulsen, Tim/0000-0001-9781-0541	Department of Pathology, Herlev Hospital; Dansk Kraeftforsknings Fond and Roche NS	Department of Pathology, Herlev Hospital; Dansk Kraeftforsknings Fond and Roche NS	This work was supported by the Department of Pathology, Herlev Hospital; Dansk Kraeftforsknings Fond and Roche NS (unrestricted grant).	Akyurek N, 2012, CANCER-AM CANCER SOC, V118, P4173, DOI 10.1002/cncr.27396; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Arboe B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157999; Aukema SM, 2011, BLOOD, V117, P2319, DOI 10.1182/blood-2010-09-297879; Ballman KV, 2015, J CLIN ONCOL, V33, P3968, DOI 10.1200/JCO.2015.63.3651; Barrans S, 2010, J CLIN ONCOL, V28, P3360, DOI 10.1200/JCO.2009.26.3947; Budczies J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051862; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; Dunleavy K, 2014, BLOOD, V124, P395; Foot NJ, 2011, J CLIN PATHOL, V64, P802, DOI 10.1136/jclinpath-2011-200015; Gang AO, 2012, ANN ONCOL, V23, P147, DOI 10.1093/annonc/mdr058; Gang AO, 2014, LEUKEMIA LYMPHOMA, P1; Green TM, 2012, J CLIN ONCOL, V30, P3460, DOI 10.1200/JCO.2011.41.4342; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Holte H, 2013, ANN ONCOL, V24, P1385, DOI 10.1093/annonc/mds621; Horn H, 2015, LEUKEMIA, V29, P1564, DOI 10.1038/leu.2015.43; Hu SM, 2013, BLOOD, V121, P4021, DOI 10.1182/blood-2012-10-460063; Johnson NA, 2012, J CLIN ONCOL, V30, P3452, DOI 10.1200/JCO.2011.41.0985; Johnson NA, 2009, BLOOD, V114, P2273, DOI 10.1182/blood-2009-03-212191; Kanungo A, 2006, MODERN PATHOL, V19, P25, DOI 10.1038/modpathol.3800500; Klapper W, 2008, LEUKEMIA, V22, P2226, DOI 10.1038/leu.2008.230; Kluk MJ, 2016, AM J CLIN PATHOL, V145, P166, DOI 10.1093/ajcp/aqv028; Kramer MH, 1998, BLOOD, P92; Kuhnl A, 2017, ANN ONCOL; Le Gouill S, 2007, HAEMATOLOGICA, V92, P1335, DOI 10.3324/haematol.11305; Li S., 2011, MODERN PATHOL, V25, P145; Li SY, 2012, MODERN PATHOL, V25, P145, DOI 10.1038/modpathol.2011.147; Lin P, 2007, HAEMATOLOGICA, V92, P1297, DOI 10.3324/haematol.11263; Mahmoud AZ, 2015, MODERN PATHOL, V28, P545, DOI 10.1038/modpathol.2014.140; Melen CM, 2016, BRIT J HAEMATOL, V175, P614, DOI 10.1111/bjh.14399; Niitsu N, 2009, LEUKEMIA, V23, P777, DOI 10.1038/leu.2008.344; Pedersen MO, 2014, EUR J HAEMATOL, V92, P42, DOI 10.1111/ejh.12212; Pedersen MO, 2012, EUR J HAEMATOL, V89, P63, DOI 10.1111/j.1600-0609.2012.01787.x; Savage KJ, 2009, BLOOD, V114, P3533, DOI 10.1182/blood-2009-05-220095; Schmitz N, 2012, LANCET ONCOL, V13, P1250, DOI 10.1016/S1470-2045(12)70481-3; Slack GW, 2011, ADV ANAT PATHOL, V18, P219, DOI 10.1097/PAP.0b013e3182169948; Snuderl M, 2010, AM J SURG PATHOL, V34, P327, DOI 10.1097/PAS.0b013e3181cd3aeb; Swerdlow SH, 2008, WHO CLASSIFICATION T; Swerdlow SH, 2016, BLOOD, V127, P2375, DOI 10.1182/blood-2016-01-643569; Tibiletti MG, 2009, HUM PATHOL, V40, P645, DOI 10.1016/j.humpath.2008.06.032; Tomita N, 2009, HAEMATOL-HEMATOL J, V94, P935, DOI 10.3324/haematol.2008.005355; Vyberg M, 2016, VIRCHOWS ARCH, V468, P19, DOI 10.1007/s00428-015-1829-1; Wasterlid T, 2017, HEMATOL ONCOL, V35, P151, DOI 10.1002/hon.2256; Wilson WH, 2008, J CLIN ONCOL, V26, P2717, DOI 10.1200/JCO.2007.13.1391; Wilson WH, 2016, BLOOD, V128, DOI 10.1182/blood.V128.22.469.469; Wilson WH, 2012, HAEMATOL-HEMATOL J, V97, P758, DOI 10.3324/haematol.2011.056531; Xu-Monette ZY, 2015, MODERN PATHOL, V28, P1555, DOI 10.1038/modpathol.2015.118	47	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186983	10.1371/journal.pone.0186983	http://dx.doi.org/10.1371/journal.pone.0186983			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088292	gold, Green Published, Green Submitted			2022-12-26	WOS:000414088900034
J	Angelo, PH; Varella, LRD; de Oliveira, MCE; Matias, MGL; de Azevedo, MAR; de Almeida, LM; de Azevedo, PRM; Micussi, MT				Angelo, Priscylla Helouyse; Dantas Varella, Larissa Ramalho; Eugenia de Oliveira, Maria Clara; Leite Matias, Monayane Grazielly; Ribeiro de Azevedo, Maria Aneilma; de Almeida, Luzinete Medeiros; Medeiros de Azevedo, Paulo Roberto; Micussi, Maria Thereza			A manometry classification to assess pelvic floor muscle function in women	PLOS ONE			English	Article							VAGINAL SQUEEZE PRESSURE; STRESS URINARY-INCONTINENCE; STRENGTH; PERINEOMETER; DELIVERY; PALPATION; PARITY; RELIABILITY; VOLUNTARY	Objective To develop a classification scale for manometry of pelvic floor muscles (PFM) in Brazilian women, according to the modified Oxford scale. Methods A cross sectional study, with 288 women enrolled in the Maternity, Natal, Brazil. Manometry and PFM strength data were collected and classified according to the modified Oxford scale. A simple linear regression was performed to determine the classification scale of manometry using the modified Oxford scale as the explanatory variable and the arithmetic mean of the manometry measurements as the response variable. Results The average age was 52.80 (+/- 8.78; CI: 51.67-53.93) years. Manometry showed an average of 35.1 (+/- 22.7; CI: 32.1-38.0) cmH(2)O and most women (29.7%) scored grade 3 on the modified Oxford scale. According to the proposed scale, values between 7.5 to 14.5 cmH(2)O correspond to very weak pressure; 14.6 to 26.5 cmH(2)O represent weak pressure; 26.6 to 41.5 cmH(2)O represent moderate pressure; 41.6 to 60.5 cmH(2)O represent good pressure, and values above 60.6 cmH(2)O correspond to strong pressure. Conclusion Manometry values were rated on a five-point scale. It is possible to rank the pressure levels performed by voluntary contraction of PFM with this new scale.	[Angelo, Priscylla Helouyse; Dantas Varella, Larissa Ramalho; Eugenia de Oliveira, Maria Clara; Leite Matias, Monayane Grazielly; Ribeiro de Azevedo, Maria Aneilma; de Almeida, Luzinete Medeiros; Micussi, Maria Thereza] Univ Fed Rio Grande do Norte, Physiotherapy Dept, Natal, RN, Brazil; [Medeiros de Azevedo, Paulo Roberto] Univ Fed Rio Grande do Norte, Stat Dept, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte	Angelo, PH (corresponding author), Univ Fed Rio Grande do Norte, Physiotherapy Dept, Natal, RN, Brazil.	priscyllahmangelo@gmail.com		Angelo, Priscylla/0000-0002-2238-1866				Barbosa PB, 2009, CLINICS, V64, P527, DOI 10.1590/S1807-59322009000600007; Batista EM, 2011, GYNECOL ENDOCRINOL, V27, P910, DOI 10.3109/09513590.2011.569603; Beuttenmüller Leila, 2011, Fisioter. Pesqui., V18, P210; Bo K, 2005, PHYS THER, V85, P269; Bo K, 2001, ACTA OBSTET GYN SCAN, V80, P883, DOI 10.1034/j.1600-0412.2001.801003.x; Brazales B, 2017, NEUROUROL, P1; Chehrehrazi M, 2009, INT UROGYNECOL J, V20, P1491, DOI 10.1007/s00192-009-0977-8; Chevalier F, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/s12905-014-0143-4; Varella LRD, 2016, J PHYS THER SCI, V28, P824, DOI 10.1589/jpts.28.824; de Assis LC, 2015, REV BRAS GINECOL OBS, V37, P460, DOI 10.1590/SO100-720320150005361; de Oliveira MCE, 2016, DIABET METAB SYND OB, V9, P207, DOI 10.2147/DMSO.S106221; Fistonic N, 2016, LASER MED SCI, V31, P635, DOI 10.1007/s10103-016-1884-0; Gameiro MO, 2011, CLINICS, V66, P1389, DOI 10.1590/S1807-59322011000800014; Hundley AF, 2005, AM J OBSTET GYNECOL, V192, P1583, DOI 10.1016/j.ajog.2004.11.015; Isherwood PJ, 2000, BRIT J OBSTET GYNAEC, V107, P1007, DOI 10.1111/j.1471-0528.2000.tb10404.x; Ferreira CHJ, 2011, PHYSIOTHERAPY, V97, P132, DOI 10.1016/j.physio.2010.06.007; Kerschan-Schindl K, 2002, NEUROUROL URODYNAM, V21, P42, DOI 10.1002/nau.2099; Laycock J., 2001, PHYSIOTHERAPY, V87, P631, DOI [10.1016/s0031-9406(05)61108-x, DOI 10.1016/S0031-9406(05)61108-X]; Lee HN, 2013, INT UROGYNECOL J, V24, P831, DOI 10.1007/s00192-012-1943-4; LEVITT EE, 1979, ARCH SEX BEHAV, V8, P425, DOI 10.1007/BF01541198; Messelink B, 2005, NEUROUROL URODYNAM, V24, P374, DOI 10.1002/nau.20144; Oversand SH, 2015, INT UROGYNECOL J, V26, P1777, DOI 10.1007/s00192-015-2793-7; Ozdemir OC, 2015, J PHYS THER SCI, V27, P2133, DOI 10.1589/jpts.27.2133; Barbosa AMP, 2005, REV BRAS GINECOL OBS, V27, P677, DOI 10.1590/S0100-72032005001100008; Pereira VS, 2014, BRAZ J PHYS THER, V18, P428, DOI 10.1590/bjpt-rbf.2014.0038; Rahmani N, 2011, J BODYW MOV THER, V15, P209, DOI 10.1016/j.jbmt.2009.07.007; Sartore A, 2003, J REPROD MED, V48, P171; Slieker-ten Hove MCP, 2009, INT UROGYNECOL J, V20, P1497, DOI 10.1007/s00192-009-0978-7; Thompson JA, 2006, INT UROGYNECOL J, V17, P624, DOI 10.1007/s00192-006-0081-2; Unger CA, 2011, OBSTET GYN CLIN N AM, V38, P23, DOI 10.1016/j.ogc.2011.02.002; Volloyhaug I, 2016, ULTRASOUND OBST GYN, V47, P768, DOI 10.1002/uog.15731; World Health Organization, 1997, OB PREV MAN GLOB EP	32	8	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187045	10.1371/journal.pone.0187045	http://dx.doi.org/10.1371/journal.pone.0187045			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084229	gold, Green Published, Green Submitted			2022-12-26	WOS:000413910200026
J	Belloir, C; Savistchenko, J; Neiers, F; Taylor, AJ; McGrane, S; Briand, L				Belloir, Christine; Savistchenko, Jimmy; Neiers, Fabrice; Taylor, Andrew J.; McGrane, Scott; Briand, Loic			Biophysical and functional characterization of the N-terminal domain of the cat T1R1 umami taste receptor expressed in Escherichia coli	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; GLOSSOPHARYNGEAL NERVE; EXTRACELLULAR DOMAIN; MOLECULAR-MECHANISM; CHORDA TYMPANI; DOMESTIC DOGS; SWEET; RESPONSES; MICE; SUBUNITS	Umami taste perception is mediated by the heterodimeric G-protein coupled receptors (GPCRs), formed by the assembly of T1R1 and T1R3 subunits. T1R1 and T1R3 subunits are class C GPCRs whose members share common structural homologies including a long N-terminal domain (NTD) linked to a seven transmembrane domain by a short cysteine-rich region. The NTD of the T1R1 subunit contains the primary binding site for umami stimuli, such as L-glutamate (L-Glu) for humans. Inosine-5'-monophosphate (IMP) binds at a location close to the opening of the T1R1-NTD "flytrap", thus creating the observed synergistic response between L-Glu and IMP. T1R1/T1R3 binding studies have revealed species-dependent differences. While human T1R1/T1R3 is activated specifically by L-Glu, the T1R1/T1R3 in other species is a broadly tuned receptor, sensitive to a range of L-amino acids. Because domestic cats are obligate carnivores, they display strong preferences for some specific amino acids. To better understand the structural basis of umami stimuli recognition by non-human taste receptors, we measured the binding of selected amino acids to cat T1R1/T1R3 (cT1R1/cT1R3) umami taste receptor. For this purpose, we expressed cT1R1-NTD in bacteria as inclusion bodies. After purification, refolding of the protein was achieved. Circular dichroism spectroscopic studies revealed that cT1R1-NTD was well renatured with evidence of secondary structures. Using size-exclusion chromatography coupled to light scattering, we found that the cT1R1-NTD behaves as a monomer. Ligand binding quantified by intrinsic tryptophan fluorescence showed that cT1R1-NTD is capable of binding L-amino acids with K-d values in the micromolar range. We demonstrated that IMP potentiates L-amino acid binding onto renatured cT1R1-NTD. Interestingly, our results revealed that IMP binds the extracellular domain in the absence of L-amino acids. Thus, this study demonstrates that the feasibility to produce milligram quantities of cT1R1-NTD for functional and structural studies.	[Belloir, Christine; Savistchenko, Jimmy; Neiers, Fabrice; Briand, Loic] Bourgogne Franche Comte Univ, Ctr Sci Gout & Alimentat, INRA, CNRS,AgroSup Dijon, Dijon, France; [Taylor, Andrew J.; McGrane, Scott] WALTHAM Ctr Pet Nutr, Melton Mowbray, Leics, England	INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Mars; WALTHAM Petcare Science Institute	Briand, L (corresponding author), Bourgogne Franche Comte Univ, Ctr Sci Gout & Alimentat, INRA, CNRS,AgroSup Dijon, Dijon, France.	loic.briand@inra.fr	Neiers, Fabrice/AAM-1637-2021	Neiers, Fabrice/0000-0002-8965-4929; Briand, Loic/0000-0002-8175-5936	WALTHAM Centre for Pet Nutrition	WALTHAM Centre for Pet Nutrition	This work was supported by a grant from the WALTHAM Centre for Pet Nutrition, which is part of Mars Petcare UK, to LB. There was no additional internal or external funding received for this study. WALTHAM Centre for Pet Nutrition provided support in the form of salaries for authors Andrew J. Taylor and Scott McGrane but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ariyasu T, 2003, IN VITRO CELL DEV-AN, V39, P80; Bachmanov AA, 2014, CURR PHARM DESIGN, V20, P2669, DOI 10.2174/13816128113199990566; Baldwin MW, 2014, SCIENCE, V345, P929, DOI 10.1126/science.1255097; Beauchamp GK, 2009, AM J CLIN NUTR, V90, p723S, DOI 10.3945/ajcn.2009.27462E; Bradshaw JWS, 2006, J NUTR, V136, p1927S, DOI 10.1093/jn/136.7.1927S; BRADSHAW JWS, 1991, P NUTR SOC, V50, P99, DOI 10.1079/PNS19910015; Chaudhari N, 2009, AM J CLIN NUTR, V90, p738S, DOI 10.3945/ajcn.2009.27462H; Choudhuri SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130088; Danilova V, 1999, CHEM SENSES, V24, P301, DOI 10.1093/chemse/24.3.301; Delay ER, 2015, CHEM SENSES, V40, P125, DOI 10.1093/chemse/bju067; Geng Y, 2016, ELIFE, V5, DOI 10.7554/eLife.13662; Geng Y, 2012, NAT NEUROSCI, V15, P970, DOI 10.1038/nn.3133; Hellekant G, 1997, J NEUROPHYSIOL, V77, P978, DOI 10.1152/jn.1997.77.2.978; Huang Y, 2009, BIOCHEMISTRY-US, V48, P388, DOI 10.1021/bi8014604; Kendig DM, 2014, AM J PHYSIOL-GASTR L, V307, pG1100, DOI 10.1152/ajpgi.00251.2014; Kuninaka A, 1960, J AGR CHEM SOC JPN, V34, P487; Kuninaka A., 1964, S FLAV POT CAMBR MA, P4; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Kusuhara Y, 2013, J PHYSIOL-LONDON, V591, P1967, DOI 10.1113/jphysiol.2012.236604; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lei WW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139670; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li X, 2001, MAMM GENOME, V12, P13, DOI 10.1007/s003350010236; Li X, 2005, PLOS GENET, V1, P27, DOI 10.1371/journal.pgen.0010003; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Maitrepierre E, 2013, BIOENGINEERED, V4, P25, DOI 10.4161/bioe.21877; Maitrepierre E, 2012, PROTEIN EXPRES PURIF, V83, P75, DOI 10.1016/j.pep.2012.03.006; Maruyama Y, 2006, J NEUROSCI, V26, P2227, DOI 10.1523/JNEUROSCI.4329-05.2006; McGrane S., 2014, CURR TOP FLAV CHEM B, P35; McGrane S, 2014, Patent application, Patent No. [WO 2014/068043., 2014068043]; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Nelson TM, 2003, CHEM SENSES, V28, P695, DOI 10.1093/chemse/bjg062; Nie Y, 2005, CURR BIOL, V15, P1948, DOI 10.1016/j.cub.2005.09.037; Nie YL, 2006, CHEM SENSES, V31, P505, DOI 10.1093/chemse/bjj053; NINOMIYA Y, 1989, COMP BIOCHEM PHYS A, V92, P365; Nuemket N, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15530; Raliou M, 2011, CHEM SENSES, V36, P527, DOI 10.1093/chemse/bjr014; Roura E, 2011, FLAVOUR FRAG J, V26, P282, DOI 10.1002/ffj.2057; Saites LN, 2015, CHEM SENSES, V40, P295, DOI 10.1093/chemse/bjv010; Sandau MM, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0170-6; SATO M, 1965, JPN J PHYSIOL, V15, P53; Stapleton JR, 2002, CHEM SENSES, V27, P375, DOI 10.1093/chemse/27.4.375; Suzuki Y, 2004, J BIOL CHEM, V279, P35526, DOI 10.1074/jbc.M404831200; Toda Y, 2013, J BIOL CHEM, V288, P36863, DOI 10.1074/jbc.M113.494443; WHITE TD, 1975, PHYSIOL PSYCHOL, V3, P405; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Xu H, 2004, P NATL ACAD SCI USA, V101, P14258, DOI 10.1073/pnas.0404384101; YAMAGUCHI S, 1991, PHYSIOL BEHAV, V49, P833, DOI 10.1016/0031-9384(91)90192-Q; YOSHII K, 1986, BRAIN RES, V367, P45, DOI 10.1016/0006-8993(86)91577-5; Zhang F, 2010, P NATL ACAD SCI USA, V107, P4752, DOI 10.1073/pnas.0911660107; Zhang F, 2008, P NATL ACAD SCI USA, V105, P20930, DOI 10.1073/pnas.0810174106	52	15	16	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187051	10.1371/journal.pone.0187051	http://dx.doi.org/10.1371/journal.pone.0187051			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084235	Green Submitted, Green Published, gold			2022-12-26	WOS:000413910200027
J	Rozera, G; Fabbri, G; Lorenzini, P; Mastrorosa, I; Timelli, L; Zaccarelli, M; Amendola, A; Vergori, A; Plazzi, MM; Cicalini, S; Antinori, A; Capobianchi, MR; Abbate, I; Ammassari, A				Rozera, Gabriella; Fabbri, Gabriele; Lorenzini, Patrizia; Mastrorosa, Ilaria; Timelli, Laura; Zaccarelli, Mauro; Amendola, Alessandra; Vergori, Alessandra; Plazzi, Maria Maddalena; Cicalini, Stefania; Antinori, Andrea; Capobianchi, Maria Rosaria; Abbate, Isabella; Ammassari, Adriana			Peripheral blood HIV-1 DNA dynamics in antiretroviral-treated HIV/HCV co-infected patients receiving directly-acting antivirals	PLOS ONE			English	Article							CD4(+) T-CELLS; INTERFERON-ALPHA; HIV-1-INFECTED PATIENTS; VIRUS-INFECTION; THERAPY; REPLICATION; PERSISTENCE; RESERVOIR; RALTEGRAVIR; DECAY	Background Aim was to determine the dynamics of peripheral blood mononuclear cells (PBMC)-associated total HIV-1 DNA in successfully ART-treated HIV/HCV co-infected patients receiving DAA treatment and to explore possible virological hypotheses underlying the phenomenon. Methods Longitudinal, single-centre study measuring total HIV-1 DNA before the start of DAA, at the end of treatment (EOT), and 3 months after treatment. Univariable and multivariable analyses were used to assess factors associated with HIV-1 DNA increase >= 0.5 Log copies/million PBMC. Episomal 2-LTR forms, residual HIV-1 viremia and proviral DNA quasispecies evolution were also investigated. Results 119 successfully ART-treated HIV/HCV co-infected patients were included. Median baseline HIV-1 DNA was 3.84 Log copies/million PBMC (95% CI 3.49-4.05), and no significant variation with respect to baseline was found at EOT and after 3 months of DAA termination. In 17% of cases an increase >= 0.5 Log copies/million PBMC was observed at EOT compared to baseline. HIV-1 DNA increase was independently associated with lower baseline HIV-1 DNA, longer HIV suppression, raltegravir-based ART and previous exposure to interferon/ribavirin for HCV treatment. In none of the patients with HIV-1 DNA increase, 2-LTR forms were detected at baseline, while in 2 cases 2-LTR forms were found at EOT, without association with residual HIV-1 RNA viremia. No evidence of viral evolution was observed. Conclusions In successfully ART-treated HIV/HCV co-infected patients receiving DAA, PBMC-associated total HIV-1 DNA was quite stable over time, but some patients showed a considerable increase at EOT when compared to baseline. A significantly higher risk of HIV DNA increase was found, in presence of lower cellular HIV reservoir at baseline. Activation of replicative-competent virus generating new rounds of viral replication seems unlikely, while mobilization of cell-associated HIV from tissue reservoirs could be hypothesized.	[Rozera, Gabriella; Amendola, Alessandra; Capobianchi, Maria Rosaria; Abbate, Isabella] IRCCS, Natl Inst Infect Dis L Spallanzani, Lab Virol, Rome, Italy; [Fabbri, Gabriele; Lorenzini, Patrizia; Mastrorosa, Ilaria; Timelli, Laura; Zaccarelli, Mauro; Vergori, Alessandra; Plazzi, Maria Maddalena; Cicalini, Stefania; Antinori, Andrea; Ammassari, Adriana] IRCCS, Natl Inst Infect Dis L Spallanzani, Clin Dept, Rome, Italy	IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani	Abbate, I (corresponding author), IRCCS, Natl Inst Infect Dis L Spallanzani, Lab Virol, Rome, Italy.; Ammassari, A (corresponding author), IRCCS, Natl Inst Infect Dis L Spallanzani, Clin Dept, Rome, Italy.	isabella.abbate@inmi.it; adriana.ammassari@inmi.it	Amendola, Alessandra/K-8835-2016; Abbate, Isabella/K-6434-2016; Amendola, Alessandra/ABC-2753-2021; Vergori, Alessandra/AAC-1171-2019; Rozera, Gabriella/B-6874-2017; Antinori, Andrea/K-7125-2016; Zaccarelli, Mauro/GYV-1093-2022	Amendola, Alessandra/0000-0002-7063-0222; Amendola, Alessandra/0000-0002-7063-0222; Vergori, Alessandra/0000-0001-6944-0686; Antinori, Andrea/0000-0003-2121-4684; Ammassari, Adriana/0000-0002-0284-0340; Timelli, Laura/0000-0003-2306-0260	HIV infection; Italian Ministry of Health	HIV infection; Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by the SIMIT 2015 Scholarship for HIV infection (G. Fabbri) and the INMI "L. Spallanzani" Ricerca Corrente grant from the Italian Ministry of Health. The funders were external to our organization and had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendola A, 2011, J CLIN VIROL, V52, P17, DOI 10.1016/j.jcv.2011.04.012; Azzoni L, 2013, J INFECT DIS, V207, P213, DOI 10.1093/infdis/jis663; Besson GJ, 2014, CLIN INFECT DIS, V59, P1312, DOI 10.1093/cid/ciu585; Bianco C, 2014, J INT AIDS SOC, V17, P197; Bucy RP, 1999, J CLIN INVEST, V103, P1391, DOI 10.1172/JCI5863; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Cope R, 2015, AIDS PATIENT CARE ST, V29, P379, DOI 10.1089/apc.2015.0004; Correll T, 2008, PHARMACOTHERAPY, V28, P90, DOI 10.1592/phco.28.1.90; Crooks AM, 2015, J INFECT DIS, V212, P1361, DOI 10.1093/infdis/jiv218; Curran R, 2002, J GEN VIROL, V83, P11, DOI 10.1099/0022-1317-83-1-11; Cuzin L, 2015, AIDS, V29, P1665, DOI 10.1097/QAD.0000000000000723; Dianzani F, 2008, J INTERF CYTOK RES, V28, P1, DOI 10.1089/jir.2007.0076; European Ass Study Liver, 2017, J HEPATOL, V66, P153, DOI 10.1016/j.jhep.2016.09.001; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Gandhi RT, 2012, JAIDS-J ACQ IMM DEF, V59, P229, DOI 10.1097/QAI.0b013e31823fd1f2; Hocqueloux L, 2013, J ANTIMICROB CHEMOTH, V68, P1169, DOI 10.1093/jac/dks533; Izopet J, 1998, J ACQ IMMUN DEF SYND, V19, P478, DOI 10.1097/00042560-199812150-00006; Jiao YM, 2015, ANTIVIR RES, V118, P118, DOI 10.1016/j.antiviral.2015.03.011; Kiselinova M, 2015, J ANTIMICROB CHEMOTH, V70, P3311, DOI 10.1093/jac/dkv250; Laanani M, 2015, CLIN INFECT DIS, V60, P1715, DOI 10.1093/cid/civ171; Lafeuillade A, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-33; Lam YMP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031990; Lamers SL, 2016, J VIROL, V90, P8968, DOI 10.1128/JVI.00674-16; Lorenzo-Redondo R, 2016, NATURE, V530, P51, DOI 10.1038/nature16933; Mexas AM, 2012, AIDS, V26, P2295, DOI 10.1097/QAD.0b013e32835a5c2f; Moron-Lopez S, 2016, J INFECT DIS, V213, P1008, DOI 10.1093/infdis/jiv521; Murray JM, 2014, J VIROL, V88, P3516, DOI 10.1128/JVI.03331-13; Nicastri E, 2011, ANTIVIR THER, V16, P797, DOI 10.3851/IMP1833; Parisi SG, 2017, MED MICROBIOL IMMUNO; Perreau M, 2013, J EXP MED, V210, P143, DOI 10.1084/jem.20121932; Poizot-Martin I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141164; Schaefer CJ, 2011, ANTIMICROB AGENTS CH, V55, P3125, DOI 10.1128/AAC.00131-11; Sharkey ME, 2000, NAT MED, V6, P76, DOI 10.1038/71569; Sozzi G, 2003, J CLIN ONCOL, V21, P3902, DOI 10.1200/JCO.2003.02.006; Sun H, 2014, J INFECT DIS, V209, P1315, DOI 10.1093/infdis/jit628; Viard JP, 2004, AIDS, V18, P45, DOI 10.1097/00002030-200401020-00005	36	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187095	10.1371/journal.pone.0187095	http://dx.doi.org/10.1371/journal.pone.0187095			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077766	Green Submitted, Green Published, gold			2022-12-26	WOS:000413861200042
J	Kentala, H; Koponen, A; Kivela, AM; Andrews, R; Li, CH; Zhou, Y; Olkkonen, VM				Kentala, Henriikka; Koponen, Annika; Kivela, Annukka M.; Andrews, Robert; Li, ChunHei; Zhou, You; Olkkonen, Vesa M.			Analysis of ORP2-knockout hepatocytes uncovers a novel function in actin cytoskeletal regulation	FASEB JOURNAL			English	Article						CRISPR-Cas9; F-actin; interactome; OSBPL2; RNA sequencing	OXYSTEROL-BINDING-PROTEIN; OSBP-RELATED PROTEIN-2; HEARING-LOSS; STEROL TRANSPORT; PLASMA-MEMBRANE; LIPID DROPLETS; EXPRESSION; ER; RHOA; GENE	ORP2 is implicated in cholesterol transport, triglyceride metabolism, and adrenocortical steroid hormone production. We addressed ORP2 function in hepatocytes by generating ORP2-knockout (KO) HuH7 cells by CRISPR-Cas9 gene editing, followed by analyses of transcriptome, F-actin morphology, migration, adhesion, and proliferation. RNA sequencing of ORP2-KO cells revealed >2-fold changes in 579 mRNAs. The Ingenuity Pathway Analysis (IPA) uncovered alterations in the following functional categories: cellular movement, cell-cell signaling and interaction, cellular development, cellular function and maintenance, cellular growth and proliferation, and cell morphology. Many pathways in these categories involved actin cytoskeleton, cell migration, adhesion, or proliferation. Analysis of the ORP2 interactome uncovered 109 putative new partners. Their IPA analysis revealed Ras homolog A (RhoA) signaling as the most significant pathway. Interactions of ORP2 with SEPT9, MLC12, and ARHGAP12 were validated by independent assays. ORP2-KO resulted in abnormal F-actin morphology characterized by impaired capacity to form lamellipodia, migration defect, and impaired adhesion and proliferation. Rescue of the migration phenotype and generation of typical cell surface morphology required an intact ORP2 phosphoinositide binding site, suggesting that ORP2 function involves phosphoinositide binding and transport. The results point at a novel function of ORP2 as a lipid-sensing regulator of the actin cytoskeleton, with impacts on hepatocellular migration, adhesion, and proliferation.-Kentala, H., Koponen, A., Kivela, A. M., Andrews, R., Li, C., Zhou, Y., Olkkonen, V. M. Analysis of ORP2-knockout hepatocytes uncovers a novel function in actin cytoskeletal regulation.	[Kentala, Henriikka; Koponen, Annika; Kivela, Annukka M.; Zhou, You; Olkkonen, Vesa M.] Minerva Fdn, Inst Med Res, Helsinki, Finland; [Andrews, Robert; Li, ChunHei; Zhou, You] Cardiff Univ, Sch Med, Syst Immun Res Inst, Cardiff, S Glam, Wales; [Li, ChunHei; Zhou, You] Cardiff Univ, Sch Med, Div Infect & Immun, Cardiff, S Glam, Wales; [Olkkonen, Vesa M.] Univ Helsinki, Fac Med, Dept Anat, Helsinki, Finland; [Olkkonen, Vesa M.] Minerva Fdn, Inst Med Res, Biomed 2U, Tukholmankatu 8, FI-00290 Helsinki, Finland	Cardiff University; Cardiff University; University of Helsinki	Olkkonen, VM (corresponding author), Minerva Fdn, Inst Med Res, Biomed 2U, Tukholmankatu 8, FI-00290 Helsinki, Finland.	vesa.olkkonen@helsinki.fi		Koponen, Annika/0000-0002-3348-9661; ZHOU, YOU/0000-0002-1743-1291; Andrews, Robert/0000-0002-3491-2361	Academy of Finland [285223]; University of Helsinki Doctoral Programme in Biomedicine; Finnish Concordia Fund; Ida Montin Foundation; Finnish Norwegian Medical Foundation; Aarne Koskelo Foundation; Sigrid Juselius Foundation; Magnus Ehrnrooth Foundation; Finnish Foundation for Cardiovascular Research; Systems Immunity Research Institute Seedcorn Fund; Novo Nordisk Fonden [NNF11OC1014724] Funding Source: researchfish	Academy of Finland(Academy of Finland); University of Helsinki Doctoral Programme in Biomedicine; Finnish Concordia Fund; Ida Montin Foundation; Finnish Norwegian Medical Foundation; Aarne Koskelo Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Magnus Ehrnrooth Foundation; Finnish Foundation for Cardiovascular Research; Systems Immunity Research Institute Seedcorn Fund; Novo Nordisk Fonden(Novo Nordisk Foundation)	The authors thank Eeva Jaaskelainen and Riikka Kosonen (Minerva Foundation Institute for Medical Research, Helsinki, Finland) for expert technical assistance; Sarah Edkins and Kevin Ashelford (Wales Gene Park, Cardiff, United Kingdom) for technical support; the Advanced Computing Research Team (Cardiff University) for high-throughput computer support; BioMediTech Protein Technologies core facility, a member of Biocenter Finland and Instruct-FI, the Helsinki University Genome Biology Unit, and the Biomedicum Functional Genomics Unit (HiLIFE Institute, Helsinki, Finland) for the use of the facilities and expertise. Dr. Shiqian Li (University of Helsinki) is thanked for kindly providing the CRISPR-Cas9 vectors. This study was supported by the Academy of Finland (Grant 285223; to V.M.O.); by the University of Helsinki Doctoral Programme in Biomedicine, the Finnish Concordia Fund, the Ida Montin Foundation; the Finnish Norwegian Medical Foundation, and the Aarne Koskelo Foundation (to H.K.); the Sigrid Juselius Foundation, the Magnus Ehrnrooth Foundation, and the Finnish Foundation for Cardiovascular Research (to V.M.O.); and Systems Immunity Research Institute Seedcorn Funding (to Y.Z.). The authors declare no conflicts of interest.	Alfaro G, 2011, TRAFFIC, V12, P1521, DOI 10.1111/j.1600-0854.2011.01265.x; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Anderson GJ, 2002, CELL BIOCHEM BIOPHYS, V36, P137, DOI 10.1385/CBB:36:2-3:137; Aoki K, 2016, P NATL ACAD SCI USA, V113, pE1863, DOI 10.1073/pnas.1600968113; Beaslas O, 2012, EXP CELL RES, V318, P1933, DOI 10.1016/j.yexcr.2012.05.026; Beh CT, 2001, GENETICS, V157, P1117; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Blom AM, 2004, MOL IMMUNOL, V40, P1333, DOI 10.1016/j.molimm.2003.12.002; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Burridge K, 2016, EXP CELL RES, V343, P14, DOI 10.1016/j.yexcr.2015.10.029; Burrows JF, 2003, J PATHOL, V201, P581, DOI 10.1002/path.1484; Castellino FJ, 2005, THROMB HAEMOSTASIS, V93, P647, DOI 10.1160/TH04-12-0842; Charman M, 2014, J BIOL CHEM, V289, P15705, DOI 10.1074/jbc.M114.571216; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Choi SY, 2015, BBA-MOL CELL BIOL L, V1851, P711, DOI 10.1016/j.bbalip.2015.01.009; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Chung J, 2015, SCIENCE, V349, P428, DOI 10.1126/science.aab1370; Chutkow WA, 2008, J BIOL CHEM, V283, P2397, DOI 10.1074/jbc.M708169200; Croft DR, 2006, MOL CELL BIOL, V26, P4612, DOI 10.1128/MCB.02061-05; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Dong R, 2016, CELL, V166, P408, DOI 10.1016/j.cell.2016.06.037; Escajadillo T, 2016, MOL CELL ENDOCRINOL, V427, P73, DOI 10.1016/j.mce.2016.03.006; Faugaret D, 2011, BIOCHEM PHARMACOL, V81, P144, DOI 10.1016/j.bcp.2010.09.014; Gesmann M, 2011, R J, V3, P40; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Hynynen R, 2005, BIOCHEM J, V390, P273, DOI 10.1042/BJ20042082; Hynynen R, 2009, J LIPID RES, V50, P1305, DOI 10.1194/jlr.M800661-JLR200; Jansen M, 2011, TRAFFIC, V12, P218, DOI 10.1111/j.1600-0854.2010.01142.x; Jiang W, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-4; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Kalikin LM, 2000, GENOMICS, V63, P165, DOI 10.1006/geno.1999.6077; Kang TH, 2016, GENES GENET SYST, V91, P289, DOI 10.1266/ggs.16-00041; Kentala H, 2015, STEROIDS, V99, P248, DOI 10.1016/j.steroids.2015.01.027; Kim H, 2010, BBA-MOL CELL RES, V1803, P975, DOI 10.1016/j.bbamcr.2010.04.001; Kozminski KG, 2006, TRAFFIC, V7, P1224, DOI 10.1111/j.1600-0854.2006.00467.x; Kuroda S, 1999, BIOCHEM BIOPH RES CO, V265, P79, DOI 10.1006/bbrc.1999.1638; Laitinen S, 2002, J LIPID RES, V43, P245; Larreaa MD, 2009, P NATL ACAD SCI USA, V106, P9268, DOI 10.1073/pnas.0805057106; Lazarini M, 2013, BBA-MOL BASIS DIS, V1832, P365, DOI 10.1016/j.bbadis.2012.11.010; Lehto M, 2008, J CELL SCI, V121, P695, DOI 10.1242/jcs.016964; Li DH, 2013, MOL BIOL CELL, V24, P848, DOI 10.1091/mbc.E12-08-0597; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McCarty OJT, 2005, J BIOL CHEM, V280, P39474, DOI 10.1074/jbc.M504672200; McGrath J, 2017, SEMIN CELL DEV BIOL, V65, P88, DOI 10.1016/j.semcdb.2016.08.017; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Moh MC, 2005, J HEPATOL, V42, P833, DOI 10.1016/j.jhep.2005.01.025; Morris SM, 2009, BRIT J PHARMACOL, V157, P922, DOI 10.1111/j.1476-5381.2009.00278.x; Nagata KI, 2005, ONCOGENE, V24, P65, DOI 10.1038/sj.onc.1208101; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Neuhaus C, 2017, CLIN GENET, V91, P892, DOI 10.1111/cge.12915; Ngo MH, 2010, BIOCHEM J, V429, P13, DOI 10.1042/BJ20100263; Nissila E, 2012, BBA-MOL CELL BIOL L, V1821, P1472, DOI 10.1016/j.bbalip.2012.08.004; Noma N, 2012, ONCOL REP, V27, P2080, DOI 10.3892/or.2012.1733; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; Olkkonen VM, 2013, PROG LIPID RES, V52, P529, DOI 10.1016/j.plipres.2013.06.004; Pedraza Neus, 2019, Small GTPases, V10, P47, DOI 10.1080/21541248.2016.1268665; Perttila J, 2009, J MOL MED, V87, P825, DOI 10.1007/s00109-009-0490-z; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Raychaudhuri S, 2010, ANNU REV CELL DEV BI, V26, P157, DOI 10.1146/annurev.cellbio.042308.113334; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Sackmann E, 2015, BBA-MOL CELL RES, V1853, P3132, DOI 10.1016/j.bbamcr.2015.06.012; Salo VT, 2016, EMBO J, V35, P2699, DOI 10.15252/embj.201695170; Schurpf T, 2012, FASEB J, V26, P3412, DOI 10.1096/fj.11-202036; Sewer MB, 2013, MOL CELL ENDOCRINOL, V371, P79, DOI 10.1016/j.mce.2012.11.014; Shathasivam P, 2017, BRIT J CANCER, V116, P1065, DOI 10.1038/bjc.2017.51; Stritt S, 2016, BLOOD, V127, P2903, DOI 10.1182/blood-2015-10-675629; Suchanek M, 2007, BIOCHEM J, V405, P473, DOI 10.1042/BJ20070176; Tan J, 2014, CRIT REV BIOCHEM MOL, V49, P33, DOI 10.3109/10409238.2013.853024; TASHIAN RE, 1989, BIOESSAYS, V10, P186, DOI 10.1002/bies.950100603; Thoenes M, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0238-5; von Filseck JM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7671; Wang C, 2002, BIOCHEM J, V361, P461, DOI 10.1042/0264-6021:3610461; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Weber-Boyvat M, 2015, CELL MOL LIFE SCI, V72, P1967, DOI 10.1007/s00018-014-1786-x; Weber-Boyvat M, 2015, EXP CELL RES, V331, P278, DOI 10.1016/j.yexcr.2014.10.019; Wight TN, 2014, BBA-GEN SUBJECTS, V1840, P2441, DOI 10.1016/j.bbagen.2013.12.028; Wilson CA, 2010, NATURE, V465, P373, DOI 10.1038/nature08994; Worthley DL, 2005, INTERN MED J, V35, P548, DOI 10.1111/j.1445-5994.2005.00908.x; Wyles JP, 2007, EXP CELL RES, V313, P1426, DOI 10.1016/j.yexcr.2007.01.018; Xing GQ, 2015, GENET MED, V17, P210, DOI 10.1038/gim.2014.90; Yamanaka H, 2000, BIOCHEM BIOPH RES CO, V271, P796, DOI 10.1006/bbrc.2000.2699; Zhang Li, 2012, Subcell Biochem, V59, P177, DOI 10.1007/978-94-007-3015-1_6; Zhong WB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12702	86	21	21	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1281	1295		10.1096/fj.201700604R	http://dx.doi.org/10.1096/fj.201700604R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29092904	Green Published			2022-12-26	WOS:000427246000014
J	Choi, JY; Jung, JH; Shin, S; Kim, YH; Han, DJ				Choi, Ji Yoon; Jung, Joo Hee; Shin, Sung; Kim, Young Hoon; Han, Duck Jong			Association between the pancreas transplantation and survival of patients with diabetes: A single center experience	PLOS ONE			English	Article							MORTALITY	Pancreas transplantation is considered a therapeutic option for patients with complicated diabetes mellitus. In this study, we compared survival rate between patients on the waiting list for pancreas transplant alone(PTA), simultaneous pancreas-kidney(SPK) transplant, and pancreas after kidney(PAK) transplant and transplant recipients. A total of 503 patients (PTA:n = 116; SPK:n = 303; PAK:n = 84) and 280 PT recipients (PTA:n = 89; SPK:n = 155; PAK:n = 36) were retrospectively analyzed at our center between February 2000 and December 2015; 11.9%(60/503) of the patients on the waiting list and 4.3%(12/280) of the PT recipients died. The overall survival rate was higher in the waiting list group for the first year (99.3% vs. 97.8%), after which it was significantly higher in PT group (p = 0.039). The overall relative risk of all-cause mortality for transplant recipients was 2.145(p = 0.285) for PTA, 0.688(p = 0.735) for PAK, however,0.361 (p = 0.012) for SPK compared with that for the waiting list patients. SPK transplant recipients had considerable higher survival benefits, despite the relatively long waiting period, especially after 1 year. In addition, PTA and PAK can also be considered as a treatment option as patient survival was not poor.	[Han, Duck Jong] Univ Ulsan, Coll Med, Dept Surg, Seoul, South Korea; Asan Med Ctr, Seoul, South Korea	University of Ulsan	Han, DJ (corresponding author), Univ Ulsan, Coll Med, Dept Surg, Seoul, South Korea.	djhan@amc.seoul.kr						Choi JY, 2016, AM J TRANSPLANT, V16, P2413, DOI 10.1111/ajt.13738; Gruessner RWG, 2004, AM J TRANSPLANT, V4, P2018, DOI 10.1111/j.1600-6143.2004.00667.x; Han DJ, 2010, GUT LIVER, V4, P450, DOI 10.5009/gnl.2010.4.4.450; Kandaswamy R, 2016, AM J TRANSPLANT, V16, P47, DOI 10.1111/ajt.13667; Kandaswamy R, 2015, Am J Transplant, V15 Suppl 2, P1, DOI 10.1111/ajt.13196; Park JB, 2012, TRANSPL P, V44, P925, DOI 10.1016/j.transproceed.2012.03.035; Reynoso JF, 2010, J HEPATO-BIL-PAN SCI, V17, P92, DOI 10.1007/s00534-009-0147-x; Stratta RJ, 2016, AM J TRANSPLANT, V16, P2556, DOI 10.1111/ajt.13890; Stratta RJ, 2016, CURR OPIN ORGAN TRAN, V21, P386, DOI 10.1097/MOT.0000000000000319; van Dellen D, 2013, NEPHROL DIAL TRANSPL, V28, P1315, DOI 10.1093/ndt/gfs613; Venstrom JM, 2003, JAMA-J AM MED ASSOC, V290, P2817, DOI 10.1001/jama.290.21.2817; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303	12	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186827	10.1371/journal.pone.0186827	http://dx.doi.org/10.1371/journal.pone.0186827			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095903	Green Published, gold, Green Submitted			2022-12-26	WOS:000414340200024
J	Islam, S; Rahman, IA; Islam, T; Ghosh, A				Islam, Shiful; Rahman, Iffat Ara; Islam, Tahmina; Ghosh, Ajit			Genome-wide identification and expression analysis of glutathione S-transferase gene family in tomato: Gaining an insight to their physiological and stress-specific roles	PLOS ONE			English	Article							SUPERGENE FAMILY; SEGMENTAL DUPLICATIONS; ARABIDOPSIS; DETOXIFICATION; TOLERANCE; EVOLUTION; GST; INDUCTION; DATABASE	Glutathione S-transferase (GST) refers to one of the major detoxifying enzymes that plays an important role in different abiotic and biotic stress modulation pathways of plant. The present study aimed to a comprehensive genome-wide functional characterization of GST genes and proteins in tomato (Solarium lycopersicum L). The whole genome sequence analysis revealed the presence of 90 GSTgenes in tomato, the largest GSTgene family reported till date. Eight segmental duplicated gene pairs might contribute significantly to the expansion of S/GSTgene family. Based on phylogenetic analysis of tomato, rice, and Arabidopsis GST proteins, GST family members could be further divided into ten classes. Members of each orthologous class showed high conservancy among themselves. Tau and lambda are the major classes of tomato; while tau and phi are the major classes for rice and Arabidopsis. Chromosomal localization revealed highly uneven distribution of S/GSTgenes in 13 different chromosomes, where chromosome 9 possessed the highest number of genes. Based on publicly available microarray data, expression analysis of 30 available S/GSTgenes exhibited a differential pattern in all the analyzed tissues and developmental stages. Moreover, most of the members showed highly induced expression in response to multiple biotic and abiotic stress inducers that could be harmonized with the increase in total GST enzyme activity under several stress conditions. Activity of tomato GST could be enhanced further by using some positive modulators (safeners) that have been predicted through molecular docking of SIGSTU5 and ligands. Moreover, tomato GST proteins are predicted to interact with a lot of other glutathione synthesizing and utilizing enzymes such as glutathione peroxidase, glutathione reductase, glutathione synthetase and gamma-glutamyl-transferase. This comprehensive genome-wide analysis and expression profiling would provide a rational platform and possibility to explore the versatile role of GSTgenes in crop engineering.	[Islam, Shiful; Ghosh, Ajit] Shahjalal Univ Sci & Technol, Dept Biochem & Mol Biol, Sylhet, Bangladesh; [Rahman, Iffat Ara; Islam, Tahmina] Univ Dhaka, Dept Bot, Plant Breeding & Biotechnol Lab, Dhaka, Bangladesh	Shahjalal University of Science & Technology (SUST); University of Dhaka	Ghosh, A (corresponding author), Shahjalal Univ Sci & Technol, Dept Biochem & Mol Biol, Sylhet, Bangladesh.	ajitghoshbd@gmail.com	Islam, Shiful/AAX-7442-2021; Islam, Tahmina/AAU-9539-2021; Ghosh, Ajit/AAC-5914-2022	Islam, Shiful/0000-0002-1826-6777; Islam, Tahmina/0000-0002-0542-0050; Ghosh, Ajit/0000-0001-9045-3916				Bagaria A, 2012, PROTEIN SCI, V21, P229, DOI 10.1002/pro.2007; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Biovia DS., DISCOVERY STUDIO MOD; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Coleman JOD, 1997, TRENDS PLANT SCI, V2, P144, DOI 10.1016/S1360-1385(97)01019-4; Csiszar J, 2014, PLANT PHYSIOL BIOCH, V78, P15, DOI 10.1016/j.plaphy.2014.02.010; Dalton DA, 2009, PLANT PHYSIOL, V150, P521, DOI 10.1104/pp.109.136630; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Dean JD, 2005, J EXP BOT, V56, P1525, DOI 10.1093/jxb/eri145; DeRidder BP, 2002, PLANT PHYSIOL, V130, P1497, DOI 10.1104/pp.010066; Dixon DP, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews3004; Dixon DP, 1998, PLANT MOL BIOL, V36, P75, DOI 10.1023/A:1005958711207; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Fernandez-Pozo N, 2015, NUCLEIC ACIDS RES, V43, pD1036, DOI 10.1093/nar/gku1195; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Frova C, 2003, PHYSIOL PLANTARUM, V119, P469, DOI 10.1046/j.1399-3054.2003.00183.x; Ghosh A, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00836; Ghosh A, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0773-9; Ghosh A, 2014, PLANT J, V80, P93, DOI 10.1111/tpj.12621; HATZIOS KK, 1986, CAN J PLANT SCI, V66, P353, DOI 10.4141/cjps86-050; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; He G, 2016, FRONT PLANT SCI, P7; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Jain M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-73; Ji W, 2010, BIOTECHNOL LETT, V32, P1173, DOI 10.1007/s10529-010-0269-x; Jiang HW, 2010, PLANT PHYSIOL, V154, P1646, DOI 10.1104/pp.110.159152; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Kearney PC, 1975, HERBICIDES CHEM DEGR; Kerwin SM, 2010, J AM CHEM SOC, V132, P2466, DOI 10.1021/ja1005306; Kilili KG, 2004, J BIOL CHEM, V279, P24540, DOI 10.1074/jbc.M309882200; Koch MA, 2000, MOL BIOL EVOL, V17, P1483, DOI 10.1093/oxfordjournals.molbev.a026248; Kumar S, 2013, PLANT MOL BIOL REP, V31, P569, DOI 10.1007/s11105-012-0524-5; Kumar S, 2013, J HAZARD MATER, V248, P228, DOI 10.1016/j.jhazmat.2013.01.004; Lallement PA, 2014, FRONT PHARMACOL, P5; Lallement PA, 2015, FEBS LETT, V589, P37, DOI 10.1016/j.febslet.2014.11.021; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Licciardello C, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-39; Liu YJ, 2013, PLANT PHYSIOL, V161, P773, DOI 10.1104/pp.112.205815; Long MY, 1999, MOL BIOL EVOL, V16, P1528, DOI 10.1093/oxfordjournals.molbev.a026065; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Mohsenzadeh S, 2011, AFR J BIOTECHNOL, V10, P8160; Mysore KS, 2001, GENOME BIOL, V2; Nianiou-Obeidat I, 2017, PLANT CELL REP, V36, P791, DOI 10.1007/s00299-017-2139-7; Nishida M, 1998, J MOL BIOL, V281, P135, DOI 10.1006/jmbi.1998.1927; Oakley A, 2011, DRUG METAB REV, V43, P138, DOI 10.3109/03602532.2011.558093; Pascal S, 1999, PHYSIOL PLANTARUM, V106, P17, DOI 10.1034/j.1399-3054.1999.106103.x; Patel BP, 2002, NEOPLASMA, V49, P260; Ramsay EE, 2015, CHANGING FACES GLUTA, P125; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Rezaei MK, 2013, J PLANT PHYSIOL, V170, P1277, DOI 10.1016/j.jplph.2013.04.005; Riechers DE, 2010, PLANT PHYSIOL, V153, P3, DOI 10.1104/pp.110.153601; Roxas VP, 2000, PLANT CELL PHYSIOL, V41, P1229, DOI 10.1093/pcp/pcd051; Samonte RV, 2002, NAT REV GENET, V3, P65, DOI 10.1038/nrg705; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Sappl PG, 2009, PLANT J, V58, P53, DOI 10.1111/j.1365-313X.2008.03761.x; Sharma R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092900; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Steinberg CE, 2012, STRESS ECOLOGY ENV S, P75; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Xu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122216; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yang Q, 2014, PLANT PHYSIOL BIOCH, V77, P99, DOI 10.1016/j.plaphy.2014.02.003; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018	69	56	58	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187504	10.1371/journal.pone.0187504	http://dx.doi.org/10.1371/journal.pone.0187504			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095889	gold, Green Submitted, Green Published			2022-12-26	WOS:000414340200105
J	Lorca, V; Rueda, D; Martin-Morales, L; Poves, C; Fernandez-Acenero, MJ; Ruiz-Ponte, C; Llovet, P; Marrupe, D; Garcia-Barberan, V; Garcia-Paredes, B; Perez-Segura, P; de la Hoya, M; Diaz-Rubio, E; Caldes, T; Garre, P				Lorca, Victor; Rueda, Daniel; Martin-Morales, Lorena; Poves, Carmen; Jesus Fernandez-Acenero, Maria; Ruiz-Ponte, Clara; Llovet, Patricia; Marrupe, David; Garcia-Barberan, Vanesa; Garcia-Paredes, Beatriz; Perez-Segura, Pedro; de la Hoya, Miguel; Diaz-Rubio, Eduardo; Caldes, Trinidad; Garre, Pilar			Role of GALNT12 in the genetic predisposition to attenuated adenomatous polyposis syndrome	PLOS ONE			English	Article							COLORECTAL-CANCER; GERMLINE MUTATIONS; HUMAN COLON; VARIANTS; AGE	The involvement of GALNT12 in colorectal carcinogenesis has been demonstrated but it is not clear to what extent it is implicated in familial CRC susceptibility. Partially inactivating variant, NM_024642.4:c.907G>A, p.(D303N), has been previously detected in familial CRC and proposed as the causative risk allele. Since phenotypes of the described carrier families showed not only CRC but also a polyp history, we hypothesized that GALNT12 could be involved in adenoma predisposition and consequently, in hereditary polyposis CRC syndromes. For that purpose, we have screened the GALNT12 gene in germline DNA from 183 unrelated attenuated polyposis patients. c.907G>A, p.(D303N) was detected in 4 cases (MAF = 1.1%) and no other candidate variants were found. After segregation studies, LOH analyses, glycosylation pattern tests and case-control studies, our results did not support the role of c.907G>A, p.(D303N) as a high-penetrance risk allele for polyposis CRC.	[Lorca, Victor; Martin-Morales, Lorena; Llovet, Patricia; Garcia-Barberan, Vanesa; de la Hoya, Miguel; Caldes, Trinidad; Garre, Pilar] Hosp Clin San Carlos, IdISSC, CIBERONC, Lab Oncol Mol, Madrid, Spain; [Rueda, Daniel] Hosp 12 Octubre, Serv Bioquim i 12, Lab Canc Hereditario, Madrid, Spain; [Poves, Carmen] Hosp Clin San Carlos, Serv Aparato Digest, Madrid, Spain; [Jesus Fernandez-Acenero, Maria] Hosp Clin San Carlos, Serv Anat Patol, Madrid, Spain; [Ruiz-Ponte, Clara] IDIS, Grp Med Xenom USC, FPGMX, SERGAS, Santiago De Compostela, Spain; [Marrupe, David] Hosp Mostoles, Serv Oncol Med, Madrid, Spain; [Garcia-Paredes, Beatriz; Perez-Segura, Pedro; Diaz-Rubio, Eduardo] Hosp Clin San Carlos, CIBERONC, Serv Oncol Med, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Hospital Clinico San Carlos; Hospital Universitario 12 de Octubre; Hospital Clinico San Carlos; Hospital Clinico San Carlos; Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Hospital Clinico San Carlos	Garre, P (corresponding author), Hosp Clin San Carlos, IdISSC, CIBERONC, Lab Oncol Mol, Madrid, Spain.	pilar_garre@hotmail.com	Rueda, Daniel/I-1176-2015; Marrupe, David/CAI-0370-2022; de la Hoya, MIguel/Z-2911-2019; Aceñero, M Jesús Fernández/ABC-5904-2020	Rueda, Daniel/0000-0002-5377-8890; Marrupe, David/0000-0002-7986-2783; Aceñero, M Jesús Fernández/0000-0002-2439-3553; Llovet, Patricia/0000-0003-0190-2105; de la Hoya, Miguel/0000-0002-8113-1410; Garcia-Barberan, Vanesa/0000-0002-2531-0203; Martin-Morales, Lorena/0000-0002-1970-8872; LORCA CASTELLANOS, VICTOR/0000-0002-3681-4319; Garre Rubio, Pilar/0000-0001-8285-4138	Instituto de Salud Carlos III, Spain; European Regional Development FEDER funds [PI14/00929, PI16/01292, PI14/00230]	Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); European Regional Development FEDER funds	The present study was supported by grants from the Instituto de Salud Carlos III, Spain (www.isciii.es) and European Regional Development FEDER funds: PI14/00929 to Pilar Garre, PI16/01292 to Trinidad Caldes and PI14/00230 to Clara Ruiz-Ponte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscnpt.	Adam R, 2016, AM J HUM GENET, V99, P337, DOI 10.1016/j.ajhg.2016.06.015; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Clarke E, 2012, HUM MUTAT, V33, P1056, DOI 10.1002/humu.22088; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Exome Variant Server, NHLBI GO EX SEQ PROJ; Guda K, 2009, P NATL ACAD SCI USA, V106, P12921, DOI 10.1073/pnas.0901454106; Guo JM, 2002, FEBS LETT, V524, P211, DOI 10.1016/S0014-5793(02)03007-7; Guo JM, 2004, ONCOLOGY-BASEL, V67, P271, DOI 10.1159/000081328; Imperiale TF, 2002, NEW ENGL J MED, V346, P1781, DOI 10.1056/NEJM200206063462304; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Palles C, 2013, NAT GENET, V45, P136, DOI 10.1038/ng.2503; Pendergrass CJ, 2008, CLIN GASTROENTEROL H, V6, P1011, DOI 10.1016/j.cgh.2008.03.022; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Segui N, 2014, HUM MUTAT, V35, P50, DOI 10.1002/humu.22454; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Weren RDA, 2015, NAT GENET, V47, P668, DOI 10.1038/ng.3287	20	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187312	10.1371/journal.pone.0187312	http://dx.doi.org/10.1371/journal.pone.0187312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095867	Green Published, gold, Green Submitted			2022-12-26	WOS:000414340200070
J	Qiao, JX; Xu, J; Bo, T; Wang, W				Qiao, Juxia; Xu, Jing; Bo, Tao; Wang, Wei			Micronucleus-specific histone H1 is required for micronuclear chromosome integrity in Tetrahymena thermophila	PLOS ONE			English	Article							LINKER HISTONE; IN-VIVO; VARIANT OVEREXPRESSION; GENE-EXPRESSION; CORE PARTICLE; DNA-DAMAGE; CHROMATIN; IDENTIFICATION; NUCLEOSOME; SEQUENCE	Histone H1 molecules play a key role in establishing and maintaining higher order chromatin structures. They can bind to linker DNA entering and exiting the nucleosome and regulate transcriptional activity. Tetrahymena thermophila has two histone H1, namely, macronuclear histone H1 and micronuclear histone H1 (Mlh1). Mlh1 is specifically localized at micro-nuclei during growth and starvation stages. Moreover, Mlh1 is localized around micronuclei and forms a specific structure during the conjugation stage. It co-localizes partially with spindle apparatus during micronuclear meiosis. Analysis of MLH1 knock-out revealed that Mlh1 was required for the micronuclear integrity and development during conjugation stage. Overexpression of Mlh1 led to abnormal conjugation progression. RT-PCR analysis indicated that the expression level of HMGB3 increased in delta MLH1 strains, while the expression level of MLH1 increased in delta HMGB3 cells during conjugation. These results indicate that micronuclear integrity and sexual development require normal expression level of Mlh1 and that HmgB3 and Mlh1 may functionally compensate each other in regulating micronuclear structure in T. thermophila.	[Qiao, Juxia; Xu, Jing; Bo, Tao; Wang, Wei] Shanxi Univ, Inst Biotechnol, Minist Educ, Key Lab Chem Biol & Mol Engn, Taiyuan, Shanxi, Peoples R China; [Xu, Jing] Shanxi Univ, Coll Life Sci, Taiyuan, Shanxi, Peoples R China; [Xu, Jing] Ocean Univ China, Inst Evolut & Marine Biodivers, Qingdao, Shandong, Peoples R China	Shanxi University; Shanxi University; Ocean University of China	Wang, W (corresponding author), Shanxi Univ, Inst Biotechnol, Minist Educ, Key Lab Chem Biol & Mol Engn, Taiyuan, Shanxi, Peoples R China.	gene@sxu.edu.cn			National Natural Scientific Foundation of China [31471999, 31572253]; International cooperation project of Shanxi Province [2015081032]; Shanxi Scholarship Council of China [2015-008]; Natural Science Foundation of Shanxi Province [2015011078]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); International cooperation project of Shanxi Province; Shanxi Scholarship Council of China; Natural Science Foundation of Shanxi Province(Natural Science Foundation of Shanxi Province)	This study was supported by grants from the National Natural Scientific Foundation of China (No.31471999), International cooperation project of Shanxi Province (2015081032), and Shanxi Scholarship Council of China(2015-008) to WW, National Natural Scientific Foundation of China (31572253) and Natural Science Foundation of Shanxi Province (2015011078) to JX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This study was supported by grants from the National Natural Scientific Foundation of China (No.31471999, 31572253), International cooperation project of Shanxi Province (2015081032), Natural Science Foundation of Shanxi Province (2015011078), Shanxi Scholarship Council of China (2015-008).	Ali T, 2004, J MOL BIOL, V337, P1123, DOI 10.1016/j.jmb.2004.02.029; ALLIS CD, 1979, P NATL ACAD SCI USA, V76, P4857, DOI 10.1073/pnas.76.10.4857; ALLIS CD, 1984, J CELL BIOL, V99, P1669, DOI 10.1083/jcb.99.5.1669; ALLIS CD, 1982, DEV BIOL, V93, P519, DOI 10.1016/0012-1606(82)90139-7; Bednar J, 2016, BBA-GENE REGUL MECH, V1859, P436, DOI 10.1016/j.bbagrm.2015.10.012; Brown DT, 1996, NUCLEIC ACIDS RES, V24, P486, DOI 10.1093/nar/24.3.486; CassidyHanley D, 1997, GENETICS, V146, P135; CASSIDYHANLEY D, 1994, GENETICS, V137, P95; CHAPMAN GE, 1976, EUR J BIOCHEM, V61, P69, DOI 10.1111/j.1432-1033.1976.tb09998.x; Downs JA, 2003, MOL CELL, V11, P1685, DOI 10.1016/S1097-2765(03)00197-7; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; Fan YH, 2003, MOL CELL BIOL, V23, P4559, DOI 10.1128/MCB.23.13.4559-4572.2003; Gorovsky M A, 1975, Methods Cell Biol, V9, P311, DOI 10.1016/S0091-679X(08)60080-1; Gunjan A, 1999, J BIOL CHEM, V274, P37950, DOI 10.1074/jbc.274.53.37950; Hamilton E, 2005, GENETICS, V170, P1611, DOI 10.1534/genetics.104.031401; Hashimoto H, 2007, DNA REPAIR, V6, P1584, DOI 10.1016/j.dnarep.2007.05.003; HAYASHI T, 1987, J BIOCHEM-TOKYO, V102, P369, DOI 10.1093/oxfordjournals.jbchem.a122063; Hergeth SP, 2015, EMBO REP, V16, P1439, DOI 10.15252/embr.201540749; Izzo A, 2008, BIOL CHEM, V389, P333, DOI 10.1515/BC.2008.037; Kasinsky HE, 2001, FASEB J, V15, P34, DOI 10.1096/fj.00-0237rev; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mayor R, 2015, J BIOL CHEM, V290, P7474, DOI 10.1074/jbc.M114.617324; Miao W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004429; Millan-Arino L, 2014, NUCLEIC ACIDS RES, V42, P4474, DOI 10.1093/nar/gku079; Nagel S, 2000, J MOL EVOL, V51, P286, DOI 10.1007/s002390010090; Ragab A, 2003, NUCLEIC ACIDS RES, V31, P7083, DOI 10.1093/nar/gkg923; ROTH SY, 1991, EMBO J, V10, P2069, DOI 10.1002/j.1460-2075.1991.tb07738.x; SHEN XT, 1995, CELL, V82, P47, DOI 10.1016/0092-8674(95)90051-9; Shen XT, 1996, CELL, V86, P475, DOI 10.1016/S0092-8674(00)80120-8; SIROTKIN AM, 1995, P NATL ACAD SCI USA, V92, P6434, DOI 10.1073/pnas.92.14.6434; Song XY, 2007, MOL CELL BIOL, V27, P2648, DOI 10.1128/MCB.01910-06; Thorslund T, 2015, NATURE, V527, P389, DOI 10.1038/nature15401; WU M, 1994, MOL CELL BIOL, V14, P10, DOI 10.1128/MCB.14.1.10; WU M, 1986, P NATL ACAD SCI USA, V83, P8674, DOI 10.1073/pnas.83.22.8674; Xiong J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030630; Xu Jiaxing, 2012, Shengwu Jiagong Guocheng, V10, P7, DOI 10.3969/j.issn.1672-3678.2012.06.002; Xu J, 2015, SCI REP-UK, V5, DOI 10.1038/srep10243; Xu J, 2013, GENE, V526, P87, DOI 10.1016/j.gene.2013.05.006; YASUDA H, 1986, J BIOL CHEM, V261, P2349; Zhou YB, 1998, NATURE, V395, P402, DOI 10.1038/26521	40	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187475	10.1371/journal.pone.0187475	http://dx.doi.org/10.1371/journal.pone.0187475			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095884	Green Published, gold, Green Submitted			2022-12-26	WOS:000414340200099
J	Sasaki, M; Kato, Y; Fujinami, K; Hirakata, T; Tsunoda, K; Watanabe, K; Akiyama, K; Noda, T				Sasaki, Mariko; Kato, Yu; Fujinami, Kaoru; Hirakata, Toshiaki; Tsunoda, Kazushige; Watanabe, Ken; Akiyama, Kunihiko; Noda, Toru			Advanced quantitative analysis of the sub-retinal pigment epithelial space in recurrent neovascular age-related macular degeneration	PLOS ONE			English	Article							POLYPOIDAL CHOROIDAL VASCULOPATHY; THERAPY; RANIBIZUMAB	To quantitatively evaluate changes in the sub-retinal pigment epithelial (RPE) space and determine the association with recurrent neovascular age-related macular degeneration (AMD). Twenty-two eyes treated with intravitreal aflibercept for treatment-naive neovascular AMD were studied retrospectively. The sub-RPE area, volume, and central retinal thickness (CRT) were evaluated 1 and 2 months after the loading phase using spectral-domain optical coherence tomography. Recurrence was defined as newly detected neovascular activity during the 6 months after the loading phase. In eyes with recurrent AMD, the sub-RPE area increased significantly (P = 0.036) from 1 to 2 months after the loading phase and the sub-RPE volume increased marginally (P = 0.06). Subgroup analysis showed significant (P = 0.008 and P = 0.016, respectively) increases in the sub-RPE area and volume in typical AMD. In eyes with no recurrence, no significant changes occurred in the two parameters. No significant CRT changes occurred in eyes with or without a recurrence. A quantitative analysis demonstrated an increased likelihood of the sub-RPE space shortly after the loading phase in eyes with recurrent AMD; no changes occurred in eyes without a recurrence. These early changes in the sub-RPE space could indicate disease activity and are valuable for predicting recurrences of neovascular AMD.	[Sasaki, Mariko; Kato, Yu; Fujinami, Kaoru; Hirakata, Toshiaki; Tsunoda, Kazushige; Watanabe, Ken; Akiyama, Kunihiko; Noda, Toru] Natl Tokyo Med Ctr, Natl Inst Sensory Organs, Dept Ophthalmol, Tokyo, Japan; [Sasaki, Mariko] Tachikawa Hosp, Dept Ophthalmol, Tokyo, Japan; [Sasaki, Mariko; Fujinami, Kaoru] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Kato, Yu] Metropolitan Komagome Hosp, Dept Ophthalmol, Tokyo, Japan; [Fujinami, Kaoru] UCL Inst Ophthalmol, Genet, London, England	Tachikawa Hospital; Keio University; University of London; University College London	Sasaki, M (corresponding author), Natl Tokyo Med Ctr, Natl Inst Sensory Organs, Dept Ophthalmol, Tokyo, Japan.; Sasaki, M (corresponding author), Tachikawa Hosp, Dept Ophthalmol, Tokyo, Japan.; Sasaki, M (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan.	mariko.sasaki@a2.keio.jp	Akiyama, Kunihiko/AAF-6894-2020	Akiyama, Kunihiko/0000-0003-3935-5434; Kato, YU/0000-0003-2568-0084; Sasaki, Mariko/0000-0001-5608-0546	Japan Society for the Promotion of Science, Japan (JSPS KAKENHI) [17K09150]; Grants-in-Aid for Scientific Research [17K09150] Funding Source: KAKEN	Japan Society for the Promotion of Science, Japan (JSPS KAKENHI); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, Japan (JSPS KAKENHI, 17K09150)to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbazetto I, 2003, ARCH OPHTHALMOL-CHIC, V121, P1253; Campbell JP, 2012, ARCH OPHTHALMOL-CHIC, V130, P794, DOI 10.1001/archophthalmol.2011.2480; Gregori G, 2011, OPHTHALMOLOGY, V118, P1373, DOI 10.1016/j.ophtha.2010.11.013; Holz FG, 2011, OPHTHALMOLOGY, V118, P663, DOI 10.1016/j.ophtha.2010.12.019; Lalwani GA, 2009, AM J OPHTHALMOL, V148, P43, DOI 10.1016/j.ajo.2009.01.024; Laude A, 2010, PROG RETIN EYE RES, V29, P19, DOI 10.1016/j.preteyeres.2009.10.001; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Parikh R, 2008, INDIAN J OPHTHALMOL, V56, P45, DOI 10.4103/0301-4738.37595; Penha FM, 2013, RETINA-J RET VIT DIS, V33, P459, DOI 10.1097/IAE.0b013e31827d2657; RAYESS N, 2015, AM J OPHTHALMOL, V159, pE1, DOI DOI 10.1016/j.ajo.2014.09.033; Schmidt-Erfurth U, 2016, PROG RETIN EYE RES, V50, P1, DOI 10.1016/j.preteyeres.2015.07.007; Schmidt-Erfurth U, 2015, OPHTHALMOLOGY, V122, P822, DOI 10.1016/j.ophtha.2014.11.017; SPAIDE RF, 1995, RETINA-J RET VIT DIS, V15, P100, DOI 10.1097/00006982-199515020-00003; Terasaki H, 2002, BRIT J OPHTHALMOL, V86, P321, DOI 10.1136/bjo.86.3.321; Wykoff CC, 2015, OPHTHALMOLOGY, V122, P2514, DOI 10.1016/j.ophtha.2015.08.009; Yannuzzi LA, 2001, RETINA-J RET VIT DIS, V21, P416, DOI 10.1097/00006982-200110000-00003; Yasukawa T, 2015, EXPERT REV OPHTHALMO, V10, P105, DOI 10.1586/17469899.2015.1019473	19	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186955	10.1371/journal.pone.0186955	http://dx.doi.org/10.1371/journal.pone.0186955			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095879	Green Submitted, Green Published, gold			2022-12-26	WOS:000414340200034
J	Henle, AM; Nassar, A; Puglisi-Knutson, D; Youssef, B; Knutson, KL				Henle, Andrea M.; Nassar, Aziza; Puglisi-Knutson, Danell; Youssef, Bahaaeldin; Knutson, Keith L.			Downregulation of TAP1 and TAP2 in early stage breast cancer	PLOS ONE			English	Article							MHC CLASS-I; MAJOR HISTOCOMPATIBILITY COMPLEX; ANTIGEN PRESENTATION; PROTEASOME SUBUNITS; TISSUE MICROARRAYS; INTERFERON-GAMMA; LUNG-CANCER; CELL LINE; TRANSPORTER; EXPRESSION	TAP1-TAP2 heterodimeric complexes are recognized as the transporter associated with antigen processing of major histocompatibility complex class I peptides for recognition by tumor-specific cytotoxic T lymphocytes. In this study, we investigated the immunohistochemical expression of TAP1 and TAP2 in 160 patients with breast cancer and correlated their expression levels with clinicopathologic parameters. The median age of the patient cohort was 52.5 years (range, 30-86 years). Both TAP1 and TAP2 immunohistochemical expression levels correlated significantly with breast cancer characteristics (P <.001). TAP1 expression levels were low to negative in stage I breast tumors. TAP1 and TAP2 levels were significantly higher in grade 3 tumors than low-grade (grade 1 and 2) tumors. TAP1 and TAP2 expression levels were not significantly different among different levels of HER2expressing tumors and did not vary by estrogen and progesterone receptor status or patient age. Both TAP1 and TAP2 overexpression in breast cancer might be an indicator of an aggressive breast tumor.	[Henle, Andrea M.] Carthage Coll, Dept Biol, Kenosha, WI 53140 USA; [Nassar, Aziza] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Puglisi-Knutson, Danell; Youssef, Bahaaeldin; Knutson, Keith L.] Mayo Clin, Dept Immunol, Jacksonville, FL 32224 USA	Mayo Clinic; Mayo Clinic	Henle, AM (corresponding author), Carthage Coll, Dept Biol, Kenosha, WI 53140 USA.	ahenle@carthage.com			National Institutes of Health [P50-CA116201, R01-CA113861, UL1-TR000135]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by National Institutes of Health Grants: P50-CA116201, R01-CA113861, and UL1-TR000135, https://www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele R, 2004, PHYSIOLOGY, V19, P216, DOI 10.1152/physiol.00002.2004; Abele R, 2006, FEBS LETT, V580, P1156, DOI 10.1016/j.febslet.2005.11.048; Alimonti J, 2000, NAT BIOTECHNOL, V18, P515, DOI 10.1038/75373; Ambagala APN, 2000, J IMMUNOL, V164, P93, DOI 10.4049/jimmunol.164.1.93; Chen HL, 1996, NAT GENET, V13, P210, DOI 10.1038/ng0696-210; CROMME FV, 1994, BRIT J CANCER, V69, P1176, DOI 10.1038/bjc.1994.231; CROMME FV, 1994, J EXP MED, V179, P335, DOI 10.1084/jem.179.1.335; Dovhey SE, 2000, CANCER RES, V60, P5789; Durgeau A, 2011, J IMMUNOL, V187, P5532, DOI 10.4049/jimmunol.1102060; Einstein MH, 2009, CLIN CANCER RES, V15, P1019, DOI 10.1158/1078-0432.CCR-08-1207; El Hage F, 2013, ANN NY ACAD SCI, V1283, P75, DOI 10.1111/j.1749-6632.2012.06777.x; Georgopoulos NT, 2000, ONCOGENE, V19, P4930, DOI 10.1038/sj.onc.1203860; Hicklin DJ, 1996, TISSUE ANTIGENS, V48, P38, DOI 10.1111/j.1399-0039.1996.tb02603.x; Johnsen A, 1998, CANCER RES, V58, P3660; KAKLAMANIS L, 1995, CANCER RES, V55, P5191; KAKLAMANIS L, 1994, AM J PATHOL, V145, P505; Koppers-Lalic D, 2003, ARCH VIROL, V148, P2023, DOI 10.1007/s00705-003-0142-5; Korkolopoulou P, 1996, BRIT J CANCER, V73, P148, DOI 10.1038/bjc.1996.28; Kutsch O, 2002, AIDS RES HUM RETROV, V18, P1319, DOI 10.1089/088922202320886361; Lampen MH, 2011, CURR OPIN IMMUNOL, V23, P293, DOI 10.1016/j.coi.2010.12.005; Lankat-Buttgereit B, 2002, PHYSIOL REV, V82, P187, DOI 10.1152/physrev.00025.2001; Leibowitz MS, 2011, CANCER IMMUNOL IMMUN, V60, P525, DOI 10.1007/s00262-010-0961-7; Liu Y, 2012, CANCER IMMUNOL IMMUN, V61, P789, DOI 10.1007/s00262-011-1137-9; Lou YM, 2005, CANCER RES, V65, P7926, DOI 10.1158/0008-5472.CAN-04-3977; Lou Y, 2008, CLIN CANCER RES, V14, P1494, DOI 10.1158/1078-0432.CCR-07-1066; Lou YM, 2007, VACCINE, V25, P2331, DOI 10.1016/j.vaccine.2006.11.064; Marincola F M, 2000, Adv Immunol, V74, P181, DOI 10.1016/S0065-2776(08)60911-6; Matsui M, 2002, J GASTROEN HEPATOL, V17, P897, DOI 10.1046/j.1440-1746.2002.02837.x; Moch H, 2001, ADV ANAT PATHOL, V8, P14, DOI 10.1097/00125480-200101000-00002; Setiadi AF, 2007, MOL CELL BIOL, V27, P7886, DOI 10.1128/MCB.01547-07; Simon Ronald, 2004, Drug Discov Today Technol, V1, P41, DOI 10.1016/j.ddtec.2004.08.003; Tao J, 2008, J INVEST DERMATOL, V128, P1991, DOI 10.1038/jid.2008.10; Torhorst J, 2001, AM J PATHOL, V159, P2249, DOI 10.1016/S0002-9440(10)63075-1; van de Rijn M, 2004, HISTOPATHOLOGY, V44, P97, DOI 10.1111/j.1365-2559.2004.01766.x; Vitale M, 1998, CANCER RES, V58, P737; Vitalis TZ, 2005, PLOS PATHOG, V1, P289, DOI 10.1371/journal.ppat.0010036; Wolff AC, 2014, ARCH PATHOL LAB MED, V138, P241, DOI 10.5858/arpa.2013-0953-SA; Yang TY, 2003, J BIOL CHEM, V278, P15291, DOI 10.1074/jbc.M300954200; Zhang H, 2015, BREAST CANCER RES TR, V151, P555, DOI 10.1007/s10549-015-3443-y; Zhang QJ, 2007, INT J CANCER, V120, P1935, DOI 10.1002/ijc.22371	40	21	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187323	10.1371/journal.pone.0187323	http://dx.doi.org/10.1371/journal.pone.0187323			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091951	Green Submitted, Green Published, gold			2022-12-26	WOS:000414229700056
J	Mei, L; Xu, S; Lu, P; Lin, HP; Guo, YB; Wang, YJ				Mei, Li; Xu, Sanger; Lu, Peng; Lin, Haiping; Guo, Yanbin; Wang, Yongjun			CsrB, a noncoding regulatory RNA, is required for BarA-dependent expression of biocontrol traits in Rahnella aquatilis HX2	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; ESCHERICHIA-COLI; GENES; SYSTEM; METABOLISM; SEQUENCE; STRAINS; VECTORS; PROTEIN; FAMILY	Background Rahnella aquatilis is ubiquitous and its certain strains have the applicative potent as a plant growthpromoting rhizobacteria. R. aquatilis HX2 is a biocontrol agent to produce antibacterial substance (ABS) and showed efficient biocontrol against crown gall caused by Agrobacterium vitis on sunflower and grapevine plants. The regulatory network of the ABS production and biocontrol activity is still limited known. Methodology/Principal findings In this study, a transposon-mediated mutagenesis strategy was used to investigate the regulators that involved in the biocontrol activity of R. aquatilis HX2. A 366-nt noncoding RNA CsrB was identified in vitro and in vivo, which regulated ABS production and biocontrol activity against crown gall on sunflower plants, respectively. The predicted product of noncoding RNA CsrB contains 14 stemloop structures and an additional pindependent terminator harpin, with 23 characteristic GGA motifs in the loops and other unpaired regions. CsrB is required for ABS production and biocontrol activity in the biocontrol regulation by a twocomponent regulatory system BarA/UvrY in R. aquatilis HX2. Conclusion/Significance The noncoding RNA CsrB regulates BarA-dependent ABS production and biocontrol activity in R. aquatilis HX2. To the best of our knowledge, this is the first report of noncoding RNA as a regulator for biocontrol function in R. aquatilis.	[Mei, Li; Xu, Sanger; Lu, Peng; Lin, Haiping; Wang, Yongjun] Zhejiang A&F Univ, Coll Forestry & Biotechnol, Linan, Peoples R China; [Guo, Yanbin] China Agr Univ, Dept Ecol Sci & Engn, Coll Resources & Environm Sci, Beijing, Peoples R China; [Wang, Yongjun] Natl & Prov Joint Engn Lab Biopesticide Preparat, Linan, Peoples R China	Zhejiang A&F University; China Agricultural University	Wang, YJ (corresponding author), Zhejiang A&F Univ, Coll Forestry & Biotechnol, Linan, Peoples R China.; Wang, YJ (corresponding author), Natl & Prov Joint Engn Lab Biopesticide Preparat, Linan, Peoples R China.	wangyj@zafu.edu.cn		Wang, Yongjun/0000-0002-8488-3423	National Natural Science Foundation of China [31200386]; Zhejiang Provincial Natural Science Foundation of China [LY12C14006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported by National Natural Science Foundation of China (31200386) and Zhejiang Provincial Natural Science Foundation of China (LY12C14006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarons S, 2000, J BACTERIOL, V182, P3913, DOI 10.1128/JB.182.14.3913-3919.2000; Altier C, 2000, MOL MICROBIOL, V35, P635, DOI 10.1046/j.1365-2958.2000.01734.x; Andrews HL, 1998, INFECT IMMUN, V66, P950, DOI 10.1128/IAI.66.3.950-958.1998; Babitzke P, 2007, CURR OPIN MICROBIOL, V10, P156, DOI 10.1016/j.mib.2007.03.007; Calvo J, 2007, INT J FOOD MICROBIOL, V113, P251, DOI 10.1016/j.ijfoodmicro.2006.07.003; Chen F, 2007, PLANT DIS, V91, P957, DOI 10.1094/PDIS-91-8-0957; Chen F, 2009, EUR J PLANT PATHOL, V124, P427, DOI 10.1007/s10658-009-9429-z; Cui Y, 2001, MOL PLANT MICROBE IN, V14, P516, DOI 10.1094/MPMI.2001.14.4.516; Dubey AK, 2005, RNA, V11, P1579, DOI 10.1261/rna.2990205; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; El-Hendawy HH, 2005, MICROBIOL RES, V160, P343, DOI 10.1016/j.micres.2005.02.008; El-Hendawy HH, 2003, FOLIA MICROBIOL, V48, P799, DOI 10.1007/BF02931517; FINAN TM, 1986, J BACTERIOL, V167, P66, DOI 10.1128/jb.167.1.66-72.1986; Gottesman S, 2002, GENE DEV, V16, P2829, DOI 10.1101/gad.1030302; Guigueno A, 2001, J BACTERIOL, V183, P1147, DOI 10.1128/JB.183.4.1147-1158.2001; Guo YB, 2009, APPL ENVIRON MICROB, V75, P6792, DOI 10.1128/AEM.00902-09; Guo YB, 2012, J BACTERIOL, V194, P6646, DOI 10.1128/JB.01769-12; Harfouche L, 2015, NEW PHYTOL, V206, P98, DOI 10.1111/nph.13195; Heeb S, 2002, J BACTERIOL, V184, P1046, DOI 10.1128/jb.184.4.1046-1056.2002; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Heurlier K, 2004, J BACTERIOL, V186, P2936, DOI 10.1128/JB.186.10.2936-2945.2004; Iimura K, 1996, INT J FOOD MICROBIOL, V30, P243, DOI 10.1016/0168-1605(96)00949-X; Jackson DW, 2002, J BACTERIOL, V184, P290, DOI 10.1128/JB.184.1.290-301.2002; Kay E, 2005, P NATL ACAD SCI USA, V102, P17136, DOI 10.1073/pnas.0505673102; LABES M, 1990, GENE, V89, P37, DOI 10.1016/0378-1119(90)90203-4; Lenz DH, 2005, MOL MICROBIOL, V58, P1186, DOI 10.1111/j.1365-2958.2005.04902.x; Li L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115010; Liu MY, 1997, J BACTERIOL, V179, P4639, DOI 10.1128/jb.179.14.4639-4642.1997; Ma WL, 2001, J BACTERIOL, V183, P1870, DOI 10.1128/JB.183.6.1870-1880.2001; Majdalani N, 2005, CRIT REV BIOCHEM MOL, V40, P93, DOI 10.1080/10409230590918702; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Moller T, 2002, MOL CELL, V9, P23, DOI 10.1016/S1097-2765(01)00436-1; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Reimmann C, 2005, J BACTERIOL, V187, P276, DOI 10.1128/JB.187.1.276-285.2005; Romeo T, 1998, MOL MICROBIOL, V29, P1321, DOI 10.1046/j.1365-2958.1998.01021.x; Romeo T, 2013, ENVIRON MICROBIOL, V15, P313, DOI 10.1111/j.1462-2920.2012.02794.x; Salis HM, 2011, METHOD ENZYMOL, V498, P19, DOI 10.1016/B978-0-12-385120-8.00002-4; Sambrook J., 2001, MOL CLONING LAB MANU; Tillett D, 2000, BIOTECHNIQUES, V28, P448, DOI 10.2144/00283st01; Valverde C, 2003, MOL MICROBIOL, V50, P1361, DOI 10.1046/j.1365-2958.2003.03774.x; VERVLIET G, 1975, J GEN VIROL, V26, P33, DOI 10.1099/0022-1317-26-1-33; Vogel J, 2005, BIOL CHEM, V386, P1219, DOI 10.1515/BC.2005.140; Wassarman KM, 1999, TRENDS MICROBIOL, V7, P37; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Weilbacher T, 2003, MOL MICROBIOL, V48, P657, DOI 10.1046/j.1365-2958.2003.03459.x; Xiao FengHu, 2015, Journal of Zhejiang University (Agriculture and Life Sciences), V41, P56; Yan Q, 2009, MICROBIOL-SGM, V155, P124, DOI 10.1099/mic.0.020750-0; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	48	2	2	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187492	10.1371/journal.pone.0187492	http://dx.doi.org/10.1371/journal.pone.0187492			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091941	Green Published, Green Submitted, gold			2022-12-26	WOS:000414229700069
J	Dultz, G; Graubard, BI; Martin, P; Welker, MW; Vermehren, J; Zeuzem, S; McGlynn, KA; Welzel, TM				Dultz, Georg; Graubard, Barry I.; Martin, Paul; Welker, Martin-Walter; Vermehren, Johannes; Zeuzem, Stefan; McGlynn, Katherine A.; Welzel, Tania M.			Liver transplantation for chronic hepatitis C virus infection in the United States 2002-2014: An analysis of the UNOS/OPTN registry	PLOS ONE			English	Article							ACTING ANTIVIRAL THERAPY; HEPATOCELLULAR-CARCINOMA; FIBROSIS PROGRESSION; RACIAL-DIFFERENCES; GENDER-DIFFERENCE; CIRRHOSIS; DISEASE; OUTCOMES; RISK; DISPARITIES	Chronic hepatitis C virus (HCV) infection is a leading cause for orthotopic liver transplantation (OLT) in the U.S. We investigated characteristics of HCV-infected patients registered for OLT, and explored factors associated with mortality. Data were obtained from the United Network for Organ Sharing and Organ Procurement and Transplantation network (UNOS/OPTN) registry. Analyses included 41,157 HCV-mono-infected patients >= 18 years of age listed for cadaveric OLT between February 2002 and June 2014. Characteristics associated with pre- and post-transplant survival and time trends over the study period were determined by logistic and Cox proportional hazard regression analyses and Poisson regressions. Most patients were white (69.1%) and male (70.8%). At waitlist registration, mean age was 54.6 years and mean MELD was 16. HCC was recorded in 26.9% of the records. A total of 51.2% of the patients received an OLT, 21.0% died or were too sick; 15.6% were delisted and 10.4% were still waiting. Factors associated with increased waitlist mortality were older age, female gender, blood type 0, diabetes, no HCC and transplant region (p<0.001). OLT recipient characteristics associated with increased risk for post OLT mortality were female gender, age, diabetes, race (p<0.0001), and allocation MELD (p = 0.005). Donor characteristics associated with waitlist mortality included age, ethnicity (p<0.0001) and diabetes (p<0.03). Waitlist registrations and OLTs for HCC significantly increased from 14.4% to 37.3% and 27.8% to 38.5%, respectively (p<0.0001). Pre- and post-transplant survival depended on a variety of patient-, donor-, and allocation-characteristics of which most remain relevant in the DAA-era. Still, intensified HCV screening strategies and timely and effective treatment of HCV are highly relevant to reduce the burden of HCV-related OLTs in the U.S.	[Dultz, Georg; Welker, Martin-Walter; Vermehren, Johannes; Zeuzem, Stefan; Welzel, Tania M.] Univ Hosp Frankfurt, Frankfurt, Germany; [Graubard, Barry I.] NCI, Div Canc Epidemiol & Genet, Biostat Branch, Bethesda, MD 20892 USA; [Martin, Paul] Univ Miami, Hepatol Div, Miami, FL USA; [McGlynn, Katherine A.] NCI, Div Canc Epidemiol & Genet, HREB, Bethesda, MD 20892 USA	Goethe University Frankfurt; Goethe University Frankfurt Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Miami; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Welzel, TM (corresponding author), Univ Hosp Frankfurt, Frankfurt, Germany.	tania.welzel@kgu.de	Dultz, Georg/AAE-2986-2019; Zeuzem, Stefan/AAE-7435-2019	Dultz, Georg/0000-0003-0775-0907; 	NATIONAL CANCER INSTITUTE [ZIACP010158] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aguilar M, 2016, LIVER INT OFFICIAL J; Ahn J, 2017, DIGEST DIS SCI, V62, P1051, DOI 10.1007/s10620-017-4469-2; Ananthakrishnan AN, 2008, AM J GASTROENTEROL, V103, P901, DOI 10.1111/j.1572-0241.2008.01809.x; Armstrong GL, 2006, ANN INTERN MED, V144; Asrani SK, 2010, LIVER TRANSPLANT, V16, P1009, DOI 10.1002/lt.22123; Barone M, 2008, TRANSPLANTATION, V85, P844, DOI 10.1097/TP.0b013e318166cc38; Belli LS, 2007, LIVER TRANSPLANT, V13, P733, DOI 10.1002/lt.21093; Beste LA, 2015, GASTROENTEROLOGY, V149, P1471, DOI 10.1053/j.gastro.2015.07.056; Biggins SW, 2012, LIVER TRANSPLANT, V18, P1471, DOI 10.1002/lt.23551; Cheung MCM, 2016, J HEPATOL, V65, P741, DOI 10.1016/j.jhep.2016.06.019; Chhatwal J, 2016, HEPATOLOGY, V64, P1442, DOI 10.1002/hep.28571; Conti F, 2016, J HEPATOL, V65, P727, DOI 10.1016/j.jhep.2016.06.015; Dyal HK, 2015, DIGEST DIS SCI, V60, P2813, DOI 10.1007/s10620-015-3760-3; Flemming JA, 2017, HEPATOLOGY, V65, P804, DOI 10.1002/hep.28923; Gentry SE, 2013, AM J TRANSPLANT, V13, P2052, DOI 10.1111/ajt.12301; Goldberg D, 2012, LIVER TRANSPLANT, V18, P434, DOI 10.1002/lt.23394; Huo SC, 2007, TRANSPLANTATION, V84, P1406, DOI 10.1097/01.tp.0000282867.92367.d0; Kim WR, 2016, AM J TRANSPLANT, V16, P69, DOI 10.1111/ajt.13668; Lai JC, 2010, AM J TRANSPLANT, V10, P2658, DOI 10.1111/j.1600-6143.2010.03326.x; Lai JC, 2016, AM J TRANSPLANTATION; Lai JC, 2011, HEPATOLOGY, V54, P418, DOI 10.1002/hep.24390; Layden JE, 2012, TRANSPLANTATION, V94, P178, DOI 10.1097/TP.0b013e318253f7fa; Lue A, 2016, WORLD J GASTROENTERO, V22, P4966, DOI 10.3748/wjg.v22.i21.4966; Ly KN, 2016, CLIN INFECT DIS, V62, P1287, DOI 10.1093/cid/ciw111; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; McTaggart RA, 2004, LIVER TRANSPLANT, V10, P975, DOI 10.1002/lt.20213; Moylan CA, 2008, JAMA-J AM MED ASSOC, V300, P2371, DOI 10.1001/jama.2008.720; Muir AJ, 2004, NEW ENGL J MED, V350, P2265, DOI 10.1056/NEJMoa032502; Myers RP, 2011, J HEPATOL, V54, P462, DOI 10.1016/j.jhep.2010.07.015; Pang PS, 2009, LIVER TRANSPLANT, V15, P1126, DOI 10.1002/lt.21835; Poynard T, 2001, J HEPATOL, V34, P730, DOI 10.1016/S0168-8278(00)00097-0; Reig M, 2016, J HEPATOL, V65, P719, DOI 10.1016/j.jhep.2016.04.008; Roche B, 2012, LIVER INT, V32, P120, DOI 10.1111/j.1478-3231.2011.02714.x; Sarkar M, 2015, J HEPATOL, V62, P946, DOI 10.1016/j.jhep.2014.11.023; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Su F, 2016, GASTROENTEROLOGY, V150, P441, DOI 10.1053/j.gastro.2015.10.043; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Trooskin SB, 2007, WORLD J GASTROENTERO, V13, P1074, DOI 10.3748/wjg.v13.i7.1074; Udompap P, 2016, J HEPATOL, V64, P1027, DOI 10.1016/j.jhep.2016.01.009; Westbrook RH, 2014, J HEPATOL, V61, pS58, DOI 10.1016/j.jhep.2014.07.012; Wong RJ, 2015, GASTROENTEROLOGY, V148, P547, DOI 10.1053/j.gastro.2014.11.039; Yeh HD, 2011, TRANSPLANTATION, V91, P479, DOI 10.1097/TP.0b013e3182066275; Younossi ZM, 2014, ALIMENT PHARM THER, V39, P518, DOI 10.1111/apt.12625; 2016, J HEPATOLOGY, V65, P734	44	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186898	10.1371/journal.pone.0186898	http://dx.doi.org/10.1371/journal.pone.0186898			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088255	Green Submitted, gold, Green Published			2022-12-26	WOS:000414088900030
J	Koyanagi, A; Stubbs, B; Smith, L; Gardner, B; Vancampfort, D				Koyanagi, Ai; Stubbs, Brendon; Smith, Lee; Gardner, Benjamin; Vancampfort, Davy			Correlates of physical activity among community-dwelling adults aged 50 or over in six low-and middle-income countries	PLOS ONE			English	Article							SEDENTARY BEHAVIOR; OLDER-ADULTS; NONCOMMUNICABLE DISEASES; BACK-PAIN; HEALTH; ASSOCIATION; PEOPLE; DEPRESSION; EXERCISE; ANXIETY	Background Considering that physical activity is associated with healthy ageing and helps to delay, prevent, or manage a plethora of non-communicable diseases in older adults, there is a need to investigate the factors that influence physical activity participation in this population. Thus, we investigated physical activity correlates among community-dwelling older adults (aged >= 50 years) in six low-and middle-income countries. Methods Cross-sectional data were analyzed from the World Health Organization's Study on Global Ageing and Adult Health. Physical activity was assessed by the Global Physical Activity Questionnaire. Participants were dichotomized into low (i.e., not meeting 150 minutes of moderate physical activity per week) and moderate-to-high physically active groups. Associations between physical activity and a range of correlates were examined using multivariable logistic regressions. Results The overall prevalence (95%CI) of people not meeting recommended physical activity levels in 34,129 participants (mean age 62.4 years, 52.1% female) was 23.5% (22.3%-24.8%). In the multivariable analysis, older age and unemployment were significant sociodemographic correlates of low physical activity. Individuals with low body mass index (< 18.5kg/m(2)), bodily pain, asthma, chronic back pain, chronic obstructive pulmonary disease, hearing problems, stroke, visual impairment, slow gait, and weak grip strength were less likely to meet physical activity targets in the overall sample (P < 0.05). The associations varied widely between countries. Conclusion Our data illustrates that a multitude of factors influence physical activity target achievement in older adults, which can inform future interventions across low- and middle-income countries to assist people of this age group to engage in regular physical activity. Future prospective cohort studies are also required to investigate the directionality and mediators of the relationships observed.	[Koyanagi, Ai] Univ Barcelona, Res & Dev Unit, Fundacio St Joan de Deu, Parc Sanitari Sant Joan de Deu, Barcelona, Spain; [Koyanagi, Ai] Inst Salud Carlos III, CIBERSAM, Ctr Invest Biomed Red Salud Mental, Madrid, Spain; [Stubbs, Brendon] South London & Maudsley NHS Fdn Trust, Physiotherapy Dept, Denmark Hill, London, England; [Stubbs, Brendon] Kings Coll London, Inst Psychiat Psychol & Neurosci, Hlth Serv & Populat Res Dept, De Crespigny Pk, London, England; [Stubbs, Brendon] Anglia Ruskin Univ, Fac Hlth Social Care & Educ, Chelmsford, England; [Smith, Lee] Anglia Ruskin Univ, Dept Life Sci, Cambridge Ctr Sport & Exercise Sci, Cambridge, England; [Gardner, Benjamin] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol, De Crespigny Pk, London, England; [Vancampfort, Davy] Katholieke Univ Leuven, Dept Rehabil Sci, Leuven, Belgium; [Vancampfort, Davy] Katholieke Univ Leuven, Univ Psychiat Ctr, Kortenberg, Belgium	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III; University of London; King's College London; Anglia Ruskin University; Anglia Ruskin University; University of London; King's College London; KU Leuven; KU Leuven	Koyanagi, A (corresponding author), Univ Barcelona, Res & Dev Unit, Fundacio St Joan de Deu, Parc Sanitari Sant Joan de Deu, Barcelona, Spain.; Koyanagi, A (corresponding author), Inst Salud Carlos III, CIBERSAM, Ctr Invest Biomed Red Salud Mental, Madrid, Spain.	a.koyanagi@pssjd.org	Vancampfort, Davy/AAD-1987-2019; Gardner, Benjamin/C-1565-2008; Koyanagi, Ai/D-3833-2018; Stubbs, Brendon/X-1904-2018	Gardner, Benjamin/0000-0003-1223-5934; Koyanagi, Ai/0000-0002-9565-5004; Stubbs, Brendon/0000-0001-7387-3791	Miguel Servet contract [CP13/00150, PI15/00862]; ISCIII - General Branch Evaluation and Promotion of Health Research; European Regional Development Fund (ERDF-FEDER); National Institute for Health Research	Miguel Servet contract; ISCIII - General Branch Evaluation and Promotion of Health Research; European Regional Development Fund (ERDF-FEDER)(European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Ai Koyanagi's work is supported by the Miguel Servet contract financed by the CP13/00150 and PI15/00862 projects, integrated into the National R + D + I and funded by the ISCIII - General Branch Evaluation and Promotion of Health Research - and the European Regional Development Fund (ERDF-FEDER). Brendon Stubbs receives funding from the National Institute for Health Research Collaboration for Leadership in Applied Health Research & Care Funding scheme. The funders had no role in: design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Abubakari AR, 2008, PUBLIC HEALTH, V122, P173, DOI 10.1016/j.puhe.2007.06.012; Arokiasamy P, 2017, AM J EPIDEMIOL, V185, P414, DOI 10.1093/aje/kww125; Atkinson Kaitlin, 2016, Prev Med Rep, V3, P40, DOI 10.1016/j.pmedr.2015.11.009; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Birdee GS, 2013, J ALTERN COMPLEM MED, V19, P550, DOI 10.1089/acm.2012.0223; Blakely T, 2005, B WORLD HEALTH ORGAN, V83, P118; Blondell SJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-510; Bull FC, 2009, J PHYS ACT HEALTH, V6, P790, DOI 10.1123/jpah.6.6.790; Cohen-Mansfield J, 2016, INT PSYCHOGERIATR, V28, P557, DOI 10.1017/S1041610215001532; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Daskalopoulou C, 2017, AGEING RES REV, V38, P6, DOI 10.1016/j.arr.2017.06.003; Doi T, 2015, GERIATR GERONTOL INT, V15, P1073, DOI 10.1111/ggi.12407; Endrighi R, 2016, BRIT J PSYCHIAT, V208, P245, DOI 10.1192/bjp.bp.114.150755; Freeman EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063315; French MT, 2009, AM J HEALTH PROMOT, V24, P2, DOI 10.4278/ajhp.0801104; Garin N, 2016, J GERONTOL A-BIOL, V71, P205, DOI 10.1093/gerona/glv128; Joint FAO/WHO Expert Consultation, 2003, JOINT WHO FAO EXP CO; Kassebaum NJ, 2016, LANCET, V388, P1603, DOI [10.1016/S0140-6736(16)31460-X, 10.1016/S0140-6736(16)31470-2]; Kowal P, 2012, INT J EPIDEMIOL, V41, P1639, DOI 10.1093/ije/dys210; Koyanagi A, 2015, SLEEP, V38, P1875, DOI 10.5665/sleep.5232; Koyanagi A, 2015, J PSYCHIATR RES, V69, P19, DOI 10.1016/j.jpsychires.2015.07.020; Koyanagi A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1362-9; Kravitz AV, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00514; Kumar A, 2016, AGE AGEING, V45, P345, DOI 10.1093/ageing/afw036; Kwak L, 2016, J SCI MED SPORT, V19, P482, DOI 10.1016/j.jsams.2015.05.008; Leach LS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-621; Leasure JL, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00156; Sosa AL, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-48; Mammen G, 2013, AM J PREV MED, V45, P649, DOI 10.1016/j.amepre.2013.08.001; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; O'Donoghue G, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2841-3; Pengpid S, 2015, INT J PUBLIC HEALTH, V60, P539, DOI 10.1007/s00038-015-0680-0; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Rubin KH, 2001, DEV PSYCHOPATHOLOGY; Ruegsegger GN, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00109; Sallis JF, 2016, LANCET, V388, P1325, DOI 10.1016/S0140-6736(16)30581-5; Sallis JF, 2016, LANCET, V387, P2207, DOI 10.1016/S0140-6736(15)01284-2; Salmon J, 2000, INT J OBESITY, V24, P600, DOI 10.1038/sj.ijo.0801203; Sazlina SG, 2012, J NUTR HEALTH AGING, V16, P498, DOI 10.1007/s12603-012-0038-8; Smit W, 2016, HEALTH PLACE, V39, P196, DOI 10.1016/j.healthplace.2016.04.006; Smith L, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007423; Soundy A, 2014, ARCH PSYCHIAT NURS, V28, P135, DOI 10.1016/j.apnu.2013.12.002; Stewart Williams Jennifer, 2015, BMC Med, V13, P147, DOI 10.1186/s12916-015-0390-8; Stubbs B, 2017, J AFFECT DISORDERS, V208, P545, DOI 10.1016/j.jad.2016.10.028; Stubbs B, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0734-z; Stubbs B, 2016, GEN HOSP PSYCHIAT, V43, P63, DOI 10.1016/j.genhosppsych.2016.09.008; Stubbs B, 2014, PAIN MED, V15, P1861, DOI 10.1111/pme.12570; Tandon A, 2001, STAT METHODS ENHANCI; Teychenne M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1843-x; Trost SG, 2002, MED SCI SPORT EXER, V34, P350, DOI 10.1097/00005768-200202000-00025; Tyrovolas S, 2015, EXPT GERONTOLOGY, V15, P123; Ustun T. B., 2010, Measuring health and disability: manual for WHO Disability Assessment Schedule (WHODAS 2.0); van Kan GA, 2009, J NUTR HEALTH AGING, V13, P881; Vancampfort D, 2015, PSYCHIAT DANUBINA, V27; Vancampfort D, 2016, DISABIL REHABIL, V38, P2047, DOI [10.3109/09638288.2015.1114037, 10.1080/09638288.2016.1260645]; Vancampfort D, 2015, ARCH PSYCHIAT NURS, V29, P196, DOI 10.1016/j.apnu.2014.08.006; Vanhees L, 2005, EUR J CARDIOV PREV R, V12, P102, DOI 10.1097/00149831-200504000-00004; Viswanath K, 2006, AM J PUBLIC HEALTH, V96, P1456, DOI 10.2105/AJPH.2003.029793; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wirth K, 2017, AGEING RES REV, V35, P87, DOI 10.1016/j.arr.2016.12.002; World Health Organization, 2010, Global recommendations on physical activity for health; Zamora-Macorra M, 2017, ARCH GERONTOL GERIAT, V68, P113, DOI 10.1016/j.archger.2016.10.005	64	22	23	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186992	10.1371/journal.pone.0186992	http://dx.doi.org/10.1371/journal.pone.0186992			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK9WD	29077744	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000413861200034
J	Passow, CN; Arias-Rodriguez, L; Tobler, M				Passow, Courtney N.; Arias-Rodriguez, Lenin; Tobler, Michael			Convergent evolution of reduced energy demands in extremophile fish	PLOS ONE			English	Article							LIFE-HISTORY EVOLUTION; WATER-BUG BELOSTOMA; BODY-SIZE; POECILIA-MEXICANA; METABOLIC-RATE; SULFIDE; PREDATION; HYPOXIA; OXYGEN; CAVE	Convergent evolution in organismal function can arise from nonconvergent changes in traits that contribute to that function. Theory predicts that low resource availability and high maintenance costs in extreme environments select for reductions in organismal energy demands, which could be attained through modifications of body size or metabolic rate. We tested for convergence in energy demands and underlying traits by investigating livebearing fish (genus Poecilia) that have repeatedly colonized toxic, hydrogen sulphide-rich springs. We quantified variation in body size and routine metabolism across replicated sulphidic and non-sulphidic populations in nature, modelled total organismal energy demands, and conducted a common-garden experiment to test whether population differences had a genetic basis. Sulphidic populations generally exhibited smaller body sizes and lower routine metabolic rates compared to non-sulphidic populations, which together caused significant reductions in total organismal energy demands in extremophile populations. Although both mechanisms contributed to variation in organismal energy demands, variance partitioning indicated reductions of body size overall had a greater effect than reductions of routine metabolism. Finally, population differences in routine metabolism documented in natural populations were maintained in common-garden reared individuals, indicating evolved differences. In combination with other studies, these results suggest that reductions in energy demands may represent a common theme in adaptation to physiochemical stressors. Selection for reduced energy demand may particularly affect body size, which has implications for life history evolution in extreme environments.	[Passow, Courtney N.; Tobler, Michael] Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS 66506 USA; [Arias-Rodriguez, Lenin] Univ Juarez Autonoma Tabasco, Div Acad Ciencias Biol, Villahermosa, Tabasco, Mexico; [Passow, Courtney N.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	Kansas State University; Universidad Juarez Autonoma de Tabasco; University of Minnesota System; University of Minnesota Twin Cities	Passow, CN (corresponding author), Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS 66506 USA.; Passow, CN (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	cpassow@umn.edu	Arias Rodriguez, Lenin/AAE-5577-2022	Tobler, Michael/0000-0002-0326-0890; ARIAS RODRIGUEZ, LENIN/0000-0002-8025-5569	American Livebearing Association; NSF [IOS-1463720, IOS-1557860]; Army Research Office [W911NF-15-1-0175]; Defense University of the U.S. Office of Naval Research [W911NF-16-1-0225]; Kansas State University; Centro de Investigacion e Innovacion para la Ensenanza y el Aprendizaje in Teapa; Direct For Biological Sciences [1557860] Funding Source: National Science Foundation	American Livebearing Association; NSF(National Science Foundation (NSF)); Army Research Office; Defense University of the U.S. Office of Naval Research(Office of Naval Research); Kansas State University; Centro de Investigacion e Innovacion para la Ensenanza y el Aprendizaje in Teapa; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Financial support was provided by the American Livebearing Association (http://www. livebearers.org; to CNP), NSF (https://www.nsf. gov; IOS-1463720, and IOS-1557860 to MT), Army Research Office (http://www.ari.army.mil/; W911NF-15-1-0175) and Defense University Research Instrumentation Program of the U.S. Office of Naval Research (https://www.onr.navy. mil., W911NF-16-1-0225 to MT). Publication of this article was funded in part by the Kansas State University Open Access Publishing Fund. No funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Centro de Investigacion e Innovacion para la Ensenanza y el Aprendizaje in Teapa for their support. We also thank R. Greenway, T. Doumas, C. Keith, and C. Saylor for help in the field and laboratory.	ARNOLD SJ, 1983, AM ZOOL, V23, P347, DOI 10.1093/icb/23.2.347; BAGARINAO T, 1992, AQUAT TOXICOL, V24, P21, DOI 10.1016/0166-445X(92)90015-F; Bierbach David, 2012, International Journal of Evolutionary Biology, P1, DOI 10.1155/2012/148745; Blanckenhorn WU, 2000, Q REV BIOL, V75, P385, DOI 10.1086/393620; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; BROWN JH, 1993, AM NAT, V142, P573, DOI 10.1086/285558; Burggren WW, 2014, J EXP BIOL, V217, P682, DOI 10.1242/jeb.086132; Burton T, 2011, P ROY SOC B-BIOL SCI, V278, P3465, DOI 10.1098/rspb.2011.1778; Careau V, 2008, OIKOS, V117, P641, DOI 10.1111/j.0030-1299.2008.16513.x; Careau V, 2012, PHYSIOL BIOCHEM ZOOL, V85, P543, DOI 10.1086/666970; CHEN KY, 1972, ENVIRON SCI TECHNOL, V6, P529, DOI 10.1021/es60065a008; Constantz G.D., 1989, P33; Cooper CE, 2008, J BIOENERG BIOMEMBR, V40, P533, DOI 10.1007/s10863-008-9166-6; Council NR, 2010, GUIDE CARE USE LAB A, DOI 10.17226/5140; Culumber ZW, 2016, AQUAT CONSERV, V26, P1155, DOI 10.1002/aqc.2640; Culver D. C., 2009, BIOL CAVES OTHER SUB, P40; Eifert C, 2015, J ZOOL, V295, P143, DOI 10.1111/jzo.12190; Endler J. A., 1986, NATURAL SELECTION WI; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Greenway R, 2016, EVOLUTION, V70, P2809, DOI 10.1111/evo.13087; Greenway Ryan, 2014, Diversity-Basel, V6, P597; Haney DC, 1997, PHYSIOL ZOOL, V70, P511, DOI 10.1086/515867; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P9493, DOI 10.1073/pnas.93.18.9493; Huppop K., 1985, Bulletin of the National Speleological Society, V47, P136; Huppop K, 2000, ECOSY WORLD, V30, P159; Ip YK, 2004, PHYSIOL BIOCHEM ZOOL, V77, P824, DOI 10.1086/423746; Isler K, 2006, BIOL LETTERS, V2, P557, DOI 10.1098/rsbl.2006.0538; ITAZAWA Y, 1986, EXPERIENTIA, V42, P152, DOI 10.1007/BF01952441; Jahn A, 1997, MAR ECOL PROG SER, V154, P175, DOI 10.3354/meps154175; Jeyasingh PD, 2007, ECOL LETT, V10, P282, DOI 10.1111/j.1461-0248.2007.01023.x; Jourdan J, 2014, PEERJ, V2, DOI 10.7717/peerj.490; Kaeuffer R, 2012, EVOLUTION, V66, P402, DOI 10.1111/j.1558-5646.2011.01440.x; Kelley JL, 2016, MOL BIOL EVOL, V33, P1419, DOI 10.1093/molbev/msw020; Klok CJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0003876; Kohler A, 2011, BEHAV ECOL SOCIOBIOL, V65, P1513, DOI 10.1007/s00265-011-1161-y; Koslow JA, 1996, J FISH BIOL, V49, P54, DOI 10.1111/j.1095-8649.1996.tb06067.x; Landry L, 2010, J EVOLUTION BIOL, V23, P2602, DOI 10.1111/j.1420-9101.2010.02121.x; Langerhans RB, 2004, AM NAT, V164, P335, DOI 10.1086/422857; Lorenzen K, 2002, P ROY SOC B-BIOL SCI, V269, P49, DOI 10.1098/rspb.2001.1853; Losos JB, 2011, EVOLUTION, V65, P1827, DOI 10.1111/j.1558-5646.2011.01289.x; Losos JB, 2010, AM NAT, V175, P623, DOI 10.1086/652433; Manceau M, 2010, PHILOS T R SOC B, V365, P2439, DOI 10.1098/rstb.2010.0104; McClain CR, 2006, J BIOGEOGR, V33, P1578, DOI 10.1111/j.1365-2699.2006.01545.x; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Palacios M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071069; Parsons PA, 2005, BIOL REV, V80, P589, DOI 10.1017/S1464793105006822; Passow CN, 2017, MOL ECOL, V26, P4211, DOI 10.1111/mec.14198; Passow CN, 2015, PHYSIOL BIOCHEM ZOOL, V88, P371, DOI 10.1086/681053; Pfenninger M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4873; Pichavant K, 2001, J FISH BIOL, V59, P875, DOI [10.1006/jfbi.2001.1702, 10.1111/j.1095-8649.2001.tb00158.x]; Pirozzi I, 2009, COMP BIOCHEM PHYS A, V152, P586, DOI 10.1016/j.cbpa.2009.01.008; Plath M, 2008, BEHAVIOUR, V145, P73, DOI 10.1163/156853908782687241; Plath M, 2007, NATURWISSENSCHAFTEN, V94, P991, DOI 10.1007/s00114-007-0279-2; Plath M, 2013, EVOLUTION, V67, P2647, DOI 10.1111/evo.12133; Plath M, 2011, EVOL ECOL RES, V13, P133; POWELL E, 1989, J MAR RES, V47, P887, DOI 10.1357/002224089785076082; Reznick DN, 1996, AM NAT, V147, P319, DOI 10.1086/285854; Riesch R., 2015, EXTREMOPHILE FISHES, P137; Riesch R, 2014, ECOL LETT, V17, P65, DOI 10.1111/ele.12209; Riesch R, 2010, BIOL J LINN SOC, V101, P417, DOI 10.1111/j.1095-8312.2010.01522.x; Riesch R, 2010, NATURWISSENSCHAFTEN, V97, P133, DOI 10.1007/s00114-009-0613-y; Riesch R, 2009, BEHAV ECOL SOCIOBIOL, V63, P1515, DOI 10.1007/s00265-009-0780-z; Rosenfeld J, 2015, J ANIM ECOL, V84, P4, DOI 10.1111/1365-2656.12260; SCHLUTER D, 1992, AM NAT, V140, P85, DOI 10.1086/285404; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schulz-Mirbach T, 2016, J ZOOL, V300, P163, DOI 10.1111/jzo.12366; Seibel BA, 2007, PHILOS T R SOC B, V362, P2061, DOI 10.1098/rstb.2007.2101; STEFFENSEN JF, 1989, FISH PHYSIOL BIOCHEM, V6, P49, DOI 10.1007/BF02995809; Tieleman BI, 2000, PHYSIOL BIOCHEM ZOOL, V73, P461, DOI 10.1086/317740; Timmerman CM, 2004, J FISH BIOL, V65, P635, DOI 10.1111/j.0022-1112.2004.00474.x; Tobler M, 2008, BIOL LETTERS, V4, P452, DOI 10.1098/rsbl.2008.0259; Tobler M, 2007, ECOL ENTOMOL, V32, P492, DOI 10.1111/j.1365-2311.2007.00892.x; Tobler M, 2006, EXTREMOPHILES, V10, P577, DOI 10.1007/s00792-006-0531-2; Tobler M, 2016, ANNU REV ECOL EVOL S, V47, P239, DOI 10.1146/annurev-ecolsys-121415-032418; Tobler M, 2016, FRESHWATER BIOL, V61, P158, DOI 10.1111/fwb.12691; Tobler M, 2015, FRESHWATER BIOL, V60, P768, DOI 10.1111/fwb.12530; Tobler Michael, 2011, P120; Tobler M, 2011, EVOLUTION, V65, P2213, DOI 10.1111/j.1558-5646.2011.01298.x; Tobler M, 2009, EVOL ECOL RES, V11, P935; Tsuboi M, 2015, EVOLUTION, V69, P190, DOI 10.1111/evo.12556; Wang T, 2006, ANNU REV PHYSIOL, V68, P223, DOI 10.1146/annurev.physiol.68.040104.105739; Welch JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008776	82	12	12	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186935	10.1371/journal.pone.0186935	http://dx.doi.org/10.1371/journal.pone.0186935			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077740	Green Published, gold, Green Submitted			2022-12-26	WOS:000413861200027
J	Mallis, RJ; Arthanari, H; Lang, MJ; Reinherz, EL; Wagner, G				Mallis, Robert J.; Arthanari, Haribabu; Lang, Matthew J.; Reinherz, Ellis L.; Wagner, Gerhard			NMR-directed design of pre-TCR beta and pMHC molecules implies a distinct geometry for pre-TCR relative to alpha beta TCR recognition of pMHC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL RECEPTORS; MHC CLASS-I; THYMIC SELECTION; THYMOCYTE DEVELOPMENT; FAB FRAGMENT; PEPTIDE; COMPLEX; PROTEINS; PREDICTION; DISCRIMINATION	The pre-T cell receptor (pre-TCR) guides early thymocytes through maturation processes within the thymus via interaction with self-ligands displayed on thymic epithelial cells. The pre-TCR is a disulfide-linked heterodimer composed of an invariant pre-TCR alpha (pT alpha) subunit and a variable beta subunit, the latter of which is incorporated into the mature TCR in subsequent developmental progression. This interaction of pre-TCR with peptide- major histocompatibility complex (pMHC) molecules has recently been shown to drive robust pre-TCR signaling and thymocyte maturation. Although the native sequences of beta are properly folded and suitable for NMR studies in isolation, a tendency to self-associate rendered binding studies with physiological ligands difficult to interpret. Consequently, to structurally define this critical interaction, we have re-engineered the extracellular regions of beta, designated as beta-c1, for prokaryotic production to be used in NMR spectroscopy. Given the large size of the full extracellular domain of class I MHC molecules such as H-K-b, we produced a truncated form termed K-b-t harboring properties favorable for NMR measurements. This system has enabled robust measurement of a pre-TCR-pMHC interaction directly analogous to that of TCR alpha beta-pMHC. Binding surface analysis identified a contact surface comparable in size to that of the TCR alpha beta-pMHC but potentially with a rather distinct binding orientation. A tilting of the pre-TCR beta when bound to the pMHC ligand recognition surface versus the upright orientation of TCR alpha beta would alter the direction of force application between pre-TCR and TCR mechanosensors, impacting signal initiation.	[Mallis, Robert J.; Arthanari, Haribabu; Wagner, Gerhard] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Arthanari, Haribabu] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Lang, Matthew J.] Vanderbilt Univ, Dept Chem & Biomol Engn, Nashville, TN 37235 USA; [Lang, Matthew J.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37235 USA; [Reinherz, Ellis L.] Harvard Med Sch, Dana Farber Canc Inst, Lab Immunobiol, Dept Med Oncol, Boston, MA 02115 USA; [Reinherz, Ellis L.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Vanderbilt University; Vanderbilt University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Wagner, G (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	gerhard_wagner@hms.harvard.edu		Arthanari, Haribabu/0000-0002-7281-1289	National Institutes of Health [P01GM04746, R01AI37581]; National Institute of Biomedical Imaging and Bioengineering [P41-EB002026, R01AI19807, R01AI100643]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019807, R01AI100643, R01AI037581, R01AI136301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002026] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by National Institutes of Health Grants P01GM04746 and R01AI37581 and National Institute of Biomedical Imaging and Bioengineering Grant P41-EB002026 (to G.W.) and R01AI19807 (to E. L. R.) and R01AI100643 (to E. L. R. and M. J. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], 2014, R LANG ENV STAT COMP; Baker BM, 2017, TRENDS IMMUNOL, V38, P2, DOI 10.1016/j.it.2016.11.003; Brazin KN, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00441; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; CRUMP AL, 1993, P NATL ACAD SCI USA, V90, P10739, DOI 10.1073/pnas.90.22.10739; Das DK, 2016, J BIOL CHEM, V291, P25292, DOI 10.1074/jbc.M116.752865; Das DK, 2015, P NATL ACAD SCI USA, V112, P1517, DOI 10.1073/pnas.1424829112; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Feng YN, 2017, P NATL ACAD SCI USA, V114, pE8204, DOI 10.1073/pnas.1703559114; Garcia KC, 2012, IMMUNITY, V36, P887, DOI 10.1016/j.immuni.2012.05.018; Hyberts SG, 2014, J MAGN RESON, V241, P60, DOI 10.1016/j.jmr.2013.11.014; IMARAI M, 1995, CELL IMMUNOL, V160, P33, DOI 10.1016/0008-8749(95)80006-5; Johnson JL, 2013, TRENDS IMMUNOL, V34, P290, DOI 10.1016/j.it.2013.01.006; Jones LL, 2006, J BIOL CHEM, V281, P25734, DOI 10.1074/jbc.M604343200; Keller R., 2004, COMPUTER AIDED RESON, V1; Kim ST, 2009, J BIOL CHEM, V284, P31028, DOI 10.1074/jbc.M109.052712; Lee D, 2006, J MAGN RESON, V178, P72, DOI 10.1016/j.jmr.2005.08.014; Liu BY, 2014, CELL, V157, P357, DOI 10.1016/j.cell.2014.02.053; Liu J, 1996, J BIOL CHEM, V271, P33639, DOI 10.1074/jbc.271.52.33639; Liu Y, 2016, P NATL ACAD SCI USA, V113, P5610, DOI 10.1073/pnas.1600163113; MacRaild CA, 2014, J BIOMOL NMR, V58, P155, DOI 10.1007/s10858-014-9813-7; Mallis RJ, 2016, BIOMOL NMR ASSIGN, V10, P35, DOI 10.1007/s12104-015-9632-0; Mallis RJ, 2015, P NATL ACAD SCI USA, V112, P8373, DOI 10.1073/pnas.1504971112; Moody AM, 2001, EUR J IMMUNOL, V31, P2791, DOI 10.1002/1521-4141(200109)31:9<2791::AID-IMMU2791>3.0.CO;2-X; Natarajan K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15260; Nitta T, 2009, P NATL ACAD SCI USA, V106, P17129, DOI 10.1073/pnas.0906956106; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Pang SS, 2010, NATURE, V467, P844, DOI 10.1038/nature09448; POWELL LD, 1987, J IMMUNOL, V139, P1206; Rudolph MG, 2001, IMMUNITY, V14, P231, DOI 10.1016/S1074-7613(01)00105-4; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; Sasada T, 2000, EUR J IMMUNOL, V30, P1281, DOI 10.1002/(SICI)1521-4141(200005)30:5<1281::AID-IMMU1281>3.3.CO;2-4; Shah DK, 2014, J IMMUNOL, V192, P4017, DOI 10.4049/jimmunol.1302259; Shen Y, 2010, J BIOMOL NMR, V48, P13, DOI 10.1007/s10858-010-9433-9; Stritesky GL, 2013, P NATL ACAD SCI USA, V110, P4679, DOI 10.1073/pnas.1217532110; Teng MK, 1998, CURR BIOL, V8, P409, DOI 10.1016/S0960-9822(98)70160-5; Tikhonova AN, 2012, IMMUNITY, V36, P79, DOI 10.1016/j.immuni.2011.11.013; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; von Boehmer H, 2003, IMMUNOL REV, V191, P62, DOI 10.1034/j.1600-065X.2003.00010.x; Wang JH, 1998, EMBO J, V17, P10, DOI 10.1093/emboj/17.1.10; Wieczorek M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00292; Zhou B, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00005	43	4	4	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 19	2018	293	3					754	766		10.1074/jbc.M117.813493	http://dx.doi.org/10.1074/jbc.M117.813493			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT1AM	29101227	Green Published, hybrid			2022-12-26	WOS:000422864500001
J	Wu, MA; Casella, F; Perego, F; Suffritti, C; Afifi, NA; Tobaldini, E; Zanichelli, A; Cogliati, C; Montano, N; Cicardi, M				Wu, Maddalena A.; Casella, Francesco; Perego, Francesca; Suffritti, Chiara; Afifi, Nada Afifi; Tobaldini, Eleonora; Zanichelli, Andrea; Cogliati, Chiara; Montano, Nicola; Cicardi, Marco			Hereditary angioedema: Assessing the hypothesis for underlying autonomic dysfunction	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; MOLECULAR-WEIGHT KININOGEN; CHOLINERGIC ANTIINFLAMMATORY PATHWAY; INHIBITOR-ASSOCIATED ANGIOEDEMA; NERVOUS-SYSTEM; VASCULAR-PERMEABILITY; HUMANISTIC BURDEN; FREQUENCY-DOMAIN; PLASMA-LEVELS; FACTOR-XII	Background Attacks of Hereditary Angioedema due to C1-inhibitor deficiency (Cl-INH-HAE) are often triggered by stressful events/hormonal changes. Objective Our study evaluates the relationship between autonomic nervous system (ANS) and contact/complement system activation. Methods Twenty-three HAE patients (6 males, mean age 47.5 +/- 11.4 years) during remission and 24 healthy controls (8 males, mean age 45.3 +/- 10.6 years) were studied. ECG, beat-by-beat blood pressure, respiratory activity were continuously recorded during rest (10') and 75degrees- head-up tilt (10'). C1-INH, C4, cleaved high molecular weight kininogen (cHK) were assessed; in 16 patients and 11 controls plasma catecholamines were also evaluated. Spectral analysis of heart rate variability allowed extraction of low-(LF) and high-(HF)frequency components, markers of sympathetic and vagal modulation respectively. Results HAE patients showed higher mean systolic arterial pressure (SAP) than controls during both rest and tilt. Tilt induced a significant increase in SAP and its variability only in controls. Although sympathetic modulation (LFnu) increased significantly with tilt in both groups, LF/HF ratio, index of sympathovagal balance, increased significantly only in controls. At rest HAE patients showed higher noradrenaline values (301.4 +/- 132.9 pg/ml vs 210.5 +/- 89.6 pg/ml, p = 0.05). Moreover, in patients tilt was associated with a significant increase in cHK, marker of contact system activation (49.5 +/- 7.5% after T vs 47.1 +/- 7.8% at R, p = 0.01). Conclusions Our data are consistent with altered ANS modulation in HAE patients, i.e. increased sympathetic activation at rest and blunted response to orthostatic challenge. Tilt test-induced increased HK cleavage suggests a link between stress and bradykinin production.	[Wu, Maddalena A.; Casella, Francesco; Perego, Francesca; Suffritti, Chiara; Afifi, Nada Afifi; Zanichelli, Andrea; Cogliati, Chiara; Cicardi, Marco] Univ Milan, Dept Biomed & Clin Sci, Milan, Italy; [Tobaldini, Eleonora; Montano, Nicola] Univ Milan, Dept Clin Sci & Community Hlth, IRCCS Ca Grande Fdn, Osped Maggiore Policlin, Milan, Italy	University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Wu, MA (corresponding author), Univ Milan, Dept Biomed & Clin Sci, Milan, Italy.	maddalena.wu@unimi.it	Wu, Maddalena/ABF-2070-2022; Perego, Francesca/K-8990-2016; Suffritti, Chiara/AAE-2940-2020; cicardi, marco/K-9219-2016	Wu, Maddalena/0000-0003-1078-1632; Perego, Francesca/0000-0003-3973-6931; Suffritti, Chiara/0000-0002-8872-8842; zanichelli, andrea/0000-0002-7512-4644; cogliati, chiara/0000-0003-2980-6158; cicardi, marco/0000-0003-1251-225X				Ashina K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132367; Beltrami L, 2011, J HYPERTENS, V29, P2273, DOI 10.1097/HJH.0b013e32834b4b9b; BERRETTINI M, 1986, BLOOD, V68, P455; Bork K, 2000, MAYO CLIN PROC, V75, P349, DOI 10.4065/75.4.349; Bork K, 2012, J ALLERGY CLIN IMMUN, V130, P692, DOI 10.1016/j.jaci.2012.05.055; Bouillet L, 2011, J ALLERGY CLIN IMMUN, V128, P232, DOI 10.1016/j.jaci.2011.02.017; Brown NJ, 1997, JAMA-J AM MED ASSOC, V278, P232, DOI 10.1001/jama.278.3.232; Burnstock G, 2014, PHARMACOL REV, V66, P102, DOI 10.1124/pr.113.008029; Buske-Kirschbaum A, 2002, J CLIN ENDOCR METAB, V87, P4245, DOI 10.1210/jc.2001-010872; Byrd JB, 2008, HYPERTENSION, V51, P141, DOI 10.1161/HYPERTENSIONAHA.107.096552; Caballero T, 2014, ALLERGY ASTHMA PROC, V35, P47, DOI 10.2500/aap.2013.34.3685; Campisi J, 2003, CELL STRESS CHAPERON, V8, P272, DOI 10.1379/1466-1268(2003)008<0272:SEHIAF>2.0.CO;2; CHENG Z, 2014, PLOS ONE, V0009; Cicardi M, 2014, ALLERGY, V69, P602, DOI 10.1111/all.12380; Cooper TM, 2015, BRAIN BEHAV IMMUN, V49, P94, DOI 10.1016/j.bbi.2014.12.017; Coviello I, 2013, CARDIOLOGY, V124, P63, DOI 10.1159/000345779; Cugno M, 1999, THROMB HAEMOSTASIS, V82, P1428; Cugno M, 1996, IMMUNOPHARMACOLOGY, V33, P361, DOI 10.1016/0162-3109(96)00086-0; Czucz J, 2012, J CLIN IMMUNOL, V32, P61, DOI 10.1007/s10875-011-9606-7; de Maat S, 2016, J ALLERGY CLIN IMMUN; Duan QL, 2005, AM J HUM GENET, V77, P617, DOI 10.1086/496899; Fleshner Monika, 2004, Behav Cogn Neurosci Rev, V3, P114, DOI 10.1177/1534582304269027; Fredly H, 2012, AM J HEMATOL, V87, P368, DOI 10.1002/ajh.23116; Furlan R, 2006, AM J PHYSIOL-REG I, V290, pR224, DOI 10.1152/ajpregu.00442.2005; GUZZETTI S, 1995, EUR HEART J, V16, P1100, DOI 10.1093/oxfordjournals.eurheartj.a061053; Han ED, 2002, J CLIN INVEST, V109, P1057, DOI 10.1172/JCI200214211; HEINER DC, 1957, PEDIATRICS, V20, P782; Janig W, 2014, AUTON NEUROSCI-BASIC, V182, P42, DOI 10.1016/j.autneu.2014.01.001; Jiang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102342; Joseph K, 2002, P NATL ACAD SCI USA, V99, P896, DOI 10.1073/pnas.022626899; Kajdacsi E, 2014, J ALLERGY CLIN IMMUN, V133, P1686, DOI 10.1016/j.jaci.2013.12.1072; Kaplan AP, 2010, ANN ALLERG ASTHMA IM, V104, P193, DOI 10.1016/j.anai.2010.01.007; Kosek E, 2015, J NEUROIMMUNOL, V280, P49, DOI 10.1016/j.jneuroim.2015.02.002; Kox M, 2012, PSYCHOSOM MED, V74, P489, DOI 10.1097/PSY.0b013e3182583c6d; Loffredo S, 2016, ALLERGY, V71, P989, DOI 10.1111/all.12862; Longhurst H, 2012, LANCET, V379, P474, DOI 10.1016/S0140-6736(11)60935-5; Lumry WR, 2010, ALLERGY ASTHMA PROC, V31, P407, DOI 10.2500/aap.2010.31.3394; Madsen F, 2012, ACTA DERM-VENEREOL, V92, P475, DOI 10.2340/00015555-1389; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; Malliani A, 1997, CIRCULATION, V96, P4143; Martelli D, 2014, AUTON NEUROSCI-BASIC, V182, P65, DOI 10.1016/j.autneu.2013.12.007; MONTANO N, 1994, CIRCULATION, V90, P1826, DOI 10.1161/01.CIR.90.4.1826; Montano N, 2009, NEUROSCI BIOBEHAV R, V33, P71, DOI 10.1016/j.neubiorev.2008.07.006; Nikolic VN, 2013, J CARDIOL, V62, P37, DOI 10.1016/j.jjcc.2013.02.013; Nussberger J, 1998, LANCET, V351, P1693, DOI 10.1016/S0140-6736(97)09137-X; Nussberger J, 1999, J ALLERGY CLIN IMMUN, V104, P1321, DOI 10.1016/S0091-6749(99)70030-8; Orsenigo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2199; Pagani M, 2001, AUTON NEUROSCI-BASIC, V90, P76, DOI 10.1016/S1566-0702(01)00270-3; Pavlov VA, 2012, NAT REV ENDOCRINOL, V8, P743, DOI 10.1038/nrendo.2012.189; PELLACANI A, 1994, CLIN SCI, V87, P567, DOI 10.1042/cs0870567; Presley T, 2008, AM J PHYSIOL-CELL PH, V295, pC1281, DOI 10.1152/ajpcell.00550.2007; SCHAPIRA M, 1983, NEW ENGL J MED, V308, P1050, DOI 10.1056/NEJM198305053081802; Schmaier A. H., 2015, J THROMB HAEMOST; Schmidt K, 2015, MICROVASC RES, V101, P111, DOI 10.1016/j.mvr.2015.07.002; Shariat-Madar Z, 2002, J BIOL CHEM, V277, P17962, DOI 10.1074/jbc.M106101200; Suffritti C, 2014, CLIN EXP ALLERGY, V44, P1503, DOI 10.1111/cea.12293; The FO, 2011, BRIT J PHARMACOL, V163, P1007, DOI 10.1111/j.1476-5381.2011.01296.x; Wu MA, 2016, CHINA ENV SCI POLLUT, P1; Zotter Z, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-44	59	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187110	10.1371/journal.pone.0187110	http://dx.doi.org/10.1371/journal.pone.0187110			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29107952	Green Published, Green Submitted, gold			2022-12-26	WOS:000414424600014
J	Cronje, HT; Nienaber-Rousseau, C; Zandberg, L; de Lange, Z; Green, FR; Pieters, M				Cronje, H. Toinet; Nienaber-Rousseau, Cornelie; Zandberg, Lizelle; de Lange, Zelda; Green, Fiona R.; Pieters, Marlien			Fibrinogen and clot-related phenotypes determined by fibrinogen polymorphisms: Independent and IL-6-interactive associations	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-HEART-DISEASE; PLASMA-FIBRINOGEN; BETA-FIBRINOGEN; LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISMS; MYOCARDIAL-INFARCTION; CIRCULATING FIBRINOGEN; SOUTH-AFRICANS; RISK	Interleukin-6 (IL-6) induces the expression of fibrinogen, and polymorphic variation within the fibrinogen genes is believed to alter the magnitude of this expression. The identification of the functional relevance of individual fibrinogen single nucleotide polymorphisms (SNPs) has been hindered by the high linkage disequilibrium (LD) reported in the European fibrinogen gene locus. This study investigated two novel and 12 known fibrinogen SNPs of potential functional relevance, in 2010 Tswana individuals known to have low LD. We aimed to identify functional polymorphisms that contribute to clot-related phenotypes and total and Y fibrinogen concentrations independently and through their interaction with IL-6, by taking advantage of the high fibrinogen and IL-6 concentrations and the low LD reported in black South Africans. Fibrinogen was significantly associated with IL-6, thereby mediating associations of IL-6 with clot formation and structure, although attenuating the association of IL-6 with clot lysis time. None of the common European fibrinogen haplotypes was present in this study population. Putative functional fibrinogen SNPs FGB-rs7439150, rs1800789 (-1420(G/A)) and rs1800787 (-148(C/T)) were significantly associated with fibrinogen concentration and altered clot properties, with several associations significantly influenced by IL-6 concentrations. The impact of harbouring several minor fibrinogen SNP alleles on the association of IL-6 and fibrinogen concentration was cumulative, with possession of each additional minor allele showing a stronger relationship of IL-6 with fibrinogen. This was also reflected in differences in clot properties, suggesting potential clinical relevance. Therefore, when investigating the effect of fibrinogen genetics on fibrinogen concentrations and CVD outcome, the possible interactions with modulating factors and the fact that SNP effects seem to be additive should be taken into account.	[Cronje, H. Toinet; Nienaber-Rousseau, Cornelie; Zandberg, Lizelle; de Lange, Zelda; Pieters, Marlien] North West Univ, Ctr Excellence Nutr, Potchefstroom, South Africa; [Green, Fiona R.] Univ Manchester, Div Cardiovasc Sci, Sch Med Sci, Fac Biol Med & Hlth, Manchester, Lancs, England	North West University - South Africa; University of Manchester	Pieters, M (corresponding author), North West Univ, Ctr Excellence Nutr, Potchefstroom, South Africa.	marlien.pieters@nwu.ac.za	Zandberg, Lizelle/AAA-9968-2021; de Lange, Zelda/AAH-3529-2021; Cronjé, Héléne Toinét/ABB-1789-2021; Pieters, Marlien/AAI-1711-2020	Zandberg, Lizelle/0000-0001-9309-8710; de Lange, Zelda/0000-0002-7250-2419; Cronjé, Héléne Toinét/0000-0001-6855-8324; Pieters, Marlien/0000-0003-2849-6370; Nienaber-Rousseau, Cornelie/0000-0001-9156-2989	South African National Research Foundation; Academy of Medical Sciences UK (Newton Fund Advanced Fellowship Grant); Medical Research Council; Academy of Medical Sciences (AMS) [AMS-NAF1-Pieters] Funding Source: researchfish	South African National Research Foundation(National Research Foundation - South Africa); Academy of Medical Sciences UK (Newton Fund Advanced Fellowship Grant); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS))	Grants from the South African National Research Foundation to MP, Academy of Medical Sciences UK (Newton Fund Advanced Fellowship Grant) to MP and FRG, and the Medical Research Council to MP, supported this study. Funding sources were not involved in the conceptualisation, collection, interpretation or writing of the data in any way. Opinions expressed and conclusions arrived at, are those of the authors and are not to be attributed to the funding sources.	Alexander KS, 2011, THROMB HAEMOSTASIS, V105, P605, DOI 10.1160/TH10-09-0626; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BAUMANN RE, 1994, HUM GENET, V94, P165; Behague I, 1996, CIRCULATION, V93, P440, DOI 10.1161/01.CIR.93.3.440; BESTER J, 2016, SCI REP, V6; Brown ET, 1998, BLOOD, V92, P3286, DOI 10.1182/blood.V92.9.3286.421k20_3286_3293; Brull DJ, 2002, THROMB HAEMOSTASIS, V87, P37; Carty CL, 2010, ANN HUM GENET, V74, P1, DOI 10.1111/j.1469-1809.2009.00551.x; CHEN YS, 1995, AM J HUM GENET, V57, P133; Cheung EYL, 2008, STROKE, V39, P1033, DOI 10.1161/STROKEAHA.107.495499; Cook DG, AM J EPIDEN; Cotton JM, 2000, THROMB HAEMOSTASIS, V84, P926, DOI 10.1055/s-0037-1614144; Danesh J, 2005, JAMA-J AM MED ASSOC, V294, P1799, DOI 10.1001/jama.294.14.1799; Danik JS, 2009, CIRC-CARDIOVASC GENE, V2, P134, DOI 10.1161/CIRCGENETICS.108.825273; Davalos D, 2012, SEMIN IMMUNOPATHOL, V34, P43, DOI 10.1007/s00281-011-0290-8; de Lange M, 2001, LANCET, V357, P101, DOI 10.1016/S0140-6736(00)03541-8; de Lange Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083151; de Moerloose P, 2010, SEMIN THROMB HEMOST, V36, P7, DOI 10.1055/s-0030-1248720; de Vries PS, 2016, HUM MOL GENET, V25, P358, DOI 10.1093/hmg/ddv454; de Willige SU, 2009, THROMB HAEMOSTASIS, V101, P1078, DOI 10.1160/TH08-12-0813; de Willige SU, 2005, BLOOD, V106, P4176, DOI 10.1182/blood-2005-05-2180; Dehghan A, 2009, CIRC-CARDIOVASC GENE, V2, P125, DOI 10.1161/CIRCGENETICS.108.825224; Drouet L, 1999, Blood Coagul Fibrinolysis, V10 Suppl 1, pS35; Duan HO, 2003, J BIOL CHEM, V278, P41270, DOI 10.1074/jbc.M304210200; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fish RJ, 2012, THROMB HAEMOSTASIS, V108, P419, DOI 10.1160/TH12-04-0273; Fuller GM, 2001, ANN NY ACAD SCI, V936, P469; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Green FR, 2001, ANN NY ACAD SCI, V936, P549; HAMSTEN A, 1987, LANCET, V2, P988; Hinds DA, 2016, HUM MOL GENET, V25, P1867, DOI 10.1093/hmg/ddw037; Huffman JE, 2015, BLOOD, V126, pE19, DOI 10.1182/blood-2015-02-624551; Jacquemin B, 2008, J AM COLL CARDIOL, V52, P941, DOI 10.1016/j.jacc.2008.06.016; Jenkins GR, 1997, BLOOD, V89, P2394, DOI 10.1182/blood.V89.7.2394; Kaptoge S, 2014, EUR HEART J, V35, P578, DOI 10.1093/eurheartj/eht367; Kathiresan S, 2006, ARTERIOSCL THROM VAS, V26, P1405, DOI 10.1161/01.ATV.0000222011.13026.25; Keavney B, 2006, INT J EPIDEMIOL, V35, P935, DOI 10.1093/ije/dyl114; Ken-Dror G, 2012, EUR J EPIDEMIOL, V27, P267, DOI 10.1007/s10654-012-9666-x; Kida M, 1997, BIOCHEM BIOPH RES CO, V230, P129, DOI 10.1006/bbrc.1996.5909; Klovaite J, 2013, AM J RESP CRIT CARE, V187, P286, DOI 10.1164/rccm.201207-1232OC; Kotze RC, 2015, BRIT J HAEMATOL, V168, P102, DOI 10.1111/bjh.13104; Lammertyn L, 2015, CLIN EXP HYPERTENS, V37, P511, DOI 10.3109/10641963.2015.1013123; Lim BCB, 2003, LANCET, V361, P1424, DOI 10.1016/S0140-6736(03)13135-2; Lisman T, 2005, BLOOD, V105, P1102, DOI 10.1182/blood-2004-08-3253; Machlus KR, 2011, BLOOD, V117, P4953, DOI 10.1182/blood-2010-11-316885; Macrae FL, 2016, SEMIN THROMB HEMOST, V42, P344, DOI 10.1055/s-0036-1572353; Mannila MN, 2006, THROMB HAEMOSTASIS, V95, P420, DOI 10.1160/TH05-11-0777; Meade TW, 2006, INT J EPIDEMIOL, V35, P944, DOI 10.1093/ije/dyl149; Meh DA, 1996, J BIOL CHEM, V271, P23121, DOI 10.1074/jbc.271.38.23121; Mills JD, 2002, CIRCULATION, V106, P1938, DOI 10.1161/01.CIR.0000033221.73082.06; Montgomery HE, 1996, ARTERIOSCL THROM VAS, V16, P386, DOI 10.1161/01.ATV.16.3.386; Morozumi T, 2009, IMMUNOL INVEST, V38, P311, DOI 10.1080/08820130902745153; Pieters M, 2008, MOL NUTR FOOD RES, V52, P164, DOI 10.1002/mnfr.200700373; Pieters M, 2013, BLOOD, V121, P3254, DOI 10.1182/blood-2012-12-471482; Pieters M, 2011, THROMB HAEMOSTASIS, V106, P448, DOI 10.1160/TH11-03-0192; Rein-Smith CM, 2013, THROMB RES, V131, P89, DOI 10.1016/j.thromres.2012.09.017; Reiner AP, 2006, J THROMB HAEMOST, V4, P1279, DOI 10.1111/j.1538-7836.2006.01907.x; Sabater-Lleal M, 2013, CIRCULATION, V128, P1310, DOI 10.1161/CIRCULATIONAHA.113.002251; Sidelmann JJ, 2000, SEMIN THROMB HEMOST, V26, P605, DOI 10.1055/s-2000-13216; Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019; Teo YY, 2010, NAT REV GENET, V11, P149, DOI 10.1038/nrg2731; THOMAS A, 1994, HUM MUTAT, V3, P79, DOI 10.1002/humu.1380030117; Tzoulaki I, 2007, CIRCULATION, V115, P2119, DOI 10.1161/CIRCULATIONAHA.106.635029; Undas A, 2008, ATHEROSCLEROSIS, V196, P551, DOI 10.1016/j.atherosclerosis.2007.05.028; Undas A, 2011, ARTERIOSCL THROM VAS, V31, pE88, DOI 10.1161/ATVBAHA.111.230631; van der Bom JG, 1998, ARTERIOSCL THROM VAS, V18, P621, DOI 10.1161/01.ATV.18.4.621; van't Hooft FM, 1999, ARTERIOSCL THROM VAS, V19, P3063, DOI 10.1161/01.ATV.19.12.3063; Verschuur M, 2005, J BIOL CHEM, V280, P16763, DOI 10.1074/jbc.M501973200; Wassel CL, 2011, BLOOD, V117, P268, DOI 10.1182/blood-2010-06-289546; WOLFENSTEINTODEL C, 1980, P NATL ACAD SCI-BIOL, V77, P5069, DOI 10.1073/pnas.77.9.5069; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Zerbino DR, 2016, DATABASE-OXFORD, DOI 10.1093/database/bav119; ZHANG ZX, 1995, J BIOL CHEM, V270, P24287, DOI 10.1074/jbc.270.41.24287	73	18	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							e0187712	10.1371/journal.pone.0187712	http://dx.doi.org/10.1371/journal.pone.0187712			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6TA	29099861	gold, Green Published			2022-12-26	WOS:000414377900039
J	Mitra, S; Banerjee, S; Hayashi, Y				Mitra, Somosmita; Banerjee, Subhashis; Hayashi, Yoichi			Volumetric brain tumour detection from MRI using visual saliency	PLOS ONE			English	Article							ATTENTION	Medical image processing has become a major player in the world of automatic tumour region detection and is tantamount to the incipient stages of computer aided design. Saliency detection is a crucial application of medical image processing, and serves in its potential aid to medical practitioners by making the affected area stand out in the foreground from the rest of the background image. The algorithm developed here is a new approach to the detection of saliency in a three dimensional multi channel MR image sequence for the glioblastoma multiforme (a form of malignant brain tumour). First we enhance the three channels, FLAIR (Fluid Attenuated Inversion Recovery), T2 and T1C (contrast enhanced with gadolinium) to generate a pseudo coloured RGB image. This is then converted to the CIE L*a*b* color space. Processing on cubes of sizes k= 4, 8,16, the L*a*b* 3D image is then compressed into volumetric units; each representing the neighbourhood information of the surrounding 64 voxels for k = 4, 512 voxels for k = 8 and 4096 voxels for k = 16, respectively. The spatial distance of these voxels are then compared along the three major axes to generate the novel 3D saliency map of a 3D image, which unambiguously highlights the tumour region. The algorithm operates along the three major axes to maximise the computation efficiency while minimising loss of valuable 3D information. Thus the 3D multichannel MR image saliency detection algorithm is useful in generating a uniform and logistically correct 3D saliency map with pragmatic applicability in Computer Aided Detection (CADe). Assignment of uniform importance to all three axes proves to be an important factor in volumetric processing, which helps in noise reduction and reduces the possibility of compromising essential information. The effectiveness of the algorithm was evaluated over the BRATS MICCAI 2015 dataset having 274 glioma cases, consisting both of high grade and low grade GBM. The results were compared with that of the 2D saliency detection algorithm taken over the entire sequence of brain data. For all comparisons, the Area Under the receiver operator characteristic (ROC) Curve (AUC) has been found to be more than 0.99 +/- 0.01 over various tumour types, structures and locations.	[Mitra, Somosmita] Inst Engn & Management, Dept Comp Sci & Engn, Kolkata 700091, W Bengal, India; [Banerjee, Subhashis] Indian Stat Inst, Machine Intelligence Unit, Kolkata 700108, W Bengal, India; [Banerjee, Subhashis] Univ Calcutta, Dept Comp Sci & Engn, Kolkata 700106, W Bengal, India; [Hayashi, Yoichi] Meiji Univ, Dept Comp Sci, Tama Ku, Kawasaki, Kanagawa 2148571, Japan	Institute of Engineering & Management (IEM), Kolkata; Indian Statistical Institute; Indian Statistical Institute Kolkata; University of Calcutta; Meiji University	Mitra, S (corresponding author), Inst Engn & Management, Dept Comp Sci & Engn, Kolkata 700091, W Bengal, India.	somosmita.mitra@gmail.com		Banerjee, Subhashis/0000-0002-2358-2096; Mitra, Somosmita/0000-0001-6573-9285	Ministry of Electronics & Information Technology(MeitY), Government of India	Ministry of Electronics & Information Technology(MeitY), Government of India	S. Banerjee acknowledges Visvesvaraya PhD Scheme by Ministry of Electronics & Information Technology(MeitY), Government of India.	Achanta R, 2008, LECT NOTES COMPUT SC, V5008, P66; Alpert S., 2014, SPIE MED IMAGING; Banerjee T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154666; Bian P, 2009, LECT NOTES COMPUT SC, V5506, P251, DOI 10.1007/978-3-642-02490-0_31; Erdem E, 2013, J VISION, V13, DOI 10.1167/13.4.11; Erihov M, 2015, LECT NOTES COMPUT SC, V9351, P636, DOI 10.1007/978-3-319-24574-4_76; Foulsham T, 2008, J VISION, V8, DOI 10.1167/8.2.6; Gatenby RA, 2013, RADIOLOGY, V269, P8, DOI 10.1148/radiol.13122697; Holland EC, 2000, P NATL ACAD SCI USA, V97, P6242, DOI 10.1073/pnas.97.12.6242; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Jampani V., 2012, P 8 IND C COMP VIS G, P80; Kistler M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2930; Ma Y.-F, 2003, P 11 ACM INT C MULTI, P374; Menze BH, 2015, IEEE T MED IMAGING, V34, P1993, DOI 10.1109/TMI.2014.2377694; Mitra S, 2015, INFORM SCIENCES, V306, P111, DOI 10.1016/j.ins.2015.02.015; Perona, 2007, ADV NEURAL INFORM PR, P545, DOI DOI 10.7551/MITPRESS/7503.003.0073; Quellec G, 2011, IEEE T MED IMAGING, V30, P523, DOI 10.1109/TMI.2010.2089383; Rosin PL, 2009, PATTERN RECOGN, V42, P2363, DOI 10.1016/j.patcog.2009.04.021; Ujjwal, 2013, I S BIOMED IMAGING, P1436; Ullman S., 1988, P 2 INT C COMP VIS, P321, DOI DOI 10.1109/CCV.1988.590008; Walther D, 2006, NEURAL NETWORKS, V19, P1395, DOI 10.1016/j.neunet.2006.10.001; Zhang LY, 2008, J VISION, V8, DOI 10.1167/8.7.32; Zinn PO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041522	23	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187209	10.1371/journal.pone.0187209	http://dx.doi.org/10.1371/journal.pone.0187209			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095877	gold, Green Published, Green Submitted			2022-12-26	WOS:000414340200058
J	Nam, K; Maruyama, CL; Wang, CS; Trump, BG; Lei, P; Andreadis, ST; Baker, OJ				Nam, Kihoon; Maruyama, Christina L.; Wang, Ching-Shuen; Trump, Bryan G.; Lei, Pedro; Andreadis, Stelios T.; Baker, Olga J.			Laminin-111-derived peptide conjugated fibrin hydrogel restores salivary gland function	PLOS ONE			English	Article							GENE DELIVERY; INTEGRIN; CHANNEL; CANCER; TUMORIGENESIS; AQUAPORIN-5; XEROSTOMIA; COLLAGEN; BINDING	Hyposalivation reduces the patient quality of life, as saliva is important for maintaining oral health. Current treatments for hyposalivation are limited to medications such as the muscarinic receptor agonists, pilocarpine and cevimeline. However, these therapies only provide temporary relief. Therefore, alternative therapies are essential to restore salivary gland function. An option is to use bioengineered scaffolds to promote functional salivary gland regeneration. Previous studies demonstrated that the laminin-111 protein is critical for intact salivary gland cell cluster formation and organization. However, laminin-111 protein as a whole is not suitable for clinical applications as some protein domains may contribute to unwanted side effects such as degradation, tumorigenesis and immune responses. Conversely, the use of synthetic laminin-111 peptides makes it possible to minimize the immune reactivity or pathogen transfer. In addition, it is relatively simple and inexpensive as compared to animal-derived proteins. Therefore, the goal of this study was to demonstrate whether a 20 day treatment with laminin-111-derived peptide conjugated fibrin hydrogel promotes tissue regeneration in submandibular glands of a wound healing mouse model. In this study, laminin-111-derived peptide conjugated fibrin hydrogel significantly accelerated formation of salivary gland tissue. The regenerated gland tissues displayed not only structural but also functional restoration.	[Nam, Kihoon; Maruyama, Christina L.; Wang, Ching-Shuen; Trump, Bryan G.; Baker, Olga J.] Univ Utah, Sch Dent, Salt Lake City, UT 84112 USA; [Lei, Pedro; Andreadis, Stelios T.] Univ Buffalo State Univ New York, Dept Chem & Biol Engn, Buffalo, NY USA; [Andreadis, Stelios T.] Univ Buffalo State Univ New York, Sch Engn & Appl Sci, Dept Biomed Engn, Buffalo, NY USA; [Andreadis, Stelios T.] Univ Buffalo State Univ New York, Ctr Bioinformat & Life Sci, Buffalo, NY USA	Utah System of Higher Education; University of Utah; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Baker, OJ (corresponding author), Univ Utah, Sch Dent, Salt Lake City, UT 84112 USA.	olga.baker@hsc.utah.edu	Lei, Pedro/U-1027-2019		National Institutes of Health-National Institute of Dental and Craniofacial Research [R01DE022971, R01DE021697]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022971, R56DE021697] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study is supported by the National Institutes of Health-National Institute of Dental and Craniofacial Research Grants R01DE022971 (to 0.B. and S.A.) and R01DE021697 (to O.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold KM, 2015, CANCER GROWTH METAST, V8, P1, DOI 10.4137/CGM.S11286; Asakura S, 1997, J BIOL CHEM, V272, P8824, DOI 10.1074/jbc.272.13.8824; Brett D, 2008, WOUNDS, V20, P347; Carlson E. R., 2015, TRAUMA INJURIES SALI, P409; Del Bufalo F, 2016, BIOMATERIALS, V84, P76, DOI 10.1016/j.biomaterials.2016.01.030; des Rieux A, 2009, J CONTROL RELEASE, V136, P148, DOI 10.1016/j.jconrel.2009.02.004; Dijkema T, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-91; Ehrlich HP, 2012, ADV WOUND CARE, V1, P3, DOI 10.1089/wound.2011.0311; Frith JE, 2012, STEM CELLS DEV, V21, P2442, DOI 10.1089/scd.2011.0615; Geiger B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005033; Ghajar CM, 2008, HISTOCHEM CELL BIOL, V130, P1105, DOI 10.1007/s00418-008-0537-1; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Jeong J, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.121; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Kesimer M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-163; Kidd ME, 2012, J CONTROL RELEASE, V157, P80, DOI 10.1016/j.jconrel.2011.08.036; Kruegel J, 2010, CELL MOL LIFE SCI, V67, P2879, DOI 10.1007/s00018-010-0367-x; Lei P, 2009, BIOMATERIALS, V30, P3790, DOI 10.1016/j.biomaterials.2009.03.049; Liang MS, 2013, BIOMATERIALS, V34, P7281, DOI 10.1016/j.biomaterials.2013.05.073; Liang MS, 2011, BIOMATERIALS, V32, P8684, DOI 10.1016/j.biomaterials.2011.07.079; Litvinov RI, 2005, BIOPHYS J, V89, P2824, DOI 10.1529/biophysj.105.061887; Maruyama CL, 2015, J DENT RES; Matsuzaki T, 1999, CELL TISSUE RES, V295, P513, DOI 10.1007/s004410051257; Matsuzaki T, 2012, ACTA HISTOCHEM CYTOC, V45, P251, DOI 10.1267/ahc.12018; Nam K, 2017, J DENT RES, V96, P798, DOI 10.1177/0022034517695496; Nam K, 2016, BIOMACROMOLECULES, V17, P2293, DOI 10.1021/acs.biomac.6b00588; O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X; Ogawa M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3498; Padmashali RM, 2011, BIOMATERIALS, V32, P3330, DOI 10.1016/j.biomaterials.2011.01.035; Parveen S, 2006, J STEM CELLS REGEN, V1, P8; Patel VN, 2014, SEMIN CELL DEV BIOL, V25, P52, DOI 10.1016/j.semcdb.2013.12.001; Pinna R, 2015, THER CLIN RISK MANAG, V11, P171, DOI 10.2147/TCRM.S70652; Pook M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138346; Rajasekaran SA, 2008, BBA-BIOMEMBRANES, V1778, P757, DOI 10.1016/j.bbamem.2007.11.007; RAO CN, 1991, CONNECT TISSUE RES, V25, P321, DOI 10.3109/03008209109029167; Rasmussen CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145389; Romanenko VG, 2010, J BIOL CHEM, V285, P12990, DOI 10.1074/jbc.M109.068544; Sonesson M, 2008, ARCH ORAL BIOL, V53, P523, DOI 10.1016/j.archoralbio.2008.01.002; Soon ASC, 2011, BIOMATERIALS, V32, P4406, DOI 10.1016/j.biomaterials.2011.02.050; Stipp CS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001355; Suehiro K, 2000, J BIOCHEM, V128, P705, DOI 10.1093/oxfordjournals.jbchem.a022804; Villa A, 2015, THER CLIN RISK MANAG, V11, P45, DOI 10.2147/TCRM.S76282; Vissink A, 2010, INT J RADIAT ONCOL, V78, P983, DOI 10.1016/j.ijrobp.2010.06.052; WEISFOGH US, 1988, EUR SURG RES, V20, P381, DOI 10.1159/000128789; Wiener RC, 2010, J AM DENT ASSOC, V141, P279, DOI 10.14219/jada.archive.2010.0161; Wilson M, 2015, MACROMOLECULES, V48, P6313, DOI 10.1021/acs.macromol.5b00885; Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005; Yuan X, 2016, TISSUE ENG PT A, V22, P928, DOI [10.1089/ten.tea.2016.0052, 10.1089/ten.TEA.2016.0052]	48	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187069	10.1371/journal.pone.0187069	http://dx.doi.org/10.1371/journal.pone.0187069			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095857	Green Published, gold, Green Submitted			2022-12-26	WOS:000414340200043
J	Wu, JC; Crawford, FW; Raag, M; Heimer, R; Uuskula, A				Wu, Jiacheng; Crawford, Forrest W.; Raag, Mait; Heimer, Robert; Uuskula, Anneli			Using data from respondent-driven sampling studies to estimate the number of people who inject drugs: Application to the Kohtla-Jarve region of Estonia	PLOS ONE			English	Article							POPULATION-SIZE; CAPTURE-RECAPTURE; ST-PETERSBURG; HIV; PREVALENCE; USERS; PREVENTION; EPIDEMIC; RUSSIA; MEN	Estimating the size of key risk populations is essential for determining the resources needed to implement effective public health intervention programs. Several standard methods for population size estimation exist, but the statistical and practical assumptions required for their use may not be met when applied to HIV risk groups. We apply three approaches to estimate the number of people who inject drugs (PWID) in the Kohtla-Jarve region of Estonia using data from a respondent-driven sampling (RDS) study: the standard "multiplier" estimate gives 654 people (95% CI 509-804), the "successive sampling" method gives estimates between 600 and 2500 people, and a network-based estimate that uses the RDS recruitment chain gives between 700 and 2800 people. We critically assess the strengths and weaknesses of these statistical approaches for estimating the size of hidden or hard-to-reach HIV risk groups.	[Wu, Jiacheng] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Crawford, Forrest W.] Yale Sch Publ Hlth, Dept Biostat, New Haven, CT 06510 USA; [Crawford, Forrest W.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Crawford, Forrest W.] Yale Sch Management, New Haven, CT 06511 USA; [Raag, Mait; Uuskula, Anneli] Univ Tartu, Inst Family Med & Publ Hlth, Tartu, Estonia; [Heimer, Robert] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA; [Heimer, Robert] Yale Sch Publ Hlth, Ctr Interdisciplinary Res AIDS, New Haven, CT USA	University of Washington; University of Washington Seattle; Yale University; Yale University; Yale University; University of Tartu; Yale University; Yale University	Crawford, FW (corresponding author), Yale Sch Publ Hlth, Dept Biostat, New Haven, CT 06510 USA.; Crawford, FW (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.; Crawford, FW (corresponding author), Yale Sch Management, New Haven, CT 06511 USA.	forrest.crawford@yale.edu	Uusküla, Anneli/H-3303-2015	Uusküla, Anneli/0000-0002-4036-3856; Crawford, Forrest/0000-0002-0046-0547	National Institutes of Health grants from Eunice Kennedy Shriver National Institute of Child Health and Human Development [DP2OD022614]; National Center for Advancing Translational Sciences [KL2 TR000140]; National Institute of Mental Health [P30MH062294]; Yale Center for Clinical Investigation; Yale Center for Interdisciplinary Research on AIDS; Estonian Ministry of Education and Research [TARTH15017I]; National Institute on Drug Abuse [1R01DA029888]; NICHD [DP2 OD022614]; NIH/NCATS [KL2 TR000140]; NIMH [P30MH062294]; NIH/NIDA [1R01DA029888]	National Institutes of Health grants from Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Yale Center for Clinical Investigation; Yale Center for Interdisciplinary Research on AIDS; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH/NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH/NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	FWC was supported by National Institutes of Health grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development DP2OD022614, National Center for Advancing Translational Sciences grant KL2 TR000140, National Institute of Mental Health P30MH062294, the Yale Center for Clinical Investigation, and the Yale Center for Interdisciplinary Research on AIDS. The Estonian Ministry of Education and Research under grant #TARTH15017I to AU. RH was also supported by the National Institute of Mental Health P30MH062294. The RDS study was funded by the National Institute on Drug Abuse grant 1R01DA029888 to RH/AU (Co-PIs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r FWC was supported by NICHD DP2 OD022614, NIH/NCATS grant KL2 TR000140, NIMH grant P30MH062294, the Yale Center for Clinical Investigation, and the Yale Center for Interdisciplinary Research on AIDS. Estonian Ministry of Education and Research under grant #TARTH15017I. The RDS study was funded by NIH/NIDA grant 1R01DA029888 to Heimer/Uuskula (Co-PIs).	Abdul-Quader AS, 2014, CURR OPIN HIV AIDS, V9, P107, DOI 10.1097/COH.0000000000000041; Bernard HR, 2010, SEX TRANSM INFECT, V86, pI11, DOI 10.1136/sti.2010.044446; Burke SE, 2015, SOC SCI MED, V130, P154, DOI 10.1016/j.socscimed.2015.02.018; CHEN Yan, 2009, J ORDNANCE ENG COLL, V21, P10; Crawford FW, 2017, J AM STAT A IN PRESS; Des Jarlais D. C., 2013, ADV PREVENTIVE MED, V2013; Development NIfH, 2014, HIV EST SIT PREV TRE; Drew R., 2008, EVALUATION FIGHTING; Gile KJ, 2015, J R STAT SOC A STAT, V178, P241, DOI 10.1111/rssa.12059; Handcock M, 2015, SSPSE ESTIMATING HID; Handcock MS, 2015, BIOMETRICS, V71, P258, DOI 10.1111/biom.12255; Handcock MS, 2014, ELECTRON J STAT, V8, P1491, DOI 10.1214/14-EJS923; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Heimer R, 2010, DRUG ALCOHOL DEPEN, V109, P79, DOI 10.1016/j.drugalcdep.2009.12.010; Johnston L, 2011, INT J DRUG POLICY, V22, P252, DOI 10.1016/j.drugpo.2011.05.007; Khalid FJ, 2014, AIDS BEHAV, V18, pS25, DOI 10.1007/s10461-013-0517-x; Laisaar K-T, 2016, EUROSURVEILLANCE, V21; Laisaar KT, 2013, AIDS CARE, V25, P863, DOI 10.1080/09540121.2013.764393; Lemsalu L, 2013, REPORT HIV INFECTED; Lewis M, 2013, WHY EUROPES HEALTHIE; Luan RS, 2005, EUR J EPIDEMIOL, V20, P581, DOI 10.1007/s10654-005-4305-4; Paz-Bailey G, 2011, SEX TRANSM INFECT, V87, P279, DOI 10.1136/sti.2010.045633; Population and Housing Census, EST POP CONC MAJ CIT; Quaye S, 2015, AIDS BEHAV, V19, pS16, DOI 10.1007/s10461-014-0943-4; Raben D, 2014, HIV AIDS TREATMENT C; Robins G, 2001, SOC NETWORKS, V23, P1, DOI 10.1016/S0378-8733(01)00029-6; Ruiz MS, 2015, AIDS BEHAV, P1; Tilling K, 2001, INT J EPIDEMIOL, V30, P12, DOI 10.1093/ije/30.1.12; Uuskula A, 2015, AIDS CARE, V27, P105, DOI 10.1080/09540121.2014.940271; Uuskula A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-517; Uuskula A, 2008, J PUBLIC HEALTH-UK, V30, P119, DOI 10.1093/pubmed/fdn014; Uuskula A, 2007, ADDICT RES THEORY, V15, P411, DOI 10.1080/16066350701417533; Uuskula A, 2013, INT J DRUG POLICY, V24, P312, DOI 10.1016/j.drugpo.2012.11.002; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wesson P, 2017, AIDS BEHAV, P1; World Health Organization, 2013, HIV AIDS SURV EUR; World Health Organization, 2010, EST SIZ POP MOST RIS; Zhao Y., 2011, WORLD J AIDS, V01, P88	38	4	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0185711	10.1371/journal.pone.0185711	http://dx.doi.org/10.1371/journal.pone.0185711			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL6FI	29095866	Green Submitted, Green Published, gold			2022-12-26	WOS:000414340200006
J	Kim, SY; Sim, S; Choi, HG				Kim, So Young; Sim, Songyong; Choi, Hyo Geun			Atopic dermatitis is associated with active and passive cigarette smoking in adolescents	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; ALLERGIC SENSITIZATION; EXPOSURE; MARKERS; ECZEMA; RISK	Objective The relationship between passive smoking and atopic dermatitis has previously been reported, but few studies have simultaneously evaluated the association of atopic dermatitis with active and passive smoking. Methods The relationships between atopic dermatitis and active and passive smoking were evaluated in Korean adolescents. We used a large, representative, population-based survey (The Korea Youth Risk Behavior Web-based Survey) conducted in 2011 and 2012. Active smoking was classified into 3 groups (0 days, 1-19 days, and > 20 days/month). Passive smoking was categorized into 3 groups (0 days, 1-4 days, and > 5 days/week). Atopic dermatitis diagnosed by a medical doctor either during the past 1 month or during the participant's lifetime was surveyed. Age, sex, obesity status, region of residence, economic level, and parental educational level of the participants were adjusted as confounders. Adjusted odds ratios (AORs) and 95% confidence intervals (CI) were calculated using multiple logistic regression analysis with complex sampling. Results A total of 6.8% (10,020/135,682) of the participants reported atopic dermatitis during the last 12 months. Active smoking was significantly associated with atopic dermatitis (previous 12 months) (AOR [95% CI] of smoking >= 20 days/month =1.18 [1.07-1.29]; 1-19 days/month = 1.11 [0.99-1.23], P = 0.002). Passive smoking was also related to atopic dermatitis (previous 12 months) (AOR [95% CI] of smoking > 5 days/week = 1.12 [1.05-1.20]; 1-4 days/week = 1.08 [1.03-1.13], P < 0.001). Conclusion Atopic dermatitis was significantly associated with active and passive smoking in Korean adolescents.	[Kim, So Young] CHA Univ, Dept Otorhinolaryngol Head & Neck Surg, CHA Bundang Med Ctr, Seongnam, South Korea; [Sim, Songyong] Hallym Univ, Dept Stat, Chunchon, South Korea; [Choi, Hyo Geun] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea	Pochon Cha University; Hallym University; Hallym University	Choi, HG (corresponding author), Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea.	pupen@naver.com	Choi, Hyo Geun/K-4461-2019	Choi, Hyo Geun/0000-0003-1655-9549	National Research Foundation (NRF) of Korea [NRF-2015-R1D1A1A01060860]; Hallym University Sacred Heart Hospital [HURF-2016-38]; Korea Ministry of Environment (MOE) as "The Environmental Health Action Program" [2016001360009]	National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Hallym University Sacred Heart Hospital; Korea Ministry of Environment (MOE) as "The Environmental Health Action Program"	This work was supported in part by a research grant (NRF-2015-R1D1A1A01060860) from the National Research Foundation (NRF) of Korea, a Research Grant funded by Hallym University Sacred Heart Hospital (HURF-2016-38), and a Korea Ministry of Environment (MOE) as "The Environmental Health Action Program"(2016001360009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, RELIABILITY VALIDITY; Bae Jisuk, 2010, J Prev Med Public Health, V43, P403, DOI 10.3961/jpmph.2010.43.5.403; Bae Jisuk, 2010, J Prev Med Public Health, V43, P396, DOI 10.3961/jpmph.2010.43.5.396; Centers for Disease Control and Prevention, BMI CHILDR TEENS; Deckers IAG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039803; Edwards K, 1999, HUM EXP TOXICOL, V18, P233, DOI 10.1191/096032799678839978; FERSON M, 1979, INT J CANCER, V23, P603, DOI 10.1002/ijc.2910230504; FORASTIERE F, 1993, ARCH ENVIRON HEALTH, V48, P230, DOI 10.1080/00039896.1993.9940364; Frohlich M, 2003, EUR HEART J, V24, P1365, DOI 10.1016/S0195-668X(03)00260-4; Graif Y, 2013, DERMATOLOGY, V226, P195, DOI 10.1159/000348333; Hancox RJ, 2008, J ALLERGY CLIN IMMUN, V121, P38, DOI 10.1016/j.jaci.2007.09.052; Jarvis D, 1999, J ALLERGY CLIN IMMUN, V104, P934, DOI 10.1016/S0091-6749(99)70071-0; Kim SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135753; Kramer U, 2004, BRIT J DERMATOL, V150, P111, DOI 10.1111/j.1365-2133.2004.05710.x; Lee CH, 2011, BRIT J DERMATOL, V164, P483, DOI 10.1111/j.1365-2133.2010.10116.x; Leow YH, 1998, CLIN DERMATOL, V16, P579, DOI 10.1016/S0738-081X(98)00042-X; Linneberg A, 2006, J ALLERGY CLIN IMMUN, V117, P184, DOI 10.1016/j.jaci.2005.09.042; MATHEWS JD, 1973, LANCET, V2, P754; Seymour BWP, 1997, J IMMUNOL, V159, P6169; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Tae B., 2016, ENV TOXICOL; Tanaka K, 2008, J ASTHMA, V45, P833, DOI 10.1080/02770900802339742; Wuthrich B, 1996, INT ARCH ALLERGY IMM, V111, P396, DOI 10.1159/000237398; Yi O, 2012, ENVIRON RES, V113, P40, DOI 10.1016/j.envres.2011.12.012	24	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187453	10.1371/journal.pone.0187453	http://dx.doi.org/10.1371/journal.pone.0187453			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091936	Green Published, Green Submitted, gold			2022-12-26	WOS:000414229700068
J	Lee, Y; Kwon, DJ; Kim, YH; Ra, M; Heo, SI; Ahn, WG; Park, JR; Lee, SR; Kim, KH; Kim, SY				Lee, Yongjun; Kwon, Dong-Joo; Kim, Young Han; Ra, Moonjin; Heo, Seong Il; Ahn, Won Gyeong; Park, Jeong-Ran; Lee, Seoung Rak; Kim, Ki Hyun; Kim, Sun Young			HIMH0021 attenuates ethanol-induced liver injury and steatosis in mice	PLOS ONE			English	Article							ACER-TEGMENTOSUM MAXIM; ALCOHOL; DISEASE; PATHOGENESIS; RATS	Chronic alcohol consumption causes alcohol-induced lipogenesis and promotes hepatic injury by preventing the oxidation of hepatocellular fatty acids through the suppression of the activation of AMP-activated protein kinase (AMPK). HIMH0021, an active flavonoid compound, which is a component of the Acer tegmentosum extract, has been shown to protect against liver damage caused by alcohol consumption. Therefore, in this study, we aimed to determine whether HIMH0021 could regulate alcoholic fatty liver and liver injury in mice. Oral administration of 10 days of Lieber-DeCarli ethanol plus a single binge of 30% ethanol (chronic-plus-binge model) induced steatosis and liver injury and inflammation in mice, which appears similar to the condition observed in human patients with alcohol-related diseases. HIMH0021, which was isolated from the active methanol extract of A. tegmentosum, inhibited alcohol-induced steatosis and attenuated the serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) during hepatocellular alcohol metabolism, both of which promote lipogenesis as well as liver inflammation. Treatment with HIMH0021 conferred protection against lipogenesis and liver injury, inhibited the expression of cytochrome P4502E1, and increased serum adiponectin levels in the mice subjected to chronic-plus-binge feeding. Furthermore, in hepatocytes, HIMH0021 activated fatty acid oxidation by activating pAMPK, which comprises pACC and CPT1 alpha. These findings suggested that HIMH0021 could be used to target a TNF alpha-related pathway for treating patients with alcoholic hepatitis.	[Lee, Yongjun; Kwon, Dong-Joo; Kim, Young Han; Ra, Moonjin; Heo, Seong Il; Ahn, Won Gyeong; Park, Jeong-Ran; Kim, Sun Young] Hongcheon Inst Med Herb, 101 Yeonbongri, Hongcheon, South Korea; [Lee, Seoung Rak; Kim, Ki Hyun] Sungkyunkwan Univ, Sch Pharm, Suwon, South Korea	Sungkyunkwan University (SKKU)	Kim, SY (corresponding author), Hongcheon Inst Med Herb, 101 Yeonbongri, Hongcheon, South Korea.	wiscsyk@naver.com	ra, moonjin/AAK-3816-2021; Kim, Sun/GSN-4867-2022		'R&D program for Forest Science Technology' - Korea Forest Service (Korea Forestry Promotion Institute) [S121415L020110]	'R&D program for Forest Science Technology' - Korea Forest Service (Korea Forestry Promotion Institute)	This study was carried out with the support of 'R&D program for Forest Science Technology' (Project No. S121415L020110) provided by Korea Forest Service (Korea Forestry Promotion Institute).	Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032; Casanova J, 2014, GASTROENT HEPAT-BARC, V37, P262, DOI 10.1016/j.gastrohep.2014.02.001; Crabb D W, 1993, Recent Dev Alcohol, V11, P207; Crabb DW, 2006, J GASTROEN HEPATOL, V21, pS56, DOI 10.1111/j.1440-1746.2006.04582.x; Crabb DW, 2004, P NUTR SOC, V63, P49, DOI 10.1079/PNS2003327; Ding WX, 2004, J CELL MOL MED, V8, P445, DOI 10.1111/j.1582-4934.2004.tb00469.x; Fromenty B, 1997, J HEPATOL, V26, P43, DOI 10.1016/S0168-8278(97)80496-5; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; GRUNNET N, 1986, ALCOHOL CLIN EXP RES, V10, pS64, DOI 10.1111/j.1530-0277.1986.tb05182.x; Hasin D, 2003, ALCOHOL RES HEALTH, V27, P5; Hwang YH, 2013, J ETHNOPHARMACOL, V148, P99, DOI 10.1016/j.jep.2013.03.074; Kiselica AM, 2015, ADDICT DISORD TREAT, V14, DOI 10.1097/ADT.0000000000000036; Li Z, 2016, BIOMED CHROMATOGR, V30, P1124, DOI 10.1002/bmc.3660; Lieber Charles S, 2004, Curr Gastroenterol Rep, V6, P60, DOI 10.1007/s11894-004-0027-0; Lieber CS, 2004, ALCOHOL, V34, P9, DOI 10.1016/j.alcohol.2004.07.008; Lieber CS, 2004, DRUG METAB REV, V36, P511, DOI 10.1081/DMR-200033441; Liu Q, 2012, NAT PROD RES, V26, P1750, DOI 10.1080/14786419.2011.608676; Mathurin P, 2000, HEPATOLOGY, V32, P1008, DOI 10.1053/jhep.2000.19621; Mueller S, 2014, WORLD J GASTROENTERO, V20, P14626, DOI 10.3748/wjg.v20.i40.14626; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; Park KM, 2006, ARCH PHARM RES, V29, P1086, DOI 10.1007/BF02969296; Pessayre D, 2001, SEMIN LIVER DIS, V21, P57, DOI 10.1055/s-2001-12929; Ronis MJ, 2010, ALCOHOL, V44, P157, DOI 10.1016/j.alcohol.2009.11.002; Shklyaev S, 2003, P NATL ACAD SCI USA, V100, P14217, DOI 10.1073/pnas.2333912100; SY Kim GP, 2015, Patent KR, Patent No. [20160079622A, 20160079622]; Tung NH, 2008, J AGR FOOD CHEM, V56, P10510, DOI 10.1021/jf8020283; Zhou ZX, 2003, AM J PATHOL, V163, P1137, DOI 10.1016/S0002-9440(10)63473-6	27	8	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0185134	10.1371/journal.pone.0185134	http://dx.doi.org/10.1371/journal.pone.0185134			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091708	Green Published, gold, Green Submitted			2022-12-26	WOS:000414229700004
J	Philip, J; Ryman, TK; Hopkins, SE; O'Brien, DM; Bersamin, A; Pomeroy, J; Thummel, KE; Austin, MA; Boyer, BB; Dombrowski, K				Philip, Jacques; Ryman, Tove K.; Hopkins, Scarlett E.; O'Brien, Diane M.; Bersamin, Andrea; Pomeroy, Jeremy; Thummel, Kenneth E.; Austin, Melissa A.; Boyer, Bert B.; Dombrowski, Kirk			Bi-cultural dynamics for risk and protective factors for cardiometabolic health in an Alaska Native (Yup'ik) population	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; YUKON-KUSKOKWIM DELTA; MARINE FOOD-INTAKE; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; MENTAL-HEALTH; INUIT YOUTH; ALCOHOL-USE; EICOSAPENTAENOIC ACID	Alaska Native people experience disparities in mortality from heart disease and stroke. This work attempts to better understand the relationships between socioeconomic, behavioral, and cardiometabolic risk factors among Yup'ik people of southwestern Alaska, with a focus on the role of the socioeconomic, and cultural components. Using a cross-sectional sample of 486 Yup'ik adults, we fitted a Partial Least Squares Path Model (PLS-PM) to assess the associations between components, including demographic factors [age and gender], socioeconomic factors [education, economic status, Yup'ik culture, and Western culture], behavioral factors [diet, cigarette smoking and smokeless tobacco use, and physical activity], and cardiometabolic risk factors [adiposity, triglyceride-HDL and LDL lipids, glycemia, and blood pressure]. We found relatively mild associations of education and economic status with cardiometabolic risk factors, in contrast with studies in other populations. The socioeconomic factor and participation in Yup'ik culture had potentially protective associations with adiposity, triglyceride-HDL lipids, and blood pressure, whereas participation in Western culture had a protective association with blood pressure. We also found a moderating effect of participation in Western culture on the relationships between Yup'ik culture participation and both blood pressure and LDL lipids, indicating a potentially beneficial additional effect of biculturalism. Our results suggest that reinforcing protective effects of both Yup'ik and Western cultures could be useful for interventions aimed at reducing cardiometabolic health disparities.	[Philip, Jacques; Hopkins, Scarlett E.; O'Brien, Diane M.; Bersamin, Andrea; Boyer, Bert B.] Univ Alaska Fairbanks, Ctr Alaska Native Hlth Res, Fairbanks, AK 99775 USA; [Ryman, Tove K.] Bill & Melinda Gates Fdn, Seattle, WA USA; [Pomeroy, Jeremy] Marshfield Clin Fdn Med Res & Educ, Res Inst, Marshfield, WI USA; [Thummel, Kenneth E.] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA; [Austin, Melissa A.] Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; [Dombrowski, Kirk] Univ Nebraska, Dept Sociol, Lincoln, NE 68588 USA	University of Alaska System; University of Alaska Fairbanks; Bill & Melinda Gates Foundation; Marshfield Clinic; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Nebraska System; University of Nebraska Lincoln	Philip, J (corresponding author), Univ Alaska Fairbanks, Ctr Alaska Native Hlth Res, Fairbanks, AK 99775 USA.	jphilip@alaska.edu	O'Brien, Diane/B-2919-2010	O'Brien, Diane/0000-0001-5807-9661	National Institute of Health [P20RR016430, P30GM103325, R01DK074842, U01GM092676, U54GM115371, U54GM104944]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103325, U54GM104944, U54GM115371, U01GM092676] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was funded by the following grants from the National Institute of Health: P20RR016430, P30GM103325, R01DK074842, U01GM092676, U54GM115371, U54GM104944.	Abel T, 2008, J EPIDEMIOL COMMUN H, V62, DOI 10.1136/jech.2007.066159; Abel T, 2012, SOC SCI MED, V74, P236, DOI 10.1016/j.socscimed.2011.10.028; Albert MA, 2006, CIRCULATION, V114, P2619, DOI 10.1161/CIRCULATIONAHA.106.660043; Allen J., 2014, AM J COMMUNITY PSYCH; Allen J, 2014, AM J COMMUN PSYCHOL, V54, P100, DOI 10.1007/s10464-014-9647-1; Arias E, 2014, AM J PUBLIC HEALTH, V104, pS312; Ayunerak Paula, 2014, Am J Community Psychol, V54, P91, DOI 10.1007/s10464-014-9652-4; Bauer KW, 2012, AM J PUBLIC HEALTH, V102, P1346, DOI 10.2105/AJPH.2011.300522; Beaulieu-Jones BR, 2015, J NUTR, V145, P931, DOI 10.3945/jn.114.209619; Berger T. R, 1985, VILLAGE JOURNEY REPO; Bersamin A, 2014, ETHNIC HEALTH, V19, P255, DOI 10.1080/13557858.2012.758691; Boden-Albala B, 2013, ETHNIC DIS, V23, P484; Boyer BB, 2007, OBESITY, V15, P2535, DOI 10.1038/oby.2007.302; Boyer Bert B, 2005, Int J Circumpolar Health, V64, P281; Brabec M, 2007, AM J HUM BIOL, V19, P459, DOI 10.1002/ajhb.20606; Brice-Bennett C., 1994, DISPOSSESSED EVICTIO; BurnSilver S, 2016, AM ANTHROPOL, V118, P121, DOI 10.1111/aman.12447; Chandler M. J., 2003, MONOGR SOC RES CHILD, P138, DOI DOI 10.2307/1166217; Chandler M. J., 1998, TRANSCULT PSYCHIATRY, V35, P191, DOI DOI 10.1177/136346159803500202; Cheadle JE, 2011, J HEALTH SOC BEHAV, V52, P228, DOI 10.1177/0022146510393973; Chen D, 2017, REV PANAM SALUD PUBL, V41; Currie CL, 2013, SOC SCI MED, V88, P1, DOI 10.1016/j.socscimed.2013.03.032; Dombrowski K., 2013, J ANTHR, V2013, DOI [10.1155/2013/185048, DOI 10.1155/2013/185048]; Dombrowski K., 2014, CULTURE POLITICS STO; Dombrowski K, 2014, IDENTITIES-GLOB STUD, V21, P134, DOI 10.1080/1070289X.2013.854718; Dombrowski K, 2013, ARCTIC ANTHROPOL, V50, P89, DOI 10.3368/aa.50.1.89; Douglas V. K., 2013, INTRO ABORIGINAL HLT; Dressler WW, 2000, AM ANTHROPOL, V102, P244, DOI 10.1525/aa.2000.102.2.244; Duran E., 1995, NATIVE AM POSTCOLONI; Edwards KL, 1998, AM J EPIDEMIOL, V147, P441, DOI 10.1093/oxfordjournals.aje.a009469; Espey DK, 2014, AM J PUBLIC HEALTH, V104, pS303, DOI 10.2105/AJPH.2013.301798; Fraser SL, 2015, SUICIDE LIFE-THREAT, V45, P141, DOI 10.1111/sltb.12122; Garroutte EM, 2003, SOC SCI MED, V56, P1571, DOI 10.1016/S0277-9536(02)00157-0; GERHARD GT, 1991, AM J CLIN NUTR, V54, P334, DOI 10.1093/ajcn/54.2.334; Gone JP, 2007, AM J COMMUN PSYCHOL, V40, P290, DOI 10.1007/s10464-007-9136-x; Gone JP, 2012, ANNU REV CLIN PSYCHO, V8, P131, DOI 10.1146/annurev-clinpsy-032511-143127; Gone JP, 2011, J PSYCHOACTIVE DRUGS, V43, P291, DOI 10.1080/02791072.2011.628915; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hallett D, 2007, COGNITIVE DEV, V22, P392, DOI 10.1016/j.cogdev.2007.02.001; Hanson RL, 2002, DIABETES, V51, P3120, DOI 10.2337/diabetes.51.10.3120; Hautala DS, 2015, YOUTH VIOLENCE JUV J; Henseler J, 2012, ELGAR ORIG REF, P252; Jacobson TA, 2012, J CLIN LIPIDOL, V6, P5, DOI 10.1016/j.jacl.2011.10.018; Jernigan VBB, 2017, AM J PUBLIC HEALTH, V107, P441, DOI 10.2105/AJPH.2016.303605; Jernigan VBB, 2015, AM J PUBLIC HEALTH, V105, pS376, DOI 10.2105/AJPH.2014.302447; Joe JR, 2014, AM INDIAN CULT RES J, V38, P123, DOI 10.17953/aicr.38.1.qj47130n435njl34; Joe JR, 2014, AM INDIAN CULT RES J, V38, P11, DOI 10.17953/aicr.38.1.w753453k6h67061m; Jorgensen ME, 2006, EUR J EPIDEMIOL, V21, P741, DOI 10.1007/s10654-006-9063-4; Kaholokula JK, 2008, DIABETES CARE, V31, P698, DOI 10.2337/dc07-1560; Kaufman CE, 2013, J CONSULT CLIN PSYCH, V81, P1040, DOI 10.1037/a0034342; Kawagley AO, 1998, J RES SCI TEACH, V35, P133, DOI 10.1002/(SICI)1098-2736(199802)35:2<133::AID-TEA4>3.3.CO;2-C; King M, 2009, LANCET, V374, P76, DOI 10.1016/S0140-6736(09)60827-8; Kirmayer L., 2003, AUSTRALAS PSYCHIATRY, V11, pS15, DOI DOI 10.1046/J.1038-5282.2003.02010.X; Kirmayer LJ, 1998, CAN J PSYCHIAT, V43, P816, DOI 10.1177/070674379804300806; Koller KR, 2015, DIABETES RES CLIN PR, V108, P423, DOI 10.1016/j.diabres.2015.03.001; Lara M, 2005, ANNU REV PUBL HEALTH, V26, P367, DOI 10.1146/annurev.publhealth.26.021304.144615; Larimore JA, 2005, SERVING NATIVE AM ST, V2005, P17, DOI DOI 10.1002/SS.150; Lazrus H, 2015, HUM ORGAN, V74, P52, DOI 10.17730/humo.74.1.q0667716284749m8; Lehti V, 2009, SOC SCI MED, V69, P1194, DOI 10.1016/j.socscimed.2009.07.045; MacDonald JP, 2015, SOC SCI MED, V141, P133, DOI 10.1016/j.socscimed.2015.07.017; MacDonald Joanna Petrasek, 2013, Int J Circumpolar Health, V72, P21775, DOI 10.3402/ijch.v72i0.21775; McIntosh CN, 2014, ORGAN RES METHODS, V17, P210, DOI 10.1177/1094428114529165; McIvor O, 2009, INT J INDIG HEALTH, V5, P6; Mendelsohn ME, 2002, AM J CARDIOL, V89, p12E; Mensah GA, 2005, CIRCULATION, V111, P1233, DOI 10.1161/01.CIR.0000158136.76824.04; Mitchell FM, 2012, HEALTH SOC WORK, V37, P71, DOI 10.1093/hsw/hls013; Mitrou F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-201; Mohatt GV, 2007, INT J CIRCUMPOL HEAL, V66, P8, DOI 10.3402/ijch.v66i1.18219; Moore K, 2014, AM J PUBLIC HEALTH, V104, pE158, DOI 10.2105/AJPH.2014.302108; Morgan M., 1992, HIST ECONOMETRIC IDE; Moses J, 2017, HUM ORGAN, V76, P171, DOI 10.17730/0018-7259.76.2.171; Napoleon H, 1991, ALASKA NATIVE KNOWLE; Nash SH, 2012, J NUTR, V142, P84, DOI 10.3945/jn.111.147595; O'Brien DM, 2017, PUBLIC HEALTH NUTR, V20, P1738, DOI 10.1017/S1368980016001853; O'Brien DM, 2014, J NUTR, V144, P706, DOI 10.3945/jn.113.189381; O'Brien DM, 2009, AM J CLIN NUTR, V89, P913, DOI 10.3945/ajcn.2008.27054; OETTING ER, 1991, INT J ADDICT, V25, P655, DOI 10.3109/10826089109077265; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; ONell TD, 1996, SOC SCI MED, V42, P565, DOI 10.1016/0277-9536(95)00157-3; Pappas RS, 2008, J ANAL TOXICOL, V32, P281, DOI 10.1093/jat/32.4.281; Parlee Brenda, 2005, EcoHealth, V2, P127, DOI 10.1007/s10393-005-3870-z; Philip J, 2016, PSYCHOSOC INTERV, V25, P45, DOI 10.1016/j.psi.2015.08.002; Piano MR, 2010, CIRCULATION, V122, P1520, DOI 10.1161/CIR.0b013e3181f432c3; R Core Team, 2021, R LANGUAGE ENV STAT; Rasmus SM, 2014, AM J COMMUN PSYCHOL, V54, P140, DOI 10.1007/s10464-014-9651-5; Reeve R, 2014, AUST NZ J PUBL HEAL, V38, P459, DOI 10.1111/1753-6405.12211; Renner CC, 2005, AM J HEALTH BEHAV, V29, P588, DOI 10.5993/AJHB.29.6.13; Roh S, 2015, AGING MENT HEALTH, V19, P371, DOI 10.1080/13607863.2014.938603; Ryman TK, 2015, NUTR METAB CARDIOVAS, V25, P1140, DOI 10.1016/j.numecd.2015.08.003; Ryman TK, 2017, ETHN HLTH, P1; Ryman TK, 2015, BRIT J NUTR, V113, P634, DOI 10.1017/S0007114514003596; Ryman TK, 2014, PUBLIC HEALTH NUTR, V17, P510, DOI 10.1017/S1368980012005411; Sanchez G., 2013, PLS PATH MODELING R; Sider Gerald, 2014, SKIN SKIN DEATH LIFE; Silviken A, 2007, J ADOLESCENCE, V30, P613, DOI 10.1016/j.adolescence.2006.06.004; Singer MK, 2012, PREV MED, V55, P356, DOI 10.1016/j.ypmed.2012.02.011; Spicer P, 2001, SOC SCI MED, V53, P227, DOI 10.1016/S0277-9536(00)00333-6; Steptoe A, 2013, ANNU REV PUBL HEALTH, V34, P337, DOI 10.1146/annurev-publhealth-031912-114452; Stone RAT, 2006, J STUD ALCOHOL, V67, P236, DOI 10.15288/jsa.2006.67.236; Sutton Peter, 2011, POLITICS SUFFERING I; Tenenhaus M, 2005, COMPUT STAT DATA AN, V48, P159, DOI 10.1016/j.csda.2004.03.005; Tester F.J., 1994, TAMMARNIIT MISTAKES; US Census Bureau, 2016, AM FACTFINDER; Valeggia CR, 2015, ANNU REV ANTHROPOL, V44, P117, DOI 10.1146/annurev-anthro-102214-013831; Veenstra G, 2014, SOCIOL HLTH ILLN MON, P31; Veenstra G, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0167-x; Wang, 2010, HDB PARTIAL LEAST SQ, P47, DOI [10.1007/978-3-540-32827-8_3, DOI 10.1007/978-3-540-32827-8]; Wetzels M, 2009, MIS QUART, V33, P177, DOI 10.2307/20650284; Wexler L, 2013, HEALTH PROMOT PRACT, V14, P617, DOI 10.1177/1524839912462390; Wexler LM, 2006, SOC SCI MED, V63, P2938, DOI 10.1016/j.socscimed.2006.07.022; Whitbeck LB, 2009, COMMUNITY MENT HLT J, V45, P62, DOI 10.1007/s10597-008-9172-5; Wijndaele K, 2006, DIABETES CARE, V29, P2329, DOI 10.2337/dc06-1341; Williams MV, 1998, ARCH INTERN MED, V158, P166, DOI 10.1001/archinte.158.2.166; Wolsko C, 2007, INT J CIRCUMPOL HEAL, V66, P51, DOI 10.3402/ijch.v66i1.18226; Wolsko C, 2006, ETHNIC HEALTH, V11, P345, DOI 10.1080/13557850600824005; Wolsko C, 2009, CULT DIVERS ETHN MIN, V15, P165, DOI 10.1037/a0015323; Zimmet P., 2005, DIABETES VOICE, V50, P31	117	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e018345	10.1371/journal.pone.0183451	http://dx.doi.org/10.1371/journal.pone.0183451			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL4VN	29091709	Green Published, gold			2022-12-26	WOS:000414229700001
J	Kouwaye, B; Rossi, F; Fonton, N; Garcia, A; Dossou-Gbete, S; Hounkonnou, MN; Cottrell, G				Kouwaye, Bienvenue; Rossi, Fabrice; Fonton, Noel; Garcia, Andre; Dossou-Gbete, Simplice; Hounkonnou, Mahouton Norbert; Cottrell, Gilles			Predicting local malaria exposure using a Lasso-based two-level cross validation algorithm	PLOS ONE			English	Article							VARIABLE SELECTION; REGULARIZATION	Recent studies have highlighted the importance of local environmental factors to determine the fine-scale heterogeneity of malaria transmission and exposure to the vector. In this work, we compare a classical GLM model with backward selection with different versions of an automatic LASSO-based algorithm with 2-level cross-validation aiming to build a predictive model of the space and time dependent individual exposure to the malaria vector, using entomological and environmental data from a cohort study in Benin. Although the GLM can outperform the LASSO model with appropriate engineering, the best model in terms of predictive power was found to be the LASSO-based model. Our approach can be adapted to different topics and may therefore be helpful to address prediction issues in other health sciences domains.	[Kouwaye, Bienvenue; Rossi, Fabrice] Univ Paris 1 Pantheon Sorbonne, Lab SAMM, EA 4543, Paris, France; [Kouwaye, Bienvenue; Fonton, Noel; Hounkonnou, Mahouton Norbert] Univ Abomey Calavi, 072 BP 50, Cotonou, Benin; [Kouwaye, Bienvenue; Fonton, Noel] Univ Abomey Calavi, LERSAB, Cotonou, Benin; [Garcia, Andre; Cottrell, Gilles] Inst Rech Dev, MERIT UMR216, Mere & Enfant Face Infect Trop, F-75006 Paris, France; [Garcia, Andre; Cottrell, Gilles] Univ Paris 05, Fac Pharm, Sorbonne Paris Cite, Paris, France; [Garcia, Andre; Cottrell, Gilles] CERPAGE, IRD, UMR 216, Fac Sci Sante, Cotonou, Benin; [Dossou-Gbete, Simplice] Univ Pau & Pays Adour, CNRS, Lab Math & Leurs Applicat Pau Fed IPRA, UMR 5142, F-64012 Pau, France	University of Abomey Calavi; University of Abomey Calavi; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); Universite de Pau et des Pays de l'Adour	Kouwaye, B (corresponding author), Univ Paris 1 Pantheon Sorbonne, Lab SAMM, EA 4543, Paris, France.; Kouwaye, B (corresponding author), Univ Abomey Calavi, 072 BP 50, Cotonou, Benin.; Kouwaye, B (corresponding author), Univ Abomey Calavi, LERSAB, Cotonou, Benin.	Kouwaye2000@yahoo.fr	Garcia, Andre/S-2959-2016; Rossi, Fabrice/H-5335-2019; Hounkonnou, Mahouton Norbert/AAF-4695-2019; Garcia, Andre/ABA-1820-2020	Garcia, Andre/0000-0002-1808-472X; Rossi, Fabrice/0000-0003-4638-1286; Hounkonnou, Mahouton Norbert/0000-0002-6231-4975; Garcia, Andre/0000-0002-1808-472X; Cottrell, Gilles/0000-0002-7964-8963				Biau G, 2008, J MACHINE LEARNING R; Bontempi G., 2005, ESANN 2005, P405; Campbell JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025661; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Damien GB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-380; Dery DB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-314; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; Fonton N, 2015, SELECTION VARIABLES; Friedman J, 2015, LASSO ELASTI NET REG; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Genuer R, 2010, PATTERN RECOGN LETT, V31, P2225, DOI 10.1016/j.patrec.2010.03.014; Gillies D, 1987, PUB S AFR I MED RES; Gillies D, 1968, PUB S AFR I MED RES; Goeman JJ, 2010, BIOMETRICAL J, V52, P70, DOI 10.1002/bimj.200900028; Gu WD, 2005, AM J TROP MED HYG, V73, P546, DOI 10.4269/ajtmh.2005.73.546; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Keerthi S, 2007, EFFICIENT METHOD GRA; Kourou K, 2015, COMPUT STRUCT BIOTEC, V13, P8, DOI 10.1016/j.csbj.2014.11.005; Kouwaye B, 2015, LASSO BASED FEATURE; Li H, 2014, BMC BIOINFORMATICS, P12; Li S, 2016, BMC BIOINFORMATICS, P13; Miller A., 1990, SUBSET SELECTION REG, P235; Oermann EK, 2016, SCI REPORTS, V13, P12; Pierrat C, 2012, PLOS ONE, V7, P8; Ratner B., 2010, J TARGETING MEASUREM, V18, P65, DOI DOI 10.1057/JT.2009.26; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tutz G, 2011, VARIABLES SELECTION; van der Ploeg T, 2016, BMC RES NOTES, P7; Wang H, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/8949835; Weiss JC, 2012, MACHINE LEARNING PER, P13; WHO, 2013, WORLD MAL REP 2013, P248; WIRTZ RA, 1987, B WORLD HEALTH ORGAN, V65, P39; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	37	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187234	10.1371/journal.pone.0187234	http://dx.doi.org/10.1371/journal.pone.0187234			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088280	Green Published, gold, Green Submitted			2022-12-26	WOS:000414088900052
J	Vazquez-Marrufo, M; Galvao-Carmona, A; Lugo, MLB; Ruiz-Pena, JL; Guerra, MB; Ayuso, GI				Vazquez-Marrufo, Manuel; Galvao-Carmona, Alejandro; Benitez Lugo, Maria Luisa; Luis Ruiz-Pena, Juan; Borges Guerra, Monica; Izquierdo Ayuso, Guillermo			Retest reliability of individual alpha ERD topography assessed by human electroencephalography	PLOS ONE			English	Article							EVENT-RELATED DESYNCHRONIZATION; SYNCHRONIZATION; P300; EEG; STIMULATION; CONSISTENCY; POTENTIALS; STABILITY	Background Despite the immense literature related to diverse human electroencephalographic (EEG) parameters, very few studies have focused on the reliability of these measures. Some of the most studied components (i.e., P3 or MMN) have received more attention regarding the stability of their main parameters, such as latency, amplitude or topography. However, spectral modulations have not been as extensively evaluated considering that different analysis methods are available. The main aim of the present study is to assess the reliability of the latency, amplitude and topography of event-related desynchronization (ERD) for the alpha band (10-14 Hz) observed in a cognitive task (visual oddball). Topography reliability was analysed at different levels (for the group, within-subjects individually and between-subjects individually). Results The latency for alpha ERD showed stable behaviour between two sessions, and the amplitude exhibited an increment (more negative) in the second session. Alpha ERD topography exhibited a high correlation score between sessions at the group level (r = 0.903, p<0.001). The mean value for within-subject correlations was 0.750 (with a range from 0.391 to 0.954). Regarding between-subject topography comparisons, some subjects showed a highly specific topography, whereas other subjects showed topographies that were more similar to those of other subjects. Conclusion ERD was mainly stable between the two sessions with the exception of amplitude, which exhibited an increment in the second session. Topography exhibits excellent reliability at the group level; however, it exhibits highly heterogeneous behaviour at the individual level. Considering that the P3 was previously evaluated for this group of subjects, a direct comparison of the correlation scores was possible, and it showed that the ERD component is less reliable in individual topography than in the ERP component (P3).	[Vazquez-Marrufo, Manuel] Univ Seville, Fac Psychol, Expt Psychol Dept, Seville, Spain; [Galvao-Carmona, Alejandro] Univ Loyola Andalucia, Dept Psychol, Seville, Spain; [Benitez Lugo, Maria Luisa] Univ Seville, Physiotherapy Dept, Fac Nursing Physiotherapy & Chiropody, Seville, Spain; [Luis Ruiz-Pena, Juan; Borges Guerra, Monica; Izquierdo Ayuso, Guillermo] Virgen Macarena Hosp, Multiple Sclerosis Unit, Seville, Spain	University of Sevilla; Universidad Loyola Andalucia; University of Sevilla; Hospital Universitario Virgen Macarena	Vazquez-Marrufo, M (corresponding author), Univ Seville, Fac Psychol, Expt Psychol Dept, Seville, Spain.	marrufo@us.es	Marrufo, Manuel Vazquez/Y-8460-2019; Benítez-Lugo, María-Luisa/J-7487-2018; Galvao-Carmona, Alejandro/A-1725-2015; peña, juan luis ruiz/Z-6168-2019	Marrufo, Manuel Vazquez/0000-0002-0456-7165; Benítez-Lugo, María-Luisa/0000-0003-2058-8799; Galvao-Carmona, Alejandro/0000-0002-5126-1273; peña, juan luis ruiz/0000-0003-3956-1131; Borges Guerra, Monica/0000-0002-4258-2390	Plan Nacional I+D+i (Ministerio de Economia y Competitividad, Government of Spain) [PSI2016-78133-P]; Asociacion Sanitaria Virgen Macarena	Plan Nacional I+D+i (Ministerio de Economia y Competitividad, Government of Spain); Asociacion Sanitaria Virgen Macarena	This study was supported by Plan Nacional I+D+i (Ministerio de Economia y Competitividad, Government of Spain, PSI2016-78133-P) and Asociacion Sanitaria Virgen Macarena. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basar E, 2014, COGN NEURODYNAMICS, V8, P437, DOI 10.1007/s11571-014-9301-5; Burgess AP, 1996, INT J PSYCHOPHYSIOL, V23, P163, DOI 10.1016/S0167-8760(96)00046-3; Cassidy SM, 2012, PSYCHOPHYSIOLOGY, V49, P659, DOI 10.1111/j.1469-8986.2011.01349.x; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Friedrich EVC, 2013, CLIN NEUROPHYSIOL, V124, P61, DOI 10.1016/j.clinph.2012.05.020; Friesen CL, 2017, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00692; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hidalgo-Munoz AR, 2014, MED BIOL ENG COMPUT, V52, P149, DOI 10.1007/s11517-013-1126-6; Karrasch M, 1998, ELECTROEN CLIN NEURO, V107, P112, DOI 10.1016/S0013-4694(98)00047-9; KILENY PR, 1987, EAR HEARING, V8, P110, DOI 10.1097/00003446-198704000-00008; KLIMESCH W, 1994, ELECTROEN CLIN NEURO, V91, P428, DOI 10.1016/0013-4694(94)90164-3; Klimesch W, 1997, PSYCHOPHYSIOLOGY, V34, P169, DOI 10.1111/j.1469-8986.1997.tb02128.x; Klimesch W, 2003, EUR J NEUROSCI, V17, P1129, DOI 10.1046/j.1460-9568.2003.02517.x; Kline P., 2000, HDB PSYCHOL TESTING; Krause CM, 2001, CLIN NEUROPHYSIOL, V112, P750, DOI 10.1016/S1388-2457(01)00501-6; Krause CM, 1996, ELECTROEN CLIN NEURO, V98, P319, DOI 10.1016/0013-4694(96)00283-0; Li MF, 2014, INT J NEUROSCI, V124, P403, DOI 10.3109/00207454.2013.850082; Marrufo MV, 2001, COGNITIVE BRAIN RES, V12, P315; Neuper C, 2005, CLIN NEUROPHYSIOL, V116, P1681, DOI 10.1016/j.clinph.2005.03.013; Notturno F, 2014, HUM BRAIN MAPP, V35, P2220, DOI 10.1002/hbm.22322; PFURTSCHELLER G, 1977, ELECTROEN CLIN NEURO, V43, P757, DOI 10.1016/0013-4694(77)90092-X; PFURTSCHELLER G, 1979, ELECTROEN CLIN NEURO, V47, P21, DOI 10.1016/0013-4694(79)90029-4; PFURTSCHELLER G, 1979, ELECTROEN CLIN NEURO, V46, P138, DOI 10.1016/0013-4694(79)90063-4; POLICH J, 1986, PSYCHOPHYSIOLOGY, V23, P590, DOI 10.1111/j.1469-8986.1986.tb00677.x; POLICH J, 1986, ELECTROEN CLIN NEURO, V65, P236, DOI 10.1016/0168-5597(86)90059-6; Polich J, 2000, INT J PSYCHOPHYSIOL, V38, P3, DOI 10.1016/S0167-8760(00)00127-6; Sanei S, 2007, EEG SIGNAL PROCESSIN; Schabus M, 2011, FUNCT NEUROL, V26, P31; Sutoh T, 2000, CLIN NEUROPHYSIOL, V111, P858, DOI 10.1016/S1388-2457(99)00321-1; VANWINSUM W, 1984, ELECTROEN CLIN NEURO, V58, P519, DOI 10.1016/0013-4694(84)90042-7; Vazquez-Marrufo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062523; Walhovd KB, 2002, INT J PSYCHOPHYSIOL, V46, P29, DOI 10.1016/S0167-8760(02)00039-9; Wright D, 2015, PSYCHOPHYSIOLOGY, V52, P638, DOI 10.1111/psyp.12399	33	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187244	10.1371/journal.pone.0187244	http://dx.doi.org/10.1371/journal.pone.0187244			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088307	Green Published, gold, Green Submitted			2022-12-26	WOS:000414088900053
J	Han, YJ; Kim, YS; Hwang, OJ; Roh, J; Ganguly, K; Kim, SK; Hwang, I; Kim, JI				Han, Yun-Jeong; Kim, Young Soon; Hwang, Ok-Jin; Roh, Jeehee; Ganguly, Keya; Kim, Seong-Ki; Hwang, Ildoo; Kim, Jeong-Il			Overexpression of Arabidopsis thaliana brassinosteroid-related acyltransferase 1 gene induces brassinosteroid-deficient phenotypes in creeping bentgrass	PLOS ONE			English	Article							PUTATIVE ACYLTRANSFERASE; DROUGHT TOLERANCE; BIOSYNTHESIS; HOMEOSTASIS; MUTANT; CYTOCHROME-P450; CYP72C1; PROTEIN; INACTIVATION; ACTIVATION	Brassinosteroids (BRs) are naturally occurring steroidal hormones that play diverse roles in various processes during plant growth and development. Thus, genetic manipulation of endogenous BR levels might offer a way of improving the agronomic traits of crops, including plant architecture and stress tolerance. In this study, we produced transgenic creeping bentgrass (Agrostis stolonifera L.) overexpressing a BR-inactivating enzyme, Arabidopsis thaliana BR-related acyltransferase 1 (AtBAT1), which is known to catalyze the conversion of BR intermediates to inactive acylated conjugates. After putative transgenic plants were selected using herbicide resistance assay, genomic integration of the AtBAT1 gene was confirmed by genomic PCR and Southern blot analysis, and transgene expression was validated by northern blot analysis. The transgenic creeping bentgrass plants exhibited BR-deficient phenotypes, including reduced plant height with shortened internodes (i.e., semi-dwarf), reduced leaf growth rates with short, wide, and thick architecture, high chlorophyll contents, decreased numbers of vascular bundles, and large lamina joint bending angles (i.e., erect leaves). Subsequent analyses showed that the transgenic plants had significantly reduced amounts of endogenous BR intermediates, including typhasterol, 6-deoxocastasterone, and castasterone. Moreover, the AtBAT1 transgenic plants displayed drought tolerance as well as delayed senescence. Therefore, the results of the present study demonstrate that overexpression of an Arabidopsis BR-inactivating enzyme can reduce the endogenous levels of BRs in creeping bentgrass resulting in BR-deficient phenotypes, indicating that the AtBAT1 gene from a dicot plant is also functional in the monocot crop.	[Han, Yun-Jeong; Kim, Young Soon; Hwang, Ok-Jin; Ganguly, Keya; Kim, Jeong-Il] Chonnam Natl Univ, Dept Biotechnol, Gwangju, South Korea; [Han, Yun-Jeong; Kim, Young Soon; Hwang, Ok-Jin; Ganguly, Keya; Kim, Jeong-Il] Chonnam Natl Univ, Kumho Life Sci Lab, Gwangju, South Korea; [Roh, Jeehee; Kim, Seong-Ki] Chung Ang Univ, Dept Life Sci, Seoul, South Korea; [Hwang, Ildoo] Pohang Univ Sci & Technol, Dept Life Sci, Pohang, South Korea; [Hwang, Ildoo] Pohang Univ Sci & Technol, Biotechnol Res Ctr, Pohang, South Korea	Chonnam National University; Chonnam National University; Chung Ang University; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Kim, JI (corresponding author), Chonnam Natl Univ, Dept Biotechnol, Gwangju, South Korea.; Kim, JI (corresponding author), Chonnam Natl Univ, Kumho Life Sci Lab, Gwangju, South Korea.	kimji@jnu.ac.kr		Kim, Jeong-Il/0000-0003-4177-4048; Ganguly, Keya/0000-0002-0235-6313	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ01104001, PJ011132, PJ01184402]; Chonnam National University	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea; Chonnam National University	This work was supported by Next-Generation BioGreen 21 Program (http://ssac.gnu.ac.kr), Rural Development Administration, Republic of Korea (Grant nos. PJ01104001 to J.-I. Kim; PJ011132 to S.-K. Kim; PJ01184402 to I. Hwang). In addition, this study was financially supported by Chonnam National University, 2016-2017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajguz A, 2009, PLANT PHYSIOL BIOCH, V47, P1, DOI 10.1016/j.plaphy.2008.10.002; Belkhadir Y, 2015, NEW PHYTOL, V206, P522, DOI 10.1111/nph.13269; Bishop GJ, 2002, PLANT CELL, V14, pS97, DOI 10.1105/tpc.001461; CHEN H, 1994, BIOTECHNIQUES, V16, P664; Cho KC, 2011, PLANT PATHOL, V60, P631, DOI 10.1111/j.1365-3059.2011.02433.x; Choi S, 2013, PLANT J, V73, P380, DOI 10.1111/tpj.12036; Choi YS, 2013, PLANT BIOTECHNOL REP, V7, P165, DOI 10.1007/s11816-012-0245-0; Choudhary SP, 2012, TRENDS PLANT SCI, V17, P594, DOI 10.1016/j.tplants.2012.05.012; Chung Y, 2013, CRIT REV PLANT SCI, V32, P396, DOI 10.1080/07352689.2013.797856; D'Auria JC, 2006, CURR OPIN PLANT BIOL, V9, P331, DOI 10.1016/j.pbi.2006.03.016; Divi UK, 2016, PLANT BIOTECHNOL J, V14, P419, DOI 10.1111/pbi.12396; Divi UK, 2009, NEW BIOTECHNOL, V26, P131, DOI 10.1016/j.nbt.2009.07.006; Feng ZM, 2016, J EXP BOT, V67, P4241, DOI 10.1093/jxb/erw204; Ferrero-Serrano A, 2016, J EXP BOT, V67, P3433, DOI 10.1093/jxb/erw183; Fujioka S, 2003, ANNU REV PLANT BIOL, V54, P137, DOI 10.1146/annurev.arplant.54.031902.134921; Ganesan M, 2012, PLANTA, V236, P1135, DOI 10.1007/s00425-012-1662-6; Han YJ, 2015, PLANT CELL REP, V34, P265, DOI 10.1007/s00299-014-1705-5; Han YJ, 2012, PLANT CELL REP, V31, P1677, DOI 10.1007/s00299-012-1280-6; Han YJ, 2009, PLANT CELL REP, V28, P397, DOI 10.1007/s00299-008-0648-0; Husar S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-51; Kagale S, 2007, PLANTA, V225, P353, DOI 10.1007/s00425-006-0361-6; Kim BK, 2008, BIOCHEM BIOPH RES CO, V374, P614, DOI 10.1016/j.bbrc.2008.07.073; Kim SJ, 2007, J PLANT BIOL, V50, P577, DOI 10.1007/BF03030712; Kim TW, 2010, ANNU REV PLANT BIOL, V61, P681, DOI 10.1146/annurev.arplant.043008.092057; Krishna P, 2003, J PLANT GROWTH REGUL, V22, P289, DOI 10.1007/s00344-003-0058-z; Kutschera U, 2012, J EXP BOT, V63, P3511, DOI 10.1093/jxb/ers065; Marsolais F, 2007, PLANTA, V225, P1233, DOI 10.1007/s00425-006-0413-y; Matsumoto Tadashi, 2013, Plants-Basel, V2, P521, DOI 10.3390/plants2030521; Mussig C, 2005, PLANT BIOLOGY, V7, P110, DOI 10.1055/s-2005-837493; Nakamura M, 2005, J EXP BOT, V56, P833, DOI 10.1093/jxb/eri073; Neff MM, 1999, P NATL ACAD SCI USA, V96, P15316, DOI 10.1073/pnas.96.26.15316; Northey JGB, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.114, 10.1038/nplants.2016.114]; Poppenberger B, 2005, P NATL ACAD SCI USA, V102, P15253, DOI 10.1073/pnas.0504279102; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Roh H, 2012, PLANT PHYSIOL, V159, P696, DOI 10.1104/pp.112.197202; Rouleau M, 1999, J BIOL CHEM, V274, P20925, DOI 10.1074/jbc.274.30.20925; Sade D, 2014, PLANT PHYSIOL, V165, P1684, DOI 10.1104/pp.114.243402; Saini S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00950; Sakamoto T, 2006, NAT BIOTECHNOL, V24, P105, DOI 10.1038/nbt1173; Sakamoto T, 2004, CURR OPIN BIOTECH, V15, P144, DOI 10.1016/j.copbio.2004.02.003; Schneider K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046805; Schroder F, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0309-0; Singh AP, 2015, J EXP BOT, V66, P1123, DOI 10.1093/jxb/erv026; Symons GM, 2004, PLANT PHYSIOL, V135, P2196, DOI 10.1104/pp.104.043034; Takahashi N, 2005, PLANT J, V42, P13, DOI 10.1111/j.1365-313X.2005.02357.x; Tanabe S, 2005, PLANT CELL, V17, P776, DOI 10.1105/tpc.104.024950; Tanaka K, 2005, PLANT PHYSIOL, V138, P1117, DOI 10.1104/pp.104.058040; Thornton LE, 2010, PLANT MOL BIOL, V74, P167, DOI 10.1007/s11103-010-9663-y; Turk EM, 2005, PLANT J, V42, P23, DOI 10.1111/j.1365-313X.2005.02358.x; Vriet C, 2012, PLANT CELL, V24, P842, DOI 10.1105/tpc.111.094912; WADA K, 1981, PLANT CELL PHYSIOL, V22, P323; Wang MJ, 2012, J EXP BOT, V63, P5787, DOI 10.1093/jxb/ers227; Warnke S., 2003, TURFGRASS BIOL GENET, P175; Wu CY, 2008, PLANT CELL, V20, P2130, DOI 10.1105/tpc.107.055087; Yang CJ, 2011, MOL PLANT, V4, P588, DOI 10.1093/mp/ssr020; Yu XH, 2009, PLANT MOL BIOL, V70, P421, DOI 10.1007/s11103-009-9482-1; Zhang C, 2014, PLANT CELL REP, V33, P683, DOI 10.1007/s00299-014-1578-7; Zhao BL, 2012, J INTEGR PLANT BIOL, V54, P746, DOI 10.1111/j.1744-7909.2012.01168.x; Zhou M, 2013, PLANT PHYSIOL, V161, P1375, DOI 10.1104/pp.112.208702; Zhu JY, 2013, DEVELOPMENT, V140, P1615, DOI 10.1242/dev.060590; Zhu WJ, 2013, MOL PLANT, V6, P546, DOI 10.1093/mp/sss144	61	5	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187378	10.1371/journal.pone.0187378	http://dx.doi.org/10.1371/journal.pone.0187378			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084267	Green Published, Green Submitted, gold			2022-12-26	WOS:000413910200054
J	Kerekes, A; Hoffmann, OI; Iski, G; Liptak, N; Gocza, E; Kues, WA; Bosze, Z; Hiripi, L				Kerekes, Andrea; Hoffmann, Orsolya Ivett; Iski, Gergely; Liptak, Nandor; Gocza, Elen; Kues, Wilfried A.; Bosze, Zsuzsanna; Hiripi, Laszlo			Secretion of a recombinant protein without a signal peptide by the exocrine glands of transgenic rabbits	PLOS ONE			English	Article							NONSPECIFIC ALKALINE-PHOSPHATASE; CLOTTING FACTOR-VIII; MAMMARY-GLAND; PROMOTER DIRECTS; EXPRESSION; MILK; MICE; PIGS; SHEEP; ACID	Transgenic rabbits carrying mammary gland specific gene constructs are extensively used for excreting recombinant proteins into the milk. Here, we report refined phenotyping of previously generated Venus transposon-carrying transgenic rabbits with particular emphasis on the secretion of the reporter protein by exocrine glands, such as mammary, salivary, tear and seminal glands. The Sleeping Beauty (SB) transposon transgenic construct contains the Venus fluorophore cDNA, but without a signal peptide for the secretory pathway, driven by the ubiquitous CAGGS (CAG) promoter. Despite the absence of a signal peptide, the fluorophore protein was readily detected in milk, tear, saliva and seminal fluids. The expression pattern was verified by Western blot analysis. Mammary gland epithelial cells of SBCAG-Venus transgenic lactating does also showed Venus-specific expression by tissue histology and fluorescence microscopy. In summary, the SB-CAG-Venus transgenic rabbits secrete the recombinant protein by different glands. This finding has relevance not only for the understanding of the biological function of exocrine glands, but also for the design of constructs for expression of recombinant proteins in dairy animals.	[Kerekes, Andrea; Hoffmann, Orsolya Ivett; Iski, Gergely; Liptak, Nandor; Gocza, Elen; Bosze, Zsuzsanna; Hiripi, Laszlo] NARIC Agr Biotechnol Inst, Dept Anim Biotechnol, Godollo, Hungary; [Kues, Wilfried A.] Friedrich Loeffler Inst, Inst Nutztiergenet, Dept Biotechnol, Neustadt, Germany	Friedrich Loeffler Institute	Hiripi, L (corresponding author), NARIC Agr Biotechnol Inst, Dept Anim Biotechnol, Godollo, Hungary.	hiripi1@gmail.com	Hiripi, Laszlo/AAL-8243-2021; Bosze, Zsuzsanna/N-9689-2019; Lipták, Nándor/ABD-1954-2021; Gocza, Elen/C-9883-2014; Gocza, Elen/A-8838-2012	Hiripi, Laszlo/0000-0002-1023-0112; Gocza, Elen/0000-0001-7720-4720; Gocza, Elen/0000-0001-7720-4720; Liptak, Nandor/0000-0002-9406-1482; Kues, Wilfried/0000-0002-0850-8103	(OTKA) National Research, Development and Innovation Office (NKFIH) NN grant [108921, PD 120870, NN 113162]	(OTKA) National Research, Development and Innovation Office (NKFIH) NN grant(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by (OTKA) National Research, Development and Innovation Office (NKFIH) NN grant no. 108921 to ZB, grant no. PD 120870 to LN and grant no. NN 113162 to LH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranyi M, 2007, J BIOTECHNOL, V128, P383, DOI 10.1016/j.jbiotec.2006.10.016; Bender B, 2015, PHYSIOL RES, V64, P731, DOI 10.33549/physiolres.932946; Bodrogi L, 2006, TRANSGENIC RES, V15, P627, DOI 10.1007/s11248-006-9015-5; Boutinaud M, 2002, REPROD NUTR DEV, V42, P133, DOI 10.1051/rnd:2002013; BUHLER TA, 1990, BIO-TECHNOL, V8, P140, DOI 10.1038/nbt0290-140; Dyck MK, 1999, NAT BIOTECHNOL, V17, P1087, DOI 10.1038/15067; Franscini N, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000071; Garrels W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023573; Golovan SP, 2001, NAT BIOTECHNOL, V19, P741, DOI 10.1038/90788; Gordon K, 1992, Biotechnology, V24, P425; Guan LZ, 2015, TRANSGENIC RES, V24, P489, DOI 10.1007/s11248-015-9863-y; Guan LZ, 2013, TRANSGENIC RES, V22, P805, DOI 10.1007/s11248-012-9682-3; Hiripi L, 2003, DNA CELL BIOL, V22, P41, DOI 10.1089/104454903321112488; Hoffmann OI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154489; Houdebine LM, 2009, COMP IMMUNOL MICROB, V32, P107, DOI 10.1016/j.cimid.2007.11.005; Ivics Z, 2014, NAT PROTOC, V9, P794, DOI 10.1038/nprot.2014.009; Katter K, 2013, FASEB J, V27, P930, DOI 10.1096/fj.12-205526; Kerr DE, 2001, NAT BIOTECHNOL, V19, P66, DOI 10.1038/83540; LeJan C, 1996, VET RES, V27, P403; MIKKELSEN TR, 1992, NUCLEIC ACIDS RES, V20, P2249, DOI 10.1093/nar/20.9.2249; MIRCHEFF AK, 1994, INT OPHTHALMOL CLIN, V34, P1, DOI 10.1097/00004397-199403410-00003; MUKHERJEE A, 2016, SCI REP, V6, P31140; Niemann H, 1999, TRANSGENIC RES, V8, P237, DOI 10.1023/A:1008999622117; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; OWERBACH D, 1980, GENETICS, V95, P129; PITTIUS CW, 1988, P NATL ACAD SCI USA, V85, P5874, DOI 10.1073/pnas.85.16.5874; SIMONS JP, 1987, NATURE, V328, P530, DOI 10.1038/328530a0; Trousdale Melvin D, 2005, J Autoimmune Dis, V2, P6, DOI 10.1186/1740-2557-2-6; Van Cott KE, 1999, GENET ANAL-BIOMOL E, V15, P155, DOI 10.1016/S1050-3862(99)00020-0; Vorberg I, 2003, J VIROL, V77, P2003, DOI 10.1128/JVI.77.3.2003-2009.2003; Wells GAH, 2003, J GEN VIROL, V84, P1021, DOI 10.1099/vir.0.18788-0; Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017593; Zhou Q, 2005, J BIOTECHNOL, V117, P57, DOI 10.1016/j.jbiotec.2005.01.001	33	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187214	10.1371/journal.pone.0187214	http://dx.doi.org/10.1371/journal.pone.0187214			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077768	Green Submitted, Green Published, gold			2022-12-26	WOS:000413861200053
J	Reiger, S; Jardim, TV; Abrahams-Gessel, S; Crowther, NJ; Wade, A; Gomez-Olive, FX; Salomon, J; Tollman, S; Gaziano, TA				Reiger, Sheridan; Jardim, Thiago Veiga; Abrahams-Gessel, Shafika; Crowther, Nigel J.; Wade, Alisha; Gomez-Olive, F. Xavier; Salomon, Joshua; Tollman, Stephen; Gaziano, Thomas A.			Awareness, treatment, and control of dyslipidemia in rural South Africa: The HAALSI (Health and Aging in Africa: A Longitudinal Study of an INDEPTH Community in South Africa) study	PLOS ONE			English	Article							RISK; COUNTRIES; DISEASES	Dyslipidemia is a primary driver for chronic cardiovascular conditions and there is no comprehensive literature about its management in South Africa. The objective of this study was to assess the prevalence, awareness, treatment, and control of dyslipidemia in rural South Africa and how they are impacted by different behaviors and non-modifiable factors. To fulfill this objective we recruited for this cohort study adults aged >= 40 years residing in the Agin-court sub-district of Mpumalanga Province. Data collection included socioeconomic and clinical data, anthropometric measures, blood pressure (BP), HIV-status, point-of-care glucose and lipid levels. Framingham CVD Risk Score was ascribed to patients based upon categories for 10 year cardiovascular risk of low (<3%), moderate (>= 3% and <15%), high (>= 15% and <30%), and very high (>= 30%).LDL cholesterol control by risk category was defined according to South African Guidelines. Multivariable logistic regression models were built to identify factors that were significantly associated with dyslipidemia and awareness of dyslipidemia From 5,059 respondents a total of 4247 subjects (83.9%) had their cholesterol levels measured and were included in our analysis. Overall, 67.3% (2860) of these met criteria for dyslipidemia, only 30 (1.05%) were aware of their condition, and only 21 subjects (0.73%) were on treatment. The majority have abnormalities in triglycerides (59.3%). As cardiovascular risk increased the rates of lipid control according to LDL level dropped. Multivariate logistic regression analyses showed that being overweight was predictive of dyslipidemia (OR 1.76; 95% CI 1.51-2.05, p<0.001) and dyslipidemia awareness (OR 2.58; 95% CI 1.19-5.58; p = 0.017). In conclusion, the very low awareness and treatment of dyslipidemia in this cohort indicate a greater need for systematic screening and education within the population and demonstrate that there are multiple opportunities to allay this burden.	[Reiger, Sheridan; Jardim, Thiago Veiga; Gaziano, Thomas A.] Brigham & Womens Hosp, Dept Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [Jardim, Thiago Veiga; Abrahams-Gessel, Shafika; Gaziano, Thomas A.] Harvard TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA USA; [Crowther, Nigel J.] Univ Witwatersrand, Natl Hlth Lab Serv, Johannesburg, South Africa; [Crowther, Nigel J.] Univ Witwatersrand, Dept Chem Pathol, Fac Hlth Sci, Johannesburg, South Africa; [Wade, Alisha; Gomez-Olive, F. Xavier; Tollman, Stephen] Univ Witwatersrand, Med Res Council, Rural Publ Hlth & Hlth Transit Res Unit, Sch Publ Hlth,Fac Hlth Sci, Johannesburg, South Africa; [Salomon, Joshua] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; National Health Laboratory Service; University of Witwatersrand; University of Witwatersrand; South African Medical Research Council; University of Witwatersrand; Harvard University; Harvard T.H. Chan School of Public Health	Jardim, TV; Gaziano, TA (corresponding author), Brigham & Womens Hosp, Dept Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA.; Jardim, TV; Gaziano, TA (corresponding author), Harvard TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA USA.	tdesouzaveigajardim@bwh.harvard.edu; tgaziano@bwh.harvard.edu	Gómez-Olivé, Francesc Xavier/AAP-7673-2021; Salomon, Joshua/S-1929-2019; Jardim, Thiago V/I-9095-2018	Gómez-Olivé, Francesc Xavier/0000-0002-4876-0848; Salomon, Joshua/0000-0003-3929-5515; Jardim, Thiago V/0000-0002-7750-2792; Wade, Alisha/0000-0002-1158-2523; Crowther, Nigel/0000-0002-5766-1745; Tollman, Stephen/0000-0003-0744-7588	National Institute on Aging within Agincourt Health and Demographic Surveillance System [P01 AG041710]; University of the Witwatersrand and Medical Research Council, South Africa; Wellcome Trust, UK [058893/A/99A, 069683/Z/02/Z, 085477/Z08/Z]; Fogarty International Center of the National Institutes of Health [K43TW010698]; FOGARTY INTERNATIONAL CENTER [K43TW010698] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG041710] Funding Source: NIH RePORTER	National Institute on Aging within Agincourt Health and Demographic Surveillance System; University of the Witwatersrand and Medical Research Council, South Africa; Wellcome Trust, UK(Wellcome Trust); Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The HAALSI study, funded by the National Institute on Aging (P01 AG041710), is nested within the Agincourt Health and Demographic Surveillance System site, funded by the University of the Witwatersrand and Medical Research Council, South Africa, and the Wellcome Trust, UK (058893/A/99A; 069683/Z/02/Z; 085477/Z08/Z). The HAALSI study has been carried out through a collaboration between the Harvard Center for Population and Development Studies from the Harvard T.H. Chan School of Public Health, the MRC/Wits Rural Public Health and Health Transitions Research Unit from the School of Public Health at the University of the Witwatersrand in South Africa, and the INDEPTH Network in Accra, Ghana. AW is supported by the Fogarty International Center of the National Institutes of Health under Award Number K43TW010698. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Achterberg S, 2012, EUR J PREV CARDIOL, V19, P5, DOI 10.1177/1741826710391117; Barquera S, 2015, ARCH MED RES, V46, P328, DOI 10.1016/j.arcmed.2015.06.006; Church K, 2015, B WORLD HEALTH ORGAN, V93, P457, DOI 10.2471/BLT.14.147215; Cohen M, 2006, DIABETES RES CLIN PR, V71, P113, DOI 10.1016/j.diabres.2005.05.013; Collins R, 2016, LANCET, V388, P2532, DOI 10.1016/S0140-6736(16)31357-5; Ferreira CED, 2015, CLIN CHIM ACTA, V446, P263, DOI 10.1016/j.cca.2015.04.036; Feigin VL, 2016, LANCET NEUROL, V15, P913, DOI 10.1016/S1474-4422(16)30073-4; Gaziano TA, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4117-y; Grover SA, 2005, AM J CARDIOL, V95, P586, DOI 10.1016/j.amjcard.2004.11.004; Jardim TV, 2017, J HYPERTENS, V35, P1283, DOI 10.1097/HJH.0000000000001312; Kahn K, 2012, INT J EPIDEMIOL, V41, P988, DOI 10.1093/ije/dys115; Klug EQ, 2015, S AFR FAM PRACT, V57, P22; Levitt NS, 2011, AM J CLIN NUTR, V94, p1690S, DOI 10.3945/ajcn.111.019075; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Lloyd-Jones DM, 2004, AM J CARDIOL, V94, P20, DOI 10.1016/j.amjcard.2004.03.023; Maimela E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147926; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Manning K, 2016, AFR J PRIM HEALTH CA, V8, DOI 10.4102/phcfm.v8i1.913; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Park PH, 2016, TROP MED INT HEALTH, V21, P437, DOI 10.1111/tmi.12653; Rutstein S. O., 2004, DHS WEALTH INDEX; Rutstein SO, 2014, STEPS TO CONSTRUCTIN; Shisana O, 2013, S AFRICAN NATL HLTH; Sundvall J, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-63; The uses of epidemiology in the study of the elderly, 1984, WHO TECH REP SER, V706, P1; Thorogood M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-326; Toth P P, 2003, J CLIN LIPI, V6, P325; WHO, 2015, CONSOLIDATED GUIDELI; World Health Organization, 2014, POL BRIEF CONS GUID; 2000, WHO TECHNICAL REPORT, V894	32	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187347	10.1371/journal.pone.0187347	http://dx.doi.org/10.1371/journal.pone.0187347			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077762	gold, Green Published, Green Submitted			2022-12-26	WOS:000413861200059
J	Schmidt, LH; Heitkotter, B; Schulze, AB; Schliemann, C; Steinestel, K; Trautmann, M; Marra, A; Hillejan, L; Mohr, M; Evers, G; Wardelmann, E; Rahbar, K; Gorlich, D; Lenz, G; Berdel, WE; Hartmann, W; Wiewrodt, R; Huss, S				Schmidt, Lars Henning; Heitkoetter, Birthe; Schulze, Arik B.; Schliemann, Christoph; Steinestel, Konrad; Trautmann, Marcel; Marra, Alessandro; Hillejan, Ludger; Mohr, Michael; Evers, Georg; Wardelmann, Eva; Rahbar, Kambiz; Gorlich, Dennis; Lenz, Georg; Berdel, Wolfgang E.; Hartmann, Wolfgang; Wiewrodt, Rainer; Huss, Sebastian			Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer	PLOS ONE			English	Article							TUMOR-ASSOCIATED NEOVASCULATURE; MONOCLONAL-ANTIBODY J591; ADVANCED SOLID TUMORS; ENDOTHELIAL-CELLS; CD34; HYDROLASE; THERAPY; TARGET	Objectives PSMA (prostate-specific membrane antigen) is overexpressed in prostate cancer cells and is reported to be a promising target for antibody-based radioligand therapy in patients with metastasized prostate cancer. Since PSMA expression is not restricted to prostate cancer, the underlying study investigates PSMA expression in non-small cell lung cancer (NSCLC). Material and methods Immunohistochemistry was used to identify PSMA expression in n = 275 samples of NSCLC tissue specimens. By means of CD34 co-expression, the level of PSMA expression in tumor associated neovasculature was investigated. The impact of PSMA expression on clinicopathologic parameters and prognosis was evaluated. Results PSMA tumor cell expression in NSCLC is as low as 6% and was predominantly found in squamous cell carcinoma (p = 0.002). Neovascular PSMA expression was found in 49% of NSCLC. High neovascular PSMA expression was associated with higher tumor grading (G3/G4) (p < 0.001). Neither for PSMA tumor cell expression, nor for PSMA neovascular cell expression prognostic effects were found for the investigated NSCLC cases. Conclusion Here, we report on the expression of PSMA in NSCLC tissue samples. Against the background of a potential treatment with radiolabeled PSMA ligands, our data might serve for the future identification of patients who could benefit from this therapeutic option.	[Schmidt, Lars Henning; Schulze, Arik B.; Schliemann, Christoph; Mohr, Michael; Evers, Georg; Lenz, Georg; Berdel, Wolfgang E.; Wiewrodt, Rainer] Univ Hosp Muenster, Dept Med Hematol Oncol & Resp Med A, Munster, Germany; [Heitkoetter, Birthe; Steinestel, Konrad; Trautmann, Marcel; Wardelmann, Eva; Hartmann, Wolfgang; Huss, Sebastian] Univ Munster, Gerhard Domagk Inst Pathol, Munster, Germany; [Steinestel, Konrad] Bundeswehrkrankenhaus Ulm, Inst Pathol & Mol Pathol, Ulm, Germany; [Marra, Alessandro] Klinikum Bremen Ost, Dept Thorac Surg, Bremen, Germany; [Hillejan, Ludger] Niels Stensen Kliniken, Dept Thorac Surg, Ostercappeln, Germany; [Rahbar, Kambiz] Univ Hosp Munster, Dept Nucl Med, Munster, Germany; [Gorlich, Dennis] Westfaelische Wilhelms Univ Muenster, Inst Biostat & Clin Res, Munster, Germany; [Lenz, Georg] Univ Hosp Muenster, Translat Oncol, Munster, Germany; [Lenz, Georg] Cells Mot, Cluster Excellence EXC 1003, Munster, Germany	University of Munster; University of Munster; Ulm University; Military Hospital Ulm; Klinikum Bremen-Ost; University of Munster; University of Munster	Schmidt, LH (corresponding author), Univ Hosp Muenster, Dept Med Hematol Oncol & Resp Med A, Munster, Germany.	larshenning.sohmidt@ukmuenster.de	Trautmann, Marcel/B-4627-2015; Görlich, Dennis/C-8950-2012; Hartmann, Wolfgang/G-1893-2017	Trautmann, Marcel/0000-0002-5842-1196; Görlich, Dennis/0000-0002-2574-9419; Hartmann, Wolfgang/0000-0002-7609-5021; Schulze, Arik B/0000-0002-1644-3573; Steinestel, Konrad/0000-0002-6549-9848; Rahbar, Kambiz/0000-0002-4591-4055	Deutsche Forschungsgemeinschaft (Cluster of Excellence "Cells in Motion") [DFG EXC1003]	Deutsche Forschungsgemeinschaft (Cluster of Excellence "Cells in Motion")	The laboratories of W.E.B. and G.L. are supported by Deutsche Forschungsgemeinschaft (DFG EXC1003, Cluster of Excellence "Cells in Motion").	Ahmadzadehfar H, 2015, EJNMMI RES, V5, P1, DOI 10.1186/s13550-015-0114-2; Bander NH, 2003, J UROLOGY, V170, P1717, DOI 10.1097/01.ju.0000091655.77601.0c; Bostwick DG, 1998, CANCER-AM CANCER SOC, V82, P2256, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2256::AID-CNCR22>3.0.CO;2-S; Carter RE, 1996, P NATL ACAD SCI USA, V93, P749, DOI 10.1073/pnas.93.2.749; Chang Sam S, 2004, Rev Urol, V6 Suppl 10, pS13; Chang SS, 1999, CLIN CANCER RES, V5, P2674; Chang SS, 1999, CANCER RES, V59, P3192; Conway RE, 2006, MOL CELL BIOL, V26, P5310, DOI 10.1128/MCB.00084-06; Evangelista L, 2016, EUROPEAN UROLOGY; FINA L, 1990, BLOOD, V75, P2417; Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735; Foss CA, 2012, CURR MED CHEM, V19, P1346; Ghosh A, 2004, J CELL BIOCHEM, V91, P528, DOI 10.1002/jcb.10661; Godeiro Katyanne Dantas, 2006, J Carcinog, V5, P21, DOI 10.1186/1477-3163-5-21; Haberkorn U, 2016, CLIN CANCER RES, V22, P9, DOI 10.1158/1078-0432.CCR-15-0820; Heitkotter B, 2016, ONCOTARGET; Kratochwil C, 2016, J NUCL MED OFFICIAL; Milowsky MI, 2007, J CLIN ONCOL, V25, P540, DOI 10.1200/JCO.2006.07.8097; Perner S, 2007, HUM PATHOL, V38, P696, DOI 10.1016/j.humpath.2006.11.012; Pinto JT, 1996, CLIN CANCER RES, V2, P1445; Rahbar K, 2016, J NUCL MED, V57, P563, DOI 10.2967/jnumed.115.169243; Rajasekaran SA, 2003, MOL BIOL CELL, V14, P4835, DOI 10.1091/mbc.E02-11-0731; Schildhaus HU, 2011, HUM PATHOL, V42, P1667, DOI 10.1016/j.humpath.2010.12.025; SCHLINGEMANN RO, 1990, LAB INVEST, V62, P690; Siemerink MJ, 2012, ANGIOGENESIS, V15, P151, DOI 10.1007/s10456-011-9251-z; Von Hoff DD, 2016, CLIN CANCER RES, V22, P3157, DOI 10.1158/1078-0432.CCR-15-2548; Wang H, 2015, ADVANCES IN ENERGY SCIENCE AND EQUIPMENT ENGINEERING, P1371; Wernicke AG, 2011, ARCH PATHOL LAB MED, V135, P1486, DOI 10.5858/arpa.2010-0740-OA	28	34	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186280	10.1371/journal.pone.0186280	http://dx.doi.org/10.1371/journal.pone.0186280			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077706	Green Published, gold			2022-12-26	WOS:000413861200010
J	Lambert, AS; Rothenbuhler, A; Charles, P; Brailly-Tabard, S; Trabado, S; Celestine, E; Durand, E; Fontaine, I; Miladi, L; Wicart, P; Bahi-Buisson, N; Linglart, A				Lambert, Anne-Sophie; Rothenbuhler, Anya; Charles, Perrine; Brailly-Tabard, Sylvie; Trabado, Severine; Celestine, Elisabeth; Durand, Emmanuel; Fontaine, Isabelle; Miladi, Lotfi; Wicart, Philippe; Bahi-Buisson, Nadia; Linglart, Agnes			Lower incidence of fracture after IV bisphosphonates in girls with Rett syndrome and severe bone fragility	PLOS ONE			English	Article							CEREBRAL-PALSY; TREAT OSTEOPENIA; CHILDREN; OSTEOPOROSIS; PAMIDRONATE; POPULATION; MANAGEMENT; MUTATIONS; MECP2; MASS	Background Classic Rett Syndrome (RS) is a disabling condition mainly caused by MECP2 mutations. Girls with RS are at risk of developing bone fragility and fractures at a young age which results in pain and may seriously impair quality of life. Objective To retrospectively assess the safety and efficacy of IV bisphosphonates on fracture, bone mineral density (BMD) and bone markers in RS girls with bone fragility. Methods RS girls received either IV pamidronate (n = 19) or IV zoledronate (n = 1) for 2 years. Results Of 20 patients studied (age: 12.5 years [6; 39]), 14 were non-ambulatory. The incidence of fracture decreased from 37 fractures in 20 patients, to 1 fracture during or after treatment (follow-up: 3.1 years [1.5; 5]). The spine BMD Z-score improved from -3.2 [-5.6; -0.1] to -2.2 [-3.8; 0.0], p = 0.0006. Most parents reported decreases in chronic pain and 2 patients started to walk. Urinary calcium excretion decreased from 0.7 [0.18; 1.5] to 0.2 [0.03; 0.67] mM/mM of creatinine (p = 0.0001). Pamidronate was well tolerated. Conclusion RS girls should be screened for impaired bone mineralization and preventive measures should be taken. In girls experiencing fractures, IV bisphosphonates constitute a beneficial adjuvant treatment to diminish the risk of fracture and restore bone density.	[Lambert, Anne-Sophie; Rothenbuhler, Anya; Linglart, Agnes] AP HP, Dept Pediat Endocrinol & Diabetol Children, Bicetre Paris Sud, Le Kremlin Bicetre, France; [Lambert, Anne-Sophie; Rothenbuhler, Anya; Linglart, Agnes] AP HP, Filiere OSCAR, Reference Ctr Rare Disorders Calcium & Phosphate, Le Kremlin Bicetre, France; [Lambert, Anne-Sophie; Rothenbuhler, Anya; Linglart, Agnes] Plateforme Expertise Malad Rares Paris Sud, Bicetre Paris Sud, Le Kremlin Bicetre, France; [Charles, Perrine] AP HP, Reference Ctr Intellectual Disabil, Dept Genet, Pitie Salpetriere Paris, Paris, France; [Brailly-Tabard, Sylvie; Trabado, Severine] AP HP, Dept Genet & Hormonol, Bicetre Paris Sud, Le Kremlin Bicetre, France; [Celestine, Elisabeth; Bahi-Buisson, Nadia] Necker Enfants Malad, AP HP, Rett Ctr, Paris, France; [Durand, Emmanuel] Univ Paris Saclay, CNRS, AP HP, Unit IR4M, Orsay, France; [Fontaine, Isabelle] IMP Marie Auxiliatrice, Draveil, France; [Miladi, Lotfi; Wicart, Philippe] Univ Paris 05, Sorbonne Paris Cite, Sch Med, Necker Enfants Malad,AP HP,Dept Pediat Orthoped, Paris, France; [Miladi, Lotfi; Wicart, Philippe] Necker Enfants Malad, AP HP, Reference Ctr Rare Disorders Calcium & Phosphate, Filiere OSCAR, Paris, France; [Bahi-Buisson, Nadia] Necker Enfants Malad, AP HP, Dept Pediat Neurol, Paris, France; [Bahi-Buisson, Nadia] Paris Descartes Sorbonne Paris Cite Univ, Imagine Inst, Lab Embryol & Genet Congenital Malformat, INSERM,UMR 1163, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Franche-Comte; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Lambert, AS (corresponding author), AP HP, Dept Pediat Endocrinol & Diabetol Children, Bicetre Paris Sud, Le Kremlin Bicetre, France.; Lambert, AS (corresponding author), AP HP, Filiere OSCAR, Reference Ctr Rare Disorders Calcium & Phosphate, Le Kremlin Bicetre, France.; Lambert, AS (corresponding author), Plateforme Expertise Malad Rares Paris Sud, Bicetre Paris Sud, Le Kremlin Bicetre, France.	anne-sophie.lambert@aphp.fr	Linglart, Agnès/A-8047-2016; Bahi-Buisson, Nadia/H-5207-2017	Linglart, Agnès/0000-0003-3455-002X; ANNE SOPHIE, LAMBERT/0000-0002-4232-3882; Bahi-Buisson, Nadia/0000-0002-5352-0929; Trabado, Severine/0000-0002-1925-1999				Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Anderson A, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-87; Bachrach LK, 2009, J CLIN ENDOCR METAB, V94, P400, DOI 10.1210/jc.2008-1531; Bahi-Buisson N, 2013, HAND CLINIC, V111, P281, DOI 10.1016/B978-0-444-52891-9.00031-2; Black DM, 2016, NEW ENGL J MED, V374, P254, DOI 10.1056/NEJMcp1513724; Boyce AM, 2014, PM&R, V6, P427, DOI 10.1016/j.pmrj.2013.10.009; Bronson WH, 2014, CURR OSTEOPOROS REP, V12, P446, DOI 10.1007/s11914-014-0239-7; Downs J, 2008, PEDIATRICS, V121, P540, DOI 10.1542/peds.2007-1641; Downs J, 2009, SPINE, V34, pE607, DOI 10.1097/BRS.0b013e3181a95ca4; Eladl A, 2011, PEDIATR RES, V70, P313, DOI 10.1038/pr.2011.538; Glaze DG, 2010, NEUROLOGY, V74, P909, DOI 10.1212/WNL.0b013e3181d6b852; Glorieux FH, 1998, NEW ENGL J MED, V339, P947, DOI 10.1056/NEJM199810013391402; Henderson RC, 2002, J PEDIATR-US, V141, P644, DOI 10.1067/mpd.2002.128207; Jefferson A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146824; Lotan M, 2013, OSTEOPOROSIS INT, V24, P3059, DOI 10.1007/s00198-013-2423-5; Nakamura A, 2010, J DIABETES INVEST, V1, P208, DOI 10.1111/j.2040-1124.2010.00046.x; Oddy WH, 2007, J PEDIATR GASTR NUTR, V45, P582, DOI 10.1097/MPG.0b013e318073cbf7; Plotkin H, 2006, DEV MED CHILD NEUROL, V48, P709, DOI 10.1017/S0012162206001526; Roende G, 2011, J BONE MINER RES, V26, P2280, DOI 10.1002/jbmr.423; Roende G, 2011, PEDIATR RES, V69, P359, DOI 10.1203/PDR.0b013e31820bc6d3; Shapiro JR, 2010, PEDIATR RES, V68, P446, DOI 10.1203/PDR.0b013e3181f2edd2; Society of osteodensitometry, 2013, OSTEOPOROSIS; STEWART AF, 1982, NEW ENGL J MED, V306, P1136, DOI 10.1056/NEJM198205133061903; Tarquinio DC, 2012, NEUROLOGY, V79, P1653, DOI 10.1212/WNL.0b013e31826e9a70; Ward L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005324.pub2; Wort UU, 2013, DEV MED CHILD NEUROL, V55, P821, DOI 10.1111/dmcn.12178	26	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186941	10.1371/journal.pone.0186941	http://dx.doi.org/10.1371/journal.pone.0186941			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073271	Green Published, Green Submitted, gold			2022-12-26	WOS:000413845400078
J	Goundry, A; Romano, A; Lima, APCA; Mottram, JC; Myburgh, E				Goundry, Amy; Romano, Audrey; Lima, Ana Paula C. A.; Mottram, Jeremy C.; Myburgh, Elmarie			Inhibitor of serine peptidase 2 enhances Leishmania major survival in the skin through control of monocytes and monocyte-derived cells	FASEB JOURNAL			English	Article						inflammatory monocytes; parasite; dermis; leishmaniasis; in vivo	DENDRITIC CELLS; NEUTROPHIL ELASTASE; MACROPHAGES; INDUCTION; INFECTION; ACTIVATION; PROTEASES; SITE; RESPONSES; IMMUNITY	Leishmania major is the causative agent of the neglected tropical disease, cutaneous leishmaniasis. In the mouse, protective immunity to Leishmaniais associated with inflammatory responses. Here, we assess the dynamics of the inflammatory responses at the lesion site during experimental long-term, low-dose intradermal infection of the ear, employing noninvasive imaging and genetically modified L. major. Significant infiltrates of neutrophils and monocytes occurred at 1-4 d and 2-4 wk, whereas dermal macrophage and dendritic cell (DC) numbers were only slightly elevated in the first days. Quantitative whole-body bioluminescence imaging of myeloperoxidase activity and the quantification of parasite loads indicated that the Leishmania virulence factor, inhibitor of serine peptidase 2 (ISP2), is required to modulate phagocyte activation and is important for parasite survival at the infection site. ISP2 played a role in the control of monocyte, monocyte-derived macrophage, and monocyte-derived DC (moDC) influx, and was required to reduce iNOS expression in monocytes, monocyte-derived cells, and dermal DCs; the expression of CD80 in moDCs; and levels of IFN-gamma in situ. Our findings indicate that the increased survival of L. major in the dermis during acute infection is associated with the down-regulation of inflammatory monocytes and monocyte-derived cells via ISP2.-Goundry, A., Romano, A., Lima, A. P. C. A., Mottram, J. C., Myburgh, E. Inhibitor of serine peptidase 2 enhances Leishmania major survival in the skin through control of monocytes and monocyte-derived cells.	[Goundry, Amy; Mottram, Jeremy C.; Myburgh, Elmarie] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Wellcome Ctr Mol Parasitol, Glasgow, Lanark, Scotland; [Goundry, Amy; Romano, Audrey; Mottram, Jeremy C.; Myburgh, Elmarie] Univ York, Ctr Immunol & Infect, Dept Biol, Wentworth Way, York YO10 5DD, N Yorkshire, England; [Goundry, Amy; Lima, Ana Paula C. A.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil	University of Glasgow; University of York - UK; Universidade Federal do Rio de Janeiro	Mottram, JC; Myburgh, E (corresponding author), Univ York, Ctr Immunol & Infect, Dept Biol, Wentworth Way, York YO10 5DD, N Yorkshire, England.	jeremy.mottram@york.ac.uk; elmarie.myburgh@york.ac.uk	Lima, Ana Paula CA/G-4122-2012	Mottram, Jeremy/0000-0001-5574-3766; Myburgh, Elmarie/0000-0002-2007-5902; Goundry, Amy/0000-0003-3406-4689; LIMA, ANA PAULA C. A./0000-0003-4631-2694	Medical Research Council (MRC) [MR/K019384]; Newton Fund [MR/N017269/1]; Wellcome Trust [104111]; Fundacao de Amparoa Pesquisa do Estado do Rio de Janeiro (FAPERJ); MRC studentship; MRC [MR/K019384/1, MR/K019384/2, MR/N017269/1] Funding Source: UKRI; Medical Research Council [MR/K019384/1, MR/K019384/2, MR/N017269/1] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Newton Fund; Wellcome Trust(Wellcome TrustEuropean Commission); Fundacao de Amparoa Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); MRC studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank the staff at Biological Services (University of Glasgow) for care of the animals used in the study. This work was supported by the Medical Research Council (MRC; MR/K019384), the Newton Fund (MR/N017269/1), the Wellcome Trust (104111), and Fundacao de Amparoa Pesquisa do Estado do Rio de Janeiro (FAPERJ). A.G. was supported by an MRC studentship. A.P.C.A.L. is a fellow of the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. The authors declare no conflicts of interest.	Adkison AM, 2002, J CLIN INVEST, V109, P363, DOI 10.1172/JCI13462; Alexander J, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00080; Belkaid Y, 2000, J IMMUNOL, V165, P969, DOI 10.4049/jimmunol.165.2.969; Bosschaerts T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001045; Carrera L, 1996, J EXP MED, V183, P515, DOI 10.1084/jem.183.2.515; Charmoy M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000755; CHUNG CH, 1983, J BIOL CHEM, V258, P1032; Contreras I, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003202; De Filippo K, 2008, J IMMUNOL, V180, P4308, DOI 10.4049/jimmunol.180.6.4308; De Trez C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000494; Eggers CT, 2004, BIOCHEM J, V379, P107, DOI 10.1042/BJ20031790; Eschenlauer SCP, 2009, CELL MICROBIOL, V11, P106, DOI 10.1111/j.1462-5822.2008.01243.x; Faria MS, 2014, FASEB J, V28, P3050, DOI 10.1096/fj.13-245126; Faria MS, 2011, J IMMUNOL, V186, P411, DOI 10.4049/jimmunol.1002175; Favila MA, 2014, J IMMUNOL, V192, P5863, DOI 10.4049/jimmunol.1203230; Gomez MA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000213; Goncalves R, 2011, J EXP MED, V208, P1253, DOI 10.1084/jem.20101751; Gonzalez-Lombana C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003243; Gross S, 2009, NAT MED, V15, P455, DOI 10.1038/nm.1886; Guyot N, 2014, AM J PATHOL, V184, P2197, DOI 10.1016/j.ajpath.2014.04.015; HART DT, 1981, PARASITOLOGY, V82, P345, DOI 10.1017/S0031182000066889; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Hurrell BP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004929; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kimblin N, 2008, P NATL ACAD SCI USA, V105, P10125, DOI 10.1073/pnas.0802331105; Krutzik SR, 2005, NAT MED, V11, P653, DOI 10.1038/nm1246; Laufs H, 2002, INFECT IMMUN, V70, P826, DOI 10.1128/IAI.70.2.826-835.2002; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Liu D, 2009, INFECT IMMUN, V77, P3272, DOI 10.1128/IAI.01447-08; LOCKSLEY RM, 1991, RES IMMUNOL, V142, P28, DOI 10.1016/0923-2494(91)90007-6; Morrison LS, 2012, CELL MICROBIOL, V14, P1271, DOI 10.1111/j.1462-5822.2012.01798.x; Owen Caroline A, 2008, Int J Chron Obstruct Pulmon Dis, V3, P253; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Petritus PM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001858; Pham CTN, 2008, INT J BIOCHEM CELL B, V40, P1317, DOI 10.1016/j.biocel.2007.11.008; Quinones MP, 2007, PARASITE IMMUNOL, V29, P211, DOI 10.1111/j.1365-3024.2006.00935.x; REINER SL, 1994, J EXP MED, V179, P447, DOI 10.1084/jem.179.2.447; Ribeiro-Gomes FL, 2014, INFECT IMMUN, V82, P2713, DOI 10.1128/IAI.01600-13; Ribeiro-Gomes FL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002536; Ritter U, 2008, MED MICROBIOL IMMUN, V197, P29, DOI 10.1007/s00430-007-0056-z; Rogers ME, 2010, MICROBES INFECT, V12, P875, DOI 10.1016/j.micinf.2010.05.014; SACKS DL, 1985, J IMMUNOL, V135, P564; Schuster S, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00067; Shapiro SD, 2002, BIOCHEM SOC T, V30, P98, DOI 10.1042/BST0300098; Shio MT, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/819512; Silva MT, 2010, J LEUKOCYTE BIOL, V87, P805, DOI 10.1189/jlb.1109767; STENGER S, 1994, J EXP MED, V180, P783, DOI 10.1084/jem.180.3.783; Svensjo E, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/143450; Thalhofer CJ, 2011, INFECT IMMUN, V79, P108, DOI 10.1128/IAI.00338-10; TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x; van Zandbergen G, 2004, J IMMUNOL, V173, P6521, DOI 10.4049/jimmunol.173.11.6521; van Zandbergen G, 2002, INFECT IMMUN, V70, P4177, DOI 10.1128/IAI.70.8.4177-4184.2002; VOULDOUKIS I, 1995, P NATL ACAD SCI USA, V92, P7804, DOI 10.1073/pnas.92.17.7804; Wiedow O, 2005, J INTERN MED, V257, P319, DOI 10.1111/j.1365-2796.2005.01476.x; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182	56	9	10	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1315	1327		10.1096/fj.201700797R	http://dx.doi.org/10.1096/fj.201700797R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29097502	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000427246000016
J	Notomi, T; Kuno, M; Hiyama, A; Nozaki, T; Ohura, K; Ezura, Y; Noda, M				Notomi, Takuya; Kuno, Miyuki; Hiyama, Akiko; Nozaki, Tadashige; Ohura, Kiyoshi; Ezura, Yoichi; Noda, Masaki			Role of lysosomal channel protein TPC2 in osteoclast differentiation and bone remodeling under normal and low-magnesium conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL; NAADP; MYOINOSITOL; SKELETAL; CALCIUM; MG2+; ACTIVATION; EXERCISE	The bone is the main storage site for Ca2+ and Mg2+ ions in the mammalian body. Although investigations into Ca2+ signaling have progressed rapidly and led to better understanding of bone biology, the Mg2+ signaling pathway and associated molecules remain to be elucidated. Here, we investigated the role of a potential Mg2+ signaling-related lysosomal molecule, two-pore channel subtype 2 (TPC2), in osteoclast differentiation and bone remodeling. Previously, we found that under normal Mg2+ conditions, TPC2 promotes osteoclastogenesis. We observed that under low-Mg2+ conditions, TPC2 inhibited, rather than promoted, the osteoclast differentiation and that the phosphatidylinositol 3,5-bisphosphate (PI(3,5) P-2) signaling pathway played a role in the TPC2 activation under low-Mg2+ conditions. Furthermore, PI(3,5) P-2 depolarized the membrane potential by increasing the intracellular Na+ levels. To investigate how membrane depolarization affects osteoclast differentiation, we generated a light-sensitive cell line and developed a system for the light-stimulated depolarization of the membrane potential. The light-induced depolarization inhibited the osteoclast differentiation. We then tested the effect of myo-inositol supplementation, which increased the PI(3,5) P-2 levels in mice fed a low-Mg2+ diet. The myo-inositol supplementation rescued the low-Mg2+ diet-induced trabecular bone loss, which was accompanied by the inhibition of osteoclastogenesis. These results indicate that low-Mg2+-induced osteoclastogenesis involves changes in the role of TPC2, which are mediated through the PI(3,5) P-2 pathway. Our findings also suggest that myo-inositol consumption might provide beneficial effects in Mg2+ deficiency-induced skeletal diseases.	[Notomi, Takuya; Ezura, Yoichi; Noda, Masaki] Tokyo Med & Dent Univ, Dept Mol Pharmacol, Med Res Inst, 1-5-45 Yushima, Tokyo 1138510, Japan; [Notomi, Takuya; Noda, Masaki] Tokyo Med & Dent Univ, Global Ctr Excellence Program Mol Sci Tooth & Bon, Tokyo 1138510, Japan; [Notomi, Takuya; Hiyama, Akiko; Nozaki, Tadashige; Ohura, Kiyoshi] Osaka Dent Univ, Dept Pharmacol, Hirakata, Osaka 5731121, Japan; [Kuno, Miyuki] Osaka City Univ, Grad Sch Med, Dept Physiol, Abeno, Osaka 5458585, Japan; [Noda, Masaki] Yokohama City Minato Red Cross Hosp, Yokohama, Kanagawa 2318682, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Osaka Metropolitan University	Notomi, T; Noda, M (corresponding author), Tokyo Med & Dent Univ, Dept Mol Pharmacol, Med Res Inst, 1-5-45 Yushima, Tokyo 1138510, Japan.	notomi@cc.osaka-dent.ac.jp; noda.mph@mri.tmd.ac.jp	Ezura, Yoichi/L-9485-2016		Uehara Memorial Foundation; Nakatomi Foundation; Naito Foundation; Japan Society for the Promotion of Science [24119505, 25670638, 26282182, 26253085, 15K15558, 16K15655]	Uehara Memorial Foundation(Uehara Memorial Foundation); Nakatomi Foundation; Naito Foundation(Naito Memorial Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by grants from the Uehara Memorial Foundation, the Nakatomi Foundation, and the Naito Foundation and by Japan Society for the Promotion of Science Grants KAKENHI 24119505, 25670638, 26282182, 26253085, 15K15558, and 16K15655. The authors declare that they have no conflicts of interest with the contents of this article.	ANGELOFF LG, 1977, ACTA PHARMACOL TOX, V40, P209; Belluci MM, 2013, J NUTR BIOCHEM, V24, P1488, DOI 10.1016/j.jnutbio.2012.12.008; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cang CL, 2013, CELL, V152, P778, DOI 10.1016/j.cell.2013.01.023; Castiglioni S, 2013, NUTRIENTS, V5, P3022, DOI 10.3390/nu5083022; CLEMENTS RS, 1980, AM J CLIN NUTR, V33, P1954, DOI 10.1093/ajcn/33.9.1954; Dai ZJ, 2011, J BONE MINER RES, V26, P582, DOI 10.1002/jbmr.240; Galione A, 2010, BIOCHEM SOC T, V38, P1424, DOI 10.1042/BST0381424; Guo JT, 2017, P NATL ACAD SCI USA, V114, P1009, DOI 10.1073/pnas.1616191114; Jha A, 2014, EMBO J, V33, P501, DOI 10.1002/embj.201387035; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kubota T, 2003, BIOCHEM BIOPH RES CO, V303, P332, DOI 10.1016/S0006-291X(03)00346-2; Nieves JW, 2013, OSTEOPOROSIS INT, V24, P771, DOI 10.1007/s00198-012-2214-4; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Notomi T, 2001, J BONE MINER RES, V16, P166, DOI 10.1359/jbmr.2001.16.1.166; Notomi T, 2015, BONE, V81, P306, DOI 10.1016/j.bone.2015.07.031; Notomi T, 2015, J BONE MINER RES, V30, P1618, DOI 10.1002/jbmr.2507; Notomi T, 2014, BONE, V65, P42, DOI 10.1016/j.bone.2014.05.002; Notomi T, 2012, J BIOL CHEM, V287, P35057, DOI 10.1074/jbc.M111.328930; Parfitt A. M., 1980, CLIN DISORDERS FLUID, P947; Pitt SJ, 2010, J BIOL CHEM, V285, P35039, DOI 10.1074/jbc.M110.156927; Romani AMP, 2000, FRONT BIOSCI, V5, pD720, DOI 10.2741/Romani; Rude RK, 2009, J AM COLL NUTR, V28, P131, DOI 10.1080/07315724.2009.10719764; Seaborn CD, 2002, BIOL TRACE ELEM RES, V89, P239, DOI 10.1385/BTER:89:3:239; Shindo Y, 2015, BBA-MOL CELL RES, V1853, P3182, DOI 10.1016/j.bbamcr.2015.08.013; Smriti AAC, 2015, P NATL ACAD SCI USA, V112, P15432, DOI 10.1073/pnas.1518253112; Suzuki Y, 2002, ANAL CHEM, V74, P1423, DOI 10.1021/ac010914j; Swaminathan R, 2003, Clin Biochem Rev, V24, P47; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Wang X, 2012, CELL, V151, P372, DOI 10.1016/j.cell.2012.08.036; Yaman F, 2016, DRUG DES DEV THER, V10, P2081, DOI 10.2147/DDDT.S109271; Zhu MX, 2010, FEBS LETT, V584, P1966, DOI 10.1016/j.febslet.2010.02.028; Zolov SN, 2012, P NATL ACAD SCI USA, V109, P17472, DOI 10.1073/pnas.1203106109	34	11	11	4	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					20998	21010		10.1074/jbc.M117.780072	http://dx.doi.org/10.1074/jbc.M117.780072			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29084844	Green Published, hybrid			2022-12-26	WOS:000418453400016
J	Kupitz, D; Wetz, C; Wissel, H; Wedel, F; Apostolova, I; Wallbaum, T; Rieke, J; Amthauer, H; Grosser, OS				Kupitz, Dennis; Wetz, Christoph; Wissel, Heiko; Wedel, Florian; Apostolova, Ivayla; Wallbaum, Thekla; Rieke, Jens; Amthauer, Holger; Grosser, Oliver S.			Software-assisted dosimetry in peptide receptor radionuclide therapy with (177)Lutetium-DOTATATE for various imaging scenarios	PLOS ONE			English	Article							NEUROENDOCRINE TUMORS; INDIVIDUALIZED DOSIMETRY; QUANTITATIVE SPECT; NUCLEAR-MEDICINE; PLANAR; KIDNEY; LU-177-DOTATATE; GUIDANCE; IMPACT; LIVER	In peptide receptor radionuclide therapy (PRRT) of patients with neuroendocrine neoplasias (NENs), intratherapeutic dosimetry is mandatory for organs at risk (e.g. kidneys) and tumours. We evaluated commercial dosimetry software (Dosimetry Toolkit) using varying imaging scenarios, based on planar and/or tomographic data, regarding the differences in calculated organ/tumour doses and the use for clinical routines. A total of 16 consecutive patients with NENs treated by PRRT with Lu-177-DOTATATE were retrospectively analysed. Single-photon emission computed tomography (SPECT)/Iow-dose computed tomography (CT) of the thorax and abdomen and whole body (WB) scintigraphy were acquired up to 7 days p.i. (at a maximum of five imaging time points). Different dosimetric scenarios were evaluated: (1) a multi-SPECT-CT scenario using SPECT/CT only; (2) a planar scenario using WB scintigraphy only; and (3) a hybrid scenario using WB scintigraphy in combination with a single SPECT/low-dose CT. Absorbed doses for the kidneys, liver, spleen, lungs, bladder wall and tumours were calculated and compared for the three different scenarios. The mean absorbed dose for the kidneys estimated by the multi-SPECT-CT, the planar and the hybrid scenario was 0.5 +/- 0.2 Sv GBq(-1), 0.8 +/- 0.4 Sv GBq(-1) and 0.6 +/- 0.3 Sv GBq(-1), respectively. The absorbed dose for the residual organs was estimated higher by the planar scenario compared to the multi-SPECT-CT or hybrid scenario. The mean absorbed tumour doses were 2.6 +/- 1.5 Gy GBq(-1) for the multi-SPECT-CT, 3.1 +/- 2.2 Gy GBq(-1) for the hybrid scenario and 5.3 +/- 6.3 Gy GBq(-1) for the planar scenario. SPECT-based dosimetry methods determined significantly lower kidney doses than the WB scintigraphy-based method. Dosimetry based completely on SPECT data is time-consuming and tedious. Approaches combining SPECT/CT and WB scintigraphy have the potential to ensure compromise between accuracy and user-friendliness.	[Kupitz, Dennis; Wetz, Christoph; Wissel, Heiko; Apostolova, Ivayla; Wallbaum, Thekla; Rieke, Jens; Amthauer, Holger; Grosser, Oliver S.] Otto Von Guericke Univ, Univ Hosp Magdeburg AoR, Dept Radiol & Nucl Med, Magdeburg, Germany; [Wedel, Florian; Amthauer, Holger] Charite, Dept Nucl Med, Berlin, Germany; [Apostolova, Ivayla] Univ Med Ctr Hamburg UKE, Dept Nucl Med, Hamburg, Germany; [Rieke, Jens] Ludwig Maximilians Univ LMU, Dept Clin Radiol, Munich, Germany	Otto von Guericke University; University Hospital Magdeburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munich	Kupitz, D (corresponding author), Otto Von Guericke Univ, Univ Hosp Magdeburg AoR, Dept Radiol & Nucl Med, Magdeburg, Germany.	dennis.kupitz@med.ovga.de	Grosser, Oliver S./L-7574-2019	Grosser, Oliver S./0000-0002-0826-0734; Amthauer, Holger/0000-0003-4414-0657	GE Healthcare	GE Healthcare(General ElectricGE Healthcare)	Oliver S. Grosser and Holger Amthauer declare that they have received research grants by GE Healthcare. Dennis Kupitz, Christoph Wetz, Heiko Wissel, Florian Wedel, Ivayla Apostolova, Thekla Wallbaum and Jens Ricke declare that they have no conflicts of interest. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Berker Y, 2011, EUR J NUCL MED MOL I, V38, P2173, DOI 10.1007/s00259-011-1889-7; Bouchet LG, 2003, J NUCL MED, V44, P1113; Cremonesi M, 2010, Q J NUCL MED MOL IM, V54, P37; Cremonesi M, 2006, J NUCL MED, V47, P1467; de Nijs R, 2014, NUCL MED COMMUN, V35, P522, DOI 10.1097/MNM.0000000000000079; Delker A, 2015, MOL IMAGING BIOL, V17, P726, DOI 10.1007/s11307-015-0839-3; Dewaraja YK, 2012, J NUCL MED, V53, P1310, DOI 10.2967/jnumed.111.100123; EMAMI B, 1991, INT J RADIAT ONCOL, V21, P109, DOI 10.1016/0360-3016(91)90171-Y; Garkavij M, 2010, CANCER-AM CANCER SOC, V116, P1084, DOI 10.1002/cncr.24796; Grosser OS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138658; Gupta SK, 2013, CLIN NUCL MED, V38, P188, DOI 10.1097/RLU.0b013e3182814ac1; He B, 2010, PHYS MED BIOL, V55, P3535, DOI 10.1088/0031-9155/55/12/017; Healthcare GE, 2011, ORG DOS EST RAD IS T; Hindorf C, 2010, EUR J NUCL MED MOL I, V37, P1238, DOI 10.1007/s00259-010-1422-4; Howard DM, 2011, CANCER BIOTHER RADIO, V26, P615, DOI 10.1089/cbr.2011.0965; Ilan E, 2015, J NUCL MED, V56, P177, DOI 10.2967/jnumed.114.148437; Jackson PA, 2013, MED PHYS, V40, DOI 10.1118/1.4824318; King M, 2003, CANCER BIOTHER RADIO, V18, P181, DOI 10.1089/108497803765036346; Koral KF, 2006, METHODS PLANAR IMAGE, P414; Kwekkeboom DJ, 2001, EUR J NUCL MED, V28, P1319, DOI 10.1007/s002590100574; Kwekkeboom DJ, 2005, J NUCL MED, V46, p62S; Larsson M, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-49; Lassmann M, 2011, EUR J NUCL MED MOL I, V38, P192, DOI 10.1007/s00259-010-1549-3; Ljungberg M, 2016, J NUCL MED, V57, P151, DOI 10.2967/jnumed.115.159012; National Electrical Manufacturers Association, 2012, NEMA STAND PUBL, V1; Park S, 2006, RADIAT PROT DOSIM, V118, P275, DOI 10.1093/rpd/nci340; Pauwels S, 2005, J NUCL MED, V46, p92S; Sandstrom M, 2013, J NUCL MED, V54, P33, DOI 10.2967/jnumed.112.107524; Sandstrom M, 2010, EUR J NUCL MED MOL I, V37, P212, DOI 10.1007/s00259-009-1216-8; Siegel JA, 1999, J NUCL MED, V40, p37S; Stabin MG, 2005, J NUCL MED, V46, P1023; Stamm G, 2002, ROFO-FORTSCHR RONTG, V174, P1570, DOI 10.1055/s-2002-35937; Strosberg J, 2016, J NUCL MED, V57; Teunissen JJM, 2011, ENDOCR-RELAT CANCER, V18, pS27, DOI 10.1530/ERC-10-0282; Yu NC, 2013, INT J RADIAT ONCOL, V85, P834, DOI 10.1016/j.ijrobp.2012.06.051; Zaknun JJ, 2013, EUR J NUCL MED MOL I, V40, P800, DOI 10.1007/s00259-012-2330-6	36	16	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187570	10.1371/journal.pone.0187570	http://dx.doi.org/10.1371/journal.pone.0187570			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29107992	Green Published, Green Submitted, gold			2022-12-26	WOS:000414424600043
J	Sewing, S; Roth, AB; Winter, M; Dieckmann, A; Bertinetti-Lapatki, C; Tessier, Y; McGinnis, C; Huber, S; Koller, E; Ploix, C; Reed, JC; Singer, T; Rathfuss, A				Sewing, Sabine; Roth, Adrian B.; Winter, Michael; Dieckmann, Andreas; Bertinetti-Lapatki, Cristina; Tessier, Yann; McGinnis, Claudia; Huber, Sylwia; Koller, Erich; Ploix, Corinne; Reed, John C.; Singer, Thomas; Rathfuss, Andreas			Assessing single-stranded oligonucleotide drug-induced effects in vitro reveals key risk factors for thrombocytopenia	PLOS ONE			English	Article							HEPARIN-INDUCED THROMBOCYTOPENIA; ANTISENSE OLIGONUCLEOTIDES; PHOSPHOROTHIOATE OLIGONUCLEOTIDE; NONHUMAN-PRIMATES; ISIS 2302; TOXICITY; 2'-O-METHOXYETHYL; HEPATOTOXICITY; INHIBITION; ACTIVATION	Single-stranded oligonucleotides (ON) comprise a promising therapeutic platform that enables selective modulation of currently undruggable targets. The development of novel ON drug candidates has demonstrated excellent efficacy, but in certain cases also some safety liabilities were reported. Among them are events of thrombocytopenia, which have recently been evident in late stage trials with ON drugs. The underlying mechanisms are poorly understood and the risk for ON candidates causing such events cannot be sufficiently assessed pre-clinically. We investigated potential thrombocytopenia risk factors of ONs and implemented a set of in vitro assays to assess these risks. Our findings support previous observations that phosphorothioate (PS)-ONs can bind to platelet proteins such as platelet collagen receptor glycoprotein VI (GPVI) and activate human platelets in vitro to various extents. We also show that these PS-ONs can bind to platelet factor 4 (PF4). Binding to platelet proteins and subsequent activation correlates with ON length and connected to this, the number of PS in the backbone of the molecule. Moreover, we demonstrate that locked nucleic acid (LNA) ribosyl modifications in the wings of the PS-ONs strongly suppress binding to GPVI and PF4, paralleled by markedly reduced platelet activation. In addition, we provide evidence that PS-ONs do not directly affect hematopoietic cell differentiation in culture but at higher concentrations show a pro-inflammatory potential, which might contribute to platelet activation. Overall, our data confirm that certain molecular attributes of ONs are associated with a higher risk for thrombocytopenia. We propose that applying the in vitro assays discussed here during the lead optimization phase may aid in deprioritizing ONs with a potential to induce thrombocytopenia.	[Sewing, Sabine; Roth, Adrian B.; Winter, Michael; Dieckmann, Andreas; Bertinetti-Lapatki, Cristina; McGinnis, Claudia; Huber, Sylwia; Koller, Erich; Ploix, Corinne; Reed, John C.; Singer, Thomas; Rathfuss, Andreas] Roche Innovat Ctr Basel, Roche Pharma Res & Early Dev, Basel, Switzerland; [Tessier, Yann] Roche Innovat Ctr Copenhagen AS, Roche Pharma Res & Early Dev, Horsholm, Denmark	Roche Holding	Sewing, S (corresponding author), Roche Innovat Ctr Basel, Roche Pharma Res & Early Dev, Basel, Switzerland.	sabine.sewing@roche.com	Tessier, Yann/GVU-4446-2022					Andrews L, 2015, HUM EXP TOXICOL, V34, P1279, DOI 10.1177/0960327115603594; Antier N, 2014, ANN INTENSIVE CARE, V4, DOI 10.1186/s13613-014-0024-x; Arepally GM, 2000, BLOOD, V95, P1533, DOI 10.1182/blood.V95.5.1533.005k01_1533_1540; Arepally GM, 2010, ANNU REV MED, V61, P77, DOI 10.1146/annurev.med.042808.171814; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Brandt S, 2014, THROMB HAEMOSTASIS, V112, P53, DOI 10.1160/TH13-08-0634; Burdick AD, 2014, NUCLEIC ACIDS RES, V42, P4882, DOI 10.1093/nar/gku142; Burel SA, 2016, NUCLEIC ACIDS RES, V44, P2093, DOI 10.1093/nar/gkv1210; Cines DB, 2007, J CLIN APHERESIS, V22, P31, DOI 10.1002/jca.20109; Crooke S.T., 2008, ANTISENSE DRUG TECHN, P327; Crooke ST, 2017, NUCLEIC ACID THER, V27, P121, DOI 10.1089/nat.2016.0650; Crooke ST, 2016, MOL THER, V24, P1771, DOI 10.1038/mt.2016.136; Flierl U, 2015, J EXP MED, V212, P130, DOI 10.1084/jem.20140391; Frazier KS, 2015, TOXICOL PATHOL, V43, P78, DOI 10.1177/0192623314551840; Ghasemzadeh M, 2013, THROMB RES, V131, P191, DOI 10.1016/j.thromres.2012.11.028; Graham MJ, 2013, CIRC RES, V112, P1479, DOI 10.1161/CIRCRESAHA.111.300367; Henry S, 2000, J PHARMACOL EXP THER, V292, P468; Henry SP, 2016, NUCLEIC ACID THER, V26, P210, DOI 10.1089/nat.2015.0593; Henry SP, 1997, ANTISENSE NUCLEIC A, V7, P473, DOI 10.1089/oli.1.1997.7.473; Henry SP, 1997, TOXICOLOGY, V120, P145, DOI 10.1016/S0300-483X(97)03661-5; Huang YY, 2017, MOL THER-NUCL ACIDS, V6, P116, DOI 10.1016/j.omtn.2016.12.003; Jaax ME, 2013, BLOOD, V122, P272, DOI 10.1182/blood-2013-01-478966; Jung SM, 2012, J BIOL CHEM, V287, P30000, DOI 10.1074/jbc.M112.359125; Kakiuchi-Kiyota S, 2016, NUCLEIC ACID THER, V26, P93, DOI 10.1089/nat.2015.0576; Koch T, 2013, CURR PHYS CHEM, V3, P55, DOI DOI 10.2174/1877946811303010009; Mangsbo SM, 2009, J IMMUNOL, V183, P6724, DOI 10.4049/jimmunol.0902374; Miura Y, 2002, J BIOL CHEM, V277, P46197, DOI 10.1074/jbc.M204029200; Moisan A, 2017, MOL THER-NUCL ACIDS, V6, P89, DOI 10.1016/j.omtn.2016.11.006; Nguyen TH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14945; Olaharski AJ, 2009, TOXICOL LETT, V188, P98, DOI 10.1016/j.toxlet.2009.03.012; Petrucci D ED, 2016, ANTISENSE OLIGONUCLE; Rich IN, 2007, EXPERT OPIN DRUG MET, V3, P295, DOI 10.1517/17425255.3.2.295; Senn JJ, 2005, J PHARMACOL EXP THER, V314, P972, DOI 10.1124/jpet.105.084004; Seth PP, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.34; Sewing S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159431; Sheehan JP, 1998, BLOOD, V92, P1617, DOI 10.1182/blood.V92.5.1617.417k13_1617_1625; Staibano P, 2017, BR J HAEMATOL; Stein CA, 1997, ANTISENSE NUCLEIC A, V7, P207, DOI 10.1089/oli.1.1997.7.207; Warkentin TE, 2003, BRIT J HAEMATOL, V121, P535, DOI 10.1046/j.1365-2141.2003.04334.x; Warkentin TE, 2007, NEW ENGL J MED, V356, P891, DOI 10.1056/NEJMp068309	40	20	20	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187574	10.1371/journal.pone.0187574	http://dx.doi.org/10.1371/journal.pone.0187574			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29107969	gold, Green Published, Green Submitted			2022-12-26	WOS:000414424600044
J	Huh, MS; Young, KG; Yan, KQ; Price-O'Dea, T; Picketts, DJ				Huh, Michael S.; Young, Kevin G.; Yan, Keqin; Price-O'Dea, Tina; Picketts, David J.			Recovery from impaired muscle growth arises from prolonged postnatal accretion of myonuclei in Atrx mutant mice	PLOS ONE			English	Article							X SYNDROME PROTEIN; SKELETAL-MUSCLE; STEM-CELLS; HISTONE CHAPERONE; SELF-RENEWAL; HYPERTROPHY; EXPRESSION; DAXX; DYSFUNCTION; SURVIVAL	Reduced muscle mass due to pathological development can occur through several mechanisms, including the loss or reduced proliferation of muscle stem cells. Muscle-specific ablation of the alpha-thalassemia mental retardation syndrome mutant protein, Atrx, in transgenic mice results in animals with a severely reduced muscle mass at three weeks of age; yet this muscle mass reduction resolves by adult age. Here, we explore the cellular mechanism underlying this effect. Analysis of Atrx mutant mice included testing for grip strength and rotorod performance. Muscle fiber length, fiber volume and numbers of myofiber-associated nuclei were determined from individual EDL or soleus myofibers isolated at three, five, or eight weeks. Myofibers from three week old Atrx mutant mice are smaller with fewer myofiber-associated nuclei and reduced volume compared to control animals, despite similar fiber numbers. Nonetheless, the grip strength of/tomutant mice was comparable to control mice when adjusted for body weight. Myofiber volume remained smaller at five weeks, becoming comparable to controls by 8 weeks of age. Concomitantly, increased numbers of myofiber-associated nuclei and Ki67(+) myoblasts indicated that the recovery of muscle mass likely arises from the prolonged accretion of new myonuclei. This suggests that under disease conditions the muscle satellite stem cell niche can remain in a prolonged active state, allowing for the addition of a minimum number of myonuclei required to achieve a normal muscle size.	[Huh, Michael S.; Young, Kevin G.; Yan, Keqin; Price-O'Dea, Tina; Picketts, David J.] Ottawa Hosp Res Inst, Regenerat Med Program, 501 Smyth Rd, Ottawa, ON, Canada; [Picketts, David J.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Picketts, David J.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa	Picketts, DJ (corresponding author), Ottawa Hosp Res Inst, Regenerat Med Program, 501 Smyth Rd, Ottawa, ON, Canada.; Picketts, DJ (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.; Picketts, DJ (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada.	dpicketts@ohri.ca			Canadian Institutes of Health Research [MOP-133586]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/37788.html), MOP-133586 (DJP).	Albini S, 2010, EXP CELL RES, V316, P3073, DOI 10.1016/j.yexcr.2010.05.023; Berube NG, 2005, J CLIN INVEST, V115, P258, DOI 10.1172/JCI200522329; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Dumont NA, 2015, NAT MED, V21, P1455, DOI 10.1038/nm.3990; Egner IM, 2016, DEVELOPMENT, V143, P2898, DOI 10.1242/dev.134411; Ferdousi LV, 2014, STEM CELL RES, V13, P492, DOI 10.1016/j.scr.2014.08.005; Frese S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132099; Fujimaki S, 2014, J BIOL CHEM, V289, P7399, DOI 10.1074/jbc.M113.539247; Gibbons R, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-15; GIBBONS RJ, 1995, AM J MED GENET, V55, P288, DOI 10.1002/ajmg.1320550309; Goh Q, 2017, ELIFE, V6, DOI 10.7554/eLife.20007; Huh MS, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.121; Huh MS, 2012, J CLIN INVEST, V122, P4412, DOI 10.1172/JCI63765; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Lagali PS, 2016, HUM MOL GENET, V25, P4787, DOI 10.1093/hmg/ddw306; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; Lee SJ, 2012, P NATL ACAD SCI USA, V109, pE2353, DOI 10.1073/pnas.1206410109; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Nogami T, 2011, HIPPOCAMPUS, V21, P678, DOI 10.1002/hipo.20782; Otis JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092363; Seale P, 2001, DEV CELL, V1, P333, DOI 10.1016/S1534-5807(01)00049-1; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Servian-Morilla E, 2016, EMBO MOL MED, V8, P1289, DOI 10.15252/emmm.201505815; Sharples AP, 2016, BIOGERONTOLOGY, V17, P603, DOI 10.1007/s10522-015-9604-x; Tang J, 2004, J BIOL CHEM, V279, P20369, DOI 10.1074/jbc.M401321200; Watson LA, 2013, J CLIN INVEST, V123, P2049, DOI 10.1172/JCI65634; White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100; Zalc A, 2014, DEVELOPMENT, V141, P2780, DOI 10.1242/dev.110155	30	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186989	10.1371/journal.pone.0186989	http://dx.doi.org/10.1371/journal.pone.0186989			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095838	gold, Green Published, Green Submitted			2022-12-26	WOS:000414340200037
J	Korf, H; Breser, L; Van Hoeck, J; Godoy, J; Cook, DP; Stijlemans, B; De Smidt, E; Moyson, C; Cunha, JPMCM; Rivero, V; Gysemans, C; Mathieu, C				Korf, Hannelie; Breser, Laura; Van Hoeck, Jelter; Godoy, Janet; Cook, Dana P.; Stijlemans, Benoit; De Smidt, Elien; Moyson, Carolien; Cunha, Joao Paulo Monteiro Carvalho Mori; Rivero, Virginia; Gysemans, Conny; Mathieu, Chantal			MIF inhibition interferes with the inflammatory and T cell-stimulatory capacity of NOD macrophages and delays autoimmune diabetes onset	PLOS ONE			English	Article							TAUTOMERASE ACTIVE-SITE; CYTOKINE PRODUCTION; REGULATORY ROLE; IMMUNE-RESPONSE; SEVERE SEPSIS; SERUM-LEVELS; MICE; ACTIVATION; BETA; RECRUITMENT	Macrophages contribute in the initiation and progression of insulitis during type 1 diabetes (T1D). However, the mechanisms governing their recruitment into the islets as well as the manner of retention and activation are incompletely understood. Here, we investigated a role for macrophage migration inhibitory factor (MIF) and its transmembrane receptor, CD74, in the progression of T1D. Our data indicated elevated MIF concentrations especially in long-standing T1D patients and mice. Additionally, NOD mice featured increased MIF gene expression and CD74(+) leukocyte frequencies in the pancreas. We identified F4/80(+) macrophages as the main immune cells in the pancreas expressing CD74 and showed that MIF antagonism of NOD macrophages prevented their activation-induced cytokine production. The physiological importance was highlighted by the fact that inhibition of MIF delayed the onset of autoimmune diabetes in two different diabetogenic T cell transfer models. Mechanistically, macrophages pre-conditioned with the MIF inhibitor featured a refractory capacity to trigger T cell activation by keeping them in a naive state. This study underlines a possible role for MIF/CD74 signaling pathways in promoting macrophage-mediated inflammation in T1D. As therapies directed at the MIF/CD74 pathway are in clinical development, new opportunities may be proposed for arresting T1D progression.	[Korf, Hannelie; Van Hoeck, Jelter; Cook, Dana P.; De Smidt, Elien; Moyson, Carolien; Cunha, Joao Paulo Monteiro Carvalho Mori; Gysemans, Conny; Mathieu, Chantal] Katholieke Univ Leuven, Dept Chron Dis Metab & Ageing CHROMETA, Lab Clin & Expt Endocrinol CEE, Leuven, Belgium; [Breser, Laura; Godoy, Janet; Rivero, Virginia] Natl Univ Cordoba, Dept Clin Biochem, Ctr Res Clin Biochem & Immunol, Cordoba, Argentina; [Stijlemans, Benoit] Vrije Univ Brussel, Lab Cellular & Mol Immunol, Brussels, Belgium; [Stijlemans, Benoit] VIB Ctr Inflammat Res Brussels, Myeloid Cell Immunol Lab, Brussels, Belgium; [Korf, Hannelie] Katholieke Univ Leuven, Dept Chron Dis Metab & Ageing CHROMETA, Lab Hepatol, Leuven, Belgium	KU Leuven; National University of Cordoba; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); KU Leuven	Korf, H (corresponding author), Katholieke Univ Leuven, Dept Chron Dis Metab & Ageing CHROMETA, Lab Clin & Expt Endocrinol CEE, Leuven, Belgium.; Korf, H (corresponding author), Katholieke Univ Leuven, Dept Chron Dis Metab & Ageing CHROMETA, Lab Hepatol, Leuven, Belgium.	hannelie.korf@kuleuven.be	Breser, Maria Laura/AAW-5618-2020; mathieu, chantal/ABD-5505-2021; da Cunha, João Paulo Monteiro Carvalho Mori/M-3310-2017; Stijlemans, Benoit/AAD-9122-2021	mathieu, chantal/0000-0002-4055-5233; da Cunha, João Paulo Monteiro Carvalho Mori/0000-0002-0749-6534; Stijlemans, Benoit/0000-0003-0082-9751; gysemans, conny/0000-0003-3559-6089; Korf, Hannelie/0000-0003-3540-0138; Van Hoeck, Jelter/0000-0003-0493-863X; Breser, Maria Laura/0000-0001-7803-2051	Flemish Research Foundation (Fonds Voor Wetenschappelijk Onderzoek Vlaanderen) [G.0649.08, G.0734.10, 1.5.118.13]; Belgium Program on Interuniversity Poles of Attraction initiated by the Belgian State [P6/40]; Katholieke Universiteit Leuven [GOA 2009/10, GOA 14/010]; seventh Framework Program of the European Union; Diabetes Fonds Nederland (DFN Expert Center Beta Cell Immunoprotection); Strategic Research Program (SRP3, VUB); N.V. Medtronic Belgium	Flemish Research Foundation (Fonds Voor Wetenschappelijk Onderzoek Vlaanderen)(FWO); Belgium Program on Interuniversity Poles of Attraction initiated by the Belgian State(Belgian Federal Science Policy Office); Katholieke Universiteit Leuven(KU Leuven); seventh Framework Program of the European Union(European Commission); Diabetes Fonds Nederland (DFN Expert Center Beta Cell Immunoprotection); Strategic Research Program (SRP3, VUB); N.V. Medtronic Belgium	This work was supported by grants from the Flemish Research Foundation (Fonds Voor Wetenschappelijk Onderzoek Vlaanderen G.0649.08, G.0734.10 and 1.5.118.13N, a doctoral fellowhip to D.P.C., a postdoctoral fellowship to H. K., and a clinical fellowship to C.M.), the Belgium Program on Interuniversity Poles of Attraction initiated by the Belgian State (P6/40), the Katholieke Universiteit Leuven (GOA 2009/10 and GOA 14/010), the seventh Framework Program of the European Union with Natural Immunomodulators as Novel Immunotherapies for Type 1 Diabetes and the Diabetes Fonds Nederland (DFN Expert Center Beta Cell Immunoprotection) and N.V. Medtronic Belgium. B.S. was supported by the Strategic Research Program (SRP3, VUB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by grants from the Flemish Research Foundation (Fonds Voor Wetenschappelijk Onderzoek Vlaanderen G.0649.08, G.0734.10 and 1.5.118.13N, a doctoral fellowhip to D. P.C., a postdoctoral fellowship to H.K., and a clinical fellowship to CM.), the Belgium Program on Interuniversity Poles of Attraction initiated by the Belgian State (P6/40), the Katholieke Universiteit Leuven (GOA 2009/10 and GOA 14/010), the seventh Framework Program of the European Union with Natural Immunomodulators as Novel Immunotherapies for Type 1 Diabetes and the Diabetes Fonds Nederland (DFN Expert Center Beta Cell Immunoprotection) and N.V. Medtronic Belgium. BS was supported by the Strategic Research Program (SRP3, VUB). The technical experience of Karolien Ciotkowski, Jos Laureys and Martin Gillis (Laboratory of Clinical and Experimental Endocrinology, Katholieke Universiteit Leuven, Belgium) is greatly appreciated. No conflict of interest to be disclosed.	Abeles D, 2012, CYTOM PART A, V81A, P823, DOI 10.1002/cyto.a.22104; Al-Abed Y, 2005, J BIOL CHEM, V280, P36541, DOI 10.1074/jbc.C500243200; Al-Abed Y, 2011, FUTURE MED CHEM, V3, P45, DOI 10.4155/FMC.10.281; Alleva DG, 2000, DIABETES, V49, P1106, DOI 10.2337/diabetes.49.7.1106; Bacher M, 1996, P NATL ACAD SCI USA, V93, P7849, DOI 10.1073/pnas.93.15.7849; Baeke F, 2012, DIABETOLOGIA, V55, P2723, DOI 10.1007/s00125-012-2630-1; Bai FW, 2012, J BIOL CHEM, V287, P30653, DOI 10.1074/jbc.M112.385583; Ben Nasr M, 2016, ATHEROSCLEROSIS, V251, P512, DOI 10.1016/j.atherosclerosis.2016.06.025; Ben Nasr M, 2015, PHARMACOL RES, V98, P31, DOI 10.1016/j.phrs.2014.07.004; Benedek G, 2013, EUR J IMMUNOL, V43, P1309, DOI 10.1002/eji.201243162; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bozza Marcelo T, 2012, J Parasitol Res, V2012, P413052, DOI 10.1155/2012/413052; Bucala R, 2013, J CLIN IMMUNOL, V33, pS72, DOI 10.1007/s10875-012-9781-1; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Calderon B, 2006, AM J PATHOL, V169, P2137, DOI 10.2353/ajpath.2006.060539; Cantor J, 2007, J IMMUNOL, V179, P5760, DOI 10.4049/jimmunol.179.9.5760; Cvetkovic I, 2005, ENDOCRINOLOGY, V146, P2942, DOI 10.1210/en.2004-1393; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fan HP, 2011, J IMMUNOL, V186, P4915, DOI 10.4049/jimmunol.1003713; Ferris ST, 2014, IMMUNITY, V41, P657, DOI 10.1016/j.immuni.2014.09.012; Fiorina P, 2008, DIABETES, V57, P3013, DOI 10.2337/db08-0420; Franchimont D, 2004, ANN NY ACAD SCI, V1024, P124, DOI 10.1196/annals.1321.009; Gerber JS, 2001, J IMMUNOL, V166, P6861, DOI 10.4049/jimmunol.166.11.6861; Gregory JL, 2004, ARTHRITIS RHEUM-US, V50, P3023, DOI 10.1002/art.20470; Gregory JL, 2006, J IMMUNOL, V177, P8072, DOI 10.4049/jimmunol.177.11.8072; Hoi Alberta Y., 2007, Inflammation & Allergy Drug Targets, V6, P183, DOI 10.2174/187152807781696455; Honda K, 2000, NEPHRON, V86, P91, DOI 10.1159/000045719; HUTCHINGS P, 1990, NATURE, V348, P639, DOI 10.1038/348639a0; JANSEN A, 1994, DIABETES, V43, P667, DOI 10.2337/diabetes.43.5.667; Jun HS, 1999, DIABETES, V48, P34, DOI 10.2337/diabetes.48.1.34; Jun HS, 1999, J EXP MED, V189, P347, DOI 10.1084/jem.189.2.347; Korf H, 2012, IMMUNOBIOLOGY, V217, P1292, DOI 10.1016/j.imbio.2012.07.018; Korf J, 2005, EUR J IMMUNOL, V35, P890, DOI 10.1002/eji.200425332; Lehmann LE, 2001, INTENS CARE MED, V27, P1412, DOI 10.1007/s001340101022; Lehuen A, 2010, NAT REV IMMUNOL, V10, P501, DOI 10.1038/nri2787; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Lubetsky JB, 2002, J BIOL CHEM, V277, P24976, DOI 10.1074/jbc.M203220200; Martin AP, 2008, DIABETES, V57, P3025, DOI 10.2337/db08-0625; Mitchell RA, 1999, J BIOL CHEM, V274, P18100, DOI 10.1074/jbc.274.25.18100; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Mizue Y, 2000, INT J MOL MED, V5, P397; Morand EF, 2006, NAT REV DRUG DISCOV, V5, P399, DOI 10.1038/nrd2029; Morrison MC, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00308; NAUJOKAS MF, 1993, CELL, V74, P257, DOI 10.1016/0092-8674(93)90417-O; Nishihira J, 2012, ANN NY ACAD SCI, V1271, P53, DOI 10.1111/j.1749-6632.2012.06735.x; Ogawa Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065211; Onodera S, 1999, CYTOKINE, V11, P163, DOI 10.1006/cyto.1998.0402; Ouertatani-Sakouhi H, 2010, J BIOL CHEM, V285, P26581, DOI 10.1074/jbc.M110.113951; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Santos LL, 2011, ARTHRITIS RHEUM-US, V63, P960, DOI 10.1002/art.30203; SERREZE DV, 1993, P NATL ACAD SCI USA, V90, P9625, DOI 10.1073/pnas.90.20.9625; Shimizu T, 2001, J INVEST DERMATOL, V116, P989, DOI 10.1046/j.0022-202x.2001.01366.x; Stoffels K, 2004, J AUTOIMMUN, V23, P9, DOI 10.1016/j.jaut.2004.03.012; Stosic-Grujicic S, 2008, J CELL PHYSIOL, V215, P665, DOI 10.1002/jcp.21346; Toso C, 2008, DIABETOLOGIA, V51, P1937, DOI 10.1007/s00125-008-1063-3; Vergani A, 2010, DIABETES, V59, P2253, DOI 10.2337/db09-1264; Xu L, 2014, J MED CHEM, V57, P3737, DOI 10.1021/jm401908w	60	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187455	10.1371/journal.pone.0187455	http://dx.doi.org/10.1371/journal.pone.0187455			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095944	gold, Green Published, Green Submitted			2022-12-26	WOS:000414340200093
J	Park, JH; Kim, CS; Won, KS; Oh, JS; Kim, JS; Kim, HW				Park, Jae Hyun; Kim, Chun Soo; Won, Kyoung Sook; Oh, Jungsu S.; Kim, Jae Seung; Kim, Hae Won			Asymmetry of cerebral glucose metabolism in very low-birth-weight infants without structural abnormalities	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; PRETERM INFANTS; WHITE-MATTER; NEURODEVELOPMENTAL OUTCOMES; FDG-PET; PALSY; PREMATURITY; PREDICT; BRAIN; MRI	Even when structural abnormalities are not observed on the brain magnetic resonance images (MRI) of very low-birth-weight (VLBW) infants, such infants are at increased risk for poor neurodevelopment. The aim of the present study was to evaluate cerebral glucose metabolism in VLBW infants without apparent structural abnormalities on MRI. Methods Thirty-six VLBW infants who underwent F-18 fluorodeoxyglucose (F-18 FDG) brain PET and MRI were prospectively enrolled, while infants with evidence of parenchymal brain injury on MRI were excluded. The regional glucose metabolic ratio and asymmetry index were calculated. The asymmetry index more than 10% (right > left asymmetry) or less than-10% (left > right asymmetry) were defined as abnormal. Regional cerebral glucose metabolism were compared between right and left cerebral hemispheres, and between the following subgroups: multiple gestations, premature rupture of membrane, bronchopulmonary dysplasia, and low-grade intraventricular hemorrhage. Results In the individual analysis, 21 (58.3%) of 36 VLBW infants exhibited asymmetric cerebral glucose metabolism. Fifteen infants (41.7%) exhibited right > left asymmetry, while six (16.7%) exhibited left > right asymmetry. In the regional analysis, right > left asymmetry was more extensive than left > right asymmetry. The metabolic ratio in the right frontal, temporal, and occipital cortices and right thalamus were significantly higher than those in the corresponding left regions. In the subgroup analyses, the cerebral glucose metabolism in infants with multiple gestations, premature rupture of membrane, bronchopulmonary dysplasia, or low-grade intraventricular hemorrhage were significantly lower than those in infants without these. Conclusion VLBW infants without structural abnormalities have asymmetry of cerebral glucose metabolism. Decreased cerebral glucose metabolism are noted in infants with neurodevelopmental risk factors. F-18 FDG PET could show microstructural abnormalities not detected by MRI in VLBW infants.	[Park, Jae Hyun; Kim, Chun Soo] Keimyung Univ, Dongsan Med Ctr, Dept Pediat, Daegu, South Korea; [Won, Kyoung Sook; Kim, Hae Won] Keimyung Univ, Dongsan Med Ctr, Dept Nucl Med, Daegu, South Korea; [Oh, Jungsu S.; Kim, Jae Seung] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Nucl Med, Seoul, South Korea	Keimyung University; Keimyung University; University of Ulsan; Asan Medical Center	Kim, HW (corresponding author), Keimyung Univ, Dongsan Med Ctr, Dept Nucl Med, Daegu, South Korea.	hwkim.nm@gmail.com			Keimyung University Dongsan Medical Center; National Research Foundation of Korea (NRF) - Korea Government (MSIP) [2014R1A5A2010008]	Keimyung University Dongsan Medical Center; National Research Foundation of Korea (NRF) - Korea Government (MSIP)	This work was supported by a research promoting grant from the Keimyung University Dongsan Medical Center in 2014 and by a National Research Foundation of Korea (NRF) grant funded by the Korea Government (MSIP) (no. 2014R1A5A2010008).	AHNSJO S, 1955, Nord Med, V54, P1657; ALTMAN DI, 1991, CLIN PERINATOL, V18, P549, DOI 10.1016/S0095-5108(18)30512-8; Bax M, 2006, JAMA-J AM MED ASSOC, V296, P1602, DOI 10.1001/jama.296.13.1602; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Behrman RE, 2007, I MED COMMITTEE UNDE; Chetelat G, 2003, NEUROLOGY, V60, P1374, DOI 10.1212/01.WNL.0000055847.17752.E6; CHUGANI HT, 1993, CLIN PERINATOL, V20, P395, DOI 10.1016/S0095-5108(18)30400-7; Degani S, 2008, GYNECOL OBSTET INVES, V66, P184, DOI 10.1159/000143157; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Hayakawa M, 2014, PEDIATR INT, V56, P215, DOI 10.1111/ped.12233; Higuchi Y, 1997, EUR J PEDIATR, V156, P236, DOI 10.1007/s004310050591; Ivancevic V, 2000, CLIN NUCL MED, V25, P596; KERRIGAN JF, 1991, PEDIATR NEUROL, V7, P415, DOI 10.1016/0887-8994(91)90024-F; Khwaja O, 2008, ARCH DIS CHILD-FETAL, V93, pF153, DOI 10.1136/adc.2006.108837; Korzeniewski SJ, 2008, J CHILD NEUROL, V23, P216, DOI 10.1177/0883073807307983; Leitner Y, 2014, NEURORADIOLOGY, V56, P669, DOI 10.1007/s00234-014-1373-8; Linsell L, 2015, JAMA PEDIATR, V169, P1162, DOI 10.1001/jamapediatrics.2015.2175; Lodha A, 2009, DEV MED CHILD NEUROL, V51, P895, DOI 10.1111/j.1469-8749.2009.03284.x; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; McClure MM, 2008, J CEREBR BLOOD F MET, V28, P995, DOI 10.1038/sj.jcbfm.9600597; Mikolajczyk K, 1998, MED INFORM, V23, P207, DOI 10.3109/14639239809001400; Msall ME, 2008, SEMIN PERINATOL, V32, P42, DOI 10.1053/j.semperi.2007.12.006; Nelson KB, 2015, NEW ENGL J MED, V373, P946, DOI 10.1056/NEJMra1505261; Ruotsalainen U, 1996, J NUCL MED, V37, P387; Schmahmann JD, 2008, ANN NY ACAD SCI, V1142, P266, DOI 10.1196/annals.1444.017; Shen XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039256; Shi Y, 2009, EARLY HUM DEV, V85, P429, DOI 10.1016/j.earlhumdev.2009.02.002; Silverman DHS, 2004, J NUCL MED, V45, P594; Son SM, 2007, NEUROSCI LETT, V420, P34, DOI 10.1016/j.neulet.2007.04.054; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Volpe JJ, 2005, PEDIATRICS, V116, P221, DOI 10.1542/peds.2005-0191; Wilke M, 2007, J NEUROSCI METH, V163, P128, DOI 10.1016/j.jneumeth.2007.01.026; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792; Xia T, 2012, PHYS MED BIOL, V57, P309, DOI 10.1088/0031-9155/57/2/309; Xiong T, 2012, WORLD J PEDIATR, V8, P293, DOI 10.1007/s12519-012-0372-2; Zeng Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023621	36	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186976	10.1371/journal.pone.0186976	http://dx.doi.org/10.1371/journal.pone.0186976			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095842	Green Published, gold, Green Submitted			2022-12-26	WOS:000414340200035
J	Pochon, X; Zaiko, A; Fletcher, LM; Laroche, O; Wood, SA				Pochon, Xavier; Zaiko, Anastasija; Fletcher, Lauren M.; Laroche, Olivier; Wood, Susanna A.			Wanted dead or alive? Using metabarcoding of environmental DNA and RNA to distinguish living assemblages for biosecurity applications	PLOS ONE			English	Article							BALLAST WATER; EXTRACELLULAR DNA; RISK-ASSESSMENT; RIBOSOMAL-RNA; BIODIVERSITY; COMMUNITIES; RARE; VESSELS; IMPACTS; SPREAD	High-throughput sequencing metabarcoding studies in marine biosecurity have largely focused on targeting environmental DNA (eDNA). DNA can persist extracellularly in the environment, making discrimination of living organisms difficult. In this study, bilge water samples (i.e., water accumulating on-board a vessel during transit) were collected from 15 small recreational and commercial vessels. eDNA and eRNA molecules were co-extracted and the V4 region of the 18S ribosomal RNA gene targeted for metabarcoding. In total, 62.7% of the Operational Taxonomic Units (OTUs) were identified at least once in the corresponding eDNA and eRNA reads, with 19.5% unique to eDNA and 17.7% to eRNA. There were substantial differences in diversity between molecular compartments; 57% of sequences from eDNA-only OTUs belonged to fungi, likely originating from legacy DNA. In contrast, there was a higher percentage of metazoan (50.2%) and ciliate (31.7%) sequences in the eRNA-only OTUs. Our data suggest that the presence of eRNA-only OTUs could be due to increased cellular activities of some rare taxa that were not identified in the eDNA datasets, unusually high numbers of rRNA transcripts in ciliates, and/or artefacts produced during the reverse transcriptase, PCR and sequencing steps. The proportions of eDNA/eRNA shared and unshared OTUs were highly heterogeneous within individual bilge water samples. Multiple factors including boat type and the activities performed on-board, such as washing of scientific equipment, may play a major role in contributing to this variability. For some marine biosecurity applications analysis, eDNA-only data may be sufficient, however there are an increasing number of instances where distinguishing the living portion of a community is essential. For these circumstances, we suggest only including OTUs that are present in both eDNA and eRNA data. OTUs found only in the eRNA data need to be interpreted with caution until further research provides conclusive evidence for their origin.	[Pochon, Xavier; Zaiko, Anastasija; Fletcher, Lauren M.; Laroche, Olivier; Wood, Susanna A.] Cawthron Inst, Coastal & Freshwater Grp, Nelson, New Zealand; [Pochon, Xavier; Zaiko, Anastasija] Univ Auckland, Inst Marine Sci, Auckland, New Zealand; [Zaiko, Anastasija] Klaipeda Univ, Marine Sci & Technol Ctr, Klaipeda, Lithuania; [Wood, Susanna A.] Univ Waikato, Environm Res Inst, Hamilton, New Zealand	Cawthron Institute; University of Auckland; Klaipeda University; University of Waikato	Pochon, X (corresponding author), Cawthron Inst, Coastal & Freshwater Grp, Nelson, New Zealand.; Pochon, X (corresponding author), Univ Auckland, Inst Marine Sci, Auckland, New Zealand.	xavier.pochon@cawthron.org.nz	Pochon, Xavier/K-5844-2019	Pochon, Xavier/0000-0001-9510-0407	National Institute of Water and Atmospheric Research Ltd under Coasts and Oceans Research Programme 6, Marine Biosecurity	National Institute of Water and Atmospheric Research Ltd under Coasts and Oceans Research Programme 6, Marine Biosecurity	This work was supported by the National Institute of Water and Atmospheric Research Ltd under Coasts and Oceans Research Programme 6, Marine Biosecurity (SCI 2016/17). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta H, 2009, ECOL MODEL, V220, P1586, DOI 10.1016/j.ecolmodel.2009.03.026; Barnes MA, 2016, CONSERV GENET, V17, P1, DOI 10.1007/s10592-015-0775-4; Brown EA, 2016, DIVERS DISTRIB, V22, P1045, DOI 10.1111/ddi.12465; Brown SP, 2015, FUNGAL ECOL, V13, P221, DOI 10.1016/j.funeco.2014.08.006; Capo E, 2015, MICROB ECOL, V70, P865, DOI 10.1007/s00248-015-0627-2; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen H., 2016, VENNDIAGRAM GENERATE; Clarke K. R., 2001, CHANGES MARINE COMMU; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cocquet J, 2006, GENOMICS, V88, P127, DOI 10.1016/j.ygeno.2005.12.013; Comtet T, 2015, BIOL INVASIONS, V17, P905, DOI 10.1007/s10530-015-0854-y; Corinaldesi C, 2008, MOL ECOL, V17, P3939, DOI 10.1111/j.1365-294X.2008.03880.x; Cristescu ME, 2014, TRENDS ECOL EVOL, V29, P566, DOI 10.1016/j.tree.2014.08.001; Cullen JJ, 2016, J APPL PHYCOL, V28, P279, DOI 10.1007/s10811-015-0601-x; Darbyson Emily, 2009, Aquatic Invasions, V4, P87, DOI 10.3391/ai.2009.4.1.9; Darling JA, 2007, BIOL INVASIONS, V9, P751, DOI 10.1007/s10530-006-9079-4; Darling JA, 2018, J SEA RES, V133, P43, DOI 10.1016/j.seares.2017.02.005; Dell'Anno A, 2005, SCIENCE, V309, P2179, DOI 10.1126/science.1117475; Doblin MA, 2007, HARMFUL ALGAE, V6, P519, DOI 10.1016/j.hal.2006.05.007; Dodgshun TJ., 2007, HUMAN MEDIATED PATHW; Dowle E, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv089; Edgar RC, 2015, BIOINFORMATICS, V31, P3476, DOI 10.1093/bioinformatics/btv401; Ficetola GF, 2015, MOL ECOL RESOUR, V15, P543, DOI 10.1111/1755-0998.12338; Fitridge I, 2012, BIOFOULING, V28, P649, DOI 10.1080/08927014.2012.700478; Fletcher LM, 2017, BIOL INVASIONS, V19, P2851, DOI 10.1007/s10530-017-1489-y; Fletcher LM, 2013, AQUACULT ENV INTERAC, V4, P17, DOI 10.3354/aei00069; Galil BS, 2002, INVASIVE AQUATIC SPECIES OF EUROPE: DISTRIBUTION, IMPACTS AND MANAGEMENT, P325; Gollasch S, 2002, BIOFOULING, V18, P105, DOI 10.1080/08927010290011361; Gollasch S, 2007, HARMFUL ALGAE, V6, P585, DOI 10.1016/j.hal.2006.12.009; Gong J, 2013, PROTIST, V164, P369, DOI 10.1016/j.protis.2012.11.006; Goodwin S, 2016, NAT REV GENET, V17, P333, DOI 10.1038/nrg.2016.49; Guillou L, 2013, NUCLEIC ACIDS RES, V41, pD597, DOI 10.1093/nar/gks1160; Hajibabaei M, 2012, TRENDS GENET, V28, P535, DOI 10.1016/j.tig.2012.08.001; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Harvey CT, 2009, DIVERS DISTRIB, V15, P429, DOI 10.1111/j.1472-4642.2008.00550.x; Hosler DM, 2011, AQUAT INVASIONS, V6, P217, DOI 10.3391/ai.2011.6.2.10; Houseley J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012271; Hu SK, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw050; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; IMO, 2004, INT CONV CONTR MAN S; IMO, 2005, GUID APPR BALL WAT M, P125; Inglis G, 2013, 201320 NZ MIN PRIM I; Inglis G.J., 2010, BIOSECURITY RISKS AS, P182; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Ji YQ, 2013, ECOL LETT, V16, P1245, DOI 10.1111/ele.12162; Johnson LE, 2001, ECOL APPL, V11, P1789, DOI 10.1890/1051-0761(2001)011[1789:ODOAIS]2.0.CO;2; Katsanevakis S, 2014, AQUAT INVASIONS, V9, P391, DOI 10.3391/ai.2014.9.4.01; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Laroche O, 2017, PEERJ, V5, DOI 10.7717/peerj.3347; Laroche O, 2016, MAR ENVIRON RES, V120, P225, DOI 10.1016/j.marenvres.2016.08.009; Logares R, 2014, CURR BIOL, V24, P813, DOI 10.1016/j.cub.2014.02.050; Mengoni A, 2005, MICROB ECOL, V50, P375, DOI 10.1007/s00248-004-0222-4; Mineur F, 2008, ENVIRON MANAGE, V42, P667, DOI 10.1007/s00267-008-9185-4; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; Nagai Koji, 1998, Mycoscience, V39, P293, DOI 10.1007/BF02464011; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Olenin S, 2007, MAR POLLUT BULL, V55, P379, DOI 10.1016/j.marpolbul.2007.01.010; Orsi W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056335; Pawlowski J, 2014, MOL ECOL RESOUR, V14, P1129, DOI 10.1111/1755-0998.12261; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pochon X, 2015, MAR POLLUT BULL, V100, P370, DOI 10.1016/j.marpolbul.2015.08.022; Pochon X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073935; Pramanik S, 2002, AM J HUM GENET, V71, P1342, DOI 10.1086/344713; R Core Team, 2012, R LANG ENV STAT COMP; Rey A, 2018, J SEA RES, V133, P134, DOI 10.1016/j.seares.2017.06.001; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Ruiz GM, 2000, NATURE, V408, P49, DOI 10.1038/35040695; Selbmann L, 2005, STUD MYCOL, P1; Selbmann L, 2013, PLANT BIOSYST, V147, P237, DOI 10.1080/11263504.2012.753134; Selbmann L, 2011, FUNGAL BIOL-UK, V115, P937, DOI 10.1016/j.funbio.2011.02.016; Shokralla S, 2012, MOL ECOL, V21, P1794, DOI 10.1111/j.1365-294X.2012.05538.x; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Sinner J, 2013, MANAGING DOMESTIC SP; Smith J, 2009, RAPID RESPONSE PLANN; Stewart FJ, 2013, METHOD ENZYMOL, V531, P187, DOI 10.1016/B978-0-12-407863-5.00010-1; Stoeck T, 2007, MICROB ECOL, V53, P328, DOI 10.1007/s00248-006-9166-1; Svarovskaia ES, 2003, FRONT BIOSCI-LANDMRK, V8, pD117, DOI 10.2741/957; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Veldhuis MJW, 1997, J PHYCOL, V33, P527, DOI 10.1111/j.0022-3646.1997.00527.x; Veldhuis MJW, 2008, FINAL REPORT LAND BA; Visco JA, 2015, ENVIRON SCI TECHNOL, V49, P7597, DOI 10.1021/es506158m; Waugh C, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0280-x; Zaiko A, 2016, BIOFOULING, V32, P671, DOI 10.1080/08927014.2016.1186165; Zaiko A, 2015, MAR POLLUT BULL, V92, P25, DOI 10.1016/j.marpolbul.2015.01.008; Zetsche EM, 2012, J PLANKTON RES, V34, P493, DOI 10.1093/plankt/fbs018; Zhan AB, 2013, METHODS ECOL EVOL, V4, P558, DOI 10.1111/2041-210X.12037	86	88	94	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187636	10.1371/journal.pone.0187636	http://dx.doi.org/10.1371/journal.pone.0187636			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095959	Green Published, Green Submitted, gold			2022-12-26	WOS:000414340200126
J	Tiret, M; Hospital, F				Tiret, Mathieu; Hospital, Frederic			Blocks of chromosomes identical by descent in a population: Models and predictions	PLOS ONE			English	Article							RANDOM MATING POPULATIONS; BY-DESCENT; DEMOGRAPHIC HISTORY; HALF-SIBS; GENOME; INDIVIDUALS; LENGTH; PROBABILITY; HAPLOTYPES; IBD	With the highly dense genomic data available nowadays, ignoring linkage between genes would result in a huge loss of information. One way to prevent such a loss is to focus on the blocks of chromosomes shared identical by descent (IBD) in populations. The development of the theoretical framework modelling IBD processes is essential to support the advent of new tools such as haplotype phasing, imputation, inferring population structure and demographic history, mapping loci or detecting signatures of selection. This article aims to present the relevant models used in this context, and specify the underlying definitions of identity by descent that are yet to be gathered at one place. In light of this, we derived a general expression for the expected IBD block length, for any population model at any generation after founding.	[Tiret, Mathieu; Hospital, Frederic] INRA, UMR Genet Anim & Biol Integrat 1313, Jouy En Josas, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Tiret, M (corresponding author), INRA, UMR Genet Anim & Biol Integrat 1313, Jouy En Josas, France.	mathieu.y.tiret@gmail.com		Tiret, Mathieu/0000-0001-5389-4886	metaprogram SelGen; Institut National de Recherche Agronomique, INRA	metaprogram SelGen; Institut National de Recherche Agronomique, INRA	This work has been supported by grants from the metaprogram SelGen, Institut National de Recherche Agronomique, INRA (to F.H.).	Ball F, 2005, MATH BIOSCI, V196, P215, DOI 10.1016/j.mbs.2005.04.005; Bickeboller H, 1996, THEOR POPUL BIOL, V50, P66, DOI 10.1006/tpbi.1996.0023; Browning S, 2002, THEOR POPUL BIOL, V62, P1, DOI 10.1006/tpbi.2002.1583; Browning SR, 2008, GENETICS, V178, P2123, DOI 10.1534/genetics.107.084624; Browning SR, 2012, ANNU REV GENET, V46, P617, DOI 10.1146/annurev-genet-110711-155534; Carmi S, 2013, GENETICS, V193, P911, DOI 10.1534/genetics.112.147215; Chapman NH, 2003, THEOR POPUL BIOL, V64, P141, DOI 10.1016/S0040-5809(03)00071-6; Clark AG, 2004, GENET EPIDEMIOL, V27, P321, DOI 10.1002/gepi.20025; DONNELLY KP, 1983, THEOR POPUL BIOL, V23, P34, DOI 10.1016/0040-5809(83)90004-7; Fisher RA, 1949, THEORY INBREEDING; Fisher RA, 1954, FULLER THEORY JUNCTI; FRANKLIN IR, 1977, THEOR POPUL BIOL, V11, P60, DOI 10.1016/0040-5809(77)90007-7; Haldane JBS, 1919, J GENET, V8, P299; Hill WG, 2011, GENET RES, V93, P47, DOI 10.1017/S0016672310000480; Hill WG, 2007, GENETICS, V176, P2307, DOI 10.1534/genetics.107.074344; Kardos M, 2017, GENETICS, V205, P1319, DOI 10.1534/genetics.116.198861; Karlin S., 1981, 2 COURSE STOCHASTIC; Knief U, 2017, HEREDITY, V118, P239, DOI 10.1038/hdy.2016.95; Martin OC, 2011, GENETICS, V189, P645, DOI 10.1534/genetics.111.129700; Odegard J, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-3; Palamara PF, 2012, AM J HUM GENET, V91, P809, DOI 10.1016/j.ajhg.2012.08.030; STAM P, 1980, GENET RES, V35, P131, DOI 10.1017/S0016672300014002; Stefanov VT, 2000, GENETICS, V156, P1403; Walters K, 2005, THEOR POPUL BIOL, V68, P55, DOI 10.1016/j.tpb.2005.03.004	24	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187416	10.1371/journal.pone.0187416	http://dx.doi.org/10.1371/journal.pone.0187416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095943	Green Published, Green Submitted, gold			2022-12-26	WOS:000414340200085
J	Wang, ST; Feng, Q; Zeng, YP; Mao, XX; Chen, YH; Xu, H				Wang, Shutao; Feng, Qian; Zeng, Yapeng; Mao, Xiaoxi; Chen, Yaheng; Xu, Hao			Dynamic changes in water and salinity in saline-alkali soils after simulated irrigation and leaching	PLOS ONE			English	Article								Soil salinization is a global problem that limits agricultural development and impacts human life. This study aimed to understand the dynamic changes in water and salinity in saline alkali soil based on an indoor soil column simulation. We studied the changes in the water and salt contents of soils with different degrees of salinization under various irrigation conditions. The results showed that after seven irrigations, the pH, conductivity and total soluble salt content of the percolation samples after irrigation generally increased initially then decreased with repeated irrigation. The soil moisture did not change significantly after irrigation. The pH, conductivity, and total soluble salt content of each layer of the soil profile exhibited general declining trends. In the soil profile from Changguo Township (CG), the pH decreased from 8.21-8.35 to 7.71-7.88, the conductivity decreased from 0.95-1.14 ms/cm to 0.45-0.68 ms/cm, and the total soluble salt content decreased from 2.63-2.81 g/kg to 2.28-2.51 g/kg. In the soil profile from Zhongjie Industrial Park (ZJ), the pH decreased from 8.36-8.54 to 7.73-7.96, the conductivity decreased from 1.58-1.68 ms/cm to 1.45-1.54 ms/cm, and the total soluble salt decreased from 2.81-4.03 g/kg to 2.56-3.28 g/kg. The transported salt ions were primarily K+, Na+ and Cl-. After several irrigations, a representative desalination effect was achieved. The results of this study can provide technical guidance for the comprehensive management of saline-alkali soils.	[Wang, Shutao; Feng, Qian; Zeng, Yapeng; Chen, Yaheng; Xu, Hao] Hebei Agr Univ, Land & Resources Coll, Baoding, Peoples R China; [Wang, Shutao] Key Lab Hebei Agr Environm, Baoding, Peoples R China; [Wang, Shutao] Minist Land & Resources, Cangzhou Field Res Stn, Land Use Circum Bohai Sea, Baoding, Peoples R China; [Mao, Xiaoxi] Hebei Acad Agr & Forestry Sci, Plant Protect Inst, Baoding, Peoples R China	Hebei Agricultural University; Ministry of Natural Resources of the People's Republic of China; Hebei Academy of Agricultural & Forestry Sciences	Chen, YH (corresponding author), Hebei Agr Univ, Land & Resources Coll, Baoding, Peoples R China.	chenyaheng@126.com	Mao, Xiaoxi/GQP-8460-2022					Ala MS, 2016, GEODERMA, V264, P132, DOI 10.1016/j.geoderma.2015.10.008; [Anonymous], 2012, YELLOW RIVER; Benduhn F, 2004, J MARINE SYST, V47, P35, DOI 10.1016/j.jmarsys.2003.12.007; Bing H, 2015, ENVIRON EARTH SCI, V74, P675, DOI 10.1007/s12665-015-4072-9; Du M., 2012, THESIS U MINNESOTA; Gao Hui, 2015, Yingyong Shengtai Xuebao, V26, P1016; Gap YH, 2011, THESIS; Garre S, 2013, VADOSE ZONE J, V12, DOI 10.2136/vzj2012.0129; Gu XB, 2009, THESIS; Guan BY, 2012, THESIS; Hansson K, 2006, COLD REG SCI TECHNOL, V44, P20, DOI 10.1016/j.coldregions.2005.06.004; [胡安焱 Hu Anyan], 2002, [水科学进展, Advances in Water Science], V13, P726; [李宝富 Li Baofu], 2013, [地理科学, Scientia Geographica Sinica], V33, P763; Li ST, 2011, THESIS; Li W. W., 2011, THESIS; Li WJ, 2014, WATER SAVING IRRIGAT, V4, P7; Liang CJ, 2014, THESIS; Lv ZW, 2005, THESIS; Phogat V, 2012, IRRIGATION SCI, V30, P315, DOI 10.1007/s00271-011-0284-2; Selim T, 2013, IRRIG DRAIN, V62, P352, DOI 10.1002/ird.1739; Siyal AA, 2013, AGR WATER MANAGE, V121, P73, DOI 10.1016/j.agwat.2013.01.005; Wang Y., 2015, THESIS; [余根坚 Yu Genjian], 2013, [水利学报, Journal of Hydraulic Engineering], V44, P826; [岳耀杰 YUE Yaojie], 2010, [资源科学, Resources Science], V32, P423; [张珂萌 Zhang Kemeng], 2015, [灌溉排水学报, Journal of Irrigation and Drainage], V34, P11	25	6	9	6	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187536	10.1371/journal.pone.0187536	http://dx.doi.org/10.1371/journal.pone.0187536			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091963	Green Submitted, gold, Green Published			2022-12-26	WOS:000414229700073
J	Wollenman, LC; Ploeg, MRV; Miller, ML; Zhang, YZ; Bazil, JN				Wollenman, Lucas C.; Ploeg, Matthew R. Vander; Miller, Mackinzie L.; Zhang, Yizhu; Bazil, Jason N.			The effect of respiration buffer composition on mitochondrial metabolism and function	PLOS ONE			English	Article							RAT-HEART MITOCHONDRIA; SKELETAL-MUSCLE MITOCHONDRIA; HYDROGEN-PEROXIDE PRODUCTION; ISOLATED LIVER-MITOCHONDRIA; CITRIC-ACID CYCLE; OXIDATIVE-PHOSPHORYLATION; DEHYDROGENASE COMPLEX; CARDIAC MITOCHONDRIA; ADENINE-NUCLEOTIDES; ADP/ATP CARRIER	Functional studies on isolated mitochondria critically rely on the right choice of respiration buffer. Differences in buffer composition can lead to dramatically different respiration rates leading to difficulties in comparing prior studies. The ideal buffer facilities high ADP-stimulated respiratory rates and minimizes substrate transport effects so that the ability to distinguish between various treatments and conditions is maximal. In this study, we analyzed a variety of respiration buffers and substrate combinations to determine the optimal conditions to support mitochondrial function through ADP-stimulated respiration and uncoupled respiration using FCCP. The buffers consisted of a standard KCI based buffer (B1) and three modified buffers with chloride replaced by the K-lactobionate, sucrose, and the antioxidant taurine (B2) or K-gluconate (B3). The fourth buffer (B4) was identical to B2 except that K-lactobionate was replaced with K-gluconate. The substrate combinations consisted of metabolites that utilize different pathways of mitochondrial metabolism. To test mitochondrial function, we used isolated cardiac guinea pig mitochondria and measured oxygen consumption for three respiratory states using an Oroboros Oxygraph-2k. These states were the leak state (energized mitochondria in the absence of adenylates), ADP-stimulated state (energized mitochondria in the presence of saturating ADP concentrations), and uncoupled state (energized mitochondria in the presence of FCCP). On average across all substrate combinations, buffers B2, B3, and B4 had an increase of 16%, 26%, and 35% for the leak state, ADP-simulated state, and uncoupled state, respectively, relative to rates using B1. The common feature distinguishing these buffers from B1 is the notable lack of high chloride concentrations. Based on the respiratory rate metrics obtained with the substrate combinations, we conclude that the adenine nucleotide translocase, the dicarboxylate carrier, and the alpha-ketoglutarate exchanger are partially inhibited by chloride. Therefore, when the goal is to maximize ADP-stimulated respiration, buffers containing K-lactobionate or K-gluconate are superior choices compared to the standard KCI-based buffers.	[Wollenman, Lucas C.; Ploeg, Matthew R. Vander; Zhang, Yizhu; Bazil, Jason N.] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA; [Wollenman, Lucas C.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Miller, Mackinzie L.] Michigan State Univ, Biomed Lab Diagnost, E Lansing, MI 48824 USA; [Miller, Mackinzie L.] Henry Ford Hosp, Nephrol & Hypertens, Detroit, MI 48202 USA	Michigan State University; Vanderbilt University; Michigan State University; Henry Ford Health System; Henry Ford Hospital	Bazil, JN (corresponding author), Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA.	jnbazil@msu.edu			NIH ROOHL121160; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL121160] Funding Source: NIH RePORTER	NIH ROOHL121160; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the NIH ROOHL121160 (to JB). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akar JG, 2003, CIRCULATION, V107, P1810, DOI 10.1161/01.CIR.0000058462.23347.93; Aldakkak M, 2010, AM J PHYSIOL-CELL PH, V298, pC530, DOI 10.1152/ajpcell.00468.2009; Aon MA, 2010, BBA-BIOENERGETICS, V1797, P71, DOI 10.1016/j.bbabio.2009.08.002; Bazil JN, 2013, J BIOENERG BIOMEMBR, V45, P177, DOI 10.1007/s10863-012-9488-2; Beadle RM, 2015, JACC-HEART FAIL, V3, P202, DOI 10.1016/j.jchf.2014.09.009; BISHOP PD, 1984, ARCH BIOCHEM BIOPHYS, V230, P335, DOI 10.1016/0003-9861(84)90116-4; Blomeyer CA, 2016, J BIOENERG BIOMEMBR, V48, P175, DOI 10.1007/s10863-016-9644-1; Boelens AD, 2013, J BIOENERG BIOMEMBR, V45, P203, DOI 10.1007/s10863-013-9500-5; Bombicino SS, 2016, INT J BIOCHEM CELL B, V81, P335, DOI 10.1016/j.biocel.2016.09.018; Bose S, 2003, J BIOL CHEM, V278, P39155, DOI 10.1074/jbc.M306409200; BURGMANN H, 1992, TRANSPLANTATION, V54, P1106; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.biochem.56.1.395; CARMELIE.EE, 1965, ARCH INT PHYS BIOCH, V73, P174; Coleman HW, 1999, EXPT UNCERTAINTY ANA, Vxvii; Coll O, 2003, HEPATOLOGY, V38, P692, DOI 10.1053/jhep.2003.50351; Contreras L, 2007, J BIOL CHEM, V282, P7098, DOI 10.1074/jbc.M610491200; Cortassa S, 2014, BBA-BIOENERGETICS, V1837, P287, DOI 10.1016/j.bbabio.2013.11.007; Csaba K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039839; Dabkowski ER, 2010, AM J PHYSIOL-HEART C, V299, pH529, DOI 10.1152/ajpheart.00267.2010; DEMELLO WC, 1960, AM J PHYSIOL, V199, P1125, DOI 10.1152/ajplegacy.1960.199.6.1125; Denton RM, 1996, ADV ENZYME REGUL, V36, P183, DOI 10.1016/0065-2571(95)00020-8; Devin A, 1997, BBA-BIOENERGETICS, V1319, P293, DOI 10.1016/S0005-2728(96)00172-7; Devin A, 1997, J BIOENERG BIOMEMBR, V29, P579, DOI 10.1023/A:1022435102552; Dueregger A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135704; Fink BD, 2017, AM J PHYSIOL-CELL PH, V313, pC146, DOI 10.1152/ajpcell.00086.2017; Glancy B, 2013, BIOCHEMISTRY-US, V52, P2793, DOI 10.1021/bi3015983; Gnaiger E, 2000, LIFE IN THE COLD; Goncalves RLS, 2015, J BIOL CHEM, V290, P209, DOI 10.1074/jbc.M114.619072; Gropp T, 1999, BIOPHYS J, V77, P714, DOI 10.1016/S0006-3495(99)76926-2; Gutierrez-Aguilar M, 2014, J MOL CELL CARDIOL, V72, P316, DOI 10.1016/j.yjmcc.2014.04.008; HACKENBROCK CR, 1966, J CELL BIOL, V30, P269, DOI 10.1083/jcb.30.2.269; HANSFORD RG, 1982, J BIOENERG BIOMEMBR, V14, P361, DOI 10.1007/BF00743064; Harrison DK, 2015, J APPL PHYSIOL, V119, P1210, DOI 10.1152/japplphysiol.00146.2015; HUCHO F, 1972, Archives of Biochemistry and Biophysics, V151, P328, DOI 10.1016/0003-9861(72)90504-8; HUTTER OF, 1961, J PHYSIOL-LONDON, V157, P335, DOI 10.1113/jphysiol.1961.sp006726; Kawamata H, 2010, ANAL BIOCHEM, V407, P52, DOI 10.1016/j.ab.2010.07.031; Kiss G, 2013, FASEB J, V27, P2392, DOI 10.1096/fj.12-220202; Krammer EM, 2009, BIOPHYS J, V97, pL25, DOI 10.1016/j.bpj.2009.08.047; Kristian T, 2007, J NEUROCHEM, V102, P1346, DOI 10.1111/j.1471-4159.2007.04626.x; Lacerda L, 2010, BASIC RES CARDIOL, V105, P751, DOI 10.1007/s00395-010-0113-4; LAMB JF, 1961, J PHYSIOL-LONDON, V157, P415, DOI 10.1113/jphysiol.1961.sp006733; LANOUE K, 1970, J BIOL CHEM, V245, P102; Lionetti L, 1996, MOL CELL BIOCHEM, V158, P133; Mannella CA, 2006, BBA-MOL BASIS DIS, V1762, P140, DOI 10.1016/j.bbadis.2005.07.001; MCCORMACK JG, 1979, BIOCHEM J, V180, P533, DOI 10.1042/bj1800533; MCKEAN TA, 1990, COMP BIOCHEM PHYS B, V97, P109, DOI 10.1016/0305-0491(90)90186-W; MILNERWH.EJ, 1971, BIOCHEM J, V122, P727, DOI 10.1042/bj1220727; Monteiro JP, 2011, J BIOENERG BIOMEMBR, V43, P287, DOI 10.1007/s10863-011-9359-2; MORENOSANCHEZ R, 1988, BIOCHEM J, V256, P403, DOI 10.1042/bj2560403; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nicholls DG, 2013, BIOENERGETICS 4, P1; NICHOLLS DG, 1978, BIOCHEM J, V176, P463, DOI 10.1042/bj1760463; Pandya Jignesh D, 2013, Front Neuroenergetics, V5, P10, DOI 10.3389/fnene.2013.00010; Perevoshchikova IV, 2013, FREE RADICAL BIO MED, V61, P298, DOI 10.1016/j.freeradbiomed.2013.04.006; Schmidt CW, 2010, ENVIRON HEALTH PERSP, V118, pA292, DOI 10.1289/ehp.118-a292; Schopf B, 2016, FEBS J, V283, P2181, DOI 10.1111/febs.13733; Southard JH, 1993, TRANSPLANT REV-ORLAN, V7, P176; STRINGHAM JC, 1994, J THORAC CARDIOV SUR, V107, P764; TAEGTMEYER H, 1980, BIOCHEM J, V186, P701, DOI 10.1042/bj1860701; TAEGTMEYER H, 1994, CURR PROB CARDIOLOGY, V19, P61, DOI 10.1016/0146-2806(94)90008-6; Territo PR, 2001, CELL CALCIUM, V30, P19, DOI 10.1054/ceca.2001.0211; Tomaskova Z, 2010, FEBS LETT, V584, P2085, DOI 10.1016/j.febslet.2010.01.035; VAUGHANJONES RD, 1979, J PHYSIOL-LONDON, V295, P83, DOI 10.1113/jphysiol.1979.sp012956; Vavrusova M, 2014, J AGR FOOD CHEM, V62, P5675, DOI 10.1021/jf501453c; Vavrusova M, 2013, J AGR FOOD CHEM, V61, P8207, DOI 10.1021/jf402124n; Vinnakota KC, 2016, BIOPHYS J, V110, P972, DOI 10.1016/j.bpj.2016.01.003; Vinnakota KC, 2011, J BIOL CHEM, V286, P30816, DOI 10.1074/jbc.M111.242529; WAN B, 1989, J BIOL CHEM, V264, P13430; Wang XM, 2005, CELL PHYSIOL BIOCHEM, V16, P147, DOI 10.1159/000089840; Wang ZV, 2015, CIRCULATION, V131, P771, DOI 10.1161/CIRCULATIONAHA.115.015357; Wei AC, 2011, BIOPHYS J, V100, P2894, DOI 10.1016/j.bpj.2011.05.027; Xu Yan-Jun, 2008, Exp Clin Cardiol, V13, P57	72	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187523	10.1371/journal.pone.0187523	http://dx.doi.org/10.1371/journal.pone.0187523			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091971	Green Published, gold, Green Submitted			2022-12-26	WOS:000414229700071
J	Rainard, P; Reperant-Ferter, M; Gitton, C; Gilbert, FB; Germon, P				Rainard, Pascal; Reperant-Ferter, Maryline; Gitton, Christophe; Gilbert, Florence B.; Germon, Pierre			Cellular and humoral immune response to recombinant Escherichia coli OmpA in cows	PLOS ONE			English	Article							MEMBRANE PROTEIN-A; MAMMARY-GLAND; INFECTION; BOVINE; SURFACE; MICE; K-12; EFFECTOR; BACTERIA; ANTIGEN	The outer membrane protein (Omp) A is a major constituent of the outer membrane of Escherichia coli. This protein has been used in several vaccine development studies, but seldom with a view to vaccinating against mastitis. The objective of this study was to investigate the immunogenicity of E. coli OmpA and its vaccine potential for cows. Both the humoral and cellular immune responses were investigated. The gene for OmpA of the mastitis- causing strain P4 was cloned and expressed, and the recombinant protein (rEcOmpA) purified. Cows were immunized twice with rEcOmpA with adjuvant one month apart by the systemic route. Before immunization, few antibodies to rEcOmpA were detected, and there was little production of IL-17A in a whole blood stimulation assay (WBA) with rEcOmpA. Antibodies to rEcOmpA were induced by immunization. These antibodies were not able to react with E. coli P4, but reacted with a rough P4 mutant prepared by inactivating the rfb locus. This suggests that the complete LPS O-chain precluded the accessibility of antibodies to their target at the outer membrane. The cellular immune response appeared to be biased towards a Th17-type, as more IL-17A than IFN-gamma was produced in the OmpA-specific WBA. There was a good correlation between antibody titers and the production of IL-17A in the WBA. The intramammary instillation of rEcOmpA elicited a slight local inflammatory response which was not related to the WBA. Overall, the interest of OmpA as vaccine immunogen was not established, although other experimental conditions (dose, adjuvant, route) need to be investigated to conclude definitively. The study pointed to several important issues such as the accessibility of OmpA to antibodies and the weakness of Th1-type response induced by OmpA.	[Rainard, Pascal; Reperant-Ferter, Maryline; Gitton, Christophe; Gilbert, Florence B.; Germon, Pierre] Univ Tours, UMR 1282, Infectiol & Sante Publ, INRA, Nouzilly, France	INRAE; Universite de Tours	Rainard, P (corresponding author), Univ Tours, UMR 1282, Infectiol & Sante Publ, INRA, Nouzilly, France.	pascal.rainard@inra.fr	GERMON, Pierre/AAC-9111-2019; GERMON, Pierre/M-5264-2019	GERMON, Pierre/0000-0003-3078-876X; Rainard, Pascal/0000-0002-5477-2626	Institut National de la Recherche Agronomique; Region Centre Val de Loire [201200073634]	Institut National de la Recherche Agronomique; Region Centre Val de Loire(Region Centre-Val de Loire)	This work was funded by the Institut National de la Recherche Agronomique (www.inra.fr) and by the Region Centre Val de Loire (Project convention 201200073634, www.regioncentre.fr). There was no additional external funding received for this study. The funders had not role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belkaid Y, 2013, TRENDS IMMUNOL, V34, P299, DOI 10.1016/j.it.2013.03.003; BRAMLEY AJ, 1976, J DAIRY RES, V43, P205, DOI 10.1017/S0022029900015752; Confer AW, 2013, VET MICROBIOL, V163, P207, DOI 10.1016/j.vetmic.2012.08.019; CRAVEN N, 1985, VET IMMUNOL IMMUNOP, V10, P71, DOI 10.1016/0165-2427(85)90039-X; Dabo SM, 2008, VACCINE, V26, P4345, DOI 10.1016/j.vaccine.2008.06.029; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; FREUDL R, 1986, J MOL BIOL, V188, P491, DOI 10.1016/0022-2836(86)90171-3; Guan QF, 2015, APPL MICROBIOL BIOT, V99, P5451, DOI 10.1007/s00253-014-6339-6; Herry V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03724-7; HILL AW, 1983, VET MICROBIOL, V8, P293, DOI 10.1016/0378-1135(83)90081-0; Hounsome JDA, 2011, INFECT IMMUN, V79, P4332, DOI 10.1128/IAI.05469-11; Hu R, 2013, ISR J VET MED, V68, P48; Jeannin P, 2002, VACCINE, V20, pA23, DOI 10.1016/S0264-410X(02)00383-3; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Krishnan S, 2012, FEBS J, V279, P919, DOI 10.1111/j.1742-4658.2012.08482.x; Lee JS, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-263; Lu QY, 2011, SOFT MATTER, V7, P9366, DOI 10.1039/c1sm05554b; McConnell MJ, 2011, PROTEIN EXPRES PURIF, V77, P98, DOI 10.1016/j.pep.2010.11.019; Perez-Toledo Marisol, 2017, Front Immunol, V8, P230, DOI 10.3389/fimmu.2017.00230; Porcherie A, 2016, J IMMUNOL, V196, P803, DOI 10.4049/jimmunol.1500705; Rainard P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154172; Rainard P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137755; ROCQUE WJ, 1987, J BACTERIOL, V169, P4003, DOI 10.1128/jb.169.9.4003-4010.1987; ROSENBUSCH JP, 1974, J BIOL CHEM, V249, P8019; Roussel P, 2015, VET RES, V46, DOI 10.1186/s13567-015-0201-4; Singh SP, 2003, INFECT IMMUN, V71, P3937, DOI 10.1128/IAI.71.7.3937-3946.2003; Smith SGJ, 2007, FEMS MICROBIOL LETT, V273, P1, DOI 10.1111/j.1574-6968.2007.00778.x; TSANG VCW, 1991, J IMMUNOL METHODS, V138, P291, DOI 10.1016/0022-1759(91)90178-I; Wang Y, 2002, BIOCHEM BIOPH RES CO, V292, P396, DOI 10.1006/bbrc.2002.6657; Welsh RM, 2002, NAT REV IMMUNOL, V2, P417, DOI 10.1038/nri820; WILLIAMS MR, 1982, RES VET SCI, V33, P47, DOI 10.1016/S0034-5288(18)32358-0; Zeng MY, 2016, IMMUNITY, V44, P647, DOI 10.1016/j.immuni.2016.02.006	32	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187369	10.1371/journal.pone.0187369	http://dx.doi.org/10.1371/journal.pone.0187369			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088296	Green Published, Green Submitted, gold			2022-12-26	WOS:000414088900076
J	Birch, JL; Walsh, NG; Cantrill, DJ; Holmes, GD; Murphy, DJ				Birch, Joanne L.; Walsh, Neville G.; Cantrill, David J.; Holmes, Gareth D.; Murphy, Daniel J.			Testing efficacy of distance and tree-based methods for DNA barcoding of grasses (Poaceae tribe Poeae) in Australia	PLOS ONE			English	Article							SPECIES DELIMITATION; GENUS; IDENTIFICATION; DIVERGENCE; TAXONOMY; LOCI	In Australia, Poaceae tribe Poeae are represented by 19 genera and 99 species, including economically and environmentally important native and introduced pasture grasses [e.g.Poa (Tussock-grasses) and Lolium (Ryegrasses)]. We used this tribe, which are well characterised in regards to morphological diversity and evolutionary relationships, to test the efficacy of DNA barcoding methods. A reference library was generated that included 93.9% of species in Australia (408 individuals, (x) over bar = 3.7 individuals per species). Molecular data were generated for official plant barcoding markers (rbcL, matK) and the nuclear ribosomal internal transcribed spacer (ITS) region. We investigated accuracy of specimen identifications using distance-(nearest neighbour, best-close match, and threshold identification) and treebased (maximum likelihood, Bayesian inference) methods and applied species discovery methods (automatic barcode gap discovery, Poisson tree processes) based on molecular data to assess congruence with recognised species. Across all methods, success rate for specimen identification of genera was high (87.5-99.5%) and of species was low (25.6-44.6%). Distance-and tree-based methods were equally ineffective in providing accurate identifications for specimens to species rank (26.1-44.6% and 25.6-31.3%, respectively). The ITS marker achieved the highest success rate for specimen identification at both generic and species ranks across the majority of methods. For distance-based analyses the best-close match method provided the greatest accuracy for identification of individuals with a high percentage of "correct" (97.6%) and a low percentage of "incorrect" (0.3%) generic identifications, based on the ITS marker. For tribe Poeae, and likely for other grass lineages, sequence data in the standard DNA barcode markers are not variable enough for accurate identification of specimens to species rank. For recently diverged grass species similar challenges are encountered in the application of genetic and morphological data to species delimitations, with taxonomic signal limited by extensive infra-specific variation and shared polymorphisms among species in both data types.	[Birch, Joanne L.; Walsh, Neville G.; Cantrill, David J.; Holmes, Gareth D.; Murphy, Daniel J.] Royal Bot Gardens Victoria, Melbourne, Vic, Australia		Birch, JL (corresponding author), Royal Bot Gardens Victoria, Melbourne, Vic, Australia.	Joanne.Birch@unimelb.edu.au	Cantrill, David/R-1415-2019; Murphy, Daniel/C-3781-2008	Cantrill, David/0000-0002-1185-4015; Murphy, Daniel/0000-0002-8358-363X; Birch, Joanne/0000-0002-8226-6085	Australian Biological Resources Study [BB210-46]	Australian Biological Resources Study	This work was supported by the Australian Biological Resources Study (http://www. environment.gov.au/science/abrs) Bush Blitz Strategic Taxonomy Grants Scheme (BB210-46) funding to DJM, NGW, and DJC.	Austerlitz F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S10; Bayon ND, 1998, CLADISTICS, V14, P287, DOI 10.1111/j.1096-0031.1998.tb00339.x; Birch JL, 2014, AUST SYST BOT, V27, P333, DOI 10.1071/SB14028; Birch JL, 2014, BOT J LINN SOC, V175, P523, DOI 10.1111/boj.12185; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; CORNISHBOWDEN A, 1985, EUR J BIOCHEM, V150, P1; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Griffin PC, 2014, ANN BOT-LONDON, V113, P953, DOI 10.1093/aob/mcu017; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hamilton CA, 2014, MOL PHYLOGENET EVOL, V71, P79, DOI 10.1016/j.ympev.2013.11.007; Hernandez-Leon S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070501; Hollingsworth PM, 2009, P NATL ACAD SCI USA, V106, P12794, DOI 10.1073/pnas.0905845106; Holmes GD, 2014, AUST SYST BOT, V27, P56, DOI 10.1071/SB13045; Inda LA, 2008, MOL PHYLOGENET EVOL, V46, P932, DOI 10.1016/j.ympev.2007.11.022; Jeanson ML, 2011, ANN BOT-LONDON, V108, P1445, DOI 10.1093/aob/mcr158; Joly S, 2014, MOL ECOL RESOUR, V14, P221, DOI 10.1111/1755-0998.12173; Kesanakurti PR, 2011, MOL ECOL, V20, P1289, DOI 10.1111/j.1365-294X.2010.04989.x; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; McClenaghan B, 2015, ECOL EVOL, V5, P3046, DOI 10.1002/ece3.1585; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Moore R. M., 1970, AUSTR GRASSLANDS, P169; Padial JM, 2010, BIOL J LINN SOC, V101, P747, DOI 10.1111/j.1095-8312.2010.01528.x; Pang XH, 2011, CLADISTICS, V27, P165, DOI 10.1111/j.1096-0031.2010.00328.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peterson Paul M., 2014, Webbia, V69, P1, DOI 10.1080/00837792.2014.927555; Pettengill JB, 2010, AM J BOT, V97, P1391, DOI 10.3732/ajb.0900176; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; R Core Team, 2013, R COR TEAM R LANG EN; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Saarela JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077982; Sauer J, 2012, CLADISTICS, V28, P300, DOI 10.1111/j.1096-0031.2011.00382.x; Schwarzfeld MD, 2015, MOL PHYLOGENET EVOL, V93, P234, DOI 10.1016/j.ympev.2015.08.003; Seberg O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004598; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Starr JR, 2009, MOL ECOL RESOUR, V9, P151, DOI 10.1111/j.1755-0998.2009.02640.x; Syme AE, 2012, DNA BARCODES, P19; Thiers B., INDEX HERBARIORUM GL; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; VICKERY J W, 1970, Contributions from the New South Wales National Herbarium, V4, P145; Wang AS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175338; Ward J, 2009, J FORENSIC SCI, V54, P1254, DOI 10.1111/j.1556-4029.2009.01196.x; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilson A, 2009, FLORA OF AUSTR A, V44A; Wyler SC, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0678-0; Yu WB, 2011, J SYST EVOL, V49, P425, DOI 10.1111/j.1759-6831.2011.00154.x; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	56	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0186259	10.1371/journal.pone.0186259	http://dx.doi.org/10.1371/journal.pone.0186259			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084279	Green Published, gold, Green Submitted			2022-12-26	WOS:000413910200005
J	Hu, XJ; Xu, JW; Wu, CY; Deng, JB; Liao, WW; Ling, YX; Yang, YX; Zhao, YN; Zhao, YL; Hu, X; Wang, H; Liu, YG				Hu, Xinjiang; Xu, Jiawen; Wu, Cuiyu; Deng, Jianbin; Liao, Wenwei; Ling, Yuxiang; Yang, Yuanxiu; Zhao, Yina; Zhao, Yunlin; Hu, Xi; Wang, Hui; Liu, Yunguo			Ethylenediamine grafted to graphene oxide@Fe3O4 for chromium(VI) decontamination: Performance, modelling, and fractional factorial design	PLOS ONE			English	Article							ACIDIC AQUEOUS-SOLUTION; ADSORPTION BEHAVIOR; BETA-CYCLODEXTRIN; ACTIVATED CARBON; CR(VI) REMOVAL; OXIDE; CU(II); IONS; PARAMETERS; ALGINATE	A method for grafting ethylenediamine to a magnetic graphene oxide composite (EDAGO@Fe3O4) was developed for Cr(VI) decontamination. The physicochemical properties of EDA-GO@Fe3O4 were characterized using HRTEM, EDS, FT-IR, TG-DSC, and XPS. The effects of pH, sorbent dose, foreign anions, time, Cr(VI) concentration, and temperature on decontamination process were studied. The solution pH can largely affect the decontamination process. The pseudo-second-order model is suitable for being applied to fit the adsorption processes of Cr(VI) with GO@Fe3O4 and EDA-GO@Fe3O4. The intra-particle diffusion is not the rate-controlling step. Isotherm experimental data can be described using the Freundlich model. The effects of multiple factors on the Cr(VI) decontamination was investigated by a 2 5-1 fractional factorial design (FFD). The adsorption process can significantly be affected by the main effects of A (pH), B (Cr(VI) concentration), and E (Adsorbent dose). The combined factors of AB (pH x Cr(VI) concentration), AE (pH x Adsorbent dose), and BC (Cr(VI) concentration x Temperature) had larger effects than other factors on Cr(VI) removal. These results indicated that EDA-GO@Fe3O4 is a potential and suitable candidate for treatment of heavy metal wastewater.	[Hu, Xinjiang; Zhao, Yunlin; Hu, Xi] Cent South Univ Forestry & Technol, Coll Environm Sci & Engn, Changsha, Hunan, Peoples R China; [Hu, Xinjiang; Zhao, Yunlin] Cent South Univ Forestry & Technol, Fac Life Sci & Technol, Changsha, Hunan, Peoples R China; [Hu, Xinjiang; Xu, Jiawen; Wu, Cuiyu; Deng, Jianbin; Liao, Wenwei; Ling, Yuxiang; Yang, Yuanxiu; Zhao, Yina] South China Agr Univ, Coll Nat Resources & Environm, Guangzhou, Guangdong, Peoples R China; [Wang, Hui] Chinese Acad Agr Sci, Inst Bast Fiber Crops, Changsha, Hunan, Peoples R China; [Liu, Yunguo] Hunan Univ, Coll Environm Sci & Engn, Changsha, Hunan, Peoples R China; [Liu, Yunguo] Hunan Univ, Minist Educ, Key Lab Environm Biol & Pollut Control, Changsha, Hunan, Peoples R China	Central South University of Forestry & Technology; Central South University of Forestry & Technology; South China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Bast Fiber Crops, CAAS; Hunan University; Hunan University	Hu, XJ; Zhao, YL; Hu, X (corresponding author), Cent South Univ Forestry & Technol, Coll Environm Sci & Engn, Changsha, Hunan, Peoples R China.; Hu, XJ; Zhao, YL (corresponding author), Cent South Univ Forestry & Technol, Fac Life Sci & Technol, Changsha, Hunan, Peoples R China.; Hu, XJ (corresponding author), South China Agr Univ, Coll Nat Resources & Environm, Guangzhou, Guangdong, Peoples R China.	huxinjiang@126.com; zyl8291290@163.com; liam.ho@live.cn	xu, jia/GSD-6347-2022	Hu, Xi/0000-0001-8809-6921; Hu, Xinjiang/0000-0001-8509-3290; Wang, Hui/0000-0002-5000-2069	National Natural Science Foundation of China [5160820]; China Postdoctoral Science Foundation [2017M610513]; Research Foundation of Education Department of Hunan Province, China [17K105]; Natural Science Foundation of Guangdong Province [2016A030310246, 2016A030310456]; Science and Technology Planning Project of Hunan Province [2016TP2007, 2016TP1014]; Scientific Research Staring Foundation for the attracted talent of Central South University of Forestry and Technology [2016YJ001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Research Foundation of Education Department of Hunan Province, China; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Hunan Province; Scientific Research Staring Foundation for the attracted talent of Central South University of Forestry and Technology	This study was financially supported by the National Natural Science Foundation of China (Grant No. 5160820 to Xinjiang Hu), the Project funded by China Postdoctoral Science Foundation (Grant No. 2017M610513 Xinjiang Hu), the Research Foundation of Education Department of Hunan Province, China (Grant No. 17K105 to Xinjiang Hu), the Natural Science Foundation of Guangdong Province (grant numbers 2016A030310246 and 2016A030310456 to Xinjiang Hu), the Science and Technology Planning Project of Hunan Province (grant numbers 2016TP2007 and 2016TP1014 to Yunlin Zhao), and the Scientific Research Staring Foundation for the attracted talent of Central South University of Forestry and Technology (grant number 2016YJ001 to Xinjiang Hu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksu Z, 2002, PROCESS BIOCHEM, V38, P89, DOI 10.1016/S0032-9592(02)00051-1; Bezerra MA, 2008, TALANTA, V76, P965, DOI 10.1016/j.talanta.2008.05.019; Chang SH, 2011, J ENVIRON MANAGE, V92, P2580, DOI 10.1016/j.jenvman.2011.05.025; Chen Z, 2008, J HAZARD MATER, V155, P327, DOI 10.1016/j.jhazmat.2007.11.064; Dinda D, 2013, J MATER CHEM A, V1, P11221, DOI 10.1039/c3ta12504a; Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5; Hu X., 2015, ALTERN MED, V2015, P1, DOI DOI 10.1371/J0URNAL.P0NE.0142351; Hu XJ, 2015, CHEM ENG RES DES, V93, P675, DOI 10.1016/j.cherd.2014.06.002; Hu XJ, 2013, SEP PURIF TECHNOL, V108, P189, DOI 10.1016/j.seppur.2013.02.011; Hu XJ, 2011, J HAZARD MATER, V185, P306, DOI 10.1016/j.jhazmat.2010.09.034; Hu XJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34378; Huang BY, 2015, RSC ADV, V5, P106339, DOI 10.1039/c5ra22862j; Huang DL, 2008, ENVIRON SCI TECHNOL, V42, P4946, DOI 10.1021/es800072c; Jiang LH, 2017, ENVIRON SCI TECHNOL, V51, P6352, DOI 10.1021/acs.est.7b00073; Jiang LH, 2017, CHEM ENG J, V308, P597, DOI 10.1016/j.cej.2016.09.067; Kiran B, 2008, BIOCHEM ENG J, V38, P47, DOI 10.1016/j.bej.2007.06.007; Lawrie G, 2007, BIOMACROMOLECULES, V8, P2533, DOI 10.1021/bm070014y; Lei YL, 2014, J MATER SCI, V49, P4236, DOI 10.1007/s10853-014-8118-2; Li LL, 2013, COLLOID SURFACE B, V107, P76, DOI 10.1016/j.colsurfb.2013.01.074; Liang J, 2015, CARBOHYD POLYM, V132, P472, DOI 10.1016/j.carbpol.2015.06.067; Liu L, 2013, J CHEM ENG DATA, V58, P209, DOI 10.1021/je300551c; Liu YG, 2013, CHEM ENG J, V226, P131, DOI 10.1016/j.cej.2013.04.048; Lu M, 2013, J CENT SOUTH UNIV, V20, P2478, DOI 10.1007/s11771-013-1760-z; Ma HL, 2012, J MATER CHEM, V22, P5914, DOI 10.1039/c2jm00145d; Madadrang CJ, 2012, ACS APPL MATER INTER, V4, P1186, DOI 10.1021/am201645g; Myers R.H., 2008, RESPONSE SURFACE MET; Phuong NTK, 2016, CHEMOSPHERE, V146, P51, DOI 10.1016/j.chemosphere.2015.12.008; Panic S, 2015, CHEMOSPHERE, V141, P87, DOI 10.1016/j.chemosphere.2015.06.042; Parida K, 2012, IND ENG CHEM RES, V51, P2235, DOI 10.1021/ie200109h; Stankovich S, 2006, NATURE, V442, P282, DOI 10.1038/nature04969; Tripathi KM, 2016, ACS SUSTAIN CHEM ENG, V4, P6399, DOI 10.1021/acssuschemeng.6b01045; Tripathi KM, 2016, RSC ADV, V6, P29545, DOI 10.1039/c5ra27432j; Tyagi A, 2016, RSC ADV, V6, P72423, DOI 10.1039/c6ra10488f; Wang H, 2013, APPL SURF SCI, V279, P432, DOI 10.1016/j.apsusc.2013.04.133; Wang H, 2014, CARBOHYD POLYM, V113, P166, DOI 10.1016/j.carbpol.2014.07.014; Wang J, 2015, CHEM ENG J, V281, P379, DOI 10.1016/j.cej.2015.06.102; Wang XS, 2007, J HAZARD MATER, V142, P468, DOI 10.1016/j.jhazmat.2006.08.047; Yang CH, 1998, J COLLOID INTERF SCI, V208, P379, DOI 10.1006/jcis.1998.5843; Zeng W, 2016, RSC ADV, V6, P19298, DOI 10.1039/c5ra27657h; Zhang YK, 2014, J MOL LIQ, V191, P177, DOI 10.1016/j.molliq.2013.12.015	40	20	22	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187166	10.1371/journal.pone.0187166	http://dx.doi.org/10.1371/journal.pone.0187166			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084287	gold, Green Submitted, Green Published			2022-12-26	WOS:000413910200037
J	Monteverde, T; Tait-Mulder, J; Hedley, A; Knight, JR; Sansom, OJ; Murphy, DJ				Monteverde, T.; Tait-Mulder, J.; Hedley, A.; Knight, J. R.; Sansom, O. J.; Murphy, D. J.			Calcium signalling links MYC to NUAK1	ONCOGENE			English	Article							ACTIVATED PROTEIN-KINASE; EPITHELIAL-MESENCHYMAL TRANSITION; TARGETING NUAK1; C-ALPHA; INDUCED APOPTOSIS; POOR-PROGNOSIS; AMPK; CANCER; BETA; EXPRESSION	NUAK1 is a member of the AMPK-related family of kinases. Recent evidence suggests that NUAK1 is an important regulator of cell adhesion and migration, cellular and organismal metabolism, and regulation of TAU stability. As such, NUAK1 may play key roles in multiple diseases ranging from neurodegeneration to diabetes and metastatic cancer. Previous work revealed a crucial role for NUAK1 in supporting viability of tumour cells specifically when MYC is overexpressed. This role is surprising, given that NUAK1 is activated by the tumour suppressor LKB1. Here we show that, in tumour cells lacking LKB1, NUAK1 activity is maintained by an alternative pathway involving calcium-dependent activation of PKC alpha. Calcium/PKC alpha-dependent activation of NUAK1 supports engagement of the AMPK-TORC1 metabolic checkpoint, thereby protecting tumour cells from MYC-driven cell death, and indeed, MYC selects for this pathway in part via transcriptional regulation of PKC alpha and ITPR. Our data point to a novel role for calcium in supporting tumour cell viability and clarify the synthetic lethal interaction between NUAK1 and MYC.	[Monteverde, T.; Tait-Mulder, J.; Sansom, O. J.; Murphy, D. J.] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland; [Hedley, A.; Knight, J. R.; Sansom, O. J.; Murphy, D. J.] CRUK Beatson Inst, Garscube Estate, Glasgow, Lanark, Scotland	University of Glasgow; Beatson Institute	Murphy, DJ (corresponding author), Univ Glasgow, Inst Canc Sci, CRUK Beatson Inst, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	daniel.murphy@glasgow.ac.uk	Murphy, Daniel/V-1079-2019; Knight, John/V-2922-2019	Murphy, Daniel/0000-0002-5538-5468; Knight, John/0000-0002-8771-5484; Sansom, Owen J./0000-0001-9540-3010	British Lung Foundation [APHD13-5]; Wellcome trust [105614/Z/14/Z]; European Commission Marie Curie actions [CIG 618448]; Cancer Research UK [22311] Funding Source: researchfish; Versus Arthritis [21139] Funding Source: researchfish	British Lung Foundation; Wellcome trust(Wellcome Trust); European Commission Marie Curie actions(European Commission); Cancer Research UK(Cancer Research UK); Versus Arthritis(Versus Arthritis)	We acknowledge valuable input from the entire Murphy laboratory and numerous colleagues at the University of Glasgow Institute of Cancer Sciences and CRUK Beatson Institute. Nuak1 inhibitors were generously provided by Nathanael Gray prior to commercial availability. TM was supported by grant APHD13-5 from the British Lung Foundation. Additional support was provided by Wellcome trust grant 105614/Z/14/Z; the European Commission Marie Curie actions CIG 618448 'SERPLUC' to DJM and institutional support provided by the University of Glasgow & CRUK Beatson Institute to DJM.	ADEREM A, 1992, CELL, V71, P713, DOI 10.1016/0092-8674(92)90546-O; Adey A, 2013, NATURE, V500, P207, DOI 10.1038/nature12064; Banerjee S, 2014, BIOCHEM J, V457, P215, DOI 10.1042/BJ20131152; Barr LF, 1997, CELL GROWTH DIFFER, V8, P381; Bell RE, 2014, J INVEST DERMATOL, V134, P441, DOI 10.1038/jid.2013.340; Benaich N, 2014, CELL REP, V9, P104, DOI 10.1016/j.celrep.2014.08.062; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; Cermelli S, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014209; Chen P, 2013, EXP LUNG RES, V39, P9, DOI 10.3109/01902148.2012.744115; Conacci-Sorrell M, 2010, CELL, V142, P480, DOI 10.1016/j.cell.2010.06.037; Courchet J, 2013, CELL, V153, P1510, DOI 10.1016/j.cell.2013.05.021; Delbridge ARD, 2015, CELL DEATH DIFFER, V22, P1071, DOI 10.1038/cdd.2015.50; DREXLER HG, 1989, BLOOD, V73, P1656; Evan GI, 2005, COLD SH Q B, V70, P263, DOI 10.1101/sqb.2005.70.054; Fisher JS, 2005, AM J PHYSIOL-ENDOC M, V289, pE986, DOI 10.1152/ajpendo.00335.2004; Fogarty S, 2010, BIOCHEM J, V426, P109, DOI 10.1042/BJ20091372; Goodwin JM, 2014, MOL CELL, V55, P436, DOI 10.1016/j.molcel.2014.06.021; Graff JR, 2005, CANCER RES, V65, P7462, DOI 10.1158/0008-5472.CAN-05-0071; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Habib T, 2007, J CELL BIOL, V179, P717, DOI 10.1083/jcb.200704173; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hardie DG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-36; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Hirano M, 2006, DEV DYNAM, V235, P2229, DOI 10.1002/dvdy.20823; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Huang X, 2014, INT J MOL MED, V34, P1599, DOI 10.3892/ijmm.2014.1940; Humbert N, 2010, EMBO J, V29, P376, DOI 10.1038/emboj.2009.342; Inazuka F, 2012, J BIOL CHEM, V287, P16379, DOI 10.1074/jbc.M111.302687; Kawakami Y, 2004, J BIOL CHEM, V279, P47720, DOI 10.1074/jbc.M408797200; Kusakai G, 2004, AM J PATHOL, V164, P987, DOI 10.1016/S0002-9440(10)63186-0; Lasagna-Reeves CA, 2016, NEURON, V92, P407, DOI 10.1016/j.neuron.2016.09.022; Li B, 2013, CLIN CANCER RES, V19, P5835, DOI 10.1158/1078-0432.CCR-12-3629; Li RJ, 2016, ELIFE, V5, DOI 10.7554/eLife.19360; Li WQ, 1999, ONCOGENE, V18, P6564, DOI 10.1038/sj.onc.1203065; Liu LD, 2012, NATURE, V483, P608, DOI 10.1038/nature10927; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Miranda F, 2016, CANCER CELL, V30, P273, DOI 10.1016/j.ccell.2016.06.020; Monteverde T, 2015, FEBS J, V282, P4658, DOI 10.1111/febs.13534; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Muthalagu N, 2014, CELL REP, V8, P1347, DOI 10.1016/j.celrep.2014.07.057; Obayashi M, 2016, ONCOTARGET, V7, P8223, DOI 10.18632/oncotarget.6972; Ohmura T, 2012, DEV DYNAM, V241, P1350, DOI 10.1002/dvdy.23816; Partovian C, 2004, CELL SIGNAL, V16, P951, DOI 10.1016/j.cellsig.2004.01.008; Phippen NT, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2015.00213; Popovics P, 2015, EXPERT OPIN THER TAR, V19, P617, DOI 10.1517/14728222.2015.1005603; Raffeiner P, 2017, ONCOTARGET, V8, P3327, DOI 10.18632/oncotarget.13759; Reihill JA, 2007, BIOCHEM BIOPH RES CO, V354, P1084, DOI 10.1016/j.bbrc.2007.01.110; Reyland ME, 2007, APOPTOSIS CELL SIGNA, V2, P1; Riester M, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju048; Ross FA, 2016, FEBS J, V283, P2987, DOI 10.1111/febs.13698; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shen L, 1999, MOL PHARMACOL, V55, P396, DOI 10.1124/mol.55.2.396; Shi L, 2014, BRIT J CANCER, V111, P2316, DOI 10.1038/bjc.2014.580; Vincent EE, 2015, ONCOGENE, V34, P3627, DOI 10.1038/onc.2014.301; Walz S, 2014, NATURE, V511, P483, DOI 10.1038/nature13473; Whelan RDH, 1999, CELL GROWTH DIFFER, V10, P271; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xiong XK, 2015, BIOCHEM BIOPH RES CO, V465, P262, DOI 10.1016/j.bbrc.2015.08.013; Zagorska A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000616; Zhang HY, 2015, ONCOL REP, V34, P1193, DOI 10.3892/or.2015.4113; Zhang XB, 2011, BBA-MOL CELL RES, V1813, P1978, DOI 10.1016/j.bbamcr.2011.03.010	64	18	19	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 22	2018	37	8					982	992		10.1038/onc.2017.394	http://dx.doi.org/10.1038/onc.2017.394			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FX2QD	29106388	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000425905700002
J	Garton, M; Sayadi, M; Kim, PM				Garton, Michael; Sayadi, Maryam; Kim, Philip M.			A computational approach for designing D-proteins with non-canonical amino acid optimised binding affinity	PLOS ONE			English	Article							THERMODYNAMIC INTEGRATION; MOLECULAR-DYNAMICS; PHAGE DISPLAY; FREE-ENERGY; PEPTIDE; SYSTEM; SIMULATION; CHAPERONE; DELIVERY; ANALOGS	Redesigning protein surface topology to improve target binding holds great promise in the search for highly selective therapeutics. While significant binding improvements can be achieved using natural amino acids, the introduction of non-canonical residues vastly increases sequence space and thus the chance to significantly out-compete native partners. The potency of protein inhibitors can be further enhanced by synthesising mirror image, D-amino versions. This renders them non-immunogenic and makes them highly resistant to proteolytic degradation. Current experimental design methods often preclude the use of D-amino acids and non-canonical amino acids for a variety of reasons. To address this, we build an in silico pipeline for D-protein designs featuring non-canonical amino acids. For a test scaffold we use an existing D-protein inhibitor of VEGF: D-RFX001. We benchmark the approach by recapitulating previous experimental optimisation with canonical amino acids. Subsequent incorporation of non-canonical amino acids allows designs that are predicted to improve binding affinity by up to -7.18 kcal/mol.	[Garton, Michael; Sayadi, Maryam; Kim, Philip M.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Kim, Philip M.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Kim, Philip M.] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto	Garton, M (corresponding author), Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada.	rnichael.garton@utoronto.ca			Canadian Institute of Health Research Operating Grant [MOP-123526]	Canadian Institute of Health Research Operating Grant(Canadian Institutes of Health Research (CIHR))	PMK acknowledges support from a Canadian Institute of Health Research Operating Grant (MOP-123526). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; PMK acknowledges support from a Canadian Institute of Health Research Operating Grant (MOP-123526).	Beierlein FR, 2011, BIOPHYS J, V101, P1130, DOI 10.1016/j.bpj.2011.07.003; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BRUGIDOU J, 1995, BIOCHEM BIOPH RES CO, V214, P685, DOI 10.1006/bbrc.1995.2340; Bruno BJ, 2013, THER DELIV, V4, P1443, DOI [10.4155/TDE.13.104, 10.4155/tde.13.104]; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chaudhury S, 2010, BIOINFORMATICS, V26, P689, DOI 10.1093/bioinformatics/btq007; Cole DJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002096; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; Gfeller D, 2013, NUCLEIC ACIDS RES, V41, pE327, DOI 10.1093/nar/gks991; Gibson JM, 2014, EXPERT OPIN DRUG SAF, V13, P1259, DOI 10.1517/14740338.2014.939951; Gonen S, 2015, SCIENCE, V348, P1365, DOI 10.1126/science.aaa9897; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Khavrutskii IV, 2011, J CHEM THEORY COMPUT, V7, P3001, DOI 10.1021/ct2003786; Kreil G, 1997, ANNU REV BIOCHEM, V66, P337, DOI 10.1146/annurev.biochem.66.1.337; Lawrenz M, 2012, METHODS MOL BIOL, V819, P469, DOI 10.1007/978-1-61779-465-0_27; Lee HC, 2014, J MOL GRAPH MODEL, V51, P37, DOI 10.1016/j.jmgm.2014.04.010; Li D, 2014, P NATL ACAD SCI USA, V111, P191, DOI 10.1073/pnas.1321797111; Liang XW, 2014, CURR MED CHEM, V21, P894, DOI 10.2174/09298673113206660264; Luo LS, 2002, BIOCHEMISTRY-US, V41, P9184, DOI 10.1021/bi026047+; Mandal K, 2012, P NATL ACAD SCI USA, V109, P14779, DOI 10.1073/pnas.1210483109; Mandell DJ, 2015, NATURE, V518, P55, DOI 10.1038/nature14121; Nickl CK, 2010, BBA-PROTEINS PROTEOM, V1804, P524, DOI 10.1016/j.bbapap.2009.12.004; Omidfar K, 2015, EXPERT OPIN DRUG DIS, V10, P651, DOI 10.1517/17460441.2015.1037738; Parker RN, 2015, BIOCHEM SOC T, V43, P856, DOI 10.1042/BST20150085; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rabideau AE, 2015, ACS CENTRAL SCI, V1, P423, DOI 10.1021/acscentsci.5b00308; Rashid MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078712; Renfrew PD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032637; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schumacher TNM, 1996, SCIENCE, V271, P1854, DOI 10.1126/science.271.5257.1854; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Shapovalov MV, 2011, STRUCTURE, V19, P844, DOI 10.1016/j.str.2011.03.019; Solomon SD, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005139.pub3; Steinbrecher T, 2011, J COMPUT CHEM, V32, P3253, DOI 10.1002/jcc.21909; Su PC, 2015, J COMPUT CHEM; Toukmaji A, 2000, J CHEM PHYS, V113, P10913, DOI 10.1063/1.1324708; Veine DM, 2014, CLIN EXP METASTASIS; Vriend G. WHAT IF, 1990, J MOL GRAPH, V8; Weinstock MT, 2014, P NATL ACAD SCI USA, V111, P11679, DOI 10.1073/pnas.1410900111; Wolf C, 2015, J AM CHEM SOC, V137, P13106, DOI 10.1021/jacs.5b08325; Wu CH, 2013, AMINO ACIDS, V44, P473, DOI 10.1007/s00726-012-1357-0; Young TS, 2010, J BIOL CHEM, V285, P11039, DOI 10.1074/jbc.R109.091306	44	6	6	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187524	10.1371/journal.pone.0187524	http://dx.doi.org/10.1371/journal.pone.0187524			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29108013	Green Published, Green Submitted, gold			2022-12-26	WOS:000414424600037
J	Grandahl, M; Larsson, M; Dalianis, T; Stenhammar, C; Tyden, T; Westerling, R; Neveus, T				Grandahl, Maria; Larsson, Margareta; Dalianis, Tina; Stenhammar, Christina; Tyden, Tanja; Westerling, Ragnar; Neveus, Tryggve			Catch-up HPV vaccination status of adolescents in relation to socioeconomic factors, individual beliefs and sexual behaviour	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; HIGH-SCHOOL-STUDENTS; CERVICAL-CANCER; DECISION-MAKING; PREDICTORS; SWEDEN; GIRLS; EXPERIENCES; PREVENTION; DAUGHTERS	In 2012, human papillomavirus (HPV) vaccination was introduced free of charge in the Swedish national school-based vaccination programme for 10-12-year-old girls, and as catch-up vaccination for young women. In Sweden, there is an ongoing discussion about including boys in the national vaccination programme. Few studies are undertaken about adolescents' knowledge, beliefs and HPV vaccination status in relation to socioeconomic status and sexual experience. Thus, the aim was to examine HPV catch-up vaccination status in adolescents in relation to 1) socioeconomic factors, 2) beliefs and knowledge about HPV prevention, and 3) sexual behaviour. The Health Belief Model was used as a theoretical framework. Upper secondary school students (n = 832) aged 16, randomly chosen from a larger sample, were invited to participate in conjunction with the general health interview with the school nurse. A total of 751/832 (90.3%), girls (n = 391, 52%) and boys (n = 360, 48%) completed the questionnaire. HPV vaccination was associated with ethnicity and the mothers' education level; i.e. girls with a non-European background and girls with a less educated mother were less likely to have received the vaccine (p < 0.01 and p = 0.04 respectively). Vaccinated girls perceived HPV infection as more severe (p = 0.01), had more insight into women's susceptibility to the infection (p = 0.02), perceived more benefits of the vaccine as protection against cervical cancer (p < 0.01) and had a higher intention to engage in HPV preventive behaviour (p = 0.01). Furthermore, boys and girls were almost equally sexually experienced, although fewer girls had used condom during first intercourse with their latest partner (p = 0.03). Finally, HPV vaccinated girls were less likely to have unprotected sex (p < 0.01). In summary, catch-up HPV vaccination among young girls was associated with a European background and high maternal education level, as well as more favourable beliefs towards HPV prevention and less sexual risk-taking. Further preventive measures should therefore be directed at the migrant population.	[Grandahl, Maria; Larsson, Margareta; Stenhammar, Christina; Tyden, Tanja; Neveus, Tryggve] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Grandahl, Maria; Westerling, Ragnar] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [Dalianis, Tina] Karolinska Univ Hosp, Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden	Uppsala University; Uppsala University; Karolinska Institutet; Karolinska University Hospital	Grandahl, M (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.; Grandahl, M (corresponding author), Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden.	maria.grandahl@pubcare.uu.se		Dalianis, Tina/0000-0001-7022-2424	Swedish Cancer Society [130744]; Uppsala Orebro Regional Research Council [RFR-387561/476021]; Swedish Association of School nurses	Swedish Cancer Society(Swedish Cancer Society); Uppsala Orebro Regional Research Council; Swedish Association of School nurses	This work was supported by the Swedish Cancer Society grant number 130744, Uppsala Orebro Regional Research Council grant number RFR-387561/476021. The sponsors had no role in the design of the study or in how it was conducted, including collection, management, analysis, and interpretation of the data as well as preparation, review, or approval of the manuscript and finally, the decision to submit the manuscript for publication.; We thank all the participants; especially the adolescents and the school nurses. We also thank the heads of the school health in each municipality and the principals of the schools. A special thanks to the Swedish Association of School nurses for support, and for allowing us to present the project at the national conference.	[Anonymous], 2013, NATIONAL HEALTH QUES; Arnheim-Dahlstom L, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5906; Bowyer HL, 2014, J FAM PLAN REPROD H, V40, P14, DOI 10.1136/jfprhc-2013-100583; Brotherton JML, 2014, J PAEDIATR CHILD H, V50, P959, DOI 10.1111/jpc.12627; Bruni L, 2016, LANCET GLOB HEALTH, V4, pE453, DOI 10.1016/S2214-109X(16)30099-7; Champion VL, 2008, HEALTH BEHAVIOR AND; Cummings T, 2015, SEX TRANSM DIS, V42, P601, DOI 10.1097/OLQ.0000000000000358; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Donadiki EM, 2014, PUBLIC HEALTH, V128, P268, DOI 10.1016/j.puhe.2013.12.004; Editors TPM, 2014, PLOS MED, V11; Ekstrand M, 2011, EUR J CONTRACEP REPR, V16, P100, DOI 10.3109/13625187.2010.549253; Fridlund V, 2014, SCAND J PUBLIC HEALT, V42, P759, DOI 10.1177/1403494814550518; Gerend MA, 2016, SEX TRANSM DIS, V43, P185, DOI 10.1097/OLQ.0000000000000408; Gerend MA, 2012, ANN BEHAV MED, V44, P171, DOI 10.1007/s12160-012-9366-5; Gordon D, 2011, VACCINE, V29, P7350, DOI 10.1016/j.vaccine.2011.07.083; Gottvall M, 2010, INT J STD AIDS, V21, P558, DOI 10.1258/ijsa.2010.010063; Gottvall M, 2013, UPSALA J MED SCI, V118, P263, DOI 10.3109/03009734.2013.809039; Grandahl M, 2017, J SCHOOL HEALTH, V87, P62, DOI 10.1111/josh.12470; Grandahl M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009875; Grandahl M, 2015, HEALTH EXPECT, V18, P344, DOI 10.1111/hex.12034; Grandahl M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-540; Grandahl M, 2014, ACTA PAEDIATR, V103, P436, DOI 10.1111/apa.12545; Hansen BT, 2015, PREV MED, V77, P4, DOI 10.1016/j.ypmed.2015.04.024; Herlitz CA, 2010, SCAND J PUBLIC HEALT, V38, P32, DOI 10.1177/1403494809355072; Hilton S, 2013, VACCINE, V31, P2543, DOI 10.1016/j.vaccine.2013.04.023; International Agency for Research on Cancer (IARC), 2012, MON EV CARC RISKS HU, V100; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Juraskova I, 2011, WOMEN HEALTH ISS, V21, P71, DOI 10.1016/j.whi.2010.08.004; Krakow MM, 2015, WOMEN HEALTH ISS, V25, P105, DOI 10.1016/j.whi.2014.11.006; Krawczyk A, 2015, HUM VACC IMMUNOTHER, V11, P322, DOI 10.1080/21645515.2014.1004030; Marek E, 2016, EUR J CANCER CARE, V25, P57, DOI 10.1111/ecc.12332; Marek E, 2011, VACCINE, V29, P8591, DOI 10.1016/j.vaccine.2011.09.018; Markowitz LE, 2012, VACCINE, V30, pF139, DOI 10.1016/j.vaccine.2012.05.039; Marlow LAV, 2009, J EPIDEMIOL COMMUN H, V63, P1010, DOI 10.1136/jech.2008.085886; Mattebo M, 2014, EUR J CONTRACEP REPR, V19, P86, DOI 10.3109/13625187.2013.878021; Ogilvie G, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000270; Oscarsson MG, 2012, SEX REPROD HEALTHC, V3, P141, DOI 10.1016/j.srhc.2012.10.002; Patel H, 2016, SEX TRANSM INFECT, V92, P474, DOI 10.1136/sextrans-2015-052341; Public Health Agency of Sweden, VACCINATION AV BARN; Public Health Agency of Sweden, STATISTICS FOR HPV V; Public Health Agency of Sweden [Folkhalsomyndigheten], HUMAN PAPILLOMAVIRUS; Reiter PL, 2009, SOC SCI MED, V69, P475, DOI 10.1016/j.socscimed.2009.05.024; Robbins SCC, 2010, HEALTH PSYCHOL, V29, P618, DOI 10.1037/a0021449; Rysavy MB, 2014, J PEDIATR ADOL GYNEC, V27, P67, DOI 10.1016/j.jpag.2013.08.009; Schreiber SMS, 2015, J ADOLESCENT HEALTH, V56, P402, DOI 10.1016/j.jadohealth.2014.12.008; Statistics Sweden, ANDELEN BARN SOM INV; Statistics Sweden, 2013, THE FUTURE POPULATIO; Stenhammar C, 2015, ACTA OBSTET GYN SCAN, V94, P253, DOI 10.1111/aogs.12565; Tung ILY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161846; Wangdahl J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1030	50	21	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							e0187193	10.1371/journal.pone.0187193	http://dx.doi.org/10.1371/journal.pone.0187193			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL6TA	29099839	Green Published, Green Submitted, gold			2022-12-26	WOS:000414377900014
J	Zhao, JF; Pu, FY; Li, YP; Xu, JW; Lie, N; Zhang, Y; Gun, JP; Pan, ZH				Zhao, Junfang; Pu, Feiyu; Li, Yunpeng; Xu, Jingwen; Lie, Ning; Zhang, Yi; Gun, Jianping; Pan, Zhihua			Assessing the combined effects of climatic factors on spring wheat phenophase and grain yield in Inner Mongolia, China	PLOS ONE			English	Article							NORTHEAST CHINA; CHANGING CLIMATE; LOESS PLATEAU; WINTER-WHEAT; APSIM-WHEAT; MODEL; MAIZE; SOIL; VALIDATION; SIMULATION	Understanding the regional relationships between climate change and crop production will benefit strategic decisions for future agricultural adaptation in China. In this study, the combined effects of climatic factors on spring wheat phenophase and grain yield over the past three decades in Inner Mongolia, China, were explored based on the daily climate variables from 1981-2014 and detailed observed data of spring wheat from 1981-2014. Inner Mongolia was divided into three different climate type regions, the eastern, central and western regions. The data were gathered from 10 representative agricultural meteorological experimental stations in Inner Mongolia and analysed with the Agricultural Production Systems Simulator (APSIM) model. First, the performance of the APSIM model in the spring wheat planting areas of Inner Mongolia was tested. Then, the key climatic factors limiting the phenophases and yield of spring wheat were identified. Finally, the responses of spring wheat phenophases and yield to climate change were further explored regionally. Our results revealed a general yield reduction of spring wheat in response to the pronounced climate warming from 1981 to 2014, with an average of 3564 kg.ha(-1). The regional differences in yields were significant. The maximum potential yield of spring wheat was found in the western region. However, the minimum potential yield was found in the middle region. The air temperature and soil surface temperature were the optimum climatic factors that affected the key phenophases of spring wheat in Inner Mongolia. The influence of the average maximum temperature on the key phenophases of spring wheat was greater than the average minimum temperature, followed by the relative humidity and solar radiation. The most insensitive climatic factors were precipitation, wind speed and reference crop evapotranspiration. As for the yield of spring wheat, temperature, solar radiation and air relative humidity were major meteorological factors that affected in the eastern and western Inner Mongolia. Furthermore, the effect of the average minimum temperature on yield was greater than that of the average maximum temperature. The increase of temperature in the western and middle regions would reduce the spring wheat yield, while in the eastern region due to the rising temperature, the spring wheat yield increased. The increase of solar radiation in the eastern and central regions would increase the yield of spring wheat. The increased air relative humidity would make the western spring wheat yield increased and the eastern spring wheat yield decreased. Finally, the models describing combined effects of these dominant climatic factors on the maturity and yield in different regions of Inner Mongolia were used to establish geographical differences. Our findings have important implications for improving climate change impact studies and for local agricultural production to cope with ongoing climate change.	[Zhao, Junfang; Zhang, Yi; Gun, Jianping] Chinese Acad Meteorol Sci, State Key Lab Severe Weather, Beijing, Peoples R China; [Pu, Feiyu; Xu, Jingwen; Lie, Ning] Sichuan Agr Univ, Resources Coll, Chengdu, Sichuan, Peoples R China; [Li, Yunpeng] Inner Mongolia Ecol & Agrometeorol Ctr, Hohhot, Peoples R China; [Pan, Zhihua] China Agr Univ, Coll Resources & Environm Sci, Beijing, Peoples R China	Chinese Academy of Meteorological Sciences (CAMS); Chinese Academy of Sciences; Sichuan Agricultural University; China Agricultural University	Zhao, JF (corresponding author), Chinese Acad Meteorol Sci, State Key Lab Severe Weather, Beijing, Peoples R China.	zhaojfcams@163.com	xu, jing/GRR-8698-2022		Chinese Academy of Meteorological Sciences Basic Research Funds-regular [2017R001, 2017Z004]; National Non-profit Research Foundation for Meteorology [GYHY201506016]	Chinese Academy of Meteorological Sciences Basic Research Funds-regular; National Non-profit Research Foundation for Meteorology	This work was supported by the Chinese Academy of Meteorological Sciences Basic Research Funds-regular (2017R001, 2017Z004) and the National Non-profit Research Foundation for Meteorology (GYHY201506016) to Junfang Zhao.	Ahmed M, 2016, COMPUT ELECTRON AGR, V123, P384, DOI 10.1016/j.compag.2016.03.015; Allen R.G., 1998, FAO IRRIGATION AND D; Asseng S, 2002, EUR J AGRON, V16, P25, DOI 10.1016/S1161-0301(01)00116-2; Asseng S, 1998, FIELD CROP RES, V57, P163, DOI 10.1016/S0378-4290(97)00117-2; Asseng S., 2014, ENCY AGR FOOD SYSTEM, V5, P102, DOI [10.1016/B978-0-444-52512-3.00233-3, DOI 10.1016/B978-0-444-52512-3.00233-3]; Balwinder-Singh, 2011, FIELD CROP RES, V124, P1, DOI 10.1016/j.fcr.2011.04.016; Bassu S, 2009, FIELD CROP RES, V111, P109, DOI 10.1016/j.fcr.2008.11.002; Chen C, 2010, AGR WATER MANAGE, V97, P1175, DOI 10.1016/j.agwat.2008.11.012; Craufurd PQ, 2009, J EXP BOT, V60, P2529, DOI 10.1093/jxb/erp196; DeJonge KC, 2012, ECOL MODEL, V231, P113, DOI 10.1016/j.ecolmodel.2012.01.024; Dong LiXia, 2013, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V21, P1016, DOI 10.3724/SP.J.1011.2013.01016; Duffie J. A., 1991, SOLAR ENGINEERING OF; Eitzinger J, 2004, ECOL MODEL, V171, P223, DOI 10.1016/j.ecolmodel.2003.08.012; Gauch HG, 2003, AGRON J, V95, P1442, DOI 10.2134/agronj2003.1442; Geum Y, 2011, MATH COMPUT MODEL, V54, P3126, DOI 10.1016/j.mcm.2011.07.042; Godwin DC, 1998, SYST APPR S, V7, P55; Gornott C, 2016, AGR FOREST METEOROL, V217, P89, DOI 10.1016/j.agrformet.2015.10.005; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Huth NI, 2002, EUR J AGRON, V18, P171, DOI 10.1016/S1161-0301(02)00103-X; IPCC, 2014, CLIMATE CHANGE IMPAC; Jones JW, 2003, EUR J AGRON, V18, P235, DOI 10.1016/S1161-0301(02)00107-7; Keating BA, 2003, EUR J AGRON, V18, P267, DOI 10.1016/S1161-0301(02)00108-9; Li KN, 2014, YIELD GAP ANALYSIS F; Licker R, 2013, AGR FOREST METEOROL, V176, P25, DOI 10.1016/j.agrformet.2013.02.010; Liu ZJ, 2016, SCI TOTAL ENVIRON, V541, P756, DOI 10.1016/j.scitotenv.2015.08.145; Liu ZJ, 2012, GLOBAL CHANGE BIOL, V18, P3441, DOI 10.1111/j.1365-2486.2012.02774.x; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Ma LW, 2009, AGRON J, V101, P572, DOI 10.2134/agronj2008.0206x; MANABE S, 1981, CLIMATIC CHANGE, V3, P347, DOI 10.1007/BF00139743; McCown RL, 1996, AGR SYST, V50, P255, DOI 10.1016/0308-521X(94)00055-V; Mo F, 2016, FIELD CROP RES, V196, P337, DOI 10.1016/j.fcr.2016.06.024; Monsi M, 2005, ANN BOT-LONDON, V95, P549, DOI 10.1093/aob/mci052; PENMAN HL, 1948, PROC R SOC LON SER-A, V193, P120, DOI 10.1098/rspa.1948.0037; Pinera-Chavez FJ, 2016, FIELD CROP RES, V196, P64, DOI 10.1016/j.fcr.2016.06.007; Ritchie JT, 1998, SYST APPR S, V7, P79; Sayre KD, 1997, CROP SCI, V37, P36, DOI 10.2135/cropsci1997.0011183X003700010006x; Sun HY, 2016, FIELD CROP RES, V194, P94, DOI 10.1016/j.fcr.2016.05.007; Tao FL, 2014, AGR FOREST METEOROL, V189, P91, DOI 10.1016/j.agrformet.2014.01.013; Valiantzas JD, 2013, J HYDROL, V505, P13, DOI 10.1016/j.jhydrol.2013.09.005; Wang XC, 2012, AGR ECOSYST ENVIRON, V161, P152, DOI 10.1016/j.agee.2012.07.013; WILLMOTT CJ, 1985, J GEOPHYS RES-OCEANS, V90, P8995, DOI 10.1029/JC090iC05p08995; Xie Y, 2012, PROCEDIA ENGINEER, V29, P3149, DOI 10.1016/j.proeng.2012.01.456; Xiong W, 2008, ECOL MODEL, V213, P365, DOI 10.1016/j.ecolmodel.2008.01.005; Yang XG, 2015, AGR FOREST METEOROL, V208, P76, DOI 10.1016/j.agrformet.2015.04.024; Zhao G, 2014, ECOL MODEL, V279, P1, DOI 10.1016/j.ecolmodel.2014.02.003; Zhao JF, 2013, MONGOLIAN PLATEAU AN; Zhao JF, 2016, SCI TOTAL ENVIRON, V573, P965, DOI 10.1016/j.scitotenv.2016.08.195; Zhao JF, 2015, AGR ECOSYST ENVIRON, V207, P79, DOI 10.1016/j.agee.2015.04.006	48	13	14	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							e0185690	10.1371/journal.pone.0185690	http://dx.doi.org/10.1371/journal.pone.0185690			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6TA	29099842	gold, Green Submitted, Green Published			2022-12-26	WOS:000414377900005
J	Baede, VO; Broens, EM; Spaninks, MP; Timmerman, AJ; Graveland, H; Wagenaar, JA; Duim, B; Hordijk, J				Baede, Valerie O.; Broens, Els M.; Spaninks, Mirlin P.; Timmerman, Arjen J.; Graveland, Haitske; Wagenaar, Jaap A.; Duim, Birgitta; Hordijk, Joost			Raw pet food as a risk factor for shedding of extended-spectrum beta-lactamase-producing Enterobacteriaceae in household cats	PLOS ONE			English	Article							AMPC-PRODUCING ENTEROBACTERIACEAE; ESCHERICHIA-COLI; ANTIMICROBIAL SUSCEPTIBILITY; COMPANION ANIMALS; DOGS PREVALENCE; CTX-M; RESISTANCE; RELATEDNESS; CARRIAGE; PATTERNS	Background Close contact between pets and owners provides the opportunity for transmission of antimicrobial resistant organisms like extended-spectrum beta-lactamase (ESBL)/AmpC beta-lactamase (AmpC)-producing Enterobacteriaceae, posing a risk to public health. Objectives To investigate whether raw feed is a risk factor for household cats to shed ESBL-producing Enterobacteriaceae, a cohort study was designed. Additionally, raw and non-raw commercial pet food products were screened for the presence of ESBL-producing Enterobacteriaceae. Methods Weekly fecal samples of 17 cats in the control group and 19 cats in the exposed group were collected for three weeks and analyzed for the presence of ESBL-producing Enterobacteriaceae. Questionnaires were obtained to determine additional risk factors. Fecal samples were cultured on MacConkey agar supplemented with 1 mg/L cefotaxime. PCR and sequence analysis was used for screening for ESBL genes in suspected isolates. Pet food samples were cultured in LB broth supplemented with 1 mg/L cefotaxime and processed as described above. Results In the cohort study, ESBL-producing bacteria were isolated from 3 of 51 (5.9%) samples in the control group compared to 37 of 57 (89.5%) samples in the exposed group. A significant association was found between ESBL shedding and feeding raw pet food products (OR = 31.5). No other risk factors were identified in this study. ESBL-producing Enterobacteriaceae were isolated from 14 of 18 (77.8%) raw pet food products and 0 of 35 that no competing interests exist. non-raw pet food products. Conclusions This study shows a strong association between shedding of ESBL-producing bacteria in household cats and feeding raw pet food. Raw pet food was often contaminated with ESBL-producing Enterobacteriaceae.	[Baede, Valerie O.; Broens, Els M.; Spaninks, Mirlin P.; Timmerman, Arjen J.; Graveland, Haitske; Wagenaar, Jaap A.; Duim, Birgitta; Hordijk, Joost] Univ Utrecht, Dept Infect Dis & Immunol, Fac Vet Med, Utrecht, Netherlands; [Wagenaar, Jaap A.] Wageningen Biovet Res, Lelystad, Netherlands; [Baede, Valerie O.] Univ Med Ctr, Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands	Utrecht University; Wageningen University & Research; Erasmus University Rotterdam; Erasmus MC	Hordijk, J (corresponding author), Univ Utrecht, Dept Infect Dis & Immunol, Fac Vet Med, Utrecht, Netherlands.	j.hordijk@uu.nl		Baede, Valerie/0000-0002-0702-8263	animal production sectors, as part of the ESBL attribution project (ESBLAT) [TKI-AF-12067]; Dutch Ministry of Economic Affairs	animal production sectors, as part of the ESBL attribution project (ESBLAT); Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	This project was funded by the Dutch Ministry of Economic Affairs and the animal production sectors, as part of the ESBL attribution project (ESBLAT), grant number TKI-AF-12067. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baede VO, 2015, ANTIMICROB AGENTS CH, V59, P3117, DOI 10.1128/AAC.04576-14; Blaak H, 2014, VET MICROBIOL, V171, P448, DOI 10.1016/j.vetmic.2014.03.007; Blaak H, 2014, INT J FOOD MICROBIOL, V168, P8, DOI 10.1016/j.ijfoodmicro.2013.10.006; Carvalho AC, 2016, BRAZ J MICROBIOL, V47, P150, DOI 10.1016/j.bjm.2015.11.005; Costa D, 2006, J ANTIMICROB CHEMOTH, V58, P1311, DOI 10.1093/jac/dkl415; Dahmen S, 2013, J ANTIMICROB CHEMOTH, V68, P2797, DOI 10.1093/jac/dkt291; Damborg P, 2012, VET MICROBIOL, V154, P298, DOI 10.1016/j.vetmic.2011.07.005; Damborg P, 2011, VET MICROBIOL, V151, P404, DOI 10.1016/j.vetmic.2011.03.015; Ewers C, 2012, CLIN MICROBIOL INFEC, V18, P646, DOI 10.1111/j.1469-0691.2012.03850.x; Ewers C, 2010, J ANTIMICROB CHEMOTH, V65, P651, DOI 10.1093/jac/dkq004; Hansen KH, 2013, APPL ENVIRON MICROB, V79, P794, DOI 10.1128/AEM.02399-12; Hordijk J, 2013, J ANTIMICROB CHEMOTH, V68, P2468, DOI 10.1093/jac/dkt219; Hordijk J, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00242; Huber H, 2013, VET MICROBIOL, V162, P992, DOI 10.1016/j.vetmic.2012.10.029; Jett BD, 1997, BIOTECHNIQUES, V23, P648, DOI 10.2144/97234bm22; Johnson JR, 2008, J INFECT DIS, V197, P218, DOI 10.1086/524844; Korzeniewska E, 2013, J ENVIRON MANAGE, V128, P904, DOI 10.1016/j.jenvman.2013.06.051; Laube H, 2014, VET MICROBIOL, V172, P519, DOI 10.1016/j.vetmic.2014.06.008; Laube H, 2013, APPL ENVIRON MICROB, V79, P4815, DOI 10.1128/AEM.00856-13; Ljungquist Oskar, 2016, Infection Ecology & Epidemiology, V6, P31514, DOI 10.3402/iee.v6.31514; Maddox TW, 2012, EQUINE VET J, V44, P297, DOI 10.1111/j.2042-3306.2011.00440.x; Nijsse R, 2015, PARASITOL RES, V114, P561, DOI 10.1007/s00436-014-4218-9; Nilsson Oskar, 2015, Infection Ecology & Epidemiology, V5, P28758, DOI 10.3402/iee.v5.28758; Poeta P, 2009, J BASIC MICROB, V49, P584, DOI 10.1002/jobm.200900066; Schmidt VM, 2015, PREV VET MED, V119, P31, DOI 10.1016/j.prevetmed.2015.01.013; Schwarz S, 2010, J ANTIMICROB CHEMOTH, V65, P601, DOI 10.1093/jac/dkq037; Shaheen BW, 2011, ANTIMICROB AGENTS CH, V55, P5666, DOI 10.1128/AAC.00656-11; Stenske KA, 2009, AM J VET RES, V70, P1108, DOI 10.2460/ajvr.70.9.1108; Strohmeyer RA, 2006, JAVMA-J AM VET MED A, V228, P537, DOI 10.2460/javma.228.4.537; Sun Y, 2010, CLIN MICROBIOL INFEC, V16, P1475, DOI 10.1111/j.1469-0691.2010.03127.x; Wedley AL, 2017, VET MICROBIOL, V199, P23, DOI 10.1016/j.vetmic.2016.11.017; Weese JS, 2005, CAN VET J, V46, P513; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x	33	39	40	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187239	10.1371/journal.pone.0187239	http://dx.doi.org/10.1371/journal.pone.0187239			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095871	Green Published, Green Submitted			2022-12-26	WOS:000414340200060
J	Chen, YC; Ho, CC; Yi, CH; Liu, XZ; Cheng, TT; Lam, CF				Chen, Yen-Cheng; Ho, Ching-Chun; Yi, Chih-Hsun; Liu, Xiu-Zhu; Cheng, Tzu-Ting; Lam, Chen-Fuh			Exendin-4, a glucagon-like peptide-1 analogue accelerates healing of chronic gastric ulcer in diabetic rats	PLOS ONE			English	Article							ACETIC-ACID ULCER; MOLECULAR-MECHANISMS; OXIDATIVE STRESS; MELLITUS; PROTEIN; MATRIX	Background Diabetes mellitus is an independent risk factor for impaired healing of peptic ulcers, and there are currently no supplementary therapeutics other than the standard antipeptic medicine to improve the ulcer healing in diabetes. This study examined the potential pleiotropic effect of a glucagon-like peptide (Glp)-1 analogue exendin (Ex)-4 on the regeneration of gastric ulcer in streptozotocin-induced diabetic rats. Methods and results Chronic ulcer was created in rat stomach by submucosal injection of acetic acid and peri-ulcer tissues were analyzed 7 days after operation. Ulcer wound healing was impaired in diabetic rats with suppressed tissue expression of eNOS and enhanced levels of pro-inflammatory reactions. Treatment with intraperitoneal injection of Ex4 (0.5 mu g/kg/d) significantly reduced the area of gastric ulcer without changing blood glucose level. Ex-4 restored the expression of pro-angiogenic factors, and attenuated the generation of regional inflammation and superoxide anions. The improvement of ulcer healing was associated with increased expression of MMP-2 and formation of granulation tissue in the peri-ulcer area. Conclusion Administration of Ex4 may induce pro-angiogenic, anti-inflammatory and anti-oxidative reactions in the peri-ulcer tissue of diabetic rats that eventually enhances tissue granulation and closure of ulcerative wounds. Our results support the potential clinical application of Glp-1 analogues as supplementary hypoglycemic agents in the antipeptic ulcer medication in diabetes.	[Chen, Yen-Cheng; Ho, Ching-Chun] Buddhist Tzu Chi Gen Hosp, Dept Surg, Hualien, Taiwan; [Yi, Chih-Hsun] Buddhist Tzu Chi Gen Hosp, Dept Internal Med, Hualien, Taiwan; [Liu, Xiu-Zhu; Lam, Chen-Fuh] Buddhist Tzu Chi Gen Hosp, Dept Anesthesiol, Hualien, Taiwan; [Cheng, Tzu-Ting; Lam, Chen-Fuh] I Shou Univ, Dept Anesthesiol, E Da Hosp, E Da Canc Hosp, Kaohsiung, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; E-Da Hospital; I Shou University	Lam, CF (corresponding author), Buddhist Tzu Chi Gen Hosp, Dept Anesthesiol, Hualien, Taiwan.; Lam, CF (corresponding author), I Shou Univ, Dept Anesthesiol, E Da Hosp, E Da Canc Hosp, Kaohsiung, Taiwan.	ed110208@edah.org.tw			Ministry of Science and Technology, Taiwan [MOST 105-2314-B-303-007-MY2]; Hualien Buddhist Tzu Chi General Hospital, Taiwan [TCRD105-07, TCRD105-06]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Hualien Buddhist Tzu Chi General Hospital, Taiwan	This work was supported, in part, by research grants obtained from the Ministry of Science and Technology, Taiwan (grant number MOST 105-2314-B-303-007-MY2 to C.F.L) and the Hualien Buddhist Tzu Chi General Hospital, Taiwan (grant numbers TCRD105-07 to Y.C.C and TCRD105-06 to C.F.L). The funders had no role in study design, data collection and analysis, decision to publish, or preparation ofthe manuscript.r This work was supported by research grants obtained from the Ministry of Science and Technology, Taiwan (grant number MOST 105-2314-B-303-007-MY2 to C.F.L) and the Hualien Buddhist Tzu Chi General Hospital, Taiwan (grant numbers TCRD105-07 to Y.C.C and TCRD105-06 to C.F.L). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arab HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122417; Arakawa T, 2012, WORLD J GASTROENTERO, V18, P4811, DOI 10.3748/wjg.v18.i35.4811; Aviram M, 2004, FREE RADICAL BIO MED, V37, P1301, DOI 10.1016/j.freeradbiomed.2004.07.009; Bacci S, 2015, EUR J PHARMACOL, V764, P346, DOI 10.1016/j.ejphar.2015.06.056; Baraka AM, 2010, BIOCHEM PHARMACOL, V79, P1634, DOI 10.1016/j.bcp.2010.02.001; Berlanga-Acosta J, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/256043; Boehme MWJ, 2007, HEPATO-GASTROENTEROL, V54, P643; Broide E, 2014, J CLIN ENDOCR METAB, V99, pE1691, DOI 10.1210/jc.2014-1114; Brzozowska I, 2004, J PHYSIOL PHARMACOL, V55, P773; Donnelly D, 2012, BRIT J PHARMACOL, V166, P27, DOI 10.1111/j.1476-5381.2011.01687.x; Fang SY, 2014, J VASC RES, V51, P81, DOI 10.1159/000357619; Fouad AA, 2010, EUR J PHARMACOL, V637, P162, DOI 10.1016/j.ejphar.2010.04.007; Gallwitz B, 2016, ENDOCR DEV, V31, P43, DOI 10.1159/000439372; Guha P, 2010, BRIT J PHARMACOL, V159, P726, DOI 10.1111/j.1476-5381.2009.00572.x; Harsch IA, 2003, EUR J PHARMACOL, V481, P249, DOI 10.1016/j.ejphar.2003.09.019; Kangwan Napapan, 2014, World J Gastrointest Pathophysiol, V5, P40, DOI 10.4291/wjgp.v5.i1.40; Kissow H, 2013, GUT, V62, P1724, DOI 10.1136/gutjnl-2012-303280; Kobayashi T, 2001, ATHEROSCLEROSIS, V155, P313, DOI 10.1016/S0021-9150(00)00583-9; Lempinen M, 2000, EUR SURG RES, V32, P169, DOI 10.1159/000008759; Lim JH, 2015, SURG ENDOSC, V29, P3666, DOI 10.1007/s00464-015-4123-z; Maity B, 2009, INT IMMUNOPHARMACOL, V9, P491, DOI 10.1016/j.intimp.2009.01.028; Mimura S, 2013, SCAND J GASTROENTERO, V48, P1152, DOI 10.3109/00365521.2013.832366; Newsholme P, 2016, BIOCHEM J, V473, P4527, DOI 10.1042/BCJ20160503C; Nystrom T, 2004, AM J PHYSIOL-ENDOC M, V287, pE1209, DOI 10.1152/ajpendo.00237.2004; Oeseburg H, 2010, ARTERIOSCL THROM VAS, V30, P1407, DOI 10.1161/ATVBAHA.110.206425; Okabe S, 2005, BIOL PHARM BULL, V28, P1321, DOI 10.1248/bpb.28.1321; OKABE S, 1972, AM J DIG DIS, V17, P619, DOI 10.1007/BF02231748; Peng YL, 2013, J GASTROEN HEPATOL, V28, P1295, DOI 10.1111/jgh.12190; Pradhan L, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000945; Rao XQ, 2014, LIFE SCI, V116, P59, DOI 10.1016/j.lfs.2014.09.015; Rashed L, 2016, TISSUE CELL, V48, P644, DOI 10.1016/j.tice.2016.09.006; Roan JN, 2017, J SURG RES, V208, P93, DOI 10.1016/j.jss.2016.09.024; Scheen AJ, 2015, DIABETES METAB, V41, P183, DOI 10.1016/j.diabet.2015.02.003; Shahin M, 2001, MICROSC RES TECHNIQ, V53, P396, DOI 10.1002/jemt.1108; Smits MM, 2016, GUT, V65, P702, DOI 10.1136/gutjnl-2015-310572; Tabit CE, 2010, REV ENDOCR METAB DIS, V11, P61, DOI 10.1007/s11154-010-9134-4; Tarnawski AS, 2005, DIGEST DIS SCI, V50, pS24, DOI 10.1007/s10620-005-2803-6; Tseng PH, 2012, DIABETES CARE, V35, P1053, DOI 10.2337/dc11-1596	38	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187434	10.1371/journal.pone.0187434	http://dx.doi.org/10.1371/journal.pone.0187434			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095895	gold, Green Published, Green Submitted			2022-12-26	WOS:000414340200089
J	Fu, C; Lv, RR; Xu, GQ; Zhang, LF; Bi, JH; Lin, L; Liu, XW; Huo, R				Fu, Cong; Lv, Renrong; Xu, Guangqi; Zhang, Linfeng; Bi, Jianhai; Lin, Li; Liu, Xiaowen; Huo, Ran			Circular RNA profile of infantile hemangioma by microarray analysis	PLOS ONE			English	Article							IDENTIFICATION; EXPRESSION; ABUNDANT; GROWTH	Background Circular RNAs (circRNAs) are a recently identified class of noncoding RNAs that participate in several physiological processes. However, the expression of circRNAs in infantile hemangioma (IH) remains unknown. Methods The profile of circRNAs was assessed by microarray in four pairs of IH and adjacent skin tissues. The expression of circRNAs was validated by quantitative reverse transcription polymerase chain reaction (qRT-PCR). Furthermore, circRNA-microRNAs (miRNA)-mRNA networks were constructed using bioinformatics tools. Results 234 up- and 374 down-regulated circRNAs were identified in IH by microarray. Among them, the expression of two up-regulated circRNAs (hsa_circRNA_100933 and hsa_-circRNA_100709) and one down-regulated circRNA (hsa_circRNA_104310) was confirmed by qRT-PCR. In addition, 3,019 miRNA response elements (MREs) of circRNAs were predicted, and two circRNA-miRNA-mRNA networks were constructed, including 100 and 94 target genes of hsa_circRNA_100933 and hsa_circRNA_104310, respectively. GO and pathway analysis showed that both networks participated in angiogenesis and vascular development-related biological processes. Conclusions This is the first study to reveal the profiling of circRNAs in IH and pave the way for further characterization of the role of circRNAs in the pathogenesis of IH.	[Fu, Cong; Lv, Renrong; Xu, Guangqi; Zhang, Linfeng; Bi, Jianhai; Lin, Li; Liu, Xiaowen; Huo, Ran] Shandong Univ, Dept Burn & Plast Surg, Shandong Prov Hosp, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Huo, R (corresponding author), Shandong Univ, Dept Burn & Plast Surg, Shandong Prov Hosp, Jinan, Shandong, Peoples R China.	huoran@medmail.com.cn			National Natural Science Foundation of China [81671927]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (Grant No. 81671927) (URL: http://www.nsfc.gov.cn/). RH received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I., 2016, ONCOTARGET; Anderson KR, 2016, J AM ACAD DERMATOL, V74, P120, DOI 10.1016/j.jaad.2015.08.024; Boeckel JN, 2015, CIRC RES, V117, P884, DOI 10.1161/CIRCRESAHA.115.306319; Chen GJ, 2010, J NEURO-ONCOL, V99, P195, DOI 10.1007/s11060-010-0125-9; Chen I, 2015, WIRES RNA, V6, P563, DOI 10.1002/wrna.1294; Chen YH, 2016, J MED GENET, V53, P359, DOI 10.1136/jmedgenet-2016-103758; COCQUERELLE C, 1993, FASEB J, V7, P155, DOI 10.1096/fasebj.7.1.7678559; Cortes-Lopez Mariela, 2016, Yale Journal of Biology and Medicine, V89, P527; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Enright AJ, 2004, GENOME BIOL, V5; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Gao F, 2017, INT J ONCOL, V50, P1821, DOI 10.3892/ijo.2017.3943; Guo JU, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0409-z; Haggstrom AN, 2007, J PEDIATR-US, V150, P291, DOI 10.1016/j.jpeds.2006.12.003; Hansen TB, 2013, CANCER RES, V73, P5609, DOI 10.1158/0008-5472.CAN-13-1568; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang J, 2017, ANN NEUROL; Itinteang T, 2014, FRONT SURG, V1, DOI 10.3389/fsurg.2014.00038; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Ji Y, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-13; Leaute-Labreze C, 2010, PRESSE MED, V39, P499, DOI 10.1016/j.lpm.2009.10.015; Li DF, 2017, INT J MOL MED, V39, P757, DOI 10.3892/ijmm.2017.2863; Liu X., 2016, TUMOUR BIOL; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Munden A, 2014, BRIT J DERMATOL, V170, P907, DOI 10.1111/bjd.12804; NIGRO JM, 1991, CELL, V64, P607, DOI 10.1016/0092-8674(91)90244-S; North PE, 2000, HUM PATHOL, V31, P11, DOI 10.1016/S0046-8177(00)80192-6; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Peres J, 2017, CANCER LETT, V405, P111, DOI 10.1016/j.canlet.2017.07.018; Przewratil P, 2010, CYTOKINE, V49, P141, DOI 10.1016/j.cyto.2009.11.012; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Salzman J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003777; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; Sand M, 2016, J DERMATOL SCI, V83, P210, DOI 10.1016/j.jdermsci.2016.05.012; Sand M, 2016, EPIGENOMICS-UK, V8, P619, DOI 10.2217/epi-2015-0019; Strub GM, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88856; Sun ZY, 2008, MED HYPOTHESES, V71, P444, DOI 10.1016/j.mehy.2008.03.013; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Wang D, 2017, J CELL BIOCH; Wu Y, 2017, ONCOL RES; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xu HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep12453; Yu XL, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0528-0; Yu Y, 2004, BLOOD, V103, P1373, DOI 10.1182/blood-2003-08-2859; Zheng QP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11215; Zou HX, 2013, CARDIOVASC PATHOL, V22, P203, DOI 10.1016/j.carpath.2012.10.001	47	17	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187581	10.1371/journal.pone.0187581	http://dx.doi.org/10.1371/journal.pone.0187581			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095957	Green Published, gold, Green Submitted			2022-12-26	WOS:000414340200120
J	Hwang, HJ; Hahne, JM; Muller, KR				Hwang, Han-Jeong; Hahne, Janne Mathias; Mueller, Klaus-Robert			Real-time robustness evaluation of regression based myoelectric control against arm position change and donning/doffing	PLOS ONE			English	Article							PATTERN-RECOGNITION; SURFACE EMG; CLASSIFICATION; ONLINE; FORCE; INFORMATION; KINEMATICS; MOVEMENTS; SIGNALS	There are some practical factors, such as arm position change and donning/doffing, which prevent robust myoelectric control. The objective of this study is to precisely characterize the impacts of the two representative factors on myoelectric controllability in practical control situations, thereby providing useful references that can be potentially used to find better solutions for clinically reliable myoelectric control. To this end, a real-time target acquisition task was performed by fourteen subjects including one individual with congenital upper-limb deficiency, where the impacts of arm position change, donning/doffing and a combination of both factors on control performance was systematically evaluated. The changes in online performance were examined with seven different performance metrics to comprehensively evaluate various aspects of myoelectric controllability. As a result, arm position change significantly affects offline prediction accuracy, but not online control performance due to real-time feedback, thereby showing no significant correlation between offline and online performance. Donning/doffing was still problematic in online control conditions. It was further observed that no benefit was attained when using a control model trained with multiple position data in terms of arm position change, and the degree of electrode shift caused by donning/doffing was not severely associated with the degree of performance loss under practical conditions (around 1 cm electrode shift). Since this study is the first to concurrently investigate the impacts of arm position change and donning/doffing in practical myoelectric control situations, all findings of this study provide new insights into robust myoelectric control with respect to arm position change and donning/doffing.	[Hwang, Han-Jeong] Kumoh Natl Inst Technol, Dept Med IT Convergence Engn, Gyeongbuk Do, Gumi, South Korea; [Hahne, Janne Mathias] Univ Med Ctr Goettingen, Dept Trauma Surg Orthoped Surg & Hand Surg, Neurorehabil Syst Res Grp, Gottingen, Germany; [Mueller, Klaus-Robert] TU Berlin, Berlin Inst Technol, Machine Learning Grp, Berlin, Germany; [Mueller, Klaus-Robert] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Mueller, Klaus-Robert] Max Planck Inst Informat, Saarbrucken, Germany	Kumoh National University Technology; University of Gottingen; Technical University of Berlin; Korea University; Max Planck Society	Hwang, HJ (corresponding author), Kumoh Natl Inst Technol, Dept Med IT Convergence Engn, Gyeongbuk Do, Gumi, South Korea.; Muller, KR (corresponding author), TU Berlin, Berlin Inst Technol, Machine Learning Grp, Berlin, Germany.; Muller, KR (corresponding author), Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea.; Muller, KR (corresponding author), Max Planck Inst Informat, Saarbrucken, Germany.	h2j@kumoh.ac.kr; klaus-robert.mueller@tu-berlin.de	Mueller, Klaus-Robert/Y-3547-2019	Mueller, Klaus-Robert/0000-0002-3861-7685; Hwang, Han-Jeong/0000-0002-1183-1219	European Marie Currie IAPP grant 'AMYO' [251555]; Institute for Information & Communications Technology Promotion (IITP) grant - Korea government [2017-0-00451]; Brain Korea 21 Plus Program; SGER through National Research Foundation of Korea (NRF) - Ministry of Education [2014055911]; DFG [DFG SPP 1527, MU 987/14-1)]	European Marie Currie IAPP grant 'AMYO'; Institute for Information & Communications Technology Promotion (IITP) grant - Korea government(Institute for Information & Communication Technology Planning & Evaluation (IITP), Republic of Korea); Brain Korea 21 Plus Program; SGER through National Research Foundation of Korea (NRF) - Ministry of Education(Ministry of Education (MOE), Republic of KoreaNational Research Foundation of Korea); DFG(German Research Foundation (DFG))	This work was supported by the European Marie Currie IAPP grant 'AMYO' (project number 251555), and also supported by Institute for Information & Communications Technology Promotion (IITP) grant funded by the Korea government (No. 2017-0-00451), the Brain Korea 21 Plus Program, and SGER Grant 2014055911 through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, and the DFG (DFG SPP 1527, MU 987/14-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewuyi AA, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0246-x; Adewuyi AA, 2016, FRONT NEUROROBOTICS, V10, DOI 10.3389/fnbot.2016.00015; Adewuyi AA, 2016, IEEE T NEUR SYS REH, V24, P485, DOI 10.1109/TNSRE.2015.2424371; Ameri A, 2014, IEEE T NEUR SYS REH, V22, P1198, DOI 10.1109/TNSRE.2014.2323576; Ameri A, 2014, BIOMED SIGNAL PROCES, V13, P8, DOI 10.1016/j.bspc.2014.03.006; Ameri A, 2014, IEEE T BIO-MED ENG, V61, P279, DOI 10.1109/TBME.2013.2281595; Blair A, 2016, TRENT INT PROSTH S; Brantly NW, 2017, SIMULTANEOUS 2 DOF P; Castellini C, 2009, BIOL CYBERN, V100, P35, DOI 10.1007/s00422-008-0278-1; d'Avella A, 2006, J NEUROSCI, V26, P7791, DOI 10.1523/JNEUROSCI.0830-06.2006; Engelhart K, 1999, MED ENG PHYS, V21, P431, DOI 10.1016/S1350-4533(99)00066-1; Englehart K, 2003, IEEE T BIO-MED ENG, V50, P848, DOI 10.1109/TBME.2003.813539; Farina D, 2014, IEEE T NEUR SYS REH, V22, P797, DOI 10.1109/TNSRE.2014.2305111; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Fougner A, 2011, IEEE T NEUR SYS REH, V19, P644, DOI 10.1109/TNSRE.2011.2163529; Gauravkumar KP, 2016, J NEURAL ENG, V13; Geng YJ, 2012, IEEE ENG MED BIO, P2772, DOI 10.1109/EMBC.2012.6346539; Geng YJ, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-74; Hahne JM, 2014, IEEE T NEUR SYS REH, V22, P269, DOI 10.1109/TNSRE.2014.2305520; Hahne JM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04255-x; Hahne JM, 2015, IEEE T NEUR SYS REH, V23, P618, DOI 10.1109/TNSRE.2015.2401134; Hahne JM, 2012, IEEE T BIO-MED ENG, V59, P1436, DOI 10.1109/TBME.2012.2188799; Hahne JM, 2016, THESIS; Hargrove L, 2008, BIOMED SIGNAL PROCES, V3, P175, DOI 10.1016/j.bspc.2007.11.005; Hargrove LJ, 2010, IEEE T NEUR SYS REH, V18, P49, DOI 10.1109/TNSRE.2009.2039590; Hofmann D, 2016, IEEE T NEUR SYS REH, V24, P1333, DOI 10.1109/TNSRE.2015.2501979; Hwang HJ, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/5/056008; Jiang NF, 2013, IEEE ENG MED BIO, P1603, DOI 10.1109/EMBC.2013.6609822; Jiang N, 2014, IEEE T NEUR SYS REH, V22, P549, DOI 10.1109/TNSRE.2013.2287383; Jiang N, 2014, IEEE T NEUR SYS REH, V22, P501, DOI 10.1109/TNSRE.2013.2278411; Jiang N, 2013, MED BIOL ENG COMPUT, V51, P143, DOI 10.1007/s11517-012-0979-4; Jiang N, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-42; Jiang N, 2012, IEEE SIGNAL PROC MAG, V29, P147, DOI 10.1109/MSP.2012.2203480; Jiang N, 2009, IEEE T BIO-MED ENG, V56, P1070, DOI 10.1109/TBME.2008.2007967; Khushaba RN, 2014, NEURAL NETWORKS, V55, P42, DOI 10.1016/j.neunet.2014.03.010; Kuiken T, 2014, P MYOEL CONTR S MEC, P117; Lemm S, 2011, NEUROIMAGE, V56, P387, DOI 10.1016/j.neuroimage.2010.11.004; Lobo-Prat J, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-68; Muceli S, 2014, IEEE T NEUR SYS REH, V22, P623, DOI 10.1109/TNSRE.2013.2282898; Muceli S, 2012, IEEE T NEUR SYS REH, V20, P371, DOI 10.1109/TNSRE.2011.2178039; Nielsen JLG, 2011, IEEE T BIO-MED ENG, V58, P681, DOI 10.1109/TBME.2010.2068298; Ortiz-Catalan M, 2013, IEEE ENG MED BIO, P6651, DOI 10.1109/EMBC.2013.6611081; Rehbaum H, 2012, IEEE ENG MED BIO, P1346, DOI 10.1109/EMBC.2012.6346187; Rickard B, 2013, P 34 INT C ART NEUR; Scheme E, 2011, IEEE ENG MED BIO, P4828, DOI 10.1109/IEMBS.2011.6091196; Scheme E, 2014, IEEE T NEUR SYS REH, V22, P149, DOI 10.1109/TNSRE.2013.2247421; Scheme E, 2011, J REHABIL RES DEV, V48, P643, DOI 10.1682/JRRD.2010.09.0177; Sebelius F., 2006, Journal of Medical Engineering & Technology, V30, P2, DOI 10.1080/03091900512331332546; Smith LH, 2011, IEEE T NEUR SYS REH, V19, P186, DOI 10.1109/TNSRE.2010.2100828; Sogaard K, 2006, J PHYSIOL-LONDON, V573, P511, DOI 10.1113/jphysiol.2005.103598; Stokes IAF, 2005, CLIN BIOMECH, V20, P9, DOI 10.1016/j.clinbiomech.2004.08.010; Sugiyama M, 2012, ADAPT COMPUT MACH LE, P1; Vidovic MMC, 2016, IEEE T NEUR SYS REH, V24, P961, DOI 10.1109/TNSRE.2015.2492619; von Bunau P, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.214101; Wurth SM, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-91; Young AJ, 2013, IEEE T BIO-MED ENG, V60, P1250, DOI 10.1109/TBME.2012.2232293; Young AJ, 2012, IEEE T BIO-MED ENG, V59, P645, DOI 10.1109/TBME.2011.2177662; Young AJ, 2011, IEEE T BIO-MED ENG, V58, P2537, DOI 10.1109/TBME.2011.2159216	58	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186318	10.1371/journal.pone.0186318	http://dx.doi.org/10.1371/journal.pone.0186318			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095846	gold, Green Published			2022-12-26	WOS:000414340200015
J	Fernandes, JR; Berthoud, TK; Kornai, A; Angel, JB				Fernandes, Jason R.; Berthoud, Tamara K.; Kornai, Ashok; Angel, Jonathan B.			IL-23 signaling in Th17 cells is inhibited by HIV infection and is not restored by HAART: Implications for persistent immune activation	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; POLYMERIC IG RECEPTOR; T-CELLS; PERIPHERAL-BLOOD; ROR-ALPHA; DIFFERENTIATION; EXPRESSION; INTERLEUKIN-17; RESPONSES; INDUCTION	Objectives HIV infection causes a profound depletion of gut derived Th17 cells, contributing to loss of mucosal barrier function and an increase in microbial translocation, thus driving systemic immune activation. Despite normalization of circulating CD4+ T cell counts with highly active antiretroviral therapy (HAART), Th17 frequency and function often remain impaired. Given the importance of interleukin (IL)-23 in the generation and stabilization of Th17 cells we hypothesized that impaired IL-23 signaling causes persistent Th17 dysfunction in HIV infection. Methods The effects of in vitro HIV infection on responses to IL-23 in Th17 cells were examined. These included the production of IL-17, phosphorylated STAT3 (pSTAT3) and the transcription of retinoic acid orphan receptor C (RORC) gene. Blood derived Th17 cells from untreated and HAART-treated HIV-infected individuals were also examined for the IL-23 induced production of phosphorylated STAT3 (pSTAT3) and the expression of the IL-23 receptors. Results In vitro HIV infection significantly inhibited IL-17 production and IL-23 induced pSTAT3 while expression of RORC RNA was unaffected. Th17 cells isolated from untreated and HAARTtreated HIV-infected individuals showed complete loss of IL-23 induced pSTAT3 without a decrease in the expression of the IL-23 receptors. Conclusions This study is the first to demonstrate an effect of HIV on the IL-23 signaling pathway in Th17 cells. We show that in vitro and in vivo HIV infection results in impaired IL-23 signaling which is not reversed by HAART nor is it a result of reduced receptor expression, suggesting that HIV interferes with IL-23-activated signaling pathways. These findings may explain the inability of HAART to restore Th17 frequency and function and the resulting persistent chronic immune activation observed in HIV infected individuals.	[Fernandes, Jason R.; Berthoud, Tamara K.; Angel, Jonathan B.] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Fernandes, Jason R.; Berthoud, Tamara K.; Kornai, Ashok; Angel, Jonathan B.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Kornai, Ashok] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON, Canada; [Angel, Jonathan B.] Ottawa Hosp, Div Infect Dis, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Ottawa Hospital Research Institute	Angel, JB (corresponding author), Ottawa Hosp Res Inst, Ottawa, ON, Canada.; Angel, JB (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.; Angel, JB (corresponding author), Ottawa Hosp, Div Infect Dis, Ottawa, ON, Canada.	jangel@ohri.ca		Angel, Jonathan B/0000-0003-3102-4462	Canadian Institutes of Health Research Grant [HOP-98830]	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant HOP-98830 to JBA and AK, http://wm.cihr-irsc.gc.cate/193.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Alvarez Y, 2013, J VIROL, V87, P10843, DOI 10.1128/JVI.01838-13; Basu R, 2013, IMMUNOL REV, V252, P89, DOI 10.1111/imr.12035; Brenchley JM, 2008, BLOOD, V112, P2826, DOI 10.1182/blood-2008-05-159301; Cao AT, 2012, J IMMUNOL, V189, P4666, DOI 10.4049/jimmunol.1200955; Caruso R, 2008, EUR J IMMUNOL, V38, P470, DOI 10.1002/eji.200737635; Cecchinato V, 2008, MUCOSAL IMMUNOL, V1, P279, DOI 10.1038/mi.2008.14; Chaudhuri A, 2008, BLOOD, V111, P2062, DOI 10.1182/blood-2007-05-091207; Chege D, 2011, AIDS, V25, P741, DOI 10.1097/QAD.0b013e328344cefb; Chen Z, 2007, ARTHRITIS RHEUM-US, V56, P2936, DOI 10.1002/art.22866; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Cheng SM, 2009, BLOOD, V113, P5192, DOI 10.1182/blood-2008-10-183525; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Crome SQ, 1950, J IMMUNOL BALTIM MD, V185; Dandekar S, 2010, CURR OPIN HIV AIDS, V5, P173, DOI 10.1097/COH.0b013e328335eda3; de Beaucoudrey L, 2008, J EXP MED, V205, P1543, DOI 10.1084/jem.20080321; Diveu C, 2009, J IMMUNOL, V182, P5748, DOI 10.4049/jimmunol.0801162; Du JG, 2008, J IMMUNOL, V180, P4785, DOI 10.4049/jimmunol.180.7.4785; Duan MC, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/898053; El Hed A, 2010, J INFECT DIS, V201, P843, DOI 10.1086/651021; Federico M, 2001, BLOOD, V98, P2752, DOI 10.1182/blood.V98.9.2752; Goodman WA, 2011, J IMMUNOL, V186, P3336, DOI 10.4049/jimmunol.1001455; Gordon SN, 2010, J IMMUNOL, V185, P5169, DOI 10.4049/jimmunol.1001801; Haller C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001212; He Y, 2012, AIDS RES HUM RETROV, V28, P339, DOI [10.1089/aid.2011.0140, 10.1089/AID.2011.0140]; Hernandez-Santos N, 2013, MUCOSAL IMMUNOL, V6, P900, DOI 10.1038/mi.2012.128; Hirota K, 2013, NAT IMMUNOL, V14, P372, DOI 10.1038/ni.2552; Honda M, 1950, J IMMUNOL BALTIM MD, V148; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jaffar Z, 2009, J IMMUNOL, V182, P4507, DOI 10.4049/jimmunol.0900237; Kim CJ, 2013, J IMMUNOL, V191, P2164, DOI 10.4049/jimmunol.1300829; Klatt NR, 2012, MUCOSAL IMMUNOL, V5, P646, DOI 10.1038/mi.2012.38; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Le Saout C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003976; Lee YK, 2009, CURR OPIN IMMUNOL, V21, P274, DOI 10.1016/j.coi.2009.05.021; Lurati A, 2015, OPEN ACCESS RHEUMATO, V7, P63, DOI 10.2147/OARRR.S81905; Macal M, 2008, MUCOSAL IMMUNOL, V1, P475, DOI 10.1038/mi.2008.35; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; Mat NFC, 2011, J INTERF CYTOK RES, V31, P363, DOI 10.1089/jir.2010.0083; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Miller RC, 2011, EUR J IMMUNOL, V41, P1058, DOI 10.1002/eji.201041198; Monteleone I, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/297645; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Morrison PJ, 2011, IMMUNOLOGY, V133, P397, DOI 10.1111/j.1365-2567.2011.03454.x; Nakayama K, 2012, AIDS RES HUM RETROV, V28, P702, DOI [10.1089/aid.2011.0073, 10.1089/AID.2011.0073]; Ndhlovu LC, 2008, AIDS, V22, P990, DOI 10.1097/QAD.0b013e3282ff884e; Neri F, 2011, VIROLOGY, V410, P316, DOI 10.1016/j.virol.2010.11.018; Ness-Schwickerath KJ, 2011, CELL MOL LIFE SCI, V68, P2371, DOI 10.1007/s00018-011-0700-z; Pallikkuth S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003471; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Peck A, 2010, IMMUNOLOGY, V129, P147, DOI 10.1111/j.1365-2567.2009.03189.x; Popik W, 1998, J VIROL, V72, P6406, DOI 10.1128/JVI.72.8.6406-6413.1998; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; Rozmyslowicz T, 2010, EXP HEMATOL, V38, P1157, DOI 10.1016/j.exphem.2010.08.009; Rudolph JM, 2009, J VIROL, V83, P11528, DOI 10.1128/JVI.01423-09; Singh A, 2012, CYTOKINE, V60, P55, DOI 10.1016/j.cyto.2012.06.288; Sohn SJ, 2013, J IMMUNOL, V191, P2205, DOI 10.4049/jimmunol.1202859; Stritesky GL, 2008, J IMMUNOL, V181, P5948, DOI 10.4049/jimmunol.181.9.5948; Xu H, 2012, MUCOSAL IMMUNOL, V5, P658, DOI 10.1038/mi.2012.39; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	68	19	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11								10.1371/journal.pone.0186823	http://dx.doi.org/10.1371/journal.pone.0186823			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091911	gold, Green Submitted, Green Published			2022-12-26	WOS:000414229700031
J	Oliverl, MD; Dattal, S; Baldwin, DR				Oliverl, Michael D.; Dattal, Subimal; Baldwin, Debora R.			A sympathetic nervous system evaluation of obesity stigma	PLOS ONE			English	Article							SALIVARY ALPHA-AMYLASE; PSYCHOSOCIAL STRESS; WEIGHT STIGMA; SELF-ESTEEM; CORTISOL REACTIVITY; CHILDHOOD OBESITY; PUBLIC-HEALTH; DISCRIMINATION; RESPONSES; STIGMATIZATION	The portrayal of obesity in the media is often one of negativity. Consequently, it may generate an increase in stigma. Obesity stigma, a form of social discrimination, is responsible for many of the negative psychological and physiological effects on individual wellness. These effects not only impact individual health, but also affect the economy, and ultimately, societal wellness. In an attempt to examine the influence of the media on obesity stigma, this study tested the hypothesis that positive priming would lead to a reduction in obesity stigma. To further our understanding of this relationship, we: 1) examined the role of priming on physiological measures (e.g. salivary alpha amylase and skin conductance) in 70 college students by introducing positive and negative media images of individuals with obesity, and 2) assessed psychological measures (e.g. perceived stress, need to belong, and selfesteem, and Body Mass Index). After the priming manipulation, participants read a vignette depicting the discrimination of an individual with obesity and answered subsequent questions assessing participants' attributional blame of obesity. Results of this study revealed that priming affects physiological responding to obesity stigmatization. In conclusion, these findings suggest that incorporating positive media images of individuals with obesity may be an effective tool for reducing stigma and the various physiological consequences associated with it, which in turn, can enhance societal health and wellness.	[Oliverl, Michael D.; Dattal, Subimal; Baldwin, Debora R.] Univ Tennessee, Dept Psychol, Coll Arts & Sci, Knoxville, TN 37996 USA; [Dattal, Subimal] Univ Tennessee, Dept Anesthesiol, Grad Sch Med, Knoxville, TN USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Health Science Center	Oliverl, MD (corresponding author), Univ Tennessee, Dept Psychol, Coll Arts & Sci, Knoxville, TN 37996 USA.	moliver8@utk.edu			National Institutes of Health Research Grant [MH59839]; Research Fund of the University of Tennessee; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059839] Funding Source: NIH RePORTER	National Institutes of Health Research Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Fund of the University of Tennessee; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study is supported by National Institutes of Health Research Grant (MH59839). The aforementioned content is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Research Fund of the University of Tennessee and the National Institutes of Health Research Grant (MH59839). MO is a doctoral student in the Department of Psychology at the University of Tennessee-Knoxville. This research is part of MO's graduate thesis. The authors would also like to acknowledge Drs. Matthew Cooper and Michael Olson for their suggestions in the earlier version of this manuscript.	Ahern J, 2007, DRUG ALCOHOL DEPEN, V88, P188, DOI 10.1016/j.drugalcdep.2006.10.014; Almela M, 2011, BIOL PSYCHOL, V87, P421, DOI 10.1016/j.biopsycho.2011.05.008; Arthur C Guyton, TXB MED PHYSL; Bach DR, 2010, INT J PSYCHOPHYSIOL, V75, P349, DOI 10.1016/j.ijpsycho.2010.01.005; Bacon JG, 2001, INT J OBESITY, V25, P252, DOI 10.1038/sj.ijo.0801537; Carroll D, 2011, BEHAV HLTH COROLLARI, P243; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Crocker J, 2003, PSYCHOL INQ, V14, P232, DOI 10.1207/S15327965PLI1403&4_9; Davison KK, 2002, DEV PSYCHOL, V38, P735, DOI 10.1037//0012-1649.38.5.735; Dutton GR, 2013, INT J OBESITY, V37, P1282, DOI 10.1038/ijo.2012.224; Ehlert U, 2006, J CLIN ENDOCR METAB, V91, P5130, DOI 10.1210/jc.2006-0461; Engert V, 2011, PSYCHONEUROENDOCRINO, V36, P1294, DOI 10.1016/j.psyneuen.2011.02.018; Farag NH, 2008, J WOMENS HEALTH, V17, P1647, DOI 10.1089/jwh.2008.0866; Gee GC, 2008, AM J PUBLIC HEALTH, V98, P493, DOI 10.2105/AJPH.2007.114025; Graves RE, 2005, SCHIZOPHR RES, V76, P317, DOI 10.1016/j.schres.2005.02.003; Hayran Osman, 2013, J Allied Health, V42, P147; Hebl MR, 2005, BASIC APPL SOC PSYCH, V27, P267, DOI 10.1207/s15324834basp2703_8; Hellhammer DH, 2009, PSYCHONEUROENDOCRINO, V34, P163, DOI 10.1016/j.psyneuen.2008.10.026; Hilbert A, 2008, OBESITY, V16, P1529, DOI 10.1038/oby.2008.263; Himmelstein MS, 2015, OBESITY, V23, P368, DOI 10.1002/oby.20959; Jackson SE, 2016, OBESITY, V24, P2515, DOI 10.1002/oby.21657; Kim SH, 2007, J HEALTH COMMUN, V12, P359, DOI 10.1080/10810730701326051; Kurzban R, 2001, PSYCHOL BULL, V127, P187, DOI 10.1037//0033-2909.127.2.187; Latner JD, 2007, BODY IMAGE, V4, P147, DOI 10.1016/j.bodyim.2007.03.002; Leary MR, 2013, J PERS ASSESS, V95, P610, DOI 10.1080/00223891.2013.819511; Lewis TT, 2009, J GERONTOL A-BIOL; Major B, 2005, ANNU REV PSYCHOL, V56, P393, DOI 10.1146/annurev.psych.56.091103.070137; Mellor D, 2008, PERS INDIV DIFFER, V45, P213, DOI 10.1016/j.paid.2008.03.020; Myers A, 1999, INT J OBESITY, V23, P221, DOI 10.1038/sj.ijo.0800765; Nater UM, 2009, PSYCHONEUROENDOCRINO, V34, P486, DOI 10.1016/j.psyneuen.2009.01.014; Nater UM, 2005, INT J PSYCHOPHYSIOL, V55, P333, DOI 10.1016/j.ijpsycho.2004.09.009; Nater UM, 2007, PSYCHONEUROENDOCRINO, V32, P392, DOI 10.1016/j.psyneuen.2007.02.007; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Olson MA, 2003, PSYCHOL SCI, V14, P636, DOI 10.1046/j.0956-7976.2003.psci_1477.x; Olson MA, 2001, PSYCHOL SCI, V12, P413, DOI 10.1111/1467-9280.00376; Papadopoulos S, 2015, OBESITY, V23, P1743, DOI 10.1002/oby.21187; Perala CH, 2007, GALVANIC SKIN RESPON; Prelow HM, 2006, J BLACK PSYCHOL, V32, P442, DOI 10.1177/0095798406292677; Puhl R M, 2003, Obes Rev, V4, P213, DOI 10.1046/j.1467-789X.2003.00122.x; Puhl RM, 2010, AM J PUBLIC HEALTH, V100, P1019, DOI 10.2105/AJPH.2009.159491; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Rohleder N, 2004, ANN NY ACAD SCI, V1032, P258, DOI 10.1196/annals.1314.033; Rohleder N, 2006, PSYCHOPHYSIOLOGY, V43, P645, DOI 10.1111/j.1469-8986.2006.00457.x; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Salimetrics, 2016, SALVIOBIO ORAL SWAB; Sapolsky R, 2003, SCI AM, V289, P86, DOI 10.1038/scientificamerican0903-86; Sawyer PJ, 2012, AM J PUBLIC HEALTH, V102, P1020, DOI 10.2105/AJPH.2011.300620; Schvey NA, 2014, PSYCHOSOM MED, V76, P156, DOI 10.1097/PSY.0000000000000031; Sharma Ratna, 2006, Indian J Physiol Pharmacol, V50, P367; Sira N, 2011, FAMILY SCI REV, V16, P57; STEPHAN CW, 1992, INT J INTERCULT REL, V16, P89, DOI 10.1016/0147-1767(92)90007-H; Storm H, 2002, ACTA ANAESTH SCAND, V46, P887, DOI 10.1034/j.1399-6576.2002.460721.x; Strauss RS, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.1.e15; Stuart H, 2006, CNS DRUGS, V20, P99, DOI 10.2165/00023210-200620020-00002; Tajfel H, PSYCHOL INTERGROUP R; Thayer JF, 2006, ANN NY ACAD SCI, V1088, P361, DOI 10.1196/annals.1366.014; Tomiyama AJ, 2014, APPETITE, V82, P8, DOI 10.1016/j.appet.2014.06.108; Torres L, 2010, CULT DIVERS ETHN MIN, V16, P561, DOI 10.1037/a0020652; van Stegeren A, 2006, PSYCHONEUROENDOCRINO, V31, P137, DOI 10.1016/j.psyneuen.2005.05.012; van Stegeren AH, 2008, INT J PSYCHOPHYSIOL, V69, P33, DOI 10.1016/j.ijpsycho.2008.02.008; Vartanian LR, 2013, J BIOETHIC INQ, V10, P49, DOI 10.1007/s11673-012-9412-9; Verkuyten M, 1998, J SOC PSYCHOL, V138, P479, DOI 10.1080/00224549809600402; White S. E., 1999, COMMUNICATION RES RE, V16, P386, DOI DOI 10.1080/08824099909388740; Zeiders KH, 2014, PSYCHONEUROENDOCRINO, V50, P280, DOI 10.1016/j.psyneuen.2014.08.023	64	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0185703	10.1371/journal.pone.0185703	http://dx.doi.org/10.1371/journal.pone.0185703			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL0OH	29084240	gold, Green Published, Green Submitted			2022-12-26	WOS:000413910200003
J	Xie, X; Almuzzaini, B; Drou, N; Kremb, S; Yousif, A; Farrants, AKO; Gunsalus, K; Percipalle, P				Xie, Xin; Almuzzaini, Bader; Drou, Nizar; Kremb, Stephan; Yousif, Ayman; Farrants, Ann-Kristin Ostlund; Gunsalus, Kristin; Percipalle, Piergiorgio			beta-Actin-dependent global chromatin organization and gene expression programs control cellular identity	FASEB JOURNAL			English	Article						chromatin; epigenetics; genomic reprogramming; genome-wide analysis; nuclear actin	NUCLEAR ACTIN; HETEROCHROMATIN; ARCHITECTURE; DYNAMICS; GROWTH; BAF; INTERPHASE; ACTIVATION; MECHANISMS; COMPLEX	During differentiation and development, cell fate and identity are established by waves of genetic reprogramming. Although the mechanisms are largely unknown, during these events, dynamic chromatin reorganization is likely to ensure that multiple genes involved in the same cellular functions are coregulated, depending on the nuclear environment. In this study, using high-content screening of embryonic fibroblasts from a beta-actin knockout (KO) mouse, we found major chromatin rearrangements and changes in histone modifications, such as methylated histone (H)3-lysine-(K)9. Genome-wide H3K9 trimethylation-(Me)3 landscape changes correlate with gene up-and down-regulation in beta-actin KO cells. Mechanistically, we found loss of chromatin association by the Brahma-related gene (Brg)/Brahma-associated factor (BAF) chromatin remodeling complex subunit Brg1 in the absence of beta-actin. This actin-dependent chromatin reorganization was concomitant with the up-regulation of sets of genes involved in angiogenesis, cytoskeletal organization, andmyofibroblast features in beta-actin KO cells. Some of these genes and phenotypes were gained in a beta-actin dose-dependent manner. Moreover, reintroducing a nuclear localization signal-containing beta-actin in the knockout cells affected nuclear features and gene expression. Our results suggest that, by affecting the genome-wide organization of heterochromatin through the chromatin-binding activity of the BAF complex, beta-actin plays an essential role in the determination of gene expression programs and cellular identity.-Xie, X., Almuzzaini, B., Drou, N., Kremb, S., Yousif, A., Ostlund Farrants, A.-K., Gunsalus, K., Percipalle, P. beta-Actin-dependent global chromatin organization and gene expression programs control cellular identity.	[Xie, Xin; Gunsalus, Kristin; Percipalle, Piergiorgio] NYUAD, Biol Program, Abu Dhabi, U Arab Emirates; [Almuzzaini, Bader] King Saud bin Abdulaziz Univ Hlth Sci, MNGHA, King Abdullah Int Med Res Ctr, Med Genom Res Dept, Riyadh, Saudi Arabia; [Drou, Nizar; Kremb, Stephan; Yousif, Ayman; Gunsalus, Kristin] NYUAD Ctr Genom & Syst Biol, Abu Dhabi, U Arab Emirates; [Farrants, Ann-Kristin Ostlund; Percipalle, Piergiorgio] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Stockholm, Sweden; [Gunsalus, Kristin] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA	King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); Ministry of National Guard - Health Affairs; Stockholm University; New York University	Percipalle, P (corresponding author), New York Univ Abu Dhabi, Expt Res Bldg C1,Room 108,Saadiyat Campus, Abu Dhabi, U Arab Emirates.	pp69@nyu.edu		Xie, Xin/0000-0002-6784-4860; Almuzzaini, Bader/0000-0003-1176-9037	Swedish Research Council (Vetenskapsradet); Swedish Cancer Society (Cancerfonden)	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society)	The authors thank Christophe Ampe (University of Gent, Belgium) for kindly providing us with the beta-actin<SUP>+/+</SUP>, beta-actin<SUP>+/-</SUP>, and beta-actin<SUP>-/-</SUP> MEFs; Jillian Rowe, Marc Arnoux, and Mehar Sultana (NYUAD Center for Genomics and Systems Biology), for technical help; the NYUAD HPC team for providing the computation platform; and the Science for Life Laboratory, the National Genomics Infrastructure, NGI, and Uppmax for providing assistance in massive parallel sequencing and computational infrastructure. This work was partly supported by grants from the Swedish Research Council (Vetenskapsradet) and the Swedish Cancer Society (Cancerfonden) (to P.P). The authors declare no conflicts of interest.	Agarwal S, 2000, FASEB J, V14, pA924; Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Alexander JM, 2015, DEVELOPMENT, V142, P1418, DOI 10.1242/dev.109496; Almuzzaini B, 2016, FASEB J, V30, P2860, DOI 10.1096/fj.201600280R; Almuzzaini B, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0147-z; Baum J, 2011, J CARDIOVASC PHARM, V57, P376, DOI 10.1097/FJC.0b013e3182116e39; Bunnell TM, 2011, MOL BIOL CELL, V22, P4047, DOI 10.1091/mbc.E11-06-0582; Burke JP, 2010, BRIT J SURG, V97, P892, DOI 10.1002/bjs.6996; Chen TP, 2014, NAT REV GENET, V15, P93, DOI 10.1038/nrg3607; Darzynkiewicz Z, 2010, ADV EXP MED BIOL, V676, P137; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dundr M, 2007, J CELL BIOL, V179, P1095, DOI 10.1083/jcb.200710058; Fraser J, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156492; Gieni RS, 2009, BIOCHEM CELL BIOL, V87, P283, DOI 10.1139/O08-133; Gonzalez-Sandoval A, 2015, CELL, V163, P1333, DOI 10.1016/j.cell.2015.10.066; Herchenhan A, 2015, J BIOL CHEM, V290, P16440, DOI 10.1074/jbc.M115.641670; Hinz B, 2004, MOL BIOL CELL, V15, P4310, DOI 10.1091/mbc.E04-05-0386; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Le HQ, 2016, NAT CELL BIOL, V18, P864, DOI 10.1038/ncb3387; Kadoch C, 2017, NAT GENET, V49, P213, DOI 10.1038/ng.3734; Kapoor P, 2014, TRENDS CELL BIOL, V24, P238, DOI 10.1016/j.tcb.2013.10.007; Kind J, 2010, CURR OPIN CELL BIOL, V22, P320, DOI 10.1016/j.ceb.2010.04.002; Lavigne M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000769; Lennartsson A, 2009, BBA-GEN SUBJECTS, V1790, P863, DOI 10.1016/j.bbagen.2008.12.006; Li JT, 2008, J GASTROENTEROL, V43, P419, DOI 10.1007/s00535-008-2180-y; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Miyamoto K, 2013, CELL MOL LIFE SCI, V70, P3289, DOI 10.1007/s00018-012-1235-7; Miyamoto K, 2011, GENE DEV, V25, P946, DOI 10.1101/gad.615211; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Morris SA, 2014, NAT STRUCT MOL BIOL, V21, P73, DOI 10.1038/nsmb.2718; Olave IA, 2002, ANNU REV BIOCHEM, V71, P755, DOI 10.1146/annurev.biochem.71.110601.135507; Poleshko A, 2013, CELL REP, V5, P292, DOI 10.1016/j.celrep.2013.09.024; Pombo A, 2015, NAT REV MOL CELL BIO, V16, P245, DOI 10.1038/nrm3965; Roy M, 2005, NEOPLASIA, V7, P253, DOI 10.1593/neo.04493; Saksouk N, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/1756-8935-8-3; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066; Serebryannyy LA, 2016, SCI REP-UK, V6, DOI 10.1038/srep28460; Sharili AS, 2016, SCI REP-UK, V6, DOI 10.1038/srep33893; Shimi T, 2004, J STRUCT BIOL, V147, P31, DOI 10.1016/j.jsb.2003.11.013; Tondeleir D, 2012, MOL CELL PROTEOMICS, V11, P255, DOI 10.1074/mcp.M111.015099; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; Visa N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000620; Vukovic LD, 2016, INT REV CEL MOL BIO, V322, P1, DOI 10.1016/bs.ircmb.2015.11.001; YU J, 1985, J BIOL CHEM, V260, P3035; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	48	34	34	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1296	1314		10.1096/fj.201700753R	http://dx.doi.org/10.1096/fj.201700753R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29101221				2022-12-26	WOS:000427246000015
J	Knopfova, L; Biglieri, E; Volodko, N; Masarik, M; Hermanova, M; Garzon, JFG; Ducka, M; Kucirkova, T; Soucek, K; Smarda, J; Benes, P; Borsig, L				Knopfova, L.; Biglieri, E.; Volodko, N.; Masarik, M.; Hermanova, M.; Garzon, J. F. Glaus; Ducka, M.; Kucirkova, T.; Soucek, K.; Smarda, J.; Benes, P.; Borsig, L.			Transcription factor c-Myb inhibits breast cancer lung metastasis by suppression of tumor cell seeding	ONCOGENE			English	Article							INFLAMMATORY CHEMOKINES; GENE; CCL2; ESTROGEN; EXTRAVASATION; SURVIVAL; REVEALS; TARGET; GROWTH; BRAIN	Metastasis accounts for most of cancer-related deaths. Paracrine signaling between tumor cells and the stroma induces changes in the tumor microenvironment required for metastasis. Transcription factor c-Myb was associated with breast cancer (BC) progression but its role in metastasis remains unclear. Here we show that increased c-Myb expression in BC cells inhibits spontaneous lung metastasis through impaired tumor cell extravasation. On contrary, BC cells with increased lung metastatic capacity exhibited low c-Myb levels. We identified a specific inflammatory signature, including Ccl2 chemokine, that was expressed in lung metastatic cells but was suppressed in tumor cells with higher c-Myb levels. Tumor cell-derived Ccl2 expression facilitated lung metastasis and rescued trans-endothelial migration of c-Myb overexpressing cells. Clinical data show that the identified inflammatory signature, together with a MYB expression, predicts lung metastasis relapse in BC patients. These results demonstrate that the c-Myb-regulated transcriptional program in BCs results in a blunted inflammatory response and consequently suppresses lung metastasis.	[Knopfova, L.; Ducka, M.; Kucirkova, T.; Soucek, K.; Smarda, J.; Benes, P.] Masaryk Univ, Dept Expt Biol, Fac Sci, Brno, Czech Republic; [Knopfova, L.; Biglieri, E.; Garzon, J. F. Glaus; Benes, P.; Borsig, L.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Knopfova, L.; Biglieri, E.; Garzon, J. F. Glaus; Benes, P.; Borsig, L.] Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Knopfova, L.; Ducka, M.; Kucirkova, T.; Soucek, K.; Benes, P.] St Annes Univ Hosp, Ctr Biol & Cellular Engn, Int Clin Res Ctr, Brno, Czech Republic; [Volodko, N.] Danylo Galytsky Lviv Natl Med Univ, Dept Oncol & Med Radiol, Lvov, Ukraine; [Masarik, M.] Masaryk Univ, Dept Physiol, Fac Med, Brno, Czech Republic; [Masarik, M.] Masaryk Univ, Dept Pathol Physiol, Fac Med, Brno, Czech Republic; [Hermanova, M.] St Annes Univ Hosp, Dept Pathol Anat 1, Brno, Czech Republic; [Hermanova, M.] Masaryk Univ, Fac Med, Brno, Czech Republic; [Soucek, K.] Czech Acad Sci, Inst Biophys, Brno, Czech Republic	Masaryk University Brno; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); St Anne's University Hospital Brno (FNUSA-ICRC); Danylo Halytsky Lviv National Medical University; Masaryk University Brno; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); Masaryk University Brno; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences	Benes, P; Borsig, L (corresponding author), Univ Zurich, Zurich Ctr Integrat Human Physiol, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	pbenes@sci.muni.cz; lborsig@access.uzh.ch	Soucek, Karel/B-3621-2008; Masarik, Michal/D-9920-2012; Benes, Petr/K-6369-2016	Soucek, Karel/0000-0001-7283-8150; Masarik, Michal/0000-0003-1172-7195; Benes, Petr/0000-0002-8297-9675; Borsig, Lubor/0000-0003-2263-9545; Hermanova, Marketa/0000-0002-3889-0905; Knopfova, Lucia/0000-0003-4897-0404	SCOPES/SNF [IZ73Z0-152361]; Czech Science Foundation [17-08985Y]; National Program of Sustainability II [LQ1605-MEYS CR]; ICRC-ERA-HumanBridge [316345]; Grant Agency of Masaryk University [MUNI/0877/2016]; SNF [310030-152901]	SCOPES/SNF; Czech Science Foundation(Grant Agency of the Czech Republic); National Program of Sustainability II; ICRC-ERA-HumanBridge; Grant Agency of Masaryk University; SNF	This work was funded by SCOPES/SNF grant IZ73Z0-152361 (L Borsig, L Knopfova and N Volodko). Further by Czech Science Foundation grant 17-08985Y (L Knopfova), National Program of Sustainability II LQ1605-MEYS CR; and ICRC-ERA-HumanBridge/no. 316345 and by the MUNI/0877/2016 project of Grant Agency of Masaryk University. This work was also supported by the SNF grant #310030-152901 (L Borsig). We acknowledge the assistance of the Center for Microscopy and Image Analysis and the Functional Genomic Center at University of Zurich.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Bauer K, 2007, INT J CANCER, V121, P1910, DOI 10.1002/ijc.22879; Bengtsen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133280; Bieche I, 2007, ENDOCR-RELAT CANCER, V14, P1039, DOI 10.1677/erc.1.01301; Borsig L, 2014, ONCOGENE, V33, P3217, DOI 10.1038/onc.2013.272; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Drabsch Y, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2614; Fang WB, 2016, ONCOTARGET, V7, P49349, DOI 10.18632/oncotarget.9885; Gonda TJ, 2008, EXPERT OPIN BIOL TH, V8, P713, DOI [10.1517/14712598.8.6.713, 10.1517/14712598.8.6.713 ]; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gruvberger S, 2001, CANCER RES, V61, P5979; Gundem G, 2012, GENOME MED, V4, DOI 10.1186/gm327; Guo P, 2014, P NATL ACAD SCI USA, V111, P14710, DOI 10.1073/pnas.1408556111; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Harrell JC, 2012, BREAST CANCER RES TR, V132, P523, DOI 10.1007/s10549-011-1619-7; Hatakeyama M, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1104-8; Hauselmann I, 2016, CANCER RES, V76, P5302, DOI 10.1158/0008-5472.CAN-16-0784; Hiratsuka S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2856; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hugo HJ, 2015, J MAMMARY GLAND BIOL, V20, P109, DOI 10.1007/s10911-015-9333-4; Hugo HJ, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3580; Johnstone CN, 2015, DIS MODEL MECH, V8, P237, DOI 10.1242/dmm.017830; Jones SE, 2008, CLIN BREAST CANCER, V8, P224, DOI 10.3816/CBC.2008.n.025; Kitamura T, 2015, J EXP MED, V212, P1043, DOI 10.1084/jem.20141836; Knopfova L, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-15; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Li YH, 2016, CANCER RES, V76, P3364, DOI 10.1158/0008-5472.CAN-15-2302; Liu LYD, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/813067; Lu X, 2007, J MAMMARY GLAND BIOL, V12, P153, DOI 10.1007/s10911-007-9047-3; Maurice D, 2007, EMBO J, V26, P3629, DOI 10.1038/sj.emboj.7601801; Miao RY, 2011, CANCER RES, V71, P7029, DOI 10.1158/0008-5472.CAN-11-1015; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; Mucha DR, 2003, AM J PHYSIOL-HEART C, V284, pH994, DOI 10.1152/ajpheart.00862.2002; Ness SA, 2003, BLOOD CELL MOL DIS, V31, P192, DOI 10.1016/S1079-9796(03)00151-7; Nicolau M, 2011, P NATL ACAD SCI USA, V108, P7265, DOI 10.1073/pnas.1102826108; Obenauf AC, 2015, TRENDS CANCER, V1, P76, DOI 10.1016/j.trecan.2015.07.009; Pekarcikova L, 2016, CELL SIGNAL, V28, P924, DOI [10.1016/j.cellsig2016.04.007, 10.1016/j.cellsig.2016.04.007]; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Roberts TK, 2012, LAB INVEST, V92, P1213, DOI 10.1038/labinvest.2012.80; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sevenich L, 2014, NAT CELL BIOL, V16, P876, DOI 10.1038/ncb3011; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Soria G, 2008, CANCER LETT, V267, P271, DOI 10.1016/j.canlet.2008.03.018; Srivastava SK, 2015, BRIT J CANCER, V113, P1694, DOI 10.1038/bjc.2015.400; Svensson S, 2015, CLIN CANCER RES, V21, P3794, DOI 10.1158/1078-0432.CCR-15-0204; Thorner AR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013073; Tichy M, 2016, TUMOR BIOL, V37, P10723, DOI 10.1007/s13277-016-4956-7; Wolf MJ, 2012, CANCER CELL, V22, P91, DOI 10.1016/j.ccr.2012.05.023; Yoshimura T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058791; Zhao L, 2011, NUCLEIC ACIDS RES, V39, P4664, DOI 10.1093/nar/gkr024	52	12	12	5	31	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 22	2018	37	8					1020	1030		10.1038/onc.2017.392	http://dx.doi.org/10.1038/onc.2017.392			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FX2QD	29084208	Green Accepted			2022-12-26	WOS:000425905700005
J	McNally, BA; Pendon, ZD; Trudeau, MC				McNally, Beth A.; Pendon, Zeus D.; Trudeau, Matthew C.			hERG1a and hERG1b potassium channel subunits directly interact and preferentially form heteromeric channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cysteine-mediated cross-linking; electrophysiology; fluorescence resonance energy transfer (FRET); hERG; potassium channel; KCNH2; Long QT syndrome; hERG1a; hERG1b; human eag-related gene	LONG-QT SYNDROME; RECTIFIER K+ CURRENT; CARDIAC-ARRHYTHMIA; DOMAIN; DEACTIVATION; FAMILY; CELLS; MOUSE; EAG; SENSITIVITY	Voltage-activated human ether-a-go-go-related gene (hERG) potassium channels are critical for the repolarization of cardiac action potentials and tune-spike frequency adaptation in neurons. Two isoforms of mammalian ERG1 channel subunits, ERG1a and ERG1b, are the principal subunits that conduct the I-Kr current in the heart and are also broadly expressed in the nervous system. However, there is little direct evidence that ERG1a and ERG1b form heteromeric channels. Here, using electrophysiology, biochemistry, and fluorescence approaches, we systematically tested for direct interactions between hERG1a and hERG1b subunits. We report 1) that hERG1a dominant-negative subunits suppress hERG1b currents (and vice versa), 2) that disulfide bonds form between single cysteine residues experimentally introduced into an extracellular loop of hERG1a and hERG1b subunits and produce hERG1a-hERG1b dimers, and 3) that hERG1a and hERG1b subunits tagged with fluorescent proteins that are FRET pairs exhibit robust energy transfer at the plasma membrane. Thus, multiple lines of evidence indicated a physical interaction between hERG1a and hERG1b, consistent with them forming heteromeric channels. Moreover, co-expression of variable ratios of hERG1a and hERG1b RNA yielded channels with deactivation kinetics that reached a plateau and were different from those of hERG1b channels, consistent with a preference of hERG1b subunits for hERG1a subunits. Cross-linking studies revealed that an equal input of hERG1a and hERG1b yields more hERG1a-hERG1a or hERG1a-hERG1b dimers than hERG1b-hERG1b dimers, also suggesting that hERG1b preferentially interacts with hERG1a. We conclude that hERG1b preferentially forms heteromeric ion channels with hERG1a at the plasma membrane.	[McNally, Beth A.; Pendon, Zeus D.; Trudeau, Matthew C.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Pendon, Zeus D.] CutisPharma Inc, Wilmington, MA 01887 USA	University System of Maryland; University of Maryland Baltimore	Trudeau, MC (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	mtrudeau@som.umaryland.edu		Trudeau, Matthew/0000-0002-6971-2589	National Institutes of Health NHLBI Grant [R01 HL083121]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083121] Funding Source: NIH RePORTER	National Institutes of Health NHLBI Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health NHLBI Grant R01 HL083121 (to M. C. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abi-Gerges N, 2011, BRIT J PHARMACOL, V164, P419, DOI 10.1111/j.1476-5381.2011.01378.x; Anderson CL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6535; CAREAGA CL, 1992, BIOPHYS J, V62, P209, DOI 10.1016/S0006-3495(92)81806-4; Chen J, 1999, J BIOL CHEM, V274, P10113, DOI 10.1074/jbc.274.15.10113; Crociani O, 2003, J BIOL CHEM, V278, P2947, DOI 10.1074/jbc.M210789200; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; FALKE JJ, 1987, SCIENCE, V237, P1596, DOI 10.1126/science.2820061; Gianulis EC, 2013, J GEN PHYSIOL, V142, P351, DOI 10.1085/jgp.201310995; Gianulis EC, 2011, J BIOL CHEM, V286, P22160, DOI 10.1074/jbc.M110.205948; Guasti L, 2005, J COMP NEUROL, V491, P157, DOI 10.1002/cne.20721; Gustina AS, 2011, J GEN PHYSIOL, V137, P315, DOI 10.1085/jgp.201010582; Gustina AS, 2009, P NATL ACAD SCI USA, V106, P13082, DOI 10.1073/pnas.0900180106; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; Jiang M, 2005, J PHYSIOL-LONDON, V569, P75, DOI 10.1113/jphysiol.2005.093682; Jones DK, 2016, PROG BIOPHYS MOL BIO, V120, P67, DOI 10.1016/j.pbiomolbio.2016.01.002; Jones DK, 2014, P NATL ACAD SCI USA, V111, P18073, DOI 10.1073/pnas.1414945111; Jones EMC, 2004, J BIOL CHEM, V279, P44690, DOI 10.1074/jbc.M408344200; Larsen AP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009021; LeesMiller JP, 1997, CIRC RES, V81, P719; Liu F, 2016, P NATL ACAD SCI USA, V113, P4859, DOI 10.1073/pnas.1521577113; Liu QN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123951; London B, 1997, CIRC RES, V81, P870; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Phartiyal P, 2008, J BIOL CHEM, V283, P3702, DOI 10.1074/jbc.M708999200; Phartiyal P, 2007, J BIOL CHEM, V282, P9874, DOI 10.1074/jbc.M610875200; Sale H, 2008, CIRC RES, V103, pE81, DOI 10.1161/CIRCRESAHA.108.185249; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; SANGUINETTI MC, 1991, AM J PHYSIOL, V260, pH393, DOI 10.1152/ajpheart.1991.260.2.H393; Sanguinetti MC, 1996, P NATL ACAD SCI USA, V93, P2208, DOI 10.1073/pnas.93.5.2208; SELVIN PR, 1995, METHOD ENZYMOL, V246, P300; Smith GAM, 2002, J BIOL CHEM, V277, P18528, DOI 10.1074/jbc.M200592200; Trudeau MC, 2011, J GEN PHYSIOL, V138, P581, DOI 10.1085/jgp.201110683; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Trudeau MC, 2004, J GEN PHYSIOL, V124, P211, DOI 10.1085/jgp.200409101; Wang WW, 2017, CELL, V169, P422, DOI 10.1016/j.cell.2017.03.048; WARMKE JW, 1994, P NATL ACAD SCI USA, V91, P3438, DOI 10.1073/pnas.91.8.3438	37	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21548	21557		10.1074/jbc.M117.816488	http://dx.doi.org/10.1074/jbc.M117.816488			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29089383	hybrid, Green Published			2022-12-26	WOS:000419013000029
J	Shi, WG; Gao, YH; Wang, YY; Zhou, J; Wei, ZL; Ma, XN; Ma, HP; Xian, CJ; Wang, JF; Chen, KM				Shi, Wengui; Gao, Yuhai; Wang, Yuanyuan; Zhou, Jian; Wei, Zhenlong; Ma, Xiaoni; Ma, Huiping; Xian, Cory J.; Wang, Jufang; Chen, Keming			The flavonol glycoside icariin promotes bone formation in growing rats by activating the cAMP signaling pathway in primary cilia of osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE ADENYLYL-CYCLASE; ESTROGEN-RECEPTOR-ALPHA; MARROW STROMAL CELLS; OSTEOGENIC DIFFERENTIATION; IN-VITRO; OSTEOCLAST FORMATION; HERBA-EPIMEDII; CYCLIC-AMP; MINERALIZATION; OSTEOPOROSIS	Icariin, a prenylated flavonol glycoside isolated from the herb Epimedium, has been considered as a potential alternative therapy for osteoporosis. Previous research has shown that, unlike other flavonoids, icariin is unlikely to act via the estrogen receptor, but its exact mechanism of action is unknown. In this study, using rat calvarial osteoblast culture and rat bone growth models, we demonstrated that icariin promotes bone formation by activating the cAMP/protein kinase A (PKA)/cAMP response element-binding protein (CREB) pathway requiring functional primary cilia of osteoblasts. We found that icariin increases the peak bone mass attained by young rats and promotes the maturation and mineralization of rat calvarial osteoblasts. Icariin activated cAMP/PKA/CREB signaling of the osteoblasts by increasing intracellular cAMP levels and facilitating phosphorylation of both PKA and CREB. Blocking cAMP/PKA/CREB signaling with inhibitors of the cAMP-synthesizing adenylyl cyclase (AC) and PKA inhibitors significantly inhibited the osteogenic effect of icariin in the osteoblasts. Icariin-activated cAMP/PKA/CREB signaling was localized to primary cilia, as indicated by localization of soluble AC and phosphorylated PKA. Furthermore, blocking ciliogenesis via siRNA knockdown of a cilium assembly protein, IFT88, inhibited icariin-induced PKA and CREB phosphorylation and also abolished icariin's osteogenic effect. Finally, several of these outcomes were validated in icariin-treated rats. Together, these results provide new insights into icariin function and its mechanisms of action and strengthen existing ties between cAMP-mediated signaling and osteogenesis.	[Shi, Wengui; Gao, Yuhai; Wang, Yuanyuan; Zhou, Jian; Wei, Zhenlong; Ma, Xiaoni; Chen, Keming] CPLA, Lanzhou Gen Hosp, Inst Orthopaed, Lanzhou 730050, Gansu, Peoples R China; [Ma, Huiping] CPLA, Lanzhou Gen Hosp, Dept Pharm, Lanzhou 730050, Gansu, Peoples R China; [Xian, Cory J.] Univ South Australia, Sch Pharm & Med Sci, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia; [Wang, Jufang] Chinese Acad Sci, Inst Modern Phys, Key Lab Space Radiobiol Gansu Prov, Lanzhou 730000, Gansu, Peoples R China	University of South Australia; Chinese Academy of Sciences; Institute of Modern Physics, CAS	Chen, KM (corresponding author), CPLA, Lanzhou Gen Hosp, Inst Orthopaed, Lanzhou 730050, Gansu, Peoples R China.; Wang, JF (corresponding author), Chinese Acad Sci, Inst Modern Phys, Key Lab Space Radiobiol Gansu Prov, Lanzhou 730000, Gansu, Peoples R China.	jufangwang@impcas.ac.cn; chenkm@lut.cn	Wang, Yuan/HHC-1520-2022; Lv, Yuanjie/AER-0767-2022; wangwangwang, yuanyaun/HHN-6432-2022; Gao, Yuhai/AHB-5767-2022; Xian, Cory/D-2646-2009	Xian, Cory/0000-0002-8467-2845; Shi, Wengui/0000-0003-1039-3576	National Natural Sciences Foundation of China [81270963, 81471090, 81770879]; International Science & Technology Cooperation Program of China [2015DFR30940]; Natural Sciences Foundation of Gansu province [1506RJZA307]; Science and Technology Research Project of Gansu Province [145RTSA012, 17JR5RA307]; National Health and Medical Research Council (NHMRC) Australia Senior Research Fellowship [1042105]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China; Natural Sciences Foundation of Gansu province; Science and Technology Research Project of Gansu Province; National Health and Medical Research Council (NHMRC) Australia Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by National Natural Sciences Foundation of China Grants 81270963, 81471090, and 81770879, the International Science & Technology Cooperation Program of China Grant 2015DFR30940, Natural Sciences Foundation of Gansu province Grant 1506RJZA307, and the Science and Technology Research Project of Gansu Province Grants 145RTSA012 and 17JR5RA307. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by National Health and Medical Research Council (NHMRC) Australia Senior Research Fellowship number 1042105.	Besschetnova TY, 2010, CURR BIOL, V20, P182, DOI 10.1016/j.cub.2009.11.072; Bodle JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062554; Chaloupka JA, 2006, MOL REPROD DEV, V73, P361, DOI 10.1002/mrd.20409; Chen BL, 2016, EXP THER MED, V11, P2399, DOI 10.3892/etm.2016.3177; Chen KM, 2007, PHARMAZIE, V62, P388, DOI 10.1691/ph.2007.5.6682; Chen KM, 2005, PHARMAZIE, V60, P939; Clement CA, 2009, METHOD CELL BIOL, V94, P181, DOI 10.1016/S0091-679X(08)94009-7; Garcia-Morales V., 2017, BIOCHEM PHARMACOL, V2952, P30567; Geng WD, 2009, J CELL PHYSIOL, V220, P332, DOI 10.1002/jcp.21767; HASLAM RJ, 1978, BIOCHEM J, V176, P83, DOI 10.1042/bj1760083; Hoey David A, 2012, Front Endocrinol (Lausanne), V3, P75, DOI 10.3389/fendo.2012.00075; Ichikawa S, 2009, CALCIFIED TISSUE INT, V84, P97, DOI 10.1007/s00223-008-9200-z; Indran IR, 2016, PHARMACOL THERAPEUT, V162, P188, DOI 10.1016/j.pharmthera.2016.01.015; Isogai Y, 1996, J BONE MINER RES, V11, P1384; Koh AJ, 1999, ENDOCRINOLOGY, V140, P3154, DOI 10.1210/en.140.7.3154; Kwon RY, 2010, FASEB J, V24, P2859, DOI 10.1096/fj.09-148007; Labour MN, 2016, SCI REP-UK, V6, DOI 10.1038/srep35542; Liang WN, 2012, INT J MOL MED, V30, P889, DOI 10.3892/ijmm.2012.1079; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; Ma HP, 2011, J CELL BIOCHEM, V112, P916, DOI 10.1002/jcb.23007; Ma XN, 2017, J ENDOCRINOL INVEST, V40, P357, DOI 10.1007/s40618-016-0568-8; Ma X. N., 2005, PLANTA MED, V60, P939; Malone AMD, 2007, P NATL ACAD SCI USA, V104, P13325, DOI 10.1073/pnas.0700636104; Marion V, 2011, KIDNEY INT, V79, P1013, DOI 10.1038/ki.2010.538; Ming LG, 2013, J CELL PHYSIOL, V228, P513, DOI 10.1002/jcp.24158; Mok SK, 2010, BRIT J PHARMACOL, V159, P939, DOI 10.1111/j.1476-5381.2009.00593.x; Mukhopadhyay S, 2013, CELL, V152, P210, DOI 10.1016/j.cell.2012.12.026; Nian H, 2009, PHYTOMEDICINE, V16, P320, DOI 10.1016/j.phymed.2008.12.006; Park YG, 2004, INT IMMUNOPHARMACOL, V4, P779, DOI 10.1016/j.intimp.2004.03.003; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Piggott LA, 2008, P NATL ACAD SCI USA, V105, P13835, DOI 10.1073/pnas.0712100105; Raychowdhury MK, 2009, AM J PHYSIOL-RENAL, V296, pF87, DOI 10.1152/ajprenal.90509.2008; Reed BY, 2002, J CLIN ENDOCR METAB, V87, P1476, DOI 10.1210/jc.87.4.1476; Rickard DJ, 2003, J CELL BIOCHEM, V89, P633, DOI 10.1002/jcb.10539; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Schmid A, 2014, BBA-MOL BASIS DIS, V1842, P2584, DOI 10.1016/j.bbadis.2014.07.010; Shi Wen-Gui, 2014, Zhongguo Zhong Yao Za Zhi, V39, P2704; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Song LG, 2013, EUR J PHARMACOL, V714, P15, DOI 10.1016/j.ejphar.2013.05.039; Suzuki A, 2008, J CELL BIOCHEM, V104, P304, DOI 10.1002/jcb.21626; Wang JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep23827; Wang LL, 2016, CURR PHARM DESIGN, V22, P328, DOI 10.2174/1381612822666151112145907; Weaver CM, 2016, OSTEOPOROSIS INT, V27, P1281, DOI 10.1007/s00198-015-3440-3; Willoughby D, 2010, J CELL SCI, V123, P107, DOI 10.1242/jcs.062067; Xiao HH, 2014, J STEROID BIOCHEM, V143, P141, DOI 10.1016/j.jsbmb.2014.02.019; Xiao ZS, 2006, J BIOL CHEM, V281, P30884, DOI 10.1074/jbc.M604772200; Xie YF, 2016, BONE, V93, P22, DOI 10.1016/j.bone.2016.09.008; Yan JL, 2015, MOL CELL ENDOCRINOL, V404, P132, DOI 10.1016/j.mce.2015.01.031; Zhai YK, 2014, BONE, V66, P189, DOI 10.1016/j.bone.2014.06.016; Zhang DW, 2016, CALCIFIED TISSUE INT, V99, P187, DOI 10.1007/s00223-016-0138-2; Zhang G, 2007, J BONE MINER RES, V22, P1072, DOI 10.1359/JBMR.070405; Zheng D, 2012, BONE, V51, P85, DOI 10.1016/j.bone.2012.04.006	52	38	42	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					20883	20896		10.1074/jbc.M117.809517	http://dx.doi.org/10.1074/jbc.M117.809517			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29089388	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000418453400007
J	Kaiser, M; Pohl, L; Ketelhut, S; Kastl, L; Gorzelanny, C; Gotte, M; Schnekenburger, J; Goycoolea, FM; Kemper, B				Kaiser, Mathias; Pohl, Luisa; Ketelhut, Steffi; Kastl, Lena; Gorzelanny, Christian; Goette, Martin; Schnekenburger, Juergen; Goycoolea, Francisco M.; Kemper, Bjoern			Nanoencapsulated capsaicin changes migration behavior and morphology of madin darby canine kidney cell monolayers	PLOS ONE			English	Article							DIGITAL HOLOGRAPHIC MICROSCOPY; POORLY ABSORBABLE DRUGS; IN-VITRO; CHITOSAN NANOCAPSULES; MOLECULAR-WEIGHT; TRANSMUCOSAL DELIVERY; ABSORPTION ENHANCERS; ION CHANNELS; TUMOR-CELLS; NANOPARTICLES	We have developed a drug delivery nanosystem based on chitosan and capsaicin. Both substances have a wide range of biological activities. We investigated the nanosystem's influence on migration and morphology of Madin Darby canine kidney (MDCK-C7) epithelial cells in comparison to the capsaicin-free nanoformulation, free capsaicin, and control cells. For minimally-invasive quantification of cell migration, we applied label-free digital holographic microscopy (DHM) and single-cell tracking. Moreover, quantitative DHM phase images were used as novel stain-free assay to quantify the temporal course of global cellular morphology changes in confluent cell layers. Cytoskeleton alterations and tight junction protein redistributions were complementary analyzed by fluorescence microscopy. Calcium influx measurements were conducted to characterize the influence of the nanoformulations and capsaicin on ion channel activities. We found that both, capsaicin-loaded and unloaded chitosan nanocapsules, and also free capsaicin, have a significant impact on directed cell migration and cellular motility. Increase of velocity and directionality of cell migration correlates with changes in the cell layer surface roughness, tight junction integrity and cytoskeleton alterations. Calcium influx into cells occurred only after nanoformulation treatment but not upon addition of free capsaicin. Our results pave the way for further studies on the biological significance of these findings and potential biomedical applications, e.g. as drug and gene carriers.	[Kaiser, Mathias; Goycoolea, Francisco M.] Westfalische Wilhelms Univ Munster, Inst Plant Biol & Biotechnol IBBP, Schlossgarten 3, Munster, Germany; [Pohl, Luisa; Ketelhut, Steffi; Kastl, Lena; Schnekenburger, Juergen; Kemper, Bjoern] Westfalische Wilhelms Univ Munster, Med Fac, Biomed Technol Ctr, Mendelstr 17, Munster, Germany; [Gorzelanny, Christian] Heidelberg Univ, Med Fac Mannheim, Dept Derimatol, Expt Dermatol, Theodor Kutzer Ufer 1-3, Mannheim, Germany; [Goette, Martin] Westfalische Wilhelms Univ Munster, Dept Gynecol & Obstet, Albert Schweitzer Campus 1, Munster, Germany; [Goycoolea, Francisco M.] Univ Leeds, Sch Food Sci & Nutr, Leeds, W Yorkshire, England	University of Munster; University of Munster; Ruprecht Karls University Heidelberg; University of Munster; University of Leeds	Goycoolea, FM (corresponding author), Westfalische Wilhelms Univ Munster, Inst Plant Biol & Biotechnol IBBP, Schlossgarten 3, Munster, Germany.; Kemper, B (corresponding author), Westfalische Wilhelms Univ Munster, Med Fac, Biomed Technol Ctr, Mendelstr 17, Munster, Germany.; Goycoolea, FM (corresponding author), Univ Leeds, Sch Food Sci & Nutr, Leeds, W Yorkshire, England.	goycoole@uni-muenster.de; bkemper@uni-muenster.de	Gotte, M/Z-5878-2019; Götte, Martin/G-2254-2018; Goycoolea, Francisco M./Q-5841-2017	Gotte, M/0000-0003-2360-2496; Götte, Martin/0000-0003-2360-2496; Goycoolea, Francisco M./0000-0001-7949-5429; Kemper, Bjorn/0000-0003-3693-9397; Schnekenburger, Juergen/0000-0002-0199-2908	DFG [GRK 1549]; European Union's Seventh Framework Programme for research, technological development and demonstration [613931]; Open Access Publication Fund of the University of Muenster; DFG, Germany [GRK 1549]; Danish Agency for Science, Technology and Innovation, Denmark (FENAMI project) [10-093456]	DFG(German Research Foundation (DFG)); European Union's Seventh Framework Programme for research, technological development and demonstration; Open Access Publication Fund of the University of Muenster; DFG, Germany(German Research Foundation (DFG)); Danish Agency for Science, Technology and Innovation, Denmark (FENAMI project)	This study was founded by the German Research foundation (DFG: (Project GRK 1549 International Research Training Group 'Molecular and Cellular GlycoSciences'), from The Danish Agency for Science, Technology and Innovation, 440 Denmark (FENAMI project 10-093456); the research leading to these results has also received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no. 613931 (Nano3Bio). We further acknowledge support by the Open Access Publication Fund of the University of Muenster.; We acknowledge support from DFG, Germany (Project GRK 1549 International Research Training Group 'Molecular and Cellular GlycoSciences'), from The Danish Agency for Science, Technology and Innovation, Denmark (FENAMI project 10-093456); the research leading to these results has also received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no. 613931 (Nano3Bio). We acknowledge support by Open Access Publication Fund of the University of Minster.	Ahmad MZ, 2010, EXPERT OPIN DRUG DEL, V7, P927, DOI 10.1517/17425247.2010.498473; ARTURSSON P, 1994, PHARMACEUT RES, V11, P1358, DOI 10.1023/A:1018967116988; Bauwens A, 2013, CELL MOL LIFE SCI, V70, P425, DOI 10.1007/s00018-012-1060-z; Beck-Broichsitter M, 2012, J CONTROL RELEASE, V161, P214, DOI 10.1016/j.jconrel.2011.12.004; Calvo P, 1997, INT J PHARM, V153, P41, DOI 10.1016/S0378-5173(97)00083-5; Carl D, 2004, APPL OPTICS, V43, P6536, DOI 10.1364/AO.43.006536; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chae SY, 2005, J CONTROL RELEASE, V102, P383, DOI 10.1016/j.jconrel.2004.10.012; Chen CH, 2015, AM J PHYSIOL-CELL PH, V309, pC600, DOI 10.1152/ajpcell.00155.2015; Chen Y, 2012, ADV DRUG DELIVER REV, V64, P640, DOI 10.1016/j.addr.2011.11.010; De Campos AM, 2001, INT J PHARM, V224, P159, DOI 10.1016/S0378-5173(01)00760-8; de la Fuente M, 2008, MACROMOL BIOSCI, V8, P441, DOI 10.1002/mabi.200700190; Dodane V, 1999, INT J PHARM, V182, P21, DOI 10.1016/S0378-5173(99)00030-7; Duncan R, 2003, NAT REV DRUG DISCOV, V2, P347, DOI 10.1038/nrd1088; Felice F, 2015, INT J BIOL MACROMOL, V76, P236, DOI 10.1016/j.ijbiomac.2015.02.041; Fernandez-Urrusuno R, 1999, PHARMACEUT RES, V16, P1576, DOI 10.1023/A:1018908705446; Foster HE, 2014, PROG DRUG RES, V68, P307, DOI 10.1007/978-3-0348-0828-6_13; Frohlich E, 2012, INT J NANOMED, V7, P5577, DOI 10.2147/IJN.S36111; Goldberg M, 2007, J BIOMAT SCI-POLYM E, V18, P241, DOI 10.1163/156856207779996931; Goycoolea FM, 2012, COLLOID POLYM SCI, V290, P1423, DOI 10.1007/s00396-012-2669-z; Goycoolea FM, 2009, BIOMACROMOLECULES, V10, P1736, DOI 10.1021/bm9001377; Haeger A, 2015, TRENDS CELL BIOL, V25, P556, DOI 10.1016/j.tcb.2015.06.003; Han JK, 2005, CYTOTECHNOLOGY, V47, P89, DOI 10.1007/s10616-005-3756-5; Han J, 2009, J AGR FOOD CHEM, V57, P11148, DOI 10.1021/jf901943q; Han JY, 2002, CYTOTECHNOLOGY, V40, P93, DOI 10.1023/A:1023922306968; He B, 2011, EUR J PHARMACOL, V667, P195, DOI 10.1016/j.ejphar.2011.06.001; Isoda H, 2001, CYTOTECHNOLOGY, V36, P155, DOI 10.1023/A:1014053306343; Kaiser A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140994; Kaiser M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10048; Kean T, 2010, ADV DRUG DELIVER REV, V62, P3, DOI 10.1016/j.addr.2009.09.004; Kemper B, 2006, P SOC PHOTO-OPT INS, P6191; Kemper B, 2008, APPL OPTICS, V47, pA52, DOI 10.1364/AO.47.000A52; Kemper B, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2204609; Kim M. K., 2010, SPIE REV, V1; Korel F, 2002, J AGR FOOD CHEM, V50, P3257, DOI 10.1021/jf010537b; Kotze AF, 1997, INT J PHARM, V159, P243, DOI 10.1016/S0378-5173(97)00287-1; Kunsmann L, 2015, SCI REP-UK, V5, DOI 10.1038/srep13252; Lichtman JW, 2005, NAT METHODS, V2, P910, DOI 10.1038/NMETH817; Lozano MV, 2008, BIOMACROMOLECULES, V9, P2186, DOI 10.1021/bm800298u; Marquet P, 2005, OPT LETT, V30, P468, DOI 10.1364/OL.30.000468; Matthews BD, 2010, INTEGR BIOL-UK, V2, P435, DOI 10.1039/c0ib00034e; Meghvansi MK, 2010, J ETHNOPHARMACOL, V132, P1, DOI 10.1016/j.jep.2010.08.034; Menchicchi B, 2014, BIOMACROMOLECULES, V15, P3550, DOI 10.1021/bm5007954; Miyazaki A, 2015, BIOCHEM BIOPH RES CO, V458, P161, DOI 10.1016/j.bbrc.2015.01.086; Nagumo Y, 2007, BIOCHEM BIOPH RES CO, V355, P520, DOI 10.1016/j.bbrc.2007.02.002; Nagumo Y, 2008, BIOCHEM BIOPH RES CO, V377, P921, DOI 10.1016/j.bbrc.2008.10.071; Nitta SK, 2013, INT J MOL SCI, V14, P1629, DOI 10.3390/ijms14011629; Nomarski G., 1955, J PHYSIQUE RADIUM, V16, P9; Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591; Pla AF, 2012, ONCOGENE, V31, P200, DOI 10.1038/onc.2011.231; Popescu G., 2011, QUANTITATIVE PHASE I; Prego C, 2006, J DRUG DELIV SCI TEC, V16, P331, DOI 10.1016/S1773-2247(06)50061-9; Prego C, 2006, J NANOSCI NANOTECHNO, V6, P2921, DOI 10.1166/jnn.2006.429; Prego C, 2006, PHARM RES-DORDR, V23, P549, DOI 10.1007/s11095-006-9570-8; Prego C, 2005, J CONTROL RELEASE, V101, P151, DOI 10.1016/j.jconrel.2004.07.030; Schipper NGM, 1996, PHARMACEUT RES, V13, P1686, DOI 10.1023/A:1016444808000; Schipper NGM, 1997, PHARMACEUT RES, V14, P923, DOI 10.1023/A:1012160102740; Schwab A, 2012, PHYSIOL REV, V92, P1865, DOI 10.1152/physrev.00018.2011; Shiobara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079954; Shotton D. M., 1997, CONFOCAL LASER SCANN; Sonaje K, 2012, MOL PHARMACEUT, V9, P1271, DOI 10.1021/mp200572t; Teijeiro-Osorio D, 2009, BIOMACROMOLECULES, V10, P243, DOI 10.1021/bm800975j; Valeur B., 2012, MOL FLUORESCENCE PRI, V2; Vicente S, 2013, J CONTROL RELEASE, V172, P773, DOI 10.1016/j.jconrel.2013.09.012; Vicente S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062500; Vllasaliu D, 2010, INT J PHARMACEUT, V400, P183, DOI 10.1016/j.ijpharm.2010.08.020; Waning J, 2007, CELL CALCIUM, V42, P17, DOI 10.1016/j.ceca.2006.11.005; Wilson T., 1984, THEORY PRACTICE SCAN; Yeh TH, 2011, BIOMATERIALS, V32, P6164, DOI 10.1016/j.biomaterials.2011.03.056; ZERNIKE F, 1955, SCIENCE, V121, P345, DOI 10.1126/science.121.3141.345; Zhang LL, 2007, CIRC RES, V100, P1063, DOI 10.1161/01.RES.0000262653.84850.8b	71	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187497	10.1371/journal.pone.0187497	http://dx.doi.org/10.1371/journal.pone.0187497			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29107993	Green Published, gold			2022-12-26	WOS:000414424600035
J	Pripp, AH; Stanisic, M				Pripp, Are Hugo; Stanisic, Milo			Association between biomarkers and clinical characteristics in chronic subdural hematoma patients assessed with lasso regression	PLOS ONE			English	Article							RISK-FACTORS; POSTOPERATIVE RECURRENCE; INFLAMMATORY CYTOKINES; MISSING DATA; SELECTION; MANAGEMENT; SHRINKAGE; MECHANISM; MARKERS; MODELS	Chronic subdural hematoma (CSDH) is characterized by an "old" encapsulated collection of blood and blood breakdown products between the brain and its outermost covering (the dura). Recognized risk factors for development of CSDH are head injury, old age and using anticoagulation medication, but its underlying pathophysiological processes are still unclear. It is assumed that a complex local process of interrelated mechanisms including inflammation, neomembrane formation, angiogenesis and fibrinolysis could be related to its development and propagation. However, the association between the biomarkers of inflammation and angiogenesis, and the clinical and radiological characteristics of CSDH patients, need further investigation. The high number of biomarkers compared to the number of observations, the correlation between biomarkers, missing data and skewed distributions may limit the usefulness of classical statistical methods. We therefore explored lasso regression to assess the association between 30 biomarkers of inflammation and angiogenesis at the site of lesions, and selected clinical and radiological characteristics in a cohort of 93 patients. Lasso regression performs both variable selection and regularization to improve the predictive accuracy and interpretability of the statistical model. The results from the lasso regression showed analysis exhibited lack of robust statistical association between the biomarkers in hematoma fluid with age, gender, brain infarct, neurological deficiencies and volume of hematoma. However, there were associations between several of the biomarkers with postoperative recurrence requiring reoperation. The statistical analysis with lasso regression supported previous findings that the immunological characteristics of CSDH are local. The relationship between biomarkers, the radiological appearance of lesions and recurrence requiring reoperation have been inclusive using classical statistical methods on these data, but lasso regression revealed an association with inflammatory and angiogenic biomarkers in hematoma fluid. We thus suggest that lasso regression should be a recommended statistical method in research on biological processes in CSDH patients.	[Pripp, Are Hugo] Oslo Univ Hosp, Oslo Ctr Biostat & Epidemiol, Res Support Serv, Oslo, Norway; [Stanisic, Milo] Oslo Univ Hosp, Dept Neurosurg, Oslo, Norway	University of Oslo; University of Oslo	Pripp, AH (corresponding author), Oslo Univ Hosp, Oslo Ctr Biostat & Epidemiol, Res Support Serv, Oslo, Norway.	apripp@ous-hf.no						Albert Venencia, 2017, BMC Res Notes, V10, P139, DOI 10.1186/s13104-017-2459-2; Almenawer SA, 2014, ANN SURG, V259, P449, DOI 10.1097/SLA.0000000000000255; Chen JCT, 2000, NEUROSURG CLIN N AM, V11, P399, DOI 10.1016/S1042-3680(18)30101-3; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Frati A, 2004, J NEUROSURG, V100, P24, DOI 10.3171/jns.2004.100.1.0024; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gao Q, 2017, SIGNAL PROCESS, V131, P1, DOI 10.1016/j.sigpro.2016.07.014; Genser B, 2016, BMC IMMUNOL, V17, DOI 10.1186/s12865-016-0149-9; GOLDEN J, 1994, CLIN NEUROPATHOL, V13, P12; Haenisch F, 2016, BRAIN BEHAV IMMUN, V52, P49, DOI 10.1016/j.bbi.2015.10.001; Harrell FE, 2015, SPRINGER SER STAT, P63, DOI 10.1007/978-3-319-19425-7_4; Hoff P, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030583; Hoff P, 2016, IMMUNOL RES, V64, P1195, DOI 10.1007/s12026-016-8868-9; Hong HJ, 2009, SURG NEUROL, V71, P161, DOI 10.1016/j.surneu.2008.01.023; James G., 2014, INTRO STAT LEARNING; Kitazono M, 2012, NEUROL MED-CHIR, V52, P810, DOI 10.2176/nmc.52.810; Kolias AG, 2014, NAT REV NEUROL, V10, P570, DOI 10.1038/nrneurol.2014.163; Long Q, 2015, BIOSTATISTICS, V16, P596, DOI 10.1093/biostatistics/kxv003; Nakaguchi H, 2001, J NEUROSURG, V95, P256, DOI 10.3171/jns.2001.95.2.0256; Ndhlovu ZM, 2013, BLOOD, V121, P801, DOI 10.1182/blood-2012-06-436295; Park KS, 2015, J KOREAN NEUROSURG S, V57, P235, DOI 10.3340/jkns.2015.57.4.235; Pope SM, 2001, J ALLERGY CLIN IMMUN, V108, P594, DOI 10.1067/mai.2001.118600; Pripp AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090149; Ro HW, 2016, ACTA NEUROCHIR, V158, P135, DOI 10.1007/s00701-015-2625-z; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Sabbe N, 2013, STAT MED, V32, P3143, DOI 10.1002/sim.5760; Schwarz F, 2015, CLIN NEUROL NEUROSUR, V138, P66, DOI 10.1016/j.clineuro.2015.08.002; Stanisic M, 2017, NEUROSURGERY; Stanisic M, 2013, ACTA NEUROCHIR, V155, P323, DOI 10.1007/s00701-012-1565-0; Stanisic M, 2012, INFLAMM RES, V61, P845, DOI 10.1007/s00011-012-0476-0; Stanisic M, 2012, ACTA NEUROCHIR, V154, P113, DOI 10.1007/s00701-011-1203-2; Tao ZQ, 2016, MED HYPOTHESES, V86, P43, DOI 10.1016/j.mehy.2015.11.027; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tibshirani R, 2011, J R STAT SOC B, V73, P273, DOI 10.1111/j.1467-9868.2011.00771.x; Wada T, 2006, NEUROSURG REV, V29, P242, DOI 10.1007/s10143-006-0019-7; Wang K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082700; Weigel R, 2003, J NEUROL NEUROSUR PS, V74, P937, DOI 10.1136/jnnp.74.7.937; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Yu GJ, 2009, BRIT J NEUROSURG, V23, P606, DOI 10.3109/02688690903386983	39	17	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0186838	10.1371/journal.pone.0186838	http://dx.doi.org/10.1371/journal.pone.0186838			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29107999	gold, Green Published, Green Submitted			2022-12-26	WOS:000414424600008
J	Vandegrift, BJ; You, C; Satta, R; Brodie, MS; Lasek, AW				Vandegrift, Bertha J.; You, Chang; Satta, Rosalba; Brodie, Mark S.; Lasek, Amy W.			Estradiol increases the sensitivity of ventral tegmental area dopamine neurons to dopamine and ethanol	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; ESTROGEN-RECEPTOR-ALPHA; SEX-DIFFERENCES; NUCLEUS-ACCUMBENS; FEMALE RATS; G-PROTEIN; ALCOHOL-CONSUMPTION; ANIMAL-MODELS; ER-BETA; COCAINE	Gender differences in psychiatric disorders such as addiction may be modulated by the steroid hormone estrogen. For instance, 1703-estradiol (E2), the predominant form of circulating estrogen in pre-menopausal females, increases ethanol consumption, suggesting that E2 may affect the rewarding properties of ethanol and thus the development of alcohol use disorder in females. The ventral tegmental area (VTA) is critically involved in the rewarding and reinforcing effects of ethanol. In order to determine the role of E2 in VTA physiology, gonadally intact female mice were sacrificed during diestrus II (high E2) or estrus (low E2) for electrophysiology recordings. We measured the excitation by ethanol and inhibition by dopamine (DA) of VTA DA neurons and found that both excitation by ethanol and inhibition by dopamine were greater in diestrus II compared with estrus. Treatment of VTA slices from mice in diestrus II with an estrogen receptor antagonist (ICI 182,780) reduced ethanol-stimulated neuronal firing, but had no effect on ethanol-stimulated firing of neurons in slices from mice in estrus. Surprisingly, IC1182,780 did not affect the inhibition by DA, indicating different mechanisms of action of estrogen receptors in altering ethanol and DA responses. We also examined the responses of VTA DA neurons to ethanol and DA in ovariectomized mice treated with E2 and found that E2 treatment enhanced the responses to ethanol and DA in a manner similar to what we observed in mice in diestrus II. Our data indicate that E2 modulates VTA neuron physiology, which may contribute to both the enhanced reinforcing and rewarding effects of alcohol and the development of other psychiatric disorders in females that involve alterations in DA neurotransmission.	[Vandegrift, Bertha J.; You, Chang; Brodie, Mark S.] Univ Illinois, Dept Physiol & Biophys, Chicago, IL 60680 USA; [Satta, Rosalba; Lasek, Amy W.] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lasek, AW (corresponding author), Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA.	alasek@uic.edu	Brodie, Mark/AAN-4076-2021; Lasek, Amy/AAV-7606-2020	Lasek, Amy/0000-0002-7099-2442; Brodie, Mark/0000-0003-3933-561X; Vandegrift, Bertha/0000-0003-0600-526X	National Institute on Alcohol Abuse and Alcoholism [AA020912, AA022538]; National Institute on Drug Abuse [DA033429]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA020912, P50AA022538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033429] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institute on Alcohol Abuse and Alcoholism (www.niaaa.nih.gov; grant AA020912 to AWL and AA022538 to AWL and MSB) and the National Institute on Drug Abuse (www.drugabuse.gov; grant DA033429 to AWL). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN JM, 1993, J PHARMACOL EXP THER, V265, P963; Anker JJ, 2011, CURR TOP BEHAV NEURO, V8, P73, DOI 10.1007/7854_2010_93; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Bechtholt AJ, 2005, BEHAV NEUROSCI, V119, P213, DOI 10.1037/0735-7044.119.1.213; Becker JB, 2016, PHARMACOL REV, V68, P242, DOI 10.1124/pr.115.011163; Becker JB, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-14; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Bobzean SAM, 2014, BRAIN RES BULL, V103, P49, DOI 10.1016/j.brainresbull.2014.02.002; Brodie MS, 2000, ALCOHOL CLIN EXP RES, V24, P1120, DOI 10.1111/j.1530-0277.2000.tb04658.x; Brodie MS, 1998, ALCOHOL CLIN EXP RES, V22, P236, DOI 10.1111/j.1530-0277.1998.tb03644.x; Brodie MS, 1999, ALCOHOL CLIN EXP RES, V23, P1848, DOI 10.1111/j.1530-0277.1999.tb04082.x; BRODIE MS, 1995, J PHARMACOL EXP THER, V273, P1139; BRODIE MS, 1990, N-S ARCH PHARMACOL, V342, P660, DOI 10.1007/BF00175709; BRODIE MS, 1990, BRAIN RES, V508, P65, DOI 10.1016/0006-8993(90)91118-Z; Calipari ES, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13877; Carroll ME, 2010, HORM BEHAV, V58, P44, DOI 10.1016/j.yhbeh.2009.10.001; Carroll ME, 2004, TRENDS PHARMACOL SCI, V25, P273, DOI 10.1016/j.tips.2004.03.011; Chen HH, 2003, CHINESE J PHYSIOL, V46, P169; Cheng HG, 2016, ALCOHOL CLIN EXP RES, V40, P816, DOI 10.1111/acer.13028; Chieng B, 2011, J PHYSIOL-LONDON, V589, P3775, DOI 10.1113/jphysiol.2011.210807; Creutz LM, 2002, J COMP NEUROL, V446, P288, DOI 10.1002/cne.10207; DAUVOIS S, 1993, J CELL SCI, V106, P1377; Dazzi L, 2007, NEUROPSYCHOPHARMACOL, V32, P892, DOI 10.1038/sj.npp.1301150; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Dichter GS, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-19; Dutton JW, 2017, ADDICT BIOL, V22, P665, DOI 10.1111/adb.12358; Dutton JW, 2016, ADDICTION BIOL; Eagon PK, 2010, WORLD J GASTROENTERO, V16, P1377, DOI 10.3748/wjg.v16.i11.1377; Febo M, 2003, J NEUROCHEM, V86, P405, DOI 10.1046/j.1471-4159.2003.01858.x; Ford MM, 2004, ALCOHOL CLIN EXP RES, V28, P20, DOI 10.1097/01.ALC.0000108647.62718.5A; Ford MM, 2002, ALCOHOL, V26, P103, DOI 10.1016/S0741-8329(01)00203-8; Ford MM, 2002, ALCOHOL CLIN EXP RES, V26, P635, DOI 10.1111/j.1530-0277.2002.tb02585.x; Galankin T, 2010, HORM BEHAV, V58, P827, DOI 10.1016/j.yhbeh.2010.08.006; GARIANO RF, 1988, BRAIN RES, V462, P194, DOI 10.1016/0006-8993(88)90606-3; GATTO GJ, 1994, ALCOHOL, V11, P557, DOI 10.1016/0741-8329(94)90083-3; GESSA GL, 1985, BRAIN RES, V348, P201, DOI 10.1016/0006-8993(85)90381-6; Gobinath AR, 2017, J NEUROSCI RES, V95, P50, DOI 10.1002/jnr.23872; Gogos A, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/615356; GORDON JH, 1989, PHARMACOL BIOCHEM BE, V33, P123, DOI 10.1016/0091-3057(89)90440-1; Howell A, 2000, CANCER-AM CANCER SOC, V89, P817, DOI 10.1002/1097-0142(20000815)89:4<817::AID-CNCR14>3.0.CO;2-6; Hu M, 2004, NEUROPSYCHOPHARMACOL, V29, P81, DOI 10.1038/sj.npp.1300301; Hu M, 2008, DRUG ALCOHOL DEPEN, V94, P56, DOI 10.1016/j.drugalcdep.2007.10.005; Huang GZ, 2012, NEURON, V74, P801, DOI 10.1016/j.neuron.2012.03.035; Jones S, 2005, CURR OPIN PHARMACOL, V5, P20, DOI 10.1016/j.coph.2004.08.011; JOYCE JN, 1982, EUR J PHARMACOL, V81, P117, DOI 10.1016/0014-2999(82)90608-2; Jury NJ, 2017, ALCOHOL, V58, P53, DOI 10.1016/j.alcohol.2016.07.007; Keyes KM, 2008, DRUG ALCOHOL DEPEN, V93, P21, DOI 10.1016/j.drugalcdep.2007.08.017; KIM KM, 1995, NEUROSCIENCE, V69, P1145, DOI 10.1016/0306-4522(95)00326-E; Kita JM, 2009, SYNAPSE, V63, P951, DOI 10.1002/syn.20676; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Koob GF, 2003, ALCOHOL CLIN EXP RES, V27, P232, DOI 10.1097/01.ALC.0000057122.36127.C2; Kritzer MF, 2008, J NEUROSCI, V28, P9525, DOI 10.1523/JNEUROSCI.2637-08.2008; Locci A, 2017, HORM BEHAV, V87, P35, DOI 10.1016/j.yhbeh.2016.10.005; Lynch WJ, 2001, PHARMACOL BIOCHEM BE, V68, P641, DOI 10.1016/S0091-3057(01)00455-5; Madularu D, 2016, HORM BEHAV, V82, P56, DOI 10.1016/j.yhbeh.2016.04.007; Madularu D, 2015, PSYCHONEUROENDOCRINO, V56, P200, DOI 10.1016/j.psyneuen.2015.02.022; MANN K, 1992, ALCOHOL CLIN EXP RES, V16, P1052, DOI 10.1111/j.1530-0277.1992.tb00698.x; Margolis EB, 2008, J NEUROSCI, V28, P8908, DOI 10.1523/JNEUROSCI.1526-08.2008; Margolis EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042365; Margolis EB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015222; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; Marinelli PW, 2003, BEHAV BRAIN RES, V139, P59, DOI 10.1016/S0166-4328(02)00057-8; Milner TA, 2010, BRAIN RES, V1351, P74, DOI 10.1016/j.brainres.2010.06.038; Mitra SW, 2003, ENDOCRINOLOGY, V144, P2055, DOI 10.1210/en.2002-221069; MUELLER AL, 1989, J NEUROSCI METH, V28, P15, DOI 10.1016/0165-0270(89)90005-8; Muti P, 1998, CANCER EPIDEM BIOMAR, V7, P189; NELSON JF, 1982, BIOL REPROD, V27, P327, DOI 10.1095/biolreprod27.2.327; Nilsson ME, 2015, ENDOCRINOLOGY, V156, P2492, DOI 10.1210/en.2014-1890; Nimitvilai S, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00434; Nimitvilai S, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00007; Nimitvilai S, 2012, NEUROPSYCHOPHARMACOL, V37, P543, DOI 10.1038/npp.2011.222; OADES RD, 1987, BRAIN RES REV, V12, P117, DOI 10.1016/0165-0173(87)90011-7; Oliva I, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00030; PARKER MG, 1993, BREAST CANCER RES TR, V26, P131, DOI 10.1007/BF00689686; Polter AM, 2014, EUR J NEUROSCI, V39, P1179, DOI 10.1111/ejn.12490; Priddy BM, 2017, PHARMACOL BIOCHEM BE, V152, P61, DOI 10.1016/j.pbb.2016.08.001; Quirarte Gina L., 2007, BMC Pharmacology, V7, P3, DOI 10.1186/1471-2210-7-3; Rajasingh J, 2007, ENDOCRINOLOGY, V148, P3618, DOI 10.1210/en.2006-1357; Reid LD, 2002, PHARMACOL BIOCHEM BE, V72, P601, DOI 10.1016/S0091-3057(02)00732-3; Reid ML, 2003, PHARMACOL BIOCHEM BE, V74, P381, DOI 10.1016/S0091-3057(02)01008-0; Rhodes JS, 2007, GENES BRAIN BEHAV, V6, P1, DOI 10.1111/j.1601-183X.2006.00210.x; Riccardi P, 2011, SYNAPSE, V65, P99, DOI 10.1002/syn.20822; Roberts AJ, 1998, ALCOHOL CLIN EXP RES, V22, P1564, DOI 10.1111/j.1530-0277.1998.tb03950.x; Rodd ZA, 2004, J NEUROSCI, V24, P1050, DOI 10.1523/JNEUROSCI.1319-03.2004; Roepke TA, 2009, J NEUROENDOCRINOL, V21, P141, DOI 10.1111/j.1365-2826.2008.01814.x; Russo SJ, 2013, NAT REV NEUROSCI, V14, P609, DOI 10.1038/nrn3381; Schultz KN, 2009, J NEUROSCI, V29, P1897, DOI 10.1523/JNEUROSCI.4647-08.2009; Segarra AC, 2010, HORM BEHAV, V58, P33, DOI 10.1016/j.yhbeh.2009.12.003; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; Silverman JL, 2007, HORM BEHAV, V52, P146, DOI 10.1016/j.yhbeh.2007.03.017; Theile JW, 2011, NEUROSCIENCE, V172, P94, DOI 10.1016/j.neuroscience.2010.10.046; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Thompson TL, 2001, BRAIN RES BULL, V54, P631, DOI 10.1016/S0361-9230(01)00472-5; THOMPSON TL, 1994, J NEUROCHEM, V62, P1750; Tremblay GB, 1997, MOL ENDOCRINOL, V11, P353, DOI 10.1210/me.11.3.353; Wade CB, 2001, ENDOCRINOLOGY, V142, P2336, DOI 10.1210/en.142.6.2336; WEISS F, 1993, J PHARMACOL EXP THER, V267, P250; Xiao L, 2003, NEUROENDOCRINOLOGY, V77, P239, DOI 10.1159/000070279; Zagni Emanuela, 2016, Neurosci J, V2016, P2827090, DOI 10.1155/2016/2827090; Zhang D, 2008, PSYCHOPHARMACOLOGY, V199, P625, DOI 10.1007/s00213-008-1188-6; Zhao L, 2005, NEUROSCIENCE, V132, P299, DOI 10.1016/j.neuroscience.2004.11.054; Zhengming Ding, 2015, 2015 11th IEEE International Conference and Workshops on Automatic Face and Gesture Recognition (FG), P1, DOI 10.1109/FG.2015.7163088; Zhou WX, 2002, MOL BRAIN RES, V100, P75, DOI 10.1016/S0169-328X(02)00134-1	103	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187698	10.1371/journal.pone.0187698	http://dx.doi.org/10.1371/journal.pone.0187698			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29107956	Green Published, gold, Green Submitted			2022-12-26	WOS:000414424600060
J	Pope, C; Piekos, SC; Chen, LM; Mishra, S; Zhong, XB				Pope, Chad; Piekos, Stephanie C.; Chen, Liming; Mishra, Shashank; Zhong, Xiao-bo			The role of H19, a long non-coding RNA, in mouse liver postnatal maturation	PLOS ONE			English	Article							GENE-EXPRESSION; BETA-CATENIN; SEQUENCING QUANTIFICATION; TISSUE DISTRIBUTION; HEPATIC ONTOGENY; MESSENGER-RNAS; REVEALS; DIFFERENTIATION; PROLIFERATION; TRANSCRIPTION	H19 RNA is highly expressed at early postnatal ages and precipitously decreases at a specific time corresponding with increases in expression of genes important for mature liver function, such as drug metabolizing enzymes. H19's role in the regulation of liver maturation is currently unknown. Using an H19 knockout mouse model to determine the role of H19 in liver development, we quantified gene expression for insulin growth factor signaling, Wnt signaling, key cytochrome P450 (P450) enzymes known to change as the liver develops, and fetal and adult plasma protein produced in liver. In mice lacking H19 expression, liver weights were significantly increased immediately after birth and significant increases were found in the number of actively proliferating cells. Increases in cell proliferation may be due to increases in beta-catenin protein affecting Wnt signaling, increases in insulin-like growth factor 2 (IGF2) expression, and/or increases in insulin-like growth factor 1 receptor (IGF1R) expression at the protein level. Loss of targeted inhibition of IGF1R by microRNA 675 (miR-675) may be the cause of IGF1R increases, as miR-675 expression is also abrogated with loss of H19 expression in our model. P450 expression patterns were largely unchanged. No change in the production of plasma proteins was found, indicating H19 may not be important for liver maturation despite its role in controlling cell proliferation during liver growth. H19 may be important for normal liver development, and understanding how the liver matures will assist in predicting drug efficacy and toxicity in pediatric populations.	[Pope, Chad; Piekos, Stephanie C.; Chen, Liming; Zhong, Xiao-bo] Univ Connecticut, Sch Pharm, Dept Pharmaceut Sci, Storrs, CT 06269 USA; [Mishra, Shashank] Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA	University of Connecticut; University of Connecticut	Pope, C (corresponding author), Univ Connecticut, Sch Pharm, Dept Pharmaceut Sci, Storrs, CT 06269 USA.	chad.pope@outlook.com	Chen, Liming/HHZ-1212-2022	Chen, Liming/0000-0001-5065-9557	National Institute of General Medical Sciences [R01GM-087376, R01GM-118367]; National Institute of Environmental Health Sciences [R01ES-019487]; Institute for System Genomics at the University of Connecticut; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118367, R01GM087376] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Institute for System Genomics at the University of Connecticut; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institute of General Medical Sciences (Grant R01GM-087376 and R01GM-118367) (to XBZ) and the National Institute of Environmental Health Sciences (Grant R01ES-019487) (to XBZ). This study was also partially supported by the Institute for System Genomics at the University of Connecticut (to XBZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apte U, 2007, AM J PHYSIOL-GASTR L, V292, pG1578, DOI 10.1152/ajpgi.00359.2006; Ariel I, 1997, J CLIN PATHOL-MOL PA, V50, P34, DOI 10.1136/mp.50.1.34; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; Bhate A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9768; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; CASCIO S, 1991, DEVELOPMENT, V113, P217; Cui JY, 2012, TOXICOL SCI, V127, P592, DOI 10.1093/toxsci/kfs107; Cui JY, 2012, DRUG METAB DISPOS, V40, P1226, DOI 10.1124/dmd.111.042697; Dey BK, 2014, GENE DEV, V28, P491, DOI 10.1101/gad.234419.113; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Hata S, 2007, DEV GROWTH DIFFER, V49, P163, DOI 10.1111/j.1440-169x.2007.00910.x; Jochheim A, 2004, INT J DEV BIOL, V48, P23, DOI 10.1387/ijdb.15005571; Kelman Z, 1997, ONCOGENE, V14, P629, DOI 10.1038/sj.onc.1200886; Keniry A, 2012, NAT CELL BIOL, V14, P659, DOI 10.1038/ncb2521; Kim KS, 1997, CANCER LETT, V119, P143, DOI 10.1016/S0304-3835(97)00264-4; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Li TT, 2009, GENOMICS, V93, P235, DOI 10.1016/j.ygeno.2008.10.006; Li Y, 2009, MOL PHARMACOL, V75, P1171, DOI 10.1124/mol.108.052993; Lu H, 2013, DRUG METAB DISPOS, V41, P844, DOI 10.1124/dmd.112.050211; Matouk IJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000845; Monga SS, 2014, GENE EXPRESSION, V16, P51, DOI 10.3727/105221614X13919976902138; PACHNIS V, 1984, P NATL ACAD SCI-BIOL, V81, P5523, DOI 10.1073/pnas.81.17.5523; Peng L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114917; Peng L, 2013, DRUG METAB DISPOS, V41, P2175, DOI 10.1124/dmd.113.054635; Peng L, 2012, DRUG METAB DISPOS, V40, P1198, DOI 10.1124/dmd.112.045088; Pope Chad, 2017, Diseases, V5, DOI 10.3390/diseases5010011; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Renaud HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104560; Renaud HJ, 2011, TOXICOL SCI, V124, P261, DOI 10.1093/toxsci/kfr240; Ripoche MA, 1997, GENE DEV, V11, P1596, DOI 10.1101/gad.11.12.1596; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sen S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2342; Septer S, 2012, AM J PHYSIOL-GASTR L, V302, pG493, DOI 10.1152/ajpgi.00056.2011; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Wang SB, 2016, FEBS LETT, V590, P559, DOI 10.1002/1873-3468.12078; Wang SH, 2016, TUMOR BIOL, V37, P9721, DOI 10.1007/s13277-016-4852-1; Yamamoto Y, 2004, J HEPATOL, V40, P808, DOI 10.1016/j.jhep.2004.01.022; Zeng G, 2007, HEPATOLOGY, V45, P195, DOI 10.1002/hep.21473; Zorn A.M., 2008, LIVER DEV	39	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							e0187557	10.1371/journal.pone.0187557	http://dx.doi.org/10.1371/journal.pone.0187557			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6TA	29099871	Green Published, Green Submitted, gold			2022-12-26	WOS:000414377900029
J	Tonoyan, Y; Chanwimalueang, T; Mandic, DP; Van Hulle, MM				Tonoyan, Yelena; Chanwimalueang, Theerasak; Mandic, Danilo P.; Van Hulle, Marc M.			Discrimination of emotional states from scalp- and intracranial EEG using multiscale Renyi entropy	PLOS ONE			English	Article							ELECTRICAL-STIMULATION; TEMPORAL DYNAMICS; RESPONSES; AMYGDALA; COMPLEXITY; ERP; IDENTIFICATION; NONLINEARITY; RECOGNITION; THETA	A data-adaptive, multiscale version of Renyi's quadratic entropy (RQE) is introduced for emotional state discrimination from EEG recordings. The algorithm is applied to scalp EEG recordings of 30 participants watching 4 emotionally-charged video clips taken from a validated public database. Krippendorffs inter-rater statistic reveals that multiscale RQE of the mid-frontal scalp electrodes best discriminates between five emotional states. Multiscale RQE is also applied to joint scalp EEG, amygdala- and occipital pole intracranial recordings of an implanted patient watching a neutral and an emotionally charged video clip. Unlike for the neutral video clip, the RQEs of the mid-frontal scalp electrodes and the amygdala-implanted electrodes are observed to coincide in the time range where the crux of the emotionally-charged video clip is revealed. In addition, also during this time range, phase synchrony between the amygdala and mid-frontal recordings is maximal, as well as our 30 participants inter-rater agreement on the same video clip. A source reconstruction exercise using intracranial recordings supports our assertion that amygdala could contribute to mid-frontal scalp EEG. On the contrary, no such contribution was observed for the occipital poles intracranial recordings. Our results suggest that emotional states discriminated from mid-frontal scalp EEG are likely to be mirrored by differences in amygdala activations in particular when recorded in response to emotionally-charged scenes.	[Tonoyan, Yelena; Van Hulle, Marc M.] Res Grp Neurophysiol, Lab Neuro & Psychophysiol, Leuven, Belgium; [Chanwimalueang, Theerasak; Mandic, Danilo P.] Imperial Coll London, Dept Elect & Elect Engn, Commun & Signal Proc Res Grp, London, England	Imperial College London	Tonoyan, Y (corresponding author), Res Grp Neurophysiol, Lab Neuro & Psychophysiol, Leuven, Belgium.	elenatonoyan@gmail.com		Van Hulle, Marc/0000-0003-1060-7044	Interuniversity Attraction Poles Programme Belgian Science Policy [IUAP P7/11]; KU Leuven [PFV/10/008, IDO/12/007, IOF/HB/12/021]; Belgian Fund for Scientific Research Flanders [G088314N, G0A0914N]; Flemish Regional Ministry of Education (Belgium) [GOA 10/019]; Hercules Foundation [AKUL 043]; EPSRC [EP/K025643/1]; Engineering and Physical Sciences Research Council [EP/K025643/1, EP/P008461/1] Funding Source: researchfish; Rosetrees Trust [M390] Funding Source: researchfish; EPSRC [EP/P009204/1, EP/P008461/1] Funding Source: UKRI	Interuniversity Attraction Poles Programme Belgian Science Policy(Belgian Federal Science Policy Office); KU Leuven(KU Leuven); Belgian Fund for Scientific Research Flanders(FWO); Flemish Regional Ministry of Education (Belgium)(FWO); Hercules Foundation; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Rosetrees Trust(Rosetrees Trust); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	YT is supported by the Interuniversity Attraction Poles Programme Belgian Science Policy (IUAP P7/11). MMVH is supported by research grants received from the Financing program (PFV/10/008), an interdisciplinary research project (IDO/12/007), and an industrial research fund project (IOF/HB/12/021) of the KU Leuven, the Belgian Fund for Scientific Research Flanders (G088314N, G0A0914N), the Interuniversity Attraction Poles Programme Belgian Science Policy (IUAP P7/11), the Flemish Regional Ministry of Education (Belgium) (GOA 10/019), and the Hercules Foundation (AKUL 043). DM is supported by an EPSRC grant (EP/K025643/1).; The authors are grateful to Prof. Alexandre Schaefer (School of Business, Monash University, Victoria, Malaysia) for his valuable input to the interpretation of the video clip data and to Prof. Alfred Meurs, Dr. Evelien Carrette, and Prof. Paul Boon (Neurology Department, Ghent University Hospital), Prof. Dirk Van Roost (Department of Neurosurgery, Ghent University Hospital) for their assistance in the ECoG experiment and Mansoureh Fahimi Hnazaee (Laboratory of Neuro- and Psychophysiology, KU Leuven) for performing the source reconstruction analysis. YT is supported by the Interuniversity Attraction Poles Programme Belgian Science Policy (IUAP P7/11). MMVH is supported by research grants received from the Financing program (PFV/10/008), an interdisciplinary research project (IDO/12/007), and an industrial research fund project (IOF/HB/12/021) of the KU Leuven, the Belgian Fund for Scientific Research-Flanders (G088314N, G0A0914N), the Interuniversity Attraction Poles Programme-Belgian Science Policy (IUAP P7/11), the Flemish Regional Ministry of Education (Belgium) (GOA 10/019), and the Hercules Foundation (AKUL 043).Part of the reported work was done while MVH was a Visiting Academic at Imperial College London. DM is supported by an EPSRC grant (EP/K025643/1).	Aftanas LI, 1998, INT J PSYCHOPHYSIOL, V28, P63, DOI 10.1016/S0167-8760(97)00067-6; AGGLETON JP, 1986, EMOTION THEORY RES E, V3, P281; Ahmed MU, 2012, B POL ACAD SCI-TECH, V60, P433, DOI 10.2478/v10175-012-0055-0; Arefian N. M., 2009, TANAFFOS - Journal of Respiratory Disease, Thoracic Surgery, Intensive Care and Tuberculosis, V8, P46; Bajaj V, 2015, INTEL SYST REF LIBR, V74, P215, DOI 10.1007/978-3-319-10978-7_8; Balconi M, 2006, NEUROSCI LETT, V392, P118, DOI 10.1016/j.neulet.2005.09.004; Bartolic EI, 1999, NEUROPSYCHOLOGIA, V37, P677, DOI 10.1016/S0028-3932(98)00123-7; Bekkedal MYV, 2011, NEUROSCI BIOBEHAV R, V35, P1959, DOI 10.1016/j.neubiorev.2011.05.001; Choppin A, 2000, THESIS; Costa M, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/68008; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Croft RJ, 2005, PSYCHOPHYSIOLOGY, V42, P16, DOI 10.1111/j.1468-8986.2005.00264.x; Daly I, 2014, NEUROSCI LETT, V573, P52, DOI 10.1016/j.neulet.2014.05.003; DAVIDSON RJ, 1992, BRAIN COGNITION, V20, P125, DOI 10.1016/0278-2626(92)90065-T; FISH DR, 1993, BRAIN, V116, P397, DOI 10.1093/brain/116.2.397; Fried I, 1997, NEURON, V18, P753, DOI 10.1016/S0896-6273(00)80315-3; Gautama T, 2003, 2003 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH, AND SIGNAL PROCESSING, VOL VI, PROCEEDINGS, P29; Gautama T, 2003, IEEE T MED IMAGING, V22, P636, DOI 10.1109/TMI.2003.812248; Goldberger AL, 2002, NEUROBIOL AGING, V23, P23, DOI 10.1016/S0197-4580(01)00266-4; Gramfort A, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-45; Guillory S. A., 2014, SOC COGN AFFECT NEUR; HALGREN E, 1978, BRAIN, V101, P83, DOI 10.1093/brain/101.1.83; Hayes AF, 2007, COMMUN METHODS MEAS, V1, P77, DOI 10.1080/19312450709336664; Holt DJ, 2006, SCHIZOPHR RES, V82, P153, DOI 10.1016/j.schres.2005.09.021; Hosseini S. A., 2011, INT J IMAGE GRAPH SI, V3, P30, DOI 10.5815/ijigsp.2011.05.05; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Jausovec N, 2001, NEUROSCI LETT, V311, P93, DOI 10.1016/S0304-3940(01)02141-3; Jessen S, 2011, NEUROIMAGE, V58, P665, DOI 10.1016/j.neuroimage.2011.06.035; Jie X, 2014, BIO-MED MATER ENG, V24, P1185, DOI 10.3233/BME-130919; JOHN ER, 1988, SCIENCE, V239, P162, DOI 10.1126/science.3336779; Kantz H., 2004, NONLINEAR TIME SERIE, V7; Kostyunina M B, 1996, Neurosci Behav Physiol, V26, P340, DOI 10.1007/BF02359037; Krolak-Salmon P, NEURON; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lanteaume L, 2007, CEREB CORTEX, V17, P1307, DOI 10.1093/cercor/bhl041; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Meletti S, 2006, EPILEPSIA, V47, P47, DOI 10.1111/j.1528-1167.2006.00877.x; Millan JDR, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00161; Naccache L, 2005, P NATL ACAD SCI USA, V102, P7713, DOI 10.1073/pnas.0500542102; Nijholt A, 2009, LECT NOTES COMPUTER, V2008, P225; Nunez P.L., 1995, NEOCORTICAL DYNAMICS; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Oya H, 2002, J NEUROSCI, V22, P9502; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Paulmann S, 2008, BRAIN LANG, V105, P59, DOI 10.1016/j.bandl.2007.11.005; Pourtois G, 2010, COGN AFFECT BEHAV NE, V10, P83, DOI 10.3758/CABN.10.1.83; Rehman N, 2010, P ROY SOC A-MATH PHY, V466, P1291, DOI 10.1098/rspa.2009.0502; Renyi A, 1961, P 4 BERK S MATH STAT, V1; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Sato W, 2011, NEUROPSYCHOLOGIA, V49, P612, DOI 10.1016/j.neuropsychologia.2010.12.025; Schaefer A, 2010, COGNITION EMOTION, V24, P1153, DOI 10.1080/02699930903274322; Schreiber T, 1996, PHYS REV LETT, V77, P635, DOI 10.1103/PhysRevLett.77.635; Sergerie K, 2008, NEUROSCI BIOBEHAV R, V32, P811, DOI 10.1016/j.neubiorev.2007.12.002; Sharma R, 2015, ENTROPY-SWITZ, V17, P669, DOI 10.3390/e17020669; Shattuck DW, 2002, MED IMAGE ANAL, V6, P129, DOI 10.1016/S1361-8415(02)00054-3; Shemyakina N. V., 2004, Fiziologiya Cheloveka, V30, P22; Soleymani M., 2011, Proceedings 2011 IEEE International Conference on Automatic Face & Gesture Recognition (FG 2011), P803, DOI 10.1109/FG.2011.5771352; Sourina O, 2011, BIOSIGNALS 2011, P82; Spreckelmeyer KN, 2009, BRAIN COGNITION, V69, P121, DOI 10.1016/j.bandc.2008.06.003; Stefanics G, 2012, NEUROIMAGE, V59, P3042, DOI 10.1016/j.neuroimage.2011.10.041; STUSS DT, 1992, J CONSULT CLIN PSYCH, V60, P349, DOI 10.1037/0022-006X.60.3.349; Tonoyan Y, 2016, INT J NEURAL SYST, V26, DOI 10.1142/S0129065716500052; VANRIJN AC, 1991, MED BIOL ENG COMPUT, V29, P433, DOI 10.1007/BF02441666; Vecchiato G, 2010, BRAIN TOPOGR, V23, P165, DOI 10.1007/s10548-009-0127-0; Verbeke G, 2009, SPRINGER SER STAT, P1; Wang XW, 2014, NEUROCOMPUTING, V129, P94, DOI 10.1016/j.neucom.2013.06.046; Zhang DD, 2014, SOC COGN AFFECT NEUR, V9, P1897, DOI 10.1093/scan/nst188	69	9	10	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							e0186916	10.1371/journal.pone.0186916	http://dx.doi.org/10.1371/journal.pone.0186916			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6TA	29099846	gold, Green Published, Green Submitted			2022-12-26	WOS:000414377900011
J	Geng, XC; Liu, YY; Diersch, S; Kotzsch, M; Grill, S; Weichert, W; Kiechle, M; Magdolen, V; Dorn, J				Geng, Xiaocong; Liu, Yueyang; Diersch, Sandra; Kotzsch, Matthias; Grill, Sabine; Weichert, Wilko; Kiechle, Marion; Magdolen, Viktor; Dorn, Julia			Clinical relevance of kallikrein-related peptidase 9,10,11, and 15 mRNA expression in advanced high-grade serous ovarian cancer	PLOS ONE			English	Article							FAVORABLE PROGNOSTIC MARKER; CELL LUNG-CANCER; BREAST-CANCER; GENE-EXPRESSION; POOR-PROGNOSIS; GASTRIC-CANCER; MULTIPLE KALLIKREINS; MOLECULAR-CLONING; PROSTATE-CANCER; 10 KLK10	KLK9, 10, 11, and 15 may represent potential cancer biomarkers for evaluating ovarian cancer prognosis. In the present study, we selected a homogeneous cohort including 139 patients of advanced high-grade serous ovarian cancer (FIGO stage III/IV) and assessed the mRNA levels of KLK9,10,11, and 15 in tumor tissue by quantitative PCR. No significant associations of KLK9, 10, 11, and 15 mRNA with established clinical parameters (residual tumor mass, ascitic fluid volume) were found. Pronounced correlations between KLK10/KLK11 (r(s)= 0.647) and between KLK9/KLK15 (r(s)= 0.716) mRNA, but not between other combinations, indicate coordinate expression of distinct pairs of peptidases. In univariate Cox regression analysis, elevated KLK11 mRNA levels were significantly linked with prolonged overall survival (OS; p = 0.021) and progression-free survival (PFS; p = 0.008). KLK15 mRNA levels showed a trend towards significance in case of OS (p = 0.06); KLK9 and KLK10 mRNA expression levels were not associated with patients' outcome. In multi-variable Cox analysis, KLK11 mRNA expression levels, apart from residual tumor mass, remained an independent predictive marker for OS (p = 0.007) and PFS (p = 0.015). Here, elevated KLK15 mRNA expression levels turned out to be significantly related to prolonged OS (p = 0.025) as well. High KLK11 but not the other KLK mRNA levels can be considered as strong independent favorable prognostic factor in this major ovarian cancer subtype.	[Geng, Xiaocong; Liu, Yueyang; Diersch, Sandra; Grill, Sabine; Kiechle, Marion; Magdolen, Viktor; Dorn, Julia] Tech Univ Munich, Dept Obstet & Gynecol, Clin Res Unit, Munich, Germany; [Kotzsch, Matthias] Med Lab Ostsachsen, Dresden, Germany; [Weichert, Wilko] Tech Univ Munich, Inst Pathol, Munich, Germany	Technical University of Munich; Technical University of Munich	Magdolen, V (corresponding author), Tech Univ Munich, Dept Obstet & Gynecol, Clin Res Unit, Munich, Germany.	viktor.magdolen@tum.de	Grill, Sabine/AAM-3978-2020		Wilhelm Sander-Stiftung [2016-024.1]; Deutsche Forschungsgemeinschaft [AV 109/74-1, D0 1772/1-1]	Wilhelm Sander-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Wilhelm Sander-Stiftung, grant 2016-024.1, http://wihelm-sander-stiftung.de, (VM); Deutsche Forschungsgemeinschaft, grant AV 109/74-1, http://www.dfg.de (WW); and Deutsche Forschungsgemeinschaft, grant D0 1772/1-1, http://www.dfg.de (JD).	Ahmed N, 2016, BIOL CHEM, V397, P1265, DOI 10.1515/hsz-2016-0177; Alexopoulou DK, 2013, CLIN BIOCHEM, V46, P1453, DOI 10.1016/j.clinbiochem.2013.03.002; Bharaj BB, 2002, PROSTATE, V51, P35, DOI 10.1002/pros.10076; Borgono CA, 2003, INT J CANCER, V106, P605, DOI 10.1002/ijc.11296; Bustin SA, 2013, REAL-TIME PCR: ADVANCED TECHNOLOGIES AND APPLICATIONS, P51; Diamandis EP, 2004, CLIN BIOCHEM, V37, P823, DOI 10.1016/j.clinbiochem.2004.04.009; Diamandis EP, 2002, CANCER RES, V62, P295; Dorn J, 2016, AM J CANCER RES, V6, P61; Drucker KL, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1566-5; El Sherbini MAH, 2011, INT J GYNECOL CANCER, V21, P625, DOI 10.1097/IGC.0b013e31821283c3; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Hu JJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17426; Jiao X, 2013, WORLD J GASTROENTERO, V19, P9425, DOI 10.3748/wjg.v19.i48.9425; Kioulafa M, 2009, ANN ONCOL, V20, P1020, DOI 10.1093/annonc/mdn733; Kipps E, 2013, NAT REV CANCER, V13, P273, DOI 10.1038/nrc3432; Koh SCL, 2011, ARCH GYNECOL OBSTET, V284, P183, DOI 10.1007/s00404-010-1605-z; Kolin DL, 2016, TUMOR BIOL, V37, P437, DOI 10.1007/s13277-015-3802-7; Kroon Evert, 1997, Genes and Function, V1, P309; Kryza T, 2016, BIOCHIMIE, V122, P283, DOI 10.1016/j.biochi.2015.09.002; Kurman RJ, 2016, AM J PATHOL, V186, P733, DOI 10.1016/j.ajpath.2015.11.011; Lawrence MG, 2010, ENDOCR REV, V31, P407, DOI 10.1210/er.2009-0034; Li L, 2015, ONCOL REP, V34, P2325, DOI 10.3892/or.2015.4211; Luo LY, 2003, CANCER RES, V63, P807; Luo LY, 2001, CLIN CANCER RES, V7, P2372; Mavridis K, 2013, PROSTATE, V73, P1191, DOI 10.1002/pros.22667; McIntosh MW, 2007, CLIN CANCER RES, V13, P4422, DOI 10.1158/1078-0432.CCR-06-2224; Paliouras M, 2008, TUMOR BIOL, V29, P63, DOI 10.1159/000135686; Paliouras M, 2007, BREAST CANCER RES TR, V102, P7, DOI 10.1007/s10549-006-9312-y; Petraki CD, 2002, J HISTOCHEM CYTOCHEM, V50, P1247, DOI 10.1177/002215540205000912; Pfaffl MW, 2012, QUANTITATIVE REAL-TIME PCR IN APPLIED MICROBIOLOGY, P53; Planque C, 2006, BIOL CHEM, V387, P783, DOI 10.1515/BC.2006.098; Prat J, 2012, VIRCHOWS ARCH, V460, P237, DOI 10.1007/s00428-012-1203-5; Santin AD, 2006, AM J OBSTET GYNECOL, V194, P1296, DOI 10.1016/j.ajog.2005.10.794; Sasaki H, 2006, CLIN LUNG CANCER, V8, P45, DOI 10.3816/CLC.2006.n.032; Seiz L, 2012, BIOL CHEM, V393, P391, DOI 10.1515/hsz-2011-0264; Shigemasa K, 2004, CLIN CANCER RES, V10, P2766, DOI 10.1158/1078-0432.CCR-03-0269; Stephan C, 2003, J UROLOGY, V169, P361, DOI 10.1016/S0022-5347(05)64127-4; Unal D, 2016, CANCER RES TREAT, V48, P98, DOI 10.4143/crt.2014.364; Wen YG, 2011, J SURG ONCOL, V104, P516, DOI 10.1002/jso.21981; White NMA, 2010, BRIT J CANCER, V102, P1244, DOI 10.1038/sj.bjc.6605634; Xu CH, 2014, TUMOR BIOL, V35, P5199, DOI 10.1007/s13277-014-1674-x; Yoon H, 2007, J BIOL CHEM, V282, P31852, DOI 10.1074/jbc.M705190200; Yousef GM, 2000, GENOMICS, V65, P184, DOI 10.1006/geno.2000.6159; Yousef GM, 2004, BRIT J CANCER, V90, P167, DOI 10.1038/sj.bjc.6601451; Yousef GM, 2003, BREAST CANCER RES TR, V78, P149, DOI 10.1023/A:1022931403825; Yousef GM, 2003, J CLIN ONCOL, V21, P3119, DOI 10.1200/JCO.2003.09.111; Yousef GM, 2003, CANCER RES, V63, P2223; Yousef GM, 2002, BRIT J CANCER, V87, P1294, DOI 10.1038/sj.bjc.6600590; Yousef GM, 2001, CANCER RES, V61, P7811; Yousef GM, 2001, J BIOL CHEM, V276, P53, DOI 10.1074/jbc.M005432200	50	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186847	10.1371/journal.pone.0186847	http://dx.doi.org/10.1371/journal.pone.0186847			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095848	Green Published, gold, Green Submitted			2022-12-26	WOS:000414340200025
J	Madbouni, MAZ; Samih, MA; Qureshi, JA; Biondi, A; Namvar, P				Madbouni, Mohammad Ali Ziaei; Samih, Mohammad Amin; Qureshi, Jawwad A.; Biondi, Antonio; Namvar, Peyman			Compatibility of insecticides and fungicides with the zoophytophagous mirid predator Nesidiocoris tenuis	PLOS ONE			English	Article							TUTA-ABSOLUTA; BIOLOGICAL-CONTROL; BEMISIA-TABACI; LIFE-HISTORY; HYMENOPTERA-APHELINIDAE; ERETMOCERUS-EREMICUS; NATURAL ENEMIES; HOST-PLANT; PESTICIDES; TOMATO	Nesidiocoris tenuis (Reuter) (Hemiptera: Miridae) is an effective predator of multiple pests of vegetable crops, such as thrips, mites, aphids, whiteflies, leafminers. It is mass-reared and released for augmentative biocontrol programs mainly aimed at controlling whiteflies and Tuta absoluta (Meyrick) (Lepidoptera: Gelechiidae) in greenhouses and open field. We evaluated the lethal and sublethal toxicity upon N. tenuis adults of label doses of three insecticides (pyriproxyfen, spirotetramat, cypermethrin) and seven fungicides (benomyl, chlor-othalonil, copper oxychloride, cyazofamid, fluopicolide + propamocarb hydrochloride (FPH), penconazol, trifloxystrobin) commonly used in various crops. Two exposure routes were tested: (i) contact with dry residues of insecticides or fungicides on tomato sprouts and (ii) multiple exposure to these chemicals via topical sprays on adults which foraged on treated sprouts; and fed on treated eggs of Ephestia kuehniella (Zeller) (Lepidoptera: Pyralidae) simultaneously. Mortality and reproductive capacity were investigated as indicators of lethal and sublethal effects on N. tenius. The tested insecticides and fungicides were all classified as harmless when predator was exposed only to the dry residues of each. However, the multiple exposure to either cypermethrin, benomyl, chlorothalonil, copper oxychloride or trifloxystrobin caused significant mortality of N. tenuis adults. Cypermethrin also significantly reduced its reproductive capacity. Interestingly, N. tenuis produced a higher number of progeny when exposed to fungicides penconazol and FPH in both exposure scenarios. Overall, findings suggest that the two insecticides, pyriproxyfen and spirotetramat but not cypermethrin, and all tested fungicides can be considered compatible with N. tenuis.	[Madbouni, Mohammad Ali Ziaei; Samih, Mohammad Amin] Vali e Asr Univ Rafsanjan, Coll Agr, Dept Plant Protect, Rafsanjan, Iran; [Qureshi, Jawwad A.] Univ Florida, IFAS, Indian River Res & Educ Ctr, Dept Entomol & Nematol, Ft Pierce, FL USA; [Biondi, Antonio] Univ Catania, Dept Agr Food & Environm, Via Santa Sofia, Catania, Italy; [Namvar, Peyman] AREEO, South Kerman Agr & Nat Resources Res & Educ Ctr, Plant Protect Res Dept, Jiroft, Iran	State University System of Florida; University of Florida; University of Catania	Qureshi, JA (corresponding author), Univ Florida, IFAS, Indian River Res & Educ Ctr, Dept Entomol & Nematol, Ft Pierce, FL USA.	jawwadq@ufl.edu	BIONDI, Antonio/I-6381-2012	BIONDI, Antonio/0000-0002-1982-7716; Qureshi, Jawwad/0000-0001-9076-4079	department of plant protection at Vali-e Asr University of Rafsanjani (Rafsanjani, Iran); department of plant protection in Agricultural and Natural Resources Research Center of Southern Kerman (Jiroft, Iran); Italian Ministry of Education, University and Research (SIR project) [RBSI14I02A]; EU FP7 [618127]	department of plant protection at Vali-e Asr University of Rafsanjani (Rafsanjani, Iran); department of plant protection in Agricultural and Natural Resources Research Center of Southern Kerman (Jiroft, Iran); Italian Ministry of Education, University and Research (SIR project); EU FP7(European Commission)	We are grateful to the department of plant protection at Vali-e Asr University of Rafsanjani (Rafsanjani, Iran) and the department of plant protection in Agricultural and Natural Resources Research Center of Southern Kerman (Jiroft, Iran) for providing financial support for this research to Mohammad Amin Samih. Antonio Biondi was founded by EU FP7 no. 618127 ARIMNet2 (Stomp project) and the Italian Ministry of Education, University and Research (SIR project, RBSI14I02A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We are grateful to the department of plant protection at Vali-e Asr University of Rafsanjani (Rafsanjani, Iran) and the department of plant protection in Agricultural and Natural Resources Research Center of Southern Kerman (Jiroft, Iran) for providing financial support for this research to Mohammad Amin Samih. Antonio Biondi was founded by EU FP7 no. 618127 ARIMNet2 (Stomp project) and the Italian Ministry of Education, University and Research (SIR project, RBSI14I02A).	Abbes K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138411; Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Alomar O, 2006, BIOL CONTROL, V36, P154, DOI 10.1016/j.biocontrol.2005.08.010; Arie T, 2007, PLANT BIOTECHNOL-NAR, V24, P135, DOI 10.5511/plantbiotechnology.24.135; Bengochea P, 2014, BIOCONTROL SCI TECHN, V24, P625, DOI 10.1080/09583157.2014.884212; Bernard MB, 2010, J ECON ENTOMOL, V103, P2061, DOI 10.1603/EC09357; Biondi A, 2015, J ECON ENTOMOL, V108, P1191, DOI 10.1093/jee/tov045; Biondi A, 2018, ANNU REV ENTOMOL, V63, P239, DOI 10.1146/annurev-ento-031616-034933; Biondi A, 2016, BIOCONTROL, V61, P79, DOI 10.1007/s10526-015-9700-5; Biondi A, 2015, CHEMOSPHERE, V128, P142, DOI 10.1016/j.chemosphere.2015.01.034; Biondi A, 2012, CHEMOSPHERE, V87, P803, DOI 10.1016/j.chemosphere.2011.12.082; Bozsik A, 2006, PEST MANAG SCI, V62, P651, DOI 10.1002/ps.1221; Broughton S, 2014, PEST MANAG SCI, V70, P389, DOI 10.1002/ps.3565; Calvo FJ, 2012, BIOCONTROL, V57, P809, DOI 10.1007/s10526-012-9455-1; Calvo J, 2009, BIOCONTROL, V54, P237, DOI 10.1007/s10526-008-9164-y; Campos MR, 2017, J PEST SCI, V90, P787, DOI 10.1007/s10340-017-0867-7; Carvalho Geraldo A., 2006, IOBC-WPRS Bulletin, V29, P349; Carvalho Geraldo A., 2006, IOBC-WPRS Bulletin, V29, P355; Castane C, 1996, ENTOMOPHAGA, V41, P211, DOI 10.1007/BF02764246; Chailleux A, 2013, J ECON ENTOMOL, V106, P2310, DOI 10.1603/EC13092; Velasco-Hernandez MC, 2015, PEST MANAG SCI, V71, P1346, DOI 10.1002/ps.3938; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Drobnjakovic T, 2016, ENTOMOL GEN, V35, P281, DOI 10.1127/entomologia/2016/0183; El-Arnaouty SA, 2014, AFR ENTOMOL, V22, P801, DOI 10.4001/003.022.0410; Francesena N, 2012, Commun Agric Appl Biol Sci, V77, P727; Garcera C, 2013, J ECON ENTOMOL, V106, P2126, DOI 10.1603/EC12510; Guedes RNC, 2014, PEST MANAG SCI, V70, P690, DOI 10.1002/ps.3669; Hall DG, 2010, BIOCONTROL, V55, P601, DOI 10.1007/s10526-010-9283-0; Hassan S. A., 1994, Bulletin OILB/SROP, V17, P1; Hoddle MS, 2001, BIOL CONTROL, V20, P122, DOI 10.1006/bcon.2000.0885; Jansen JP, 1996, ENTOMOPHAGA, V41, P37, DOI 10.1007/BF02893290; Martinou AF, 2014, CHEMOSPHERE, V96, P167, DOI 10.1016/j.chemosphere.2013.10.024; Michaud J. P., 2001, Journal of Insect Science (Tucson), V1, P1; Mills NJ, 2016, BIOL CONTROL, V102, P17, DOI 10.1016/j.biocontrol.2015.05.006; Molla O, 2014, BIOCONTROL, V59, P175, DOI 10.1007/s10526-013-9553-8; Nauen R., 2008, Bayer CropScience Journal, V61, P245; OOMEN P A, 1991, Bulletin OEPP, V21, P701, DOI 10.1111/j.1365-2338.1991.tb01304.x; Perdikis D, 2016, ENTOMOL GEN, V35, P297, DOI 10.1127/entomologia/2016/0219; Planes L, 2013, J PEST SCI, V86, P321, DOI 10.1007/s10340-012-0440-3; Pratissoli D, 2010, CHIL J AGR RES, V70, P323; Qureshi JA, PLOS ONE, V9; Rimoldi F, 2008, ENVIRON ENTOMOL, V37, P1252, DOI 10.1603/0046-225X(2008)37[1252:SOCEEN]2.0.CO;2; Roditakis E, 2014, PEST MANAG SCI, V70, P1460, DOI 10.1002/ps.3723; Salehi Z, 2016, ENTOMOL GEN, V36, P127, DOI 10.1127/entomologia/2016/0339; Sanchez JA, 2009, J APPL ENTOMOL, V133, P125, DOI 10.1111/j.1439-0418.2008.01342.x; SARODE SV, 1999, STEPH PESTICIDE RES, V11, P97; Tan Y, 2012, ECOTOXICOLOGY, V21, P1989, DOI 10.1007/s10646-012-0933-0; Urbaneja A, 2005, BIOCONTROL SCI TECHN, V15, P513, DOI 10.1080/09583150500088777; Urbaneja A, 2008, PEST MANAG SCI, V64, P834, DOI 10.1002/ps.1572; Urbaneja-Bernat P, 2013, BIOCONTROL, V58, P57, DOI 10.1007/s10526-012-9466-y; Vanaclocha P, 2013, J PEST SCI, V86, P329, DOI 10.1007/s10340-012-0448-8; Vos CM, 2014, BIOL CONTROL, V74, P65, DOI 10.1016/j.biocontrol.2014.04.004; Wanumen AC, 2016, J INSECT SCI, V16, DOI 10.1093/jisesa/iew084; Yardim EN, 1998, AGR ECOSYST ENVIRON, V70, P31, DOI 10.1016/S0167-8809(97)00160-6; Zappala L, 2012, J APPL ENTOMOL, V136, P401, DOI 10.1111/j.1439-0418.2011.01662.x; Zappala L, 2013, J PEST SCI, V86, P635, DOI 10.1007/s10340-013-0531-9	56	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187439	10.1371/journal.pone.0187439	http://dx.doi.org/10.1371/journal.pone.0187439			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095873	gold, Green Submitted, Green Published			2022-12-26	WOS:000414340200091
J	Frison, S; Kerac, M; Checchi, F; Nicholas, J				Frison, Severine; Kerac, Marko; Checchi, Francesco; Nicholas, Jennifer			A novel, efficient method for estimating the prevalence of acute malnutrition in resource-constrained and crisis-affected settings: A simulation study	PLOS ONE			English	Article							UPPER ARM CIRCUMFERENCE; WEIGHT-FOR-HEIGHT; LOW-INCOME; HIGH-RISK; NUTRITION; CHILDREN; DEATH	Introduction The assessment of the prevalence of acute malnutrition in children under five is widely used for the detection of emergencies, planning interventions, advocacy, and monitoring and evaluation. This study examined PROBIT Methods which convert parameters (mean and standard deviation (SD)) of a normally distributed variable to a cumulative probability below any cut-off to estimate acute malnutrition in children under five using Middle-Upper Arm Circumference (MUAC). Methods We assessed the performance of: PROBIT Method I, with mean MUAC from the survey sample and MUAC SD from a database of previous surveys; and PROBIT Method II, with mean and SD of MUAC observed in the survey sample. Specifically, we generated sub samples from 852 survey datasets, simulating 100 surveys for eight sample sizes. Overall the methods were tested on 681 600 simulated surveys. Results PROBIT methods relying on sample sizes as small as 50 had better performance than the classic method for estimating and classifying the prevalence of acute malnutrition. They had better precision in the estimation of acute malnutrition for all sample sizes and better coverage for smaller sample sizes, while having relatively little bias. They classified situations accurately for a threshold of 5% acute malnutrition. Both PROBIT methods had similar outcomes. Conclusions PROBIT Methods have a clear advantage in the assessment of acute malnutrition prevalence based on MUAC, compared to the classic method. Their use would require much lower sample sizes, thus enable great time and resource savings and permit timely and/or locally relevant prevalence estimates of acute malnutrition for a swift and well-targeted response.	[Frison, Severine; Kerac, Marko; Checchi, Francesco; Nicholas, Jennifer] LSHTM, Dept Populat Hlth, London, England	University of London; London School of Hygiene & Tropical Medicine	Frison, S (corresponding author), LSHTM, Dept Populat Hlth, London, England.	severine.frison@gmail.com	Kerac, Marko/G-1777-2010; Kerac, Marko/GQR-1136-2022	Kerac, Marko/0000-0002-3745-7317; Frison, Severine/0000-0002-1586-9564; Checchi, Francesco/0000-0001-9030-5382	OFDA [ITDCZD07]; WFP [ITDCZD07]; National Institute for Health Research [ACF-2008-18-010, CL-2012-18-005] Funding Source: researchfish	OFDA; WFP; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by OFDA and WFP, grant number ITDCZD07.	ALAM N, 1989, AM J CLIN NUTR, V49, P884, DOI 10.1093/ajcn/49.5.884; Ale FGB, 2016, ARCH PUBLIC HEALTH, V74, DOI 10.1186/s13690-016-0149-5; [Anonymous], 1995, PHYS STAT UINT ANT; Berkley J, 2005, JAMA-J AM MED ASSOC, V294, P591, DOI 10.1001/jama.294.5.591; BINKIN N, 1992, DISASTERS, V16, P97, DOI 10.1111/j.1467-7717.1992.tb00383.x; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Blackwell N, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0074-z; Blanton CJ, PROBIT APPROACH ESTI; BRIEND A, 1986, BRIT MED J, V293, P373, DOI 10.1136/bmj.293.6543.373; BRIEND A, 1989, EUR J CLIN NUTR, V43, P715; BRIEND A, 1987, LANCET, V2, P725; Briend A, 2012, MATERN CHILD NUTR, V8, P130, DOI 10.1111/j.1740-8709.2011.00340.x; Dale NM, 2013, PUBLIC HEALTH NUTR, V16, P858, DOI 10.1017/S1368980012003345; Darcy J, ACCORDING NEED BRITA; Frison S, 2016, EMERG THEMES EPIDEMI, V13, DOI 10.1186/s12982-016-0048-9; Frison S, 2015, AM J CLIN NUTR, V102, P1176, DOI 10.3945/ajcn.115.108282; Shoham J, 2001, USE NUTR INDICATORS; Spiegel PB, 2004, JAMA-J AM MED ASSOC, V292, P613, DOI 10.1001/jama.292.5.613; Tuffrey V., 2016, BMC NUTR, V2; Tuffrey V., 2016, NUTR SURVEILLANCE SY; Tuffrey V, 2016, EMERG THEMES EPIDEMI, V13, DOI 10.1186/s12982-016-0045-z; United Nations' Children's Fund (UNICEF), 2015, STAT WORLDS CHILDR 2; Vella V, PUBLIC HEAL BRIEFS; Young H, 2004, LANCET, V364, P1899, DOI 10.1016/S0140-6736(04)17447-3; Young H., 2006, HUMANITARIAN PRACTIC, V44, P1; Young H., 2009, REV NUTR MORTALITY I, P78	26	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0186328	10.1371/journal.pone.0186328	http://dx.doi.org/10.1371/journal.pone.0186328			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091927	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000414229700016
J	Boiko, N; Medrano, G; Montano, E; Jiang, N; Williams, CR; Madungwe, NB; Bopassa, JC; Kim, CC; Parrish, JZ; Hargreaves, KM; Stockand, JD; Eaton, BA				Boiko, Nina; Medrano, Geraldo; Montano, Elizabeth; Jiang, Nan; Williams, Claire R.; Madungwe, Ngonidzashe B.; Bopassa, Jean C.; Kim, Charles C.; Parrish, Jay Z.; Hargreaves, Kenneth M.; Stockand, James D.; Eaton, Benjamin A.			TrpA1 activation in peripheral sensory neurons underlies the ionic basis of pain hypersensitivity in response to vinca alkaloids	PLOS ONE			English	Article							DORSAL-ROOT GANGLION; POTENTIAL ANKYRIN 1; ACETYL-L-CARNITINE; NEUROPATHIC PAIN; NERVE HYPEREXCITABILITY; MECHANOSENSORY NEURONS; NOCICEPTIVE NEURONS; DROSOPHILA LARVAL; COLD HYPERALGESIA; PACLITAXEL	Chemotherapy induced peripheral neuropathy (CIPN), a side effect of many anti-cancer drugs including the vinca alkaloids, is characterized by a severe pain syndrome that compromises treatment in many patients. Currently there are no effective treatments for this pain syndrome except for the reduction of anti-cancer drug dose. Existing data supports the model that the pain associated with CIPN is the result of anti-cancer drugs augmenting the function of the peripheral sensory nociceptors but the cellular mechanisms underlying the effects of anti-cancer drugs on sensory neuron function are not well described. Studies from animal models have suggested a number of disease etiologies including mitotoxicity, axonal degeneration, immune signaling, and reduced sensory innervations but these outcomes are the result of prolonged treatment paradigms and do not necessarily represent the early formative events associated with CIPN. Here we show that acute exposure to vinca alkaloids results in an immediate pain syndrome in both flies and mice. Furthermore, we demonstrate that exposure of isolated sensory neurons to vinca alkaloids results in the generation of an inward sodium current capable of depolarizing these neurons to threshold resulting in neuronal firing. These neuronal effects of vinca alkaloids require the transient receptor potential ankyrin-1 (TrpA1) channel, and the hypersensitization to painful stimuli in response to the acute exposure to vinca alkaloids is reduced in TrpA1 mutant flies and mice. These findings demonstrate the direct excitation of sensory neurons by CIPN-causing chemotherapy drugs, and identify TrpA1 as an important target during the pathogenesis of CIPN.	[Boiko, Nina; Medrano, Geraldo; Montano, Elizabeth; Madungwe, Ngonidzashe B.; Bopassa, Jean C.; Stockand, James D.; Eaton, Benjamin A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Integrat Physiol, San Antonio, TX 78229 USA; [Jiang, Nan; Williams, Claire R.; Parrish, Jay Z.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Kim, Charles C.] Verily, San Francisco, CA USA; [Hargreaves, Kenneth M.] Univ Texas Hlth Sci Ctr San Antonio, Dept Endodont, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Health San Antonio	Eaton, BA (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Integrat Physiol, San Antonio, TX 78229 USA.	eatonb@uthscsa.edu	Jiang, Nan/AAJ-7102-2021	Jiang, Nan/0000-0003-4174-0657; Madungwe, Ngonidzashe/0000-0002-2975-1487; Williams, Claire/0000-0001-5467-149X; Stockand, James/0000-0002-3817-4319	CPRIT IIRG [RP150408]; NIH/NCI [CA194138]; NATIONAL CANCER INSTITUTE [R21CA194138] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL138093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076614, R25NS080684] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	CPRIT IIRG; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by a CPRIT IIRG grant (RP150408) and a NIH/NCI R21 grant (CA194138) to JDS and BAE. The funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; Al-Anzi B, 2006, CURR BIOL, V16, P1034, DOI 10.1016/j.cub.2006.04.002; Barriere DA, 2012, PAIN, V153, P553, DOI 10.1016/j.pain.2011.11.019; Bhattacharya MRC, 2012, J NEUROSCI, V32, P5054, DOI 10.1523/JNEUROSCI.4951-11.2012; Boiko N, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.411736; Boyette-Davis JA, 2015, PAIN MANAG, V5, P285, DOI [10.2217/pmt.15.19, 10.2217/PMT.15.19]; Chen Y, 2011, NEUROSCIENCE, V193, P440, DOI 10.1016/j.neuroscience.2011.06.085; Cheng LE, 2010, NEURON, V67, P373, DOI 10.1016/j.neuron.2010.07.004; Cordero-Morales JF, 2011, P NATL ACAD SCI USA, V108, pE1184, DOI 10.1073/pnas.1114124108; [李永洙 Li Yongzhu], 2015, [生态学报, Acta Ecologica Sinica], V35, P1601; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Du EJ, 2016, ELIFE, V5, DOI 10.7554/eLife.18425; Du EJ, 2015, MOL CELLS, V38, P911, DOI 10.14348/molcells.2015.0215; Flatters SJL, 2006, PAIN, V122, P245, DOI 10.1016/j.pain.2006.01.037; Flatters SJL, 2006, NEUROSCI LETT, V397, P219, DOI 10.1016/j.neulet.2005.12.013; Fowler MA, 2013, LIFE SCI, V92, P394, DOI 10.1016/j.lfs.2012.07.029; Gibbs JL, 2006, PAIN, V124, P167, DOI 10.1016/j.pain.2006.04.013; Green DP, 2016, MOL PAIN, V12, DOI 10.1177/1744806916661725; Grueber W B JA LYJ YN, 2002, TILING DROSOPHILA EP, P1; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Guntur AR, 2015, P NATL ACAD SCI USA, V112, pE5753, DOI 10.1073/pnas.1514862112; Hao JZ, 2010, J NEUROSCI, V30, P13384, DOI 10.1523/JNEUROSCI.2926-10.2010; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hill A, 2010, BMC CANCER, V10, P573; Hu J, 2006, J PHYSIOL-LONDON, V577, P815, DOI 10.1113/jphysiol.2006.117648; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Hynkova A, 2016, N TERMINAL TETRAPEPT, P1; Ibarra Y, 2013, MOL PHARMACOL, V83, P1120, DOI 10.1124/mol.112.084194; Im SH, 2012, DEV DYNAM, V241, P16, DOI 10.1002/dvdy.22737; Jabba S, 2014, NEURON, V82, P1017, DOI 10.1016/j.neuron.2014.04.016; Jaggi AS, 2012, TOXICOLOGY, V291, P1, DOI 10.1016/j.tox.2011.10.019; Jiang N, 2014, DEVELOPMENT, V141, P2657, DOI 10.1242/dev.107573; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Kang KJ, 2012, NATURE, V481, P76, DOI 10.1038/nature10715; Kang K, 2010, NATURE, V464, P597, DOI 10.1038/nature08848; Kim SH, 2010, P NATL ACAD SCI USA, V107, P8440, DOI 10.1073/pnas.1001425107; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; Kremeyer B, 2016, CLIN STUDY, P1; KRISHTAL OA, 1981, NEUROSCIENCE, V6, P2599, DOI 10.1016/0306-4522(81)90105-6; Kucher Volodymyr, 2013, Methods Mol Biol, V998, P385, DOI 10.1007/978-1-62703-351-0_30; Kuo CT, 2005, P NATL ACAD SCI USA, V102, P15230, DOI 10.1073/pnas.0507393102; Kwon Y, 2010, CURR BIOL, V20, P1672, DOI 10.1016/j.cub.2010.08.016; Lucchetta M, 2012, CANCER CHEMOTH PHARM, V70, P899, DOI 10.1007/s00280-012-2006-8; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Malik B, 2008, CURR NEUROL NEUROSCI, V8, P56, DOI 10.1007/s11910-008-0010-5; Materazzi S, 2012, PFLUG ARCH EUR J PHY, V463, P561, DOI 10.1007/s00424-011-1071-x; Matz M, 1999, NUCLEIC ACIDS RES, V27, P1558, DOI 10.1093/nar/27.6.1558; Meotti FC, 2013, CHEM-BIOL INTERACT, V203, P440, DOI 10.1016/j.cbi.2013.03.008; Mogos S., 2013, P ASME 2013 PRESS VE, P1; Moparthi L, 2014, P NATL ACAD SCI USA, V111, P16901, DOI 10.1073/pnas.1412689111; Morota S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067747; Nassini R, 2011, PAIN, V152, P1621, DOI 10.1016/j.pain.2011.02.051; Neely GG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024343; Obata K, 2005, J CLIN INVEST, V115, P2393, DOI 10.1172/JCI23437; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Patwardhan AM, 2006, PAIN, V125, P114, DOI 10.1016/j.pain.2006.05.007; Petalidis L, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng142; Petruska JC, 2002, NEUROSCIENCE, V115, P15, DOI 10.1016/S0306-4522(02)00409-8; Polomano RC, 2001, PAIN, V94, P293, DOI 10.1016/S0304-3959(01)00363-3; Prager-Khoutorsky M, 2014, NEURON, V83, P866, DOI 10.1016/j.neuron.2014.07.023; Nieto FR, 2008, PAIN, V137, P520, DOI 10.1016/j.pain.2007.10.012; Rau KK, 2005, J NEUROPHYSIOL, V93, P1358, DOI 10.1152/jn.00591.2004; Ruparel NB, 2008, PAIN, V135, P271, DOI 10.1016/j.pain.2007.06.005; Siau C, 2006, EXP NEUROL, V201, P507, DOI 10.1016/j.expneurol.2006.05.007; Starkov AA, 2010, FEBS J, V277, P3652, DOI 10.1111/j.1742-4658.2010.07756.x; STEWART DJ, 1984, J NEURO-ONCOL, V2, P133; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Trevisan G, 2013, CANCER RES, V73, P3120, DOI 10.1158/0008-5472.CAN-12-4370; Venkatachalam K, 2014, HANDB EXP PHARMACOL, V223, P937, DOI 10.1007/978-3-319-05161-1_9; Williams CR, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-016-1457-z; Williams CR, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0956-2; Wilson RH, 2002, J CLIN ONCOL, V20, P1767, DOI 10.1200/JCO.2002.07.056; Wu D, 2012, NATURE, V484, P214, DOI [10.1038/nature10931, 10.1038/nature11685]; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Xiao WH, 2012, NEUROSCIENCE, V203, P194, DOI 10.1016/j.neuroscience.2011.12.023; Xiao WH, 2011, NEUROSCIENCE, V199, P461, DOI 10.1016/j.neuroscience.2011.10.010; Xiao WH, 2008, PAIN, V135, P262, DOI 10.1016/j.pain.2007.06.001; Xiao WH, 2012, PAIN, V153, P704, DOI 10.1016/j.pain.2011.12.011; Yan Z, 2012, ACTA PHARMACOL SIN, V33, P852, DOI 10.1038/aps.2012.44; Zhang HJ, 2014, ANESTHESIOLOGY, V120, P1463, DOI 10.1097/ALN.0000000000000176; Zhang W, 2015, CELL, V162, P1391, DOI 10.1016/j.cell.2015.08.024; Zhong LX, 2012, CELL REP, V1, P43, DOI 10.1016/j.celrep.2011.11.002; Zhong LX, 2010, CURR BIOL, V20, P429, DOI 10.1016/j.cub.2009.12.057	86	15	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0186888	10.1371/journal.pone.0186888	http://dx.doi.org/10.1371/journal.pone.0186888			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084244	Green Submitted, Green Published, gold			2022-12-26	WOS:000413910200016
J	Zeune, L; van Dalum, G; Decraene, C; Proudhon, C; Fehm, T; Neubauer, H; Rack, B; Alunni-Fabbroni, M; Terstappen, LWMM; van Gils, SA; Brune, C				Zeune, Leonie; van Dalum, Guus; Decraene, Charles; Proudhon, Charlotte; Fehm, Tanja; Neubauer, Hans; Rack, Brigitte; Alunni-Fabbroni, Marianna; Terstappen, Leon W. M. M.; van Gils, Stephan A.; Brune, Christoph			Quantifying HER-2 expression on circulating tumor cells by ACCEPT	PLOS ONE			English	Article							GENE STATUS; CANCER; BLOOD	Circulating tumor cells (CTCs) isolated from blood can be probed for the expression of treatment targets. Immunofluorescence is often used for both the enumeration of CTC and the determination of protein expression levels related to treatment targets. Accurate and reproducible assessment of such treatment target expression levels is essential for their use in the clinic. To enable this, an open source image analysis program named ACCEPT was developed in the EU-FP7 CTCTrap and CANCER-ID programs. Here its application is shown on a retrospective cohort of 132 metastatic breast cancer patients from which blood samples were processed by CellSearch (R) and stained for HER-2 expression as additional marker. Images were digitally stored and reviewers identified a total of 4084 CTCs. CTC's HER-2 expression was determined in the thumbnail images by ACCEPT. 150 of these images were selected and sent to six independent investigators to score the HER-2 expression with and without ACCEPT. Concordance rate of the operators' scoring results for HER2 on CTCs was 30% and could be increased using the ACCEPT tool to 51%. Automated assessment of HER-2 expression by ACCEPT on 4084 CTCs of 132 patients showed 8 (6.1%) patients with all CTCs expressing HER-2, 14 (10.6%) patients with no CTC expressing HER-2 and 110 (83.3%) patients with CTCs showing a varying HER-2 expression level. In total 1576 CTCs were determined HER-2 positive. We conclude that the use of image analysis enables a more reproducible quantification of treatment targets on CTCs and leads the way to fully automated and reproducible approaches.	[Zeune, Leonie; van Gils, Stephan A.; Brune, Christoph] Univ Twente, MIRA Inst, Dept Appl Math, Enschede, Netherlands; [Zeune, Leonie; van Dalum, Guus; Terstappen, Leon W. M. M.] Univ Twente, MIRA Inst, Dept Med Cell BioPhys, Enschede, Netherlands; [Decraene, Charles] PSL Res Univ, Inst Curie, Translat Res Dept, Circulating Tumor Biomarkers Lab,SiRIC, Paris, France; [Decraene, Charles; Proudhon, Charlotte] PSL Res Univ, Inst Curie, CNRS, UMR144, Paris, France; [Fehm, Tanja; Neubauer, Hans] Univ Dusseldorf, Dept Gynecol & Obstet, Dusseldorf, Germany; [Rack, Brigitte; Alunni-Fabbroni, Marianna] Univ Munich, Dept Gynecol & Obstet, Munich, Germany	University of Twente; University of Twente; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Heinrich Heine University Dusseldorf; University of Munich	Zeune, L (corresponding author), Univ Twente, MIRA Inst, Dept Appl Math, Enschede, Netherlands.; Zeune, L (corresponding author), Univ Twente, MIRA Inst, Dept Med Cell BioPhys, Enschede, Netherlands.	l.l.zeune@utwente.nl	terstappen, leon/O-4923-2018; Neubauer, Hans/C-4467-2016; Brune, Christoph/C-1700-2013	terstappen, leon/0000-0001-5944-3787; Neubauer, Hans/0000-0002-3467-4105; Brune, Christoph/0000-0003-0145-5069; Proudhon, Charlotte/0000-0002-4649-4574; Fehm, Tanja/0000-0002-4926-0108	EUFP7 [305341 CTCTrap]; EU I MI [115749-1 CANCER-ID]	EUFP7(European Commission); EU I MI(European Commission)	This work was supported by EUFP7 # 305341 CTCTrap; EU I MI # 115749-1 CANCER-ID.	Alix-Panabieres C, 2014, NAT REV CANCER, V14, P623, DOI 10.1038/nrc3820; Allard WJ, 2015, CLIN CANCER RES, V21, P2883, DOI 10.1158/1078-0432.CCR-14-2559; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Attard G, 2009, CANCER RES, V69, P2912, DOI 10.1158/0008-5472.CAN-08-3667; Barradas Ana M C, 2013, Cancers (Basel), V5, P1619, DOI 10.3390/cancers5041619; Benning M, 2013, J SCI COMPUT, V54, P269, DOI 10.1007/s10915-012-9650-3; Brune C, 2011, INT J COMPUT VISION, V92, P211, DOI 10.1007/s11263-010-0339-5; de Bono JS, 2007, CLIN CANCER RES, V13, P3611, DOI 10.1158/1078-0432.CCR-07-0268; Hayes DF, 2002, INT J ONCOL, V21, P1111; Hiltermann TJN, 2012, ANN ONCOL, V23, P2937, DOI 10.1093/annonc/mds138; Ignatiadis M, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3647; Janni WJ, 2016, CLIN CANCER RES, V22, P2583, DOI 10.1158/1078-0432.CCR-15-1603; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; Ligthart ST, 2013, ANN ONCOL, V24, P1231, DOI 10.1093/annonc/mds625; Ligthart ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067148; Ligthart ST, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027419; Mazel M, 2015, MOL ONCOL, V9, P1773, DOI 10.1016/j.molonc.2015.05.009; Meng SD, 2004, P NATL ACAD SCI USA, V101, P9393, DOI 10.1073/pnas.0402993101; Meng S, 2006, P NATL ACAD SCI USA, V103, P17361, DOI 10.1073/pnas.0608113103; Miller MC, 2010, J ONCOL, V2010, DOI 10.1155/2010/617421; Myung JH, 2015, LAB CHIP, V15, P4500, DOI 10.1039/c5lc00947b; Rao CG, 2005, INT J ONCOL, V27, P49; Ross JS, 2003, ONCOLOGIST, V8, P307, DOI 10.1634/theoncologist.8-4-307; Smerage JB, 2013, MOL ONCOL, V7, P680, DOI 10.1016/j.molonc.2013.02.013; Van Dalum G, 2015, INT J ONCOL, V46, P1361, DOI 10.3892/ijo.2015.2824; Zeune L, 2017, SIAM J IMAGING SCI, V10, P111, DOI 10.1137/16M1074503	26	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0186562	10.1371/journal.pone.0186562	http://dx.doi.org/10.1371/journal.pone.0186562			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084234	Green Submitted, Green Published, gold			2022-12-26	WOS:000413910200009
J	Olafsdottir, GA; Petursdottir, G; Bardarson, H; Edvardsson, R				Olafsdottir, Gudbjorg Asta; Petursdottir, Groa; Bardarson, Hlynur; Edvardsson, Ragnar			A millennium of north-east Atlantic cod juvenile growth trajectories inferred from archaeological otoliths	PLOS ONE			English	Article							GADUS-MORHUA L.; LIFE-HISTORY; MARINE FISH; SIZE; TEMPERATURE; AGE; VARIABILITY; FISHERIES; RECRUITMENT; PERSPECTIVE	Archaeological excavations of historical fishing sites across the North Atlantic have recovered high quantities of Atlantic cod (Gadus morhua) bones. In the current study we use Atlantic cod otoliths from archaeological excavations of a historical fishing sites in northwest Iceland, dated to AD 970 -AD 1910 to examine historical growth trajectories of cod. No large scale growth variations or shifts in growth patterns were observed in the current chronologies, supporting the stability of historical Atlantic cod growth trajectories. The most significant variation in growth patterns was consistent with those that have been observed in recent times, for example, reduced early juvenile growth during periods of colder ocean temperature. The current results represent a high resolution chronological record of north-east Atlantic cod growth, greatly increasing the prior temporal range of such data, thereby providing a valuable baseline for a broad range of studies on Atlantic cod growth.	[Olafsdottir, Gudbjorg Asta; Edvardsson, Ragnar] Univ Iceland, Res Ctr Westfjords, Adalstraeti Bolungarvik, Iceland; [Petursdottir, Groa; Bardarson, Hlynur] Marine & Freshwater Res Inst, Skulagata Reykjavik, Iceland	University of Iceland; Marine & Freshwater Research Institute (MFRI)	Olafsdottir, GA (corresponding author), Univ Iceland, Res Ctr Westfjords, Adalstraeti Bolungarvik, Iceland.	gaol@hi.is	Edvardsson, Ragnar/M-2632-2015; Olafsdottir, Gudbjorg Asta/M-2722-2015	Olafsdottir, Gudbjorg Asta/0000-0002-2814-9160; Edvardsson, Ragnar/0000-0002-3663-1205	Icelandic Research Fund	Icelandic Research Fund	This study was partly funded by a grant to GAO from the Icelandic Research Fund. Other cost was covered by the University of Iceland and the Marine Research Institute through salaries of the authors. There was no additional external funding received for this study. The funders had no role in the subsequent work.	AMOROSI T, 1994, ICES MAR SC, V198, P31; Andersen KH, 2007, ECOL MODEL, V204, P246, DOI 10.1016/j.ecolmodel.2007.01.002; Astthorsson OS, 2007, DEEP-SEA RES PT II, V54, P2456, DOI 10.1016/j.dsr2.2007.07.030; ASTTHORSSON OS, 1994, ICES MAR SC, V198, P529; Barrett JH, 2011, J ARCHAEOL SCI, V38, P1516, DOI 10.1016/j.jas.2011.02.017; Barrett JH, 2004, P ROY SOC B-BIOL SCI, V271, P2417, DOI 10.1098/rspb.2004.2885; Barrett JH, 1997, ANTIQUITY, V71, P616, DOI 10.1017/S0003598X00085367; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baumann H, 2012, NAT CLIM CHANGE, V2, P38, DOI 10.1038/NCLIMATE1291; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Bianchi G, 2000, ICES J MAR SCI, V57, P558, DOI 10.1006/jmsc.2000.0727; Bjornsson B, 2002, CAN J FISH AQUAT SCI, V59, P494, DOI [10.1139/f02-028, 10.1139/F02-028]; BRANDER KM, 1995, ICES J MAR SCI, V52, P1, DOI 10.1016/1054-3139(95)80010-7; CAMPANA SE, 1990, CAN J FISH AQUAT SCI, V47, P2219, DOI 10.1139/f90-246; Campana SE, 1996, MAR ECOL PROG SER, V135, P21, DOI 10.3354/meps135021; CAMPANA SE, 1993, CAN J FISH AQUAT SCI, V50, P1062, DOI 10.1139/f93-123; Campana SE, 2001, CAN J FISH AQUAT SCI, V58, P30, DOI 10.1139/f00-177; Cheung WWL, 2013, NAT CLIM CHANGE, V3, P254, DOI 10.1038/NCLIMATE1691; Dalley EL, 1997, CAN J FISH AQUAT SCI, V54, P168, DOI 10.1139/cjfas-54-S1-168; Disspain MCF, 2016, J ARCHAEOL SCI-REP, V6, P623, DOI 10.1016/j.jasrep.2015.05.012; Drinkwater KF, 2005, ICES J MAR SCI, V62, P1327, DOI 10.1016/j.icesjms.2005.05.015; Edvardsson R., 2010, THESIS; Freitas C, 2015, ECOL EVOL, V5, P2070, DOI 10.1002/ece3.1496; Geffen AJ, 2011, ICES J MAR SCI; Gibb FM, 2007, MAR BIOL, V151, P1185, DOI 10.1007/s00227-006-0565-0; Haddon M., 2011, MODELLING QUANTITATI; Hufthammer AK, 2010, J ARCHAEOL SCI, V37, P78, DOI 10.1016/j.jas.2009.09.001; Hutchings JA, 2005, PHILOS T R SOC B, V360, P315, DOI 10.1098/rstb.2004.1586; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jonsdottir IG, 2008, MAR BIOL, V154, P867, DOI 10.1007/s00227-008-0979-y; Jonsdottir ODB, 2002, FISH RES, V55, P37, DOI 10.1016/S0165-7836(01)00296-X; Jorgensen C, 2009, EVOL APPL, V2, P356, DOI 10.1111/j.1752-4571.2009.00075.x; JORGENSEN T, 1992, ICES J MAR SCI, V49, P263, DOI 10.1093/icesjms/49.3.263; Kristiansen T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017456; Li L, 2008, CAN J FISH AQUAT SCI, V65, P2496, DOI 10.1139/F08-157; Limburg KE, 2008, P ROY SOC B-BIOL SCI, V275, P2659, DOI 10.1098/rspb.2008.0711; Limburg KE, 1994, AQUAC INT, V2, P75; MacKenzie BR, 2007, FISH RES, V87, P106, DOI 10.1016/j.fishres.2007.07.003; Mirman D., 2014, GROWTH CURVE ANAL VI; Ogilvie AEJ, 2001, CLIMATIC CHANGE, V48, P9, DOI 10.1023/A:1005625729889; Ogle D., 2016, FSA FISHERIES STOCK; Ogle D., 2016, INTRO FISHERIES ANAL; Olafsdottir GA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2976; Opdal AF, 2015, GLOBAL CHANGE BIOL, V21, P1521, DOI 10.1111/gcb.12773; Orton DC, 2016, PERSPECTIVES OCEANS, P47; Patterson WP, 2010, P NATL ACAD SCI USA, V107, P5306, DOI 10.1073/pnas.0902522107; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Perdikaris S., 2009, CATCH FISHERIES N AT, V41, P61; Petersen MF, 2003, J EXP BIOL, V206, P359, DOI 10.1242/jeb.00111; Pinnegar JK, 2008, REV FISH BIOL FISHER, V18, P1, DOI 10.1007/s11160-007-9058-6; Portner HO, 2001, CONT SHELF RES, V21, P1975, DOI 10.1016/S0278-4343(01)00038-3; Poulsen B, 2007, FISH RES, V87, P181, DOI 10.1016/j.fishres.2007.07.014; R Core Team, 2021, R LANGUAGE ENV STAT; Ratz HJ, 2003, FISH RES, V60, P369, DOI 10.1016/S0165-7836(02)00132-7; Reibisch J., 1899, WISSENSCHAFTLICHE ME, V4, P233; Rochet MJ, 1998, ICES J MAR SCI, V55, P371, DOI 10.1006/jmsc.1997.0324; Rowell K, 2010, ENVIRON BIOL FISH, V89, P415, DOI 10.1007/s10641-010-9687-9; Swain DP, 2007, P ROY SOC B-BIOL SCI, V274, P1015, DOI 10.1098/rspb.2006.0275; TAYLOR C. C., 1958, JOUR CONS PERM INTERNATL EXPLOR MER, V23, P366; TRIPPEL EA, 1995, BIOSCIENCE, V45, P759, DOI 10.2307/1312628; Van Neer W, 1999, INT J OSTEOARCHAEOL, V9, P116, DOI 10.1002/(SICI)1099-1212(199903/04)9:2<116::AID-OA465>3.3.CO;2-8; Van Neer Wim, 2002, Environmental Archaeology, V7, P61	62	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187134	10.1371/journal.pone.0187134	http://dx.doi.org/10.1371/journal.pone.0187134			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077736	Green Published, Green Submitted, gold			2022-12-26	WOS:000413861200047
J	dos Santos, SP; Benda, RN; Couto, CR; Campos, CE; Andrade, AGP; Lage, GM; Ugrinowitsch, H				dos Santos, Suziane Peixoto; Benda, Rodolfo N.; Couto, Crislaine Rangel; Campos, Carlos Eduardo; Pereira Andrade, Andre Gustavo; Lage, Guilherme M.; Ugrinowitsch, Herbert			The level of performance stabilization influences motor adaptation on an isometric force control task	PLOS ONE			English	Article							ARM MOVEMENTS; STABILITY; JOINT; PERTURBATIONS; COACTIVATION; COORDINATION; VARIABILITY; STIFFNESS; DYNAMICS; IMPROVES	This study compared the effects of two levels of performance stabilization on the adaptation to unpredictable perturbations in an isometric control force task with the goal of controlling 40% of the maximum force. The experiment consisted of pre-exposure and exposure phases. In the pre-exposure two levels of performance stabilization were manipulated: a stabilization group (SG) performed three trials in a row while maintaining 40% of the maximum force for three seconds and an absolute error less than or equal to 5% (i.e., the criteria of performance), and a superstabilization group (SSG) performed six blocks of the same criteria. During the exposure phase, the task was the same as that in the pre-exposure phase; however, it was inserted 9 trials of perturbations when the task goal changed to 60% of the maximum force. We measured the % RMSE, RMS from the biceps and triceps brachii and co-contraction. In the pre-exposure phase, both groups showed similar performance and muscle activity. When exposed to the perturbations, SSG performance more quickly returned to the previous level of accuracy, showed lower muscle activation and demonstrated a greater muscle co-contraction than did SG. The results give support to the adaptive process model on motor learning.	[dos Santos, Suziane Peixoto] Univ Fed Triangulo Mineiro, Uberaba, MG, Brazil; [Benda, Rodolfo N.; Pereira Andrade, Andre Gustavo; Lage, Guilherme M.; Ugrinowitsch, Herbert] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil; [Couto, Crislaine Rangel] Ctr Univ Izabela Hendrix, Belo Horizonte, MG, Brazil; [Campos, Carlos Eduardo] Univ Itauna, Itauna, MG, Brazil	Universidade Federal do Triangulo Mineiro; Universidade Federal de Minas Gerais; Universidade de Itauna	dos Santos, SP (corresponding author), Univ Fed Triangulo Mineiro, Uberaba, MG, Brazil.	suziane.naves@uftm.edu.br	Ugrinowitsch, Herbert/G-8859-2012; Lage, Guilherme/F-4355-2011; ANDRADE, A G P/GLR-3846-2022	Ugrinowitsch, Herbert/0000-0003-0317-1940; Lage, Guilherme/0000-0001-8296-3676; ANDRADE, A G P/0000-0003-3406-4558	FAPEMIG	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	The author(s) received specific funding for this work at FAPEMIG.	Anwar MN, 2011, BRAIN RES, V1395, P21, DOI 10.1016/j.brainres.2011.04.030; BARATTA R, 1988, AM J SPORT MED, V16, P113, DOI 10.1177/036354658801600205; BENECKE R, 1986, EXP BRAIN RES, V63, P585, DOI 10.1007/BF00237481; Berniker M, 2008, NAT NEUROSCI, V11, P1454, DOI 10.1038/nn.2229; Brownstone RM, 2015, CURR OPIN NEUROBIOL, V33, P166, DOI 10.1016/j.conb.2015.04.007; Carvalho MFSP, 2012, J SPORT EXERCISE PSY, V34, pS74; Carvalho MFS., 2013, HUMAN MOVEMENT, V14, P20, DOI DOI 10.2478/V10038-012-0050-1; Coca Ugrinowitsch A. A., 2014, PERCEPT MOTOR SKILL, V118, P1; Diedrichsen J, 2007, CURR BIOL, V17, P1675, DOI 10.1016/j.cub.2007.08.051; Fitts PM., 1967, HUM PERFORM; Fonseca FD, 2012, NEUROSCI LETT, V517, P123, DOI 10.1016/j.neulet.2012.04.041; Franklin DW, 2003, EXP BRAIN RES, V151, P145, DOI 10.1007/s00221-003-1443-3; Gabriel DA, 2002, J ELECTROMYOGR KINES, V12, P407, DOI 10.1016/S1050-6411(02)00026-3; Gomi H, 1996, SCIENCE, V272, P117, DOI 10.1126/science.272.5258.117; Granata KP, 2001, J BIOMECH, V34, P1117, DOI 10.1016/S0021-9290(01)00081-1; Guthrie E. R., 1952, PSYCHOL LEARNING; Haith AM, 2013, ADV EXP MED BIOL, V782, P1, DOI 10.1007/978-1-4614-5465-6_1; HAMMOND MC, 1988, ARCH PHYS MED REHAB, V69, P348; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hewett TE, 1999, AM J SPORT MED, V27, P699, DOI 10.1177/03635465990270060301; HOGAN N, 1985, BIOL CYBERN, V52, P315, DOI 10.1007/BF00355754; JOHANSSON H, 1991, CRIT REV BIOMED ENG, V18, P341; KEARNEY RE, 1990, CRIT REV BIOMED ENG, V18, P55; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; Laidlaw DH, 1999, J APPL PHYSIOL, V87, P1786, DOI 10.1152/jappl.1999.87.5.1786; Latash ML, 2003, HUM MOVEMENT SCI, V22, P153, DOI 10.1016/S0167-9457(02)00157-4; Levin MF, 2000, BRAIN RES, V853, P352, DOI 10.1016/S0006-8993(99)02298-2; Li L, 2005, HUM MOVEMENT SCI, V24, P257, DOI 10.1016/j.humov.2005.03.003; Maestu J, 2006, J STRENGTH COND RES, V20, P824; Novakovic V, 2011, EXP BRAIN RES, V209, P425, DOI 10.1007/s00221-011-2573-7; OSTERNIG LR, 1995, MED SCI SPORT EXER, V27, P805; Osu R, 2002, J NEUROPHYSIOL, V88, P991, DOI 10.1152/jn.2002.88.2.991; Pinter IJ, 2011, J ELECTROMYOGR KINES, V21, P960, DOI 10.1016/j.jelekin.2011.08.001; Proteau L., 1992, VISION MOTOR CONTROL, V85, P67, DOI DOI 10.1016/S0166-4115(08)62011-7; Rand MK, 2004, EXP BRAIN RES, V154, P50, DOI 10.1007/s00221-003-1637-8; Richter S, 2004, PSYCHOL RES-PSYCH FO, V68, P245, DOI 10.1007/s00426-003-0140-y; Rieger M, 2005, EXP BRAIN RES, V163, P487, DOI 10.1007/s00221-004-2203-8; Santos-Naves S. P., 2012, J SPORT EXERCISE PSY, V34, P114; Shemmell J, 2010, CLIN NEUROPHYSIOL, V121, P1680, DOI 10.1016/j.clinph.2010.02.166; Torre K, 2011, J EXP PSYCHOL HUMAN, V37, P539, DOI 10.1037/a0020556; TURKER KS, 1993, PHYS THER, V73, P698; Turvey M.T., 1982, HUMAN MOTOR BEHAV IN, P239; TURVEY MT, 1990, AM PSYCHOL, V45, P938, DOI 10.1037/0003-066X.45.8.938; Ugrinowitsch H., 2014, AM J LIFE SCI, V2, P90, DOI DOI 10.11648/J.AJLS.20140202.19; VANSOEST AJ, 1993, BIOL CYBERN, V69, P195, DOI 10.1007/BF00198959; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5	46	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0185939	10.1371/journal.pone.0185939	http://dx.doi.org/10.1371/journal.pone.0185939			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073273	gold, Green Published, Green Submitted			2022-12-26	WOS:000413845400009
J	Fang, XM; Zhang, XL; Zong, YY; Zhang, Y; Wan, SZ; Bu, WS; Chen, FS				Fang, Xiang-Min; Zhang, Xiu-Lan; Zong, Ying-Ying; Zhang, Yang; Wan, Song-Ze; Bu, Wen-Sheng; Chen, Fu-Sheng			Soil phosphorus functional fractions and tree tissue nutrient concentrations influenced by stand density in subtropical Chinese fir plantation forests	PLOS ONE			English	Article							LOWLAND TROPICAL FOREST; HEDLEY FRACTIONATION; SPECIES-DIVERSITY; SOUTHERN CHINA; NITROGEN; RHIZOSPHERE; LIMITATION; RESORPTION; PINE; PRODUCTIVITY	Stand density regulation is an important measure of plantation forest management, and phosphorus (P) is often the limiting factor of tree productivity, especially in the subtropics and tropics. However, the stand density influence on ecosystem P cycling is unclear in Chinese fir (Cunninghamia lanceolata) plantations of subtropical China. We collected rhizosphere and bulk soils, leaves and twigs with different ages and roots with different orders to measure P and nitrogen (N) variables in Chinese fir plantations with low density (LDCF) and high density (HDCF) at Fujian and Hunan provinces of subtropical China. Rhizosphere soil labile P, slow P, occluded P and extractable P were higher in LDCF than HDCF at two sites. Meanwhile, P and N concentrations of 1-year-old leaves and twigs were higher in LDCF than HDCF and leaf N/P ratio generally increased with increasing leaf age at two sites. Rhizosphere vs. bulk soil labile P and occluded P were greater in LDCF than HDCF at Fujian. Nitrogen resorption efficiencies (NRE) of leaves and twigs were higher in LDCF than HDCF at Fujian, while their P resorption efficiencies (PRE) were not different between two densities at two sites. The average NRE of leaves (41.7%) and twigs (65.6%) were lower than the corresponding PRE (67.8% and 78.0%, respectively). Our results suggest that reducing stem density in Chinese fir plantations might be helpful to increase soil active P supplies and meet tree nutrient requirements.	[Fang, Xiang-Min; Zhang, Xiu-Lan; Zong, Ying-Ying; Zhang, Yang; Wan, Song-Ze; Bu, Wen-Sheng; Chen, Fu-Sheng] Jiangxi Agr Univ, Coll Forestry, Jiangxi Prov Key Lab Silviculture, Nanchang, Jiangxi, Peoples R China; [Fang, Xiang-Min; Bu, Wen-Sheng; Chen, Fu-Sheng] Jiangxi Agr Univ, Jiulianshan Natl Observat & Res Stn Chinese Fores, Collaborat Innovat Ctr Jiangxi Typ Trees Cultivat, Nanchang, Jiangxi, Peoples R China	Jiangxi Agricultural University; Jiangxi Agricultural University	Chen, FS (corresponding author), Jiangxi Agr Univ, Coll Forestry, Jiangxi Prov Key Lab Silviculture, Nanchang, Jiangxi, Peoples R China.; Chen, FS (corresponding author), Jiangxi Agr Univ, Jiulianshan Natl Observat & Res Stn Chinese Fores, Collaborat Innovat Ctr Jiangxi Typ Trees Cultivat, Nanchang, Jiangxi, Peoples R China.	chenfush@yahoo.com		Chen, Fu-Sheng/0000-0001-5126-3298	National Key Research and Development Program of China [2016YFD0600202-2]; National Natural Science Foundation of China [31360179]; Jiangxi Provincial Department of Science and Technology [20153BCB22008, 20151BAB214020, 20165BCB19006]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangxi Provincial Department of Science and Technology	This work was supported by the National Key Research and Development Program of China (2016YFD0600202-2), the National Natural Science Foundation of China (31360179) and Jiangxi Provincial Department of Science and Technology (20153BCB22008, 20151BAB214020 and 20165BCB19006).	Aerts R, 1996, J ECOL, V84, P597, DOI 10.2307/2261481; Allen SE, 1989, CHEM ANAL ECOLOGICAL; Ares A, 2010, FOREST ECOL MANAG, V260, P1104, DOI 10.1016/j.foreco.2010.06.023; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Blanco JA, 2009, ECOL APPL, V19, P682, DOI 10.1890/1051-0761-19.3.682; Blevins DP, 2005, CAN J FOREST RES, V35, P2851, DOI 10.1139/X05-204; BORMANN BT, 1984, ECOLOGY, V65, P394, DOI 10.2307/1941402; Braakhekke WG, 1999, J VEG SCI, V10, P187, DOI 10.2307/3237140; Cameron AD, 2002, FORESTRY, V75, P25, DOI 10.1093/forestry/75.1.25; Carey AB, 2003, FORESTRY, V76, P127, DOI 10.1093/forestry/76.2.127; CARLYLE JC, 1995, CAN J FOREST RES, V25, P1278, DOI 10.1139/x95-141; CHAPIN FS, 1983, ECOLOGY, V64, P376, DOI 10.2307/1937083; Chen FS, 2015, TREE PHYSIOL, V35, P1106, DOI 10.1093/treephys/tpv076; Chen Fu-sheng, 2010, Journal of Forestry Research (Harbin), V21, P39, DOI 10.1007/s11676-010-0006-2; Chen HJ, 2003, FOREST ECOL MANAG, V178, P301, DOI 10.1016/S0378-1127(02)00478-4; CROSS AF, 1995, GEODERMA, V64, P197, DOI 10.1016/0016-7061(94)00023-4; Dakora FD, 2002, PLANT SOIL, V245, P35, DOI 10.1023/A:1020809400075; Davis MR, 2004, CAN J FOREST RES, V34, P2037, DOI [10.1139/x04-067, 10.1139/X04-067]; Ding JingYi, 2016, Acta Ecologica Sinica - International Journal, V36, P377, DOI 10.1016/j.chnaes.2016.05.004; Fan J, 2014, URBAN FOR URBAN GREE, V13, P576, DOI 10.1016/j.ufug.2014.03.002; Feller IC, 2003, BIOGEOCHEMISTRY, V62, P145, DOI 10.1023/A:1021166010892; Fu XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128894; Giuggiola A, 2013, FOREST ECOL MANAG, V310, P827, DOI 10.1016/j.foreco.2013.09.030; HEDLEY MJ, 1982, SOIL SCI SOC AM J, V46, P970, DOI 10.2136/sssaj1982.03615995004600050017x; Hinsinger P, 1998, ADV AGRON, V64, P225, DOI 10.1016/S0065-2113(08)60506-4; HIROSE T, 1988, OECOLOGIA, V77, P145, DOI 10.1007/BF00379180; Horner GJ, 2010, FOREST ECOL MANAG, V259, P286, DOI 10.1016/j.foreco.2009.10.015; Koerselman W, 1996, J APPL ECOL, V33, P1441, DOI 10.2307/2404783; Liu Yu, 2013, Yingyong Shengtai Xuebao, V24, P1501; Lopez BC, 2003, TREE PHYSIOL, V23, P1217, DOI 10.1093/treephys/23.17.1217; Mayor JR, 2014, J ECOL, V102, P36, DOI 10.1111/1365-2745.12190; Mirabello MJ, 2013, SOIL RES, V51, P215, DOI 10.1071/SR12188; Motavalli PP, 2002, BIOL FERT SOILS, V36, P35, DOI 10.1007/s00374-002-0500-6; Negassa W, 2009, J PLANT NUTR SOIL SC, V172, P305, DOI 10.1002/jpln.200800223; Phillips RP, 2008, SOIL SCI SOC AM J, V72, P453, DOI 10.2136/sssaj2006.0389; Phillips RP, 2006, ECOLOGY, V87, P1302, DOI 10.1890/0012-9658(2006)87[1302:TSAMAI]2.0.CO;2; SPSS Inc, 2007, SPSS WIND 16 0; TATE RL, 1991, SOIL SCI SOC AM J, V55, P998, DOI 10.2136/sssaj1991.03615995005500040018x; Tian YuMing, 2011, Scientia Silvae Sinicae, V47, P102; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; Wright IJ, 2003, FUNCT ECOL, V17, P10, DOI 10.1046/j.1365-2435.2003.00694.x; Yang X, 2011, BIOGEOSCIENCES, V8, P2907, DOI 10.5194/bg-8-2907-2011; Zhang YanJie, 2011, Scientia Silvae Sinicae, V47, P75; Zhao DH, 2012, CAN J FOREST RES, V42, P111, DOI [10.1139/x11-166, 10.1139/X11-166]; Zhu FF, 2014, J PLANT ECOL, V7, P526, DOI 10.1093/jpe/rtu001	45	25	34	7	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186905	10.1371/journal.pone.0186905	http://dx.doi.org/10.1371/journal.pone.0186905			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073278	Green Published, gold, Green Submitted			2022-12-26	WOS:000413845400073
J	Verma, SK; Leikina, E; Melikov, K; Gebert, C; Kram, V; Young, MF; Uygur, B; Chernomordik, LV				Verma, Santosh K.; Leikina, Evgenia; Melikov, Kamran; Gebert, Claudia; Kram, Vardit; Young, Marian F.; Uygur, Berna; Chernomordik, Leonid V.			Cell-surface phosphatidylserine regulates osteoclast precursor fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGE FUSION; MEMBRANE-FUSION; ANNEXIN A1; INTERCELLULAR FUSION; DC-STAMP; EXPRESSION; PROTEIN; VIRUS; SYNCYTIN-1; ENVELOPE	Bone-resorbing multinucleated osteoclasts that play a central role in the maintenance and repair of our bones are formed from bone marrow myeloid progenitor cells by a complex differentiation process that culminates in fusion of mononuclear osteoclast precursors. In this study, we uncoupled the cell fusion step from both pre-fusion stages of osteoclastogenic differentiation and the post-fusion expansion of the nascent fusion connections. We accumulated ready-to-fuse cells in the presence of the fusion inhibitor lysophosphatidylcholine and then removed the inhibitor to study synchronized cell fusion. We found that osteoclast fusion required the dendrocyte-expressed seven transmembrane protein (DC-STAMP)-dependent non-apoptotic exposure of phosphatidylserine at the surface of fusion-committed cells. Fusion also depended on extracellular annexins, phosphatidylserine-binding proteins, which, along with annexin-binding protein S100A4, regulated fusogenic activity of syncytin 1. Thus, in contrast to fusion processes mediated by a single protein, such as epithelial cell fusion in Caenorhabditis elegans, the cell fusion step in osteoclastogenesis is controlled by phosphatidylserine-regulated activity of several proteins.	[Verma, Santosh K.; Leikina, Evgenia; Melikov, Kamran; Uygur, Berna; Chernomordik, Leonid V.] Eunice Kennedy Shriver NICHD, Sect Membrane Biol, Bethesda, MD 20892 USA; [Gebert, Claudia] Eunice Kennedy Shriver NICHD, Sect Genom Imprinting, Bethesda, MD 20892 USA; [Kram, Vardit; Young, Marian F.] NIDCR, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Chernomordik, LV (corresponding author), Eunice Kennedy Shriver NICHD, Sect Membrane Biol, Bethesda, MD 20892 USA.	chernoml@mail.nih.gov	Uygur, Berna/AAD-1043-2020; Verma, Santosh/AAQ-8952-2020	Verma, Santosh/0000-0001-6058-6494; Young, Marian F/0000-0003-0929-8854	Intramural Research Program of the Eunice Kennedy Shriver NICHD, National Institutes of Health; NIDCR, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000379] Funding Source: NIH RePORTER	Intramural Research Program of the Eunice Kennedy Shriver NICHD, National Institutes of Health; NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Intramural Research Program of the Eunice Kennedy Shriver NICHD, National Institutes of Health (to the L. V. C. laboratory), and by the NIDCR, National Institutes of Health (to the M. F. Y. laboratory). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ADLER RR, 1995, BIOL REPROD, V53, P905, DOI 10.1095/biolreprod53.4.905; Lizarbe MA, 2013, INT J MOL SCI, V14, P2652, DOI 10.3390/ijms14022652; Antony JM, 2007, J IMMUNOL, V179, P1210, DOI 10.4049/jimmunol.179.2.1210; Belluoccio D, 2010, J BONE MINER RES, V25, P141, DOI 10.1359/jbmr.090710; Bizzarro V, 2010, J CELL PHYSIOL, V224, P757, DOI 10.1002/jcp.22178; Bjerregard B, 2014, CELL TISSUE RES, V357, P355, DOI 10.1007/s00441-014-1930-9; Brachvogel B, 2003, MOL CELL BIOL, V23, P2907, DOI 10.1128/MCB.23.8.2907-2913.2003; Chang C, 2004, BIOL REPROD, V71, P1956, DOI 10.1095/biolreprod.104.033340; Chen EH, 2007, FEBS LETT, V581, P2181, DOI 10.1016/j.febslet.2007.03.033; Chen X, 2004, J IMMUNOL, V173, P2985, DOI 10.4049/jimmunol.173.5.2985; Chen XD, 2003, CALCIFIED TISSUE INT, V72, P577, DOI 10.1007/s00223-002-1101-y; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Chiu YH, 2016, J CELL PHYSIOL, V231, P2402, DOI 10.1002/jcp.25389; Chuprin A, 2013, GENE DEV, V27, P2356, DOI 10.1101/gad.227512.113; Ciechonska M, 2014, TRENDS MICROBIOL, V22, P715, DOI 10.1016/j.tim.2014.08.005; Coudert A., 2015, 4 JOINT M EUR CALC T, P194; Curia CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071995; Damazo AS, 2007, BIRTH DEFECTS RES A, V79, P524, DOI 10.1002/bdra.20368; Das M, 2004, PLACENTA, V25, P396, DOI 10.1016/j.placenta.2003.11.004; DEGRELLE SA, 2017, SCI REP, V7, P4217, DOI DOI 10.1016/J.PLACENTA.2013.06.287; Eden ER, 2016, DEV CELL, V37, P473, DOI 10.1016/j.devcel.2016.05.005; Erlandsson MC, 2013, BBA-MOL CELL RES, V1833, P2653, DOI 10.1016/j.bbamcr.2013.06.020; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Frese S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132099; Hamilton BS, 2012, VIRUSES-BASEL, V4, P1144, DOI 10.3390/v4071144; Hannon R, 2002, FASEB J, V16, P253, DOI 10.1096/fj.02-0239fje; Helming L, 2009, TRENDS CELL BIOL, V19, P514, DOI 10.1016/j.tcb.2009.07.005; Hobolt-Pedersen AS, 2014, CALCIFIED TISSUE INT, V95, P73, DOI 10.1007/s00223-014-9864-5; Hochreiter-Hufford AE, 2013, NATURE, V497, P263, DOI 10.1038/nature12135; Hwang SY, 2011, BBA-MOL CELL RES, V1813, P979, DOI 10.1016/j.bbamcr.2010.11.002; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Kang H, 2014, CELL REP, V8, P1210, DOI 10.1016/j.celrep.2014.07.032; Konig J, 1998, J BIOL CHEM, V273, P19679, DOI 10.1074/jbc.273.31.19679; Leikina E, 2015, SCI REP-UK, V5, DOI 10.1038/srep18246; Leikina E, 2013, J CELL BIOL, V200, P109, DOI 10.1083/jcb.201207012; Levaot N, 2015, BONE, V79, P21, DOI 10.1016/j.bone.2015.05.021; Li FH, 2005, J BONE MINER RES, V20, P1161, DOI 10.1359/JBMR.050207; LYDEN TW, 1993, PLACENTA, V14, P177, DOI 10.1016/S0143-4004(05)80259-0; Mah SJ, 2015, ARCH ORAL BIOL, V60, P1215, DOI 10.1016/j.archoralbio.2015.05.014; Markosyan RM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005373; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Menaa C, 1999, J CLIN INVEST, V103, P1605, DOI 10.1172/JCI6374; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Miyamoto H, 2012, J BONE MINER RES, V27, P1289, DOI 10.1002/jbmr.1575; Miyamoto Takeshi, 2011, Keio Journal of Medicine, V60, P101; Moller AMJ, 2017, J CELL PHYSIOL, V232, P1396, DOI 10.1002/jcp.25633; Moss B, 2016, SEMIN CELL DEV BIOL, V60, P89, DOI 10.1016/j.semcdb.2016.07.015; Myrvang HK, 2013, FEBS LETT, V587, P3210, DOI 10.1016/j.febslet.2013.08.012; Oikawa T, 2012, J CELL BIOL, V197, P553, DOI 10.1083/jcb.201111116; Otzen DE, 2012, BBA-BIOMEMBRANES, V1818, P1019, DOI 10.1016/j.bbamem.2011.08.032; Park SY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10871; Pellegatti P, 2011, FASEB J, V25, P1264, DOI 10.1096/fj.10-169854; Podbilewicz B, 2006, DEV CELL, V11, P471, DOI 10.1016/j.devcel.2006.09.004; Podbilewicz B, 2014, ANNU REV CELL DEV BI, V30, P111, DOI 10.1146/annurev-cellbio-101512-122422; Rhee I, 2013, MOL CELL BIOL, V33, P2458, DOI 10.1128/MCB.00197-13; Richard JP, 2011, BIOCHEM J, V440, P185, DOI 10.1042/BJ20111243; Rizo J, 2015, ANNU REV BIOPHYS, V44, P339, DOI 10.1146/annurev-biophys-060414-034057; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Shin NY, 2014, J CELL BIOL, V207, P73, DOI 10.1083/jcb.201401137; Soe K, 2011, BONE, V48, P837, DOI 10.1016/j.bone.2010.11.011; Suzuki J., 2013, J BIOL CHEM; van den Eijnde SM, 2001, J CELL SCI, V114, P3631; van Genderen HO, 2008, BBA-MOL CELL RES, V1783, P953, DOI 10.1016/j.bbamcr.2008.01.030; Verma SK, 2014, BIOCHEM J, V464, P293, DOI 10.1042/BJ20141233; Vignery Agnes, 2008, V475, P149, DOI 10.1007/978-1-59745-250-2_9; White JM, 2016, TRAFFIC, V17, P593, DOI 10.1111/tra.12389; Witwicka H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128275; Wu Z, 2010, J IMMUNOL, V184, P3191, DOI 10.4049/jimmunol.0803609; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Youn MY, 2010, BIOSCI BIOTECH BIOCH, V74, P1956, DOI 10.1271/bbb.100280; Zaitseva E, 2017, CELL HOST MICROBE, V22, P99, DOI 10.1016/j.chom.2017.06.012	71	37	38	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	2018	293	1					254	270		10.1074/jbc.M117.809681	http://dx.doi.org/10.1074/jbc.M117.809681			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FS0GX	29101233	Green Published, hybrid			2022-12-26	WOS:000419453200022
J	Cevik, O; Li, D; Baljinnyam, E; Manvar, D; Pimenta, EM; Waris, G; Barnes, BJ; Kaushik-Basu, N				Cevik, Ozge; Li, Dan; Baljinnyam, Erdene; Manvar, Dinesh; Pimenta, Erica M.; Waris, Gulam; Barnes, Betsy J.; Kaushik-Basu, Neerja			Interferon regulatory factor 5 (IRF5) suppresses hepatitis C virus (HCV) replication and HCV-associated hepatocellular carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hepatitis C virus (HCV); hepatocellular carcinoma; immunosuppression; interferon regulatory factor (IRF); tumor suppressor gene; viral immunology	INDUCED APOPTOSIS; TRANSCRIPTION FACTOR; TUMOR-SUPPRESSOR; RNA REPLICATION; BREAST-CANCER; CELL-DEATH; BECLIN 1; INDUCTION; AUTOPHAGY; EXPRESSION	Hepatitis C virus (HCV) infection is a major risk factor for the development of chronic liver disease. The disease typically progresses from chronic HCV to fibrosis, cirrhosis, hepatocellular carcinoma (HCC), and death. Chronic inflammation associated with HCV infection is implicated in cirrhosis and HCC, but the molecular players and signaling pathways contributing to these processes remain largely unknown. Interferon regulatory factor 5 (IRF5) is a molecule of interest in HCV-associated HCC because it has critical roles in virus-, Toll-like receptor (TLR)-, and IFN-induced signaling pathways. IRF5 is also a tumor suppressor, and its expression is dysregulated in several human cancers. Here, we present first evidence that IRF5 expression and signaling are modulated during HCV infection. Using HCV infection of human hepatocytes and cells with autonomously replicating HCV RNA, we found that levels of IRF5 mRNA and protein expression were down-regulated. Of note, reporter assays indicated that IRF5 re-expression inhibited HCV protein translation and RNA replication. Gene expression analysis revealed significant differences in the expression of cancer pathway mediators and autophagy proteins rather than in cytokines between IRF5- and empty vector-transfected HCV replicon cells. IRF5 re-expression induced apoptosis via loss in mitochondrial membrane potential, down-regulated autophagy, and inhibited hepatocyte cell migration/invasion. Analysis of clinical HCC specimens supports a pathologic role for IRF5 in HCV-induced HCC, as IRF5 expression was down-regulated in livers from HCV-positive versus HCV-negative HCC patients or healthy donor livers. These results identify IRF5 as an important suppressor of HCV replication and HCC pathogenesis.	[Cevik, Ozge; Li, Dan; Baljinnyam, Erdene; Manvar, Dinesh; Pimenta, Erica M.; Barnes, Betsy J.; Kaushik-Basu, Neerja] Rutgers Biomed & Hlth Sci, Dept Microbiol Biochem & Mol Genet, Newark, NJ 07103 USA; [Cevik, Ozge] Cumhuriyet Univ, Fac Pharm, Dept Biochem, TR-58140 Sivas, Turkey; [Li, Dan; Pimenta, Erica M.; Barnes, Betsy J.] New Jersey Med Sch Canc Ctr, Rutgers Biomed & Hlth Sci, Newark, NJ 07103 USA; [Li, Dan; Barnes, Betsy J.] Northwell Hlth, Feinstein Inst Med Res, Ctr Autoimmune & Musculoskeletal Dis, Manhasset, NY 11030 USA; [Waris, Gulam] Rosalind Franklin Univ Med & Sci, Chicago, IL 60064 USA; [Kaushik-Basu, Neerja] NIH, Infect Dis & Microbiol Integrated Review Grp, Ctr Sci Review, Bldg 10, Bethesda, MD 20892 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Cumhuriyet University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Northwell Health; Chicago Medical School; Rosalind Franklin University Medical & Science; National Institutes of Health (NIH) - USA	Kaushik-Basu, N (corresponding author), NIH, Infect Dis & Microbiol Integrated Review Grp, Ctr Sci Review, Bldg 10, Bethesda, MD 20892 USA.; Barnes, BJ (corresponding author), Feinstein Inst Med Res, 350 Community Dr,Rm 3238, Manhasset, NY 11030 USA.	bbarnes1@northwell.edu; neerja.kaushik-basu@nih.gov	Cevik, Ozge/Z-2790-2019		National Institutes of Health [CA153147, CA191903]; International Postdoctoral Research Fellowship Program by the Scientific and Technological Research Council of Turkey (TUBITAK) [2219]; NATIONAL CANCER INSTITUTE [R21CA191903, R21CA153147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Postdoctoral Research Fellowship Program by the Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants CA153147 (to N. K.-B.) and CA191903 (to B. J. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by the International Postdoctoral Research Fellowship Program provided by the Scientific and Technological Research Council of Turkey (TUBITAK) 2219.	Alzaid F, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88689; Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Attar Bashar M, 2016, World J Gastrointest Pharmacol Ther, V7, P33, DOI 10.4292/wjgpt.v7.i1.33; Barnes BJ, 2003, CANCER RES, V63, P6424; Barnes BJ, 2002, MOL CELL BIOL, V22, P5721, DOI 10.1128/MCB.22.16.5721-5740.2002; Barnes BJ, 2001, J BIOL CHEM, V276, P23382, DOI 10.1074/jbc.M101216200; Barth H, 2015, WORLD J HEPATOL, V7, P725, DOI 10.4254/wjh.v7.i5.725; Beales LP, 2003, J VIROL, V77, P6574, DOI 10.1128/JVI.77.11.6574-6579.2003; Bi XH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3053; Binder M, 2007, HEPATOLOGY, V46, P1365, DOI 10.1002/hep.21829; Bishayee A, 2012, CURR CANCER DRUG TAR, V12, P1095; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Brault C, 2013, VIRUSES-BASEL, V5, P954, DOI 10.3390/v5030954; Chu JS, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-16; Courties G, 2014, J AM COLL CARDIOL, V63, P1556, DOI 10.1016/j.jacc.2013.11.023; Couzinet A, 2008, P NATL ACAD SCI USA, V105, P2556, DOI 10.1073/pnas.0712295105; Dreux M, 2009, P NATL ACAD SCI USA, V106, P14046, DOI 10.1073/pnas.0907344106; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Fresquet V, 2012, BRIT J HAEMATOL, V158, P712, DOI 10.1111/j.1365-2141.2012.09226.x; Ghosh AK, 2003, VIROLOGY, V306, P51, DOI 10.1016/S0042-6822(02)00029-6; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hu GD, 2005, CANCER RES, V65, P7403, DOI 10.1158/0008-5472.CAN-05-0583; Ikushima H, 2013, COLD SH Q B, V78, P105, DOI 10.1101/sqb.2013.78.020321; Kemik O, 2010, BRATISL MED J, V111, P485; Kim H, 2012, J VIROL, V86, P9919, DOI 10.1128/JVI.00388-12; Kim K, 2010, FEBS LETT, V584, P707, DOI 10.1016/j.febslet.2009.12.019; Kucukguzel I, 2013, EUR J MED CHEM, V69, P931, DOI 10.1016/j.ejmech.2013.08.043; Li D, 2016, SCI REP-UK, V6, DOI 10.1038/srep31002; Li H, 2011, AUTOPHAGY, V7, P1239, DOI 10.4161/auto.7.10.16490; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Luo S, 2010, CELL DEATH DIFFER, V17, P268, DOI 10.1038/cdd.2009.121; Mancl ME, 2005, J BIOL CHEM, V280, P21078, DOI 10.1074/jbc.M500543200; Mori T, 2002, ONCOGENE, V21, P2914, DOI 10.1038/sj.onc.1205459; Murata T, 2005, VIROLOGY, V331, P407, DOI 10.1016/j.virol.2004.10.036; Nandakumar R, 2013, GASTROENTEROLOGY, V145, P1414, DOI 10.1053/j.gastro.2013.08.037; Pflugheber J, 2002, P NATL ACAD SCI USA, V99, P4650, DOI 10.1073/pnas.062055699; Pimenta EM, 2015, IMMUNOL CELL BIOL, V93, P486, DOI 10.1038/icb.2014.110; Pimenta EM, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0305-5; Rautou PE, 2011, AM J PATHOL, V178, P2708, DOI 10.1016/j.ajpath.2011.02.021; Raychoudhuri A, 2010, J VIROL, V84, P10991, DOI 10.1128/JVI.00900-10; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Shrivastava S, 2012, J VIROL, V86, P8705, DOI 10.1128/JVI.00616-12; Shrivastava S, 2011, HEPATOLOGY, V53, P406, DOI 10.1002/hep.24073; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Vescozo T., 2014, BIOMED RES INT, V2014; Wack A, 2015, NAT IMMUNOL, V16, P802, DOI 10.1038/ni.3212; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Wirawan E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.16; Yanai H, 2007, P NATL ACAD SCI USA, V104, P3402, DOI 10.1073/pnas.0611559104; Zhao GN, 2015, BBA-MOL BASIS DIS, V1852, P365, DOI 10.1016/j.bbadis.2014.04.030; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069	53	28	28	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 29	2017	292	52					21676	21689		10.1074/jbc.M117.792721	http://dx.doi.org/10.1074/jbc.M117.792721			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FR4CJ	29079574	Green Published, hybrid			2022-12-26	WOS:000419013000041
J	Hammersen, F; Lewin, P; Gebauer, J; Kreitschmann-Andermahr, I; Brabant, G; Katalinic, A; Waldmann, A				Hammersen, Friederike; Lewin, Philip; Gebauer, Judith; Kreitschmann-Andermahr, Ilonka; Brabant, Georg; Katalinic, Alexander; Waldmann, Annika			Sleep quality and health-related quality of life among long-term survivors of (non-) Hodgkin lymphoma in Germany	PLOS ONE			English	Article							CANCER-RELATED FATIGUE; B-CELL LYMPHOMA; BREAST-CANCER; DISEASE SURVIVORS; DISTURBANCES; POPULATION; ADULTS; DISORDERS; INSOMNIA; REGISTRY	This study investigated sleep quality and health-related quality of life (HRQOL) among long-term survivors of Hodgkin (HL) and non-Hodgkin lymphoma (NHL). The aim was to explore the impact of personal and health-related factors on sleep quality as well as associations between sleep quality and HRQOL. For the postal survey, participants with a minimum age of 18 years initially treated between 1998 and 2008 were recruited via the population-based cancer registry in Schleswig-Holstein, Northern Germany. Questionnaires included amongst others the Pittsburg Sleep Quality Index (PSQI) and the 36-Item Short Form Health Survey (SF-36v1). Descriptive and comparative statistics were performed. Additionally, a regression analysis was conducted to identify predictors of sleep quality. In total, we recruited 515 participants (398 NHL, 117 HL) with a mean age of 63.1 years. Approximately half of the survivors were classified as good sleepers. HRQOL scores differed between good and poor sleepers with lower scores in poor sleepers. In a prediction model, self-reported depression, exhaustion, higher age, inability to work, endocrinological disorders and female gender classified as predictors of sleep quality. This study highlights the impact of sleep quality on HRQOL in long-term survivors of NHL and HL. Thus, sleep quality should be routinely assessed during follow-up of cancer survivors with special attention to patients with potential risk factors.	[Hammersen, Friederike; Lewin, Philip; Katalinic, Alexander; Waldmann, Annika] Univ Lubeck, Inst Social Med & Epidemiol, Lubeck, Germany; [Gebauer, Judith; Brabant, Georg] Univ Hosp Schleswig Holstein, Dept Internal Med 1, Expt & Clin Endocrinol, Campus Luebeck, Lubeck, Germany; [Kreitschmann-Andermahr, Ilonka] Univ Duisburg Essen, Univ Hosp Essen, Dept Neurosurg, Essen, Germany; [Katalinic, Alexander] Univ Lubeck, Inst Canc Epidemiol eV, Lubeck, Germany; [Waldmann, Annika] Hamburg Canc Registry, Hamburg, Germany	University of Lubeck; University of Kiel; Schleswig Holstein University Hospital; University of Duisburg Essen; University of Lubeck	Hammersen, F (corresponding author), Univ Lubeck, Inst Social Med & Epidemiol, Lubeck, Germany.	Friederike.Hammersen@uksh.de	Katalinic, Alexander/D-2512-2010	Katalinic, Alexander/0000-0003-0490-1554	Pfizer Inc. [WI172075]; Land Schleswig-Holstein within the funding program Open Access Publikationsfonds	Pfizer Inc.(Pfizer); Land Schleswig-Holstein within the funding program Open Access Publikationsfonds	We acknowledge financial support by Pfizer Inc. (WI172075 to GB) and Land Schleswig-Holstein within the funding program Open Access Publikationsfonds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We acknowledge financial support by Land Schleswig-Holstein within the funding program Open Access Publikationsfonds.	Berger AM, 2007, PSYCHO-ONCOLOGY, V16, P401, DOI 10.1002/pon.1079; Bonsignore M, 2001, EUR ARCH PSY CLIN N, V251, P27; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Costa AR, 2014, BREAST, V23, P697, DOI 10.1016/j.breast.2014.09.003; Daniels LA, 2013, ANN HEMATOL, V92, P1023, DOI 10.1007/s00277-013-1793-2; Fortner BV, 2002, J PAIN SYMPTOM MANAG, V24, P471, DOI 10.1016/S0885-3924(02)00500-6; Ganz PA, 2007, ACTA ONCOL, V46, P474, DOI 10.1080/02841860701367845; Gebauer J, 2015, EUR J ENDOCRINOL, V173, P139, DOI 10.1530/EJE-15-0174; Harris B, 2014, CANCER J, V20, P299, DOI 10.1097/PPO.0000000000000067; Health Council of the Netherlands, 2014, POP SCREEN BREAST CA; Hiripi E, 2012, ANN ONCOL, V23, P472, DOI 10.1093/annonc/mdr131; Hjermstad MJ, 2006, EUR J CANCER, V42, P327, DOI 10.1016/j.ejca.2005.09.028; Hjermstad MJ, 2005, J CLIN ONCOL, V23, P6587, DOI 10.1200/JCO.2005.09.936; Hoskin PJ, 2013, CLIN ONCOL-UK, V25, P49, DOI 10.1016/j.clon.2012.07.011; Lis CG, 2008, SUPPORT CARE CANCER, V16, P261, DOI 10.1007/s00520-007-0314-z; Liu LQ, 2013, BEHAV SLEEP MED, V11, P189, DOI 10.1080/15402002.2012.660589; Loge JH, 1999, ANN ONCOL, V10, P71, DOI 10.1023/A:1008315525997; Lowe B, 2004, J AFFECT DISORDERS, V78, P131, DOI 10.1016/S0165-0327(02)00237-9; Morfeld M, 2011, SF 36 FRAGEBOGEN ZUM, V2nd; Nutt David, 2008, Dialogues Clin Neurosci, V10, P329; Oerlemans S, 2013, HAEMATOLOGICA, V98, P479, DOI 10.3324/haematol.2012.064907; Olson K, 2014, SLEEP MED, V15, P496, DOI 10.1016/j.sleep.2014.01.006; Quinten C, 2009, LANCET ONCOL, V10, P865, DOI 10.1016/S1470-2045(09)70200-1; Rizvi SJ, 2015, CAN J PSYCHIAT, V60, P14, DOI 10.1177/070674371506000105; Robert Koch-Institut, 2010, DEPR ERKR GES BUND; Robert Koch-Institut, 2010, VERBR KREBS DEUTSCHL; Roscoe JA, 2007, ONCOLOGIST, V12, P35, DOI 10.1634/theoncologist.12-S1-35; Ruffer JU, 2003, EUR J CANCER, V39, P2179, DOI 10.1016/S0959-8049(03)00545-8; Sandadi S, 2011, GYNECOL ONCOL, V123, P351, DOI 10.1016/j.ygyno.2011.07.028; Savard J, 2009, J CLIN ONCOL, V27, P5233, DOI 10.1200/JCO.2008.21.6333; Schlack R, 2013, BUNDESGESUNDHEITSBLA, V56, P740, DOI 10.1007/s00103-013-1689-2; Sehn LH, 2005, J CLIN ONCOL, V23, P5027, DOI 10.1200/JCO.2005.09.137; Topp CW, 2015, PSYCHOTHER PSYCHOSOM, V84, DOI 10.1159/000376585; Tribl GG, 2002, SLEEP MED, V3, P21, DOI 10.1016/S1389-9457(01)00117-4; VANTULDER MW, 1994, ANN ONCOL, V5, P153, DOI 10.1093/oxfordjournals.annonc.a058768; Vargo JA, 2015, J CLIN ONCOL, V33, P3710, DOI 10.1200/JCO.2015.61.7654; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P903, DOI 10.1016/S0895-4356(98)00081-X; Wenzel L, 2005, J CLIN ONCOL, V23, P5605, DOI 10.1200/JCO.2005.08.147; Zeitlhofer J, 2000, ACTA NEUROL SCAND, V102, P249, DOI 10.1034/j.1600-0404.2000.102004249.x	40	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187673	10.1371/journal.pone.0187673	http://dx.doi.org/10.1371/journal.pone.0187673			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL7JU	29107959	Green Published, gold, Green Submitted			2022-12-26	WOS:000414424600057
J	Perju-Dumbrava, L; Lau, K; Phyland, D; Papanikolaou, V; Finlay, P; Beare, R; Bardin, P; Stuckey, S; Kempster, P; Thyagarajan, D				Perju-Dumbrava, Laura; Lau, Ken; Phyland, Debbie; Papanikolaou, Vicki; Finlay, Paul; Beare, Richard; Bardin, Philip; Stuckey, Stephen; Kempster, Peter; Thyagarajan, Dominic			Arytenoid cartilage movements are hypokinetic in Parkinson's disease: A quantitative dynamic computerised tomographic study	PLOS ONE			English	Article							FUNDAMENTAL-FREQUENCY; PHARYNGEAL MUSCLES; VOICE ANALYSIS; SPEECH; DYSFUNCTIONS; VARIABILITY; DISORDERS; LEVODOPA	Background Voice change is one of the earliest features of Parkinson's disease. However, quantitative studies of vocal fold dynamics which are needed to provide insight into disease biology, aid diagnosis, or track progression, are few. Methods We therefore quantified arytenoid cartilage movements and glottic area during repeated phonation in 15 patients with Parkinson's disease (symptom duration < 6 years) and 19 controls, with 320-slice computerised tomography (CT). We related these measures to perceptual voice evaluations and spirometry. We hypothesised that Parkinson's disease patients have a smaller inter-arytenoid distance, a preserved or larger glottic area because vocal cord bowing has previously been reported, less variability in loudness, more voice dysdiadochokinesis and breathiness and a shortened phonation time because of arytenoid hypokinesis relative to glottic area. Results Inter-arytenoid distance in Parkinson's disease patients was moderately smaller (Mdn = 0.106, IQR = 0.091-0.116) than in controls (Mdn = 0.132, IQR = 0.116-0.166) (W = 212, P = 0.015, r = -0.42), normalised for anatomical and other inter-subject variance, analysed with two-tailed Wilcoxon's rank sum test. This finding was confirmed in a linear mixed model analysis-Parkinson's disease significantly predicted a reduction in the dependent variable, inter-arytenoid distance (b = -0.87, SEb = 0.39, 95% CI [-1.66, -0.08], t(31) = -2.24, P = 0.032). There was no difference in glottic area. On perceptual voice evaluation, patients had more breathiness and dysdiadochokinesis, a shorter maximum phonation time, and less variability in loudness than controls. There was no difference in spirometry after adjustment for smoking history. Conclusions As predicted, vocal fold adduction movements are reduced in Parkinson's disease on repeated phonation but glottic area is maintained. Some perceptual characteristics of Parkinsonian speech reflect these changes. We are the first to use 320-slice CT to study laryngeal motion. Our findings indicate how Parkinson's disease affects intrinsic laryngeal muscle position and excursion.	[Perju-Dumbrava, Laura; Beare, Richard; Kempster, Peter; Thyagarajan, Dominic] Monash Med Ctr, Dept Neurosci, Clayton, Vic, Australia; [Lau, Ken; Stuckey, Stephen] Monash Med Ctr, Dept Med Imaging, Clayton, Vic, Australia; [Phyland, Debbie] Monash Med Ctr, Dept Surg, Clayton, Vic, Australia; [Papanikolaou, Vicki; Finlay, Paul; Bardin, Philip] Monash Med Ctr, Dept Resp Med, Clayton, Vic, Australia	Monash University; Monash University; Monash University; Monash University	Thyagarajan, D (corresponding author), Monash Med Ctr, Dept Neurosci, Clayton, Vic, Australia.	dominic.thyagarajan@monash.edu	Phyland, Debra J./N-5584-2015; Thyagarajan, Dominic E S/H-6633-2014	Phyland, Debra J./0000-0002-8916-3695; Thyagarajan, Dominic E S/0000-0002-7766-4003; Beare, Richard/0000-0002-7530-5664	Allergan; Ipsen; Departments of Neuroscience and Medical Imaging, Monash Medical Centre	Allergan(AbbVieAllergan); Ipsen(Ipsen); Departments of Neuroscience and Medical Imaging, Monash Medical Centre	Dr. Laura Perju-Dumbrava's salary was indirectly received from Allergan and Ipsen as support for a Movement Disorder Fellowship. All other funding for this study was obtained from the Departments of Neuroscience and Medical Imaging, Monash Medical Centre.; We acknowledge Ipsen and Allergan for indirect funding support for Dr. Perju-Dumbrava's fellowship salary.	[Anonymous], 2011, UNDERSTANDING VOICE; [Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 1969, VOICE ARTICULATION D; Blumin JH, 2004, ANN OTO RHINOL LARYN, V113, P253, DOI 10.1177/000348940411300401; Chhetri DK, 2014, J ACOUST SOC AM, V135, P2052, DOI 10.1121/1.4865918; Hammer MJ, 2010, EXP BRAIN RES, V201, P401, DOI 10.1007/s00221-009-2048-2; HANSON DG, 1984, LARYNGOSCOPE, V94, P348; Harel B, 2004, BRAIN COGNITION, V56, P24, DOI 10.1016/j.bandc.2004.05.002; Hewavitharanage S, 2015, IEEE ENG MED BIO, P3105, DOI 10.1109/EMBC.2015.7319049; Hewavitharanage S, 2015, IEEE ENG MED BIO, P739, DOI 10.1109/EMBC.2015.7318468; Ho AK, 2008, MOVEMENT DISORD, V23, P574, DOI 10.1002/mds.21899; Holmes PW, 2009, RESPIROLOGY, V14, P1106, DOI 10.1111/j.1440-1843.2009.01629.x; Holmes RJ, 2000, INT J LANG COMM DIS, V35, P407; HUGHES AJ, 1992, NEUROLOGY, V42, P1142, DOI 10.1212/WNL.42.6.1142; IZQUIERDOALONSO JL, 1994, LUNG, V172, P47; Joosten S, 2012, THORAX, V67, P95, DOI 10.1136/thx.2009.132035; KNUDSON RJ, 1976, AM REV RESPIR DIS, V113, P587; Krausert CR, 2011, J VOICE, V25, P395, DOI 10.1016/j.jvoice.2010.02.001; Lim VPC, 1998, J VOICE, V12, P68, DOI 10.1016/S0892-1997(98)80076-3; LOGEMANN JA, 1978, J SPEECH HEAR DISORD, V43, P47, DOI 10.1044/jshd.4301.47; Monteiro L, 2012, CLIN THER, V34, P1049, DOI 10.1016/j.clinthera.2012.03.001; Mu LC, 2013, J NEUROPATH EXP NEUR, V72, P119, DOI 10.1097/NEN.0b013e3182801cde; Mu LC, 2012, J NEUROPATH EXP NEUR, V71, P520, DOI 10.1097/NEN.0b013e318258381b; Oates J, 1998, J VOICE, V12, P500, DOI 10.1016/S0892-1997(98)80059-3; Perez KS, 1996, J VOICE, V10, P354, DOI 10.1016/S0892-1997(96)80027-0; Pinheiro J, 2016, R CORE TEAM; Poletto CJ, 2004, J APPL PHYSIOL, V97, P858, DOI 10.1152/japplphysiol.00087.2004; Postuma RB, 2012, BRAIN, V135, P1860, DOI 10.1093/brain/aws093; Ramig Lorraine O, 2008, Expert Rev Neurother, V8, P297, DOI 10.1586/14737175.8.2.297; Ramig Lorraine Olson, 2007, Handb Clin Neurol, V83, P385, DOI 10.1016/S0072-9752(07)83017-X; Rusz J, 2016, J NEURAL TRANSM, V123, P379, DOI 10.1007/s00702-016-1515-8; Sabate M, 1996, J NEUROL SCI, V138, P114, DOI 10.1016/0022-510X(96)00003-2; Sadagopan N, 2007, MOVEMENT DISORD, V22, P651, DOI 10.1002/mds.21375; Sapir S, 2008, CURR OPIN OTOLARYNGO, V16, P205, DOI 10.1097/MOO.0b013e3282febd3a; Shill H, 2002, SEM RESP CRIT CARE M, V23, P261, DOI 10.1055/s-2002-33034; Skodda S, 2011, J VOICE, V25, P76, DOI 10.1016/j.jvoice.2009.07.005; SMITH ME, 1995, J VOICE, V9, P453, DOI 10.1016/S0892-1997(05)80210-3; TANAKA S, 1994, ANN OTO RHINOL LARYN, V103, P357, DOI 10.1177/000348949410300504; Tsui PH, 2011, MED PHYS, V38, P2019, DOI 10.1118/1.3562899; Yuceturk AV, 2002, EUR ARCH OTO-RHINO-L, V259, P290, DOI 10.1007/s00405-002-0462-1	40	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							e0186611	10.1371/journal.pone.0186611	http://dx.doi.org/10.1371/journal.pone.0186611			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6TA	29099841	Green Published, Green Submitted, gold			2022-12-26	WOS:000414377900007
J	Jeong, K; Julia, CC; Waters, DLE; Pantoja, O; Wissuwa, M; Heuer, S; Liu, L; Rose, TJ				Jeong, Kwanho; Julia, Cecile C.; Waters, Daniel L. E.; Pantoja, Omar; Wissuwa, Matthias; Heuer, Sigrid; Liu, Lei; Rose, Terry J.			Remobilisation of phosphorus fractions in rice flag leaves during grain filling: Implications for photosynthesis and grain yields	PLOS ONE			English	Article							LEAF SENESCENCE; USE-EFFICIENCY; CARBON METABOLISM; PHOSPHATE; PLANTS; PROTEACEAE; NUTRITION; BARLEY; WHEAT	Phosphorus (P) is translocated from vegetative tissues to developing seeds during senescence in annual crop plants, but the impact of this P mobilisation on photosynthesis and plant performance is poorly understood. This study investigated rice (Oryza sativa L.) flag leaf photosynthesis and P remobilisation in a hydroponic study where P was either supplied until maturity or withdrawn permanently from the nutrient solution at anthesis, 8 days after anthesis (DAA) or 16 DAA. Prior to anthesis, plants received either the minimum level of P in nutrient solution required to achieve maximum grain yield ('adequate P treatment'), or received luxury levels of P in the nutrient solution (luxury P treatment'). Flag leaf photosynthesis was impaired at 16 DAA when P was withdrawn at anthesis or 8 DAA under adequate P supply but only when P was withdrawn at anthesis under luxury P supply. Ultimately, reduced photosynthesis did not translate into grain yield reductions. There was some evidence plants remobilised less essential P pools (e.g. Pi) or replaceable P pools (e.g. phos-pholipid-P) prior to remobilisation of P in pools critical to leaf function such as nucleic acid-P and cytosolic Pi. Competition for P between vegetative tissues and developing grains can impair photosynthesis when P supply is withdrawn during early grain filling. A reduction in the P sink strength of grains by genetic manipulation may enable leaves to sustain high rates of photosynthesis until the later stages of grain filling.	[Jeong, Kwanho; Julia, Cecile C.; Waters, Daniel L. E.; Liu, Lei; Rose, Terry J.] Southern Cross Univ, Southern Cross Plant Sci, Lismore, NSW, Australia; [Jeong, Kwanho; Julia, Cecile C.; Rose, Terry J.] Southern Cross Univ, Southern Cross GeoSci, Lismore, NSW, Australia; [Pantoja, Omar] Univ Nacl Autonoma Mexico, Inst Biotecnol, Apdo, Cuernavaca, Morelos, Mexico; [Wissuwa, Matthias] Japan Int Res Ctr Agr Sci, Crop Livestock & Environm Div, 1-1 Ohwashi, Tsukuba, Ibaraki, Japan; [Heuer, Sigrid] Rothamsted Res, Dept Plant Biol & Crop Sci, West Common, Harpenden, Herts, England; [Waters, Daniel L. E.] Charles Sturt Univ, ARC ITTC Funct Grains, Wagga Wagga, NSW, Australia	Southern Cross University; Southern Cross University; Universidad Nacional Autonoma de Mexico; Japan International Research Center for Agricultural Sciences; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Charles Sturt University	Rose, TJ (corresponding author), Southern Cross Univ, Southern Cross Plant Sci, Lismore, NSW, Australia.; Rose, TJ (corresponding author), Southern Cross Univ, Southern Cross GeoSci, Lismore, NSW, Australia.	terry.rose@scu.edu.au	Liu, Lei/AAM-2739-2021; Jeong, Kwanho/AAQ-4929-2020	Liu, Lei/0000-0002-3710-7042; Waters, Daniel/0000-0002-8622-3162; Pantoja, Omar/0000-0002-6538-9059; Rose, Terry/0000-0001-5386-6818; Wissuwa, Matthias/0000-0003-3505-9398	Global Rice Science Partnership (GRiSP) New Frontiers Research Project; Biotechnology and Biological Sciences Research Council [BBS/E/C/000I0220] Funding Source: researchfish; BBSRC [BBS/E/C/000I0220] Funding Source: UKRI	Global Rice Science Partnership (GRiSP) New Frontiers Research Project; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research work was supported by funding from the Global Rice Science Partnership (GRiSP) New Frontiers Research Project.	BENNETT J, 1983, BIOCHEM J, V212, P1; BIELESKI RL, 1968, PLANT PHYSIOL, V43, P1297, DOI 10.1104/pp.43.8.1297; Childers DL, 2011, BIOSCIENCE, V61, P117, DOI 10.1525/bio.2011.61.2.6; DUFF SMG, 1994, PHYSIOL PLANTARUM, V90, P791, DOI 10.1111/j.1399-3054.1994.tb02539.x; GEIGER DR, 1994, ANNU REV PLANT PHYS, V45, P235, DOI 10.1146/annurev.pp.45.060194.001315; GRABAU LJ, 1986, PLANT PHYSIOL, V82, P1008, DOI 10.1104/pp.82.4.1008; Gregersen PL, 2008, PLANT BIOLOGY, V10, P37, DOI 10.1111/j.1438-8677.2008.00114.x; Hidaka A, 2013, ECOL EVOL, V3, P4872, DOI 10.1002/ece3.861; Jeong K, 2017, PLANT BIOTECHNOL J, V15, P15, DOI 10.1111/pbi.12586; Julia C, 2016, ANN BOT-LONDON, V118, P1151, DOI 10.1093/aob/mcw164; Kong LG, 2015, PLANTA, V241, P789, DOI 10.1007/s00425-015-2260-1; Kong XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069847; Lambers H, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2015.109, 10.1038/NPLANTS.2015.109]; Lambers H, 2012, NEW PHYTOL, V196, P1098, DOI 10.1111/j.1469-8137.2012.04285.x; Lee YS, 2015, J PLANT BIOL, V58, P353, DOI 10.1007/s12374-015-0425-x; Levy YY, 1998, PLANT CELL, V10, P1973, DOI 10.1105/tpc.10.12.1973; Li YueNa, 2010, Agricultural Science & Technology - Hunan, V11, P11; Mimura T, 1996, PLANT CELL ENVIRON, V19, P311, DOI 10.1111/j.1365-3040.1996.tb00253.x; MONDAL WA, 1985, PHYSIOL PLANTARUM, V65, P221, DOI 10.1111/j.1399-3054.1985.tb02386.x; OGAWA M, 1979, PLANT CELL PHYSIOL, V20, P19; Plaxton WC, 2011, PLANT PHYSIOL, V156, P1006, DOI 10.1104/pp.111.175281; R Core Team, 2013, R LANG ENV STAT COMP; Reich PB, 2009, OECOLOGIA, V160, P207, DOI 10.1007/s00442-009-1291-3; Rose TJ, 2008, EUR J AGRON, V28, P371, DOI 10.1016/j.eja.2007.11.003; Rose TJ, 2010, FIELD CROP RES, V119, P154, DOI 10.1016/j.fcr.2010.07.004; Stigter Kyla A., 2015, Plants-Basel, V4, P773, DOI 10.3390/plants4040773; Veneklaas EJ, 2012, NEW PHYTOL, V195, P306, DOI 10.1111/j.1469-8137.2012.04190.x; VSN International, 2014, GENSTAT WIND HEM HEM; Wang FM, 2016, J EXP BOT, V67, P1221, DOI 10.1093/jxb/erv517; Xu SB, 2008, PLANT PHYSIOL, V148, P908, DOI 10.1104/pp.108.125633; Yang JC, 2001, FIELD CROP RES, V71, P47, DOI 10.1016/S0378-4290(01)00147-2; YOSHIDA S, 1976, LAB MANUAL PHYSL STU, P1; Yu HT, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00707	33	23	25	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187521	10.1371/journal.pone.0187521	http://dx.doi.org/10.1371/journal.pone.0187521			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095945	Green Published, gold, Green Submitted			2022-12-26	WOS:000414340200109
J	Li, XD; Wan, JF; Zhang, S; Lin, P; Zhang, YS; Yang, GH; Wang, MK; Duan, WS; Sun, JA; Yang, L				Li, Xiaodong; Wan, Jiangfeng; Zhang, Sheng; Lin, Ping; Zhang, Yanshi; Yang, Guanghui; Wang, Mengke; Duan, Wenshan; Sun, Jian'an; Yang, Lei			Preliminary research on flow rate and free surface of the accelerator driven subcritical system gravity-driven dense granular-flow target	PLOS ONE			English	Article							SPALLATION TARGET; DISCHARGE RATE; HOPPER FLOWS; ORIFICE; SIMULATION; DESIGN; SILO	A spallation target is one of the three core parts of the accelerator driven subcritical system (ADS), which has already been investigated for decades. Recently, a gravity-driven Dense Granular-flow Target (DGT) is proposed, which consists of a cylindrical hopper and an internal coaxial cylindrical beam pipe. The research on the flow rate and free surface are important for the design of the target whether in Heavy Liquid Metal (HLM) targets or the DGT. In this paper, the relations of flow rate and the geometry of the DGT are investigated. Simulations based on the discrete element method (DEM) implementing on Graphics Processing Units (GPUs) and experiments are both performed. It is found that the existence of an internal pipe doesn't influence the flow rate when the distance from the bottom of the pipe to orifice is large enough even in a larger system. Meanwhile, snapshots of the free surface formed just below the beam pipe are given. It is observed that the free surface is stable over time. The entire research is meaningful for the design of DGT.	[Li, Xiaodong; Duan, Wenshan; Sun, Jian'an] NWNU, Coll Phys & Elect Engn, Lanzhou, Gansu, Peoples R China; [Li, Xiaodong; Duan, Wenshan; Sun, Jian'an] NWNU, Joint Lab Atom & Mol Phys, Lanzhou, Gansu, Peoples R China; [Li, Xiaodong; Wan, Jiangfeng; Zhang, Sheng; Lin, Ping; Zhang, Yanshi; Yang, Guanghui; Wang, Mengke; Yang, Lei] Chinese Acad Sci, Inst Modern Phys, Lanzhou, Gansu, Peoples R China; [Wan, Jiangfeng; Yang, Guanghui; Wang, Mengke] Univ Chinese Acad Sci, Sch Phys Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Modern Physics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, L (corresponding author), Chinese Acad Sci, Inst Modern Phys, Lanzhou, Gansu, Peoples R China.	lyang@impcas.ac.cn	林, ping/AGE-1236-2022	wan, Jiangfeng/0000-0002-9632-9139; Lin, Ping/0000-0002-3317-5793	National Magnetic Confinement Fusion Science Program of China [2014GB104002]; National Natural Science Foundation of P.R. China [11647313]	National Magnetic Confinement Fusion Science Program of China; National Natural Science Foundation of P.R. China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Magnetic Confinement Fusion Science Program of China [grant number 2014GB104002; url:http://www.most.gov.cn] and National Natural Science Foundation of P.R. China [grant number 11647313; url:http://wmv.nsfc.gov.cn]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by the National Magnetic Confinement Fusion Science Program of China [grant number 2014GB104002] to Lei Yang and National Natural Science Foundation of P.R. China [grant number 11647313] to Wenshan Duan.	Ahn HJ, 2008, POWDER TECHNOL, V186, P65, DOI 10.1016/j.powtec.2007.11.001; Balevicius R, 2011, POWDER TECHNOL, V214, P322, DOI 10.1016/j.powtec.2011.08.042; Batta A, 2015, NUCL ENG DES, V290, P107, DOI 10.1016/j.nucengdes.2014.11.009; Batta A, 2009, HYDRAULIC ANAL HEAVY; Batta A, 2009, HELIMERT 2009, P115; Batta A., 2008, P 2008 INT C ADV NUC; Bauer GS, 2010, J NUCL MATER, V398, P19, DOI 10.1016/j.jnucmat.2009.10.005; BEVERLOO WA, 1961, CHEM ENG SCI, V15, P260, DOI 10.1016/0009-2509(61)85030-6; BOWMAN CD, 1992, NUCL INSTRUM METH A, V320, P336, DOI 10.1016/0168-9002(92)90795-6; Carminati F, 1993, ENERGY AMPLIFIER CLE; Class AG, 2014, J NUCL MATER, V450, P204, DOI 10.1016/j.jnucmat.2013.09.005; Class AG, 2011, J NUCL MATER, V415, P378, DOI 10.1016/j.jnucmat.2011.04.050; Dierckx M., 2009, TARGET AREA DESIGN O; Furukawa K., 1985, JAP US SEM THOR FUEL, P271; Guertin A, 2010, 1 INT WORKSH TECHN C; Jeanmart H, 2011, J NUCL MATER, V415, P385, DOI 10.1016/j.jnucmat.2011.04.046; Lin P, 2015, PHYSICA A, V417, P29, DOI 10.1016/j.physa.2014.09.032; Litfin K, 2015, J RADIOANAL NUCL CH, V305, P795, DOI 10.1007/s10967-015-4002-z; Mankoc C, 2007, GRANUL MATTER, V9, P407, DOI 10.1007/s10035-007-0062-2; NEDDERMAN RM, 1982, CHEM ENG SCI, V37, P1597, DOI 10.1016/0009-2509(82)80029-8; Nedderman RM, 2005, STATICS KINEMATICS G; Nifenecker H, 2001, NUCL INSTRUM METH A, V463, P428, DOI 10.1016/S0168-9002(01)00160-7; Profir M, LEADING CFD MODELS I; Riemer B, 2016, SPALLATION TARGET DE, P273; Su GY, 2012, ANN NUCL ENERGY, V43, P142, DOI 10.1016/j.anucene.2012.01.010; Tian Y, 2013, AW SCI TECHN UB MED; Tian Y, 2017, COMPUT CHEM ENG, V104, P231, DOI 10.1016/j.compchemeng.2017.04.019; Unac RO, 2012, POWDER TECHNOL, V225, P214, DOI 10.1016/j.powtec.2012.04.013; Wan J. -F., 2016, J NUCL SCI TECHNOL, P1; Yang L, 2015, SCI CHINA TECHNOL SC, V58, P1705, DOI 10.1007/s11431-015-5894-0; Zatloukal Z, 2012, PARTICUL SCI TECHNOL, V30, P316, DOI 10.1080/02726351.2011.573839; Zhang S, 2014, GRANUL MATTER, V16, P857, DOI 10.1007/s10035-014-0533-1; Zhu HP, 2008, CHEM ENG SCI, V63, P5728, DOI 10.1016/j.ces.2008.08.006; Zuriguel I, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.030301	34	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187435	10.1371/journal.pone.0187435	http://dx.doi.org/10.1371/journal.pone.0187435			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095910	Green Published, Green Submitted, gold			2022-12-26	WOS:000414340200090
J	Lopes, VG; Branco, CWC; Kozlowsky-Suzuki, B; Sousa, IF; Souza, LCE; Bini, LM				Lopes, Vanessa Guimaraes; Castelo Branco, Christina W.; Kozlowsky-Suzuki, Betina; Sousa-Filho, Izidro F.; e Souza, Leonardo Coimbra; Bini, Luis Mauricio			Predicting temporal variation in zooplankton beta diversity is challenging	PLOS ONE			English	Article							ENVIRONMENTAL HETEROGENEITY; BIOTIC HOMOGENIZATION; BIODIVERSITY; COMMUNITIES; TURNOVER; SIMILARITY; HABITAT; CLIMATE; IMPACT; INFORM	Beta diversity, the spatial variation in species composition, has been related to different explanatory variables, including environmental heterogeneity, productivity and connectivity. Using a long-term time series of zooplankton data collected over 62 months in a tropical reservoir (Ribeirao das Lajes Reservoir, Rio de Janeiro State, Brazil), we tested whether beta diversity (as measured across six sites distributed along the main axis of the reservoir) was correlated with environmental heterogeneity (spatial environmental variation in a given month), chlorophyll-a concentration (a surrogate for productivity) and water level. We did not found evidence for the role of these predictors, suggesting the need to reevaluate predictions or at least to search for better surrogates of the processes that hypothetically control beta diversity variation. However, beta diversity declined over time, which is consistent with the process of biotic homogenization, a worldwide cause of concern.	[Lopes, Vanessa Guimaraes; Bini, Luis Mauricio] Univ Fed Goias, Dept Ecol, Goias, Brazil; [Castelo Branco, Christina W.; e Souza, Leonardo Coimbra] Univ Fed Estado Rio de Janeiro, Dept Zool, Rio De Janeiro, Brazil; [Kozlowsky-Suzuki, Betina] Univ Fed Estado Rio de Janeiro, Dept Ecol & Recursos Marinhos, Rio De Janeiro, Brazil; [Sousa-Filho, Izidro F.] Univ Fed Rio de Janeiro, Lab Radioisotopos Eduardo Penna Franca IBCCF CCS, Rio De Janeiro, Brazil	Universidade Federal de Goias; Universidade Federal do Estado do Rio de Janeiro; Universidade Federal do Estado do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Lopes, VG (corresponding author), Univ Fed Goias, Dept Ecol, Goias, Brazil.	vglopes@gmail.com	Bini, Luis Mauricio/D-5865-2013	Bini, Luis Mauricio/0000-0003-3398-9399; Sousa-Filho, Izidro/0000-0001-9210-0399; Castelo Branco, Christina W/0000-0002-0509-171X	Light Energia CORP. (Projects of research and development-Light/ANEEL/UNIRIO); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); MCTIC/CNpq [465610/2014-5]; FAPEG; CNPq Productivity Grants	Light Energia CORP. (Projects of research and development-Light/ANEEL/UNIRIO); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); MCTIC/CNpq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEG(Fundacao de Amparo a Pesquisa do Estado do Goias (FAPEG)); CNPq Productivity Grants	The authors received logistic and financial support for this work from Light Energia CORP. (Projects of research and development-Light/ANEEL/UNIRIO), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). This work was also developed in the context of National Institutes for Science and Technology (INCT) in Ecology, Evolution and Biodiversity Conservation, supported by MCTIC/CNpq(proc. 465610/2014-5) and FAPEG". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors wish to thank Light Energia CORP. for logistic support in carrying out this study (Projects of research and development?Light/ANEEL/UNIRIO). We are also thankful to anonymous reviewers for excellent comments that improved this paper. This work was developed in the context of National Institutes for Science and Technology (INCT) in Ecology, Evolution and Biodiversity Conservation, supported by MCTIC/CNpq (proc. 465610/2014-5) and FAPEG. Research by LMB has been continuously supported by CNPq Productivity Grants.	Adamczuk M, 2015, ENVIRON EARTH SCI, V73, P8189, DOI 10.1007/s12665-014-3977-z; Akasaka M, 2012, ECOLOGY, V93, P967, DOI 10.1890/11-0879.1; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; APHA, 2005, STAND METH EX WAT WA, V20th; Astorga A, 2014, ECOL EVOL, V4, P2693, DOI 10.1002/ece3.1124; Baselga A, 2007, BIOLOGY LETT, V3, P642, DOI 10.1098/rsbl.2007.0449; Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Bini LM, 2014, ECOLOGY, V95, P1569, DOI 10.1890/13-0656.1; Bledzki L.A., 2016, FRESHWATER CRUSTACEA, DOI [DOI 10.1007/978-3-319-29871-9, 10.1007/978-3-319-29871-9]; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Boyer JN, 2009, ECOL INDIC, V9, pS56, DOI 10.1016/j.ecolind.2008.11.013; Bozelli RL, 2015, HYDROBIOLOGIA, V753, P233, DOI 10.1007/s10750-015-2209-1; Branco Christina W. C., 2009, Lakes & Reservoirs Research and Management, V14, P175, DOI 10.1111/j.1440-1770.2009.00403.x; Buckley LB, 2008, P NATL ACAD SCI USA, V105, P17836, DOI 10.1073/pnas.0803524105; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; Chase JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00117.1; Chase JM, 2011, PHILOS T R SOC B, V366, P2351, DOI 10.1098/rstb.2011.0063; Chase JM, 2010, SCIENCE, V328, P1388, DOI 10.1126/science.1187820; Chick JH, 2010, LIMNOL OCEANOGR-METH, V8, P79, DOI 10.4319/lom.2010.8.0079; Cottenie K, 2003, ECOLOGY, V84, P991, DOI 10.1890/0012-9658(2003)084[0991:ZMSRVL]2.0.CO;2; Declerck SAJ, 2011, ECOGRAPHY, V34, P296, DOI 10.1111/j.1600-0587.2010.06462.x; Deflandre G., 1928, ARCHIV PROTISTENKUND, V64, P152; Deflandre G, 1929, ARCH PROTISTENKD, V67, P323; Dornelas M, 2014, SCIENCE, V344, P296, DOI 10.1126/science.1248484; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Ellis LE, 2013, ENVIRON REV, V21, P136, DOI 10.1139/er-2012-0064; Elmoor-Loureiro L. M. A., 1997, MANUAL IDENTIFICACAO; Forbes AE, 2002, OIKOS, V96, P433, DOI 10.1034/j.1600-0706.2002.960305.x; Ford DE, 1990, RESERVOIR LIMNOLOGY; Gianuca AT, 2017, ECOGRAPHY COP, P1; Ginders MA, 2016, RIVER RES APPL, V32, P1675, DOI 10.1002/rra.3008; Guarino AWS., 2005, ACTA LIMNOL BRAS, V17, P129; Heino J, 2015, ECOL EVOL, V5, P1235, DOI 10.1002/ece3.1439; Heino J, 2015, FRESHWATER BIOL, V60, P223, DOI 10.1111/fwb.12502; Heino J, 2013, FRESHW SCI, V32, P142, DOI 10.1899/12-083.1; Jyrkankallio-Mikkola J, 2016, FRESHWATER BIOL, V61, P239, DOI 10.1111/fwb.12697; Kimmel B.L., 1990, RESERVOIR LIMNOLOGY, P133; Koste W., 1978, RADERTIERE MITTLEURO; Langenheder S, 2012, ISME J, V6, P1107, DOI 10.1038/ismej.2011.177; Legendre P, 2013, ECOL LETT, V16, P951, DOI 10.1111/ele.12141; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lomolino MV, 2004, FRONTIERS OF BIOGEOGRAPHY: NEW DIRECTIONS IN THE GEOGRAPHY OF NATURE, P1; Lopes PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109581; Magurran AE, 2010, PHILOS T R SOC B, V365, P3611, DOI 10.1098/rstb.2010.0285; Marzolf G.R., 1990, P195; McGarvey DJ, 2014, FRESHW SCI, V33, P18, DOI 10.1086/674967; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; McKnight MW, 2007, PLOS BIOL, V5, P2424, DOI 10.1371/journal.pbio.0050272; Mello Nelson Azevedo S.T., 2011, Oecologia Australis, V15, P559; Nogrady T, 1995, RIOTIFERA, V3, P1; NOGRADY T, 2002, GUIDES IDENTIFICATIO; Nusch E., 1975, GAS WASSERFACH WASSE, V116; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Olden JD, 2006, GLOBAL ECOL BIOGEOGR, V15, P113, DOI 10.1111/j.1466-822x.2006.00214.x; Olden JD, 2004, ECOLOGY, V85, P1867, DOI 10.1890/03-3131; Olden JD, 2003, AM NAT, V162, P442, DOI 10.1086/378212; Passy SI, 2007, DIVERS DISTRIB, V13, P670, DOI 10.1111/j.1472-4642.2007.00361.x; Pennisi E, 2005, SCIENCE, V309, P90, DOI 10.1126/science.309.5731.90; Pinheiro J, 2020, R PACKAGE VERSION 31; Poff NL, 2010, FRESHWATER BIOL, V55, P147, DOI 10.1111/j.1365-2427.2009.02204.x; R Core Team, 2021, R LANGUAGE ENV STAT; Sartori LP, 2009, BRAZ J BIOL, V69, P1, DOI 10.1590/S1519-69842009000100002; Seda J, 2000, J PLANKTON RES, V22, P1829, DOI 10.1093/plankt/22.10.1829; Segers H., 1995, ROTIFERA LECANIDAE M; Siqueira T, 2015, HYDROBIOLOGIA, V750, P5, DOI 10.1007/s10750-014-2071-6; Soares CEA, 2015, NAT CONSERVACAO, V13, P74, DOI 10.1016/j.ncon.2015.04.002; Soares MCS, 2012, LIMNOLOGICA, V42, P197, DOI 10.1016/j.limno.2011.11.002; Soares Maria Carolina S., 2008, Lakes & Reservoirs Research and Management, V13, P257, DOI 10.1111/j.1440-1770.2008.00379.x; Socolar JB, 2016, TRENDS ECOL EVOL, V31, P67, DOI 10.1016/j.tree.2015.11.005; Thomaz SM, 2007, HYDROBIOLOGIA, V579, P1, DOI 10.1007/s10750-006-0285-y; Veech JA, 2007, GLOBAL ECOL BIOGEOGR, V16, P650, DOI 10.1111/j.1466-8238.2007.00315.x; VELHO L.F.M., 1996, STUDIES NEOTROPOICAL, V31, P174; Vellend M, 2014, OIKOS, V123, P1420, DOI 10.1111/oik.01493; Vucetich MC, 1973, REV MUS PLATA, VXI; Zorzal-Almeida S, HYDROBIOLOG IN PRESS; Zuur A, 2009, MIXED EFFECTS MODELS	80	13	15	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187499	10.1371/journal.pone.0187499	http://dx.doi.org/10.1371/journal.pone.0187499			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095892	gold, Green Submitted, Green Published			2022-12-26	WOS:000414340200104
J	Ribak, G; Barkan, S; Soroker, V				Ribak, Gal; Barkan, Shay; Soroker, Victoria			The aerodynamics of flight in an insect flight mill	PLOS ONE			English	Article							STALK-EYED FLIES; COLEOPTERA BUPRESTIDAE; LOCUST FLIGHT; PERFORMANCE; MANEUVERS; BIOLOGY; PHYSICS; LIFT	Predicting the dispersal of pest insects is important for pest management schemes. Flight mills provide a simple way to evaluate the flight potential of insects, but there are several complications in relating tethered-flight to natural flight. We used high-speed video to evaluate the effect of flight-mill design on flight of the red palm weevil (Rynchophorous ferruginneus) in four variants of a flight-mill. Two variants had the rotating radial arm pivoted on the main shaft of the rotation axis, allowing freedom to elevate the arm as the insect applied lift force. Two other variants had the pivot point fixed, restricting the radial arm to horizontal motion. Beetles were tethered with their lateral axis horizontal or rotated by 40, as in a banked turn. Flight-mill type did not affect flight speed or wing-beat frequency, but did affect flapping kinematics. The wingtip internal to the circular trajectory was always moved faster relative to air, suggesting that the beetles were attempting to steer in the opposite direction to the curved trajectory forced by the flight-mill. However, banked beetles had lower flapping asymmetry, generated higher lift forces and lost more of their body mass per time and distance flown during prolonged flight compared to beetles flying level. The results indicate, that flapping asymmetry and low lift can be rectified by tethering the beetle in a banked orientation, but the flight still does not correspond directly to free-flight. This should be recognized and taken into account when designing flight-mills and interoperating their data.	[Ribak, Gal] Tel Aviv Univ, Sch Zool, Fac Life Sci, Tel Aviv, Israel; [Ribak, Gal] Steinhardt Museum Nat Hist, Tel Aviv, Israel; [Ribak, Gal] Israel Natl Ctr Biodivers Studies, Tel Aviv, Israel; [Barkan, Shay; Soroker, Victoria] Agr Res Org, Dept Entomol, Volcani Ctr, Rishon Leziyyon, Israel	Tel Aviv University; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Ribak, G (corresponding author), Tel Aviv Univ, Sch Zool, Fac Life Sci, Tel Aviv, Israel.; Ribak, G (corresponding author), Steinhardt Museum Nat Hist, Tel Aviv, Israel.; Ribak, G (corresponding author), Israel Natl Ctr Biodivers Studies, Tel Aviv, Israel.	gribak@post.tau.ac.il	Soroker, Victoria/AAO-1632-2020	Ribak, Gal/0000-0002-6267-5471	ISRAEL SCIENCE FOUNDATION [1625/15, 849/15]	ISRAEL SCIENCE FOUNDATION(Israel Science Foundation)	This research was supported in part by THE ISRAEL SCIENCE FOUNDATION grant no. 1625/15 and 849/15 to GR.	Axenfeld D, 1911, B ACCAD MED ROMA, V37, P123; CHAMBERS DL, 1976, BEHAV RES METH INSTR, V8, P352, DOI 10.3758/BF03201790; CHANCE M A, 1971, Quaestiones Entomologicae, V7, P253; David G, 2014, J APPL ENTOMOL, V138, P566, DOI 10.1111/jen.12110; Dickson WB, 2004, J EXP BIOL, V207, P4269, DOI 10.1242/jeb.01266; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P1, DOI 10.1098/rstb.1984.0049; ELLINGTON CP, 1990, NATURE, V347, P472, DOI 10.1038/347472a0; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P17, DOI 10.1098/rstb.1984.0050; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P41, DOI 10.1098/rstb.1984.0051; ELLINGTON CP, 1984, PHILOS T ROY SOC B, V305, P145, DOI 10.1098/rstb.1984.0054; Fry SN, 2005, J EXP BIOL, V208, P2303, DOI 10.1242/jeb.01612; Fry SN, 2003, SCIENCE, V300, P495, DOI 10.1126/science.1081944; Hedrick TL, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/3/034001; HEINRICH B, 1971, J EXP BIOL, V54, P141; HEINRICH B, 1974, SCIENCE, V185, P747, DOI 10.1126/science.185.4153.747; Hocking B., 1953, T ROY ENT SOC LONDON, V104, P223; Hoddle MS, 2015, J ECON ENTOMOL, V108, P2599, DOI 10.1093/jee/tov240; JENSEN M, 1956, PHILOS T ROY SOC B, V239, P511, DOI 10.1098/rstb.1956.0009; KENNEDY J. S., 1948, Anti-Locust Bull.; KROGH A, 1952, J EXP BIOL, V29, P211; Lopez VM, 2014, J ECON ENTOMOL, V107, P1127, DOI 10.1603/EC13525; Maes S, 2014, BIOCONTROL, V59, P415, DOI 10.1007/s10526-014-9576-9; Miller TA., 2012, INSECT NEUROPHYSIOLO; RAYNER JMV, 1985, J EXP BIOL, V118, P247; Ribak G, 2007, J COMP PHYSIOL A, V193, P1065, DOI 10.1007/s00359-007-0259-1; Ribak G, 2009, BIOL J LINN SOC, V98, P860, DOI 10.1111/j.1095-8312.2009.01326.x; Riley JR, 1997, ENTOMOL EXP APPL, V83, P317, DOI 10.1023/A:1003034517752; Sane SP, 2003, J EXP BIOL, V206, P4191, DOI 10.1242/jeb.00663; Schumacher P, 1997, PHYSIOL ENTOMOL, V22, P149, DOI 10.1111/j.1365-3032.1997.tb01152.x; Taylor RAJ, 2010, J INSECT BEHAV, V23, P128, DOI 10.1007/s10905-010-9202-3; Tsunoda T, 2008, APPL ENTOMOL ZOOL, V43, P451, DOI 10.1303/aez.2008.451; valos J.A., 2014, B ENTOMOL RES, V104, P462; Walker SM, 2009, J R SOC INTERFACE, V6, P735, DOI 10.1098/rsif.2008.0435; Weihs D, 1979, H7917 SW FISH CTR AD; WEISFOGH T, 1964, J EXP BIOL, V41, P257	35	25	25	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0186441	10.1371/journal.pone.0186441	http://dx.doi.org/10.1371/journal.pone.0186441			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091924	Green Submitted, Green Published, gold			2022-12-26	WOS:000414229700018
J	Levin, E; Ballester, AR; Raphael, G; Feigenberg, O; Liu, YS; Norelli, J; Gonzalez-Candelas, L; Mao, J; Dardick, C; Wisniewski, M; Droby, S				Levin, Elena; Rosa Ballester, Ana; Raphael, Ginat; Feigenberg, Oleg; Liu, Yongsheng; Norelli, John; Gonzalez-Candelas, Luis; Mao, Jing; Dardick, Christopher; Wisniewski, Michael; Droby, Samir			Identification and characterization of LysM effectors in Penicillium expansum	PLOS ONE			English	Article							CHITIN-TRIGGERED IMMUNITY; MAGNAPORTHE-ORYZAE; PROTEINS; VIRULENCE; GENE; SEQUENCE; BINDING; PLANTS; TRANSCRIPTOME; SUPPRESSION	P. expansum is regarded as one of the most important postharvest rots of apple fruit and is also of great concern to fruit processing industries. Elucidating the pathogenicity mechanism of this pathogen is of utmost importance for the development of effective and safe management strategies. Although, many studies on modification of the host environment by the pathogen were done, its interactions with fruit during the early stages of infection and the virulence factors that mediate pathogenicity have not been fully defined. Effectors carrying LysM domain have been identified in numerous pathogenic fungi and their role in the first stages of infection has been established. In this study, we identified 18 LysM genes in the P. expansum genome. Amino acid sequence analysis indicated that P. expansum LysM proteins belong to a clade of fungal-specific LysM. Eleven of the discovered LysM genes were found to have secretory pathway signal peptide, among them, 4 (PeLysM1 PeLysM2, PeLysM3 and PeLysM4) were found to be highly expressed during the infection and development of decay of apple fruit. Effect of targeted deletion of the four putative PeLysM effectors on the growth and pathogenicity was studied. Possible interactions of PeLysM with host proteins was investigated using the yeast-two-hybrid system.	[Levin, Elena; Raphael, Ginat; Feigenberg, Oleg; Droby, Samir] ARO, Dept Postharvest Sci, Volcani Ctr, Bet Dagan, Israel; [Rosa Ballester, Ana; Gonzalez-Candelas, Luis] CSIC, IATA, Avda Agustin Escardino, Valencia, Spain; [Liu, Yongsheng] Hefei Univ Technol, Sch Biotechnol & Food Engn, Hefei, Peoples R China; [Norelli, John; Mao, Jing; Dardick, Christopher; Wisniewski, Michael] USDA ARS, Appalachian Fruit Res Stn, 45 Wiltshire Rd, Kearneysville, WV 25430 USA	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); Hefei University of Technology; United States Department of Agriculture (USDA)	Droby, S (corresponding author), ARO, Dept Postharvest Sci, Volcani Ctr, Bet Dagan, Israel.	samird@volcani.agri.gov.il	Ballester, Ana-Rosa/D-9677-2011; Gonzalez-Candelas, Luis/B-7998-2008	Ballester, Ana-Rosa/0000-0002-7688-7838; Gonzalez-Candelas, Luis/0000-0002-2579-6880; Levin, Elena/0000-0001-6398-9651; Wisniewski, Michael/0000-0002-7481-5590	Israel Binational Agricultural Research and Development Fund (BARD) [US-4774-14C]; Israel Science Foundation (ISF); National Natural Science Foundation of China (NSFC) [1936/14]	Israel Binational Agricultural Research and Development Fund (BARD)(US-Israel Binational Science Foundation); Israel Science Foundation (ISF)(Israel Science Foundation); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	Israel Binational Agricultural Research and Development Fund (BARD), US-4774-14C, Prof. Samir Droby and Dr. Michael Wisniewski; Israel Science Foundation (ISF) and National Natural Science Foundation of China (NSFC), 1936/14, Prof. Samir Droby and Prof. Yongsheng Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcapinar GB, 2015, CURR GENET, V61, P103, DOI 10.1007/s00294-014-0471-9; Akimitsu K, 2004, PHYSIOL MOL PLANT P, V65, P271, DOI 10.1016/j.pmpp.2005.03.001; Ballester AR, 2015, MOL PLANT MICROBE IN, V28, P232, DOI 10.1094/MPMI-09-14-0261-FI; Beck J, 1990, EUROPEAN J BIOCH; Berry MD, 2000, J NEUROSCI RES, V60, P150, DOI 10.1002/(SICI)1097-4547(20000415)60:2<150::AID-JNR3>3.0.CO;2-4; Bolton MD, 2008, MOL MICROBIOL, V69, P119, DOI 10.1111/j.1365-2958.2008.06270.x; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Buron-Moles G, 2012, INT J FOOD MICROBIOL, V160, P162, DOI 10.1016/j.ijfoodmicro.2012.10.005; CAPPELLINI RA, 1987, PLANT DIS, V71, P852; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Coletta A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-43; Constabel C. Peter, 2008, P253, DOI 10.1007/978-1-4020-8182-8_12; Crespo-Sempere A, 2013, FOOD RES INT, V54, P697, DOI 10.1016/j.foodres.2013.08.008; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; de Jonge R, 2009, TRENDS MICROBIOL, V17, P151, DOI 10.1016/j.tim.2009.01.002; de Wit PJGM, 2009, MOL PLANT PATHOL, V10, P735, DOI 10.1111/j.1364-3703.2009.00591.x; Deak M, 1999, NAT BIOTECHNOL, V17, P192, DOI 10.1038/6198; DeCristofaro MF, 2001, J CELL PHYSIOL, V186, P136; DEMONT N, 1993, J BIOL CHEM, V268, P20134; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; Doong H, CANC LETT S, V1; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Farrow SC, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00524; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Frandsen RJN, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-70; Friesen TL, 2008, CELL MICROBIOL, V10, P1421, DOI 10.1111/j.1462-5822.2008.01153.x; Frith MC, 2008, PLOS COMPUTATIONAL B; GARVEY KJ, 1986, NUCLEIC ACIDS RES, V14, P10001, DOI 10.1093/nar/14.24.10001; Grudkowska M, 2004, ACTA BIOCHIM POL, V51, P609; Jain S., 2015, ADV PLANTS AGR RES, V2, DOI DOI 10.15406/APAR.2015.02.00077; Jurick II WM, 2011, PLANT BREEDING; Kombrink A, 2017, MOL PLANT PATHOL, V18, P596, DOI 10.1111/mpp.12520; Kombrink A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003769; Kruger J, 2002, SCIENCE, V296, P744, DOI 10.1126/science.1069288; Leatherwood J, 1998, CURR OPIN CELL BIOL, V10, P742, DOI 10.1016/S0955-0674(98)80117-8; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Limpens E, 2003, SCIENCE, V302, P630, DOI 10.1126/science.1090074; Liu ZH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000581; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; Marshall R, 2011, PLANT PHYSIOL, V156, P756, DOI 10.1104/pp.111.176347; Mayer AM, 2006, PHYTOCHEMISTRY, V67, P2318, DOI 10.1016/j.phytochem.2006.08.006; McCallum JL, 2002, J FOOD PROTECT, V65, P1937, DOI 10.4315/0362-028X-65.12.1937; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Mentlak TA, 2012, PLANT CELL, V24, P322, DOI 10.1105/tpc.111.092957; Mitchell A, 2015, NUCL ACIDS RES; Mosquera G, 2009, PLANT CELL, V21, P1273, DOI 10.1105/tpc.107.055228; Mukamolova GV, 2006, MOL MICROBIOL, V59, P84, DOI 10.1111/j.1365-2958.2005.04930.x; Mukamolova GV, 2002, MOL MICROBIOL, V46, P611, DOI 10.1046/j.1365-2958.2002.03183.x; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oliver RP, 2004, TRENDS PLANT SCI, V9, P472, DOI 10.1016/j.tplants.2004.08.006; PELSER PDT, 1977, PHYTOPATHOLOGY, V67, P747; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PIERSON CH, 1971, AGR HDB, V376; Potrykus J, 2013, PLOS PATHOG, V9, P10, DOI DOI 10.1371/J0URNAL.PPAT.1003676; Prusky D, 2003, MOL PLANT PATHOL, V4, P509, DOI [10.1046/j.1364-3703.2003.00196.x, 10.1046/J.1364-3703.2003.00196.X]; Prusky D, 2001, MOL PLANT MICROBE IN, V14, P1105, DOI 10.1094/MPMI.2001.14.9.1105; Prusky DB, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01306; Ravagnani A, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-39; Richau KH, 2012, PLANT PHYSIOL, V158, P1583, DOI 10.1104/pp.112.194001; Sanzani SM, 2009, EUR J PLANT PATHOL, V125, P223, DOI 10.1007/s10658-009-9475-6; Seidl-Seiboth V, 2013, FEBS J, V280, P1226, DOI 10.1111/febs.12113; Sperschneider J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004806; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; Takahara H, 2016, NEW PHYTOL, V211, P1323, DOI 10.1111/nph.13994; van der Hoorn RAL, 2004, CURR OPIN PLANT BIOL, V7, P400, DOI 10.1016/j.pbi.2004.04.003; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; van Pijkeren JP, 2006, APPL ENVIRON MICROB, V72, P4143, DOI 10.1128/AEM.03023-05; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Werck-Reichhart D, 2000, GENOME BIOL, V6, P1, DOI [10.1186/GB-2000-1-6-REVIEWS3003, DOI 10.1186/GB-2000-1-6-REVIEWS3003]; Wolpert TJ, 2002, ANNU REV PHYTOPATHOL, V40, P251, DOI 10.1146/annurev.phyto.40.011402.114210; Wouters M.F.A., 1996, WHO FOOD ADDIT SER, V35, P377	74	18	19	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0186023	10.1371/journal.pone.0186023	http://dx.doi.org/10.1371/journal.pone.0186023			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084256	Green Submitted, gold, Green Published			2022-12-26	WOS:000413910200004
J	Kugler, R; Mietens, A; Seidensticker, M; Tasch, S; Wagenlehner, FM; Kaschtanow, A; Tjahjono, Y; Tomczyk, CU; Beyer, D; Risbridger, GP; Exintaris, B; Ellem, SJ; Middendorff, R				Kuegler, Robert; Mietens, Andrea; Seidensticker, Mathias; Tasch, Sabine; Wagenlehner, Florian M.; Kaschtanow, Andre; Tjahjono, Yudy; Tomczyk, Claudia U.; Beyer, Daniela; Risbridger, Gail P.; Exintaris, Betty; Ellem, Stuart J.; Middendorff, Ralf			Novel imaging of the prostate reveals spontaneous gland contraction and excretory duct quiescence together with different drug effects	FASEB JOURNAL			English	Article						contractility; time-lapse imaging; 3D imaging; PDE5 inhibitors	URINARY-TRACT SYMPTOMS; PHOSPHODIESTERASE 5 INHIBITORS; REGIONAL-VARIATION; TISSUE; METAANALYSIS; ANTAGONISTS; SILODOSIN; SECONDARY; BLADDER; SYSTEM	Prostate carcinoma and benign prostate hyperplasia (BPH) with associated lower urinary tract symptoms (LUTS) are among the most prevalent and clinically relevant diseases in men. BPH is characterized by an enlargement of prostate tissue associated with increased tone of smooth muscle cells (SMCs) which surround the single glands composing the prostate. Secretions of the glands leave the prostate through local excretory ducts during the emission phase of ejaculation. Pharmacological treatment of BPH suggests different local drug targets based on reduction of prostate smooth muscle tone as the main effect and disturbed ejaculation as a common side effect. This highlights the need for detailed investigation of single prostate glands and ducts. We combined structural and functional imaging techniques-notably, clear lipid-exchanged, acrylamide-hybridized rigid imaging/immunostaining/in situ hybridization-compatible tissue-hydrogel (CLARITY) and time-lapse imaging- and defined glands and ducts as distinct SMC compartments in human and rat prostate tissue. The single glands of the prostate (comprising the secretory part) are characterized by spontaneous contractions mediated by the surrounding SMCs, whereas the ducts (excretory part) are quiescent. In both SMC compartments, phosphodiesterase (PDE)-5 is expressed. PDE5 inhibitors have recently emerged as alternative treatment options for BPH. We directly visualized that the PDE5 inhibitors sildenafil and tadalafil act by reducing spontaneous contractility of the glands, thereby reducing the muscle tone of the organ. In contrast, the ductal (excretory) system and thus the prostate's contribution to ejaculation is unaffected by PDE5 inhibitors. Our differentiated imaging approach reveals new details about prostate function and local drug actions and thus may support clinical management of BPH.	[Kuegler, Robert; Mietens, Andrea; Seidensticker, Mathias; Tasch, Sabine; Kaschtanow, Andre; Tjahjono, Yudy; Tomczyk, Claudia U.; Beyer, Daniela; Middendorff, Ralf] Justus Liebig Univ Giessen, Inst Anat & Cell Biol, Aulweg 123, D-35392 Giessen, Germany; [Wagenlehner, Florian M.] Justus Liebig Univ Giessen, Dept Urol Pediat Urol & Androl, Giessen, Germany; [Risbridger, Gail P.; Ellem, Stuart J.] Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic, Australia; [Exintaris, Betty] Monash Inst Pharmaceut Sci, Drug Discovery Biol, Melbourne, Vic, Australia	Justus Liebig University Giessen; Justus Liebig University Giessen; Monash University	Middendorff, R (corresponding author), Justus Liebig Univ Giessen, Inst Anat & Cell Biol, Aulweg 123, D-35392 Giessen, Germany.	ralf.middendorff@anatomie.med.uni-giessen.de	Risbridger, Gail P/B-8655-2008; Exintaris, Betty/ABB-8055-2021	Risbridger, Gail P/0000-0003-3089-4028; Tjahjono, Yudy/0000-0003-0187-0270; Exintaris, Betty/0000-0002-3260-2175	Deutsche Forschungsgemeinschaft [GRK 1871]; Monash University, Australia	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Monash University, Australia(Monash University)	The authors thank Dr. Laurinda Jaffe (University of Connecticut Health Center, Farmington, CT), for providing us with anti-PDE5 antibodies; Dr. Dieter Muller (Justus-Liebig-University Giessen, Germany), for helpful discussions; and Ingrid Schneider-Huther, Tania Bloch, and Kerstin Wilhelm (Justus-Liebig-University), for excellent technical assistance. Funding was provided by the Deutsche Forschungsgemeinschaft Grant GRK 1871 and funding from Monash University, Australia, to the International Research Training Group (IRTG), a collaboration between Justus-Liebig-University Giessen and Monash University. The authors declare no conflicts of interest.	Andersson KE, 2007, NAT CLIN PRACT UROL, V4, P368, DOI 10.1038/ncpuro0836; Angulo J, 2012, J SEX MED, V9, P2293, DOI 10.1111/j.1743-6109.2012.02821.x; AUA Practise Guidelines Committee, 2003, J UROLOGY, V170, P530, DOI 10.1097/01.ju.0000078083.38675.79; Bozkurt O, 2015, UROLOGY, V85, P1085, DOI 10.1016/j.urology.2015.01.011; Calmasini FB, 2016, UROLOGY, V94, P312, DOI 10.1016/j.urology.2016.04.023; Capogrosso P, 2015, ANDROLOGY-US, V3, P1076, DOI 10.1111/andr.12095; Chapple CR, 2004, BJU INT, V94, P738, DOI 10.1111/j.1464-410X.2004.05022.x; Chung K, 2013, NAT METHODS, V10, P508, DOI [10.1038/nmeth.2481, 10.1038/NMETH.2481]; Corbin JD, 1999, J BIOL CHEM, V274, P13729, DOI 10.1074/jbc.274.20.13729; Dey A, 2012, J UROLOGY, V187, P2254, DOI 10.1016/j.juro.2012.01.072; Donatucci CF, 2011, BJU INT, V107, P1110, DOI 10.1111/j.1464-410X.2010.09687.x; Gacci M, 2016, EUR UROL, V70, P124, DOI 10.1016/j.eururo.2015.12.048; Gacci M, 2012, EUR UROL, V61, P994, DOI 10.1016/j.eururo.2012.02.033; Hennenberg M, 2016, PROSTATE, V76, P1364, DOI 10.1002/pros.23208; ICHIHARA I, 1978, CELL TISSUE RES, V192, P381; Juilfs D M, 1999, Rev Physiol Biochem Pharmacol, V135, P67, DOI 10.1007/BFb0033670; Kaplan Steven A, 2009, Rev Urol, V11, pS14; LEE C, 1990, BIOL REPROD, V43, P1079, DOI 10.1095/biolreprod43.6.1079; McNeal J. E, 1983, PROSTATE GLAND MORPH; McVary KT, 2011, J UROLOGY, V185, P1793, DOI 10.1016/j.juro.2011.01.074; Mietens A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092603; Muller D, 2011, REPRODUCTION, V142, P333, DOI 10.1530/REP-10-0517; Nemeth JA, 1996, PROSTATE, V28, P124; Nguyen DTT, 2011, J UROLOGY, V185, P347, DOI 10.1016/j.juro.2010.09.036; Oelke M, 2013, EUR UROL, V64, P118, DOI 10.1016/j.eururo.2013.03.004; Plant TM, 2015, KNOBIL NEILLS PHYSL; Roehrborn CG, 2008, INT J IMPOT RES, V20, pS11, DOI 10.1038/ijir.2008.55; Rybalkin SD, 2002, J BIOL CHEM, V277, P3310, DOI 10.1074/jbc.M106562200; Saboor F, 2016, EUR RESPIR J, V47, P876, DOI 10.1183/13993003.00574-2015; Tatemichi S, 2012, UROLOGY, V80, DOI 10.1016/j.urology.2012.01.039; Uckert S, 2001, J UROLOGY, V166, P2484, DOI 10.1016/S0022-5347(05)65621-2; Uckert S, 2008, UROLOGY, V71, P526, DOI 10.1016/j.urology.2007.10.051; Wang L, 2015, UROLOGY, V85, DOI 10.1016/j.urology.2014.12.005; Wang X., 2014, J CHEM-NY, V2014, P9, DOI [DOI 10.1016/J.PLANTSCI.2014.10.009, 10.1155/2014/681364, DOI 10.1155/2014/681364]; Wang XH, 2015, ASIAN J ANDROL, V17, P1022, DOI 10.4103/1008-682X.154990; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017	36	5	5	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1130	1138		10.1096/fj.201700430R	http://dx.doi.org/10.1096/fj.201700430R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29089445				2022-12-26	WOS:000427246000003
J	Jee, PF; Tiong, V; Shu, MH; Khoo, JJ; Wong, WF; Rahim, RA; AbuBakar, S; Chang, LY				Jee, Pui-Fong; Tiong, Vunjia; Shu, Meng-Hool; Khoo, Jing-Jing; Wong, Won Fen; Rahim, Raha Abdul; AbuBakar, Sazaly; Chang, Li-Yen			Oral immunization of a non-recombinant Lactococcus lactis surface displaying influenza hemagglutinin 1 (HA1) induces mucosal immunity in mice	PLOS ONE			English	Article							CROSS-PROTECTION; IGA ANTIBODIES; ESCHERICHIA-COLI; SECRETORY IGA; A VIRUSES; SUBUNIT; VACCINE; INFECTION; RESPONSES; LIVE	Mucosal immunization of influenza vaccine is potentially an effective approach for the prevention and control of influenza. The objective of the present study was to evaluate the ability of oral immunization with a non-recombinant Lactococcus lactis displaying HA1/L/AcmA recombinant protein, LL-HA1/L/AcmA, to induce mucosal immune responses and to accord protection against influenza virus infection in mice. The LL-HA1/LIAcmA was orally administered into mice and the immune response was evaluated. Mice immunized with LL-HA1/L/AcmA developed detectable specific sIgA in faecal extract, small intestine wash, BAL fluid and nasal fluid. The results obtained demonstrated that oral immunization of mice with LL-HA1/L/AcmA elicited mucosal immunity in both the gastrointestinal tract and the respiratory tract. The protective efficacy of LL-HA1/L/AcmA in immunized mice against a lethal dose challenge with influenza virus was also assessed. Upon challenge, the non-immunized group of mice showed high susceptibility to influenza virus infection. In contrast, 7/8 of mice orally immunized with LL-HA1/L/AcmA survived. In conclusion, oral administration of LL-HA1/L/AcmA in mice induced mucosal immunity and most importantly, provided protection against lethal influenza virus challenge. These results highlight the potential application of L. lactis as a platform for delivery of influenza virus vaccine.	[Jee, Pui-Fong; Tiong, Vunjia; Shu, Meng-Hool; Wong, Won Fen; AbuBakar, Sazaly; Chang, Li-Yen] Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia; [Shu, Meng-Hool; Khoo, Jing-Jing; AbuBakar, Sazaly] Univ Malaya, TIDREC, Kuala Lumpur, Malaysia; [Rahim, Raha Abdul] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Cell & Mol Biol, Serdang, Selangor, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Putra Malaysia	Chang, LY (corresponding author), Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia.	changliyen@um.edu.my	Khoo, Jing Jing/G-6198-2013; Tiong, Vunjia/ABI-7994-2020; abubakar, sazaly/B-3957-2010; Wong, Won Fen/D-3087-2012; CHANG, LI-YEN/B-8353-2010	Khoo, Jing Jing/0000-0003-1285-6052; Tiong, Vunjia/0000-0003-3795-6332; abubakar, sazaly/0000-0002-9267-1420; Wong, Won Fen/0000-0003-1082-1956; 	Malaysian Institute of Pharmaceuticals and Nutraceuticals, Ministry of Science, Technology and Innovation [09-05-IFN-MEB-005]; University of Malaya-MOHE [E000013-20001]; University of Malaya [FL001-13HTM, PG056-2014B]	Malaysian Institute of Pharmaceuticals and Nutraceuticals, Ministry of Science, Technology and Innovation; University of Malaya-MOHE; University of Malaya(Universiti Malaya)	This work was funded in parts by Pharmaceutical & Nutraceutical R&D initiatives fund (09-05-IFN-MEB-005) from Malaysian Institute of Pharmaceuticals and Nutraceuticals, Ministry of Science, Technology and Innovation, the University of Malaya-MOHE High Impact Research Fund (E000013-20001), the University of Malaya Research Grant (FL001-13HTM) to Sazaly AbuBakar, and the University of Malaya Postgraduate Research Fund (PG056-2014B) to Pui-Fong Jee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed B, 2014, VACCINE, V32, P3909, DOI 10.1016/j.vaccine.2014.05.054; Arulanandam BP, 1999, J INFECT DIS, V180, P940, DOI 10.1086/314996; Asahi-Ozaki Y, 2004, J MED VIROL, V74, P328, DOI 10.1002/jmv.20173; Audouy SAL, 2007, VACCINE, V25, P2497, DOI 10.1016/j.vaccine.2006.09.026; Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; Buccato S, 2006, J INFECT DIS, V194, P331, DOI 10.1086/505433; Carter NJ, 2011, DRUGS, V71, P1591, DOI 10.2165/11206860-000000000-00000; Chopra A, 2010, J Ayurveda Integr Med, V1, P243, DOI 10.4103/0975-9476.74423; Cox MMJ, 2009, BIOLOGICALS, V37, P182, DOI 10.1016/j.biologicals.2009.02.014; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; CZERKINSKY C, 1991, INFECT IMMUN, V59, P996, DOI 10.1128/IAI.59.3.996-1001.1991; de Haan A, 2012, VACCINE, V30, P4884, DOI 10.1016/j.vaccine.2012.04.032; Gao SY, 2015, INT IMMUNOPHARMACOL, V24, P140, DOI 10.1016/j.intimp.2014.10.032; Haaheim LR, 2009, VIRUSES-BASEL, V1, P1089, DOI 10.3390/v1031089; Hauri AM, 2004, INT J STD AIDS, V15, P7, DOI 10.1258/095646204322637182; Jee PF, 2017, BIOTECHNOL PROGR, V33, P154, DOI 10.1002/btpr.2400; Joan SSX, 2016, BIOTECHNOL LETT, V38, P793, DOI 10.1007/s10529-016-2034-2; Kim Sae-Hae, 2012, Immune Netw, V12, P165, DOI 10.4110/in.2012.12.5.165; Kunkel EJ, 2003, NAT REV IMMUNOL, V3, P822, DOI 10.1038/nri1203; Lee MH, 2001, VACCINE, V19, P3927, DOI 10.1016/S0264-410X(01)00119-0; Lei H, 2015, ARCH VIROL, V160, P3011, DOI 10.1007/s00705-015-2587-8; Lei H, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0287-4; Lei H, 2015, VIROLOGY, V476, P189, DOI 10.1016/j.virol.2014.12.017; Lei H, 2011, CLIN VACCINE IMMUNOL, V18, P1046, DOI 10.1128/CVI.00050-11; Lei H, 2010, VIROLOGY, V407, P319, DOI 10.1016/j.virol.2010.08.007; Levine MM, 2003, NAT MED, V9, P99, DOI 10.1038/nm0103-99; LIEW FY, 1984, EUR J IMMUNOL, V14, P350, DOI 10.1002/eji.1830140414; Marelli B, 2011, J VIROL METHODS, V175, P28, DOI 10.1016/j.jviromet.2011.04.011; Mbow ML, 2010, CURR OPIN IMMUNOL, V22, P411, DOI 10.1016/j.coi.2010.04.004; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Norton PM, 1996, FEMS IMMUNOL MED MIC, V14, P167, DOI 10.1111/j.1574-695X.1996.tb00284.x; Pei HD, 2005, APPL MICROBIOL BIOT, V68, P220, DOI 10.1007/s00253-004-1869-y; Poles J, 2014, AIDS RES HUM RETROV, V30, P1027, DOI 10.1089/aid.2014.0233; Ramasamy R, 2006, VACCINE, V24, P3900, DOI 10.1016/j.vaccine.2006.02.040; Robinson K, 1997, NAT BIOTECHNOL, V15, P653, DOI 10.1038/nbt0797-653; Saluja V, 2010, AAPS J, V12, P109, DOI 10.1208/s12248-009-9168-2; Shi SH, 2014, VIROLOGY, V464, P166, DOI 10.1016/j.virol.2014.07.011; Shukla SH, 2010, PHARMACOGN RES, V2, P359, DOI 10.4103/0974-8490.75455; Sim ACN, 2008, VACCINE, V26, P1145, DOI 10.1016/j.vaccine.2007.12.047; Sybesma W, 2006, ELECTRON J BIOTECHN, V9, P424, DOI 10.2225/vol9-issue4-fulltext-12; TAMURA S, 1990, VACCINE, V8, P479, DOI 10.1016/0264-410X(90)90250-P; TAMURA S, 1991, EUR J IMMUNOL, V21, P1337, DOI 10.1002/eji.1830210602; TAYLOR HP, 1985, J EXP MED, V161, P198, DOI 10.1084/jem.161.1.198; VANCOTT JL, 1994, J IMMUNOL, V152, P3980; Varma Nadimpalli Ravi S, 2013, Biotechnol Res Int, V2013, P431315, DOI 10.1155/2013/431315; Visweswaran GRR, 2014, APPL MICROBIOL BIOT, V98, P4331, DOI 10.1007/s00253-014-5633-7; Wang ZS, 2012, FUTURE MICROBIOL, V7, P1003, DOI [10.2217/FMB.12.69, 10.2217/fmb.12.69]; Wang ZS, 2012, CLIN VACCINE IMMUNOL, V19, P174, DOI 10.1128/CVI.05618-11; WHO, 2014, INFL SEAS 2014; Xin KQ, 2003, BLOOD, V102, P223, DOI 10.1182/blood-2003-01-0110; Zhang NR, 2015, MICROBES INFECT, V17, P123, DOI 10.1016/j.micinf.2014.12.006; Zhang QX, 2011, MICROBIOL RES, V166, P111, DOI 10.1016/j.micres.2010.02.002	53	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187718	10.1371/journal.pone.0187718	http://dx.doi.org/10.1371/journal.pone.0187718			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29108012	Green Published, Green Submitted, gold			2022-12-26	WOS:000414424600064
J	Tuveng, TR; Rothweiler, U; Udatha, G; Vaaje-Kolstad, G; Smalas, A; Eijsink, VGH				Tuveng, Tina Rise; Rothweiler, Ulli; Udatha, Gupta; Vaaje-Kolstad, Gustav; Smalas, Arne; Eijsink, Vincent G. H.			Structure and function of a CE4 deacetylase isolated from a marine environment	PLOS ONE			English	Article							DEFINED CHITOSAN OLIGOMERS; CHITIN DEACETYLASE; CARBOHYDRATE ESTERASE; POLYSACCHARIDE DEACETYLASE; PEPTIDOGLYCAN DEACETYLASE; ACETYLXYLAN ESTERASE; CHITOOLIGOSACCHARIDES; MECHANISM; ENZYMES; PLANT	Chitin, a polymer of beta(1-4)-linked N-acetylglucosamine found in e.g. arthropods, is a valuable resource that may be used to produce chitosan and chitooligosaccharides, two compounds with considerable industrial and biomedical potential. Deacetylating enzymes may be used to tailor the properties of chitin and its derived products. Here, we describe a novel CE4 enzyme originating from a marine Arthrobacterspecies (ArCE4A). Crystal structures of this novel deacetylase were determined, with and without bound chitobiose [(GIcNAc)(2)], and refined to 2.1 angstrom and 1.6 angstrom, respectively. In-depth biochemical characterization showed that ArCE4A has broad substrate specificity, with higher activity against longer oligosaccharides. Mass spectrometry-based sequencing of reaction products generated from a fully acetylated pentamer showed that internal sugars are more prone to deacetylation than the ends. These enzyme properties are discussed in the light of the structure of the enzymeligand complex, which adds valuable information to our still rather limited knowledge on enzyme-substrate interactions in the CE4 family.	[Tuveng, Tina Rise; Vaaje-Kolstad, Gustav; Eijsink, Vincent G. H.] Norwegian Univ Life Sci NMBU, Fac Chem Biotechnol & Food Sci, As, Norway; [Rothweiler, Ulli; Udatha, Gupta; Smalas, Arne] Arctic Univ Norway, Dept Chem, Norwegian Struct Biol Ctr, Tromso, Norway	Norwegian University of Life Sciences; UiT The Arctic University of Tromso	Eijsink, VGH (corresponding author), Norwegian Univ Life Sci NMBU, Fac Chem Biotechnol & Food Sci, As, Norway.	vincent.eijsink@nmbu.no		Tuveng, Tina Rise/0000-0002-5926-2633; Eijsink, Vincent/0000-0002-9220-8743	Research Council of Norway through the MarPol project [221576]	Research Council of Norway through the MarPol project(Research Council of Norway)	This research was supported by the Research Council of Norway through the MarPol project (221576). A.S. and V.G.H.E received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aam BB, 2010, MAR DRUGS, V8, P1482, DOI 10.3390/md8051482; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andres E, 2014, ANGEW CHEM INT EDIT, V53, P6882, DOI 10.1002/anie.201400220; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Bahrke S, 2002, BIOMACROMOLECULES, V3, P696, DOI 10.1021/bm020010n; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Biely P, 1996, FEBS LETT, V396, P257, DOI 10.1016/0014-5793(96)01080-0; Blair DE, 2006, BIOCHEMISTRY-US, V45, P9416, DOI 10.1021/bi0606694; Blair DE, 2005, P NATL ACAD SCI USA, V102, P15429, DOI 10.1073/pnas.0504339102; Blair DE, 2004, FEBS LETT, V570, P13, DOI 10.1016/j.febslet.2004.06.013; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Bramucci E, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S2; Caufrier F, 2003, CARBOHYD RES, V338, P687, DOI 10.1016/S0008-6215(03)00002-8; Cord-Landwehr S, 2016, SCI REP-UK, V6, DOI 10.1038/srep38018; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fukushima T, 2005, J BACTERIOL, V187, P1287, DOI 10.1128/JB.187.4.1287-1292.2005; HACKMAN RH, 1954, AUST J BIOL SCI, V7, P168, DOI 10.1071/BI9540168; Hamer SN, 2015, SCI REP-UK, V5, DOI 10.1038/srep08716; Hekmat O, 2003, BIOCHEM J, V374, P369, DOI 10.1042/BJ20030204; Jeuniaux C, 1978, P 1 INT C CHIT CHIT; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krug M, 2012, J APPL CRYSTALLOGR, V45, P568, DOI 10.1107/S0021889812011715; Liu ZL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02043-1; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Manucharova NA, 2008, BIOL BULL+, V35, P549, DOI 10.1134/S1062359008050191; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morelle W, 2005, RAPID COMMUN MASS SP, V19, P1145, DOI 10.1002/rcm.1900; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Naqvi S, 2016, APPL ENVIRON MICROB, V82, P6645, DOI 10.1128/AEM.01961-16; Bui NK, 2011, BIOCHEM PHARMACOL, V82, P43, DOI 10.1016/j.bcp.2011.03.028; Ni YQ, 2015, MBIO, V6, DOI 10.1128/mBio.01263-15; PETERS W, 1966, EXPERIENTIA, V22, P820, DOI 10.1007/BF01897437; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Popper ZA, 2010, PLANT PHYSIOL, V153, P373, DOI 10.1104/pp.110.158055; Puchart V, 2006, BBA-PROTEINS PROTEOM, V1764, P263, DOI 10.1016/j.bbapap.2005.11.023; Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Tang MC, 2011, J BIOTECHNOL, V155, P257, DOI 10.1016/j.jbiotec.2011.06.041; Taylor EJ, 2006, J BIOL CHEM, V281, P10968, DOI 10.1074/jbc.M513066200; Urch JE, 2009, PROTEIN SCI, V18, P1197, DOI 10.1002/pro.128; Varum KM, 2001, CARBOHYD POLYM, V46, P89, DOI 10.1016/S0144-8617(00)00288-5; Webb E. C., 1992, ENZYME NOMENCLATURE; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xia WS, 2011, FOOD HYDROCOLLOID, V25, P170, DOI 10.1016/j.foodhyd.2010.03.003	46	27	27	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187544	10.1371/journal.pone.0187544	http://dx.doi.org/10.1371/journal.pone.0187544			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29107991	Green Published, gold, Green Submitted			2022-12-26	WOS:000414424600039
J	Cassidy, C; Yamashita, M; Cheung, M; Kalale, C; Adaniya, H; Kuwahara, R; Shintake, T				Cassidy, Cathal; Yamashita, Masao; Cheung, Martin; Kalale, Chola; Adaniya, Hidehito; Kuwahara, Ryusuke; Shintake, Tsumoru			Water without windows: Evaluating the performance of open cell transmission electron microscopy under saturated water vapor conditions, and assessing its potential for microscopy of hydrated biological specimens	PLOS ONE			English	Article							ENERGY-LOSS SPECTROSCOPY; IN-SITU; IMAGE-RESOLUTION; RADIATION-DAMAGE; LIQUID; GAS; SAMPLES; PHAGE; BEAM; ETEM	We have performed open cell transmission electron microscopy experiments through pure water vapor in the saturation pressure regime (> 0.6 kPa), in a modern microscope capable of sub-angstrom resolution. We have systematically studied achievable pressure levels, stability and gas purity, effective thickness of the water vapor column and associated electron scattering processes, and the effect of gas pressure on electron optical resolution and image contrast. For example, for 1.3 kPa pure water vapor and 300kV electrons, we report pressure stability of +/- 20 Pa over tens of minutes, effective thickness of 0.57 inelastic mean free paths, lattice resolution of 0.14 nm on a reference Au specimen, and no significant degradation in contrast or stability of a biological specimen (M13 virus, with 6 nm body diameter). We have also done some brief experiments to confirm feasibility of loading specimens into an in situ water vapor ambient without exposure to intermediate desiccating conditions. Finally, we have also checked if water experiments had any discernible impact on the microscope performance, and report pertinent vacuum and electron optical data, for reference purposes.	[Cassidy, Cathal; Yamashita, Masao; Cheung, Martin; Kalale, Chola; Adaniya, Hidehito; Kuwahara, Ryusuke; Shintake, Tsumoru] OIST Grad Univ, Quantum Wave Microscopy, 1919-1 Tancha, Okinawa 9040495, Japan	Okinawa Institute of Science & Technology Graduate University	Cassidy, C (corresponding author), OIST Grad Univ, Quantum Wave Microscopy, 1919-1 Tancha, Okinawa 9040495, Japan.	c.cassidy@oist.jp	; Kuwahara, Ryusuke/J-5024-2015	Cassidy, Cathal/0000-0003-0828-731X; Kuwahara, Ryusuke/0000-0002-7041-0828	OIST Graduate University	OIST Graduate University	Research funding was provided by OIST Graduate University.	Baker LA, 2010, METHOD ENZYMOL, V481, P371, DOI 10.1016/S0076-6879(10)81015-8; Bright AN, 2013, ULTRAMICROSCOPY, V124, P46, DOI 10.1016/j.ultramic.2012.08.007; CAMERON RE, 1994, J MICROSC-OXFORD, V173, P227, DOI 10.1111/j.1365-2818.1994.tb03445.x; Cassidy C, 2017, APPL PHYS LETT, V110, DOI 10.1063/1.4981809; Colby R, 2015, ULTRAMICROSCOPY, V153, P55, DOI 10.1016/j.ultramic.2015.01.002; Crozier PA, 2011, ULTRAMICROSCOPY, V111, P177, DOI 10.1016/j.ultramic.2010.11.005; Egerton RF, 2013, ULTRAMICROSCOPY, V127, P100, DOI 10.1016/j.ultramic.2012.07.006; Elton DC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10193; Frank J, 2017, NAT PROTOC, V12, P209, DOI 10.1038/nprot.2017.004; Germann M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.095501; Jain T, 2012, J STRUCT BIOL, V179, P68, DOI 10.1016/j.jsb.2012.04.020; Jinschek JR, 2014, CHEM COMMUN, V50, P2696, DOI [10.1039/C3CC49092K, 10.1039/c3cc49092k]; Jinschek JR, 2012, MICRON, V43, P1156, DOI 10.1016/j.micron.2012.01.006; KOBAYASHI K, 1983, J PHYS CHEM-US, V87, P4317, DOI 10.1021/j100244a065; Laage D, 2017, CHEM REV, V117, P10694, DOI 10.1021/acs.chemrev.6b00765; LASSETTRE EN, 1974, J CHEM PHYS, V60, P2460, DOI 10.1063/1.1681382; LEAPMAN RD, 1995, ULTRAMICROSCOPY, V59, P71, DOI 10.1016/0304-3991(95)00019-W; Lee YJ, 2009, SCIENCE, V324, P1051, DOI [10.1126/science.1171541, 10.1126/science.1169041]; Li K, 2010, BIOCONJUGATE CHEM, V21, P1369, DOI 10.1021/bc900405q; MacLaren I, 2013, ADV FUNCT MATER, V23, P683, DOI 10.1002/adfm.201201835; Miller BK, 2013, MICROSC MICROANAL, V19, P461, DOI 10.1017/S1431927612014122; Miller L., 2013, THESIS, V1, P461; Mitchell DRG, 2005, ULTRAMICROSCOPY, V103, P319, DOI 10.1016/j.ultramic.2005.02.003; Miyata T, 2017, ULTRAMICROSCOPY, V178, P81, DOI 10.1016/j.ultramic.2016.10.009; Mortensen PM, 2015, ULTRAMICROSCOPY, V152, P1, DOI 10.1016/j.ultramic.2014.12.007; Ngweniform P, 2009, SMALL, V5, P1963, DOI 10.1002/smll.200801902; Park J, 2015, NANO LETT, V15, P4737, DOI 10.1021/acs.nanolett.5b01636; PARSONS DF, 1974, SCIENCE, V186, P407, DOI 10.1126/science.186.4162.407; Razinkov I, 2016, J STRUCT BIOL, V195, P190, DOI 10.1016/j.jsb.2016.06.001; Ross FM, 2016, MRS BULL, V41, P791, DOI 10.1557/mrs.2016.212; Ross FM, 2015, SCIENCE, V350, DOI 10.1126/science.aaa9886; Schneider NM, 2014, J PHYS CHEM C, V118, P22373, DOI 10.1021/jp507400n; Scott J, 2008, ULTRAMICROSCOPY, V108, P1586, DOI 10.1016/j.ultramic.2008.05.006; Stevens GB, 2011, EUR BIOPHYS J BIOPHY, V40, P1197, DOI 10.1007/s00249-011-0743-y; Taheri ML, 2016, ULTRAMICROSCOPY, V170, P86, DOI 10.1016/j.ultramic.2016.08.007; Timischl F, 2015, SCANNING, V37, P54, DOI 10.1002/sca.21179; Utke I, 2008, J VAC SCI TECHNOL B, V26, P1197, DOI 10.1116/1.2955728; Vulovic M, 2013, J STRUCT BIOL, V183, P19, DOI 10.1016/j.jsb.2013.05.008; Wagner JB, 2012, MICRON, V43, P1169, DOI 10.1016/j.micron.2012.02.008; Wu JB, 2016, ADV MATER, V28, P9686, DOI 10.1002/adma.201602519; Yoshida H, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.195428; Yoshida K, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/42/425702; Yuk JM, 2012, SCIENCE, V336, P61, DOI 10.1126/science.1217654; Zhang LX, 2013, NANO LETT, V13, P679, DOI 10.1021/nl304333h	45	1	1	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							e0186899	10.1371/journal.pone.0186899	http://dx.doi.org/10.1371/journal.pone.0186899			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6TA	29099843	Green Published, gold, Green Submitted			2022-12-26	WOS:000414377900010
J	Chung, EJ; Jun, DR; Kim, DW; Han, MJ; Kwon, TK; Choi, SW; Kwon, SK				Chung, Eun-Jae; Jun, Dae-Ryong; Kim, Dong-Wook; Han, Mi-Jung; Kwon, Tack-Kyun; Choi, Sung-Wook; Kwon, Seong Keun			Prevention of polydimethylsiloxane microsphere migration using a mussel-inspired polydopamine coating for potential application in injection therapy	PLOS ONE			English	Article							URINARY-INCONTINENCE; VESICOURETERAL REFLUX; DERMAL FILLER; SILICONE; POLY(DIMETHYLSILOXANE); PHAGOCYTOSIS; MACROPHAGES; SUBSTANCES; IMPLANTS; WRINKLES	The use of injectable bulking agents is a feasible alternative procedure for conventional surgical therapy. In this study, poly(dimethylsiloxane) (PDMS) microspheres coated with polydopamine (PDA) were developed as a potential injection agent to prevent migration in vocal fold. Uniform PDMS microspheres are fabricated using a simple fluidic device and then coated with PDA. Cell attachment test reveals that the PDA-coated PDMS (PDA-PDMS) substrate favors cell adhesion and attachment. The injected PDA-PDMS microspheres persist without migration on reconstructed axial CT images, whereas, pristine PDMS locally migrates over a period of 12 weeks. The gross appearance of the implants retrieved at 4, 8, 12 and 34 weeks indicates that the PDA-PDMS group maintained their original position without significant migration until 34 weeks after injection. By contrast, there is diffuse local migration of the pristine PDMS group from 4 weeks after injection. The PDA-coated PDMS microspheres can potentially be used as easily injectable, non-absorbable filler without migration.	[Chung, Eun-Jae; Kim, Dong-Wook; Han, Mi-Jung; Kwon, Tack-Kyun; Kwon, Seong Keun] Seoul Natl Univ Hosp, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea; [Jun, Dae-Ryong; Choi, Sung-Wook] Catholica Univ Korea, Dept Biotechnol, Gyeonggi Do, South Korea	Seoul National University (SNU); Seoul National University Hospital; Catholic University of Korea	Kwon, SK (corresponding author), Seoul Natl Univ Hosp, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea.; Choi, SW (corresponding author), Catholica Univ Korea, Dept Biotechnol, Gyeonggi Do, South Korea.	choisw@catholic.ac.kr; otolarynx@snuh.org			Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2017M3A9B4032446]; "GRRC" Project of the Gyeonggi Provincial Government, Korea	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; "GRRC" Project of the Gyeonggi Provincial Government, Korea	This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2017M3A9B4032446), and a grant from the "GRRC" Project of the Gyeonggi Provincial Government, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation ofthe manuscript.r This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2017M3A9B4032446), and a grant from the "GRRC" Project of the Gyeonggi Provincial Government, Korea.	Belanger MC, 2001, J BIOMED MATER RES, V58, P467, DOI 10.1002/jbm.1043; Bondurant S, 2005, SAFETY SILICONE BREA, P1; BOYKIN W, 1989, J UROLOGY, V141, P1199, DOI 10.1016/S0022-5347(17)41213-4; BRANDWOOD A, 1992, BIOMATERIALS, V13, P646, DOI 10.1016/0142-9612(92)90035-M; Chuah YJ, 2015, BIOMATER SCI-UK, V3, P383, DOI 10.1039/c4bm00268g; Conrad K, 1996, ARCH OTOLARYNGOL, V122, P664; DEHEER DH, 1995, J HAND SURG-AM, V20A, pS101, DOI 10.1016/S0363-5023(95)80180-4; Delor-Jestin F, 2008, SCI TECHNOL ADV MAT, V9, DOI 10.1088/0031-8949/9/2/024406; Fuard D, 2008, MICROELECTRON ENG, V85, P1289, DOI 10.1016/j.mee.2008.02.004; Grunebaum LD, 2010, DERMATOL SURG, V36, P760, DOI 10.1111/j.1524-4725.2010.01555.x; HENLY DR, 1995, J UROLOGY, V153, P2039, DOI 10.1016/S0022-5347(01)67398-1; Hexsel DM, 2003, SEMIN CUTAN MED SURG, V22, P107, DOI 10.1053/sder.2003.50010; Joyner BD, 1997, UROLOGY, V50, P489, DOI 10.1016/S0090-4295(97)00261-6; Jun DR, 2014, COLLOID SURFACE B, V121, P395, DOI 10.1016/j.colsurfb.2014.06.027; Keegan PE, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003881.pub2; Kershen RT, 2000, WORLD J UROL, V18, P51, DOI 10.1007/PL00007072; Kim BS, 2000, WORLD J UROL, V18, P2, DOI 10.1007/s003450050002; Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241; Lee JN, 2004, LANGMUIR, V20, P11684, DOI 10.1021/la048562+; Lemperle G, 1998, AESTHET PLAST SURG, V22, P356, DOI 10.1007/s002669900217; MALIZIA AA, 1984, JAMA-J AM MED ASSOC, V251, P3277, DOI 10.1001/jama.251.24.3277; MITTLEMAN RE, 1983, ARCH PATHOL LAB MED, V107, P611; Morhenn VB, 2002, DERMATOL SURG, V28, P484, DOI 10.1046/j.1524-4725.2002.01273.x; Pannek J, 2001, J UROLOGY, V166, P1350, DOI 10.1016/S0022-5347(05)65767-9; POLLACK SV, 1999, J CUTAN MED SURG S4, V3, P27; Sclafani AP, 2002, ANN PLAS SURG, V49, P181, DOI 10.1097/00000637-200208000-00011; Shin YM, 2012, BIOMACROMOLECULES, V13, P2020, DOI 10.1021/bm300194b; Yanagihara M, 2000, J CUTAN PATHOL, V27, P301, DOI 10.1034/j.1600-0560.2000.027006301.x	28	5	6	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0186877	10.1371/journal.pone.0186877	http://dx.doi.org/10.1371/journal.pone.0186877			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095854	Green Published, Green Submitted, gold			2022-12-26	WOS:000414340200028
J	Han, RW; Li, SL; Wang, J; Yu, ZN; Wang, JQ; Zheng, N				Han, Rongwei; Li, Songli; Wang, Jun; Yu, Zhongna; Wang, Jiaqi; Zheng, Nan			Elimination kinetics of ceftiofur hydrochloride in milk after an 8-day extended intramammary administration in healthy and infected cows	PLOS ONE			English	Article							LACTATING DAIRY-COWS; RANDOMIZED CLINICAL-TRIAL; STAPHYLOCOCCUS-AUREUS; SUBCLINICAL MASTITIS; CEPHAPIRIN SODIUM; THERAPY PROGRAM; EFFICACY; INFUSION; PHARMACOKINETICS; PIRLIMYCIN	Ceftiofur hydrochloride (CEF) is occasionally used for the intramammary (IMM) treatment of mastitis. This extralabel manner could result in a drug-residue violation of the milk. The objective of this study was to determine the elimination kinetics of IMM CEF in lactating dairy cattle. The pharmacokinetic profile of CEF after repeated IMM administration in nine healthy cows and nine Staphylococcus aureus infected cows was investigated, alongside determining the MICs of Staph, aureus field strains. The MIC 90 value for CEF in Staph, aureus field strains (n = 31) was 0.25 mu g/mL. The t>MIC CEF values for low-production quarters were longer than those for high- and mid- production quarters. The results showed that ceftiofur was detected in milk up to 108 h after the last infusion in both healthy and infected cows. Cows with low milk production eliminate IMM drugs more slowly than cows with higher production. Our findings suggest that this extralabel use is not encouraged and a prudent use is recommended for mastitis therapy. The use of CEF should be reserved for infections where susceptibility tests indicate its efficacy and when alternatives are not available.	[Han, Rongwei; Wang, Jun] Qingdao Agr Univ, Coll Food Sci & Technol, Qingdao, Peoples R China; [Li, Songli; Wang, Jiaqi; Zheng, Nan] Chinese Acad Agr Sci, Inst Anim Sci, State Key Lab Anim Nutr, Beijing, Peoples R China; [Yu, Zhongna] Qingdao Agr Univ, Haidu Coll, Laiyang, Peoples R China	Qingdao Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Qingdao Agricultural University	Zheng, N (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, State Key Lab Anim Nutr, Beijing, Peoples R China.	zhengnan_1980@126.com	Wang, Jun/H-4803-2011	Wang, Jun/0000-0001-7676-0493	Special Fund for Agro-scientific Research in the Public Interest [201403071]; Natural Science Foundation of Shandong Province of the PR China [ZR2015CQ020]; Key Research Program of Shandong Province [2016GSF120010]; Scientific Research Foundation of the Higher Education Institutions of Shandong Province [J17KA131]	Special Fund for Agro-scientific Research in the Public Interest; Natural Science Foundation of Shandong Province of the PR China; Key Research Program of Shandong Province; Scientific Research Foundation of the Higher Education Institutions of Shandong Province	The authors gratefully acknowledge the Special Fund for Agro-scientific Research in the Public Interest (201403071) to Rongwei Han, Natural Science Foundation of Shandong Province of the PR China (ZR2015CQ020) to Rongwei Han, Key Research Program of Shandong Province (2016GSF120010) to Jun Wang and Scientific Research Foundation of the Higher Education Institutions of Shandong Province (J17KA131) to Zhongna Yu for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkema HW, 2006, J DAIRY SCI, V89, P1877, DOI 10.3168/jds.S0022-0302(06)72256-1; Cagnardi P, 2010, J DAIRY SCI, V93, P4105, DOI 10.3168/jds.2010-3379; Committee for Medicinal Products for Veterinary Use (CVMP), 2009, EMEACVMPSAGAM8173020; Constable PD, 2003, VET CLIN N AM-FOOD A, V19, P139, DOI 10.1016/S0749-0720(02)00068-3; Deluyker HA, 2005, J DAIRY SCI, V88, P604, DOI 10.3168/jds.S0022-0302(05)72724-7; Gehring R, 2006, J VET PHARMACOL THER, V29, P237, DOI 10.1111/j.1365-2885.2006.00750.x; Gibaldi M, 1982, NONCOMPARTMENTAL ANA, P409; Gorden PJ, 2013, J DAIRY SCI, V96, P4455, DOI 10.3168/jds.2012-6487; Hogeveen H, 2011, NEW ZEAL VET J, V59, P16, DOI 10.1080/00480169.2011.547165; Kromker V, 2010, BERL MUNCH TIERARZTL, V123, P147, DOI 10.2376/0005-9366-123-147; Mckellar OA, 2004, J VET PHARMACOL THER, V27, P503, DOI 10.1111/j.1365-2885.2004.00603.x; MOA, 2012, B MIN AGR PEOPL REP, V235; Oliver SP, 2004, J DAIRY SCI, V87, P2393, DOI 10.3168/jds.S0022-0302(04)73361-5; OWENS WE, 1990, J DAIRY SCI, V73, P3449, DOI 10.3168/jds.S0022-0302(90)79043-1; Pu WX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088134; Roy JP, 2012, VET CLIN N AM-FOOD A, V28, P39, DOI 10.1016/j.cvfa.2011.12.004; Roy JP, 2009, CAN VET J, V50, P1257; Schukken YH, 2011, J DAIRY SCI, V94, P6203, DOI 10.3168/jds.2011-4290; Smith GW, 2005, JAVMA-J AM VET MED A, V226, P1994, DOI 10.2460/javma.2005.226.1994; Smith GW, 2004, JAVMA-J AM VET MED A, V224, P1827, DOI 10.2460/javma.2004.224.1827; Stockler RM, 2009, J DAIRY SCI, V92, P4262, DOI 10.3168/jds.2008-1916; Truchetti G, 2014, CAN J VET RES, V78, P31; US FDA CfVM, 2013, ANN REP 2012; USDA, 2009, DAIR 2007 5; Whittem T, 1999, J VET PHARMACOL THER, V22, P41, DOI 10.1046/j.1365-2885.1999.00187.x; Zonca A, 2011, J DAIRY SCI, V94, P3455, DOI 10.3168/jds.2010-4109	26	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187261	10.1371/journal.pone.0187261	http://dx.doi.org/10.1371/journal.pone.0187261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095869	gold, Green Submitted, Green Published			2022-12-26	WOS:000414340200063
J	Zanlungo, F; Yucel, Z; Brscic, D; Kanda, T; Hagita, N				Zanlungo, Francesco; Yucel, Zeynep; Brscic, Drazen; Kanda, Takayuki; Hagita, Norihiro			Intrinsic group behaviour: Dependence of pedestrian dyad dynamics on principal social and personal features	PLOS ONE			English	Article							EYE-CONTACT; DENSITY; SPACES	Being determined by human social behaviour, pedestrian group dynamics may depend on "intrinsic properties" such as the purpose of the pedestrians, their personal relation, gender, age, and body size. In this work we investigate the dynamical properties of pedestrian dyads (distance, spatial formation and velocity) by analysing a large data set of automatically tracked pedestrian trajectories in an unconstrained "ecological" setting (a shopping mall), whose apparent physical and social group properties have been analysed by three different human coders. We observed that females walk slower and closer than males, that workers walk faster, at a larger distance and more abreast than leisure oriented people, and that inter-group relation has a strong effect on group structure, with couples walking very close and abreast, colleagues walking at a larger distance, and friends walking more abreast than family members. Pedestrian height (obtained automatically through our tracking system) influences velocity and abreast distance, both growing functions of the average group height. Results regarding pedestrian age show that elderly people walk slowly, while active age adults walk at the maximum velocity. Groups with children have a strong tendency to walk in a non-abreast formation, with a large distance (despite a low abreast distance). A cross-analysis of the interplay between these intrinsic features, taking in account also the effect of an "extrinsic property" such as crowd density, confirms these major results but reveals also a richer structure. An interesting and unexpected result, for example, is that the velocity of groups with children increases with density, at least in the low-medium density range found under normal conditions in shopping malls. Children also appear to behave differently according to the gender of the parent.	[Zanlungo, Francesco; Yucel, Zeynep; Kanda, Takayuki; Hagita, Norihiro] ATR Int, Kyoto, Japan; [Yucel, Zeynep] Okayama Univ, Okayama, Japan; [Brscic, Drazen] Univ Rijeka, Fac Engn, Rijeka, Croatia	Okayama University; University of Rijeka	Zanlungo, F (corresponding author), ATR Int, Kyoto, Japan.	zanlungo@atr.jp	Brščić, Dražen/Q-7952-2018; Yucel, Zeynep/V-9340-2019; Yucel, Zeynep/AAW-8179-2021; Yucel, Zeynep/E-7906-2015; Kanda, Takayuki/I-5843-2016	Brščić, Dražen/0000-0001-8477-6460; Yucel, Zeynep/0000-0003-3404-4485; Kanda, Takayuki/0000-0002-9546-5825	Ministry of Internal Affairs and Communications of Japan quot;Research and development project on autonomous personal mobility including robotsquot;; JST, CREST; JSPS KAKENHI RDP grant [16J40223]; ATR	Ministry of Internal Affairs and Communications of Japan quot;Research and development project on autonomous personal mobility including robotsquot;; JST, CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); JSPS KAKENHI RDP grant; ATR	This work was supported by the Ministry of Internal Affairs and Communications of Japan "Research and development project on autonomous personal mobility including robots" (http://www.soumu.go.jp/english/), JST, CREST (http://www.jst.go.jp/kisoken/crest/en/) project webpage http://www.irc.atr.jp/crest2010 HRI/index.html, and JSPS KAKENHI (https://www.jsps.go.jp/english/index.html) RDP grant https://www.jsps.go.jp/j-pd/rpd_gaiyo.html) grant number 16J40223. ATR provides the salary of two of the authors, TK and NH, and at the time of the first submission provided also the salary of the corresponding author, FZ. At the moment, FZ and ZY are affiliated to ATR as visiting researchers to facilitate their collaboration with former colleagues, but do not receive a salary from this company. Nevertheless, the company did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There will be no patent application or other commercial interest directly related to the results of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This research is partly supported by the Ministry of Internal Affairs and Communications (MIC), Japan, Research and development project on autonomous personal mobility including robots, by CREST, JST and JSPS KAKENHI Grant Number 16J40223.	ARGYLE M, 1965, SOCIOMETRY, V28, P289, DOI 10.2307/2786027; Bandini Stefania, 2016, Cross-Cultural Design. 8th International Conference, CCD 2016, held as part of HCI International 2016. Proceedings: LNCS 9741, P491, DOI 10.1007/978-3-319-40093-8_49; Bandini S, 2014, 2014 IEEE 17TH INTERNATIONAL CONFERENCE ON INTELLIGENT TRANSPORTATION SYSTEMS (ITSC), P572, DOI 10.1109/ITSC.2014.6957751; Bode N, P 2016 PED EV DYN C; Bode N, PLOS ONE; Bohannon RW, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.1.15; Brscic D, 2017, 2017 40TH INTERNATIONAL CONVENTION ON INFORMATION AND COMMUNICATION TECHNOLOGY, ELECTRONICS AND MICROELECTRONICS (MIPRO), P564, DOI 10.23919/MIPRO.2017.7973489; Brscic D, 2014, TRANSP RES PROC, V2, P77, DOI 10.1016/j.trpro.2014.09.011; Brscic D, 2013, IEEE T HUM-MACH SYST, V43, P522, DOI 10.1109/THMS.2013.2283945; CORBETTA A, P 2016 PED EV DYN C; Corbetta A, 2014, TRANSP RES PROC, V2, P96, DOI 10.1016/j.trpro.2014.09.013; Costa M, 2010, J NONVERBAL BEHAV, V34, P15, DOI 10.1007/s10919-009-0077-y; Faria JJ, 2010, ANIM BEHAV, V79, P895, DOI 10.1016/j.anbehav.2009.12.039; Feng Y, P 2016 PED EV DYN C; Gorrini A, P 2016 PED EV DYN C; Gorrini A, 2015, 11 C INT TRAFF GRAN; He L, 2016, IEEE INT CONF ROBOT, P292, DOI 10.1109/ICRA.2016.7487147; HENDERSON LF, 1972, NATURE, V240, P353, DOI 10.1038/240353a0; Huang J, P 2016 PED EV DYN C; Kachroo P, 2008, UNDERST COMPLEX SYST, P1; Kanda T., 2009, 2009 4th ACM/IEEE International Conference on Human-Robot Interaction (HRI), P173; Karamouzas I, P 2010 17 ACM S VIRT, P183; Kim Sujeong, 2012, P ACM SIGGRAPH S INT; KLEINKE CL, 1986, PSYCHOL BULL, V100, P78, DOI 10.1037/0033-2909.100.1.78; Knapp M., 2012, NONVERBAL COMMUNICAT; Koster G, 2011, CONTEMP SOC SCI, V6, P397, DOI 10.1080/21582041.2011.619867; Koster G., 2014, PEDESTRIAN EVACUATIO, P1051, DOI [10.1007/978-3-319-02447-9_87, DOI 10.1007/978-3-319-02447-9_87]; Kumagai K, P 2016 PED EV DYN C; Levine RV, 1999, J CROSS CULT PSYCHOL, V30, P178, DOI 10.1177/0022022199030002003; Manfredi M, 2014, PATTERN RECOGN LETT, V44, P39, DOI 10.1016/j.patrec.2013.11.001; Mawson A. R., 2012, MASS PANIC SOCIAL AT; Morales Y, 2013 IEEE RSJ INT C; Moussaid M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010047; Muller F, 2016, TRAFFIC GRANULAR FLO; Muller F, 2016, TRAFFIC GRANULAR FLO; Murakami R, P 2014 ACM IEEE INT, P471; Reicher SD, 2001, BLACKWELL HDB SOCIAL, V44; Robinson, 2009, UNDERSTANDING CROWD, P11; Schultz M, 2014, PEDESTR EVAC DYN, V2012, P1097; Seer S, 2014, TRANSPORT RES C-EMER, V48, P212, DOI 10.1016/j.trc.2014.08.012; Seitz MJ, 2017, REV GEN PSYCHOL, V21, P95, DOI 10.1037/gpr0000092; Shiomi M, 2014, INT J SOC ROBOT, V6, P443, DOI 10.1007/s12369-014-0238-y; Templeton A, 2015, REV GEN PSYCHOL, V19, P215, DOI 10.1037/gpr0000032; TURCHETTI G, EPL-EUROPHYS LETT, V78, P58003, DOI DOI 10.1016/J.ANBEHAV.2009.12.039; von Kruchten C, 2017, PHYSICA A, V475, P129, DOI 10.1016/j.physa.2017.02.004; VONSIVERS I, P 2016 PED EV DYN C; Wang W, P 2016 PED EV DYN C; Wei XG, 2015, COMPLEXITY, V20, P87, DOI 10.1002/cplx.21633; Yijiang Zhang, 2011, 2011 12th International Conference on Computer-Aided Design and Computer Graphics, P275, DOI 10.1109/CAD/Graphics.2011.48; Yucel Z, 2013, SENSORS-BASEL, V13, P875, DOI 10.3390/s130100875; Zanlungo F, 2015, EPL-EUROPHYS LETT, V111, DOI 10.1209/0295-5075/111/38007; Zanlungo F, 2013, COGSCI13 2013 COGN S; Zanlungo F, P 2016 PED EV DYN C; Zanlungo F, 2014, TRANSP RES PROC, V2, P149, DOI 10.1016/j.trpro.2014.09.020; Zanlungo F, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.062810; Zanlungo F, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.012811; Zhang J, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/06/P06004; Zhao P, P 2016 PED EV DYN C	58	29	29	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2017	12	11							e0187253	10.1371/journal.pone.0187253	http://dx.doi.org/10.1371/journal.pone.0187253			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6FI	29095913	Green Published, Green Submitted, gold			2022-12-26	WOS:000414340200062
J	da Silva, WQA; Fontes, EB; Forti, RM; Lima, ZL; Machado, DGD; Deslandes, AC; Hussey, E; Ward, N; Mesquita, RC; Okano, AH; Elsangedy, HM				Alves da Silva, Weslley Quirino; Fontes, Eduardo Bodnariuc; Forti, Rodrigo Menezes; Lima, Zayonara Larissa; da Silva Machado, Daniel Gomes; Deslandes, Andrea Camaz; Hussey, Erika; Ward, Nathan; Mesquita, Rickson Coelho; Okano, Alexandre Hideki; Elsangedy, Hassan Mohamed			Affect during incremental exercise: The role of inhibitory cognition, autonomic cardiac function, and cerebral oxygenation	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; PUBLIC-HEALTH PROBLEM; PHYSICAL INACTIVITY; EXECUTIVE FUNCTION; PREFRONTAL CORTEX; PERFORMANCE; INTENSITY; EVOLUTIONARY; DISPLEASURE; TOLERANCE	Background Pleasure is a key factor for physical activity behavior in sedentary individuals. Inhibitory cognitive control may play an important role in pleasure perception while exercising, especially at high intensities. In addition, separate work suggests that autonomic regulation and cerebral hemodynamics influence the affective and cognitive responses during exercise. Purpose We investigated the effects of exercise intensity on affect, inhibitory control, cardiac autonomic function, and prefrontal cortex (PFC) oxygenation. Methods Thirty-seven sedentary young adults performed two experimental conditions (exercise and control) in separate sessions in a repeated-measures design. In the exercise condition, participants performed a maximum graded exercise test on a cycle ergometer as we continuously measured oxygen consumption, heart rate variability (HRV), and PFC oxygenation. At each of 8 intensity levels we also measured inhibitory control (Stroop test), associative and dissociative thoughts (ADT), and affective/pleasure ratings. In the control condition, participants sat motionless on a cycle ergometer without active pedaling, and we collected the same measures at the same points in time as the exercise condition. We evaluated the main effects and interactions of exercise condition and intensity level for each measure using two-way repeated measures ANOVAs. Additionally, we evaluated the relationship between affect and inhibitory control, ADT, HRV, and PFC oxygenation using Pearson's correlation coefficients. Results For exercise intensities below and at the ventilatory threshold (VT), participants reported feeling neutral, with preservation of inhibitory control, while intensities above the VT were associated with displeasure (p<0.001), decreased inhibitory control and HRV (p<0.001), and increased PFC oxygenation (p<0.001). At the highest exercise intensity, pleasure was correlated with the low-frequency index of HRV (r =-0.34; p<0.05) and the low-frequency/high-frequency HRV ratio (r =-0.33; p<0.05). PFC deoxyhemoglobin was correlated with pleasure two stages above the VT (r =-0.37; p<0.05). Conclusion Our results support the notion that exercise at high intensities influences inhibitory control and one's perception of pleasure, which are linked to changes in cardiac autonomic control and cerebral hemodynamics. These findings strengthen the existence of an integrated brain-heart-body system and highlight the importance of exercise intensity in exercise related behavior in sedentary individuals.	[Alves da Silva, Weslley Quirino; Fontes, Eduardo Bodnariuc; Lima, Zayonara Larissa; da Silva Machado, Daniel Gomes; Okano, Alexandre Hideki; Elsangedy, Hassan Mohamed] Univ Fed Rio Grande do Norte, Dept Phys Educ, Natal, RN, Brazil; [Alves da Silva, Weslley Quirino; Lima, Zayonara Larissa] Natalense Fac Educ & Culture, Grad Program Phys Educ, Natal, RN, Brazil; [Forti, Rodrigo Menezes; Mesquita, Rickson Coelho] Univ Estadual Campinas, Inst Phys Gleb Wataghin, Campinas, SP, Brazil; [Forti, Rodrigo Menezes; Mesquita, Rickson Coelho] Brazilian Inst Neurosci & Neurotechnol BRAINN, Campinas, SP, Brazil; [da Silva Machado, Daniel Gomes; Okano, Alexandre Hideki] Univ Estadual Londrina, Ctr Phys Educ & Sport, Londrina, PR, Brazil; [Deslandes, Andrea Camaz] Univ Estado Rio De Janeiro, Inst Phys Educ & Sport, Rio De Janeiro, RJ, Brazil; [Hussey, Erika] Tufts Univ, Ctr Appl Brain & Cognit Sci, Medford, MA 02155 USA; [Hussey, Erika] Natick Soldier Res Dev & Engn Ctr, Cognit Sci Team, Natick, MA USA; [Ward, Nathan] Tufts Univ, Dept Psychol, Medford, MA 02155 USA	Universidade Federal do Rio Grande do Norte; Universidade Estadual de Campinas; Universidade Estadual de Londrina; Universidade do Estado do Rio de Janeiro; Tufts University; United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); Tufts University	da Silva, WQA (corresponding author), Univ Fed Rio Grande do Norte, Dept Phys Educ, Natal, RN, Brazil.; da Silva, WQA (corresponding author), Natalense Fac Educ & Culture, Grad Program Phys Educ, Natal, RN, Brazil.	weslleyqurino@gmail.com	Elsangedy, Hassan M/L-6919-2013; Machado, Daniel Gomes da Silva/GQQ-1775-2022; Fontes, Eduardo B/D-7241-2013; da Silva, Weslley/E-5266-2019; Deslandes, Andrea C/F-3545-2010; Ward, Nathan/AAB-5713-2021; Forti, Rodrigo Menezes/K-2285-2017; Deslandes, Andrea/AAF-4525-2021; Okano, Alexandre Hideki/C-2757-2013; da Silva Machado, Daniel Gomes/F-8065-2017	Machado, Daniel Gomes da Silva/0000-0002-8426-0488; da Silva, Weslley/0000-0001-9332-4001; Deslandes, Andrea C/0000-0001-5941-9111; Forti, Rodrigo Menezes/0000-0002-8978-2525; Deslandes, Andrea/0000-0001-5941-9111; Okano, Alexandre Hideki/0000-0002-8995-1392; da Silva Machado, Daniel Gomes/0000-0002-8426-0488	Coordination for the Improvement of Higher Education Personnel (CAPES)	Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	We thank the Coordination for the Improvement of Higher Education Personnel (CAPES) for providing a scholarship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agricola P. M. D., 2016, SLOW DOWN ENJOY EFFE; Arnsten AFT, 2012, J AM ACAD CHILD PSY, V51, P356, DOI 10.1016/j.jaac.2012.01.008; BALKE B, 1959, U S Armed Forces Med J, V10, P675; Binder RK, 2008, EUR J CARDIOV PREV R, V15, P726, DOI 10.1097/HJR.0b013e328304fed4; Blair SN, 2009, BRIT J SPORT MED, V43, P1; Brewer BW, 2006, KINESIOL SLOVEN, V12, P82; Buchheit M, 2007, AM J PHYSIOL-HEART C, V293, pH133, DOI 10.1152/ajpheart.00062.2007; Camm AJ, 1996, CIRCULATION, V93, P1043; Chang YK, 2012, BRAIN RES, V1453, P87, DOI 10.1016/j.brainres.2012.02.068; Comte M., 2014, DISSOCIATING BOTTOM; Critchley Hugo D, 2013, Handb Clin Neurol, V117, P59, DOI 10.1016/B978-0-444-53491-0.00006-7; Damasio A, 2013, NAT REV NEUROSCI, V14, P143, DOI 10.1038/nrn3403; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; Dietrich A, 2006, PSYCHIAT RES, V145, P79, DOI 10.1016/j.psychres.2005.07.033; Ekkekakis P, 2005, J SPORT SCI, V23, P477, DOI 10.1080/02640410400021492; Ekkekakis P, 2003, COGNITION EMOTION, V17, P213, DOI 10.1080/02699930302292; Ekkekakis P., 2006, PSYCHOBIOLOGY PHYS A, P91; Ekkekakis P, 2011, SPORTS MED, V41, P641, DOI 10.2165/11590680-000000000-00000; Gibson AS, 2018, EUR J SPORT SCI, V18, P25, DOI 10.1080/17461391.2017.1321688; Hansen AL, 2004, EUR J APPL PHYSIOL, V93, P263, DOI 10.1007/s00421-004-1208-0; Hardy CJ, 1989, NOT WHAT ONE FEELS M, V11; HARRIS FJ, 1978, P IEEE, V66, P51, DOI 10.1109/PROC.1978.10837; Hughes MM, 2014, BEHAV RES METHODS, V46, P702, DOI 10.3758/s13428-013-0411-5; Huppert TJ, 2009, APPL OPTICS, V48, pD280, DOI 10.1364/AO.48.00D280; Hureau TJ, 2018, EUR J SPORT SCI, V18, P13, DOI 10.1080/17461391.2016.1252428; Hutchinson JC, 2007, PSYCHOL SPORT EXERC, V8, P233, DOI 10.1016/j.psychsport.2006.03.006; Jones AM, 2000, SPORTS MED, V29, P373, DOI 10.2165/00007256-200029060-00001; Jones CM, 2017, SPORTS MED, V47, P943, DOI 10.1007/s40279-016-0619-5; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Labelle V., 2012, FITNESS LEVEL MODERA; Labelle V, 2013, BRAIN COGNITION, V81, P10, DOI 10.1016/j.bandc.2012.10.001; Lambourne K, 2010, BRAIN RES, V1341, P12, DOI 10.1016/j.brainres.2010.03.091; Loprinzi PD, 2016, HEALTH PROMOT PERSPE, V6, P180, DOI 10.15171/hpp.2016.29; Martin K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159907; Matsudo S, 2001, REV BRAS ATIV SAUDE, V6, P5, DOI DOI 10.12820/RBAFS.V.6N2P5-18; Mekari S., 2015, EUR J APPL PHYSL; Morgan W P, 1977, Ann N Y Acad Sci, V301, P382, DOI 10.1111/j.1749-6632.1977.tb38215.x; N?brega OT., 2008, NEUROCIENCIAS, V4, P75; Noakes TD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00082; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Perini R, 2003, EUR J APPL PHYSIOL, V90, P317, DOI 10.1007/s00421-003-0953-9; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; RAGLIN JS, 1994, INT J SPORTS MED, V15, P84, DOI 10.1055/s-2007-1021025; Rhodes RE, 2015, ANN BEHAV MED, V49, P715, DOI 10.1007/s12160-015-9704-5; Rivera-Brown AM, 2012, PM&R, V4, P797, DOI 10.1016/j.pmrj.2012.10.007; Robertson CV, 2016, J APPL PHYSIOL, V120, P464, DOI 10.1152/japplphysiol.00363.2015; Rooks CR, 2010, PROG NEUROBIOL, V92, P134, DOI 10.1016/j.pneurobio.2010.06.002; Ross D., 1973, BRIT J SURG, P227; Sakaki M, 2016, NEUROIMAGE, V139, P44, DOI 10.1016/j.neuroimage.2016.05.076; Sarmiento S, 2013, J SYST SCI COMPLEX, V26, P104, DOI 10.1007/s11424-013-2287-y; Silvers JA, 2015, SOC COGN AFFECT NEUR, V10, P10, DOI 10.1093/scan/nsu016; Smith M, 2016, J HUM KINET, V51, P27, DOI 10.1515/hukin-2015-0167; Subudhi AW, 2011, J APPL PHYSIOL, V111, P1727, DOI 10.1152/japplphysiol.00569.2011; Tammen VV, 1996, J APPL SPORT PSYCHOL, V8, P1, DOI 10.1080/10413209608406304; Tempest G., 2015, COGN AFFECT BEHAV NE; Tempest GD, 2017, BRAIN COGNITION, V113, P133, DOI 10.1016/j.bandc.2017.02.001; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004; Trost SG, 2014, BRIT J SPORT MED, V48, P169, DOI 10.1136/bjsports-2013-093372	59	18	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11								10.1371/journal.pone.0186926	http://dx.doi.org/10.1371/journal.pone.0186926			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL4VN	29091915	Green Published, gold, Green Submitted			2022-12-26	WOS:000414229700034
J	Jordi, M; Marty, J; Mordasini, V; Lunemann, A; McComb, S; Bernasconi, M; Nadal, D				Jordi, Marc; Marty, Jeannine; Mordasini, Vanessa; Lunemann, Anna; McComb, Scott; Bernasconi, Michele; Nadal, David			IRAK4 is essential for TLR9-induced suppression of Epstein-Barr virus BZLF1 transcription in Akata Burkitt's lymphoma cells	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; NF-KAPPA-B; LYTIC CYCLE; HISTONE MODIFICATION; SIGNAL-TRANSDUCTION; CROSS-LINKING; LATENCY; EBV; REACTIVATION; ACTIVATION	Burkitt's lymphoma (BL) is the most common childhood cancer in equatorial Africa, and is endemic to areas where people are chronically co-infected with Epstein-Barr virus (EBV) and the malaria pathogen Plasmodium falciparum. The contribution of these pathogens in the oncogenic process remains poorly understood. We showed earlier that the activation of Toll-like receptor (TLR) 9 by hemozoin, a disposal product formed from the digestion of blood by P. falciparum, suppresses the lytic reactivation of EBV in BL cells. EBV lytic reactivation is regulated by the expression of transcription factor Zta (ZEBRA), encoded by the EBV gene BZLF1. Here, we explore in the BL cell line Akata, the mechanism involved in repression by TLR9 of expression of BZLF1. We show that BZLF1 repression is mediated upon TLR9 engagement by a mechanism that is largely independent of de novo protein synthesis. By CRISPR/Cas9-induced inactivation of TLR9, MyD88, IRAK4 and IRAK1 we confirm that BZLF1 repression is dependent on functional TLR9 and MyD88 signaling, and identify IRAK4 as an essential element for TLR9-induced repression of BZLF1 expression upon BCR cross-linking. Our results unprecedentedly show that TLR9-mediated inhibition of lytic EBV is largely independent of new protein synthesis and demonstrate the central roles of MyD88 and IRAK4 in this process contributing to EBV's persistence in the host's B-cell pool.	[Jordi, Marc; Marty, Jeannine; Mordasini, Vanessa; Lunemann, Anna; McComb, Scott; Bernasconi, Michele; Nadal, David] Univ Zurich, Univ Childrens Hosp Zurich, Lab Expt Infect Dis & Canc Res, Div Infect Dis, Zurich, Switzerland; [Jordi, Marc; Marty, Jeannine; Mordasini, Vanessa; Lunemann, Anna; McComb, Scott; Bernasconi, Michele; Nadal, David] Univ Zurich, Univ Childrens Hosp Zurich, Hosp Epidemiol, Zurich, Switzerland; [Jordi, Marc; Marty, Jeannine; Mordasini, Vanessa; Lunemann, Anna; McComb, Scott; Bernasconi, Michele; Nadal, David] Univ Zurich, Univ Childrens Hosp Zurich, Div Oncol, Zurich, Switzerland; [Jordi, Marc; Marty, Jeannine; Mordasini, Vanessa; Lunemann, Anna; McComb, Scott; Bernasconi, Michele; Nadal, David] Univ Zurich, Univ Childrens Hosp Zurich, Childrens Res Ctr, Zurich, Switzerland; [Nadal, David] Univ Childrens Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland	University Children's Hospital Zurich; University of Zurich; University Children's Hospital Zurich; University of Zurich; University Children's Hospital Zurich; University of Zurich; University Children's Hospital Zurich; University of Zurich; University Children's Hospital Zurich	Nadal, D (corresponding author), Univ Zurich, Univ Childrens Hosp Zurich, Lab Expt Infect Dis & Canc Res, Div Infect Dis, Zurich, Switzerland.; Nadal, D (corresponding author), Univ Zurich, Univ Childrens Hosp Zurich, Hosp Epidemiol, Zurich, Switzerland.; Nadal, D (corresponding author), Univ Zurich, Univ Childrens Hosp Zurich, Div Oncol, Zurich, Switzerland.; Nadal, D (corresponding author), Univ Zurich, Univ Childrens Hosp Zurich, Childrens Res Ctr, Zurich, Switzerland.; Nadal, D (corresponding author), Univ Childrens Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland.	david.nadal@kispi.uzh.ch	Bernasconi, Michele/C-6734-2008; Bernasconi, Michele/GOH-1815-2022; Bernasconi, Michele/CAG-2492-2022	Bernasconi, Michele/0000-0002-5746-8806; Bernasconi, Michele/0000-0002-5746-8806; Bernasconi, Michele/0000-0002-5746-8806	Swiss National Foundation [310040-568 114118]; Edoardo R., Giovanni, Giuseppe and Chiarina Sassella Foundation; OPO Foundation; Wolfermann-Nageli Foundation	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Edoardo R., Giovanni, Giuseppe and Chiarina Sassella Foundation; OPO Foundation; Wolfermann-Nageli Foundation	This work was supported by grants from the Swiss National Foundation (#310040-568 114118), Edoardo R., Giovanni, Giuseppe and Chiarina Sassella Foundation, OPO Foundation, and Wolfermann-Nageli Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYA T, 1991, LANCET, V337, P1190, DOI 10.1016/0140-6736(91)92861-U; Brady G, 2008, POSTGRAD MED J, V84, P372, DOI 10.1136/jcp.2007.047977; Bryant H, 2002, J VIROL, V76, P10290, DOI 10.1128/JVI.76.20.10290-10298.2002; Callan MFC, 2004, MICROBES INFECT, V6, P937, DOI 10.1016/j.micinf.2004.04.014; Chene A, 2007, PLOS PATHOG, V3, P826, DOI 10.1371/journal.ppat.0030080; COUNTRYMAN J, 1987, J VIROL, V61, P3672, DOI 10.1128/JVI.61.12.3672-3679.1987; Countryman JK, 2008, J VIROL, V82, P4706, DOI 10.1128/JVI.00116-08; DIRENZO L, 1994, INT J CANCER, V57, P914, DOI 10.1002/ijc.2910570623; Duellman SJ, 2009, J GEN VIROL, V90, P2251, DOI 10.1099/vir.0.012260-0; FLEMINGTON EK, 1991, J VIROL, V65, P7073, DOI 10.1128/JVI.65.12.7073-7077.1991; Haas F, 2014, J VIROL, V88, P10002, DOI 10.1128/JVI.01486-14; Heeg K, 2008, INT J MED MICROBIOL, V298, P33, DOI 10.1016/j.ijmm.2007.07.007; Hislop AD, 2015, CURR TOP MICROBIOL, V391, P325, DOI 10.1007/978-3-319-22834-1_11; Izumiya Y, 2009, J VIROL, V83, P4435, DOI 10.1128/JVI.01999-08; Jenkins PJ, 2000, J VIROL, V74, P710, DOI 10.1128/JVI.74.2.710-720.2000; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; KLEIN G, 1994, CELL, V77, P791, DOI 10.1016/0092-8674(94)90125-2; Ladell K, 2007, CELL MICROBIOL, V9, P2055, DOI 10.1111/j.1462-5822.2007.00937.x; Lunemann A, 2015, CURR TOP MICROBIOL, V391, P265, DOI 10.1007/978-3-319-22834-1_9; LUKA J, 1979, VIROLOGY, V94, P228, DOI 10.1016/0042-6822(79)90455-0; Middeldorp JM, 2015, CURR TOP MICROBIOL, V391, P289, DOI 10.1007/978-3-319-22834-1_10; Murata T, 2012, J VIROL, V86, P4752, DOI 10.1128/JVI.06768-11; NEMEROW GR, 1987, J VIROL, V61, P1416, DOI 10.1128/JVI.61.5.1416-1420.1987; Ramasubramanyan S, 2012, J VIROL, V86, P1809, DOI 10.1128/JVI.06334-11; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rechsteiner MP, 2008, J VIROL, V82, P1739, DOI 10.1128/JVI.01723-07; ROWE DT, 1986, EMBO J, V5, P2599, DOI 10.1002/j.1460-2075.1986.tb04540.x; Rowe M, 2009, SEMIN CANCER BIOL, V19, P377, DOI 10.1016/j.semcancer.2009.07.004; Speck SH, 2010, CELL HOST MICROBE, V8, P100, DOI 10.1016/j.chom.2010.06.014; TAKADA K, 1984, INT J CANCER, V33, P27, DOI 10.1002/ijc.2910330106; Takeshita F, 2004, SEMIN IMMUNOL, V16, P17, DOI 10.1016/j.smim.2003.10.009; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; TOVEY MG, 1978, NATURE, V276, P270, DOI 10.1038/276270a0; Ye JJ, 2010, J VIROL, V84, P12405, DOI 10.1128/JVI.01415-10; Yin QY, 2004, VIROLOGY, V327, P134, DOI 10.1016/j.virol.2004.06.026; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zauner L, 2010, ONCOGENE, V29, P4588, DOI 10.1038/onc.2010.203; ZURHAUSEN H, 1978, NATURE, V272, P373	38	7	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186614	10.1371/journal.pone.0186614	http://dx.doi.org/10.1371/journal.pone.0186614			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088270	Green Submitted, Green Accepted, gold, Green Published			2022-12-26	WOS:000414088900018
J	Mogire, RM; Akala, HM; Macharia, RW; Juma, DW; Cheruiyot, AC; Andagalu, B; Brown, ML; El-Shemy, HA; Nyanjom, SG				Mogire, Reagan M.; Akala, Hoseah M.; Macharia, Rosaline W.; Juma, Dennis W.; Cheruiyot, Agnes C.; Andagalu, Ben; Brown, Mathew L.; El-Shemy, Hany A.; Nyanjom, Steven G.			Target-similarity search using Plasmodium falciparum proteome identifies approved drugs with anti-malarial activity and their possible targets	PLOS ONE			English	Article							CIS-TRANS ISOMERASE; IN-VITRO ACTIVITY; DASATINIB BMS-354825; KINASE INHIBITOR; DNA TOPOISOMERASES; ACID METABOLISM; HDAC INHIBITORS; MOSQUITO-STAGE; RESISTANCE; DISCOVERY	Malaria causes about half a million deaths annually, with Plasmodium falciparum being responsible for 90% of all the cases. Recent reports on artemisinin resistance in Southeast Asia warrant urgent discovery of novel drugs for the treatment of malaria. However, most bioactive compounds fail to progress to treatments due to safety concerns. Drug repositioning offers an alternative strategy where drugs that have already been approved as safe for other diseases could be used to treat malaria. This study screened approved drugs for antimalarial activity using an in silico chemogenomics approach prior to in vitro verification. All the P. falciparum proteins sequences available in NCBI RefSeq were mined and used to perform a similarity search against DrugBank, TTD and STITCH databases to identify similar putative drug targets. Druggability indices of the potential P. falciparum drug targets were obtained from TDR targets database. Functional amino acid residues of the drug targets were determined using ConSurf server which was used to fine tune the similarity search. This study predicted 133 approved drugs that could target 34 P. falciparum proteins. A literature search done at PubMed and Google Scholar showed 105 out of the 133 drugs to have been previously tested against malaria, with most showing activity. For further validation, drug susceptibility assays using SYBR Green I method were done on a representative group of 10 predicted drugs, eight of which did show activity against P. falciparum 3D7 clone. Seven had IC50 values ranging from 1 mu M to 50 mu M. This study also suggests drug-target association and hence possible mechanisms of action of drugs that did show anti-plasmodial activity. The study results validate the use of proteome-wide target similarity approach in identifying approved drugs with activity against P. falciparum and could be adapted for other pathogens.	[Mogire, Reagan M.] Pan African Univ Inst Sci Technol & Innovat, Dept Mol Biol & Biotechnol, Nairobi, Kenya; [Akala, Hoseah M.; Juma, Dennis W.; Cheruiyot, Agnes C.; Andagalu, Ben; Brown, Mathew L.] Kenya Med Res Inst KEMRI, Walter Reed Project, DEID, USAMRD K, Kisumu, Kenya; [Macharia, Rosaline W.] Univ Nairobi, Ctr Biotechnol & Bioinformat, Nairobi, Kenya; [El-Shemy, Hany A.] Cairo Univ, Dept Biochem, Fac Agr, Giza, Egypt; [Nyanjom, Steven G.] Jomo Kenyatta Univ Agr & Technol, Dept Biochem, Nairobi, Kenya	Kenya Medical Research Institute; University of Nairobi; Egyptian Knowledge Bank (EKB); Cairo University; Jomo Kenyatta University of Agriculture & Technology	Mogire, RM (corresponding author), Pan African Univ Inst Sci Technol & Innovat, Dept Mol Biol & Biotechnol, Nairobi, Kenya.	reaganmoseti@gmail.com	El-Shemy, Hany A./A-6367-2008	Akala, Hoseah/0000-0001-8584-2706; Mogire, Reagan/0000-0001-6454-1613; Nyanjom, Steven/0000-0002-6290-991X	Japan International Cooperation Agency (AFRICA-ai-JAPAN Research Fund) [JKU/ADM/10B]; JICA [iCMOB/05/16]	Japan International Cooperation Agency (AFRICA-ai-JAPAN Research Fund); JICA	This work was supported by the Japan International Cooperation Agency (AFRICA-ai-JAPAN Research Fund), grant no; JKU/ADM/10B, (url: https//wwwJica.go.jp/keriya/english/). The grant number for financial support I received from JICA to facilitate part of this study is iCMOB/05/16 to RMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaki M, 2002, PARASITOL RES, V88, P1044, DOI 10.1007/s00436-002-0690-8; Akala HM, 2011, AM J TROP MED HYG, V85, P34, DOI 10.4269/ajtmh.2011.10-0674; Alam A, 2014, HINDAWI PUBLISHING C, V2014; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews KT, 2012, IMMUNOL CELL BIOL, V90, P66, DOI 10.1038/icb.2011.97; Andrews KT, 2009, CURR TOP MED CHEM, V9, P292, DOI 10.2174/156802609788085313; Andrews KT, 2006, ANTIMICROB AGENTS CH, V50, P639, DOI 10.1128/AAC.50.2.639-648.2006; Andrews KT, 2000, INT J PARASITOL, V30, P761, DOI 10.1016/S0020-7519(00)00043-6; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bajsa J, 2010, BIOORGANIC MED CHEM; Baldwin J, 2005, J BIOL CHEM, V280, P21847, DOI 10.1074/jbc.M501100200; Baniecki ML, 2007, ANTIMICROB AGENTS CH, V51, P716, DOI 10.1128/AAC.01144-06; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; BELL A, 1994, BIOCHEM PHARMACOL, V48, P495, DOI 10.1016/0006-2952(94)90279-8; Bentley R, 2000, CHEM REV, V100, P3801, DOI 10.1021/cr990097b; Bispo NA, 2013, PLOS ONE, P8; Bobbala D, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-102; Bodley AL, 1998, BIOCHEM PHARMACOL, V55, P709, DOI 10.1016/S0006-2952(97)00556-X; Boruah L, 2013, IJPBR, V1, P60; Buchholz K, 2011, J INFECT DIS, V203, P1445, DOI 10.1093/infdis/jir037; Burchard GD, 2014, INTERNIST, V55, P165, DOI 10.1007/s00108-013-3390-9; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chen LQ, 2007, CURR OPIN DRUG DISC, V10, P403; Chen ZM, 2006, MOL PHARMACOL, V69, P1527, DOI 10.1124/mol.105.020172; Cheruiyot AC, 2016, ANTIMICROB AGENTS CH, V60, P2417, DOI 10.1128/AAC.00527-15; Chong CR, 2006, NAT CHEM BIOL, V2, P415, DOI 10.1038/nchembio806; DarkinRattray SJ, 1996, P NATL ACAD SCI USA, V93, P13143, DOI 10.1073/pnas.93.23.13143; Das J, 2006, J MED CHEM, V49, P6819, DOI 10.1021/jm060727j; DAVIS R, 1994, DRUGS, V47, P677, DOI 10.2165/00003495-199447040-00008; Dechamps S, 2010, MOL BIOCHEM PARASIT, V173, P69, DOI 10.1016/j.molbiopara.2010.05.006; Delves M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001169; Derbyshire ER, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002178; Doerig C, 2004, BBA-PROTEINS PROTEOM, V1697, P155, DOI 10.1016/j.bbapap.2003.11.021; Doerig C, 2002, TRENDS PARASITOL, V18, P366, DOI 10.1016/S1471-4922(02)02321-8; Doerig C, 2008, TRENDS PARASITOL, V24, P570, DOI 10.1016/j.pt.2008.08.007; Dohse M, 2010, DRUG METAB DISPOS, V38, P1371, DOI 10.1124/dmd.109.031302; Drlica K, 1997, MICROBIOL MOL BIOL R, V61, P377, DOI 10.1128/.61.3.377-392.1997; Ekins S, 2011, PHARM RES-DORDR, V28, P1785, DOI 10.1007/s11095-011-0486-6; Engel JA, 2015, INT J PARASITOL-DRUG, V5, P117, DOI 10.1016/j.ijpddr.2015.05.004; FIGGITT D, 1992, ANTIMICROB AGENTS CH, V36, P1644, DOI 10.1128/AAC.36.8.1644; Finn RS, 2007, BREAST CANCER RES TR, V105, P319, DOI 10.1007/s10549-006-9463-x; Fiskus W, 2006, CLIN CANCER RES, V12, P5869, DOI 10.1158/1078-0432.CCR-06-0980; Flannery EL, 2013, NAT REV MICROBIOL, V11, P849, DOI 10.1038/nrmicro3138; Gandhi V, 2003, CLIN CANCER RES, V9, P6335; Garcia-Estrada C, 2010, P ROY SOC B-BIOL SCI, V277, P1777, DOI 10.1098/rspb.2009.2176; Gardner MJ, 2013, GENOME SEQUENCE HUMA, V419, P3; Garmory HS, 2004, INFECT IMMUN, V72, P6757, DOI 10.1128/IAI.72.12.6757-6763.2004; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Gego A, 2006, ANTIMICROB AGENTS CH, V50, P1586, DOI 10.1128/AAC.50.4.1586-1589.2006; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; goston A V, 2005, TRENDS PHARMACOL SCI, V26, P178; Graewe S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002224; Hampton T, 2004, JAMA-J AM MED ASSOC, V292, P419, DOI 10.1001/jama.292.4.419; Hamzah J, 2000, ACTA TROP, V74, P39, DOI 10.1016/S0001-706X(99)00051-0; Hedstrom L, 2011, CURR MED CHEM, V18, P1909, DOI 10.2174/092986711795590129; HERLEKAR I, 2014, CURR SCI INDIA, V106, P345, DOI DOI 10.1038/NATURE12876; Imming P, 2006, NAT REV DRUG DISCOV, V5, P821, DOI 10.1038/nrd2132; Jirage Dayadevi, 2010, Infectious Disorders - Drug Targets, V10, P134; Johnson FM, 2005, CLIN CANCER RES, V11, P6924, DOI 10.1158/1078-0432.CCR-05-0757; Johnson JD, 2007, ANTIMICROB AGENTS CH, V51, P1926, DOI 10.1128/AAC.01607-06; Kamath AV, 2008, CANCER CHEMOTH PHARM, V61, P365, DOI 10.1007/s00280-007-0478-8; Ke HJ, 2015, CELL REP, V11, P164, DOI 10.1016/j.celrep.2015.03.011; Ke HJ, 2014, J BIOL CHEM, V289, P34827, DOI 10.1074/jbc.M114.615831; Kesely KR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164895; Knockaert M, 2002, TRENDS PHARMACOL SCI, V23, P417, DOI 10.1016/S0165-6147(02)02071-0; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Koenderink JB, 2010, TRENDS PARASITOL, V26, P440, DOI 10.1016/j.pt.2010.05.002; Kuhn M, 2012, NUCLEIC ACIDS RES, V40, pD876, DOI 10.1093/nar/gkr1011; Bao LQ, 2017, IMMUNOLOGY, V150, P155, DOI 10.1111/imm.12661; Lee BJ, 2003, ANTIMICROB AGENTS CH, V47, P3810, DOI 10.1128/AAC.47.12.3810-3814.2003; Leprohon P, 2011, ESSAYS BIOCHEM, V50, P121, DOI [10.1042/BSE0500121, 10.1042/bse0500121]; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Li QL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-353; Liao CZ, 2011, FUTURE MED CHEM, V3, P1057, DOI [10.4155/FMC.11.63, 10.4155/fmc.11.63]; Lotharius J, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-143; Lucet IS, 2012, FUTURE MED CHEM, V4, P2295, DOI [10.4155/FMC.12.183, 10.4155/fmc.12.183]; Ma Y, 2010, PHYTOTHER RES, V24, P146, DOI 10.1002/ptr.2860; Macarron R, 2011, NAT REV DRUG DISCOV, V10, P188, DOI 10.1038/nrd3368; Magarinos MP, 2012, NUCLEIC ACIDS RES, V40, pD1118, DOI 10.1093/nar/gkr1053; Mahmoudi N, 2003, ANTIMICROB AGENTS CH, V47, P2636, DOI 10.1128/AAC.47.8.2636-2639.2003; Matthews H., 2013, ACCELERATING ANTIMAL; Menezes CMS, 2002, MEM I OSWALDO CRUZ F, P97; Meshnick Sr, 2001, INFEC DIS S, P15; Metz J, 2007, FOOD NUTR BULL, V28, pS540, DOI 10.1177/15648265070284S407; Monaghan P, 2005, MOL BIOCHEM PARASIT, V139, P185, DOI 10.1016/j.molbiopara.2004.10.007; Morgan S, 2011, HEALTH POLICY, V100, P4, DOI 10.1016/j.healthpol.2010.12.002; NAIR L, 1994, JPN J MED SCI BIOL, V47, P241, DOI 10.7883/yoken1952.47.241; Nasveld Peter, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P552; Neves BJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003435; Nezami A, 2003, BIOCHEMISTRY-US, V42, P8459, DOI 10.1021/bi034131z; Nsanzabana C, 2011, ANTIMICROB AGENTS CH, V55, P5073, DOI 10.1128/AAC.05130-11; Owens J, 2007, NAT REV DRUG DISCOV, V6, P187, DOI 10.1038/nrd2275; Pradines B, 2007, ANTIMICROB AGENTS CH, V51, P2654, DOI 10.1128/AAC.01330-06; Preuss J, 2012, IUBMB LIFE, V64, P603, DOI 10.1002/iub.1047; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Quintas-Cardama Alfonso, 2006, Future Oncol, V2, P655, DOI 10.2217/14796694.2.6.655; Raj DK, 2009, J BIOL CHEM, V284, P7687, DOI 10.1074/jbc.M806944200; Rijpma SR, 2016, MOL MICROBIOL, V101, P78, DOI 10.1111/mmi.13373; Sekhon B.S., 2013, J PHARM ED RES, V4, P1; Serrels A, 2006, MOL CANCER THER, V5, P3014, DOI 10.1158/1535-7163.MCT-06-0382; Sinou V, 1996, ANTIMICROB AGENTS CH, V40, P358, DOI 10.1128/AAC.40.2.358; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Sriram S, 2009, ANTIMALARIAL DRUG DE, P13; Stowers AW, 2001, INFECT IMMUN, V69, P1536, DOI 10.1128/IAI.69.3.1536-1546.2001; T D R Targets, 2015, TDR TARG DAT, P1; Talele TT, 2010, CURR TOP MED CHEM, V10, P127, DOI 10.2174/156802610790232251; Tam RC, 2001, ANTIVIR CHEM CHEMOTH, V12, P261, DOI 10.1177/095632020101200501; Tang YQ, 2004, MED RES REV, V24, P425, DOI 10.1002/med.10066; Team RDC, 2004, R LANG ENV STAT COMP; THOMSON AW, 1995, THER DRUG MONIT, V17, P584, DOI 10.1097/00007691-199512000-00007; Ting LM, 2005, J BIOL CHEM, V280, P9547, DOI 10.1074/jbc.M412693200; Tyler PC, 2007, J AM CHEM SOC, V129, P6872, DOI 10.1021/ja0708363; van Erp NP, 2009, CANCER TREAT REV, V35, P692, DOI 10.1016/j.ctrv.2009.08.004; van Niekerk DD, 2016, PLASMODIUM FALCIPARU, V283, P634; van Schaijk BCL, 2014, EUKARYOT CELL, V13, P550, DOI 10.1128/EC.00264-13; Velankar S, 2012, NUCLEIC ACIDS RES, V40, pD445, DOI 10.1093/nar/gkr998; Veletzky L, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-476; Wang LF, 2008, DRUG METAB DISPOS, V36, P1828, DOI 10.1124/dmd.107.020255; Wang Yufeng, 2004, Current Drug Targets - Infectious Disorders, V4, P25, DOI 10.2174/1568005043480952; WATT G, 1991, J INFECT DIS, V164, P602, DOI 10.1093/infdis/164.3.602; Wegscheid-Gerlach C, 2010, CURR TOP MED CHEM, V10, P346, DOI 10.2174/156802610790725461; White Nicholas J, 2008, Malar J, V7 Suppl 1, pS8, DOI 10.1186/1475-2875-7-S1-S8; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI [10.1172/JCI21682, 10.1172/JCI200421682]; WHO, 2006, AIR QUAL GUID GLOB U, DOI DOI 10.1016/0004-6981(88)90109-6; World Health Organization, 2016, WORLD MALARIA REPORT; Wu ZK, 2013, MOL BIOSYST, V9, P1268, DOI 10.1039/c3mb25382a; Yeh I, 2006, MINI-REV MED CHEM, V6, P177, DOI 10.2174/138955706775475957; Yu EY, 2009, CLIN CANCER RES, V15, P7421, DOI 10.1158/1078-0432.CCR-09-1691; Zhu F, 2012, NUCLEIC ACIDS RES, V40, pD1128, DOI 10.1093/nar/gkr797; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008; Zvegy-Laczka C, 2009, BRIT J PHARMACOL, P1153	131	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0186364	10.1371/journal.pone.0186364	http://dx.doi.org/10.1371/journal.pone.0186364			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088219	Green Submitted, gold, Green Published			2022-12-26	WOS:000414088900009
J	Oka, S; Furukawa, H; Yasunami, M; Kawasaki, A; Nakamura, H; Nakamura, M; Komori, A; Abiru, S; Nagaoka, S; Hashimoto, S; Naganuma, A; Naeshiro, N; Yoshizawa, K; Yamashita, H; Ario, K; Ohta, H; Sakai, H; Yabuuchi, I; Takahashi, A; Abe, K; Yatsuhashi, H; Tohma, S; Ohira, H; Tsuchiya, N; Migita, K				Oka, Shomi; Furukawa, Hiroshi; Yasunami, Michio; Kawasaki, Aya; Nakamura, Hitomi; Nakamura, Minoru; Komori, Atsumasa; Abiru, Seigo; Nagaoka, Shinya; Hashimoto, Satoru; Naganuma, Atsushi; Naeshiro, Noriaki; Yoshizawa, Kaname; Yamashita, Haruhiro; Ario, Keisuke; Ohta, Hajime; Sakai, Hironori; Yabuuchi, Iwao; Takahashi, Atsushi; Abe, Kazumichi; Yatsuhashi, Hiroshi; Tohma, Shigeto; Ohira, Hiromasa; Tsuchiya, Naoyuki; Migita, Kiyoshi			HLA-DRB1 and DQB1 alleles in Japanese type 1 autoimmune hepatitis: The predisposing role of the DR4/DR8 heterozygous genotype	PLOS ONE			English	Article							HLA-DR; SUSCEPTIBILITY; HAPLOTYPES; ASSOCIATION; PROTECTION; MECHANISMS; SEQUENCES; ANTIGENS; REGION	Objective Autoimmune hepatitis (AIH) is a chronic progressive liver disease. AIH is composed predominantly of type 1 in Japanese populations. The genetic and environmental factors are associated with the pathogenesis of AIH. HLA-DRB1* 03: 01 and * 04: 01 are associated with type 1 AIH in European and * 04: 05 in Japanese populations. Here, we conducted an HLA association study in order to find HLA alleles or haplotypes predisposing or protective for Japanese AIH. Methods HLA-DRB1 and DQB1 genotyping of 360 type 1 AIH patients and 1026 healthy controls was performed. Results The predisposing association of DRB1*04: 01 (P = 0.0006, corrected P [Pc] = 0.0193, odds ratio [OR] 2.97, 95% confidence interval [CI] 1.62-5.43), DRB1*04: 05 (P = 1.89x10(-21), Pc = 5.86x10(-20), OR 3.41, 95% CI 2.65-4.38), and DQB1*04: 01 (P = 4.66x10(-18), Pc = 6.99x10(-17), OR 3.89, 95% CI 2.84-5.33) and the protective association of DRB1*13: 02 (P = 0.0003, Pc = 0.0080, OR 0.48, 95% CI 0.32-0.72) with Japanese type 1 AIH were observed. An association of the DR4/DR8 heterozygous genotype with Japanese AIH was identified for the first time (P = 3.12x10(-9), OR 3.52, 95% CI 2.34-5.29). Susceptible diplotypes were DRB1*04: 05-DQB1*04: 01/DRB1*08: 02-DQB1*03: 02 (P = 0.0004, OR 24.77, 95% CI 1.45-424.31) and DRB1*04: 05-DQB1*04: 01/DRB1*08: 03-DQB1*06: 01 (P = 1.18x10(-6), OR 10.64, 95% CI 3.19-35.46). Serum levels of Immunoglobulin G and Immunoglobulin M, International Autoimmune Hepatitis Group score, positive rate of anti-smooth muscle antibodies, and the rate of definite AIH were higher in AIH patients with DRB1*04: 05 than without. Conclusions The important roles of specific combinations of DRB1 and DQB1 alleles or haplotypes in the pathogenesis of type 1 AIH were suggested. The association of DR4/DR8 heterozygous genotype suggested the pathologic importance of trans-complementing DQ alpha-beta heterodimer molecules encoded by DQA1 allele of one haplotype and the DQB1 allele of the other haplotype, as it was proposed in the HLA association studies of Type 1 diabetes.	[Oka, Shomi; Furukawa, Hiroshi; Kawasaki, Aya; Tsuchiya, Naoyuki] Univ Tsukuba, Mol & Genet Epidemiol Lab, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan; [Oka, Shomi; Furukawa, Hiroshi; Tohma, Shigeto] Sagamihara Natl Hosp, Natl Hosp Org, Clin Res Ctr Allergy & Rheumatol, Minami Ku, 18-1 Sakuradai, Sagamihara, Kanagawa, Japan; [Yasunami, Michio] Saga Ken Med Ctr Koseikan, Inst Life Sci, Dept Med Gen, 400 Kasemachi Nakabaru, Saga, Japan; [Yasunami, Michio; Nakamura, Hitomi] Nagasaki Univ, Dept Clin Med, Inst Trop Med, 1-12-4 Sakamoto, Nagasaki, Japan; [Nakamura, Minoru] Nagasaki Univ, Dept Hepatol, Grad Sch Biomed Sci, 1-12-4 Sakamoto, Nagasaki, Japan; [Nakamura, Minoru; Komori, Atsumasa; Yatsuhashi, Hiroshi; Migita, Kiyoshi] Natl Hosp Org, Nagasaki Med Ctr, Clin Res Ctr, 2-1001-1 Kubara, Omura, Japan; [Nakamura, Minoru; Komori, Atsumasa; Abiru, Seigo; Nagaoka, Shinya; Hashimoto, Satoru; Naganuma, Atsushi; Naeshiro, Noriaki; Yoshizawa, Kaname; Yamashita, Haruhiro; Ario, Keisuke; Ohta, Hajime; Sakai, Hironori; Yabuuchi, Iwao; Yatsuhashi, Hiroshi; Migita, Kiyoshi] Natl Hosp Org, Nagasaki Med Ctr, NHO AIH study Grp, 2-1001-1 Kubara, Omura, Japan; [Takahashi, Atsushi; Abe, Kazumichi; Ohira, Hiromasa; Migita, Kiyoshi] Fukushima Med Univ, Sch Med, Dept Gastroenterol & Rheumatol, 1 Hikarigaoka, Fukushima, Japan	University of Tsukuba; Nagasaki University; Nagasaki University; Fukushima Medical University	Furukawa, H (corresponding author), Univ Tsukuba, Mol & Genet Epidemiol Lab, Fac Med, 1-1-1 Tennodai, Tsukuba, Ibaraki, Japan.; Furukawa, H (corresponding author), Sagamihara Natl Hosp, Natl Hosp Org, Clin Res Ctr Allergy & Rheumatol, Minami Ku, 18-1 Sakuradai, Sagamihara, Kanagawa, Japan.	furukawa-tky@umin.org	Tsuchiya, Naoyuki/CAA-4545-2022	Tsuchiya, Naoyuki/0000-0002-6776-5580; Naganuma, Atsushi/0000-0003-0663-0102	Japan Society for the Promotion of Science [26293076]; Grants-in-Aid for Scientific Research [17H04169] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The work was supported by Grants-in-Aid for Clinical Research from National Hospital Organization and Grants-in-Aid for Scientific Research (B) (26293076) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparing the manuscript.	Alvarez E, 1999, J HEPATOL, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; Baharlou R, 2016, HUM IMMUNOL, V77, P330, DOI 10.1016/j.humimm.2016.01.007; Czaja AJ, 2010, GASTROENTEROLOGY, V139, P58, DOI 10.1053/j.gastro.2010.04.053; de Boer YS, 2014, GASTROENTEROLOGY, V147, P443, DOI 10.1053/j.gastro.2014.04.022; Duarte-Rey C, 2009, AUTOIMMUN REV, V8, P325, DOI 10.1016/j.autrev.2008.11.005; Erlich H, 2008, DIABETES, V57, P1084, DOI 10.2337/db07-1331; Fortes MD, 2007, LIVER INT, V27, P1409, DOI 10.1111/j.1478-3231.2007.01581.x; Furukawa H, 2017, GENES IMMUN IN PRESS, V2017; Furukawa H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154255; Furumoto Y, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0360-9; Goldberg AC, 2001, HUM IMMUNOL, V62, P165, DOI 10.1016/S0198-8859(00)00234-2; Hassan N, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.13598; Kamatani N, 2004, TISSUE CULTURE RES C, V23, P71; Kaur N, 2014, J CLIN EXP HEPATOL, V4, P14, DOI 10.1016/j.jceh.2013.12.002; Kawabata Y, 2002, DIABETES, V51, P545, DOI 10.2337/diabetes.51.2.545; Koning F, 2015, NAT REV RHEUMATOL, V11, P450, DOI 10.1038/nrrheum.2015.59; Krawitt EL, 2006, NEW ENGL J MED, V354, P54, DOI 10.1056/NEJMra050408; Lim YS, 2008, J HEPATOL, V48, P133, DOI 10.1016/j.jhep.2007.08.019; Maeda Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146048; Manns MP, 2006, HEPATOLOGY, V43, pS132, DOI 10.1002/hep.21059; Migita K, 2012, LIVER INT, V32, P837, DOI 10.1111/j.1478-3231.2011.02734.x; Miyadera H, 2015, J CLIN INVEST, V125, P275, DOI 10.1172/JCI74961; Nakajima F, 2001, MHC, V8, P1; Oka S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099453; Pando M, 1999, HEPATOLOGY, V30, P1374, DOI 10.1002/hep.510300611; Reveille John D., 1998, Current Opinion in Rheumatology, V10, P187, DOI 10.1097/00002281-199805000-00007; Strettell MDJ, 1997, GASTROENTEROLOGY, V112, P2028, DOI 10.1053/gast.1997.v112.pm9178696; Umemura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100565; Vazquez-Garcia MN, 1998, J HEPATOL, V28, P985, DOI 10.1016/S0168-8278(98)80347-4; Yoshizawa K, 2005, J HEPATOL, V42, P578, DOI 10.1016/j.jhep.2004.12.019	30	16	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187325	10.1371/journal.pone.0187325	http://dx.doi.org/10.1371/journal.pone.0187325			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL2ZD	29088299	Green Published, gold, Green Submitted			2022-12-26	WOS:000414088900066
J	Kompaniyets, L; Evans, MA				Kompaniyets, Lyudmyla; Evans, Marc A.			Modeling the relationship between wolf control and cattle depredation	PLOS ONE			English	Article							NORTHWESTERN UNITED-STATES; LIVESTOCK DEPREDATION	Wolf control to reduce cattle depredation is an important issue to ecology and agriculture in the United States. Two recent papers use the same dataset having wolf population characteristics and cattle depredation, but come to opposing conclusions concerning the link between wolf control and cattle depredation. Our paper aims to resolve this issue by using the same dataset and developing a model based on a causal association that would explain the nature of the relationship between wolf control and cattle depredation. We use the data on wolf population, number of cattle, number of wolves killed and number of cattle killed, from the U.S. Fish and Wildlife Services Interagency Annual Wolf Reports over the period of 1987-2012. We find a positive link between wolf control and cattle depredation. However, it would be incorrect to infer that wolf control has a positive effect on the number of cattle depredated. We maintain that this link comes from a growing wolf population, which increases cattle depredation, and in turn, causes an increase in the number of wolves killed. While the wolf population is growing, we see both wolf removal and cattle depredation simultaneously grow. It is not until the wolf population growth nears the steady state, that removal of wolves has a sufficient negative effect to reduce or stabilize the number of cattle depredated.	[Kompaniyets, Lyudmyla] Washington State Univ, Sch Econ Sci, Pullman, WA 99164 USA; [Evans, Marc A.] Washington State Univ, Dept Math & Stat, Pullman, WA 99164 USA	Washington State University; Washington State University	Kompaniyets, L (corresponding author), Washington State Univ, Sch Econ Sci, Pullman, WA 99164 USA.; Evans, MA (corresponding author), Washington State Univ, Dept Math & Stat, Pullman, WA 99164 USA.	l.kompaniyets@wsu.edu; marcevan@wsu.edu						[Anonymous], 2015, NO ROCK MOUNT GRAY W; [Anonymous], 1996, CATEGORICAL DATA ANA; [Anonymous], 2016, GRAY WOLV NO ROCK MO; Bangs EE, 2005, CONSERV BIOL SER, V9, P340; Blejwas KM, 2002, J WILDLIFE MANAGE, V66, P451, DOI 10.2307/3803178; Bradley EH, 2005, CONSERV BIOL, V19, P1498, DOI 10.1111/j.1523-1739.2005.00102.x; Bradley EH, 2015, J WILDLIFE MANAGE, V79, P1337, DOI 10.1002/jwmg.948; Creel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012918; Kutner M., 2004, APPL LINEAR STAT MOD; McCullagh P, 1989, GEN LINEAR MODELS; Mech LD, 2010, J WILDLIFE MANAGE, V74, P1421, DOI 10.2193/2009-540; Muhly TB, 2009, ECOL ECON, V68, P2439, DOI 10.1016/j.ecolecon.2009.04.008; Murray DL, 2010, BIOL CONSERV, V143, P2514, DOI 10.1016/j.biocon.2010.06.018; Musiani M, 2005, WILDLIFE SOC B, V33, P876, DOI 10.2193/0091-7648(2005)33[876:SARODA]2.0.CO;2; Naughton-Treves L, 2003, CONSERV BIOL, V17, P1500, DOI 10.1111/j.1523-1739.2003.00060.x; Packer C, 2003, ECOL LETT, V6, P797, DOI 10.1046/j.1461-0248.2003.00500.x; Parsons DR, 1998, WILDLIFE SOC B, V26, P799; Poudyal N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148743; SAS Institute Inc, 2011, BAS SAS 9 3 PROC GUI; Wielgus RB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113505	20	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187264	10.1371/journal.pone.0187264	http://dx.doi.org/10.1371/journal.pone.0187264			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084261	Green Published, Green Submitted, gold			2022-12-26	WOS:000413910200045
J	Figueroa, A; Gulati, RK; Rainey, JJ				Figueroa, Argelia; Gulati, Reena K.; Rainey, Jeanette J.			Estimating the frequency and characteristics of respiratory disease outbreaks at mass gatherings in the United States: Findings from a state and local health department assessment	PLOS ONE			English	Article							PANDEMIC INFLUENZA; INFECTIOUS-DISEASE; VIRUS; RISK	Mass gatherings create environments conducive to the transmission of infectious diseases. Thousands of mass gatherings are held annually in the United States; however, information on the frequency and characteristics of respiratory disease outbreaks and on the use of non-pharmaceutical interventions at these gatherings is scarce. We administered an online assessment to the 50 state health departments and 31 large local health departments in the United States to gather information about mass gathering-related respiratory disease outbreaks occurring between 2009 and 2014. The assessment also captured information on the use of nonpharmaceutical interventions to slow disease transmission in these settings. We downloaded respondent data into a SAS dataset for descriptive analyses. We received responses from 43 (53%) of the 81 health jurisdictions. Among these, 8 reported 18 mass gathering outbreaks. More than half (n = 11) of the outbreaks involved zoonotic transmission of influenza A (H3N2v) at county and state fairs. Other outbreaks occurred at camps (influenza A (H1N1) pdm09 [n = 2] and A (H3) [n = 1]), religious gatherings (influenza A (H1N1) pdm09 [n = 1] and unspecified respiratory virus [n = 1]), at a conference (influenza A (H1N1) pdm09), and a sporting event (influenza A). Outbreaks ranged from 5 to 150 reported cases. Of the 43 respondents, 9 jurisdictions used nonpharmaceutical interventions to slow or prevent disease transmission. Although respiratory disease outbreaks with a large number of cases occur at many types of mass gatherings, our assessment suggests that such outbreaks may be uncommon, even during the 2009 influenza A (H1N1) pandemic, which partially explains the reported, but limited, use of nonpharmaceutical interventions. More research on the characteristics of mass gatherings with respiratory disease outbreaks and effectiveness of nonpharmaceutical interventions would likely be beneficial for decision makers at state and local health departments when responding to future outbreaks and pandemics.	[Figueroa, Argelia; Gulati, Reena K.] Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA USA; [Rainey, Jeanette J.] Ctr Dis Control & Prevent, Div Global Hlth Protect, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Rainey, JJ (corresponding author), Ctr Dis Control & Prevent, Div Global Hlth Protect, Atlanta, GA 30333 USA.	jkr7@cdc.gov						Abubakar I, 2012, LANCET INFECT DIS, V12, P66, DOI 10.1016/S1473-3099(11)70246-8; Aiello AE, 2008, AM J PUBLIC HEALTH, V98, P1372, DOI 10.2105/AJPH.2007.124610; American Camp Association, 2017, ACA SIT FAC PROGR RE; Blyth CC, 2010, EMERG INFECT DIS, V16, P809, DOI 10.3201/eid1605.091136; Botelho-Nevers E, 2010, J TRAVEL MED, V17, P197, DOI 10.1111/j.1708-8305.2010.00410.x; Centers for Disease Control and Prevention, THE FLU SEAS; Centers for Disease Control and Prevention (CDC), FLU PREV MASS GATH; Centers for Disease Control and Prevention (CDC), 2009, CDC HLTH UPD SCH K 1; Centers for Disease Control and Prevention (CDC), FLU ACT 2012 2013 SE; Chowell G, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-159; Coletta M., 2006, Morbidity and Mortality Weekly Report, V55, P71; Glatman-Freedman A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050228; Gundlapalli AV, 2006, EMERG INFECT DIS, V12, P144, DOI 10.3201/eid1201.050645; Gutierrez I, 2009, EUROSURVEILLANCE, V2009, P14; Ishola DA, 2011, J EPIDEMIOL GLOB HEA, V1, P33, DOI 10.1016/j.jegh.2011.06.004; Jefferson T, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006207.pub4; Jhung MA, 2013, CLIN INFECT DIS, V57, P1703, DOI 10.1093/cid/cit649; Johansson A, 2012, LANCET INFECT DIS, V12, P150, DOI 10.1016/S1473-3099(11)70287-0; Khan K, 2012, LANCET INFECT DIS, V12, P222, DOI 10.1016/S1473-3099(11)70313-9; Kniss Krista, 2011, Morbidity and Mortality Weekly Report, V60, P705; Michael J A, 1997, Prehosp Disaster Med, V12, P305; PricewaterhouseCoopers, 2014, EC SIGN M US EC INT; Qualls N, 2017, MMWR RECOMM REP, V66, P1, DOI 10.15585/mmwr.rr6601a1; Rainey JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160378; Rashid H, 2008, LANCET INFECT DIS, V8, P526, DOI 10.1016/S1473-3099(08)70186-5; Robinson S, 2012, PEDIATR INFECT DIS J, V31, P547, DOI 10.1097/INF.0b013e31824f8124; SAENZ AC, 1969, LANCET, V1, P91; Selig B, 2013, J EMERG NURS, V39, pE39, DOI 10.1016/j.jen.2011.10.002; Shi PY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-778; Tsalik EL, 2011, J AM COLL HEALTH, V59, P419, DOI 10.1080/07448481.2010.534215; Vaughan E, 2009, AM J PUBLIC HEALTH, V99, pS324, DOI 10.2105/AJPH.2009.162537; Weber TP, 2008, J INFECTION, V57, P361, DOI 10.1016/j.jinf.2008.08.013; Zielinski Andrzej, 2009, Przegl Epidemiol, V63, P343	33	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186730	10.1371/journal.pone.0186730	http://dx.doi.org/10.1371/journal.pone.0186730			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077750	Green Submitted, gold, Green Published			2022-12-26	WOS:000413861200019
J	Kramer, DB; Stevens, K; Williams, NE; Sistla, SA; Roddy, AB; Urquhart, GR				Kramer, Daniel B.; Stevens, Kara; Williams, Nicholas E.; Sistla, Seeta A.; Roddy, Adam B.; Urquhart, Gerald R.			Coastal livelihood transitions under globalization with implications for trans-ecosystem interactions	PLOS ONE			English	Article							COVER CHANGE; CONSERVATION; POVERTY	Anthropogenic threats to natural systems can be exacerbated due to connectivity between marine, freshwater, and terrestrial ecosystems, complicating the already daunting task of governance across the land-sea interface. Globalization, including new access to markets, can change social-ecological, land-sea linkages via livelihood responses and adaptations by local people. As a first step in understanding these trans-ecosystem effects, we examined exit and entry decisions of artisanal fishers and smallholder farmers on the rapidly globalizing Caribbean coast of Nicaragua. We found that exit and entry decisions demonstrated clear temporal and spatial patterns and that these decisions differed by livelihood. In addition to household characteristics, livelihood exit and entry decisions were strongly affected by new access to regional and global markets. The natural resource implications of these livelihood decisions are potentially profound as they provide novel linkages and spatially explicit feedbacks between terrestrial and marine ecosystems. Our findings support the need for more scientific inquiry in understanding trans-ecosystem tradeoffs due to linked-livelihood transitions as well as the need for a trans-ecosystem approach to natural resource management and development policy in rapidly changing coastal regions.	[Kramer, Daniel B.] Michigan State Univ, James Madison Coll, E Lansing, MI 48824 USA; [Stevens, Kara] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Stevens, Kara] NOAA, 1315 East West Highway, Silver Spring, MD USA; [Williams, Nicholas E.] Univ Colorado, Environm Studies Program, Boulder, CO 80309 USA; [Sistla, Seeta A.] Hampshire Coll, Amherst, MA 01002 USA; [Roddy, Adam B.] Yale Univ, Yale Sch Forestry & Environm Studies, New Haven, CT USA; [Urquhart, Gerald R.] Michigan State Univ, Lyman Briggs Coll, E Lansing, MI 48824 USA; [Urquhart, Gerald R.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder; Yale University; Michigan State University; Michigan State University	Kramer, DB (corresponding author), Michigan State Univ, James Madison Coll, E Lansing, MI 48824 USA.	dbk@msu.edu	Roddy, Adam/M-4523-2013	Roddy, Adam/0000-0002-4423-8729	U.S. National Science Foundation [CNH-0815966]; U.S. National Socio-Environmental Synthesis Center (SESYNC); German Center for Integrative Biodiversity Research (iDIV)	U.S. National Science Foundation(National Science Foundation (NSF)); U.S. National Socio-Environmental Synthesis Center (SESYNC)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); German Center for Integrative Biodiversity Research (iDIV)	This work was supported by U.S. National Science Foundation CNH-0815966, https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=13681; U.S. National Socio-Environmental Synthesis Center (SESYNC), https://www.sesync.org/; and the German Center for Integrative Biodiversity Research (iDIV), https://www.idiv.de/sdiv.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adger WN, 2002, AMBIO, V31, P358, DOI 10.1639/0044-7447(2002)031[0358:MRLTAS]2.0.CO;2; Adger WN, 2005, SCIENCE, V309, P1036, DOI 10.1126/science.1112122; Alvarez-Romero JG, 2015, BIOL CONSERV, V191, P799, DOI 10.1016/j.biocon.2015.07.003; Alvarez-Romero JG, 2011, ANNU REV ECOL EVOL S, V42, P381, DOI 10.1146/annurev-ecolsys-102209-144702; [Anonymous], 2011, REEFS RISK REVISITED; Auguie B, 2017, GRIDEXTRA MISCELLANE; Barrett CB, 2001, FOOD POLICY, V26, P367, DOI 10.1016/S0306-9192(01)00017-3; Barton K., 2013, MUMIN MULTIMODEL INT; Bebbington A, 1999, CAPITALS CAPABILITIE; Bene C, 2011, PROG DEV STUD, V11, P119, DOI 10.1177/146499341001100203; Bhandari PB, 2013, J RURAL STUD, V32, P126, DOI 10.1016/j.jrurstud.2013.05.001; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CGIAR Research Program on Aquatic Agricultural Systems, 2012, RES LIV FOOD SEC COA; Christie, 2000, TAKING CARE WHAT WE; Cinner JE, 2009, CONSERV BIOL, V23, P124, DOI 10.1111/j.1523-1739.2008.01041.x; Cinner JE, 2016, NATURE, V535, P416, DOI 10.1038/nature18607; Cinner JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011999; Convention on the International Trade of Endagered Species, 2014, CITES EXT LEG CONTR; Daw TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031460; Ferrol-Schulte D, 2013, MAR POLICY, V42, P253, DOI 10.1016/j.marpol.2013.03.007; Food and Agricultural Organization of the United Nations, 2017, SMALL SAL FISH; Garland K.A., 2010, CONSERV SOC, V8, P55, DOI 10.4103/0972-4923.62675; Glaeser B, 2010, HUM ECOL REV, V17, P135; Hviding E, 1998, OCEAN COAST MANAGE, V40, P253, DOI 10.1016/S0964-5691(98)00042-8; International Fund for Agricultural Development & United Nations Development Programme, 2013, SMALL HOLD FOOD SEC; Ivarez-romero JG, 2013, CONSERV LETT, P1; Ivarez-romero JG, 2015, PLOS ONE, V10; Jamieson M, 2011, NATL INTEGRATION CON, P283; Jordan CA, 2010, TAPIR CONSERV, V19; Kramer DB, 2009, ECOL ECON, V68, P2897, DOI 10.1016/j.ecolecon.2009.06.026; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; MacNeil MA, 2010, PHILOS T R SOC B, V365, P3753, DOI 10.1098/rstb.2010.0289; McCauley DJ, 2013, BIOL CONSERV, V165, P139, DOI 10.1016/j.biocon.2013.05.026; Mcneely J. A, 2003, ECOAGRICULTURE STRAT; Mora C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000131; Muallil RN, 2011, FISH RES, V111, P74, DOI 10.1016/j.fishres.2011.06.013; Nakazawa M, 2015, PACKAGE FMSB; Nations F& AO of the U, 2014, STAT FOOD AGR; Olsoy PJ, 2016, BIOL CONSERV, V203, P8, DOI 10.1016/j.biocon.2016.08.037; Reuter K, 2016, ENVIRON CONSERV, P1; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Schmitt KM, 2009, ENVIRON CONSERV, V36, P289, DOI 10.1017/S0376892910000159; Sistla SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162529; Stevens K, 2014, MAR POLICY, V50, P46, DOI 10.1016/j.marpol.2014.05.007; Sunderlin WD, 2000, ENVIRON CONSERV, V27, P284, DOI 10.1017/S0376892900000321; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams, 2015, DYNAMIC INTERRELATIO; Williams NE, 2016, J POLIT ECOL, V23, P223, DOI 10.2458/v23i1.20210; Witt CM, 2015, SCIENCE, V347, pS50	49	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186683	10.1371/journal.pone.0186683	http://dx.doi.org/10.1371/journal.pone.0186683			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK9WD	29077748	Green Published, Green Submitted, gold			2022-12-26	WOS:000413861200016
J	Kulaeva, OA; Zhernakov, AI; Afonin, AM; Boikov, SS; Sulima, AS; Tikhonovich, IA; Zhukov, VA				Kulaeva, Olga A.; Zhernakov, Aleksandr I.; Afonin, Alexey M.; Boikov, Sergei S.; Sulima, Anton S.; Tikhonovich, Igor A.; Zhukov, Vladimir A.			Pea Marker Database (PMD) - A new online database combining known pea (Pisum sativum L.) gene-based markers	PLOS ONE			English	Article							MEDICAGO-TRUNCATULA; INEFFECTIVE NODULATION; NITROGEN-FIXATION; CANDIDATE GENES; LINKAGE MAPS; POLYMORPHISM; NODULES; GENOME; IDENTIFICATION; CONSERVATION	Pea (Pisum sativum L.) is the oldest model object of plant genetics and one of the most agriculturally important legumes in the world. Since the pea genome has not been sequenced yet, identification of genes responsible for mutant phenotypes or desirable agricultural traits is usually performed via genetic mapping followed by candidate gene search. Such mapping is best carried out using gene-based molecular markers, as it opens the possibility for exploiting genome synteny between pea and its close relative Medicago truncatula Gaertn., possessing sequenced and annotated genome. In the last 5 years, a large number of pea gene-based molecular markers have been designed and mapped owing to the rapid evolution of "next-generation sequencing" technologies. However, the access to the complete set of markers designed worldwide is limited because the data are not uniformed and therefore hard to use. The Pea Marker Database was designed to combine the information about pea markers in a form of user-friendly and practical online tool. Version 1 (PMD1) comprises information about 2484 genic markers, including their locations in linkage groups, the sequences of corresponding pea transcripts and the names of related genes in M. truncatula. Version 2 (PMD2) is an updated version comprising 15944 pea markers in the same format with several advanced features. To test the performance of the PMD, fine mapping of pea symbiotic genes Sym13 and Sym27 in linkage groups VII and V, respectively, was carried out. The results of mapping allowed us to propose the Sen1 gene (a homologue of SEN1 gene of Lotus japonicus (Regel) K. Larsen) as the best candidate gene for Sym13, and to narrow the list of possible candidate genes for Sym27 to ten, thus proving PMD to be useful for pea gene mapping and cloning.	[Kulaeva, Olga A.; Zhernakov, Aleksandr I.; Afonin, Alexey M.; Boikov, Sergei S.; Sulima, Anton S.; Tikhonovich, Igor A.; Zhukov, Vladimir A.] All Russia Res Inst Agr Microbiol, St Petersburg, Russia; [Tikhonovich, Igor A.] St Petersburg State Univ, Univ Skaya Embankment, St Petersburg, Russia	Saint Petersburg State University	Zhukov, VA (corresponding author), All Russia Res Inst Agr Microbiol, St Petersburg, Russia.	VZhukov@arriam.ru	Afonin, Alexey m./K-4186-2017; Zhernakov, Aleksandr/AAB-7596-2020; Tikhonovich, Igor A./C-1744-2014; Sulima, Anton/AAB-7597-2020; Zhukov, Vladimir/A-4781-2014	Afonin, Alexey m./0000-0002-8530-0226; Tikhonovich, Igor A./0000-0001-8968-854X; Zhukov, Vladimir/0000-0002-2411-9191; Sulima, Anton/0000-0002-2300-857X; Zhernakov, Aleksandr/0000-0001-8961-9317	Russian Science Foundation [14-24-00135, 16-16-00118]; Russian Foundation for Basic Research [16-34-60132]	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	The work of AMA and IAT on development of PMD1 and localization of the Sym27 gene was supported by the Russian Science Foundation (http://www.rscf.ru/en) (Grant # 14-24-00135). The work of OAK on development of PMD2 was supported by the Russian Foundation for Basic Research (http://www.rfbr.ru/rffi/eng) (Grant # 16-34-60132). The work of AIZ, ASS and VAZ on localization of the Sym13 gene and Sen1 sequencing was supported by the Russian Science Foundation (http://www.rscf.ru/en) (Grant # 16-16-00118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonin A, 2017, GENOM DATA, V11, P85, DOI 10.1016/j.gdata.2016.12.003; Alves-Carvalho S, 2015, PLANT J, V84, P1, DOI 10.1111/tpj.12967; Armstead I, 2007, SCIENCE, V315, P73, DOI 10.1126/science.1132912; Aubert G, 2006, THEOR APPL GENET, V112, P1024, DOI 10.1007/s00122-005-0205-y; Bohra A, 2014, THEOR APPL GENET, V127, P1263, DOI 10.1007/s00122-014-2301-3; Bordat A, 2011, G3-GENES GENOM GENET, V1, P93, DOI 10.1534/g3.111.000349; Borisov AY, 2007, APPL BIOCHEM MICRO+, V43, P237, DOI 10.1134/S0003683807030027; Borisov AY, 1997, MOL GEN GENET, V254, P592, DOI 10.1007/s004380050456; Bourgeois M, 2011, PROTEOMICS, V11, P1581, DOI 10.1002/pmic.201000687; Boutet G, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2447-2; Burstin J, 2001, PLANT BREEDING, V120, P311, DOI 10.1046/j.1439-0523.2001.00608.x; Choi HK, 2004, P NATL ACAD SCI USA, V101, P15289, DOI 10.1073/pnas.0402251101; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Demason D. A., 2006, Pisum Genetics, V38, P3; Deulvot C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-468; Duarte J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-126; Ellis THN, 2002, NEW PHYTOL, V153, P17, DOI 10.1046/j.0028-646X.2001.00302.x; ENGVILD KC, 1987, THEOR APPL GENET, V74, P711, DOI 10.1007/BF00247546; Franssen SU, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-227; Gilpin BJ, 1997, THEOR APPL GENET, V95, P1289, DOI 10.1007/s001220050695; Hakoyama T, 2012, PLANT CELL PHYSIOL, V53, P225, DOI 10.1093/pcp/pcr167; He J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-441; Hecht V, 2005, PLANT PHYSIOL, V137, P1420, DOI 10.1104/pp.104.057018; Ivanova KA, 2015, PROTOPLASMA, V252, P1505, DOI 10.1007/s00709-015-0780-y; Jing R, 2007, GENETICS, V177, P2263, DOI 10.1534/genetics.107.081323; Kalo P, 2004, MOL GENET GENOMICS, V272, P235, DOI 10.1007/s00438-004-1055-z; Kaur S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-104; KNEEN BE, 1990, PLANT PHYSIOL, V94, P899, DOI 10.1104/pp.94.3.899; KNEEN BE, 1988, PLANT SCI, V58, P177, DOI 10.1016/0168-9452(88)90007-6; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Laucou V, 1998, THEOR APPL GENET, V97, P905, DOI 10.1007/s001220050971; Lejeune-Henaut I, 2008, THEOR APPL GENET, V116, P1105, DOI 10.1007/s00122-008-0739-x; Leonforte A, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-161; Loridon K, 2005, THEOR APPL GENET, V111, P1022, DOI 10.1007/s00122-005-0014-3; Ma Y, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-016-0956-4; Macas J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-427; Morzhina EV, 2000, PLANT SCI, V155, P75, DOI 10.1016/S0168-9452(00)00207-7; Neff MM, 2002, TRENDS GENET, V18, P613, DOI 10.1016/S0168-9525(02)02820-2; Page D, 2002, MOL GENET GENOMICS, V267, P359, DOI 10.1007/s00438-002-0667-4; Platten JD, 2005, PLANT PHYSIOL, V139, P1472, DOI 10.1104/pp.105.067462; Prioul-Gervais S, 2007, THEOR APPL GENET, V114, P971, DOI 10.1007/s00122-006-0492-y; Rameau C, 1998, THEOR APPL GENET, V97, P916, DOI 10.1007/s001220050972; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; Royal Botanic Gardens, KEW PLANT DNA C VAL; Serova TA, 2017, J PLANT PHYSIOL, V212, P29, DOI 10.1016/j.jplph.2017.01.012; Sindhu A, 2014, THEOR APPL GENET, V127, P2225, DOI 10.1007/s00122-014-2375-y; Smykal P, 2012, AGRONOMY-BASEL, V2, P74, DOI 10.3390/agronomy2020074; Sorefan K, 2003, GENE DEV, V17, P1469, DOI 10.1101/gad.256603; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Sudheesh S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1815-7; Tang HB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-312; Tayeh N, 2015, PLANT J, V84, P1257, DOI 10.1111/tpj.13070; Tayeh N, 2013, MOL BREEDING, V32, P279, DOI 10.1007/s11032-013-9869-1; Varshney RK, 2010, MOLECULAR TECHNIQUES IN CROP IMPROVEMENT, SECOND EDITION, P119, DOI 10.1007/978-90-481-2967-6_5; Verdier J, 2008, PLANT MOL BIOL, V67, P567, DOI 10.1007/s11103-008-9320-x; Vilmorin PD, 1911, P ROY SOC LOND B BIO, V84, P9; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Weeden NF, 1998, PISUM GENET, V30, P4; Wellensiek SJ, 1925, GENETIC MONOGRAPH PI; Yang T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139775; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhernakov A, 2017, GENOM DATA, V11, P75, DOI 10.1016/j.gdata.2016.12.004; Zhukov V. A., 2007, Pisum Genetics, V39, P19; Zhukov VA, 2015, INT J GENOMICS, V2015, DOI 10.1155/2015/695947	64	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2017	12	10							e0186713	10.1371/journal.pone.0186713	http://dx.doi.org/10.1371/journal.pone.0186713			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9QH	29073280	Green Submitted, Green Published, gold			2022-12-26	WOS:000413845400043
J	Kim, HR; Kim, YS; Yoon, JA; Yang, SC; Park, M; Seol, DW; Lyu, SW; Jun, JH; Lim, HJ; Lee, DR; Song, H				Kim, Hye-Ryun; Kim, Yeon Sun; Yoon, Jung Ah; Yang, Seung Chel; Park, Mira; Seol, Dong-Won; Lyu, Sang Woo; Jun, Jin Hyun; Lim, Hyunjung Jade; Lee, Dong Ryul; Song, Haengseok			Estrogen induces EGR1 to fine-tune its actions on uterine epithelium by controlling PR signaling for successful embryo implantation	FASEB JOURNAL			English	Article						P-4 signaling; transcription factor; uterine receptivity; epithelial cell differentiation	PROGESTERONE-RECEPTORS MEDIATE; ZINC-FINGER GENE; NGFI-A; CELL-PROLIFERATION; NERVOUS-SYSTEM; BISPHENOL-A; C/EBP-BETA; MICE; EXPRESSION; UTERUS	The harmonized actions of ovarian E-2 and progesterone (P-4) regulate the proliferation and differentiation of uterine cells in a spatiotemporal manner. Imbalances between these hormones often lead to infertility and gynecologic diseases. Whereas numerous factors that are involved in P-4 signaling have been identified, few local factors that mediate E-2 actions in the uterus have been revealed. Here, we demonstrate that estrogen induces the transcription factor, early growth response 1 (Egr1), to fine-tune its actions in uterine epithelial cells (ECs) that are responsible for uterine receptivity for embryo implantation. In the presence of exogenous gonadotrophins, ovulation, fertilization, and embryonic development normally occur in Egr1(-/-) mice, but these animals experience the complete failure of embryo implantation with reduced artificial decidualization. Although serum levels of E-2 and P-4 were comparable between Egr1(+/+) and Egr1(-/-) mice on d 4 of pregnancy, aberrantly reduced levels of progesterone receptor in Egr1(-/-) uterine ECs caused enhanced E-2 activity and impaired P-4 response. Ultrastructural analyses revealed that Egr1(-/-) ECs are not fully able to provide proper uterine receptivity. Uterine mRNA landscapes in Egr1(-/-) mice revealed that EGR1 controls the expression of a subset of E-2-regulated genes. In addition, P-4 signaling was unable to modulate estrogen actions, including those that are involved in cell-cycle progression, in ECs that were deficient in EGR1. Furthermore, primary coculture of Egr1(-/-) ECs with Egr1(+/+) stromal cells, and vice versa, supported the notion that Egr1 is required tomodulate E-2 actions on ECs to prepare the uterine environment for embryo implantation. In contrast to its role in ECs, loss of Egr1 in stroma significantly reduced stromal cell proliferation. Collectively, our results demonstrate that E-2 induces EGR1 to streamline its actions for the preparation of uterine receptivity for embryo implantation in mice.	[Kim, Hye-Ryun; Kim, Yeon Sun; Yang, Seung Chel; Park, Mira; Seol, Dong-Won; Lee, Dong Ryul; Song, Haengseok] CHA Univ, Dept Biomed Sci, Seongnam, South Korea; [Yoon, Jung Ah; Lyu, Sang Woo] CHA Univ, CHA Gangnam Med Ctr, Fertil Ctr, Seoul, South Korea; [Jun, Jin Hyun] Eulji Univ, Grad Sch Hlth Sci, Dept Biomed Lab Sci, Seongnam, South Korea; [Lim, Hyunjung Jade] Konkuk Univ, Dept Vet Med, Seoul, South Korea	Pochon Cha University; Pochon Cha University; Eulji University; Konkuk University; Konkuk University Medical Center	Song, H (corresponding author), CHA Univ, Dept Biomed Sci, CHA Biocomplex 612,335 Pangyo Ro, Seongnam Si 13488, Gyeonggi Do, South Korea.	hssong@cha.ac.kr	Lim, Hyunjung J/D-5343-2011	Lim, Hyunjung J/0000-0003-2191-666X; Song, Haengseok/0000-0002-5027-7310	National Research Foundation of Korea - South Korean government [NRF-2012R1A2A2A01011274, NRF-2015R1A2A2A01006714, NRF-2016R1C1B1015648]	National Research Foundation of Korea - South Korean government	This work was supported, in part, by grants from the National Research Foundation of Korea funded by the South Korean government [NRF-2012R1A2A2A01011274 and NRF-2015R1A2A2A01006714 (to H.S.), and NRF-2016R1C1B1015648 (to H.-R.K.)]. The authors declare no conflicts of interest.	Albert Y, 2005, J CELL BIOL, V169, P257, DOI 10.1083/jcb.200501156; Andrade J., 2015, END SOC 97 ANN M EXP; Bhattacharyya S, 2013, J PATHOL, V229, P286, DOI 10.1002/path.4131; Brown SB, 2015, STEROIDS, V99, P8, DOI 10.1016/j.steroids.2014.12.013; Chung D, 2011, ENDOCRINOLOGY, V152, P3246, DOI 10.1210/en.2011-0223; DeSouza MM, 1998, BIOL REPROD, V58, P1503, DOI 10.1095/biolreprod58.6.1503; Fang F, 2013, AM J PATHOL, V183, P1197, DOI 10.1016/j.ajpath.2013.06.016; Franco HL, 2012, FASEB J, V26, P1218, DOI 10.1096/fj.11-193334; Guo B, 2014, CELL CYCLE, V13, P2626, DOI 10.4161/15384101.2014.943581; Hewitt SC, 2003, MOL ENDOCRINOL, V17, P2070, DOI 10.1210/me.2003-0146; Huang N, 2015, PROSTAG OTH LIPID M, V121, P170, DOI 10.1016/j.prostaglandins.2015.08.002; HUETHUDSON YM, 1989, ENDOCRINOLOGY, V125, P1683, DOI 10.1210/endo-125-3-1683; Jeong JW, 2009, P NATL ACAD SCI USA, V106, P8677, DOI 10.1073/pnas.0903632106; Jones A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001551; Katzenellenbogen B S, 1979, Recent Prog Horm Res, V35, P259; Kawagoe J, 2012, DEV CELL, V23, P858, DOI 10.1016/j.devcel.2012.09.002; Kim HR, 2014, REPROD TOXICOL, V50, P60, DOI 10.1016/j.reprotox.2014.10.010; Kim Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep19548; Knobil E., 2006, KNOBIL NEILLS PHYSL, V2; Kommagani R, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005937; Kurihara I, 2007, PLOS GENET, V3, P1053, DOI 10.1371/journal.pgen.0030102; Kurita T, 1998, ENDOCRINOLOGY, V139, P4708, DOI 10.1210/en.139.11.4708; LEE SL, 1995, J BIOL CHEM, V270, P9971, DOI 10.1074/jbc.270.17.9971; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; Li QX, 2011, SCIENCE, V331, P912, DOI 10.1126/science.1197454; Liang XH, 2014, J BIOL CHEM, V289, P23534, DOI 10.1074/jbc.M114.588897; Lopez-Lopez D, 2017, EPILEPSY BEHAV, V71, P226, DOI 10.1016/j.yebeh.2015.12.020; Mantena SR, 2006, P NATL ACAD SCI USA, V103, P1870, DOI 10.1073/pnas.0507261103; Murphy CR, 2004, CELL RES, V14, P259, DOI 10.1038/sj.cr.7290227; Pagel JI, 2012, INT J MOL SCI, V13, P13104, DOI 10.3390/ijms131013104; Ramathal C, 2010, MOL CELL BIOL, V30, P1607, DOI 10.1128/MCB.00872-09; SCHNEIDERMAUNOURY S, 1993, CELL, V75, P1199, DOI 10.1016/0092-8674(93)90329-O; Seo Bong-Jong, 2014, Dev Reprod, V18, P1, DOI 10.12717/DR.2014.18.1.001; Simon L, 2009, ENDOCRINOLOGY, V150, P3871, DOI 10.1210/en.2008-1691; Sun XF, 2013, MOL ENDOCRINOL, V27, P1492, DOI 10.1210/me.2013-1086; SWIATEK PJ, 1993, GENE DEV, V7, P2071, DOI 10.1101/gad.7.11.2071; SWIRNOFF AH, 1995, MOL CELL BIOL, V15, P2275; Topilko P, 1998, MOL ENDOCRINOL, V12, P107, DOI 10.1210/mend.12.1.0049; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Tourtellotte WG, 2000, MOL CELL BIOL, V20, P5261, DOI 10.1128/MCB.20.14.5261-5268.2000; Tourtellotte WG, 1999, DEVELOPMENT, V126, P5061; WILKINSON DG, 1989, NATURE, V337, P461, DOI 10.1038/337461a0; Xiao S, 2011, REPROD TOXICOL, V32, P434, DOI 10.1016/j.reprotox.2011.08.010; Yan SF, 1999, J BIOL CHEM, V274, P15030, DOI 10.1074/jbc.274.21.15030	44	19	20	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2018	32	3					1184	1195		10.1096/fj.201700854RR	http://dx.doi.org/10.1096/fj.201700854RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FZ0GN	29092905				2022-12-26	WOS:000427246000007
J	Li, Y; Zhao, M; Guo, C; Chu, H; Li, W; Chen, X; Wang, X; Li, Y; Jia, Y; Koussatidjoa, S; Zhu, F; Wang, J; Wang, X; Wang, Q; Zhao, W; Shi, Y; Chen, W; Zhang, L				Li, Y.; Zhao, M.; Guo, C.; Chu, H.; Li, W.; Chen, X.; Wang, X.; Li, Y.; Jia, Y.; Koussatidjoa, S.; Zhu, F.; Wang, J.; Wang, X.; Wang, Q.; Zhao, W.; Shi, Y.; Chen, W.; Zhang, L.			Intracellular mature IL-37 suppresses tumor metastasis via inhibiting Rac1 activation	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; RHO GTPASES; HEPATOCELLULAR-CARCINOMA; INNATE INFLAMMATION; CYTOKINE PRODUCTION; POLYBASIC REGION; CANCER CELLS; LUNG-CANCER; IN-VIVO; INTERLEUKIN-37	IL-37, a newly found anti-inflammatory cytokine of the IL-1 family, has both extracellular and intracellular functions. Accumulating evidences indicate that it is also involved in tumor progression. However, the mechanism and its intracellular target are unclear. In this study, clinical data from 84 patients showed that loss or reduced expression of IL-37 in lung adenocarcinoma tissues was significantly associated with tumor metastasis. We further provided evidence that IL-37 inhibited effectively tumor metastasis in vitro and in vivo. Moreover, we uncovered a novel mechanism by which IL-37 suppressed tumor cell migration via its intracellular mature form (amino acids 46-218). Intracellular mature form of IL-37, but not its extracellular form, markedly inhibited migration of multiple kinds of tumor cells through inhibiting Rac1 activation. Mechanistically, intracellular mature IL-37 directly bound to the CAAX motif in the C-terminal hypervariable region of Rac1, and then inhibited Rac1 membrane translocation and subsequent downstream signaling. Our research identifies intracellular mature IL-37 as a novel endogenous inhibitor of Rac1. Given the crucial roles of Rac1 in tumor angiogenesis and metastasis, intracellular mature IL-37 might serve as a potential strategy for the control of Rac1 activity and tumor progression.	[Li, Y.; Zhao, M.; Guo, C.; Chu, H.; Li, W.; Chen, X.; Wang, X.; Li, Y.; Jia, Y.; Koussatidjoa, S.; Zhu, F.; Wang, J.; Wang, X.; Wang, Q.; Zhao, W.; Shi, Y.; Zhang, L.] Shandong Univ, Sch Basic Med Sci, Dept Immunol, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China; [Li, Y.; Zhao, M.; Guo, C.; Chu, H.; Li, W.; Chen, X.; Wang, X.; Li, Y.; Jia, Y.; Koussatidjoa, S.; Zhu, F.; Wang, J.; Wang, X.; Wang, Q.; Zhao, W.; Shi, Y.; Zhang, L.] Shandong Univ, Sch Basic Med Sci, Key Lab Infect & Immun Shandong Prov, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China; [Chen, W.] NIDCR, Mucosal Immunol Sect, NIH, Bethesda, MD USA	Shandong University; Shandong University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Zhang, L (corresponding author), Shandong Univ, Sch Basic Med Sci, Dept Immunol, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.; Zhang, L (corresponding author), Shandong Univ, Sch Basic Med Sci, Key Lab Infect & Immun Shandong Prov, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.	zhanglining@sdu.edu.cn		Zhao, Wei/0000-0001-8440-2274	national key research and development plan of China [2016YFC1303405]; National Natural Science Foundation of China [31470856, 91439124]; Shandong Provincial Natural Science Foundation, China [2014GSF118076, ZR2011HZ003]; Fundamental Research Funds of Shandong University [2014QY004]; Major Project of Science and Technology of Shandong Province [2015ZDJS04001]; NIH, NIDCR, USA	national key research and development plan of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province); Fundamental Research Funds of Shandong University; Major Project of Science and Technology of Shandong Province; NIH, NIDCR, USA	This research is supported by the national key research and development plan of China (No. 2016YFC1303405), the National Natural Science Foundation of China (31470856 and 91439124), Shandong Provincial Natural Science Foundation, China (2014GSF118076, ZR2011HZ003), the Fundamental Research Funds of Shandong University (2014QY004) and Major Project of Science and Technology of Shandong Province (2015ZDJS04001). WC is supported by the Intramural Research Program of NIH, NIDCR, USA.	Abulkhir A, 2017, J LEUKOCYTE BIOL, V101, P395, DOI 10.1189/jlb.5RU0816-341R; Ballak DB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5711; Boraschi D, 2011, EUR CYTOKINE NETW, V22, P127, DOI 10.1684/ecn.2011.0288; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; Bulau AM, 2014, P NATL ACAD SCI USA, V111, P2650, DOI 10.1073/pnas.1324140111; Bulau AM, 2011, THESCIENTIFICWORLDJO, V11, P2480, DOI 10.1100/2011/968479; Busfield SJ, 2000, GENOMICS, V66, P213, DOI 10.1006/geno.2000.6184; Cao XL, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-149; Chai M, 2015, J INTERF CYTOK RES, V35, P530, DOI 10.1089/jir.2014.0212; Chen QY, 2011, INT J MOL MED, V28, P769, DOI 10.3892/ijmm.2011.775; Chen YH, 2016, ONCOL REP, V36, P2017, DOI 10.3892/or.2016.4995; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Cherfils J, 2011, NAT CHEM BIOL, V7, P493, DOI 10.1038/nchembio.608; Coll-Miro M, 2016, P NATL ACAD SCI USA, V113, P1411, DOI 10.1073/pnas.1523212113; Dinarello CA, 2016, EUR J IMMUNOL, V46, P1067, DOI 10.1002/eji.201545828; Fang D, 2017, ONCOGENE, V36, P1546, DOI 10.1038/onc.2016.323; Gao JH, 2009, AM J TRANSL RES, V1, P312; Gao WT, 2003, J IMMUNOL, V170, P107, DOI 10.4049/jimmunol.170.1.107; Ge GQ, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0293-3; Karnoub AE, 2004, BREAST CANCER RES TR, V84, P61, DOI 10.1023/B:BREA.0000018427.84929.5c; Kreis P, 2009, CELL SIGNAL, V21, P384, DOI 10.1016/j.cellsig.2008.11.001; Kumar S, 2000, J BIOL CHEM, V275, P10308, DOI 10.1074/jbc.275.14.10308; Kumar S, 2002, CYTOKINE, V18, P61, DOI 10.1006/cyto.2002.0873; Lanning CC, 2004, J BIOL CHEM, V279, P44197, DOI 10.1074/jbc.M404977200; Li SZ, 2015, P NATL ACAD SCI USA, V112, P2497, DOI 10.1073/pnas.1424626112; Li ZQ, 2016, ONCOTARGET, V7, P62224, DOI 10.18632/oncotarget.11406; Lin Y, 2015, EXPERT OPIN DRUG DIS, V10, P991, DOI 10.1517/17460441.2015.1058775; Liu R, 2016, ONCOTARGET, V7, P85079, DOI 10.18632/oncotarget.13196; Liu SJ, 2008, HEPATOLOGY, V47, P1964, DOI 10.1002/hep.22240; Lunding L, 2015, ALLERGY, V70, P366, DOI 10.1111/all.12566; Luo YC, 2014, P NATL ACAD SCI USA, V111, P15178, DOI 10.1073/pnas.1416714111; McNamee EN, 2011, P NATL ACAD SCI USA, V108, P16711, DOI 10.1073/pnas.1111982108; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Modha R, 2008, J BIOL CHEM, V283, P1492, DOI 10.1074/jbc.M706760200; Moretti S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004462; Nold MF, 2010, NAT IMMUNOL, V11, P1014, DOI 10.1038/ni.1944; Nold-Petry CA, 2015, NAT IMMUNOL, V16, P354, DOI 10.1038/ni.3103; Quirk S, 2014, EXPERT REV CLIN IMMU, V10, P1703, DOI 10.1586/1744666X.2014.971014; Rathinam R, 2011, FRONT BIOSCI-LANDMRK, V16, P2561, DOI 10.2741/3872; Schaefer Antje, 2014, Small GTPases, V5, P6, DOI 10.4161/21541248.2014.968004; Smithers CC, 2016, CELLS, V5, P2; Teng X, 2014, J IMMUNOL, V192, P1815, DOI 10.4049/jimmunol.1300047; Wang CQ, 2016, AM J CANCER RES, V6, P1873; Wang S, 2015, J CANCER, V6, P962, DOI 10.7150/jca.12266; Wang ZJ, 2012, P NATL ACAD SCI USA, V109, P15413, DOI 10.1073/pnas.1204525109; Wittinghofer A, 2011, ANNU REV BIOCHEM, V80, P943, DOI 10.1146/annurev-biochem-062708-134043; Wu B, 2014, CLIN EXP IMMUNOL, V176, P438, DOI 10.1111/cei.12284; Yan XF, 2017, ONCOTARGET, V8, P49064, DOI 10.18632/oncotarget.17093; Ye L, 2015, J IMMUNOL, V194, P5110, DOI 10.4049/jimmunol.1401810; Ye L, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-69; Zhao JJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05177; Zou T, 2017, CLIN GENET, V91, P520, DOI 10.1111/cge.12908	52	19	19	3	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 22	2018	37	8					1095	1106		10.1038/onc.2017.405	http://dx.doi.org/10.1038/onc.2017.405			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FX2QD	29106392				2022-12-26	WOS:000425905700012
J	Kelley, RA; Al-Ubaidi, MR; Sinha, T; Genc, AM; Makia, MS; Ikelle, L; Naash, MI				Kelley, Ryan A.; Al-Ubaidi, Muayyad R.; Sinha, Tirthankar; Genc, Ayse M.; Makia, Mustafa S.; Ikelle, Larissa; Naash, Muna I.			Ablation of the riboflavin-binding protein retbindin reduces flavin levels and leads to progressive and dose-dependent degeneration of rods and cones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECESSIVE RETINITIS-PIGMENTOSA; EPITHELIUM-DERIVED FACTOR; FATTY ACYL DERIVATIVES; MACULAR DEGENERATION; OXYGEN-CONSUMPTION; OUTER RETINA; COENZYME-A; IDENTIFICATION; DEHYDROGENASE; METABOLISM	The interface between the neural retina and the retinal pigment epithelium (RPE) is critical for several processes, including visual pigment regeneration and retinal attachment to the RPE. One of its most important functions is the exchange of metabolites between the photoreceptors and RPE because photoreceptor cells have very high energy demands, largely satisfied by oxidative metabolism. The riboflavin (RF) cofactors, flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN), are two key cofactors involved in oxidative metabolism. We have previously shown that retbindin is a photoreceptor-specific RF-binding protein exclusively expressed in the rods and present in the interphotoreceptor matrix at the interface between the RPE and photoreceptor outer segments. Here, we show that retbindin ablation in mice causes a retinal phenotype characterized by time- and dose-dependent declines in rod and cone photoreceptor functions as early as 120 days of age. Whereas minor retinal ultrastructural defects were observed at all ages examined, a significant decline occurred in photoreceptor nuclei at 240 days of age (similar to 36.8% rods and similar to 19.9% cones). Interestingly, significant reductions in FAD and FMN levels were observed before the onset of degeneration (similar to 46.1% FAD and similar to 45% FMN). These findings suggest that the reduced levels of these flavins result in the disruption of intracellular mechanisms, leading to photoreceptor cell death. Altogether, our results suggest that retbindin is a key player in the acquisition and retention of flavins in the neural retina, warranting future investigation into retbindin's role in photoreceptor cell death in models of retinal degenerative disorders.	[Kelley, Ryan A.; Al-Ubaidi, Muayyad R.; Sinha, Tirthankar; Genc, Ayse M.; Makia, Mustafa S.; Ikelle, Larissa; Naash, Muna I.] Univ Houston, Dept Biomed Engn, 3517 Cullen Blvd,SERC 2011, Houston, TX 77204 USA; [Kelley, Ryan A.] Univ Colorado, Anschutz Med Ctr, Skaggs Sch Pharm & Pharmaceut Sci, Aurora, CO 80045 USA	University of Houston System; University of Houston; University of Colorado System; University of Colorado Anschutz Medical Campus	Al-Ubaidi, MR; Naash, MI (corresponding author), Univ Houston, Dept Biomed Engn, 3517 Cullen Blvd,SERC 2011, Houston, TX 77204 USA.	malubaid@central.uh.edu; mnaash@central.uh.edu	Sinha/A-5725-2013	Sinha/0000-0002-7138-0907	NEI, National Institutes of Health [R01EY026499, R01-EY10609]; Foundation Fighting Blindness; NATIONAL EYE INSTITUTE [R01EY026499, R01EY010609] Funding Source: NIH RePORTER	NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Foundation Fighting Blindness(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NEI, National Institutes of Health, Grants R01EY026499 and R01-EY10609 (to M. I. N. and M. R. A.) and the Foundation Fighting Blindness (to M. R. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALDER VA, 1990, INVEST OPHTH VIS SCI, V31, P1029; Ban Y, 2000, DEV BRAIN RES, V121, P89; Bandah-Rozenfeld D, 2010, AM J HUM GENET, V87, P199, DOI 10.1016/j.ajhg.2010.07.004; BATEY DW, 1991, INVEST OPHTH VIS SCI, V32, P1981; BATEY DW, 1992, EXP EYE RES, V54, P605, DOI 10.1016/0014-4835(92)90139-J; BATEY DW, 1990, ANAL BIOCHEM, V188, P164, DOI 10.1016/0003-2697(90)90546-L; BRAUN RD, 1995, INVEST OPHTH VIS SCI, V36, P542; Bridges CC, 2002, CURR EYE RES, V24, P129, DOI 10.1076/ceyr.24.2.129.8167; Byun JY, 2006, MOL VIS, V12, P949; Campochiaro PA, 2006, HUM GENE THER, V17, P167, DOI 10.1089/hum.2006.17.167; Chakraborty D, 2016, HUM MOL GENET, V25, P3500, DOI 10.1093/hmg/ddw193; Cheng T, 1997, J NEUROSCI, V17, P8118, DOI 10.1523/jneurosci.17-21-08118.1997; Conley SM, 2017, HUM MOL GENET, V26, P509, DOI 10.1093/hmg/ddw408; CRANE FL, 1956, J BIOL CHEM, V218, P701; CRANE FL, 1956, J BIOL CHEM, V218, P717; den Hollander AI, 2009, INVEST OPHTH VIS SCI, V50, P1864, DOI 10.1167/iovs.08-2497; ECKHERT CD, 1993, EXPERIENTIA, V49, P1084, DOI 10.1007/BF01929917; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; FUTTERMAN S, 1959, J BIOL CHEM, V234, P723; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Huvaere K, 2010, J PHYS CHEM B, V114, P5583, DOI 10.1021/jp9121744; Kansara V, 2005, J OCUL PHARMACOL TH, V21, P275, DOI 10.1089/jop.2005.21.275; Kelley RA, 2015, J BIOL CHEM, V290, P5041, DOI 10.1074/jbc.M114.624189; Kim HJ, 2013, BBA-BIOENERGETICS, V1827, P627, DOI 10.1016/j.bbabio.2013.01.012; Kozhevnikova OS, 2013, CELL CYCLE, V12, P1745, DOI 10.4161/cc.24825; Kruse HD, 1940, PUBLIC HEALTH REP, V55, P157, DOI 10.2307/4583161; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Lin JM, 2008, AM J OPHTHALMOL, V145, P716, DOI 10.1016/j.ajo.2007.11.006; Machalinska Anna, 2012, Klin Oczna, V114, P115; Murray AR, 2015, HUM MOL GENET, V24, P2709, DOI 10.1093/hmg/ddv031; Said HM, 2005, J PHYSIOL-LONDON, V566, P369, DOI 10.1113/jphysiol.2005.085811; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sparrrow JR, 2010, CURR MOL MED, V10, P802; Stricker HM, 2005, BIOCHEM J, V388, P605, DOI 10.1042/BJ20041960; Stuck MW, 2015, J BIOL CHEM, V290, P27901, DOI 10.1074/jbc.M115.683698; Tan E, 2001, INVEST OPHTH VIS SCI, V42, P589; THORPE C, 1979, BIOCHEMISTRY-US, V18, P331, DOI 10.1021/bi00569a016; Tomitsuka E, 2003, J BIOCHEM, V134, P191, DOI 10.1093/jb/mvg144; Wang L, 1997, INVEST OPHTH VIS SCI, V38, P48; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352; WINKLER BS, 1981, J GEN PHYSIOL, V77, P667, DOI 10.1085/jgp.77.6.667	42	18	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 22	2017	292	51					21023	21034		10.1074/jbc.M117.785105	http://dx.doi.org/10.1074/jbc.M117.785105			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ6DG	29079576	hybrid, Green Published			2022-12-26	WOS:000418453400018
J	Barrios, D; Morillo, R; Guerassirnova, I; Barbero, E; Escobar-Morreale, H; Cohen, AT; Becattini, C; Tapson, V; Yusen, R; Jimenez, D				Barrios, Deisy; Morillo, Raquel; Guerassirnova, Ina; Barbero, Esther; Escobar-Morreale, Hector; Cohen, Alexander T.; Becattini, Cecilia; Tapson, Victor; Yusen, Roger; Jimenez, David			Sex differences in the characteristics and short-term prognosis of patients presenting with acute symptomatic pulmonary embolism	PLOS ONE			English	Article							RISK STRATIFICATION; OUTCOMES; GENDER; THROMBOEMBOLISM; PREDICTION; MANAGEMENT; DIAGNOSIS; THERAPY	Background We sought to examine sex-related differences in the characteristics and outcome in patients presenting with acute symptomatic pulmonary embolism (PE). Methods We conducted a retrospective cohort study of 2,096 patients diagnosed with acute PE. The characteristics were recorded at presentation. Treatment was at the discretion of patients' physicians. The primary study outcome, all-cause mortality, and the secondary outcomes of PE-specific mortality, recurrent venous thromboembolism, and major bleeding were assessed during the first month of follow-up after PE diagnosis. Results Overall, the women were older than the men and had significantly higher rates of immobilization. They had significantly lower rates of chronic obstructive pulmonary disease and cancer. Women had a higher prevalence of syncope and elevated brain natriuretic peptide levels. Thirty-day all-cause mortality was similar between women and men (7.1% versus 6.2%; P= 0.38). Male gender was not independently significantly associated with PE-related death (adjusted odds ratio [OR] 1.02; 95% Cl, 0.50 to 2.07; P= 0.96). Restricting the analyses to haemodynamically stable patients (n = 2,021), female gender was an independent predictor of all-cause (adjusted OR 1.56; 95% Cl, 1.07 to 2.28; P= 0.02) and PE-specific mortality (adjusted OR 1.85; 95% Cl, 1.02 to 3.33; P= 0.04). Compared with men, women were 2.05 times more likely to experience a major bleed. Conclusions Women and men with PE had different clinical characteristics, presentation, and outcomes. Women receiving anticoagulation have a significantly higher risk of major bleeding, suggesting the need for careful monitoring of anticoagulant intensity in women.	[Barrios, Deisy; Morillo, Raquel; Guerassirnova, Ina; Barbero, Esther; Jimenez, David] Univ Alcala IRYCIS, Resp Dept, Hosp Ramon y Cajal, Madrid, Spain; [Barrios, Deisy; Morillo, Raquel; Guerassirnova, Ina; Barbero, Esther; Escobar-Morreale, Hector; Jimenez, David] Univ Alcala IRYCIS, Med Dept, Madrid, Spain; [Escobar-Morreale, Hector] Univ Alcala IRYCIS, Hosp Ramon y Cajal, Endocrinol Dept, Madrid, Spain; [Cohen, Alexander T.] Guys & St Thomas NHS Fdn Trust, Dept Haematol Med, London, England; [Becattini, Cecilia] Univ Perugia, Internal & Cardiovasc Med, Perugia, Italy; [Tapson, Victor] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Yusen, Roger] Washington Univ, Sch Med, Div Pulm & Crit Care Med, St Louis, MO USA; [Yusen, Roger] Washington Univ, Sch Med, Div Gen Med Sci, St Louis, MO USA	Hospital Universitario Ramon y Cajal; Universidad de Alcala; Universidad de Alcala; Hospital Universitario Ramon y Cajal; Universidad de Alcala; Guy's & St Thomas' NHS Foundation Trust; University of Perugia; Cedars Sinai Medical Center; Washington University (WUSTL); Washington University (WUSTL)	Jimenez, D (corresponding author), Univ Alcala IRYCIS, Resp Dept, Hosp Ramon y Cajal, Madrid, Spain.; Jimenez, D (corresponding author), Univ Alcala IRYCIS, Med Dept, Madrid, Spain.	djimnez.hrc@gmail.com	Escobar-Morreale, Héctor F/G-5468-2010; Becattini, Cecilia/L-1739-2018; Jimenez, David/G-1627-2015	Escobar-Morreale, Héctor F/0000-0002-6890-1644; Jimenez, David/0000-0002-4571-7721; BECATTINI, Cecilia/0000-0002-8343-4888	Instituto de Salud Carlos III [PIE1600050 SEXCOMPLEX]; Spanish Ministry of Economy and Competitiveness; Fondo Europeo de Desarrollo Regional FEDER	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government); Fondo Europeo de Desarrollo Regional FEDER(European CommissionSpanish Government)	This work was supported by Grant PIE1600050 SEXCOMPLEX from Instituto de Salud Carlos III to DJ, Spanish Ministry of Economy and Competitiveness. CIBERDEM is also an initiative of Instituto de Salud Carlos III. This work was also supported in part by Fondo Europeo de Desarrollo Regional FEDER to DJ.	Agarwal S, 2015, AM J CARDIOL, V116, P1270, DOI 10.1016/j.amjcard.2015.07.048; Aujesky D, 2005, AM J RESP CRIT CARE, V172, P1041, DOI 10.1164/rccm.200506-862OC; BarrettConnor E, 1997, CIRCULATION, V95, P252, DOI 10.1161/01.CIR.95.1.252; Barrios D, 2017, SEMIN RESP CRIT CARE, V38, P11, DOI 10.1055/s-0036-1597556; Becattini C, 2016, EUR RESPIR J, V48, P780, DOI 10.1183/13993003.00024-2016; Beemath A, 2006, AM J CARDIOL, V98, P793, DOI 10.1016/j.amjcard.2006.03.064; Blanco-Molina A, 2014, MEDICINE, V93, P309, DOI 10.1097/MD.0000000000000114; Dries DL, 1997, J AM COLL CARDIOL, V29, P1074, DOI 10.1016/S0735-1097(97)00019-3; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Hochman JS, 1999, NEW ENGL J MED, V341, P226, DOI 10.1056/NEJM199907223410402; Jimenez D, 2010, ARCH INTERN MED, V170, P1383, DOI 10.1001/archinternmed.2010.199; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kasper W, 1997, J AM COLL CARDIOL, V30, P1165, DOI 10.1016/S0735-1097(97)00319-7; Kearon C, 1998, ANN INTERN MED, V129, P1044, DOI 10.7326/0003-4819-129-12-199812150-00009; Kuijer PMM, 1999, ARCH INTERN MED, V159, P457, DOI 10.1001/archinte.159.5.457; Lapner ST, 2014, J THROMB HAEMOST, V12, P595, DOI 10.1111/jth.12529; Marrugat J, 1999, J CARDIOVASC RISK, V6, P89; Marshall PS, 2015, SEMIN RESP CRIT CARE, V36, P835, DOI 10.1055/s-0035-1564733; Panigada G, 2016, ACTA CLIN BELG, V71, P142, DOI 10.1080/17843286.2015.1133003; PRANDONI P, 1993, CIRCULATION, V88, P1730, DOI 10.1161/01.CIR.88.4.1730; REMYJARDIN M, 1992, RADIOLOGY, V185, P381, DOI 10.1148/radiology.185.2.1410342; Riera-Mestre A, 2012, J THROMB HAEMOST, V10, P751, DOI 10.1111/j.1538-7836.2012.04698.x; Sanchez D, 2011, J THROMB HAEMOST, V9, P2201, DOI 10.1111/j.1538-7836.2011.04490.x; STEGNAR M, 1993, THROMB RES, V69, P81, DOI 10.1016/0049-3848(93)90005-9; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753	26	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187648	10.1371/journal.pone.0187648	http://dx.doi.org/10.1371/journal.pone.0187648			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	29107971	Green Published, Green Submitted, gold			2022-12-26	WOS:000414424600053
J	Mautner, ME; Santangelo, AP; Bielsa, RMC; Sala, A; Ginart, S; Corach, D				Mautner, Martin E.; Perez Santangelo, Agustin; Corti Bielsa, Rodrigo M.; Sala, Andrea; Ginart, Santiago; Corach, Daniel			Using long ssDNA polynucleotides to amplify STRs loci in degraded DNA samples	PLOS ONE			English	Article							DEVELOPMENTAL VALIDATION; AMPLIFICATION; REPEAT; IDENTIFICATION; SEQUENCES; ASSAY; KIT	Obtaining informative short tandem repeat (STR) profiles from degraded DNA samples is a challenging task usually undermined by locus or allele dropouts and peak-high imbalances observed in capillary electrophoresis (CE) electropherograms, especially for those markers with large amplicon sizes. We hereby show that the current STR assays may be greatly improved for the detection of genetic markers in degraded DNA samples by using long single stranded DNA polynucleotides (ssDNA polynucleotides) as surrogates for PCR primers. These long primers allow a closer annealing to the repeat sequences, thereby reducing the length of the template required for the amplification in fragmented DNA samples, while at the same time rendering amplicons of larger sizes suitable for multiplex assays. We also demonstrate that the annealing of long ssDNA polynucleotides does not need to be fully complementary in the 5' region of the primers, thus allowing for the design of practically any long primer sequence for developing new multiplex assays. Furthermore, genotyping of intact DNA samples could also benefit from utilizing long primers since their close annealing to the target STR sequences may overcome wrong profiling generated by insertions/deletions present between the STR region and the annealing site of the primers. Additionally, long ssDNA polynucleotides might be utilized in multiplex PCR assays for other types of degraded or fragmented DNA, e.g. circulating, cell-free DNA (ccfDNA).	[Mautner, Martin E.; Corti Bielsa, Rodrigo M.] Biodynam SRL, Buenos Aires, DF, Argentina; [Perez Santangelo, Agustin] Univ Torcuato Tella, Lab Neurociencia, Buenos Aires, DF, Argentina; [Sala, Andrea; Ginart, Santiago; Corach, Daniel] Univ Buenos Aires, Sch Pharm & Biochem, Dept Forens Genet, Buenos Aires, DF, Argentina; [Sala, Andrea; Ginart, Santiago; Corach, Daniel] Univ Buenos Aires, Sch Pharm & Biochem, DNA Fingerprinting Serv, Buenos Aires, DF, Argentina	Universidad Torcuato Di Tella; University of Buenos Aires; University of Buenos Aires	Mautner, ME (corresponding author), Biodynam SRL, Buenos Aires, DF, Argentina.	martin@biodynamics.com.ar		Ginart, Santiago/0000-0002-6318-7795	Biodynamics S.R.L. (Argentina); National Research Council of Argentina (CONICET, Argentina)	Biodynamics S.R.L. (Argentina); National Research Council of Argentina (CONICET, Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	In part this research was supported by Biodynamics S.R.L. (Argentina) to MEM and resources raised by the DNA Fingerprinting Service (Servicio de Huellas Digitales Geneticas) of the School of Pharmacy and Biochemistry, Universidad de Buenos Aires, Argentina to DC. APS and SG are doctoral fellows granted by Doctoral Fellowships of the National Research Council of Argentina (CONICET, Argentina) and receive financial support as a result of these fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; MEM is the inventor of USPTO application 15/283,851 and PCT application EP2017/067189 related to using long ssDNA polynucleotides in PCR. APS and SG are doctoral fellows granted by Doctoral Fellowships and AS and DC are members of Carrera del Investigador Cientifico of the National Research Council of Argentina (CONICET, Argentina).; In part this research was supported by Biodynamics S.R.L. (Argentina) and resources raised by the DNA Fingerprinting Service (Servicio de Huellas Digitales Geneticas) of the School of Pharmacy and Biochemistry, Universidad de Buenos Aires, Argentina.	ADAMSON D, 1995, AM J HUM GENET, V57, P619; Aghanoori MR, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.026; [Anonymous], TECHN MAN TMD045; [Anonymous], TECHN MAN TM293; [Anonymous], TECHN MAN TMD039; [Anonymous], TECHN MAN TM346; [Anonymous], TECHN MAN TM332; Butler JM, 2003, J FORENSIC SCI, V48, P1054; Butler JM, 2012, ADVANCED TOPICS IN FORENSIC DNA TYPING: METHODOLOGY, P1; Butler JM., 2012, FUNDAMENTALS FORENSI, P329; Butler JM, 2007, BIOTECHNIQUES S, V43, pSii; Ensenberger MG, 2016, FORENSIC SCI INT-GEN, V21, P134, DOI 10.1016/j.fsigen.2015.12.011; FREGEAU CJ, 1993, BIOTECHNIQUES, V15, P100; GROSSMAN PD, 1994, NUCLEIC ACIDS RES, V22, P4527, DOI 10.1093/nar/22.21.4527; HAMMOND HA, 1994, AM J HUM GENET, V55, P175; Hill CR, 2008, J FORENSIC SCI, V53, P73, DOI 10.1111/j.1556-4029.2008.00595.x; Hill CR, 2009, J FORENSIC SCI, V54, P1008, DOI 10.1111/j.1556-4029.2009.01110.x; JURKA J, 1995, J MOL EVOL, V40, P120, DOI 10.1007/BF00167107; Kraemer M, 2017, FORENSIC SCI INT-GEN, V29, P9, DOI 10.1016/j.fsigen.2017.03.012; LITT M, 1989, AM J HUM GENET, V44, P397; Locascio L, 2008, STANDARD REFERENCE M; Mautner ME, 2016, USPTO Application, Patent No. [15/283, 851, 15283851, 15/283,851]; Mautner ME, 2017, [No title captured], Patent No. [EP 2017/067189, 2017067189, PCT EP2017/067189]; Neumaier M, 2016, Patent No. [20160168644 A1, 20160168644]; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Vallone PM, 2004, BIOTECHNIQUES, V37, P226, DOI 10.2144/04372ST03; Wang DY, 2015, FORENSIC SCI INT-GEN, V19, P148, DOI 10.1016/j.fsigen.2015.07.013; WEBER JL, 1989, AM J HUM GENET, V44, P388; WHITAKER JP, 1995, BIOTECHNIQUES, V18, P670; Wilson R, 2011, NUCLEIC ACID THER, V21, P437, DOI 10.1089/nat.2011.0322; Yang Yaran, 2014, Genomics Proteomics & Bioinformatics, V12, P190, DOI 10.1016/j.gpb.2014.09.001	31	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							e0187190	10.1371/journal.pone.0187190	http://dx.doi.org/10.1371/journal.pone.0187190			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6TA	29099837	Green Published, Green Submitted, gold			2022-12-26	WOS:000414377900013
J	Mihailovic, PM; Lio, WM; Yano, J; Zhao, XN; Zhou, JC; Chyu, KY; Shah, PK; Cercek, B; Dimayuga, PC				Mihailovic, Peter M.; Lio, Wai Man; Yano, Juliana; Zhao, Xiaoning; Zhou, Jianchang; Chyu, Kuang-Yuh; Shah, Prediman K.; Cercek, Bojan; Dimayuga, Paul C.			The cathelicidin protein CRAMP is a potential atherosclerosis self-antigen in ApoE(-/-) mice	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; ANTIMICROBIAL PEPTIDE LL-37; CD8 T-CELLS; CORONARY-ARTERY-DISEASE; MYOCARDIAL-INFARCTION; HLA PEPTIDOME; INFLAMMATION; AUTOIMMUNITY; DEFICIENCY; EXPRESSION	Auto-immunity is believed to contribute to inflammation in atherosclerosis. The antimicrobial peptide LL-37, a fragment of the cathelicidin protein precursor hCAP18, was previously identified as an autoantigen in psoriasis. Given the reported link between psoriasis and coronary artery disease, the biological relevance of the autoantigen to atherosclerosis was tested in vitro using a truncated (t) form of the mouse homolog of hCAP18, CRAMP, on splenocytes from athero-prone ApoE(-/-) mice. Stimulation with tCRAMP resulted in increased CD8+ T cells with Central Memory and Effector Memory phenotypes in ApoE(-/-) mice, differentially activated by feeding with normal chow or high fat diet. Immunization of ApoE(-/-) with different doses of the shortened peptide (Cramp) resulted in differential outcomes with a lower dose reducing atherosclerosis whereas a higher dose exacerbating the disease with increased neutrophil infiltration of the atherosclerotic plaques. Low dose Cramp immunization also resulted in increased splenic CD8+ T cell degranulation and reduced CD11b+ CD11c+ conventional dendritic cells (cDCs), whereas high dose increased CD11b+CD11c+ cDCs. Our results identified CRAMP, the mouse homolog of hCAP-18, as a potential self antigen involved in the immune response to atherosclerosis in the ApoE(-/-) mouse model.	[Mihailovic, Peter M.; Lio, Wai Man; Yano, Juliana; Zhao, Xiaoning; Zhou, Jianchang; Chyu, Kuang-Yuh; Shah, Prediman K.; Cercek, Bojan; Dimayuga, Paul C.] Cedars Sinai Heart Inst, Oppenheimer Atherosclerosis Res Ctr, Div Cardiol, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center	Dimayuga, PC (corresponding author), Cedars Sinai Heart Inst, Oppenheimer Atherosclerosis Res Ctr, Div Cardiol, Los Angeles, CA 90048 USA.	dimayugap@cshs.org	Mihailovic, Peter Marko/ABG-5713-2020		Eleanor and Harold Foonberg Endowed Chair in Cardiac Intensive Care Fund; Joe Weider Foundation; Heart Foundation; Petersen Foundation	Eleanor and Harold Foonberg Endowed Chair in Cardiac Intensive Care Fund; Joe Weider Foundation; Heart Foundation; Petersen Foundation	Funding was provided by the Eleanor and Harold Foonberg Endowed Chair in Cardiac Intensive Care Fund (PMM). This work was also supported by the Joe Weider Foundation, Heart Foundation, and the Petersen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlehoff O, 2011, J INTERN MED, V270, P237, DOI 10.1111/j.1365-2796.2011.02368.x; Almanzar G, 2012, J AUTOIMMUN, V39, P441, DOI 10.1016/j.jaut.2012.07.006; Bassani-Sternberg M, 2010, P NATL ACAD SCI USA, V107, P18769, DOI 10.1073/pnas.1008501107; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Bourdetsky D, 2014, P NATL ACAD SCI USA, V111, pE1591, DOI 10.1073/pnas.1321902111; Chen M, 2012, BLOOD, V119, P127, DOI 10.1182/blood-2011-06-363994; Chyu KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030780; Ciornei Cristina D, 2006, BMC Cardiovasc Disord, V6, P49, DOI 10.1186/1471-2261-6-49; Daissormont ITMN, 2011, CIRC RES, V109, P1387, DOI 10.1161/CIRCRESAHA.111.256529; Dhanji S, 2006, J IMMUNOL, V177, P138, DOI 10.4049/jimmunol.177.1.138; Dimayuga PC, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005318; DiSpirito JR, 2010, CELL RES, V20, P13, DOI 10.1038/cr.2009.140; Doring Y, 2012, CIRC RES, V110, P1052, DOI 10.1161/CIRCRESAHA.112.265868; Doring Y, 2012, CIRCULATION, V125, P1673, DOI 10.1161/CIRCULATIONAHA.111.046755; Edfeldt K, 2006, ARTERIOSCL THROM VAS, V26, P1551, DOI 10.1161/01.ATV.0000223901.08459.57; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Haluszczak C, 2009, J EXP MED, V206, P435, DOI 10.1084/jem.20081829; Hickman HD, 2010, P NATL ACAD SCI USA, V107, P18747, DOI 10.1073/pnas.1013851107; Kahlenberg JM, 2013, J IMMUNOL, V191, P4895, DOI 10.4049/jimmunol.1302005; Kurts C, 1999, P NATL ACAD SCI USA, V96, P12703, DOI 10.1073/pnas.96.22.12703; Lande R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6621; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Legein B, 2015, SCI REP-UK, V5, DOI 10.1038/srep15414; MacLeod MKL, 2011, P NATL ACAD SCI USA, V108, P7914, DOI 10.1073/pnas.1104588108; MacRitchie N, 2012, ARTERIOSCL THROM VAS, V32, P2569, DOI 10.1161/ATVBAHA.112.251314; Mangold A, 2015, CIRC RES, V116, P1182, DOI 10.1161/CIRCRESAHA.116.304944; Martinic MM, 2010, J AUTOIMMUN, V35, P404, DOI 10.1016/j.jaut.2010.08.006; Nilsson J, 2008, J INTERN MED, V263, P464, DOI 10.1111/j.1365-2796.2008.01945.x; Nilsson J, 2012, CURR OPIN LIPIDOL, V23, P422, DOI 10.1097/MOL.0b013e328356ec7c; Paulson KE, 2010, CIRC RES, V106, P383, DOI 10.1161/CIRCRESAHA.109.210781; Picard D, 2014, BRIT J DERMATOL, V171, P580, DOI 10.1111/bjd.13155; Rombouts M, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6467375; Sage AP, 2014, CIRCULATION, V130, P1363, DOI 10.1161/CIRCULATIONAHA.114.011090; Santilli S, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0947-0; Shaw MK, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00095; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; STEMME S, 1995, P NATL ACAD SCI USA, V92, P3893, DOI 10.1073/pnas.92.9.3893; Swee LK, 2014, EUR J IMMUNOL, V44, P1299, DOI 10.1002/eji.201343840; Terrell CE, 2013, BLOOD, V121, P5184, DOI 10.1182/blood-2013-04-495309; Tse K, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00493; Turner MJ, 2008, J EXP MED, V205, P1859, DOI 10.1084/jem.20072390; Van Brussel I, 2015, J IMMUNOL METHODS, V417, P76, DOI 10.1016/j.jim.2014.12.010; Van Vre EA, 2006, CORONARY ARTERY DIS, V17, P243, DOI 10.1097/00019501-200605000-00007; Vezys V, 2000, IMMUNITY, V12, P505, DOI 10.1016/S1074-7613(00)80202-2; Wu HZ, 2004, J IMMUNOL, V173, P297, DOI 10.4049/jimmunol.173.1.297; Yun TJ, 2016, CELL METAB, V23, P852, DOI 10.1016/j.cmet.2016.04.010; Zhang ZY, 2015, IMMUNITY, V43, P1137, DOI 10.1016/j.immuni.2015.10.018; Zhao HJ, 2012, J ATHEROSCLER THROMB, V19, P357, DOI 10.5551/jat.10108; Zhou JC, 2014, BIOCHEM BIOPH RES CO, V443, P864, DOI 10.1016/j.bbrc.2013.12.057	49	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0187432	10.1371/journal.pone.0187432	http://dx.doi.org/10.1371/journal.pone.0187432			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091929	Green Published, Green Submitted, gold			2022-12-26	WOS:000414229700064
J	Neto, AF; Rocha, PRD; Perez, EC; Xavier, JG; Peres, GB; Spadacci-Morena, DD; Alvares-Saraiva, AM; Lallo, MA				Neto, Aldo Francisco; Dell'Armelina Rocha, Paulo Ricardo; Perez, Elizabeth Christina; Xavier, Jose Guilherme; Peres, Giovani Bravin; Spadacci-Morena, Diva Denelle; Alvares-Saraiva, Anuska Marcelino; Lallo, Maria Anete			Diabetes mellitus increases the susceptibility to encephalitozoonosis in mice	PLOS ONE			English	Article							CUNICULI INFECTION; IMMUNOSUPPRESSED MICE; IMMUNE-RESPONSE; URINARY-TRACT; ENTEROCYTOZOON-BIENEUSI; POSTMENOPAUSAL WOMEN; COMMON INFECTIONS; RISK; CYCLOPHOSPHAMIDE; MICROSPORIDIOSIS	Microsporidiosis are diseases caused by opportunistic intracellular fungi in immunosuppressed individuals, as well as in transplanted patients, the elderly and children, among others. Diabetes mellitus (DM) is a metabolic disease characterized by hyperglycemia and decreased T cell response, neutrophil function, humoral immunity failure, increasing the susceptibility to infections. Here, we investigated the susceptibility of streptozotocin (STZ)induced type I diabetic and/or immunosuppressed mice to encephalitozoonosis by Encephalitozoon cuniculi. Microscopically, granulomatous hepatitis, interstitial pneumonia and pielonephritis were observed in all infected groups. STZ treatment induced an immunossupressor effect in the populations of B (B-1 and B2) and CD4(+) T lymphocytes. Moreover, infection decreased CD4(+) and CD8(+) T lymphocytes and macrophages of DM mice. Furthermore, infection induced a significant increase of IL-6 and TNF-alpha cytokine serum levels in DM mice. IFN-y, the most important cytokine for the resolution of encephalitozoonosis, increased only in infected mice. In addition to the decreased immune response, DM mice were more susceptible to encephalitozoonosis, associated with increased fungal burden, and symptoms. Additionally, cyclophosphamide immunosuppression in DM mice further increased the susceptibility to encephalitozoonosis. Thus, microsporidiosis should be considered in the differential diagnosis of comorbidities in diabetics.	[Neto, Aldo Francisco; Dell'Armelina Rocha, Paulo Ricardo; Perez, Elizabeth Christina; Xavier, Jose Guilherme; Peres, Giovani Bravin; Alvares-Saraiva, Anuska Marcelino; Lallo, Maria Anete] Univ Paulista UNIP, Programa Patol Ambiental & Expt, Sao Paulo, Brazil; [Spadacci-Morena, Diva Denelle] Inst Butantan, Dept Fisiopatol, Sao Paulo, Brazil	Universidade Paulista; Instituto Butantan	Lallo, MA (corresponding author), Univ Paulista UNIP, Programa Patol Ambiental & Expt, Sao Paulo, Brazil.	anetelallo@hotmail.com	Spadacci-Morena, Diva Denelle/P-6390-2015; Alvares-Saraiva, Anuska M/J-1128-2016; Pérez, Elizabeth C/E-8057-2012; Rocha, Paulo Ricardo Dell'Armelina/AAW-3255-2020; Lallo, Maria Anete/D-5976-2012; Peres, Giovani B/D-4553-2013	Spadacci-Morena, Diva Denelle/0000-0003-1225-1715; Alvares-Saraiva, Anuska M/0000-0001-8899-4182; Pérez, Elizabeth C/0000-0003-3038-9902; Rocha, Paulo Ricardo Dell'Armelina/0000-0002-3086-2301; Peres, Giovani B/0000-0003-3890-5334; Lallo, Maria Anete/0000-0003-3578-3087	Fundagao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP, Brazil [2012/51727-5]	Fundagao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP, Brazil	This work was supported by Fundagao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP, Brazil, (Process number 2012/51727-5), to Dr Maria Anete Lallo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvares-Saraiva AM, 2015, EUR J IMMUNOL, V45, P1452, DOI 10.1002/eji.201445409; Anane S, 2010, GASTROEN CLIN BIOL, V34, P450, DOI 10.1016/j.gcb.2010.07.003; Boyko EJ, 2002, DIABETES CARE, V25, P1778, DOI 10.2337/diacare.25.10.1778; Braunfuchsova P, 2001, INT J PARASITOL, V31, P681, DOI 10.1016/S0020-7519(01)00134-5; Brode S, 2008, CRIT REV IMMUNOL, V28, P109, DOI 10.1615/CritRevImmunol.v28.i2.20; Brodsky RA, 2010, IMMUNOL RES, V47, P179, DOI 10.1007/s12026-009-8149-y; Calvet HM, 2001, INFECT DIS CLIN N AM, V15, P407, DOI 10.1016/S0891-5520(05)70153-7; Casqueiro Juliana, 2012, Indian J Endocrinol Metab, V16 Suppl 1, pS27, DOI 10.4103/2230-8210.94253; Chaudhry ZZ, 2013, LAB ANIM-UK, V47, P257, DOI 10.1177/0023677213489548; Cuomo CA, 2012, GENOME RES, V22, P2478, DOI 10.1101/gr.142802.112; Delamaire M, 1997, DIABETIC MED, V14, P29, DOI 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V; Didier ES, 2014, MICROSPORIDIA: PATHOGENS OF OPPORTUNITY, 1ST EDITION, P307; Didier ES, 2011, CURR OPIN INFECT DIS, V24, P490, DOI 10.1097/QCO.0b013e32834aa152; Ditrich O, 2011, J CLIN MICROBIOL, V49, P2769, DOI 10.1128/JCM.00620-11; Elnadi Nada A, 2015, J Egypt Soc Parasitol, V45, P443; Emadi A, 2009, NAT REV CLIN ONCOL, V6, P638, DOI 10.1038/nrclinonc.2009.146; Farnsworth CW, 2015, INFECT IMMUN, V83, P2264, DOI 10.1128/IAI.03074-14; Geerlings SE, 1999, FEMS IMMUNOL MED MIC, V26, P259, DOI 10.1016/S0928-8244(99)00142-X; Geerlings SE, 2000, EUR J CLIN INVEST, V30, P995, DOI 10.1046/j.1365-2362.2000.00745.x; Gill SK, 2016, SCI REP-UK, V6, DOI 10.1038/srep27636; Hinney B, 2016, INT J PARASITOL-PAR, V5, P76, DOI 10.1016/j.ijppaw.2016.01.001; Hu KK, 2004, ARCH INTERN MED, V164, P989, DOI 10.1001/archinte.164.9.989; Khan IA, 1999, INFECT IMMUN, V67, P1887; Khan IA, 2001, MICROBES INFECT, V3, P401, DOI 10.1016/S1286-4579(01)01397-1; Kicia M, 2014, J CLIN MICROBIOL, V52, P1780, DOI 10.1128/JCM.03328-13; Kowalewska B, 2016, PATIENT PREFER ADHER, V10, P591, DOI 10.2147/PPA.S97852; Lallo MA, 2005, ARQ NEURO-PSIQUIAT, V63, P246, DOI 10.1590/S0004-282X2005000200010; Lallo MA, 2002, REV SAUDE PUBL, V36, P621, DOI 10.1590/S0034-89102002000600012; Lallo MA, 2012, EXP PARASITOL, V131, P339, DOI 10.1016/j.exppara.2012.04.019; Lawlor EM, 2010, INFECT IMMUN, V78, P3097, DOI 10.1128/IAI.00181-10; Lores B, 2002, CLIN INFECT DIS, V34, P918, DOI 10.1086/339205; Martinez N, 2016, MICROBES INFECT, V18, P649, DOI 10.1016/j.micinf.2016.05.007; Metenier G, 2001, MICROBES INFECT, V3, P407, DOI 10.1016/S1286-4579(01)01398-3; Mohammad MK, 2006, INT IMMUNOL, V18, P1101, DOI 10.1093/intimm/dxl045; Moretto M, 2004, J IMMUNOL, V172, P4402, DOI 10.4049/jimmunol.172.7.4402; Muller A, 2001, J CLIN MICROBIOL, V39, P1630, DOI 10.1128/JCM.39.4.1630-1632.2001; Muller LMAJ, 2005, CLIN INFECT DIS, V41, P281, DOI 10.1086/431587; Nagib PRA, 2010, IMMUNOBIOLOGY, V215, P971, DOI 10.1016/j.imbio.2010.02.001; Peleg AY, 2007, DIABETES-METAB RES, V23, P3, DOI 10.1002/dmrr.682; Price CL, 2010, J CELL MOL MED, V14, P1806, DOI 10.1111/j.1582-4934.2009.00803.x; Salat J, 2004, FOLIA PARASIT, V51, P275, DOI 10.14411/fp.2004.033; Salat J, 2006, PARASITOL RES, V99, P682, DOI 10.1007/s00436-006-0208-x; Shah BR, 2003, DIABETES CARE, V26, P510, DOI 10.2337/diacare.26.2.510; Tsaousis AD, 2008, NATURE, V453, P553, DOI 10.1038/nature06903; Valencakova A, 2012, COMP IMMUNOL MICROB, V35, P1, DOI 10.1016/j.cimid.2011.11.004; da Costa LFV, 2017, IMMUNOBIOLOGY, V222, P218, DOI 10.1016/j.imbio.2016.09.018; Weidner E, 1999, J MED ENTOMOL, V36, P522, DOI 10.1093/jmedent/36.4.522; Weiss LM, 2014, MICROSPORIDIA: PATHOGENS OF OPPORTUNITY, 1ST EDITION, P371	48	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11								10.1371/journal.pone.0186954	http://dx.doi.org/10.1371/journal.pone.0186954			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091912	Green Submitted, gold, Green Published			2022-12-26	WOS:000414229700036
J	Nunez, IA; Carlock, MA; Allen, JD; Owino, SO; Moehling, KK; Nowalk, P; Susick, M; Diagle, K; Sweeney, K; Mundle, S; Vogel, TU; Delagrave, S; Ramgopal, M; Zimmerman, RK; Kleanthous, H; Ross, TM				Nunez, Ivette A.; Carlock, Michael A.; Allen, James D.; Owino, Simon O.; Moehling, Krissy K.; Nowalk, Patricia; Susick, Michael; Diagle, Kensington; Sweeney, Kristen; Mundle, Sophia; Vogel, Thorsten U.; Delagrave, Simon; Ramgopal, Moti; Zimmerman, Richard K.; Kleanthous, Harry; Ross, Ted M.			Impact of age and pre-existing influenza immune responses in humans receiving split inactivated influenza vaccine on the induction of the breadth of antibodies to influenza A strains	PLOS ONE			English	Article							SEASONAL INFLUENZA; INTRINSIC DEFECTS; RANDOMIZED-TRIAL; B-CELLS; VIRUS; PROTECTION; INFECTION; EFFICACY; PEOPLE; NAIVE	Most humans have pre-existing immunity to influenza viruses. In this study, volunteers (ages of 18-85 years) were vaccinated with split, inactivated Fluzone TM influenza vaccine in four consecutive influenza seasons from 2013 to 2016 seasons. The impact of repeated vaccination on breadth and durability of antibodies was assessed as a result of vaccine strain changes. Total IgG anti-hemagglutinin (HA) binding antibodies and hemagglutinationinhibition (HAI) activity increased in all age groups against both influenza A HA components in the vaccine post-vaccination(day 21). However, younger subjects maintained seroprotective titers to the vaccine strains, which resulted in higher seroconversion rates in the elderly, since the HAI titers in elderly subjects were more likely to decline prior to the next season. Young subjects had significant HAI activity against historical, as well as contemporary H1 and H3 vaccine strains from the mid-1980s to present. In contrast, elderly subjects had HAI activity to H1 strains from all years, but were more likely to have HAI activity to older strains from 1918-1950s. They also had a more restricted HAI profile against H3 viruses compared to young subjects recognizing H3N2 influenza viruses from the mid-2000s to present. Vaccine recipients were then categorized by whether subjects seroconverted from a seronegative or seropositive pre-vaccination state. Regardless of age, immunological recall or 'back boosting' to antigenically related strains were associated with seroconversion to the vaccine strain. Overall, both younger and older people have the ability to mount a breadth of immune responses following influenza vaccination. This report describes how imprinting exposure differs across age groups, influences antibody cross-reactivity to past hemagglutinin antigenic variants, and shapes immune responses elicited by current split inactivated influenza vaccines. Understanding how current influenza vaccines are influenced by pre-existing immunity in people of different ages is critical for designing the next-generation of 'universal' or broadly-protective influenza vaccines.	[Nunez, Ivette A.; Carlock, Michael A.; Allen, James D.; Owino, Simon O.; Ross, Ted M.] Univ Georgia, Ctr Vaccines & Immunol, Athens, GA 30602 USA; [Moehling, Krissy K.; Nowalk, Patricia; Susick, Michael] Univ Pittsburgh, Dept Family Med, Pittsburgh, PA USA; [Diagle, Kensington; Sweeney, Kristen; Ramgopal, Moti; Kleanthous, Harry] Martin Hlth Syst, Clin Res Div, Stuart, FL USA; [Mundle, Sophia; Vogel, Thorsten U.; Delagrave, Simon] Sanofi Pasteur Inc, Res North Amer, Cambridge, MA USA; [Zimmerman, Richard K.; Ross, Ted M.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA	University System of Georgia; University of Georgia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Georgia; University of Georgia	Ross, TM (corresponding author), Univ Georgia, Ctr Vaccines & Immunol, Athens, GA 30602 USA.; Ross, TM (corresponding author), Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA.	tedross@uga.edu		Nunez, Ivette/0000-0003-3213-3628; Ross, Ted/0000-0003-1947-7469	Sanofi Pasteur, Inc.; Merck Co, Inc.; Pfizer Inc.; Georgia Research Alliance	Sanofi Pasteur, Inc.; Merck Co, Inc.(Merck & Company); Pfizer Inc.(Pfizer); Georgia Research Alliance	TMR and RKZ have research funding from Sanofi Pasteur, Inc. RKZ and MPN have additional support from Merck & Co, Inc., Pfizer Inc. TMR is also supported, in part, by the Georgia Research Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Agency EM Use CfMPfH], 2014, EMACHMPVWP4572592014; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Andrews SF, 2015, J VIROL, V89, P3308, DOI 10.1128/JVI.02871-14; Blomberg BB, 2011, J CLIN INVEST, V121, P2981, DOI 10.1172/JCI58406; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Cobey S, 2017, CURR OPIN VIROL, V22, P105, DOI 10.1016/j.coviro.2016.12.004; deBruijn IA, 1997, VACCINE, V15, P1323, DOI 10.1016/S0264-410X(97)00019-4; Deenick EK, 2013, J EXP MED, V210, P2739, DOI 10.1084/jem.20130323; Flannery B, 2017, MMWR-MORBID MORTAL W, V66, P167, DOI 10.15585/mmwr.mm6606a3; Fonville JM, 2014, SCIENCE, V346, P996, DOI 10.1126/science.1256427; Francis T, 1960, P AM PHILOS SOC, V104, P572, DOI DOI 10.1371/JOURNAL.PPAT.1005806; Frasca D, 2012, INT IMMUNOL, V24, P175, DOI 10.1093/intimm/dxr123; Frasca D, 2010, VACCINE, V28, P8077, DOI 10.1016/j.vaccine.2010.10.023; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Gostic KM, 2016, SCIENCE, V354, P722, DOI 10.1126/science.aag1322; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hay AJ, 2001, PHILOS T R SOC B, V356, P1861, DOI 10.1098/rstb.2001.0999; Hensley SE, 2014, CURR OPIN VIROL, V8, P85, DOI 10.1016/j.coviro.2014.07.007; Huang KYA, 2015, J CLIN INVEST, V125, P2631, DOI 10.1172/JCI81104; Jiang J, 2013, EXP GERONTOL, V48, P579, DOI 10.1016/j.exger.2013.02.027; Kaml M, 2006, VACCINE, V24, P6808, DOI 10.1016/j.vaccine.2006.06.037; Kim JH, 2016, VACCINE, V34, P4594, DOI 10.1016/j.vaccine.2016.07.018; Lee J, 2016, NAT MED, V22, P1023, DOI 10.1038/nm.4145; Lefebvre JS, 2016, SCI REP-UK, V6, DOI 10.1038/srep25051; McElhaney JE, 2013, LANCET INFECT DIS, V13, P485, DOI 10.1016/S1473-3099(13)70046-X; Miller MS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006637; Moens L, 2016, IMMUNOL CELL BIOL, V94, P774, DOI 10.1038/icb.2016.41; Murasko DM, 2002, EXP GERONTOL, V37, P427, DOI 10.1016/S0531-5565(01)00210-8; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Pera A, 2015, MATURITAS, V82, P50, DOI 10.1016/j.maturitas.2015.05.004; Plant EP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05579-4; Pritz T, 2015, EUR J IMMUNOL, V45, P738, DOI 10.1002/eji.201444878; Reed C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118369; Ross TM, 2014, HUM VACC IMMUNOTHER, V10, P1195, DOI 10.4161/hv.28313; Sasaki S, 2011, J CLIN INVEST, V121, P3109, DOI 10.1172/JCI57834; Sasaki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002975; Shinde V, 2009, NEW ENGL J MED, V360, P2616; Skowronski DM, 2017, J INFECT DIS, V215, P1059, DOI 10.1093/infdis/jix074; Skowronski DM, 2012, J INFECT DIS, V206, P1852, DOI 10.1093/infdis/jis500; Skowronski DM, 2011, J INFECT DIS, V203, P158, DOI 10.1093/infdis/jiq039; Souty C, 2015, HUM VACC IMMUNOTHER, V11, P1621, DOI 10.1080/21645515.2015.1046661; Valero-Pacheco N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150146; van Essen GA, 2014, INFLUENZA OTHER RESP, V8, P452, DOI 10.1111/irv.12245; Wong TM, 2017, J VIROL IN PRESS; World Health Organization, 2011, MAN LAB DIAGN VIR SU	46	45	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2017	12	11							e0185666	10.1371/journal.pone.0185666	http://dx.doi.org/10.1371/journal.pone.0185666			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL4VN	29091724	Green Published, Green Submitted, gold			2022-12-26	WOS:000414229700009
J	Garbarino, S; Magnavita, N; Guglielmi, O; Maestri, M; Dini, G; Bersi, FM; Toletone, A; Chiorri, C; Durando, P				Garbarino, Sergio; Magnavita, Nicola; Guglielmi, Ottavia; Maestri, Michelangelo; Dini, Guglielmo; Bersi, Francesca Maria; Toletone, Alessandra; Chiorri, Carlo; Durando, Paolo			Insomnia is associated with road accidents. Further evidence from a study on truck drivers	PLOS ONE			English	Article							SLEEP DISORDERS; SHIFT WORK; IMPACT; RISK; INJURIES; DURATION; FATIGUE; HABITS; HEALTH; ADULTS	Background Sleep-related problems are known risk factors for road accidents. However, very few studies have investigated the role played by insomnia and its components, and no data are available for a population of occupational drivers at risk, such as the truck driver category. Objective To measure the prevalence and impact of insomnia on motor vehicle accidents (MVAs) and near-miss accidents (NMAs) in 949 truck drivers. Design Cross-sectional survey. Results Insomnia affected 27.5% of the sample. Compared to other drivers, in the 3 years prior to the study, truck drivers with insomnia had reported a significantly higher number of MVAs; they had also reported a greater number of NMAs in the previous 6 months. After correction for the presence of obstructive sleep apnea, excessive daytime sleepiness, short sleep duration, and other concurrent diseases, insomniac truck drivers had an almost two-fold risk of driving accidents (OR: 1.82, CI 95%: 1.33-2.49) and a more than three-fold increased risk of near-miss accidents (OR: 3.35, CI95%: 2.06-5.45) compared to non-insomniac drivers. Conclusion Insomnia emerged as an independent risk factor for MVAs and NMAs. We strongly advise screening commercial drivers for signs and symptoms of insomnia in order to improve health and safety on the road.	[Garbarino, Sergio; Guglielmi, Ottavia] Univ Genoa, Dept Neurosci Rehabil Ophthalmol Genet & Maternal, Genoa, Italy; [Garbarino, Sergio; Dini, Guglielmo; Bersi, Francesca Maria; Toletone, Alessandra; Durando, Paolo] Univ Genoa, Postgrad Sch Occupat Med, Dept Hlth Sci, Genoa, Italy; [Magnavita, Nicola] Univ Cattolica Sacro Cuore, Inst Publ Hlth, Occupat Hlth Unit, Rome, Italy; [Maestri, Michelangelo] Univ Pisa, Dept Clin & Expt Med, Neurol Unit, Pisa, Italy; [Dini, Guglielmo; Bersi, Francesca Maria; Durando, Paolo] Osped Policlin San Martino, Occupat Med Unit, Genoa, Italy; [Chiorri, Carlo] Univ Genoa, Dept Educ Sci, Genoa, Italy	University of Genoa; University of Genoa; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Pisa; University of Genoa	Magnavita, N (corresponding author), Univ Cattolica Sacro Cuore, Inst Publ Hlth, Occupat Hlth Unit, Rome, Italy.	nicolamagnavita@gmail.com	Garbarino, Sergio/X-5368-2018; Maestri, Michelangelo/AAJ-2879-2020; Magnavita, Nicola/J-6074-2014; Garbarino, Sergio/AAV-4629-2021	Garbarino, Sergio/0000-0002-8508-552X; Maestri, Michelangelo/0000-0003-0960-4938; Magnavita, Nicola/0000-0002-0988-7344; Garbarino, Sergio/0000-0002-8508-552X	CNH Iveco Industrial Corporation [25171877]	CNH Iveco Industrial Corporation	Medical examinations were funded by CNH Iveco Industrial Corporation, Grant n.25171877. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Printing expenses were covered with University funds (D1, 2015) of the Corresponding Author (NM).	Adams RJ, 2017, SLEEP HEALTH, V3, P35, DOI 10.1016/j.sleh.2016.11.005; Akerstedt T, 2002, J SLEEP RES, V11, P69, DOI 10.1046/j.1365-2869.2002.00287.x; American Academy of Sleep Medicine, 2005, INT CLASSLEEP DIS; American Psychiatric Association, 2013, DSM 5 DIAGN STAT MAN, V5th; [Anonymous], 2014, INT CLASSIFICATION S; Arnold PK, 1997, ACCIDENT ANAL PREV, V29, P471, DOI 10.1016/S0001-4575(97)00026-2; CDC-Centers for Disease Control and Prevention. Short sleep duration among workers D United States, 2010, MMWR-MORBID MORTAL W, V61, P281; Dembe AE, 2005, OCCUP ENVIRON MED, V62, P588, DOI 10.1136/oem.2004.016667; Folkard S, 2003, OCCUP MED-OXFORD, V53, P95, DOI 10.1093/occmed/kqg047; Fragoso CAV, 2010, J AM GERIATR SOC, V58, P1878, DOI 10.1111/j.1532-5415.2010.03083.x; Garbarino S, 2001, SLEEP, V24, P203; Garbarino S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166262; James L, 2017, AM J IND MED, V60, P449, DOI 10.1002/ajim.22714; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kessler RC, 2012, SLEEP, V35, P825, DOI 10.5665/sleep.1884; Kumar S, 2016, HEALTHCARE-BASEL, V4, DOI 10.3390/healthcare4030037; Laraqui O, 2008, ARCH MAL PROF ENVIRO, V69, P574, DOI 10.1016/j.admp.2008.02.018; Laugsand LE, 2014, SLEEP, V37, P1776, DOI 10.5665/sleep.4170; Leger D, 2002, SLEEP, V25, P625; Leger D, 2006, SLEEP, V29, P171; Leger D, 2014, J SLEEP RES, V23, P143, DOI 10.1111/jsr.12104; Lerman SE, 2012, J OCCUP ENVIRON MED, V54, P231, DOI 10.1097/JOM.0b013e318247a3b0; Lian YL, 2015, J PSYCHOSOM RES, V78, P45, DOI 10.1016/j.jpsychores.2014.09.009; Mohebbi I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031790; Moradifar Razmik, 2014, Electron Physician, V6, P827, DOI 10.14661/2014.932-827-831; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; NSF, 2009, SLEEP AM POLL; O'Mahony S, 2017, AM J HOSP PALLIAT CA; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Patel SR, 2007, SLEEP, V30, P1077, DOI 10.1093/sleep/30.9.1077; Perez-Chada D, 2005, SLEEP, V28, P1103, DOI 10.1093/sleep/28.9.1103; Perrier J, 2014, SLEEP, V37, P1565, DOI 10.5665/sleep.4012; Philip P, 2010, SLEEP MED, V11, P973, DOI 10.1016/j.sleep.2010.07.010; Sateia MJ, 2017, J CLIN SLEEP MED, V13, P307, DOI 10.5664/jcsm.6470; Shahly V, 2012, ARCH GEN PSYCHIAT, V69, P1054, DOI 10.1001/archgenpsychiatry.2011.2188; Smolensky MH, 2011, ACCIDENT ANAL PREV, V43, P533, DOI 10.1016/j.aap.2009.12.004; Souza JC, 2005, ARQ NEURO-PSIQUIAT, V63, P925, DOI 10.1590/S0004-282X2005000600004; Swanson LM, 2011, J SLEEP RES, V20, P487, DOI 10.1111/j.1365-2869.2010.00890.x; Sweetman AM, 2017, SLEEP MED REV, V33, P28, DOI 10.1016/j.smrv.2016.04.004; Tahghighi M, 2017, J ADV NURS, V73, P2065, DOI 10.1111/jan.13283; Talmage JB, 2008, J OCCUP ENVIRON MED, V50, P324, DOI 10.1097/JOM.0b013e3181617ab8; Uehli K, 2014, SLEEP MED REV, V18, P61, DOI 10.1016/j.smrv.2013.01.004; Van Dongen HPA, 2009, IND HEALTH, V47, P518, DOI 10.2486/indhealth.47.518; Wong CKH, 2012, J OCCUP ENVIRON MED, V54, P989, DOI 10.1097/JOM.0b013e3182535d7d	44	51	52	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2017	12	10							e0187256	10.1371/journal.pone.0187256	http://dx.doi.org/10.1371/journal.pone.0187256			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FL2ZD	29088276	Green Published, Green Submitted, gold			2022-12-26	WOS:000414088900055
J	Johnsenl, A; Kearns, AM; Omland, KE; Anmarkrud, JA				Johnsenl, Arild; Kearns, Anna M.; Omland, Kevin E.; Anmarkrud, Jarl Andreas			Sequencing of the complete mitochondrial genome of the common raven Corvus corax (Aves: Corvidae) confirms mitogenome-wide deep lineages and a paraphyletic relationship with the Chihuahuan raven C. cryptoleucus	PLOS ONE			English	Article							PASSERIFORMES CORVIDAE; GENE ORDER; CROW; PHYLOGENETICS; EVOLUTION; HISTORY; DNA	Previous studies based on single mitochondrial markers have shown that the common raven (Corvus corax) consists of two highly diverged lineages that are hypothesised to have undergone speciation reversal upon secondary contact. Furthermore, common ravens are paraphyletic with respect to the Chihuahuan raven (C. cryptoleucus) based on mitochondrial DNA (mtDNA). Here we explore the causes of mtDNA paraphyly by sequencing whole mitochondrial genomes of 12 common ravens from across the Northern Hemisphere, in addition to three Chihuahuan ravens and one closely related brown-necked raven (C. ruficollis) using a long-range PCR protocol. Our raven mitogenomes ranged between 16925-16928 bp in length. GC content varied from 43.3% to 43.8% and the 13 protein coding genes, two rRNAs and 22 tRNAs followed a standard avian mitochondrial arrangement. The overall divergence between the two common raven clades was 3% (range 0.3-5.8% in 16 regions including the protein coding genes, rRNAs and the control region). Phylogenies constructed from whole mitogenomes recovered the previously found mitochondrial sister relationship between the common raven California clade and the Chihuahuan raven (overall divergence 1.1%), which strengthens the hypothesis that mtDNA paraphyly in the common raven results from speciation reversal of previously distinct Holarctic and California lineages.	[Johnsenl, Arild; Kearns, Anna M.; Anmarkrud, Jarl Andreas] Univ Oslo, Nat Hist Museum, Oslo, Norway; [Kearns, Anna M.; Omland, Kevin E.] Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21228 USA; [Kearns, Anna M.] Smithsonian Conservat Biol Inst, Ctr Conservat Gen, Natl Zool Pk, Washington, DC USA	University of Oslo; University System of Maryland; University of Maryland Baltimore County; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Johnsenl, A (corresponding author), Univ Oslo, Nat Hist Museum, Oslo, Norway.	arild.johnsen@nhm.uio.no	Anmarkrud, Jarl Andreas/R-1822-2019; Anmarkrud, Jarl Andreas/G-2651-2015; Kearns, Anna M/H-5812-2019	Anmarkrud, Jarl Andreas/0000-0002-7496-4430; Anmarkrud, Jarl Andreas/0000-0002-7496-4430; Kearns, Anna M/0000-0002-8502-7442; Johnsen, Arild/0000-0003-4864-6284	Norwegian Research Council [213592]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This study was financed by a grant to AJ from the Norwegian Research Council, https://www.forskningsradet.no/en/Home_page/1177315753906 (grant no 213592). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allcock AL, 2011, ZOOL J LINN SOC-LOND, V161, P573, DOI 10.1111/j.1096-3642.2010.00656.x; Anmarkrud JA, 2017, MOL ECOL RESOUR, V17, P334, DOI 10.1111/1755-0998.12600; Baker JM, 2006, IBIS, V148, P174, DOI 10.1111/j.1474-919X.2006.00493.x; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bragg LM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003031; del Hoyo J, 2009, HDB BIRDS WORLD, V14; DESJARDINS P, 1990, J MOL BIOL, V212, P599, DOI 10.1016/0022-2836(90)90225-B; Ekblom R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-467; Feldman CR, 2005, ZOOL SCR, V34, P145, DOI 10.1111/j.1463-6409.2005.00182.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fleischer RC, 2008, MOL ECOL, V17, P464, DOI 10.1111/j.1365-294X.2007.03532.x; Galtier N, 2006, GENOME RES, V16, P215, DOI 10.1101/gr.4305906; Gibb GC, 2007, MOL BIOL EVOL, V24, P269, DOI 10.1093/molbev/msl158; Gibb GC, 2015, GENOME BIOL EVOL, V7, P2983, DOI 10.1093/gbe/evv196; Hahn C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt371; Haran J, 2013, MOL PHYLOGENET EVOL, V67, P156, DOI 10.1016/j.ympev.2012.12.022; Haring E, 2012, J ZOOL SYST EVOL RES, V50, P230, DOI 10.1111/j.1439-0469.2012.00664.x; Irwin DE, 2009, BIOL J LINN SOC, V98, P422, DOI 10.1111/j.1095-8312.2009.01282.x; Johnsen A, 2010, J ORNITHOL, V151, P565, DOI 10.1007/s10336-009-0490-3; Jonsson KA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-72; Krzeminska U, 2016, MITOCHONDRIAL DNA A, V27, P974, DOI 10.3109/19401736.2014.926512; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Li XF, 2016, MITOCHONDRIAL DNA A, V27, P4213, DOI 10.3109/19401736.2015.1022745; Lifjeld JT, 2016, BMC ZOOL, V1, DOI 10.1186/s40850-016-0008-4; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Miya M, 2015, ICHTHYOL RES, V62, P29, DOI 10.1007/s10228-014-0440-9; Moray C, 2014, GENOME BIOL EVOL, V6, P161, DOI 10.1093/gbe/evu005; Nei M., 2000, MOL EVOLUTION PHYLOG; Omland KE, 2006, MOL ECOL, V15, P795, DOI 10.1111/j.1365-294X.2005.02827.x; Omland KE, 2000, P ROY SOC B-BIOL SCI, V267, P2475, DOI 10.1098/rspb.2000.1308; Rutz C, 2016, NATURE, V537, P403, DOI 10.1038/nature19103; Scofield RP, 2017, MOL PHYLOGENET EVOL, V106, P136, DOI 10.1016/j.ympev.2016.09.022; Singh TR, 2008, MOL BIOL EVOL, V25, P475, DOI 10.1093/molbev/msn003; Sloan DB, 2017, MOL ECOL, V26, P2212, DOI 10.1111/mec.13959; Smith DR, 2016, BRIEF FUNCT GENOMICS, V15, P47, DOI 10.1093/bfgp/elv027; Smith DR, 2015, P NATL ACAD SCI USA, V112, P10177, DOI 10.1073/pnas.1422049112; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Talavera G, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-315; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Webb WC, 2011, MOL ECOL, V20, P2390, DOI 10.1111/j.1365-294X.2011.05095.x; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615	43	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2017	12	10							e0187316	10.1371/journal.pone.0187316	http://dx.doi.org/10.1371/journal.pone.0187316			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL0OH	29084259	Green Published, Green Submitted, gold			2022-12-26	WOS:000413910200048
J	Campbell, DC; Piller, KR				Campbell, D. Cooper; Piller, Kyle R.			Let's jump in: A phylogenetic study of the great basin springfishes and poolfishes, Crenichthys and Empetrichthys (Cyprinodontiformes: Goodeidae)	PLOS ONE			English	Article							AMERICAN FRESH-WATER; BAYESIAN-INFERENCE; CRYPTIC DIVERSITY; GENE; CONSERVATION; TELEOSTEI; SEQUENCE; FISHES; PHYLOGEOGRAPHY; PERCIDAE	North America's Great Basin has long been of interest to biologists due to its high level of organismal endemicity throughout its endorheic watersheds. One example of such a group is the subfamily Empetricthyinae. In this paper, we analyzed the relationships of the Empetrichtyinae and assessed the validity of the subspecies designations given by Williams and Wilde within the group using concatenated phylogenetic tree estimation and species tree estimation. Samples from 19 populations were included covering the entire distribution of the three extant species of Empetricthyinae-Crenichthys nevadae, Crenichthys baileyi and Empetricthys latos. Three nuclear introns (S8 intron 4, S7 intron 1, and P0 intron 1) and one mitochondrial gene (Cytb) were sequenced for phylogenetic analysis. Using these sequences, we generated two separate hypotheses of the evolutionary relationships of Empetrichtyinae-one based on the mitochondrial data and one based on the nuclear data using Bayesian phylogenetics. Haplotype networks were also generated to look at the relationships of the populations within Empetrichthyinae. After comparing the two phylogenetic hypotheses, species trees were generated using *BEAST with the nuclear data to further test the validity of the subspecies within Empetrichthyinae. The mitochondrial analyses supported four lineages within C. baileyi and 2 within C. nevadae. The concatenated nuclear tree was more conserved, supporting one clade and an unresolved polytomy in both species. The species tree analysis supported the presence of two species within both C. baileyi and C. nevadae. Based on the results of these analyses, the subspecies designations of Williams and Wilde are not valid, rather a conservative approach suggests there are two species within C. nevadae and two species within C. baileyi. No structure was found for E. latos or the populations of Empetricthyinae. This study represents one of many demonstrating the invalidity of subspecies and their detriment to species identification, conservation, and understanding.	[Campbell, D. Cooper; Piller, Kyle R.] Southeastern Louisiana Univ, Dept Biol Sci, Hammond, LA 70402 USA	University of Louisiana System; Southeastern Louisiana University	Piller, KR (corresponding author), Southeastern Louisiana Univ, Dept Biol Sci, Hammond, LA 70402 USA.	kyle.piller@selu.edu			Division Of Environmental Biology [1354930] Funding Source: National Science Foundation	Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		BALL RM, 1992, AUK, V109, P626; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Braby MF, 2012, BIOL J LINN SOC, V106, P699, DOI 10.1111/j.1095-8312.2012.01909.x; Burbrink FT, 2009, SOC STUDY EVOLUTION, V54, P2107; Burkhead NM, 2012, BIOSCIENCE, V62, P798, DOI 10.1525/bio.2012.62.9.5; Chow S, 1999, MOL ECOL, V8, P513; Chow Seinen, 2016, International Aquatic Research, V8, P29, DOI 10.1007/s40071-016-0122-5; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Deacon JE, 2010, WEST N AM NATURALIST, V70, P425, DOI 10.3398/064.070.0401; Doadrio I, 2004, MOL PHYLOGENET EVOL, V31, P416, DOI 10.1016/j.ympev.2003.08.022; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Escobar-Camacho D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135569; FROST DR, 1994, CLADISTICS, V10, P259, DOI 10.1111/j.1096-0031.1994.tb00178.x; FROST DR, 1990, HERPETOLOGICA, V46, P87; GHISELIN MT, 1974, SYST ZOOL, V23, P536, DOI 10.2307/2412471; Gilbert C. H., 1893, North American Fauna, VNo. 7, P229, DOI 10.3996/nafa.7.0003; GRANT EC, 1995, COPEIA, P209; Guadalupe K, 2012, NEVADA DEP WILDLIFE, V2, P81; Halas D, 2014, MOL PHYLOGENET EVOL, V70, P13, DOI 10.1016/j.ympev.2013.08.014; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hundt PJ, 2016, ZOOLOGICAL J LINNEAN; Jelks HL, 2008, FISHERIES, V33, P372, DOI 10.1577/1548-8446-33.8.372; Jorgensen MC, 2013, ZOOL SCR, V42, P317, DOI 10.1111/zsc.12003; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; La Rivers I, 1994, FISHES FISHERIES NEV; La Voie A, 2004, FED REGISTER, V69, P17383; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Leache AD, 2010, P ROY SOC B-BIOL SCI, V277, P3071, DOI 10.1098/rspb.2010.0662; Manier MK, 2004, BIOL J LINN SOC, V83, P65, DOI 10.1111/j.1095-8312.2004.00373.x; Mayden RL, 2002, FISH FISH, V3, P171, DOI 10.1046/j.1467-2979.2002.00086.x; Mayr E., 1942, P1; MAYR E, 1982, AUK, V99, P593; MAYR E., 1991, PRINCIPLES SYSTEMATI, V2nd; McMahan CD, 2013, J BIOGEOGR, V40, P894, DOI 10.1111/jbi.12036; Miller M.A., 2010, P GAT COMP ENV WORKS; MILLER RR, 1989, FISHERIES, V14, P22, DOI 10.1577/1548-8446(1989)014<0022:EONAFD>2.0.CO;2; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; Parenti LR, 1981, B AM MUS NAT HIST, V168, P335, DOI DOI 10.1080/00222930210135631; Piller KR, 2008, MOL PHYLOGENET EVOL, V46, P974, DOI 10.1016/j.ympev.2007.11.023; Piller Kyle R., 2001, Copeia, V2001, P802, DOI 10.1643/0045-8511(2001)001[0802:MVOTRD]2.0.CO;2; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; RYDER OA, 1986, TRENDS ECOL EVOL, V1, P9, DOI 10.1016/0169-5347(86)90059-5; SCHMIDT TR, 1993, COPEIA, P880; Scoppettone GG, 2004, WEST N AM NATURALIST, V64, P45; SIMPSON GG, 1951, EVOLUTION, V5, P285, DOI 10.2307/2405675; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; US Fish and Wildlife Service, 1996, RAILR VALL SPRINGF C; WILEY EO, 1978, SYST ZOOL, V27, P17, DOI 10.2307/2412809; WILEY EO, 1981, PHYLOGENETICS THEORY; WILLIAMS J E, 1981, Southwestern Naturalist, V25, P485, DOI 10.2307/3670848; Williams JE, 1996, ENVIRON BIOL FISH, V45, P272, DOI 10.1007/BF00003095; WILSON EO, 1953, SYST ZOOL, V2, P97, DOI 10.2307/2411818; Witt JDS, 2006, MOL ECOL, V15, P3073, DOI 10.1111/j.1365-294X.2006.02999.x; Zink RM, 2004, P ROY SOC B-BIOL SCI, V271, P561, DOI 10.1098/rspb.2003.2617	59	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0185425	10.1371/journal.pone.0185425	http://dx.doi.org/10.1371/journal.pone.0185425			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077708	gold, Green Submitted, Green Published			2022-12-26	WOS:000413861200004
J	Ghodsalavi, B; Svenningsen, NB; Hao, XL; Olsson, S; Nicolaisen, MH; Abu Al-Soud, W; Sorensen, SJ; Nybroe, O				Ghodsalavi, Behnoushsadat; Svenningsen, Nanna Bygvraa; Hao, Xiuli; Olsson, Stefan; Nicolaisen, Mette Haubjerg; Abu Al-Soud, Waleed; Sorensen, Soren J.; Nybroe, Ole			A novel baiting microcosm approach used to identify the bacterial community associated with Penicillium bilaii hyphae in soil	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGUS; RHIZOSPHERE BACTERIA; SELECTION; POPULATIONS; MYCOSPHERE; DIVERSITY	It is important to identify and recover bacteria associating with fungi under natural soil conditions to enable eco-physiological studies, and to facilitate the use of bacterial-fungal consortia in environmental biotechnology. We have developed a novel type of baiting microcosm, where fungal hyphae interact with bacteria under close-to-natural soil conditions; an advantage compared to model systems that determine fungal influences on bacterial communities in laboratory media. In the current approach, the hyphae are placed on a solid support, which enables the recovery of hyphae with associated bacteria in contrast to model systems that compare bulk soil and mycosphere soil. We used the baiting microcosm approach to determine, for the first time, the composition of the bacterial community associating in the soil with hyphae of the phosphate-solubilizer, Penicillium bilaii. By applying a cultivation-independent 16S rRNA gene-targeted amplicon sequencing approach, we found a hypha-associated bacterial community with low diversity compared to the bulk soil community and exhibiting massive dominance of Burkholderia OTUs. Burkholderia is known be abundant in soil environments affected by fungi, but the discovery of this massive dominance among bacteria firmly associating with hyphae in soil is novel and made possible by the current bait approach.	[Ghodsalavi, Behnoushsadat; Svenningsen, Nanna Bygvraa; Hao, Xiuli; Olsson, Stefan; Nicolaisen, Mette Haubjerg; Nybroe, Ole] Univ Copenhagen, Sect Microbial Ecol & Biotechnol, Dept Plant & Environm Sci, Frederiksberg C, Denmark; [Olsson, Stefan] Fujian Agr & Forestry Univ, State Key Lab Ecol Pest Control Fujian & Taiwan C, Fuzhou, Fujian, Peoples R China; [Abu Al-Soud, Waleed; Sorensen, Soren J.] Univ Copenhagen, Sect Microbiol, Dept Biol, Copenhagen, Denmark	University of Copenhagen; Fujian Agriculture & Forestry University; University of Copenhagen	Nybroe, O (corresponding author), Univ Copenhagen, Sect Microbial Ecol & Biotechnol, Dept Plant & Environm Sci, Frederiksberg C, Denmark.	oln@plen.ku.dk	Olsson, Stefan/I-5889-2019; Sørensen, Søren Johannes/N-2120-2019; Abu Al-Soud, Waleed/AAH-3477-2021; Nybroe, Ole/G-2421-2014; Sørensen, Søren J/J-5015-2014; Abu Al-Soud, Waleed/K-4408-2014; Olsson, Stefan/H-2617-2014; Nicolaisen, Mette/H-1853-2014	Olsson, Stefan/0000-0003-1931-9081; Sørensen, Søren Johannes/0000-0001-6227-9906; Abu Al-Soud, Waleed/0000-0002-1143-9233; Nybroe, Ole/0000-0001-7354-0188; Sørensen, Søren J/0000-0001-6227-9906; Abu Al-Soud, Waleed/0000-0002-1143-9233; Olsson, Stefan/0000-0003-1931-9081; Nicolaisen, Mette/0000-0002-0983-2466	Innovation Fund Denmark from the Council for Strategic Research [1308-00016B]	Innovation Fund Denmark from the Council for Strategic Research	This study was funded by Innovation Fund Denmark (https://innovationsfonden.dk/en) through grant number 1308-00016B from the Council for Strategic Research to Ole Nybroe. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.; This work was supported by Innovation Fund Denmark by grant number 1308-00016B from the Council for Strategic Research.	Ballhausen MB, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01416; Boersma FGH, 2010, SOIL BIOL BIOCHEM, V42, P2137, DOI 10.1016/j.soilbio.2010.08.009; Cruz Andre Freire, 2004, Acta Bot. Bras., V18, P473, DOI 10.1590/S0102-33062004000300007; Daniel R, 2005, NAT REV MICROBIOL, V3, P470, DOI 10.1038/nrmicro1160; Eberl L, 2016, F1000; Frey-Klett P, 2007, NEW PHYTOL, V176, P22, DOI 10.1111/j.1469-8137.2007.02191.x; Furuno S, 2012, MICROB BIOTECHNOL, V5, P142, DOI 10.1111/j.1751-7915.2011.00309.x; Halsey JA, 2016, ANTON LEEUW INT J G, V109, P1353, DOI 10.1007/s10482-016-0734-1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harrington BJ, 2003, LAB MED, V34, P361, DOI 10.1309/EPH2TDT8335GH0R3; Ipcho S, 2016, G3-GENES GENOM GENET, V6, P1585, DOI 10.1534/g3.116.027987; Johansson JF, 2004, FEMS MICROBIOL ECOL, V48, P1, DOI 10.1016/j.femsec.2003.11.012; Kirk JL, 2004, J MICROBIOL METH, V58, P169, DOI 10.1016/j.mimet.2004.04.006; Kost T, 2014, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00421; Lumini E, 2007, CELL MICROBIOL, V9, P1716, DOI 10.1111/j.1462-5822.2007.00907.x; Nazir R., 2013, MICROB DISCOV, V10, P1; Nazir R, 2010, FEMS MICROBIOL ECOL, V71, P169, DOI 10.1111/j.1574-6941.2009.00807.x; Cuong ND, 2011, MICROB ECOL, V62, P425, DOI 10.1007/s00248-011-9823-x; Nuccio EE, 2013, ENVIRON MICROBIOL, V15, P1870, DOI 10.1111/1462-2920.12081; Ravnskov S, 1999, NEW PHYTOL, V142, P113, DOI 10.1046/j.1469-8137.1999.00374.x; Ritz K., 2004, Mycologist, V18, P52, DOI 10.1017/S0269915X04002010; Rudnick MB, 2015, SOIL BIOL BIOCHEM, V88, P73, DOI 10.1016/j.soilbio.2015.04.015; Sahin N, 2003, RES MICROBIOL, V154, P399, DOI 10.1016/S0923-2508(03)00112-8; Scheublin TR, 2010, ISME J, V4, P752, DOI 10.1038/ismej.2010.5; Simon A, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv116; Stopnisek N, 2016, ISME J, V10, P253, DOI 10.1038/ismej.2015.73; Sundberg C, 2013, FEMS MICROBIOL ECOL, V85, P612, DOI 10.1111/1574-6941.12148; Takeda M, 2006, CAN J MICROBIOL, V52, P1121, DOI 10.1139/W06-074; Taktek S, 2015, SOIL BIOL BIOCHEM, V90, P1, DOI 10.1016/j.soilbio.2015.07.016; Timonen S, 2006, CAN J MICROBIOL, V52, P769, DOI 10.1139/W06-016; Toljander JF, 2006, FEMS MICROBIOL LETT, V254, P34, DOI 10.1111/j.1574-6968.2005.00003.x; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Ul Haq I, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw164; van der Bom F, 2017, EUR J AGRON, V86, P12, DOI 10.1016/j.eja.2017.02.006; Warmink JA, 2008, ISME J, V2, P887, DOI 10.1038/ismej.2008.41	35	16	16	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0187116	10.1371/journal.pone.0187116	http://dx.doi.org/10.1371/journal.pone.0187116			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077733	Green Published, gold, Green Submitted			2022-12-26	WOS:000413861200046
J	Yamada, Y; Shimada, T; Motomura, Y; Sato, F				Yamada, Yasuyuki; Shimada, Tomoe; Motomura, Yukiya; Sato, Fumihiko			Modulation of benzylisoquinoline alkaloid biosynthesis by heterologous expression of CjWRKY1 in Eschscholzia californica cells	PLOS ONE			English	Article							OPIUM POPPY; MOLECULAR-CLONING; COPTIS-JAPONICA; SANGUINARINE BIOSYNTHESIS; TRANSCRIPTION FACTORS; ENZYME; PLANTS; BERBERINE; PATHWAY; PROTEIN	Transcription factors control many processes in plants and have high potentials to manipulate specialized metabolic pathways. Transcriptional regulation of the biosynthesis of mono-terpenoid indole alkaloids (MIAs), nicotine alkaloids, and benzylisoquinoline alkaloids (BIAs) has been characterized using Catharanthus roseus, Nicotiana and Coptis plants. However, metabolic engineering in which specific transcription factors are used in alkaloid biosynthesis is limited. In this study, we characterized the effects of ectopic expression of CjWRKY1, which is a transcriptional activator with many targets in BIA biosynthesis in Coptis japonica (Ranunculaceae) and Eschscholzia californica (California poppy, Papaveraceae). Heterologous expression of CjWRKY1 in cultured California poppy cells induced increases in transcripts of several genes encoding BIA biosynthetic enzymes. Metabolite analyses indicated that the overexpression of the CjWRKY1 gene also induced increases in the accumulation of BIAs such as sanguinarine, chelerythrine, chelirubine, protopine, allocryptopine, and 10-hydroxychelerythrine in the culture medium. Previous characterization of EcbHLH1 and current results indicated that both transcription factors, WRKY1 and bHLH1, are substantially involved in the regulation of BIA biosynthesis. We discuss the function of CjWRKY1 in E. californica cells and its potential for metabolic engineering in BIA biosynthesis.	[Yamada, Yasuyuki; Shimada, Tomoe; Motomura, Yukiya; Sato, Fumihiko] Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Dept Plant Gene & Totipotency, Kyoto, Japan; [Yamada, Yasuyuki] Kobe Pharmaceut Univ, Lab Med Cell Biol, Kobe, Hyogo, Japan	Kyoto University; Kobe Pharmaceutical University	Yamada, Y; Sato, F (corresponding author), Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Dept Plant Gene & Totipotency, Kyoto, Japan.; Yamada, Y (corresponding author), Kobe Pharmaceut Univ, Lab Med Cell Biol, Kobe, Hyogo, Japan.	yyamada.m08@lif.kyoto-u.ac.jp; fsato@lif.kyoto-u.ac.jp	Sato, Fumihiko/C-1078-2011; Yamada, Yasuyuki/AAG-7576-2020	Sato, Fumihiko/0000-0001-9497-4452; Yamada, Yasuyuki/0000-0003-4699-9799	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [26221201]	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [Grant-in-Aid for Scientific Research (S); 26221201 to F.S.]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagoz Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep30910; Apuya NR, 2008, PLANT BIOTECHNOL J, V6, P160, DOI 10.1111/j.1467-7652.2007.00302.x; Beaudoin GAW, 2013, BIOCHEM BIOPH RES CO, V431, P597, DOI 10.1016/j.bbrc.2012.12.129; Boke H, 2015, PLANT BIOTECHNOL J, V13, P409, DOI 10.1111/pbi.12346; Dewey RE, 2013, PHYTOCHEMISTRY, V94, P10, DOI 10.1016/j.phytochem.2013.06.002; DITTRICH H, 1991, P NATL ACAD SCI USA, V88, P9969, DOI 10.1073/pnas.88.22.9969; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Facchini PJ, 2008, PLANT J, V54, P763, DOI 10.1111/j.1365-313X.2008.03438.x; Facchini PJ, 2001, ANNU REV PLANT PHYS, V52, P29, DOI 10.1146/annurev.arplant.52.1.29; Hagel JM, 2013, PLANT CELL PHYSIOL, V54, P647, DOI 10.1093/pcp/pct020; Hagel JM, 2012, J BIOL CHEM, V287, P42972, DOI 10.1074/jbc.M112.420414; Heinze M, 2015, PLANT CELL, V27, P448, DOI 10.1105/tpc.114.135343; Ikezawa N, 2009, PLANT CELL REP, V28, P123, DOI 10.1007/s00299-008-0624-8; Ikezawa N, 2007, FEBS J, V274, P1019, DOI 10.1111/j.1742-4658.2007.05652.x; Inui T, 2007, PLANT CELL PHYSIOL, V48, P252, DOI 10.1093/pcp/pcl062; Kato N, 2007, PLANT CELL PHYSIOL, V48, P8, DOI 10.1093/pcp/pcl041; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; LINSMAIER EM, 1965, PHYSIOL PLANTARUM, V18, P100, DOI 10.1111/j.1399-3054.1965.tb06874.x; Liscombe DK, 2007, J BIOL CHEM, V282, P14741, DOI 10.1074/jbc.M611908200; Mishra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052784; Purwanto R, 2017, PLANT CELL PHYSIOL, V58, P1528, DOI 10.1093/pcp/pcx093; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Sato F, 2013, BIOSCI BIOTECH BIOCH, V77, P1, DOI 10.1271/bbb.120759; Takemura T, 2013, PHYTOCHEMISTRY, V91, P100, DOI 10.1016/j.phytochem.2012.02.013; Takemura T, 2010, PLANT CELL PHYSIOL, V51, P949, DOI 10.1093/pcp/pcq063; Yamada Y, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01352; Yamada Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep31988; Yamada Y, 2015, PLANT CELL PHYSIOL, V56, P1019, DOI 10.1093/pcp/pcv027; Yamada Y, 2011, PLANT CELL PHYSIOL, V52, P1131, DOI 10.1093/pcp/pcr062; Zhou M, 2016, BIOTECHNOL ADV; Zhu XX, 2014, FRONT MED-PRC, V8, P285, DOI 10.1007/s11684-014-0350-2	33	10	14	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2017	12	10							e0186953	10.1371/journal.pone.0186953	http://dx.doi.org/10.1371/journal.pone.0186953			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FK9WD	29077729	Green Published, gold, Green Submitted			2022-12-26	WOS:000413861200029
J	Ahn, S; Choe, K; Lee, S; Kim, K; Song, E; Seo, H; Kim, I; Kim, P				Ahn, Soyeon; Choe, Kibaek; Lee, Seunghun; Kim, Kangsan; Song, Eunjoo; Seo, Howon; Kim, Injune; Kim, Pilhan			Intravital longitudinal wide-area imaging of dynamic bone marrow engraftment and multilineage differentiation through nuclear-cytoplasmic labeling	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; PROGENITOR CELLS; CONFOCAL MICROSCOPY; SELF-RENEWAL; MULTIPHOTON MICROSCOPY; FLUORESCENT PROTEINS; NICHE; TRANSPLANTATION; MOUSE; TRACKING	Bone marrow is a vital tissue that produces the majority of erythrocytes, thrombocytes, and immune cells. Bone marrow transplantation (BMT) has been widely performed in patients with blood disorders and cancers. However, the cellular-level behaviors of the transplanted bone marrow cells over wide-areas of the host bone marrow after the BMT are not fully understood yet. In this work, we performed a longitudinal wide-area cellular-level observation of the calvarial bone marrow after the BMT in vivo. Using a H2B-GFP/beta-actin-DsRed double-transgenic mouse model as a donor, a subcellular-level nuclear-cytoplasmic visualization of the transplanted bone marrow cells was achieved, which enabled a direct in vivo dynamic monitoring of the distribution and proliferation of the transplanted bone marrow cells. The same spots in the wide-area of the calvarial bone marrow were repeatedly identified using fluorescently labeled vasculature as a distinct landmark. It revealed various dynamic cellular-level behaviors of the transplanted BM cells in early stage such as cluster formation, migration, and active proliferation in vivo.	[Ahn, Soyeon; Choe, Kibaek; Song, Eunjoo; Seo, Howon; Kim, Pilhan] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, Daejeon, South Korea; [Ahn, Soyeon; Choe, Kibaek; Song, Eunjoo; Seo, Howon; Kim, Pilhan] Korea Adv Inst Sci & Technol, KIHST, Daejeon, South Korea; [Lee, Seunghun; Kim, Kangsan; Kim, Injune] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Kim, P (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, Daejeon, South Korea.; Kim, P (corresponding author), Korea Adv Inst Sci & Technol, KIHST, Daejeon, South Korea.	pilhan.kim@kaist.ac.kr	Lee, Tae-Hoon/AAR-3708-2021; Kim, Pilhan/C-1836-2011; Kim, Injune/C-1710-2011	Lee, Tae-Hoon/0000-0003-0105-1750; Kim, Pilhan/0000-0001-8388-1840; Kim, Injune/0000-0001-9244-815X; SONG, Eunjoo/0000-0003-3597-3593; Ahn, Soyeon/0000-0002-4955-523X	Global Frontier Project - Ministry of Science, ICT and Future Planning, Republic of Korea [NRF-2013M3A6A4044716]; Bio & Medical Technology Development Program - Ministry of Science, ICT and Future Planning, Republic of Korea [NRF-2017M3A9E4047243]; Korea Healthcare Technology R&D Project - Ministry of Health and Welfare, Republic of Korea [HI13C2181, HI15C0399]	Global Frontier Project - Ministry of Science, ICT and Future Planning, Republic of Korea; Bio & Medical Technology Development Program - Ministry of Science, ICT and Future Planning, Republic of Korea; Korea Healthcare Technology R&D Project - Ministry of Health and Welfare, Republic of Korea	This work was supported by the Global Frontier Project (NRF-2013M3A6A4044716) and the Bio & Medical Technology Development Program (NRF-2017M3A9E4047243) funded by the Ministry of Science, ICT and Future Planning, Republic of Korea and the Korea Healthcare Technology R&D Project (HI13C2181, HI15C0399) funded by Ministry of Health and Welfare, Republic of Korea.; Authors thank Yoonha Hwang, Jinhyo Ahn and Inwon Park at KAIST for their help on this project. This work was supported by the Global Frontier Project (NRF-2013M3A6A4044716) and the Bio & Medical Technology Development Program (NRF-2017M3A9E4047243) funded by the Ministry of Science, ICT and Future Planning, Republic of Korea and the Korea Healthcare Technology R&D Project funded by Ministry of Health and Welfare, Republic of Korea (HI13C2181, HI15C0399).	Ahn YC, 2014, BIOMED OPT EXPRESS, V5, P312, DOI 10.1364/BOE.5.000312; Appelbaum F, 2009, THOMAS HEMATOPOIETIC; Arber C, 2003, BLOOD, V102, P421, DOI 10.1182/blood-2002-12-3834; Askenasy N, 2003, BRIT J HAEMATOL, V120, P505, DOI 10.1046/j.1365-2141.2003.04114.x; BitMansour A, 2002, BLOOD, V100, P4660, DOI 10.1182/blood-2002-05-1552; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Carlson AL, 2013, PLOS ONE, V8; Choe K, 2015, J CLIN INVEST, V125, P4042, DOI 10.1172/JCI76509; Choe K, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.3.036005; Fuchs E, 2011, NAT CELL BIOL, V13, P513, DOI 10.1038/ncb0511-513; Fujisaki J, 2011, NATURE, V474, P216, DOI 10.1038/nature10160; Giebel B, 2008, CURR STEM CELL RES T, V3, P9, DOI 10.2174/157488808783489444; Hoffman RM, 2008, SENSORS-BASEL, V8, P1157, DOI 10.3390/s8021157; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Horan JT, 2008, J CLIN ONCOL, V26, P5797, DOI 10.1200/JCO.2007.13.5244; Hwang Y, 2014, OPT EXPRESS, V22, P11465, DOI 10.1364/OE.22.011465; Khurana M, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2965545; KING MA, 1979, J NUCL MED, V20, P1142; Kohler A, 2009, BLOOD, V114, P290, DOI 10.1182/blood-2008-12-195644; Kopp HG, 2005, PHYSIOLOGY, V20, P349, DOI 10.1152/physiol.00025.2005; Lo Celso C, 2011, NAT PROTOC, V6, P1, DOI 10.1038/nprot.2010.168; Lo Celso C, 2009, J BIOPHOTONICS, V2, P619, DOI 10.1002/jbio.200910072; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Luznik L, 2008, BIOL BLOOD MARROW TR, V14, P641, DOI 10.1016/j.bbmt.2008.03.005; Malide D, 2014, JOVE-J VIS EXP, DOI 10.3791/51669; Malide D, 2012, BLOOD, V120, pE105, DOI 10.1182/blood-2012-06-440636; Marques PE, 2015, NAT PROTOC, V10, P258, DOI 10.1038/nprot.2015.006; Rieger MA, 2008, CELLS TISSUES ORGANS, V188, P139, DOI 10.1159/000114540; Rompolas P, 2013, NATURE, V502, P513, DOI 10.1038/nature12602; Rompolas P, 2012, NATURE, V487, P496, DOI 10.1038/nature11218; Runnels JM, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3520571; Scott MK, 2014, JOVE-J VIS EXP, DOI 10.3791/51683; Seita J, 2010, WIRES SYST BIOL MED, V2, P640, DOI 10.1002/wsbm.86; Seo H, 2015, BIOMED OPT EXPRESS, V6, P2158, DOI 10.1364/BOE.6.002158; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Song E, 2015, BIOMED OPT EXPRESS, V6, P4154, DOI 10.1364/BOE.6.004154; Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034; Suarez-Alvarez B, 2012, ADV EXP MED BIOL, V741, P152, DOI 10.1007/978-1-4614-2098-9_11; Sugiyama N, 2012, BIOMED OPT EXPRESS, V3, P2175, DOI 10.1364/BOE.3.002175; Tamplin OJ, 2015, CELL, V160, P241, DOI 10.1016/j.cell.2014.12.032; Tang ZY, 2004, P NATL ACAD SCI USA, V101, P18012, DOI 10.1073/pnas.0408600102; Ting SB, 2012, BLOOD, V119, P2510, DOI 10.1182/blood-2011-11-393272; Turcotte R, 2014, BIOMED OPT EXPRESS, V5, P3578, DOI 10.1364/BOE.5.003578; Veilleux I, 2008, IEEE J SEL TOP QUANT, V14, P10, DOI 10.1109/JSTQE.2007.912751; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Wang LD, 2011, NAT REV MOL CELL BIO, V12, P643, DOI 10.1038/nrm3184; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Zhao YB, 2013, METHODS MOL BIOL, V1052, P57, DOI 10.1007/7651_2013_28	49	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2017	12	11							e0187660	10.1371/journal.pone.0187660	http://dx.doi.org/10.1371/journal.pone.0187660			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL6TA	29190775	Green Published, gold, Green Submitted			2022-12-26	WOS:000414377900036
J	Ahn, SH; Chun, SM; Park, C; Lee, JH; Lee, SW; Lee, TH				Ahn, Sun-Hee; Chun, Sung-Min; Park, Chungoo; Lee, Jong-Hee; Lee, Seok-Woo; Lee, Tae-Hoon			Transcriptome profiling analysis of senescent gingival fibroblasts in response to Fusobacterium nucleatum infection	PLOS ONE			English	Article							PORPHYROMONAS-GINGIVALIS; OXIDATIVE STRESS; GENE-EXPRESSION; CELLS; PATHWAYS; SEQUENCE; DISEASES; GROWTH	Periodontal disease is caused by dental plaque biofilms. Fusobacterium nucleatum is an important periodontal pathogen involved in the development of bacterial complexity in dental plaque biofilms. Human gingival fibroblasts (GFs) act as the first line of defense against oral microorganisms and locally orchestrate immune responses by triggering the production of reactive oxygen species and pro-inflammatory cytokines (IL-6 and IL-8). The frequency and severity of periodontal diseases is known to increase in elderly subjects. However, despite several studies exploring the effects of aging in periodontal disease, the underlying mechanisms through which aging affects the interaction between F. nucleatum and human GFs remain unclear. To identify genes affected by infection, aging, or both, we performed an RNA-Seq analysis using GFs isolated from a single healthy donor that were passaged for a short period of time (P4) 'young GFs' or for longer period of time (P22) 'old GFs', and infected or not with F. nucleatum. Comparing F. nucleatum-infected and uninfected GF (P4) cells the differentially expressed genes (DEGs) were involved in host defense mechanisms (i.e., immune responses and defense responses), whereas comparing F. nucleatum-infected and uninfected GF(P22) cells the DEGs were involved in cell maintenance (i.e., TGF-beta signaling, skeletal development). Most DEGs in F. nucleatum-infected GF(P22) cells were downregulated (85%) and were significantly associated with host defense responses such as inflammatory responses, when compared to the DEGs in F. nucleatum-infected GF (P4) cells. Five genes (GADD45b, KLF10, CSRNP1, ID1, and TM4SF1) were upregulated in response to F. nucleatum infection; however, this effect was only seen in GF(P22) cells. The genes identified here appear to interact with each other in a network associated with free radical scavenging, cell cycle, and cancer; therefore, they could be potential candidates involved in the aged GF's response to F. nucleatum infection. Further studies are needed to confirm these observations.	[Ahn, Sun-Hee; Lee, Tae-Hoon] Chonnam Natl Univ, Sch Dent, Med Res Ctr Biomineralizat Disorders, Dept Oral Biochem,Dent Sci Res Inst, Gwangju, South Korea; [Chun, Sung-Min; Park, Chungoo] Chonnam Natl Univ, Sch Biol Sci & Technol, Gwangju, South Korea; [Lee, Jong-Hee] World Inst Kimchi, Gwangju, South Korea; [Lee, Seok-Woo] Chonnam Natl Univ, Dent Sci Res Inst, Sch Dent, Dept Dent Educ & Periodontol, Gwangju, South Korea; [Lee, Tae-Hoon] Chonnam Natl Univ, Grad Sch, Dept Mol Med BK21plus, Gwangju, South Korea	Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University	Lee, TH (corresponding author), Chonnam Natl Univ, Sch Dent, Med Res Ctr Biomineralizat Disorders, Dept Oral Biochem,Dent Sci Res Inst, Gwangju, South Korea.; Lee, TH (corresponding author), Chonnam Natl Univ, Grad Sch, Dept Mol Med BK21plus, Gwangju, South Korea.	thlee83@jnu.ac.kr	Lee, Tae-Hoon/AAR-3708-2021; Kim, Pilhan/C-1836-2011; Kim, Injune/C-1710-2011	Lee, Tae-Hoon/0000-0003-0105-1750; Kim, Pilhan/0000-0001-8388-1840; Kim, Injune/0000-0001-9244-815X; SONG, Eunjoo/0000-0003-3597-3593; Ahn, Soyeon/0000-0002-4955-523X	National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning [2016M3A9B6903087, 2017R1A2B2005938]; NRF - Ministry of Education [2016R1A6A3A11932468]; World Institute of Kimchi [KE1701-2]	National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning; NRF - Ministry of Education; World Institute of Kimchi	This work was supported by the Bio & Medical Technology Development Program (2016M3A9B6903087) and the Basic Science Research Program (2017R1A2B2005938) of the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning. Sun Hee Ahn was supported by the Basic Science Research Program (2016R1A6A3A11932468) through the NRF funded by the Ministry of Education and The grant from the World Institute of Kimchi (KE1701-2) to Dr. Jong-Hee Lee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SH, 2016, MOL ORAL MICROBIOL; Ahn SH, 2016, ARCH MICROBIOL, V198, P573, DOI 10.1007/s00203-016-1223-7; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; BIRKEDALHANSEN H, 1993, J PERIODONTOL, V64, P474, DOI 10.1902/jop.1993.64.5s.474; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Bruno VM, 2010, GENOME RES, V20, P1451, DOI 10.1101/gr.109553.110; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Cao ZX, 2009, J BIOL CHEM, V284, P24914, DOI 10.1074/jbc.M109.000059; Cekici A, 2014, PERIODONTOL 2000, V64, P57, DOI 10.1111/prd.12002; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Chen Z, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.300; Davanian H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046440; Diaz PI, 2002, MICROBIOL-SGM, V148, P467, DOI 10.1099/00221287-148-2-467; Domon H, 2014, J PERIODONTAL RES, V49, P536, DOI 10.1111/jre.12134; Eftang LL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-9; Gavazzi G, 2004, CLIN INFECT DIS, V39, P83, DOI 10.1086/421559; Gavazzi G, 2002, LANCET INFECT DIS, V2, P659, DOI 10.1016/S1473-3099(02)00437-1; Gomes P, 2009, OXID MED CELL LONGEV, V2, P138, DOI 10.4161/oxim.2.3.8819; Gonzalez OA, 2014, J CLIN PERIODONTOL, V41, P327, DOI 10.1111/jcpe.12212; Guo W, 2013, INT J CANCER, V133, P2043, DOI 10.1002/ijc.28223; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; Hajishengallis G, 2010, MOL ORAL MICROBIOL, V25, P25, DOI 10.1111/j.2041-1014.2009.00562.x; Handfield M, 2008, J DENT RES, V87, P203, DOI 10.1177/154405910808700302; Hansen KD, 2011, NAT BIOTECHNOL, V29, P572, DOI 10.1038/nbt.1910; Harrison DE, 2014, IMMUN AGEING, V11, DOI 10.1186/s12979-014-0024-6; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; He Y, 2010, ADV EXP MED BIOL, V664, P165, DOI 10.1007/978-1-4419-1399-9_20; Humphrys MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080597; Kang CI, 2011, INT J INFECT DIS, V15, pE58, DOI 10.1016/j.ijid.2010.09.012; Kim SS, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0164800, 10.1371/journal.pone.0147745]; Kolenbrander PE, 2000, ANNU REV MICROBIOL, V54, P413, DOI 10.1146/annurev.micro.54.1.413; Krustrup U, 2006, ACTA ODONTOL SCAND, V64, P65, DOI 10.1080/00016350500377859; Liu B, 2009, NEUROBIOL DIS, V33, P104, DOI 10.1016/j.nbd.2008.09.020; Liu YC, 2013, BIOINFORMATICS, V29, P308, DOI [10.1093/bioinformatics/btt688, 10.1093/bioinformatics/bts690]; Meyer Keith C, 2005, Proc Am Thorac Soc, V2, P433, DOI 10.1513/pats.200508-081JS; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Naito Y, 2005, DIGESTION, V72, P164, DOI 10.1159/000088396; Naylor RM, 2013, CLIN PHARMACOL THER, V93, P105, DOI 10.1038/clpt.2012.193; Oshlack A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-220; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pechenino AS, 2006, PROSTATE, V66, P522, DOI 10.1002/pros.20364; Rajendran Maheaswari, 2013, J Indian Soc Periodontol, V17, P169, DOI 10.4103/0972-124X.113064; Shaik-Dasthagirisaheb Yazdani B, 2010, Immun Ageing, V7, P15, DOI 10.1186/1742-4933-7-15; SHARMA SA, 1995, INFECT IMMUN, V63, P1681, DOI 10.1128/IAI.63.5.1681-1687.1995; Sharma-Kuinkel BK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060463; Sharpless NE, 2004, J CLIN INVEST, V113, P160, DOI 10.1172/JCI200420761; Signat B, 2011, CURR ISSUES MOL BIOL, V13, P25; Sikder HA, 2003, CANCER CELL, V3, P525, DOI 10.1016/S1535-6108(03)00141-7; Subramaniam M, 1995, NUCLEIC ACIDS RES, V23, P4907, DOI 10.1093/nar/23.23.4907; Subramaniam M, 2005, MOL CELL BIOL, V25, P1191, DOI 10.1128/MCB.25.3.1191-1199.2005; Swarbrick A, 2008, P NATL ACAD SCI USA, V105, P5402, DOI 10.1073/pnas.0801505105; Tal S, 2005, J INFECTION, V50, P296, DOI 10.1016/j.jinf.2004.04.004; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; van Winkelhoff AJ, 2002, J CLIN PERIODONTOL, V29, P1023, DOI 10.1034/j.1600-051X.2002.291107.x; Yoshikawa TT, 2000, CLIN INFECT DIS, V30, P931, DOI 10.1086/313792; YOSHIKAWA TT, 1984, GERONTOLOGY, V30, P275, DOI 10.1159/000212646; Zhan YB, 2014, J PERIODONTOL, V85, P1059, DOI 10.1902/jop.2014.130523; Zhang HQ, 2015, FREE RADICAL BIO MED, V88, P314, DOI 10.1016/j.freeradbiomed.2015.05.036	59	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2017	12	11							e0188755	10.1371/journal.pone.0188755	http://dx.doi.org/10.1371/journal.pone.0188755			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FO4UI	29190775	Green Published, Green Submitted, gold			2022-12-26	WOS:000416841900118
